Citrus Sinensis ID: 036879
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1029 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.878 | 0.895 | 0.375 | 1e-158 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.981 | 0.861 | 0.342 | 1e-149 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.892 | 0.890 | 0.346 | 1e-149 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.884 | 0.887 | 0.376 | 1e-147 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.919 | 0.757 | 0.332 | 1e-136 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.908 | 0.746 | 0.325 | 1e-130 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.943 | 0.881 | 0.336 | 1e-128 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.937 | 0.809 | 0.317 | 1e-125 | |
| Q9SSL9 | 1123 | Leucine-rich repeat recep | no | no | 0.935 | 0.857 | 0.321 | 1e-124 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.921 | 0.830 | 0.318 | 1e-124 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 561 bits (1445), Expect = e-158, Method: Compositional matrix adjust.
Identities = 370/985 (37%), Positives = 543/985 (55%), Gaps = 81/985 (8%)
Query: 97 RLKYLSFRS--NNFSSIEIPPWLDSFP--------------KLEHLYLDGNSFIGTIPPS 140
R L F+S + + + W SFP ++ HL L G I PS
Sbjct: 26 RQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVISPS 85
Query: 141 ICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMP-SIYNTSPLQNIDM 199
I N+S L++LDL N G +P + + L +D+ N GP+P +YN S L N
Sbjct: 86 IGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLN--- 142
Query: 200 QYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVY 259
L L N+L G +PS L L L+L NN G +P +GN+T+L+ L L +
Sbjct: 143 -------LRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSH 195
Query: 260 TNLTGEI-----QGLQV--LALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIG 312
NL GEI Q Q+ L L +N +GV PP + N+SSL +L + N+ G L ++G
Sbjct: 196 NNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLG 255
Query: 313 HSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIP--------------- 357
LPNL +GGN TG IP+++SN S L + M N +G IP
Sbjct: 256 ILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPTFGNVPNLKLLFLHT 315
Query: 358 NSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIK 417
NSLG D L FLTSLTNC L L + N L G LPISI NLS + L L I
Sbjct: 316 NSLGSDSSRD-LEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLIS 374
Query: 418 GSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRS 477
GSIP +IGNL NL L L+ N L+G +P ++G+L L+ L L N+L G I + +
Sbjct: 375 GSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTM 434
Query: 478 LSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLN 537
L N G +P L + L L +G N+L IP + ++ +L +++S NSL
Sbjct: 435 LETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLI 494
Query: 538 GTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTS 597
G+LP +IG L+ + + L N LSG++P ++G+ M+ L L N F G IPD L GL
Sbjct: 495 GSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGLVG 553
Query: 598 LNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLC 657
+ +D+S+N+LSG IP + S L++LNLSFN L+G+VP G F N ++ S VGN LC
Sbjct: 554 VKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLC 613
Query: 658 GA-PELKFPACKAKSNKIARKTDKNIFIYVFPIAASILLVL-----SLSVVLIRRQKRNT 711
G + C +++ + +K + V ++ I L+L S++++ +R++K+N
Sbjct: 614 GGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNK 673
Query: 712 GLQIDEEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKG-TLSDGMQIAVKVF 770
+ EV +ISY +L AT+GFS +N++G GSFG+VYK L++ +AVKV
Sbjct: 674 ETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVL 733
Query: 771 NLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS-----DHFKALVLEYMPNGSLENWM 825
N++ G ++SF AECE L IRHRNLVK+++ CSS + F+AL+ E+MPNGSL+ W+
Sbjct: 734 NMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWL 793
Query: 826 YNK--------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVA 877
+ + +R+ +L+RLN+ IDVAS L+YLH PI HCDL PSN+LL++ + A
Sbjct: 794 HPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTA 853
Query: 878 CLSDFGISKLL--GDETS----MTQTQTLATIGYMAPEWKL----SRKGDVYSYGIILME 927
+SDFG+++LL DE S ++ TIGY APE+ + S GDVYS+GI+L+E
Sbjct: 854 HVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLE 913
Query: 928 TFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLA 987
FT K+PT+ELF G +L S +L +I+++VD ++L +C++ V +
Sbjct: 914 MFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVG 973
Query: 988 MQCTRESAEERINIKEALTKLLKIR 1012
++C ES R+ + +L+ IR
Sbjct: 974 LRCCEESPMNRLATSIVVKELISIR 998
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 528 bits (1361), Expect = e-149, Method: Compositional matrix adjust.
Identities = 393/1147 (34%), Positives = 599/1147 (52%), Gaps = 137/1147 (11%)
Query: 9 ALLALKAHVTNDPLNVLASNWSTNTSV--CNWFGVTCSPRHRRVTALNLAYMGLLGTIPP 66
AL + K ++NDPL VL S+W+ S+ CNW G+TC V +++L L G + P
Sbjct: 33 ALKSFKNGISNDPLGVL-SDWTIIGSLRHCNWTGITCDSTGH-VVSVSLLEKQLEGVLSP 90
Query: 67 ELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHL 126
+ NL++L +L++T+NSF+G +P ++ L L L N FS IP + + +L
Sbjct: 91 AIANLTYLQVLDLTSNSFTGKIPAEIGKLTELNQLILYLNYFSG-SIPSGIWELKNIFYL 149
Query: 127 YLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPS----------------------- 163
L N G +P IC SSL+ + +N L G +P
Sbjct: 150 DLRNNLLSGDVPEEICKTSSLVLIGFDYNNLTGKIPECLGDLVHLQMFVAAGNHLTGSIP 209
Query: 164 -SILNIPSLLAIDLSNNQFSGPMPSIY-NTSPLQNIDMQYN--------------SLAEL 207
SI + +L +DLS NQ +G +P + N LQ++ + N SL +L
Sbjct: 210 VSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQL 269
Query: 208 HLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEI- 266
L NQL+G+IP+ L QL+ L + N SIP + +T L L L +L G I
Sbjct: 270 ELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPIS 329
Query: 267 ------QGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQ 320
+ L+VL L SN TG P I N+ +LTVL++ NN+ G LP+++G L NL+
Sbjct: 330 EEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL-LTNLRN 388
Query: 321 LILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPN----------SLGFCHPYDELG 370
L N LTGPIPSSISN + L L+D+ +N +G IP S+G H E+
Sbjct: 389 LSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFISIGRNHFTGEIP 448
Query: 371 FLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNL 430
+ NC +L L +++N L+G L IG L + +L +S ++ G IP EIGNL +L
Sbjct: 449 --DDIFNCSNLETLSVADNNLTGTLKPLIGKL-QKLRILQVSYNSLTGPIPREIGNLKDL 505
Query: 431 TTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLR-------------- 476
L+L +N TG IP+ + L LQGL + N L+G I ++ ++
Sbjct: 506 NILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSG 565
Query: 477 ----------SLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLW-SLRD 525
SL+ GN+ NGS+P L SL L T + N LT IP L SL++
Sbjct: 566 QIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKN 625
Query: 526 I-LNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKN----------- 573
+ L +N S+N L GT+P E+G L++V +IDLS N SG IP S+ KN
Sbjct: 626 MQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNL 685
Query: 574 --------------MQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKAL 619
+ L+L+ N F G IP S G +T L LD+SSNNL+GEIP SL L
Sbjct: 686 SGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANL 745
Query: 620 SLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPE-LKFPACKAKSNKIARKT 678
S LK L L+ N L+G VP G F N+++ +GN LCG+ + LK K KS+ +++T
Sbjct: 746 STLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRT 805
Query: 679 DKNIFIY---VFPIAASILLVLSLSVVLIRRQKRNTGLQIDEEMSPEVTWRRISYQELFR 735
+ I + +L+++ ++ N+ ++ + +R +EL +
Sbjct: 806 RVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQ 865
Query: 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRS---FDAECEILGSIR 792
ATD F+ N++G S +VYKG L DG IAVKV NL+ E + S F E + L ++
Sbjct: 866 ATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLK-EFSAESDKWFYTEAKTLSQLK 924
Query: 793 HRNLVKIIS-TCSSDHFKALVLEYMPNGSLENWMYNKNRSF-DILQRLNMVIDVASALEY 850
HRNLVKI+ S KALVL +M NG+LE+ ++ +L+++++ + +AS ++Y
Sbjct: 925 HRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDY 984
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG---DETSMTQTQTL-ATIGYM 906
LH + PI+HCDL P+NILL+ VA +SDFG +++LG D ++ T TIGY+
Sbjct: 985 LHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYL 1044
Query: 907 APEW----KLSRKGDVYSYGIILMETFTKKKPT--DELFVGEISLKSRVNDSLHGKIINV 960
APE+ K++ K DV+S+GII+ME TK++PT ++ +++L+ V S+ +
Sbjct: 1045 APEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGM 1104
Query: 961 VDINLLQKEDAYLTAK-EQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNI 1019
V + ++ D+ ++ K E+ + L L + CT E+R ++ E LT L+K+R +
Sbjct: 1105 VRVLDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLRGKANSFR 1164
Query: 1020 ENSSDKR 1026
E+ ++ R
Sbjct: 1165 EDRNEDR 1171
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 528 bits (1361), Expect = e-149, Method: Compositional matrix adjust.
Identities = 370/1068 (34%), Positives = 546/1068 (51%), Gaps = 150/1068 (14%)
Query: 6 DQSALLALKAHVT-NDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTI 64
D ALL K+ V+ N+ VLAS W+ ++ CNW GVTC R RV +LNL L
Sbjct: 31 DMQALLEFKSQVSENNKREVLAS-WNHSSPFCNWIGVTCGRRRERVISLNLGGFKL---- 85
Query: 65 PPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLE 124
+G + + NL L+ L+ N+F S
Sbjct: 86 --------------------TGVISPSIGNLSFLRLLNLADNSFGS-------------- 111
Query: 125 HLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGP 184
TIP + + L L++S+N L+G +PSS+ N L +DLS+N
Sbjct: 112 -----------TIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLSTVDLSSN----- 155
Query: 185 MPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPR 244
HL + +PS L +L IL LS NN G+ P
Sbjct: 156 -----------------------HLGHG-----VPSELGSLSKLAILDLSKNNLTGNFPA 187
Query: 245 EIGNITMLKGLYLVYTNLTGEI-------QGLQVLALSSNRLTGVIPPEIINISSLTVLS 297
+GN+T L+ L Y + GEI + ++ N +G PP + NISSL LS
Sbjct: 188 SLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLS 247
Query: 298 LTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIP 357
L N+ GNL ++ G+ LPNL++L+LG N+ TG IP +++N S L D+ N SG IP
Sbjct: 248 LADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIP 307
Query: 358 NSLGFCHPYDELG---------------FLTSLTNCKDLRKLILSENPLSGVLPISIGNL 402
S G LG F+ ++ NC L L + N L G LP SI NL
Sbjct: 308 LSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANL 367
Query: 403 SNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHN 462
S + L+L I G+IP +IGNL +L L LETN L+G +P + G+L LQ + L N
Sbjct: 368 STTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSN 427
Query: 463 KLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWS 522
+ G I + + L + + + N +G +PQ L L L + NRL IP +
Sbjct: 428 AISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQ 487
Query: 523 LRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADN 582
+ + ++LS+N L G P E+G L+++ + S N LSG++P +IG +M+ L + N
Sbjct: 488 IPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGN 547
Query: 583 KFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPF 642
F G+IPD + L SL +D S+NNLSG IP L +L L+ LNLS N +G+VP G F
Sbjct: 548 SFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVF 606
Query: 643 TNLSSQSFVGNKGLCGA-PELKFPACKAKSNKIARK---TDKNIFIYVFPIAASILLVLS 698
N ++ S GN +CG E++ C +++ RK K + + AS+LL++
Sbjct: 607 RNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIII 666
Query: 699 LSVV--LIRRQKRNTGLQIDEEMSPEVTW--RRISYQELFRATDGFSENNLLGKGSFGSV 754
++ + ++R+K+N + S + ++SY+EL AT FS NL+G G+FG+V
Sbjct: 667 VASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNV 726
Query: 755 YKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS-----DHF 808
+KG L + +AVKV NL G +SF AECE IRHRNLVK+I+ CSS + F
Sbjct: 727 FKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDF 786
Query: 809 KALVLEYMPNGSLENWMY--------NKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
+ALV E+MP GSL+ W+ + +RS ++LN+ IDVASALEYLH P+
Sbjct: 787 RALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVA 846
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLL---GDETSMTQTQTL---ATIGYMAPEWKL-- 912
HCD+ PSNILL++ + A +SDFG+++LL E+ + Q + TIGY APE+ +
Sbjct: 847 HCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGG 906
Query: 913 --SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970
S +GDVYS+GI+L+E F+ KKPTDE F G+ +L S L G
Sbjct: 907 QPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILSG-----------CTSS 955
Query: 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTN 1018
A ++ + VL + ++C+ E +R+ EA+ +L+ IR+ ++
Sbjct: 956 GGSNAIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSS 1003
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 523 bits (1347), Expect = e-147, Method: Compositional matrix adjust.
Identities = 373/990 (37%), Positives = 535/990 (54%), Gaps = 80/990 (8%)
Query: 101 LSFRS--NNFSSIEIPPWLDSFP---------KLEH-----LYLDGNSFIGTIPPSICNI 144
L F+S + S + + W DS P L+H + L G G + P + N+
Sbjct: 45 LEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVSPFVGNL 104
Query: 145 SSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSL 204
S L +L+L+ N G +PS + N+ L +++SNN F G +P + + +SL
Sbjct: 105 SFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNC---------SSL 155
Query: 205 AELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTG 264
+ L L+ N L +P +L +LSL NN G P +GN+T L+ L +Y + G
Sbjct: 156 STLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEG 215
Query: 265 EIQG-------LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPN 317
EI G + ++ N+ GV PP I N+SSL LS+T N+ G L + G LPN
Sbjct: 216 EIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPN 275
Query: 318 LQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLG---------------F 362
LQ L +G N TG IP ++SN S L +D+P N +G IP S G
Sbjct: 276 LQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLG 335
Query: 363 CHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPS 422
+ +L FL +LTNC L+ L + N L G LP+ I NLS + L L I GSIP
Sbjct: 336 NYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPH 395
Query: 423 EIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFY 482
IGNL +L TL L N LTG +P ++G L +L+ + L N L G I + L + L+ Y
Sbjct: 396 GIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLY 455
Query: 483 SDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPV 542
N GS+P L S L L+LG N+L IP L L ++ +N+S N L G L
Sbjct: 456 LLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQ 515
Query: 543 EIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLD 602
+IG LK + +D+S N LSG+IP ++ + +++ L L N F G IPD + GLT L FLD
Sbjct: 516 DIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLTGLRFLD 574
Query: 603 MSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGA-PE 661
+S NNLSG IP + S L+ LNLS N G VP G F N S+ S GN LCG P
Sbjct: 575 LSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPS 634
Query: 662 LKFPACKAKSNKIARKTDKNIFIYVFPIAASILLVLSLSVVLIRRQKRNTGLQI-----D 716
L+ C + + K I I V + A++LL+ V L + R ++ D
Sbjct: 635 LQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNEND 694
Query: 717 EEMSP-EVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLEL 774
SP + + +ISY EL++ T GFS +NL+G G+FG+V+KG L S +A+KV NL
Sbjct: 695 RSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCK 754
Query: 775 EGTLRSFDAECEILGSIRHRNLVKIISTCSS-----DHFKALVLEYMPNGSLENWMY--- 826
G +SF AECE LG IRHRNLVK+++ CSS + F+ALV E+MPNG+L+ W++
Sbjct: 755 RGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDE 814
Query: 827 -----NKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSD 881
N +R+ + RLN+ IDVASAL YLH PI HCD+ PSNILL++ + A +SD
Sbjct: 815 IEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSD 874
Query: 882 FGISKLLGD------ETSMTQTQTLATIGYMAPEWKL----SRKGDVYSYGIILMETFTK 931
FG+++LL + TIGY APE+ + S GDVYS+GI+L+E FT
Sbjct: 875 FGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTG 934
Query: 932 KKPTDELFVGEISLKSRVNDSLHGK-IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQC 990
K+PT++LFV ++L S +L + +++ D +L+ A +C++ V + + C
Sbjct: 935 KRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSC 994
Query: 991 TRESAEERINIKEALTKLLKIRNTLLTNIE 1020
+ ES RI++ EA++KL+ IR + + E
Sbjct: 995 SEESPVNRISMAEAISKLVSIRESFFRDEE 1024
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 487 bits (1254), Expect = e-136, Method: Compositional matrix adjust.
Identities = 357/1074 (33%), Positives = 546/1074 (50%), Gaps = 128/1074 (11%)
Query: 46 RHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRS 105
R RV +L L L G IP ELGN S L++ N +GT+P +L L L+ L+ +
Sbjct: 189 RLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLAN 248
Query: 106 NNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSI 165
N+ + EIP L +L++L L N G IP S+ ++ +L TLDLS N L G +P
Sbjct: 249 NSLTG-EIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEF 307
Query: 166 LNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFEC 225
N+ LL + L+NN SG +P ++I +L +L L+ QLSG+IP L +C
Sbjct: 308 WNMSQLLDLVLANNHLSGSLP--------KSICSNNTNLEQLVLSGTQLSGEIPVELSKC 359
Query: 226 KQLKILSLSVNNFIGSIPR------------------------EIGNITMLKGLYLVYTN 261
+ LK L LS N+ GSIP I N+T L+ L L + N
Sbjct: 360 QSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNN 419
Query: 262 LTGEI-------QGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHS 314
L G++ + L+VL L NR +G IP EI N +SL ++ + N+ G +P +IG
Sbjct: 420 LEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGR- 478
Query: 315 LPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLT- 373
L L L L N L G +P+S+ N L ++D+ N SG IP+S GF ++L
Sbjct: 479 LKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNN 538
Query: 374 --------SLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACN--IKGSIPSE 423
SL + ++L ++ LS N L+G +I L + L N + IP E
Sbjct: 539 SLQGNLPDSLISLRNLTRINLSHNRLNG----TIHPLCGSSSYLSFDVTNNGFEDEIPLE 594
Query: 424 IGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYS 483
+GN NL L L N+LTG IP +G++++L L + N L G+I L + L+
Sbjct: 595 LGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDL 654
Query: 484 DGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVE 543
+ N L+G +P L L L L L N+ +P+ L++ +L ++L NSLNG++P E
Sbjct: 655 NNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQE 714
Query: 544 IGNLKVVT------------------------KIDLSRNDLSGEIPSSIGDLKNMQH-LS 578
IGNL + ++ LSRN L+GEIP IG L+++Q L
Sbjct: 715 IGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALD 774
Query: 579 LADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH 638
L+ N F G IP ++G L+ L LD+S N L+GE+P S+ + L +LN+SFN L G++
Sbjct: 775 LSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK 834
Query: 639 GGPFTNLSSQSFVGNKGLCGAPELKFPAC-KAKSNKIARKTDKNIFIYVFPIAA-SILLV 696
F+ + SF+GN GLCG+P C + +SN + + + I+A + + +
Sbjct: 835 --QFSRWPADSFLGNTGLCGSP---LSRCNRVRSNNKQQGLSARSVVIISAISALTAIGL 889
Query: 697 LSLSVVLIRRQKRN------------TGLQIDEEMSPEVTWRR------ISYQELFRATD 738
+ L + L +Q+ + T + + + +R I ++++ AT
Sbjct: 890 MILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATH 949
Query: 739 GFSENNLLGKGSFGSVYKGTLSDGMQIAVK--VFNLELEGTLRSFDAECEILGSIRHRNL 796
SE ++G G G VYK L +G +AVK ++ +L +SF E + LG IRHR+L
Sbjct: 950 NLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSN-KSFSREVKTLGRIRHRHL 1008
Query: 797 VKIISTCS--SDHFKALVLEYMPNGSLENWMY-------NKNRSFDILQRLNMVIDVASA 847
VK++ CS S+ L+ EYM NGS+ +W++ K + D RL + + +A
Sbjct: 1009 VKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQG 1068
Query: 848 LEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG---DETSMTQTQTLATIG 904
+EYLH+D PI+H D+ SN+LL+ +M A L DFG++K+L D + + T + G
Sbjct: 1069 VEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYG 1128
Query: 905 YMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960
Y+APE+ K + K DVYS GI+LME T K PTD +F E+ + V H ++
Sbjct: 1129 YIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVET--HLEVAGS 1186
Query: 961 VDINLLQ-KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013
L+ K L +E VL +A+QCT+ S +ER + ++A LL + N
Sbjct: 1187 ARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSLLHVYN 1240
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 466 bits (1198), Expect = e-130, Method: Compositional matrix adjust.
Identities = 343/1053 (32%), Positives = 536/1053 (50%), Gaps = 118/1053 (11%)
Query: 60 LLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDS 119
L G IP E+GN + L+L N +G+LP +L+ L+ L+ L+ N+FS EIP L
Sbjct: 204 LEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSG-EIPSQLGD 262
Query: 120 FPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNN 179
+++L L GN G IP + +++L TLDLS N L G + + L + L+ N
Sbjct: 263 LVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKN 322
Query: 180 QFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFI 239
+ SG +P + I SL +L L+ QLSG+IP+ + C+ LK+L LS N
Sbjct: 323 RLSGSLP--------KTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLT 374
Query: 240 GSIP------------------------REIGNITMLKGLYLVYTNLTGEI-------QG 268
G IP I N+T L+ L + NL G++
Sbjct: 375 GQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGK 434
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
L+++ L NR +G +P EI N + L + N L G +PS+IG L +L +L L N L
Sbjct: 435 LEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGR-LKDLTRLHLRENEL 493
Query: 329 TGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYD---------ELGFLTSLTNCK 379
G IP+S+ N +T+ID+ N SG IP+S GF + + SL N K
Sbjct: 494 VGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLK 553
Query: 380 DLRKLILSENPLSGVLPISIGNLSN-AMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETN 438
+L ++ S N +G + G+ S + DV + +G IP E+G NL L L N
Sbjct: 554 NLTRINFSSNKFNGSISPLCGSSSYLSFDV---TENGFEGDIPLELGKSTNLDRLRLGKN 610
Query: 439 ELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDS 498
+ TG IP+ G++ +L L + N L G I +L + L+ + N L+G +P L
Sbjct: 611 QFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGK 670
Query: 499 LISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKID---- 554
L L L L N+ +P+ ++SL +IL + L NSLNG++P EIGNL+ + ++
Sbjct: 671 LPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEEN 730
Query: 555 --------------------LSRNDLSGEIPSSIGDLKNMQH-LSLADNKFQGSIPDSLG 593
LSRN L+GEIP IG L+++Q L L+ N F G IP ++
Sbjct: 731 QLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTIS 790
Query: 594 GLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGN 653
L L LD+S N L GE+P + + L +LNLS+N L+G++ F+ + +FVGN
Sbjct: 791 TLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQADAFVGN 848
Query: 654 KGLCGAPELKFPACKAKSNKIARKTDKNIFIYVFPIAA-SILLVLSLSVVLIRRQKRNTG 712
GLCG+P C +K R + + I++ + + ++ L ++L +Q +
Sbjct: 849 AGLCGSP---LSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLF 905
Query: 713 LQID-----------EEMSPEVT----WRRISYQELFRATDGFSENNLLGKGSFGSVYKG 757
++ +P + I + ++ AT +E ++G G G VYK
Sbjct: 906 KKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKA 965
Query: 758 TLSDGMQIAVK--VFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS--DHFKALVL 813
L +G IAVK ++ +L +SF+ E + LG+IRHR+LVK++ CSS D L+
Sbjct: 966 ELKNGETIAVKKILWKDDLMSN-KSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIY 1024
Query: 814 EYMPNGSLENWMY-NKN-RSFDIL---QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSN 868
EYM NGS+ +W++ N+N + ++L RL + + +A +EYLHYD PI+H D+ SN
Sbjct: 1025 EYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSN 1084
Query: 869 ILLNESMVACLSDFGISKLL-GDETSMTQTQTL--ATIGYMAPEW----KLSRKGDVYSY 921
+LL+ ++ A L DFG++K+L G+ + T++ T+ + GY+APE+ K + K DVYS
Sbjct: 1085 VLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSM 1144
Query: 922 GIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE-DAYLTAKEQCV 980
GI+LME T K PT+ +F E + V L + L+ E + L +E+
Sbjct: 1145 GIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAA 1204
Query: 981 SSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013
VL +A+QCT+ +ER + ++A LL + N
Sbjct: 1205 YQVLEIALQCTKSYPQERPSSRQASEYLLNVFN 1237
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 460 bits (1183), Expect = e-128, Method: Compositional matrix adjust.
Identities = 363/1080 (33%), Positives = 522/1080 (48%), Gaps = 109/1080 (10%)
Query: 9 ALLALKAHVTNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPEL 68
LL KA + ND LAS +++ CNW G+ C+ R VT+++L M L GT+ P +
Sbjct: 30 VLLEFKAFL-NDSNGYLASWNQLDSNPCNWTGIACT-HLRTVTSVDLNGMNLSGTLSPLI 87
Query: 69 GNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYL 128
L L LNV+ N SG +P LS R L+ L +N F + IP L L+ LYL
Sbjct: 88 CKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGV-IPIQLTMIITLKKLYL 146
Query: 129 DGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPS- 187
N G+IP I N+SSL L + N L G +P S+ + L I N FSG +PS
Sbjct: 147 CENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSE 206
Query: 188 IYNTSPLQNIDMQYN--------------SLAELHLAYNQLSGQIPSTLFECKQLKILSL 233
I L+ + + N +L +L L N+LSG+IP ++ +L++L+L
Sbjct: 207 ISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLAL 266
Query: 234 SVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQ-------GLQVLALSSNRLTGVIPPE 286
N F GSIPREIG +T +K LYL LTGEI + S N+LTG IP E
Sbjct: 267 HENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKE 326
Query: 287 IINISSLTVLSLTANNLLGNLPSNIG-----------------------HSLPNLQQLIL 323
+I +L +L L N LLG +P +G LP L L L
Sbjct: 327 FGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQL 386
Query: 324 GGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLT---------- 373
N+L G IP I S +++DM N SG IP FC + L L+
Sbjct: 387 FDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAH--FCR-FQTLILLSLGSNKLSGNI 443
Query: 374 --SLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLT 431
L CK L KL+L +N L+G LPI + NL N + L L + G+I +++G L NL
Sbjct: 444 PRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQN-LTALELHQNWLSGNISADLGKLKNLE 502
Query: 432 TLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGS 491
L L N TG IP IG L K+ G + N+L G I +L ++ GN+ +G
Sbjct: 503 RLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGY 562
Query: 492 LPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVT 551
+ Q L L+ L L L NRLT IP S L ++ + L N L+ +PVE+G L T
Sbjct: 563 IAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKL---T 619
Query: 552 KIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGE 611
+ +S L+++ N G+IPDSLG L L L ++ N LSGE
Sbjct: 620 SLQIS--------------------LNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGE 659
Query: 612 IPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPELK----FPAC 667
IP S+ L L N+S N L G VP F + S +F GN GLC + P
Sbjct: 660 IPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHS 719
Query: 668 KAKSNKIARKTDKNIFIYVFPIA-ASILLVLSLSVVLIRRQKRNTGLQIDEEMSPEVT-- 724
+K N + + + + + I S+ L+ L + +++ + ++++ P+V
Sbjct: 720 DSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDS 779
Query: 725 ----WRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEG--TL 778
+ +YQ L AT FSE+ +LG+G+ G+VYK +S G IAVK N EG +
Sbjct: 780 YYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSD 839
Query: 779 RSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMY--NKNRSFDILQ 836
SF AE LG IRHRN+VK+ C + L+ EYM GSL + KN D
Sbjct: 840 NSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNA 899
Query: 837 RLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896
R + + A L YLH+D I+H D+ +NILL+E A + DFG++KL+ S +
Sbjct: 900 RYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSM 959
Query: 897 TQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS 952
+ + GY+APE+ K++ K D+YS+G++L+E T K P L G L + V S
Sbjct: 960 SAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG-DLVNWVRRS 1018
Query: 953 LHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012
+ I + + + T E +S VL +A+ CT S R ++E + + + R
Sbjct: 1019 IRNMIPTIEMFDARLDTNDKRTVHE--MSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1159), Expect = e-125, Method: Compositional matrix adjust.
Identities = 365/1149 (31%), Positives = 534/1149 (46%), Gaps = 184/1149 (16%)
Query: 36 CNWFGVTC------------------SPRH----RRVTALNLAYMGLLGTIPPELGNLSF 73
C+W GVTC P+ + + L LA G IPPE+ NL
Sbjct: 55 CDWVGVTCLLGRVNSLSLPSLSLRGQIPKEISSLKNLRELCLAGNQFSGKIPPEIWNLKH 114
Query: 74 LSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSF 133
L L+++ NS +G LP LS L +L YL N+FS P + S P L L + NS
Sbjct: 115 LQTLDLSGNSLTGLLPRLLSELPQLLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNNSL 174
Query: 134 IGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMP-SIYNTS 192
G IPP I +S+L L + N G +PS I NI L + F+GP+P I
Sbjct: 175 SGEIPPEIGKLSNLSNLYMGLNSFSGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKLK 234
Query: 193 PLQNIDMQYN--------SLAELH------LAYNQLSGQIPSTLFECKQLKILSLSVNNF 238
L +D+ YN S ELH L +L G IP L CK LK L LS N+
Sbjct: 235 HLAKLDLSYNPLKCSIPKSFGELHNLSILNLVSAELIGLIPPELGNCKSLKSLMLSFNSL 294
Query: 239 IGSIPREI-----------------------GNITMLKGLYLVYTNLTGEIQG------- 268
G +P E+ G +L L L +GEI
Sbjct: 295 SGPLPLELSEIPLLTFSAERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPM 354
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
L+ L+L+SN L+G IP E+ SL + L+ N L G + + +L +L+L N++
Sbjct: 355 LKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTI-EEVFDGCSSLGELLLTNNQI 413
Query: 329 TGPIPSSISNASMLTLIDMPYNLFSGFIPNSLG-------FCHPYDEL-GFL-TSLTNCK 379
G IP + ++ L D+ N F+G IP SL F Y+ L G+L + N
Sbjct: 414 NGSIPEDLWKLPLMAL-DLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAA 472
Query: 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNE 439
L++L+LS+N L+G +P IG L+ ++ VL L+A +G IP E+G+ +LTTL L +N
Sbjct: 473 SLKRLVLSDNQLTGEIPREIGKLT-SLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNN 531
Query: 440 LTGSIPKAIGRLQKLQGLYLQHNKLQGSITT------------DLCGLRSLSEFYSDGNE 487
L G IP I L +LQ L L +N L GSI + DL L+ F N
Sbjct: 532 LQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNR 591
Query: 488 LNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGN- 546
L+G +P+ L + L +SL N L+ IP+SL L ++ ++LS N+L G++P E+GN
Sbjct: 592 LSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNS 651
Query: 547 -----------------------LKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLA--- 580
L + K++L++N L G +P+S+G+LK + H+ L+
Sbjct: 652 LKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNN 711
Query: 581 ---------------------DNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKAL 619
NKF G IP LG LT L +LD+S N LSGEIP + L
Sbjct: 712 LSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGL 771
Query: 620 SLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPELKFPACKAKSNKIARKTD 679
L+FLNL+ N L+G+VP G + S GNK LCG + CK + K+
Sbjct: 772 PNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCG--RVVGSDCKIEGTKLRSAWG 829
Query: 680 KNIFIYVFPIAASILLVLSLSVVLIRRQKRNTGLQIDEE-------------------MS 720
+ F I + + + +R K+ + EE
Sbjct: 830 IAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSRE 889
Query: 721 P--------EVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNL 772
P E ++ ++ ATD FS+ N++G G FG+VYK L +AVK +
Sbjct: 890 PLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSE 949
Query: 773 ELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSF 832
R F AE E LG ++H NLV ++ CS K LV EYM NGSL++W+ N+
Sbjct: 950 AKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGML 1009
Query: 833 DIL---QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889
++L +RL + + A L +LH+ IIH D+ SNILL+ ++DFG+++L+
Sbjct: 1010 EVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLIS 1069
Query: 890 DETSMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFV---GE 942
S T T GY+ PE+ + + KGDVYS+G+IL+E T K+PT F G
Sbjct: 1070 ACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGG 1129
Query: 943 ISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIK 1002
+ + GK ++V+D L+ A + +L +AM C E+ +R N+
Sbjct: 1130 NLVGWAIQKINQGKAVDVIDPLLVS------VALKNSQLRLLQIAMLCLAETPAKRPNML 1183
Query: 1003 EALTKLLKI 1011
+ L L +I
Sbjct: 1184 DVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1148), Expect = e-124, Method: Compositional matrix adjust.
Identities = 350/1089 (32%), Positives = 532/1089 (48%), Gaps = 126/1089 (11%)
Query: 25 LASNWSTNTSV---CNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTN 81
+ S W N S CNWFG+TC + V +LN + G + PE+G L L +L+++
Sbjct: 50 VTSTWKINASEATPCNWFGITCD-DSKNVASLNFTRSRVSGQLGPEIGELKSLQILDLST 108
Query: 82 NSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSI 141
N+FSGT+P L N +L L N FS +IP LDS +LE LYL N G +P S+
Sbjct: 109 NNFSGTIPSTLGNCTKLATLDLSENGFSD-KIPDTLDSLKRLEVLYLYINFLTGELPESL 167
Query: 142 CNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMP-SIYNTSPLQNIDMQ 200
I L L L +N L G +P SI + L+ + + NQFSG +P SI N+S LQ + +
Sbjct: 168 FRIPKLQVLYLDYNNLTGPIPQSIGDAKELVELSMYANQFSGNIPESIGNSSSLQILYLH 227
Query: 201 YNSLA--------------ELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREI 246
N L L + N L G + CK L L LS N F G +P +
Sbjct: 228 RNKLVGSLPESLNLLGNLTTLFVGNNSLQGPVRFGSPNCKNLLTLDLSYNEFEGGVPPAL 287
Query: 247 GNITMLKGLYLVYTNLTGEI-------QGLQVLALSSNRLTGVIPPEIINISSLTVLSLT 299
GN + L L +V NL+G I + L +L LS NRL+G IP E+ N SSL +L L
Sbjct: 288 GNCSSLDALVIVSGNLSGTIPSSLGMLKNLTILNLSENRLSGSIPAELGNCSSLNLLKLN 347
Query: 300 ANNLLGNLPSNIGH----------------SLP-------NLQQLILGGNRLTGPIPSSI 336
N L+G +PS +G +P +L QL++ N LTG +P +
Sbjct: 348 DNQLVGGIPSALGKLRKLESLELFENRFSGEIPIEIWKSQSLTQLLVYQNNLTGELPVEM 407
Query: 337 SNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFL------------------------ 372
+ L + + N F G IP LG +E+ F+
Sbjct: 408 TEMKKLKIATLFNNSFYGAIPPGLGVNSSLEEVDFIGNKLTGEIPPNLCHGRKLRILNLG 467
Query: 373 ---------TSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSE 423
S+ +CK +R+ IL EN LSG+LP + +++ L ++ N +G IP
Sbjct: 468 SNLLHGTIPASIGHCKTIRRFILRENNLSGLLPEF--SQDHSLSFLDFNSNNFEGPIPGS 525
Query: 424 IGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYS 483
+G+ NL++++L N TG IP +G LQ L + L N L+GS+ L SL F
Sbjct: 526 LGSCKNLSSINLSRNRFTGQIPPQLGNLQNLGYMNLSRNLLEGSLPAQLSNCVSLERFDV 585
Query: 484 DGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVE 543
N LNGS+P + L TL L NR + IP L L+ + + ++ N+ G +P
Sbjct: 586 GFNSLNGSVPSNFSNWKGLTTLVLSENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSS 645
Query: 544 IGNLK-VVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLD 602
IG ++ ++ +DLS N L+GEIP+ +GDL + L++++N GS+ L GLTSL +D
Sbjct: 646 IGLIEDLIYDLDLSGNGLTGEIPAKLGDLIKLTRLNISNNNLTGSL-SVLKGLTSLLHVD 704
Query: 603 MSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPEL 662
+S+N +G IP++L+ L + + S N +PH +N S + L
Sbjct: 705 VSNNQFTGPIPDNLEGQLLSEPSSFSGNP-NLCIPHSFSASNNSRSA------------L 751
Query: 663 KFPACKAKSNKIARKTDKNIFIYVFPIAASILLVLSLSVVLIRRQK---RNTGLQIDEEM 719
K+ ++KS K T + + I V +++VL+L + +RR+K +E
Sbjct: 752 KYCKDQSKSRKSGLSTWQIVLIAVLSSLLVLVVVLALVFICLRRRKGRPEKDAYVFTQEE 811
Query: 720 SPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVK--VFNLELEGT 777
P + ++ ATD +E +G+G+ G VY+ +L G AVK VF +
Sbjct: 812 GPSLLLNKV-----LAATDNLNEKYTIGRGAHGIVYRASLGSGKVYAVKRLVFASHIRAN 866
Query: 778 LRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYN---KNRSFDI 834
+S E + +G +RHRNL+K+ ++ YMP GSL + ++ K D
Sbjct: 867 -QSMMREIDTIGKVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVLDW 925
Query: 835 LQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894
R N+ + VA L YLHYD PI+H D+ P NIL++ + + DFG+++LL D T
Sbjct: 926 SARYNVALGVAHGLAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLDDSTVS 985
Query: 895 TQTQTLATIGYMAPEWKLS----RKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN 950
T T T T GY+APE R+ DVYSYG++L+E T+K+ D+ F + S V
Sbjct: 986 TATVT-GTTGYIAPENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKSFPESTDIVSWVR 1044
Query: 951 DSLHGKIINVVDI------NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEA 1004
+L NV D+ +L E + +EQ V V LA+ CT++ R +++A
Sbjct: 1045 SALSSSNNNVEDMVTTIVDPILVDELLDSSLREQ-VMQVTELALSCTQQDPAMRPTMRDA 1103
Query: 1005 LTKLLKIRN 1013
+ L +++
Sbjct: 1104 VKLLEDVKH 1112
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1147), Expect = e-124, Method: Compositional matrix adjust.
Identities = 333/1045 (31%), Positives = 521/1045 (49%), Gaps = 97/1045 (9%)
Query: 28 NWST--NTSVCNWFGVTCS-----------------------PRHRRVTALNLAYMGLLG 62
NW++ NT NW +TCS P R + L ++ L G
Sbjct: 60 NWNSIDNTPCNNWTFITCSSQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTG 119
Query: 63 TIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPK 122
T+P LG+ L +L++++N G +P LS LR L+ L SN + +IPP + K
Sbjct: 120 TLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTG-KIPPDISKCSK 178
Query: 123 LEHLYLDGNSFIGTIPPSICNISSLLTLDLSFN-QLQGHVPSSILNIPSLLAIDLSNNQF 181
L+ L L N G+IP + +S L + + N ++ G +PS I + +L + L+
Sbjct: 179 LKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSV 238
Query: 182 SGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGS 241
SG +PS + L L + +SG+IPS L C +L L L N+ GS
Sbjct: 239 SGNLPSSLG---------KLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGS 289
Query: 242 IPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTAN 301
IPREIG +T L+ L+L N L G IP EI N S+L ++ L+ N
Sbjct: 290 IPREIGQLTKLEQLFLW-----------------QNSLVGGIPEEIGNCSNLKMIDLSLN 332
Query: 302 NLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLG 361
L G++PS+IG L L++ ++ N+ +G IP++ISN S L + + N SG IP+ LG
Sbjct: 333 LLSGSIPSSIGR-LSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELG 391
Query: 362 -------FCHPYDEL--GFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLS 412
F ++L L +C DL+ L LS N L+G +P + L N +L +S
Sbjct: 392 TLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLIS 451
Query: 413 ACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDL 472
++ G IP EIGN ++L L L N +TG IP IG L+K+ L N+L G + ++
Sbjct: 452 N-SLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEI 510
Query: 473 CGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLS 532
L N L GSLP + SL L+ L + N+ + IP+SL L + + LS
Sbjct: 511 GSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILS 570
Query: 533 SNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQ-HLSLADNKFQGSIPDS 591
N +G++P +G + +DL N+LSGEIPS +GD++N++ L+L+ N+ G IP
Sbjct: 571 KNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSK 630
Query: 592 LGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFV 651
+ L L+ LD+S N L G++ L + L LN+S+N G +P F LS Q
Sbjct: 631 IASLNKLSILDLSHNMLEGDLA-PLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLE 689
Query: 652 GNKGLCGAPELKFPACKAKSNKI-----ARKTDKNIFIYVFPIAASILLVLSLSVVLIRR 706
GNK LC + + K N + A +T K I +++L++ L V + R
Sbjct: 690 GNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMI-LGAVAVIR 748
Query: 707 QKRNTGLQIDEEMSPEVTWRRISYQELFRATDG----FSENNLLGKGSFGSVYKGTLSDG 762
+RN + D E+ W+ +Q+L + D E N++GKG G VY+ + +G
Sbjct: 749 ARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNG 808
Query: 763 MQIAVKVF---------NLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813
IAVK + + + SF AE + LG+IRH+N+V+ + C + + + L+
Sbjct: 809 EVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMY 868
Query: 814 EYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN 872
+YMPNGSL + ++ + S D R +++ A L YLH+D PI+H D+ +NIL+
Sbjct: 869 DYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIG 928
Query: 873 ESMVACLSDFGISKLLGDETSMTQTQTLA-TIGYMAPEW----KLSRKGDVYSYGIILME 927
++DFG++KL+ + + T+A + GY+APE+ K++ K DVYSYG++++E
Sbjct: 929 LDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLE 988
Query: 928 TFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLA 987
T K+P D I L V + + V+D L + +A Q VL A
Sbjct: 989 VLTGKQPIDPTVPEGIHLVDWVRQNRGS--LEVLDSTLRSRTEAEADEMMQ----VLGTA 1042
Query: 988 MQCTRESAEERINIKEALTKLLKIR 1012
+ C S +ER +K+ L +I+
Sbjct: 1043 LLCVNSSPDERPTMKDVAAMLKEIK 1067
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1029 | ||||||
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.976 | 0.924 | 0.520 | 0.0 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.985 | 0.931 | 0.505 | 0.0 | |
| 449465016 | 1092 | PREDICTED: probable LRR receptor-like se | 0.986 | 0.929 | 0.497 | 0.0 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.937 | 0.947 | 0.483 | 0.0 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.953 | 0.940 | 0.491 | 0.0 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.931 | 0.903 | 0.489 | 0.0 | |
| 359483685 | 1046 | PREDICTED: LRR receptor-like serine/thre | 0.962 | 0.946 | 0.476 | 0.0 | |
| 359497186 | 1140 | PREDICTED: LRR receptor-like serine/thre | 0.978 | 0.883 | 0.445 | 0.0 | |
| 298204751 | 1979 | unnamed protein product [Vitis vinifera] | 0.914 | 0.475 | 0.492 | 0.0 | |
| 359485176 | 1160 | PREDICTED: probable LRR receptor-like se | 0.956 | 0.848 | 0.441 | 0.0 |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1000 bits (2586), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 548/1053 (52%), Positives = 716/1053 (67%), Gaps = 48/1053 (4%)
Query: 6 DQSALLALKAHVTNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIP 65
DQS+LLALKAH+T DP +VLA NWST TS C W GV+C+ + +RV AL+L+ +GL GTIP
Sbjct: 32 DQSSLLALKAHITLDPHHVLAGNWSTKTSFCEWIGVSCNAQQQRVIALDLSNLGLRGTIP 91
Query: 66 PELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEH 125
P+LGNLSFL L++++N+F G +P+++ L L ++ + N S +IPP + +L+
Sbjct: 92 PDLGNLSFLVSLDLSSNNFHGPVPVEVGQLTSLLSMNLQYNLLSG-QIPPSFGNLNRLQS 150
Query: 126 LYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPM 185
L+L NSF GTIPPSI N+S L TL L N LQG++P I + ++ +D+ +NQ G +
Sbjct: 151 LFLGNNSFTGTIPPSIGNMSMLETLGLGGNHLQGNIPEEIGKLSTMKILDIQSNQLVGAI 210
Query: 186 PS-IYNTSPLQNIDMQYNSLAE----------------LHLAYNQLSGQIPSTLFECKQL 228
PS I+N S LQ I + YNSL+ + L+ N+ +G IPS L +C +L
Sbjct: 211 PSAIFNISSLQEIALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTGPIPSNLSKCGEL 270
Query: 229 KILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQ-------GLQVLALSSNRLTG 281
+ L LS N F G IPR I ++T L L L +L+GE+ L VL + N LTG
Sbjct: 271 QTLYLSFNKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTLNVLNIEDNSLTG 330
Query: 282 VIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASM 341
IP +I NISS+ SLT NNL GNLP N G LPNL+ LIL N L+G IPSSI NAS
Sbjct: 331 HIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLSGIIPSSIGNASK 390
Query: 342 LTLIDMPYNLFSGFIPNSLGFCHPYD----------------ELGFLTSLTNCKDLRKLI 385
L +D YN+ +G IP++LG + EL FLTSLTNCK LR L
Sbjct: 391 LRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLTNCKRLRILY 450
Query: 386 LSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIP 445
LS NPL G+LPISIGNLS ++ + C +KG+IP+EIGNL+NL L L N+LTG+IP
Sbjct: 451 LSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTIP 510
Query: 446 KAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTL 505
+IG+LQKLQGLYL NKLQGSI D+C LR+L E + N+L+GS+P CL L LR L
Sbjct: 511 PSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRHL 570
Query: 506 SLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIP 565
LG N+L S IPS+LWSL IL++++SSN L G LP ++GNLKV+ KIDLSRN LSGEIP
Sbjct: 571 YLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIP 630
Query: 566 SSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFL 625
S+IG L+++ LSLA N+F+G I S L SL F+D+S N L GEIP SL+ L LK+L
Sbjct: 631 SNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYL 690
Query: 626 NLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPELKFPACKAKSNKIARKTDKNIFIY 685
++SFNGL G++P GPF N S++SF+ NK LCG+P LK P C+ + + + + Y
Sbjct: 691 DVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGT-RWSTTISWLLLKY 749
Query: 686 VFPIAASILLVLSLSVVLIRRQKRNTGLQIDEEMSPEVTWRRISYQELFRATDGFSENNL 745
+ P S LL L+L V R +KRN L E TWRRISYQE+F+AT+GFS NL
Sbjct: 750 ILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNL 809
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS 805
LG+GS GSVY+GTLSDG A+KVFNL+ E +SFDAECE++ IRHRNL+KI+S+CS+
Sbjct: 810 LGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSN 869
Query: 806 DH--FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
+ FKALVLEY+PNGSLE W+Y+ N DILQRLN++IDVA A+EYLH+ TP++HCD
Sbjct: 870 SYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCD 929
Query: 864 LNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVY 919
L PSNILL+E + DFGI+KLL +E S+ +TQTLATIGYMAP++ ++ GDVY
Sbjct: 930 LKPSNILLDEDFGGHVGDFGIAKLLREEESIRETQTLATIGYMAPKYVSNGIVTTSGDVY 989
Query: 920 SYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQC 979
SYGI+LMETFT+++PTDE+F E+S+K+ V D L G I VVD NLL+ ED AK+QC
Sbjct: 990 SYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFMAKKQC 1049
Query: 980 VSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012
+S +L LAM C +S EERI +K+ +T L KI+
Sbjct: 1050 ISLILGLAMDCVADSPEERIKMKDVVTTLKKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 980 bits (2534), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 537/1063 (50%), Positives = 713/1063 (67%), Gaps = 49/1063 (4%)
Query: 6 DQSALLALKAHVTNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIP 65
D SALL LK H DP ++ NWS+ TS C+W+GVTCS RH RV AL L+ MG+ G +P
Sbjct: 31 DLSALLVLKEHSNFDPF--MSKNWSSATSFCHWYGVTCSERHNRVVALTLSNMGIKGIVP 88
Query: 66 PELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEH 125
P +GNLSFL ++++NNS+SG LP +L NL RLK+++F +N+F EIP L PKL+H
Sbjct: 89 PHIGNLSFLVHIDMSNNSYSGHLPNELGNLHRLKFMNFSNNSFVG-EIPSSLAMLPKLQH 147
Query: 126 LYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSIL-NIPSLLAIDLSNNQFSGP 184
L L NS SI NI++L TLDL+ N L G++ +I N+ +L +++ NQ SG
Sbjct: 148 LLLANNSLTAG-RSSIFNITTLNTLDLNDNLLGGNILDNIGGNLSNLQVLNMGLNQLSGS 206
Query: 185 MP-SIYNTSPLQNIDMQYNSLAE---------------LHLAYNQLSGQIPSTLFECKQL 228
P I + L+ I +Q N+L+ L+LA NQL GQIPS L++CK+L
Sbjct: 207 FPPKILDLPSLKFIYLQVNNLSGNLKEILCNQNSKLQLLNLAGNQLYGQIPSDLYKCKEL 266
Query: 229 KILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEI-------QGLQVLALSSNRLTG 281
+ L+L N F GSIPR IGN+T LK L L NLTG I Q LQ++ LS N L G
Sbjct: 267 RSLALHANKFTGSIPRTIGNLTKLKWLSLGRNNLTGRIPLEIGNLQNLQIVHLSFNNLNG 326
Query: 282 VIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASM 341
IP + NIS++ +++T+NNLLGNLP+++G LPNL L LG N+L+GPIPS ISNAS
Sbjct: 327 SIPHALFNISTMKWIAMTSNNLLGNLPTSLGLHLPNLIWLYLGINKLSGPIPSYISNASK 386
Query: 342 LTLIDMPYNLFSGFIPNSLGFCH----------------PYDELGFLTSLTNCKDLRKLI 385
LT++++P N F+GFIP+SLG EL +SL NC++L+ L
Sbjct: 387 LTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQELTIFSSLKNCQNLKYLW 446
Query: 386 LSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIP 445
LS NPL G LP S+GNLSN+++ S IKGS+ IGNL++LT L+L N+LTG IP
Sbjct: 447 LSYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRLNLGNNDLTGRIP 506
Query: 446 KAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTL 505
IG L+ LQGLYL N L GSI ++LC LR+L GN+L+GS+P C +L SLR L
Sbjct: 507 TTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRNL 566
Query: 506 SLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIP 565
L NR S I S+LW+L+DIL VNL+SN L G+LP EI NL+ V I++S+N LSGEIP
Sbjct: 567 FLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEIP 626
Query: 566 SSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFL 625
SIG L+++ L L+ NK QG IP S+G + SL FLD+SSNNLSG IP SL L LK+
Sbjct: 627 ISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYF 686
Query: 626 NLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPELKFPACKAKSNKIARKTDKNIFI- 684
N+SFN LQG++P GG F+N S+QSF+GN+ LCG+ L+ CK +++ I +
Sbjct: 687 NVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIVLR 746
Query: 685 YVFPIAASILLVLSLSVVLIRRQKRNTGLQIDEEMSPEVTWRRISYQELFRATDGFSENN 744
YV P + VL+ ++L R +R I+++ T RRISY EL AT+GF E+N
Sbjct: 747 YVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLATNGFQESN 806
Query: 745 LLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
LG GSFGSVYKGTLSDG IA KVFNL+LE +SFD ECE+L ++RHRNLVKII++CS
Sbjct: 807 FLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCS 866
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
+FKALVLE+MPN SLE W+Y+ + + LQRLN+++DVAS LEYLH+ + P+ HCD+
Sbjct: 867 GPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDI 926
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYS 920
PSN+LLNE MVA L+DFGISKLLG+E S+ QT TLATIGYMAPE+ +S +GDVYS
Sbjct: 927 KPSNVLLNEDMVAFLADFGISKLLGEEGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYS 986
Query: 921 YGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCV 980
YG++LMETFT+KKPTD++F ++SLKS V SL ++ V+D NLL E+ +L AK+ C+
Sbjct: 987 YGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLAAKKDCI 1046
Query: 981 SSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIENSS 1023
S+L LA+QC+ + +RI++K +T L KI+ L +I S
Sbjct: 1047 VSILKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLRDIRQLS 1089
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449465016|ref|XP_004150225.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 968 bits (2502), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 542/1090 (49%), Positives = 730/1090 (66%), Gaps = 75/1090 (6%)
Query: 2 NVGRDQSALLALKAHVTNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLL 61
N+ DQ+ALLAL+AH+T+DP + +NWS TSVCNW G+ C +H+RVT+LN ++MGL
Sbjct: 6 NITTDQAALLALRAHITSDPFGITTNNWSATTSVCNWVGIICGVKHKRVTSLNFSFMGLT 65
Query: 62 GTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFP 121
GT PPE+G LSFL+ + + NNSF LPI+L+NL RLK +S +NNFS EIP W+ P
Sbjct: 66 GTFPPEVGTLSFLTYVTIKNNSFHDPLPIELTNLPRLKMMSLGNNNFSG-EIPTWIGRLP 124
Query: 122 KLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILN-------------- 167
++E LYL GN F G IP S+ N++SL+ L+L NQL G +P I N
Sbjct: 125 RMEELYLYGNQFSGLIPTSLFNLTSLIMLNLQENQLSGSIPREIGNLTLLQDLYLNSNQL 184
Query: 168 --IP-------SLLAIDLSNNQFSGPMP-SIYNTSPLQNIDMQYN--------------- 202
IP SL +D+ N FSGP+P I+N S L + + N
Sbjct: 185 TEIPTEIGTLQSLRTLDIEFNLFSGPIPLFIFNLSSLVILGLSGNNFIGGLPDDICEDLP 244
Query: 203 SLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNL 262
SL L+L+YNQLSGQ+PSTL++C+ L+ ++L+ N F GSIPR +GN+T +K ++L L
Sbjct: 245 SLGGLYLSYNQLSGQLPSTLWKCENLEDVALAYNQFTGSIPRNVGNLTRVKQIFLGVNYL 304
Query: 263 TGEI-------QGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSL 315
+GEI Q L+ LA+ N G IPP I N+S L ++L N L G LP+++G L
Sbjct: 305 SGEIPYELGYLQNLEYLAMQENFFNGTIPPTIFNLSKLNTIALVKNQLSGTLPADLGVGL 364
Query: 316 PNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCH----------- 364
PNL QL+LG N LTG IP SI+N+SMLTL D+ N FSG IPN G
Sbjct: 365 PNLVQLMLGRNELTGTIPESITNSSMLTLFDVGDNSFSGLIPNVFGRFENLRWINLELNN 424
Query: 365 -----PYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGS 419
P E G + LTN L +L LS NPL+ LP S N S++ L + IKG
Sbjct: 425 FTTESPPSERGIFSFLTNLTSLVRLELSHNPLNIFLPSSFVNFSSSFQYLSMVNTGIKGM 484
Query: 420 IPSEIGN-LNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSL 478
IP +IGN L +L L ++ N++TG+IP +IG+L++LQGL+L +N L+G+I ++C L +L
Sbjct: 485 IPKDIGNFLRSLIVLVMDDNQITGTIPTSIGKLKQLQGLHLSNNSLEGNIPAEICQLENL 544
Query: 479 SEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNG 538
E Y N+L+G++P+C D+L +LRTLSLG N L S +PSSLWSL IL++NLSSNSL G
Sbjct: 545 DELYLANNKLSGAIPECFDNLSALRTLSLGSNNLNSTMPSSLWSLSYILHLNLSSNSLRG 604
Query: 539 TLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSL 598
+LPVEIGNL+VV ID+S+N LSGEIPSSIG L N+ +LSL N+ +GSIPDS G L +L
Sbjct: 605 SLPVEIGNLEVVLDIDVSKNQLSGEIPSSIGGLINLVNLSLLHNELEGSIPDSFGNLVNL 664
Query: 599 NFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCG 658
LD+SSNNL+G IP SL+ LS L+ N+SFN L+G++P+GGPF+N S+QSF+ N GLC
Sbjct: 665 EILDLSSNNLTGVIPRSLEKLSHLEQFNVSFNQLEGEIPNGGPFSNFSAQSFISNIGLCS 724
Query: 659 A-PELKFPACKAKSNK-IARKTDKNIFIYVFP-IAASILLVLSLSVVLIRRQKRNTGLQI 715
A + C K+++ RKT+K +Y+ P I ++L ++ L + + R ++ ++
Sbjct: 725 ASSRFQVAPCTTKTSQGSGRKTNK--LVYILPSILLAMLSLILLLLFMTYRHRKKEQVRE 782
Query: 716 DEEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE 775
D + + WRR +YQEL +ATDGFSE+NL+G+GSFGSVYK TLSDG AVK+F+L +
Sbjct: 783 DTPLPYQPAWRRTTYQELSQATDGFSESNLIGRGSFGSVYKATLSDGTIAAVKIFDLLTQ 842
Query: 776 GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDIL 835
+SF+ ECEIL +IRHRNLVKII++CSS FKAL+LEYMPNG+L+ W+YN + ++L
Sbjct: 843 DANKSFELECEILCNIRHRNLVKIITSCSSVDFKALILEYMPNGNLDMWLYNHDCGLNML 902
Query: 836 QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895
+RL++VIDVA AL+YLH + PI+HCDL P+NILL+ MVA L+DFGISKLLG S+T
Sbjct: 903 ERLDIVIDVALALDYLHNGYGKPIVHCDLKPNNILLDGDMVAHLTDFGISKLLGGGDSIT 962
Query: 896 QTQTLATIGYMAPEWKL----SRKGDVYSYGIILMETFTKKKPTDELF-VGEISLKSRVN 950
QT TLAT+GYMAPE L SRK DVYSYGI+LMETFT+KKPTDE+F GE+SL+ V
Sbjct: 963 QTITLATVGYMAPELGLDGIVSRKCDVYSYGILLMETFTRKKPTDEMFSAGEMSLREWVA 1022
Query: 951 DSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010
+ I NVVD +LL + ++ A E C+SS++ LA+ CT ES E+R + K+ L L K
Sbjct: 1023 KAYPHSINNVVDPDLLNDDKSFNYASE-CLSSIMLLALTCTAESPEKRASSKDVLNSLNK 1081
Query: 1011 IRNTLLTNIE 1020
I+ +LT E
Sbjct: 1082 IKAMILTYSE 1091
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 930 bits (2403), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 500/1035 (48%), Positives = 668/1035 (64%), Gaps = 70/1035 (6%)
Query: 6 DQSALLALKAHVTNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIP 65
DQSALLA K H+T DP N+L +WS+ TS CNW GV+CS R +RVTAL+L+ MGLLGTIP
Sbjct: 31 DQSALLAFKDHITFDPQNMLTHSWSSKTSFCNWMGVSCSLRRQRVTALDLSSMGLLGTIP 90
Query: 66 PELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEH 125
P+LGNLSFL L + NNSF G LP ++ NLRRL+ + SN S + +P + +LE
Sbjct: 91 PQLGNLSFLQYLILYNNSFHGDLPSEIGNLRRLQVMDIGSNKLSLVIVPESFGNLHRLEE 150
Query: 126 LYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPM 185
L DGN+ GTIP S+I NI SL +DL N G +
Sbjct: 151 LRFDGNNLTGTIP------------------------STIFNISSLKVLDLMFNGLFGSL 186
Query: 186 PSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPRE 245
P +N+ L L L+ NQLSGQIPS LF+C++L++L L NNF G IP E
Sbjct: 187 P--------KNMCDHLPRLEMLLLSSNQLSGQIPSDLFKCRELQLLWLPYNNFTGVIPEE 238
Query: 246 IGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLG 305
+G + ML +VL L N L+G +P I N++SL + + NNL G
Sbjct: 239 LGFLPML-----------------EVLNLGVNMLSGDLPRSIFNMTSLRTMQICCNNLSG 281
Query: 306 NLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLG---- 361
++P LPNL++L L N +TG +P + N S L ++D+ YN +G + G
Sbjct: 282 SIPQENSIDLPNLEELQLNLNGITGSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRA 341
Query: 362 ----------FC-HPYDE-LGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVL 409
F HP + L F+TSLTN + L++L + +NPL G+LP S+GNLS+ +
Sbjct: 342 LQVLSLQSNSFTNHPSSQTLNFITSLTNSRQLKELHIGDNPLDGMLPNSVGNLSSFLTKF 401
Query: 410 YLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSIT 469
Y+ A +KG+IP EIGNL+NL L LE N L G IP +G L+K+Q LYL N L GSI
Sbjct: 402 YVYASKLKGNIPGEIGNLSNLIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIP 461
Query: 470 TDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNV 529
+D+C R L + + N L+G +P C+ +L SLR L L FN L+S IP +LWSL+D+L +
Sbjct: 462 SDICLARRLVDITLNNNVLSGEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLIL 521
Query: 530 NLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIP 589
NL SN L G+LP ++G ++ I LS N LSG IPS+IG L+N+ SL+ N FQGSIP
Sbjct: 522 NLHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIP 581
Query: 590 DSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQS 649
++ GGL SL LD+S NNLSGEIP SL+AL L+F ++SFNGLQG++P GGPF N +++S
Sbjct: 582 EAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARS 641
Query: 650 FVGNKGLCGAPELKFPACKAKSNKIARKTDKNIFIYVFPIAASILLVLSLSVVLIRRQKR 709
F+ NKGLCG L+ P C +S K + KT + + P ASILLV++ +++ ++R
Sbjct: 642 FIMNKGLCGPSRLQVPPCSIESRKDS-KTKSRLLRFSLPTVASILLVVAFIFLVMGCRRR 700
Query: 710 NTGLQIDEEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKV 769
I E + RRISY EL AT+ F E+NLLG GSFGSVY+G L DG+ +AVK+
Sbjct: 701 YRKDPIPEALPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKI 760
Query: 770 FNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKN 829
FNL+L+ RSFD ECEI+ +IRHRNLVKII +CS+ FKALVLEYMP GSLE W+Y+ N
Sbjct: 761 FNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHN 820
Query: 830 RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889
DI+QR+N++IDVASALEYLH+ +P+P++HCDL PSN+LL+E MVA + DFGI+KLLG
Sbjct: 821 YCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLLG 880
Query: 890 DETSMTQTQTLATIGYMAPEWKL----SRKGDVYSYGIILMETFTKKKPTDELFVGEISL 945
+ S QT+TLATIGYMAPE+ L S K DVYS+GI+LME T+K+PTDE+F GE+SL
Sbjct: 881 ENESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSL 940
Query: 946 KSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
K V +SL +I++VD N+L + D Y KE CV+S++ LA+QC ES ER+ + E L
Sbjct: 941 KRLVKESLPDSVIDIVDSNMLNRGDGYSVKKEHCVTSIMELALQCVNESPGERMAMVEIL 1000
Query: 1006 TKLLKIRNTLLTNIE 1020
+L I+ L + E
Sbjct: 1001 ARLKNIKAEFLRDSE 1015
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 925 bits (2391), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 517/1052 (49%), Positives = 701/1052 (66%), Gaps = 71/1052 (6%)
Query: 1 TNVGRDQSALLALKAHVTNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGL 60
TN+ DQ ALLALK + DP N+LA+NWS TSVC W GVTC RH RVTAL+L+ MGL
Sbjct: 29 TNIASDQDALLALKVRIIRDPNNLLAANWSITTSVCTWVGVTCGARHGRVTALDLSDMGL 88
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSF 120
GTIPP LGNLSFL+ ++ NN F G+LP +LS LRR+K +N FS EIP W+ SF
Sbjct: 89 TGTIPPHLGNLSFLAFISFYNNRFHGSLPDELSKLRRIKAFGMSTNYFSG-EIPSWIGSF 147
Query: 121 PKLEHLYLDGNSFIGTIPPSICN--ISSLLTLDLSFNQLQGHVPSSIL-NIPSLLAIDLS 177
+L+ L L N F G +P + N ISSL LD N L G +P +I ++ +L A+ L+
Sbjct: 148 TQLQRLSLSSNKFTGLLPAILANNTISSLWLLDFGTNNLTGRLPPNIFTHLANLRALYLN 207
Query: 178 NNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNN 237
+N F+GP IPSTL C+QLK+L+LS N+
Sbjct: 208 SNLFNGP---------------------------------IPSTLMACQQLKLLALSFNH 234
Query: 238 FIGSIPREIGNITMLKGLYLVYTNLTGEI-------QGLQVLALSSNRLTGVIPPEIINI 290
F GSI ++IGN+TML+ LYL N +G I L+ + L+ N L+G++P I N
Sbjct: 235 FEGSIHKDIGNLTMLQELYLGGNNFSGTIPDEIGDLAHLEEIILNVNGLSGLVPSGIYNA 294
Query: 291 SSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYN 350
S +T + L N L G LPS+ +LPNL+ I+ N TGPIP S+ NAS L ID+ +N
Sbjct: 295 SKMTAIGLALNQLSGYLPSS--SNLPNLEFFIIEDNNFTGPIPVSLFNASKLGNIDLGWN 352
Query: 351 LFSGFIPNSLGFCHPYDELGFLTS----------------LTNCKDLRKLILSENPLSGV 394
F G IP+ LG + F + LT CK LR+ LS NPL+G
Sbjct: 353 SFYGPIPDELGNLKSLEVFSFWVNHLTVKSSSSGLSLFSSLTKCKHLRRFDLSNNPLNGN 412
Query: 395 LPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKL 454
LPIS+GNLS++++V+ + C I G+IP EIGNL++L+ L L N+L G+IP I +L KL
Sbjct: 413 LPISVGNLSSSLEVVEIFDCGITGTIPKEIGNLSSLSWLDLGANDLRGTIPTTIRKLGKL 472
Query: 455 QGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTS 514
Q L L +N+L+GS +LC L+SL+ Y + N L+G +P CL ++ SLRTLS+G N+ +S
Sbjct: 473 QELKLHYNRLEGSFPYELCDLQSLAYLYLEVNALSGQIPSCLGNVNSLRTLSMGMNKFSS 532
Query: 515 VIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNM 574
IPS+LW L DIL +NLSSNSL+G+L V+IGNLK VT IDLS N LSG IPSSIG LK +
Sbjct: 533 TIPSTLWRLADILELNLSSNSLSGSLAVDIGNLKAVTLIDLSGNQLSGHIPSSIGGLKTL 592
Query: 575 QHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQG 634
+LSLA N+ +GSIP G SL LD+S+NNLSGEIP SL+ L L + N+SFN LQG
Sbjct: 593 LNLSLAVNRLEGSIPQLFGDAISLQLLDLSNNNLSGEIPKSLEELRYLTYFNVSFNELQG 652
Query: 635 QVPHGGPFTNLSSQSFVGNKGLCGAPELKFPACKAKSNKIARKTDKNIFIY-VFPIAASI 693
++P+G F NLS++SF+GNKGLCGA +L+ C+ +++ ++ K Y + +I
Sbjct: 653 EIPNGRAFINLSAKSFMGNKGLCGAAKLQVQPCETSTHQGSKAASKLALRYGLMATGLTI 712
Query: 694 LLVLSLSVVLIRRQKRNTGLQIDEEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGS 753
L V +++++ IR +KRN ++I E + P T +RISY+EL +ATD F+E NLLG+GSFGS
Sbjct: 713 LAVAAVAIIFIRSRKRN--MRITEGLLPLATLKRISYRELEQATDKFNEMNLLGRGSFGS 770
Query: 754 VYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDH--FKAL 811
VYKGT SDG +AVKVFNL++EG +SFD ECE+L IRHRNLVKII++CS + FKAL
Sbjct: 771 VYKGTFSDGSSVAVKVFNLQVEGAFKSFDVECEVLRMIRHRNLVKIITSCSDINIDFKAL 830
Query: 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL 871
VLE+MPN SLE W+ + ++L+RLN+++DVASA+EYLH+ + PI+HCDL PSNILL
Sbjct: 831 VLEFMPNYSLEKWLCSPKHFLELLERLNIMLDVASAVEYLHHGYAMPIVHCDLKPSNILL 890
Query: 872 NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILME 927
+E+MVA ++DFGI+KLLGDE S QT TLAT+GYMAPE+ +S GD+YS+GI+LME
Sbjct: 891 DENMVAHVTDFGIAKLLGDEHSFIQTITLATVGYMAPEYGSEGVVSTGGDIYSFGILLME 950
Query: 928 TFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLA 987
TFT+KKPTD++F EIS+K V +S+ G + + D +LL+ E+ + +AK+ C+ SV+ +A
Sbjct: 951 TFTRKKPTDDMFNEEISMKQWVQESVPGGVTQITDPDLLRIEEQHFSAKKDCILSVMQVA 1010
Query: 988 MQCTRESAEERINIKEALTKLLKIRNTLLTNI 1019
+QC+ + EER NI++ L L + L +I
Sbjct: 1011 LQCSADLPEERPNIRDVLNTLNHTKVKFLKDI 1042
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 917 bits (2370), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/1058 (48%), Positives = 686/1058 (64%), Gaps = 99/1058 (9%)
Query: 58 MGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPP-W 116
M L GT+PP++GNLSFL +N++NNSF G LP +L++L RLK ++ NNF+ +IP W
Sbjct: 1 MRLEGTLPPQVGNLSFLVSINLSNNSFHGYLPRELTHLHRLKDMNLAYNNFAG-DIPSSW 59
Query: 117 LDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDL 176
P+L+HL+L NS G+IP S+ N+++L TL+L N ++G++ I N+ +L +DL
Sbjct: 60 FAMLPQLQHLFLTNNSLAGSIPSSLFNVTALETLNLEGNFIEGNISEEIRNLSNLKILDL 119
Query: 177 SNNQFSGPM-PSIYNTSPLQNIDMQYNSLAE-----------------LHLAYNQLSGQI 218
+N FSG + P ++N L+ I+++ NSL+ L+L YNQL G+I
Sbjct: 120 GHNHFSGVISPILFNMPSLRLINLRANSLSGILQVVMIMSNIPSTLEVLNLGYNQLHGRI 179
Query: 219 PSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQG---------- 268
PS L +C +L++L L N F GSIP+EI +T LK LYL NLTG+I G
Sbjct: 180 PSNLHKCTELRVLDLESNRFTGSIPKEICTLTKLKELYLGKNNLTGQIPGEIARLVSLEK 239
Query: 269 ---------------------LQVLALSSNRLTGVIPPEIINISSLTVLSLTANN----- 302
L + + +N LTGVIP E+ N+ +L L L NN
Sbjct: 240 LGLEVNGLNGNIPREIGNCTYLMEIHVENNNLTGVIPNEMGNLHTLQELDLGFNNITGSI 299
Query: 303 -------------------LLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLT 343
L G+LPSN G LPNL++L L N L+GPIP SI NAS L
Sbjct: 300 PSTFFNFSILRRVNMAYNYLSGHLPSNTGLGLPNLEELYLEKNELSGPIPDSIGNASKLI 359
Query: 344 LIDMPYNLFSGFIPNSLGFCHPYDELGF----LTS------------LTNCKDLRKLILS 387
++D+ YN FSG IP+ LG +L LTS L+NC+ L L +
Sbjct: 360 VLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTSKSLRSELSFLSSLSNCRSLAYLRFN 419
Query: 388 ENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKA 447
NPL G LP+SIGNLS +++ LY C I G+IP IGNL+NL L L+ NELTG+IP
Sbjct: 420 GNPLRGRLPVSIGNLSASLEELYAFDCRIIGNIPRGIGNLSNLIGLILQQNELTGAIPSE 479
Query: 448 IGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSL 507
IGRL+ LQ L NKLQG I ++C L LS Y N +GSLP CL ++ SLR L L
Sbjct: 480 IGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGFSGSLPACLSNITSLRELYL 539
Query: 508 GFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSS 567
G NR TS IP++ WSL+D+L +NLS NSL GTLP+EIGNLKVVT ID S N LSG+IP+S
Sbjct: 540 GSNRFTS-IPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKVVTVIDFSSNQLSGDIPTS 598
Query: 568 IGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNL 627
I DL+N+ H SL+DN+ QG IP S G L SL FLD+S N+LSG IP SL+ L LK N+
Sbjct: 599 IADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSLEKLVHLKTFNV 658
Query: 628 SFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPELKFPACKAKSNKIARKTDKNIFI-YV 686
SFN LQG++ GGPF N S +SF+ N+ LCG ++ P CK+ S K + I Y+
Sbjct: 659 SFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQSKRPREFVIRYI 718
Query: 687 FPIAASILLVLSLSVVLIRRQKRNTGLQIDEEMSPEVTWRRISYQELFRATDGFSENNLL 746
P A I+LVL+L+V++ RR + L E+ P TWR+ISY EL+RAT+GF+E NLL
Sbjct: 719 VPAIAFIILVLALAVIIFRRSHKRK-LSTQEDPLPPATWRKISYHELYRATEGFNETNLL 777
Query: 747 GKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSD 806
G GS GSVYKGTLSDG+ IAVKVF+L+LEG L FD+ECE+L +RHRNLVKIIS+C +
Sbjct: 778 GTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCCNL 837
Query: 807 HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNP 866
FKAL+LE++P+GSLE W+Y+ N DILQRLN++IDVASALEYLH+ P++HCDL P
Sbjct: 838 DFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVVHCDLKP 897
Query: 867 SNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL----SRKGDVYSYG 922
SN+L+NE MVA +SDFGIS+LLG+ ++TQT TLATIGYMAPE+ L S KGDVYSYG
Sbjct: 898 SNVLINEDMVAHVSDFGISRLLGEGDAVTQTLTLATIGYMAPEYGLEGIVSVKGDVYSYG 957
Query: 923 IILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSS 982
I LMETFT+KKPTD++F GE+SLK+ V SL I V+D NLL +E+ ++ AK+ C++S
Sbjct: 958 IFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLLIEEEHFV-AKKDCITS 1016
Query: 983 VLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIE 1020
+L+LA++C+ + ERI +++ L L KI+ ++E
Sbjct: 1017 ILNLALECSADLPGERICMRDVLPALEKIKLKYKKDVE 1054
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 903 bits (2333), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/1058 (47%), Positives = 693/1058 (65%), Gaps = 68/1058 (6%)
Query: 6 DQSALLALKAHVTNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIP 65
D+ AL+ALKAH+T D +LA+NWST +S CNW+G++C+ +RV+A+NL+ MGL GTI
Sbjct: 9 DEFALIALKAHITYDSQGILATNWSTKSSYCNWYGISCNAPQQRVSAINLSNMGLEGTIA 68
Query: 66 PELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEH 125
P++GNLSFL L++T N F+G++P + NL L+ LS R+N+ + EIP L +L
Sbjct: 69 PQVGNLSFLVSLDLTYNDFTGSIPNGIGNLVELQRLSLRNNSLTG-EIPSNLSHCRELRG 127
Query: 126 LYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPM 185
L L N F G IP +I ++S+L L L++N+L G +P I N+ +L + L +N SGP+
Sbjct: 128 LSLSINQFTGGIPQAIGSLSNLEELYLNYNKLTGGIPREIGNLSNLNILQLGSNGISGPI 187
Query: 186 PS-IYNTSPLQNIDMQYNSLAE---------------LHLAYNQLSGQIPSTLFECKQLK 229
P+ I+ S LQ I NSL+ L+L+ N LSGQ+P+TL C++L
Sbjct: 188 PAEIFTVSSLQRIIFANNSLSGSLPMDICKHLPNLQGLYLSQNHLSGQLPTTLSLCRELL 247
Query: 230 ILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEI-- 287
L+L +N F GSIPREIGN++ L+ EI LS N L G IP
Sbjct: 248 SLALPMNKFTGSIPREIGNLSKLE-----------EID------LSENSLIGSIPTSFGN 290
Query: 288 --------INISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNA 339
NIS L L L N+L G+LPS+IG LP+L+ L +G N +G IP SISN
Sbjct: 291 LMTLKFLSFNISKLQTLGLVQNHLSGSLPSSIGTWLPDLEGLYIGINEFSGTIPMSISNM 350
Query: 340 SMLTLIDMPYNLFSGFIP----------------NSLGFCHPYDELGFLTSLTNCKDLRK 383
S LT++ + N F+G +P N L H +GFLTSLTNCK LR
Sbjct: 351 SKLTVLSLSDNSFTGNVPKDLCNLTKLQFLDLAYNQLTDEHLASGVGFLTSLTNCKFLRN 410
Query: 384 LILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGS 443
L + NPL+G LP S+GNL A+++ SAC +G+IP+ IGNL NL L L N+LTGS
Sbjct: 411 LWIGYNPLTGTLPNSLGNLPIALEIFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGS 470
Query: 444 IPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLR 503
IP +G+LQKLQ L + N+++GSI DLC L++L N+L+GS+P C L +LR
Sbjct: 471 IPTTLGQLQKLQALSIVGNRIRGSIPNDLCHLKNLGYLRLSYNKLSGSIPSCFGDLPALR 530
Query: 504 TLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGE 563
LSL N L IP S WSLRD+L +NLSSN L G LP E+GN+K +T +DLS+N +SG
Sbjct: 531 ELSLDSNVLAFNIPMSFWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGY 590
Query: 564 IPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLK 623
IPS +G L+N+ LSL+ NK QG IP G L SL LD+S NNLSG IP +L+AL LK
Sbjct: 591 IPSRMGKLQNLITLSLSQNKLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKTLEALIYLK 650
Query: 624 FLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPELKFPACKAKSNKIARKTDKNIF 683
+LN+SFN LQG++P+GGPF +++SF+ N+ LCGAP + AC + + KT I
Sbjct: 651 YLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFIL 710
Query: 684 IYV-FPIAASILLVLSLSVVLIRRQKRNTGLQIDEEMSPEVTWRRISYQELFRATDGFSE 742
Y+ P+ +++ LV+ + + + RR ID + T +IS+Q+L AT+ F E
Sbjct: 711 KYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPIDSWLPG--THEKISHQQLLYATNDFGE 768
Query: 743 NNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIIST 802
+NL+GKGS G VYKG LS+G+ +A+KVFNLE +G LRSF++ECE++ IRHRNLV+II+
Sbjct: 769 DNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHRNLVRIITC 828
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
CS+ FKALVL+YMPNGSLE +Y+ D++QRLN++IDVASALEYLH+D + ++HC
Sbjct: 829 CSNLDFKALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHC 888
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDV 918
DL PSN+LL++ MVA ++DFGI+KLL + SM QT+TL+TIGYMAPE +S K DV
Sbjct: 889 DLKPSNVLLDDDMVAHVADFGIAKLLTETESMQQTKTLSTIGYMAPEHGSAGIVSTKSDV 948
Query: 919 YSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQ 978
YSYGI+LME F +KKP DE+F G+++LK+ V +SL +I VVD+NLL++ED L K
Sbjct: 949 YSYGILLMEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLATKLS 1007
Query: 979 CVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016
C+SS+++LA+ CT +S EERI++K+A+ +L K R LL
Sbjct: 1008 CLSSIMALALACTTDSPEERIDMKDAVVELKKSRIKLL 1045
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 889 bits (2297), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 506/1135 (44%), Positives = 694/1135 (61%), Gaps = 128/1135 (11%)
Query: 6 DQSALLALKAHVTNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIP 65
D+ AL+ALKAH+T D +LA+NWST + C+W G++C+ + V+A+NL+ MGL GTI
Sbjct: 9 DEFALIALKAHITYDSQGILATNWSTKSPHCSWIGISCNAPQQSVSAINLSNMGLEGTIA 68
Query: 66 PELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEH 125
P++GNLSFL L++++N F G+LP + + L+ L+ +N IP + + KLE
Sbjct: 69 PQVGNLSFLVSLDLSDNYFHGSLPKDIGKCKELQQLNLFNNKLVG-GIPEAICNLSKLEE 127
Query: 126 LYLDGNSFIG------------------------TIPPSICNISSLLT------------ 149
LYL N IG +IP +I NISSLL
Sbjct: 128 LYLGNNQLIGEIPKKMNHLQNLKVLSFPMNNLTGSIPATIFNISSLLNISLSNNNLSGSL 187
Query: 150 -------------LDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPS--------- 187
L+LS N L G +P+ + L I L+ N F+G +PS
Sbjct: 188 PMDMCYANPKLKELNLSSNHLSGKIPTGLGQCIQLQVISLAYNDFTGSIPSGIDNLVELQ 247
Query: 188 -----------------------IYNTSPLQNIDMQYNSLAE---------------LHL 209
I+N S LQ I NSL+ L L
Sbjct: 248 RLSLQNNSFTAFKDISKALLFAEIFNVSSLQVIAFTDNSLSGSLPKDICKHLPNLQGLSL 307
Query: 210 AYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEI--- 266
+ N LSGQ+P+TL C +L LSLS N F GSIP+EIGN++ L+ +YL +L G I
Sbjct: 308 SQNHLSGQLPTTLSLCGELLFLSLSFNKFRGSIPKEIGNLSKLEEIYLGTNSLIGSIPTS 367
Query: 267 ----QGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLI 322
+ L+ L L N LTG +P I NIS L L++ N+L G+LPS+IG LP+L+ L
Sbjct: 368 FGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLPDLEGLF 427
Query: 323 LGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFC----------------HPY 366
+ GN +G IP SISN S LT++ + N F+G +P LG H
Sbjct: 428 IAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVA 487
Query: 367 DELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGN 426
E+GFLTSLTNCK L+ L + P G LP S+GNL A++ SAC +G+IP+ IGN
Sbjct: 488 SEVGFLTSLTNCKFLKNLWIGNIPFKGTLPNSLGNLPIALESFIASACQFRGTIPTGIGN 547
Query: 427 LNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGN 486
L NL L L N+LTGSIP +G+LQKLQ LY+ N+++GSI DLC L+ L + N
Sbjct: 548 LTNLIRLDLGANDLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCHLKDLGYLFLSSN 607
Query: 487 ELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGN 546
+L+GS+P C L++L+ L L N L IP+SLWSLRD+L +NLSSN L G LP E+GN
Sbjct: 608 KLSGSIPSCFGDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTGNLPPEVGN 667
Query: 547 LKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSN 606
+K +T +DLS+N +SG IPS +G L+++ LSL+ N+ QG IP G L SL LD+S N
Sbjct: 668 MKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLSQN 727
Query: 607 NLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPELKFPA 666
NLSG IP SL+AL LK+LN+S N LQG++P+GGPF N +++SF+ N+ LCGAP + A
Sbjct: 728 NLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMA 787
Query: 667 CKAKSNKIARKTDKNIFIYV-FPIAASILLVLSLSVVLIRRQKRNTGLQIDEEMSPEVTW 725
C + + KT I Y+ P+ + + LV+ + + + RR ID + T
Sbjct: 788 CDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLPG--TH 845
Query: 726 RRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAEC 785
+IS+Q+L AT+ F E+NL+GKGS G VYKG LS+G+ +A+KVFNLE +G LRSFD+EC
Sbjct: 846 EKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSEC 905
Query: 786 EILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVA 845
E++ IRHRNLV+II+ CS+ FKALVLEYMPNGSLE W+Y+ N D++QRLN++IDVA
Sbjct: 906 EVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVA 965
Query: 846 SALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGY 905
SALEYLH+D + ++HCDL P+N+LL++ MVA ++DFGI+KLL SM QT+TL TIGY
Sbjct: 966 SALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTESMQQTKTLGTIGY 1025
Query: 906 MAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961
MAPE +S K DVYSYGI+LME F++KKP DE+F G ++LK+ V +SL +I VV
Sbjct: 1026 MAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGGLTLKTWV-ESLSNSVIQVV 1084
Query: 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016
D NLL++ED L K C+SS+++LA+ CT S E+R+N+K+A+ +L K + LL
Sbjct: 1085 DANLLRREDEDLATKLSCLSSIMALALACTTNSPEKRLNMKDAVVELKKSKMKLL 1139
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204751|emb|CBI25249.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 886 bits (2290), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/1040 (49%), Positives = 667/1040 (64%), Gaps = 99/1040 (9%)
Query: 6 DQSALLALKAHVTNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIP 65
DQS+LLALKAH+T DP +VLA NWST TS C W GV+C+ + +RV AL+L+ +GL GTIP
Sbjct: 507 DQSSLLALKAHITLDPHHVLAGNWSTKTSFCEWIGVSCNAQQQRVIALDLSNLGLRGTIP 566
Query: 66 PELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEH 125
P+LGNLSFL L++++N+F G +P NL RL+ L +N+F+ IPP + + LE
Sbjct: 567 PDLGNLSFLVSLDLSSNNFHGPIPPSFGNLNRLQSLFLGNNSFTGT-IPPSIGNMSMLET 625
Query: 126 LYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPM 185
L + N +G IP +I NISSL + L++N L G +P I +PSL + L +N F+ P+
Sbjct: 626 LDIQSNQLVGAIPSAIFNISSLQEIALTYNSLSGTIPEEISFLPSLEYLYLRSNSFTSPI 685
Query: 186 PS-IYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQ--LKILSLSVNNFIGSI 242
PS I+ S L+ ID L N SG +P + + L+++ L N F G+I
Sbjct: 686 PSAIFKISTLKAID----------LGKNGFSGSMPLDIMCAHRPSLQLIGLDSNRFTGTI 735
Query: 243 PREIGNITMLKGLYLVYTNLT--------GEIQGLQVLALSSNRLTGVIPPEIINISSLT 294
IGN T L+ LYL +LT G + L VL + N LTG IP +I NISS+
Sbjct: 736 HGGIGNCTSLRELYLSSNDLTAGEVPCEIGSLCTLNVLNIEDNSLTGHIPFQIFNISSMV 795
Query: 295 VLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSG 354
SLT NNL GNLP N G LPNL+ LIL N L+G IPSSI NAS L +D YN+ +G
Sbjct: 796 SGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLSGIIPSSIGNASKLRSLDFGYNMLTG 855
Query: 355 FIPNSLGFCHPYD----------------ELGFLTSLTNCKDLRKLILSENPLSGVLPIS 398
IP++LG + EL FLTSLTNCK LR L LS NPL G+LPIS
Sbjct: 856 SIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLTNCKRLRILYLSFNPLIGILPIS 915
Query: 399 IGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLY 458
IGNLS ++ + C +KG+IP+EIGNL+NL L L N+LTG+IP +IG+LQKLQGLY
Sbjct: 916 IGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQGLY 975
Query: 459 LQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPS 518
L NKLQGSI D+C LR+L E + N+L+GS+P CL L LR L LG N+L S IPS
Sbjct: 976 LPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNSTIPS 1035
Query: 519 SLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLS 578
+LWSL IL++++SSN L G LP ++GNLKV+ KIDLSRN LSGEIPS+IG L+++ LS
Sbjct: 1036 TLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLS 1095
Query: 579 LADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH 638
LA N+F+G I S L SL F+D+S N L GEIP SL+ L LK+L++SFNGL G++P
Sbjct: 1096 LAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPP 1155
Query: 639 GGPFTNLSSQSFVGNKGLCGAPELKFPACKAKSNKIARKTDKNIFIYVFPIAASILLVLS 698
GPF N S++SF+ NK LC
Sbjct: 1156 EGPFANFSAESFMMNKALC----------------------------------------- 1174
Query: 699 LSVVLIRRQKRNTGLQIDEEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGT 758
+KRN L E TWRRISYQE+F+AT+GFS NLLG+GS GSVY+GT
Sbjct: 1175 --------RKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGT 1226
Query: 759 LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDH--FKALVLEYM 816
LSDG A+KVFNL+ E +SFDAECE++ IRHRNL+KI+S+CS+ + FKALVLEY+
Sbjct: 1227 LSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYV 1286
Query: 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV 876
PNGSLE W+Y+ N DILQRLN++IDVA A+EYLH+ TP++HCDL PSNILL+E
Sbjct: 1287 PNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFG 1346
Query: 877 ACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKK 932
+ DFGI+KLL +E S+ +TQTLATIGYMAP++ ++ GDVYSYGI+LMETFT++
Sbjct: 1347 GHVGDFGIAKLLREEESIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRR 1406
Query: 933 KPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTR 992
+PTDE+F E+S+K+ V D L G I VVD NLL+ ED EQ + + A
Sbjct: 1407 RPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGED------EQFLERLHLGANNLKG 1460
Query: 993 ESAEERINIKEALTKLLKIR 1012
ES+ + ++ +LT ++R
Sbjct: 1461 ESSIQELSFLTSLTNCKRLR 1480
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485176|ref|XP_002280075.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2283), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/1154 (44%), Positives = 704/1154 (61%), Gaps = 170/1154 (14%)
Query: 6 DQSALLALKAHVTNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIP 65
D+ +LLA+KAH+T+D +VLA+NWST TS CNWFGV+C +RV AL+L+ M L GTI
Sbjct: 34 DELSLLAMKAHITSDSKDVLATNWSTTTSYCNWFGVSCDAARQRVIALDLSNMDLEGTIA 93
Query: 66 PELGNLSFLSLLNVTNNSF----------------------------------------- 84
P++GNLSFL L+++NNSF
Sbjct: 94 PQVGNLSFLVTLDLSNNSFHASIPNEIAKCRELRQLYLFNNRLTGSIPQAIGNLSKLEQL 153
Query: 85 -------SGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWL-------------------- 117
+G +P ++S+L LK LSFRSNN ++ IP +
Sbjct: 154 YLGGNQLTGEIPREISHLLSLKILSFRSNNLTA-SIPSAIFNISSLQYIGLTYNSLSGTL 212
Query: 118 -----DSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLL 172
S PKL LYL GN G IP S+ L + LSFN+ G +P I ++ L
Sbjct: 213 PMDMCYSLPKLRGLYLSGNQLSGKIPTSLGKCGRLEEISLSFNEFMGSIPRGIGSLSVLE 272
Query: 173 AIDLSNNQFSGPMP-SIYNTSPLQNIDMQYNSLAEL---------------HLAYNQLSG 216
+ L +N G +P +++N S L+N ++ N+L + +L+ NQL G
Sbjct: 273 VLYLGSNNLEGEIPQTLFNLSSLRNFELGSNNLGGILPADMCYSLPRLQVINLSQNQLKG 332
Query: 217 QIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTG------------ 264
+IP +L C +L++L LS+N FIG IP IGN++ ++ +YL NL G
Sbjct: 333 EIPPSLSNCGELQVLGLSINEFIGRIPSGIGNLSGIEKIYLGGNNLMGTIPSSFGNLSAL 392
Query: 265 --------EIQG-----------LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLG 305
+IQG LQ L+L+SN LTG +P I NIS+L + L N+L G
Sbjct: 393 KTLYLEKNKIQGNIPKELGHLSELQYLSLASNILTGSVPEAIFNISNLQFIVLADNHLSG 452
Query: 306 NLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFC-- 363
NLPS+IG SLP L++L++GGN L+G IP+SISN + LT +D+ YNL +GF+P LG
Sbjct: 453 NLPSSIGTSLPQLEELLIGGNYLSGIIPASISNITKLTRLDLSYNLLTGFVPKDLGNLRS 512
Query: 364 --------------HPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVL 409
+ ELGFLTSL+NCK LR L + +NPL G LP S+GNLS ++ +
Sbjct: 513 LQHLGFGNNQLSGEYSTSELGFLTSLSNCKFLRNLWIQDNPLKGTLPNSLGNLSLSLQSI 572
Query: 410 YLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSIT 469
SAC KG IP+ IGNL NL L L N+LTG IP +G+L+KLQ L
Sbjct: 573 NASACQFKGVIPAGIGNLTNLIELGLGDNDLTGMIPTTLGQLKKLQRL------------ 620
Query: 470 TDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNV 529
Y GN ++GS+P + L +L L L N+L+ ++PSSLWSL +L V
Sbjct: 621 ------------YIAGNRIHGSVPNGIGHLANLVYLFLSSNQLSGLVPSSLWSLNRLLVV 668
Query: 530 NLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIP 589
NLSSN L G LPVE+G++K +TK+DLS+N SG IPS++G L + LSL+ N+ QG IP
Sbjct: 669 NLSSNFLTGDLPVEVGSMKTITKLDLSQNQFSGHIPSTMGQLGGLVELSLSKNRLQGPIP 728
Query: 590 DSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQS 649
G L SL LD+S NNLSG IP SL+AL LK+LN+SFN L+G++P GPF N +++S
Sbjct: 729 REFGNLLSLESLDLSWNNLSGAIPRSLEALVSLKYLNVSFNKLEGEIPDKGPFANFTTES 788
Query: 650 FVGNKGLCGAPELKFPACKAKSNKIARKTDKNIF-IYVFPIAASILLVLSLSVVLIRRQK 708
F+ N GLCGAP + C+ ++ +R + + P+ A+++ V + ++ RR K
Sbjct: 789 FISNAGLCGAPRFQIIECEKDASGQSRNATSFLLKCILIPVVAAMVFVAFVVLIRRRRSK 848
Query: 709 RNTGLQIDEEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVK 768
Q++ ++ RRIS+QEL AT+ F E+N++G GS G V++G LSDG +AVK
Sbjct: 849 SKAPAQVNSFHLGKL--RRISHQELIYATNYFGEDNMIGTGSLGMVHRGVLSDGSIVAVK 906
Query: 769 VFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNK 828
VFNLE +G +SFDAECEI+ +I+HRNLVKIIS+CS +FKALVLEYMPNGSLE W+Y+
Sbjct: 907 VFNLEFQGAFKSFDAECEIMRNIQHRNLVKIISSCSILNFKALVLEYMPNGSLEKWLYSH 966
Query: 829 NRSFDILQRLNMVIDVASALEYLHYDHPT-PIIHCDLNPSNILLNESMVACLSDFGISKL 887
N +++QRLN++IDVASALEYLH+D P++HCDL P+N+LL+E MVA L DFGISKL
Sbjct: 967 NYCLNLVQRLNIMIDVASALEYLHHDFSVNPVVHCDLKPNNVLLDEEMVARLGDFGISKL 1026
Query: 888 LGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI 943
L + SM QT+TL TIGYMAPE+ +S +GDVYSYGI++METF +KKPTDE+F GE+
Sbjct: 1027 LTETESMEQTRTLGTIGYMAPEYGSEGIVSTRGDVYSYGIMMMETFARKKPTDEMFGGEV 1086
Query: 944 SLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKE 1003
+L+S V +SL G+++ VVD NL+++ED + KE C+ S+++LA++CT ES +RI++KE
Sbjct: 1087 TLRSWV-ESLAGRVMEVVDGNLVRREDQHFGIKESCLRSIMALALECTTESPRDRIDMKE 1145
Query: 1004 ALTKLLKIRNTLLT 1017
+ +L KIR LL
Sbjct: 1146 VVVRLKKIRIKLLV 1159
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1029 | ||||||
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.822 | 0.825 | 0.372 | 3.1e-153 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.682 | 0.695 | 0.336 | 1.1e-94 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.660 | 0.663 | 0.355 | 9.4e-98 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.741 | 0.609 | 0.311 | 8.3e-129 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.666 | 0.679 | 0.332 | 3e-112 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.683 | 0.681 | 0.328 | 2.1e-91 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.666 | 0.678 | 0.323 | 2.5e-90 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.581 | 0.478 | 0.340 | 2.2e-121 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.838 | 0.735 | 0.328 | 3.6e-112 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.713 | 0.643 | 0.304 | 8.1e-121 |
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1336 (475.4 bits), Expect = 3.1e-153, Sum P(2) = 3.1e-153
Identities = 342/917 (37%), Positives = 486/917 (52%)
Query: 97 RLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQ 156
R+ L RS+N S I I P L + L L L N G IPP + +S L L+LS N
Sbjct: 80 RVVKLLLRSSNLSGI-ISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNS 138
Query: 157 LQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSG 216
+QG +P++I L ++DLS+NQ G +P + I L+ L+L N LSG
Sbjct: 139 IQGSIPAAIGACTKLTSLDLSHNQLRGMIP--------REIGASLKHLSNLYLYKNGLSG 190
Query: 217 QIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSS 276
+IPS L L+ LS N G+IP +G ++ L LT + L
Sbjct: 191 EIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSL---------LT--------MNLGQ 233
Query: 277 NRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSI 336
N L+G+IP I N+SSL S+ N L G +P+N +L L+ + +G NR G IP+S+
Sbjct: 234 NNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASV 293
Query: 337 SNASMLTLIDMPYNLFSGFIPNSLG----FCHPY-----------DELGFLTSLTNCKDL 381
+NAS LT+I + NLFSG I + G Y D+ GF++ LTNC L
Sbjct: 294 ANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKL 353
Query: 382 RKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGXXXXXXXXXXXXXXXX 441
+ L L EN L GVLP S NLS ++ L L I GSIP +IG
Sbjct: 354 QTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFR 413
Query: 442 GSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLIS 501
GS+P ++GRL+ L L N L GSI + L L+ N+ +G +P L +L +
Sbjct: 414 GSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTN 473
Query: 502 LRTLSLGFNRLTSVIPSSLWSLRDIXXXXXXXXXXX-GTLPVEIGNLKVVTKIDLSRNDL 560
L +L L N L+ IPS L++++ + G++P EIG+LK + + N L
Sbjct: 474 LLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRL 533
Query: 561 SGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPXXXXXXX 620
SG+IP+++GD + +++L L +N GSIP +LG L L LD+SSNNLSG+IP
Sbjct: 534 SGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADIT 593
Query: 621 XXXXXXXXXXXXQGQVPHGGPFTNLSSQSFVGNKGLCGA-PELKFPACKAKSNKIARKTD 679
G+VP G F S S GN LCG P+L P C RK
Sbjct: 594 MLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLEN--RKHF 651
Query: 680 KNIFIYV-FPXXXXXXXXXXXXXXXXRRQKRNTGLQIDEEMSPEVTWRRISYQELFRATD 738
+ I V +R K+ + + P V SY +L +ATD
Sbjct: 652 PVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSMKGHPLV-----SYSQLVKATD 706
Query: 739 GFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVK 798
GF+ NLLG GSFGSVYKG L+ +AVKV LE L+SF AECE L ++RHRNLVK
Sbjct: 707 GFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVK 766
Query: 799 IISTCSS-DH----FKALVLEYMPNGSLENWMYNKN------RSFDILQRLNMVIDVASA 847
I++ CSS D+ FKA+V ++MPNGSLE+W++ + R ++ +R+ +++DVA A
Sbjct: 767 IVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACA 826
Query: 848 LEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT-----LAT 902
L+YLH P P++HCD+ SN+LL+ MVA + DFG++++L D TS+ Q T + T
Sbjct: 827 LDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGT 886
Query: 903 IGYMAPEWKL----SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKII 958
IGY APE+ + S GD+YSYGI+++E T K+PTD F ++ L+ V LHG++
Sbjct: 887 IGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVT 946
Query: 959 NVVDINLLQKEDAYLTA 975
+VVD L+ + +L +
Sbjct: 947 DVVDTKLILDSENWLNS 963
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 942 (336.7 bits), Expect = 1.1e-94, P = 1.1e-94
Identities = 255/758 (33%), Positives = 374/758 (49%)
Query: 96 RRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFN 155
+R+ +L + I P + + L L L N F GTIP + +S L LD+ N
Sbjct: 66 KRVTHLELGRLQLGGV-ISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGIN 124
Query: 156 QLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLS 215
L+G +P + N LL + L +N+ G +PS L N L +L+L N +
Sbjct: 125 YLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPS--ELGSLTN-------LVQLNLYGNNMR 175
Query: 216 GQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALS 275
G++P++L L+ L+LS NN G IP ++ +T +I LQ++A
Sbjct: 176 GKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLT--------------QIWSLQLVA-- 219
Query: 276 SNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSS 335
N +GV PP + N+SSL +L + N+ G L ++G LPNL +GGN TG IP++
Sbjct: 220 -NNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTT 278
Query: 336 ISNASMLTLIDMPYNLFSGFIP---------------NSLGFCHPYDELGFLTSLTNCKD 380
+SN S L + M N +G IP NSLG D L FLTSLTNC
Sbjct: 279 LSNISTLERLGMNENNLTGSIPTFGNVPNLKLLFLHTNSLGSDSSRD-LEFLTSLTNCTQ 337
Query: 381 LRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGXXXXXXXXXXXXXXX 440
L L + N L G LPISI NLS + L L I GSIP +IG
Sbjct: 338 LETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNML 397
Query: 441 XGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLI 500
G +P ++G+L L+ L L N+L G I + + L N G +P L +
Sbjct: 398 SGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCS 457
Query: 501 SLRTLSLGFNRLTSVIPSSLWSLRDIXXXXXXXXXXXGTLPVEIGNLKVVTKIDLSRNDL 560
L L +G N+L IP + ++ + G+LP +IG L+ + + L N L
Sbjct: 458 HLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKL 517
Query: 561 SGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPXXXXXXX 620
SG++P ++G+ M+ L L N F G IPD L GL + +D+S+N+LSG IP
Sbjct: 518 SGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGLVGVKEVDLSNNDLSGSIPEYFASFS 576
Query: 621 XXXXXXXXXXXXQGQVPHGGPFTNLSSQSFVGNKGLCGA-PELKFPACKAKSNKIARKTD 679
+G+VP G F N ++ S VGN LCG + C +++ + +K
Sbjct: 577 KLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHS 636
Query: 680 ---KNIFIYVFPXXXXXXXXXXXXXXXX--RRQKRNTGLQIDEEMSPEVTWRRISYQELF 734
K + I V R++K+N + EV +ISY +L
Sbjct: 637 SRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLR 696
Query: 735 RATDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRH 793
AT+GFS +N++G GSFG+VYK L ++ +AVKV N++ G ++SF AECE L IRH
Sbjct: 697 NATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRH 756
Query: 794 RNLVKIISTCSS-----DHFKALVLEYMPNGSLENWMY 826
RNLVK+++ CSS + F+AL+ E+MPNGSL+ W++
Sbjct: 757 RNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLH 794
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 971 (346.9 bits), Expect = 9.4e-98, P = 9.4e-98
Identities = 264/743 (35%), Positives = 364/743 (48%)
Query: 128 LDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPS 187
L G G + P + N+S L +L+L+ N G +PS + N+ L +++SNN F G +P
Sbjct: 88 LGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPV 147
Query: 188 IY-NTSPLQNIDMQYNSLAE--------------LHLAYNQLSGQIPSTLFECKQLKILS 232
+ N S L +D+ N L + L L N L+G+ P++L L++L
Sbjct: 148 VLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLD 207
Query: 233 LSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISS 292
N G IP G+I LK +++ + AL N+ GV PP I N+SS
Sbjct: 208 FIYNQIEGEIP---GDIARLK--QMIFFRI----------AL--NKFNGVFPPPIYNLSS 250
Query: 293 LTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLF 352
L LS+T N+ G L + G LPNLQ L +G N TG IP ++SN S L +D+P N
Sbjct: 251 LIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHL 310
Query: 353 SGFIP----------------NSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLP 396
+G IP NSLG + +L FL +LTNC L+ L + N L G LP
Sbjct: 311 TGKIPLSFGRLQNLLLLGLNNNSLGN-YSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLP 369
Query: 397 ISIGNLSNAMDVLYLSACNIKGSIPSEIGXXXXXXXXXXXXXXXXGSIPKAIGRLQKLQG 456
+ I NLS + L L I GSIP IG G +P ++G L +L+
Sbjct: 370 VFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRK 429
Query: 457 LYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVI 516
+ L N L G I + L + L+ Y N GS+P L S L L+LG N+L I
Sbjct: 430 VLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSI 489
Query: 517 PSSLWSLRDIXXXXXXXXXXXGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQH 576
P L L + G L +IG LK + +D+S N LSG+IP ++ + +++
Sbjct: 490 PHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEF 549
Query: 577 LSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPXXXXXXXXXXXXXXXXXXXQGQV 636
L L N F G IPD + GLT L FLD+S NNLSG IP G V
Sbjct: 550 LLLQGNSFVGPIPD-IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAV 608
Query: 637 PHGGPFTNLSSQSFVGNKGLCGA-PELKFPACKAKSNKIARKTDKNIFIYVFPXXXXXXX 695
P G F N S+ S GN LCG P L+ C + + K I I V
Sbjct: 609 PTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLL 668
Query: 696 XXXXXXXX---XRRQK--RNTGLQIDEEMSPEVT-WRRISYQELFRATDGFSENNLLGKG 749
R K R + D SP + + +ISY EL++ T GFS +NL+G G
Sbjct: 669 LCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSG 728
Query: 750 SFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS--- 805
+FG+V+KG L S +A+KV NL G +SF AECE LG IRHRNLVK+++ CSS
Sbjct: 729 NFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDF 788
Query: 806 --DHFKALVLEYMPNGSLENWMY 826
+ F+ALV E+MPNG+L+ W++
Sbjct: 789 EGNDFRALVYEFMPNGNLDMWLH 811
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 838 (300.0 bits), Expect = 8.3e-129, Sum P(2) = 8.3e-129
Identities = 255/818 (31%), Positives = 379/818 (46%)
Query: 46 RHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRS 105
R + + LNL G IP +LG+L + LN+ N G +P +L+ L L+ L S
Sbjct: 238 RLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSS 297
Query: 106 NNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSIC-NISSLLTLDLSFNQLQGHVPSS 164
NN + + I +LE L L N G++P +IC N +SL L LS QL G +P+
Sbjct: 298 NNLTGV-IHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAE 356
Query: 165 ILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFE 224
I N SL +DLSNN +G +P S Q ++ L L+L N L G + S++
Sbjct: 357 ISNCQSLKLLDLSNNTLTGQIPD----SLFQLVE-----LTNLYLNNNSLEGTLSSSISN 407
Query: 225 CKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQ---G----LQVLALSSN 277
L+ +L NN G +P+EIG + L+ +YL +GE+ G LQ + N
Sbjct: 408 LTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGN 467
Query: 278 RLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSIS 337
RL+G IP I + LT L L N L+GN+P+++G+ + + L N+L+G IPSS
Sbjct: 468 RLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNC-HQMTVIDLADNQLSGSIPSSFG 526
Query: 338 NASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTN------CKDLRKLI--LSEN 389
+ L L + N G +P+SL + F ++ N C L ++EN
Sbjct: 527 FLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTEN 586
Query: 390 PLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGXXXXXXXXXXXXXXXXGSIPKAIG 449
G +P+ +G +N +D L L G IP G G IP +G
Sbjct: 587 GFEGDIPLELGKSTN-LDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELG 645
Query: 450 RLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGF 509
+KL + L +N L G I T L L L E N+ GSLP + SL ++ TL L
Sbjct: 646 LCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDG 705
Query: 510 NRLTSVIPSSLWSLRDIXXXXXXXXXXXGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIG 569
N L IP + +L+ + G LP IG L + ++ LSRN L+GEIP IG
Sbjct: 706 NSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIG 765
Query: 570 DLKNMQH-LSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPXXXXXXXXXXXXXXX 628
L+++Q L L+ N F G IP ++ L L LD+S N L GE+P
Sbjct: 766 QLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLS 825
Query: 629 XXXXQGQVPHGGPFTNLSSQSFVGNKGLCGAPELKFPACKAKSNKIARK-TDKNIFIYVF 687
+G++ F+ + +FVGN GLCG+P C +K R + K + I
Sbjct: 826 YNNLEGKLKK--QFSRWQADAFVGNAGLCGSP---LSHCNRAGSKNQRSLSPKTVVIISA 880
Query: 688 PXXXXXXXXXXXXXXXXRRQKR---------NTGLQIDEEMSPEVTWRR------ISYQE 732
+Q N+ + S + I + +
Sbjct: 881 ISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDD 940
Query: 733 LFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVK--VFNLELEGTLRSFDAECEILGS 790
+ AT +E ++G G G VYK L +G IAVK ++ +L +SF+ E + LG+
Sbjct: 941 IMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSN-KSFNREVKTLGT 999
Query: 791 IRHRNLVKIISTCSS--DHFKALVLEYMPNGSLENWMY 826
IRHR+LVK++ CSS D L+ EYM NGS+ +W++
Sbjct: 1000 IRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLH 1037
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 955 (341.2 bits), Expect = 3.0e-112, Sum P(2) = 3.0e-112
Identities = 246/740 (33%), Positives = 370/740 (50%)
Query: 113 IPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLL 172
I P + + L +L L NSF GTIP + N+ L L + FN L+G +P+S+ N LL
Sbjct: 82 ISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLL 141
Query: 173 AIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILS 232
+DL +N +PS L ++ L L+L N L G+ P + L +L+
Sbjct: 142 YLDLFSNNLGDGVPS-----ELGSL----RKLLYLYLGLNDLKGKFPVFIRNLTSLIVLN 192
Query: 233 LSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISS 292
L N+ G IP +I ++ + +LT L+ N +GV PP N+SS
Sbjct: 193 LGYNHLEGEIPDDIAMLSQM-------VSLT----------LTMNNFSGVFPPAFYNLSS 235
Query: 293 LTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLF 352
L L L N GNL + G+ LPN+ +L L GN LTG IP++++N S L + + N
Sbjct: 236 LENLYLLGNGFSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRM 295
Query: 353 SGFI-PN---------------SLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLP 396
+G I PN SLG + + +L FL +LTNC L L +S N L G LP
Sbjct: 296 TGSISPNFGKLENLHYLELANNSLG-SYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALP 354
Query: 397 ISIGNLSNAMDVLYLSACNIKGSIPSEIGXXXXXXXXXXXXXXXXGSIPKAIGRLQKLQG 456
SI N+S + VL L I GSIP +IG G +P ++G L L
Sbjct: 355 TSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGE 414
Query: 457 LYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVI 516
L L N+ G I + + L L + Y N G +P L + L +G+N+L I
Sbjct: 415 LILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTI 474
Query: 517 PSSLWSLRDIXXXXXXXXXXXGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQH 576
P + + + G+LP +IG L+ + ++ L N+LSG +P ++G +M+
Sbjct: 475 PKEIMQIPTLVHLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEV 534
Query: 577 LSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPXXXXXXXXXXXXXXXXXXXQGQV 636
+ L +N F G+IPD + GL + +D+S+NNLSG I +G+V
Sbjct: 535 IYLQENHFDGTIPD-IKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRV 593
Query: 637 PHGGPFTNLSSQSFVGNKGLCGA-PELKFPACKAKSNKIARKTD---KNIFIYVFPXXXX 692
P G F N + S GNK LCG+ ELK C A++ + + K + I V
Sbjct: 594 PTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIAL 653
Query: 693 XXXXXXXXXXXXRRQKRNTGLQIDEEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFG 752
+++K N + + E+ ++SY +L ATDGFS +N++G GSFG
Sbjct: 654 LLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFG 713
Query: 753 SVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS-----D 806
+V+K L ++ +AVKV N++ G ++SF AECE L IRHRNLVK+++ C+S +
Sbjct: 714 TVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGN 773
Query: 807 HFKALVLEYMPNGSLENWMY 826
F+AL+ E+MPNGSL+ W++
Sbjct: 774 EFRALIYEFMPNGSLDKWLH 793
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 911 (325.7 bits), Expect = 2.1e-91, P = 2.1e-91
Identities = 250/760 (32%), Positives = 368/760 (48%)
Query: 96 RRLKYLSFRSNNFSSIE-IPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSF 154
RR + +S F I P + + L L L NSF TIP + + L L++S+
Sbjct: 71 RRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSY 130
Query: 155 NQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQL 214
N L+G +PSS+ N L +DLS+N +PS L ++ + LA L L+ N L
Sbjct: 131 NLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPS-----ELGSL----SKLAILDLSKNNL 181
Query: 215 SGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLAL 274
+G P++L L+ L + N G IP E+ +T + V+ Q+ AL
Sbjct: 182 TGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQM-----VF---------FQI-AL 226
Query: 275 SSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPS 334
+S +G PP + NISSL LSL N+ GNL ++ G+ LPNL++L+LG N+ TG IP
Sbjct: 227 NS--FSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPK 284
Query: 335 SISNASMLTLIDMPYNLFSGFIPNSLGFCHPY-------DELG--------FLTSLTNCK 379
+++N S L D+ N SG IP S G + LG F+ ++ NC
Sbjct: 285 TLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCT 344
Query: 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGXXXXXXXXXXXXXX 439
L L + N L G LP SI NLS + L+L I G+IP +IG
Sbjct: 345 QLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNM 404
Query: 440 XXGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSL 499
G +P + G+L LQ + L N + G I + + L + + + N +G +PQ L
Sbjct: 405 LSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRC 464
Query: 500 ISLRTLSLGFNRLTSVIPSSLWSLRDIXXXXXXXXXXXGTLPVEIGNLKVVTKIDLSRND 559
L L + NRL IP + + + G P E+G L+++ + S N
Sbjct: 465 RYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNK 524
Query: 560 LSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPXXXXXX 619
LSG++P +IG +M+ L + N F G+IPD + L SL +D S+NNLSG IP
Sbjct: 525 LSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASL 583
Query: 620 XXXXXXXXXXXXXQGQVPHGGPFTNLSSQSFVGNKGLCGAP-ELKFPACKAKSNKIARK- 677
+G+VP G F N ++ S GN +CG E++ C +++ RK
Sbjct: 584 PSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKP 643
Query: 678 --TDKNIF--IYVFPXXXXXXXXXXXXXXXXRRQKRNTGLQIDEEMSPEVTW--RRISYQ 731
K + I + +R+K+N + S + ++SY+
Sbjct: 644 LSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYE 703
Query: 732 ELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGS 790
EL AT FS NL+G G+FG+V+KG L + +AVKV NL G +SF AECE
Sbjct: 704 ELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKG 763
Query: 791 IRHRNLVKIISTCSS-----DHFKALVLEYMPNGSLENWM 825
IRHRNLVK+I+ CSS + F+ALV E+MP GSL+ W+
Sbjct: 764 IRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWL 803
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 901 (322.2 bits), Expect = 2.5e-90, P = 2.5e-90
Identities = 242/748 (32%), Positives = 369/748 (49%)
Query: 122 KLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQF 181
++ HL L G G + PSI N+S L++LDLS N G +P + N+ L + ++ N
Sbjct: 67 RVTHLNLGGLQLGGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSL 126
Query: 182 SGPMPS-IYNTSPLQNIDMQYNSLAE--------------LHLAYNQLSGQIPSTLFECK 226
G +P+ + N S L N+D+ N L + L L N L G++P +L
Sbjct: 127 EGGIPATLSNCSRLLNLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLT 186
Query: 227 QLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPE 286
LK L + NN G +P E+ ++ + GL LS N+ GV PP
Sbjct: 187 SLKSLGFTDNNIEGEVPDELARLSQMVGL-----------------GLSMNKFFGVFPPA 229
Query: 287 IINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLID 346
I N+S+L L L + G+L + G+ LPN+++L LG N L G IP+++SN S L
Sbjct: 230 IYNLSALEDLFLFGSGFSGSLKPDFGNLLPNIRELNLGENDLVGAIPTTLSNISTLQKFG 289
Query: 347 MPYNLFSGFI-PN-----SLGFC----HP-----YDELGFLTSLTNCKDLRKLILSENPL 391
+ N+ +G I PN SL + +P + +L F+ SLTNC L+ L + L
Sbjct: 290 INKNMMTGGIYPNFGKVPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRL 349
Query: 392 SGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGXXXXXXXXXXXXXXXXGSIPKAIGRL 451
G LP SI N+S + L L + GSIP +IG G +P ++G+L
Sbjct: 350 GGALPTSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKL 409
Query: 452 QKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNR 511
+L L L N++ G I + + L L Y N G +P L + L +G+N+
Sbjct: 410 LRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNK 469
Query: 512 LTSVIPSSLWSLRDIXXXXXXXXXXXGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDL 571
L IP + + + G+LP +IG+L+ + K+ L N SG +P ++G+
Sbjct: 470 LNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNC 529
Query: 572 KNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPXXXXXXXXXXXXXXXXXX 631
M+ L L N F G+IP+ + GL + +D+S+N+LSG IP
Sbjct: 530 LAMEQLFLQGNSFDGAIPN-IRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINN 588
Query: 632 XQGQVPHGGPFTNLSSQSFV-GNKGLCGA-PELKFPACKAKSNKIARKTD---KNIFIYV 686
G+VP G F N S+ FV GNK LCG +LK C A+ + K K + I V
Sbjct: 589 FTGKVPSKGNFQN-STIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILV 647
Query: 687 FPXXXXXXXXXXXXXXXXRRQKRNTGLQIDEEMSP--EVTWRRISYQELFRATDGFSENN 744
+KR Q + + E+ +ISY +L AT+GFS +N
Sbjct: 648 SIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSN 707
Query: 745 LLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
++G GSFG+V+K L ++ +AVKV N++ G ++SF AECE L RHRNLVK+++ C
Sbjct: 708 MVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTAC 767
Query: 804 SS-----DHFKALVLEYMPNGSLENWMY 826
+S + F+AL+ EY+PNGS++ W++
Sbjct: 768 ASTDFQGNEFRALIYEYLPNGSVDMWLH 795
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 776 (278.2 bits), Expect = 2.2e-121, Sum P(2) = 2.2e-121
Identities = 215/631 (34%), Positives = 320/631 (50%)
Query: 3 VGRDQSALLALKAH-VTNDPLNVLASNW-STNTSVCNWFGVTCSPRHR-RVTALNLAYMG 59
+ D LL +K VTN + W S N + C+W GVTC RV ALNL +G
Sbjct: 23 INNDLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTGLFRVIALNLTGLG 82
Query: 60 LLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDS 119
L G+I P G L L++++N+ G +P LSNL L+ L SN + EIP L S
Sbjct: 83 LTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTG-EIPSQLGS 141
Query: 120 FPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNN 179
+ L + N +G IP ++ N+ +L L L+ +L G +PS + + + ++ L +N
Sbjct: 142 LVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQDN 201
Query: 180 QFSGPMPS-IYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNF 238
GP+P+ + N S D+ + AE N L+G IP+ L + L+IL+L+ N+
Sbjct: 202 YLEGPIPAELGNCS-----DLTVFTAAE-----NMLNGTIPAELGRLENLEILNLANNSL 251
Query: 239 IGSIPREIGNITMLKGLYLVYTNLTG-------EIQGLQVLALSSNRLTGVIPPEIINIS 291
G IP ++G ++ L+ L L+ L G ++ LQ L LS+N LTG IP E N+S
Sbjct: 252 TGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMS 311
Query: 292 SLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNL 351
L L L N+L G+LP +I + NL+QL+L G +L+G IP +S L +D+ N
Sbjct: 312 QLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNS 371
Query: 352 FSGFIPNSLG--------FCHPYDELGFLT-SLTNCKDLRKLILSENPLSGVLPISIGNL 402
+G IP +L + H G L+ S++N +L+ L+L N L G LP I L
Sbjct: 372 LAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISAL 431
Query: 403 SNAMDVLYLSACNIKGSIPSEIGXXXXXXXXXXXXXXXXGSIPKAIGRLQKLQGLYLQHN 462
++VL+L G IP EIG G IP +IGRL++L L+L+ N
Sbjct: 432 RK-LEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQN 490
Query: 463 KLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWS 522
+L G + L L+ N+L+GS+P L L L L N L +P SL S
Sbjct: 491 ELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLIS 550
Query: 523 LRDIXXXXXXXXXXXGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADN 582
LR++ GT+ G+ ++ D++ N EIP +G+ +N+ L L N
Sbjct: 551 LRNLTRINLSHNRLNGTIHPLCGSSSYLS-FDVTNNGFEDEIPLELGNSQNLDRLRLGKN 609
Query: 583 KFQGSIPDSLGGLTSLNFLDMSSNNLSGEIP 613
+ G IP +LG + L+ LDMSSN L+G IP
Sbjct: 610 QLTGKIPWTLGKIRELSLLDMSSNALTGTIP 640
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1107 (394.7 bits), Expect = 3.6e-112, P = 3.6e-112
Identities = 301/917 (32%), Positives = 454/917 (49%)
Query: 57 YMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPW 116
Y L G IP LG+L L + N +G++P+ + L L L N + +IP
Sbjct: 177 YNNLTGKIPECLGDLVHLQMFVAAGNHLTGSIPVSIGTLANLTDLDLSGNQLTG-KIPRD 235
Query: 117 LDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDL 176
+ L+ L L N G IP I N SSL+ L+L NQL G +P+ + N+ L A+ +
Sbjct: 236 FGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRI 295
Query: 177 SNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVN 236
N+ + +PS + L L L+ N L G I + + L++L+L N
Sbjct: 296 YKNKLTSSIPSSL---------FRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSN 346
Query: 237 NFIGSIPREIGNITMLKGLYLVYTNLTGEIQG-------LQVLALSSNRLTGVIPPEIIN 289
NF G P+ I N+ L L + + N++GE+ L+ L+ N LTG IP I N
Sbjct: 347 NFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISN 406
Query: 290 ISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPY 349
+ L +L L+ N + G +P G NL + +G N TG IP I N S L + +
Sbjct: 407 CTGLKLLDLSHNQMTGEIPRGFGRM--NLTFISIGRNHFTGEIPDDIFNCSNLETLSVAD 464
Query: 350 NLFSGFIPNSLGFCHP-------YDEL-GFLT-SLTNCKDLRKLILSENPLSGVLPISIG 400
N +G + +G Y+ L G + + N KDL L L N +G +P +
Sbjct: 465 NNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMS 524
Query: 401 NLSNAMDVLYLSACNIKGSIPSEIGXXXXXXXXXXXXXXXXGSIPKAIGRLQKLQGLYLQ 460
NL+ + L + + +++G IP E+ G IP +L+ L L LQ
Sbjct: 525 NLT-LLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQ 583
Query: 461 HNKLQGSITTDLCGLRSLSEFYSDGNELNGSLP-QCLDSLISLRT-LSLGFNRLTSVIPS 518
NK GSI L L L+ F N L G++P + L SL +++ L+ N LT IP
Sbjct: 584 GNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPK 643
Query: 519 SLWSLRDIXXXXXXXXXXXGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQ-HL 577
L L + G++P + K V +D S+N+LSG IP + +M L
Sbjct: 644 ELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISL 703
Query: 578 SLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPXXXXXXXXXXXXXXXXXXXQGQVP 637
+L+ N F G IP S G +T L LD+SSNNL+GEIP +G VP
Sbjct: 704 NLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVP 763
Query: 638 HGGPFTNLSSQSFVGNKGLCGAPE-LKFPACKAKSNKIARKTDKNIFIYVFPXXXXXXXX 696
G F N+++ +GN LCG+ + LK K KS+ +++T + + +
Sbjct: 764 ESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRT--RVILIILGSAAALLLV 821
Query: 697 XXXXXXXXRRQKRNTGLQIDEEMS-PEVT----WRRISYQELFRATDGFSENNLLGKGSF 751
+K+ ++ E S P++ +R +EL +ATD F+ N++G S
Sbjct: 822 LLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSL 881
Query: 752 GSVYKGTLSDGMQIAVKVFNLELEGTLRS---FDAECEILGSIRHRNLVKIISTC-SSDH 807
+VYKG L DG IAVKV NL+ E + S F E + L ++HRNLVKI+ S
Sbjct: 882 STVYKGQLEDGTVIAVKVLNLK-EFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGK 940
Query: 808 FKALVLEYMPNGSLENWMYNKNRSF-DILQRLNMVIDVASALEYLHYDHPTPIIHCDLNP 866
KALVL +M NG+LE+ ++ +L+++++ + +AS ++YLH + PI+HCDL P
Sbjct: 941 TKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKP 1000
Query: 867 SNILLNESMVACLSDFGISKLLG-DETSMTQTQTLA---TIGYMAPEW----KLSRKGDV 918
+NILL+ VA +SDFG +++LG E T T A TIGY+APE+ K++ K DV
Sbjct: 1001 ANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADV 1060
Query: 919 YSYGIILMETFTKKKPT 935
+S+GII+ME TK++PT
Sbjct: 1061 FSFGIIMMELMTKQRPT 1077
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 814 (291.6 bits), Expect = 8.1e-121, Sum P(2) = 8.1e-121
Identities = 236/776 (30%), Positives = 362/776 (46%)
Query: 21 PLNVLASNWST--NTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLN 78
P ++ NW++ NT NW +TCS + +T +++ + L ++P L L L
Sbjct: 53 PSSLSLFNWNSIDNTPCNNWTFITCSSQGF-ITDIDIESVPLQLSLPKNLPAFRSLQKLT 111
Query: 79 VTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIP 138
++ + +GTLP L + LK L SN +IP L LE L L+ N G IP
Sbjct: 112 ISGANLTGTLPESLGDCLGLKVLDLSSNGLVG-DIPWSLSKLRNLETLILNSNQLTGKIP 170
Query: 139 PSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNN-QFSGPMPSIYNTSPLQNI 197
P I S L +L L N L G +P+ + + L I + N + SG +PS
Sbjct: 171 PDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDC----- 225
Query: 198 DMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYL 257
++L L LA +SG +PS+L + K+L+ LS+ G IP ++GN + L L+L
Sbjct: 226 ----SNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFL 281
Query: 258 VYTNLTGEIQ---G----LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSN 310
+L+G I G L+ L L N L G IP EI N S+L ++ L+ N L G++PS+
Sbjct: 282 YENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSS 341
Query: 311 IGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLG-------FC 363
IG L L++ ++ N+ +G IP++ISN S L + + N SG IP+ LG F
Sbjct: 342 IGR-LSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFF 400
Query: 364 HPYDEL-GFLT-SLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIP 421
++L G + L +C DL+ L LS N L+G +P + L N +L +S ++ G IP
Sbjct: 401 AWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISN-SLSGFIP 459
Query: 422 SEIGXXXXXXXXXXXXXXXXGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEF 481
EIG G IP IG L+K+ L N+L G + ++ L
Sbjct: 460 QEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMI 519
Query: 482 YSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDIXXXXXXXXXXXGTLP 541
N L GSLP + SL L+ L + N+ + IP+SL L + G++P
Sbjct: 520 DLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIP 579
Query: 542 VEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQ-HLSLADNKFQGSIPDSLGGLTSLNF 600
+G + +DL N+LSGEIPS +GD++N++ L+L+ N+ G IP + L L+
Sbjct: 580 TSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSI 639
Query: 601 LDMSSNNLSGEIPXXXXXXXXXXXXXXXXXXXQGQVPHGGPFTNLSSQSFVGNKGLCGAP 660
LD+S N L G++ G +P F LS Q GNK LC +
Sbjct: 640 LDLSHNMLEGDL-APLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSST 698
Query: 661 ELKFPACKAKSNKIARKTD----KNIFIYVFPXXXXXXXXXXXXXXXXRRQKRNTGLQID 716
+ K N + D + + + + R +RN + D
Sbjct: 699 QDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERD 758
Query: 717 EEMSPEVTWRRISYQELFRATDGFS----ENNLLGKGSFGSVYKGTLSDGMQIAVK 768
E+ W+ +Q+L + D E N++GKG G VY+ + +G IAVK
Sbjct: 759 SELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVK 814
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3756 | 0.8785 | 0.8950 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00025217001 | SubName- Full=Chromosome chr9 scaffold_33, whole genome shotgun sequence; (2202 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1029 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-111 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-19 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 8e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-04 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 4e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.002 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.002 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.003 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.004 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 368 bits (945), Expect = e-111
Identities = 311/1020 (30%), Positives = 473/1020 (46%), Gaps = 126/1020 (12%)
Query: 10 LLALKAHVTNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELG 69
LL+ K+ + NDPL L SNW+++ VC W G+TC+ RV +++L+ + G I +
Sbjct: 34 LLSFKSSI-NDPLKYL-SNWNSSADVCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIF 90
Query: 70 NLSFLSLLNVTNNSFSGTLPIQLSNL-RRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYL 128
L ++ +N++NN SG +P + L+YL+ +NNF+ IP S P LE L L
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG-SIPR--GSIPNLETLDL 147
Query: 129 DGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSI 188
N G IP I + SSL LDL N L G +P+S+ N+ SL +F
Sbjct: 148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSL--------EF------- 192
Query: 189 YNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGN 248
L LA NQL GQIP L + K LK + L NN G IP EIG
Sbjct: 193 ------------------LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG 234
Query: 249 ITMLKGLYLVYTNLTGEI-------QGLQVLALSSNRLTGVIPPEIINISSLTVLSLTAN 301
+T L L LVY NLTG I + LQ L L N+L+G IPP I ++ L L L+ N
Sbjct: 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294
Query: 302 NLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLG 361
+L G +P + L NL+ L L N TG IP ++++ L ++ + N FSG IP +LG
Sbjct: 295 SLSGEIPELVIQ-LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLG 353
Query: 362 FCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIP 421
N + VL LS N+ G IP
Sbjct: 354 ----------------------------------------KHNNLTVLDLSTNNLTGEIP 373
Query: 422 SEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEF 481
+ + NL L L +N L G IPK++G + L+ + LQ N G + ++ L +
Sbjct: 374 EGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433
Query: 482 YSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLP 541
N L G + + SL+ LSL N+ +P S S R + N++LS N +G +P
Sbjct: 434 DISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKR-LENLDLSRNQFSGAVP 492
Query: 542 VEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFL 601
++G+L + ++ LS N LSGEIP + K + L L+ N+ G IP S + L+ L
Sbjct: 493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQL 552
Query: 602 DMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPE 661
D+S N LSGEIP +L + L +N+S N L G +P G F +++ + GN LCG
Sbjct: 553 DLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDT 612
Query: 662 LK-FPACKAKSNKIARKTDKNIFIYVFPIAASILLVLSLSVVLIRRQKRNTGLQIDEEMS 720
P C K RKT F + A ++L L + R + N L+ E
Sbjct: 613 TSGLPPC-----KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVEN-- 665
Query: 721 PEVTWRRISYQELFRAT-------DGFSENNLLGKGSFGSVYKG-TLSDGMQIAVKVFNL 772
+ TW + + E N++ +G G+ YKG ++ +GMQ VK N
Sbjct: 666 EDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN- 724
Query: 773 ELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSF 832
++ S A+ +G ++H N+VK+I C S+ L+ EY+ +L + R+
Sbjct: 725 DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNL 777
Query: 833 DILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892
+R + I +A AL +LH ++ +L+P I+++ L + LL
Sbjct: 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL---- 832
Query: 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSR 948
T T+ + Y+APE + ++ K D+Y +G+IL+E T K P D F S+
Sbjct: 833 -CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891
Query: 949 VNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008
+++ I+ + D + E + V++LA+ CT R + L L
Sbjct: 892 ARYCYSDCHLDMW-IDPSIRGDVSVNQNE--IVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 1e-46
Identities = 67/190 (35%), Positives = 99/190 (52%), Gaps = 12/190 (6%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLR-SFDAECEILGSIRHRNLVKIISTC 803
LG+G FG+VY G ++A+K+ E +L E EIL + H N+VK+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
++ LV+EY GSL++ + + L +++ + LEYLH IIH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117
Query: 864 LNPSNILLNE-SMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE-----WKLSRKGD 917
L P NILL+ + L+DFG+SKLL + S+ +T + T YMAPE S K D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKSD 176
Query: 918 VYSYGIILME 927
++S G+IL E
Sbjct: 177 IWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 9e-44
Identities = 69/197 (35%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNL--ELEGTLRSFDAECEILGSIRHRNLVKIIST 802
LG GSFG+VYK G +AVK+ E ++ E IL + H N+V++I
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
LV+EY G L +++ ++ + + + + LEYLH + IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLHSNG---IIHR 122
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL-----SRKGD 917
DL P NILL+E+ V ++DFG++K L +S T T YMAPE L K D
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVD 181
Query: 918 VYSYGIILMETFTKKKP 934
V+S G+IL E T K P
Sbjct: 182 VWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 75/270 (27%), Positives = 114/270 (42%), Gaps = 31/270 (11%)
Query: 744 NLLGKGSFGSVYKGT-LSDGMQIAVKVFNLE-LEGTLRSFDAECEILGSIRHRNLVKIIS 801
LG+GSFG VY G +A+KV + ++ E +IL ++H N+V++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIH 861
+ LV+EY G L + + K + + + SALEYLH I+H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLHSKG---IVH 120
Query: 862 CDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGD 917
DL P NILL+E L+DFG+++ L + T + T YMAPE + D
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 918 VYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKE 977
++S G+IL E T K P F G+ L + K E
Sbjct: 179 IWSLGVILYELLTGKPP----FPGDDQLL--------------ELFKKIGKPKPPFPPPE 220
Query: 978 QCVS-SVLSLAMQCTRESAEERINIKEALT 1006
+S L + + E+R+ +EAL
Sbjct: 221 WDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 149 bits (380), Expect = 2e-40
Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 20/199 (10%)
Query: 746 LGKGSFGSVYKGTL-----SDGMQIAVKVFNLELEGT----LRSFDAECEILGSIRHRNL 796
LG+G+FG VYKGTL ++AVK EG F E I+ + H N+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEEREEFLEEASIMKKLSHPNI 63
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
V+++ C+ +V EYMP G L +++ + L M + +A +EYL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE-SK- 121
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLL-GDETSMTQTQTLATIGYMAPE----WK 911
+H DL N L+ E++V +SDFG+S+ + D+ + I +MAPE K
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 912 LSRKGDVYSYGIILMETFT 930
+ K DV+S+G++L E FT
Sbjct: 181 FTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 35/278 (12%)
Query: 743 NNLLGKGSFGSVYKGTLSDG-----MQIAVKVFNLE-LEGTLRSFDAECEILGSIRHRNL 796
LG+G+FG VYKGTL +++AVK + E + F E I+ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWM-YNKNRSFDILQRLNMVIDVASALEYLHYDH 855
VK++ C+ + +V+EYMP G L +++ N+ + + L+ + +A +EYL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE-SK 122
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE-WKLSR 914
IH DL N L+ E++V +SDFG+S+ L D+ I +MAPE K +
Sbjct: 123 N--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 915 ---KGDVYSYGIILMETFTK-KKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970
K DV+S+G++L E FT ++P + N + + K+
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGM----------SNAEVLEYL----------KKG 220
Query: 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008
L C + L +QC E E+R E + L
Sbjct: 221 YRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 76/277 (27%), Positives = 124/277 (44%), Gaps = 34/277 (12%)
Query: 743 NNLLGKGSFGSVYKGTLSD-----GMQIAVKVFNLE-LEGTLRSFDAECEILGSIRHRNL 796
LG+G+FG VYKG L +++AVK + E + F E I+ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
VK++ C+ + +V+EYM G L +++ + L+ + +A +EYL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE-SK- 121
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE-WKLSR- 914
IH DL N L+ E++V +SDFG+S+ L D+ + I +MAPE K +
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 915 --KGDVYSYGIILMETFTK-KKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971
K DV+S+G++L E FT ++P + N+ + + K
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPYPGM----------SNEEVLEYL----------KNGY 220
Query: 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008
L C + L +QC E E+R E + L
Sbjct: 221 RLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 744 NLLGKGSFGSVYKGTLSD-GMQIAVKVFNLE--LEGTLRSFDAECEILGSIRHRNLVKII 800
LLG+GSFGSVY D G +AVK L E L + + E IL S++H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 801 STCSSDHFKAL--VLEYMPNGSLENWMYNKNRSFD--ILQRLNMVIDVASALEYLHYDHP 856
+ + L LEY+ GSL + + K ++++ + L YLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKY--TRQILEGLAYLHSNG- 121
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA-TIGYMAPEW----K 911
I+H D+ +NIL++ V L+DFG +K LGD + T ++ T +MAPE +
Sbjct: 122 --IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 912 LSRKGDVYSYGIILMETFTKKKP 934
R D++S G ++E T K P
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 42/284 (14%)
Query: 744 NLLGKGSFGSVYKGTLSDG----MQIAVKVFNLE-LEGTLRSFDAECEILGSIRHRNLVK 798
LG+G+FG VYKG L ++AVK + E + F E ++ + H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 799 IISTCSSDHFKALVLEYMPNGSL--------ENWMYNKNRSFDILQRLNMVIDVASALEY 850
++ C+ + LVLEYM G L + + + + L+ I +A +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS-MTQTQTLATIGYMAPE 909
L +H DL N L+ E +V +SDFG+S+ + D+ +T I +MAPE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 910 ----WKLSRKGDVYSYGIILMETFTK-KKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964
+ K DV+S+G++L E FT P L N+ + +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL----------SNEEVLEYL------- 220
Query: 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008
++ L E C + L + C + E+R E + +L
Sbjct: 221 ---RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 70/233 (30%), Positives = 105/233 (45%), Gaps = 37/233 (15%)
Query: 744 NLLGKGSFGSVYKGT-LSDGMQIAVKVFNL------ELEGTLRSFDAECEILGSIRHRNL 796
+GKGSFG VY SDG +K +L E E L E +IL + H N+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61
Query: 797 VKIISTCSSDHFKA-----LVLEYMPNGSLENWMYNKNRSFDIL---QRLNMVIDVASAL 848
+K + F+ +V+EY G L + + + Q L+ + + AL
Sbjct: 62 IKYY-----ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAP 908
+YLH I+H D+ P NI L + + L DFGISK+L + +T + T Y++P
Sbjct: 117 KYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSP 172
Query: 909 E-WK---LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKI 957
E + + K D++S G +L E T K P F GE +L L G+
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE-NLLELALKILKGQY 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 64/191 (33%), Positives = 104/191 (54%), Gaps = 14/191 (7%)
Query: 745 LLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+GKG FG V G G ++AVK + ++F AE ++ ++RH NLV+++
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDIL-QRLNMVIDVASALEYLHYDHPTPIIHCD 863
+ +V EYM GSL +++ ++ R+ L Q+L +DV +EYL + +H D
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRD 127
Query: 864 LNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGDVY 919
L N+L++E +VA +SDFG++K E S Q + + APE K S K DV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 920 SYGIILMETFT 930
S+GI+L E ++
Sbjct: 184 SFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 38/209 (18%)
Query: 746 LGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRS-FDAECEILGSIRHRNLVKIISTC 803
LG+GS G VYK G A+K +++ + R E + L S +VK C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 804 SSDHFK----ALVLEYMPNGSLENWMYNKNRSFDILQRLNMV---------IDVASALEY 850
+K ++VLEYM GSL D+L+++ + + L+Y
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLA----------DLLKKVGKIPEPVLAYIARQILKGLDY 114
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT-LATIGYMAPE 909
LH IIH D+ PSN+L+N ++DFGISK+L E ++ Q T + T+ YM+PE
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPE 170
Query: 910 W----KLSRKGDVYSYGIILMETFTKKKP 934
S D++S G+ L+E K P
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 68/193 (35%), Positives = 101/193 (52%), Gaps = 9/193 (4%)
Query: 745 LLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLR-SFDAECEILGSIRHRNLVKIISTC 803
+GKG+FG VYKG L ++AVK L L+ F E EIL H N+VK+I C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
+V+E +P GSL ++ K + + L M +D A+ +EYL + IH D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 864 LNPSNILLNESMVACLSDFGISKL-LGDETSMTQTQTLATIGYMAPE----WKLSRKGDV 918
L N L+ E+ V +SDFG+S+ G +++ I + APE + + + DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 919 YSYGIILMETFTK 931
+SYGI+L ETF+
Sbjct: 179 WSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+GKG FG VYK G ++A+KV LE + E +IL +H N+VK +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
+V+E+ GSL++ + + N++ Q + ++ LEYLH + IIH D+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDI 124
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE-WKLSR---KGDVYS 920
+NILL L DFG+S L + + + T +MAPE K D++S
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWS 182
Query: 921 YGIILMETFTKKKP 934
GI +E K P
Sbjct: 183 LGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 65/275 (23%), Positives = 125/275 (45%), Gaps = 30/275 (10%)
Query: 740 FSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKI 799
F+ LG G FG V++G + +++A+K+ + + F E + L +RH++L+ +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYN-KNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
+ CS ++ E M GSL ++ + + + + ++M VA + YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--- 124
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSR 914
IH DL NIL+ E +V ++DFG+++L+ ++ ++ + + + APE S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP-YKWTAPEAASHGTFST 183
Query: 915 KGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY-L 973
K DV+S+GI+L E FT G++ N + Q Y +
Sbjct: 184 KSDVWSFGILLYEMFTY---------GQVPYPGMNNHEV-----------YDQITAGYRM 223
Query: 974 TAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008
+C + + ++C E+R + K +L
Sbjct: 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 78/294 (26%), Positives = 122/294 (41%), Gaps = 55/294 (18%)
Query: 746 LGKGSFGSVYKGTLS------DGMQIAVKVFNLELEGTLRS----FDAECEILGSIRHRN 795
LG+G+FG V+ G D +AVK E F+ E E+L + +H N
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK---ETASNDARKDFEREAELLTNFQHEN 69
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDIL-------------QRLNMVI 842
+VK C+ +V EYM +G L ++ + L Q L + +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 843 DVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK-LLGDETSMTQTQTLA 901
+AS + YL H +H DL N L+ +V + DFG+S+ + + T+
Sbjct: 130 QIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 902 TIGYMAPEWKLSRK----GDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGK 956
I +M PE + RK DV+S+G++L E FT K+P L E
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------------- 232
Query: 957 IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010
+I + L L C S V + + C + ++RINIK+ +L K
Sbjct: 233 VIECITQGRL------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 75/261 (28%), Positives = 121/261 (46%), Gaps = 34/261 (13%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTC 803
LG G FG V+ GT + ++AVK GT+ +F E +I+ +RH LV++ + C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRL-NMVIDVASALEYLHYDHPTPIIHC 862
S + +V EYM GSL +++ + L +L +M +A + YL + IH
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHR 127
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGDV 918
DL NIL+ E++V ++DFG+++L+ D+ + I + APE + + K DV
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187
Query: 919 YSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY-LTAKE 977
+S+GI+L E T G + N + L Q E Y +
Sbjct: 188 WSFGILLTEIVTY---------GRVPYPGMTNREV-----------LEQVERGYRMPRPP 227
Query: 978 QCVSSVLSLAMQCTRESAEER 998
C + L +QC + EER
Sbjct: 228 NCPEELYDLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 78/270 (28%), Positives = 122/270 (45%), Gaps = 24/270 (8%)
Query: 744 NLLGKGSFGSVYKGTL-----SDGMQIAVKVFNLELEGTLRS-FDAECEILGSIRHRNLV 797
LG+G FG V + G Q+AVK N E RS F+ E EIL ++ H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 798 KIISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH 855
K C ++ L++EY+P+GSL +++ ++ + L + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 856 PTPIIHCDLNPSNILL-NESMVACLSDFGISKLL--GDETSMTQTQTLATIGYMAPE--- 909
IH DL NIL+ +E +V +SDFG++K+L + + + I + APE
Sbjct: 130 ---YIHRDLAARNILVESEDLVK-ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 910 -WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968
K S DV+S+G+ L E FT P+ + R+ G++I + LL K
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQS----PPAEFLRMIGIAQGQMIVTRLLELL-K 240
Query: 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEER 998
E L C V L C ++R
Sbjct: 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDR 270
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 67/191 (35%), Positives = 99/191 (51%), Gaps = 8/191 (4%)
Query: 745 LLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLR-SFDAECEILGSIRHRNLVKIISTC 803
LLGKG+FG V+KGTL D +AVK +L L+ F +E IL H N+VK+I C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
+ +V+E +P G +++ K Q + +D A+ + YL + IH D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRD 118
Query: 864 LNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKGDVY 919
L N L+ E+ V +SDFG+S+ D + I + APE + S + DV+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 920 SYGIILMETFT 930
SYGI+L ETF+
Sbjct: 179 SYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 744 NLLGKGSFGSVYKG-TLSDGMQIAVKVFNLE--LEGTLRSFDAECEILGSIRHRNLVKII 800
+L+G+G+FG VYKG L G +A+K +LE E L+S E ++L +++H N+VK I
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 801 -STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
S +SD ++LEY NGSL + K F + + V L+ L Y H +
Sbjct: 66 GSIETSDSL-YIILEYAENGSLRQ-IIKK---FGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRK 915
IH D+ +NIL + V L+DFG++ L D S + T +MAPE S
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDV-SKDDASVVGTPYWMAPEVIEMSGASTA 179
Query: 916 GDVYSYGIILMETFTKKKP 934
D++S G ++E T P
Sbjct: 180 SDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 76/285 (26%), Positives = 137/285 (48%), Gaps = 40/285 (14%)
Query: 741 SENNLLGKGSFGSVYKGTL--SDGMQIAVKVFNLE---LEGTLRSFDAECEILGSIRHRN 795
++ ++G G FG V++G L ++AV + L+ E + F +E I+G H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH 855
++++ + ++ EYM NG+L+ ++ + + F Q + M+ +A+ ++YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---S 124
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG--YMAPEW--- 910
+H DL NIL+N ++ +SDFG+S++L D+ T T + I + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 911 -KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968
K + DV+S+GI++ E + ++P ++ E+ K IN
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM-----------KAIN--------- 224
Query: 969 EDAY-LTAKEQCVSSVLSLAMQCTRESAEER---INIKEALTKLL 1009
D + L A C S+V L +QC ++ R ++I L KLL
Sbjct: 225 -DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 68/193 (35%), Positives = 107/193 (55%), Gaps = 20/193 (10%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS 805
+GKG FG V G G ++AVK ++ + T ++F AE ++ +RH NLV+++
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 806 DHFKA-LVLEYMPNGSLENWMYNKNRSF---DILQRLNMVIDVASALEYLHYDHPTPIIH 861
+ +V EYM GSL +++ ++ RS D L L +DV A+EYL ++ +H
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLEANN---FVH 125
Query: 862 CDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGD 917
DL N+L++E VA +SDFG++K E S TQ + + APE K S K D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 918 VYSYGIILMETFT 930
V+S+GI+L E ++
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 107 bits (266), Expect = 1e-24
Identities = 88/300 (29%), Positives = 127/300 (42%), Gaps = 32/300 (10%)
Query: 745 LLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGT---LRSFDAECEILGSIRH-RNLVKII 800
LG+GSFG VY D +A+KV +LE + F E +IL S+ H N+VK+
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYN--KNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
+ LV+EY+ GSLE+ + + + L ++ + SALEYLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 859 IIHCDLNPSNILLNE-SMVACLSDFGISKLLGDETSMTQTQTLA-----TIGYMAPEW-- 910
IIH D+ P NILL+ V L DFG++KLL D S + L T GYMAPE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 911 -----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965
S D++S GI L E T P + K+ S KII +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFE-------GEKNSSATSQTLKIILELPTPS 234
Query: 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIENSSDK 1025
L + E + L + + + R++ L+ L L + + K
Sbjct: 235 LAS-PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLK 293
|
Length = 384 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 76/261 (29%), Positives = 127/261 (48%), Gaps = 35/261 (13%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTC 803
LG+G FG V+ GT + ++A+K GT+ +F E +++ +RH LV++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDIL-QRLNMVIDVASALEYLHYDHPTPIIHC 862
S + +V EYM GSL +++ + + L Q ++M +AS + Y+ + +H
Sbjct: 71 SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL----SRKGDV 918
DL +NIL+ E++V ++DFG+++L+ D + I + APE L + K DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 919 YSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY-LTAKE 977
+S+GI+L E TK G + VN + L Q E Y +
Sbjct: 187 WSFGILLTELTTK---------GRVPYPGMVNREV-----------LDQVERGYRMPCPP 226
Query: 978 QCVSSVLSLAMQCTRESAEER 998
+C S+ L QC R+ EER
Sbjct: 227 ECPESLHDLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 744 NLLGKGSFGSVYKGTLSD-GMQIAVKVF---NLELEGTLRSFDAECEILGSIRHRNLVKI 799
+ LG G +G VY+G + +AVK +E+E F E ++ I+H NLV++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKEIKHPNLVQL 67
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRS-FDILQRLNMVIDVASALEYLHYDHPTP 858
+ C+ + ++ E+M G+L +++ NR + + L M ++SA+EYL +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--- 124
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSR 914
IH DL N L+ E+ + ++DFG+S+L+ +T I + APE K S
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 915 KGDVYSYGIILMETFT 930
K DV+++G++L E T
Sbjct: 185 KSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 64/205 (31%), Positives = 116/205 (56%), Gaps = 17/205 (8%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS 805
+G+G FG+V +G + G ++AVK N++ + T ++F E ++ + H+NLV+++
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 806 DHFKALVLEYMPNGSLENWMYNKNRSF-DILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
+ +V+E M G+L N++ + R+ ++Q L +DVA +EYL ++H DL
Sbjct: 71 NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGDVYS 920
NIL++E VA +SDFG++++ SM + + + APE K S K DV+S
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWS 182
Query: 921 YGIILMETFT-KKKPTDELFVGEIS 944
YG++L E F+ + P ++ + E+
Sbjct: 183 YGVLLWEVFSYGRAPYPKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 73/270 (27%), Positives = 121/270 (44%), Gaps = 31/270 (11%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRS--FDAECEILGSIRHRNLVKIISTC 803
LG G FG V+ G + +A+K+ EG + F E +++ + H NLV++ C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
+ +V EYM NG L N++ + L+M DV A+EYL + IH D
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 864 LNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKGDVY 919
L N L+ E V +SDFG+++ + D+ + T + + PE + S K DV+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185
Query: 920 SYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQC 979
S+G+++ E F++ K E F S V +S+ L +
Sbjct: 186 SFGVLMWEVFSEGKMPYERFS-----NSEVVESVSAGYR--------------LYRPKLA 226
Query: 980 VSSVLSLAMQCTRESAEERINIKEALTKLL 1009
+ V ++ C E E+R K+ L++L
Sbjct: 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRS--FDAECEILGSIRHRNLVKIISTC 803
LG G FG V G +A+K+ EG++ F E +++ + H LV++ C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
+ +V EYM NG L N++ + F Q L M DV + YL IH D
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRD 125
Query: 864 LNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKGDVY 919
L N L+++ +SDFG+S+ + D+ + + + + PE K S K DV+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 920 SYGIILMETFT-KKKPTDELFVGEISLK 946
++G+++ E ++ K P + E K
Sbjct: 186 AFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 83/284 (29%), Positives = 126/284 (44%), Gaps = 26/284 (9%)
Query: 745 LLGKGSFGSVYK---GTLSD--GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKI 799
LGKG+FGSV L D G +AVK LR F+ E EIL S++H N+VK
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 800 ISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
C S + LV+EY+P GSL +++ D + L + +EYL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR-- 128
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLL--GDETSMTQTQTLATIGYMAPEW----K 911
+H DL NIL+ + DFG++K+L E + + I + APE K
Sbjct: 129 -YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 912 LSRKGDVYSYGIILMETFT---KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968
S DV+S+G++L E FT K F+ + + G++I I LL K
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAEFM------RMMGNDKQGQMIVYHLIELL-K 240
Query: 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012
+ L A C + + ++ +C +R + E ++ IR
Sbjct: 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 69/259 (26%), Positives = 119/259 (45%), Gaps = 31/259 (11%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTC 803
+G G FG V+ G + ++A+K EG + F E +++ + H LV++ C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
+ LV E+M +G L +++ + F L M +DV + YL + +IH D
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRD 125
Query: 864 LNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKGDVY 919
L N L+ E+ V +SDFG+++ + D+ + T T + + +PE K S K DV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 920 SYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQC 979
S+G+++ E F++ G+ ++R N + V IN + L
Sbjct: 186 SFGVLMWEVFSE---------GKTPYENRSNSEV------VETINAGFR----LYKPRLA 226
Query: 980 VSSVLSLAMQCTRESAEER 998
SV L C +E E+R
Sbjct: 227 SQSVYELMQHCWKERPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 58/192 (30%), Positives = 102/192 (53%), Gaps = 13/192 (6%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTC 803
LG G FG V++G ++ +AVK GT+ + F AE +I+ +RH L+++ + C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 804 SSDHFKALVLEYMPNGSLENWMYN-KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
+ + +V E M GSL ++ R+ + Q ++M VAS + YL + IH
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGDV 918
DL N+L+ E+ + ++DFG+++++ ++ + I + APE + S K DV
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 919 YSYGIILMETFT 930
+S+GI+L E T
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 6e-23
Identities = 70/208 (33%), Positives = 93/208 (44%), Gaps = 35/208 (16%)
Query: 746 LGKGSFGSVYKGTLSDGMQI-AVKVFN----LELEGTLRSFDAECEILGSIRHRNLVKII 800
LGKGSFG V D ++ A+KV ++ + + E IL I H +VK+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIVKLH 59
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVI---------DVASALEYL 851
++ LVLEY P G L F L + ++ ALEYL
Sbjct: 60 YAFQTEEKLYLVLEYAPGGEL----------FSHLSKEGRFSEERARFYAAEIVLALEYL 109
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK 911
H II+ DL P NILL+ L+DFG++K L E S T T T Y+APE
Sbjct: 110 HSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEV- 164
Query: 912 LSRKG-----DVYSYGIILMETFTKKKP 934
L KG D +S G++L E T K P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 75/261 (28%), Positives = 126/261 (48%), Gaps = 35/261 (13%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTC 803
LG G FG V+ GT + ++AVK GT+ SF E +I+ +RH LV++ +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 804 SSDHFKALVLEYMPNGSLENWMYN-KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
S + +V EYM GSL +++ + + R+ + ++M VA+ + Y+ + IH
Sbjct: 71 SEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHR 126
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKGDV 918
DL +NIL+ + +V ++DFG+++L+ D + I + APE + + K DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 919 YSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY-LTAKE 977
+S+GI+L E TK G + N + L Q E Y + +
Sbjct: 187 WSFGILLTELVTK---------GRVPYPGMNNREV-----------LEQVERGYRMPCPQ 226
Query: 978 QCVSSVLSLAMQCTRESAEER 998
C S+ L +QC ++ EER
Sbjct: 227 DCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 7e-22
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 745 LLGKGSFGSVYKGTLS--DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKI 799
++G G FG V G L +I V + L+ E R F +E I+G H N++ +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
+ +V EYM NGSL+ ++ + F ++Q + M+ +AS ++YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGY 127
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGD--ETSMTQTQTLATIGYMAPEW----KLS 913
+H DL NIL+N ++V +SDFG+S++L D E + T I + APE K +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187
Query: 914 RKGDVYSYGIILMETFT 930
DV+SYGI++ E +
Sbjct: 188 SASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 8e-22
Identities = 68/280 (24%), Positives = 108/280 (38%), Gaps = 38/280 (13%)
Query: 745 LLGKGSFGSVYKGT----LSDGMQIAVKVFNLE-LEGTLRSFDAECEILGSIRHRNLVKI 799
LG GSFG V +G + +AVK + L + F E I+ S+ H NL+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 800 ISTCSSDHFKALVLEYMPNGSL-ENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
+ +V E P GSL + + F I + + +A+ + YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM--TQTQTLATIGYMAPE----WKL 912
IH DL NILL + DFG+ + L + + APE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 913 SRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHG-KIINVVDINLLQKED 970
S DV+ +G+ L E FT ++P + G L G +I+ +D KE
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEP----WAG-----------LSGSQILKKID-----KEG 217
Query: 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010
L E C + ++ +QC + +R L +
Sbjct: 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 36/281 (12%)
Query: 746 LGKGSFGSVYKGT---LSDGMQIAVKVFNLELEGTLRSFDA---ECEILGSIRHRNLVKI 799
LG G+FG+VYKG + ++I V + L E + ++ E ++ S+ H ++V++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
+ C S L+ + MP G L +++ N + LN + +A + YL +
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---L 130
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLG-DETSMTQTQTLATIGYMAPE----WKLSR 914
+H DL N+L+ ++DFG++KLL DE I +MA E +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 915 KGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYL 973
K DV+SYG+ + E T KP + I V+I L ++ L
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEG--------------------IPAVEIPDLLEKGERL 230
Query: 974 TAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014
C V + ++C AE R KE + + K+
Sbjct: 231 PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 61/196 (31%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 746 LGKGSFGSVYKGT--LSDGMQIAVKVFNL---ELEGTLRSFDAECEILGSIRHRNLVKII 800
LG G+FGSV KG + G ++ V V L + + F E ++ + H +V++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
C + LV+E P G L ++ K R + + VA + YL H +
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKH---FV 117
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT--IGYMAPE----WKLSR 914
H DL N+LL A +SDFG+S+ LG + + T + + APE K S
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177
Query: 915 KGDVYSYGIILMETFT 930
K DV+SYG+ L E F+
Sbjct: 178 KSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 740 FSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVK 798
F LG+GS+GSVYK G +A+KV + +E L+ E IL +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
+ + +V+EY GS+ + M N++ + ++ LEYLH +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--- 119
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPE----WK 911
IH D+ NILLNE A L+DFG+S L D +M + T+ IG +MAPE
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTV--IGTPFWMAPEVIQEIG 175
Query: 912 LSRKGDVYSYGIILMETFTKKKP 934
+ K D++S GI +E K P
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 32/218 (14%)
Query: 745 LLGKGSFGSVYKGTL-SDGMQIAVKVFN---LELEGTLRSFDAECEILGSI-RHRNLVKI 799
++G+GSF +V + A+K+ + L E ++ E E+L + H ++K+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
T + VLEY PNG L ++ K S D ++ ALEYLH I
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLHSKG---I 123
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG--------------- 904
IH DL P NILL++ M ++DFG +K+L +S + AT
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183
Query: 905 ----YMAPEW----KLSRKGDVYSYGIILMETFTKKKP 934
Y++PE + D+++ G I+ + T K P
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 29/206 (14%)
Query: 743 NNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLELEGTLRS---------FDAECEILG 789
++G G FG V +G L + +A+K TL++ F E I+G
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIK--------TLKAGSSDKQRLDFLTEASIMG 60
Query: 790 SIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALE 849
H N++++ + ++ EYM NGSL+ ++ + F + Q + M+ +AS ++
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120
Query: 850 YLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT-LATIGYMAP 908
YL + +H DL NIL+N ++V +SDFG+S+ L D + T+ I + AP
Sbjct: 121 YLS-EMNY--VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
Query: 909 EW----KLSRKGDVYSYGIILMETFT 930
E K + DV+S+GI++ E +
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-21
Identities = 61/199 (30%), Positives = 105/199 (52%), Gaps = 16/199 (8%)
Query: 745 LLGKGSFGSVYKGTLS--DGMQIAVKVFNLE---LEGTLRSFDAECEILGSIRHRNLVKI 799
++G G FG V +G L +I V + L+ E R F +E I+G H N++ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
+ ++ E+M NG+L++++ + F ++Q + M+ +A+ ++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETS-MTQTQTLA---TIGYMAPEW----K 911
+H DL NIL+N ++V +SDFG+S+ L D+TS T T +L I + APE K
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 912 LSRKGDVYSYGIILMETFT 930
+ DV+SYGI++ E +
Sbjct: 188 FTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 16/196 (8%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTC 803
LG G FG V+ G +++A+K N EG + F E +++ + H LV++ C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSF--DILQRLNMVIDVASALEYLHYDHPTPIIH 861
+ +V E+M NG L N++ + D+L L+M DV +EYL + IH
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERNS---FIH 123
Query: 862 CDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGD 917
DL N L++ + V +SDFG+++ + D+ + + + + PE K S K D
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 918 VYSYGIILMETFTKKK 933
V+S+G+++ E FT+ K
Sbjct: 184 VWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 8e-21
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 32/213 (15%)
Query: 746 LGKGSFGSVYKGTL------SDGMQIAVKVFNLELEGTLRS-FDAECEILGSIRHRNLVK 798
LG+G+FG VYKG L +A+K E ++ F E E++ ++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKN---------------RSFDILQRLNMVID 843
++ C+ + ++ EY+ +G L ++ + S D L++ I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL--GDETSMTQTQTLA 901
+A+ +EYL H +H DL N L+ E + +SDFG+S+ + D + Q+++L
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV-QSKSLL 188
Query: 902 TIGYMAPE----WKLSRKGDVYSYGIILMETFT 930
+ +M PE K + + D++S+G++L E F+
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 68/252 (26%), Positives = 112/252 (44%), Gaps = 29/252 (11%)
Query: 746 LGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRS-FDAECEILGSIRHRNLVKIISTC 803
+G+G+FG V+ G L +D +AVK L L++ F E IL H N+V++I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
+ +V+E + G ++ + + + + MV + A+ +EYL H IH D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 864 LNPSNILLNESMVACLSDFGISKLLGDET-SMTQTQTLATIGYMAPE----WKLSRKGDV 918
L N L+ E V +SDFG+S+ D + T + + APE + S + DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 919 YSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQ 978
+S+GI+L E F+ +G + + N I ++ L E
Sbjct: 180 WSFGILLWEAFS---------LGAVPYANLSNQQTREAI----------EQGVRLPCPEL 220
Query: 979 CVSSVLSLAMQC 990
C +V L +C
Sbjct: 221 CPDAVYRLMERC 232
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 745 LLGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGT-----LRSFDAECEILGSIRHRNLVK 798
LLG GSFGSVY+G L DG AVK +L +G ++ + E +L ++H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
+ T + + LE +P GSL + K SF + LEYLH +
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--- 122
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPEWKLSRK 915
+H D+ +NIL++ + V L+DFG++K + + + G +MAPE +
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 916 G-----DVYSYGIILMETFTKKKPTDELF 939
G D++S G ++E T K P +L
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLE 206
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 71/261 (27%), Positives = 124/261 (47%), Gaps = 35/261 (13%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTC 803
LG+G FG V+ GT + ++A+K GT+ +F E +I+ +RH LV + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
S + +V E+M GSL +++ + + + Q ++M +A + Y+ + IH
Sbjct: 71 SEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHR 126
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL----SRKGDV 918
DL +NIL+ +++V ++DFG+++L+ D + I + APE L + K DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 919 YSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY-LTAKE 977
+S+GI+L E TK G + VN + L Q E Y + +
Sbjct: 187 WSFGILLTELVTK---------GRVPYPGMVNREV-----------LEQVERGYRMPCPQ 226
Query: 978 QCVSSVLSLAMQCTRESAEER 998
C S+ L C ++ +ER
Sbjct: 227 GCPESLHELMKLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 60/195 (30%), Positives = 87/195 (44%), Gaps = 11/195 (5%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRS-FDAECEILGSIRHRNLVKIISTC 803
LG G+ G V K G +AVK LE+ ++ E +IL +V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
++ ++ +EYM GSL+ + + + V L YLH H IIH D
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 864 LNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKGDVY 919
+ PSNIL+N L DFG+S L + + T T + YMAPE S K D++
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS---YMAPERIQGNDYSVKSDIW 183
Query: 920 SYGIILMETFTKKKP 934
S G+ L+E T + P
Sbjct: 184 SLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 14/211 (6%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
LG G+FG VYK G+ A K+ +E E L F E +IL +H N+V +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
++ +++E+ G+L++ M R Q + + AL +LH H +IH DL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH-SH--KVIHRDL 129
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR---------K 915
NILL L+DFG+S T + T +MAPE K
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPYDYK 188
Query: 916 GDVYSYGIILMETFTKKKPTDELFVGEISLK 946
D++S GI L+E + P EL + LK
Sbjct: 189 ADIWSLGITLIELAQMEPPHHELNPMRVLLK 219
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 744 NLLGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGTLRSFDA---ECEILGSIRHRNLVKI 799
N +G G+FG VY L G +AVK ++ + ++ E ++L ++H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQ-DNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWM-YNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
+ +EY G+LE + + + +++ + + L YLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY--TLQLLEGLAYLHSHG--- 119
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM--TQTQTLA-TIGYMAPEW----K 911
I+H D+ P+NI L+ + V L DFG + L + T+ + Q+LA T YMAPE K
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 912 LSRKG---DVYSYGIILMETFTKKKPTDEL 938
G D++S G +++E T K+P EL
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 4e-20
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 746 LGKGSFGSVYKGTLS------DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKI 799
LG+G+FG V+ D M +AVK E + F E E+L ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDIL--------------QRLNMVIDVA 845
C+ +V EYM +G L ++ + IL Q L + +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 846 SALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK-LLGDETSMTQTQTLATIG 904
S + YL H +H DL N L+ + +V + DFG+S+ + + +T+ I
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 905 YMAPEWKLSRK----GDVYSYGIILMETFTKKK 933
+M PE L RK D++S+G++L E FT K
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 67/212 (31%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 740 FSENN---LLGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRN 795
+ EN +LGKG++G VY LS ++IA+K ++ E + ++HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH 855
+V+ + + S + F + +E +P GSL + +K ++ ++ LE L Y H
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIIFYTKQILEGLKYLH 125
Query: 856 PTPIIHCDLNPSNILLNE-SMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR 914
I+H D+ N+L+N S V +SDFG SK L T+T T T+ YMAPE +
Sbjct: 126 DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQYMAPE--VID 182
Query: 915 KG--------DVYSYGIILMETFTKKKPTDEL 938
KG D++S G ++E T K P EL
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 739 GFSENNLLGKGSFGSVYKGTLSDGMQI-AVKVFNLEL---EGTLRSFDAECEILGSIRHR 794
F ++GKG+FG V D ++ A+K N + +G++R+ E IL + H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 795 NLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD 854
LV + + + LV++ + G L + ++ F Q + ++ ALEYLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLR-YHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR 914
IIH D+ P NILL+E ++DF I+ + +T T T T GYMAPE L R
Sbjct: 120 G---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPE-VLCR 173
Query: 915 KG-----DVYSYGIILMETFTKKKP 934
+G D +S G+ E K+P
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 66/261 (25%), Positives = 120/261 (45%), Gaps = 35/261 (13%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTC 803
LG G FG V+ G + ++A+K +G++ +F AE ++ ++H LV++ +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRS-FDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
+ + ++ EYM NGSL +++ I + ++M +A + ++ + IH
Sbjct: 71 TQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHR 126
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKGDV 918
DL +NIL++E++ ++DFG+++L+ D + I + APE + K DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 919 YSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY-LTAKE 977
+S+GI+L E T G I N + I N+ E Y + +
Sbjct: 187 WSFGILLTEIVT---------YGRIPYPGMTNPEV---IQNL--------ERGYRMPRPD 226
Query: 978 QCVSSVLSLAMQCTRESAEER 998
C + L C +E EER
Sbjct: 227 NCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 66/260 (25%), Positives = 122/260 (46%), Gaps = 32/260 (12%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTC 803
LG G FG V+ G ++ ++AVK GT+ ++F E ++ +++H LV++ +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASAL-EYLHYDHPTPIIHC 862
+ + ++ EYM GSL +++ + +L +L ID ++ + E + Y IH
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNYIHR 127
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKGDV 918
DL +N+L++ES++ ++DFG+++++ D + I + APE + K DV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 919 YSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQ 978
+S+GI+L E T G+I N D+ + + E
Sbjct: 188 WSFGILLYEIVT---------YGKIPYPGMSNS----------DVMSALQRGYRMPRMEN 228
Query: 979 CVSSVLSLAMQCTRESAEER 998
C + + C +E AEER
Sbjct: 229 CPDELYDIMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFD-----AECEILGSIRHRNLVK- 798
+GKGSFG+V K SDG + K + G + + +E IL ++H N+V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDY---GNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 799 ---IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQR---LNMVIDVASALEYLH 852
II + + +V+EY G L + + ++ ++ + AL H
Sbjct: 65 YDRIIDRSNQTLY--IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 853 Y-DHPTP-IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW 910
P ++H DL P+NI L+ + L DFG++K+LG ++S +T + T YM+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMSPEQ 181
Query: 911 ----KLSRKGDVYSYGIILMETFTKKKP 934
K D++S G ++ E P
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 22/201 (10%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLELE--G----TLRSFDAECEILGSIRHRNLVK 798
+G+G++G VYK G +A+K +E E G +R E ++L +RH N+V+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 799 IISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
+ +S + +V EYM + L + + F Q + + L+YLH +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG- 120
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL---- 912
I+H D+ SNIL+N V L+DFG+++ S T + T+ Y PE L
Sbjct: 121 --ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178
Query: 913 -SRKGDVYSYGIILMETFTKK 932
+ D++S G IL E F K
Sbjct: 179 YGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 746 LGKGSFGS--VYKGTLSDGMQIAVKVFNLELEGTLRSFDA--ECEILGSIRHRNLVKIIS 801
LGKG+FG +Y+ T D + K NL DA E IL ++H N++ +
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 802 TCSSDHFKALVLEYMPNGSL-ENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
D+ + +EY G+L + + K + F+ L + + SA+ Y+H I+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---IL 123
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKG 916
H D+ NI L ++ + L DFGISK+LG E SM +T + T YM+PE K + K
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNFKS 182
Query: 917 DVYSYGIILMETFTKKK 933
D+++ G +L E T K+
Sbjct: 183 DIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-18
Identities = 50/139 (35%), Positives = 72/139 (51%), Gaps = 24/139 (17%)
Query: 529 VNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI 588
+ L + L G +P +I L+ + I+LS N + G IP S+G + +++ L L+ N F GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 589 PDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQ 648
P+SLG LTSL L+++ N+LSG +P +L L H F
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLL----------------HRASF------ 520
Query: 649 SFVGNKGLCGAPELKFPAC 667
+F N GLCG P L AC
Sbjct: 521 NFTDNAGLCGIPGL--RAC 537
|
Length = 623 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 746 LGKGSFGSVYKGTL---SDGMQIAVKVFNLELEGTLR-SFDAECEILGSIRHRNLVKIIS 801
LG G+FG V KG + +A+KV E E ++R E EI+ + + +V++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIH 861
C ++ LV+E G L ++ K + + ++ V+ ++YL + +H
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVH 118
Query: 862 CDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT--IGYMAPEW----KLSRK 915
DL N+LL A +SDFG+SK LG + S + ++ + + APE K S +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 916 GDVYSYGIILMETFT-KKKPTDEL 938
DV+SYGI + E F+ +KP ++
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 50/285 (17%)
Query: 746 LGKGSFGSVYKGT------LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKI 799
LG+G+FG V+ D M +AVK + F E E+L +++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWM---------------YNKNRSFDILQRLNMVIDV 844
C +V EYM +G L ++ + Q L++ +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 845 ASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK-LLGDETSMTQTQTLATI 903
AS + YL H +H DL N L+ +++ + DFG+S+ + + T+ I
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 904 GYMAPEWKLSRK----GDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKII 958
+M PE + RK DV+S+G+IL E FT K+P +L E+ + G+++
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV-----IECITQGRVL 244
Query: 959 NVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKE 1003
+ C V + + C + ++R+NIKE
Sbjct: 245 ERPRV---------------CPKEVYDIMLGCWQREPQQRLNIKE 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-18
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 33/213 (15%)
Query: 745 LLGKGSFGSVYKGTLS--DGMQIAVKVFNLELEGTLRS----FDAECEILGSIRHRNLVK 798
+LG+G FGSV +G LS DG Q+ V V ++L+ S F +E + H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 799 IISTC--SSDHFK----ALVLEYMPNGSLENWMY----NKNRSFDILQRL-NMVIDVASA 847
+I C +S K ++L +M +G L +++ LQ L ++D+A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 848 LEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMA 907
+EYL + IH DL N +L E M C++DFG+SK + Q + I M
Sbjct: 126 MEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR----IAKMP 178
Query: 908 PEWK---------LSRKGDVYSYGIILMETFTK 931
+W + K DV+++G+ + E T+
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 69/206 (33%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 739 GFSENNLLGKGSFGSVYK-GTLSDGMQIAVKVFNLELEGTLRSFDA--ECEILGSIRHRN 795
F LGKGS+GSVYK LSD A+K +L DA E IL S+ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQR---LNMVIDVASALEYLH 852
++ + +V+EY P G L + + + ++ + I + L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 853 YDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE-WK 911
I+H DL +NILL + + + D GISK+L + +M +TQ T YMAPE WK
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI-GTPHYMAPEVWK 174
Query: 912 ---LSRKGDVYSYGIILMETFTKKKP 934
S K D++S G +L E T P
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 16/190 (8%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLE---LEGTLRSFDAECEILGSIRHRNLVKIIS 801
+G+G+ G VYK T + G ++A+K L E + E I+ +H N+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMKDCKHPNIVDYYD 82
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIH 861
+ +V+EYM GSL + + + Q + +V LEYLH + +IH
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIH 139
Query: 862 CDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGD 917
D+ NILL++ L+DFG + L E S + + T +MAPE K D
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-VGTPYWMAPEVIKRKDYGPKVD 198
Query: 918 VYSYGIILME 927
++S GI+ +E
Sbjct: 199 IWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 8e-18
Identities = 69/262 (26%), Positives = 123/262 (46%), Gaps = 29/262 (11%)
Query: 740 FSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLE------LEGTLRSFDAECEILGSIRH 793
+++ +LGKG++G+VY G + G IAVK L+ E E ++L S++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 794 RNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHY 853
N+V+ + TC D+ ++ +E++P GS+ + + NR F L L+ + Y
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL---NR-FGPLPEPVFCKYTKQILDGVAY 117
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL------GDETSMTQTQTLATIGYMA 907
H ++H D+ +N++L + + L DFG ++ L G ++M ++ T +MA
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYWMA 176
Query: 908 P----EWKLSRKGDVYSYGIILMETFTKKKPTDEL-------FVGE-ISLKSRVNDSLHG 955
P E RK D++S G + E T K P + ++G L R+ DS
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236
Query: 956 KIINVVDINLLQKEDAYLTAKE 977
I+ V L + + +A +
Sbjct: 237 AAIDFVTSCLTRDQHERPSALQ 258
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 77/221 (34%), Positives = 108/221 (48%), Gaps = 32/221 (14%)
Query: 735 RATDGFSENNLLGKGSFGSVYKGTLSD-GMQIAVKVFNL--ELEGTLRSFDAECEILGSI 791
R D F +G+G++G VYK D G +A+K L E EG + E +IL +
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63
Query: 792 RHRNLVKI--ISTCSSD--HFKA------LVLEYMPN---GSLENWM--YNKNRSFDILQ 836
HRN+V + I T D FK LV EYM + G LE+ + ++++ ++
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 837 RLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896
+L LE L+Y H +H D+ SNILLN L+DFG+++L E S
Sbjct: 124 QL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 897 TQTLATIGYMAPEWKL--SRKG---DVYSYGIILMETFTKK 932
T + T+ Y PE L R G DV+S G IL E FTKK
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 745 LLGKGSFGSVYKG-TLSDGMQIAVKVFNL----------ELEGTLRSFDAECEILGSIRH 793
L+GKG++G VY ++ G +AVK L + +++ +E E L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 794 RNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHY 853
N+V+ + +++ + ++ LEY+P GS+ + + R + L R V L YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLHS 126
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYMAPE--- 909
I+H DL N+L++ + +SDFGISK D Q ++ ++ +MAPE
Sbjct: 127 KG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 910 ---WKLSRKGDVYSYGIILMETFTKKKP 934
S K D++S G +++E F ++P
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 746 LGKGSFGSVYKGTLSD-GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
LG G+FG VYK + G A KV + E L + E EIL + H +VK++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
D +++E+ P G+++ M +R L + + LE L Y H IIH DL
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR---------K 915
N+LL L+DFG+S +T + + T +MAPE + K
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYK 195
Query: 916 GDVYSYGIILMETFTKKKPTDEL 938
D++S GI L+E + P EL
Sbjct: 196 ADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 66/209 (31%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 745 LLGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGT---------LRSFDAECEILGSIRHR 794
L+G GSFGSVY G S G +AVK L L + E +L ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 795 NLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD 854
N+V+ + + + LEY+P GS+ + N +F+ N V + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLVRNFVRQILKGLNYLHN- 124
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT-----LATIGYMAPE 909
IIH D+ +NIL++ +SDFGISK L + T+T ++ +MAPE
Sbjct: 125 --RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 910 ----WKLSRKGDVYSYGIILMETFTKKKP 934
+RK D++S G +++E T K P
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 72/287 (25%), Positives = 118/287 (41%), Gaps = 46/287 (16%)
Query: 744 NLLGKGSFGSVYKGTLS--DG----MQIAVKVF-NLELEGTLRSFDAECEILGSIRHRNL 796
LG G+FG VY+G DG +Q+AVK E F E I+ H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWM-YNKNR-----SFDILQRLNMVIDVASALEY 850
V++I + ++LE M G L++++ N+ R S + L DVA +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 851 LHYDHPTPIIHCDLNPSNILLN---ESMVACLSDFGISK-LLGDETSMTQTQTLATIGYM 906
L +H IH D+ N LL VA ++DFG+++ + + + I +M
Sbjct: 132 LEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 907 APEWKL----SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962
PE L + K DV+S+G++L E F+ +G + R N +
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS---------LGYMPYPGRTNQ----------E 229
Query: 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEER---INIKEALT 1006
+ L + C V + C + + E+R I E +
Sbjct: 230 VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 4e-17
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 744 NLLGKGSFGSVYKGT-LSDGMQIAVK----VFNLELEG--TLRSFDAECEILGSIRHRNL 796
+G G++G V G ++A+K VF+ ++ LR E ++L +RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61
Query: 797 VKIISTC---SSDHFKAL--VLEYMPNGSLENWMYNKNR-SFDILQRLNMVIDVASALEY 850
+ ++ S + F + V E M L + + + D +Q + + L+Y
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYF--LYQILRGLKY 118
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT--LATIGYMAP 908
LH + +IH DL PSNIL+N + + DFG+++ + + T + T Y AP
Sbjct: 119 LHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175
Query: 909 EWKLSRKG-----DVYSYGIILMETFTKK 932
E LS D++S G I E T+K
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 60/193 (31%), Positives = 92/193 (47%), Gaps = 18/193 (9%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+G G++G VYK ++ G +A+KV LE E +L RH N+V +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
+V+EY GSL++ +Y R L L + L+ L Y H T IH D+
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IYQVTR--GPLSELQIAYVCRETLKGLAYLHETGKIHRDI 127
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPE-WKLSRKG---- 916
+NILL E L+DFG+S L ++ + ++ IG +MAPE + RKG
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLT--ATIAKRKSF--IGTPYWMAPEVAAVERKGGYDG 183
Query: 917 --DVYSYGIILME 927
D+++ GI +E
Sbjct: 184 KCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 745 LLGKGSFGSVYKGTLSDGMQ--IAVK---VFNLELEGTLRSFD-------AECEILG-SI 791
LG G+FG VYK + Q +A+K V N R D +E I+ +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 792 RHRNLVKIISTCSSDHFKALVLEYM---PNGSLENWMYNKNRSFDILQRLNMVIDVASAL 848
RH N+V+ T + +V++ + P G N + K + F + N+ + + AL
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAP 908
YLH + I+H DL P+NI+L E ++DFG++K E+ + T + TI Y P
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--TSVVGTILYSCP 182
Query: 909 EWKLS----RKGDVYSYGIILMETFTKKKP 934
E + K DV+++G IL + T + P
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 18/212 (8%)
Query: 745 LLGKGSFGSVYKGT-LSDG----MQIAVKVFNLELEGTLRS--FDAECEILGSIRHRNLV 797
+LG G+FG+VYKG + +G + +A+K+ N E G + F E I+ S+ H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
+++ C S + LV + MP+G L ++++ + LN + +A + YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR-- 129
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLL-GDETSMTQTQTLATIGYMAPEW----KL 912
++H DL N+L+ ++DFG+++LL GDE I +MA E K
Sbjct: 130 -LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 913 SRKGDVYSYGIILMETFT-KKKPTDELFVGEI 943
+ + DV+SYG+ + E T KP D + EI
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-17
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 745 LLGKGSFGSVYKGTLSD-GMQIAVKVFNL-----ELEGTLRSFDAECEILGSIRHRNLVK 798
LLG+G+FG VY D G ++AVK E + + + + E ++L +++H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
D ++ +EYMP GS+++ + + + R + +EYLH +
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHSNM--- 124
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPEWKL--- 912
I+H D+ +NIL + + L DFG SK L + T + G +M+PE
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 913 -SRKGDVYSYGIILMETFTKKKPTDEL 938
RK DV+S G ++E T+K P E
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPPWAEF 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 743 NNLLGKGSFGSVYKGTL----SDGMQIAVKVFNLELEGTLRS-FDAECEILGSIRHRNLV 797
+G+G FG VY+G ++ + +AVK ++R F E I+ H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
K+I + + +V+E P G L +++ S D+ + +++AL YL
Sbjct: 71 KLIGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLS 913
+H D+ N+L++ L DFG+S+ L DE+ ++ I +MAPE + +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 914 RKGDVYSYGIILMETFTK-KKP 934
DV+ +G+ + E KP
Sbjct: 187 SASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 26/207 (12%)
Query: 746 LGKGSFGSVYKGTLSD------GMQIAVK-VFNLELEGTLRSFDAECEILGSIRHRNLVK 798
LG+GSFG VY+G ++A+K V F E ++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNK------NRSFDILQR---LNMVIDVASALE 849
++ S+ +V+E M G L++++ ++ N + M ++A +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 850 YLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ--TQTLATIGYMA 907
YL +H DL N ++ E + + DFG+++ + ET + + L + +MA
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189
Query: 908 PE----WKLSRKGDVYSYGIILMETFT 930
PE + K DV+S+G++L E T
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 79/286 (27%), Positives = 120/286 (41%), Gaps = 32/286 (11%)
Query: 746 LGKGSFGSV----YKGTLSD-GMQIAVKVFNLELEGTLRS-FDAECEILGSIRHRNLVKI 799
LG+G FG V Y G +AVK E S + E IL ++ H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 800 ISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
CS K L++EY+P GSL + Y ++ Q L + + YLH H
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRD--YLPKHKLNLAQLLLFAQQICEGMAYLHSQH-- 127
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLL--GDETSMTQTQTLATIGYMAP----EWK 911
IH DL N+LL+ + + DFG++K + G E + + + + A E K
Sbjct: 128 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 912 LSRKGDVYSYGIILMETFT----KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967
S DV+S+G+ L E T K+ P + F I K G++ V I LL+
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQ-------GQMTVVRLIELLE 238
Query: 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013
+ L + C V L C A+ R + + L ++ +
Sbjct: 239 RGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 1e-16
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLEL--EG----TLRSFDAECEILGSIRHRNLVK 798
LG+G++G VYK G +A+K L+ EG LR E +L ++H N+VK
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELKHPNIVK 62
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
++ ++ LV EY L+ ++ + +++ + L Y H
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--- 118
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-- 916
I+H DL P NIL+N V L+DFG+++ G T T + T+ Y APE L K
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYS 177
Query: 917 ---DVYSYGIILMETFTKKKPTDELFVGE 942
D++S G I E T K LF G+
Sbjct: 178 TAVDIWSVGCIFAEMITGK----PLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 76/302 (25%), Positives = 128/302 (42%), Gaps = 55/302 (18%)
Query: 746 LGKGSFGSVYKGTL------SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKI 799
LG+G+FG V+ D + +AVK + + F E E+L +++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMY------------NKNRSFDILQRLNMVIDVASA 847
C +V EYM +G L ++ N+ Q L++ +A+
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 848 LEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK-LLGDETSMTQTQTLATIGYM 906
+ YL H +H DL N L+ E+++ + DFG+S+ + + T+ I +M
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 907 APEWKLSRK----GDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVV 961
PE + RK DV+S G++L E FT K+P +L E+ I +
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-------------IECIT 236
Query: 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIEN 1021
+LQ+ C V L + C + R+NIKE ++LL N+
Sbjct: 237 QGRVLQR-------PRTCPKEVYDLMLGCWQREPHMRLNIKEI--------HSLLQNLAK 281
Query: 1022 SS 1023
+S
Sbjct: 282 AS 283
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 20/219 (9%)
Query: 740 FSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL-EGTLRSFDAECEIL------GSI 791
F + +LG G+FG+VYKG + +G ++ + V EL E T S A EIL S+
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV 66
Query: 792 RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL 851
+ ++ +++ C + + L+ + MP G L +++ + LN + +A + YL
Sbjct: 67 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG-DETSMTQTQTLATIGYMAPE- 909
++H DL N+L+ ++DFG++KLLG DE I +MA E
Sbjct: 126 EERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 910 ---WKLSRKGDVYSYGIILMETFT-KKKPTDELFVGEIS 944
+ + DV+SYG+ + E T KP D + EIS
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 68/281 (24%), Positives = 119/281 (42%), Gaps = 50/281 (17%)
Query: 744 NLLGKGSFGSVYKGTLSDGM-----QIAVKVFNLELEGTLRS---FDAECEILGSIRHRN 795
N LG G+FG VY+GT +D + I V V L T + F E ++ + H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYN-KNRSF-----DILQRLNMVIDVASALE 849
+VK++ C + + +++E M G L +++ + + F + + L++ +DVA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 850 YLHYDHPTPIIHCDLNPSNILLNESMVAC-----LSDFGISK-LLGDETSMTQTQTLATI 903
YL H IH DL N L++E + DFG+++ + + + + L +
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 904 GYMAPE----WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959
+MAPE K + + DV+S+G+++ E T +G+ + N
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT---------LGQQPYPALNN--------- 219
Query: 960 VVDINLLQ--KEDAYLTAKEQCVSSVLSLAMQCTRESAEER 998
+LQ L E C + L C + ER
Sbjct: 220 ---QEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSER 257
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 65/199 (32%), Positives = 93/199 (46%), Gaps = 34/199 (17%)
Query: 746 LGKGSFGSV----YKGTLSDGMQIAVKVFNLE-------LEGTLRSFDAECEILGSIRHR 794
LG GSFG V +KG+ G A+K+ + +E L E IL SIRH
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVL----NEKRILQSIRHP 61
Query: 795 NLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD 854
LV + + D LV+EY+P G L + + K+ F V ALEYLH
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYMAPEWKLS 913
I++ DL P N+LL+ ++DFG +K + +T TL T Y+APE +
Sbjct: 121 D---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPE-IIL 171
Query: 914 RKG-----DVYSYGIILME 927
KG D ++ GI++ E
Sbjct: 172 SKGYGKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 79/321 (24%), Positives = 136/321 (42%), Gaps = 63/321 (19%)
Query: 721 PEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTL- 778
P + W I +Q++ +G+G+FG V K + DG+++ + ++ +
Sbjct: 2 PVLEWNDIKFQDV------------IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD 49
Query: 779 --RSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNK------- 828
R F E E+L + H N++ ++ C + L +EY P+G+L +++
Sbjct: 50 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 109
Query: 829 -----NRSFDIL---QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLS 880
N + L Q L+ DVA ++YL IH DL NIL+ E+ VA ++
Sbjct: 110 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIA 166
Query: 881 DFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFTKKKPTD 936
DFG+S+ G E + +T + +MA E + DV+SYG++L E +
Sbjct: 167 DFGLSR--GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------ 218
Query: 937 ELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAE 996
+G L+ K+ + L C V L QC RE
Sbjct: 219 ---LGGTPYCGMTCAELYEKL----------PQGYRLEKPLNCDDEVYDLMRQCWREKPY 265
Query: 997 ERINIKE---ALTKLLKIRNT 1014
ER + + +L ++L+ R T
Sbjct: 266 ERPSFAQILVSLNRMLEERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 744 NLLGKGSFGSVYKGTLS-DG--MQIAVKVFN-LELEGTLRSFDAECEILGSI-RHRNLVK 798
+++G+G+FG V + + DG M A+K+ E R F E E+L + H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDI----------------LQRLNMVI 842
++ C + + + +EY P G+L +++ K+R + Q L
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 843 DVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT 902
DVA+ ++YL IH DL N+L+ E++ + ++DFG+S+ G+E + +T
Sbjct: 127 DVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLP 181
Query: 903 IGYMAPE----WKLSRKGDVYSYGIILME 927
+ +MA E + K DV+S+G++L E
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 740 FSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDA--ECEILGSIRHRNL 796
F N +GKGSFG V+K +D A+K +L +A E +L + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENW--MYNKNR-SFDILQRLNMVIDVASALEYLHY 853
++ + +V+EY NG L M D + R I + L +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRF--FIQILLGLAHLH- 118
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW--- 910
I+H D+ N+ L+ + D G++KLL D T+ T + T Y++PE
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCED 175
Query: 911 -KLSRKGDVYSYGIILMETFTKKKPTD 936
+ K DV++ G++L E T K P D
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 744 NLLGKGSFGSVYKGTL--SDGMQI--AVKVFN-LELEGTLRSFDAECEILGSIRHRNLVK 798
++GKG FG VY GTL SDG +I AVK N + + F E I+ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 799 IISTC-SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
++ C S+ +VL YM +G L N++ ++ + + + + VA +EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASK 117
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDE---TSMTQTQTLATIGYMAPE----W 910
+H DL N +L+ES ++DFG+++ + D+ + T + +MA E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 911 KLSRKGDVYSYGIILMETFTKKKP 934
K + K DV+S+G++L E T+ P
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 11/217 (5%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGT-LRSFDAECEILGSIRHRNLVKIISTC 803
+G G+ VY L + ++A+K +LE T + E + + H N+VK ++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
LV+ Y+ GSL + M + L + + L+ L Y H IH D
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRD 127
Query: 864 LNPSNILLNESMVACLSDFGISKLL---GDETSMTQTQTLATIGYMAPEWKLSRKG---- 916
+ NILL E ++DFG+S L GD T + + T +MAPE G
Sbjct: 128 IKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK 187
Query: 917 -DVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS 952
D++S+GI +E T P + ++ + + ND
Sbjct: 188 ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP 224
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 66/203 (32%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 738 DGFSENNLLGKGSFGSVYKGTLSDGMQI-AVKVF----NLELEGT-LRSFDAECEILGSI 791
+ E + LG+G+ GSV K L + I A+K N +L+ LR E EI S
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR----ELEINKSC 56
Query: 792 RHRNLVKIISTCSSDHFK--ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVA-SAL 848
+ +VK + + +EY GSL++ +Y K + ++ +A S L
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAP 908
+ L Y H IIH D+ PSNILL L DFG+S L + + T T T YMAP
Sbjct: 116 KGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAP 172
Query: 909 E----WKLSRKGDVYSYGIILME 927
E S DV+S G+ L+E
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 55/295 (18%)
Query: 746 LGKGSFGSVY------------KGTLSDGM-----QIAVKVFNL-ELEGTLRSFDAECEI 787
LG+G FG V+ K + +AVKV + F E +I
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 788 LGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENW------------MYNKNRSFDIL 835
L + N+ +++ C+ D +++EYM NG L + +K+ SF L
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 836 QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK-LLGDETSM 894
L M +AS + YL +H DL N L+ ++ ++DFG+S+ L +
Sbjct: 133 --LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187
Query: 895 TQTQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFT--KKKPTDELFVGEISLKSR 948
Q + I +MA E K + K DV+++G+ L E T +++P + L
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL---------- 237
Query: 949 VNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKE 1003
+ I N YL C + L ++C R E+R +E
Sbjct: 238 ---TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFRE 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 54/197 (27%), Positives = 98/197 (49%), Gaps = 15/197 (7%)
Query: 745 LLGKGSFGSVYKGTL---SDGMQIAVKVFNLELEGTLRSFDAECE---ILGSIRHRNLVK 798
LLG G FG+V+KG D ++I V + ++ ++F + +GS+ H +V+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
++ C + LV + P GSL + + S D + LN + +A + YL +H
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE-EHR-- 129
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLL-GDETSMTQTQTLATIGYMAPE----WKLS 913
++H +L NILL + ++DFG++ LL D+ ++ I +MA E + +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 914 RKGDVYSYGIILMETFT 930
+ DV+SYG+ + E +
Sbjct: 190 HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 61/279 (21%), Positives = 113/279 (40%), Gaps = 40/279 (14%)
Query: 739 GFSENNLLGKGSFGSVY----KGTLSDGMQ--IAVKVFN-LELEGTLRSFDAECEILGSI 791
E LG+G FG V+ KG +G + + VK + E F E ++ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 792 RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWM--------YNKNRSFDILQRLNMVID 843
H+N+V+++ C ++LEY G L+ ++ K Q++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATI 903
+A +++L +H DL N L++ +S +SK + + L +
Sbjct: 126 IALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 904 GYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959
++APE S K DV+S+G+++ E FT+ GE+ ++ +
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQ---------GELPFYGLSDEEV------ 227
Query: 960 VVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEER 998
+N LQ L E C S + L +C + ++R
Sbjct: 228 ---LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 23/202 (11%)
Query: 746 LGKGSFGSVY---KGTLSDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVKI 799
+ KG++G V+ K + D A+KV + + + E +IL + +VK+
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
+ LV+EY+P G L + + N S D + ++ ALEYLH + I
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---I 114
Query: 860 IHCDLNPSNILLNESMVACLSDFGISK--LLGDETSMTQT-----QTLATIGYMAPEWKL 912
IH DL P NIL++ + L+DFG+SK L+ + ++ + + T Y+APE L
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 913 ----SRKGDVYSYGIILMETFT 930
S+ D +S G IL E
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 745 LLGKGSFGSVY--KGTLSDGMQIAVKVFNLE--LEGTLRSFDAECEILGSIRHRNLVKII 800
++G+G+FG V+ + +D + +K +E + + EC++L + H N+++
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEY-------LHY 853
D +V+EY P G+L + I +R N ++D + L + LH+
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEY---------IQKRCNSLLDEDTILHFFVQILLALHH 116
Query: 854 DHPTPIIHCDLNPSNILLNE-SMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL 912
H I+H DL NILL++ MV + DFGISK+L ++ + T Y++PE
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AYTVVGTPCYISPELCE 174
Query: 913 SR----KGDVYSYGIILMETFTKKKPTD 936
+ K D+++ G +L E + K+ +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 28/198 (14%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNL-ELEG-----TLRSFDAECEILGSIRHRNLVK 798
+G+G+ G V+K G +A+K L LEG LR E + L + +H +VK
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVK 63
Query: 799 I--ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQ--RLNMVIDVASALEYLHYD 854
+ + S F LV+EYMP L + ++ R Q ++ L+ + Y
Sbjct: 64 LLDVFPHGS-GF-VLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML-----LKGVAYM 115
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL-S 913
H I+H DL P+N+L++ V ++DFG+++L +E + +AT Y APE +
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 914 RK----GDVYSYGIILME 927
RK D+++ G I E
Sbjct: 176 RKYDPGVDLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 64/216 (29%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 740 FSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVK 798
F+ +GKGSFG VYK +A+KV +LE +AE EI + ++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE--------EAEDEIEDIQQE---IQ 51
Query: 799 IISTCSSDH-----------FK-ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVAS 846
+S C S + K +++EY GS + + K D ++ +V
Sbjct: 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLL 109
Query: 847 ALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYM 906
LEYLH + IH D+ +NILL+E L+DFG+S L S T + T +M
Sbjct: 110 GLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWM 165
Query: 907 APE----WKLSRKGDVYSYGIILMETFTKKKPTDEL 938
APE K D++S GI +E + P +L
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 735 RATDGFSE---NNLLGKGSFGSVYKGT-LSDGMQIAVKVF--NLELEGTLRSFDAECEIL 788
A SE N +G G+ G+VYK G A+KV N E + R E EIL
Sbjct: 68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEIL 126
Query: 789 GSIRHRNLVKIISTCSSDHFKA----LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDV 844
+ H N+VK C ++LE+M GSLE + + R +
Sbjct: 127 RDVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-----QI 177
Query: 845 ASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG 904
S + YLH H I+H D+ PSN+L+N + ++DFG+S++L +T ++ TI
Sbjct: 178 LSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA-QTMDPCNSSVGTIA 233
Query: 905 YMAPE---WKLSR------KGDVYSYGIILMETFTKKKP 934
YM+PE L+ GD++S G+ ++E + + P
Sbjct: 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 746 LGKGSFGSVYK----GTLSDGMQIAVKVFNLELEGTL---RSFDAECEILGSIRHRNLVK 798
+G+G+FG V++ G L V V L+ E + F E ++ H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWM--------------------YNKNRS-FDILQR 837
++ C+ L+ EYM G L ++ N ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 838 LNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK--LLGDETSMT 895
L + VA+ + YL +H DL N L+ E+MV ++DFG+S+ D +
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 896 QTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT 930
+ + I +M PE + + + DV++YG++L E F+
Sbjct: 190 ENDAIP-IRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 745 LLGKGSFGSV-YKGTLSDGMQIAVKVFNLE--LEGTLRSFDAECEILGSIRHRNLVKIIS 801
+LG G+ G+V +SDG AVKV ++E E AE L + ++VK
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK--- 95
Query: 802 TCSSDHFK------------ALVLEYMPNGSLENWMYNK---NRSFDILQRLNMVIDVAS 846
C D K ALVL+Y G L + ++ NR+F + + I V
Sbjct: 96 -CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154
Query: 847 ALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGY 905
A+ ++H H +IH D+ +NILL + + L DFG SK+ S +T T Y
Sbjct: 155 AVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211
Query: 906 MAPE-WK---LSRKGDVYSYGIILMETFTKKKPTD 936
+APE W+ S+K D++S G++L E T K+P D
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDA-----ECEILGSIRH---RN 795
L+G+G++G+VY+G + G +A+K+ NL+ D E +L +R N
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQSQPPN 63
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVI--DVASALEYLHY 853
+ K + +++EY GS+ M ++ I ++ VI +V AL+Y+H
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHK 119
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL- 912
+IH D+ +NIL+ + L DFG++ LL +S T T +MAPE
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITE 175
Query: 913 ----SRKGDVYSYGIILMETFTKKKP 934
K D++S GI + E T P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 746 LGKGSFGSVYKGTLSD-GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
LG G+FG VYK + G+ A KV + + E L + E +IL S H N+VK++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
++ +++E+ G+++ M R L + + LE L+Y H IIH DL
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR---------K 915
NIL L+DFG+S T + + T +MAPE + K
Sbjct: 130 KAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 188
Query: 916 GDVYSYGIILMETFTKKKPTDELFVGEISLK 946
DV+S GI L+E + P EL + LK
Sbjct: 189 ADVWSLGITLIEMAQIEPPHHELNPMRVLLK 219
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 24/199 (12%)
Query: 744 NLLGKGSFGSVYKGT-LSDGMQIAVK-VFNLELEGTLR--SFDA--ECEILGSIRHRNLV 797
LG+G++ VYK G +A+K + E + +F A E ++L ++H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSF---DILQRLNMVIDVASALEYLHYD 854
++ LV E+M LE + +K+ DI + M + LEYLH +
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RGLEYLHSN 121
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD-ETSMTQTQTLATIGYMAPEWKL- 912
I+H DL P+N+L+ V L+DFG+++ G MT Q + T Y APE
Sbjct: 122 W---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQ-VVTRWYRAPELLFG 176
Query: 913 SRK----GDVYSYGIILME 927
+R D++S G I E
Sbjct: 177 ARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 70/292 (23%), Positives = 127/292 (43%), Gaps = 53/292 (18%)
Query: 746 LGKGSFGSVYKGTLS-DGMQ----IAVKVF-NLELEGTLRSFDAECEILGSIRHRNLVKI 799
LG+ +FG +YKG L GM +A+K ++ F E ++ + H N+V +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKN----------------RSFDILQRLNMVID 843
+ + + ++ EY+ G L ++ ++ S D L++ I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 844 VASALEYL--HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK-LLGDETSMTQTQTL 900
+A+ +EYL H+ +H DL NIL+ E + +SD G+S+ + + Q ++L
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 901 ATIGYMAPE----WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGK 956
I +M PE K S D++S+G++L E F+ L+ S + +
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS------------FGLQPYYGFS-NQE 234
Query: 957 IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008
+I +V ++ L E C + SL +C +E R K+ T+L
Sbjct: 235 VIEMV------RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 55/194 (28%), Positives = 103/194 (53%), Gaps = 18/194 (9%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTC 803
LG G FG V+ T + ++AVK G++ +F AE ++ +++H LVK+ +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 804 SSDHFKALVLEYMPNGSLENWMYNK--NRSFDILQRLNMVIDVASAL-EYLHYDHPTPII 860
+ + ++ E+M GSL +++ + ++ Q L +ID ++ + E + + I
Sbjct: 71 TKEPI-YIITEFMAKGSLLDFLKSDEGSK-----QPLPKLIDFSAQIAEGMAFIEQRNYI 124
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKG 916
H DL +NIL++ S+V ++DFG+++++ D + I + APE + K
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 917 DVYSYGIILMETFT 930
DV+S+GI+LME T
Sbjct: 185 DVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 69/231 (29%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 723 VTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSD-GMQIAVKV--FNLELEGTLR 779
+ WRR LLG+G+FG VY D G ++A K F+ E T +
Sbjct: 2 INWRR---------------GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSK 46
Query: 780 SFDA-ECEI--LGSIRHRNLVKIISTCSSDHFK---ALVLEYMPNGSLENWMYNKNRSFD 833
A ECEI L +++H +V+ C D + + +EYMP GS+++ + +++
Sbjct: 47 EVSALECEIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYG 101
Query: 834 ILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893
L LE + Y H I+H D+ +NIL + + L DFG SK L
Sbjct: 102 ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTIC 160
Query: 894 MTQTQTLATIG---YMAPE----WKLSRKGDVYSYGIILMETFTKKKPTDE 937
M+ T + G +M+PE RK DV+S G ++E T+K P E
Sbjct: 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 740 FSENNL-----LGKGSFGSVYKGTL-----SDG-MQIAVKVFNLELEGTLRSFD-----A 783
F NNL LG G+FG V + T SD M++AVK+ L+ T S + +
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKM----LKPTAHSSEREALMS 87
Query: 784 ECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSF-DILQRLNMV 841
E +I+ + H N+V ++ C+ ++ EY G L N++ K SF + L+
Sbjct: 88 ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147
Query: 842 IDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK-LLGDETSMTQTQTL 900
VA + +L + IH DL N+LL + + DFG+++ ++ D + +
Sbjct: 148 YQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNAR 204
Query: 901 ATIGYMAPEWKL----SRKGDVYSYGIILMETFT 930
+ +MAPE + + DV+SYGI+L E F+
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 46/220 (20%)
Query: 746 LGKGSFGSVYKGTL---SDGMQ---IAVKVFNLELEGTLRS-FDAECEILGSIRHRNLVK 798
LG+ FG VYKG L + G Q +A+K + EG LR F E + ++H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQR---------------LNMVID 843
++ + + +++ Y + L ++ ++ D+ +++V
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGI---------SKLLGDETSM 894
+A+ +E+L H ++H DL N+L+ + + +SD G+ KL+G+
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN---- 185
Query: 895 TQTQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFT 930
+L I +M+PE K S D++SYG++L E F+
Sbjct: 186 ----SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 31/209 (14%)
Query: 744 NLLGKGSFGSVYKGTLS-DGMQI--AVKVFN-LELEGTLRSFDAECEILGSI-RHRNLVK 798
+++G+G+FG V K + DG+++ A+K + R F E E+L + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDI----------------LQRLNMVI 842
++ C + L +EY P+G+L +++ K+R + Q L+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 843 DVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT 902
DVA ++YL IH DL NIL+ E+ VA ++DFG+S+ G E + +T
Sbjct: 120 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 174
Query: 903 IGYMAPE----WKLSRKGDVYSYGIILME 927
+ +MA E + DV+SYG++L E
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 740 FSENNLLGKGSFGSVYKGTLSDGMQI-AVKVFNLE-LEGTLRSFDAECEILGSIRHRNLV 797
F++ +GKGSFG V+KG + Q+ A+K+ +LE E + E +L +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
K + +++EY+ GS + + + FD Q M+ ++ L+YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDYLHSEKK- 122
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLS 913
IH D+ +N+LL+E L+DFG++ L D T + + + T +MAPE
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVIQQSAYD 179
Query: 914 RKGDVYSYGIILMETFTKKKPTDEL 938
K D++S GI +E + P ++
Sbjct: 180 SKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 20/200 (10%)
Query: 745 LLGKGSFGSVYKGTLSDGMQ-IAVKVFNLELEGTLRSFD---AECEILGSIRHRNLVKII 800
+G G+FG V+ A+KV + L+ E +L + H ++++
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
T F +++EY+P G L +++ N F L ++ ALEYLH I+
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLH---SKEIV 123
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYMAPEWKLSRKG--- 916
+ DL P NILL++ L+DFG +K L D +T TL T Y+APE + KG
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEYLAPE-VIQSKGHNK 177
Query: 917 --DVYSYGIILMETFTKKKP 934
D ++ GI++ E P
Sbjct: 178 AVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 745 LLGKGSFGSVYK------GTLSDGMQIA-VKVFNLELEGTLRSFDAECEILGSIRHRNLV 797
LG G+F S Y+ GTL Q+ V+ + E E + + E ++ + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 798 KII-STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
+++ +TC HF L +E+M GS+ + + +K +F +N + L YLH +
Sbjct: 67 RMLGATCEDSHFN-LFVEWMAGGSVSH-LLSKYGAFKEAVIINYTEQLLRGLSYLHENQ- 123
Query: 857 TPIIHCDLNPSNILLNES-MVACLSDFGISKLL---GDETSMTQTQTLATIGYMAPE--- 909
IIH D+ +N+L++ + ++DFG + L G Q Q L TI +MAPE
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 910 -WKLSRKGDVYSYGIILMETFTKKKP 934
+ R DV+S G +++E T K P
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 746 LGKGSFGSVYKG---TLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKII 800
LG G+FG+V KG +AVK+ + E ++ + + +V++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
C ++ + LV+E G L ++ KN+ +V V+ ++YL T +
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLE---ETNFV 117
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT--IGYMAPE----WKLSR 914
H DL N+LL A +SDFG+SK LG + + + +T + + APE +K S
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 915 KGDVYSYGIILMETFT-KKKP 934
K DV+S+G+++ E F+ +KP
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 745 LLGKGSFGSVYKGTLSD-GMQIAVKV--FNLELEGTLRSFDA-ECEI--LGSIRHRNLVK 798
LLG+G+FG VY +D G ++AVK F+ + + T + +A ECEI L ++RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 799 IISTCSSDHFK---ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH 855
C D + ++ +EYMP GS+++ + +++ L L+ + Y H
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSYLH 123
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPE--- 909
I+H D+ +NIL + + L DFG SK + M+ T + G +M+PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 910 -WKLSRKGDVYSYGIILMETFTKKKPTDE 937
RK DV+S ++E T+K P E
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 72/288 (25%), Positives = 124/288 (43%), Gaps = 52/288 (18%)
Query: 746 LGKGSFGSVYKGTLSDGMQ----------------IAVKVFNLELEGTLRS-FDAECEIL 788
LG+G FG V+ ++G+ +AVK+ ++ T R+ F E +I+
Sbjct: 13 LGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 789 GSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMY-----------NKNRSFDILQR 837
+++ N+++++ C SD ++ EYM NG L ++ N S I
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 838 LNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK-LLGDETSMTQ 896
L M + +AS ++YL +H DL N L+ ++DFG+S+ L + Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 897 TQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFT--KKKPTDELFVGEISLKSRVN 950
+ + I +MA E K + DV+++G+ L E FT K++P L ++
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV------- 241
Query: 951 DSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEER 998
I N + Q YL+ C S V L M+C ++R
Sbjct: 242 ------IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDR 283
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 7e-14
Identities = 74/234 (31%), Positives = 111/234 (47%), Gaps = 50/234 (21%)
Query: 745 LLGKGSFGSVY---KGTLSDGMQI-AVKVFNLELEGTLRS------FDAECEILGSIRHR 794
+LGKG +G V+ K T +D +I A+KV L+ +R+ AE IL +++H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKV--LKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 795 NLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVI-DVAS------- 846
+V +I + L+LEY+ G L F L+R + + D A
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGEL----------FMHLEREGIFMEDTACFYLSEIS 110
Query: 847 -ALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGY 905
ALE+LH II+ DL P NILL+ L+DFG+ K E ++T T TI Y
Sbjct: 111 LALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEY 166
Query: 906 MAPEWKLSRKG-----DVYSYGIILMETFT---------KKKPTDELFVGEISL 945
MAPE L R G D +S G ++ + T +KK D++ G+++L
Sbjct: 167 MAPEI-LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 7e-14
Identities = 68/273 (24%), Positives = 118/273 (43%), Gaps = 24/273 (8%)
Query: 746 LGKGSFGSVY------KGTLSDGMQIAVKVFNLELEGT-LRSFDAECEILGSIRHRNLVK 798
LG+G FG V +G + G Q+AVK E G + E EIL ++ H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 799 IISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
C+ D L++E++P+GSL+ ++ ++ Q+L + + ++YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ- 129
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLL-GDETSMTQTQTL-ATIGYMAPEW---- 910
+H DL N+L+ + DFG++K + D+ T L + + + APE
Sbjct: 130 --YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 911 KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970
K DV+S+G+ L E T ++L ++ HG++ + +L+ E
Sbjct: 188 KFYIASDVWSFGVTLYELLTYCDSE----SSPMTLFLKMIGPTHGQMTVTRLVRVLE-EG 242
Query: 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKE 1003
L C V L +C +R +
Sbjct: 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQN 275
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 36/208 (17%)
Query: 746 LGKGSFGSVYKGTL-SDGMQIAVK------VFNLELEGTLRSFDAECEILGSIRHRNLVK 798
LG G FG V + S A+K + + + S E EIL H +VK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVID------VASALEYLH 852
+ T + +++EY G L + IL+ + + +A +
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGEL----------WTILRDRGLFDEYTARFYIACVVLAFE 107
Query: 853 YDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYMAPEWK 911
Y H II+ DL P N+LL+ + L DFG +K L S +T T T Y+APE
Sbjct: 108 YLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK---SGQKTWTFCGTPEYVAPEII 164
Query: 912 LSRKG-----DVYSYGIILMETFTKKKP 934
L+ KG D +S GI+L E T + P
Sbjct: 165 LN-KGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 746 LGKGSFGSVY--KGTLSDGMQIAVKVFNLELEGTLRSFDAECEI--LGSIRHRNLVKIIS 801
+G+GSFG +Y K SD +K +L ++ E+ L ++H N+V +
Sbjct: 8 IGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFDIL----QRLNMVIDVASALEYLHYDHPT 857
+ + +V+EY G L M NR +L Q L+ + ++ L+++H
Sbjct: 67 SFQENGRLFIVMEYCDGGDL---MKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DR 120
Query: 858 PIIHCDLNPSNILLNES-MVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR-- 914
I+H D+ NI L+++ MVA L DFGI++ L D + T + T Y++PE +R
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQNRPY 179
Query: 915 --KGDVYSYGIILMETFTKKKP 934
K D++S G +L E T K P
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 57/211 (27%), Positives = 103/211 (48%), Gaps = 32/211 (15%)
Query: 746 LGKGSFGSVYKGTLSDG---MQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKII 800
LG+G FGSV +G L+ +++AVK + + + F +E + H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 801 STC----SSDHFKA--LVLEYMPNGSLENWM-YNKNRSFDILQRLNMVI----DVASALE 849
C S+ + + ++L +M +G L +++ Y++ M++ D+AS +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 850 YLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE 909
YL IH DL N +LNE+M C++DFG+SK + + Q + I M +
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGR----IAKMPVK 179
Query: 910 W---------KLSRKGDVYSYGIILMETFTK 931
W + K DV+S+G+ + E T+
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 745 LLGKGSFGSVYKGTLSD-GMQIAVKV--FNLELEGTLRSFDA-ECEI--LGSIRHRNLVK 798
LLG+G+FG VY +D G ++AVK F+ E T + +A ECEI L ++ H +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 799 IISTCSSDHFKAL--VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
+ L +E+MP GS+++ + +S+ L LE + Y H
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPEW--- 910
I+H D+ +NIL + L DFG SK L ++ T + G +M+PE
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 911 -KLSRKGDVYSYGIILMETFTKKKPTDEL 938
RK D++S G ++E T+K P E
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEF 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 69/219 (31%), Positives = 92/219 (42%), Gaps = 52/219 (23%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVF----NLE--------LEGTLRSFDA----ECEI 787
+G G+ G VYK G +AVK N E L+ L+S D +C
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKC-- 79
Query: 788 LGSIRHRNLVKI----ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVID 843
G + V I +STC D + +P DIL + M +
Sbjct: 80 YGYFITDSDVFICMELMSTCL-DKLLKRIQGPIPE--------------DILGK--MTVA 122
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATI 903
+ AL YL H +IH D+ PSNILL+ S L DFGIS L D S +T++
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD--SKAKTRSAGCA 178
Query: 904 GYMAPEW--------KLSRKGDVYSYGIILMETFTKKKP 934
YMAPE K + DV+S GI L+E T + P
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-13
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 740 FSENNLLGKGSFGSVYKGTLSDGMQI-AVKVFNLE-LEGTLRSFDAECEILGSIRHRNLV 797
F++ +GKGSFG V+KG + ++ A+K+ +LE E + E +L +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
K + D +++EY+ GS + + + D Q ++ ++ L+YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKK- 122
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLS 913
IH D+ +N+LL+E L+DFG++ L D T + + + T +MAPE
Sbjct: 123 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 914 RKGDVYSYGIILMETFTKKKPTDEL 938
K D++S GI +E + P EL
Sbjct: 180 SKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 735 RATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVK--VFNLELEG----TLRSFDAECEI 787
R+ D + + N + +G++G VY+ G +A+K E EG +LR E I
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR----EINI 57
Query: 788 LGSIRHRNLVKI--ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVA 845
L ++H N+V + + S+ +V+EY+ + L++ M + F + +++ +
Sbjct: 58 LLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLL 116
Query: 846 SALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGY 905
S + +LH D+ I+H DL SN+LLN + + DFG+++ G TQ + T+ Y
Sbjct: 117 SGVAHLH-DNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PYTQLVVTLWY 172
Query: 906 MAPEWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVGE 942
APE L S D++S G I E TK LF G+
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTK----KPLFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 70/302 (23%), Positives = 130/302 (43%), Gaps = 55/302 (18%)
Query: 746 LGKGSFGSVYKGTLSDGMQ------------------IAVKVFNLELEGTLRS-FDAECE 786
LG+G FG V+ ++GM+ +AVK+ + R+ F E +
Sbjct: 13 LGEGQFGEVHLCE-AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 787 ILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYN----------KNRSFDILQ 836
I+ ++ N++++++ C + ++ EYM NG L ++ +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 837 RLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL--GDETSM 894
+ M +AS ++YL +H DL N L+ ++ ++DFG+S+ L GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 895 TQTQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFT--KKKPTDELFVGEISLKSR 948
Q + + I +M+ E K + DV+++G+ L E T K++P +L ++
Sbjct: 189 -QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV----- 242
Query: 949 VNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008
I N + Q YL C S+ L + C R +A+ER + +E L
Sbjct: 243 --------IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294
Query: 1009 LK 1010
L+
Sbjct: 295 LE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 54/167 (32%), Positives = 75/167 (44%), Gaps = 34/167 (20%)
Query: 745 LLGKGSFGSVY----KGTLSDGMQIAVKV---FNLELEGTLRSFDAECEILGSIRHRNLV 797
LLGKG G V+ KGT G A+KV + ++ E EIL ++ H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNM-----------VIDVAS 846
+ ++ ++ + LV++Y P G L F +LQR +V
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGEL----------FRLLQRQPGKCLSEEVARFYAAEVLL 114
Query: 847 ALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893
ALEYLH I++ DL P NILL+ES LSDF +SK E
Sbjct: 115 ALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 745 LLGKGSFGSVYKGTLSD-GMQIAVKVFNLELEGT-------LRSFDAECEILGSIRHRNL 796
++G+G++G V K G +A+K F E E LR E ++L +RH N+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALR----EVKVLRQLRHENI 62
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDH 855
V + LV EY+ LE + D ++ + + A+ Y H +
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSY--IWQLLQAIAYCHSHN 120
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR- 914
IIH D+ P NIL++ES V L DFG ++ L + T +AT Y APE +
Sbjct: 121 ---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 915 ---KG-DVYSYGIILMETFTKKKPTDELFVGE 942
K DV++ G I+ E + LF G+
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEP----LFPGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 740 FSENNLLGKGSFGSVYKGTLSD-GMQIAVKV--FNLELEGTLRSFDAECEILGSIRHRNL 796
F + N +G+G++G VY+ + G +A+K + E +G S E +L ++RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 797 VKIISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD 854
V++ H + LV+EY L + + N F Q +++ + L+YLH +
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD-ETSMTQTQTLATIGYMAPEWKLS 913
IIH DL SN+LL + ++DFG+++ G M T + T+ Y APE L
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYRAPELLLG 182
Query: 914 RKG-----DVYSYGIILMETFTKK 932
D+++ G IL E K
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNL--ELEGTLRSFDAECEILGSIRHRNLVKIIST 802
+G+G++G VYK G +A+K L E EG + E +L + H N+VK++
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQ----RLNMVID-VASALEYLHYDHPT 857
+++ LV E++ + L+ +M D L ++ + L+ L + H
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFM-------DASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL----- 912
++H DL P N+L+N L+DFG+++ G T T + T+ Y APE L
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYY 178
Query: 913 SRKGDVYSYGIILMETFTKKKPTDELFVGE 942
S D++S G I E T++ LF G+
Sbjct: 179 STAVDIWSLGCIFAEMVTRRA----LFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 48/229 (20%)
Query: 740 FSENNL-----LGKGSFGSVYKGTLSD-GMQIAVK------------VFNLELEGTLRSF 781
F+ +L +G+G+FG+V K G +AVK ++L+ +RS
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS- 59
Query: 782 DAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENW---MYNKNRSF---DIL 835
++C +VK + + +E M + SL+ + +Y +S +IL
Sbjct: 60 -SDCP--------YIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEIL 109
Query: 836 QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895
++ + AL YL + IIH D+ PSNILL+ + L DFGIS L D S+
Sbjct: 110 GKIAVA--TVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SIA 163
Query: 896 QTQTLATIGYMAPEWKLS--RKG-----DVYSYGIILMETFTKKKPTDE 937
+T+ YMAPE R G DV+S GI L E T K P +
Sbjct: 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 74/262 (28%), Positives = 112/262 (42%), Gaps = 35/262 (13%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTL-RSFDAECEILGSIRHRNLVKIISTC 803
LG G+ G+VYK L +AVKV L++ L + +E EIL ++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
++ ++ E+M GSL+ +Y K +L R+ + V L YL I+H D
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPE-HVLGRI--AVAVVKGLTYLW---SLKILHRD 120
Query: 864 LNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRK----GDVY 919
+ PSN+L+N L DFG+S L + + T T A YMAPE + DV+
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNA---YMAPERISGEQYGIHSDVW 177
Query: 920 SYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ---KEDAYLTAK 976
S GI ME + P ++ + SL + + LLQ ED +
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSL---------------MPLQLLQCIVDEDPPVLPV 222
Query: 977 EQCVSSVLSLAMQCTRESAEER 998
Q + QC R+ +ER
Sbjct: 223 GQFSEKFVHFITQCMRKQPKER 244
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 69/237 (29%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVFNLELEG-------TLRSFDAECEILGSIRHRNL 796
L+G+GS+G V K + QI A+K F LE E +R E +L +RH NL
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMR----EIRMLKQLRHENL 62
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
V +I LV E++ + L++ N D + + + +E+ H +
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHN- 120
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW-----K 911
IIH D+ P NIL+++S V L DFG ++ L + T +AT Y APE K
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-TDYVATRWYRAPELLVGDTK 177
Query: 912 LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968
R D+++ G ++ E T + LF G+ + D L+ II + NL+ +
Sbjct: 178 YGRAVDIWAVGCLVTEMLT----GEPLFPGDSDI-----DQLY-HIIKCLG-NLIPR 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 39/230 (16%)
Query: 746 LGKGSFGSVY--------KGTLSDGMQIAVKVFNLE-LEGTLRSFDAECEILGSI-RHRN 795
LG+G FG V K + + +AVK+ + E L +E E++ I +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNK-----NRSFDILQ----------RLNM 840
++ ++ C+ D +++EY G+L ++ + S+DI + ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 841 VIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT- 899
VA +EYL IH DL N+L+ E+ V ++DFG+++ + + +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 900 LATIGYMAPEWKLSR----KGDVYSYGIILMETFT------KKKPTDELF 939
+ +MAPE R + DV+S+G+++ E FT P +ELF
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 32/217 (14%)
Query: 746 LGKGSFGSVYKGT------LSDGMQIAVKVFNLELEGT-LRSFDAECEILGSIRHRNLVK 798
LG+G FG V K T + +AVK+ + LR +E +L + H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWM--------------YNKNRSFDI---LQRLNMV 841
+ CS D L++EY GSL +++ N+N S+ + L M
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 842 IDVASALEY---LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK-LLGDETSMTQT 897
++ A + + Y ++H DL N+L+ E +SDFG+S+ + +++ + ++
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 898 QTLATIGYMAPEWKL----SRKGDVYSYGIILMETFT 930
+ + +MA E + + DV+S+G++L E T
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 24/215 (11%)
Query: 745 LLGKGSFGSVYKGT-LSDG----MQIAVKVF--NLELEGTLRSFDAECEILGSIRHRNLV 797
+LG G+FG+VYKG + DG + +A+KV N + D E ++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAGVGSPYVC 72
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMY-NKNR--SFDILQRLNMVIDVASALEYLHYD 854
+++ C + + LV + MP G L +++ NK+R S D+ LN + +A + YL
Sbjct: 73 RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDL---LNWCVQIAKGMSYL--- 125
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG-DETSMTQTQTLATIGYMAPEWKLS 913
++H DL N+L+ ++DFG+++LL DET I +MA E L
Sbjct: 126 EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185
Query: 914 RK----GDVYSYGIILMETFT-KKKPTDELFVGEI 943
R+ DV+SYG+ + E T KP D + EI
Sbjct: 186 RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 43/214 (20%)
Query: 745 LLGKGSFGSVY---KGTLSDGMQI-AVKVF---NLELEGTLRSFDAECEILGSIRHRNLV 797
+LG+GSFG V+ K T D Q+ A+KV L++ +R+ E +IL + H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVI------------DVA 845
K+ ++ L+L+++ G D+ RL+ + ++A
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELA 108
Query: 846 SALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGY 905
AL++LH II+ DL P NILL+E L+DFG+SK D + T+ Y
Sbjct: 109 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEY 164
Query: 906 MAPEWKLSRKG-----DVYSYGIILMETFTKKKP 934
MAPE ++R+G D +S+G+++ E T P
Sbjct: 165 MAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLR-----SFDAECEILGSIRHRNLVKII 800
+G G FG V G GM A +V EL + F E + + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSF-------DILQRLNMVIDVASALEYLHY 853
C LVLE+ P G L+N++ NR D+LQR M +VAS L +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQR--MACEVASGLLWLHQ 118
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGIS-KLLGDETSMTQTQTLATIGYMAPEW-- 910
IH DL N L + + D+G++ + ++ +T+ + ++APE
Sbjct: 119 AD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 911 ---------KLSRKGDVYSYGIILMETFT 930
++K +++S G+ + E FT
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLELEG------TLRSFDAECEILGSIRHRNLVK 798
+G+G++G VYK G +A+K L E LR E ++L + H N++K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
++ LV E+M + L + ++ R + + + L + H
Sbjct: 63 LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--- 118
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-- 916
I+H DL P N+L+N V L+DFG+++ G T + T Y APE L KG
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP-YTHYVVTRWYRAPELLLGDKGYS 177
Query: 917 ---DVYSYGIILME 927
D++S G I E
Sbjct: 178 TPVDIWSVGCIFAE 191
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 37/229 (16%)
Query: 745 LLGKGSFGSVYKGTLSD------GMQIAVKVFNLE-LEGTLRSFDAECEILGSI-RHRNL 796
LG+G+FG V K +AVK+ + E L +E E++ I +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWM---------YNKNRSFDILQRL------NMV 841
+ ++ C+ + +V+EY +G+L +++ + + + L +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 842 IDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD-ETSMTQTQTL 900
VA +E+L IH DL N+L+ E V ++DFG+++ + + T
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 901 ATIGYMAPEWKLSR----KGDVYSYGIILMETFT------KKKPTDELF 939
+ +MAPE R + DV+S+G++L E FT P +ELF
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 64/235 (27%), Positives = 100/235 (42%), Gaps = 58/235 (24%)
Query: 740 FSENNLLGKGSFGSVYKGT-LSDGMQIAVK--VFNLELEG----TLRSFDAECEI----- 787
+ E +G+G++G+VYK L+ G +A+K L EG TLR EI
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR------EIALLKQ 54
Query: 788 LGSIRHRNLVKIISTCSSDHFK-----ALVLEYM-----------PNGSLENWMYNKNRS 831
L S H N+V+++ C LV E++ P L K+
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETI-KDLM 113
Query: 832 FDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891
+L +++LH I+H DL P NIL+ ++DFG++++ E
Sbjct: 114 RQLL----------RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160
Query: 892 TSMTQTQTLATIGYMAPEWKL----SRKGDVYSYGIILMETFTKKKPTDELFVGE 942
M T + T+ Y APE L + D++S G I E F +++P LF G
Sbjct: 161 --MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRP---LFRGT 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 746 LGKGSFGSVYKGTL----SDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKI 799
+GKGS+G V +L +DG Q +K NL ++ + E ++L ++H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 800 ISTCS-SDHFKALVLEYMPNGSLENWMYNKNRSFDIL---QRLNMVIDVASALEYLHYDH 855
+ D +V+ + G L + + K + +L Q + + +A AL+YLH H
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR- 914
I+H DL N+ L + + + D GI+++L ++ M T + T YM+PE ++
Sbjct: 123 ---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNKP 178
Query: 915 ---KGDVYSYGIILMETFTKK 932
K DV++ G + E T K
Sbjct: 179 YNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 44/112 (39%), Positives = 62/112 (55%), Gaps = 14/112 (12%)
Query: 833 DILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892
DIL + + + + ALEYLH +IH D+ PSN+L+N + L DFGIS L D
Sbjct: 103 DILGK--IAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD-- 156
Query: 893 SMTQTQTLATIGYMAPEW---KLSRKG-----DVYSYGIILMETFTKKKPTD 936
S+ +T YMAPE +L++KG DV+S GI ++E T + P D
Sbjct: 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 740 FSENNLLGKGSFGSVYKGT-LSDGMQIAVK---VFNLELEGTLRSFDAECEILGSIRHRN 795
F +G+G F VY+ T L DG+ +A+K +F+L E ++L + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRL-------NMVIDVASAL 848
++K ++ D+ +VLE G L + + F +RL + + SAL
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMI----KHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAP 908
E++H ++H D+ P+N+ + + V L D G+ + +T+ + + T YM+P
Sbjct: 120 EHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSP 175
Query: 909 EW----KLSRKGDVYSYGIILMETFTKKKP 934
E + K D++S G +L E + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 746 LGKGSFGSVYKG--TLSDGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIIST 802
LG+G++ +V+KG L++ + +A+K LE E G + E +L ++H N+V +
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
+D LV EY+ + L+ +M + +I+ N+ I + L L Y H ++H
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYM---DDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL-----SRKGD 917
DL P N+L+NE L+DFG+++ T T + + T+ Y P+ L S + D
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQID 187
Query: 918 VYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLH 954
++ G I E + + LF G S V D LH
Sbjct: 188 MWGVGCIFFEMASGRP----LFPG-----STVEDELH 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 740 FSENNLLGKGSFGSVYKGTL----SDGMQIAVKVFNLELEGT--LRSFDAECEILGSIRH 793
F+ +LGKG FGSV + L ++AVK+ ++ + + F E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 794 RNLVKIISTCSSDHFKA------LVLEYMPNGSLENWMYNK---NRSFDILQR--LNMVI 842
N++K+I K ++L +M +G L ++ F + + + +I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 843 DVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL--GDETSMTQTQTL 900
D+AS +EYL + IH DL N +LNE+M C++DFG+SK + GD L
Sbjct: 121 DIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 901 ATIGYMAPEW----KLSRKGDVYSYGIILMETFTK 931
+ ++A E + DV+++G+ + E T+
Sbjct: 178 P-VKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 740 FSENNLLGKGSFGSVYKGTLSDGMQI-AVKVFNLE-LEGTLRSFDAECEILGSIRHRNLV 797
F++ +GKGSFG VYKG + ++ A+K+ +LE E + E +L +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
+ + +++EY+ GS + + K + ++ ++ L+YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSERK- 122
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE-WKLSR-- 914
IH D+ +N+LL+E L+DFG++ L D T + + + T +MAPE K S
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 915 -KGDVYSYGIILMETFTKKKPTDEL 938
K D++S GI +E + P +L
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 49/192 (25%), Positives = 84/192 (43%), Gaps = 12/192 (6%)
Query: 745 LLGKGSFGSVYKGTLS----DGMQIAVKVFNLELEGTLR-SFDAECEILGSIRHRNLVKI 799
+LG G FG + +G L + +A+ R F AE LG H N+V++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
+ + +V EYM NG+L++++ Q + M+ +AS ++YL
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGY 128
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRK 915
+H L +L+N +V +S F + E T + + + APE S
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA 188
Query: 916 GDVYSYGIILME 927
DV+S+GI++ E
Sbjct: 189 SDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVK---VFNLELEGTLRSFDAECEILGSIRHRNLVKIIS 801
+G+G F VY+ T L D +A+K +F + + E ++L + H N++K +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 802 TCSSDHFKALVLEYMPNGSLENW-MYNKNRSFDILQRL--NMVIDVASALEYLHYDHPTP 858
+ D+ +VLE G L Y K + I +R + + SA+E++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--- 126
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSR 914
++H D+ P+N+ + + V L D G+ + +T+ + + T YM+PE +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHENGYNF 185
Query: 915 KGDVYSYGIILMETFTKKKP 934
K D++S G +L E + P
Sbjct: 186 KSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 61/232 (26%), Positives = 107/232 (46%), Gaps = 43/232 (18%)
Query: 746 LGKGSFGSVY--------KGTLSDGMQIAVKVFNLELEGT---LRSFDAECEILGSI-RH 793
LG+G FG V K + + +AVK+ L+ + T L +E E++ I +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 794 RNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNK-----NRSFDILQRLNMVI------ 842
+N++ ++ C+ D +++EY G+L ++ + + SFD + +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 843 ----DVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD-ETSMTQT 897
VA +EYL IH DL N+L+ E V ++DFG+++ + + + T
Sbjct: 138 SCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 898 QTLATIGYMAPEWKLSR----KGDVYSYGIILMETFTKKK------PTDELF 939
+ +MAPE R + DV+S+G++L E FT P +ELF
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 737 TDGFSENNLLGKGSFGSVYKGT-LSDGMQIA---VKVFNLELEGTLRSFDAECEILGSIR 792
F +GKG F VYK L DG +A V++F + + E ++L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALE 849
H N++K +++ ++ +VLE G L + + + R + + SALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 850 YLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE 909
++H I+H D+ P+N+ + + V L D G+ + +T+ + + T YM+PE
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPE 176
Query: 910 --------WKLSRKGDVYSYGIILMETFTKKKP 934
+ K D++S G +L E + P
Sbjct: 177 RIHENGYNF----KSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+G+G+ G+VY ++ G ++A+K NL+ + E ++ +H N+V + +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
+V+EY+ GSL + + D Q + + ALE+LH + +IH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 141
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-----DVY 919
NILL L+DFG + E S ++ + T +MAPE ++RK D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPE-VVTRKAYGPKVDIW 199
Query: 920 SYGIILMETFTKKKP 934
S GI+ +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 38/211 (18%)
Query: 746 LGKGSFGSVYK-GTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
LG G+ GSV K + G +A KV ++ + ++R +IL R L +I+ C
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK-----QIL-----REL-QIMHECR 61
Query: 805 SDHFKA------------LVLEYMPNGSLENWMYNKNR--SFDILQRLNMVIDVASALEY 850
S + + + +E+M GSL+ +Y K +IL ++ + V L Y
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKI--AVAVVEGLTY 118
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW 910
L+ H I+H D+ PSNIL+N L DFG+S L + S+ T + T YM+PE
Sbjct: 119 LYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN--SIADT-FVGTSTYMSPER 173
Query: 911 ----KLSRKGDVYSYGIILMETFTKKKPTDE 937
K + K DV+S GI ++E K P
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 746 LGKGSFGSVY----KGTLSDGMQIAVKVFN----LELEGTLRSFDAECEILGSIRHRN-L 796
LG G++G V+ G G A+KV ++ T E ++L ++R L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVI-DVASALEYLHYDH 855
V + +D L+L+Y+ G L +Y + F + + I ++ AL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH-FT-ESEVRVYIAEIVLALDHLH--- 122
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRK 915
II+ D+ NILL+ L+DFG+SK E TI YMAPE + R
Sbjct: 123 QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE--VIRG 180
Query: 916 G--------DVYSYGIILMETFTKKKP 934
G D +S G++ E T P
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 61/234 (26%), Positives = 107/234 (45%), Gaps = 47/234 (20%)
Query: 746 LGKGSFGSVYKGTLSDGM-----------QIAVKVFNLEL-EGTLRSFDAECEILGSI-R 792
LG+G FG V +++ + ++AVK+ + E L +E E++ I +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWM---------YNKNRSFDILQRLNM--- 840
H+N++ ++ C+ D +++EY G+L ++ Y N + ++L+
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 841 ---VIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG--DETSMT 895
VA +EYL IH DL N+L+ E V ++DFG+++ + D T
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 896 QTQTLATIGYMAPEWKLSR----KGDVYSYGIILMETFT------KKKPTDELF 939
L + +MAPE R + DV+S+G++L E FT P +ELF
Sbjct: 200 TNGRLP-VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-11
Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 16/105 (15%)
Query: 296 LSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGF 355
L L L G +P++I L +LQ + L GN + G IP S+ + + L ++D+ YN F+G
Sbjct: 423 LGLDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 356 IPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIG 400
IP S LG LTS LR L L+ N LSG +P ++G
Sbjct: 482 IPES---------LGQLTS------LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIIST 802
+G+G++G VYKG G +A+K LE E G + E +L ++H N+V +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMV-----IDVASALEYLH----- 852
+ L+ E++ S D+ + L+ + +D YL+
Sbjct: 68 LMQESRLYLIFEFL--------------SMDLKKYLDSLPKGQYMDAELVKSYLYQILQG 113
Query: 853 --YDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW 910
+ H ++H DL P N+L++ V L+DFG+++ G + T + T+ Y APE
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV-YTHEVVTLWYRAPEV 172
Query: 911 KL-----SRKGDVYSYGIILMETFTKK------KPTDELF 939
L S D++S G I E TKK D+LF
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTC 803
LG+G++ +VYKG + G +A+K +L+ EGT + E ++ ++H N+V++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 804 SSDHFKALVLEYMPNGSLENWM--YNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIH 861
+++ LV EYM + L+ +M + + D + + L+ + + H ++H
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL---LKGIAFCHENRVLH 123
Query: 862 CDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL-----SRKG 916
DL P N+L+N+ L+DFG+++ G + T + + T+ Y AP+ L S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSI 182
Query: 917 DVYSYGIILMETFTKKKPTDELFVG 941
D++S G I+ E T + LF G
Sbjct: 183 DIWSVGCIMAEMITGRP----LFPG 203
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 45/233 (19%)
Query: 746 LGKGSFGSVYKGTLSDGMQ---------IAVKVFNLELEGT---LRSFDAECEILGSI-R 792
LG+G FG V + + G+ +AVK+ L+ T L +E E++ I +
Sbjct: 20 LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLISEMELMKLIGK 76
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNK-----NRSFDILQR---------- 837
H+N++ ++ C+ + +++EY G+L ++ + + +FDI +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 838 LNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897
++ VA +EYL IH DL N+L+ E V ++DFG+++ + D +T
Sbjct: 137 VSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 898 QT-LATIGYMAPEWKLSR----KGDVYSYGIILMETFT------KKKPTDELF 939
+ +MAPE R + DV+S+GI++ E FT P +ELF
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 6e-11
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 42/220 (19%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKII 800
++G+G+FG V+ D Q+ A+KV + AE +IL +VK+
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
+ + LV+EYMP G L N + K+ + R + ++ AL+ +H I
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARF-YIAELVLALDSVHKLG---FI 123
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGD-----------------------ETSMTQT 897
H D+ P NIL++ L+DFG+ K + Q
Sbjct: 124 HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQR 183
Query: 898 QTLA--TIG---YMAPEWKLSRKG-----DVYSYGIILME 927
+ A T+G Y+APE L D +S G+IL E
Sbjct: 184 RVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 7e-11
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 744 NLLGKGSFGSVYKGT-LSDGMQIAVK--------VFNLELEGTLRSFDAECEILGSIRHR 794
+ +G+G++G V T G+++A+K F TLR E +IL +H
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR---TLR----EIKILRRFKHE 63
Query: 795 NLVKIISTCSSDHFKA-----LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALE 849
N++ I+ F++ +V E M L + ++ S D +Q I L
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQI-----LR 117
Query: 850 YLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL---LGDETSMTQTQTLATIGYM 906
L Y H ++H DL PSN+LLN + + DFG++++ D T T+ +AT Y
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL-TEYVATRWYR 176
Query: 907 APEWKLSRKG-----DVYSYGIILMETFTKK 932
APE L+ KG D++S G IL E + +
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 31/84 (36%), Positives = 53/84 (63%), Gaps = 1/84 (1%)
Query: 253 KGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIG 312
+GL N +++ LQ + LS N + G IPP + +I+SL VL L+ N+ G++P ++G
Sbjct: 428 QGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487
Query: 313 HSLPNLQQLILGGNRLTGPIPSSI 336
L +L+ L L GN L+G +P+++
Sbjct: 488 Q-LTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIIST 802
+G+G++G VYK IA+K LE E G + E +L ++H N+V++
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMV-IDVASALEYLHYDHPTPIIH 861
S+ LV EY+ + L+ M + S D + ++ + L + Y H ++H
Sbjct: 70 VHSEKRLYLVFEYL-DLDLKKHM---DSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLH 125
Query: 862 CDLNPSNILLNESMVAC-LSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG---- 916
DL P N+L++ A L+DFG+++ G T T + T+ Y APE L +
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTP 184
Query: 917 -DVYSYGIILMETFTKK------KPTDELF 939
D++S G I E +K DELF
Sbjct: 185 VDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214
|
Length = 294 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 738 DGFSENNLLGKGSFGSVYK-GTLSDGMQIAVKVFNLELEGTLRS-FDAECEILGSIRHRN 795
D F + LG G+ G V K G+ +A K+ +LE++ +R+ E ++L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNR-SFDILQRLNMVIDVASALEYLHYD 854
+V SD ++ +E+M GSL+ + R +IL +++ I V L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVS--IAVLRGLAYLREK 122
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----W 910
H I+H D+ PSNIL+N L DFG+S L D SM + + T YM+PE
Sbjct: 123 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANS-FVGTRSYMSPERLQGT 177
Query: 911 KLSRKGDVYSYGIILMETFTKKKP 934
S + D++S G+ L+E + P
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 23/220 (10%)
Query: 729 SYQELFRATDG---FSENNLLGKGSFGSVYKGTLSDGMQI-AVKVFNLELEGTLRSFD-- 782
ELF D F++ +G GSFG+VY ++ A+K + + + +
Sbjct: 3 EIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI 62
Query: 783 -AECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMV 841
E L +RH N ++ +H LV+EY GS + + + LQ + +
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKP---LQEVEIA 118
Query: 842 IDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA 901
AL+ L Y H IH D+ NILL E L+DFG + L+ S +
Sbjct: 119 AICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-----VG 173
Query: 902 TIGYMAPEWKLSR-------KGDVYSYGIILMETFTKKKP 934
T +MAPE L+ K DV+S GI +E +K P
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 118 DSFPKLEHLY---LDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAI 174
+ KL HL L GNS G IPPS+ +I+SL LDLS+N G +P S+ + SL +
Sbjct: 436 NDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRIL 495
Query: 175 DLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAEL 207
+L+ N SG +P+ L + A L
Sbjct: 496 NLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL 528
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 18/102 (17%)
Query: 212 NQ-LSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQ 270
NQ L G IP+ + + + L+ ++LS N+ G+IP +G+IT L+
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT-----------------SLE 469
Query: 271 VLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIG 312
VL LS N G IP + ++SL +L+L N+L G +P+ +G
Sbjct: 470 VLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 54/210 (25%), Positives = 81/210 (38%), Gaps = 42/210 (20%)
Query: 736 ATDGFSENNLLGKGSFGSVYKGTLSD-GMQIAVKVFNLELEGTLRSFDAECEILGSIR-- 792
T F ++G+G++G VYK G +A+K+ ++ D E EI
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-------DEEEEIKEEYNIL 56
Query: 793 -----HRNLV-------KIISTCSSDHFKALVLEYMPNGS---LENWMYNKNRSFD---- 833
H N+ K + D LV+E GS L + K +
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQL-WLVMELCGGGSVTDLVKGLRKKGKRLKEEWI 115
Query: 834 --ILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891
IL+ + L YLH + +IH D+ NILL ++ L DFG+S L D
Sbjct: 116 AYILR------ETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL-DS 165
Query: 892 TSMTQTQTLATIGYMAPEWKLSRKGDVYSY 921
T + + T +MAPE + SY
Sbjct: 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASY 195
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 746 LGKGSFGSVYKG--TLSDGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIIST 802
LG+G++ +VYKG L+D + +A+K LE E G + E +L ++H N+V +
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
++ LV EY+ + L+ ++ + + + N+ + + L L+Y H ++H
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYL---DDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL-----SRKGD 917
DL P N+L+NE L+DFG+++ T T + + T+ Y P+ L S + D
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQID 187
Query: 918 VYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLH 954
++ G I E T + LF G S V + LH
Sbjct: 188 MWGVGCIFYEMSTGRP----LFPG-----STVEEQLH 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 14/204 (6%)
Query: 738 DGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRS-FDAECEILGSIRHRN 795
D F + + LG G+ G V+K + G+ +A K+ +LE++ +R+ E ++L
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRLNMVIDVASALEYLHYD 854
+V SD ++ +E+M GSL+ + R + IL +++ I V L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS--IAVIKGLTYLREK 122
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----W 910
H I+H D+ PSNIL+N L DFG+S L D SM + + T YM+PE
Sbjct: 123 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANS-FVGTRSYMSPERLQGT 177
Query: 911 KLSRKGDVYSYGIILMETFTKKKP 934
S + D++S G+ L+E + P
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 23/217 (10%)
Query: 746 LGKGSFGSVYKG--TLSDGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIIST 802
LG+G++ +V+KG L++ + +A+K LE EG + E +L +++H N+V +
Sbjct: 13 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
++ LV EY+ + L+ ++ N +++ N+ I + L L Y H I+H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL-----SRKGD 917
DL P N+L+NE L+DFG+++ T T + + T+ Y P+ L S D
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPID 186
Query: 918 VYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLH 954
++ G IL E T + +F G S V + LH
Sbjct: 187 MWGVGCILYEMATGRP----MFPG-----STVKEELH 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 734 FRATDGFSENNLLGKGSFGSVYKG-TLSDGMQIAVKVFNL-ELEGTLRSFDAECEILGSI 791
F D + + LG+GS+ +VYKG + +G +A+KV L E EGT + E +L +
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60
Query: 792 RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL 851
+H N+V + + LV EY+ + L +M ++ L N+ + + L L
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYM---DKHPGGLHPENVKLFLFQLLRGL 116
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK 911
Y H I+H DL P N+L++++ L+DFG+++ S T + + T+ Y P+
Sbjct: 117 SYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 912 LSRKG-----DVYSYGIILME 927
L D++ G I +E
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVE 196
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 37/214 (17%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAEC----EILGSIR----HRNL 796
LG G+FGSVY G +A+K ++ S++ EC E+ S+R H N+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKK----MKKKFYSWE-ECMNLREVK-SLRKLNEHPNI 60
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYN-KNRSFDILQRLNMVIDVASALEYLH--- 852
VK+ + V EYM G+L M + K + F +++ + L ++H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 853 YDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL 912
+ H DL P N+L++ V ++DFG+++ + + T ++T Y APE L
Sbjct: 120 F------FHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPPYTDYVSTRWYRAPEILL 171
Query: 913 -----SRKGDVYSYGIILMETFTKKKPTDELFVG 941
S D+++ G I+ E +T +P LF G
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYT-LRP---LFPG 201
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 18/216 (8%)
Query: 728 ISYQELFRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECE 786
+ + L TD + +GKG++G VYK T DG AVK+ + + +AE
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYN 70
Query: 787 ILGSI-RHRNLVKIISTC-SSDHFKA----LVLEYMPNGSLENWMYNKNRSFDILQRLNM 840
IL S+ H N+VK +D LVLE GS+ + L +
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 841 VIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL 900
+ AL L + H IIH D+ +NILL L DFG+S L T + + ++
Sbjct: 131 SYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSV 189
Query: 901 ATIGYMAPE---------WKLSRKGDVYSYGIILME 927
T +MAPE + + DV+S GI +E
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 4e-10
Identities = 73/243 (30%), Positives = 113/243 (46%), Gaps = 39/243 (16%)
Query: 744 NLLGKGSFGSVYKGTLSD-GMQIAVKVFNLELEGTL---RSFDAECEILGSIRHRNLVKI 799
+ +G G++G V + G ++A+K + + + R++ E +L + H N++ +
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGL 79
Query: 800 IS----TCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHY 853
+ S + F+ LV M L N + + S D +Q L V + L+Y+H
Sbjct: 80 LDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFL--VYQILRGLKYIHS 136
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLS 913
IIH DL PSNI +NE + DFG+++ DE M T +AT Y APE L+
Sbjct: 137 AG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--M--TGYVATRWYRAPEIMLN 189
Query: 914 RKG-----DVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV---DINL 965
D++S G I+ E T K LF G S D L +I+N+V D L
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGKT----LFPG-----SDHIDQLK-RIMNLVGTPDEEL 239
Query: 966 LQK 968
LQK
Sbjct: 240 LQK 242
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 44/220 (20%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVK--VFNLELEG----TLRSFDAECEILGSIRHRNLVK 798
LG+G+FG VYK + G +A+K + + E +G LR E +IL ++H N+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71
Query: 799 IISTC---SSDHFKA-----LVLEYMP---NGSLENWMYNKNRSFDILQRLNMVIDVASA 847
+I + +V YM +G LEN + Q ++ +
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN----PSVKLTESQIKCYMLQLLEG 127
Query: 848 LEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ----------T 897
+ YLH +H I+H D+ +NIL++ + ++DFG+++ + T
Sbjct: 128 INYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 898 QTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKK 932
+ T Y PE L + D++ G + E FT++
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 36/215 (16%)
Query: 738 DGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNL 796
D F + LG G+ G V K G+ +A K+ +LE++ +R+ +I+ R L
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN-----QII-----REL 50
Query: 797 VKIISTCSSDH----FKALV--------LEYMPNGSLENWMYNKNR-SFDILQRLNMVID 843
K++ C+S + + A +E+M GSL+ + R +IL +++ I
Sbjct: 51 -KVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS--IA 107
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATI 903
V L YL H I+H D+ PSNIL+N L DFG+S L D SM + + T
Sbjct: 108 VLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANS-FVGTR 162
Query: 904 GYMAPE----WKLSRKGDVYSYGIILMETFTKKKP 934
YM+PE + + D++S G+ L+E + P
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 70/267 (26%), Positives = 112/267 (41%), Gaps = 61/267 (22%)
Query: 777 TLRSFDAECEILGSIRHRNLVKI--ISTCSSDHFKA--LVLEYMPNGSLENWMYNKN--- 829
TLR E +IL +H N++ I I FK +V++ M + L + +++
Sbjct: 51 TLR----ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLT 105
Query: 830 ----RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885
R F L +L L L Y H +IH DL PSN+L+NE + DFG++
Sbjct: 106 EEHIRYF--LYQL---------LRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMA 154
Query: 886 KLLG---DETSMTQTQTLATIGYMAPEWKLS-----RKGDVYSYGIILMETFTKKKPTDE 937
+ L E T+ +AT Y APE LS D++S G I E ++ +
Sbjct: 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR----Q 210
Query: 938 LF-----VGEISLKSRVNDSLHGKIINVVDINLLQK-------------EDAYLTAKEQC 979
LF V ++ L V S +++N + + ++K + A +
Sbjct: 211 LFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPE- 269
Query: 980 VSSVLSLAMQCTRESAEERINIKEALT 1006
L L Q + EERI +++AL
Sbjct: 270 ---ALDLLSQMLQFDPEERITVEQALQ 293
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 39/219 (17%)
Query: 745 LLGKGSFGSV----YKGTLSDGMQIAVKVFNLELEGTLRSFDAEC-----EILG-SIRHR 794
+LGKGSFG V KGT D + AVKV L+ + L+ D EC +L + +H
Sbjct: 2 VLGKGSFGKVLLAELKGT--DEL-YAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHP 56
Query: 795 NLVKIISTCSSDHFKALVLEYMPNGSLENWMYN--KNRSFDILQRLNMVIDVASALEYLH 852
L ++ S + V+EY+ G L M++ ++ FD + ++ L++LH
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 853 YDHPTPIIHCDLNPSNILLNESMVACLSDFGISK--LLGDETSMTQTQTL-ATIGYMAPE 909
+ II+ DL N+LL+ ++DFG+ K +LG T T T T Y+APE
Sbjct: 114 -ER--GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDYIAPE 166
Query: 910 ----WKLSRKGDVYSYGIILMETFTKKKP-----TDELF 939
D ++ G++L E + P DELF
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 5e-10
Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+G+G+ G+V+ ++ G ++A+K NL+ + E ++ +++ N+V + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
+V+EY+ GSL + + D Q + + ALE+LH + +IH D+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDI 141
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-----DVY 919
N+LL L+DFG + E S T + T +MAPE ++RK D++
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPE-VVTRKAYGPKVDIW 199
Query: 920 SYGIILMETFTKKKP 934
S GI+ +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 25/206 (12%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVFNLELEGTLRS----FDAECEILGSIRHRNLVKI 799
++G+G+FG V ++ A+K+ + + E RS F E +I+ +V++
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLN--MVIDVASALEYLHYDHPT 857
D + +V+EYMP G L N M N +D+ ++ +V AL+ +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIH---SM 161
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT-LATIGYMAPEWKLSRKG 916
+IH D+ P N+LL++ L+DFG + DET M + T + T Y++PE S+ G
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 917 DVY--------SYGIILMETFTKKKP 934
D Y S G+ L E P
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLELEG------TLRSFDAECEILGSIRHRNLVK 798
+G+G++G VYK G +A+K LE E +R E +L + H N+V+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWM---YNKNRSFDILQRLNMVIDVASALEYLHYDH 855
++ S++ LV E++ + L+ +M +++ + L+ + Y H
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQL-----LQGIAYCH 116
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL--- 912
++H DL P N+L++ L+DFG+++ G T T + T+ Y APE L
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSR 175
Query: 913 --SRKGDVYSYGIILMETFTKK------KPTDELF 939
S D++S G I E ++ D+LF
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 35/211 (16%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVK--VFNLELEG----TLRSFDAECEILGSIRHRNLVK 798
+G+G+FG V+K +A+K + E EG LR E +IL ++H N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 75
Query: 799 IISTCSS-----DHFKA---LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEY 850
+I C + + +K LV E+ + L + NKN F + + ++ + + L Y
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL-----GDETSMTQTQTLATIGY 905
+H + I+H D+ +NIL+ + + L+DFG+++ T + T+ Y
Sbjct: 135 IHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY--TNRVVTLWY 189
Query: 906 MAPEWKLSRKG-----DVYSYGIILMETFTK 931
PE L + D++ G I+ E +T+
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 7e-10
Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 33/202 (16%)
Query: 746 LGKGSFGSVYKGTLSDGMQI-AVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+GKG+FG VY+ D +I A+KV + + A+ E+ +I RN++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE------IVAKKEVAHTIGERNILVRTLLDE 54
Query: 805 SDHFKAL------------VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLH 852
S L V +YM G L W K F + + ++ ALE+LH
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGEL-FWHLQKEGRFSEDRAKFYIAELVLALEHLH 113
Query: 853 -YDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYMAPEW 910
YD I++ DL P NILL+ + L DFG+SK + T T T T Y+APE
Sbjct: 114 KYD----IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEV 167
Query: 911 KLSRKG-----DVYSYGIILME 927
L KG D +S G+++ E
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 31/202 (15%)
Query: 746 LGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTC 803
LGKG++GSVYK G+ +A+K LEL E E +IL +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSF-----DILQRLNMVIDVASALEYLHYDHPTP 858
+ + +EYM GSL+ +Y + D+L+R+ V L++L +H
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYA--VVKGLKFLKEEHN-- 123
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPE------ 909
IIH D+ P+N+L+N + L DFG+S L S+ +T IG YMAPE
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKTN----IGCQSYMAPERIKSGG 177
Query: 910 ----WKLSRKGDVYSYGIILME 927
+ + DV+S G+ ++E
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 20/200 (10%)
Query: 746 LGKGSFGSVYKGTLSDGMQI-AVKVFNLELEGTLRSFD---AECEILGSIRHRNLVKIIS 801
+G GSFG+VY T S ++ AVK + + T + E + L ++H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIH 861
+H LV+EY GS + + + LQ + + AL+ L Y H +IH
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKP---LQEVEIAAITHGALQGLAYLHSHNMIH 144
Query: 862 CDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR------- 914
D+ NILL E L+DFG + S T +MAPE L+
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPY-----WMAPEVILAMDEGQYDG 199
Query: 915 KGDVYSYGIILMETFTKKKP 934
K DV+S GI +E +K P
Sbjct: 200 KVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 36/205 (17%)
Query: 748 KGSFGSVYKG-TLSDGMQIAVKVF---NLELEGTLRSFDAECEILGSIRHR-NLVKIIST 802
KG+FGSVY S G A+KV ++ + + + AE I+ + K+ +
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRL---------NMVIDVASALEYLHY 853
S + LV+EY+ G + +++ L + +V +E LH
Sbjct: 66 FQSKDYLYLVMEYLNGGDCAS----------LIKTLGGLPEDWAKQYIAEVVLGVEDLHQ 115
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL- 912
IIH D+ P N+L++++ L+DFG+S + + + T Y+APE L
Sbjct: 116 RG---IIHRDIKPENLLIDQTGHLKLTDFGLS-----RNGLENKKFVGTPDYLAPETILG 167
Query: 913 ---SRKGDVYSYGIILMETFTKKKP 934
+ D +S G ++ E P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 31/197 (15%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+G+GS G V T S G Q+AVK +L + E I+ +H N+V++ S+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVID--------VASALEYLHYDHP 856
+V+E++ G+L DI+ M + V AL +LH
Sbjct: 87 VGDELWVVMEFLEGGALT----------DIVTHTRMNEEQIATVCLAVLKALSFLH---A 133
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGY-MAPEWKLSRK 915
+IH D+ +ILL LSDFG + E + + ++L Y MAPE +SR
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPE-VISRL 190
Query: 916 -----GDVYSYGIILME 927
D++S GI+++E
Sbjct: 191 PYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 746 LGKGSFGSVYKGTLSDGMQI-AVKVFNLE--LEGTLRSFDAECEILGSIRHRNLVKIIST 802
+G+G++G+V+K + +I A+K L+ EG S E +L ++H+N+V++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
SD LV EY + L+ + + N D + + + L + H + ++H
Sbjct: 68 LHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHR 123
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-----D 917
DL P N+L+N++ L+DFG+++ G + + T+ Y P+ K D
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSID 182
Query: 918 VYSYGIILMETFTKKKPTDELFVG 941
++S G I E +P LF G
Sbjct: 183 MWSAGCIFAELANAGRP---LFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVFNLELEGTLRSFDAECEILG------SIRHRNLV 797
+LGKGSFG V+ L Q A+K L+ + L D EC ++ + H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKN--RSFDILQRLNMVIDVASALEYLHYDH 855
+ T + V+EY+ G L M++ FD+ + ++ L++LH
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLH--- 113
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISK--LLGDETSMTQTQTLATIGYMAPEWKLS 913
I++ DL NILL+ ++DFG+ K +LGD + T T Y+APE L
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT---FCGTPDYIAPEILLG 170
Query: 914 RKG----DVYSYGIILMETFTKKKP-----TDELF 939
+K D +S+G++L E + P +ELF
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 746 LGKGSFGSVYKGTLSDGM---QIAVKVFNLELEGTL-----RSFDAECEILGSIRHRNLV 797
+G G FG V G ++ G Q+ VK EL + F E + S++H NL+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVK----ELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYN----KNRSFDILQRLNMVIDVASALEYLHY 853
+ + C+ LV+E+ P G L+ ++ + + + D M ++A L +LH
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKL-LGDETSMTQTQTLATIGYMAPEW-- 910
++ IH DL N LL + + D+G+S ++ +T Q + ++APE
Sbjct: 119 NN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 911 ---------KLSRKGDVYSYGIILMETF 929
+++ +V+S G+ + E F
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-09
Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 21/188 (11%)
Query: 762 GMQIAVKVF---NLELEGTLRSFDAECEILGSIRHRNLVKII-STCSSDHFKALVLEYMP 817
G ++A+K+ E E F E + + H N+V ++ S + V EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 818 NGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV- 876
+L + L + L+ L H I+H DL P NI+++++ V
Sbjct: 63 GRTLREVLAADG----ALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118
Query: 877 --ACLSDFGISKLL-----GDETSMTQT-QTLATIGYMAPEW----KLSRKGDVYSYGII 924
A + DFGI LL D ++T+T + L T Y APE ++ D+Y++G+I
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 925 LMETFTKK 932
+E T +
Sbjct: 179 FLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 56/200 (28%), Positives = 85/200 (42%), Gaps = 15/200 (7%)
Query: 746 LGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDA---ECEILGSIRHRNLVKIIS 801
LGKG FG V + + G A K N + + ++ E IL + R +V +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
+ LV+ M G L +YN +N F + + S LE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKGDV 918
II+ DL P N+LL+ +SD G++ L D S T+ T G+MAPE + D
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDF 176
Query: 919 ----YSYGIILMETFTKKKP 934
++ G+ L E + P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 49/181 (27%), Positives = 76/181 (41%), Gaps = 13/181 (7%)
Query: 746 LGKGSFGSVYKGTLSD-GMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVKIIS 801
LGKG FG V + G A K + L+ + E +IL + R +V +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPII 860
+ LV+ M G L+ +YN F + + + LE+LH I+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKGDVYS 920
+ DL P N+LL++ +SD G++ L T GYMAPE +G+VY
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPE---VLQGEVYD 172
Query: 921 Y 921
+
Sbjct: 173 F 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 33/88 (37%), Positives = 48/88 (54%)
Query: 433 LHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSL 492
L L+ L G IP I +L+ LQ + L N ++G+I L + SL N NGS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 493 PQCLDSLISLRTLSLGFNRLTSVIPSSL 520
P+ L L SLR L+L N L+ +P++L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 740 FSENNLLGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGTLRSFD---AECEILGSIRHRN 795
FS+ +G GSFG+VY + + +A+K + + + + E L +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH 855
++ +H LV+EY GS + + + LQ + + AL+ L Y H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLH 132
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR- 914
+IH D+ NILL+E + L DFG + ++ T +MAPE L+
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPY-----WMAPEVILAMD 187
Query: 915 ------KGDVYSYGIILMETFTKKKP 934
K DV+S GI +E +K P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 22/200 (11%)
Query: 746 LGKGSFG-SVYKGTLSDGMQIAVKVFNL------ELEGTLRSFDAECEILGSIRHRNLVK 798
+G+GSFG ++ + DG Q +K N+ E E + + E +L +++H N+V+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK----EVAVLSNMKHPNIVQ 63
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRS--FDILQRLNMVIDVASALEYLHYDHP 856
+ + +V++Y G L + N R F Q L+ + + AL+++H
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVH---D 119
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR-- 914
I+H D+ NI L + L DFGI+++L + +T + T Y++PE +R
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICENRPY 178
Query: 915 --KGDVYSYGIILMETFTKK 932
K D+++ G +L E T K
Sbjct: 179 NNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 1/93 (1%)
Query: 73 FLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNS 132
F+ L + N G +P +S LR L+ ++ S N IPP L S LE L L NS
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINL-SGNSIRGNIPPSLGSITSLEVLDLSYNS 477
Query: 133 FIGTIPPSICNISSLLTLDLSFNQLQGHVPSSI 165
F G+IP S+ ++SL L+L+ N L G VP+++
Sbjct: 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVFNLELEGTLRSFDAEC-----EILG-SIRHRNLV 797
+LGKGSFG V L ++ A+KV L+ + L+ D +C IL + +H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYN--KNRSFDILQRLNMVIDVASALEYLHYDH 855
+ + V+EY+ G L M+ ++R FD + +V AL +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAP----EWK 911
+I+ DL NILL+ L+DFG+ K G +T T T Y+AP E +
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 912 LSRKGDVYSYGIILMETFTKKKP-----TDELF 939
D ++ G+++ E + P D+LF
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+G G++G VYK ++ G A+KV LE E ++ +H N+V +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
+ +E+ GSL++ +Y+ L + L+ L+Y H +H D+
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGP---LSESQIAYVSRETLQGLYYLHSKGKMHRDI 132
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE-WKLSRKG------D 917
+NILL ++ L+DFG+S + T + + T +MAPE + RKG D
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQI-TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191
Query: 918 VYSYGIILMETFTKKKPTDEL 938
+++ GI +E + P +L
Sbjct: 192 IWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 75/316 (23%), Positives = 125/316 (39%), Gaps = 71/316 (22%)
Query: 743 NNLLGKGSFGSVYKG--TLSDGMQIAVKVFNLELEGTLRSFDA-------------ECEI 787
LG+G++G V K TL+ + KV +E+ + E +I
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 788 LGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASA 847
+ I+H N++ ++ F LV++ M L+ + K R Q +++ + +
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR-LTESQVKCILLQILNG 131
Query: 848 LEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG----------DETSMTQ- 896
L LH + +H DL+P+NI +N + ++DFG+++ G DET +
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 897 --TQTLATIGYMAPEW-----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV 949
T + T+ Y APE K D++S G I E T K LF GE +
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP----LFPGENEI---- 240
Query: 950 NDSLHGKIINVVDINLLQKEDAYLTAKE--------------------QCVSSVLSLAMQ 989
D L G+I ++ ED + AK+ + L
Sbjct: 241 -DQL-GRIFELLGT---PNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQS 295
Query: 990 CTRESAEERINIKEAL 1005
+ + ERI+ KEAL
Sbjct: 296 LLKLNPLERISAKEAL 311
|
Length = 335 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 745 LLGKGSFGSVY---KGTLSD-----GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRN- 795
+LG G++G V+ K T D M++ K ++ T+ E +L +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH 855
LV + ++ L+L+Y+ G + +Y ++ + R ++ ALE+LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF-YSGEIILALEHLH--- 122
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRK 915
I++ D+ NILL+ L+DFG+SK E TI YMAPE +
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG 182
Query: 916 G-----DVYSYGIILMETFTKKKP 934
G D +S GI++ E T P
Sbjct: 183 GHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 20/195 (10%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGTLRSFDA--ECEILGSIRHRNLV---KI 799
LG+GS+ +VYKG + +G +A+KV +++ E + F A E +L ++H N+V I
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
I T + F V EYM + L +M + + L Y+H H I
Sbjct: 72 IHTKETLTF---VFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---I 124
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL-----SR 914
+H DL P N+L++ L+DFG+++ S T + + T+ Y P+ L S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183
Query: 915 KGDVYSYGIILMETF 929
D++ G I +E
Sbjct: 184 ALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 4e-09
Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+G+G+ G+VY ++ G ++A++ NL+ + E ++ ++ N+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
+V+EY+ GSL + + D Q + + ALE+LH + +IH D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 142
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-----DVY 919
NILL L+DFG + E S ++ + T +MAPE ++RK D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPE-VVTRKAYGPKVDIW 200
Query: 920 SYGIILMETFTKKKP 934
S GI+ +E + P
Sbjct: 201 SLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 37/212 (17%)
Query: 745 LLGKGSFGSV----YKGTLSDGMQIAVKVFNLEL----EGTLRS----FDAECEILGSIR 792
++G+G+FG V +K T KV+ ++L E RS F E +I+
Sbjct: 50 VIGRGAFGEVQLVRHKST--------RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLN--MVIDVASALEY 850
+V++ D + +V+EYMP G L N M N +D+ ++ +V AL+
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDA 157
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW 910
+H IH D+ P N+LL++S L+DFG + E + + T Y++PE
Sbjct: 158 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214
Query: 911 KLSRKGDVY--------SYGIILMETFTKKKP 934
S+ GD Y S G+ L E P
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 745 LLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILG----SIRHRN--LV 797
+LGKGSFG V L G AVK L+ + L D EC ++ ++ N L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
+ T + V+E++ G L + +K R FD+ + ++ L++LH
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH---SK 115
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISK--LLGDETSMTQTQTLATIGYMAPE----WK 911
II+ DL N++L+ ++DFG+ K + GD + T T Y+APE K
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST---FCGTPDYIAPEILQGLK 172
Query: 912 LSRKGDVYSYGIILMETFTKKKP-----TDELF 939
+ D +S+G++L E + P DELF
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-09
Identities = 32/91 (35%), Positives = 51/91 (56%)
Query: 406 MDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQ 465
+D L L ++G IP++I L +L +++L N + G+IP ++G + L+ L L +N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 466 GSITTDLCGLRSLSEFYSDGNELNGSLPQCL 496
GSI L L SL +GN L+G +P L
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 5e-09
Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 732 ELFRATDG---FSENNLLGKGSFGSVY-KGTLSDGMQIAVKVFNLELEGTLRSFD---AE 784
ELF D F++ +G GSFG+VY + +A+K + + + + E
Sbjct: 16 ELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKE 75
Query: 785 CEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDV 844
+ L I+H N ++ +H LV+EY GS + + + LQ + +
Sbjct: 76 VKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKP---LQEVEIAAIT 131
Query: 845 ASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG 904
AL+ L Y H +IH D+ NILL E L+DFG + + S T
Sbjct: 132 HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPY----- 186
Query: 905 YMAPEWKLSR-------KGDVYSYGIILMETFTKKKP 934
+MAPE L+ K DV+S GI +E +K P
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-09
Identities = 29/86 (33%), Positives = 51/86 (59%)
Query: 484 DGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVE 543
D L G +P + L L++++L N + IP SL S+ + ++LS NS NG++P
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 544 IGNLKVVTKIDLSRNDLSGEIPSSIG 569
+G L + ++L+ N LSG +P+++G
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVFNLELEGTLRSFDAECE-------ILGSIRHRNL 796
+LGKGSFG V L + A+K L+ + L D EC L H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAW-EHPFL 58
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
+ T + V+EY+ G L + + R FD + ++ L++LH
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKKG- 116
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISK--LLGDETSMTQTQTLATIGYMAPE----W 910
II+ DL N+LL++ ++DFG+ K + G+ + T T Y+APE
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST---FCGTPDYIAPEILKGQ 171
Query: 911 KLSRKGDVYSYGIILMETFTKKKP-----TDELF 939
K + D +S+G++L E + P DELF
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 16/194 (8%)
Query: 746 LGKGSFGSVY-----KGTLSDGMQI--AVKVFNLELEGTLRSFDAECEILGSIRHRNLVK 798
LGKGSFG+VY K + +++ + V L T+++ + E ++L + H +VK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
++ ++ EY L+ + + L + L +HY H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-- 916
I+H DL NI L +++ + DFG+S+LL + T T T YM+PE L +G
Sbjct: 127 ILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFT-GTPYYMSPE-ALKHQGYD 183
Query: 917 ---DVYSYGIILME 927
D++S G IL E
Sbjct: 184 SKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-09
Identities = 30/85 (35%), Positives = 47/85 (55%), Gaps = 1/85 (1%)
Query: 391 LSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGR 450
L G +P I L + + + LS +I+G+IP +G++ +L L L N GSIP+++G+
Sbjct: 430 LRGFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 451 LQKLQGLYLQHNKLQGSITTDLCGL 475
L L+ L L N L G + L G
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 8e-09
Identities = 18/40 (45%), Positives = 26/40 (65%), Gaps = 2/40 (5%)
Query: 6 DQSALLALKAHVTNDPLNVLASNWSTNTSV-CNWFGVTCS 44
D+ ALLA K+ + DP L+S W+ ++S C+W GVTC
Sbjct: 4 DRDALLAFKSSLNGDPSGALSS-WNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 8e-09
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 746 LGKGSFGSV-YKGTLSDGMQIAVKVFNLELEGTLRSFDA--ECEILGSIRHRNLVKIIST 802
+G G++G+V G ++A+K + L + A E +L ++H N++ ++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 803 CSSD------HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
+ D H LV+ +M L M ++ S D +Q L V L+ L Y H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFL-----VYQMLKGLKYIHA 136
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----W-K 911
IIH DL P N+ +NE + DFG+++ +T T + T Y APE W
Sbjct: 137 AGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVVTRWYRAPEVILNWMH 192
Query: 912 LSRKGDVYSYGIILMETFTKK---KPTDEL 938
++ D++S G I+ E T K K D L
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 60/262 (22%), Positives = 110/262 (41%), Gaps = 46/262 (17%)
Query: 765 IAVKVFNLELEGTLRS-FDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLEN 823
+AVK+ + R+ F E +IL ++ N+++++ C + ++ EYM NG L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 824 WMYNKNR--------------------SFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
++ + + S+ L L++ + +AS ++YL +H D
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSL--LHVALQIASGMKYLS---SLNFVHRD 163
Query: 864 LNPSNILLNESMVACLSDFGISK-LLGDETSMTQTQTLATIGYMAPEW----KLSRKGDV 918
L N L+ E++ ++DFG+S+ L + Q + + I +MA E K + DV
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223
Query: 919 YSYGIILMETFT--KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAK 976
+++G+ L E K++P EL ++ I N + Q YL
Sbjct: 224 WAFGVTLWEILMLCKEQPYGELTDEQV-------------IENAGEFFRDQGRQVYLFRP 270
Query: 977 EQCVSSVLSLAMQCTRESAEER 998
C + L +QC ER
Sbjct: 271 PPCPQGLYELMLQCWSRDCRER 292
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 47/223 (21%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVF-----NLEL-EGTLRSFDAECEILGSIRHRNLV 797
++G+G++G V K + +I A+K F N E+ E TLR E ++L +++ N+V
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR----ELKMLRTLKQENIV 63
Query: 798 KIISTCSSDHFKALVLEY-----------MPNGSLENWMYNKNRSFDILQRLNMVIDVAS 846
++ LV EY MPNG K RS+ +
Sbjct: 64 ELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE----KVRSY-----------IYQ 108
Query: 847 ALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYM 906
++ +H+ H I+H D+ P N+L++ + V L DFG ++ L + ++ T+ +AT Y
Sbjct: 109 LIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYR 168
Query: 907 APEWKL----SRKGDVYSYGIILME------TFTKKKPTDELF 939
+PE L + D++S G IL E F + D+LF
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 52/195 (26%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+G+G+ G+VY ++ G ++A+K NL+ + E ++ ++ N+V + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
+V+EY+ GSL + + D Q + + AL++LH + +IH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDI 141
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-----DVY 919
NILL L+DFG + E S T + T +MAPE ++RK D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPE-VVTRKAYGPKVDIW 199
Query: 920 SYGIILMETFTKKKP 934
S GI+ +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+G G++G VYK L G AVK+ LE E ++ +H N+V +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
S + +EY GSL++ +Y+ LQ + + L YLH +H D+
Sbjct: 77 SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHRDI 132
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-------D 917
+NILL ++ L+DFG++ + T + + T +MAPE K D
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKI-TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCD 191
Query: 918 VYSYGIILMETFTKKKPTDEL 938
+++ GI +E + P +L
Sbjct: 192 IWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 51/175 (29%), Positives = 79/175 (45%), Gaps = 24/175 (13%)
Query: 746 LGKGSFGSVYKGTLSDGMQI-AVKVFNLELEG-------TLRSFDAECEILGSIRHRNLV 797
+G+GS+G V+K + QI A+K F +E E LR E +L ++H NLV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALR----EIRMLKQLKHPNLV 63
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
+I LV EY + ++ N + R ++ A+ + H +
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN-- 120
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLL---GDETSMTQTQTLATIGYMAPE 909
IH D+ P NIL+ + L DFG +++L GD+ T +AT Y APE
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD----YTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 34/90 (37%), Positives = 48/90 (53%)
Query: 456 GLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSV 515
GL L + L+G I D+ LR L GN + G++P L S+ SL L L +N
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 516 IPSSLWSLRDILNVNLSSNSLNGTLPVEIG 545
IP SL L + +NL+ NSL+G +P +G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 35/112 (31%), Positives = 60/112 (53%), Gaps = 8/112 (7%)
Query: 370 GFLTS-LTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLN 428
GF+ + ++ + L+ + LS N + G +P S+G+++ +++VL LS + GSIP +G L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT-SLEVLDLSYNSFNGSIPESLGQLT 490
Query: 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSE 480
+L L+L N L+G +P A+G G L + LCG+ L
Sbjct: 491 SLRILNLNGNSLSGRVPAALG------GRLLHRASFNFTDNAGLCGIPGLRA 536
|
Length = 623 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 36/219 (16%)
Query: 738 DGFSENNLLGKGSFGSVYKGTLSDGM-----QIAVK-VFNLELEGTLRSFDAECEILGSI 791
D + ++LL +G+FG ++ G L D ++ VK V + E + E +L +
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 792 RHRNLVKIISTCSSDHFKALVLE-YMPNGSLENWM-------YNKNRSFDILQRLNMVID 843
H+N++ I+ C D VL YM G+L+ ++ N ++ Q ++M I
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK--------LLGDETSMT 895
+A + YLH +IH D+ N +++E + ++D +S+ LGD +
Sbjct: 126 IACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR- 181
Query: 896 QTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT 930
+ +MA E + S DV+S+G++L E T
Sbjct: 182 ------PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGTL---RSFDAECEILGSIRHRNLVKIIS 801
+G G++GSV G+++AVK + + + R++ E +L ++H N++ ++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 802 ----TCSSDHFKALVL-EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
S + F + L ++ L N + + + D +Q L + L L Y H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 138
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL---- 912
IIH DL PSN+ +NE + DFG+++ DE T +AT Y APE L
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 194
Query: 913 -SRKGDVYSYGIILMETFTKK 932
++ D++S G I+ E T +
Sbjct: 195 YNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-08
Identities = 49/162 (30%), Positives = 70/162 (43%), Gaps = 15/162 (9%)
Query: 783 AECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVI 842
+E L + H +VK SD L++EY G L NK + + L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL-----NKQIKQRLKEHLPFQE 168
Query: 843 DVASALEY-----LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897
L Y L H ++H DL +NI L + + L DFG SK D S+
Sbjct: 169 YEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 898 QTL-ATIGYMAPE-W---KLSRKGDVYSYGIILMETFTKKKP 934
+ T Y+APE W + S+K D++S G+IL E T +P
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 58/172 (33%), Positives = 85/172 (49%), Gaps = 14/172 (8%)
Query: 745 LLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFD-----AECEIL-GSIRHRNLV 797
++GKGSFG V SDG AVKV L+ + L+ + AE +L +++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
+ + + VL+Y+ G L + + R F + +VASA+ YLH +
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGEL-FFHLQRERCFLEPRARFYAAEVASAIGYLHSLN-- 116
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE 909
II+ DL P NILL+ L+DFG+ K G E T + T Y+APE
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 746 LGKGSFGSVYKGTLSD-GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKI---IS 801
LG GS G V+ SD ++AVK L +++ E +I+ + H N+VK+ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 802 TCSSD---------HFKAL--VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEY 850
SD ++ V EYM L N + + + RL M L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL-EQGPLSEEHARLFMY----QLLRG 126
Query: 851 LHYDHPTPIIHCDLNPSNILLN-ESMVACLSDFGISKLLGDETSMTQ--TQTLATIGYMA 907
L Y H ++H DL P+N+ +N E +V + DFG+++++ S ++ L T Y +
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 908 PEWKLS-----RKGDVYSYGIILMETFTKKKPTDELFVG 941
P LS + D+++ G I E T K LF G
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAG 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-08
Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 9/97 (9%)
Query: 126 LYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPM 185
L LD G IP I + L +++LS N ++G++P S+ +I SL +DLS N F+G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 186 PSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTL 222
P Q SL L+L N LSG++P+ L
Sbjct: 483 PESLG---------QLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 48/207 (23%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 746 LGKGSFGSVY----KGTLSDGMQIAVKVFNLELEGTLR---SFDAECEILGSIRHRNLVK 798
LG+GSFG VY KG + D + V + + ++R F E ++ ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMY--------NKNRSFDILQRL-NMVIDVASALE 849
++ S +++E M G L++++ N ++ L+++ M ++A +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 850 YLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT--QTLATIGYMA 907
YL+ + +H DL N ++ E + DFG+++ + ET + + L + +M+
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLPVRWMS 189
Query: 908 PE----WKLSRKGDVYSYGIILMETFT 930
PE + DV+S+G++L E T
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 55/170 (32%), Positives = 81/170 (47%), Gaps = 10/170 (5%)
Query: 745 LLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEIL-GSIRHRNLVKI 799
++GKGSFG V DG AVKV ++ + AE +L +++H LV +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
+ + VL+++ G L + + RSF + ++ASAL YLH I
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL-FFHLQRERSFPEPRARFYAAEIASALGYLH---SINI 117
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE 909
++ DL P NILL+ L+DFG+ K G S T T T Y+APE
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 746 LGKGSFGSVYKGTLSD------GMQIAVKVFNLELEGTLR---SFDAECEILGSIRHRNL 796
LG+GSFG VY+G D ++AVK N +LR F E ++ ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 71
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMY--------NKNRSFDILQRL-NMVIDVASA 847
V+++ S +V+E M +G L++++ N R LQ + M ++A
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 848 LEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT--QTLATIGY 905
+ YL + +H DL N ++ + DFG+++ + ET + + L + +
Sbjct: 132 MAYL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLPVRW 187
Query: 906 MAPE----WKLSRKGDVYSYGIILMETFT 930
MAPE + D++S+G++L E +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 23/201 (11%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKII-- 800
++G G++G VYKG + G A+KV ++ E E +L HRN+
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 801 ----STCSSDHFKALVLEYMPNGSLENWMYN-KNRSFDILQRLNMVIDVASALEYLHYDH 855
S D LV+E+ GS+ + + N K + + ++ L +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK 141
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE------ 909
+IH D+ N+LL E+ L DFG+S L D T + + T +MAPE
Sbjct: 142 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPEVIACDE 197
Query: 910 ---WKLSRKGDVYSYGIILME 927
+ D++S GI +E
Sbjct: 198 NPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-08
Identities = 64/238 (26%), Positives = 106/238 (44%), Gaps = 35/238 (14%)
Query: 738 DGFSENNLLGKGSFGSVYKGTLSDGMQI-AVKVFNLELEGTLRS----FDAECEILGSIR 792
+ F ++G+G+FG V Q+ A+K+ + + E RS F E +I+
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEERDIMAHAN 101
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNM--VIDVASALEY 850
+V++ D + +V+EYMP G L N M N +DI ++ +V AL+
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDA 157
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT-LATIGYMAPE 909
+H IH D+ P N+LL++S L+DFG + D M + T + T Y++PE
Sbjct: 158 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYISPE 213
Query: 910 WKLSRKGDVY--------SYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959
S+ GD Y S G+ L E+ VG+ + + KI++
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLY----------EMLVGDTPFYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 57/169 (33%), Positives = 82/169 (48%), Gaps = 10/169 (5%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLEL---EGTLRSFDAECEIL-GSIRHRNLVKII 800
+GKGSFG V +DG AVKV + + + AE +L +++H LV +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
+ + VL+Y+ G L + + RSF + ++ASAL YLH II
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL-FFHLQRERSFPEPRARFYAAEIASALGYLH---SLNII 118
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE 909
+ DL P NILL+ L+DFG+ K G E S T + T Y+APE
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 63/251 (25%), Positives = 108/251 (43%), Gaps = 65/251 (25%)
Query: 746 LGKGSFGSVYKG-TLSDGMQ-IAVKVFNLELE------GTLRSFDAECEILGSIRHRNLV 797
+G+G++G V+K L +G + +A+K ++ T+R A L + H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNVV 67
Query: 798 KIISTCS---SDHFKALVLEY------------------MPNGSLENWMYNKNRSFDILQ 836
++ C+ +D L L + +P ++++ M+ R D L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL- 126
Query: 837 RLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896
H ++H DL P NIL+ S L+DFG++++ + M
Sbjct: 127 ------------------HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MAL 166
Query: 897 TQTLATIGYMAPEWKLSRKG----DVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS 952
T + T+ Y APE L D++S G I E F ++KP LF G + D
Sbjct: 167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDV-----DQ 217
Query: 953 LHGKIINVVDI 963
L GKI++V+ +
Sbjct: 218 L-GKILDVIGL 227
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 38/219 (17%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIR---HRNLVKI 799
+G G++G+VYK G +A+K ++ +G S E +L + H N+V++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 800 ISTCSSDHFK-----ALVLEYMPNGSLENWMYNK-------NRSFDILQRLNMVIDVASA 847
+ C++ LV E++ + L ++ D++++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQF------LRG 120
Query: 848 LEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMA 907
L++LH + I+H DL P NIL+ L+DFG++++ M T + T+ Y A
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRA 175
Query: 908 PEWKL----SRKGDVYSYGIILMETFTKKKPTDELFVGE 942
PE L + D++S G I E F ++KP LF G
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCGN 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-08
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 11/99 (11%)
Query: 150 LDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMP-SIYNTSPLQNIDMQYNSLAELH 208
L L L+G +P+ I + L +I+LS N G +P S+ + + L+ +D
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLD---------- 472
Query: 209 LAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIG 247
L+YN +G IP +L + L+IL+L+ N+ G +P +G
Sbjct: 473 LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 745 LLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAEC-----EILGSIR-HRNLV 797
+LGKGSFG V L G AVKV L+ + L+ D EC IL R H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYN--KNRSFDILQRLNMVIDVASALEYLHYDH 855
++ + V+E++ G L M++ K+R FD + ++ SAL +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLH--- 113
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAP----EWK 911
II+ DL N+LL+ L+DFG+ K G T + T Y+AP E
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 912 LSRKGDVYSYGIILMETFTKKKP-----TDELF 939
D ++ G++L E P D+LF
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 66/260 (25%), Positives = 118/260 (45%), Gaps = 29/260 (11%)
Query: 746 LGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+G+GS G V T G Q+AVK +L + E I+ H N+V + ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
+V+E++ G+L + + + + + Q + + V AL YLH +IH D+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIATVCLSVLRALSYLH---NQGVIHRDI 144
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR-----KGDVY 919
+ILL LSDFG + E ++ + T +MAPE +SR + D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS-LVGTPYWMAPE-VISRLPYGTEVDIW 202
Query: 920 SYGIILMETFTKKKPTDELFVGEISLKS--RVNDSLHGKIINV----------VDINLLQ 967
S GI+++E + P + E L++ R+ D+L ++ + +D+ L++
Sbjct: 203 SLGIMVIEMIDGEPP----YFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVR 258
Query: 968 KEDAYLTAKEQCVSSVLSLA 987
+ TA+E L LA
Sbjct: 259 EPSQRATAQELLQHPFLKLA 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 7e-08
Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 10/145 (6%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLEL-EGTLRSFDA--ECEILGSIRHRNLVKIIS 801
LG+GS+ +VYKG + G +A+K LE EG F A E +L ++H N+V +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--PFTAIREASLLKDLKHANIVTLHD 70
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIH 861
+ LV EY+ + L+ +M + L N+ + + L L Y H ++H
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQRRVLH 126
Query: 862 CDLNPSNILLNESMVACLSDFGISK 886
DL P N+L++E L+DFG+++
Sbjct: 127 RDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 30/90 (33%), Positives = 52/90 (57%), Gaps = 1/90 (1%)
Query: 272 LALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGP 331
L L + L G IP +I + L ++L+ N++ GN+P ++G S+ +L+ L L N G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVLDLSYNSFNGS 481
Query: 332 IPSSISNASMLTLIDMPYNLFSGFIPNSLG 361
IP S+ + L ++++ N SG +P +LG
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 56/197 (28%), Positives = 82/197 (41%), Gaps = 30/197 (15%)
Query: 746 LGKGSFGSVYKGTLSDGMQI-AVKVFN---LELEGTLRSFDAECEILGSIRHRNLVKIIS 801
+G+G +G V+ D +I A+K L +R E +IL + + LVK++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNM--VIDVASALEYLHYDHPTPI 859
D + L +EY+P G + N + R M + + AL L Y
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY------ 122
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA--TIG---YMAPEW---- 910
IH DL P N L++ S L+DFG+SK T A +G YMAPE
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSK---------GIVTYANSVVGSPDYMAPEVLRGK 173
Query: 911 KLSRKGDVYSYGIILME 927
D +S G +L E
Sbjct: 174 GYDFTVDYWSLGCMLYE 190
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 740 FSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLEL----EGTLRSFDAECEILGSIRHR 794
F + +LGKG FG V + + G A K + +G + + E +IL + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQ 60
Query: 795 NLVKIISTCSSDHFKALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHY 853
+V + + LVL M G L+ +YN N F+ + L ++ LE LH
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE-WKL 912
++ ++ DL P NILL++ +SD G++ + + S+ + T+GYMAPE
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI--RGRVGTVGYMAPEVLNN 175
Query: 913 SRKG---DVYSYGIILMETFTKKKP 934
R D + G ++ E + P
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 740 FSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLE------LEGTLRSFDAECEILGSIR 792
F + +LGKG FG V + + G A K LE +G + + E +IL +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGESMALN-EKQILEKVN 58
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRS-FDILQRLNMVIDVASALEYL 851
R +V + + LVL M G L+ +Y+ + F+ + + ++ LE L
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL----ATIGYMA 907
H + I++ DL P NILL++ +SD G++ + + QT+ T+GYMA
Sbjct: 119 HQER---IVYRDLKPENILLDDHGHIRISDLGLA------VHVPEGQTIKGRVGTVGYMA 169
Query: 908 PEW----KLSRKGDVYSYGIILMETFTKKKP 934
PE + + D ++ G +L E + P
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 75/263 (28%), Positives = 114/263 (43%), Gaps = 35/263 (13%)
Query: 367 DELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGN 426
L +L N L L L+ N L + + + L N IP IG
Sbjct: 81 SSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLD---NNNITDIPPLIGL 137
Query: 427 LN-NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485
L NL L L N++ S+P + L L+ L L N L + L L +L+ G
Sbjct: 138 LKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSG 195
Query: 486 NELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIG 545
N+++ LP ++ L +L L L N + ++ S +
Sbjct: 196 NKIS-DLPPEIELLSALEELDLSNNSIIELLSS-------------------------LS 229
Query: 546 NLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSS 605
NLK ++ ++LS N ++P SIG+L N++ L L++N Q S SLG LT+L LD+S
Sbjct: 230 NLKNLSGLELSNN-KLEDLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSG 286
Query: 606 NNLSGEIPNSLKALSLLKFLNLS 628
N+LS +P L LL+ L
Sbjct: 287 NSLSNALPLIALLLLLLELLLNL 309
|
Length = 394 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 59/213 (27%), Positives = 88/213 (41%), Gaps = 33/213 (15%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSI-------RHRNL 796
L+G G++G VYKG + G A+KV ++ + D E EI I HRN+
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDV-------TGDEEEEIKQEINMLKKYSHHRNI 65
Query: 797 VKIISTC------SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEY 850
D LV+E+ GS+ + + KN + L+ + L
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRG 123
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE- 909
L + H +IH D+ N+LL E+ L DFG+S L D T + + T +MAPE
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPEV 182
Query: 910 --------WKLSRKGDVYSYGIILMETFTKKKP 934
K D++S GI +E P
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 54/186 (29%), Positives = 84/186 (45%), Gaps = 19/186 (10%)
Query: 746 LGKGSFGSV----YKGTLSDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVK 798
LGKG FG V K T G A K + L+ + + E EIL + +V
Sbjct: 1 LGKGGFGEVCAVQVKNT---GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYN-KNRSFDILQRLNMVIDVASALEYLHYDHPT 857
+ S LV+ M G L+ +YN R ++ + ++ + + +LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SM 114
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKGD 917
I++ D+ P N+LL++ LSD G++ L D ++TQ T GYMAPE K +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPE---ILKEE 169
Query: 918 VYSYGI 923
YSY +
Sbjct: 170 PYSYPV 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 22/200 (11%)
Query: 746 LGKGSFGSVYKGTLSDGMQ-IAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKII-- 800
+G G++GSV + Q +AVK + + + R E +L ++H N++ ++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 801 ---STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
+T + + ++ + L N + + S + +Q L + L L Y H
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL-----IYQLLRGLKYIHSA 137
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL----- 912
IIH DL PSN+ +NE + DFG+++ DE T +AT Y APE L
Sbjct: 138 GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHY 193
Query: 913 SRKGDVYSYGIILMETFTKK 932
++ D++S G I+ E K
Sbjct: 194 NQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 746 LGKGSFGSVYKGTLSD-GMQIAVKVFNLELEG------TLRSFDAECEILGSIRHRNLVK 798
+G+G++G V S+ ++A+K + TLR E ++L + H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68
Query: 799 ---IISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHY 853
I+ + F +V E M + ++ S D Q + L L Y
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYF-----LYQLLRGLKY 123
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLS 913
H ++H DL PSN+LLN + + DFG+++ E T+ + T Y APE L+
Sbjct: 124 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 914 RKG-----DVYSYGIILMETFTKK 932
DV+S G I E +K
Sbjct: 183 CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 55/229 (24%)
Query: 746 LGKGSFGSV----YKGTLSDGMQIAVK----VFNLEL--EGTLRSFDAECEILGSIR-HR 794
LG+G++G V T S+ +A+K VF+ ++ + LR E ++L R H+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHK 62
Query: 795 NLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLH-- 852
N+ + +V N ++Y + D L+ +I L H
Sbjct: 63 NITCLYDM-------DIVFPGNFNEL---YLYEELMEAD----LHQIIRSGQPLTDAHFQ 108
Query: 853 -----------YDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD---ETSMTQTQ 898
Y H ++H DL P N+L+N + DFG+++ + E + T+
Sbjct: 109 SFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE 168
Query: 899 TLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKPTDELFVGE 942
+AT Y APE LS + DV+S G IL E +KP +F G+
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 20/180 (11%)
Query: 740 FSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLEL----EGTLRSFDAECEILGSIRHR 794
F +LGKG FG V + + G A K + +G + + E IL + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKRILEKVNSR 60
Query: 795 NLVKIISTCSSDHFKALVLEYMPNGSLENWMYN-KNRSFDILQRLNMVIDVASALEYLHY 853
+V + + LVL M G L+ +YN N FD + + ++ LE L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL----ATIGYMAPE 909
+ I++ DL P NILL++ +SD G++ + + +T+ T+GYMAPE
Sbjct: 121 ER---IVYRDLKPENILLDDRGHIRISDLGLA------VQIPEGETVRGRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 2e-07
Identities = 70/220 (31%), Positives = 100/220 (45%), Gaps = 57/220 (25%)
Query: 746 LGKGSFGSVYKGTLSD---GMQIAVKVFNLELEGTLRSFDA------------ECEILGS 790
LGKG++G V+K D +A+K + FDA E L
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQE 62
Query: 791 IR-HRNLVKIISTCSSDHFKA-------LVLEYMPNGSLENWMYNKNRSFDILQRLNMVI 842
+ H N+VK+++ KA LV EYM E ++ R+ +IL+ ++
Sbjct: 63 LGDHPNIVKLLNV-----IKAENDKDIYLVFEYM-----ETDLHAVIRA-NILEDVHKRY 111
Query: 843 DVASALEYLHYDHPTPIIHCDLNPSNILLN-ESMVACLSDFG----ISKLLGDETSMTQT 897
+ L+ L Y H +IH DL PSNILLN + V L+DFG +S+L + + T
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVK-LADFGLARSLSELEENPENPVLT 170
Query: 898 QTLATIGYMAPEWKL-SR---KG-DVYSYGIILMETFTKK 932
+AT Y APE L S KG D++S G IL E K
Sbjct: 171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 19/199 (9%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFD-----AECEILGSIRHRNLVKII 800
LG GSFG V T + V + E ++ +E +IL I H V +
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
+ + + LVLE++ G ++ +N+ F + EYL I+
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIV 153
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYMAPEWKLS----RK 915
+ DL P N+LL++ ++DFG +K++ T+T TL T Y+APE L+ +
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFAKVVD-----TRTYTLCGTPEYIAPEILLNVGHGKA 208
Query: 916 GDVYSYGIILMETFTKKKP 934
D ++ GI + E P
Sbjct: 209 ADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 745 LLGKGSFGSVY---------KGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRN 795
+LG G++G V+ G L M++ K ++ T E ++L IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLY-AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 796 -LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD 854
LV + +D L+L+Y+ G L + + R F + ++ ALE+LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER-FKEQEVQIYSGEIVLALEHLH-- 122
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR 914
II+ D+ NILL+ + L+DFG+SK ++ TI YMAP+ + R
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD--IVR 179
Query: 915 KGDV--------YSYGIILMETFTKKKP 934
GD +S G+++ E T P
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 745 LLGKGSFGS--VYKGTLSDGMQIAVKVFNLELEGT-LRSFDAECEILGSIRHRNLVKIIS 801
++G+GSFG + + SD A+K L + + E +L ++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQK-YAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 802 TCSSDHFKALVLEYMPNGSL-ENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
+ +D +V+EY G L + + + F L + + ++++H ++
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VL 122
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE-WK---LSRKG 916
H D+ NI L ++ L DFG ++LL + T + T Y+ PE W+ + K
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWENMPYNNKS 181
Query: 917 DVYSYGIILMETFTKKKP 934
D++S G IL E T K P
Sbjct: 182 DIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-07
Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 784 ECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMY-NKNRSFDILQRLNMVI 842
E IL +I H +++++ T + + F L+L P + + Y R+ I L +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 843 DVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT 902
V A++YLH + IIH D+ NI +N CL DFG + D + T
Sbjct: 190 SVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 903 IGYMAPEWKLSRKG-----DVYSYGIILMETFT 930
I APE L+R D++S GI+L E T
Sbjct: 247 IATNAPEL-LARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 60/231 (25%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 746 LGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+G+GS G V T+ S G +AVK +L + E I+ +H N+V++ ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
+V+E++ G+L + + + + + Q + + V AL LH +IH D+
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIAAVCLAVLKALSVLH---AQGVIHRDI 142
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR-----KGDVY 919
+ILL LSDFG + E ++ + T +MAPE +SR + D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS-LVGTPYWMAPEL-ISRLPYGPEVDIW 200
Query: 920 SYGIILMETFTKKKPTDELFVGEISLKS--RVNDSLHGKIINVVDINLLQK 968
S GI+++E + P + E LK+ + D+L K+ N+ ++ K
Sbjct: 201 SLGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLK 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 60/269 (22%), Positives = 106/269 (39%), Gaps = 40/269 (14%)
Query: 753 SVYKGTLSDGMQIAVKVFNLELEG---TLRSFDAECEILGSIRHRNLVKI----ISTCSS 805
S+YKG + ++ ++ F +G + + E + L I N++KI I
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 806 DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLN 865
+L+LEY G L + + +L+M ID L L+ P + +L
Sbjct: 94 LPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 866 PSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW------KLSRKGDVY 919
+ L+ E+ + G+ K+L S + + + Y + + + + K D+Y
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIY 206
Query: 920 SYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQC 979
S G++L E FT K P + L EI +L+ ++ L C
Sbjct: 207 SLGVVLWEIFTGKIPFENLTTKEI-------------------YDLIINKNNSLKLPLDC 247
Query: 980 VSSVLSLAMQCTRESAEERINIKEALTKL 1008
+ + CT + +R NIKE L L
Sbjct: 248 PLEIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 746 LGKGSFGSVYK-GTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKIISTC 803
+GKG++G V+K +G + AVK+ + + +AE IL ++ H N+VK
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 804 SSDHFKA-----LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
K LVLE GS+ + + + + ++ + + AL L + H
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE--------- 909
IH D+ +NILL L DFG+S L T + + ++ T +MAPE
Sbjct: 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-TRLRRNTSVGTPFWMAPEVIACEQQLD 203
Query: 910 WKLSRKGDVYSYGIILMETFTKKKPTDEL 938
+ DV+S GI +E P +L
Sbjct: 204 STYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 47/188 (25%), Positives = 84/188 (44%), Gaps = 16/188 (8%)
Query: 784 ECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVID 843
E +L ++ H +++++ T S +VL + + L ++ ++R I Q L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL-LGDETSMTQTQTLAT 902
+ L YLH IIH D+ NI +N+ C+ D G ++ + + T+ T
Sbjct: 166 ILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET 222
Query: 903 IGYMAPEW----KLSRKGDVYSYGIILMET--FTKKKPTDELFVGEISLKSRVNDSLHGK 956
APE K + K D++S GI+L E + D E +KS + L K
Sbjct: 223 ---NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL--K 277
Query: 957 IINVVDIN 964
II+ + ++
Sbjct: 278 IISTLKVH 285
|
Length = 357 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 746 LGKGSFGSVYKGTLSDGMQI-AVK-------VFNLELEGTLRSFDAECEILGSIRHRNLV 797
+GKGSFG V + D +I A+K V E+ TL AE +L + +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTL----AERTVLAQVNCPFIV 56
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
+ + S LVL ++ G L + + + R FD+ + ++ ALE LH
Sbjct: 57 PLKFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH---KF 112
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL----S 913
+I+ DL P NILL+ L DFG+ KL + T T T Y+APE L +
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYT 171
Query: 914 RKGDVYSYGIILMETFTKKKP 934
+ D ++ G++L E T P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 32/207 (15%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLR----------SFDAECEILGSIRHRN 795
LG+G+F ++YKG L + + E+ L+ +F ++ + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH 855
LVK+ C D +V EY+ G L+ +++ + + + +L++ +ASAL YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 856 PTPIIHCDLNPSNILL-----NESMVAC--LSDFGISKLLGDETSMTQTQTLATIGYMAP 908
++H ++ NIL+ NE V LSD GI T +++ + + I ++AP
Sbjct: 122 ---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-----TVLSREERVERIPWIAP 173
Query: 909 EW------KLSRKGDVYSYGIILMETF 929
E L+ D +S+G L+E
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEIC 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 33/208 (15%)
Query: 746 LGKGSFGSVYKGT---LSDG-----MQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLV 797
LG+G+F ++KG + D ++ +KV + SF ++ + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 798 KI--ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH 855
+ C + +V EY+ GSL+ ++ +I +L + +A AL +L
Sbjct: 63 LNYGVCVCGDESI--MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---E 117
Query: 856 PTPIIHCDLNPSNILLNESMVAC--------LSDFGISKLLGDETSMTQTQTLATIGYMA 907
+ H ++ N+LL LSD GIS T + + L I ++
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI-----TVLPKEILLERIPWVP 172
Query: 908 PEW-----KLSRKGDVYSYGIILMETFT 930
PE LS D +S+G L E F+
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 9e-07
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTL---RSFDAECEILGSIRHRNLVKII 800
+G G++GSV G ++A+K + + + R++ E +L ++H N++ ++
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGLL 80
Query: 801 ----STCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD 854
S S D F+ LV+ YM L+ M + S D +Q L V L L Y
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP-LSEDKVQYL-----VYQMLCGLKYI 133
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLS- 913
H IIH DL P N+ +NE + DFG+++ E T + T Y APE L+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNW 189
Query: 914 ----RKGDVYSYGIILMETFTKKKPTDELFVGE 942
+ D++S G I+ E T K LF G+
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGKT----LFKGK 218
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 23/217 (10%)
Query: 738 DGFSENNLLGKGSFGSVY----KGTLSDGMQIAVKVFN---LELEGTLRSFDAECEILGS 790
F +L+G+G FG V K T G A+KV L + T+ F+ E +IL
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 791 IRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEY 850
+ ++ LV+EY P G L + + NR D +A +
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLA 114
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW 910
+H H +H D+ P N+L++ + L+DFG + L + + T Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 911 KLSRKG----------DVYSYGIILMETFTKKKPTDE 937
+ G D +S G+I E + P E
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 30/203 (14%)
Query: 740 FSENNLLGKGSFGSV----YKGTLSDGMQIAVKVFNLELEGTLR-----SFDAECEILGS 790
F LG GSFG V +KGT G A+K L+ L+ E IL
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKC--LKKREILKMKQVQHVAQEKSILME 74
Query: 791 IRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEY 850
+ H +V ++ + ++ +LE++ G L + R + + + ++ A EY
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA-ELVLAFEY 133
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYMAPE 909
LH II+ DL P N+LL+ ++DFG +K + D +T TL T Y+APE
Sbjct: 134 LH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPE 185
Query: 910 WKLSRKG-----DVYSYGIILME 927
+ KG D ++ G++L E
Sbjct: 186 -VIQSKGHGKAVDWWTMGVLLYE 207
|
Length = 329 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 21/199 (10%)
Query: 746 LGKGSFGSV-YKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+G+GS G V G Q+AVK+ +L + E I+ +H+N+V++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
+++E++ G+L + + ++ R L + S L+ L Y H +IH D+
Sbjct: 89 VGEELWVLMEFLQGGALTD-IVSQTR----LNEEQIATVCESVLQALCYLHSQGVIHRDI 143
Query: 865 NPSNILLNESMVACLSDFG----ISKLLGDETSMTQTQTLATIGYMAPEWKLSR-----K 915
+ILL LSDFG ISK + S+ T +MAPE +SR +
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-----WMAPE-VISRTPYGTE 197
Query: 916 GDVYSYGIILMETFTKKKP 934
D++S GI+++E + P
Sbjct: 198 VDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 7/103 (6%)
Query: 45 PRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFR 104
+ R + ++NL+ + G IPP LG+++ L +L+++ NSF+G++P L L L+ L+
Sbjct: 439 SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498
Query: 105 SNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSL 147
N+ S +P L L SF T +C I L
Sbjct: 499 GNSLSG-RVPAALGGRL------LHRASFNFTDNAGLCGIPGL 534
|
Length = 623 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 740 FSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLE------LEGTLRSFDAECEILGSIR 792
F +LGKG FG V + + G A K LE +G + + E +IL +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALN-EKQILEKVN 58
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYN-KNRSFDILQRLNMVIDVASALEYL 851
R +V + + LVL M G L+ +YN N FD + + ++ LE L
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL----ATIGYMA 907
H + I++ DL P NILL++ +SD G++ + + +T+ T+GYMA
Sbjct: 119 HRER---IVYRDLKPENILLDDYGHIRISDLGLA------VEIPEGETIRGRVGTVGYMA 169
Query: 908 PE----WKLSRKGDVYSYGIILMETFTKKKP 934
PE + + D + G ++ E K P
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 13/198 (6%)
Query: 745 LLGKGSFGSV-YKGTLSDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKII 800
LLGKG+FG V + G A+K+ E+ + + E +L + RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
+ + V+EY+ G L + ++ R F + ++ SAL+YLH I+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGEL-FFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIV 117
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKG 916
+ DL N++L++ ++DFG+ K G + T T Y+APE R
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 917 DVYSYGIILMETFTKKKP 934
D + G+++ E + P
Sbjct: 177 DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 44/221 (19%)
Query: 746 LGKGSFGSV----YKGTLSDGMQIAVKVF-------NLELEGTL---RSFDAECEILGSI 791
LG+G FG V YK T G A+K E+E + R F E S
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIF----ETANSE 59
Query: 792 RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL 851
RH LV + + ++ V+EY G L M+ F + + V L+YL
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQYL 117
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK---LLGDETSMTQTQTL-ATIGYMA 907
H ++ I++ DL N+LL+ ++DFG+ K GD TS T T ++A
Sbjct: 118 H-ENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS-----TFCGTPEFLA 169
Query: 908 PE----WKLSRKGDVYSYGIILMETFTKKKP-----TDELF 939
PE +R D + G+++ E + P +E+F
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 62/259 (23%), Positives = 102/259 (39%), Gaps = 56/259 (21%)
Query: 739 GFSENNLLGKGSFGSVYKG---TLSDGMQIAVKVF---NLELEGTLRSFDAECEILGSIR 792
+ +G+G++G VYK DG + A+K F + G +S E +L ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 793 HRNLVKIISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQ--------RLNMVI 842
H N+V ++ K+ L+ +Y D+ Q + +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYA--------------EHDLWQIIKFHRQAKRVSIP 106
Query: 843 D--VASA----LEYLHYDHPTPIIHCDLNPSNILL----NESMVACLSDFGISKLLGD-- 890
V S L +HY H ++H DL P+NIL+ E V + D G+++L
Sbjct: 107 PSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 891 ETSMTQTQTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKPTDELFVG-EIS 944
+ + TI Y APE L + D+++ G I E T +P +F G E
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEP---IFKGREAK 222
Query: 945 LKSRV---NDSLHGKIINV 960
+K D L +I V
Sbjct: 223 IKKSNPFQRDQL-ERIFEV 240
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 31/214 (14%)
Query: 734 FRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTL---RSFDAECEILG 789
F T+ + + +G G+FG V G +A+K + R++ E ++L
Sbjct: 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLK 64
Query: 790 SIRHRNLVKIISTCSSDHFKA------LVLEYMPNGSLENWMYNKNRSFDILQRLNMVID 843
+RH N++ SD F + V E + L + ++ +Q I
Sbjct: 65 HLRHENII-----SLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQI- 117
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATI 903
L L Y H ++H DL PSNIL+NE+ + DFG++++ + M T ++T
Sbjct: 118 ----LRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQM--TGYVSTR 169
Query: 904 GYMAPE----W-KLSRKGDVYSYGIILMETFTKK 932
Y APE W K + D++S G I E K
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 54/236 (22%), Positives = 100/236 (42%), Gaps = 44/236 (18%)
Query: 738 DGFSENNLLGKGSFGSVYKG-TLSDGMQIAVKVFNLELE------GTLRSFDAECEILGS 790
D + + +G+G++G VYK + G +A+K LE++ LR E +L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQM 56
Query: 791 IRHRN-LVKIISTCS--SDHFKA---LVLEYMPNGSLENWMYNKNRSF------DILQRL 838
+ +V+++ + K LV EY+ + L+ +M + R ++
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 839 --NMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC-LSDFGISKLLGDETSMT 895
++ VA + H ++H DL P N+L+++ ++D G+ + +
Sbjct: 116 MYQLLKGVA-------HCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-S 167
Query: 896 QTQTLATIGYMAPEWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVGEISLK 946
T + T+ Y APE L S D++S G I E K+ LF G+ L+
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP----LFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVK----VFNLELEGTLRSFDAECEILGSIRHRN---LV 797
+G G+FG V+ T DG ++A+K VF L R F E ++L +H N +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVF-RELKMLCFFKHDNVLSAL 65
Query: 798 KIISTCSSDHFKAL-VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
I+ D F+ + V+ + L + + ++ + + L+YLH
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLHSAG- 123
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL---- 912
I+H D+ P N+L+N + V + DFG++++ + S TQ + T Y APE +
Sbjct: 124 --ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRH 181
Query: 913 -SRKGDVYSYGIILMETFTKK 932
+ D++S G I E ++
Sbjct: 182 YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 745 LLGKGSFGSVY----KGTLSDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLV 797
LLGKG+FG V K T G A+K+ E+ + + E +L + RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
+ + V+EY G L + ++ R F + ++ SALEYLH
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 115
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKL-LGDETSMTQTQTLATIGYMAPEW----KL 912
+++ D+ N++L++ ++DFG+ K + D +M T Y+APE
Sbjct: 116 -VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDY 172
Query: 913 SRKGDVYSYGIILMETFTKKKP 934
R D + G+++ E + P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 37/225 (16%)
Query: 737 TDGFSENNLLGKGSFGSVY----KGTLSDGMQIAVKVFNLELEGTLRSFDAEC-----EI 787
F +LGKGSFG V KGT A+K+ L+ + ++ D EC +
Sbjct: 1 DFNFL--MVLGKGSFGKVMLAERKGT---DELYAIKI--LKKDVVIQDDDVECTMVEKRV 53
Query: 788 LGSIRHRNLVKIISTC--SSDHFKALVLEYMPNGSLENWMYNKNR--SFDILQRLNMVID 843
L + + +C + D V+EY+ G L MY+ + F Q + +
Sbjct: 54 LALQDKPPFLTQLHSCFQTVDRL-YFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAE 109
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATI 903
++ L +LH II+ DL N++L+ ++DFG+ K + T+T T
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCGTP 165
Query: 904 GYMAPE----WKLSRKGDVYSYGIILMETFTKKKP-----TDELF 939
Y+APE + D ++YG++L E + P DELF
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 42/228 (18%)
Query: 746 LGKGSFGSVYKGTLSD---------GMQIAVKVFNLELEGTLR----SFDAECEILGSIR 792
LG+G+ +Y G L+ + +KV L+ + R +F ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLH 852
H+++V + C D +V E++ G L+ +M+ K+ + + +ASAL YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL- 121
Query: 853 YDHPTPIIHCDLNPSNILLNESMVAC-------LSDFGISKLLGDETSMTQTQTLATIGY 905
++H ++ NILL + LSD GI T +++ + + I +
Sbjct: 122 --EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI-----TVLSRQECVERIPW 174
Query: 906 MAPEW-----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSR 948
+APE LS D +S+G L E + GEI LK +
Sbjct: 175 IAPECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLKDK 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-06
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 31/209 (14%)
Query: 745 LLGKGSFGSV--YKGTLSDGMQIAVK----VFNLELEGT--LRSFDAECEILGSIRHRNL 796
++GKGS+G V T + G ++A+K VF + T LR E ++L +RH ++
Sbjct: 7 VIGKGSYGVVCSAIDTHT-GEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDI 61
Query: 797 VKIISTC---SSDHFKAL--VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL 851
V+I S FK + V E M E+ ++ ++ D L + + L L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT--QTQTLATIGYMAPE 909
Y H + H DL P NIL N + DFG++++ ++T T +AT Y APE
Sbjct: 117 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176
Query: 910 W------KLSRKGDVYSYGIILMETFTKK 932
K + D++S G I E T K
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRS------FDAECEILGSIRHRNLV 797
++GKGSFG V ++ AVKV L+ + L+ +L +++H LV
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
+ + + VL+Y+ G L + + R F + ++ASAL YLH
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPRARFYAAEIASALGYLH---SL 115
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLS 913
I++ DL P NILL+ L+DFG+ K + T T T Y+APE
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQPYD 174
Query: 914 RKGDVYSYGIILMETFTKKKP 934
R D + G +L E P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-06
Identities = 45/168 (26%), Positives = 69/168 (41%), Gaps = 24/168 (14%)
Query: 779 RSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNK-------NRS 831
++ E +IL +I HR ++ +I +K+ V MP + + Y ++
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYR---WKSTVCMVMPKYKCDLFTYVDRSGPLPLEQA 187
Query: 832 FDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891
I +RL LE L Y H IIH D+ NI L+E A L DFG + L
Sbjct: 188 ITIQRRL---------LEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 892 TSMTQTQTLA-TIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKP 934
Q + T+ +PE K D++S G++L E K
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 746 LGKGSFGSVYKGTLSDGM---QIAVKVFNLELEGTLRSFDA--ECEILGSIRHRNLVKI- 799
+G+G++G VYK DG + A+K ++EGT S A E +L ++H N++ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 800 -ISTCSSDHFKALVLEYMPNGSLENWMYNK----NRSFDILQRLNMVIDVASALEYLHYD 854
+ SD L+ +Y + +++ N+ L R + + L+ +HY
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 855 HPTPIIHCDLNPSNILL----NESMVACLSDFGISKLLGDETS--MTQTQTLATIGYMAP 908
H ++H DL P+NIL+ E ++D G ++L + T Y AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 909 EWKL-----SRKGDVYSYGIILMETFTKK 932
E L ++ D+++ G I E T +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 67/251 (26%), Positives = 109/251 (43%), Gaps = 41/251 (16%)
Query: 745 LLGKGSFGSVYKGTLSDGMQ-IAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVKII 800
L+ G++G+VY + Q A+K N L L ++ E +IL + +V +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMF 67
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLH-YDHPTPI 859
+ + +V+EY+ G + N + R+ + ALEYLH Y I
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARM-YFAETVLALEYLHNYG----I 122
Query: 860 IHCDLNPSNILLNESMVACLSDFGISK--LLGDETSMTQ------------TQTLATIGY 905
+H DL P N+L+ L+DFG+SK L+ T++ + Q T Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 906 MAPEWKLSRKG-----DVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960
+APE L R+G D ++ GIIL E P F G+ + L G++I+
Sbjct: 183 IAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVP----FFGDTP------EELFGQVIS- 230
Query: 961 VDINLLQKEDA 971
DI + ++A
Sbjct: 231 DDIEWPEGDEA 241
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 34/145 (23%), Positives = 60/145 (41%), Gaps = 11/145 (7%)
Query: 745 LLGKGSFG----SVYKGTLSDGMQIAVKVFNLELEGT--LRSFDAECEILGSIRHRNLVK 798
L+GK + K ++ + +AVK NL+ L+ E ++H N++
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPT 857
+++ D +V M GS E+ + L ++ DV +AL+Y+H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG-- 121
Query: 858 PIIHCDLNPSNILLNESMVACLSDF 882
IH + S+ILL+ LS
Sbjct: 122 -FIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-05
Identities = 34/122 (27%), Positives = 60/122 (49%), Gaps = 14/122 (11%)
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK-LLGDETSMTQTQTLAT 902
VA+ +E+L + +H DL N+L+ E + + DFG+++ ++ D +++ T
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 903 IGYMAPEWKL----SRKGDVYSYGIILMETFT------KKKPTDELFVGEISLKSRVNDS 952
+ +MAPE + DV+S+GI+L E FT + P +E F I R+
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP 364
Query: 953 LH 954
H
Sbjct: 365 AH 366
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 745 LLGKGSFGSVY----KGTLSDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLV 797
LLGKG+FG V K T G A+K+ E+ + + E +L + RH L
Sbjct: 2 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
+ + + V+EY G L + ++ R F + ++ SAL+YLH +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK-- 115
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLS 913
+++ DL N++L++ ++DFG+ K G + T T Y+APE
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 914 RKGDVYSYGIILMETFTKKKP 934
R D + G+++ E + P
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-05
Identities = 21/59 (35%), Positives = 31/59 (52%)
Query: 550 VTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNL 608
+ +DLS N L+ + L N++ L L+ N P++ GL SL LD+S NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 74/300 (24%), Positives = 119/300 (39%), Gaps = 45/300 (15%)
Query: 65 PPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLE 124
EL L+ L+ L++ NN+ + P+ LK L N
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNK----------------- 151
Query: 125 HLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGP 184
I ++P + N+ +L LDLSFN L +P + N+ +L +DLS N+ S
Sbjct: 152 ---------IESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDL 201
Query: 185 MPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPR 244
P I S L+ +D+ NS+ ++ S+L K L L LS NN + +P
Sbjct: 202 PPEIELLSALEELDLSNNSII-----------ELLSSLSNLKNLSGLELS-NNKLEDLPE 249
Query: 245 EIGNITMLKGLYLVYTNLT-----GEIQGLQVLALSSNRLTGVIPPEI-INISSLTVLSL 298
IGN++ L+ L L ++ G + L+ L LS N L+ +P + + +L+L
Sbjct: 250 SIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNL 309
Query: 299 TANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPN 358
L N N+ + I S++N L NL + N
Sbjct: 310 LLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYIVKN 369
|
Length = 394 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 31/121 (25%), Positives = 60/121 (49%), Gaps = 9/121 (7%)
Query: 816 MPNGSLENWMY-NKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES 874
+ ++N + + + L L+ VA +E+L + +H DL N+LL +
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQG 273
Query: 875 MVACLSDFGISK-LLGDETSMTQTQTLATIGYMAPEWKL----SRKGDVYSYGIILMETF 929
+ + DFG+++ ++ D +++ T + +MAPE + DV+SYGI+L E F
Sbjct: 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF 333
Query: 930 T 930
+
Sbjct: 334 S 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 39/219 (17%)
Query: 745 LLGKGSFGSVY----KGTLSDGMQIAVKVFNLELEGTLRSFDAECEI-------LGSIRH 793
+LGKGSFG V KGT D + A+K+ L+ + ++ D EC + L +
Sbjct: 7 VLGKGSFGKVMLAERKGT--DEL-YAIKI--LKKDVIIQDDDVECTMVEKRVLALPG-KP 60
Query: 794 RNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNR--SFDILQRLNMVIDVASALEYL 851
L ++ S + V+EY+ G L MY+ + F + ++A L +L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFL 117
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK--LLGDETSMTQTQTLATIGYMAPE 909
H II+ DL N++L+ ++DFG+ K + G +T+ T T Y+APE
Sbjct: 118 H---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCGTPDYIAPE 171
Query: 910 WKL----SRKGDVYSYGIILMETFTKKKP-----TDELF 939
+ D +++G++L E + P DELF
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 15/104 (14%)
Query: 836 QRLNMVIDVASALEYLHYD--------HPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887
Q + M +D + YL Y H IIH DL PSNI++ + DFG+++
Sbjct: 109 QVIQMDLD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167
Query: 888 LGDETSMTQTQTLATIGYMAPEWKL----SRKGDVYSYGIILME 927
G M T + T Y APE L D++S G I+ E
Sbjct: 168 AGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-05
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 173 AIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILS 232
+ L N G +P+ + S L++ L ++L+ N + G IP +L L++L
Sbjct: 422 GLGLDNQGLRGFIPN--DISKLRH-------LQSINLSGNSIRGNIPPSLGSITSLEVLD 472
Query: 233 LSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQG 268
LS N+F GSIP +G +T L+ L L +L+G +
Sbjct: 473 LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-05
Identities = 52/146 (35%), Positives = 80/146 (54%), Gaps = 6/146 (4%)
Query: 64 IPPELGNL-SFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPK 122
IPP +G L S L L++++N +LP L NL LK L N+ S ++P L +
Sbjct: 131 IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS--DLPKLLSNLSN 187
Query: 123 LEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFS 182
L +L L GN I +PP I +S+L LDLS N + + SS+ N+ +L ++LSNN+
Sbjct: 188 LNNLDLSGNK-ISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE 245
Query: 183 GPMPSIYNTSPLQNIDMQYNSLAELH 208
SI N S L+ +D+ N ++ +
Sbjct: 246 DLPESIGNLSNLETLDLSNNQISSIS 271
|
Length = 394 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 746 LGKGSFGSVYKGTLSDGMQ---IAVKVFNLELEGTLRSFDA--ECEILGSIRHRNLVKI- 799
+G+G++G VYK DG A+K ++EGT S A E +L ++H N++ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALK----QIEGTGISMSACREIALLRELKHPNVISLQ 64
Query: 800 -ISTCSSDHFKALVLEYMPNGSLENWMYNK----NRSFDILQRLNMVIDVASALEYLHYD 854
+ +D L+ +Y + +++ N+ L R + + L+ +HY
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 855 HPTPIIHCDLNPSNILL----NESMVACLSDFGISKLLGDETS--MTQTQTLATIGYMAP 908
H ++H DL P+NIL+ E ++D G ++L + T Y AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 909 EWKL-----SRKGDVYSYGIILMETFTKK 932
E L ++ D+++ G I E T +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK-LLGDETSMTQTQTLAT 902
VA +E+L IH DL NILL+E+ V + DFG+++ + D + +
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 903 IGYMAPEWKLSR----KGDVYSYGIILMETFT 930
+ +MAPE + + DV+S+G++L E F+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 4e-05
Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 20/163 (12%)
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLH 852
+ N +K+ + ++ L+++Y+ +G L + + K + ++ + AL LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL-KKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 853 YDHPTPIIHCDLNPSNILLNESMV-ACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK 911
+ IIH D+ N+L + + L D+G+ K++G + T+ Y +PE K
Sbjct: 127 KHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-----GTLDYFSPE-K 177
Query: 912 LSRKGDVYSY-------GIILMETFTKKKPTDELFVGEISLKS 947
+ KG Y G++ E T K P E E+ L+S
Sbjct: 178 I--KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES 218
|
Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 38/233 (16%)
Query: 745 LLGKGSFGSVY----KGTLSDGMQIAVKVFNL-------ELEGTLRSFDAECEILGSIRH 793
LLGKG+FG V K T G A+K+ E+ TL E +L + RH
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTL----TESRVLQNTRH 54
Query: 794 RNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHY 853
L + + + V+EY G L + ++ R F + ++ SAL YLH
Sbjct: 55 PFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALGYLH- 112
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYMAPEW-- 910
+++ DL N++L++ ++DFG+ K + +T T Y+APE
Sbjct: 113 --SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLE 168
Query: 911 --KLSRKGDVYSYGIILMETFTKKKP-----TDELF----VGEISLKSRVNDS 952
R D + G+++ E + P ++LF + EI ++
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-05
Identities = 30/105 (28%), Positives = 50/105 (47%), Gaps = 8/105 (7%)
Query: 831 SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK-LLG 889
+ D L+ VA + +L + IH DL NILL + + DFG+++ +
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 890 DETSMTQTQTLATIGYMAPEWKL----SRKGDVYSYGIILMETFT 930
D + + + +MAPE + + DV+SYGI+L E F+
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK-LLGDETSMTQTQTLAT 902
VA +E+L IH DL NILL+E+ V + DFG+++ + D + +
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 903 IGYMAPEWKLSR----KGDVYSYGIILMETFT 930
+ +MAPE R + DV+S+G++L E F+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK-LLGDETSMTQTQTLAT 902
VA +E+L IH DL NILL+E+ V + DFG+++ + D + +
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 903 IGYMAPEWKLSR----KGDVYSYGIILMETFT 930
+ +MAPE + + DV+S+G++L E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 61/253 (24%), Positives = 117/253 (46%), Gaps = 44/253 (17%)
Query: 745 LLGKGSFGSVYKGTLSD-GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIIST- 802
++G+G FG VY +D G A+K + + R + E L ++ R ++ ++ST
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIMLSLVSTG 54
Query: 803 ------CSSDHFKA-----LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL 851
C + F +L+ M G L ++ +++ F + ++ LE++
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDL-HYHLSQHGVFSEKEMRFYATEIILGLEHM 113
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK 911
H +++ DL P+NILL+E +SD G++ D + ++ T GYMAPE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPE-- 165
Query: 912 LSRKG-------DVYSYGIILME------TFTKKKPTDELFVGEISLKSRVN--DSLHGK 956
+ +KG D +S G +L + F + K D+ + ++L V DS +
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPE 225
Query: 957 IINVVDINLLQKE 969
+ ++++ LLQ++
Sbjct: 226 LKSLLE-GLLQRD 237
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-04
Identities = 45/146 (30%), Positives = 76/146 (52%), Gaps = 12/146 (8%)
Query: 748 KGSFGSVYKGTLSDGMQI-AVKVF---NLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
+G+FG VY G + ++ AVKV ++ + + AE + L + +V + +
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 804 SSDHFKALVLEYMPNGSLENW--MYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIH 861
S + LV+EY+ G +++ +Y FD + + +VA AL+YLH H IIH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLH-RHG--IIH 127
Query: 862 CDLNPSNILLNESMVACLSDFGISKL 887
DL P N+L++ L+DFG+SK+
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 44/184 (23%), Positives = 78/184 (42%), Gaps = 33/184 (17%)
Query: 762 GMQIAVKVFNLELEGTLRSFDA--ECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNG 819
G+ +AVK + + + A E +L + H+N++ +++ + P
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQK 93
Query: 820 SLEN----WMYNKNRSFDILQRLNMVIDVASALEYLHYD--------HPTPIIHCDLNPS 867
SLE ++ + ++ Q ++M +D + YL Y H IIH DL PS
Sbjct: 94 SLEEFQDVYLVMELMDANLCQVIHMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 152
Query: 868 NILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKGDVYSYGI 923
NI++ + DFG+++ T+ T + T Y APE D++S G
Sbjct: 153 NIVVKSDCTLKILDFGLARTAC--TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 210
Query: 924 ILME 927
I+ E
Sbjct: 211 IMGE 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 33/140 (23%), Positives = 62/140 (44%), Gaps = 11/140 (7%)
Query: 799 IISTCSSDHFKALVLEYMPN---GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH 855
S S + + + + S + + D+ L VA +++L +
Sbjct: 173 FSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN 232
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISK-LLGDETSMTQTQTLATIGYMAPEWKL-- 912
IH D+ N+LL + VA + DFG+++ ++ D + + + +MAPE
Sbjct: 233 ---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDC 289
Query: 913 --SRKGDVYSYGIILMETFT 930
+ + DV+SYGI+L E F+
Sbjct: 290 VYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 744 NLLGKGSFGSVYKGTLSD-GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIIST 802
N++G GSFG VY+ D ++A+K + + R E I+ ++ H N++ +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDY 127
Query: 803 CSSDHFKA--------LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD 854
++ FK +V+E++P ++ +M + R+ L + + L Y
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 855 HPTPIIHCDLNPSNILLN-ESMVACLSDFGISK-LLGDETSMTQTQTLATIGYMAPEWKL 912
H I H DL P N+L++ + L DFG +K LL + S++ + + Y APE L
Sbjct: 187 HSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---ICSRFYRAPELML 243
Query: 913 SRKG-----DVYSYGIILMET------FTKKKPTDEL 938
D++S G I+ E F+ + D+L
Sbjct: 244 GATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280
|
Length = 440 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 2e-04
Identities = 21/60 (35%), Positives = 33/60 (55%)
Query: 573 NMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGL 632
N++ L L++N+ + GL +L LD+S NNL+ P + L L+ L+LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 19/60 (31%), Positives = 25/60 (41%), Gaps = 1/60 (1%)
Query: 74 LSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSF 133
L L+++NN + L LK L NN +SI P P L L L GN+
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSIS-PEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 31/165 (18%)
Query: 784 ECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLEN----WMYNKNRSFDILQRLN 839
E ++ + H+N++ +++ + P SLE ++ + ++ Q +
Sbjct: 66 ELVLMKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQ 113
Query: 840 MVIDVASALEYLHYD--------HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891
M +D + YL Y H IIH DL PSNI++ + DFG+++ G
Sbjct: 114 MELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 170
Query: 892 TSMTQTQTLATIGYMAPEWKL----SRKGDVYSYGIILMETFTKK 932
TS T + T Y APE L D++S G I+ E K
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-04
Identities = 54/226 (23%), Positives = 90/226 (39%), Gaps = 40/226 (17%)
Query: 745 LLGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGTLR---SFDAECEILGSIRHRNLVKII 800
L+GKG G VY ++A+K +L F E +I + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQR-----------LNMVIDVASALE 849
S CS + Y+ +L++ + + + L + L++ + + +E
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSV-WQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 850 YLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE----------------TS 893
Y+H ++H DL P NILL + D+G + E +S
Sbjct: 128 YVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 894 MTQT-QTLATIGYMAPEWKL----SRKGDVYSYGIILMETFTKKKP 934
MT + + T YMAPE L S D+Y+ G+IL + T P
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 31/160 (19%)
Query: 784 ECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLEN----WMYNKNRSFDILQRLN 839
E ++ + H+N++ +++ + P SLE ++ + ++ Q +
Sbjct: 73 ELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQ 120
Query: 840 MVIDVASALEYLHYD--------HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891
M +D + YL Y H IIH DL PSNI++ + DFG+++ G
Sbjct: 121 MELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 177
Query: 892 TSMTQTQTLATIGYMAPEWKL----SRKGDVYSYGIILME 927
TS T + T Y APE L D++S G I+ E
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-04
Identities = 66/248 (26%), Positives = 108/248 (43%), Gaps = 58/248 (23%)
Query: 784 ECEILGSIRHRNLVKIISTCSSDHF--KA-----LVLEYMPNGSLENWMYNKNRSFDILQ 836
E ++ ++H+N+V+ I D F KA +++E+ G L + + F ++
Sbjct: 62 EVNVMRELKHKNIVRYI-----DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIE 116
Query: 837 RLNMVIDVAS----ALEYLHYDHPTP----IIHCDLNPSNILL----------------- 871
+ ++D+ AL Y H P ++H DL P NI L
Sbjct: 117 E-HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 872 NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR------KGDVYSYGIIL 925
N +A + DFG+SK +G E SM + + T Y +PE L K D+++ G I+
Sbjct: 176 NGRPIAKIGDFGLSKNIGIE-SMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233
Query: 926 METFTKKKPTDEL--FVGEIS-LKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSS 982
E + K P + F IS LK + + GK ++N+L K L+AKE+
Sbjct: 234 YELCSGKTPFHKANNFSQLISELKRGPDLPIKGK---SKELNILIKNLLNLSAKER---- 286
Query: 983 VLSLAMQC 990
A+QC
Sbjct: 287 --PSALQC 292
|
Length = 1021 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 745 LLGKGSFGSVYKGTLSD-GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIIST- 802
++G+G FG VY +D G A+K + + R + E L ++ R ++ ++ST
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIMLSLVSTG 54
Query: 803 ------CSSDHFK-----ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL 851
C S F + +L+ M G L ++ +++ F + ++ LE++
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEAEMRFYAAEIILGLEHM 113
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK 911
H +++ DL P+NILL+E +SD G L D + ++ T GYMAPE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLG---LACDFSKKKPHASVGTHGYMAPE-- 165
Query: 912 LSRKG-------DVYSYGIILMETFTKKKP 934
+ +KG D +S G +L + P
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 45/198 (22%), Positives = 86/198 (43%), Gaps = 29/198 (14%)
Query: 763 MQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLE 822
+++ +KV + +F ++ + H +L + C +V E++ +G L+
Sbjct: 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 823 NWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL-------NESM 875
+ + + ++ + +ASAL YL + ++H ++ NILL S
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSP 161
Query: 876 VACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW-----KLSRKGDVYSYGIILMETFT 930
LSD G+S T++++ + + I ++APE LS D +S+G L+E
Sbjct: 162 FIKLSDPGVSF-----TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-- 214
Query: 931 KKKPTDELFVGEISLKSR 948
F GE+ LK R
Sbjct: 215 -------CFDGEVPLKER 225
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-04
Identities = 41/152 (26%), Positives = 64/152 (42%), Gaps = 10/152 (6%)
Query: 738 DGFSENNLLGKGSFGSVYKGTLSD-----GMQIAVKVFNLELEGTLRSFDAECEILGSIR 792
D F ++G+G+FG V D M+I K LE E + AE +IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE-QVAHIRAERDILVEAD 59
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLH 852
+VK+ + L++E++P G + + K D L +A + +
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAID 115
Query: 853 YDHPTPIIHCDLNPSNILLNESMVACLSDFGI 884
H IH D+ P N+LL+ LSDFG+
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 4e-04
Identities = 39/210 (18%), Positives = 66/210 (31%), Gaps = 60/210 (28%)
Query: 731 QELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKV--------FNLELEGTLRSFD 782
+ELF F + S V++ L G ++AVKV +L+ R
Sbjct: 122 EELFSE---FEPEPI-ASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLAR 177
Query: 783 AECEILGSIRHRNLVKIISTCSS---------------DHFKA----------------- 810
+ R +LV+++ + F+
Sbjct: 178 LIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEY 237
Query: 811 -----LVLEYMPNGSLENWMYNKNRSFD---ILQRLNMVIDVASALEYLHYDHPTPIIHC 862
L +E++ + + K+ D + + L V + L L D H
Sbjct: 238 TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELL-----VRAFLRQLLRDG---FFHA 289
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDET 892
D +P NIL+ L DFGI L +
Sbjct: 290 DPHPGNILVRSDGRIVLLDFGIVGRLDPKF 319
|
Length = 517 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 42/154 (27%), Positives = 66/154 (42%), Gaps = 14/154 (9%)
Query: 738 DGFSENNLLGKGSFGSVYKGTLSD-----GMQIAVKVFNLELE--GTLRSFDAECEILGS 790
+ F ++G+G+FG V D M+I K LE E G +R AE +IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIR---AERDILVE 57
Query: 791 IRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEY 850
+VK+ + L++E++P G + + K D L +A +
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLA 113
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGI 884
+ H IH D+ P N+LL+ LSDFG+
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 55/233 (23%), Positives = 108/233 (46%), Gaps = 36/233 (15%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVFNLELEGTLRS----FDAECEILGSIRHRNLVKI 799
++G+G+FG V L + ++ A+K+ N + E R+ F E ++L + ++ + +
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILN-KWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYN-KNRSFDILQRL---NMVIDVASALEYLHYDH 855
++ LV++Y G L + ++R + + R MVI + S + LHY
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS-VHQLHY-- 123
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE------ 909
+H D+ P NIL++ + L+DFG L ++ ++ + + T Y++PE
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 910 ---WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959
K + D +S G+ + E + P F E +++ +GKI+N
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETP----FYAESLVET------YGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 21/94 (22%), Positives = 45/94 (47%), Gaps = 11/94 (11%)
Query: 792 RHRNLV-KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEY 850
R V K++++ SD + L++E++ +L+ ++ ++ +A L
Sbjct: 50 RKGLPVPKVLASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAK 101
Query: 851 LHYDHPTP-IIHCDLNPSNILLNESMVACLSDFG 883
LH P + H DL+P NIL+++ + + D+
Sbjct: 102 LH-QLPLLVLCHGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 8e-04
Identities = 21/60 (35%), Positives = 23/60 (38%)
Query: 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNEL 488
NL +L L N LT A L L+ L L N L GL SL GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.002
Identities = 69/279 (24%), Positives = 113/279 (40%), Gaps = 51/279 (18%)
Query: 397 ISIGNLSNA--MDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKL 454
I +LS A ++ L LS C+ +PS I LN L L + E +P I L
Sbjct: 648 KEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI----NL 703
Query: 455 QGLYLQHNKLQGSITTDLC-GLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLT 513
+ LY + C L+S + ++ + L+ + +LR +L L
Sbjct: 704 KSLY--------RLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNLRLENLDELILC 755
Query: 514 SVIPSSLWSLRDILN--VNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDL 571
+ LW L + + S SL T++ LS E+PSSI +L
Sbjct: 756 EMKSEKLWERVQPLTPLMTMLSPSL--------------TRLFLSDIPSLVELPSSIQNL 801
Query: 572 KNMQHLSLADNKFQGSIPD--SLGGLTSLN---------FLDMSSN----NLSG----EI 612
++HL + + ++P +L L SL+ F D+S+N NLS E+
Sbjct: 802 HKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDISTNISDLNLSRTGIEEV 861
Query: 613 PNSLKALSLLKFLNLS-FNGLQGQVPHGGPFTNLSSQSF 650
P ++ S L FL+++ N LQ + +L + F
Sbjct: 862 PWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDF 900
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 64/294 (21%), Positives = 124/294 (42%), Gaps = 57/294 (19%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGTLRSFD-----AECEILGSIR-HRNLVK 798
+G+G+F V K + G A+K ++ +S + E + L + H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 799 IISTCSSDHFK------ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLH 852
+I F ALV E M + +L + + R + + + + +L+++H
Sbjct: 63 LIEV----LFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 853 YDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL 912
+ I H D+ P NIL+ + ++ L+DFG + G + T+ ++T Y APE L
Sbjct: 118 RNG---IFHRDIKPENILIKDDILK-LADFGSCR--GIYSKPPYTEYISTRWYRAPECLL 171
Query: 913 -----SRKGDVYSYGIILMETFTKKKPTDELFVG--EISLKSRVNDSL---HGKII---- 958
K D+++ G + E + LF G E+ ++++D L +++
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS----LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227
Query: 959 --NVVDINLLQKEDAYLT-----AKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
++ N K+ L A + + + L +ERI K+AL
Sbjct: 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYD----PDERITAKQAL 277
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 745 LLGKGSFGSVY----KGTLSDGMQIAVKVFNLELEGTLRSFDAECEILG------SIRHR 794
+LGKGSFG V KGT D + A+K+ L+ + ++ D EC ++ S +
Sbjct: 7 VLGKGSFGKVMLAERKGT--DEL-YAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 795 NLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNR--SFDILQRLNMVIDVASALEYLH 852
L ++ S + V+EY+ G L MY + F + ++A L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 853 YDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE--- 909
II+ DL N++L+ ++DFG+ K + T+T T Y+APE
Sbjct: 119 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIAPEIIA 174
Query: 910 -WKLSRKGDVYSYGIILMETFTKKKP-----TDELF 939
+ D +++G++L E + P DELF
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 55/240 (22%), Positives = 107/240 (44%), Gaps = 36/240 (15%)
Query: 738 DGFSENNLLGKGSFGSVYKGTLSDGMQI-AVKVFNLELEGTLRS----FDAECEILGSIR 792
D F ++G+G+FG V + +I A+K+ N + E R+ F E +L +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-KWEMLKRAETACFREERNVLVNGD 59
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYN-KNRSFDILQRL---NMVIDVASAL 848
+ + + +++ LV++Y G L + ++R + + R MV+ + S +
Sbjct: 60 CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS-I 118
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAP 908
LHY +H D+ P N+LL+ + L+DFG + + ++ + + T Y++P
Sbjct: 119 HQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172
Query: 909 E---------WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959
E K + D +S G+ + E + P F E +++ +GKI+N
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP----FYAESLVET------YGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 18/197 (9%)
Query: 739 GFSENNLLGKGSFGSVYKGTLSDGMQ-IAVKVFNLELEGTLRSFDAECEILGSIRHRNLV 797
GF+ + L GS G V++ + D Q + VK G S E +L + H ++
Sbjct: 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKA------GWYASSVHEARLLRRLSHPAVL 223
Query: 798 KIISTCSSDHFKALVL-EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
++ LVL +Y L ++ + R + Q + + SA++Y+H +
Sbjct: 224 ALLDVRVVGGLTCLVLPKY--RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG- 280
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLL-GDETSMTQTQTLATIGYMAPEW----K 911
IIH D+ N+L+N CL DFG + G ++ T+ APE
Sbjct: 281 --IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDP 338
Query: 912 LSRKGDVYSYGIILMET 928
+ D++S G+++ E
Sbjct: 339 YTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.004
Identities = 21/61 (34%), Positives = 29/61 (47%), Gaps = 2/61 (3%)
Query: 122 KLEHLYLDGNSFIGTIPPSIC-NISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQ 180
L+ L L N + IP + +L LDLS N L P + +PSL ++DLS N
Sbjct: 1 NLKSLDLSNNR-LTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 181 F 181
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.004
Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 10/153 (6%)
Query: 738 DGFSENNLLGKGSFGSV-YKGTLSDGMQIAVKVFNLELE----GTLRSFDAECEILGSIR 792
+ F ++GKG+FG V G A+K L+ E L AE ++L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLH 852
+V + + + L++E++P G L + + + + R M + A+E +H
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVLAIEAVH 118
Query: 853 YDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885
IH D+ P NIL++ LSDFG+S
Sbjct: 119 ---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 39/161 (24%), Positives = 70/161 (43%), Gaps = 22/161 (13%)
Query: 784 ECEILGSIRHRNLVKIISTCSSDHFKALVLE--------YMPNGSLENWMYNKNRSFDIL 835
E LG + H N++KI S+ ++ + +M + + + W K+R +
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-W---KDRPL-LK 267
Query: 836 QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895
Q ++ + A+EY+H +IH D+ NI LN L DFG + E
Sbjct: 268 QTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 896 QTQTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTK 931
+ T+ +PE L+ G D++S G+IL++ +
Sbjct: 325 DYGWVGTVATNSPE-ILAGDGYCEITDIWSCGLILLDMLSH 364
|
Length = 501 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1029 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.27 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.13 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.07 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.04 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.03 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.03 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.02 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.97 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.95 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.71 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.71 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.7 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.69 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.57 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.52 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.35 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.33 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-113 Score=1101.37 Aligned_cols=913 Identities=32% Similarity=0.517 Sum_probs=698.5
Q ss_pred chhHHHHHHHHHHhccCCCCCcccCCCCCCCCCCceeeEEEcCCCCceEEEecccccccccCCccCCCCcCCCeEeccCc
Q 036879 3 VGRDQSALLALKAHVTNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNN 82 (1029)
Q Consensus 3 ~~~~~~al~~~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n 82 (1029)
.+.|+.||++||+++. +|.+.+++ |+.+.|||.|.||+|+. .++|+.|+|+++++.|.+|+.+..+++|+.|+|++|
T Consensus 27 ~~~~~~~l~~~~~~~~-~~~~~~~~-w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSIN-DPLKYLSN-WNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhCC-CCcccCCC-CCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence 4689999999999995 78888877 98889999999999985 469999999999999999999999999999999999
Q ss_pred ccccCCccccc-cccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCCcCcccC
Q 036879 83 SFSGTLPIQLS-NLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHV 161 (1029)
Q Consensus 83 ~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 161 (1029)
+++|.+|..+. .+++|++|+|++|+++. .+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~-~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 180 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTG-SIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCcccc-ccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccC
Confidence 99999998765 89999999999999985 3454 56899999999999999999999999999999999999999999
Q ss_pred CccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcccccccCC
Q 036879 162 PSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGS 241 (1029)
Q Consensus 162 p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (1029)
|..+.++++|++|+|++|.+++.+ |..++.+++|++|+|++|++++.
T Consensus 181 p~~~~~l~~L~~L~L~~n~l~~~~---------------------------------p~~l~~l~~L~~L~L~~n~l~~~ 227 (968)
T PLN00113 181 PNSLTNLTSLEFLTLASNQLVGQI---------------------------------PRELGQMKSLKWIYLGYNNLSGE 227 (968)
T ss_pred ChhhhhCcCCCeeeccCCCCcCcC---------------------------------ChHHcCcCCccEEECcCCccCCc
Confidence 999999999999988888876543 44455555555555555555555
Q ss_pred CCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceE
Q 036879 242 IPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQL 321 (1029)
Q Consensus 242 ~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L 321 (1029)
+|..|+++++|+ +|+|++|++++.+|..+.++++|++|+|++|.+.+.+|..+. .+++|++|
T Consensus 228 ~p~~l~~l~~L~-----------------~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L 289 (968)
T PLN00113 228 IPYEIGGLTSLN-----------------HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF-SLQKLISL 289 (968)
T ss_pred CChhHhcCCCCC-----------------EEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHh-hccCcCEE
Confidence 555555444333 444555555555555555555556666655555555555554 25556666
Q ss_pred eecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccC
Q 036879 322 ILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGN 401 (1029)
Q Consensus 322 ~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 401 (1029)
+|++|.+++.+|..+.++++|+.|++++|.+.+.+|..+ ..+++|+.|++++|.+.+.+|..++.
T Consensus 290 ~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~---------------~~l~~L~~L~L~~n~l~~~~p~~l~~ 354 (968)
T PLN00113 290 DLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL---------------TSLPRLQVLQLWSNKFSGEIPKNLGK 354 (968)
T ss_pred ECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhH---------------hcCCCCCEEECcCCCCcCcCChHHhC
Confidence 666666655556556666666666666666555444332 34566666777777766666766666
Q ss_pred chhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEE
Q 036879 402 LSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEF 481 (1029)
Q Consensus 402 l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 481 (1029)
+.+ |+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|++++..+..|..+++|+.|
T Consensus 355 ~~~-L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 433 (968)
T PLN00113 355 HNN-LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433 (968)
T ss_pred CCC-CcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEE
Confidence 655 7777777777777777777777888888888888887778888888888888888888887778788888888888
Q ss_pred ecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCC
Q 036879 482 YSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLS 561 (1029)
Q Consensus 482 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 561 (1029)
++++|.+++.+|..+..+++|+.|+|++|++.+..|..+ ..++|+.|++++|++++..|..+.++++|+.|+|++|+++
T Consensus 434 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 512 (968)
T PLN00113 434 DISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLS 512 (968)
T ss_pred ECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcce
Confidence 888888888888888888999999999999988877765 4588999999999999999999999999999999999999
Q ss_pred CCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCCCC
Q 036879 562 GEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGP 641 (1029)
Q Consensus 562 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 641 (1029)
+.+|..+..+++|+.|+|++|.+++.+|..|..+++|+.|||++|++++.+|..+.+++.|+.|++++|+++|.+|..+.
T Consensus 513 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~ 592 (968)
T PLN00113 513 GEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592 (968)
T ss_pred eeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcch
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccCcccccCCCCCCCCCC-CCCCCCCCccccccccCCccEEEEeechhhHHHHHHHhhhheeeeccccccccccccCC
Q 036879 642 FTNLSSQSFVGNKGLCGAPE-LKFPACKAKSNKIARKTDKNIFIYVFPIAASILLVLSLSVVLIRRQKRNTGLQIDEEMS 720 (1029)
Q Consensus 642 ~~~l~~~~~~~n~~~c~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~r~k~~~~~~~~~~~~ 720 (1029)
+..+...++.||+.+||.+. ...++|... ++...+.+++++.+++++++++++++++++|+++....+..+...
T Consensus 593 ~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (968)
T PLN00113 593 FLAINASAVAGNIDLCGGDTTSGLPPCKRV-----RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENED 667 (968)
T ss_pred hcccChhhhcCCccccCCccccCCCCCccc-----cccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccccccc
Confidence 99999999999999999653 345667432 111222222222222222222222223332222211111111100
Q ss_pred c--c------ccccccCHHHHHHHhCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeecccchhhHHHHHHHHHHhcC
Q 036879 721 P--E------VTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSI 791 (1029)
Q Consensus 721 ~--~------~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l 791 (1029)
. + .....+.+.+ ....|...+.||+|+||.||+|+. .++..||||.+..... ....|++.++++
T Consensus 668 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l 740 (968)
T PLN00113 668 GTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKL 740 (968)
T ss_pred ccccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhC
Confidence 0 0 0011223333 345678889999999999999987 4789999998864322 223568899999
Q ss_pred CCCceEEEEEEEecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE
Q 036879 792 RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL 871 (1029)
Q Consensus 792 ~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill 871 (1029)
+|||||+++++|.+++..++||||+++|+|.++++ .++|..+..++.|+|+|++|||..++++|+||||||+||++
T Consensus 741 ~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~ 816 (968)
T PLN00113 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816 (968)
T ss_pred CCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE
Confidence 99999999999999999999999999999999984 37899999999999999999997777899999999999999
Q ss_pred CCCCcEEEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccch
Q 036879 872 NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKS 947 (1029)
Q Consensus 872 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~ 947 (1029)
+.++.+++. ||.+...... ....++++|+|||+. ++.++|||||||++|||+||+.||+...........
T Consensus 817 ~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~ 890 (968)
T PLN00113 817 DGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVE 890 (968)
T ss_pred CCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHH
Confidence 999988876 6655433211 223588999999984 678999999999999999999999654444444444
Q ss_pred hchhccchh-hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 948 RVNDSLHGK-IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 948 ~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
|+....... ....+|+...... ..+.....++.+++.+||+.+|++||||+||++.|+++.+.-
T Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 891 WARYCYSDCHLDMWIDPSIRGDV----SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHhcCccchhheeCccccCCC----CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 443322111 2233333332111 112334567889999999999999999999999999987644
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-59 Score=602.75 Aligned_cols=519 Identities=36% Similarity=0.564 Sum_probs=473.5
Q ss_pred cCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcC-CCCCccceeccccccccCCCcccccCccccCeE
Q 036879 72 SFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWL-DSFPKLEHLYLDGNSFIGTIPPSICNISSLLTL 150 (1029)
Q Consensus 72 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 150 (1029)
..++.|+|++|.++|.+|..|..+++|++|+|++|+++. .+|..+ ..+++|++|+|++|++++.+|. +.+++|++|
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~-~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L 145 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSG-PIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETL 145 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCC-cCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEE
Confidence 467889999999999999999999999999999999875 567655 4888999999999998887775 457888999
Q ss_pred eccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccce
Q 036879 151 DLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKI 230 (1029)
Q Consensus 151 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 230 (1029)
+|++|.+++.+|..++++++|++|+|++|.+. +.+|..++++++|++
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~---------------------------------~~~p~~~~~l~~L~~ 192 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV---------------------------------GKIPNSLTNLTSLEF 192 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCccc---------------------------------ccCChhhhhCcCCCe
Confidence 99999888888888888887777777766654 356778889999999
Q ss_pred EEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCch
Q 036879 231 LSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSN 310 (1029)
Q Consensus 231 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~ 310 (1029)
|+|++|++++.+|..++++++|+ +|+|++|++++.+|..+.++++|++|+|++|.+.+.+|..
T Consensus 193 L~L~~n~l~~~~p~~l~~l~~L~-----------------~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 255 (968)
T PLN00113 193 LTLASNQLVGQIPRELGQMKSLK-----------------WIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS 255 (968)
T ss_pred eeccCCCCcCcCChHHcCcCCcc-----------------EEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChh
Confidence 99999999999999998877665 7788888898899999999999999999999999899988
Q ss_pred hhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCc
Q 036879 311 IGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENP 390 (1029)
Q Consensus 311 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~ 390 (1029)
+. .+++|++|+|++|++++.+|..+.++++|+.|++++|.+.+.+|..+ ..+++|+.|++++|.
T Consensus 256 l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~---------------~~l~~L~~L~l~~n~ 319 (968)
T PLN00113 256 LG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV---------------IQLQNLEILHLFSNN 319 (968)
T ss_pred Hh-CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhH---------------cCCCCCcEEECCCCc
Confidence 76 59999999999999999999999999999999999999998877654 478899999999999
Q ss_pred CCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccc
Q 036879 391 LSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITT 470 (1029)
Q Consensus 391 l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 470 (1029)
+.+.+|..+..+++ |+.|++++|.+.+.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|++++|.+.+..+.
T Consensus 320 ~~~~~~~~~~~l~~-L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~ 398 (968)
T PLN00113 320 FTGKIPVALTSLPR-LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398 (968)
T ss_pred cCCcCChhHhcCCC-CCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCH
Confidence 99999999999887 99999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccc
Q 036879 471 DLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVV 550 (1029)
Q Consensus 471 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 550 (1029)
.+..+++|+.|++++|++++..|..|..+++|+.|++++|++++.+|..++.+++|+.|+|++|++.+..|..+ ..++|
T Consensus 399 ~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L 477 (968)
T PLN00113 399 SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRL 477 (968)
T ss_pred HHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999998888766 45899
Q ss_pred cEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCC
Q 036879 551 TKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFN 630 (1029)
Q Consensus 551 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 630 (1029)
+.|++++|++++..|..|..+++|+.|+|++|++++.+|..+..+++|++|+|++|++++.+|..+..+++|+.|+|++|
T Consensus 478 ~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 557 (968)
T PLN00113 478 ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQN 557 (968)
T ss_pred eEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCC-CCCCccCcccccCCCCCCCCCC
Q 036879 631 GLQGQVPHG-GPFTNLSSQSFVGNKGLCGAPE 661 (1029)
Q Consensus 631 ~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~~~ 661 (1029)
++++.+|.. ..+..+..+.+.+|+..+..|.
T Consensus 558 ~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~ 589 (968)
T PLN00113 558 QLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589 (968)
T ss_pred cccccCChhHhcCcccCEEeccCCcceeeCCC
Confidence 999988863 5677888999999998876664
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-47 Score=419.13 Aligned_cols=285 Identities=42% Similarity=0.670 Sum_probs=243.0
Q ss_pred cccccCHHHHHHHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEE
Q 036879 724 TWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803 (1029)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 803 (1029)
....|++.++..+|++|...+.||+|+||.||+|...+|+.||||++........++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 67789999999999999999999999999999999999999999987765433145699999999999999999999999
Q ss_pred ecCC-eEEEEEeccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEc
Q 036879 804 SSDH-FKALVLEYMPNGSLENWMYNKNR-SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSD 881 (1029)
Q Consensus 804 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~D 881 (1029)
.+.+ ..+|||||+++|+|.++++.... .++|..|++||.++|+||+|||+.....||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999987766 899999999999999999999988878899999999999999999999999
Q ss_pred cCCceecCC-CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCccc-ccccccchhchhccch
Q 036879 882 FGISKLLGD-ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELF-VGEISLKSRVNDSLHG 955 (1029)
Q Consensus 882 fg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~ 955 (1029)
||+|+..+. ..... +...||.+|+|||+. .+.|+|||||||+++|++||+.|.+... .++..+..|+...+..
T Consensus 221 FGLa~~~~~~~~~~~-~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVS-TTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCcccccee-eecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999976544 22211 111799999999984 7889999999999999999999987654 4455577777666644
Q ss_pred -hhhhhhhhhhhh-hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 956 -KIINVVDINLLQ-KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 956 -~~~~~~d~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.+.+++|+.+.. .+.. ......+..++..|++.+|++||+|.||++.|+.+...
T Consensus 300 ~~~~eiiD~~l~~~~~~~-----~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPD-----EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cchhheeCCCccCCCCCh-----HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 588889988763 2211 13456699999999999999999999999999666543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=378.68 Aligned_cols=248 Identities=27% Similarity=0.339 Sum_probs=205.9
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC-eEEEEEecc
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH-FKALVLEYM 816 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~ 816 (1029)
.+....||+|..|+|||++++ +++.+|+|.+.... ....+++.+|+++++..+||+||.+||+|...+ ...++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 345678999999999999987 78899999996654 344678999999999999999999999999988 599999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
++|+|++++... +.+++.....++.++.+||.|||+ +++||||||||+|||++..|++||||||.+..+... ..
T Consensus 161 DgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a 234 (364)
T KOG0581|consen 161 DGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA 234 (364)
T ss_pred CCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence 999999988543 669999999999999999999994 256999999999999999999999999999877543 33
Q ss_pred ccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
...+||..|||||++ |+.++||||||++++|+++|+.||........ .+.+.++....+.+
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~------------~~~~Ll~~Iv~~pp--- 299 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL------------DIFELLCAIVDEPP--- 299 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC------------CHHHHHHHHhcCCC---
Confidence 457899999999995 77899999999999999999999876411111 12222332222211
Q ss_pred hHHHH-HHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 973 LTAKE-QCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 973 ~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
+..|. .+++++.+++..|+++||.+||+++|+++|=
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 22334 4899999999999999999999999999853
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=373.73 Aligned_cols=251 Identities=26% Similarity=0.341 Sum_probs=205.2
Q ss_pred HhCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeecccc-------hhhHHHHHHHHHHhcCCCCceEEEEEEEecCC
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELE-------GTLRSFDAECEILGSIRHRNLVKIISTCSSDH 807 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 807 (1029)
..+.|.+.+.+|+|+||.|-+|.. ++|+.||||++++... .....+.+|+++|++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345688889999999999999975 4899999999986531 12334679999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC---CcEEEEccCC
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES---MVACLSDFGI 884 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~---~~~kl~Dfg~ 884 (1029)
..|+||||++||+|.+++..+ +.+.+..-..+++|++.|+.||| ++||+||||||+|||+..+ ..+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999999998544 45667777889999999999999 8889999999999999755 8899999999
Q ss_pred ceecCCCCCceeccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhh
Q 036879 885 SKLLGDETSMTQTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKI 957 (1029)
Q Consensus 885 a~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 957 (1029)
|+..+.... ....+||+.|.|||++ +..++|+||+||++|-+++|.+||.+......
T Consensus 326 AK~~g~~sf--m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-------------- 389 (475)
T KOG0615|consen 326 AKVSGEGSF--MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-------------- 389 (475)
T ss_pred hhcccccee--hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--------------
Confidence 998864322 2346799999999995 34489999999999999999999976321110
Q ss_pred hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 958 INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 958 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
+.+....+++...+..+...+.+..++|.+|+..||++|||++|++++=
T Consensus 390 --l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 390 --LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred --HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 1111122333333445566788999999999999999999999999753
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=388.28 Aligned_cols=254 Identities=31% Similarity=0.491 Sum_probs=210.0
Q ss_pred CCCceeccCcceEEEEEEecCCcEEEEEEeecccchh--hHHHHHHHHHHhcCCCCceEEEEEEEecCC-eEEEEEeccC
Q 036879 741 SENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGT--LRSFDAECEILGSIRHRNLVKIISTCSSDH-FKALVLEYMP 817 (1029)
Q Consensus 741 ~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~~ 817 (1029)
...+.+|+|+||+||+|.+.....||||++....... .+.|.+|+.++++++|||||+++|+|.+.. ..++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3445599999999999999655559999998654222 568999999999999999999999999887 7899999999
Q ss_pred CCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEEcCCCCCCEEECCCC-cEEEEccCCceecCCCCCc
Q 036879 818 NGSLENWMYN-KNRSFDILQRLNMVIDVASALEYLHYDHPTP-IIHCDLNPSNILLNESM-VACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 818 ~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~g-ivH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+|+|.++++. ..+.+++..++.|+.|||+|++||| +.+ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 9999999987 4788999999999999999999999 667 99999999999999997 99999999998764421 2
Q ss_pred eeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
..+...||+.|||||++ ++.|+||||||+++|||+||+.||......+. .. .++ .
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~--~~-----------~v~------~ 260 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV--AS-----------AVV------V 260 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH--HH-----------HHH------h
Confidence 22335799999999983 67799999999999999999999987532111 10 000 0
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcc
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLT 1017 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~ 1017 (1029)
...+...+..+++.+..++..||..||++||++.|++..|+.+......
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 1112233344788999999999999999999999999999999886653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=389.15 Aligned_cols=250 Identities=30% Similarity=0.505 Sum_probs=214.0
Q ss_pred CCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCC
Q 036879 740 FSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNG 819 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 819 (1029)
+...+.||+|-||+||.|.++....||+|.++.. ......|.+|+++|++++|++||+++|+|..++.+|||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3456789999999999999988889999999765 334577889999999999999999999999999999999999999
Q ss_pred CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 820 SLENWMYN-KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 820 sL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
+|.+|++. .+..+...+.+.++.|||+|++||+ ++.+|||||.++|||++++..+||+|||+|+...+++......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 99999986 5667899999999999999999999 7779999999999999999999999999999766666655565
Q ss_pred ccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhh
Q 036879 899 TLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYL 973 (1029)
Q Consensus 899 ~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 973 (1029)
..-++.|.|||. .++.|||||||||+||||+| |+.||.+.... +++. .+ ..+.+.
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----------------ev~~-~l--e~GyRl 423 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----------------EVLE-LL--ERGYRL 423 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----------------HHHH-HH--hccCcC
Confidence 667889999998 47889999999999999999 77787653111 1111 01 123345
Q ss_pred HHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 974 TAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 974 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
+.|+.||..+.++|..||..+|++|||++.+...++++..
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 6678899999999999999999999999999999987764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=386.05 Aligned_cols=244 Identities=25% Similarity=0.353 Sum_probs=209.1
Q ss_pred CCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeecc---cchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLE---LEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.+|...+.||+|||+.||.++. ++|+.||+|++.+. .....+.+.+|++|.++|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 78999999999874 3455678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
|+|+.++|..+++ .++.+++.+++.+++||+.|+.||| +.+|+|||||..|++++++.++||+|||+|..+..+..
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999885 7788999999999999999999999 78899999999999999999999999999998865433
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
. .....|||-|.|||+. .+..+||||+|||||-|+.|++||+.... .+..+......
T Consensus 174 r-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-----------------kety~~Ik~~~- 234 (592)
T KOG0575|consen 174 R-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-----------------KETYNKIKLNE- 234 (592)
T ss_pred c-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-----------------HHHHHHHHhcC-
Confidence 3 3346799999999995 56789999999999999999999986311 11111111111
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...|...+.++.++|.++++++|.+|||+++|+.+
T Consensus 235 ---Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 ---YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 12344567889999999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=367.98 Aligned_cols=197 Identities=31% Similarity=0.520 Sum_probs=175.9
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecc--cchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLE--LEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
..++|...+.||+|+||+||+|++. ++.+||||.+.+. .....+.+..|+++++.++|||||++++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3567888899999999999999976 7899999999876 455667789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC------CcEEEEccCCce
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES------MVACLSDFGISK 886 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~------~~~kl~Dfg~a~ 886 (1029)
||||.||+|.+|++.+ +.+++..+..++.|+|.|+++|| +++||||||||+|||++.. ..+||+|||+|+
T Consensus 88 MEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999654 47899999999999999999999 6669999999999999854 679999999999
Q ss_pred ecCCCCCceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhcCCCCCCcc
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDEL 938 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~elltg~~p~~~~ 938 (1029)
.+... .......|++.|||||+ .|+.|+|+||+|+++|+|++|+.||+..
T Consensus 164 ~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 164 FLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 88643 23345679999999998 4899999999999999999999999853
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=390.43 Aligned_cols=480 Identities=29% Similarity=0.437 Sum_probs=353.2
Q ss_pred eEEEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccc
Q 036879 50 VTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLD 129 (1029)
Q Consensus 50 v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls 129 (1029)
...+.+++|.+. .+.+.+.+|..|++|++++|+++ .+|.+++.+..++.|+.++|+++ ++|..++++.+|..|+.+
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls--~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS--ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh--hccHHHhhhhhhhhhhcc
Confidence 457889999987 88889999999999999999998 89999999999999999999999 689999999999999999
Q ss_pred cccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhcc
Q 036879 130 GNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHL 209 (1029)
Q Consensus 130 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~L 209 (1029)
+|++. .+|++++.+..|+.|+..+|+++ ..|+.++++.+|..|++.+|++...+|...+++ .|++||.
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~----------~L~~ld~ 190 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMK----------RLKHLDC 190 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHH----------HHHhccc
Confidence 99999 89999999999999999999999 899999999999999999999998888765443 5667777
Q ss_pred ccccccCCCCcccccccccceEEcccccccCCCCccccccccccceeecccccc-------cccCcccEEEccCCcccCC
Q 036879 210 AYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT-------GEIQGLQVLALSSNRLTGV 282 (1029)
Q Consensus 210 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~-------~~l~~L~~L~Ls~N~l~~~ 282 (1029)
-.|-++ .+|..++.+.+|+.|+|.+|++. .+| +|+.+..|++|+++.|++. ..++++.+|||++|+++ .
T Consensus 191 ~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e 266 (565)
T KOG0472|consen 191 NSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-E 266 (565)
T ss_pred chhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-c
Confidence 777776 68999999999999999999988 677 8999999999999999987 36778899999999998 7
Q ss_pred CCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCccccccc--ccceecC--CCccccCCCCC
Q 036879 283 IPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNAS--MLTLIDM--PYNLFSGFIPN 358 (1029)
Q Consensus 283 ~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~l--s~N~l~~~~p~ 358 (1029)
.|++++-+.+|++||+|+|.|+ .+|..++. + +|+.|-+.||.+..+-.+.+++-+ -|++|.= ..-.++.. +
T Consensus 267 ~Pde~clLrsL~rLDlSNN~is-~Lp~sLgn-l-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~s--e 341 (565)
T KOG0472|consen 267 VPDEICLLRSLERLDLSNNDIS-SLPYSLGN-L-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQS--E 341 (565)
T ss_pred CchHHHHhhhhhhhcccCCccc-cCCccccc-c-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCC--c
Confidence 8999999999999999999996 78888874 6 899999999988743333222221 2222221 00011100 0
Q ss_pred CCCCCCCCc-ccccccccccccccceeeccCCcCCCCCCccccCchh--hhcceeccccccccccccccCCcCcCcE-EE
Q 036879 359 SLGFCHPYD-ELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSN--AMDVLYLSACNIKGSIPSEIGNLNNLTT-LH 434 (1029)
Q Consensus 359 ~~~~~~~~~-~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--~L~~L~L~~n~l~~~~p~~~~~l~~L~~-L~ 434 (1029)
. +.....+ .-.-+.......+.+.|++++-+++ .+|+.++.... -++..+++.|++. .+|..+..+..+.+ +.
T Consensus 342 ~-~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~ 418 (565)
T KOG0472|consen 342 G-GTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLV 418 (565)
T ss_pred c-cccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHH
Confidence 0 0000000 0011122334556667777777766 44544443222 2455666666666 55555555544433 34
Q ss_pred ecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccC
Q 036879 435 LETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTS 514 (1029)
Q Consensus 435 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 514 (1029)
+++|.++ .+|..++.+++|..|+|++|.+- .+|..++.+..|+.|++++|++.
T Consensus 419 lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-------------------------~LP~e~~~lv~Lq~LnlS~NrFr- 471 (565)
T KOG0472|consen 419 LSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-------------------------DLPEEMGSLVRLQTLNLSFNRFR- 471 (565)
T ss_pred hhcCccc-cchHHHHhhhcceeeecccchhh-------------------------hcchhhhhhhhhheecccccccc-
Confidence 4444444 55666666666666666666553 55666666666777777777665
Q ss_pred CCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccccccccc
Q 036879 515 VIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQ 585 (1029)
Q Consensus 515 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 585 (1029)
..|..+..+..|+.+-.++|++....|..+.++.+|+.|||.+|.+. .+|..+++|++|++|.|++|+|+
T Consensus 472 ~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 472 MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 46666666666666666667776655555777777777777777776 66777777777777777777776
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=353.16 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=201.5
Q ss_pred CCCCCceeccCcceEEEEEEe-cCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEE-EEecC-CeEEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIIS-TCSSD-HFKALVL 813 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~-~~~~lV~ 813 (1029)
.|++.++||+|.||+||++.. .+|..||.|.++-.. .........|+.++++++|||||++++ .+.++ +..++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 477788999999999999985 589999999988543 344567899999999999999999998 45444 4589999
Q ss_pred eccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 814 EYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTP-IIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 814 E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~g-ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
|||.+|+|.+.++. .++.+++..+++++.|++.||.++|+.-.+| |+||||||.||+++.+|.+|++|||+++++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999998753 4567999999999999999999999643333 7899999999999999999999999999987
Q ss_pred CCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
..... ....+|||+||+||++ ++.||||||+||++|||+.-++||.+. .+.+....+
T Consensus 180 s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI------------- 240 (375)
T KOG0591|consen 180 SKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKI------------- 240 (375)
T ss_pred chhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHH-------------
Confidence 65444 3457899999999985 788999999999999999999999873 111111111
Q ss_pred hhhhhhhhHHH-HHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 966 LQKEDAYLTAK-EQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 966 ~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
... ...+.| +.++..+.++|..|+..||+.||+...+++.+
T Consensus 241 ~qg--d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 241 EQG--DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HcC--CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 111 111223 56789999999999999999999865555444
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=381.13 Aligned_cols=497 Identities=28% Similarity=0.353 Sum_probs=361.6
Q ss_pred CCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCe
Q 036879 70 NLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLT 149 (1029)
Q Consensus 70 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 149 (1029)
.-..|+.|++++|.++ .+-+.+.++..|.+|++.+|++. ++|+.++.+..++.|+.++|++. .+|+.++.+.+|..
T Consensus 43 ~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~--~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~ 118 (565)
T KOG0472|consen 43 EQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS--QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVK 118 (565)
T ss_pred hhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh--hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhh
Confidence 3455788899999988 77778889999999999999998 57899999999999999999988 88999999999999
Q ss_pred EeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccc
Q 036879 150 LDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLK 229 (1029)
Q Consensus 150 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 229 (1029)
|+.++|.+. .+|+.++.+-.|+.|+..+|+++..+++++.+. ++..|++.+|++....|..+. ++.|+
T Consensus 119 l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~----------~l~~l~~~~n~l~~l~~~~i~-m~~L~ 186 (565)
T KOG0472|consen 119 LDCSSNELK-ELPDSIGRLLDLEDLDATNNQISSLPEDMVNLS----------KLSKLDLEGNKLKALPENHIA-MKRLK 186 (565)
T ss_pred hhcccccee-ecCchHHHHhhhhhhhccccccccCchHHHHHH----------HHHHhhccccchhhCCHHHHH-HHHHH
Confidence 999999998 788889999999999999999998888877654 455566667777654555444 88999
Q ss_pred eEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCc
Q 036879 230 ILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPS 309 (1029)
Q Consensus 230 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~ 309 (1029)
+||.-.|-+. .+|..++.+.+|. .|+|+.|+|. .+| +|.+++.|++|+++.|.|. .+|.
T Consensus 187 ~ld~~~N~L~-tlP~~lg~l~~L~-----------------~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpa 245 (565)
T KOG0472|consen 187 HLDCNSNLLE-TLPPELGGLESLE-----------------LLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPA 245 (565)
T ss_pred hcccchhhhh-cCChhhcchhhhH-----------------HHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHH
Confidence 9999888765 7888888887766 4556666666 555 7888888888888888885 7888
Q ss_pred hhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCC
Q 036879 310 NIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSEN 389 (1029)
Q Consensus 310 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N 389 (1029)
..++.+++|..|||.+|+++ ..|+.++.+.+|++||+|+|.+++..+ ++.++ +|+.|-+.+|
T Consensus 246 e~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~----------------sLgnl-hL~~L~leGN 307 (565)
T KOG0472|consen 246 EHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPY----------------SLGNL-HLKFLALEGN 307 (565)
T ss_pred HHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCc----------------ccccc-eeeehhhcCC
Confidence 88877888888888888888 678888888888888888888875332 24466 7888888888
Q ss_pred cCCCCCCccccCchh-hhcceec--cccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccC
Q 036879 390 PLSGVLPISIGNLSN-AMDVLYL--SACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQG 466 (1029)
Q Consensus 390 ~l~~~~p~~~~~l~~-~L~~L~L--~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 466 (1029)
.+...-.+.+..-+. -|++|.= ..-+++..--..- ..-+ ...+..| ....+.+.+.|+++.=+++.
T Consensus 308 PlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e------~~~t----~~~~~~~-~~~~~i~tkiL~~s~~qlt~ 376 (565)
T KOG0472|consen 308 PLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTE------TAMT----LPSESFP-DIYAIITTKILDVSDKQLTL 376 (565)
T ss_pred chHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccccc------ccCC----CCCCccc-chhhhhhhhhhccccccccc
Confidence 876322222222111 1222211 0001110000000 0000 0000001 11223334444444444443
Q ss_pred cccccccCCC--CCcEEecCCCcccCcccccccccccccee-eccCccccCCCCCCccCCCCCcEEEccCCcccCcCCcc
Q 036879 467 SITTDLCGLR--SLSEFYSDGNELNGSLPQCLDSLISLRTL-SLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVE 543 (1029)
Q Consensus 467 ~~~~~~~~l~--~L~~L~l~~N~l~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 543 (1029)
.+.+.|...+ -....+++.|++. .+|..+..++.+.+. ++++|.+ +.+|..++.+++|..|+|++|-+. .+|..
T Consensus 377 VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e 453 (565)
T KOG0472|consen 377 VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEE 453 (565)
T ss_pred CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchh
Confidence 3333333221 1344455555554 677777777766554 4555555 588899999999999999999998 68999
Q ss_pred ccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccc
Q 036879 544 IGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLK 623 (1029)
Q Consensus 544 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 623 (1029)
++.+..|+.||+|+|++. ..|..+..+..|+.+-.++|++..+.|..+.+|.+|.+|||.+|.+. .+|..++++.+|+
T Consensus 454 ~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~ 531 (565)
T KOG0472|consen 454 MGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLR 531 (565)
T ss_pred hhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhcccccee
Confidence 999999999999999998 78888888888888888889999766677999999999999999998 8888999999999
Q ss_pred eeeccCCCCcCCCCC
Q 036879 624 FLNLSFNGLQGQVPH 638 (1029)
Q Consensus 624 ~L~l~~N~l~~~~~~ 638 (1029)
.|+++||++. ++++
T Consensus 532 hLeL~gNpfr-~Pr~ 545 (565)
T KOG0472|consen 532 HLELDGNPFR-QPRH 545 (565)
T ss_pred EEEecCCccC-CCHH
Confidence 9999999998 5554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=390.15 Aligned_cols=258 Identities=28% Similarity=0.504 Sum_probs=213.9
Q ss_pred hCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
..+.+..+.||+|+||+||+|+.. +.+.||||.++..++. ...+|++|++.+..++|||||+++|.|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344556788999999999999753 3467999999988766 678999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc
Q 036879 810 ALVLEYMPNGSLENWMYNKN-------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV 876 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~ 876 (1029)
++|+|||..|+|.+|++... .+++..+.+.||.|||.|++||-+. .+|||||.++|+||++...
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 99999999999999996432 2277889999999999999999954 4999999999999999999
Q ss_pred EEEEccCCceecCC-CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhch
Q 036879 877 ACLSDFGISKLLGD-ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVN 950 (1029)
Q Consensus 877 ~kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 950 (1029)
|||+|||+++..-. ++........-+++|||||.+ ++.+||||||||++||+++ |+.||.+....+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV------- 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV------- 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------
Confidence 99999999986543 333333356678999999984 7889999999999999999 8999876422211
Q ss_pred hccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcc
Q 036879 951 DSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLT 1017 (1029)
Q Consensus 951 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~ 1017 (1029)
++. .. .+...+.|+.||.+++++|..||+..|++||+++||-..|+.....-..
T Consensus 715 ----------Ie~--i~-~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 715 ----------IEC--IR-AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred ----------HHH--HH-cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 111 11 1112556788999999999999999999999999999999988765443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=342.92 Aligned_cols=262 Identities=22% Similarity=0.313 Sum_probs=201.6
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
++|+...++|+|+||+|||++.+ +|+.||||++....+ ...+-..+|++++++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 56888899999999999999976 799999999975543 234557899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
||+..-|+ -+.......+...+..++.|+++|+.|+| +.++|||||||+|||++.+|.+|+||||+|+.+.. ...
T Consensus 82 ~~dhTvL~-eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd 156 (396)
T KOG0593|consen 82 YCDHTVLH-ELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD 156 (396)
T ss_pred ecchHHHH-HHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence 99775554 45667777999999999999999999999 66799999999999999999999999999998863 233
Q ss_pred eeccccCCccccCccC-----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc---cchhhhhhhhhh--
Q 036879 895 TQTQTLATIGYMAPEW-----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS---LHGKIINVVDIN-- 964 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~-----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~d~~-- 964 (1029)
..+..+.|+.|+|||. .|++.+||||+||++.||++|.+.|.+.. +++....+... ...+....+...
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S--DiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS--DIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc--hHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 4566889999999998 47889999999999999999999886632 22211111110 000101111000
Q ss_pred -----hh--hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 036879 965 -----LL--QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 965 -----~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1006 (1029)
+. +...+-...-...+..+.++++.|++.||++|++.++++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 00 0000001111223557899999999999999999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=351.03 Aligned_cols=246 Identities=29% Similarity=0.371 Sum_probs=203.3
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
..++|++.+.||+|+||+||.++.. +++.+|+|++++.. ....+....|..++.+++||.||+++..|++.+..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4567999999999999999999865 78999999998763 3456788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
|+||+.||.|..++. +.+.+++..+..++.+|+.||.||| ++||||||+||+|||+|.+|+++|+|||+++..-..
T Consensus 103 Vld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 999999999999984 5667999999999999999999999 888999999999999999999999999999865443
Q ss_pred CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.. .....+||+.|||||++ ++..+|+||+|+++|||++|.+||.... ...+..... ..
T Consensus 179 ~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~------------~~ 240 (357)
T KOG0598|consen 179 GD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKIL------------KG 240 (357)
T ss_pred CC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHh------------cC
Confidence 33 23347899999999994 7889999999999999999999997631 111111111 11
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCC----CHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERI----NIKEALT 1006 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp----t~~evl~ 1006 (1029)
+ ....+...+.+..+++.+.+..||++|. ++.++.+
T Consensus 241 k---~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 241 K---LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred c---CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 1 1112233577889999999999999996 5555543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=358.30 Aligned_cols=255 Identities=31% Similarity=0.460 Sum_probs=206.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCC--eEEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDH--FKALVL 813 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 813 (1029)
..+|...+.||+|+||.||++... +|...|||.+........+.+.+|+.++++++|||||+++|.....+ ..++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345777889999999999999876 58999999988764444677999999999999999999999865544 689999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC-CCcEEEEccCCceecCC--
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-SMVACLSDFGISKLLGD-- 890 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~-- 890 (1029)
||+++|+|.+++...+..+++..+..+++||++||+||| ++|||||||||+|||++. ++.+||+|||.++....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999999877668999999999999999999999 889999999999999999 79999999999987653
Q ss_pred CCCceeccccCCccccCccCCC-----CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
..........||+.|||||++. .+++||||+||++.||+||++||.+.. . ... ..+..
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-~---~~~-----------~~~~i-- 235 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-E---EAE-----------ALLLI-- 235 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-c---hHH-----------HHHHH--
Confidence 2222233467999999999954 238999999999999999999997630 0 000 00000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
......+..|...+....+++++|+..+|++||||.|++++.-...
T Consensus 236 -g~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 236 -GREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred -hccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 0000112344557888999999999999999999999999875544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=357.10 Aligned_cols=266 Identities=24% Similarity=0.312 Sum_probs=209.6
Q ss_pred hCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC--CeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD--HFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 811 (1029)
.+.|+.+++||+|.||.||+|+. .+|+.||+|++..+. ++...-..+|+.|++++.||||+++.+...+. ...|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 44577788999999999999985 489999999998765 45567788999999999999999999998776 78999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
|+|||++ +|.-++....-.|++.++..+++|++.||+|+| ++||+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999965 888888777778999999999999999999999 889999999999999999999999999999988776
Q ss_pred CCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhc---hhccchhhh--hhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV---NDSLHGKII--NVV 961 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~--~~~ 961 (1029)
.....+..+.|..|+|||.+ |+.++|+||.|||+.||++|++.|++...-++ +.... ......-|. ++.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ-l~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ-LHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH-HHHHHHHhCCCChhccccccCC
Confidence 66567778899999999984 77899999999999999999999987422111 11000 000000011 111
Q ss_pred hhhhhh---hhhhh-hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 DINLLQ---KEDAY-LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 d~~~~~---~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...... .+... .+.-...+....+++..++..||.+|.||.++++.
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 001111 11110 11123457788999999999999999999999863
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=369.52 Aligned_cols=376 Identities=23% Similarity=0.255 Sum_probs=339.7
Q ss_pred cccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecC
Q 036879 268 GLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDM 347 (1029)
Q Consensus 268 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l 347 (1029)
.-+.||+++|+|..+.+..|.++++|+++++..|.++ .||.... ...+|+.|+|.+|.|+..-.+.++.++.|+.|||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~-~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL 156 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGH-ESGHLEKLDLRHNLISSVTSEELSALPALRSLDL 156 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccc-cccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence 4568999999999999999999999999999999996 8997654 4778999999999999999999999999999999
Q ss_pred CCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCc
Q 036879 348 PYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNL 427 (1029)
Q Consensus 348 s~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l 427 (1029)
|.|.|+...-.+ +..-.++++|+|++|.|+..--..|..+.+ |..|.|+.|+|+...+..|.++
T Consensus 157 SrN~is~i~~~s---------------fp~~~ni~~L~La~N~It~l~~~~F~~lns-L~tlkLsrNrittLp~r~Fk~L 220 (873)
T KOG4194|consen 157 SRNLISEIPKPS---------------FPAKVNIKKLNLASNRITTLETGHFDSLNS-LLTLKLSRNRITTLPQRSFKRL 220 (873)
T ss_pred hhchhhcccCCC---------------CCCCCCceEEeeccccccccccccccccch-heeeecccCcccccCHHHhhhc
Confidence 999998543333 334568999999999999888899999885 9999999999998888899999
Q ss_pred CcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeec
Q 036879 428 NNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSL 507 (1029)
Q Consensus 428 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 507 (1029)
++|+.|+|..|+|.-.-.-.|.++++|+.|.|..|.|.....+.|.++.+++.|+|..|++...-..++.++++|+.|+|
T Consensus 221 ~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~l 300 (873)
T KOG4194|consen 221 PKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDL 300 (873)
T ss_pred chhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhcc
Confidence 99999999999999443678999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccccccccccc
Q 036879 508 GFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGS 587 (1029)
Q Consensus 508 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 587 (1029)
|+|.|..+.++.+...++|++|+|++|+|+...+..|..+..|++|+|++|.++..-...|..+++|+.|||++|.|+..
T Consensus 301 S~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~ 380 (873)
T KOG4194|consen 301 SYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWC 380 (873)
T ss_pred chhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEE
Confidence 99999999999999999999999999999999999999999999999999999988788999999999999999999987
Q ss_pred CC---ccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCCCCCCccCcccccCCCCCCCCCC
Q 036879 588 IP---DSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPE 661 (1029)
Q Consensus 588 ~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~~ 661 (1029)
+. ..|.+|++|+.|+|.+|+|..+...+|.+++.|+.|||.+|.+...-|....-..+..+.+..-.++|+|..
T Consensus 381 IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql 457 (873)
T KOG4194|consen 381 IEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQL 457 (873)
T ss_pred EecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccH
Confidence 65 458889999999999999997877899999999999999999998666543333677777888888999953
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=324.93 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=206.4
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
++|...+++|+|.||.||+|++. +|+.||||+++... ++......+|++.++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888899999999999999864 89999999998653 3335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|++ .+|...++++...++..++..++.++.+|++|+| ++.|+||||||.|+|++++|.+||+|||+|+.++....
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~- 156 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR- 156 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-
Confidence 995 6999999888889999999999999999999999 67799999999999999999999999999998876533
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhc------hhccchh------h
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV------NDSLHGK------I 957 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~------~~~~~~~------~ 957 (1029)
..+..+.|..|+|||.+ |+..+||||.|||+.||+-|.+-|.+.. ++.+.. .....++ +
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s----DidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS----DIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc----hHHHHHHHHHHcCCCCcccCcccccc
Confidence 33344789999999984 6677999999999999999988775522 121110 1111111 2
Q ss_pred hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 958 INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 958 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+.++........... .-..++..+.+++.+|+..+|.+|+|++|++++
T Consensus 233 pdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 2222222111111110 112356677999999999999999999999975
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=357.44 Aligned_cols=266 Identities=22% Similarity=0.286 Sum_probs=208.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhH-HHHHHHHHHhcCC-CCceEEEEEEEecCC-eEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLR-SFDAECEILGSIR-HRNLVKIISTCSSDH-FKAL 811 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 811 (1029)
..++|...++||.|.||.||+|+.. +|..||||.+++......+ .=.+|++.++++. |||||++.+.+.+.+ ..|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3567888999999999999999854 7999999999876544322 3468999999997 999999999998887 9999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
|||||+ .+|.+.++.+++.|++..+..|+.||++||+|+| +.|+.|||+||+|||+.....+||+|||+|+.....
T Consensus 88 VfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence 999994 6999999988899999999999999999999999 888999999999999999999999999999987543
Q ss_pred CCceeccccCCccccCccC-----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccc--hhchhccchh------hh
Q 036879 892 TSMTQTQTLATIGYMAPEW-----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLK--SRVNDSLHGK------II 958 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~-----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~------~~ 958 (1029)
...+.++.|+.|+|||+ .|+.+.||||+|||++|+.+-++.|.+...-++-+. +.......+. +.
T Consensus 164 --pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 164 --PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred --CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 34566889999999998 478899999999999999999999876422111110 0000000111 11
Q ss_pred hhhhhhhhhh-hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 959 NVVDINLLQK-EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 959 ~~~d~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..+..++... +..-...-..++.++.++|.+|+++||++||||+|++++
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111111 111111223378899999999999999999999999985
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=361.64 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=211.5
Q ss_pred CCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 738 DGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
..|..-.+||+|+.|.||.|+. .+++.||||.+........+-+.+|+.+|+..+|+|||++++.|...+..++||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4577778899999999999975 478999999999887777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
+||+|.+.+. ...+++.++..|++++++||+||| .+||+|||||.+|||++.+|.+||+|||++..+..... ..
T Consensus 353 ~ggsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 353 EGGSLTDVVT--KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred CCCchhhhhh--cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 9999999874 344899999999999999999999 88899999999999999999999999999988766544 44
Q ss_pred ccccCCccccCccC----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
...+||++|||||+ .|++|+||||||++++||+-|.+||-.. ..+. . + +.+.....+.
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE----~Plr---------A---l--yLIa~ng~P~ 488 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPLR---------A---L--YLIATNGTPK 488 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC----ChHH---------H---H--HHHhhcCCCC
Confidence 56789999999999 4899999999999999999999998531 0000 0 0 1122334444
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...++..+..+.+|+.+|+..||++|++|.|++++
T Consensus 489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 55667789999999999999999999999999984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=355.56 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=208.3
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCe
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHF 808 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 808 (1029)
.+...+|.+++.||+|+|++|++|+.. +++++|||++.+.- +...+.+..|-++|.+| .||.|++++..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 455678999999999999999999864 79999999987652 34456678899999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.|+|+||+++|+|.++|.+ .+.+++...+.++.||..|++||| +.|||||||||+|||+|.++++||+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999999954 477999999999999999999999 889999999999999999999999999999987
Q ss_pred CCCCCc------------eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc
Q 036879 889 GDETSM------------TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS 952 (1029)
Q Consensus 889 ~~~~~~------------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 952 (1029)
.+.... .....+||..|.+||++ .++.+|+|+||||+|+|+.|++||.+.. +...
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--eyli------- 295 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--EYLI------- 295 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--HHHH-------
Confidence 532111 11347899999999994 6789999999999999999999997631 1100
Q ss_pred cchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 953 LHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 953 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
+..+++. ..+.++..++.+.+++++.+..||.+|+|++++.++
T Consensus 296 ----FqkI~~l--------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 ----FQKIQAL--------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----HHHHHHh--------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111111 123345567889999999999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=356.48 Aligned_cols=262 Identities=26% Similarity=0.441 Sum_probs=212.5
Q ss_pred HHHHHHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCe
Q 036879 731 QELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHF 808 (1029)
Q Consensus 731 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 808 (1029)
.++++..+.+.+.+.||+|+||+||+|++.. .||||++.... ....+.|+.|+..+++=+|.||+-+.|||..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4445555667788999999999999999874 59999998764 3456789999999999999999999999998887
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.+|+.+|+|-+|..+++..+..|+..+.+.|++|||+|+.||| .++|||||+|..||++.+++.|||+|||++..-
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 9999999999999999988889999999999999999999999 888999999999999999999999999998643
Q ss_pred CCC-CCceeccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhh
Q 036879 889 GDE-TSMTQTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960 (1029)
Q Consensus 889 ~~~-~~~~~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1029)
..- .........|..-|||||++ +++.+||||||+|+|||++|..||.....+++ +. ++..-+
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-if-mVGrG~------- 609 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-IF-MVGRGY------- 609 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-EE-Eecccc-------
Confidence 211 01111223477889999984 78899999999999999999999974222222 11 111100
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 961 ~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.-++ .......|+.++.+++..||..++++||.+.+++..|+.+..+
T Consensus 610 l~pd-------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 610 LMPD-------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cCcc-------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 0000 1122345788999999999999999999999999999988876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=338.36 Aligned_cols=257 Identities=23% Similarity=0.313 Sum_probs=206.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.+.|+..+.||.|..++||+|+.. .+..||||++..+. ....+.+.+|+..|+.++||||++++..|..+...++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 567899999999999999999864 78999999998664 3346889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC-
Q 036879 815 YMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET- 892 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 892 (1029)
||.+|++.+.++.. ...+++..+..|.+++++||.||| .+|.||||||+.||||+.+|.|||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999765 345999999999999999999999 8889999999999999999999999999876543321
Q ss_pred --CceeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 893 --SMTQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 893 --~~~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
.......+||+.|||||+. |+.|+||||||++.+|+++|..||....+.+.-+.. ..+...-..
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-----Lqn~pp~~~--- 253 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-----LQNDPPTLL--- 253 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-----hcCCCCCcc---
Confidence 1111345899999999992 788999999999999999999999875433221111 111100000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. .....+....+...|.+++..|+.+||++||||++++++
T Consensus 254 t---~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 T---SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred c---ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0 000112223456689999999999999999999999963
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=382.17 Aligned_cols=259 Identities=28% Similarity=0.476 Sum_probs=215.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec--CCc----EEEEEEeecc-cchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS--DGM----QIAVKVFNLE-LEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
....+..+.||+|+||.||.|... +|. .||||.+++. +.+...+|.+|+.+|+.++|||||+++|+|.+.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 344556788999999999999864 343 4899998765 356678999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccC
Q 036879 810 ALVLEYMPNGSLENWMYNK------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFG 883 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg 883 (1029)
++++|||++|+|..|+++. ...+...+.+.++.|||+|+.||+ ++.+|||||.++|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999887 566899999999999999999999 5559999999999999999999999999
Q ss_pred CceecCCCCCceecc-ccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhh
Q 036879 884 ISKLLGDETSMTQTQ-TLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKI 957 (1029)
Q Consensus 884 ~a~~~~~~~~~~~~~-~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 957 (1029)
+|+.+...+.+.... ..-+.+|||||. +++.|+|||||||++||++| |..||......+.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-------------- 913 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-------------- 913 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--------------
Confidence 999544444444333 355789999998 58999999999999999999 7888865321111
Q ss_pred hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccc
Q 036879 958 INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTN 1018 (1029)
Q Consensus 958 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~ 1018 (1029)
+...+ .+.+.+.|..|+..++++|.+||+.+|++||++..+++.+.++.+....+
T Consensus 914 ---~~~~~---~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 914 ---LLDVL---EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred ---HHHHH---hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 11111 12256778899999999999999999999999999999999998766543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=340.90 Aligned_cols=271 Identities=25% Similarity=0.395 Sum_probs=206.8
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcC--CCCceEEEEEEEecCC----eEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSI--RHRNLVKIISTCSSDH----FKA 810 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~ 810 (1029)
.+..+..+.||+|+||.||||++. ++.||||++... ..+.|+.|-+|++.. +|+||++++++-.... .+.
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 344556678999999999999985 489999999743 457889999998765 8999999999876655 788
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCcEEcCCCCCCEEECCCCcEEEEccCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD------HPTPIIHCDLNPSNILLNESMVACLSDFGI 884 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~------~~~givH~Dlk~~Nill~~~~~~kl~Dfg~ 884 (1029)
||+||++.|+|.+|+. ....+|.+..+|+..+++||+|||+. ++++|+|||||.+|||+..|++..|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999995 45689999999999999999999975 567899999999999999999999999999
Q ss_pred ceecCCCCCce-eccccCCccccCccCC-----CC-----CCcchhHHHHHHHHHhcCCCCCCccccccc--ccchhchh
Q 036879 885 SKLLGDETSMT-QTQTLATIGYMAPEWK-----LS-----RKGDVYSYGIILMETFTKKKPTDELFVGEI--SLKSRVND 951 (1029)
Q Consensus 885 a~~~~~~~~~~-~~~~~gt~~y~aPE~~-----~~-----~~~DvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~ 951 (1029)
|.++....... ....+||.+|||||++ +. ++.||||+|.|+|||+++..-++....++. .+...+.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG- 441 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG- 441 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc-
Confidence 98876433222 2236899999999984 11 368999999999999998876532112222 2222222
Q ss_pred ccchhhhhhhhhhhhhhhhhhhHHH---HHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 952 SLHGKIINVVDINLLQKEDAYLTAK---EQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 952 ~~~~~~~~~~d~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
.+..+.++-+....++.++..+.. ......+.+.+..||++||+.|.|+.-|-+++.++...-
T Consensus 442 -~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 442 -NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred -CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 222233333333333332222211 134567899999999999999999999999998887544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=361.40 Aligned_cols=263 Identities=26% Similarity=0.431 Sum_probs=213.4
Q ss_pred HHHHHHhCCCCCCceeccCcceEEEEEEec--CC---cEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEE
Q 036879 731 QELFRATDGFSENNLLGKGSFGSVYKGTLS--DG---MQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIIST 802 (1029)
Q Consensus 731 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~---~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~ 802 (1029)
+.++...++....++||+|+||.||+|++. ++ ..||||..+... ......+.+|+++|+.++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 344445556666789999999999999865 22 238999988632 5567889999999999999999999999
Q ss_pred EecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEcc
Q 036879 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDF 882 (1029)
Q Consensus 803 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Df 882 (1029)
+......|+|||+|.||+|.+|+++....++..++..++.++|.||+||| +++++||||.++|+|++.++.+||+||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999999887778999999999999999999999 777999999999999999999999999
Q ss_pred CCceecCCCCCceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhh
Q 036879 883 GISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKI 957 (1029)
Q Consensus 883 g~a~~~~~~~~~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 957 (1029)
|+++.-. ..........-+..|+|||. +++.++|||||||++||+++ |..||.+.... ....++
T Consensus 307 GLs~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI-------- 375 (474)
T KOG0194|consen 307 GLSRAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKI-------- 375 (474)
T ss_pred ccccCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHH--------
Confidence 9987543 22222223346789999998 58899999999999999999 88898764211 111111
Q ss_pred hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 958 INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 958 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
. ....+...+...+.++..++.+||..+|+.||+|.++.+.++.+.....
T Consensus 376 --------~-~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 376 --------V-KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --------H-hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 0 0111122233567889999999999999999999999999999987655
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=359.58 Aligned_cols=364 Identities=22% Similarity=0.252 Sum_probs=222.5
Q ss_pred eEEcccccccCCCCccccccccccceeecccccc------cccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCccc
Q 036879 230 ILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT------GEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNL 303 (1029)
Q Consensus 230 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 303 (1029)
.||+++|++...-+..|.++++|+++++.+|.++ +...+|+.|+|.+|.|+.+-.+++..++.|+.||||.|.|
T Consensus 82 ~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~i 161 (873)
T KOG4194|consen 82 TLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLI 161 (873)
T ss_pred eeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchh
Confidence 3444444444444444444444444444444443 1223467888888888888888888888899999999988
Q ss_pred CCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccce
Q 036879 304 LGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRK 383 (1029)
Q Consensus 304 ~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~ 383 (1029)
+ ++|..-|..-.++++|+|++|+|+..-...|.++.+|..|.|+.|+++...+. +|+++++|+.
T Consensus 162 s-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r---------------~Fk~L~~L~~ 225 (873)
T KOG4194|consen 162 S-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQR---------------SFKRLPKLES 225 (873)
T ss_pred h-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHH---------------Hhhhcchhhh
Confidence 6 77776665567888999999998887777787777777777777777754332 2456777777
Q ss_pred eeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEecccc
Q 036879 384 LILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNK 463 (1029)
Q Consensus 384 L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 463 (1029)
|+|..|+|.-.---.|.++.. |+.|.|..|.|.....++|..+.++++|+|+.|+++..-.+++.+++.|+.|+||+|.
T Consensus 226 LdLnrN~irive~ltFqgL~S-l~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~Na 304 (873)
T KOG4194|consen 226 LDLNRNRIRIVEGLTFQGLPS-LQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNA 304 (873)
T ss_pred hhccccceeeehhhhhcCchh-hhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhh
Confidence 777777766333344445544 6666666666665555666666666666666666665555566666666666666666
Q ss_pred ccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCcc
Q 036879 464 LQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVE 543 (1029)
Q Consensus 464 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 543 (1029)
|+.+....+...++|++|+|+.|+|+...++.|..+..|++|+|+.|+++.+...+|..+.+|+.|||+.|.|+..+.+
T Consensus 305 I~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED- 383 (873)
T KOG4194|consen 305 IQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED- 383 (873)
T ss_pred hheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec-
Confidence 6666666666566666666666666655555666666666666666666555555555555555555555555532221
Q ss_pred ccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccc
Q 036879 544 IGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLK 623 (1029)
Q Consensus 544 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 623 (1029)
....|.+|++|+.|.|.+|+|+.+...+|.++..|++|||.+|.|-.+-|.+|..+ +|+
T Consensus 384 --------------------aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk 442 (873)
T KOG4194|consen 384 --------------------AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELK 442 (873)
T ss_pred --------------------chhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhh
Confidence 12234445555555555555553333455555555555555555555555555555 555
Q ss_pred eeeccCCCC
Q 036879 624 FLNLSFNGL 632 (1029)
Q Consensus 624 ~L~l~~N~l 632 (1029)
.|-+..-.+
T Consensus 443 ~Lv~nSssf 451 (873)
T KOG4194|consen 443 ELVMNSSSF 451 (873)
T ss_pred hhhhcccce
Confidence 555444333
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=350.30 Aligned_cols=246 Identities=27% Similarity=0.414 Sum_probs=205.3
Q ss_pred CCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 742 ENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 742 ~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
.++-+|.|+.|.||.|+++ ++.||||+++.- -..+++-+++|+||||+.|.|+|.....++||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3567999999999999984 689999987532 23578889999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccC
Q 036879 822 ENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA 901 (1029)
Q Consensus 822 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 901 (1029)
...++ .++.+.......|.++||.|+.||| ...|||||+|.-||||+.+..|||+|||-++...+. .....+.|
T Consensus 200 ~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaG 273 (904)
T KOG4721|consen 200 YEVLK-AGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAG 273 (904)
T ss_pred HHHHh-ccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhh
Confidence 99985 4566777888899999999999999 445999999999999999999999999999876543 23344679
Q ss_pred CccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHH
Q 036879 902 TIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKE 977 (1029)
Q Consensus 902 t~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 977 (1029)
|..|||||++ .++|+||||||||+|||+||..||.+.....+.+.. ....-....|.
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV-------------------GsNsL~LpvPs 334 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV-------------------GSNSLHLPVPS 334 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec-------------------cCCcccccCcc
Confidence 9999999996 578999999999999999999999875433332110 01111234567
Q ss_pred HHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccccc
Q 036879 978 QCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIE 1020 (1029)
Q Consensus 978 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~ 1020 (1029)
.|+..|.-++++||+..|..||++++++.+|+.....+..+..
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~te 377 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTE 377 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccH
Confidence 8999999999999999999999999999999988877765543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=346.80 Aligned_cols=243 Identities=28% Similarity=0.418 Sum_probs=204.0
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
++|.+.+.||+|+||+||||+.+ +.+.||+|.+.+.. +...+.+.+|++|++.++|||||.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999866 78899999998764 3456779999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+.| +|..++. ..+.+++..+..++.++..||.||| +.+|.|||+||+|||++..+++|+||||+|+.+.....
T Consensus 82 ~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~- 155 (808)
T KOG0597|consen 82 YAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS- 155 (808)
T ss_pred hhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCce-
Confidence 9966 9999984 5667999999999999999999999 77899999999999999999999999999998766543
Q ss_pred eeccccCCccccCccC----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
..+...|||.|||||. .++..+|+||+||++||+++|++||... .+.+.+..+ ....
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I------------~~d~-- 216 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSI------------LKDP-- 216 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHH------------hcCC--
Confidence 3445679999999998 4788999999999999999999999652 111111111 1111
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...|...+..+..++...+.+||..|.|-.+++.+
T Consensus 217 --v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 --VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11123567789999999999999999999988864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=352.09 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=203.8
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecc----cc-hhhHHHHHHHHHHhcCC-CCceEEEEEEEecCC
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLE----LE-GTLRSFDAECEILGSIR-HRNLVKIISTCSSDH 807 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 807 (1029)
...++|...+.||+|+||+|+.|... ++..||+|++... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34678999999999999999999765 7899999977654 12 23456778999999998 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC-CcEEEEccCCce
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES-MVACLSDFGISK 886 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~-~~~kl~Dfg~a~ 886 (1029)
..++||||+.||+|.+++.. .+.+.+..+..+++|++.|++|+| ++||+||||||+||+++.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999977 777888999999999999999999 8889999999999999999 999999999998
Q ss_pred ecCCCCCceeccccCCccccCccCC-----C-CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhh
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK-----L-SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~-----~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1029)
... ..........||+.|+|||++ | +.++||||+||++|.|++|+.||++.. .......
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-----~~~l~~k--------- 234 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-----VPNLYRK--------- 234 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-----HHHHHHH---------
Confidence 773 122233446799999999984 2 468999999999999999999998621 1110000
Q ss_pred hhhhhhhhhhhhhHHHHHH-HHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 961 VDINLLQKEDAYLTAKEQC-VSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 961 ~d~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
........|... +.++..++.+|+..+|.+|+|+.|++++
T Consensus 235 -------i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 235 -------IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred -------HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 011112223334 7788999999999999999999999953
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=343.75 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=206.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
...|...+.||+|+||.||+|.+. +++.||+|++..+. +...+.+++|+.++.+++++||.++|+.|..+...+++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 345777789999999999999865 78999999998764 5567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
||.||++.+.+. .+..+++..+..+++++..|+.|+| ..+.+|||||+.||++..+|.+|++|||.+.........
T Consensus 92 y~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 92 YCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 999999999884 3444588888899999999999999 777999999999999999999999999999887655444
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
. ...+||+.|||||++ |+.|+||||||++.+||++|.+|+....+....+ ... +..
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------lIp------------k~~- 227 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------LIP------------KSA- 227 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------ecc------------CCC-
Confidence 4 568899999999995 7889999999999999999999997754321111 100 000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+.....++..+.+++..|++++|+.||+|.+++++
T Consensus 228 -PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 228 -PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 111122567889999999999999999999999974
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=361.80 Aligned_cols=253 Identities=26% Similarity=0.507 Sum_probs=212.6
Q ss_pred CCCCCceeccCcceEEEEEEec----CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
...+.++||.|.||+||+|+++ ....||||.++... +...+.|..|+.||.+++||||+++.|........++|+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3456789999999999999976 24579999998654 455678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
|||++|+|+.|++++.+.|.+.+...|.++||.|+.||- ++++|||||.++|||++.+...|++|||+++.+.++..
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 999999999999999999999999999999999999999 88899999999999999999999999999998765442
Q ss_pred ceec--cccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 894 MTQT--QTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 894 ~~~~--~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
...+ ...-+++|.|||.+ ++.+|||||||++|||.++ |..||-+ |-++.+ +. .+.
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd----------mSNQdV-------Ik-aIe 848 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD----------MSNQDV-------IK-AIE 848 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc----------cchHHH-------HH-HHH
Confidence 2222 22346789999984 6889999999999999887 7777533 222111 11 111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.+.+.+.|.+||.++.++|..||++|=.+||++.+++..|.++.+.
T Consensus 849 --~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 849 --QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred --hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 1223556778999999999999999999999999999999998753
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=317.02 Aligned_cols=233 Identities=25% Similarity=0.325 Sum_probs=196.9
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|+..+.+|.|+||+|..++.+ +|..+|+|++.+..- ...+...+|..+++.+.||.++++++.+.+....|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 456888999999999999999976 788999999987642 2345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||++||.|..+++ +.+++++..+..++.||+.|++||| +.+|++||+||+|||+|.+|.+||+|||+|++.....
T Consensus 123 meyv~GGElFS~Lr-k~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT 198 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR-KSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT 198 (355)
T ss_pred EeccCCccHHHHHH-hcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCcE
Confidence 99999999999995 4567999999999999999999999 7779999999999999999999999999999875542
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
-..+|||.|+|||++ +++++|.|||||++|||+.|.+||....... .... .
T Consensus 199 ----~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-----iY~K----------------I 253 (355)
T KOG0616|consen 199 ----WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-----IYEK----------------I 253 (355)
T ss_pred ----EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-----HHHH----------------H
Confidence 235699999999996 5678999999999999999999998643210 0111 1
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCC
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEER 998 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 998 (1029)
.......|...+.++.+++...++.|-.+|
T Consensus 254 ~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 254 LEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 112234456678889999999999998888
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=381.80 Aligned_cols=501 Identities=29% Similarity=0.375 Sum_probs=333.6
Q ss_pred EecccccccccCCccCCCCcCCCeEeccCcccccCCccc-cccccCCceeecccccccCCCCCCcCCCCCccceeccccc
Q 036879 53 LNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQ-LSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGN 131 (1029)
Q Consensus 53 l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N 131 (1029)
+|+++.++. -||..+..-..++.|+++.|-+- ..|-+ +.+.-+|+.||+++|++. ..|..+..+++|+.|.++.|
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~--~fp~~it~l~~L~~ln~s~n 78 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS--SFPIQITLLSHLRQLNLSRN 78 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc--cCCchhhhHHHHhhcccchh
Confidence 445555554 56666655555777777777665 33322 333444777777777776 35666777777777777777
Q ss_pred cccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhcccc
Q 036879 132 SFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAY 211 (1029)
Q Consensus 132 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~ 211 (1029)
.+. .+|.+.+++.+|++|.|.+|++. ..|.++..+.+|++|++|.|++...++-+..+.. ..++..++
T Consensus 79 ~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~~Pl~i~~lt~----------~~~~~~s~ 146 (1081)
T KOG0618|consen 79 YIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGPIPLVIEVLTA----------EEELAASN 146 (1081)
T ss_pred hHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCCCchhHHhhhH----------HHHHhhhc
Confidence 766 66677777777777777777776 6777777777777777777777655544433322 23344444
Q ss_pred ccccCCCCcccccccccceEEcccccccCCCCccccccccccceeecccccc----cccCcccEEEccCCcccCCCCCCc
Q 036879 212 NQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT----GEIQGLQVLALSSNRLTGVIPPEI 287 (1029)
Q Consensus 212 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~----~~l~~L~~L~Ls~N~l~~~~p~~~ 287 (1029)
|... ..++... .+.++|..|.+.+.++.++.+++. .|+|.+|++. ..+.+|++|....|+++.. .
T Consensus 147 N~~~----~~lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~dls~~~~l~~l~c~rn~ls~l----~ 215 (1081)
T KOG0618|consen 147 NEKI----QRLGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVLDLSNLANLEVLHCERNQLSEL----E 215 (1081)
T ss_pred chhh----hhhcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhhhhhhhhccchhhhhhhhcccceE----E
Confidence 4111 1122222 566666666666666666666554 3444444333 1122333444444444311 1
Q ss_pred ccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCc
Q 036879 288 INISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYD 367 (1029)
Q Consensus 288 ~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~ 367 (1029)
...++|+.|+.++|.+....+... -.+|+++++++|++++ +|++++.
T Consensus 216 ~~g~~l~~L~a~~n~l~~~~~~p~---p~nl~~~dis~n~l~~-lp~wi~~----------------------------- 262 (1081)
T KOG0618|consen 216 ISGPSLTALYADHNPLTTLDVHPV---PLNLQYLDISHNNLSN-LPEWIGA----------------------------- 262 (1081)
T ss_pred ecCcchheeeeccCcceeeccccc---cccceeeecchhhhhc-chHHHHh-----------------------------
Confidence 123344555555555442222221 1344555555555542 2244444
Q ss_pred ccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCcccccccccc
Q 036879 368 ELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKA 447 (1029)
Q Consensus 368 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~ 447 (1029)
+.+|+.|+..+|+++ .+|..+..... |+.|.+..|.+. -+|....++++|++|+|..|+|....+..
T Consensus 263 ----------~~nle~l~~n~N~l~-~lp~ri~~~~~-L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~ 329 (1081)
T KOG0618|consen 263 ----------CANLEALNANHNRLV-ALPLRISRITS-LVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNF 329 (1081)
T ss_pred ----------cccceEecccchhHH-hhHHHHhhhhh-HHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHH
Confidence 455555555555553 55666666555 778888888887 66777888999999999999998444433
Q ss_pred ccCCCC-CCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCC
Q 036879 448 IGRLQK-LQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDI 526 (1029)
Q Consensus 448 ~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 526 (1029)
|.-+.. |..|+.+.|++...+...=.....|++|++.+|.++...-..+.+.++|+.|+|++|+|..++...+.++..|
T Consensus 330 l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~L 409 (1081)
T KOG0618|consen 330 LAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEEL 409 (1081)
T ss_pred HhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHh
Confidence 444443 7888889998876654444456789999999999998888889999999999999999998888889999999
Q ss_pred cEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccC-CccccCCCCCCEEeCcC
Q 036879 527 LNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI-PDSLGGLTSLNFLDMSS 605 (1029)
Q Consensus 527 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~ 605 (1029)
++|+||||+++ .+|..+.++..|++|...+|++. ..| .+..++.|+.+|+|.|.|+... |.... .++|++|||++
T Consensus 410 eeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSG 485 (1081)
T KOG0618|consen 410 EELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSG 485 (1081)
T ss_pred HHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC-CcccceeeccC
Confidence 99999999999 78899999999999999999998 677 8899999999999999998543 33333 38999999999
Q ss_pred CcccCcCchhhhcccccceeeccCC
Q 036879 606 NNLSGEIPNSLKALSLLKFLNLSFN 630 (1029)
Q Consensus 606 N~l~~~~~~~~~~l~~L~~L~l~~N 630 (1029)
|.-....-..|..+..+...+++-|
T Consensus 486 N~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 486 NTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred CcccccchhhhHHhhhhhheecccC
Confidence 9744355667777888888877776
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=349.22 Aligned_cols=246 Identities=24% Similarity=0.355 Sum_probs=208.9
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.+.|+.++.||.|+-|.|..|++. +|+.+|||++.+.. ......+.+|+-+|+-+.||||+++|+.++...+.|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 355788899999999999999865 89999999998763 22356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
.||+++|.|.+|+.+ ++++++.++.++++||..|+.|+|..+ |+|||+||+|+|+|..+.+||+|||+|..-..+
T Consensus 91 lEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred EEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 999999999999954 556889999999999999999999555 999999999999999999999999999764332
Q ss_pred CceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
... ...+|++.|.|||++ .+.++||||.|||+|.++||+.||++. .++.-+.+
T Consensus 166 klL-eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---------------------Nir~LLlK 223 (786)
T KOG0588|consen 166 KLL-ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---------------------NIRVLLLK 223 (786)
T ss_pred ccc-cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---------------------cHHHHHHH
Confidence 222 346799999999995 466899999999999999999999852 12222333
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
......+.|...+.++.+++++|+..||++|.|++||.+|-.
T Consensus 224 V~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 224 VQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 344445566778899999999999999999999999999753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=353.74 Aligned_cols=256 Identities=24% Similarity=0.416 Sum_probs=200.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEe------cCCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecC-
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL------SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSD- 806 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 806 (1029)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456799999999999999999974 235789999987543 23356789999999999 899999999988764
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC---------------------------------------------------------
Q 036879 807 HFKALVLEYMPNGSLENWMYNKN--------------------------------------------------------- 829 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 829 (1029)
+..++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46789999999999999986532
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc-eeccccCCcc
Q 036879 830 ----RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM-TQTQTLATIG 904 (1029)
Q Consensus 830 ----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~ 904 (1029)
..+++..+..++.||++||+||| ++||+||||||+||+++.++.+||+|||+++........ ......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 23677888999999999999999 778999999999999999999999999999865432221 1223346788
Q ss_pred ccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHH
Q 036879 905 YMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQC 979 (1029)
Q Consensus 905 y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 979 (1029)
|+|||++ ++.++|||||||++|||++ |+.||......+. +.. . ..+.. ....+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~--------~---~~~~~-------~~~~~~~~ 302 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQ--------R---LKDGT-------RMRAPENA 302 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHH--------H---HhcCC-------CCCCCCCC
Confidence 9999974 6789999999999999997 9999875321110 000 0 00000 01112345
Q ss_pred HHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 980 VSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 980 ~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 6778999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=337.62 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=201.0
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
+...++|+.+..||+|+||.||.|+-+ +|..+|+|++++.. ....+.+..|-.+|....+|.||+++..|++.+..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 346688999999999999999999865 79999999998764 45567788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
||||||++||++...|. ..+.+++..+..++.+++-|++.+| +.|+|||||||+|+|||..|++||+|||++.-+.
T Consensus 217 YLiMEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999985 4567889999999999999999999 8889999999999999999999999999985321
Q ss_pred C----------------------CCCc-----ee-------------------ccccCCccccCccCC----CCCCcchh
Q 036879 890 D----------------------ETSM-----TQ-------------------TQTLATIGYMAPEWK----LSRKGDVY 919 (1029)
Q Consensus 890 ~----------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~----~~~~~Dvw 919 (1029)
. .... .. -..+|||.|||||++ ++..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 00 114799999999996 56789999
Q ss_pred HHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCC
Q 036879 920 SYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI 999 (1029)
Q Consensus 920 SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 999 (1029)
|+|||||||+.|.+||....+.+ .+..++.++.. -..+....++.++.++|.+|+. ||+.|.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~-------------T~rkI~nwr~~----l~fP~~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQE-------------TYRKIVNWRET----LKFPEEVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHH-------------HHHHHHHHhhh----ccCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence 99999999999999997632211 12222222110 0111122345789999999999 999998
Q ss_pred ---CHHHHHH
Q 036879 1000 ---NIKEALT 1006 (1029)
Q Consensus 1000 ---t~~evl~ 1006 (1029)
.++||.+
T Consensus 435 G~~G~~EIK~ 444 (550)
T KOG0605|consen 435 GSKGAEEIKK 444 (550)
T ss_pred CcccHHHHhc
Confidence 5777765
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=319.45 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=202.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEec--CCeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSS--DHFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 811 (1029)
.+.|++++.|++|.||.||+|+++ +++.||+|+++.+.+ +-.-...+|+.++.+++|||||.+-.+... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 355888999999999999999976 789999999987643 233456789999999999999999888754 467899
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
|||||++ +|...+..-..+|...++..++.|+++|++||| ...|+|||+||+|+|++..|.+||+|||+|+.++..
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999975 899999877889999999999999999999999 666999999999999999999999999999998765
Q ss_pred CCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh----ccchhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND----SLHGKIINVVD 962 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~d 962 (1029)
. ...+..+.|..|+|||.+ |+.+.|+||+|||+.||+++++-|.+. ++++-.+.+-. .....|..+.+
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~--sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK--SEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC--chHHHHHHHHHHhCCCccccCCCccc
Confidence 3 345567889999999984 677899999999999999999988763 22211111100 00011111111
Q ss_pred hh------hhhhhhh--hhHHHHH-HHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 963 IN------LLQKEDA--YLTAKEQ-CVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 963 ~~------~~~~~~~--~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.. +.+.+.. +..++.. .+..-.+++..++..||.+|.||.|.+++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11 0000000 0011111 34677899999999999999999999875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=326.00 Aligned_cols=269 Identities=22% Similarity=0.274 Sum_probs=204.2
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeec--ccchhhHHHHHHHHHHhcCCCCceEEEEEEEec-----
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNL--ELEGTLRSFDAECEILGSIRHRNLVKIISTCSS----- 805 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 805 (1029)
+.....|...+.||+|+||.|+.|... +|+.||||++.. ......+...+|+++++.++|+||+.+.+.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 345566777889999999999999876 799999999983 344556788999999999999999999999855
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 806 DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 806 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
....|+|+|+| +.+|.+.++ .++.++......++.|+++||.|+| +.+|+|||+||+|++++.+..+||+|||+|
T Consensus 98 f~DvYiV~elM-etDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred cceeEEehhHH-hhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence 46789999999 678988874 4455889999999999999999999 888999999999999999999999999999
Q ss_pred eecCCCC-CceeccccCCccccCccC-----CCCCCcchhHHHHHHHHHhcCCCCCCcccc-cccccchhchhccchh-h
Q 036879 886 KLLGDET-SMTQTQTLATIGYMAPEW-----KLSRKGDVYSYGIILMETFTKKKPTDELFV-GEISLKSRVNDSLHGK-I 957 (1029)
Q Consensus 886 ~~~~~~~-~~~~~~~~gt~~y~aPE~-----~~~~~~DvwSlGvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~-~ 957 (1029)
+...... ...-+..+.|..|+|||. .++.+.||||.|||+.||++|++-|.+... .+..+...+-....++ +
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 9875321 112255788999999998 378899999999999999999999876321 1111111111111111 1
Q ss_pred --------hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 958 --------INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 958 --------~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+.........+....-+...+.+.+++.+|+..||.+|+|++|++++
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111111111111111122456788999999999999999999999985
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=340.37 Aligned_cols=251 Identities=25% Similarity=0.447 Sum_probs=216.0
Q ss_pred CCCCCceeccCcceEEEEEEecC---C--cEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLSD---G--MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~~---~--~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.....++||.|-||.||+|...+ | -.||||..+.+. ....+.|.+|+.+|+.++|||||+++|+|.+. ..++|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 34556789999999999998642 3 358999988753 44578899999999999999999999999865 46899
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
||.++-|.|..|++.....++......++.||+.||+||| ++.+|||||..+|||+.+...+|++|||+++.+.++.
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999999999999999999999999999999999 7789999999999999999999999999999998888
Q ss_pred CceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.+..+...-++.|||||. .++.+||||.|||+|||++. |..||++....+.-. .-
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~--------------------~i 605 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG--------------------HI 605 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE--------------------Ee
Confidence 877777777899999998 47889999999999999887 899998753332211 11
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
..+.+.+.|+.|++.++.++.+||.++|.+||++.|+...|+++..
T Consensus 606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1223456678899999999999999999999999999999988775
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.17 Aligned_cols=262 Identities=22% Similarity=0.327 Sum_probs=207.8
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++.|++.+.||+|+|+.||+.... +|+.+|+|++.... ....+.+.+|++|.+.++|||||+++..+.+.+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456888889999999999998754 89999999886542 335678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC---CCCcEEEEccCCceecCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN---ESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~---~~~~~kl~Dfg~a~~~~~ 890 (1029)
|+|.|++|..-|.+. .-+++..+...++||++|+.|+| ..+|||||+||+|+++. ...-+|++|||+|...+.
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999999997655332 45788889999999999999999 78899999999999995 455799999999998873
Q ss_pred CCCceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
+ ......+|||+|||||+ .++..+|||+.||++|-++.|++||.+.... +.....+.
T Consensus 166 g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-----------------rlye~I~~ 226 (355)
T KOG0033|consen 166 G--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----------------RLYEQIKA 226 (355)
T ss_pred c--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-----------------HHHHHHhc
Confidence 3 23345789999999999 4889999999999999999999998652111 01111111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcccccC
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIEN 1021 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~~ 1021 (1029)
..+....+.+...+++..+++++|+..||.+|.|+.|++.+-+...++...+.-+
T Consensus 227 g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H 281 (355)
T KOG0033|consen 227 GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIH 281 (355)
T ss_pred cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhh
Confidence 1222222223445778999999999999999999999998766655544444333
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=345.40 Aligned_cols=241 Identities=25% Similarity=0.399 Sum_probs=205.7
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCHH
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLE 822 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 822 (1029)
-++|+|.||+||.|++. +...+|||.+..........+.+|+...++++|.|||+++|.+.+++..-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 36999999999999975 56778999998887777888999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC-CCCcEEEEccCCceecCCCCCceeccc
Q 036879 823 NWMYNKNRSF--DILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN-ESMVACLSDFGISKLLGDETSMTQTQT 899 (1029)
Q Consensus 823 ~~l~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 899 (1029)
+.++.+-+++ .+.++-.+.+||++||.|||+++ |||||||.+|||++ -.|.+||+|||-++++..-... ....
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-TETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcc-cccc
Confidence 9999888877 77888889999999999999665 99999999999996 7899999999999887544333 3346
Q ss_pred cCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhh
Q 036879 900 LATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYL 973 (1029)
Q Consensus 900 ~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 973 (1029)
.||..|||||++ |++++|||||||++.||.||++||.+....+. .++.- +-+...+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------------AMFkV---GmyKvHP 798 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------------AMFKV---GMYKVHP 798 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------------hhhhh---cceecCC
Confidence 699999999995 78899999999999999999999977432221 11111 1122234
Q ss_pred HHHHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 036879 974 TAKEQCVSSVLSLAMQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 974 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1006 (1029)
+.|++.+.+...+|.+|+.+||..||+|+++++
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 567888999999999999999999999999986
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.79 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=198.7
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--------------hhhHHHHHHHHHHhcCCCCceEEE
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--------------GTLRSFDAECEILGSIRHRNLVKI 799 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l 799 (1029)
...+.|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+.+.+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 45678999999999999999999976 799999999975321 123578999999999999999999
Q ss_pred EEEEec--CCeEEEEEeccCCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc
Q 036879 800 ISTCSS--DHFKALVLEYMPNGSLENWMYNKNRS-FDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV 876 (1029)
Q Consensus 800 ~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~ 876 (1029)
+++..+ .+..|+|+|||..|.+... ...+. +++.+++.+++++..||+||| .+|||||||||+|+|++++|+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence 999976 4678999999998887542 22334 889999999999999999999 667999999999999999999
Q ss_pred EEEEccCCceecCCCC----CceeccccCCccccCccCC--------CCCCcchhHHHHHHHHHhcCCCCCCcccccccc
Q 036879 877 ACLSDFGISKLLGDET----SMTQTQTLATIGYMAPEWK--------LSRKGDVYSYGIILMETFTKKKPTDELFVGEIS 944 (1029)
Q Consensus 877 ~kl~Dfg~a~~~~~~~----~~~~~~~~gt~~y~aPE~~--------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~ 944 (1029)
+||+|||.+..+.... ...-...+|||.|+|||.. .+.+.||||+||++|.|+.|+.||.+... ..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--~~ 326 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--LE 326 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--HH
Confidence 9999999998763221 1111236899999999983 35678999999999999999999965311 10
Q ss_pred cchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 945 LKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 945 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
-+...+...+. .+..++....+.++|.+|+++||+.|.+..+|..+..--+
T Consensus 327 -----------l~~KIvn~pL~------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 327 -----------LFDKIVNDPLE------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred -----------HHHHHhcCccc------CCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 01111111110 0111234677899999999999999999999998875443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=335.22 Aligned_cols=243 Identities=24% Similarity=0.350 Sum_probs=195.8
Q ss_pred CceeccCcceEEEEEEecCCcEEEEEEeecccchh---hHHHHHHHHHHhcCCCCceEEEEEEEec----CCeEEEEEec
Q 036879 743 NNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGT---LRSFDAECEILGSIRHRNLVKIISTCSS----DHFKALVLEY 815 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~ 815 (1029)
...||+|++|.||+|++ +|+.||||.++...... .+.+.+|++++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 68999999987653322 4678899999999999999999999876 3467899999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++|+|.+++.. .+.+++.....++.|++.|++|||.. .+++||||||+||+++.++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 104 CTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 999999999865 45688999999999999999999932 368899999999999999999999999998654321
Q ss_pred eccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
....++..|+|||+. ++.++|||||||++|||++|+.||......+. .+.......
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-----------------~~~i~~~~~ 239 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-----------------YDLIINKNN 239 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-----------------HHHHHhcCC
Confidence 224588999999984 46799999999999999999999975321110 000000000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
....+..++..+.+++.+||+.||++|||++|+++.|+++.
T Consensus 240 --~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 --SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 01112245778999999999999999999999999998875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=325.98 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=196.6
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCC-----eEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDH-----FKAL 811 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 811 (1029)
-.|+..+.+|+|+||.||+|+.. ++..||||++-.+.+ --.+|+++|+.++|||||++..+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 34666789999999999999865 679999998865532 2347999999999999999999886532 2358
Q ss_pred EEeccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC-CcEEEEccCCcee
Q 036879 812 VLEYMPNGSLENWMYNK---NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES-MVACLSDFGISKL 887 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~-~~~kl~Dfg~a~~ 887 (1029)
||||++ .+|.++++.. +..++...+.-++.||.+|++||| +.||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 999995 5999988642 667888899999999999999999 6789999999999999965 9999999999998
Q ss_pred cCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccch---hchhccchhhhh
Q 036879 888 LGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKS---RVNDSLHGKIIN 959 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~ 959 (1029)
+..++.. ....+|+.|+|||.+ |+.+.||||.|||+.||+-|++-|.+.... .++.. .......+++..
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHHHhCCCCHHHHhh
Confidence 8655433 346799999999985 567899999999999999999998763221 11111 111111111111
Q ss_pred hhh-------hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH--HHHhHH
Q 036879 960 VVD-------INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK--LLKIRN 1013 (1029)
Q Consensus 960 ~~d-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~i~~ 1013 (1029)
+-- +.+...+..+ -.....+++..+++.+++..+|.+|.++.|++++ +.++++
T Consensus 253 mn~~y~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cCcccccccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 111 1111111100 0123457789999999999999999999999963 444443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=303.51 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=207.8
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
+.++|++.+.||+|.||.||.|+.+ ++-.||+|++.+.. .+...++.+|++|.+.++||||.+++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4577999999999999999999865 78889999987652 4456789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 812 VLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
++||..+|++...++.. ...+++.....++.|+|.|+.|+| .+.|+||||||+|+|++..+.+||+|||.+...+.
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 99999999999999744 456999999999999999999999 77799999999999999999999999999976542
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.......||..|.|||+. .+..+|+|++|++.||++.|.+||+... ....+. ...
T Consensus 177 ---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYk------------rI~----- 235 (281)
T KOG0580|consen 177 ---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYK------------RIR----- 235 (281)
T ss_pred ---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHH------------HHH-----
Confidence 233446799999999994 6778999999999999999999997632 111111 111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
......|...+.++.++|..|+..+|.+|.+..|++++-..
T Consensus 236 ---k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 236 ---KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred ---HccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 11122234567789999999999999999999999987643
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=303.69 Aligned_cols=259 Identities=23% Similarity=0.311 Sum_probs=207.0
Q ss_pred HHhCCCCCCceeccCcceEEEEEE-ecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecC-----Ce
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSD-----HF 808 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 808 (1029)
...++|.+.+.+|+|||+.||.++ ..++..+|+|++........+..++|++..++++||||++++++...+ .+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 456789999999999999999998 458899999999887767778899999999999999999999887433 45
Q ss_pred EEEEEeccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 809 KALVLEYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
.|+++.|+..|+|.+++.. ++..+++.+++.|+.++++||++||+.. .+++||||||.||++++++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999864 3446999999999999999999999442 24999999999999999999999999998
Q ss_pred eecCCCCCcee--------ccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch
Q 036879 886 KLLGDETSMTQ--------TQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN 950 (1029)
Q Consensus 886 ~~~~~~~~~~~--------~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 950 (1029)
....-...... ....+|..|+|||.+ .++++|||||||++|+|+.|..||+........+.--+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 76532211110 123589999999984 578999999999999999999999864332222211110
Q ss_pred hccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 951 DSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 951 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
...+ ..+....++..+.++++.|++.||.+||++.+++.+++.+
T Consensus 257 -----------n~q~------s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 257 -----------NAQI------SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----------cccc------ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0000 0011112678899999999999999999999999998765
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.74 Aligned_cols=247 Identities=28% Similarity=0.370 Sum_probs=209.8
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCe-EEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHF-KALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV 812 (1029)
.++|+..+.+|+|+||.++.++.+ ++..+|+|.+.... +...+...+|+.++++++|||||.+.+.|.+++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357889999999999999999876 78899999988654 3345578899999999999999999999999888 8999
Q ss_pred EeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 813 LEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
|+|++||++.+.+.+.+ ..+++..+..|+.|++.|+.||| +..|+|||||+.||+++.++.|||+|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999987665 67999999999999999999999 555999999999999999999999999999998776
Q ss_pred CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.... ...+||+.||+||.. |+.|+||||+||++|||++-+++|.+...... +. .....
T Consensus 160 ~~~a-~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-----i~------------ki~~~ 221 (426)
T KOG0589|consen 160 DSLA-STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-----IL------------KINRG 221 (426)
T ss_pred hhhh-heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-----HH------------HHhhc
Confidence 5333 457899999999984 78899999999999999999999986421111 11 11111
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. ..+.+..++.++..++..|++.+|+.||++.+++.+
T Consensus 222 ~---~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 L---YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred c---CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 234456678999999999999999999999999986
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=331.68 Aligned_cols=252 Identities=24% Similarity=0.391 Sum_probs=202.0
Q ss_pred hCCCCCCceeccCcceEEEEEEec----CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
..+|++.+.||+|+||.||+|.+. .+..||+|.++.... ...+.+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999753 367899999886532 334678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++|+|.+++......+++..++.++.|++.|++||| +.|++||||||+||+++.++.+|++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999776667899999999999999999999 778999999999999999999999999987654332
Q ss_pred CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.........++..|+|||.. ++.++|||||||++||+++ |+.||......+ ... ...+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~-----------~~~~~--- 224 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIK-----------AVEDG--- 224 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH-----------HHHCC---
Confidence 22222223456789999973 6779999999999999775 999986531110 000 00000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
...+.+..++..+.+++.+||+.+|++||+++++.+.|+++
T Consensus 225 ----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 ----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00112345677899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=318.63 Aligned_cols=245 Identities=25% Similarity=0.356 Sum_probs=210.1
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
|.+.+++|+|+||.||+|.++ +|+.||||.+..+ ....++.+|+.+|++++.|+||++||.|-.....++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 566788999999999999876 7999999997644 5567889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|+..+.++..++++.+.++..+++..++||+||| ...-+|||||+.|||++-+|.+|++|||.|..+.+... ....
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRNT 188 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRNT 188 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhCc
Confidence 9999999999999999999999999999999999 44589999999999999999999999999987654322 3345
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..||+.|||||++ |..++||||+|++..||..|++||.+..+...-+ .+...+.+...
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------------------MIPT~PPPTF~ 250 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------------------MIPTKPPPTFK 250 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------------------eccCCCCCCCC
Confidence 7899999999994 7889999999999999999999998754332211 01223334455
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.|+.++.++.++++.|+-+.|++|.||-+++++-
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 6788999999999999999999999999998753
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=318.63 Aligned_cols=269 Identities=24% Similarity=0.319 Sum_probs=203.2
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCc-eEEEEEEEecCC------
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRN-LVKIISTCSSDH------ 807 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 807 (1029)
..|+..++||+|+||+||+|+.. +|+.||+|++....+ +......+|+.+++.++|+| ||++++++.+..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 44666788999999999999865 899999999986643 45667789999999999999 999999998876
Q ss_pred eEEEEEeccCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCC
Q 036879 808 FKALVLEYMPNGSLENWMYNKN---RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGI 884 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~ 884 (1029)
..++|+||+ .-+|..|+.... ...+...+..+++||++|++||| +++|+||||||+||+++++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence 789999999 569999997765 45788899999999999999999 88899999999999999999999999999
Q ss_pred ceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccc--cchhchhccchhh
Q 036879 885 SKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEIS--LKSRVNDSLHGKI 957 (1029)
Q Consensus 885 a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~ 957 (1029)
|+.+.... ...+..++|..|+|||++ |+...||||+||+++||+++++-|.+...-+.. +-..........|
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 99765332 234567899999999994 567899999999999999999988763221110 0000011111112
Q ss_pred hhhh---hhhh-hhhhhhhhHHHHHH---HHHHHHHHHHcccccccCCCCHHHHHHH--HHHh
Q 036879 958 INVV---DINL-LQKEDAYLTAKEQC---VSSVLSLAMQCTRESAEERINIKEALTK--LLKI 1011 (1029)
Q Consensus 958 ~~~~---d~~~-~~~~~~~~~~~~~~---~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~i 1011 (1029)
..+. +... .............. .....+++.+|++.+|.+|.|+++++++ +..+
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 2211 1111 00000011111111 2478999999999999999999999987 5444
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=333.07 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=197.7
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.|+..+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+++++.++|++|+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677899999999999999864 79999999987543 2223467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 815 YMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
|+++|+|.+++... ...+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999999887643 346899999999999999999999 78899999999999999999999999999987643322
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
.....|+..|+|||++ ++.++||||+||++|||++|+.||........ .+.++.....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--------------~~~~~~~~~~-- 219 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--------------REEVDRRVKE-- 219 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--------------HHHHHHHhhc--
Confidence 2335689999999984 67789999999999999999999975321100 0001110100
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERIN-----IKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~~ 1007 (1029)
.....+...+..+.+++.+||+.||++||+ ++|++++
T Consensus 220 -~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 -DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 001112235677899999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=332.77 Aligned_cols=260 Identities=22% Similarity=0.398 Sum_probs=213.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
+.....+.++||+|-||+|..+....+..||||+++..+.. ....|.+|+++|.+++|||||+++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 44556778999999999999999988899999999987644 45889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC-
Q 036879 815 YMPNGSLENWMYNKNRS-FDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET- 892 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 892 (1029)
|+++|+|.+|+.++..+ .....-.+|+.|||.|++||. +-.+||||+.++|+|+|.++++||+|||+++-+-.++
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999999877543 366677789999999999999 5559999999999999999999999999998554443
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc--CCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT--KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.......+-+++|||||.+ ++.+||||+|||++||+++ ...||.+..++ ...+....+.+..
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e----------~vven~~~~~~~~-- 760 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE----------QVVENAGEFFRDQ-- 760 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH----------HHHHhhhhhcCCC--
Confidence 3344456778999999984 7889999999999999876 56777653222 2222222333221
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
....+...|..|+..+.++|..||+.+.++||+++++...|.+.
T Consensus 761 -~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 -GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12223445678999999999999999999999999999988753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=333.76 Aligned_cols=266 Identities=19% Similarity=0.223 Sum_probs=199.6
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999986 68899999987543 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|++++.+..+. .....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99987766543 44567899999999999999999999 778999999999999999999999999999876443332
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccc--cchhchhccchhhh---------h
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEIS--LKSRVNDSLHGKII---------N 959 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~---------~ 959 (1029)
......|++.|+|||++ ++.++||||+||++|||++|++||......+.. ............+. .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 33345689999999973 577899999999999999999999753211110 00000000000000 0
Q ss_pred hhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 960 VVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 960 ~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+................+.++.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000011122356789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=335.34 Aligned_cols=257 Identities=23% Similarity=0.426 Sum_probs=197.0
Q ss_pred hCCCCCCceeccCcceEEEEEEecC-----------------CcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSD-----------------GMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVK 798 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~-----------------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 798 (1029)
.++|++.+.||+|+||.||+|.+.+ +..||+|.+..... .....+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999999997532 34699999876533 33567899999999999999999
Q ss_pred EEEEEecCCeEEEEEeccCCCCHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 036879 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKN------------------RSFDILQRLNMVIDVASALEYLHYDHPTPII 860 (1029)
Q Consensus 799 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~giv 860 (1029)
+++++.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 9999999999999999999999999985422 23677889999999999999999 77899
Q ss_pred EcCCCCCCEEECCCCcEEEEccCCceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc--CCC
Q 036879 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT--KKK 933 (1029)
Q Consensus 861 H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt--g~~ 933 (1029)
||||||+||+++.++.+||+|||+++........ ......++..|+|||++ ++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433221 12233457889999973 5779999999999999987 556
Q ss_pred CCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 934 PTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 934 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
||......+ ....+. ...... ........+..++..+.+++.+||+.+|++|||+.|+.+.|+
T Consensus 241 p~~~~~~~~--~~~~~~--------~~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQ--VIENAG--------EFFRDQ---GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHH--HHHHHH--------HHhhhc---cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 776432111 000000 000000 000001112345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=368.11 Aligned_cols=483 Identities=29% Similarity=0.369 Sum_probs=380.8
Q ss_pred eEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCC
Q 036879 76 LLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFN 155 (1029)
Q Consensus 76 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 155 (1029)
.+|.+..++. .||..+.+-..|+.|+++.|-+-.-++ +++..-.+|+.|||++|++. ..|..+..+..|+.|.++.|
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl-~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n 78 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPL-EFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRN 78 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccccCch-HHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchh
Confidence 3567777776 778777766668888888887764321 22333444777777777766 67777777777777777777
Q ss_pred cCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEccc
Q 036879 156 QLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSV 235 (1029)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 235 (1029)
.+. .+|.+..++.+|++|.|.+|++. ..|..+..+++|++|++|.
T Consensus 79 ~i~-~vp~s~~~~~~l~~lnL~~n~l~----------------------------------~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 79 YIR-SVPSSCSNMRNLQYLNLKNNRLQ----------------------------------SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred hHh-hCchhhhhhhcchhheeccchhh----------------------------------cCchhHHhhhcccccccch
Confidence 777 67777777777777777766655 3566677777777777777
Q ss_pred ccccCCCCccccccccccceeeccccccccc--CcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhh
Q 036879 236 NNFIGSIPREIGNITMLKGLYLVYTNLTGEI--QGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGH 313 (1029)
Q Consensus 236 N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~ 313 (1029)
|++. .+|..+..++.++++..++|.....+ ...+.++|..|.+.+.++.++.++.. .|||++|++. .+. + .
T Consensus 124 N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~d--l-s 196 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-VLD--L-S 196 (1081)
T ss_pred hccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh-hhh--h-h
Confidence 7765 67777777777777777777222211 22778899999999999998888887 8999999985 222 2 2
Q ss_pred cccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCC
Q 036879 314 SLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSG 393 (1029)
Q Consensus 314 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 393 (1029)
.+++|+.|....|++... --..++|+.|+.++|.+....+. ..-.+|+.+++++|+++
T Consensus 197 ~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~-----------------p~p~nl~~~dis~n~l~- 254 (1081)
T KOG0618|consen 197 NLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDVH-----------------PVPLNLQYLDISHNNLS- 254 (1081)
T ss_pred hccchhhhhhhhcccceE----EecCcchheeeeccCcceeeccc-----------------cccccceeeecchhhhh-
Confidence 478999999999998732 23457899999999998743322 12368999999999999
Q ss_pred CCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCccccccc
Q 036879 394 VLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLC 473 (1029)
Q Consensus 394 ~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 473 (1029)
.+|.+++...+ ++.+.+.+|++. .+|..+...++|+.|...+|.++ -+|.....++.|++|+|..|+|...+...|.
T Consensus 255 ~lp~wi~~~~n-le~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~ 331 (1081)
T KOG0618|consen 255 NLPEWIGACAN-LEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLA 331 (1081)
T ss_pred cchHHHHhccc-ceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHh
Confidence 66799999887 999999999996 88999999999999999999999 5677788899999999999999877666666
Q ss_pred CCCC-CcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccE
Q 036879 474 GLRS-LSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTK 552 (1029)
Q Consensus 474 ~l~~-L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 552 (1029)
.+.. |..|+.+.|.+....-..=..++.|+.|.+.+|.+++..-..+.+...|+.|+|++|+|.......+.++..|++
T Consensus 332 v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~Lee 411 (1081)
T KOG0618|consen 332 VLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEE 411 (1081)
T ss_pred hhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHH
Confidence 5554 888888999887554333346678999999999999887788999999999999999999666667899999999
Q ss_pred EEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCc-CchhhhcccccceeeccCCC
Q 036879 553 IDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGE-IPNSLKALSLLKFLNLSFNG 631 (1029)
Q Consensus 553 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~ 631 (1029)
|+||+|+++ .+|..+..+..|++|..-+|+|. ..| .+..+++|+++|+|.|+|+.. +|..... ++|++|||+||.
T Consensus 412 L~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 412 LNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNT 487 (1081)
T ss_pred Hhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCc
Confidence 999999998 78899999999999999999998 778 799999999999999999853 3333333 899999999998
Q ss_pred C
Q 036879 632 L 632 (1029)
Q Consensus 632 l 632 (1029)
.
T Consensus 488 ~ 488 (1081)
T KOG0618|consen 488 R 488 (1081)
T ss_pred c
Confidence 5
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=332.96 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=199.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 467999999999999999999875 78999999987543 2234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|++ ++|.+++......+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 84 YLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 997 5999998766667899999999999999999999 77899999999999999999999999999976533221
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhc---hhccchhhhhhhhhh--
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV---NDSLHGKIINVVDIN-- 964 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~d~~-- 964 (1029)
......+++.|+|||++ ++.++||||+||++|||++|++||......+. +.... .....+.+....+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchhh
Confidence 22334678999999974 46689999999999999999999965322111 00000 000001111110000
Q ss_pred ---hhhh--hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 965 ---LLQK--EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 965 ---~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.... ...........+.++.+++.+|+..||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 000011111235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=339.78 Aligned_cols=238 Identities=23% Similarity=0.321 Sum_probs=192.5
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNG 819 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 819 (1029)
+.||+|+||.||+|+.. +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 78999999997643 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccc
Q 036879 820 SLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT 899 (1029)
Q Consensus 820 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 899 (1029)
+|.+++.. .+.+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 155 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTF 155 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccce
Confidence 99998854 456899999999999999999999 77899999999999999999999999999875422211 12235
Q ss_pred cCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHH
Q 036879 900 LATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTA 975 (1029)
Q Consensus 900 ~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 975 (1029)
.||+.|+|||++ ++.++||||+||++|||++|+.||....... .. ..+ ... ....
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-----~~---------~~~---~~~----~~~~ 214 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LF---------ELI---LME----EIRF 214 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-----HH---------HHH---HcC----CCCC
Confidence 689999999984 5778999999999999999999996521100 00 000 000 0111
Q ss_pred HHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 976 KEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 976 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
+...+.++.+++.+|++.||++|| ++.+++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 234567789999999999999999 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=303.17 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=207.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--------hhhHHHHHHHHHHhcC-CCCceEEEEEEEecC
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--------GTLRSFDAECEILGSI-RHRNLVKIISTCSSD 806 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 806 (1029)
-.+|+..+.+|+|..++|.+...+ +|.++|+|++..... ...+.-.+|+.|++++ .||+|+.+.++|+++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 456777889999999999998765 789999999875421 1234456899999998 699999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 807 HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
...++|+|.|+.|.|.||+. ....+++....+|++|+.+|++||| .+.|||||+||+|||++++.++||+|||+|.
T Consensus 96 sF~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred chhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceee
Confidence 99999999999999999995 4556899999999999999999999 6679999999999999999999999999999
Q ss_pred ecCCCCCceeccccCCccccCccCC----------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchh
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK----------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGK 956 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 956 (1029)
.+..++.. ....|||+|+|||.+ |+..+|+|+.||+||-++.|.+||-. . .
T Consensus 172 ~l~~GekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH--R---------------k 232 (411)
T KOG0599|consen 172 QLEPGEKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH--R---------------K 232 (411)
T ss_pred ccCCchhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH--H---------------H
Confidence 88776543 346799999999983 67789999999999999999999832 1 1
Q ss_pred hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 957 IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 957 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
-.-++...+.+.+....+.+...+....++|.+|++.||.+|.|++|++++
T Consensus 233 QmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 233 QMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 112233334445555555666778899999999999999999999999985
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=326.18 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=199.0
Q ss_pred CCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccC
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMP 817 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 817 (1029)
++|++.+.||+|+||.||+|++.++..+|+|.+... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999999888889999988644 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceec
Q 036879 818 NGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897 (1029)
Q Consensus 818 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 897 (1029)
+|+|.+++......+++..+..++.|++.|++||| +.||+||||||+||+++.++.+|++|||.++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999999766567899999999999999999999 777999999999999999999999999999865433222222
Q ss_pred cccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 898 QTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 898 ~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
...++..|+|||+. ++.++||||||+++|||++ |+.||...... ..+....... .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-----~~~~~i~~~~---------------~ 219 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-----EVVEMISRGF---------------R 219 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHCCC---------------C
Confidence 33456789999984 4678999999999999999 89998652110 0000000000 0
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
...+...+..+.+++.+||+.+|++||+++|+++.|
T Consensus 220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 011122356789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=336.04 Aligned_cols=242 Identities=24% Similarity=0.305 Sum_probs=197.6
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999876 78999999987542 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 99999999999864 456889999999999999999999 7789999999999999999999999999998654321
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
....|++.|+|||++ ++.++||||+||++|||++|+.||......+. . ......
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-----~--------~~i~~~------ 213 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-----Y--------EKILAG------ 213 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----H--------HHHHhC------
Confidence 224589999999984 57789999999999999999999865311100 0 000000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCC-----HHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERIN-----IKEALTKL 1008 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~~L 1008 (1029)
....+...+..+.+++.+|++.||.+||+ ++|++++-
T Consensus 214 --~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 214 --KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred --CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 01112234567899999999999999995 88888763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=316.39 Aligned_cols=245 Identities=23% Similarity=0.344 Sum_probs=205.7
Q ss_pred hCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
..+|++.+.||+|.||.|-+|+. ..|+.||||.++++. +++.-.+.+|++||+.+.||||+.++.+|+..+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 34677888999999999999985 589999999998764 34455688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||..+|.|.+|+. ..+.+++.++..+++||..|+.|+| ..++||||+|.+|||+|.++++||+|||++..+.+..
T Consensus 132 MEYaS~GeLYDYiS-er~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 132 MEYASGGELYDYIS-ERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEecCCccHHHHHH-HhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 99999999999994 5567999999999999999999999 7779999999999999999999999999998876543
Q ss_pred CceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.-+..+|++-|.+||++ -++.+|-||+||++|-++.|..||++. +....+.++..+.+.
T Consensus 208 --fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQIs~GaYr--------- 271 (668)
T KOG0611|consen 208 --FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQISRGAYR--------- 271 (668)
T ss_pred --HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHhhccccc---------
Confidence 23447899999999995 466899999999999999999999873 222223322222211
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
.+.-+....-+|++|+..+|++|.|..+|..+.+
T Consensus 272 --------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 272 --------EPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred --------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1122556778999999999999999999998874
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=333.73 Aligned_cols=267 Identities=22% Similarity=0.309 Sum_probs=199.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+++++.++||||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3578999999999999999999976 789999999875432 23346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||++ +++.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 9995 6888888776677899999999999999999999 7789999999999999999999999999997543221
Q ss_pred ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhhhhh-----
Q 036879 894 MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKIINV----- 960 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~----- 960 (1029)
.......+++.|+|||++ ++.++||||+||++|||++|+.||.+.......+..... ......+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 122335688999999974 456799999999999999999999763221111110000 0000000000
Q ss_pred hhhh-hh--hhhhhhh-HHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 961 VDIN-LL--QKEDAYL-TAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 961 ~d~~-~~--~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+.. .. ....... ......+..+.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000 00 0000000 0001124568899999999999999999999973
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=343.18 Aligned_cols=253 Identities=24% Similarity=0.403 Sum_probs=198.8
Q ss_pred HhCCCCCCceeccCcceEEEEEEe------cCCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCC
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL------SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDH 807 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 807 (1029)
..++|++.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+++++.+ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345788899999999999999963 246689999987543 23446788999999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCC----------------------------------------------------------
Q 036879 808 FKALVLEYMPNGSLENWMYNKN---------------------------------------------------------- 829 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 829 (1029)
..++||||+++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999986432
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 830 ----------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 830 ----------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
..+++..+..++.||++|++||| ++||+||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 14678889999999999999999 77899999999999999999999999999986644322
Q ss_pred ce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 894 MT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 894 ~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.. .....++..|+|||+. ++.++|||||||++|||++ |..||........ +. ..+....
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~------------~~~~~~~-- 334 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FY------------KMIKEGY-- 334 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HH------------HHHHhCc--
Confidence 11 1223356789999984 6789999999999999998 8888865321110 11 1111000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
....+...+.++.+++.+||+.||++||+++|+++.|++
T Consensus 335 ----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 335 ----RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 001112235678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=339.33 Aligned_cols=242 Identities=22% Similarity=0.270 Sum_probs=197.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 356888999999999999999876 68999999987542 22345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++|+|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999999864 456888899999999999999999 7789999999999999999999999999998764322
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
....|++.|+|||++ ++.++|||||||++|||++|+.||......+ .. ......
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~--------~~i~~~----- 230 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-----IY--------EKILAG----- 230 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-----HH--------HHHhcC-----
Confidence 124689999999984 5778999999999999999999996521100 00 000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERIN-----IKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~~ 1007 (1029)
....+..++..+.+++.+||+.||++||+ +++++++
T Consensus 231 ---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 231 ---RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00111224566889999999999999996 6888865
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=336.62 Aligned_cols=240 Identities=24% Similarity=0.306 Sum_probs=200.6
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeE
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 809 (1029)
...++|...++||+|.||+|+.|..+ +++.+|||.+++.. +++.+..+.|.+|+... +||.++.++.+|++.++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999876 68899999999874 56778899999998887 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
|+||||+.||++.. ..+.+.+++..+..++..++.||+||| +.|||+||||.+|||+|.+|++||+|||+++...
T Consensus 445 ~fvmey~~Ggdm~~--~~~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMH--HIHTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEecCCCcEEE--EEecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999999544 345678999999999999999999999 7789999999999999999999999999998643
Q ss_pred CCCCceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
.... ......|||.|||||+ .|+..+|+|||||+||||+.|..||.+...+ ++.|..+
T Consensus 520 ~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----------------e~FdsI~ 581 (694)
T KOG0694|consen 520 GQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----------------EVFDSIV 581 (694)
T ss_pred CCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHHHh
Confidence 2222 3455789999999998 4889999999999999999999999863221 1122222
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINI 1001 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 1001 (1029)
.... .-|..++.++..++++++..+|++|.-+
T Consensus 582 ~d~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 NDEV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cCCC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1111 1134567889999999999999999954
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=342.68 Aligned_cols=255 Identities=24% Similarity=0.422 Sum_probs=200.0
Q ss_pred HhCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCC
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDH 807 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 807 (1029)
..++|++.+.||+|+||.||+|+.. ++..||+|.++... ......+.+|+++++.+ +|||||++++++...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 4457889999999999999999742 34579999997653 23346788999999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCC----------------------------------------------------------
Q 036879 808 FKALVLEYMPNGSLENWMYNKN---------------------------------------------------------- 829 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 829 (1029)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999985421
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce-ec
Q 036879 830 -----------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT-QT 897 (1029)
Q Consensus 830 -----------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~ 897 (1029)
..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++......... ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 23678889999999999999999 7889999999999999999999999999998654332211 11
Q ss_pred cccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 898 QTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 898 ~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
...++..|+|||++ ++.++|||||||++|||++ |+.||........ +. ....... .
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~------------~~~~~~~------~ 333 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FY------------KMVKRGY------Q 333 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HH------------HHHHccc------C
Confidence 23356789999973 6789999999999999997 9999865321110 00 0000000 0
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
...+...+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0011123567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=345.74 Aligned_cols=255 Identities=24% Similarity=0.329 Sum_probs=205.9
Q ss_pred hCCCCCCceeccCcceEEEEEEecCC-cEEEEEEeecccchhhHHHHHHHHHHhcCC-CCceEEEEEE-Eec------CC
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDG-MQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKIIST-CSS------DH 807 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~ 807 (1029)
..++++.+.|.+|||+.||.|....+ ..||+|++-..++...+.+.+|+++|+.|+ |+|||.+++. ... ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 44567788999999999999998755 999999998888888899999999999997 9999999993 321 23
Q ss_pred eEEEEEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 808 FKALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
+.+|.||||+||.|-+++..+ ...+.+.++++|+.|+++|+++||+. +.+|||||||-+|||++.++..||||||.|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 568999999999999999643 34599999999999999999999977 4679999999999999999999999999986
Q ss_pred ecCCCC-Cce-------eccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh
Q 036879 887 LLGDET-SMT-------QTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND 951 (1029)
Q Consensus 887 ~~~~~~-~~~-------~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 951 (1029)
...... ... .-....|+.|+|||++ .++|+|||+|||++|-++....||++...-.+.-
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln------ 268 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN------ 268 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe------
Confidence 432211 100 0113579999999994 5889999999999999999999998732111100
Q ss_pred ccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 952 SLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 952 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
..+ ..+....++..+.++|+.||+.+|++||++-+|++.+.++.+.-
T Consensus 269 ---------------g~Y--~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 269 ---------------GNY--SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------------ccc--cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 000 01111356888999999999999999999999999998887643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.85 Aligned_cols=264 Identities=25% Similarity=0.421 Sum_probs=204.4
Q ss_pred HHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcC--CCCceEEEEEEEecC----Ce
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSI--RHRNLVKIISTCSSD----HF 808 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~ 808 (1029)
.........+.||+|.||+||+|++ .|..||||++...+ .+.+.+|.+|++.+ +|+||..+++.-..+ .+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3456677889999999999999999 57899999997554 36788899999876 999999999886543 35
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCcEEcCCCCCCEEECCCCcEEEEccC
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHY-----DHPTPIIHCDLNPSNILLNESMVACLSDFG 883 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-----~~~~givH~Dlk~~Nill~~~~~~kl~Dfg 883 (1029)
.+||++|++.|||.||+.+ ..++....++++..+|.||+|||. +.+..|.|||||++|||+..++...|+|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 6899999999999999954 678999999999999999999994 366789999999999999999999999999
Q ss_pred CceecCCCCCc---eeccccCCccccCccCCC----------CCCcchhHHHHHHHHHhcCC----------CCCCcccc
Q 036879 884 ISKLLGDETSM---TQTQTLATIGYMAPEWKL----------SRKGDVYSYGIILMETFTKK----------KPTDELFV 940 (1029)
Q Consensus 884 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~----------~~~~DvwSlGvil~elltg~----------~p~~~~~~ 940 (1029)
+|......... .....+||.+|||||++- -+.+||||||.|+||++-+. .||.+..+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99877554322 234578999999999841 23589999999999998743 35544333
Q ss_pred cccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 941 GEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
.+..+. ++.+++..+.....-+..-....+...+.++|+.||..+|..|.||-.+.+.+.++.+
T Consensus 442 ~DPs~e---------eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPSFE---------EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCHH---------HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 333222 2333332221111111111122356778999999999999999999999999988875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=332.18 Aligned_cols=262 Identities=24% Similarity=0.310 Sum_probs=201.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||.||+|+.. ++..||+|.+..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999876 788999999876533 335679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+++++|.+++.. ...+++..+..++.|++.|++|||+. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 84 HMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 9999999999854 34688999999999999999999932 269999999999999999999999999997654322
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc----c------------
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL----H------------ 954 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~------------ 954 (1029)
.....|++.|+|||+. ++.++|||||||++|||++|+.||......+. ........ .
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL--EAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccccccCCccccCccccc
Confidence 2234689999999984 67789999999999999999999965322111 00000000 0
Q ss_pred ---------------hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 955 ---------------GKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 955 ---------------~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
....+..+....... .......++.++.+++.+||+.||++|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPP--PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCC--cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000000000000 0000113467899999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=337.66 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=198.9
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999976 68999999997653 233457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++++|.+++.. ...+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999999854 456889999999999999999999 77899999999999999999999999999976533
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......||+.|+|||++ ++.++||||+||++|||++|+.||......+. +.. +. .+..... .+
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~-i~-----~~~~~~~-----~~ 220 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WEN-LK-----YWKETLQ-----RP 220 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHH-HH-----hcccccc-----CC
Confidence 22335689999999984 67789999999999999999999975321111 000 00 0000000 00
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. .......++.++.+++.+|+..+|++||+++|++++
T Consensus 221 ~-~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 V-YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred C-CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0 000002346678999999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=329.72 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=213.5
Q ss_pred HHHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 732 ELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 732 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
+++-...+.....+||-|.||.||.|.|+ -.-.||||.++.+ ....++|.+|+.+|+.++|||+|+++|+|..+...|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 34444455667789999999999999987 4678999998755 345688999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 811 LVLEYMPNGSLENWMYNKNRS-FDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
||+|||..|+|.+|+++..+. ++..-.+.|+.||+.|++||. .+.+||||+.++|.|++++..+|++|||+++.+.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999999887653 666677889999999999999 6669999999999999999999999999999887
Q ss_pred CCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
.+.........-++.|.|||-+ ++-|+|||+|||++||+.| |-.||.+. ++.+ ..+.++
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSq---------VY~LLE-- 480 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQ---------VYGLLE-- 480 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHH---------HHHHHh--
Confidence 6655554445568899999984 6779999999999999999 55666552 2211 111221
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
.+.+++.|+.|++.++++|+.||+++|.+||+++|+-+.++.+.
T Consensus 481 ----kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 481 ----KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ----ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 22345667899999999999999999999999999999997654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.73 Aligned_cols=244 Identities=34% Similarity=0.569 Sum_probs=190.2
Q ss_pred CCceeccCcceEEEEEEec-----CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 742 ENNLLGKGSFGSVYKGTLS-----DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 742 ~~~~lg~G~fg~V~~~~~~-----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..+.||.|+||.||+|.+. .+..||||.++.... ...+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999876 367899999965433 3468899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC-
Q 036879 816 MPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS- 893 (1029)
Q Consensus 816 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 893 (1029)
+++|+|.+++... ...+++..+..|+.||++||+||| +++++||||+++||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999877 677999999999999999999999 66799999999999999999999999999987632222
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
...........|+|||.. ++.++||||||+++||+++ |+.||.+....+ +.. ...+
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~~-----------~~~~------ 220 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--IIE-----------KLKQ------ 220 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HHH-----------HHHT------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccc-----------cccc------
Confidence 222334577899999983 6789999999999999999 678876531111 000 0000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
......+..++..+.+++..||+.+|++|||++++++.|
T Consensus 221 -~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 -GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 011122334677899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=322.60 Aligned_cols=248 Identities=26% Similarity=0.431 Sum_probs=199.6
Q ss_pred CCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccC
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMP 817 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 817 (1029)
++|++.+.||+|+||+||+|+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578889999999999999988777789999887442 334678999999999999999999999999888999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceec
Q 036879 818 NGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897 (1029)
Q Consensus 818 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 897 (1029)
+++|.+++......+++..++.++.|++.|++||| +.|++|+||||+||+++.++.+||+|||.++...........
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99999999766667899999999999999999999 778999999999999999999999999999866443322222
Q ss_pred cccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 898 QTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 898 ~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
...++..|+|||.. ++.++|||||||++|||++ |+.||....... ... .... ...
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~-----------~~~~----~~~--- 219 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVE-----------KVSQ----GLR--- 219 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH-----------HHhc----CCC---
Confidence 23456789999984 5778999999999999998 999986532110 000 0000 000
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
...+...+..+.+++.+||+.+|++||++.++++.++
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0011123567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=334.57 Aligned_cols=238 Identities=23% Similarity=0.313 Sum_probs=191.9
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNG 819 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 819 (1029)
+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999865 78999999997642 234456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccc
Q 036879 820 SLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT 899 (1029)
Q Consensus 820 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 899 (1029)
+|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 99988854 456899999999999999999999 7789999999999999999999999999987532221 122235
Q ss_pred cCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHH
Q 036879 900 LATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTA 975 (1029)
Q Consensus 900 ~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 975 (1029)
.|++.|+|||++ ++.++|||||||++|||++|+.||........ .. .... . ....
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-----~~--------~~~~----~----~~~~ 214 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FE--------LILM----E----EIRF 214 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-----HH--------HHhc----C----CCCC
Confidence 689999999984 57789999999999999999999865311100 00 0000 0 0011
Q ss_pred HHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 976 KEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 976 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
+..++..+.+++.+|++.||++|| ++.+++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 234567789999999999999998 89998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=332.95 Aligned_cols=236 Identities=24% Similarity=0.299 Sum_probs=189.8
Q ss_pred eccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 746 LGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 746 lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999876 68899999987542 33456678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccC
Q 036879 822 ENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA 901 (1029)
Q Consensus 822 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 901 (1029)
.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....... ......|
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g 155 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCG 155 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccC
Confidence 999864 456899999999999999999999 77899999999999999999999999999975432221 2233568
Q ss_pred CccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHH
Q 036879 902 TIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKE 977 (1029)
Q Consensus 902 t~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 977 (1029)
|+.|+|||++ ++.++||||+||++|||++|+.||...... ..... ... .....+.
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~--------~~~--------~~~~~~~ 214 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRK--------ILQ--------EPLRFPD 214 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHH--------HHc--------CCCCCCC
Confidence 9999999984 677899999999999999999999652111 00000 000 0011123
Q ss_pred HHHHHHHHHHHHcccccccCCCC---HHHHHHH
Q 036879 978 QCVSSVLSLAMQCTRESAEERIN---IKEALTK 1007 (1029)
Q Consensus 978 ~~~~~l~~li~~cl~~dP~~Rpt---~~evl~~ 1007 (1029)
..+..+.+++.+||+.||++||+ +.|++.+
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 45677899999999999999984 6676654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=339.63 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=200.9
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||+||+|+.. +++.||+|+++.... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999875 789999999986532 24466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999777678999999999999999999999 77899999999999999999999999999987654433
Q ss_pred ceeccccCCccccCccCC----------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
.......||+.|+|||++ ++.++|||||||++|||++|+.||........ +......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------------~~~i~~~ 224 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-------------YNNIMNF 224 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-------------HHHHHcC
Confidence 333345689999999984 35689999999999999999999965321100 0001000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
... ...+.....+..+.+++..|+. +|++||++.+++++
T Consensus 225 ~~~----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 225 QRF----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCc----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000 0000011245678899999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=323.50 Aligned_cols=250 Identities=24% Similarity=0.437 Sum_probs=202.1
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46788999999999999999998888899999876543 23567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 817 PNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 817 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
++++|.+++... ...+++..+..++.|+++|++||| +.+++||||||+||+++.++.++|+|||.+..........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999998654 456888999999999999999999 6779999999999999999999999999998765432222
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
.....++..|+|||+. ++.++|||||||++|||++ |+.||....... .... +....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~--------~~~~~--------- 221 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSA--------LQRGY--------- 221 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHH--------HHcCC---------
Confidence 2233456789999984 5668999999999999998 999986521111 0000 00000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
..+....++.++.+++.+|+..+|++||+++++.+.|++
T Consensus 222 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 222 -RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 001112345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=341.12 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=199.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
..++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567999999999999999999875 68999999997532 2234567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++|+|.+++.. ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999998854 35788889999999999999999 778999999999999999999999999999876433
Q ss_pred CCceeccccCCccccCccCC--------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK--------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~--------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
.........||+.|+|||++ ++.++|||||||++|||++|+.||....... .+......
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------------~~~~i~~~ 262 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------------TYSKIMDH 262 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-------------HHHHHHcC
Confidence 22223345699999999974 5678999999999999999999997531100 00111110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccC--CCCHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEE--RINIKEALTK 1007 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~ 1007 (1029)
. .....+....++..+.+++.+|++.+|++ |+++.|++++
T Consensus 263 ~----~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 263 K----NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred C----CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 00000111124677899999999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=333.65 Aligned_cols=238 Identities=24% Similarity=0.310 Sum_probs=192.5
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNG 819 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 819 (1029)
+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 78999999997642 234567888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccc
Q 036879 820 SLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT 899 (1029)
Q Consensus 820 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 899 (1029)
+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 155 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTF 155 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccccc
Confidence 99988854 456899999999999999999999 77899999999999999999999999999875432211 22235
Q ss_pred cCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHH
Q 036879 900 LATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTA 975 (1029)
Q Consensus 900 ~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 975 (1029)
.||+.|+|||++ ++.++||||+||++|||++|+.||......+ ...... .. ....
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-----~~~~~~------------~~----~~~~ 214 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELIL------------ME----DIKF 214 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-----HHHHhc------------cC----CccC
Confidence 689999999984 5778999999999999999999996521110 000000 00 0111
Q ss_pred HHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 976 KEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 976 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
+...+..+.+++.+|++.||++|+ ++.|++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 223466789999999999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.78 Aligned_cols=247 Identities=28% Similarity=0.454 Sum_probs=198.8
Q ss_pred CCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccC
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMP 817 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 817 (1029)
.+|++.+.||+|+||.||+|++.++..+|+|.+..... ....+.+|+++++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35788899999999999999987778899999864422 33568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceec
Q 036879 818 NGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897 (1029)
Q Consensus 818 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 897 (1029)
+++|.+++......+++..+..++.|+++|++||| +.||+||||||+||+++.++.+||+|||.++...+.......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999999776667899999999999999999999 778999999999999999999999999999866443222222
Q ss_pred cccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 898 QTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 898 ~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
...++..|+|||.. ++.++||||||+++||+++ |+.||......+. .. .+.... .
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~------------~~~~~~------~ 219 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV--VE------------SVSAGY------R 219 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH--HH------------HHHcCC------c
Confidence 22345679999974 5678999999999999999 8999865321110 00 000000 0
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
...+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111223577899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=322.35 Aligned_cols=250 Identities=25% Similarity=0.448 Sum_probs=201.2
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.+|++.+.||+|+||.||+|... .++.||+|.+... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778899999999999999865 6889999998754 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 817 PNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 817 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
++++|.+++... ...+++..+..++.|+++|++||| ++|++||||||+||++++++.+||+|||.+..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999998654 345899999999999999999999 7789999999999999999999999999998765432222
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
.....++..|+|||.. ++.++|||||||++|||++ |..||......+ ... .+....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~------------~~~~~~----- 222 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYE------------LLEKGY----- 222 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH------------HHHCCC-----
Confidence 2223346789999974 5678999999999999998 899986421110 000 000000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
....+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 223 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 -RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0111234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.02 Aligned_cols=251 Identities=26% Similarity=0.462 Sum_probs=202.3
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..++|++.+.||+|+||.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346688999999999999999998788899999987543 2356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++++|.+++.... ..+++..+..++.|++.|++||| ++||+||||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999986543 56899999999999999999999 778999999999999999999999999999876533222
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
.......+..|+|||+. ++.++||||||+++|||++ |+.||........ ...++...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--------------~~~~~~~~---- 221 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV--------------LQQVDQGY---- 221 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--------------HHHHHcCC----
Confidence 22222234689999984 5678999999999999999 9999865311100 00000000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
....+..++..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 --RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 001122346779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=336.18 Aligned_cols=243 Identities=21% Similarity=0.289 Sum_probs=196.8
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-C-CcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-D-GMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~-~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
..++|++.+.||+|+||.||+|+.. + +..||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3456899999999999999999864 3 3689999987542 233456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+++|+|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 108 lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999854 456899999999999999999999 77899999999999999999999999999986543
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.. ....||+.|+|||++ ++.++||||+||++|||++|+.||...... . .. .......
T Consensus 184 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~-~~-----------~~i~~~~-- 244 (340)
T PTZ00426 184 RT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-L-IY-----------QKILEGI-- 244 (340)
T ss_pred Cc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-H-HH-----------HHHhcCC--
Confidence 21 234689999999984 677899999999999999999999753110 0 00 0000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
...+...+..+.+++.+|++.||++|+ +++|++++
T Consensus 245 ------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 ------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011223456678999999999999995 89999876
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=320.55 Aligned_cols=252 Identities=26% Similarity=0.485 Sum_probs=202.8
Q ss_pred hCCCCCCceeccCcceEEEEEEec----CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
.++|++.+.||+|+||.||+|++. +...||||.++... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 356889999999999999999874 24579999987553 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++++|.+++......+++..+..++.|++.|++||| +++|+||||||+||++++++.++++|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999776678999999999999999999999 778999999999999999999999999999876522
Q ss_pred -CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 892 -TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 892 -~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
.........++..|+|||.. ++.++||||||+++|||++ |..||......+ .. +.+....
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~------------~~~~~~~ 225 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VI------------KAVEDGY 225 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HH------------HHHHcCC
Confidence 11122223456789999984 5778999999999999998 999985431110 00 0000000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
..+.+..++..+.+++.+||+.+|++||++.|++++|+++
T Consensus 226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011234567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=331.17 Aligned_cols=240 Identities=25% Similarity=0.370 Sum_probs=199.3
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchh---hHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGT---LRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
|+.++.||.|+||.||-|++. +...||||++....... -.++.+|++++++++|||+|.+-|||-.+.+.++||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 555678999999999999865 78889999998665443 34688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
| -|+-.|.+...++++.+..+..|..+.+.||+||| +.+.||||||+.|||+++.|.||++|||.|....+..
T Consensus 108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn--- 180 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN--- 180 (948)
T ss_pred H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCchh---
Confidence 9 67899999888999999999999999999999999 6679999999999999999999999999998765433
Q ss_pred eccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
.++|||+|||||++ |+-|+||||+|++..|+...++|.......-. +.++. ..
T Consensus 181 --sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-------------LYHIA-----QN 240 (948)
T KOG0577|consen 181 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------LYHIA-----QN 240 (948)
T ss_pred --cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-------------HHHHH-----hc
Confidence 36799999999994 78899999999999999999999644211100 00110 01
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..+.. ...+++..|.+|+..|+++-|++|||..+++++
T Consensus 241 esPtL-qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 241 ESPTL-QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCC-CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11101 124568889999999999999999999999875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=339.24 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=198.3
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
....++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+++++.++||||+++++++..++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 345578999999999999999999976 68899999987532 22345688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++|+|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999999854 35788899999999999999999 7789999999999999999999999999998764
Q ss_pred CCCCceeccccCCccccCccCC--------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK--------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~--------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
...........||+.|+|||++ ++.++||||+||++|||++|+.||....... .+....
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-------------~~~~i~ 260 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-------------TYSKIM 260 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-------------HHHHHH
Confidence 3332233345799999999974 5678999999999999999999997531100 011111
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccC--CCCHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEE--RINIKEALTK 1007 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~ 1007 (1029)
+... ....+.....+..+.+++..|+..+|.+ |+++.|++++
T Consensus 261 ~~~~----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKN----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCc----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1000 0000111124566888999999755544 8899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=335.98 Aligned_cols=260 Identities=22% Similarity=0.239 Sum_probs=194.2
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..+|++.+.||+|+||.||+|+.. +++.||+|... ...+.+|++++++++||||+++++++......++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999875 78999999643 23567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+. ++|..++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+|+.........
T Consensus 165 ~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 165 YK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred CC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 94 789888754 356889999999999999999999 7789999999999999999999999999997543322222
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccc------cchhchhc----------cch
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEIS------LKSRVNDS----------LHG 955 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~------~~~~~~~~----------~~~ 955 (1029)
.....||+.|+|||++ ++.++||||+||++|||++|+.||.+....... +...+... ...
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 2345699999999984 677899999999999999999886542211100 00000000 000
Q ss_pred hhhhhh---hhhhhhhh--hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 KIINVV---DINLLQKE--DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 ~~~~~~---d~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+.... ........ ..........+.++.+++.+|++.||++|||++|++++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00000000 00011112346688999999999999999999999974
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=324.11 Aligned_cols=252 Identities=25% Similarity=0.478 Sum_probs=206.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
...+|++.+.||.|+||.||+|+..++..||+|.+..........+..|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45568888999999999999999888999999999876655567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++++|.+++... ...+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 9999999999764 346899999999999999999999 77899999999999999999999999999976644322
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......++..|+|||.. ++.++||||||+++|+|++ |+.||......+. + +.... .
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~-------------~-~~~~~----~- 220 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV-------------Y-DQITA----G- 220 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH-------------H-HHHHh----C-
Confidence 12234467789999973 5678999999999999998 8999865321100 0 00000 0
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
.....+..++.++.+++.+||+.+|++|||++++++.|+.+
T Consensus 221 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 -YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00112234567899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=337.17 Aligned_cols=244 Identities=26% Similarity=0.368 Sum_probs=192.2
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
++|+..+.||+|+||.||+|+.. +++.||||++..... .....+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34566788999999999999875 789999999875433 3356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+. ....+..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....... .
T Consensus 154 ~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 154 MDGGSLEGT-----HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred CCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 999998653 23456778899999999999999 77899999999999999999999999999987643221 1
Q ss_pred eccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.....|+..|+|||++ .+.++|||||||++|||++|+.||.....+ .+.. .......
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~------------~~~~~~~ 290 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWAS------------LMCAICM 290 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHH------------HHHHHhc
Confidence 2335689999999974 234899999999999999999999732111 1100 0000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
......+..++..+.+++.+||+.||++|||+.|++++
T Consensus 291 ---~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 ---SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011123456779999999999999999999999986
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=337.03 Aligned_cols=257 Identities=24% Similarity=0.426 Sum_probs=202.0
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCC-CCceEEEEEEEecC
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELE-GTLRSFDAECEILGSIR-HRNLVKIISTCSSD 806 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 806 (1029)
...++|.+.+.||+|+||.||+|+.. .+..||||+++.... ...+.+.+|+++++++. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34678899999999999999999753 234699999975533 33467899999999996 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC---------------------------------------------------------
Q 036879 807 HFKALVLEYMPNGSLENWMYNKN--------------------------------------------------------- 829 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 829 (1029)
+..++||||+++|+|.+++.+..
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999999986421
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE
Q 036879 830 --------------------------------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL 871 (1029)
Q Consensus 830 --------------------------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill 871 (1029)
..+++..+..++.|+++|++||| +.+|+||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEE
Confidence 23677888999999999999999 7789999999999999
Q ss_pred CCCCcEEEEccCCceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCccccccccc
Q 036879 872 NESMVACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISL 945 (1029)
Q Consensus 872 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~ 945 (1029)
+.++.+||+|||+++........ ......++..|+|||.+ ++.++|||||||++|||++ |+.||.........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~- 349 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF- 349 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH-
Confidence 99999999999999865432221 12234567889999984 5779999999999999997 89998653111100
Q ss_pred chhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 946 KSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 946 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
. ..+. .. .....+..++..+.+++.+||+.+|++||++.++.+.|+++.+
T Consensus 350 ~------------~~~~----~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 Y------------NKIK----SG--YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred H------------HHHh----cC--CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0 0000 00 0011223457789999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=324.71 Aligned_cols=254 Identities=27% Similarity=0.475 Sum_probs=203.6
Q ss_pred CCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888899999999999999752 345689999876655566789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEE
Q 036879 812 VLEYMPNGSLENWMYNKN------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACL 879 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl 879 (1029)
||||+++++|.+++.... ..+++..+..++.|++.|++||| ++|++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 999999999999986432 24899999999999999999999 778999999999999999999999
Q ss_pred EccCCceecCCCCC-ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhcc
Q 036879 880 SDFGISKLLGDETS-MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSL 953 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 953 (1029)
+|||+++....... .......++..|+|||+. ++.++|||||||++|||++ |+.||......+. .....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~-----~~~i~ 236 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-----IECIT 236 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHH
Confidence 99999976533221 112233457789999984 5778999999999999998 8999865321110 00000
Q ss_pred chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 954 HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 954 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.+ .. ...+..++.++.+++.+||+.+|.+|||+.|+.+.|+++.+.
T Consensus 237 ~~--------~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 237 QG--------RV-------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred cC--------Cc-------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 00 00 011123456799999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=334.27 Aligned_cols=262 Identities=23% Similarity=0.275 Sum_probs=192.5
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC-----CeEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD-----HFKA 810 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 810 (1029)
+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5788899999999999999865 78999999987432 22345688999999999999999999988543 3479
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||++ ++|.+++.. ...+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 689988854 446899999999999999999999 77899999999999999999999999999975432
Q ss_pred CCC--ceeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh----ccch---
Q 036879 891 ETS--MTQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND----SLHG--- 955 (1029)
Q Consensus 891 ~~~--~~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~~~--- 955 (1029)
... .......|++.|+|||+. ++.++|||||||++|||++|++||........ ...+.. ....
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ--LDLITDLLGTPSPETIS 233 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH--HHHHHHHhCCCCHHHHH
Confidence 211 112335689999999973 56789999999999999999999965321100 000000 0000
Q ss_pred -----hhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 -----KIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 -----~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+....................+..+.+++.+||+.+|++|||++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000000000011235678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=329.92 Aligned_cols=254 Identities=24% Similarity=0.454 Sum_probs=201.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCc----EEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGM----QIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
..+|+..+.||+|+||.||+|++. ++. .||+|.++... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356899999999999999999864 343 48999987543 33456788999999999999999999999765 467
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+|+||+++|+|.+++......+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999999877777899999999999999999999 77899999999999999999999999999987654
Q ss_pred CCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 891 ETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 891 ~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
..... .....++..|+|||+. ++.++|||||||++|||++ |+.||++....+ +.. .....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~------------~~~~~ 227 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS------------ILEKG 227 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHH------------HHhCC
Confidence 32221 1223346789999984 5778999999999999998 999986531111 000 00000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.....+..++..+.+++.+||..+|++||++.+++..+.++.+.
T Consensus 228 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 228 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 00111223556789999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=324.05 Aligned_cols=251 Identities=27% Similarity=0.531 Sum_probs=201.2
Q ss_pred CCCCCCceeccCcceEEEEEEecC------CcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLSD------GMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~~------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
.+|++.+.||+|+||.||+|.... ...||+|.+..... .....+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998642 25799999875533 33467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC
Q 036879 811 LVLEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM 875 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~ 875 (1029)
+||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 9999999999999996532 45788899999999999999999 77899999999999999999
Q ss_pred cEEEEccCCceecCCCCC-ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhc
Q 036879 876 VACLSDFGISKLLGDETS-MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRV 949 (1029)
Q Consensus 876 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 949 (1029)
.+||+|||++........ .......+++.|+|||.. ++.++|||||||++|||++ |..||.+....+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999976533221 122334567889999973 5778999999999999998 999987532111
Q ss_pred hhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 950 NDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 950 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
+...+... .....+..++.++.+++.+||+.+|++||+++|++++|+.+
T Consensus 235 -------~~~~i~~~------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 -------VIEMIRSR------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -------HHHHHHcC------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 00111000 01112345788899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=330.86 Aligned_cols=238 Identities=26% Similarity=0.324 Sum_probs=190.6
Q ss_pred ceeccCcceEEEEEEe----cCCcEEEEEEeeccc----chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 744 NLLGKGSFGSVYKGTL----SDGMQIAVKVFNLEL----EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+.||+|+||.||+++. .+++.||+|+++... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 357899999987542 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++.. ...+.+..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V 156 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence 999999998854 455788888999999999999999 77899999999999999999999999999875433222 1
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
.....|++.|+|||++ ++.++||||+||++|||++|+.||...... .. .......
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~--------~~~~~~~-------- 215 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KT--------IDKILKG-------- 215 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HH--------HHHHHcC--------
Confidence 2234689999999984 567899999999999999999999753111 00 0000000
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
....+...+..+.+++.+|++.+|++|| ++.+++++
T Consensus 216 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 216 KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 0111223456789999999999999999 88888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=346.34 Aligned_cols=246 Identities=24% Similarity=0.294 Sum_probs=198.9
Q ss_pred CCCCCceeccCcceEEEEEEec-C-CcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-D-GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++|||||++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999764 4 6789999876665555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 817 PNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 817 ~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
++|+|.+++.+ ....+++..+..++.|++.||+|+| +++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998854 2446889999999999999999999 77899999999999999999999999999987644322
Q ss_pred c-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 894 M-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 894 ~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
. ......||++|+|||++ ++.++|||||||++|||++|+.||......+ .........
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-----------------~~~~~~~~~ 287 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-----------------IMQQVLYGK 287 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHhCC
Confidence 1 22335689999999984 6778999999999999999999986521110 000000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. ...+..++..+.+++..||..+|++||++++++.+
T Consensus 288 ~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 288 Y---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred C---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 0 11122356779999999999999999999999753
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=320.79 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=200.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 457999999999999999999864 7889999999766555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++.. ...+++..+..++.|+++|++||| +.||+|||+||+||+++.++.+||+|||++........ .
T Consensus 88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 88 CGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 999999998854 456899999999999999999999 77899999999999999999999999999986643221 1
Q ss_pred eccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
.....+++.|+|||.. ++.++||||+||++|||++|+.||......+.. ..+..... ..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~~~--------~~----- 228 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKSNF--------QP----- 228 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecCCC--------CC-----
Confidence 2234588899999974 356899999999999999999998643211110 00000000 00
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
........++..+.+++.+||..+|++||+++++++++
T Consensus 229 --~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 --PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000123456789999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.37 Aligned_cols=248 Identities=24% Similarity=0.297 Sum_probs=195.7
Q ss_pred CCCCCceeccCcceEEEEEEe----cCCcEEEEEEeeccc----chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeE
Q 036879 739 GFSENNLLGKGSFGSVYKGTL----SDGMQIAVKVFNLEL----EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 809 (1029)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+..|+++++.+ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999975 258899999987532 22345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++|+|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999999854 456889999999999999999999 7789999999999999999999999999998654
Q ss_pred CCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
...........||+.|+|||++ ++.++|||||||++|||++|+.||........ .. .+.. .
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~--------~~~~----~ 222 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QS--------EVSR----R 222 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HH--------HHHH----H
Confidence 3333223345689999999984 46689999999999999999999964211110 00 0000 0
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
.... ....+...+..+.+++.+|++.||++|| ++++++++
T Consensus 223 ~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 223 ILKC---DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HhcC---CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0000 0111223466789999999999999999 77888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.89 Aligned_cols=238 Identities=23% Similarity=0.317 Sum_probs=191.5
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNG 819 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 819 (1029)
+.||+|+||.||+|+.. +|+.||+|++.... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 78999999997642 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 820 SLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP-TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 820 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
+|.+++.. ...+++..+..++.|++.||+||| + +||+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT 155 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence 99988854 456899999999999999999999 5 6899999999999999999999999999875432221 1223
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..||+.|+|||++ ++.++|||||||++|||++|+.||........ ...+... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--------------~~~i~~~-------~~~ 214 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--------------FELILME-------EIR 214 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--------------HHHHhcC-------CCC
Confidence 4689999999984 57899999999999999999999965211100 0000000 001
Q ss_pred HHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
.+...+.++.+++.+|++.||++|+ ++++++++
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1223466789999999999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=337.58 Aligned_cols=248 Identities=21% Similarity=0.308 Sum_probs=192.7
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.|+..+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999865 78999999997642 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC-
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS- 893 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 893 (1029)
|+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999999998643 45888999999999999999999 77899999999999999999999999999754311000
Q ss_pred ---------------------------------------------ceeccccCCccccCccCC----CCCCcchhHHHHH
Q 036879 894 ---------------------------------------------MTQTQTLATIGYMAPEWK----LSRKGDVYSYGII 924 (1029)
Q Consensus 894 ---------------------------------------------~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvi 924 (1029)
......+||+.|+|||++ ++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 001124699999999984 6778999999999
Q ss_pred HHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHH--cccccccCCCCHH
Q 036879 925 LMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQ--CTRESAEERINIK 1002 (1029)
Q Consensus 925 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rpt~~ 1002 (1029)
+|||++|+.||......+... ...... .....+....++.++.+++.+ |+..+|..||+++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~-------------~i~~~~----~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQL-------------KVINWE----NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHH-------------HHHccc----cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 999999999997532111100 000000 000001111245677888887 5566667799999
Q ss_pred HHHHH
Q 036879 1003 EALTK 1007 (1029)
Q Consensus 1003 evl~~ 1007 (1029)
|++++
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=325.53 Aligned_cols=250 Identities=24% Similarity=0.314 Sum_probs=207.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccch---hhHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG---TLRSFDAECEILGSIR-HRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 810 (1029)
....|++.+.||+|.||.||+++.. +|+.+|+|.+.+.... ....+.+|+++|+++. |||||.++++|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4567888899999999999999976 5999999999876532 3468999999999998 999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC----CCcEEEEccCCce
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE----SMVACLSDFGISK 886 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~----~~~~kl~Dfg~a~ 886 (1029)
+|||++.||.|.+.+... .+++.++..++.|++.|++|+| +.||||||+||+|+|+.. ++.+|++|||+|.
T Consensus 113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 999999999999999766 3999999999999999999999 788999999999999963 3589999999999
Q ss_pred ecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhh
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 962 (1029)
+... .......+||+.|+|||+. ++..+||||+||++|.|++|.+||.+....+... .+..
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------------~i~~ 252 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------------AILR 252 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------------HHHc
Confidence 8876 2334457899999999984 6789999999999999999999997642222111 0000
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
.......+.....+..+.++++.|+..||.+|+|+.+++++-+
T Consensus 253 ----~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 253 ----GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred ----CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 0011111222345778999999999999999999999999743
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=337.98 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=199.9
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||+||+|+.. +++.||+|+++... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999976 78999999997643 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC-
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET- 892 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 892 (1029)
||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999998655 67899999999999999999999 7889999999999999999999999999998664432
Q ss_pred ---------------------------CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCccccc
Q 036879 893 ---------------------------SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVG 941 (1029)
Q Consensus 893 ---------------------------~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~ 941 (1029)
........||+.|+|||++ ++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 1122335689999999984 677999999999999999999999753211
Q ss_pred ccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCC-HHHHHHH
Q 036879 942 EISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERIN-IKEALTK 1007 (1029)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~evl~~ 1007 (1029)
+. ........ .....+....++..+.+++..|+. +|++||+ ++|++++
T Consensus 237 ~~-------------~~~i~~~~----~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ET-------------YNKIINWK----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH-------------HHHHhccC----CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 00 00000000 000000011146778999999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=337.80 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=195.3
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999875 68999999997542 233456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999999999865 346899999999999999999999 77899999999999999999999999999875432110
Q ss_pred c-------------------------------------eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCC
Q 036879 894 M-------------------------------------TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKK 932 (1029)
Q Consensus 894 ~-------------------------------------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~ 932 (1029)
. .....+||+.|+|||++ ++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 00123589999999984 677899999999999999999
Q ss_pred CCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCC---HHHHHHH
Q 036879 933 KPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERIN---IKEALTK 1007 (1029)
Q Consensus 933 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~evl~~ 1007 (1029)
.||......+. ........ .....+.....+..+.+++.+|+. +|.+|++ ++|++++
T Consensus 237 ~Pf~~~~~~~~-------------~~~i~~~~----~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQET-------------YRKIINWK----ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHHH-------------HHHHHcCC----CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99975321110 00000000 000000001235678899999996 9999998 9998874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=329.73 Aligned_cols=241 Identities=22% Similarity=0.318 Sum_probs=190.6
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHH---hcCCCCceEEEEEEEecCCeEEEE
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEIL---GSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667889999999999999875 78999999997542 22345566776655 566899999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++++|..++. ...+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 99999999998874 356899999999999999999999 7789999999999999999999999999987532221
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
. ......|++.|+|||.+ ++.++|||||||++|||++|+.||......+. ...... .
T Consensus 156 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-------------~~~i~~----~- 216 (324)
T cd05589 156 D-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-------------FDSIVN----D- 216 (324)
T ss_pred C-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHh----C-
Confidence 1 22335689999999984 57789999999999999999999965311100 000000 0
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
....+..++..+.+++.+|+..||++|| ++.+++++
T Consensus 217 ---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 ---EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0111233567789999999999999999 57777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=335.67 Aligned_cols=251 Identities=26% Similarity=0.461 Sum_probs=209.9
Q ss_pred CCCCceeccCcceEEEEEEec-CC----cEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DG----MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
....++||+|+||+||+|.+- .| .+||+|++.... .....++.+|+-+|.+++|||+++++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 344578999999999999863 33 468999886553 345678999999999999999999999998766 78999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC-C
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE-T 892 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~-~ 892 (1029)
+|++.|+|.+|++.++..+-....+.|..|||+|+.||| .+++|||||.++|||+.....+||.|||+|+....+ .
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999999999999999999999999999999 777999999999999999999999999999977543 3
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.+........+.|||-|.+ ++.++|||||||++||++| |..|+++....++ .+. .+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--------------~dl-----le 914 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--------------PDL-----LE 914 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--------------hHH-----Hh
Confidence 3334444567889999983 7889999999999999999 8899877433322 111 12
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.+. +...|+.|+.++..++.+||..|++.||+++++.+.+.+..++
T Consensus 915 ~ge-RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 915 KGE-RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ccc-cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 222 2566788999999999999999999999999999999887654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=328.93 Aligned_cols=261 Identities=25% Similarity=0.330 Sum_probs=198.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||.||+|+.. ++..+|+|.+..... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999876 688999999876532 345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+++++|.+++.. ...+++..+..++.|++.|++|||.. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 158 (333)
T cd06650 84 HMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (333)
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence 9999999999854 44588899999999999999999932 369999999999999999999999999997553321
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhh-------------
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKI------------- 957 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------- 957 (1029)
.....|+..|+|||++ ++.++|||||||++|||++|+.||......+.. ........+..
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE--LMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred -cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH--HHhcCcccCCccccccCcccCCcc
Confidence 1234689999999984 567899999999999999999999753221110 00000000000
Q ss_pred ----------------hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 958 ----------------INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 958 ----------------~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+.... ...... .....+.++.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVN-EPPPKL-PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhc-CCCccC-CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000000000 000000 001135678999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=317.35 Aligned_cols=254 Identities=21% Similarity=0.338 Sum_probs=202.6
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999865 78999999876432 233457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 814 EYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 814 E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
||+++++|.+++.. ....+++..+..++.|+++|++||| +.+++||||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988753 2345788999999999999999999 77899999999999999999999999999987644
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
... ......+++.|+|||.. .+.++|+||+|+++|||++|+.||.........+... +..
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~------------~~~--- 222 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK------------IEQ--- 222 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH------------Hhc---
Confidence 322 12234588899999984 5678999999999999999999986422111111110 000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
.. ........++..+.+++.+||..+|++||++.|+++.+++++
T Consensus 223 -~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 -CD-YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -CC-CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00 000112235677999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=335.80 Aligned_cols=256 Identities=22% Similarity=0.297 Sum_probs=200.3
Q ss_pred HHHHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecC
Q 036879 731 QELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSD 806 (1029)
Q Consensus 731 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 806 (1029)
.+.....++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344456689999999999999999999876 68899999987532 22345678899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 807 HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
...++||||+++|+|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999998854 35788889999999999999999 7889999999999999999999999999998
Q ss_pred ecCCCCCceeccccCCccccCccCC--------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhh
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK--------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKII 958 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~--------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1029)
..............||+.|+|||++ ++.++||||+||++|||++|+.||...... .. ..
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~--------~~ 257 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GT--------YS 257 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-----HH--------HH
Confidence 7654333233346799999999983 567899999999999999999999753111 00 00
Q ss_pred hhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccC--CCCHHHHHHHH
Q 036879 959 NVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEE--RINIKEALTKL 1008 (1029)
Q Consensus 959 ~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~L 1008 (1029)
..... ......+.....+..+.+++..|+...+.+ |+++.|++++.
T Consensus 258 ~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 258 KIMNH----KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHHcC----CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00000 000000111234667899999999844433 77999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=329.19 Aligned_cols=251 Identities=18% Similarity=0.251 Sum_probs=196.7
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||+||+|+.. +++.||+|++.+.. ....+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999875 68999999997532 233456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++.+....+++..+..++.||+.|++||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999766677899999999999999999999 77899999999999999999999999999976654333
Q ss_pred ceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
.......||+.|+|||++ ++.++||||+||++|||++|+.||......+ .... .....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-----~~~~--------i~~~~ 224 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGK--------IMNHK 224 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-----HHHH--------HHcCC
Confidence 333335689999999974 3568999999999999999999996521110 0000 00000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHccccccc--CCCCHHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAE--ERINIKEALTK 1007 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~Rpt~~evl~~ 1007 (1029)
. ..........++..+.+++.+|+..+++ .|+++.+++++
T Consensus 225 ~---~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 225 E---HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C---cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 0000001112466788899887754433 48899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=321.76 Aligned_cols=254 Identities=27% Similarity=0.473 Sum_probs=203.5
Q ss_pred CCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
.+|.+.+.||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778899999999999999742 356689999876655556779999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc
Q 036879 812 VLEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV 876 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~ 876 (1029)
||||+++++|.+++.... ..+++..++.++.|++.|++||| ++||+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999996532 34789999999999999999999 778999999999999999999
Q ss_pred EEEEccCCceecCCCCC-ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhch
Q 036879 877 ACLSDFGISKLLGDETS-MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVN 950 (1029)
Q Consensus 877 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 950 (1029)
++|+|||++........ .......++..|+|||.+ ++.++|||||||++|||++ |+.||......+ .+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----~~~ 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-----VIE 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHH
Confidence 99999999976543221 112234567889999974 5778999999999999999 999986532111 000
Q ss_pred hccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 951 DSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 951 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
....+ .. ...+..++..+.+++.+||+.+|++||+++++++.|+++.+.
T Consensus 237 ~~~~~--------~~-------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 CITQG--------RV-------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHhCC--------CC-------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 00000 00 011123466789999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=316.27 Aligned_cols=249 Identities=28% Similarity=0.477 Sum_probs=199.2
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++||+++++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 457888999999999999999988888999999875433 34678999999999999999999998854 5578999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 817 PNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 817 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
++++|.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||.+..+.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999998654 345899999999999999999999 6779999999999999999999999999998765433222
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
.....++..|+|||.. ++.++||||||+++|||++ |+.||......+ ..+.+...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------------~~~~~~~~------ 219 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--------------VLEQVERG------ 219 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--------------HHHHHHcC------
Confidence 2223456789999984 5678999999999999999 888986521110 00000000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
...+.+...+..+.+++.+|+..+|++|||++++.+.|++
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011123446779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=328.85 Aligned_cols=238 Identities=24% Similarity=0.302 Sum_probs=189.1
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||+||+|+.. +++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 68899999987542 23445677888888776 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|+|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTST 155 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cccc
Confidence 999998854 456899999999999999999999 77899999999999999999999999999875432211 2233
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..||+.|+|||++ ++.++||||+||++|||++|+.||......+ ..... ... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i--------~~~--------~~~ 214 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-----LFEAI--------LND--------EVV 214 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----HHHHH--------hcC--------CCC
Confidence 5689999999984 5778999999999999999999997532110 00000 000 001
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCH------HHHHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINI------KEALTK 1007 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~------~evl~~ 1007 (1029)
.+...+..+.+++.+|++.||++||++ ++++++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 112345678999999999999999998 666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=330.23 Aligned_cols=256 Identities=24% Similarity=0.424 Sum_probs=199.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEec-C
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSS-D 806 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~ 806 (1029)
..++|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.+++++ +||||++++++|.. +
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3457999999999999999999642 35789999987543 22345678899999999 89999999998865 4
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC---------------------------------------------------------
Q 036879 807 HFKALVLEYMPNGSLENWMYNKN--------------------------------------------------------- 829 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 829 (1029)
...++||||+++++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 57789999999999999985432
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC-ceeccccCCccc
Q 036879 830 ---RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS-MTQTQTLATIGY 905 (1029)
Q Consensus 830 ---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y 905 (1029)
..+++..+..++.||+.|++||| +.||+||||||+||+++.++.+||+|||++..+..... .......++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 25788999999999999999999 77899999999999999999999999999986543222 122234567789
Q ss_pred cCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHH
Q 036879 906 MAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCV 980 (1029)
Q Consensus 906 ~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 980 (1029)
+|||+. ++.++||||+||++|||++ |+.||......+. +. ..+.... ....+..++
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~------------~~~~~~~------~~~~~~~~~ 302 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FC------------RRLKEGT------RMRAPEYAT 302 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HH------------HHHhccC------CCCCCccCC
Confidence 999973 6779999999999999998 9999865321110 00 0000000 011122345
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 981 SSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 981 ~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
.++.+++.+||+.+|++||++.|++++|+++..
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=318.88 Aligned_cols=253 Identities=24% Similarity=0.417 Sum_probs=198.9
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCc----EEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGM----QIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
++|++.+.||+|+||+||+|++. +++ .||+|.+.... ......+..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46888899999999999999864 444 47778775432 2334677888889999999999999998864 45678
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
|+||+++|+|.+++......+++..+..++.|++.|++||| +++++||||||+||++++++.+||+|||.++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999877778999999999999999999999 778999999999999999999999999999866433
Q ss_pred CC-ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 892 TS-MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 892 ~~-~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
.. .......++..|+|||.. ++.++|||||||++||+++ |+.||.+...... .+.+...
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~--------------~~~~~~~- 227 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV--------------PDLLEKG- 227 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--------------HHHHHCC-
Confidence 21 122334567889999984 6778999999999999998 9999865321110 0111000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.....+..++..+.+++.+||..+|++|||+.|+++.+..+.++
T Consensus 228 -----~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 228 -----ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 00011123456678899999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=333.09 Aligned_cols=196 Identities=23% Similarity=0.362 Sum_probs=169.3
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|++++.+++||+|+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999865 68999999997643 223456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++.+ .+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999999864 456899999999999999999999 78899999999999999999999999999875432110
Q ss_pred c----------------------------------eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCC
Q 036879 894 M----------------------------------TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPT 935 (1029)
Q Consensus 894 ~----------------------------------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~ 935 (1029)
. .....+||+.|+|||++ ++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 01134699999999984 677899999999999999999999
Q ss_pred Cc
Q 036879 936 DE 937 (1029)
Q Consensus 936 ~~ 937 (1029)
..
T Consensus 237 ~~ 238 (363)
T cd05628 237 CS 238 (363)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=312.46 Aligned_cols=245 Identities=21% Similarity=0.330 Sum_probs=207.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
..=|...+.||+|-|++|-.|++- +|..||||++.+..- -....+.+|++.|+-++|||||++|++...+...|+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 344777788999999999999854 899999999987643 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE-CCCCcEEEEccCCceecCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL-NESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|.-++|+|.+||.++...+.+....+++.||..|+.|+|..| |||||+||+||.+ ..-|-+|+.|||++..+.++.
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999999999999999999999999999999999877 9999999999975 678999999999998886654
Q ss_pred CceeccccCCccccCccCCC-----CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~~-----~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.. +...|+..|-|||++. -+++||||+|||+|.+++|++||++..+.+. +..++|-
T Consensus 174 kL--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------------LTmImDC---- 234 (864)
T KOG4717|consen 174 KL--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------------LTMIMDC---- 234 (864)
T ss_pred hh--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------hhhhhcc----
Confidence 43 3457999999999963 3579999999999999999999987543322 1111221
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
+...|...+.+..++|..|+..||++|.+.+|++..
T Consensus 235 ----KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 ----KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ----cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 123345667888999999999999999999999863
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=327.79 Aligned_cols=243 Identities=21% Similarity=0.279 Sum_probs=192.1
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCC-CceEEEEEEEecCCeEEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRH-RNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 813 (1029)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999876 67899999997642 2345667889999999976 56888999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 99999999998854 446889999999999999999999 77899999999999999999999999999875322211
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......||+.|+|||++ ++.++||||+||++|||++|+.||......+. .......
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------------~~~i~~~------ 216 (324)
T cd05587 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------------FQSIMEH------ 216 (324)
T ss_pred -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHcC------
Confidence 22235689999999984 56789999999999999999999975321100 0000000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCH-----HHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINI-----KEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~evl~~ 1007 (1029)
....+...+..+.+++.+|+..+|++|+++ +++.++
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 --NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011122345678999999999999999976 566654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.92 Aligned_cols=262 Identities=24% Similarity=0.386 Sum_probs=199.1
Q ss_pred CCCCceeccCcceEEEEEEe-----cCCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecC--CeEEE
Q 036879 740 FSENNLLGKGSFGSVYKGTL-----SDGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSD--HFKAL 811 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 811 (1029)
|+..+.||+|+||+||++.. .++..||+|.++.... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988653 3578899999876532 3456788999999999999999999988653 46789
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++++|.+++.. ..+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999999854 35899999999999999999999 778999999999999999999999999999866433
Q ss_pred CCce--eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch-hccchhhhhhhhhh
Q 036879 892 TSMT--QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN-DSLHGKIINVVDIN 964 (1029)
Q Consensus 892 ~~~~--~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~d~~ 964 (1029)
.... .....++..|+|||.. .+.++||||||+++|||++|+.||............... ......+.+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 2211 1223356679999974 577999999999999999999998653221111111000 00001111111111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
. ....+..++..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 241 ~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 M------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred C------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1 01112345678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=321.06 Aligned_cols=250 Identities=28% Similarity=0.513 Sum_probs=199.8
Q ss_pred hCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
.++|.+.+.||+|+||.||+|+.. ++..||+|.++..... ..+.+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 345788899999999999999863 3478999998765444 457899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc
Q 036879 810 ALVLEYMPNGSLENWMYNKN-------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV 876 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~ 876 (1029)
++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 99999999999999996542 34788899999999999999999 778999999999999999999
Q ss_pred EEEEccCCceecCCCCC-ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhch
Q 036879 877 ACLSDFGISKLLGDETS-MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVN 950 (1029)
Q Consensus 877 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 950 (1029)
+||+|||++........ .......+++.|+|||++ ++.++||||+||++|||++ |+.||......+. +
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~-----~- 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV-----I- 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-----H-
Confidence 99999999976533221 112233467889999973 6778999999999999998 9999865321110 0
Q ss_pred hccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 951 DSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 951 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
+.+. ... ....+..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus 235 --------~~~~---~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 --------ECIT---QGR---LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --------HHHH---cCC---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0000 000 01112235677999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=326.16 Aligned_cols=237 Identities=21% Similarity=0.298 Sum_probs=186.2
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||+||+|+.. +++.||+|.++... ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 68899999997643 22344556677777654 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|+|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 999998854 346899999999999999999999 7789999999999999999999999999997653322 22233
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..||+.|+|||++ ++.++||||+||++|||++|+.||......+. .. .+.. ....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~-----~~---------~i~~-------~~~~ 214 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-----FD---------SILN-------DRPH 214 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH-----HH---------HHHc-------CCCC
Confidence 5689999999984 57789999999999999999999975321100 00 0000 0011
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCHH-HHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINIK-EALT 1006 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~-evl~ 1006 (1029)
.+..++.++.+++.+||+.+|++||++. ++.+
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1223456788999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=320.94 Aligned_cols=251 Identities=21% Similarity=0.397 Sum_probs=197.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHF 808 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 808 (1029)
..++|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5677999999999999999999753 35679999986543 2334568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEE
Q 036879 809 KALVLEYMPNGSLENWMYNKN---------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACL 879 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl 879 (1029)
.++||||+++++|.+++.... ...++..+..++.|+++|++||| +.|++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532 23577889999999999999999 778999999999999999999999
Q ss_pred EccCCceecCCCCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhcc
Q 036879 880 SDFGISKLLGDETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSL 953 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 953 (1029)
+|||+++......... .....+++.|+|||.+ ++.++|||||||++|||++ |+.||.+..... ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~~------ 232 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VLR------ 232 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH------
Confidence 9999997654322211 1223457789999983 5778999999999999999 688886531110 000
Q ss_pred chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 954 HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 954 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
....... ...+..++..+.+++.+||+.+|++|||+.|+++.++
T Consensus 233 -----~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 -----FVMEGGL-------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -----HHHcCCc-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0000000 0112234667899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=321.77 Aligned_cols=263 Identities=22% Similarity=0.312 Sum_probs=191.5
Q ss_pred CCCCCCceeccCcceEEEEEEec--CCcEEEEEEeeccc--chhhHHHHHHHHHHhcC---CCCceEEEEEEEe-----c
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS--DGMQIAVKVFNLEL--EGTLRSFDAECEILGSI---RHRNLVKIISTCS-----S 805 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 805 (1029)
.+|++.+.||+|+||+||+|+.. +++.||+|.++... ......+.+|+++++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 47889999987543 22234566777777665 6999999999985 2
Q ss_pred CCeEEEEEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCC
Q 036879 806 DHFKALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGI 884 (1029)
Q Consensus 806 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~ 884 (1029)
....++||||++ ++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456789999996 6999988654 345899999999999999999999 77899999999999999999999999999
Q ss_pred ceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc---cchhh
Q 036879 885 SKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS---LHGKI 957 (1029)
Q Consensus 885 a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~ 957 (1029)
++...... ......|++.|+|||.+ ++.++||||+||++|||++|++||......+. +....... ....+
T Consensus 157 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 157 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDW 233 (290)
T ss_pred eEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCChhhc
Confidence 98764331 22335689999999974 57789999999999999999999976322110 10000000 00000
Q ss_pred hhhh---hhhhhhh-hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 958 INVV---DINLLQK-EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 958 ~~~~---d~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.... ....... ...........+..+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 0000000 000001112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=320.16 Aligned_cols=265 Identities=27% Similarity=0.439 Sum_probs=201.7
Q ss_pred CCCCCCceeccCcceEEEEEEec-----CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEec--CCeEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-----DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS--DHFKA 810 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 810 (1029)
.+|++.+.||+|+||.||+|..+ ++..||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888899999999999999742 578999999887666666789999999999999999999998754 35678
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999766667899999999999999999999 77899999999999999999999999999987644
Q ss_pred CCCce--eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccch--hhhhhhh
Q 036879 891 ETSMT--QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG--KIINVVD 962 (1029)
Q Consensus 891 ~~~~~--~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~d 962 (1029)
..... .....++..|+|||+. ++.++|||||||++|||++|..|+...... +.......... ......+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHH
Confidence 32211 1122344569999983 577899999999999999998776432111 00000000000 0000000
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
. .. .....+.+..++..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 238 ~-~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 L-LK--NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred H-Hh--cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0 00 0001112234567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.14 Aligned_cols=250 Identities=27% Similarity=0.469 Sum_probs=199.6
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.++|++.++||+|+||.||+|++.++..||+|+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 456899999999999999999987777899999875432 34578999999999999999999998754 5578999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 817 PNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 817 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
++|+|.+++.+. ...+++..+..++.|+++||+|+| +++|+||||||+||++++++.+||+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999754 345789999999999999999999 7789999999999999999999999999998665433222
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
.....++..|+|||+. ++.++|||||||++|||++ |+.||......+. .+......
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~--------------~~~~~~~~----- 220 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY----- 220 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH--------------HHHHhcCC-----
Confidence 2234467789999984 5778999999999999999 7888865321110 00000000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
....+..++..+.+++.+|++.+|++||+++++++.|++.
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0011234567789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=325.11 Aligned_cols=265 Identities=22% Similarity=0.331 Sum_probs=199.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 367899999999999999999876 68899999987543 2234467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|++ +++.+++......+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 85 YLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 996 4898888776667899999999999999999999 77899999999999999999999999999976543222
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhc---hhccchhhhhhhhh---
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV---NDSLHGKIINVVDI--- 963 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~d~--- 963 (1029)
......+++.|+|||.. ++.++||||+||++|||++|+.||......+. +.... .......+......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchhhh
Confidence 12234578999999974 46689999999999999999999975322111 00000 00000001110000
Q ss_pred ---hhhhh-hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 ---NLLQK-EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ---~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..... ...........+.++.+++.+|++.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000 000001112346678999999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=321.91 Aligned_cols=259 Identities=24% Similarity=0.451 Sum_probs=202.8
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCc--EEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGM--QIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 812 (1029)
++|++.+.||+|+||.||+|+.. ++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999875 343 47888877432 33456789999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcE
Q 036879 813 LEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVA 877 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~ 877 (1029)
|||+++++|.+++.... ..+++..+..++.|++.|++||| ++||+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999996532 34788999999999999999999 7789999999999999999999
Q ss_pred EEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhc
Q 036879 878 CLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDS 952 (1029)
Q Consensus 878 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 952 (1029)
||+|||++...... ........+..|+|||+. ++.++|||||||++|||++ |+.||......+. .
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-----~--- 228 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-----Y--- 228 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----H---
Confidence 99999998643211 111112235679999984 5778999999999999997 9999865321110 0
Q ss_pred cchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcccccC
Q 036879 953 LHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIEN 1021 (1029)
Q Consensus 953 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~~ 1021 (1029)
....... ....+..++..+.+++.+||+.+|.+||+++++++.|+.+.+......+.
T Consensus 229 ------~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~~~ 285 (297)
T cd05089 229 ------EKLPQGY------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNM 285 (297)
T ss_pred ------HHHhcCC------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccccc
Confidence 0000000 01112345678899999999999999999999999999998877665543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=328.15 Aligned_cols=238 Identities=23% Similarity=0.298 Sum_probs=190.0
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 68899999997642 23345677889988866 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|+|.+++.. .+.+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT 155 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence 999988854 456889999999999999999999 77899999999999999999999999999975432222 2233
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..|++.|+|||++ ++.++||||+||++|||++|+.||......+. +..... .. ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-------------~~~i~~----~~----~~ 214 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-------------FESILH----DD----VL 214 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-------------HHHHHc----CC----CC
Confidence 5689999999983 67799999999999999999999975321100 000000 00 00
Q ss_pred HHHHHHHHHHHHHHHcccccccCCC-------CHHHHHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERI-------NIKEALTK 1007 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rp-------t~~evl~~ 1007 (1029)
.+..++.++.+++.+|++.||++|| ++++++++
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1122456789999999999999999 88888865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=319.47 Aligned_cols=247 Identities=24% Similarity=0.319 Sum_probs=197.2
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.|++.+.||+|+||+||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999875 789999999875421 223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 815 YMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
|+++|+|.+++... ...+++..+..++.|++.|++||| +.||+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999888654 346899999999999999999999 77899999999999999999999999999987643322
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
.....|++.|+|||++ ++.++||||+||++|||++|+.||...... ... ..+...+. ..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~---------~~~~~~~~----~~- 220 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKR---------EEVERRVK----ED- 220 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHH---------HHHHHHhh----hc-
Confidence 1234689999999984 567899999999999999999999752110 000 00000000 00
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
....+...+..+.+++.+||..||++|| ++++++++
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 --QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0111233567789999999999999999 88898775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=313.69 Aligned_cols=243 Identities=27% Similarity=0.446 Sum_probs=193.6
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999875 78999999876543 33456789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce-ecccc
Q 036879 822 ENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT-QTQTL 900 (1029)
Q Consensus 822 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~ 900 (1029)
.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+|++|||++.......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999766667899999999999999999999 7789999999999999999999999999987543321111 11112
Q ss_pred CCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHH
Q 036879 901 ATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTA 975 (1029)
Q Consensus 901 gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 975 (1029)
.+..|+|||.+ ++.++||||+||++|||++ |..||....... ....+.... ....
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--------------~~~~~~~~~------~~~~ 217 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--------------TREAIEQGV------RLPC 217 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--------------HHHHHHcCC------CCCC
Confidence 34679999984 5668999999999999998 888886421110 001111000 0111
Q ss_pred HHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 976 KEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 976 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
+..++..+.+++.+|+..+|++|||+.|+.+.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.53 Aligned_cols=243 Identities=30% Similarity=0.488 Sum_probs=194.8
Q ss_pred ceeccCcceEEEEEEecCCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCHH
Q 036879 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLE 822 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 822 (1029)
+.||+|+||.||+|...+++.||+|.++.... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999876543 23446889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccCC
Q 036879 823 NWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT 902 (1029)
Q Consensus 823 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 902 (1029)
+++......+++..+..++.|++.|+.|+| ++|++||||||+||+++.++.+|++|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999766667899999999999999999999 77899999999999999999999999999975433222122222346
Q ss_pred ccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHH
Q 036879 903 IGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKE 977 (1029)
Q Consensus 903 ~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 977 (1029)
..|+|||+. ++.++|||||||++||+++ |..||........ .. .. ... . ....+.
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~--~~--------~~----~~~----~--~~~~~~ 217 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA--RE--------QV----EKG----Y--RMSCPQ 217 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH--HH--------HH----HcC----C--CCCCCC
Confidence 789999974 5668999999999999998 9999865311100 00 00 000 0 001122
Q ss_pred HHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 978 QCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 978 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
.++..+.+++.+|+..+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 34677999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=336.15 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=192.9
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999865 78999999987542 233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++.. .+.+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999999854 456889999999999999999999 78899999999999999999999999999964321100
Q ss_pred c----------------------------------------------eeccccCCccccCccCC----CCCCcchhHHHH
Q 036879 894 M----------------------------------------------TQTQTLATIGYMAPEWK----LSRKGDVYSYGI 923 (1029)
Q Consensus 894 ~----------------------------------------------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGv 923 (1029)
. .....+||+.|+|||++ ++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 00124689999999984 678999999999
Q ss_pred HHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCC---CC
Q 036879 924 ILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEER---IN 1000 (1029)
Q Consensus 924 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---pt 1000 (1029)
++|||++|+.||......+. +.. ..... .....+.....+..+.+++.+|+. +|.+| ++
T Consensus 237 il~elltG~~Pf~~~~~~~~-~~~------------i~~~~----~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 237 IMFECLIGWPPFCSENSHET-YRK------------IINWR----ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHH-HHH------------HHccC----CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999965321110 000 00000 000000011235678899999997 67665 59
Q ss_pred HHHHHHH
Q 036879 1001 IKEALTK 1007 (1029)
Q Consensus 1001 ~~evl~~ 1007 (1029)
+.|++++
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=315.28 Aligned_cols=250 Identities=24% Similarity=0.430 Sum_probs=200.7
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..++|++.++||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3467889999999999999999988899999999875433 3467889999999999999999999874 4568999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++++|.+++... ...+++..+..++.|++.|++||| +.|++||||||+||++++++.++++|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999998654 346899999999999999999999 778999999999999999999999999999876533222
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......++..|+|||+. ++.++||||||+++||+++ |+.||......+. . ......
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~------------~~~~~~----- 219 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV--I------------QNLERG----- 219 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH--H------------HHHHcC-----
Confidence 22233467789999974 5778999999999999999 9999865321110 0 000000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
...+.+..++.++.+++.+|+..+|++||+++++.+.|+.
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 -YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0011122345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=318.51 Aligned_cols=241 Identities=26% Similarity=0.316 Sum_probs=190.9
Q ss_pred eccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 746 LGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 746 lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
||+|+||+||++... +++.||+|.+..... ...+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 789999999875432 2235677899999999999999999999999999999999999999
Q ss_pred HHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 822 ENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 822 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
.+++.. ....+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.+..+...... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 988754 3356899999999999999999999 778999999999999999999999999999866443222 223
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..|++.|+|||++ ++.++|||||||++|||++|+.||........ .. ..... .... ...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~------------~~~~~-~~~~---~~~ 219 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NK------------ELKQR-ILND---SVT 219 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HH------------HHHHh-hccc---CCC
Confidence 4689999999984 56789999999999999999999965211100 00 00000 0000 011
Q ss_pred HHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
.+..++..+.+++.+|++.||++|| ++++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1234567789999999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=327.43 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=190.1
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||.||+|+.. +++.||+|++++.. ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 68899999998642 23345678889888776 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|+|..++.. ...+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST 155 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence 999988754 456899999999999999999999 77899999999999999999999999999975322211 2223
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..||+.|+|||++ ++.++|||||||++|||++|+.||............ ........+ .. ....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~-----~~~~~~~~i----~~---~~~~ 223 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-----TEDYLFQVI----LE---KQIR 223 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccc-----cHHHHHHHH----hc---CCCC
Confidence 5689999999984 577899999999999999999999642211110000 000000000 00 0011
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCC------HHHHHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERIN------IKEALTK 1007 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt------~~evl~~ 1007 (1029)
.+...+..+.+++.+|++.||++||+ +.+++++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 22345667899999999999999998 4677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.08 Aligned_cols=254 Identities=24% Similarity=0.415 Sum_probs=202.7
Q ss_pred hCCCCCCceeccCcceEEEEEEecC----CcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSD----GMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
.++|.+.+.||+|+||.||+|...+ ...||+|...... ....+.+.+|+.++++++||||+++++++.. +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3457888999999999999998643 3468999887654 3445689999999999999999999999875 45689
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999999776667899999999999999999999 778999999999999999999999999999866443
Q ss_pred CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.........++..|+|||.+ ++.++|||||||++||+++ |+.||......+. .....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~~~---------------- 222 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IGRIE---------------- 222 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHH----------------
Confidence 32222333355689999974 5678999999999999986 9999865321111 00000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
. ......+..++..+.+++.+|+..+|++|||+.++++.|+++.+.
T Consensus 223 ~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 223 N--GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred c--CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 000112234567899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=327.45 Aligned_cols=247 Identities=21% Similarity=0.296 Sum_probs=191.2
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|..+++.+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999875 78999999998643 23345688899999988 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|+|.+++.. .+.+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST 155 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence 999988854 457899999999999999999999 7789999999999999999999999999987432211 12233
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..||+.|+|||++ ++.++||||+||++|||++|+.||+........... ......+.+ ... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~-----~~~~~~~~~----~~~---~~~ 223 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN-----TEDYLFQVI----LEK---QIR 223 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccccc-----chHHHHHHH----HcC---CCC
Confidence 5689999999984 577899999999999999999999642211100000 000000000 000 011
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCC------HHHHHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERIN------IKEALTK 1007 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt------~~evl~~ 1007 (1029)
.+..++..+.+++.+|++.||++|++ +++++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 22335667899999999999999997 6777754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.66 Aligned_cols=250 Identities=26% Similarity=0.454 Sum_probs=197.6
Q ss_pred CCCCCCceeccCcceEEEEEEe-----cCCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTL-----SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
++|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999974 246789999987543 2334678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC
Q 036879 812 VLEYMPNGSLENWMYNKN----------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM 875 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~ 875 (1029)
||||+++++|.+++.... ..+++..+..++.|++.|++||| ++||+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 999999999999985321 24778889999999999999999 77899999999999999999
Q ss_pred cEEEEccCCceecCCCCC-ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhc
Q 036879 876 VACLSDFGISKLLGDETS-MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRV 949 (1029)
Q Consensus 876 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 949 (1029)
.+||+|||+++....... .......++..|+|||+. ++.++|||||||++|||++ |..||...... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~--- 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVI--- 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHH---
Confidence 999999999986543221 112233456789999984 5778999999999999998 88898652110 000
Q ss_pred hhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 950 NDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 950 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
+.+.... ....+..++..+.+++.+||+.+|++||++.++.+++..
T Consensus 237 ---------~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 ---------EMVRKRQ------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---------HHHHcCC------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111000 011123456778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=326.12 Aligned_cols=242 Identities=20% Similarity=0.277 Sum_probs=191.7
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999876 67899999988643 22334567788888777 6899999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 99999999998854 356889999999999999999999 77899999999999999999999999999975432221
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......||+.|+|||++ ++.++|||||||++|||++|+.||........ .. .....
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~~-----------~i~~~------ 216 (323)
T cd05616 157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQ-----------SIMEH------ 216 (323)
T ss_pred -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--HH-----------HHHhC------
Confidence 22335689999999984 57799999999999999999999975321100 00 00000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCH-----HHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINI-----KEALT 1006 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~evl~ 1006 (1029)
....+...+.++.+++.+|++.+|++|+++ .++.+
T Consensus 217 --~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 217 --NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred --CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 001122346678999999999999999974 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=320.29 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=203.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888999999999999999875 6899999999876666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||.+........ .
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 9999999999776778999999999999999999999 77899999999999999999999999999876533221 2
Q ss_pred eccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.....+++.|+|||.. ++.++||||+||++|||++|+.||........ .....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-------------~~~~~----- 221 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-------------LLKIL----- 221 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-------------HHHHh-----
Confidence 2334688999999974 35589999999999999999999875311100 00000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.........+..++.++.+++..||..+|++||++.+++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 222 KSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00000111123456678999999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=319.17 Aligned_cols=247 Identities=27% Similarity=0.380 Sum_probs=198.9
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++..+...++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999876 5788999998766555567789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
++|..++......+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||++........ ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc-cccc
Confidence 9999988766677999999999999999999999 77899999999999999999999999999876533221 2223
Q ss_pred ccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 899 TLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 899 ~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
..++..|+|||++ ++.++||||+||++|||++|++||......+. +. ..... .
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~--------~~~~~-----~ 224 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-----LL--------KIAKS-----E 224 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-----HH--------HHhhc-----C
Confidence 4688999999974 34589999999999999999999865311100 00 00000 0
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
......+..++..+.+++.+||+.+|++||++.+++++-
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 225 PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 000111223466789999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.06 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=200.7
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
+.+++.+.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+++++.++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345666666789999999999999865 6788999998776655667899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC-CCcEEEEccCCceecC
Q 036879 813 LEYMPNGSLENWMYNKNRSF--DILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-SMVACLSDFGISKLLG 889 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~ 889 (1029)
|||+++++|.+++......+ ++..+..++.|++.|++||| ++||+||||||+||+++. ++.++|+|||.+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999997655555 78888999999999999999 778999999999999986 6799999999997654
Q ss_pred CCCCceeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
.... ......++..|+|||+. ++.++||||+|+++|+|++|+.||........... ..
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~---------------~~ 224 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF---------------KV 224 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh---------------hh
Confidence 3222 12224578999999974 56789999999999999999999865321111000 00
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
... ......+..++..+.+++.+||+.+|++|||+.|++++
T Consensus 225 ~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 225 GMF---KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hhh---ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000 00011223456678999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=325.07 Aligned_cols=236 Identities=21% Similarity=0.310 Sum_probs=186.5
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||.||+|+.. +|+.||+|.++... .........|.+++... +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999876 68999999997643 23345567788887754 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|+|.+++.. ...+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RAST 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ceec
Confidence 999998854 456889999999999999999999 77899999999999999999999999999875322211 2233
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..||+.|+|||++ ++.++||||+||++|||++|+.||......+ .. +.+... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~------------~~~~~~-------~~~ 214 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LF------------ESIRVD-------TPH 214 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HH------------HHHHhC-------CCC
Confidence 5689999999984 6778999999999999999999996531110 00 000000 001
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCHH-HHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINIK-EAL 1005 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~-evl 1005 (1029)
.+..++.++.+++.+|++.||++||++. ++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1122456789999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=336.47 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=192.3
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6889999999999999999865 68999999987542 2234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC---
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE--- 891 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~--- 891 (1029)
|+++|+|.+++.. .+.+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+|..+...
T Consensus 82 ~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999854 446788889999999999999999 778999999999999999999999999997533100
Q ss_pred ---------------------------------------CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHH
Q 036879 892 ---------------------------------------TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMET 928 (1029)
Q Consensus 892 ---------------------------------------~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~el 928 (1029)
.........||+.|+|||++ ++.++||||+||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00001124689999999984 57789999999999999
Q ss_pred hcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCC---CHHHHH
Q 036879 929 FTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI---NIKEAL 1005 (1029)
Q Consensus 929 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---t~~evl 1005 (1029)
++|+.||......+.. ....... ...........+..+.+++.+|+ .+|++|+ ++.|++
T Consensus 238 l~G~~Pf~~~~~~~~~-------------~~i~~~~----~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 238 LVGQPPFLADTPAETQ-------------LKVINWE----TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred hhCCCCCCCCCHHHHH-------------HHHhccC----ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 9999999753211110 0000000 00000001123556788888876 5999999 899999
Q ss_pred HH
Q 036879 1006 TK 1007 (1029)
Q Consensus 1006 ~~ 1007 (1029)
++
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 76
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=323.50 Aligned_cols=237 Identities=22% Similarity=0.327 Sum_probs=187.2
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhc-CCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGS-IRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..+++. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999876 68899999998652 2334556778888876 4999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|+|.+++.. ...+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence 999998854 356889999999999999999999 77899999999999999999999999999875432211 1223
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..||+.|+|||++ ++.++||||+||++|||++|+.||......+ .. +.+.. .. ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~------------~~i~~---~~----~~ 214 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LF------------QSIRM---DN----PC 214 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HH------------HHHHh---CC----CC
Confidence 4689999999984 5778999999999999999999996531110 00 00000 00 00
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCHH-HHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINIK-EALT 1006 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~-evl~ 1006 (1029)
.+..++.++.+++.+|++.+|++||++. ++.+
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1123456789999999999999999997 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=317.99 Aligned_cols=249 Identities=27% Similarity=0.363 Sum_probs=201.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.+.|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467889999999999999999876 6899999999876666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
++++++..++.+....+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.+...... ...
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~ 166 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQR 166 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc-ccc
Confidence 9999999988776677999999999999999999999 778999999999999999999999999998754322 111
Q ss_pred eccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.....+++.|+|||++ ++.++|||||||++|||++|+.||........ +. ....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~------------~~~~---- 229 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LL------------KIAK---- 229 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-HH------------HHhc----
Confidence 2234578899999985 35579999999999999999999865211000 00 0000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
........+..++..+.+++.+||..+|++||++.|++++
T Consensus 230 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 230 -SEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -CCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000011122345678999999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.80 Aligned_cols=242 Identities=28% Similarity=0.483 Sum_probs=192.3
Q ss_pred eccCcceEEEEEEec---CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 746 LGKGSFGSVYKGTLS---DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 746 lg~G~fg~V~~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++||||+++++++.. +..++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999764 456799999876533 234678999999999999999999999864 467899999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce--eccc
Q 036879 822 ENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT--QTQT 899 (1029)
Q Consensus 822 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~ 899 (1029)
.+++......+++..+..++.|++.|++||| ++|++||||||+||+++.++.+||+|||++.......... ....
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 9999766778999999999999999999999 7789999999999999999999999999998654332221 1112
Q ss_pred cCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 900 LATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 900 ~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
.++..|+|||. .++.++|||||||++||+++ |+.||......+. . ..+... ....
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~------------~~~~~~------~~~~ 218 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV--M------------SFIEQG------KRLD 218 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH--H------------HHHHCC------CCCC
Confidence 33578999997 35778999999999999996 9999875321110 0 000000 0011
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
.+..++.++.+++.+||..+|++||++.++.+.|+.+
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2234577899999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.79 Aligned_cols=249 Identities=26% Similarity=0.443 Sum_probs=198.1
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++|||++++++++.. +..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 35688889999999999999998777789999876543 234678899999999999999999998854 5678999999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 817 PNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 817 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
++++|.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||++++++.++|+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 9999999996543 45889999999999999999999 7789999999999999999999999999998764433222
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
.....++..|+|||.. .+.++|||||||++|||++ |+.||.+....+. .. ..... .
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~------------~~~~~----~- 220 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV--LE------------QVERG----Y- 220 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH------------HHHcC----C-
Confidence 2233467789999974 5778999999999999999 8999865321110 00 00000 0
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
....+...+..+.+++.+||..+|++||+++++.+.|++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 -RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 001123346779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=325.24 Aligned_cols=238 Identities=23% Similarity=0.290 Sum_probs=190.4
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||+||+|+.. +++.||+|+++... ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 68899999998653 23345677889998888 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 999998854 346899999999999999999999 77899999999999999999999999999875322211 1223
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..|++.|+|||++ ++.++||||+||++|||++|+.||....... ... ..... ...
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-----~~~--------~i~~~--------~~~ 214 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-----LFQ--------SILED--------EVR 214 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-----HHH--------HHHcC--------CCC
Confidence 4689999999984 5778999999999999999999996532110 000 00000 001
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCH-----HHHHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINI-----KEALTK 1007 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~evl~~ 1007 (1029)
.+..++..+.+++.+||+.||++||++ .+++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 122346678999999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=326.02 Aligned_cols=251 Identities=17% Similarity=0.231 Sum_probs=197.0
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||+||+++.. +++.||+|++.+.. ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999876 57889999986532 223445888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++.+....+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999776677899999999999999999999 77899999999999999999999999999976543333
Q ss_pred ceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
.......||+.|+|||++ ++.++|||||||++|||++|+.||...... ... .......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-----~~~--------~~i~~~~ 224 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETY--------GKIMNHK 224 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-----HHH--------HHHhCCC
Confidence 333345699999999974 467899999999999999999999652110 000 0000000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccC--CCCHHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEE--RINIKEALTK 1007 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~ 1007 (1029)
. ..........++..+.+++.+|+..++++ |++++|++++
T Consensus 225 ~---~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 225 E---RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c---cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 00001111234677889999988655444 7899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=332.15 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=196.0
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC-----eEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH-----FKA 810 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 810 (1029)
+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999875 78999999986542 234567889999999999999999999998766 789
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+. ++|.+++. ....+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999995 68888774 3456899999999999999999999 77899999999999999999999999999986544
Q ss_pred CCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhc---hhccchhhhhhh-
Q 036879 891 ETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV---NDSLHGKIINVV- 961 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~- 961 (1029)
..........+++.|+|||++ ++.++||||+||++|||++|+.||......+. +.... .......+....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-LDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCHHHHHHhhH
Confidence 333333345688999999974 46789999999999999999999975321110 00000 000000000000
Q ss_pred --hhhhhhhhhhh------hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 --DINLLQKEDAY------LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 --d~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
........... .......+.++.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000 00111235678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=341.11 Aligned_cols=250 Identities=26% Similarity=0.325 Sum_probs=199.0
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC----
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH---- 807 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 807 (1029)
...++|++.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+.++..++|+|++++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34578999999999999999999864 79999999987543 334567889999999999999999988775432
Q ss_pred ----eEEEEEeccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEE
Q 036879 808 ----FKALVLEYMPNGSLENWMYNK---NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLS 880 (1029)
Q Consensus 808 ----~~~lV~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~ 880 (1029)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|+| ++||+||||||+||+++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence 367999999999999998643 346889999999999999999999 7889999999999999999999999
Q ss_pred ccCCceecCCCC-CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccch
Q 036879 881 DFGISKLLGDET-SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG 955 (1029)
Q Consensus 881 Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 955 (1029)
|||+++.+.... ........||+.|+|||++ ++.++|||||||++|||++|+.||...... .
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----~-------- 252 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-----E-------- 252 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----H--------
Confidence 999998764321 1122335689999999984 677899999999999999999999652111 0
Q ss_pred hhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 KIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+........ ...+..++..+.+++.+||+.+|++||++.+++++
T Consensus 253 ----~~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 ----VMHKTLAGRY---DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ----HHHHHhcCCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111110000 11223456789999999999999999999999875
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=312.37 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=197.9
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-----chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-----EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999864 78999999987542 1224578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++++|.+++.. ...+++..+..++.|++.|++||| +.||+||||+|+||++++++.++|+|||.++.....
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999999998854 345888999999999999999999 778999999999999999999999999999765432
Q ss_pred CCcee--ccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 892 TSMTQ--TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 892 ~~~~~--~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
..... ....++..|+|||.. ++.++||||+|+++|||++|+.||........ .......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------------~~~~~~~-- 222 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-------------IFKIATQ-- 222 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-------------HHHHhcc--
Confidence 21111 234578899999984 56789999999999999999999865211100 0000000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
......+..++..+.+++.+||..+|++|||+.|++++
T Consensus 223 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 ----PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00011223456778999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.72 Aligned_cols=245 Identities=25% Similarity=0.422 Sum_probs=201.4
Q ss_pred CCceeccCcceEEEEEEec--CCc--EEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 742 ENNLLGKGSFGSVYKGTLS--DGM--QIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 742 ~~~~lg~G~fg~V~~~~~~--~~~--~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
..++||+|.||.|++|.|. +|+ .||||.++..... ...+|.+|+.+|-+|+|||++++||...+ ....+|||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3467999999999999875 344 5799999877654 67899999999999999999999999987 6678999999
Q ss_pred CCCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 817 PNGSLENWMYN-KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 817 ~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+.|+|.+.+++ .+..+.......++.|||.|+.||. ++++||||+.++|+++-....+||+|||+.+-++..+.+-
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 99999999987 5567888899999999999999999 7889999999999999999999999999999886544332
Q ss_pred --eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 896 --QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 896 --~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
.........|+|||.+ ++.++|||+|||++|||+| |..||-+....+ +.+.+|
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q--------------IL~~iD------ 329 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ--------------ILKNID------ 329 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH--------------HHHhcc------
Confidence 2223456789999984 7889999999999999999 677876531111 122222
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
.+.....++.|+++++++++.||.+.|++|||+.++.+.+-.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 112234467899999999999999999999999999865543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=310.88 Aligned_cols=245 Identities=25% Similarity=0.375 Sum_probs=199.8
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999875 78999999987542 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++++|.+++... ...+++..+..++.|++.|++||| +.||+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999765 457899999999999999999999 778999999999999999999999999999876543322
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
.....+++.|+|||+. ++.++|+|||||++|||++|+.||....... ... .... .
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~-----------~~~~----~--- 216 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LIL-----------KIIR----G--- 216 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHH-----------HHHc----C---
Confidence 2234578899999984 5678999999999999999999986532110 000 0000 0
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....+..++..+.+++.+||+.+|++||++.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0011122456779999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.88 Aligned_cols=256 Identities=28% Similarity=0.465 Sum_probs=199.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCc--EEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGM--QIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 811 (1029)
.++|++.+.||+|+||.||+|.+. ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 356888899999999999999865 454 45777765432 33456788999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc
Q 036879 812 VLEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV 876 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~ 876 (1029)
||||+++++|.+++.... ..+++..+..++.|++.|++||| ++||+||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 999999999999996432 25789999999999999999999 788999999999999999999
Q ss_pred EEEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchh
Q 036879 877 ACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVND 951 (1029)
Q Consensus 877 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 951 (1029)
+||+|||++..... ........++..|+|||.. ++.++|||||||++|||+| |..||......+ ...
T Consensus 163 ~kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~---- 234 (303)
T cd05088 163 AKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYE---- 234 (303)
T ss_pred EEeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHH----
Confidence 99999999864321 1111122346689999973 5779999999999999998 999986421110 000
Q ss_pred ccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcc
Q 036879 952 SLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLT 1017 (1029)
Q Consensus 952 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~ 1017 (1029)
.+.... ....+..++..+.+++.+||+.+|++||+++++++.++++.....+
T Consensus 235 --------~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 235 --------KLPQGY------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred --------HHhcCC------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 000000 0011122456789999999999999999999999999988766553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=316.82 Aligned_cols=266 Identities=23% Similarity=0.400 Sum_probs=200.6
Q ss_pred CCCCCCceeccCcceEEEEEEe-----cCCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecC--CeE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTL-----SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSD--HFK 809 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 809 (1029)
.-|++.+.||+|+||.||.|+. .++..||+|.++... ......+.+|++++++++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999974 257889999987553 33456789999999999999999999998775 568
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++++|.+++.+....+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 8999999999999999766667899999999999999999999 7789999999999999999999999999998664
Q ss_pred CCCCc--eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 890 DETSM--TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 890 ~~~~~--~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
..... ......++..|+|||+. ++.++|||||||++|||++++.|+................. ......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 238 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ--MTVTRLVRV 238 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc--ccHHHHHHH
Confidence 33221 11224466789999973 56789999999999999998877543211100000000000 000000000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
.. .....+.+..++..+.+++.+|++.+|++|||++++++.++++
T Consensus 239 -~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 -LE--EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HH--cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 0001111234567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.13 Aligned_cols=249 Identities=26% Similarity=0.468 Sum_probs=198.9
Q ss_pred CCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
.+|...+.||+|+||.||+|... ++..+|+|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45777899999999999999642 466899999876655666789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcE
Q 036879 812 VLEYMPNGSLENWMYNKN--------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVA 877 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~ 877 (1029)
||||+++++|.+++.... ..+++..+..++.|++.|++||| +.||+||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 999999999999986543 24788999999999999999999 7789999999999999999999
Q ss_pred EEEccCCceecCCCCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchh
Q 036879 878 CLSDFGISKLLGDETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVND 951 (1029)
Q Consensus 878 kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 951 (1029)
||+|||++.......... .....+++.|+|||.. ++.++|||||||++|||++ |++||......+. .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-----~-- 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-----I-- 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-----H--
Confidence 999999997654322111 1223457889999973 5778999999999999998 8999865321110 0
Q ss_pred ccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 952 SLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 952 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
...... . ....+..++..+.+++.+||+.||++||++.|+.+.|+
T Consensus 235 ------~~~~~~----~---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ------ECITQG----R---ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ------HHHHcC----c---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000000 0 01112345677899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=334.06 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=190.8
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.|+..+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999875 78899999987543 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC--
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET-- 892 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-- 892 (1029)
|+++|+|.+++.+. ..+++..+..++.||+.|++||| +.||+||||||+||+++.++.+||+|||+|..+....
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999998653 46888899999999999999999 7789999999999999999999999999975321000
Q ss_pred --------------------------------------------CceeccccCCccccCccCC----CCCCcchhHHHHH
Q 036879 893 --------------------------------------------SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGII 924 (1029)
Q Consensus 893 --------------------------------------------~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvi 924 (1029)
.......+||+.|+|||++ ++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0001124689999999984 5778999999999
Q ss_pred HHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCC---H
Q 036879 925 LMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERIN---I 1001 (1029)
Q Consensus 925 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~ 1001 (1029)
+|||++|+.||......+. ........ .....+.....+.++.+++.+|+ .+|++|++ +
T Consensus 238 l~elltG~~Pf~~~~~~~~-------------~~~i~~~~----~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLET-------------QMKVINWQ----TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred HHHHHhCCCCCCCCCHHHH-------------HHHHHccC----CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 9999999999975321110 00000000 00000011123556778887765 49999997 8
Q ss_pred HHHHHH
Q 036879 1002 KEALTK 1007 (1029)
Q Consensus 1002 ~evl~~ 1007 (1029)
.|++++
T Consensus 300 ~ei~~h 305 (382)
T cd05625 300 DEIKAH 305 (382)
T ss_pred HHHhcC
Confidence 888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.03 Aligned_cols=235 Identities=22% Similarity=0.366 Sum_probs=186.4
Q ss_pred ceeccCcceEEEEEEecC-------------CcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 744 NLLGKGSFGSVYKGTLSD-------------GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~-------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
+.||+|+||.||+|+..+ ...||+|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358999877665555667889999999999999999999999988999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc-------EEEEccC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV-------ACLSDFG 883 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~-------~kl~Dfg 883 (1029)
+||||+++++|..++......+++..+..++.||++|++||| +++|+||||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998766677999999999999999999999 788999999999999987664 8999999
Q ss_pred CceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHh-cCCCCCCcccccccccchhchhccchhh
Q 036879 884 ISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETF-TKKKPTDELFVGEISLKSRVNDSLHGKI 957 (1029)
Q Consensus 884 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 957 (1029)
.+...... ....++..|+|||.. ++.++|||||||++|||+ +|+.||......+. .
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~----------- 219 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--E----------- 219 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--H-----------
Confidence 98754322 224578899999974 466899999999999998 58888754211100 0
Q ss_pred hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 958 INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 958 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
........ .....+..+.+++.+||+.||++||++.++++.+
T Consensus 220 -~~~~~~~~--------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 -RFYEGQCM--------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -HHHhcCcc--------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00000000 0011245688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.85 Aligned_cols=255 Identities=24% Similarity=0.457 Sum_probs=201.2
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecC
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSD 806 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 806 (1029)
...++|+..+.||+|+||.||+|... ....||+|.+.... ......+.+|+++++++ +||||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34567888999999999999999864 23679999987543 23345688999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE
Q 036879 807 HFKALVLEYMPNGSLENWMYNK---------------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL 871 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill 871 (1029)
+..++||||+++|+|.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence 9999999999999999998642 345889999999999999999999 7789999999999999
Q ss_pred CCCCcEEEEccCCceecCCCCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCccccccccc
Q 036879 872 NESMVACLSDFGISKLLGDETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISL 945 (1029)
Q Consensus 872 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~ 945 (1029)
+.++.+||+|||.++.+....... .....++..|+|||+. ++.++|||||||++||+++ |..||......+.
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 243 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-- 243 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH--
Confidence 999999999999998764432211 1222356789999973 6778999999999999997 8888864211100
Q ss_pred chhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 946 KSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 946 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
.+..... .....+..++..+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 244 ------------~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 ------------FKLLKEG------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------------HHHHHcC------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0000000 001112334667899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.96 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=200.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..+|+..+.||+|+||.||+|+.. +++.||+|.+..........+.+|+++++.++||||+++++++..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 457889999999999999999864 7899999999876555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++.. ..+++.++..++.|++.|++||| +.||+||||||+||+++.++.+||+|||.+........ .
T Consensus 99 ~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred cCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 999999999853 35788999999999999999999 77899999999999999999999999999876543221 1
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
.....+++.|+|||.. .+.++|||||||++|||++|+.||............ . .. ...
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~-~-----------~~------~~~ 234 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-A-----------TN------GTP 234 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH-h-----------cC------CCC
Confidence 2234688999999973 567899999999999999999999653211110000 0 00 000
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+...+..+.+++.+||..+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 011123345678999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=313.33 Aligned_cols=249 Identities=27% Similarity=0.474 Sum_probs=195.6
Q ss_pred CCCCceeccCcceEEEEEEec-C---CcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCe-----
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-D---GMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHF----- 808 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~---~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 808 (1029)
|.+.+.||+|+||.||+|... + +..||+|.++... ......+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567789999999999999864 2 3679999987543 2335678999999999999999999998866544
Q ss_pred -EEEEEeccCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEcc
Q 036879 809 -KALVLEYMPNGSLENWMYNK-----NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDF 882 (1029)
Q Consensus 809 -~~lV~E~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Df 882 (1029)
.++||||+++++|..++... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 78999999999999988542 235889999999999999999999 778999999999999999999999999
Q ss_pred CCceecCCCCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchh
Q 036879 883 GISKLLGDETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGK 956 (1029)
Q Consensus 883 g~a~~~~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 956 (1029)
|.++......... .....++..|+|||.. ++.++|||||||++|||++ |..||.+....+ .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~----------- 224 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--I----------- 224 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--H-----------
Confidence 9998764432221 1223356789999973 6779999999999999999 888886532111 0
Q ss_pred hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 957 IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 957 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
.....+.. ....+..++..+.+++.+||+.||++||++.|+++.|+++
T Consensus 225 ~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 225 YDYLRHGN-------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHcCC-------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00000000 0112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=320.48 Aligned_cols=256 Identities=23% Similarity=0.432 Sum_probs=201.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec--------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecC
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS--------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSD 806 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 806 (1029)
.++|.+.+.||+|+||.||+|+.. ++..||+|.++... ......+.+|+++++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357899999999999999999752 23579999987643 33446688899999999 799999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE
Q 036879 807 HFKALVLEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL 871 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill 871 (1029)
+..++||||+++|+|.+++.... ..+++.++..++.|++.|++||| +.|++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence 99999999999999999996542 24788999999999999999999 7789999999999999
Q ss_pred CCCCcEEEEccCCceecCCCCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCccccccccc
Q 036879 872 NESMVACLSDFGISKLLGDETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISL 945 (1029)
Q Consensus 872 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~ 945 (1029)
+.++.+||+|||.+.......... .....+++.|+|||.. ++.++||||+||++|||++ |+.||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 999999999999997654322111 1112345689999973 5778999999999999998 88888542110
Q ss_pred chhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 946 KSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 946 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
. +.+.+.. ......+..++.++.+++.+||..+|++|||+.|+++.|+++....
T Consensus 250 -~---------~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 -E---------LFKLLKE------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred -H---------HHHHHHc------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 0 0000000 0011223345678899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=312.80 Aligned_cols=252 Identities=27% Similarity=0.508 Sum_probs=200.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CC---cEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DG---MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
..+|+..+.||+|+||.||+|+.. ++ ..+|+|.+.... ....+.+..|++++++++|||++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346788899999999999999875 33 379999987553 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++++|.+++......+++..+..++.|++.|++||| +.|++||||||+||+++.++.+|++|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999776677899999999999999999999 778999999999999999999999999999766432
Q ss_pred CCcee--ccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 892 TSMTQ--TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 892 ~~~~~--~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
..... .....+..|+|||+. ++.++|||||||++|||++ |+.||......+ +...+...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--------------~~~~i~~~ 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--------------VMKAINDG 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--------------HHHHHhcC
Confidence 22111 112234579999974 5678999999999999997 999985421110 00011000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
...+.+..++.++.+++.+||..+|++||++.++++.|+++
T Consensus 227 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00111223567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=312.98 Aligned_cols=252 Identities=28% Similarity=0.493 Sum_probs=200.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-C---CcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-D---GMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
..+|++.+.||+|+||.||+|+.. + +..||+|.++... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 356888899999999999999864 2 3479999987543 3345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999776677899999999999999999999 778999999999999999999999999999876543
Q ss_pred CCcee--ccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 892 TSMTQ--TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 892 ~~~~~--~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
..... ....++..|+|||.. ++.++|||||||++||+++ |+.||.+....+ .... +.+.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~--------~~~~---- 225 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKA--------IEEG---- 225 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHH--------HhCC----
Confidence 22211 112235689999984 5778999999999999886 999986532111 0000 0000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
. ..+.+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus 226 ----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 ----Y--RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----C--cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0111223466789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=314.86 Aligned_cols=234 Identities=23% Similarity=0.363 Sum_probs=185.4
Q ss_pred eeccCcceEEEEEEec-------------------------CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEE
Q 036879 745 LLGKGSFGSVYKGTLS-------------------------DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKI 799 (1029)
Q Consensus 745 ~lg~G~fg~V~~~~~~-------------------------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 799 (1029)
.||+|+||.||+|... ....||+|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999999742 123589998876555455678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC----
Q 036879 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM---- 875 (1029)
Q Consensus 800 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~---- 875 (1029)
++++.+....++||||+++|+|..++......+++..+..++.|+++|++||| ++||+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999776777899999999999999999999 78899999999999997543
Q ss_pred ---cEEEEccCCceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHh-cCCCCCCcccccccccc
Q 036879 876 ---VACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETF-TKKKPTDELFVGEISLK 946 (1029)
Q Consensus 876 ---~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~ell-tg~~p~~~~~~~~~~~~ 946 (1029)
.+|++|||.+...... ....++..|+|||.+ ++.++|||||||++||++ +|+.||......+. .
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~ 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--E 231 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--H
Confidence 4899999988643221 123477889999964 467899999999999984 78999865321110 0
Q ss_pred hhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 947 SRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 947 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
....... ..+......+.+++.+||+.+|++|||+.++++.|
T Consensus 232 ------------~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 ------------RFYEKKH--------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ------------HHHHhcc--------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 0000000 00111234689999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=314.99 Aligned_cols=254 Identities=23% Similarity=0.426 Sum_probs=200.2
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCc----EEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGM----QIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
.++|+..+.||+|+||+||+|++. +|. .||+|.++... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 457888999999999999999854 444 48999987543 33456788999999999999999999998754 467
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
++|||+++|+|.+++......+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999776677999999999999999999999 77899999999999999999999999999987643
Q ss_pred CCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 891 ETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 891 ~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
..... .....++..|+|||.. ++.++|||||||++|||++ |..||+...... +... +...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~------------~~~~ 227 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDL------------LEKG 227 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH------------HHCC
Confidence 32211 1122356789999984 5778999999999999998 889986521110 1110 0000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
...+.+..++..+.+++.+||..||++||++.|+++.++.+.+.
T Consensus 228 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 228 ------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 00111223566789999999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=316.96 Aligned_cols=252 Identities=25% Similarity=0.437 Sum_probs=199.1
Q ss_pred CCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
+|++.+.||+|+||.||+|... ....||+|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999753 235789998875532 335678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCC
Q 036879 812 VLEYMPNGSLENWMYNKN-----------------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSN 868 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~N 868 (1029)
||||+.+++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999985421 34788899999999999999999 7789999999999
Q ss_pred EEECCCCcEEEEccCCceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccc
Q 036879 869 ILLNESMVACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGE 942 (1029)
Q Consensus 869 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~ 942 (1029)
|++++++.+||+|||+++........ ......++..|+|||.. ++.++||||||+++|||++ |+.||......+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999765332221 12223456789999974 5778999999999999998 999986532111
Q ss_pred cccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 943 ISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
+. +...... ....+..++.++.+++..||+.+|++||+++|+++.|+++..
T Consensus 238 --~~------------~~~~~~~------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 --LF------------NLLKTGY------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred --HH------------HHHhCCC------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11 1111000 011123356678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=343.26 Aligned_cols=256 Identities=22% Similarity=0.310 Sum_probs=199.7
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.++||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999875 68999999987542 223457899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccC
Q 036879 814 EYMPNGSLENWMYNK----------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFG 883 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg 883 (1029)
||++||+|.+++... ....++..+..++.||++||+||| ++||+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988532 123556778899999999999999 7789999999999999999999999999
Q ss_pred CceecCCCCC-----------------ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccc
Q 036879 884 ISKLLGDETS-----------------MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGE 942 (1029)
Q Consensus 884 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~ 942 (1029)
+++....... ......+||+.|+|||+. ++.++||||+||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521100 011124689999999984 5778999999999999999999996522111
Q ss_pred cccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCC-CHHHHHHHHHHhHHh
Q 036879 943 ISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-NIKEALTKLLKIRNT 1014 (1029)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~evl~~L~~i~~~ 1014 (1029)
...... ..++. ........+..+.+++.+|++.||++|| +++++.+.|+.....
T Consensus 239 i~~~~~-----------i~~P~-------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISYRDV-----------ILSPI-------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhhh-----------ccChh-------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 110000 00000 0001123466789999999999999996 677777888776553
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=329.34 Aligned_cols=255 Identities=23% Similarity=0.421 Sum_probs=199.9
Q ss_pred HhCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCC-CCceEEEEEEEecCC
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELE-GTLRSFDAECEILGSIR-HRNLVKIISTCSSDH 807 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 807 (1029)
..++|.+.+.||+|+||.||+|++. .+..||+|+++.... ...+.+.+|++++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 4456778899999999999999853 346899999976532 33457889999999997 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCC----------------------------------------------------------
Q 036879 808 FKALVLEYMPNGSLENWMYNKN---------------------------------------------------------- 829 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 829 (1029)
..++||||+++|+|.+++++..
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999996432
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEE
Q 036879 830 ---------------------------------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNIL 870 (1029)
Q Consensus 830 ---------------------------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nil 870 (1029)
..+++..+..++.|++.|++||| +++|+||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEE
Confidence 13567788899999999999999 788999999999999
Q ss_pred ECCCCcEEEEccCCceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccc
Q 036879 871 LNESMVACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEIS 944 (1029)
Q Consensus 871 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 944 (1029)
+++++.+||+|||+++........ ......++..|+|||.+ ++.++|||||||++|||++ |+.||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 999999999999999865332211 12224567889999984 5778999999999999998 8889865321111
Q ss_pred cchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 945 LKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 945 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
....+.... ....+..++.++.+++.+||..+|++||+++|+++.|+++.
T Consensus 351 ------------~~~~~~~~~------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 ------------FYNAIKRGY------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ------------HHHHHHcCC------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 001110000 01112234678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.75 Aligned_cols=251 Identities=28% Similarity=0.483 Sum_probs=202.3
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..++|++.+.||+|+||.||+|...+++.||||.+.... ...+.+.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 456789999999999999999998888899999987543 2346789999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.+|++|||.+.........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 99999999997644 46899999999999999999999 677999999999999999999999999999876543222
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......++..|+|||.. .+.++||||+||++||+++ |+.||........ + .... ...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-~------------~~~~-~~~---- 221 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV-L------------EQVE-RGY---- 221 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-H------------HHHH-cCC----
Confidence 22223356789999974 5678999999999999998 9999854211100 0 0000 000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
....+..++..+.+++.+|+..+|++||+++++.+.|+.
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 --RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001112335678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=327.02 Aligned_cols=234 Identities=26% Similarity=0.332 Sum_probs=187.5
Q ss_pred ceeccCcceEEEEEEe----cCCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccC
Q 036879 744 NLLGKGSFGSVYKGTL----SDGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMP 817 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~----~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 817 (1029)
+.||+|+||.||+++. .+|+.||+|++..... .....+..|++++++++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999975 3688999999976432 223457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceec
Q 036879 818 NGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897 (1029)
Q Consensus 818 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 897 (1029)
+|+|.+++.. ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~ 156 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY 156 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence 9999999854 456899999999999999999999 77899999999999999999999999999976543322 122
Q ss_pred cccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhh
Q 036879 898 QTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYL 973 (1029)
Q Consensus 898 ~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 973 (1029)
...|++.|+|||.+ ++.++|||||||++|||++|+.||......+. .. .... . ..
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-----~~--------~i~~----~----~~ 215 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET-----MT--------MILK----A----KL 215 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH-----HH--------HHHc----C----CC
Confidence 35689999999984 57789999999999999999999975311100 00 0000 0 01
Q ss_pred HHHHHHHHHHHHHHHHcccccccCCCCHHH
Q 036879 974 TAKEQCVSSVLSLAMQCTRESAEERINIKE 1003 (1029)
Q Consensus 974 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e 1003 (1029)
..+...+..+.+++.+||+.||++||++.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 112334667899999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=325.44 Aligned_cols=246 Identities=27% Similarity=0.361 Sum_probs=205.8
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
|+++..||.|+||.||+|..+ ++...|.|++........+.|.-|++|+..++||+||++++.|...+..+++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 455677999999999999876 4555688999888788889999999999999999999999999989999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|-....+-.-++.+.+.++..+++|++.||.||| +..|||||+|+.|||++-+|.++++|||.+...... ......
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRDs 189 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRDS 189 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH-Hhhhcc
Confidence 9999999888999999999999999999999999 667999999999999999999999999988654322 223345
Q ss_pred ccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 899 TLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 899 ~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
..|||+|||||+. |+.++||||||+++.||..+.+|..+...... .+ .+....
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV----------------ll--KiaKSe 251 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV----------------LL--KIAKSE 251 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH----------------HH--HHhhcC
Confidence 7899999999983 67799999999999999999999765321111 01 111122
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+..-.|..++..|.+|+..|+..+|..||++++++++
T Consensus 252 PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 252 PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 22233456678899999999999999999999999864
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=313.23 Aligned_cols=241 Identities=23% Similarity=0.323 Sum_probs=188.7
Q ss_pred eccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 746 LGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 746 lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
||+|+||.||+++.. +|+.||+|.+.... ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 68999999986532 12234566799999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecccc
Q 036879 822 ENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL 900 (1029)
Q Consensus 822 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 900 (1029)
.+++.... ..+++..+..++.|++.|++||| ++||+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 98885443 45889999999999999999999 7889999999999999999999999999998764432 223346
Q ss_pred CCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHH
Q 036879 901 ATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAK 976 (1029)
Q Consensus 901 gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 976 (1029)
|+..|+|||++ ++.++||||+||++|||++|+.||...... ...... .......... ...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~--------~~~~~~~~~~-------~~~ 219 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEEL--------KRRTLEDEVK-------FEH 219 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHH--------HHHhhccccc-------ccc
Confidence 89999999984 677899999999999999999998652111 000000 0000000000 001
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 977 EQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 977 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..++.++.+++.+||+.||++||+++|+++.
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 1346678999999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.89 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=197.6
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
++|++.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999865 68999999987665555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
++++|.+++.. .+.+++.++..++.|++.|++||| +.||+|+||||+||+++.++.+||+|||.+........ ..
T Consensus 89 ~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06645 89 GGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KR 163 (267)
T ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-cc
Confidence 99999998854 456899999999999999999999 77899999999999999999999999999876643221 22
Q ss_pred ccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
....|+..|+|||+. ++.++||||+||++|||++|+.||......... ..... .. ....
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~~~~----~~----~~~~----- 229 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMTK----SN----FQPP----- 229 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-Hhhhc----cC----CCCC-----
Confidence 334689999999974 456899999999999999999998643211110 00000 00 0000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.......++..+.+++.+|+..+|++||++++++++
T Consensus 230 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 --KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000001234568899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=323.44 Aligned_cols=251 Identities=17% Similarity=0.244 Sum_probs=197.1
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||+||+++.. +++.||+|++.... ......+.+|..++..++|++|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999876 68899999987532 223456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999776677899999999999999999999 78899999999999999999999999999987654433
Q ss_pred ceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
.......|++.|+|||++ ++.++||||+||++|||++|+.||......+ . ........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~--------~~~i~~~~ 224 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----T--------YGKIMNHE 224 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-----H--------HHHHHcCC
Confidence 333345699999999963 4568999999999999999999996521110 0 00000000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccC--CCCHHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEE--RINIKEALTK 1007 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~ 1007 (1029)
. .. .........+.++.+++.+|+..++++ |+++++++++
T Consensus 225 ~--~~-~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 E--RF-QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred C--cc-cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 00 000011224567889999998866554 5688888875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=294.05 Aligned_cols=256 Identities=23% Similarity=0.286 Sum_probs=203.5
Q ss_pred ceeccCcceEEEEEE-ecCCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 744 NLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
+.||+|+|+.|.-++ ..+|.++|||++.+...+....+.+|++++.+. .|+||++++++|+++...|+|||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999999886 568999999999998888888999999999999 599999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC---cEEEEccCCceecCC--CCC---
Q 036879 822 ENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM---VACLSDFGISKLLGD--ETS--- 893 (1029)
Q Consensus 822 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~---~~kl~Dfg~a~~~~~--~~~--- 893 (1029)
..+|. +++.|.+.++.+++++||.||.||| .+||.|||+||+|||..... -+|||||.++.-... +-+
T Consensus 164 LshI~-~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 164 LSHIQ-KRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHH-HhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 99985 4567999999999999999999999 99999999999999997544 589999998754321 111
Q ss_pred -ceeccccCCccccCccC---------CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc-chhhhhhhh
Q 036879 894 -MTQTQTLATIGYMAPEW---------KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL-HGKIINVVD 962 (1029)
Q Consensus 894 -~~~~~~~gt~~y~aPE~---------~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~d 962 (1029)
..-...+|+..|||||+ +|+++.|.||+|||+|-|+.|.+||.+....+-.+ -.... +..-.+.+.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW---drGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW---DRGEVCRVCQNKLFE 316 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc---cCCCccHHHHHHHHH
Confidence 11223568889999998 47889999999999999999999998755433222 11111 111122222
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1006 (1029)
..-.+.+......+...+.+..+++...+..|+..|.++..++.
T Consensus 317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 22222333333334567888999999999999999999999887
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=310.41 Aligned_cols=247 Identities=27% Similarity=0.449 Sum_probs=198.6
Q ss_pred CCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccC
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMP 817 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 817 (1029)
.+|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|++++++++||+++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46788899999999999999887788999998865432 34578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceec
Q 036879 818 NGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897 (1029)
Q Consensus 818 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 897 (1029)
+++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+............
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999776667899999999999999999999 777999999999999999999999999999866443222222
Q ss_pred cccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 898 QTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 898 ~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
...++.+|+|||.. ++.++||||+|+++|||++ |+.||......+ .... +.+.. .
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~-----~~~~~----------~ 219 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-----VVET-----INAGF----------R 219 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-----HHHH-----HhCCC----------C
Confidence 23456789999974 5668999999999999998 999986522110 0000 00000 0
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
...+...+.++.+++.+||..+|++|||+.|+++.|
T Consensus 220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 000112356789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=309.31 Aligned_cols=246 Identities=28% Similarity=0.493 Sum_probs=200.4
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888999999999999999874 78999999976644 4577899999999999999999999999899999999999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 817 PNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 817 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
++++|.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999986544 36899999999999999999999 77899999999999999999999999999986633221
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
....+..|+|||.. ++.++||||||+++||+++ |+.||......+ . ...+...
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~------------~~~~~~~------ 215 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--V------------VPHVEKG------ 215 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--H------------HHHHhcC------
Confidence 23356789999974 5668999999999999997 999986431110 0 0000000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
.....+..++..+.+++.+|+..+|++|||+.|+++.|+.+
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00111233567889999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.96 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=197.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHF 808 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 808 (1029)
..++|.+.+.||+|+||.||+|.+. .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3467888999999999999999875 35678999886543 3334578999999999999999999999999889
Q ss_pred EEEEEeccCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC---cEEE
Q 036879 809 KALVLEYMPNGSLENWMYNKN------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM---VACL 879 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~---~~kl 879 (1029)
.++||||+++++|.+++.... ..+++..+..++.||+.|++||| +++++||||||+||+++.++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999986543 25889999999999999999999 77899999999999998654 6999
Q ss_pred EccCCceecCCCCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhcc
Q 036879 880 SDFGISKLLGDETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSL 953 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 953 (1029)
+|||+++......... ......+..|+|||+. ++.++|||||||++|||++ |+.||........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---------- 230 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---------- 230 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----------
Confidence 9999998653222111 1122345689999984 6789999999999999997 9999865321110
Q ss_pred chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 954 HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 954 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
.+.+... .....+..++..+.+++.+|++.+|++||++.+|+++|.
T Consensus 231 ----~~~~~~~------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 ----MEFVTGG------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----HHHHHcC------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0111000 001112345677899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=309.22 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=203.9
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 89999999886432 233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 814 EYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 814 E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
||+++++|.+++.. ....+++..+..++.|+++|++||| +.||+||||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998854 2345889999999999999999999 77899999999999999999999999999986643
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
... ......+++.|+|||.. ++.++|||||||++|+|++|+.||.... .......... ..
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~---------~~--- 222 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKI---------EK--- 222 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhh---------hc---
Confidence 322 12234588899999984 5668999999999999999999986432 1111110000 00
Q ss_pred hhhhhhhHH-HHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 967 QKEDAYLTA-KEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 967 ~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
.. ..+. ...++..+.+++.+||..+|++|||+.++++.++++.
T Consensus 223 ~~---~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 CD---YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CC---CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00 0001 1245667899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=310.12 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=197.9
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
+|++.+.||+|+||.||+++.. +++.||+|.++... ....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999876 78999999986543 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 817 PNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 817 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
++++|.+++... ...+++..+..++.|++.|++||| +.||+|+||||+||++++++.++++|||.+........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999988653 445889999999999999999999 77899999999999999999999999999976643322 1
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
.....+++.|+|||+. .+.++|+||||+++|+|++|+.||...... ........+.
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~~--------------- 216 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILKVCQGS--------------- 216 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHHHhcCC---------------
Confidence 2234688899999984 577899999999999999999999652110 0000000000
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+..++..+.+++.+||+.||++||++.|++..
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 001122345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=314.84 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=202.7
Q ss_pred HhCCCCCCceeccCcceEEEEEEecC-----CcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEec-CCe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSD-----GMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSS-DHF 808 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 808 (1029)
..++|++.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678889999999999999998765 6889999887543 3345678899999999999999999998766 567
Q ss_pred EEEEEeccCCCCHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEc
Q 036879 809 KALVLEYMPNGSLENWMYNKN-------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSD 881 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~D 881 (1029)
.++++||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence 899999999999999986532 45889999999999999999999 77899999999999999999999999
Q ss_pred cCCceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccch
Q 036879 882 FGISKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHG 955 (1029)
Q Consensus 882 fg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 955 (1029)
||+++.+...... ......++..|+|||+. ++.++|||||||++||+++ |+.||..... ..+..++..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~---- 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKD---- 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHc----
Confidence 9999865432211 11223456789999974 5778999999999999999 9999865311 111111000
Q ss_pred hhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 956 KIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 956 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.. ....+..++..+.+++.+||..+|++|||+.|+++.|+.+.+.
T Consensus 235 --------~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 --------GY------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred --------CC------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 00 0011123466789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=314.48 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=199.4
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecc--cchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLE--LEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 812 (1029)
....|++.++||+||.+.||++...+.+.+|+|++... +......|.+|++.+.++ .|.+||++++|-..++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 34568889999999999999999888888999877543 455678899999999999 499999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||= ..+|..++.++....+...+..+..||+.|+.++| ..||||.|+||.|+|+ -.|.+||+|||.|..+..+.
T Consensus 439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence 9985 56999999877766664588899999999999999 7789999999999998 46899999999998876554
Q ss_pred C-ceeccccCCccccCccCC---------------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchh
Q 036879 893 S-MTQTQTLATIGYMAPEWK---------------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGK 956 (1029)
Q Consensus 893 ~-~~~~~~~gt~~y~aPE~~---------------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 956 (1029)
. ......+||+-||+||.+ .++++||||+|||+|+|+.|+.||+....... .
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a------------K 581 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA------------K 581 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH------------H
Confidence 3 334557899999999973 46789999999999999999999976321111 1
Q ss_pred hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 957 IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 957 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
+....|+.-.-.+ .+.++ ..++.++|+.|+..||.+||+..|++++
T Consensus 582 l~aI~~P~~~Ief---p~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 LHAITDPNHEIEF---PDIPE--NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHhhcCCCccccc---cCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1222222110000 01111 1228999999999999999999999974
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=312.52 Aligned_cols=249 Identities=25% Similarity=0.441 Sum_probs=192.1
Q ss_pred CCCCceeccCcceEEEEEEecC-Cc--EEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC------Ce
Q 036879 740 FSENNLLGKGSFGSVYKGTLSD-GM--QIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD------HF 808 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~~-~~--~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 808 (1029)
|.+.+.||+|+||.||+|++.+ +. .||+|.++... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3466889999999999998753 33 68999887542 34457789999999999999999999987432 24
Q ss_pred EEEEEeccCCCCHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccC
Q 036879 809 KALVLEYMPNGSLENWMYN-----KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFG 883 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg 883 (1029)
.++||||+++|+|.+++.. ....+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999998742 2234789999999999999999999 7789999999999999999999999999
Q ss_pred CceecCCCCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhh
Q 036879 884 ISKLLGDETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKI 957 (1029)
Q Consensus 884 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 957 (1029)
+++......... .....+++.|+|||.. ++.++|||||||++|||++ |+.||......+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~---------- 225 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IYD---------- 225 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----------
Confidence 998764332211 1223456789999984 5778999999999999999 788886521111 000
Q ss_pred hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 958 INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 958 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
.+.. . .....+..++..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 226 --~~~~----~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 --YLRQ----G--NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --HHHc----C--CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 0 00011223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=318.11 Aligned_cols=256 Identities=23% Similarity=0.442 Sum_probs=201.4
Q ss_pred HhCCCCCCceeccCcceEEEEEEec--------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS--------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSS 805 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 805 (1029)
..++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567888899999999999999741 34579999987543 33456789999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEE
Q 036879 806 DHFKALVLEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNIL 870 (1029)
Q Consensus 806 ~~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nil 870 (1029)
....++||||+++++|.+++.... ..+++..+..++.||++|++||| +.||+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence 999999999999999999996532 34778889999999999999999 778999999999999
Q ss_pred ECCCCcEEEEccCCceecCCCCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccc
Q 036879 871 LNESMVACLSDFGISKLLGDETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEIS 944 (1029)
Q Consensus 871 l~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 944 (1029)
++.++.+||+|||.++......... .....+++.|+|||+. ++.++||||||+++|||++ |..||......+
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-- 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence 9999999999999998765432221 1223456789999984 5678999999999999998 778875421110
Q ss_pred cchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 945 LKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 945 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
... .+.. . .....+..++..+.+++.+||+.+|++||++.|+++.|+++...
T Consensus 248 ---~~~---------~~~~----~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 ---LFK---------LLKE----G--HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ---HHH---------HHHc----C--CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 000 0000 0 00111234567899999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=322.09 Aligned_cols=237 Identities=22% Similarity=0.302 Sum_probs=188.4
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIR-HRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 813 (1029)
+|+..+.||+|+||+||+|+.. +|+.||+|++.... ....+.+..|.++++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777899999999999999865 78999999987642 233456778889988885 577888999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++.. ...+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 99999999998854 356899999999999999999999 77899999999999999999999999999875432221
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......||+.|+|||++ ++.++||||+||++|||++|+.||........ ........
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------------~~~i~~~~----- 217 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-------------FQSIMEHN----- 217 (323)
T ss_pred -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHhCC-----
Confidence 22234589999999984 57789999999999999999999975321100 00000000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINI 1001 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 1001 (1029)
...+..++..+.+++.+|++.+|++|+++
T Consensus 218 ---~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 ---VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01122345678999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=322.21 Aligned_cols=244 Identities=21% Similarity=0.271 Sum_probs=190.3
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||+||+|+.. +++.||+|+++... ....+.+.+|+.++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 68899999998653 23345688999999888 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|+|.+++.. .+.+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTST 155 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ceec
Confidence 999988854 456899999999999999999999 77899999999999999999999999999975322211 2233
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCccccccc-ccchhchhccchhhhhhhhhhhhhhhhhhh
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI-SLKSRVNDSLHGKIINVVDINLLQKEDAYL 973 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 973 (1029)
..||+.|+|||++ ++.++||||+||++|||++|+.||........ ........ ..... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~------------~~~~~---~~ 220 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ------------VILEK---PI 220 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH------------HHHhC---CC
Confidence 5689999999984 57799999999999999999999964321111 00000000 00000 01
Q ss_pred HHHHHHHHHHHHHHHHcccccccCCCCH------HHHHHH
Q 036879 974 TAKEQCVSSVLSLAMQCTRESAEERINI------KEALTK 1007 (1029)
Q Consensus 974 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~evl~~ 1007 (1029)
..+...+..+.+++.+|++.||++|+++ .++.++
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1223345678999999999999999985 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=312.86 Aligned_cols=254 Identities=22% Similarity=0.352 Sum_probs=202.3
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||.||+|+.. ++..||||.+.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46788899999999999999864 88999999886532 233457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 814 EYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 814 E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
||+++++|.+++.. ....+++..+..++.|++.|++||| +.|++|+||||+||+++.++.++++|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998853 2345899999999999999999999 77899999999999999999999999999876644
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.... .....++..|+|||+. .+.++||||||+++|||++|+.||.............+. ..
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~------ 223 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE--------QC------ 223 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh--------cC------
Confidence 3222 2234588899999984 566899999999999999999998642211111110000 00
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
.. ....+..++..+.+++.+||..+|++|||+.+|.+.++++.
T Consensus 224 -~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 224 -DY--PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -CC--CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00 00011235678999999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=309.77 Aligned_cols=242 Identities=26% Similarity=0.442 Sum_probs=191.5
Q ss_pred eeccCcceEEEEEEec---CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCC
Q 036879 745 LLGKGSFGSVYKGTLS---DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNG 819 (1029)
Q Consensus 745 ~lg~G~fg~V~~~~~~---~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 819 (1029)
.||+|+||.||+|.+. ++..||+|+++.... ...+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 578899999875432 34567899999999999999999999986 45668999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce--ec
Q 036879 820 SLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT--QT 897 (1029)
Q Consensus 820 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~ 897 (1029)
+|.+++.. ...+++..+..++.|++.|++|+| ++||+||||||+||+++.++.+||+|||++.......... ..
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 99999854 356899999999999999999999 7789999999999999999999999999998765432211 12
Q ss_pred cccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 898 QTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 898 ~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
...++..|+|||.. ++.++|||||||++|||++ |+.||......+ .. +.+... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~------------~~i~~~------~~ 216 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VT------------QMIESG------ER 216 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH------------HHHHCC------CC
Confidence 22346789999974 5668999999999999998 999987532111 11 111110 01
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
.+.+..++..+.+++.+||+.||++||++++|.+.|+..
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 112234577899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=312.57 Aligned_cols=250 Identities=27% Similarity=0.509 Sum_probs=198.8
Q ss_pred CCCCCceeccCcceEEEEEEec-CC---cEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DG---MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.|++.+.||+|+||.||+|+.. ++ ..||+|.+.... ......+..|+.+++.++||||+++++++..+...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4778899999999999999875 33 369999987653 334568999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++++|.+++......+++.++..++.|++.|++||| +.|++||||||+||+++.++.+|++|||.+........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999999777777899999999999999999999 77899999999999999999999999999876543221
Q ss_pred c-eecc-c--cCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 894 M-TQTQ-T--LATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 894 ~-~~~~-~--~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
. .... . ..+..|+|||.. ++.++||||+||++||+++ |+.||...... ....++ ...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i------------~~~ 227 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAI------------EQD 227 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHH------------HcC
Confidence 1 1111 1 124579999984 4678999999999999886 99998653111 000000 000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
...+.+..++..+.+++..||+.+|++||++.++++.|+++
T Consensus 228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00111234567789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=323.56 Aligned_cols=233 Identities=29% Similarity=0.360 Sum_probs=183.1
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHH-HHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECE-ILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||+||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999975 78999999997542 122334445544 56889999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTST 155 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-cccc
Confidence 999998854 456889999999999999999999 77899999999999999999999999999875422211 2233
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..||+.|+|||++ ++.++|||||||++|||++|+.||...... .... ...... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~--------~i~~~~--------~~ 214 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYD--------NILNKP--------LR 214 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHH--------HHHcCC--------CC
Confidence 5689999999984 577899999999999999999999653111 0000 000000 01
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINIK 1002 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 1002 (1029)
.+...+..+.+++.+|++.||++||+++
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1122366789999999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=334.78 Aligned_cols=261 Identities=21% Similarity=0.326 Sum_probs=190.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecC--------
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSD-------- 806 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 806 (1029)
...+|++.+.||+|+||.||+|+.. +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999875 68999999886432 2345799999999999999999876432
Q ss_pred CeEEEEEeccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC-cEEEEcc
Q 036879 807 HFKALVLEYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM-VACLSDF 882 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~-~~kl~Df 882 (1029)
...++||||++ +++.+++.. ....+++..+..++.||+.||+||| ++||+||||||+||+++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 24679999996 577776643 4567899999999999999999999 77899999999999999654 7999999
Q ss_pred CCceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccc
Q 036879 883 GISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLH 954 (1029)
Q Consensus 883 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~ 954 (1029)
|+|+.+..... .....||+.|+|||++ ++.++||||+||++|||++|++||.+....+ .+..... ....
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCH
Confidence 99986643322 2235689999999974 5678999999999999999999997532111 1111100 0000
Q ss_pred hhhhhh----hhhhhh--hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 955 GKIINV----VDINLL--QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 955 ~~~~~~----~d~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
+.+..+ .+.... .........+...+.++.+++.+||..||.+|||+.|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000 000000 00000111223346789999999999999999999999964
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.10 Aligned_cols=249 Identities=22% Similarity=0.411 Sum_probs=196.3
Q ss_pred CCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
+|++.+.||+|+||.||+|... ++..||+|+++..... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667788999999999999863 2578999999765433 34668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc
Q 036879 812 VLEYMPNGSLENWMYNK---------------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV 876 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~ 876 (1029)
++||+++++|.+++... ...+++..+..++.|++.|++|+| ++||+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence 99999999999998421 234788889999999999999999 778999999999999999999
Q ss_pred EEEEccCCceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhch
Q 036879 877 ACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVN 950 (1029)
Q Consensus 877 ~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 950 (1029)
+||+|||+++........ ......+++.|+|||.. ++.++||||+||++|||++ |..||.+....+ ...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~--- 237 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VIE--- 237 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH---
Confidence 999999998765432221 11223457889999984 5678999999999999998 888876521110 000
Q ss_pred hccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 951 DSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 951 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
...+.. ....+..++..+.+++..||+.+|++||+++|+++.|+.
T Consensus 238 --------~i~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 --------MIRNRQ-------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --------HHHcCC-------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 000000 011123467789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=319.38 Aligned_cols=266 Identities=22% Similarity=0.319 Sum_probs=199.9
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 457899999999999999999875 68899999987543 2334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|++ ++|.+++......+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 996 6999998776777899999999999999999999 78899999999999999999999999999975433221
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccc--cchhchhccchhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEIS--LKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
......+++.|+|||.. ++.++||||+||++|||++|++||......+.. +...........+....+.....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 12234578899999974 456899999999999999999999753221110 00000000001111111110000
Q ss_pred h---hh----hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 K---ED----AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~---~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. +. .........+..+.+++.+|+..||.+|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 00 0001112346678999999999999999999999973
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=315.92 Aligned_cols=254 Identities=22% Similarity=0.389 Sum_probs=197.7
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCC
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDH 807 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 807 (1029)
...++|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999653 255899998865432 23346788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEE
Q 036879 808 FKALVLEYMPNGSLENWMYNKN---------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC 878 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~k 878 (1029)
..++||||+++|+|.+++.... ...++..+..++.|++.|++||| +++|+||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999996432 23466788899999999999999 77899999999999999999999
Q ss_pred EEccCCceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhc
Q 036879 879 LSDFGISKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDS 952 (1029)
Q Consensus 879 l~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 952 (1029)
++|||+++........ ......++..|+|||.. ++.++|||||||++|||++ |+.||......+ ...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~----- 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLK----- 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH-----
Confidence 9999999765332211 11223456789999984 5778999999999999998 788886521111 000
Q ss_pred cchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 953 LHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 953 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
...+.. ....+..++..+.+++.+|++.+|++|||+.++++.+++.
T Consensus 233 ------~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 ------FVMDGG-------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ------HHHcCC-------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 000000 0111223467899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=309.09 Aligned_cols=247 Identities=29% Similarity=0.392 Sum_probs=202.2
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|+..+.||+|+||.||+|+.. +++.||+|.+..... .+.+.+|++++++++||||+++++++..+...++|+||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 367889999999999999999976 489999999875533 67899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++......+++..+..++.|++.|++||| +.+|+||||+|+||+++.++.+||+|||++........ .
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999999999777778999999999999999999999 77799999999999999999999999999987644321 2
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
.....++..|+|||+. ++.++|||||||++|||++|+.||........... ... ....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--------------~~~----~~~~ 217 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--------------IPN----KPPP 217 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--------------hcc----CCCC
Confidence 2334578899999983 56789999999999999999999875321111000 000 0000
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+..++..+.+++.+||+.+|++|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 111123456678999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=307.87 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=202.2
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||.||+|+.. +++.+|+|.+........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367889999999999999999875 6789999999876555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++......+++..+..++.|++.|++||| +.+|+||||+|+||+++.++.+||+|||.+........ .
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 9999999998776677999999999999999999999 67899999999999999999999999999876543221 1
Q ss_pred eccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
.....++..|+|||.. ++.++|||||||++|||++|+.||.+......... ......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-------------~~~~~~--- 221 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-------------ISKSNF--- 221 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHhccC---
Confidence 2234578899999984 34579999999999999999999865321111000 000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.......+...+.++.+++.+||..+|++|||+.+++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 222 PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000011123356778999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=317.23 Aligned_cols=257 Identities=25% Similarity=0.427 Sum_probs=195.3
Q ss_pred hCCCCCCceeccCcceEEEEEEecC---------------CcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSD---------------GMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKII 800 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~---------------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~ 800 (1029)
.++|++.+.||+|+||.||+++... ...||+|.++... ......+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578899999999999999987532 2348999987653 33345789999999999999999999
Q ss_pred EEEecCCeEEEEEeccCCCCHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCE
Q 036879 801 STCSSDHFKALVLEYMPNGSLENWMYNKN-----------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNI 869 (1029)
Q Consensus 801 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Ni 869 (1029)
+++...+..++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence 99999999999999999999999985432 23688899999999999999999 77899999999999
Q ss_pred EECCCCcEEEEccCCceecCCCCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc--CCCCCCcccccc
Q 036879 870 LLNESMVACLSDFGISKLLGDETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT--KKKPTDELFVGE 942 (1029)
Q Consensus 870 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt--g~~p~~~~~~~~ 942 (1029)
+++.++.+||+|||++.......... .....++..|+|||.. ++.++|||||||++|||++ |..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999997654332211 1223457789999974 5779999999999999998 556765421111
Q ss_pred cccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 943 ISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
. ... .....+... .......+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus 241 ~--~~~--------~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 V--IEN--------TGEFFRNQG---RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred H--HHH--------HHHhhhhcc---ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 0 000 000000000 00000111234678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=311.48 Aligned_cols=248 Identities=25% Similarity=0.329 Sum_probs=194.7
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999864 78999999987553 33346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|..+. .+++..+..++.|++.|++||| +.||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 9999997652 4678889999999999999999 7789999999999999999999999999997654322
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
.....++..|+|||++ ++.++|||||||++|||++|+.||............ ........+.....
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~------~~~~~~~~~~~~~~---- 219 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP------LQLLQCIVDEDPPV---- 219 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch------HHHHHHHhccCCCC----
Confidence 2235689999999984 577899999999999999999999753221111000 00000000000000
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
......+.++.+++.+|++.+|++||+++|++++-
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 220 --LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred --CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 00112356789999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=315.60 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=198.7
Q ss_pred hCCCCCCceeccCcceEEEEEEecC-----------------CcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSD-----------------GMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVK 798 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~-----------------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 798 (1029)
..+|++.+.||+|+||.||+|+... +..||+|.+..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999987642 24689999876543 34567899999999999999999
Q ss_pred EEEEEecCCeEEEEEeccCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCC
Q 036879 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKN----------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSN 868 (1029)
Q Consensus 799 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~N 868 (1029)
+++++..++..++||||+++++|.+++.... ..+++..++.++.|++.|++||| +.||+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 9999999999999999999999999986543 26899999999999999999999 7789999999999
Q ss_pred EEECCCCcEEEEccCCceecCCCCCc-eeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc--CCCCCCccccc
Q 036879 869 ILLNESMVACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT--KKKPTDELFVG 941 (1029)
Q Consensus 869 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt--g~~p~~~~~~~ 941 (1029)
|+++.++.++|+|||+++........ ......+++.|+|||. .++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 99999999999999999765433211 1223446788999997 35778999999999999998 67777543211
Q ss_pred ccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 942 EISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
+ ...... ..... .........+..++.++.+++.+|++.+|++|||+.|+++.|+
T Consensus 241 ~--~~~~~~--------~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q--VIENAG--------HFFRD---DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H--HHHHHH--------hcccc---ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 000000 00000 0000001112234578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=309.15 Aligned_cols=250 Identities=24% Similarity=0.443 Sum_probs=200.0
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..++|++.+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|+||+++++++.. ...++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 45678999999999999999999877888999988754 2345678899999999999999999999987 778999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++++|.+++... ....++..+..++.|++.|++||| +.|++||||||+||+++.++.+||+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999654 345788899999999999999999 678999999999999999999999999999866433222
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......++..|+|||++ ++.++|+|||||++|++++ |+.||........ .... ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--~~~~------------~~~~---- 220 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--IRAL------------ERGY---- 220 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH--HHHH------------hCCC----
Confidence 22233456789999984 5678999999999999998 8999865311110 0000 0000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
..+.+...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 221 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 --RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001112345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=315.72 Aligned_cols=257 Identities=24% Similarity=0.324 Sum_probs=200.0
Q ss_pred CHHHHHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEe--
Q 036879 729 SYQELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCS-- 804 (1029)
Q Consensus 729 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-- 804 (1029)
.++.+..+.++|++.+.||+|+||.||+|+.. +++.+|+|.+.... .....+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34455567889999999999999999999875 68899999876432 2235678899999999 6999999999873
Q ss_pred ---cCCeEEEEEeccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEE
Q 036879 805 ---SDHFKALVLEYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC 878 (1029)
Q Consensus 805 ---~~~~~~lV~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~k 878 (1029)
.++..++||||+++++|.+++.. ....+++..+..++.|+++|+.||| +.+|+||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEE
Confidence 34678999999999999998753 3456888999999999999999999 77899999999999999999999
Q ss_pred EEccCCceecCCCCCceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhc
Q 036879 879 LSDFGISKLLGDETSMTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV 949 (1029)
Q Consensus 879 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 949 (1029)
++|||++....... .......|++.|+|||++ ++.++||||+||++|||++|+.||........ +..
T Consensus 165 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~-- 240 (286)
T cd06638 165 LVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFK-- 240 (286)
T ss_pred EccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhh--
Confidence 99999998664322 122334689999999974 46789999999999999999999865321100 000
Q ss_pred hhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 950 NDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 950 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
... ........+..++..+.+++.+||+.+|++|||+.|++++.
T Consensus 241 ----------~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 ----------IPR-----NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ----------ccc-----cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 00000001122355789999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=323.31 Aligned_cols=256 Identities=23% Similarity=0.403 Sum_probs=197.4
Q ss_pred HhCCCCCCceeccCcceEEEEEEe------cCCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEec-C
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL------SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSS-D 806 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~ 806 (1029)
..++|++.+.||+|+||+||+|++ .+++.||||+++... ....+.+.+|++++.++ +||||+++++++.. +
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346799999999999999999974 357889999997643 23346788999999999 68999999998865 4
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC---------------------------------------------------------
Q 036879 807 HFKALVLEYMPNGSLENWMYNKN--------------------------------------------------------- 829 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 829 (1029)
...++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56789999999999999986432
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC-ceeccc
Q 036879 830 ---------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS-MTQTQT 899 (1029)
Q Consensus 830 ---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~ 899 (1029)
..+++..+..++.|+++|++||| ++||+||||||+||+++.++.+||+|||++........ ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 23577888899999999999999 78899999999999999999999999999976533221 111223
Q ss_pred cCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 900 LATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 900 ~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
.++..|+|||.. ++.++||||||+++|||++ |..||........ .. ..+... ....
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~------------~~~~~~------~~~~ 302 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FC------------RRLKEG------TRMR 302 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HH------------HHHhcc------CCCC
Confidence 456789999974 5778999999999999997 8889865321110 00 000000 0011
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
.+...++++.+++..||..+|++|||+.|++++|+.+.+
T Consensus 303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 112235678999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=307.53 Aligned_cols=244 Identities=28% Similarity=0.468 Sum_probs=192.4
Q ss_pred ceeccCcceEEEEEEec-C---CcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-D---GMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~---~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
++||+|+||.||+|++. . +..||+|.+..... ...+.+.+|+++++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999753 2 36899999876543 34567899999999999999999999876 4457999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee--
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ-- 896 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-- 896 (1029)
++|.+++.... .+++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|||.++..........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999996544 7899999999999999999999 77799999999999999999999999999986644332211
Q ss_pred ccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
....++..|+|||.. ++.++|||||||++|||++ |+.||...... .+..++... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~~------------------~ 215 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLESG------------------E 215 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcC------------------C
Confidence 112235689999984 5678999999999999998 99998653211 111111000 0
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
....+..++..+.+++.+||..+|++||++.++++.|+++.
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01112335677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=312.31 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=195.2
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecC------C
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSD------H 807 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~ 807 (1029)
+.+.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5667888899999999999999875 68899999987553 2345788899999998 799999999998652 4
Q ss_pred eEEEEEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 808 FKALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
..++||||+++++|.+++... ...+++..+..++.|++.|++||| +++|+||||||+||++++++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 678999999999999998764 346889999999999999999999 7789999999999999999999999999997
Q ss_pred ecCCCCCceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhh
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKI 957 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 957 (1029)
....... ......|+..|+|||++ ++.++||||+||++|||++|+.||..........
T Consensus 160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------------ 226 (272)
T cd06637 160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------------ 226 (272)
T ss_pred ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------------
Confidence 6533221 22335688999999974 4557999999999999999999986432110000
Q ss_pred hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 958 INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 958 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.... .. ........++..+.+++.+||..+|.+|||+.|++++
T Consensus 227 -~~~~-~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 227 -LIPR-NP-----APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -HHhc-CC-----CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0000 00 0000112245678999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=330.25 Aligned_cols=385 Identities=26% Similarity=0.418 Sum_probs=231.3
Q ss_pred CCccceecccccccc-CCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCccccc
Q 036879 120 FPKLEHLYLDGNSFI-GTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNID 198 (1029)
Q Consensus 120 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~ 198 (1029)
++-.+-.|+++|.|+ +..|.++.+++++++|.|...++. .+|+.++.+.+|++|.+++|++..+.
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vh------------- 71 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVH------------- 71 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhh-------------
Confidence 445566788888888 478888888888888888888887 78888888888888777777765332
Q ss_pred ccccccchhccccccccCCCCcccccccccceEEccccccc-CCCCccccccccccceeecccccccccCcccEEEccCC
Q 036879 199 MQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFI-GSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSN 277 (1029)
Q Consensus 199 l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N 277 (1029)
..+..|+.|+.+.+..|++. +.+|..+..|..|+ +||||+|
T Consensus 72 ---------------------GELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt-----------------~lDLShN 113 (1255)
T KOG0444|consen 72 ---------------------GELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLT-----------------ILDLSHN 113 (1255)
T ss_pred ---------------------hhhccchhhHHHhhhccccccCCCCchhcccccce-----------------eeecchh
Confidence 23334444555555555543 22444444443322 4555555
Q ss_pred cccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCC
Q 036879 278 RLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIP 357 (1029)
Q Consensus 278 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p 357 (1029)
+++ ..|..+..-+++-.|+||+|+|. .||..+|-+|+.|-.|||++|++. .+|..+..+.+|++|++++|.+..+.
T Consensus 114 qL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQ- 189 (1255)
T KOG0444|consen 114 QLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQ- 189 (1255)
T ss_pred hhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHH-
Confidence 555 55666666667777777777774 777777777777777777777776 45555666666666666666553210
Q ss_pred CCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecC
Q 036879 358 NSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLET 437 (1029)
Q Consensus 358 ~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 437 (1029)
+..+..+++|+.|.+++.+=+ ...+|..+..+.+|..+||+.
T Consensus 190 --------------LrQLPsmtsL~vLhms~TqRT------------------------l~N~Ptsld~l~NL~dvDlS~ 231 (1255)
T KOG0444|consen 190 --------------LRQLPSMTSLSVLHMSNTQRT------------------------LDNIPTSLDDLHNLRDVDLSE 231 (1255)
T ss_pred --------------HhcCccchhhhhhhcccccch------------------------hhcCCCchhhhhhhhhccccc
Confidence 111223444455555444321 123555556666666666666
Q ss_pred ccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCC
Q 036879 438 NELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIP 517 (1029)
Q Consensus 438 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 517 (1029)
|.+. .+|..+..+++|+.|+||+|+|+. +..+.+...+|++|+||.|+++ .+|
T Consensus 232 N~Lp-~vPecly~l~~LrrLNLS~N~ite-------------------------L~~~~~~W~~lEtLNlSrNQLt-~LP 284 (1255)
T KOG0444|consen 232 NNLP-IVPECLYKLRNLRRLNLSGNKITE-------------------------LNMTEGEWENLETLNLSRNQLT-VLP 284 (1255)
T ss_pred cCCC-cchHHHhhhhhhheeccCcCceee-------------------------eeccHHHHhhhhhhccccchhc-cch
Confidence 6666 566666666666666666666641 1122233334444444444444 344
Q ss_pred CCccCCCCCcEEEccCCccc-CcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCC
Q 036879 518 SSLWSLRDILNVNLSSNSLN-GTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLT 596 (1029)
Q Consensus 518 ~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 596 (1029)
++++.++.|+.|.+.+|+++ .-+|..++.+.+|+.+..++|.+. ..|..++.+..|+.|.|++|++- .+|+++.-++
T Consensus 285 ~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~ 362 (1255)
T KOG0444|consen 285 DAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLP 362 (1255)
T ss_pred HHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcC
Confidence 44444444444444444443 135666777777777777777776 66777777777777777777776 5777777777
Q ss_pred CCCEEeCcCCcccCcCchhhhcccccceeec
Q 036879 597 SLNFLDMSSNNLSGEIPNSLKALSLLKFLNL 627 (1029)
Q Consensus 597 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 627 (1029)
.|+.|||..|.=-..+|.--..-+.|+.-++
T Consensus 363 ~l~vLDlreNpnLVMPPKP~da~~~lefYNI 393 (1255)
T KOG0444|consen 363 DLKVLDLRENPNLVMPPKPNDARKKLEFYNI 393 (1255)
T ss_pred CcceeeccCCcCccCCCCcchhhhcceeeec
Confidence 7777777777433344433222234444433
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=328.88 Aligned_cols=262 Identities=21% Similarity=0.232 Sum_probs=194.8
Q ss_pred HhCCCCCCceeccCcceEEEEEEec---CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS---DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
...+|++.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3457999999999999999999753 4678999987643 3456899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
||++. ++|.+++ .....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 165 ~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 165 MPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred ehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 99995 6888888 44567899999999999999999999 7789999999999999999999999999997664432
Q ss_pred Cc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCccccccc--ccchhchhc----------cch
Q 036879 893 SM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI--SLKSRVNDS----------LHG 955 (1029)
Q Consensus 893 ~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~----------~~~ 955 (1029)
.. ......||+.|+|||++ ++.++||||+||++|||++|+.||.+...... .+...+... ...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 21 22245689999999984 57789999999999999999999865322110 000000000 000
Q ss_pred hhhhhhh-hhhhhhhhhh---hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 KIINVVD-INLLQKEDAY---LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 ~~~~~~d-~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+..... .....+.... ......++.++.+++.+|+..||++|||+.|++.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 0000000000 00001235678899999999999999999999986
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=316.55 Aligned_cols=253 Identities=23% Similarity=0.401 Sum_probs=199.8
Q ss_pred hCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHF 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 808 (1029)
.++|++.+.||+|+||.||+|... ++..||+|.++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 456888999999999999999742 35579999987553 33346789999999999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 809 KALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
.++||||+++|+|.+++.... ..+++.++..++.|++.|++||| +.+|+|+||||+||+++.++.++++|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999996543 34899999999999999999999 77899999999999999999999999999986
Q ss_pred cCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhh
Q 036879 888 LGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 888 ~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
....... ......++..|+|||.+ ++.++||||+||++|||++ |+.||......+. +....
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-------------~~~~~ 257 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-------------FYKLI 257 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-------------HHHHH
Confidence 6443221 12223457789999974 5678999999999999998 9999865321110 00111
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
+... ....+...+..+.+++.+|+..+|++|||+.|+++.|++.
T Consensus 258 ~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 KEGY------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HcCC------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1000 0001122356789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=322.86 Aligned_cols=235 Identities=27% Similarity=0.336 Sum_probs=183.0
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHH-HHHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAEC-EILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||+||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 678899999875421 2223344444 457889999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
++|.+++.. ...+++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~ 155 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTST 155 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cccc
Confidence 999998854 456788888899999999999999 77899999999999999999999999999975432221 2233
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..||+.|+|||++ ++.++||||+||++|||++|+.||......+. +....... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------~~~i~~~~--------~~ 214 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-------------YDNILNKP--------LQ 214 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-------------HHHHHhCC--------cC
Confidence 5689999999984 57789999999999999999999965311100 00000000 01
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCHHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINIKEA 1004 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev 1004 (1029)
.+...+..+.+++.+|++.+|.+||++.+.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 112346678999999999999999987743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=310.74 Aligned_cols=246 Identities=24% Similarity=0.343 Sum_probs=186.9
Q ss_pred eeccCcceEEEEEEec---CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCC
Q 036879 745 LLGKGSFGSVYKGTLS---DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGS 820 (1029)
Q Consensus 745 ~lg~G~fg~V~~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 820 (1029)
.||+|+||.||+|... ++..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999864 346799998876542 334578899999999999999999999999889999999999999
Q ss_pred HHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc-e
Q 036879 821 LENWMYNKN----RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM-T 895 (1029)
Q Consensus 821 L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~ 895 (1029)
|.+++.... ...++..+..++.|++.|++||| +++++||||||+||+++.++.+|++|||.+......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999996532 24567788899999999999999 778999999999999999999999999999754332211 1
Q ss_pred eccccCCccccCccCC-----------CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK-----------LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-----------~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
.....++..|+|||++ ++.++|||||||++|||++ |+.||......+. ....+. .......+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~----~~~~~~~~- 232 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVR----EQQLKLPK- 232 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhh----cccCCCCC-
Confidence 2234567889999974 2678999999999999996 9999965322111 000000 00000000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
.......+..+.+++..|| .+|++|||++||++.|+
T Consensus 233 ---------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 ---------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ---------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0001123556788999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=315.50 Aligned_cols=257 Identities=24% Similarity=0.424 Sum_probs=196.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-----------------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-----------------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVK 798 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-----------------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 798 (1029)
.++|++.+.||+|+||.||++... ++..||+|.+.... ......+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356899999999999999998532 24468999987553 334567899999999999999999
Q ss_pred EEEEEecCCeEEEEEeccCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCC
Q 036879 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKN----------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSN 868 (1029)
Q Consensus 799 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~N 868 (1029)
+++++...+..++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.||+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence 9999999999999999999999999986532 23677889999999999999999 7789999999999
Q ss_pred EEECCCCcEEEEccCCceecCCCCCce-eccccCCccccCccC----CCCCCcchhHHHHHHHHHhc--CCCCCCccccc
Q 036879 869 ILLNESMVACLSDFGISKLLGDETSMT-QTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT--KKKPTDELFVG 941 (1029)
Q Consensus 869 ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt--g~~p~~~~~~~ 941 (1029)
|+++.++.++++|||+++.+....... .....++..|+|||. .++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999997654332211 122334678999996 36779999999999999998 67787542211
Q ss_pred ccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 942 EISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
+. .... ........ .....+.+..++..+.+++.+||+.||++||++.|+.+.|+
T Consensus 241 ~~--~~~~--------~~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QV--IENT--------GEFFRDQG---RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH--HHHH--------HHHHhhcc---ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 0000 00000000 00001112335678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=288.99 Aligned_cols=246 Identities=25% Similarity=0.309 Sum_probs=194.8
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEecc
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.+.+..||.|..|.||+++.. +|..+|||.+.+.. ....+.+...++++..- .+|.||+.+|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344567999999999999875 68999999998664 33455666677776555 5999999999999998889999998
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
...++..++...+++++..+-.+...+.+||.||.+.| ||+|||+||+|||+|+.|.+|+||||.+.++-+. ...
T Consensus 174 -s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAh 248 (391)
T KOG0983|consen 174 -STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAH 248 (391)
T ss_pred -HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--ccc
Confidence 45667777777888999999999999999999999766 8999999999999999999999999999877543 344
Q ss_pred ccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
+...|.+.|||||.+ |+-++||||||++++|++||+.||..-..+-..+ ..+++ ..
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l------------tkvln-----~e 311 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL------------TKVLN-----EE 311 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH------------HHHHh-----cC
Confidence 456799999999985 5668999999999999999999997632211111 11111 01
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+..+....+++.|.+++..|+.+|+.+||.+.+++++
T Consensus 312 PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11112222368889999999999999999999998864
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=311.56 Aligned_cols=246 Identities=24% Similarity=0.317 Sum_probs=195.1
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
|+..+.||+|+||+||+|... +++.||+|.+.... ......+.+|+++++.++|++|+++++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667788999999999999875 78999999987542 22234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++++|.+++... ...+++..+..++.|++.|++||| ++||+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999999888654 346999999999999999999999 78899999999999999999999999999976543222
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
.....|+..|+|||+. ++.++|+||+||++|||++|+.||........ . +.+........
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~-------------~~~~~~~~~~~- 221 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-R-------------EEVDRRVLETE- 221 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-H-------------HHHHHhhhccc-
Confidence 1234689999999984 57789999999999999999999975311100 0 00000000000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERIN-----IKEALTK 1007 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~~ 1007 (1029)
...+..++..+.+++..|++.+|++||+ +.+++++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 --EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0112234567899999999999999999 6777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.65 Aligned_cols=262 Identities=24% Similarity=0.318 Sum_probs=199.3
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
++|++.+.||+|+||.||+|+.. ++..||+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999875 688899999875533 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++... ..+++..+..++.|+++|++|||+. .+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999999998654 5688999999999999999999931 479999999999999999999999999987553321
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccc-----------------
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLH----------------- 954 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----------------- 954 (1029)
.....+++.|+|||.. ++.++|||||||++|||++|+.||....... ..........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccccCCcccccCCCCC
Confidence 1234688999999973 5678999999999999999999986432111 1100000000
Q ss_pred ----hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 955 ----GKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 955 ----~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
....+..+..... ..+. .....++.++.+++.+|+..+|++|||+.|++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 233 SPRPMAIFELLDYIVNE-PPPK-LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred ccchhhHHHHHHHHhcC-CCcc-CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0000000000000 0000 001124667999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=317.20 Aligned_cols=190 Identities=23% Similarity=0.319 Sum_probs=155.8
Q ss_pred CceeccCcceEEEEEEec---CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEec--CCeEEEEEeccC
Q 036879 743 NNLLGKGSFGSVYKGTLS---DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS--DHFKALVLEYMP 817 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~ 817 (1029)
.++||+|+||+||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 56789999986442 23457789999999999999999999854 456789999985
Q ss_pred CCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE----CCCCcEEEEccCCc
Q 036879 818 NGSLENWMYNK--------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL----NESMVACLSDFGIS 885 (1029)
Q Consensus 818 ~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill----~~~~~~kl~Dfg~a 885 (1029)
++|.+++... ...+++..+..++.|++.||+||| +.||+||||||+||++ +.++.+||+|||+|
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5888877432 224888999999999999999999 7789999999999999 46689999999999
Q ss_pred eecCCCCCc--eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcc
Q 036879 886 KLLGDETSM--TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDEL 938 (1029)
Q Consensus 886 ~~~~~~~~~--~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~ 938 (1029)
+.+...... ......+|+.|+|||++ ++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876432211 12335689999999974 466899999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=307.95 Aligned_cols=247 Identities=26% Similarity=0.452 Sum_probs=189.7
Q ss_pred ceeccCcceEEEEEEec----CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEe-cCCeEEEEEeccC
Q 036879 744 NLLGKGSFGSVYKGTLS----DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCS-SDHFKALVLEYMP 817 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~~ 817 (1029)
+.||+|+||.||+|.+. +...||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 24579999886432 334567889999999999999999999775 4556789999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc---
Q 036879 818 NGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM--- 894 (1029)
Q Consensus 818 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--- 894 (1029)
+++|.+++.......++..+..++.|+++|++||| +.+++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999766666788888999999999999999 778999999999999999999999999999755332111
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCC-CCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKK-KPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......++..|+|||.. ++.++|||||||++|||++|+ +||..... ..... .+. ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~------------~~~---~~-- 218 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITV------------YLL---QG-- 218 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH------------HHh---cC--
Confidence 11123456789999974 567899999999999999964 55543210 00000 000 00
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
.....+..++..+.+++.+||..+|++||++.|+++.++++..
T Consensus 219 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 219 -RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0011122345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=314.74 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=200.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..+|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 467999999999999999999864 7999999999866555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++.+ ..+++..+..++.|++.|++||| +.||+||||||+||+++.++.++|+|||.+........ .
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~ 171 (297)
T cd06656 98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (297)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence 999999998853 45788899999999999999999 77899999999999999999999999999976543322 1
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
.....+++.|+|||.. ++.++|||||||++|++++|+.||.............. ....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~------------------~~~~ 233 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------------NGTP 233 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc------------------CCCC
Confidence 2234688899999984 56789999999999999999999965321111000000 0000
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+...+..+.+++.+||..+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011123345668899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=311.16 Aligned_cols=249 Identities=31% Similarity=0.464 Sum_probs=195.5
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhh--HHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
|+..+.||+|+||+||+|+.. +++.||+|.+........ ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567789999999999999986 577899999987754332 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
++++|.+++. ....+++..+..++.|+++||++|| +.+|+||||||+||+++.++.++|+|||.+..... .....
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF 155 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred cccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-ccccc
Confidence 9999999996 4566899999999999999999999 66899999999999999999999999999986422 22233
Q ss_pred ccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
....++..|+|||+. .+.++||||+|+++|+|++|+.||........ .. .+......... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~--~~--------~~~~~~~~~~~----~ 221 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ--LE--------IIEKILKRPLP----S 221 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH--HH--------HHHHHHHTHHH----H
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhh--hh--------hhhhccccccc----c
Confidence 446689999999983 56789999999999999999999876300000 00 00000000000 0
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...........+.+++.+|++.||++||++.+++++
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 222 SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000001113789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=307.35 Aligned_cols=244 Identities=30% Similarity=0.466 Sum_probs=194.8
Q ss_pred CCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEe-cCCeEEEEEecc
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS-SDHFKALVLEYM 816 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~ 816 (1029)
++|++.+.||+|+||.||+|.. .|..||+|.++... ..+.+.+|+.++++++|+|++++++++. .+...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4688889999999999999976 47889999986442 3467889999999999999999999764 556789999999
Q ss_pred CCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 817 PNGSLENWMYNKNR-SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
++++|.+++..... .+++..+..++.|++.|++||| +.||+||||||+||+++.++.+|++|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 99999999876543 4889999999999999999999 7789999999999999999999999999987653322
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
....++..|+|||+. ++.++|||||||++|||++ |+.||..... ...... +. ...
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~---------~~----~~~- 216 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPR---------VE----KGY- 216 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH---------Hh----cCC-
Confidence 123356789999983 5678999999999999997 9999864211 110000 00 000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
....+..++..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 -KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0011234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=311.50 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=196.6
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|++|+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677789999999999999875 78999999987543 2223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 815 YMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
|+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999999885543 46899999999999999999999 77899999999999999999999999999976543322
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
. ....|+..|+|||++ ++.++||||+||++|||++|+.||........ .+......+..
T Consensus 158 ~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~----------~~~~~~~~~~~----- 220 (285)
T cd05630 158 I--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----------REEVERLVKEV----- 220 (285)
T ss_pred c--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch----------HHHHHhhhhhh-----
Confidence 1 234689999999984 57789999999999999999999975311100 00001111000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERIN-----IKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~~ 1007 (1029)
....+..++.++.+++.+||+.||++||| ++|++++
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 221 --QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00112335667899999999999999999 8899884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=323.11 Aligned_cols=264 Identities=20% Similarity=0.227 Sum_probs=193.2
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC-----
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD----- 806 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 806 (1029)
...++|++.+.||+|+||.||+|+.. +|..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34678999999999999999999875 68999999987542 23356678999999999999999999998644
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 807 -HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 807 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
...++||||+++ ++.+++. ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 357999999965 6666553 34788889999999999999999 778999999999999999999999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc--------
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL-------- 953 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 953 (1029)
+...... ......+|+.|+|||++ ++.++||||+||++|||++|+.||........ +........
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-WNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCcHHHHH
Confidence 7543321 22335689999999984 57789999999999999999999975321110 000000000
Q ss_pred --chhhhhhhhhhhhhhh------------hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 954 --HGKIINVVDINLLQKE------------DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 954 --~~~~~~~~d~~~~~~~------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
................ ..........+..+.+++.+|+..||++|||+.|++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000000000000000 000000112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=321.65 Aligned_cols=233 Identities=28% Similarity=0.336 Sum_probs=182.2
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHH-HHHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAEC-EILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||.||+|+.. +++.||+|++.... ......+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 68899999987542 12233444554 467889999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
++|..++.. ...+++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTST 155 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cccc
Confidence 999988754 456888899999999999999999 77899999999999999999999999999875322221 2233
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..|++.|+|||++ ++.++||||+||++|||++|+.||...... .... ..... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~--------~i~~~--------~~~ 214 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-----QMYD--------NILHK--------PLQ 214 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-----HHHH--------HHhcC--------CCC
Confidence 5689999999984 577999999999999999999999653110 0000 00000 011
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINIK 1002 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 1002 (1029)
.+...+..+.+++.+|++.+|++||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1123456789999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=345.04 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=196.4
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEec--CCe
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSS--DHF 808 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 808 (1029)
....++|++.+.||+|+||+||+|+.. ++..||+|.+.... ......+..|+.+++.++|||||+++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345678999999999999999999876 67889999987542 3345678999999999999999999998854 467
Q ss_pred EEEEEeccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCcEEcCCCCCCEEECC--------
Q 036879 809 KALVLEYMPNGSLENWMYNK---NRSFDILQRLNMVIDVASALEYLHYDH----PTPIIHCDLNPSNILLNE-------- 873 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~----~~givH~Dlk~~Nill~~-------- 873 (1029)
.++||||+++|+|.+++... ...+++..++.|+.||+.||+|||... ..+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999998643 356899999999999999999999532 156999999999999964
Q ss_pred ---------CCcEEEEccCCceecCCCCCceeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcc
Q 036879 874 ---------SMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDEL 938 (1029)
Q Consensus 874 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~ 938 (1029)
.+.+||+|||++..+..... .....||+.|+|||++ ++.++|||||||++|||++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 34599999999986643321 2335689999999974 567899999999999999999999642
Q ss_pred cccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 939 FVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.. ....+. .+. ..+. ......+..+.++|..||..+|++||++.|++++
T Consensus 247 ~~----~~qli~---------~lk----~~p~---lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 NN----FSQLIS---------ELK----RGPD---LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred Cc----HHHHHH---------HHh----cCCC---CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 11 111000 000 0000 0011235678999999999999999999999953
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=327.26 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=192.3
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|+..+.||+|+||+||+|+.. +++.||+|+++... ......+.+|++++..++||+|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999875 68999999997542 233467888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999999854 456889999999999999999999 78899999999999999999999999999875422100
Q ss_pred ----------------------------------ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCC
Q 036879 894 ----------------------------------MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPT 935 (1029)
Q Consensus 894 ----------------------------------~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~ 935 (1029)
......+||+.|+|||++ ++.++||||+||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 001124689999999984 677899999999999999999999
Q ss_pred CcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCC---HHHHHHH
Q 036879 936 DELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERIN---IKEALTK 1007 (1029)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~evl~~ 1007 (1029)
........ ........ .....+.....+.++.+++.+|+ .+|++|++ +.|++++
T Consensus 237 ~~~~~~~~-------------~~~i~~~~----~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQET-------------YRKVMNWK----ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHHH-------------HHHHHcCC----CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 75321110 00000000 00000000113556788888876 49999984 6777765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=312.71 Aligned_cols=266 Identities=25% Similarity=0.431 Sum_probs=204.8
Q ss_pred CCCCCCceeccCcceEEEEEEec-----CCcEEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEEec--CCeE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-----DGMQIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTCSS--DHFK 809 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 809 (1029)
+.|+..+.||+|+||.||+|+.. ++..||||.+...... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999854 3688999999866443 46789999999999999999999999877 5678
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++++|.+++......+++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999776667999999999999999999999 7789999999999999999999999999998765
Q ss_pred CCCCce--eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhc-hhccchhhhhhhh
Q 036879 890 DETSMT--QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV-NDSLHGKIINVVD 962 (1029)
Q Consensus 890 ~~~~~~--~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~d 962 (1029)
...... .....++..|+|||.. ++.++||||||+++|||++|+.|+.............. .......+.+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 332211 1122355679999973 56789999999999999999999865322211100000 0000111111111
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
. ......+..++.++.+++.+||+.+|++||||.|+++.|+.++
T Consensus 241 ~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 241 E------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred c------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1 0011122345678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=298.63 Aligned_cols=249 Identities=27% Similarity=0.347 Sum_probs=199.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.+.|+..+.||+|.-|+||.+... ++..+|+|++.+.. +....+.+.|-+|++.++||.++.+|+.++.++..++|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 345667788999999999999986 46889999998764 34456788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 813 LEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+||+|....+++ .+.+++..+..++.++.-||+||| -.|||.||+||+|||+.++|++-|+||.++......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999887654 557999999999999999999999 888999999999999999999999999987532110
Q ss_pred --------------------------------C-C----------------------ceeccccCCccccCccCC----C
Q 036879 892 --------------------------------T-S----------------------MTQTQTLATIGYMAPEWK----L 912 (1029)
Q Consensus 892 --------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~----~ 912 (1029)
. . ......+||-.|.|||++ .
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 011124688899999997 4
Q ss_pred CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHccc
Q 036879 913 SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTR 992 (1029)
Q Consensus 913 ~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 992 (1029)
+.++|+|+|||++|||+.|+.||.+....+. +.. ++-....- +.....+..+.++|++.+.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-l~N------------Iv~~~l~F------p~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-LRN------------IVGQPLKF------PEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh-HHH------------HhcCCCcC------CCCCcchhHHHHHHHHHhc
Confidence 6689999999999999999999987432221 221 22111110 0011346778999999999
Q ss_pred ccccCCCC----HHHHHHH
Q 036879 993 ESAEERIN----IKEALTK 1007 (1029)
Q Consensus 993 ~dP~~Rpt----~~evl~~ 1007 (1029)
+||++|.. |.||.++
T Consensus 374 KdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred cChhhhhccccchHHhhcC
Confidence 99999997 8888764
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=307.84 Aligned_cols=243 Identities=27% Similarity=0.430 Sum_probs=194.6
Q ss_pred ceeccCcceEEEEEEecC--C--cEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLSD--G--MQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~--~--~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999987655 556789999999999999999999999988 888999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc--e
Q 036879 819 GSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM--T 895 (1029)
Q Consensus 819 gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~ 895 (1029)
++|.+++.+.. ..+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997655 56899999999999999999999 778999999999999999999999999999876442211 1
Q ss_pred eccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
.....++..|+|||. .++.++|||||||++|||++ |+.||......+. . ..+....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~------------~~~~~~~----- 217 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI--L------------KKIDKEG----- 217 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--H------------HHHHhcC-----
Confidence 112446788999997 35778999999999999998 9999864311110 0 0000000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
.....+..++..+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001112234677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=322.82 Aligned_cols=234 Identities=28% Similarity=0.360 Sum_probs=183.2
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHH-HHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECE-ILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||+||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999875 78999999997542 223344555554 57789999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|+|..++. ....+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (325)
T cd05604 81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTT 155 (325)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cccc
Confidence 99998885 4457899999999999999999999 78899999999999999999999999999875422211 2233
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..|++.|+|||++ ++.++||||+||++|||++|+.||......+ .. ........ .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~~--------~~~~~~~~--------~ 214 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-----MY--------DNILHKPL--------V 214 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-----HH--------HHHHcCCc--------c
Confidence 5689999999984 5778999999999999999999996531110 00 00110000 0
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINIKE 1003 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~e 1003 (1029)
.+...+..+.+++.+|++.+|++||++++
T Consensus 215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 215 LRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 01123566789999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.64 Aligned_cols=243 Identities=32% Similarity=0.497 Sum_probs=195.5
Q ss_pred ceeccCcceEEEEEEecCCcEEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCHH
Q 036879 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLE 822 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 822 (1029)
++||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765443 4567899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee-ccccC
Q 036879 823 NWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ-TQTLA 901 (1029)
Q Consensus 823 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~g 901 (1029)
+++......+++..+..++.+++.|++||| +.+++||||||+||+++.++.+||+|||.+........... .....
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999776667889999999999999999999 77799999999999999999999999999976542221111 11234
Q ss_pred CccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHH
Q 036879 902 TIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAK 976 (1029)
Q Consensus 902 t~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 976 (1029)
+..|+|||.. ++.++|||||||++|||++ |..||....... ..+.+.... ....+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--------------~~~~~~~~~------~~~~~ 217 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--------------TRERIESGY------RMPAP 217 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--------------HHHHHhcCC------CCCCC
Confidence 5679999973 5778999999999999999 888886532110 001110000 01112
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 977 EQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 977 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
..++..+.+++.+|+..+|++|||+.|+++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=316.50 Aligned_cols=257 Identities=24% Similarity=0.439 Sum_probs=201.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec--------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecC
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS--------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSD 806 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 806 (1029)
.++|.+.+.||+|+||.||+|+.. ....||+|.++... ......+.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457888999999999999999742 24579999987543 23456788999999999 699999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE
Q 036879 807 HFKALVLEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL 871 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill 871 (1029)
+..++||||+++|+|.+++.... ..+++.++..++.|++.|++||| ++||+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence 99999999999999999996532 34788899999999999999999 7789999999999999
Q ss_pred CCCCcEEEEccCCceecCCCCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCccccccccc
Q 036879 872 NESMVACLSDFGISKLLGDETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISL 945 (1029)
Q Consensus 872 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~ 945 (1029)
+.++.+||+|||.++......... .....++..|+|||++ ++.++|||||||++|||++ |+.||......+ .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~ 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--L 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 999999999999998654322111 1112345679999974 5778999999999999999 888886421110 0
Q ss_pred chhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 946 KSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 946 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
.. ... .. .....+..++..+.+++.+||..+|++|||+.|+++.|+++.....
T Consensus 246 ~~------------~~~----~~--~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 246 FK------------LLR----EG--HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred HH------------HHH----cC--CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 00 000 00 0011123446678899999999999999999999999999887554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.22 Aligned_cols=243 Identities=30% Similarity=0.524 Sum_probs=198.7
Q ss_pred ceeccCcceEEEEEEecC----CcEEEEEEeecccchh-hHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLSD----GMQIAVKVFNLELEGT-LRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~----~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||.||+|.... +..||+|.++...... .+.+.+|+++++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998753 8899999998665433 67899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 819 GSLENWMYNK--------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 819 gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
++|.+++... ...+++..+..++.|+++|++||| +++|+||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765 477999999999999999999999 78899999999999999999999999999987654
Q ss_pred CCC-ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 891 ETS-MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 891 ~~~-~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
... .......++..|+|||.. ++.++||||+||++|||++ |+.||......+ +.. ...+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~-----------~~~~-- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLE-----------YLRK-- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--HHH-----------HHHc--
Confidence 321 122334578899999974 5678999999999999999 699987641110 000 0000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
......+..++.++.+++.+||..+|++|||+.|++++|+
T Consensus 223 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 -----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111223445778999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=311.50 Aligned_cols=250 Identities=24% Similarity=0.412 Sum_probs=198.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
.++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 457888999999999999999864 24689999987553 23345788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEE
Q 036879 810 ALVLEYMPNGSLENWMYNKN---------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLS 880 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~ 880 (1029)
++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999986432 23678899999999999999999 7789999999999999999999999
Q ss_pred ccCCceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccc
Q 036879 881 DFGISKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLH 954 (1029)
Q Consensus 881 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 954 (1029)
|||+++........ ......++..|+|||.. .+.++|||||||++||+++ |+.||.+....+ ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~-------- 231 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VL-------- 231 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HH--------
Confidence 99999765433221 12233467899999973 6778999999999999998 888886421111 00
Q ss_pred hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 955 GKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 955 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
.... . ......+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 232 ----~~~~----~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 232 ----KFVI----D--GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ----HHHh----c--CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0000 0 0011122334678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=314.08 Aligned_cols=246 Identities=23% Similarity=0.337 Sum_probs=199.5
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.+|++.+.||.|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46889999999999999999864 78999999987665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
++++|.+++.. ..+++.++..++.|++.|++||| +.|++||||||+||+++.++.+||+|||++........ ..
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 99999998853 35899999999999999999999 77899999999999999999999999999876543322 12
Q ss_pred ccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
....++..|+|||.+ ++.++|||||||++|+|++|+.||.......... .. . ......
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-------------~~-~----~~~~~~ 234 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------------LI-A----TNGTPE 234 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HH-H----hcCCcc
Confidence 234588899999984 5678999999999999999999996532111000 00 0 000000
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+..++..+.+++.+||..+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11123456678999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.59 Aligned_cols=235 Identities=24% Similarity=0.346 Sum_probs=186.2
Q ss_pred ceeccCcceEEEEEEec-C-------CcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 744 NLLGKGSFGSVYKGTLS-D-------GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+.||+|+||.||+|... . ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36899999999999764 2 234888888655555567788999999999999999999999998899999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc--------EEEEccCCcee
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV--------ACLSDFGISKL 887 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~--------~kl~Dfg~a~~ 887 (1029)
+++|+|.+++......+++..+..++.||+.|++||| ++||+||||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999776667899999999999999999999 778999999999999987765 69999998865
Q ss_pred cCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCC-CCCCcccccccccchhchhccchhhhhhh
Q 036879 888 LGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKK-KPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
.... ....+++.|+|||++ ++.++|||||||++|||++|. .||........ ....
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--------------~~~~ 218 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--------------LQFY 218 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--------------HHHH
Confidence 4322 224578899999984 466899999999999999995 55443111000 0000
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.. ....+......+.+++.+||+.+|++|||++++++.|
T Consensus 219 ~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 219 ED--------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred Hc--------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 0011112345689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=313.03 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=198.7
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
++|++.+.||+|+||.||+|+.. ++..||+|.++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888899999999999999976 78999999887543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 816 MPNGSLENWMYNK--NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 816 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
+++++|.+++... ...+++..+..++.|+++|++|||+ +.+|+||||||+||+++.++.+||+|||.+..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999988653 2368999999999999999999993 2479999999999999999999999999997653322
Q ss_pred ceeccccCCccccCccCC----------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
.....++..|+|||.. ++.++||||+||++|||++|+.||........ . ..+....+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~--------~~~~~~~~~ 225 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--F--------AQLSAIVDG 225 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--H--------HHHHHHhhc
Confidence 1224578899999984 26689999999999999999999964211100 0 000001110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....+..++.++.+++.+||..+|++||++.+++.+
T Consensus 226 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 226 -------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0011223467788999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=318.51 Aligned_cols=267 Identities=18% Similarity=0.255 Sum_probs=194.2
Q ss_pred CCceeccC--cceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 742 ENNLLGKG--SFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 742 ~~~~lg~G--~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
+.++||+| +||+||+++.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78899999865 78999999987653 233467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc-
Q 036879 817 PNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM- 894 (1029)
Q Consensus 817 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 894 (1029)
++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998654 345899999999999999999999 778999999999999999999999999865433211100
Q ss_pred -----eeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccc---------
Q 036879 895 -----TQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLH--------- 954 (1029)
Q Consensus 895 -----~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------- 954 (1029)
......++..|+|||++ ++.++|||||||++|||++|+.||............ ......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTTIP 237 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccchh
Confidence 01123467789999984 457899999999999999999999753221110000 000000
Q ss_pred -hh-------------hhhhhh---hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH--HHHhH
Q 036879 955 -GK-------------IINVVD---INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK--LLKIR 1012 (1029)
Q Consensus 955 -~~-------------~~~~~d---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~i~ 1012 (1029)
+. +.+... ................++..+.+++.+||+.||++|||++|++++ +.++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 00 000000 000000000011122346789999999999999999999999984 44443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.12 Aligned_cols=244 Identities=29% Similarity=0.493 Sum_probs=190.0
Q ss_pred ceeccCcceEEEEEEec-CCc--EEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGM--QIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||.||+|+.. ++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 35899999999999875 444 46888877432 33456788999999999 899999999999999999999999999
Q ss_pred CCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccC
Q 036879 819 GSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFG 883 (1029)
Q Consensus 819 gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg 883 (1029)
++|.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 24788999999999999999999 7789999999999999999999999999
Q ss_pred CceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhh
Q 036879 884 ISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKII 958 (1029)
Q Consensus 884 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1029)
++..... .........+..|+|||+. ++.++|||||||++|||++ |..||......+ ...
T Consensus 158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~----------- 222 (270)
T cd05047 158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYE----------- 222 (270)
T ss_pred Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HHH-----------
Confidence 9863221 1111122346679999984 5778999999999999997 999986421110 000
Q ss_pred hhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 959 NVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 959 ~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
.+.... ..+.+..++..+.+++.+||+.+|.+|||+.|+++.|.++.
T Consensus 223 -~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 223 -KLPQGY------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -HHhCCC------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000000 01112234567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=311.82 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=195.9
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|++.+.||+|+||.||+|+.. ++..||+|.++... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999875 78999999987543 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 816 MPNGSLENWMYNKN--RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
++ ++|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68988885433 56899999999999999999999 77899999999999999999999999999976543221
Q ss_pred ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccc--hhchhccchhh---hhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLK--SRVNDSLHGKI---INVVDI 963 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~---~~~~d~ 963 (1029)
......+++.|+|||+. ++.++||||+||++|||++|++||.+......... ..........+ ....+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 22234578899999974 46689999999999999999999975321100000 00000000000 000000
Q ss_pred hh--hh-hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 NL--LQ-KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~~--~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.. .. ...........++.++.+++.+|+..||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00 00 0000001112246778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=348.27 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=203.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.+-++.....||.|.||.||.|.. ++|.-.|+|.+.... ....+.+.+|+.++..++|||+|+++|+-...+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 345677789999999999999985 579999999887543 33456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
||||++|+|.+.+ +.++..++.-...+..|++.|++||| +.|||||||||.||+++.+|.+|.+|||.|..+....
T Consensus 1313 MEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999987 56666777778889999999999999 7779999999999999999999999999999876543
Q ss_pred Cc---eeccccCCccccCccCCCC-------CCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhh
Q 036879 893 SM---TQTQTLATIGYMAPEWKLS-------RKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962 (1029)
Q Consensus 893 ~~---~~~~~~gt~~y~aPE~~~~-------~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 962 (1029)
.. .-....||+.|||||++.+ .+.||||+|||+.||+||+.||.+......-. ..
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM---------------y~ 1453 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM---------------YH 1453 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH---------------hH
Confidence 11 1224679999999999743 36899999999999999999998743221110 00
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
- ..+..++.|+..+.+-.+++..|+..||++|.++.|++++
T Consensus 1454 V----~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 V----AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred H----hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 0 1112234455678889999999999999999999877764
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=321.17 Aligned_cols=261 Identities=20% Similarity=0.252 Sum_probs=191.7
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
....+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 45568999999999999999999876 6788999975432 2346899999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+ .++|.+++......+++..+..++.||+.||+||| ++|||||||||+||+++.++.+||+|||.++......
T Consensus 137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 999 46899998777778999999999999999999999 7789999999999999999999999999997543221
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCC-Ccccccccccchhchhccch-------------
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPT-DELFVGEISLKSRVNDSLHG------------- 955 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~-~~~~~~~~~~~~~~~~~~~~------------- 955 (1029)
......||+.|+|||++ ++.++|||||||++|||+++..|+ +...................
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 12234689999999984 577899999999999999866554 33211101000000000000
Q ss_pred ------hhhhhhhhhhhhh-h-hh-hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 ------KIINVVDINLLQK-E-DA-YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 ------~~~~~~d~~~~~~-~-~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....++...... . .. ........+..+.++|.+||+.||++||||.|++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000000000000 0 00 000011234566789999999999999999999875
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=318.31 Aligned_cols=190 Identities=29% Similarity=0.415 Sum_probs=165.4
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCC-C-----CceEEEEEEEecCCeEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIR-H-----RNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 811 (1029)
+|++.+.||+|+||.|.+|.+. +++.||||+++.. ..-..+-..|++++..++ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999865 7999999999865 334566778999999996 4 389999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC--CCCcEEEEccCCceec
Q 036879 812 VLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN--ESMVACLSDFGISKLL 888 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~--~~~~~kl~Dfg~a~~~ 888 (1029)
|+|.+ ..+|.++++... ..++...++.|+.||+.||.+|| +.+|||+||||+|||+. ....+||+|||.|.+.
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 679999997654 46899999999999999999999 67799999999999996 3458999999999876
Q ss_pred CCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCc
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDE 937 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~ 937 (1029)
...- . ..+.++.|+|||++ ++.+.||||||||++||++|.+.|.+
T Consensus 342 ~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 342 SQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred CCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 4432 1 46688999999995 68899999999999999999888865
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.22 Aligned_cols=245 Identities=28% Similarity=0.425 Sum_probs=195.2
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccch---------hhHHHHHHHHHHhcCCCCceEEEEEEEecCCe
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG---------TLRSFDAECEILGSIRHRNLVKIISTCSSDHF 808 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 808 (1029)
+|.+.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999865 6889999988654321 23568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.++||||+++++|.+++... ..+++..+..++.|++.|++||| +.|++||||+|+||+++.++.++|+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999999543 56888999999999999999999 778999999999999999999999999999866
Q ss_pred CCCCCc-----eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhh
Q 036879 889 GDETSM-----TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959 (1029)
Q Consensus 889 ~~~~~~-----~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1029)
...... ......++..|+|||.. ++.++||||+||++|||++|+.||........ +..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------------~~~ 223 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-------------IFK 223 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-------------HHH
Confidence 422110 11123478899999974 56789999999999999999999975311100 000
Q ss_pred hhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 960 VVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 960 ~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
... ......+..++..+.+++.+||+.+|++||++.|++++
T Consensus 224 ~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 224 IGE-------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred Hhc-------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 000 00011123356778999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=308.31 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=201.2
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCc----EEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGM----QIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
..+|++.+.||+|+||.||+|... +|. .||+|.+..... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356888899999999999999864 333 589998875543 345678899999999999999999999987 7789
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+++|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.++....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999877777999999999999999999999 67899999999999999999999999999987643
Q ss_pred CCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 891 ETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 891 ~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
..... .....++..|+|||.. ++.++|+|||||++||+++ |+.||......+ +.+. +..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~------------~~~- 226 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDL------------LEK- 226 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHH------------HhC-
Confidence 32211 1122245689999973 5678999999999999998 999987532111 1110 000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
. .....+..++..+.+++.+||..+|++||++.++++.++++.+
T Consensus 227 --~---~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 227 --G---ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --C---CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 0011122345678999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=320.26 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=193.9
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecC----
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSD---- 806 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 806 (1029)
....++|++.+.||+|+||+||+|... +++.||||.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 445688999999999999999999864 788999999875432 2345677899999999999999999987543
Q ss_pred --CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCC
Q 036879 807 --HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGI 884 (1029)
Q Consensus 807 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~ 884 (1029)
...+++||++ +++|.+++. ...+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 3568999998 789988774 356899999999999999999999 77899999999999999999999999999
Q ss_pred ceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc--cchhh
Q 036879 885 SKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS--LHGKI 957 (1029)
Q Consensus 885 a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~ 957 (1029)
++..... .....+++.|+|||++ ++.++||||+||++|||++|+.||......+ .+....... .....
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSPEV 239 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence 9865432 2234689999999974 5678999999999999999999996532110 000000000 00000
Q ss_pred hhhhhh----hhhh----hhh-hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 958 INVVDI----NLLQ----KED-AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 958 ~~~~d~----~~~~----~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+.. .... ... ..........+.+.+++.+|+..||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000 000 0000011234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=312.39 Aligned_cols=251 Identities=24% Similarity=0.448 Sum_probs=198.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
.++|++.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999863 467899999876533 3346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCC
Q 036879 810 ALVLEYMPNGSLENWMYNKN---------------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSN 868 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~N 868 (1029)
++||||+++++|.+++.... ..+++..++.++.|++.||+||| +++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999996432 24678889999999999999999 7789999999999
Q ss_pred EEECCCCcEEEEccCCceecCCCCCc-eeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccc
Q 036879 869 ILLNESMVACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGE 942 (1029)
Q Consensus 869 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~ 942 (1029)
|+++.++.++|+|||++......... .......++.|+|||. .++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999998765332211 1222345678999997 35778999999999999997 888875421111
Q ss_pred cccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 943 ISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
.. ....+... ...+..++.++.+++.+|++.+|++|||+.|+++.|++
T Consensus 241 -----~~--------~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -----VI--------YYVRDGNV-------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HH--------HHHhcCCC-------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 00 00000000 01122356779999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.22 Aligned_cols=244 Identities=27% Similarity=0.348 Sum_probs=198.6
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
++|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999876 68999999987653 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++... .+++..+..++.|++.|++||| +++++||||+|+||++++++.++|+|||.++...... ..
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 154 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK 154 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence 9999999998543 7899999999999999999999 7789999999999999999999999999998775432 12
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
.....+++.|+|||+. ++.++|||||||++|||++|+.||........ ... +.....
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-----~~~-----~~~~~~--------- 215 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-----LFL-----IPKNNP--------- 215 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-----HHH-----hhhcCC---------
Confidence 2334678899999984 57789999999999999999999965321110 000 000000
Q ss_pred hhHHHHH-HHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 972 YLTAKEQ-CVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 972 ~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+.. ++.++.+++.+||..+|++|||+++++++
T Consensus 216 -~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 216 -PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000111 46678999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=311.87 Aligned_cols=262 Identities=22% Similarity=0.305 Sum_probs=190.4
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcC---CCCceEEEEEEEec-----CC
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSI---RHRNLVKIISTCSS-----DH 807 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 807 (1029)
+|++.+.||+|+||+||+|+.. +++.||+|.++.... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888899999999999999876 789999999875432 2234566777777665 69999999998864 34
Q ss_pred eEEEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 808 FKALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
..++||||++ ++|.+++.... ..+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5789999997 58988886543 45899999999999999999999 7789999999999999999999999999998
Q ss_pred ecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhhhh
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKIIN 959 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~ 959 (1029)
...... ......++..|+|||++ ++.++||||+||++|||++|++||......+. +..... ......+..
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHHHHHHhCCCChhhCcc
Confidence 664322 12234678999999984 57789999999999999999999865321110 000000 000000000
Q ss_pred hhh---hhhh-hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 960 VVD---INLL-QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 960 ~~d---~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
... .... ............++..+.+++.+|++.||++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 0000 00000011112346678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=324.07 Aligned_cols=262 Identities=20% Similarity=0.235 Sum_probs=193.9
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
...+|.+.+.||+|+||.||+|+.. .++.||||... ...+.+|++++++++|||||++++++...+..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3557999999999999999999876 68899999632 2346789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC-
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS- 893 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 893 (1029)
++ .++|.+++......+++..+..++.|++.||+||| ++|||||||||+||+++.++.+||+|||+++.......
T Consensus 241 ~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 241 KY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 99 47999988766667999999999999999999999 77899999999999999999999999999986543221
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCccccc--ccccchhchhccch------hhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVG--EISLKSRVNDSLHG------KIINVV 961 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~------~~~~~~ 961 (1029)
.......||+.|+|||++ ++.++|||||||++|||++|..|+...... ...+...+...... .+....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 112234689999999984 677899999999999999988765322111 00010000000000 000000
Q ss_pred hhhhhhhhh-------------hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 DINLLQKED-------------AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 d~~~~~~~~-------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+..... ............+.+++.+|++.||++|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 0000001224578899999999999999999999986
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=304.39 Aligned_cols=246 Identities=30% Similarity=0.535 Sum_probs=197.8
Q ss_pred CCCCceeccCcceEEEEEEecC-----CcEEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 740 FSENNLLGKGSFGSVYKGTLSD-----GMQIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
+++.+.||+|+||.||+|+..+ +..||+|.+...... ..+.+..|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999998753 388999999765433 5678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 814 EYMPNGSLENWMYNKNRS-FDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
||+++++|.+++...... +++..+..++.|++.|++||| +.|++||||||+||+++.++.++++|||.+.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999998765544 899999999999999999999 7789999999999999999999999999998765543
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
........++..|+|||.. .+.++||||+|++++||++ |+.||..... ..+.+. .....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~-----------~~~~~--- 221 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEY-----------LKKGY--- 221 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH-----------HhcCC---
Confidence 3322223477899999973 6789999999999999998 7888764211 000000 00000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
....+..++..+.+++.+|+..+|++|||+.|+++.|
T Consensus 222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111223567899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=303.06 Aligned_cols=246 Identities=27% Similarity=0.353 Sum_probs=199.9
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|+..+.||+|+||.||.++.. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999865 68999999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++++|.+++.+. ...+++..+..++.|++.|++||| +.|++||||+|+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999765 456899999999999999999999 77899999999999999999999999999987644332
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
......+++.|+|||.. .+.++||||+|+++|||++|+.||...... ..+..... ...
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~------------~~~- 218 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIVQ------------GNY- 218 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHc------------CCC-
Confidence 22335688999999984 466899999999999999999998652111 00100000 000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
...+..++..+.+++.+||..+|++||++.|++++.
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 --TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 011133467789999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=309.77 Aligned_cols=264 Identities=22% Similarity=0.270 Sum_probs=201.5
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999875 78999999987654 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+ +++|.+++......+++..+..++.|+++|++||| +.+|+|+||||+||+++.++.++++|||.+..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 99999999776778999999999999999999999 7789999999999999999999999999998765433222
Q ss_pred eccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhhhhh---hhhh
Q 036879 896 QTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKIINV---VDIN 964 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~---~d~~ 964 (1029)
.....++..|+|||++ ++.++||||+||+++||++|++||....... .+..... ......+.+. .+..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHHHHHHcCCCChHHHhhccCcchhh
Confidence 3335688999999984 4678999999999999999988876432111 0000000 0000000000 0000
Q ss_pred h---hhh-hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 965 L---LQK-EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 965 ~---~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. ... ...........+.++.+++.+|+..+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000 000001112345789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.32 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=198.3
Q ss_pred CCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
++|+..+.||+|+||.||+|+.+ +.+.||+|.+...... ..+.+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999864 3467999988654433 4567999999999999999999999999989999
Q ss_pred EEEeccCCCCHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEcc
Q 036879 811 LVLEYMPNGSLENWMYNKN--------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDF 882 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Df 882 (1029)
+||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999986543 15899999999999999999999 777999999999999999999999999
Q ss_pred CCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhh
Q 036879 883 GISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKI 957 (1029)
Q Consensus 883 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 957 (1029)
|++...............++..|+|||.. .+.++||||||+++|||++ |..||....... .+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-----~~~~~~~~~~ 236 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-----VLNRLQAGKL 236 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-----HHHHHHcCCc
Confidence 99875433322233334567889999974 4668999999999999998 788886422111 0100000000
Q ss_pred hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 958 INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 958 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
....+..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus 237 --------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 --------------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --------------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00111235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=322.75 Aligned_cols=263 Identities=20% Similarity=0.237 Sum_probs=193.6
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC-----
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD----- 806 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 806 (1029)
...++|+..+.||+|+||.||+|... .++.||||.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35678999999999999999999865 68999999987543 23346778899999999999999999988543
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 807 -HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 807 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
...++||||+++ ++.+++. ..+++..+..++.|+++||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 356899999964 6766663 34788899999999999999999 788999999999999999999999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc---------
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS--------- 952 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------- 952 (1029)
+...... ......+|+.|+|||++ ++.++|||||||++|||++|+.||.+....+. +...+...
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMK 243 (355)
T ss_pred ccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence 8654322 22335689999999984 57789999999999999999999975321110 00000000
Q ss_pred -cchhhhhhhhhhhh----------hh--hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 953 -LHGKIINVVDINLL----------QK--EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 953 -~~~~~~~~~d~~~~----------~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.........+.... .. ..............+.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000000000 00 000000111234578999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=302.35 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=196.0
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEec-CCeEEEEEe
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSS-DHFKALVLE 814 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E 814 (1029)
+|++.+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|++++++++|||++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999875 67899999987543 2345678899999999999999999998864 446789999
Q ss_pred ccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 815 YMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
|+++++|.+++... ...+++.++..++.|++.|++||| +.||+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999998764 345899999999999999999999 77899999999999999999999999999987643322
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......+++.|+|||+. ++.++||||+||+++||++|+.||...... ........+. .
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~~~~--------~---- 219 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRIIEGK--------L---- 219 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHhcC--------C----
Confidence 22234578899999984 466899999999999999999998642110 0000000000 0
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+...+..+.+++.+|++.+|++||++.+++++
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01123456779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=312.61 Aligned_cols=264 Identities=22% Similarity=0.297 Sum_probs=196.8
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|+..+.||+|+||.||+|+.. +|+.||+|.++.... .....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999875 789999999875432 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
++ ++|.+++......+++..+..++.||++|++||| +++|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence 96 5888888766677999999999999999999999 77899999999999999999999999999986543221 1
Q ss_pred eccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhh---hhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKI---INVVDIN 964 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~---~~~~d~~ 964 (1029)
.....++..|+|||++ ++.++||||+||++|||++|+.|+......+..+..... ......+ ....+..
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 2234578899999973 467899999999999999999986432211111100000 0000000 0000000
Q ss_pred hhhhh---hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 965 LLQKE---DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 965 ~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..... ..........+.++.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 00011112346788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.50 Aligned_cols=245 Identities=24% Similarity=0.342 Sum_probs=184.8
Q ss_pred eeccCcceEEEEEEecC---CcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCC
Q 036879 745 LLGKGSFGSVYKGTLSD---GMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGS 820 (1029)
Q Consensus 745 ~lg~G~fg~V~~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 820 (1029)
.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+++++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 4568888776443 2334578899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc-e
Q 036879 821 LENWMYNKNR----SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM-T 895 (1029)
Q Consensus 821 L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~ 895 (1029)
|.+++..... ..++.....++.|++.|++||| +++|+||||||+||+++.++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999966432 2467788899999999999999 778999999999999999999999999998654322111 1
Q ss_pred eccccCCccccCccCC-----------CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK-----------LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-----------~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
.....+++.|+|||+. .+.++||||+||++|||++ |..||......+. +...+. . .+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~----~-----~~~ 228 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVR----E-----QDI 228 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HHHHhh----c-----cCc
Confidence 2233467789999972 4668999999999999999 7788765321110 000000 0 000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.. . ....+..++..+.+++..|| .||++|||++||++.+
T Consensus 229 ~~---~--~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KL---P--KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cC---C--CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 00 0 00112235667788999999 5999999999999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=312.36 Aligned_cols=254 Identities=26% Similarity=0.462 Sum_probs=198.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCc----EEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGM----QIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
.++|+..+.||+|+||.||+|++. +|. .||+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456788899999999999999864 444 478888765432 2344688999999999999999999998754 467
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+|+||+++|+|.+++......+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999999777767899999999999999999999 77899999999999999999999999999986643
Q ss_pred CCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 891 ETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 891 ~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
.... ......++..|+|||.. ++.++|||||||++|||++ |+.||.+..... ... .+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~------------~~~~~ 227 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPD------------LLEKG 227 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH------------HHHCC
Confidence 2221 12223457789999974 5678999999999999997 899986531111 111 11000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.....+..++..+.+++..||..+|++||+++++++.++++.+.
T Consensus 228 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 228 ------ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00011123456789999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=303.14 Aligned_cols=245 Identities=22% Similarity=0.339 Sum_probs=198.3
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|++.+.||+|+||.||+++.. +|+.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999865 78999999987542 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++++|.+++.... ..+++..+..++.|++.|++||| +.|++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999999886543 35789999999999999999999 77899999999999999999999999999986644322
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
......+++.|+|||+. .+.++|+|||||++++|++|+.||...... . .++......
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~------------~~~~~~~~~-- 217 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----N------------LVLKIIRGS-- 217 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----H------------HHHHHhcCC--
Confidence 12234578899999984 466899999999999999999998642110 0 111111000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+..++..+.+++.+||+.+|++||++.||+++
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 011123456779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=305.58 Aligned_cols=247 Identities=24% Similarity=0.381 Sum_probs=195.8
Q ss_pred CCCCCceeccCcceEEEEEEecCCcEEEEEEeeccc------chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL------EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
+|...+.||+|+||+||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999887542 12245688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++++|.+++.+. ..+++..+..++.|++.|++||| +.+|+|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999998543 46789999999999999999999 7789999999999999999999999999987543210
Q ss_pred -----CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 893 -----SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 893 -----~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
........++..|+|||++ ++.++||||+||++|||++|+.||........ ... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~------------~~~~ 223 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFY------------IGAH 223 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHH------------hhhc
Confidence 1111234588899999984 56789999999999999999999964211100 000 0000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.......+..++.++.+++.+||..+|++||++.|++++
T Consensus 224 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 224 -----RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -----cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000011122356778999999999999999999999763
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=310.64 Aligned_cols=255 Identities=27% Similarity=0.311 Sum_probs=199.0
Q ss_pred HHHHHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecC-
Q 036879 730 YQELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSD- 806 (1029)
Q Consensus 730 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 806 (1029)
..++..+.++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3444556888999999999999999999875 78899999986542 2345678899999999 899999999998653
Q ss_pred ----CeEEEEEeccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEE
Q 036879 807 ----HFKALVLEYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACL 879 (1029)
Q Consensus 807 ----~~~~lV~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl 879 (1029)
+..++||||+++++|.+++.. ....+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEE
Confidence 357999999999999998753 3456899999999999999999999 778999999999999999999999
Q ss_pred EccCCceecCCCCCceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch
Q 036879 880 SDFGISKLLGDETSMTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN 950 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 950 (1029)
+|||.+........ ......++..|+|||.+ ++.++|||||||++|||++|+.||........ +..
T Consensus 170 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~--- 244 (291)
T cd06639 170 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFK--- 244 (291)
T ss_pred eecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHH---
Confidence 99999876543221 12234578899999974 46789999999999999999999865321100 000
Q ss_pred hccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 951 DSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 951 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
... ........++.....+.+++.+||+.+|++||++.|++++
T Consensus 245 -~~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 -IPR-------------NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -Hhc-------------CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000 0000011122345678999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=307.11 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=197.5
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
++|+..+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999876 689999998865432 233567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|++++.+..++. ....+++..+..++.|++.|++||| +.|++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 999988887764 4456899999999999999999999 67899999999999999999999999999987644321
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccc--hhchhccchhhhhhhhhh---
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLK--SRVNDSLHGKIINVVDIN--- 964 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~d~~--- 964 (1029)
......++..|+|||++ ++.++||||+||++|||++|+.||.+....+.... ........ ......+..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP-RHQQIFSTNQFF 234 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh-HHhhhccccccc
Confidence 12234578899999974 45689999999999999999999975332111100 00000000 000000000
Q ss_pred ---hhhhhh---hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 965 ---LLQKED---AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 965 ---~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...... .........+..+.+++.+||+.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000 0000112346778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=316.38 Aligned_cols=254 Identities=23% Similarity=0.435 Sum_probs=199.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec--------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecC
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS--------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSD 806 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 806 (1029)
..+|++.+.||+|+||.||+|+.. .+..||+|.++... ....+.+.+|+++++++ +||||+++++++..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 346889999999999999999742 12468999887543 23456789999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE
Q 036879 807 HFKALVLEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL 871 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill 871 (1029)
+..++||||+++|+|.+++.+.. ..+++.++..++.|+++|++||| +.||+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence 99999999999999999986532 24788899999999999999999 7789999999999999
Q ss_pred CCCCcEEEEccCCceecCCCCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCccccccccc
Q 036879 872 NESMVACLSDFGISKLLGDETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISL 945 (1029)
Q Consensus 872 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~ 945 (1029)
+.++.+||+|||+++......... .....++..|+|||+. ++.++|||||||++|||++ |..||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 244 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 244 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence 999999999999998664322211 1222345679999984 5678999999999999998 888886521111
Q ss_pred chhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 946 KSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 946 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
. .+.+... ...+.+..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 245 --~---------~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 245 --L---------FKLLKEG------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred --H---------HHHHHcC------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 0 0000000 0011122346678999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=308.53 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=199.2
Q ss_pred CHHHHHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEec-
Q 036879 729 SYQELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSS- 805 (1029)
Q Consensus 729 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 805 (1029)
+..+...+.+.|++.+.||+|+||.||+|+.. +++.||+|.+.... .....+..|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44555567788999999999999999999875 68899999986543 3345688899999998 79999999999853
Q ss_pred -----CCeEEEEEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEE
Q 036879 806 -----DHFKALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACL 879 (1029)
Q Consensus 806 -----~~~~~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl 879 (1029)
....++||||+++|+|.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 46789999999999999988654 345788889999999999999999 778999999999999999999999
Q ss_pred EccCCceecCCCCCceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch
Q 036879 880 SDFGISKLLGDETSMTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN 950 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 950 (1029)
+|||++........ ......+++.|+|||.+ ++.++|||||||++|||++|+.||..........
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~----- 236 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF----- 236 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-----
Confidence 99999875532211 12234688999999974 4558999999999999999999996532111100
Q ss_pred hccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 951 DSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 951 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. ... ..........++..+.+++.+||+.||++|||+.|++++
T Consensus 237 --------~-~~~-----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 --------L-IPR-----NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --------h-Hhh-----CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 000 000001112356789999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=309.10 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=195.8
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
...|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 355888899999999999999875 78999999986442 22345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||++ |++.+++......+++..+..++.|++.|+.||| +.+|+||||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99996 6788877666667999999999999999999999 778999999999999999999999999998765332
Q ss_pred CceeccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
....++..|+|||+. ++.++||||||+++|||++|+.||........ . ......
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-----~--------~~~~~~-- 229 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----L--------YHIAQN-- 229 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-----H--------HHHhcC--
Confidence 124578899999974 46689999999999999999999864311100 0 000000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
......+..++..+.+++.+||+.+|++||++.+++.+.
T Consensus 230 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 230 ----DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ----CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000001123566799999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=304.43 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=198.7
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..|+..+.||.|+||.||+|+.. ++..||+|.+.... ......+.+|+++++++.||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34677788999999999999875 68899999987543 34456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++.. ..+++..+..++.|++.|++|+| +.+++|+||+|+||+++.++.++++|||++........ .
T Consensus 84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 999999998853 45888999999999999999999 77899999999999999999999999999976644322 2
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
.....++..|+|||.. .+.++|+|||||++|||++|+.||.+....... ..... ..
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--------------~~~~~------~~ 217 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--------------FLIPK------NN 217 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--------------hhhhc------CC
Confidence 2234578899999984 567899999999999999999998753211110 00000 00
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+..++..+.+++.+||+.+|++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 011233457788999999999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=306.64 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=198.0
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCC------
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDH------ 807 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 807 (1029)
+.++|++.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999975 678999999876543 346789999999999 7999999999996543
Q ss_pred eEEEEEeccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCC
Q 036879 808 FKALVLEYMPNGSLENWMYNK---NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGI 884 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~ 884 (1029)
..++||||+++++|.+++... ...+++..+..++.|+++|++||| +.+++||||+|+||+++.++.+|++|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999988543 357899999999999999999999 78899999999999999999999999999
Q ss_pred ceecCCCCCceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccch
Q 036879 885 SKLLGDETSMTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG 955 (1029)
Q Consensus 885 a~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 955 (1029)
+........ ......++..|+|||+. ++.++||||+||++|||++|+.||........ ..
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~--------- 228 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LF--------- 228 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HH---------
Confidence 976543222 22334588999999973 45679999999999999999999864211100 00
Q ss_pred hhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 KIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.... ........+..++.++.+++.+||..||++|||+.+++++
T Consensus 229 ---~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 229 ---KIPR-----NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ---Hhhc-----cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0000 0000011122356788999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=329.56 Aligned_cols=263 Identities=22% Similarity=0.237 Sum_probs=188.1
Q ss_pred HHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCC------CceEEEEEEEec
Q 036879 733 LFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRH------RNLVKIISTCSS 805 (1029)
Q Consensus 733 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~ 805 (1029)
+....++|++.+.||+|+||+||+|+.. +++.||||+++... ...+.+..|+++++.++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445688999999999999999999875 68899999986432 223445667777777654 468999999876
Q ss_pred C-CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCEEECCCC--------
Q 036879 806 D-HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP-TPIIHCDLNPSNILLNESM-------- 875 (1029)
Q Consensus 806 ~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~givH~Dlk~~Nill~~~~-------- 875 (1029)
. ...++|||++ +++|.+++.+. ..+++..+..++.||+.||+||| + .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence 4 5788999988 78899888543 56899999999999999999999 5 4899999999999998765
Q ss_pred --------cEEEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCccccccc
Q 036879 876 --------VACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI 943 (1029)
Q Consensus 876 --------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~ 943 (1029)
.+||+|||.+..... .....+||+.|+|||++ ++.++|||||||++|||++|+.||......+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred cccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998864322 22345789999999984 67789999999999999999999975321110
Q ss_pred ccchhchhc---cchhh---------hhhhhhhh------hhh----h-hhhhHHHHHHHHHHHHHHHHcccccccCCCC
Q 036879 944 SLKSRVNDS---LHGKI---------INVVDINL------LQK----E-DAYLTAKEQCVSSVLSLAMQCTRESAEERIN 1000 (1029)
Q Consensus 944 ~~~~~~~~~---~~~~~---------~~~~d~~~------~~~----~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt 1000 (1029)
...+... ....+ .+..+... ... . .............+.+++.+|++.||++|||
T Consensus 354 --~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 354 --LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred --HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 0000000 00000 00000000 000 0 0000000112456889999999999999999
Q ss_pred HHHHHHH
Q 036879 1001 IKEALTK 1007 (1029)
Q Consensus 1001 ~~evl~~ 1007 (1029)
++|++++
T Consensus 432 a~e~L~H 438 (467)
T PTZ00284 432 ARQMTTH 438 (467)
T ss_pred HHHHhcC
Confidence 9999984
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=302.35 Aligned_cols=246 Identities=21% Similarity=0.342 Sum_probs=182.8
Q ss_pred eeccCcceEEEEEEecCC---cEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCC
Q 036879 745 LLGKGSFGSVYKGTLSDG---MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGS 820 (1029)
Q Consensus 745 ~lg~G~fg~V~~~~~~~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 820 (1029)
.||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999976443 345677665443 2345689999999999999999999999999999999999999999
Q ss_pred HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC-Ccee
Q 036879 821 LENWMYNKN---RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET-SMTQ 896 (1029)
Q Consensus 821 L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~ 896 (1029)
|.+++.+.. ...++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999996532 34567778899999999999999 7789999999999999999999999999986432111 1112
Q ss_pred ccccCCccccCccCC-----------CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK-----------LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~-----------~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
....++..|+|||+. ++.++|||||||++|||++ |..||......+ .......+......++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-----VLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHhhcccccCCCc
Confidence 234578899999974 2568999999999999997 566775421110 00000001001111111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
. +..+...+.+++..|| .+|++||+++|+++.|.
T Consensus 234 ~----------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 L----------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred c----------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1 1123566888999999 67999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.72 Aligned_cols=244 Identities=25% Similarity=0.355 Sum_probs=195.7
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556678999999999999865 68899999987543 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
++++|.+++. ...+++..+..++.|+++|++||| +++++|+||+|+||++++++.++++|||++........ ..
T Consensus 85 ~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06642 85 GGGSALDLLK--PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch-hh
Confidence 9999999884 356889999999999999999999 77899999999999999999999999999976543221 22
Q ss_pred ccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
....++..|+|||.. ++.++|||||||++|||++|+.||......... .. .... ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~------------~~~~------~~ 218 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL--FL------------IPKN------SP 218 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH--hh------------hhcC------CC
Confidence 234578899999984 566899999999999999999998653211110 00 0000 00
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
......++..+.+++.+||+.+|++||++.+++++-
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 011123466789999999999999999999999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=319.27 Aligned_cols=262 Identities=19% Similarity=0.230 Sum_probs=192.7
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC------
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD------ 806 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 806 (1029)
..++|++.+.||+|+||.||+|+.. .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4678999999999999999999865 68899999987542 33446788899999999999999999987543
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 807 HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
...++||||++ +++.+++. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 35799999996 47777763 34788899999999999999999 7789999999999999999999999999998
Q ss_pred ecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh----------c
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND----------S 952 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----------~ 952 (1029)
...... ......+|+.|+|||++ ++.++|||||||++|||++|+.||......+. +...... .
T Consensus 175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHh
Confidence 654322 22335689999999984 57789999999999999999999975321110 0000000 0
Q ss_pred cchhhhhhhhhhhh-hhh-----------hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 953 LHGKIINVVDINLL-QKE-----------DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 953 ~~~~~~~~~d~~~~-~~~-----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.............. ... .............+.+++.+|++.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000000 000 00000011124568899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=319.27 Aligned_cols=237 Identities=24% Similarity=0.287 Sum_probs=183.5
Q ss_pred eccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC---CCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 746 LGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI---RHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 746 lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
||+|+||+||+|+.. +++.||+|++.... ......+..|..++... +||+|+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999875 68999999987542 12233455666776655 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|+|.+++.. ...+++..+..++.||++|++||| +.||+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 155 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT 155 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence 999998854 456899999999999999999999 77899999999999999999999999999875432221 1223
Q ss_pred ccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhh
Q 036879 899 TLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYL 973 (1029)
Q Consensus 899 ~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 973 (1029)
..||+.|+|||++ ++.++||||+||++|||++|+.||...... ........+. ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~~i~~~~------~~~-------- 216 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYRNIAFGK------VRF-------- 216 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHHHHHcCC------CCC--------
Confidence 5689999999974 567899999999999999999998653111 0000000000 000
Q ss_pred HHHHHHHHHHHHHHHHcccccccCCC----CHHHHHHH
Q 036879 974 TAKEQCVSSVLSLAMQCTRESAEERI----NIKEALTK 1007 (1029)
Q Consensus 974 ~~~~~~~~~l~~li~~cl~~dP~~Rp----t~~evl~~ 1007 (1029)
.....+..+.+++.+|++.||++|| ++.+++++
T Consensus 217 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 217 -PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred -CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 0012356788999999999999998 56776663
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=307.53 Aligned_cols=266 Identities=22% Similarity=0.314 Sum_probs=196.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||.||+|+.. +++.||+|.+...... ....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 467899999999999999999876 7899999998755322 23456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|++ ++|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 997 5999998776667899999999999999999999 77899999999999999999999999999875432211
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhhhhhhhh---
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKIINVVDI--- 963 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~d~--- 963 (1029)
......++..|+|||+. ++.++||||+||++|||++|+.||.........+..... ....+.+......
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 11223467889999974 456899999999999999999999654311111110000 0000000000000
Q ss_pred ---hhhh-hhhhhhHHHHHH--HHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 ---NLLQ-KEDAYLTAKEQC--VSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ---~~~~-~~~~~~~~~~~~--~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.... ............ ...+.+++.+|++.+|++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 000000000011 2667899999999999999999998863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=307.98 Aligned_cols=267 Identities=22% Similarity=0.300 Sum_probs=195.9
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++++|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678999999999999999999865 789999999875532 22346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+. +++.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9995 7888877665566788889999999999999999 77899999999999999999999999999875432211
Q ss_pred ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh---ccchhh------hh
Q 036879 894 MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND---SLHGKI------IN 959 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~------~~ 959 (1029)
......++..|+|||.+ ++.++||||+||++|||++|+.||+........+...+.. .....+ ..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 12234578899999985 3557999999999999999999997532211111110000 000000 00
Q ss_pred hhhhhhhhhhhhhhHH---HHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 960 VVDINLLQKEDAYLTA---KEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 960 ~~d~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
................ ....+..+.+++.+|+..||++|||++|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000000000 00124578899999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=324.19 Aligned_cols=372 Identities=28% Similarity=0.384 Sum_probs=295.4
Q ss_pred cCcccEEEccCCccc-CCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccce
Q 036879 266 IQGLQVLALSSNRLT-GVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTL 344 (1029)
Q Consensus 266 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 344 (1029)
++=.+-.|+++|.++ +-.|..+..+++++.|.|...++. .+|+.+.+ +.+|++|.+++|++. .+-..++.++.|+.
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~-lqkLEHLs~~HN~L~-~vhGELs~Lp~LRs 82 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSR-LQKLEHLSMAHNQLI-SVHGELSDLPRLRS 82 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHH-HhhhhhhhhhhhhhH-hhhhhhccchhhHH
Confidence 344456788888888 567888888888888888888885 88888875 888888888888887 56677888888888
Q ss_pred ecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceecccccccccccccc
Q 036879 345 IDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI 424 (1029)
Q Consensus 345 L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~ 424 (1029)
+++..|++.. .+.++.+..+..|+.||||+|++. ..|..+....+ +-+|+||+|+|..+...-|
T Consensus 83 v~~R~N~LKn--------------sGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn-~iVLNLS~N~IetIPn~lf 146 (1255)
T KOG0444|consen 83 VIVRDNNLKN--------------SGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKN-SIVLNLSYNNIETIPNSLF 146 (1255)
T ss_pred Hhhhcccccc--------------CCCCchhcccccceeeecchhhhh-hcchhhhhhcC-cEEEEcccCccccCCchHH
Confidence 8888888742 122334457888888899998888 67777776665 6688888988885555567
Q ss_pred CCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCccc-Cccccccccccccc
Q 036879 425 GNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELN-GSLPQCLDSLISLR 503 (1029)
Q Consensus 425 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~ 503 (1029)
.+++.|-.|||++|++. .+|..+.++..|+.|.|++|.+.-.-...+..+++|+.|.+++.+-+ ..+|..+..+.+|.
T Consensus 147 inLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~ 225 (1255)
T KOG0444|consen 147 INLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLR 225 (1255)
T ss_pred HhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhh
Confidence 78888888999999888 67778888888899999998886555566667778888888876543 46788888888888
Q ss_pred eeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccccccc
Q 036879 504 TLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNK 583 (1029)
Q Consensus 504 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 583 (1029)
.+|||.|.+. +.|+++..+++|+.|+||+|+|+ .+....+...+|+.|+||+|+++ .+|..+.++++|+.|++.+|+
T Consensus 226 dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~Nk 302 (1255)
T KOG0444|consen 226 DVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNK 302 (1255)
T ss_pred hccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCc
Confidence 8888888887 68888888888888888888888 46666677788888888888887 788888888888888888888
Q ss_pred cccc-CCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCCCCCCccCcccccCCCCCCCCCC
Q 036879 584 FQGS-IPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPE 661 (1029)
Q Consensus 584 l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~~ 661 (1029)
++-. +|..++.+.+|+.+..++|.+. .+|+.+..+..|+.|.|+.|++-+.+-.-.-++.+..+.+-.||.+--+|-
T Consensus 303 L~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 303 LTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred ccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCCC
Confidence 7632 6788888888888888888887 888888888888888888888876554445567788888888888777663
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=305.04 Aligned_cols=249 Identities=27% Similarity=0.314 Sum_probs=200.0
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999876 68999999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP-TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++++|.+++......+++..+..++.|++.|++|+| + .|++||||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999999999766578899999999999999999999 6 78999999999999999999999999998765332111
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
...++..|+|||.. ++.++||||+|+++|+|++|+.||.............. ........
T Consensus 158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~----- 221 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL--------QYIVNEPP----- 221 (265)
T ss_pred ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH--------HHHhcCCC-----
Confidence 15588899999984 56789999999999999999999865322111111100 00000000
Q ss_pred hhhHHHH-HHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 971 AYLTAKE-QCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 971 ~~~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+. .++..+.++|.+||..+|++|||+.+++.+
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 --PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 00111 156778999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=309.96 Aligned_cols=188 Identities=23% Similarity=0.330 Sum_probs=154.5
Q ss_pred ceeccCcceEEEEEEec---CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEec--CCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS---DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS--DHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~~ 818 (1029)
.+||+|+||+||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 57999999999999864 45789999886542 23467889999999999999999998853 567799999986
Q ss_pred CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE----CCCCcEEEEccCCce
Q 036879 819 GSLENWMYNK--------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL----NESMVACLSDFGISK 886 (1029)
Q Consensus 819 gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill----~~~~~~kl~Dfg~a~ 886 (1029)
++|.+++... ...+++..+..++.|++.||+||| +.||+||||||+||++ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 5787776421 234788899999999999999999 7789999999999999 567899999999998
Q ss_pred ecCCCCCc--eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCc
Q 036879 887 LLGDETSM--TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDE 937 (1029)
Q Consensus 887 ~~~~~~~~--~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~ 937 (1029)
........ ......+|+.|+|||++ ++.++||||+||++|||+||++||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76443211 12234689999999974 46789999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=301.83 Aligned_cols=241 Identities=28% Similarity=0.521 Sum_probs=193.1
Q ss_pred CCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccC
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMP 817 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 817 (1029)
++|++.+.||+|+||.||+|.. +++.||+|.++... ....+.+|+.++++++|||++++++++.... .++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence 4588899999999999999975 67889999986543 3467889999999999999999999987654 689999999
Q ss_pred CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 818 NGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 818 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
+++|.+++.... ..+++..+..++.|+++|++||| +.|++||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999997553 35889999999999999999999 7789999999999999999999999999997643221
Q ss_pred ccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
.....+..|+|||.+ ++.++|||||||++|||++ |+.||......+. .+......
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--------------~~~~~~~~------ 214 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV--------------KECVEKGY------ 214 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH--------------HHHHhCCC------
Confidence 122346789999974 5678999999999999997 9999865321110 00111000
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
....+..++..+.+++.+||+.+|++||+++++++.++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 01112345677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=300.53 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=191.0
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-----chhhHHHHHHHHHHhcCCCCceEEEEEEEec--CCeE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-----EGTLRSFDAECEILGSIRHRNLVKIISTCSS--DHFK 809 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 809 (1029)
.+|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999875 68999999886442 1234568899999999999999999999865 4677
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++++|.+++... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 8999999999999998543 45788999999999999999999 7789999999999999999999999999987653
Q ss_pred CCC--CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 890 DET--SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 890 ~~~--~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
... ........++..|+|||.. ++.++||||+||++||+++|+.||......+. ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-------------~~~~~-- 222 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-------------IFKIA-- 222 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-------------HHHHh--
Confidence 211 1111224578899999984 46789999999999999999999975311100 00000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. .......+......+.+++ .||..+|++||+++|++++
T Consensus 223 -~---~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 223 -T---QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -c---CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0 0000111233455677777 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=303.90 Aligned_cols=243 Identities=27% Similarity=0.483 Sum_probs=191.1
Q ss_pred ceeccCcceEEEEEEecC-------CcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 744 NLLGKGSFGSVYKGTLSD-------GMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~-------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+.||+|+||.||+|+..+ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 358999999999998642 2579999886543 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC-----cEEEEccCC
Q 036879 816 MPNGSLENWMYNK------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM-----VACLSDFGI 884 (1029)
Q Consensus 816 ~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~-----~~kl~Dfg~ 884 (1029)
+++++|.+++... ...+++.++..++.|++.|++||| +.+++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999653 234788999999999999999999 77899999999999999877 899999999
Q ss_pred ceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhh
Q 036879 885 SKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKII 958 (1029)
Q Consensus 885 a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1029)
+......... ......++..|+|||.. ++.++|||||||++|||++ |+.||......+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~----------- 224 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQ----------- 224 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHH-----------
Confidence 9765432211 11223457789999973 6779999999999999998 999986431110 000
Q ss_pred hhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 959 NVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 959 ~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
.++. ......+..++..+.+++.+||+.+|++||+++++.+.|+
T Consensus 225 -~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 225 -HVTA------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -HHhc------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0000 0011122345678899999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=301.14 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=200.3
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
++|++.+.||.|+||+||+|... ++..+|+|.+.... ....+.+.+|+++++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999865 68899999987543 23567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 816 MPNGSLENWMYNK--NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 816 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
+++++|.+++... ...+++..+..++.|++.|++||| +.||+||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999998654 246899999999999999999999 77899999999999999999999999999876643322
Q ss_pred c---eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 894 M---TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 894 ~---~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
. ......++..|+|||+. .+.++|+|||||++|||++|+.||........ +...... . ....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~----~-----~~~~ 227 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQN----D-----PPSL 227 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhcC----C-----CCCc
Confidence 1 12234588999999973 56789999999999999999999975322110 1110000 0 0000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. .......++..+.+++.+||..+|++||++.+++++
T Consensus 228 ~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 E-----TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred C-----CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 000012456778999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=300.73 Aligned_cols=244 Identities=26% Similarity=0.365 Sum_probs=197.0
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-----chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-----EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
+|+..+.||+|+||+||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999876 78999999987543 22456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++++|.+++... ..+++..+..++.|+++|++||| +.||+|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999998644 45889999999999999999999 7789999999999999999999999999988654332
Q ss_pred CceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
......++..|+|||.. .+.++|+|||||++|+|++|+.||........ .. ....
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~-~~------------~~~~----- 216 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-VF------------KIGR----- 216 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH-HH------------HHHh-----
Confidence 12334588899999973 56789999999999999999999875321000 00 0000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.......+..++..+.+++.+||..+|++||++.+++++
T Consensus 217 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 217 -SKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -cccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 000011122346778999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=309.95 Aligned_cols=244 Identities=23% Similarity=0.304 Sum_probs=194.6
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
|.....||+|+||.||+|... ++..||||.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333467999999999999875 6889999998766555567789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
++|.+++.. ..+++..+..++.|++.|++||| +++|+||||||+||+++.++.++|+|||++........ ....
T Consensus 104 ~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 177 (292)
T cd06658 104 GALTDIVTH--TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS 177 (292)
T ss_pred CcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence 999998743 45889999999999999999999 77899999999999999999999999999876533222 1223
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..++..|+|||.. ++.++|||||||++|||++|+.||........ + . .+....... ..
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~-~--------~~~~~~~~~--------~~ 239 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-M-R--------RIRDNLPPR--------VK 239 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-H--------HHHhcCCCc--------cc
Confidence 4588999999984 57789999999999999999999864211000 0 0 000000000 00
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....+..+.+++.+|+..||++|||++|++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111245678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=301.31 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=195.3
Q ss_pred CCCCCceeccCcceEEEEEEecC--CcEEEEEEeeccc----------chhhHHHHHHHHHHhc-CCCCceEEEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLSD--GMQIAVKVFNLEL----------EGTLRSFDAECEILGS-IRHRNLVKIISTCSS 805 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~~--~~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 805 (1029)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... ......+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999764 7889999886321 2234557788888865 799999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEcc
Q 036879 806 DHFKALVLEYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDF 882 (1029)
Q Consensus 806 ~~~~~lV~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Df 882 (1029)
++..++||||+++++|.+++.. ....+++..++.++.|++.|+.|||. ..+++||||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 34568999999999999999999993 257999999999999999999999999
Q ss_pred CCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhh
Q 036879 883 GISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKII 958 (1029)
Q Consensus 883 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1029)
|.+....... ......++..|+|||.. ++.++||||||+++|||++|+.||...... ....
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-----~~~~-------- 223 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-----SLAT-------- 223 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-----HHHH--------
Confidence 9998765432 22345688999999984 567899999999999999999998642111 0000
Q ss_pred hhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 959 NVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 959 ~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
...+.... ......++..+.+++.+||+.||++||++.|+.++++
T Consensus 224 ~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 KIVEAVYE------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHhhccCC------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00000000 0001124567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=308.62 Aligned_cols=264 Identities=25% Similarity=0.332 Sum_probs=197.5
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
++|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999976 689999998865432 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|++++++.++... ...+++..+..++.|+++|++||| +.||+|||++|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 9999988887643 345899999999999999999999 77899999999999999999999999999986543322
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCccccccc--ccchhchhccchhhhhhhhhh---
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI--SLKSRVNDSLHGKIINVVDIN--- 964 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~--- 964 (1029)
......++..|+|||+. ++.++|||||||++|||++|++||......+. .+..... ..........+..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG-NLIPRHQEIFQKNPLF 234 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhC-CCchhhHHHhccchHh
Confidence 22234578899999974 45689999999999999999999864321100 0000000 0000000000000
Q ss_pred ---hh---hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 965 ---LL---QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 965 ---~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.. ............++..+.+++.+||+.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 00000011112356789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=306.94 Aligned_cols=260 Identities=22% Similarity=0.260 Sum_probs=200.4
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56788899999999999999865 68899999887553 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++.. .+.+++..+..++.|++.|+.|||+. .+++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 85 MDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred CCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 999999998854 45689999999999999999999942 479999999999999999999999999987543221
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
.....++..|+|||++ .+.++|||||||++||+++|+.||......+.. . .....+.+.......... .
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~-~ 231 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG--Q----DDPMGILDLLQQIVQEPP-P 231 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh--h----hhhhHHHHHHHHHhhccC-C
Confidence 1234689999999984 467899999999999999999999753221110 0 000000111111000000 0
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
......++..+.+++.+|++.||++|||+.|++++..-+
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 232 -RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred -CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 000122567799999999999999999999999875333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=303.69 Aligned_cols=244 Identities=25% Similarity=0.403 Sum_probs=196.0
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCC---CCceEEEEEEEecCCeEEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIR---HRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999864 78999999987553 334567889999999996 999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++++|.+++.. ..+++..+..++.|++.|++||| +.||+||||+|+||+++.++.++++|||.+........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999999998854 36889999999999999999999 77899999999999999999999999999987654332
Q ss_pred ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
......|+..|+|||.. ++.++|||||||++|+|++|+.||........ ........ ...+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-----~~~~~~~~-----~~~~~-- 223 (277)
T cd06917 157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----MMLIPKSK-----PPRLE-- 223 (277)
T ss_pred -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-----hhccccCC-----CCCCC--
Confidence 22334688899999974 46789999999999999999999975321110 00000000 00000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+.++.+++.+||+.||++||++.|++++
T Consensus 224 -------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 224 -------DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 01145678999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=299.36 Aligned_cols=244 Identities=23% Similarity=0.403 Sum_probs=196.3
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|+..+.||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999865 78899999987542 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC-CcEEEEccCCceecCCCCC
Q 036879 816 MPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES-MVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~ 893 (1029)
+++++|.+++.+.. ..+++..+..++.|+++|++||| +.||+||||+|+||+++.+ +.+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999997653 45899999999999999999999 7789999999999999854 5689999999987654321
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
.....++..|+|||.. .+.++||||||+++|+|++|+.||...... ..+.... ...
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~------------~~~- 217 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKIM------------SGT- 217 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHHHH------------hcC-
Confidence 1234578899999984 567899999999999999999998653111 1000000 000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+..++..+.+++.+||..+|++|||+.|++++
T Consensus 218 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 --FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 001112346678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=300.02 Aligned_cols=233 Identities=25% Similarity=0.411 Sum_probs=184.8
Q ss_pred ceeccCcceEEEEEEecC-C----------cEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 744 NLLGKGSFGSVYKGTLSD-G----------MQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~-~----------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
+.||+|+||.||+|...+ + ..||+|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999998763 3 25788877654333 6788999999999999999999999988 778999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC-------cEEEEccCCc
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM-------VACLSDFGIS 885 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~-------~~kl~Dfg~a 885 (1029)
|||+++|+|.+++......+++..+..++.|++.|++||| ++||+||||||+||+++.++ .+|++|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999776657899999999999999999999 77899999999999999888 8999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC------CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKII 958 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1029)
..... .....++..|+|||+. ++.++|||||||++||+++ |..||......+ ...+..
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~~~~~~-------- 220 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--KERFYQ-------- 220 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--HHHHHh--------
Confidence 86543 1224467789999984 4568999999999999999 577775532110 000000
Q ss_pred hhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 959 NVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 959 ~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
...... ......+.+++.+||..+|++|||+.|+++.|
T Consensus 221 ---~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 ---DQHRLP---------MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ---cCCCCC---------CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000000 00125788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=308.06 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=196.9
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccch-----hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG-----TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
+|+..+.||+|+||.||+|... +++.||+|.+...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999875 7899999999765322 234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+ +++|.+++......+++..+..++.|+++||+||| ++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 89999999665557999999999999999999999 7789999999999999999999999999998765432
Q ss_pred CceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh---ccchhhhh---hh
Q 036879 893 SMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND---SLHGKIIN---VV 961 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~---~~ 961 (1029)
. ......+++.|+|||.+ ++.++|||||||++|||++|.+||......+ .+...... .....+.. ..
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhccccc
Confidence 2 12223467889999974 4567999999999999999988776422110 00000000 00000000 00
Q ss_pred hhhhhh--hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 DINLLQ--KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 d~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
+..... ............+..+.+++.+||+.+|++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 0000001112345678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=298.94 Aligned_cols=246 Identities=23% Similarity=0.321 Sum_probs=191.9
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-----chhhHHHHHHHHHHhcCCCCceEEEEEEEecC--CeE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-----EGTLRSFDAECEILGSIRHRNLVKIISTCSSD--HFK 809 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 809 (1029)
++|++.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57888999999999999999875 68999999886432 12345788999999999999999999998763 567
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 8999999999999998644 45788889999999999999999 7789999999999999999999999999987553
Q ss_pred CCCC--ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 890 DETS--MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 890 ~~~~--~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
.... .......++..|+|||.. .+.++|||||||++|||++|+.||........ + ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~------------~~~~-- 222 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-I------------FKIA-- 222 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-H------------HHHh--
Confidence 2111 111224588899999984 56789999999999999999999865211100 0 0000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. . ......+...+..+.+++.+|+. +|++||+++|++++
T Consensus 223 -~-~--~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 -T-Q--PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -c-C--CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0 0 00011233445678889999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=305.00 Aligned_cols=241 Identities=25% Similarity=0.311 Sum_probs=196.5
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999876 68999999987542 233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++++|.+++... ..+++..+..++.|+++||+||| +.||+||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999998554 56899999999999999999999 778999999999999999999999999999876443
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
.....+++.|+|||.. .+.++||||||+++|+|++|+.||...... .. ......
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~--------~~~~~~------- 212 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-----QI--------YEKILE------- 212 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----HH--------HHHHhc-------
Confidence 2234588999999984 456899999999999999999998653210 00 000000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
.....+...+..+.+++.+||..+|++|+ +++|++++
T Consensus 213 -~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 213 -GKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -CCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 00111223466789999999999999999 77888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=330.48 Aligned_cols=276 Identities=22% Similarity=0.284 Sum_probs=220.1
Q ss_pred HHHHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecc---cchhhHHHHHHHHHHhcCCCCceEEEEEEEecC
Q 036879 731 QELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLE---LEGTLRSFDAECEILGSIRHRNLVKIISTCSSD 806 (1029)
Q Consensus 731 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 806 (1029)
.++....++|++++.||+|+||.|..++.+ +++.||+|++.+- .+...+.|..|-.+|..-..+=|+.++.+|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 344556788999999999999999999976 7889999999762 345567899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 807 HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
...|+||||++||+|-..+.+.. .+++..+..++..|.-||..+| +.|+|||||||+|||+|..|++|++|||.+-
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHH
Confidence 99999999999999999986666 8999999999999999999999 8889999999999999999999999999998
Q ss_pred ecCCCCCceeccccCCccccCccC---------CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhh
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEW---------KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKI 957 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~---------~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 957 (1029)
.+..+........+|||.|.+||+ .|++.+|+||+||++|||+.|..||+... +. +.+
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----lv--------eTY 290 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----LV--------ETY 290 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----HH--------HHH
Confidence 887666667777899999999998 37889999999999999999999997521 11 111
Q ss_pred hhhhhhh-hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCC---HHHHHHHH-------HHhHHhhc-ccccCCCCc
Q 036879 958 INVVDIN-LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERIN---IKEALTKL-------LKIRNTLL-TNIENSSDK 1025 (1029)
Q Consensus 958 ~~~~d~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~evl~~L-------~~i~~~~~-~~~~~~~~~ 1025 (1029)
..+++.. ....+ .....+....++|...+. +|+.|.. +.++..|- ..|++..+ .-.+-.+.+
T Consensus 291 ~KIm~hk~~l~FP-----~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~ 364 (1317)
T KOG0612|consen 291 GKIMNHKESLSFP-----DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDD 364 (1317)
T ss_pred HHHhchhhhcCCC-----cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCC
Confidence 1111110 00000 112246677888887765 6788886 88888753 44554433 445556666
Q ss_pred cccC
Q 036879 1026 RYCN 1029 (1029)
Q Consensus 1026 ~~c~ 1029 (1029)
++||
T Consensus 365 DTsn 368 (1317)
T KOG0612|consen 365 DTSN 368 (1317)
T ss_pred cccc
Confidence 6665
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=305.53 Aligned_cols=247 Identities=25% Similarity=0.330 Sum_probs=199.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367889999999999999999864 7889999998765555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++.+ ..+++..+..++.|++.|++||| ++|++||||||+||+++.++.++|+|||++........ .
T Consensus 98 ~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 999999999854 35788899999999999999999 77899999999999999999999999999876543322 2
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
.....+++.|+|||.. ++.++|||||||++||+++|+.||........ .... . .....
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~----~-------------~~~~~ 233 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLI----A-------------TNGTP 233 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeeh----h-------------cCCCC
Confidence 2234588899999984 56789999999999999999999965321111 0000 0 00000
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+...+..+.+++.+||..+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122345678899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=303.40 Aligned_cols=246 Identities=28% Similarity=0.350 Sum_probs=190.8
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHHH-HhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECEI-LGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
++|++.+.||+|+||.||+|+.. +|+.||+|.++.... .....+..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999876 799999999876532 233455556665 666799999999999999999999999
Q ss_pred ccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 815 YMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPT-PIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 815 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
|++ |+|.+++.. ....+++..+..++.|++.|++||| ++ +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 688877754 3356899999999999999999999 55 799999999999999999999999999986543
Q ss_pred CCCceeccccCCccccCccCC--------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK--------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~--------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 962 (1029)
.. ......++..|+|||.+ ++.++|+||+||++|||++|+.||.........+. ....
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------------~~~~ 222 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK------------QVVE 222 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH------------HHHh
Confidence 21 22234578899999974 36789999999999999999999864211111000 0000
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.... ......++.++.+++.+||..+|++||++++++++
T Consensus 223 ~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 223 EPSP------QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred cCCC------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00011246778999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.38 Aligned_cols=248 Identities=27% Similarity=0.382 Sum_probs=197.5
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|+..+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999865 789999999886644 3567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++... ...++..+..++.|+++|++||| +.||+||||+|+||++++++.+||+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999998643 45788999999999999999999 7789999999999999999999999999998765432221
Q ss_pred ec---cccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 896 QT---QTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 896 ~~---~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
.. ...+++.|+|||+. .+.++||||||+++||+++|+.||........ .......
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~~~~-------------- 221 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFHVGA-------------- 221 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHHHhc--------------
Confidence 11 24578899999984 45679999999999999999999965321110 0000000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
......+....++..+.+++.+||+.+|++||++.|++.+
T Consensus 222 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 222 --GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred --CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000111235667899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.69 Aligned_cols=263 Identities=26% Similarity=0.322 Sum_probs=197.7
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC--CeEEEEEe
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD--HFKALVLE 814 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~E 814 (1029)
|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999876 58999999998763 33346788999999999999999999999887 88999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|++ ++|.+++......+++..+..++.|+++|++||| +.|++|+||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 997 5899888666568999999999999999999999 778999999999999999999999999999876544322
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhc---hhccchhhhhhhhh---
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV---NDSLHGKIINVVDI--- 963 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~d~--- 963 (1029)
......++..|+|||.. ++.++||||||+++|||++|+.||........ +.... .......+....+.
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccccchhh
Confidence 23334578889999963 46789999999999999999999875321110 00000 00000000000000
Q ss_pred -----hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 -----NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 -----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...............++..+.+++.+||..+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000000111136789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.58 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=194.4
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc----------hhhHHHHHHHHHHhcCCCCceEEEEEEEecCC
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE----------GTLRSFDAECEILGSIRHRNLVKIISTCSSDH 807 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 807 (1029)
+|...+.||+|+||.||+|... +|+.||+|.++.... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4777889999999999999865 789999998864311 11346788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
..++||||+++++|.+++... ..+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++++|||.+..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999998654 56889999999999999999999 77899999999999999999999999999976
Q ss_pred cCCCCCc-eeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhh
Q 036879 888 LGDETSM-TQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960 (1029)
Q Consensus 888 ~~~~~~~-~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1029)
....... ......++..|+|||.. ++.++||||+|+++||+++|+.||......+. .. +.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~---------~~ 224 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA----MF---------KL 224 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH----HH---------Hh
Confidence 5432111 12234578899999973 46789999999999999999999854211100 00 00
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 961 ~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..... ...........++..+.+++.+||..+|++||++.+++++
T Consensus 225 ~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 225 GNKRS--APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred hcccc--CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000 0000001112346789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.11 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=198.1
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEec--CCeEEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSS--DHFKALVL 813 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 813 (1029)
+|++.+.||.|+||.||+|... +++.||+|.+.... ....+.+..|++++++++||||+++++++.. +...++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999865 78899999987542 3345678899999999999999999998754 45678999
Q ss_pred eccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 814 EYMPNGSLENWMYNK---NRSFDILQRLNMVIDVASALEYLHYDH--PTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~--~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
||+++++|.+++... ...+++..++.++.|+++|++|||..+ +.+++||||||+||+++.++.+|++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 456899999999999999999999554 667999999999999999999999999999876
Q ss_pred CCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
...... .....+++.|+|||++ .+.++||||||+++++|++|+.||.... ...+.+ .+...
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~------------~~~~~ 225 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLAS------------KIKEG 225 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHH------------HHhcC
Confidence 543321 2234688999999984 4668999999999999999999987532 111110 00000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....+...+..+.+++.+|++.+|++||++++|+++
T Consensus 226 ------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 ------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0011223456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=304.97 Aligned_cols=265 Identities=23% Similarity=0.285 Sum_probs=197.0
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecC--CeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSD--HFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 811 (1029)
.++|++.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++++++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357888999999999999999976 688999999875432 2234567899999999999999999998776 88999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||++ ++|.+++......+++..+..++.|+++||+||| +.|++||||||+||+++.++.+||+|||.+......
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999996 5999988766667999999999999999999999 778999999999999999999999999999876543
Q ss_pred CCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccch---hchhccchhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKS---RVNDSLHGKIINVVDI 963 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~d~ 963 (1029)
.. ......+++.|+|||.+ .+.++|+||+|+++|||++|+.||........ +.. .+.......+....+.
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhcc
Confidence 21 12234578899999974 36689999999999999999999975321110 000 0000000000000000
Q ss_pred hhhh-------hhh-hhhHHHHH-HHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 NLLQ-------KED-AYLTAKEQ-CVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~~~~-------~~~-~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.... ... .....+.. .+..+.+++.+||+.+|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 000 00001111 36678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=308.30 Aligned_cols=242 Identities=23% Similarity=0.316 Sum_probs=193.4
Q ss_pred CCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCC
Q 036879 742 ENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGS 820 (1029)
Q Consensus 742 ~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 820 (1029)
....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999875 789999999876555556678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecccc
Q 036879 821 LENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL 900 (1029)
Q Consensus 821 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 900 (1029)
|.+++.. ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++........ ......
T Consensus 105 L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~ 178 (297)
T cd06659 105 LTDIVSQ--TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLV 178 (297)
T ss_pred HHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccccee
Confidence 9997743 45889999999999999999999 77899999999999999999999999999875543221 223356
Q ss_pred CCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHH
Q 036879 901 ATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAK 976 (1029)
Q Consensus 901 gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 976 (1029)
++..|+|||+. ++.++|||||||++|||++|+.||......+. + ..+... ........
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~-~~~~~~----------------~~~~~~~~ 240 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-M-KRLRDS----------------PPPKLKNA 240 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHhcc----------------CCCCcccc
Confidence 88999999984 56789999999999999999999864211100 0 000000 00000011
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 977 EQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 977 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+..+.+++.+|++.+|++||++.+++++
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1235668899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=305.22 Aligned_cols=250 Identities=23% Similarity=0.306 Sum_probs=193.0
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999876 68899999987653 223457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC-
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET- 892 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 892 (1029)
||+++++|.+++... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+|++|||+++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999998554 56889999999999999999999 7789999999999999999999999999986421100
Q ss_pred -------------CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccch
Q 036879 893 -------------SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG 955 (1029)
Q Consensus 893 -------------~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 955 (1029)
........++..|+|||.+ ++.++|+|||||++|||++|+.||.+....+ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-----~~~----- 226 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-----LFG----- 226 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHH-----
Confidence 0011123578899999984 5778999999999999999999986421110 000
Q ss_pred hhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 956 KIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 956 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
....... ........++..+.+++.+||+.+|++||++.++.+.++
T Consensus 227 ---~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 227 ---QVISDDI-----EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ---HHHhccc-----CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 0000000 000001134667899999999999999998554444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=299.53 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=196.1
Q ss_pred CCCCCceeccCcceEEEEEEe-cCCcEEEEEEeeccc------chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLEL------EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
+|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 478999999987543 1234678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC-cEEEEccCCceecCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM-VACLSDFGISKLLGD 890 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~ 890 (1029)
||||+++++|.+++.+ ...+++..+..++.|++.|++||| ++|++||||+|+||+++.++ .+||+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 9999999999999854 346889999999999999999999 77899999999999998775 699999999976643
Q ss_pred CCC---ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 891 ETS---MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 891 ~~~---~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
... .......++..|+|||.+ ++.++||||+|+++++|++|+.||........ ... +.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~--------~~~~~~- 225 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LAL--------IFKIAS- 225 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHH--------HHHHhc-
Confidence 211 111234578899999974 56789999999999999999999864211100 000 000000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.......+...+..+.+++.+|+..+|++||++.|++++
T Consensus 226 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 226 -----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 000112233456788999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=304.24 Aligned_cols=265 Identities=23% Similarity=0.282 Sum_probs=197.4
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999876 68899999887542 2334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|++++.+..+. .....+++..+..++.|+++|++||| +.+++|||++|+||++++++.+||+|||.+.........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 99886666554 44556899999999999999999999 677999999999999999999999999999876544322
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccc--hhchhccchhhhhh--hhhhh
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLK--SRVNDSLHGKIINV--VDINL 965 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~--~d~~~ 965 (1029)
......++..|+|||+. ++.++||||||+++|||++|++||......+.... ....... ...... .+...
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLP-PSHQELFSSNPRF 235 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-HHHhhhcccCccc
Confidence 22335678899999984 45689999999999999999999875321110000 0000000 000000 00000
Q ss_pred hh--------hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 966 LQ--------KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 966 ~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.. ........+..++..+.+++++||..+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 0000001122347789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=304.29 Aligned_cols=244 Identities=23% Similarity=0.337 Sum_probs=195.3
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
|+..+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+++++.++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667789999999999999865 78999999987542 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+. |++.+++......+++.++..++.|++.|+.||| +.||+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 96 5888887666677999999999999999999999 778999999999999999999999999998754332
Q ss_pred eccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
....+++.|+|||.+ ++.++|||||||++|||++|+.||........ + ........
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~------------~~~~~~~~--- 241 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-L------------YHIAQNES--- 241 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-H------------HHHHhccC---
Confidence 224578899999984 46689999999999999999999865211100 0 00000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
.......++..+.+++.+||+.+|++||++.+++++...+
T Consensus 242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 0011123456789999999999999999999999876443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=303.83 Aligned_cols=263 Identities=23% Similarity=0.332 Sum_probs=194.7
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|+..+.||.|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 789999998875432 2335788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+. ++|.+++... ...+++..+..++.|+++|++||| +.+++||||+|+||+++.++.+|++|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 6898888654 356899999999999999999999 77899999999999999999999999999876543221
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh---ccchhhh---hhhhh
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND---SLHGKII---NVVDI 963 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~---~~~d~ 963 (1029)
......+++.|+|||.. .+.++|||||||++|||+||+.||....... ...+.... .....+. .....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 12233468899999974 3668999999999999999999986532111 01000000 0000000 00000
Q ss_pred --hhhh-hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 --NLLQ-KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 --~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.... ............+..+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 0000011112245678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=299.51 Aligned_cols=256 Identities=25% Similarity=0.275 Sum_probs=195.3
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEec--CCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSS--DHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 813 (1029)
++|+..+.||.|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||++++++|.. ....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999975 689999999875433 345678999999999999999999999865 34689999
Q ss_pred eccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 814 EYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 814 E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
||+++++|.+++.. ....+++..+..++.|+++|++||| +.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988643 3456888999999999999999999 77899999999999999999999999999875533
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
... ....++..|+|||.. ++.++||||+||++|||++|+.||+............ ..........
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~~ 226 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL--------LSYIVNMPNP 226 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH--------HHHHhcCCch
Confidence 221 123478899999974 5678999999999999999999997542110000000 0000000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
... .........+..+.+++.+||+.+|++|||+.|++++-
T Consensus 227 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 227 ELK-DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred hhc-cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 000 00000012356789999999999999999999999843
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=305.95 Aligned_cols=247 Identities=23% Similarity=0.305 Sum_probs=204.9
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
....|.+...||+|.|++|..|+.. ++..||||.+++..- .....+.+|+++|+.+.|||||+++++.+.....|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4567888999999999999999875 799999999987642 2335689999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+.+|.+++|+..+++..+ ..+..++.|+..|++|+| ++.|||||||++||+++.+..+||+|||++.++...
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred EEeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc-
Confidence 999999999999987766555 888899999999999999 788999999999999999999999999999988533
Q ss_pred CceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.......|++.|.|||++ .++++|+||+|+++|-++.|..||++..-. ..-+..+..
T Consensus 209 -~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-----------------~Lr~rvl~g 270 (596)
T KOG0586|consen 209 -LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-----------------ELRPRVLRG 270 (596)
T ss_pred -ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-----------------cccchheee
Confidence 223446799999999995 466899999999999999999999863111 111111222
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
+++ .+...+.+..+++++++..+|.+|++++++.++-+
T Consensus 271 k~r----Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 271 KYR----IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred eec----ccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 221 22334566789999999999999999999988653
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=300.13 Aligned_cols=249 Identities=26% Similarity=0.449 Sum_probs=192.3
Q ss_pred CCCCceeccCcceEEEEEEec----CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC------
Q 036879 740 FSENNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH------ 807 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 807 (1029)
|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566788999999999999753 46889999987543 234567889999999999999999999885432
Q ss_pred eEEEEEeccCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEcc
Q 036879 808 FKALVLEYMPNGSLENWMYNK-----NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDF 882 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Df 882 (1029)
..++++||+.+|+|.+++... ...+++..+..++.|++.|++||| +.||+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999999887432 224788899999999999999999 778999999999999999999999999
Q ss_pred CCceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchh
Q 036879 883 GISKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGK 956 (1029)
Q Consensus 883 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 956 (1029)
|.++........ ......++..|++||.. ++.++|||||||++|||++ |++||......+ ...+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~~~~------ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYNYLI------ 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHHHHH------
Confidence 999865433211 11223456789999973 5778999999999999999 888886532110 000000
Q ss_pred hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 957 IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 957 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
.... ...+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 230 -----~~~~-------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 -----KGNR-------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -----cCCc-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 001123456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=299.01 Aligned_cols=242 Identities=26% Similarity=0.393 Sum_probs=195.4
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccC
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMP 817 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 817 (1029)
|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 677789999999999999865 78899999886443 3345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceec
Q 036879 818 NGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897 (1029)
Q Consensus 818 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 897 (1029)
+++|.+++.. ..+++..+..++.|++.|++||| +.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 86 ~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06641 86 GGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhc
Confidence 9999998853 46889999999999999999999 7889999999999999999999999999987664322 1222
Q ss_pred cccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhh
Q 036879 898 QTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYL 973 (1029)
Q Consensus 898 ~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 973 (1029)
...++..|+|||.. .+.++|+|||||++|+|++|+.||........ . ..+.. . ...
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~---------~~~~~----~--~~~ 219 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV-----L---------FLIPK----N--NPP 219 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH-----H---------HHHhc----C--CCC
Confidence 34578899999984 46689999999999999999999865211100 0 00000 0 000
Q ss_pred HHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 974 TAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 974 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..+..++.++.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1122346678999999999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=300.72 Aligned_cols=244 Identities=23% Similarity=0.300 Sum_probs=195.3
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
|...+.||+|++|.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444578999999999999864 7899999998765555556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
++|.+++.. ..+++..+..++.|++.|++||| +.||+||||+|+||+++.++.++|+|||.+........ ....
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 174 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS 174 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence 999999865 56889999999999999999999 77899999999999999999999999998875543322 2223
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..+++.|+|||.. ++.++|||||||++|||++|+.||...... .... ..... ......
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-----~~~~-----~~~~~--------~~~~~~ 236 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-----QAMK-----RIRDN--------LPPKLK 236 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-----HHHH-----HHHhc--------CCCCCc
Confidence 4588999999984 567899999999999999999998642110 0000 00000 000001
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+..++..+.+++.+||..+|++||++.+++++
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 112245679999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.85 Aligned_cols=241 Identities=24% Similarity=0.423 Sum_probs=189.3
Q ss_pred CCceeccCcceEEEEEEec-CCcEEEEEEeecc----cchhhHHHHHHHHHHhcCCCCceEEEEEEEecCC--eEEEEEe
Q 036879 742 ENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLE----LEGTLRSFDAECEILGSIRHRNLVKIISTCSSDH--FKALVLE 814 (1029)
Q Consensus 742 ~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~E 814 (1029)
..+.||+|+|-+||+|.+. +|.+||=-.++.. .....+.|..|+++++.|+|||||+++.++.+.. ...+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3467999999999999875 6777763322211 2344578999999999999999999999998754 4789999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC-CCCcEEEEccCCceecCCCCC
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN-ESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
.+..|+|..|+.+. +......+..|++||++||.|||.. ..+|+|||||-+||+|+ ..|.|||+|.|+|........
T Consensus 124 L~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred cccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 99999999998654 4578889999999999999999976 47899999999999997 679999999999987654322
Q ss_pred ceeccccCCccccCccC---CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccch-hhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEW---KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG-KIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~---~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~ 969 (1029)
...+|||.|||||+ .|++.+||||||++|+||+|+..||.+=..... +...|...... .+..+
T Consensus 202 ---ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-IYKKV~SGiKP~sl~kV--------- 268 (632)
T KOG0584|consen 202 ---KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-IYKKVTSGIKPAALSKV--------- 268 (632)
T ss_pred ---ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-HHHHHHcCCCHHHhhcc---------
Confidence 23789999999999 489999999999999999999999876222211 11111111111 11111
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
-.+++.+||.+|+.. ..+|||+.|++++
T Consensus 269 ---------~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 ---------KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ---------CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 135689999999999 8999999999973
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=293.52 Aligned_cols=246 Identities=28% Similarity=0.407 Sum_probs=201.0
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccC
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMP 817 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 817 (1029)
.|+..+.||+|++|.||+|... +++.||+|++..........+.+|+++++.++||+++++++++..+...++|+||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999976 789999999987655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceec
Q 036879 818 NGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897 (1029)
Q Consensus 818 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 897 (1029)
+++|.+++......+++..+..++.|+++|++||| ..|++||||+|+||++++++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99999998766567999999999999999999999 68899999999999999999999999999987654432 23
Q ss_pred cccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhh
Q 036879 898 QTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYL 973 (1029)
Q Consensus 898 ~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 973 (1029)
...++..|+|||.. .+.++||||||+++++|++|+.||........ .. .... ......
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~--------~~~~-----~~~~~~ 217 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-----LF--------KIAT-----NGPPGL 217 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-----HH--------HHHh-----cCCCCc
Confidence 34588899999984 47789999999999999999999865311000 00 0000 000000
Q ss_pred HHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 974 TAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 974 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....++..+.+++.+||+.||++|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111235678999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=300.22 Aligned_cols=249 Identities=26% Similarity=0.327 Sum_probs=201.2
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
..+.|+..+.||+|+||.||+|+.. ++..||+|.+..... ..+.+.+|+++++.++|+|++++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566888899999999999999986 789999999976544 45678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+++++|.+++......+++..+..++.|++.|++||| +.||+|+||+|+||+++.++.++|+|||.+........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 99999999999766557999999999999999999999 78899999999999999999999999998875543221
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
......++..|+|||.. ++.++|||||||++|+|++|+.||........ .. ..... ..
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-~~------------~~~~~-----~~ 233 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LF------------LITTK-----GI 233 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-HH------------HHHhc-----CC
Confidence 11223578899999984 57789999999999999999999864211100 00 00000 00
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....+..++..+.+++.+|++.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 234 PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0011122356779999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=296.30 Aligned_cols=248 Identities=25% Similarity=0.326 Sum_probs=201.4
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
++|++.+.||+|++|.||+|+.. +++.||+|++..... .....+.+|++.+++++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999876 599999999876643 4467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP-TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++++|.+++... ..+++..+..++.|+++|++||| + .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999998654 66899999999999999999999 7 88999999999999999999999999999876443322
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
. ....++..|+|||.. .+.++||||||+++|||++|+.||..... ....+..... .....
T Consensus 157 ~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~--------~~~~~----- 220 (264)
T cd06623 157 C-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAI--------CDGPP----- 220 (264)
T ss_pred c-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHH--------hcCCC-----
Confidence 1 234578899999984 56689999999999999999999876422 0111111000 00000
Q ss_pred hhhHHHHH-HHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 971 AYLTAKEQ-CVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 971 ~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+.. ++..+.+++.+|+..+|++||++.|++++
T Consensus 221 --~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 --PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011122 56789999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=300.75 Aligned_cols=259 Identities=21% Similarity=0.290 Sum_probs=192.7
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCC-CCceEEEEEEEecC--CeEEEEEe
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECEILGSIR-HRNLVKIISTCSSD--HFKALVLE 814 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~E 814 (1029)
|++.+.||+|+||.||+|... +++.||+|.++.... .......+|+.+++++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999865 789999999875432 22234457888898885 99999999999887 88999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|++ +++.+++......+++..+..++.|++.||+||| +.|++||||+|+||+++. +.+||+|||.+.........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 996 5888888766667899999999999999999999 778999999999999999 99999999999866433221
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc---chhhhhhh-----
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL---HGKIINVV----- 961 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~----- 961 (1029)
....++..|+|||+. .+.++||||+||++|||++|+.||......+ ......... ...+....
T Consensus 156 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 156 --TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred --CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhccccc
Confidence 224578899999963 4678999999999999999999996532111 000000000 00000000
Q ss_pred -hhhhhhh-hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 -DINLLQK-EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 -d~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
+...... ...........+..+.+++.+|++.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000 000011123457889999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=285.35 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=201.7
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
..++|+.++.+|+|.||.|..++-+ +|+.+|+|++++.. ++..+.-..|-++++..+||.+..+-..|+..+..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467888999999999999999865 89999999998764 4455666789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||..||.|.-++. +.+.+++.....+-..|..||.||| +++||.||+|.+|.++|.+|++||+|||+++.--..
T Consensus 246 VMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 999999999988874 4567888888999999999999999 778999999999999999999999999999853322
Q ss_pred CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
........|||.|+|||++ ++..+|+|.+|||||||++|+.||..... +.+-+.+ +.
T Consensus 322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--------------~kLFeLI---l~- 382 (516)
T KOG0690|consen 322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--------------EKLFELI---LM- 382 (516)
T ss_pred -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--------------hHHHHHH---Hh-
Confidence 2233447899999999995 78899999999999999999999975211 1111111 00
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
.....|...+++...++...+.+||.+|. .++||.++
T Consensus 383 ---ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 383 ---EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ---hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 01233455677889999999999999997 67777653
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=300.21 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=197.5
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
+|++.+.||.|++|.||+|+.. +|+.||||.++.... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4888999999999999999976 689999999876543 23466778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 817 PNGSLENWMYNKN--RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 817 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+ ++|.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||++++++.++++|||.+........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 7 48988886544 46899999999999999999999 77899999999999999999999999999976543221
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhhhhhhhhh--
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKIINVVDIN-- 964 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~d~~-- 964 (1029)
......++..|+|||+. ++.++||||+||++|||++|+.||.+....+. +..... ......+....+..
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCchh
Confidence 12234578899999974 46689999999999999999999975322111 000000 00000000000000
Q ss_pred ---hh-hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 965 ---LL-QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 965 ---~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.. ..........+..+..+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 00000111123456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=306.12 Aligned_cols=248 Identities=27% Similarity=0.360 Sum_probs=196.9
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888899999999999999876 589999999976532 24567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 814 EYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
||+.+++|.+++... ...+++..+..++.|+++|++||| +.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998653 356899999999999999999999 7789999999999999999999999999987543211
Q ss_pred Cc----------------------------eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccc
Q 036879 893 SM----------------------------TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFV 940 (1029)
Q Consensus 893 ~~----------------------------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~ 940 (1029)
.. ......|+..|+|||+. .+.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11123578899999984 56789999999999999999999965321
Q ss_pred cccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCC----HHHHHHH
Q 036879 941 GEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERIN----IKEALTK 1007 (1029)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~evl~~ 1007 (1029)
... +......... .......+..+.+++.+|+..+|++||+ ++|++.+
T Consensus 238 ~~~-------------~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DET-------------FSNILKKEVT------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHH-------------HHHHhcCCcc------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 110 1111110000 0001114677999999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=305.43 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=193.6
Q ss_pred CCCCCceeccCcceEEEEEEec---CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecC--CeEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS---DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSD--HFKA 810 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~---~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 810 (1029)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999875 47899999998743 33446778899999999999999999999887 8899
Q ss_pred EEEeccCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC----CCcEEEEcc
Q 036879 811 LVLEYMPNGSLENWMYNK----NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE----SMVACLSDF 882 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~----~~~~kl~Df 882 (1029)
+||||+++ ++.+++... ...+++..+..++.|++.|++||| +++|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 677666432 236889999999999999999999 778999999999999999 999999999
Q ss_pred CCceecCCCCC--ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccch
Q 036879 883 GISKLLGDETS--MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG 955 (1029)
Q Consensus 883 g~a~~~~~~~~--~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 955 (1029)
|++........ .......++..|+|||.. ++.++|||||||+++||++|++||.................. .
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~ 235 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL-E 235 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH-H
Confidence 99986543322 112234578899999963 466899999999999999999999764332200000000000 0
Q ss_pred hhhhhhh------------------------hhhhhhhhhhhHHHH--HHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 KIINVVD------------------------INLLQKEDAYLTAKE--QCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 ~~~~~~d------------------------~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+.+.+. ............... ..+..+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 000000000000011 345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=328.86 Aligned_cols=257 Identities=25% Similarity=0.453 Sum_probs=209.3
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec----C----CcEEEEEEeecccc-hhhHHHHHHHHHHhcC-CCCceEEEEEEEe
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS----D----GMQIAVKVFNLELE-GTLRSFDAECEILGSI-RHRNLVKIISTCS 804 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~----~----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 804 (1029)
...++..+.+.+|+|+||.|++|... . ...||||..+.... ...+.+..|+++|+.+ +||||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 34444556669999999999999743 1 45799999886543 4567899999999999 7999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCE
Q 036879 805 SDHFKALVLEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNI 869 (1029)
Q Consensus 805 ~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Ni 869 (1029)
..+..++|+||++.|+|.+|++..+ ..+...+.+.++.|||.|++||+ ++++||||+.++||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhE
Confidence 9999999999999999999998776 34888999999999999999999 77799999999999
Q ss_pred EECCCCcEEEEccCCceecCCCCCceecccc--CCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccc
Q 036879 870 LLNESMVACLSDFGISKLLGDETSMTQTQTL--ATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGE 942 (1029)
Q Consensus 870 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~--gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~ 942 (1029)
|++++..+||+|||+|+.......+...... -+..|||||. .++.|||||||||++||++| |..||.+... .
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-~ 528 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-T 528 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-H
Confidence 9999999999999999976554444433222 3567999998 47889999999999999999 7778765210 0
Q ss_pred cccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 943 ISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
. ++.. .-+.+.+.+.|..|+.+++++|+.||+.+|++||++.++++.++....
T Consensus 529 ~---------------~l~~---~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 529 E---------------ELLE---FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred H---------------HHHH---HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 0 1111 112333456678899999999999999999999999999999998543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=305.37 Aligned_cols=267 Identities=24% Similarity=0.295 Sum_probs=196.9
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccch--hhHHHHHHHHHHhcCCCCceEEEEEEEecC--CeEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG--TLRSFDAECEILGSIRHRNLVKIISTCSSD--HFKA 810 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 810 (1029)
..++|++.+.||+|+||.||+|+.. +|+.||+|.++..... ....+.+|++++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3567999999999999999999875 6899999998754322 233566899999999999999999998754 5689
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||++ ++|.+++......+++..+..++.|+++|++||| +.|++||||||+||+++.++.+||+|||.+.....
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999996 5898888766677999999999999999999999 77899999999999999999999999999987654
Q ss_pred CCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKIINVVD 962 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~d 962 (1029)
... ......++..|+|||.. ++.++||||+||++|||++|++||......+. +..... ......+.+..+
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-LDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChhhchhhhc
Confidence 321 12223467889999974 46789999999999999999999975321110 000000 000000000000
Q ss_pred h------hhhhhh-hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 963 I------NLLQKE-DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 963 ~------~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
. ...... ..........+..+.+++.+|++.||++|||+.|++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 000000 000000112366788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=309.34 Aligned_cols=269 Identities=21% Similarity=0.290 Sum_probs=195.8
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecC-----CeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSD-----HFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 809 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||+|.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 568999999999999999999865 78999999986432 23446678899999999999999999887543 357
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||++ +++.+++. ...+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELME-TDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhcc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 99999996 58888773 356899999999999999999999 7789999999999999999999999999997654
Q ss_pred CCCCce--eccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCccccccc--ccchhchhccchhhhhh
Q 036879 890 DETSMT--QTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI--SLKSRVNDSLHGKIINV 960 (1029)
Q Consensus 890 ~~~~~~--~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 960 (1029)
...... .....+++.|+|||.. ++.++||||+||++|||++|+.||.+...... ...........+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 322111 1234678999999973 46689999999999999999999965321100 00000000000111111
Q ss_pred hhhhhh--------hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH--HHHh
Q 036879 961 VDINLL--------QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK--LLKI 1011 (1029)
Q Consensus 961 ~d~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~i 1011 (1029)
.+.... .............+..+.+++.+||+.+|++|||+.|++++ ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 110000 00000001112245678999999999999999999999987 5444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=303.86 Aligned_cols=267 Identities=26% Similarity=0.327 Sum_probs=197.6
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCC----
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDH---- 807 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 807 (1029)
...++|++.+.||+|+||.||+|... +|+.||+|.++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999976 689999999875532 23356778999999999999999999987654
Q ss_pred ------eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEc
Q 036879 808 ------FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSD 881 (1029)
Q Consensus 808 ------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~D 881 (1029)
..++||||+++ ++.+++......+++..+..++.|++.||+||| +.||+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999975 777777666667999999999999999999999 77899999999999999999999999
Q ss_pred cCCceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh----c
Q 036879 882 FGISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND----S 952 (1029)
Q Consensus 882 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~ 952 (1029)
||.+...............++..|+|||.. .+.++||||+||++|||++|++||..... ......+.. .
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--~~~~~~~~~~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LAQLELISRLCGSP 237 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCC
Confidence 999986643322222223467889999974 46789999999999999999999964211 000000000 0
Q ss_pred cchhhhhhhhhhhh------h-hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 953 LHGKIINVVDINLL------Q-KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 953 ~~~~~~~~~d~~~~------~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+.+....... . ............+..+.+++..||..+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000000000 0 0000001112346779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=300.94 Aligned_cols=262 Identities=23% Similarity=0.301 Sum_probs=194.7
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
|++.+.||.|++|.||+|... +|..||+|++.... ....+.+.+|+++++.++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677889999999999999875 79999999987553 223456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 817 PNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 817 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+ ++|.+++.... ..+++..+..++.|+++||+||| +++++||||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 68999886543 46899999999999999999999 67899999999999999999999999999976533211 1
Q ss_pred eccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh---ccchhh------hhhh
Q 036879 896 QTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND---SLHGKI------INVV 961 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~------~~~~ 961 (1029)
.....++..|+|||++ ++.++||||+||++|||++|+.||........ +...... .....+ .+..
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhhhhhchhhh
Confidence 1223568899999974 36689999999999999999999965321110 0000000 000000 0000
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..................+..+.+++.+|++.+|++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000011122345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.81 Aligned_cols=244 Identities=27% Similarity=0.342 Sum_probs=197.8
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
+|++.+.||.|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999876 68999999997543 2345788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+++++|.+++... ..+++..+..++.|+++|++||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999998654 57899999999999999999999 7789999999999999999999999999988664432
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
......++..|+|||.. .+.++|+||+|+++|+|++|+.||....... .. .+......
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~--------~~~~~~~~------- 216 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---RD--------QIRAKQET------- 216 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---HH--------HHHHHhcc-------
Confidence 12234578899999984 5778999999999999999999987532110 00 00000000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCH--HHHHH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINI--KEALT 1006 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~--~evl~ 1006 (1029)
.....+...+..+.+++.+||+.||++||++ +|+++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1112223456788999999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=280.70 Aligned_cols=269 Identities=21% Similarity=0.292 Sum_probs=195.0
Q ss_pred HhCCCCCCceeccCcceEEEEEEec---C--CcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEec-CC
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS---D--GMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSS-DH 807 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~---~--~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 807 (1029)
....|+....||+|.||.||+|..+ + ...+|+|.++.... +......+|+..++.++||||+.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3456899999999999999999643 2 23689999986643 334567899999999999999999999877 78
Q ss_pred eEEEEEeccCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC----CcEEE
Q 036879 808 FKALVLEYMPNGSLENWMYNK----NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES----MVACL 879 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~----~~~kl 879 (1029)
..++++||.++ +|.+.|+-+ .+.++...+..|+.||..|+.|||++. |+|||+||.||++..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 88999999976 787777533 345888899999999999999999666 9999999999999866 99999
Q ss_pred EccCCceecCCCCCc--eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccc-----cch
Q 036879 880 SDFGISKLLGDETSM--TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEIS-----LKS 947 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~-----~~~ 947 (1029)
+|||+|+.+...-.. .....+.|+.|+|||.+ ++++.|||++|||+.||+|-++-|.+....-.. ..+
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999988654322 23456789999999984 788999999999999999998887653211000 000
Q ss_pred --hchh----ccchhhhhh---hhh-h----hhhhhhh------hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 948 --RVND----SLHGKIINV---VDI-N----LLQKEDA------YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 948 --~~~~----~~~~~~~~~---~d~-~----~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
++-+ ...+.|.++ .+. . +...+.. +......-++...+++.+++..||.+|.|+++++++
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 0000 000111111 111 0 0000000 000001112347899999999999999999999986
Q ss_pred H
Q 036879 1008 L 1008 (1029)
Q Consensus 1008 L 1008 (1029)
.
T Consensus 338 ~ 338 (438)
T KOG0666|consen 338 P 338 (438)
T ss_pred c
Confidence 4
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=307.45 Aligned_cols=265 Identities=24% Similarity=0.290 Sum_probs=195.7
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcC-CCCceEEEEEEEecC--CeE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSI-RHRNLVKIISTCSSD--HFK 809 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 809 (1029)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567889999999999999999876 68899999886432 23345677899999999 999999999998653 467
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||++ ++|.+++... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999996 5999988543 7889999999999999999999 7789999999999999999999999999998654
Q ss_pred CCCC----ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh---ccchhh
Q 036879 890 DETS----MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND---SLHGKI 957 (1029)
Q Consensus 890 ~~~~----~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~ 957 (1029)
.... .......++..|+|||.+ .+.++||||||+++|||++|+.||......+. ....... ...+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHH
Confidence 3321 122234688999999974 46789999999999999999999965321110 0000000 000000
Q ss_pred --------hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 958 --------INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 958 --------~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+................++.++.+++.+||+.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00011000000000011112256789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=299.70 Aligned_cols=255 Identities=20% Similarity=0.235 Sum_probs=181.6
Q ss_pred HhCCCCCCceeccCcceEEEEEEecC----CcEEEEEEeecccchhh-----------HHHHHHHHHHhcCCCCceEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSD----GMQIAVKVFNLELEGTL-----------RSFDAECEILGSIRHRNLVKII 800 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vAvK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~ 800 (1029)
..++|++.+.||+|+||+||+|+..+ +..+|+|.......... .....+...+..++|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34679999999999999999998753 45667776443321110 1122333456677899999999
Q ss_pred EEEecCC----eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc
Q 036879 801 STCSSDH----FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV 876 (1029)
Q Consensus 801 ~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~ 876 (1029)
+++.... ..++++|++. .++.+.+.. ....++..+..++.|+++|++||| +++|+||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCc
Confidence 9875543 4478888873 466665533 344678888999999999999999 778999999999999999999
Q ss_pred EEEEccCCceecCCCCC------ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccc
Q 036879 877 ACLSDFGISKLLGDETS------MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLK 946 (1029)
Q Consensus 877 ~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~ 946 (1029)
++|+|||+|+.+..... .......||+.|+|||+. ++.++||||+||++|||++|+.||........ ..
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HH
Confidence 99999999987643211 111224689999999983 67899999999999999999999976421111 00
Q ss_pred hhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 947 SRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 947 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.... .+.... +. ........++..+.+++..|+..+|++||++.++.+.+
T Consensus 244 ~~~~-------~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAK-------CDFIKR-LH----EGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhH-------HHHHHH-hh----hhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0000 000000 00 00111234567899999999999999999999999876
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=297.31 Aligned_cols=238 Identities=19% Similarity=0.267 Sum_probs=184.2
Q ss_pred eeccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHH---HhcCCCCceEEEEEEEecCCeEEEEEeccC
Q 036879 745 LLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEI---LGSIRHRNLVKIISTCSSDHFKALVLEYMP 817 (1029)
Q Consensus 745 ~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 817 (1029)
.||+|+||.||+|... +++.||+|.+..... .....+.+|..+ +...+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999875 689999998875421 112233444433 334479999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceec
Q 036879 818 NGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897 (1029)
Q Consensus 818 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 897 (1029)
+++|.+++.. ...+++..+..++.|++.|++||| +.+|+||||||+||++++++.++++|||++........ .
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~ 153 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---c
Confidence 9999998854 346899999999999999999999 77899999999999999999999999999975543221 2
Q ss_pred cccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 898 QTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 898 ~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
...|+..|+|||.. ++.++||||+||++|||++|+.||......... .. ..... ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~--------~~~~~-------~~~ 215 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EI--------DRMTL-------TVN 215 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HH--------HHHhh-------cCC
Confidence 34589999999974 466899999999999999999999753211110 00 00000 000
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
...+..++.++.+++.+|++.||++|| +++|++++
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 112234567899999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=300.52 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=193.1
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCe-----
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSI-RHRNLVKIISTCSSDHF----- 808 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~----- 808 (1029)
++|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++++ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999875 789999998865432 2345688899999999 46999999999977655
Q ss_pred EEEEEeccCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC-CCcEEEEccC
Q 036879 809 KALVLEYMPNGSLENWMYNKN----RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-SMVACLSDFG 883 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-~~~~kl~Dfg 883 (1029)
.|+||||+++ ++.+++.... ..+++..+..++.||++||+||| ++||+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 8988886432 35799999999999999999999 778999999999999998 8999999999
Q ss_pred CceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccch
Q 036879 884 ISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHG 955 (1029)
Q Consensus 884 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~ 955 (1029)
.+..+..... ......+++.|+|||.. ++.++|||||||++|||++|+.||........ +..... .....
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHhCCCChh
Confidence 9986533211 11223568889999973 46789999999999999999999865321110 000000 00000
Q ss_pred hhhhhhhhhh---hh--hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 KIINVVDINL---LQ--KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 ~~~~~~d~~~---~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+....+... .. .........+..+..+.+++.+|+..+|++||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 00 0000011112356778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=308.20 Aligned_cols=267 Identities=21% Similarity=0.277 Sum_probs=196.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEec----CCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSS----DHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 809 (1029)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999865 79999999987543 2335667889999999999999999998753 3567
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+. ++|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999995 689888854 455899999999999999999999 7789999999999999999999999999997653
Q ss_pred CCCCc---eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCccccccc----------ccchhchh
Q 036879 890 DETSM---TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI----------SLKSRVND 951 (1029)
Q Consensus 890 ~~~~~---~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~----------~~~~~~~~ 951 (1029)
..... ......++..|+|||.+ ++.++||||+||++|||++|+.||........ ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 32211 11234688899999973 56789999999999999999999965321100 00000000
Q ss_pred ccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 952 SLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 952 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
..........+.................+..+.+++.+|++.+|++||++++++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 000001111110000000000111123467899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=295.50 Aligned_cols=245 Identities=25% Similarity=0.368 Sum_probs=195.3
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|+..+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|+++++.++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999876 68899999987542 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC-cEEEEccCCceecCCCCC
Q 036879 816 MPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM-VACLSDFGISKLLGDETS 893 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 893 (1029)
+++++|.+++.... ..+++..+..++.|+++|++||| +.+++|+||||+||++++++ .+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999986543 35789999999999999999999 67799999999999999875 569999999976644322
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......|++.|+|||.. .+.++|||||||+++||++|+.||.... ....+....... .
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~--------~---- 219 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGY--------F---- 219 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhccc--------C----
Confidence 12234588899999973 5678999999999999999999986421 111111111000 0
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.......+..+.+++.+|+..+|++|||+.|++++
T Consensus 220 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 ---APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00112235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=292.27 Aligned_cols=243 Identities=19% Similarity=0.262 Sum_probs=187.3
Q ss_pred HHHhCCCCCCcee--ccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeE
Q 036879 734 FRATDGFSENNLL--GKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 734 ~~~~~~~~~~~~l--g~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 809 (1029)
....++|++.+.+ |+|+||.||++... ++..+|+|.+........ |+.....+ +||||+++++++...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3345677777776 99999999999865 788999999865422111 22222222 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC-cEEEEccCCceec
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM-VACLSDFGISKLL 888 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~ 888 (1029)
++||||+++++|.+++... ..+++..+..++.|+++|++||| +.|++||||||+||+++.++ .++|+|||.+...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999998654 37899999999999999999999 77899999999999999988 9999999999865
Q ss_pred CCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
.... ...++..|+|||+. ++.++||||+||++|||++|+.||............+....
T Consensus 161 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 223 (267)
T PHA03390 161 GTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ------------ 223 (267)
T ss_pred CCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh------------
Confidence 4322 23578999999984 56789999999999999999999975322221111110000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCC-HHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERIN-IKEALTK 1007 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~evl~~ 1007 (1029)
......+...+..+.+++.+|++.+|++||+ ++|++++
T Consensus 224 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 -----QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -----cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0011112245778999999999999999996 5888753
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=301.78 Aligned_cols=268 Identities=22% Similarity=0.301 Sum_probs=193.2
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCC-----
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDH----- 807 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 807 (1029)
..++|++.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3467999999999999999999875 789999999865432 22345678999999999999999999986644
Q ss_pred ---eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCC
Q 036879 808 ---FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGI 884 (1029)
Q Consensus 808 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~ 884 (1029)
..++||||+. +++.+++......+++.++..++.|++.|++||| +.|++|+||||+||+++.++.+||+|||.
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999995 5888888666667899999999999999999999 77899999999999999999999999999
Q ss_pred ceecCCCCCc---eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCccccccc-cc-chhchhccc
Q 036879 885 SKLLGDETSM---TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI-SL-KSRVNDSLH 954 (1029)
Q Consensus 885 a~~~~~~~~~---~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~-~~-~~~~~~~~~ 954 (1029)
+..+...... ......++..|+|||.. .+.++||||||+++|||++|++||........ .. .........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9765432211 11234578889999973 46789999999999999999999865321100 00 000000000
Q ss_pred hhhhhh-----hhh-hhhhhhhhhhH---HHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 955 GKIINV-----VDI-NLLQKEDAYLT---AKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 955 ~~~~~~-----~d~-~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
+.+.+. .+. ........... .+......+.+++.+|+..+|++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000 000 00000000000 000123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-33 Score=323.57 Aligned_cols=250 Identities=27% Similarity=0.356 Sum_probs=185.4
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEE---------
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTC--------- 803 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~--------- 803 (1029)
+...+|+..+.||+||||.||+++.+ ||+.||||++.... ......+.+|++++++++|||||+++..+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567888899999999999999988 99999999998664 33456788999999999999999997211
Q ss_pred ---------------------------------------------------e------c------------C--------
Q 036879 804 ---------------------------------------------------S------S------------D-------- 806 (1029)
Q Consensus 804 ---------------------------------------------------~------~------------~-------- 806 (1029)
. . +
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0 0 0
Q ss_pred ---------------------------------CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 036879 807 ---------------------------------HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHY 853 (1029)
Q Consensus 807 ---------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~ 853 (1029)
...||-||||+..++.+++.+....-.....++++++|++|++|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH- 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH- 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH-
Confidence 1257889999988888887554433357788999999999999999
Q ss_pred cCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC------C-----------CCCceeccccCCccccCccCC-----
Q 036879 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG------D-----------ETSMTQTQTLATIGYMAPEWK----- 911 (1029)
Q Consensus 854 ~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~----- 911 (1029)
++|||||||||.||++++++.|||+|||+|.... . ......+..+||--|+|||++
T Consensus 715 --~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 715 --DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred --hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 8889999999999999999999999999998621 0 011134567899999999983
Q ss_pred --CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHH
Q 036879 912 --LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQ 989 (1029)
Q Consensus 912 --~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~ 989 (1029)
++.|+|+||+|||++||+. ||.-.... .......-.+.+... ........+.-..+|++
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER----a~iL~~LR~g~iP~~------------~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMER----ASILTNLRKGSIPEP------------ADFFDPEHPEEASLIRW 853 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHH----HHHHHhcccCCCCCC------------cccccccchHHHHHHHH
Confidence 6789999999999999987 55432110 000000000111100 00001112334689999
Q ss_pred cccccccCCCCHHHHHH
Q 036879 990 CTRESAEERINIKEALT 1006 (1029)
Q Consensus 990 cl~~dP~~Rpt~~evl~ 1006 (1029)
|+++||.+||||.|++.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999985
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-33 Score=292.08 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=203.4
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
..+.|+.-++||+|+||.||.++.. +|+.+|.|.+.+.. +........|-.++.++..+.||.+-.+|++.+..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3456788899999999999999865 79999999886542 2334456789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 812 VLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
|+..|.||+|.-+|...+ +.|++..++.++.+|+.||++|| ..+||.||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999998887654 46999999999999999999999 78899999999999999999999999999998876
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
..... ..+||.+|||||++ |+...|.||+||++|||+.|+.||...- ..+. .+-+|....
T Consensus 340 g~~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K-------eKvk-------~eEvdrr~~ 403 (591)
T KOG0986|consen 340 GKPIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK-------EKVK-------REEVDRRTL 403 (591)
T ss_pred CCccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh-------hhhh-------HHHHHHHHh
Confidence 54433 35899999999984 7788999999999999999999996521 1111 112333333
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALT 1006 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 1006 (1029)
... .+.++.+++++.++.+..+..||++|. .++||.+
T Consensus 404 ~~~---~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 404 EDP---EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred cch---hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 222 122355688899999999999999997 4556655
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=292.07 Aligned_cols=245 Identities=28% Similarity=0.387 Sum_probs=200.3
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|++.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999876 689999999876543 4556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 816 MPNGSLENWMYNK---NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 816 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
+++++|.+++... ...+++..+..++.++++|++||| +.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998765 377999999999999999999999 7789999999999999999999999999998765432
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
.......+++.|+|||.. .+.++||||+|+++++|++|+.||...... ...... ....
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~--------~~~~---- 219 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALKI--------LKGQ---- 219 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHHH--------hcCC----
Confidence 122334688899999973 567899999999999999999998653111 100000 0000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+..++..+.+++.+||..+|++|||+.|++++
T Consensus 220 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 ---YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011122446778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=304.99 Aligned_cols=263 Identities=19% Similarity=0.243 Sum_probs=193.9
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC-----
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD----- 806 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 806 (1029)
...++|+..+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 45688999999999999999999875 78999999986532 23345677899999999999999999998643
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 807 -HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 807 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
...++||||+. ++|.+++... +++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35699999995 5888877432 888899999999999999999 778999999999999999999999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc--cchhhhh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS--LHGKIIN 959 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 959 (1029)
+....... .....++..|+|||.+ ++.++||||+||++|+|++|+.||....... .+....... ....+.+
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 87644322 2234578899999984 6778999999999999999999996532110 000000000 0000000
Q ss_pred hhhhh----hhhhh----hh-------------hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 960 VVDIN----LLQKE----DA-------------YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 960 ~~d~~----~~~~~----~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..+.. ..... .. ....+...+..+.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00000 00 000011245678999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=289.60 Aligned_cols=244 Identities=30% Similarity=0.429 Sum_probs=199.0
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|++.+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999875 688999999976643 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++... ..+++..+..++.|++.|++||| +.||+||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999998544 67899999999999999999999 778999999999999999999999999999876544322
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
.....++..|+|||.. .+.++||||+|+++|+|++|+.||...... .... .... ..
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~---------~~~~-------~~ 215 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALF---------RIVQ-------DD 215 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHH---------HHhc-------cC
Confidence 2234578899999973 467899999999999999999998653210 0000 0000 00
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+...+..+.+++.+|+..+|++||++.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 011122346678999999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=305.23 Aligned_cols=270 Identities=19% Similarity=0.260 Sum_probs=198.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC-----Ce
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD-----HF 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 808 (1029)
.++|.+.+.||+|+||+||+|+.. +++.||||.+.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 567999999999999999999865 78999999987532 23345677899999999999999999988654 34
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.++||||+. ++|.+++.. ...+++..+..++.|++.|++||| +++++||||||+||+++.++.+||+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999995 789888854 456899999999999999999999 778999999999999999999999999999865
Q ss_pred CCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCccccccc-c-cchhchhccc-------
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI-S-LKSRVNDSLH------- 954 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~-~-~~~~~~~~~~------- 954 (1029)
..... ......++..|+|||.+ ++.++|||||||++|+|++|+.||........ . ..........
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 43321 12234578899999963 56789999999999999999999965311000 0 0000000000
Q ss_pred -hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH--HHHhH
Q 036879 955 -GKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK--LLKIR 1012 (1029)
Q Consensus 955 -~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~i~ 1012 (1029)
......+.................++..+.+++.+|++.+|++|||++|++++ ++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00001110000000000011122456788999999999999999999999987 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=320.78 Aligned_cols=268 Identities=18% Similarity=0.195 Sum_probs=185.4
Q ss_pred HhCCCCCCceeccCcceEEEEEEec--CCcEEEEEEe--------------ec---ccchhhHHHHHHHHHHhcCCCCce
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS--DGMQIAVKVF--------------NL---ELEGTLRSFDAECEILGSIRHRNL 796 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vAvK~~--------------~~---~~~~~~~~~~~E~~~l~~l~h~ni 796 (1029)
..++|++.+.||+|+||+||++... .+..+++|.+ .+ ........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998753 2222232211 00 112234568899999999999999
Q ss_pred EEEEEEEecCCeEEEEEeccCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC
Q 036879 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKN----RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN 872 (1029)
Q Consensus 797 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~ 872 (1029)
+++++++...+..|+|+|++ ++++.+++.... .......+..++.|++.||+||| ++|||||||||+||+++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 99999999999999999998 467877775432 22345667789999999999999 77899999999999999
Q ss_pred CCCcEEEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCC-CCccccc-ccccc
Q 036879 873 ESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKP-TDELFVG-EISLK 946 (1029)
Q Consensus 873 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p-~~~~~~~-~~~~~ 946 (1029)
.++.+||+|||+++.+............||+.|+|||++ ++.++|||||||++|||++|+.+ |...... ...+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987754433333345799999999984 57789999999999999998864 4321111 01111
Q ss_pred hhchhc--cch-------hhhhhhhhhhhhh-hhhhhH--HHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 947 SRVNDS--LHG-------KIINVVDINLLQK-EDAYLT--AKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 947 ~~~~~~--~~~-------~~~~~~d~~~~~~-~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...... ..+ .+.+.++...... ...... .....+..+.+++.+|+..||++|||+.|++++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 100000 000 0111111100000 000000 001134567888999999999999999999974
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=299.50 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=195.1
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecc---cchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLE---LEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.|+..+.||+|+||.||+|+.. ++..||+|.+... .......+.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999975 6889999998643 22334568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+. |++.+++......+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 996 6888877666667899999999999999999999 778999999999999999999999999998765432
Q ss_pred eeccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
....+++.|+|||.+ .+.++|||||||++|||++|+.||........ .. ....
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~------------~~~~----- 228 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LY------------HIAQ----- 228 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-HH------------HHhh-----
Confidence 124578899999974 45689999999999999999999865211100 00 0000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
... .......++..+.+++.+||+.+|++||++.+++++-....
T Consensus 229 ~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 229 NES-PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred cCC-CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 000 00011235667899999999999999999999998754433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=294.58 Aligned_cols=240 Identities=23% Similarity=0.296 Sum_probs=188.9
Q ss_pred eccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 746 LGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 746 lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
||+|+||+||+|... +|+.||+|.+.... ......+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 78999999987542 22345667899999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecccc
Q 036879 822 ENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL 900 (1029)
Q Consensus 822 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 900 (1029)
.+++.... ..+++..+..++.|++.|+.||| +.|++||||+|+||+++.++.++|+|||.+........ .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccccc
Confidence 99986544 36899999999999999999999 77899999999999999999999999999876543221 22345
Q ss_pred CCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHH
Q 036879 901 ATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAK 976 (1029)
Q Consensus 901 gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 976 (1029)
++..|+|||+. ++.++||||+||++|+|++|+.||........ . ..+.... .. .....+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~---------~~~~~~~----~~---~~~~~~ 218 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-K---------EELKRRT----LE---MAVEYP 218 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-H---------HHHHhcc----cc---ccccCC
Confidence 78899999984 56689999999999999999999965321000 0 0000000 00 001112
Q ss_pred HHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 977 EQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 977 ~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
..++..+.+++.+||+.+|++|| ++.+++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 23467789999999999999999 77777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=301.46 Aligned_cols=261 Identities=19% Similarity=0.286 Sum_probs=189.7
Q ss_pred ceeccC--cceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKG--SFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G--~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
..||+| +||+||+|++. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999875 79999999987543 23456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce--
Q 036879 819 GSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT-- 895 (1029)
Q Consensus 819 gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 895 (1029)
+++.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999986543 45889999999999999999999 7789999999999999999999999998654321111000
Q ss_pred ----eccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc--------ch--
Q 036879 896 ----QTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL--------HG-- 955 (1029)
Q Consensus 896 ----~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~-- 955 (1029)
.....++..|+|||+. ++.++||||+||++|||++|+.||.................. ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0112345679999984 457899999999999999999999754221110000000000 00
Q ss_pred --------hhhh-hhhhh-------hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 --------KIIN-VVDIN-------LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 --------~~~~-~~d~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+.. ..+.. ..............++..+.+++++||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 00000 0000001112234567889999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=274.74 Aligned_cols=249 Identities=22% Similarity=0.252 Sum_probs=193.8
Q ss_pred hCCCCC-CceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHh-cCCCCceEEEEEEEec----CCeE
Q 036879 737 TDGFSE-NNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILG-SIRHRNLVKIISTCSS----DHFK 809 (1029)
Q Consensus 737 ~~~~~~-~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~ 809 (1029)
+++|++ .++||-|-.|.|..+..+ +++.+|+|++... ....+|++.-- .-.|||||.++++|+. ....
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 445554 367999999999998765 7999999987533 45567888743 4479999999999854 4567
Q ss_pred EEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC---CCCcEEEEccCCc
Q 036879 810 ALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN---ESMVACLSDFGIS 885 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~---~~~~~kl~Dfg~a 885 (1029)
.+|||.++||.|...+.+++ ..|.+.++..|++||+.|+.||| +..|.||||||+|+|.. .+..+|++|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccc
Confidence 89999999999999997664 46999999999999999999999 67799999999999996 5678999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
+.-... ..-.....|++|.|||++ +++..|+||+||+||-|++|.+||.......+ .+ .+-
T Consensus 212 K~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-sp------------gMk 276 (400)
T KOG0604|consen 212 KETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SP------------GMK 276 (400)
T ss_pred cccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-Ch------------hHH
Confidence 865332 222335689999999994 77889999999999999999999986432111 11 111
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.......+....+.+...+++..++|+.+++.+|.+|.|+.|++.+=
T Consensus 277 ~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 277 RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 11112222223344556788899999999999999999999998653
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=296.90 Aligned_cols=240 Identities=25% Similarity=0.327 Sum_probs=191.1
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
|...+.||+|+||+||+|+.. +++.||+|.+..... ...+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566678999999999999875 789999999875432 3345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+. +++.+++......+++.++..++.|++.|++||| +.||+||||+|+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---- 174 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---- 174 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence 95 6888888666677899999999999999999999 778999999999999999999999999988643221
Q ss_pred eccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
....++..|+|||++ ++.++|||||||++|||++|+.||......... . .......
T Consensus 175 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-----~--------~~~~~~~--- 237 (313)
T cd06633 175 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----Y--------HIAQNDS--- 237 (313)
T ss_pred -CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-----H--------HHHhcCC---
Confidence 234588899999985 455799999999999999999998653111000 0 0000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. ......++..+.+++.+||+.+|++||++.+++++
T Consensus 238 ~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 P---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00011234568999999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=297.13 Aligned_cols=240 Identities=23% Similarity=0.291 Sum_probs=191.7
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCHH
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLE 822 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 822 (1029)
..||+|+||.||+|... ++..||+|.+..........+.+|+.+++.++|+|++++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999875 78999999987655555677899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccCC
Q 036879 823 NWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT 902 (1029)
Q Consensus 823 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 902 (1029)
+++. ...+++..+..++.|++.|++||| +.|++||||+|+||+++.++.++|+|||++........ ......++
T Consensus 106 ~~~~--~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 179 (292)
T cd06657 106 DIVT--HTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 179 (292)
T ss_pred HHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccC
Confidence 9874 345789999999999999999999 77899999999999999999999999999876543221 12234578
Q ss_pred ccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHH
Q 036879 903 IGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQ 978 (1029)
Q Consensus 903 ~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 978 (1029)
+.|+|||.. ++.++|+||+||++|||++|+.||...... ..... +....... ......
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~--------~~~~~~~~--------~~~~~~ 241 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKM--------IRDNLPPK--------LKNLHK 241 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH--------HHhhCCcc--------cCCccc
Confidence 899999984 467899999999999999999998642110 00000 00000000 001112
Q ss_pred HHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 979 CVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 979 ~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
++..+.+++.+||+.+|.+||++.+++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 35568899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=289.26 Aligned_cols=247 Identities=28% Similarity=0.394 Sum_probs=200.7
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecC--CeEEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSD--HFKALVL 813 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 813 (1029)
+|...+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++||||+++++.+... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999976 789999999876542 4467889999999999999999999999888 8899999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++++|.+++.... .+++..+..++.|+++|++||| +.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999986544 8899999999999999999999 67899999999999999999999999999987654432
Q ss_pred c-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 894 M-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 894 ~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
. ......++..|+|||.. .+.++||||||+++++|++|+.||........ .. .....
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~--------~~~~~------ 218 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA----AL--------YKIGS------ 218 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----HH--------Hhccc------
Confidence 1 12335688899999984 56789999999999999999999976420000 00 00000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.......+...+..+.+++.+|+..+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 001111223346789999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=296.24 Aligned_cols=248 Identities=23% Similarity=0.280 Sum_probs=194.1
Q ss_pred CCCCCceeccCcceEEEEEEe----cCCcEEEEEEeecccc----hhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeE
Q 036879 739 GFSENNLLGKGSFGSVYKGTL----SDGMQIAVKVFNLELE----GTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~----~~~~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 809 (1029)
+|++.+.||+|+||.||+|+. .+|..||+|++..... ...+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 3689999999875421 2345678899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++++|.+++... ..+++..+..++.|+++|++||| +.|++||||+|+||+++.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999998643 46788899999999999999999 7789999999999999999999999999998664
Q ss_pred CCCCceeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
...........++..|+|||.. .+.++||||||+++|+|++|+.||...... .... +..+.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~------------~~~~~ 223 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQA------------EISRR 223 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHH------------HHHHH
Confidence 4322222234588999999985 356899999999999999999998632110 0000 01110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
..... ...+..++..+.+++.+|++.+|++|| ++.+++++
T Consensus 224 ~~~~~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 224 ILKSE----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred hhccC----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00000 011223567789999999999999997 77777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=294.24 Aligned_cols=262 Identities=23% Similarity=0.319 Sum_probs=198.8
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
|++.+.||+|++|.||+|... +++.+|+|.+..... .....+.+|++++++++||||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999875 789999999875532 24567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
++ ++.+++......+++..+..++.|+++|++||| +.+|+|+||||+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 64 888888776678999999999999999999999 7779999999999999999999999999998765433 122
Q ss_pred ccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhhhhhhh------
Q 036879 897 TQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKIINVVD------ 962 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~d------ 962 (1029)
....++..|+|||.. .+.++||||+|+++|+|++|+.||......+. +..... ......+....+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchHhcccchhhhhhhh
Confidence 234578889999973 46689999999999999999999865321110 000000 000000000000
Q ss_pred hhhhh-hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 963 INLLQ-KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 963 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..... .........+.++..+.+++.+||+.||++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000 0000112234567889999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=290.00 Aligned_cols=246 Identities=23% Similarity=0.322 Sum_probs=193.2
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-----chhhHHHHHHHHHHhcCCCCceEEEEEEEecC--CeE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-----EGTLRSFDAECEILGSIRHRNLVKIISTCSSD--HFK 809 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 809 (1029)
.+|++.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999865 68999999875431 23446788999999999999999999998764 567
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++++|.+++... ..+++..+..++.|++.|++||| +.|++||||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 8999999999999998643 45788999999999999999999 7789999999999999999999999999997653
Q ss_pred CCC--CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 890 DET--SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 890 ~~~--~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
... ........++..|+|||.. .+.++|||||||++||+++|+.||.+....+. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------------~~~~~-- 222 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-------------IFKIA-- 222 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-------------HHHHH--
Confidence 211 1111234588999999984 56789999999999999999999875311100 00000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. .......+...+..+.+++.+|+. +|.+||++.+++.+
T Consensus 223 -~---~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 223 -T---QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -c---CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0 000011234456789999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=297.10 Aligned_cols=264 Identities=24% Similarity=0.311 Sum_probs=193.0
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
++|++.+.||+|++|.||+|+.. +|+.||+|.+..... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999876 789999999865432 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC-CCcEEEEccCCceecCCCC
Q 036879 815 YMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-SMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|++ +++.+++.... ..+++..+..++.||+.||+||| +++|+||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 58888775433 34678888899999999999999 778999999999999985 5679999999997654321
Q ss_pred CceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhhhhh---h
Q 036879 893 SMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKIINV---V 961 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~---~ 961 (1029)
. ......+++.|+|||++ ++.++||||+||++|+|++|++||......+. +..... ......+... .
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhccccccch
Confidence 1 12234578899999974 46689999999999999999999965321111 000000 0000000000 0
Q ss_pred hhhh-hh--hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 DINL-LQ--KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 d~~~-~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
+... .. ............+..+.+++.+|++.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00 0000001112345678999999999999999999999974
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=298.47 Aligned_cols=249 Identities=26% Similarity=0.324 Sum_probs=189.6
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIR-HRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..++||||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999875 68999999987543 334567889999999996 99999999999998899999999
Q ss_pred cCCCCHHHHH---hc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 816 MPNGSLENWM---YN-KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 816 ~~~gsL~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
+. +++.++. .. ....+++..+..++.|+++|++|||+ +.+|+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 4555432 22 24568999999999999999999993 247999999999999999999999999999765432
Q ss_pred CCceeccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
.. .....+++.|+|||++ ++.++||||+||++|||++|+.||..... ............ .+.
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~-----~~~ 230 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKGD-----PPI 230 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCCC-----CCc
Confidence 21 1223578899999974 45689999999999999999999865320 000000000000 000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. ....+..++..+.+++.+||+.+|++|||+.+++++
T Consensus 231 ~------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 L------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred C------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 001112356779999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=290.44 Aligned_cols=243 Identities=27% Similarity=0.356 Sum_probs=197.7
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|++.+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999865 78899999987543 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 816 MPNGSLENWMYNK---NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 816 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
+++++|.+++.+. ...+++..+..++.|+++|++||| +.|++||||+|+||+++.++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998652 356889999999999999999999 788999999999999999999999999999876543
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
......++..|+|||.. ++.++|+||+|+++|||++|+.||......+ +.. ....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~------------~~~~----- 215 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LRY------------KVQR----- 215 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH------------HHhc-----
Confidence 12224578899999984 5668999999999999999999986532110 000 0000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
......+..++.++.+++.+|+..+|++||++.|++++
T Consensus 216 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 216 -GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00111223456779999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=251.90 Aligned_cols=263 Identities=22% Similarity=0.313 Sum_probs=201.0
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+|...++||+|.||+||+|+.. +++.||+|.++.+. ++......+|+-+++.++|+|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666788999999999999864 68899999988654 44567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
| ..+|..|...-.+.++.+.+..++.|+.+|+.|+| ++.+.|||+||.|.+|+.+|++|++|||+|+.++..-. .
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvr-c 157 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-C 157 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-e
Confidence 9 56899998888889999999999999999999999 55599999999999999999999999999998875432 3
Q ss_pred eccccCCccccCccCC-----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccch--hch-hccchhh---hhhhhh
Q 036879 896 QTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKS--RVN-DSLHGKI---INVVDI 963 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~--~~~-~~~~~~~---~~~~d~ 963 (1029)
.+..+.|..|++|+++ ++...|+||-||++.|+.. |++.|.+....++ +.. ++- ...++.| .+..|.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq-lkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH-HHHHHHHhCCCccccCCccccCCCC
Confidence 3456789999999995 5667899999999999998 4555655322211 111 111 1111122 222333
Q ss_pred hhhhhhhhh---hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 NLLQKEDAY---LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....+... ...-+.....=.+++.+.+.-+|..|.++++++++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 322222111 11112223345788888899999999999999875
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=298.24 Aligned_cols=251 Identities=25% Similarity=0.293 Sum_probs=193.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 812 (1029)
..++|++.+.||+|+||.||+|+.. +++.||||.++... ......+..|+.++.+. .||||+++++++.++...++|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3466888999999999999999986 48999999997543 23345566777777666 499999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||++ +++.++.......+++..+..++.|+++|++|||.. .||+||||+|+||++++++.+||+|||.+..+....
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 99984 578877766566889999999999999999999932 479999999999999999999999999997654322
Q ss_pred CceeccccCCccccCccCC--------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK--------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~--------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
.. ....++..|+|||.+ ++.++||||||+++|||++|+.||.........+. ......
T Consensus 170 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------------~~~~~~ 235 (296)
T cd06618 170 AK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT------------KILQEE 235 (296)
T ss_pred cc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH------------HHhcCC
Confidence 21 223578899999985 35579999999999999999999864211100000 001000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.. .......++.++.+++.+||..||++||++.+++++-
T Consensus 236 ~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 236 PP-----SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CC-----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00 0000112456789999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-34 Score=280.03 Aligned_cols=248 Identities=26% Similarity=0.270 Sum_probs=190.4
Q ss_pred CCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHHH-HhcCCCCceEEEEEEEecCCeEEEEEeccC
Q 036879 741 SENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECEI-LGSIRHRNLVKIISTCSSDHFKALVLEYMP 817 (1029)
Q Consensus 741 ~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 817 (1029)
+....||.|+||+|+|-.++ .|+.+|||+++.... ....++..|.+. ++.-+.||||+++|++-.++..++-||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 33467999999999999876 799999999987654 456678888876 55558999999999999899999999999
Q ss_pred CCCHHHHHh---c-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 818 NGSLENWMY---N-KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 818 ~gsL~~~l~---~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
..++..+-. . .+..+++...-.|+.....||.||.+.+ .|||||+||+|||++..|.+|+||||.+..+.+ +
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--S 221 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--S 221 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--H
Confidence 456654332 1 3455788888888888999999998654 599999999999999999999999999976643 3
Q ss_pred ceeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
...+..+|...|||||.+ ++-+|||||+|++++|+.||+.|+..+..--..+.+.+. + |+....
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~----g------dpp~l~ 291 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI----G------DPPILL 291 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc----C------CCCeec
Confidence 445566799999999995 566899999999999999999998774321111111111 0 110000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. ......++..+..++.-|+.+|-..||.+.++.++
T Consensus 292 ~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 F----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred C----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 0 00112357789999999999999999999998763
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=290.50 Aligned_cols=238 Identities=28% Similarity=0.346 Sum_probs=190.6
Q ss_pred eccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 746 LGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 746 lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
||.|+||.||+|+.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999976 58999999987543 23446789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccC
Q 036879 822 ENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA 901 (1029)
Q Consensus 822 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 901 (1029)
.+++... ..+++..+..++.|+++|++||| +.+++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 9998543 45889999999999999999999 7789999999999999999999999999998765432 1223457
Q ss_pred CccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHH
Q 036879 902 TIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKE 977 (1029)
Q Consensus 902 t~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 977 (1029)
+..|+|||.. ++.++|+||+|+++|||++|+.||.......... .....+ .......+.
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----------~~~~~~------~~~~~~~~~ 217 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI-----------YNDILK------GNGKLEFPN 217 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH-----------HHHHhc------cCCCCCCCc
Confidence 8899999984 5678999999999999999999997642111000 001110 000111122
Q ss_pred HHHHHHHHHHHHcccccccCCCC-----HHHHHH
Q 036879 978 QCVSSVLSLAMQCTRESAEERIN-----IKEALT 1006 (1029)
Q Consensus 978 ~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 1006 (1029)
..+..+.+++.+||+.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 33678999999999999999999 777766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=289.33 Aligned_cols=237 Identities=22% Similarity=0.297 Sum_probs=182.1
Q ss_pred ceeccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHH-HhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEI-LGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..+ ....+|||++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 689999999875431 222334455544 4455899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
++|.+++.. ...+++..+..++.|++.||+||| +.+++||||+|+||+++.++.+||+|||++..... ...
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 999999854 346889999999999999999999 77899999999999999999999999999875433 123
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..++..|+|||.. ++.++||||+|+++|||++|..||....... .... ... ........
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~--------~~~----~~~~~~~~ 215 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-----VFDN--------ILS----RRINWPEE 215 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHH--------HHh----cccCCCCc
Confidence 4578899999984 4678999999999999999999996531110 0000 000 00000011
Q ss_pred HHHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 036879 975 AKEQCVSSVLSLAMQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 975 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1006 (1029)
....++..+.+++.+||..+|++||++.++.+
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 12245778999999999999999997754443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=302.12 Aligned_cols=270 Identities=21% Similarity=0.262 Sum_probs=201.6
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC-----eEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH-----FKA 810 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 810 (1029)
+|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888899999999999999976 58999999987653 334567899999999999999999999987765 789
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||++ ++|.+++.. ...+++..+..++.|++.|++||| +.||+||||||+||+++.++.++|+|||.+.....
T Consensus 81 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999997 589888854 347899999999999999999999 77899999999999999999999999999987654
Q ss_pred CCC--ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---h--------c
Q 036879 891 ETS--MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---D--------S 952 (1029)
Q Consensus 891 ~~~--~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~--------~ 952 (1029)
... .......++..|+|||.+ .+.++|+||+|+++|+|++|+.||......+. +..... . .
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHhcCCCChhHhhhc
Confidence 321 112334578899999984 46689999999999999999999975422110 000000 0 0
Q ss_pred cchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH--HHHhHHh
Q 036879 953 LHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK--LLKIRNT 1014 (1029)
Q Consensus 953 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~i~~~ 1014 (1029)
......+.+..................+..+.+++.+||+.+|++||++.+++++ ++.+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0000000110000000000111112246778999999999999999999999985 6555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=298.17 Aligned_cols=257 Identities=19% Similarity=0.237 Sum_probs=187.8
Q ss_pred ceeccCcceEEEEEEecCCcEEEEEEeecc--cchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLE--LEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
+.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++||||+++++++...+..+++|||++++++
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3444455555555443 7899999998765 234557899999999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC------c
Q 036879 822 ENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS------M 894 (1029)
Q Consensus 822 ~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------~ 894 (1029)
.+++... ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+|++|||.+........ .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9998754 346889999999999999999999 77899999999999999999999999998875532111 0
Q ss_pred eeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc----chh-hh----h
Q 036879 895 TQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL----HGK-II----N 959 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~-~~----~ 959 (1029)
......++..|+|||++ ++.++||||+||++|||++|+.||........ ......... ... .. .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhhcCC
Confidence 11223467789999973 56789999999999999999999975322111 000000000 000 00 0
Q ss_pred -------hhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 960 -------VVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 960 -------~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..+... ............+.++.+++.+||..+|++|||+++++++
T Consensus 243 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 243 MSQSRSSNEHPNN--RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCcccccccccch--hhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 0001111223456788999999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=302.69 Aligned_cols=275 Identities=25% Similarity=0.321 Sum_probs=200.8
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC------eEEE
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH------FKAL 811 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 811 (1029)
|...+.||+|+||.||+|+.+ +|+.||||.++... ....+...+|++++++++|||||+++++-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 444578999999999999954 89999999998654 234567889999999999999999999865543 5679
Q ss_pred EEeccCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC--C--CCcEEEEccCCc
Q 036879 812 VLEYMPNGSLENWMYNK--NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN--E--SMVACLSDFGIS 885 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~--~--~~~~kl~Dfg~a 885 (1029)
|||||.+|+|..++.+. ...+++.+.+.++..++.||.||| +.|||||||||.||++- + .-..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999764 356999999999999999999999 56799999999999973 3 335799999999
Q ss_pred eecCCCCCceeccccCCccccCccC-----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchh--hh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEW-----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGK--II 958 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 958 (1029)
+...++. .....+||..|.+||+ .++..+|.|||||++||++||..||.......-.....+....... ..
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9887654 4456789999999997 3677899999999999999999999653322211111111111000 00
Q ss_pred hhhhhhhh-----hhh-hhhhHHHHHHHHHHHHHHHHcccccccCCC--CHHHHHHHHHHhHHhhcccc
Q 036879 959 NVVDINLL-----QKE-DAYLTAKEQCVSSVLSLAMQCTRESAEERI--NIKEALTKLLKIRNTLLTNI 1019 (1029)
Q Consensus 959 ~~~d~~~~-----~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp--t~~evl~~L~~i~~~~~~~~ 1019 (1029)
-..+.... ... .............+...+..++..+|++|- ...+.-..+..|.+.-..++
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvhi 318 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVHI 318 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeEE
Confidence 00111000 000 000001112233455666778888999999 88888888888887665444
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=289.69 Aligned_cols=238 Identities=21% Similarity=0.278 Sum_probs=184.1
Q ss_pred eeccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHH---HHHhcCCCCceEEEEEEEecCCeEEEEEeccC
Q 036879 745 LLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAEC---EILGSIRHRNLVKIISTCSSDHFKALVLEYMP 817 (1029)
Q Consensus 745 ~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 817 (1029)
.||+|+||.||+|+.. +++.||+|.+..... .....+..|. +.++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999865 689999999875421 1112233343 34555689999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceec
Q 036879 818 NGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897 (1029)
Q Consensus 818 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 897 (1029)
+++|.+++.. ...+++..+..++.|+++|++||| +.+|+||||||+||+++.++.+||+|||++..+..... .
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~ 153 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---c
Confidence 9999998854 456899999999999999999999 77899999999999999999999999999876533221 2
Q ss_pred cccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 898 QTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 898 ~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
...|+..|+|||.. ++.++||||+||++|||++|+.||.......... . +.... ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-----------~----~~~~~---~~~ 215 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-----------I----DRMTL---TMA 215 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-----------H----HHHhh---ccC
Confidence 34689999999984 4678999999999999999999997632111100 0 00000 000
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
...+..++..+.+++.+|+..+|++|| ++.|++++
T Consensus 216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 111223467789999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=295.40 Aligned_cols=252 Identities=24% Similarity=0.282 Sum_probs=196.2
Q ss_pred CCCCCceeccCcceEEEEEEe----cCCcEEEEEEeeccc----chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeE
Q 036879 739 GFSENNLLGKGSFGSVYKGTL----SDGMQIAVKVFNLEL----EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 809 (1029)
+|++.+.||+|+||.||+|+. .+++.||||.++... ....+.+.+|+++++++ +||||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 377889999999999999974 257889999987532 22345688999999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++++|.+++.. ...+++..+..++.|+++|++||| +.+++||||+|+||+++.++.++++|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999998854 346889999999999999999999 7789999999999999999999999999987654
Q ss_pred CCCCceeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
...........++..|+|||.. .+.++||||+|+++|||++|+.||...... .... .+....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~---------~~~~~~-- 224 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQS---------EISRRI-- 224 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHH---------HHHHHH--
Confidence 4333223334588999999984 456899999999999999999998532100 0000 000000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
... ....+..++..+.+++.+||+.+|++|||++++.+.++..
T Consensus 225 --~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 225 --LKS---KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --Hcc---CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 000 0111233566789999999999999999988887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=292.00 Aligned_cols=238 Identities=28% Similarity=0.361 Sum_probs=189.1
Q ss_pred eccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 746 LGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 746 lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
||+|+||.||+|+.. +|+.||+|.+..... ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 599999999875532 3456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC-------c
Q 036879 822 ENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS-------M 894 (1029)
Q Consensus 822 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-------~ 894 (1029)
.+++.+.. .+++..+..++.|+++||+||| +.|++||||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99986544 7899999999999999999999 77899999999999999999999999999875433211 1
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
......++..|+|||.. .+.++||||||+++||+++|+.||......+. . ..... ..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~--------~~~~~----~~-- 217 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-----F--------QNILN----GK-- 217 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-----H--------HHHhc----CC--
Confidence 22334578899999984 56689999999999999999999865321100 0 00000 00
Q ss_pred hhhHHHHH--HHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 971 AYLTAKEQ--CVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 971 ~~~~~~~~--~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
...+.. .+..+.+++.+||+.+|++|||+.++.+.+
T Consensus 218 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 218 --IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred --cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 001111 267789999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=297.95 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=195.5
Q ss_pred HHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEec-CCe
Q 036879 733 LFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSS-DHF 808 (1029)
Q Consensus 733 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 808 (1029)
+...+++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456889999999999999999999865 79999999886532 2234678899999999999999999999865 567
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.++||||+ +++|.+++. ...+++..+..++.|+++|++||| +.+|+||||+|+||++++++.++|+|||.+...
T Consensus 85 ~~lv~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEEEeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 88999998 568988874 345788888899999999999999 778999999999999999999999999998754
Q ss_pred CCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCccccccc-c-cc--------hhchhcc
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI-S-LK--------SRVNDSL 953 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~-~-~~--------~~~~~~~ 953 (1029)
... .....++..|+|||.. ++.++||||+||++|||++|+.||........ . .. ++.....
T Consensus 159 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 159 DPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred CCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 321 1224578899999973 46789999999999999999999965321000 0 00 0000000
Q ss_pred chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 954 HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 954 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+...+...........+.......++..+.+++.+|++.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000000011112245789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=302.72 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=193.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecC---------
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSD--------- 806 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 806 (1029)
..+|++.+.||+|+||.||+|... +|..||+|.+........+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367999999999999999999875 6899999998776555667788999999999999999999776543
Q ss_pred -----CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC-CCCcEEEE
Q 036879 807 -----HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN-ESMVACLS 880 (1029)
Q Consensus 807 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~-~~~~~kl~ 880 (1029)
...++||||++ ++|.+++.. ..+++..+..++.|+++|++||| +.||+||||||+||+++ +++.+|++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 589888743 45889999999999999999999 77899999999999997 56688999
Q ss_pred ccCCceecCCCCCc--eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc-
Q 036879 881 DFGISKLLGDETSM--TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS- 952 (1029)
Q Consensus 881 Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~- 952 (1029)
|||.+......... ......++..|+|||.. ++.++|||||||++|||++|+.||......+. ........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~ 236 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVP 236 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence 99999765322111 11223578899999963 46689999999999999999999965321111 00000000
Q ss_pred -----cchhhhhhhhhhhh----hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 953 -----LHGKIINVVDINLL----QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 953 -----~~~~~~~~~d~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.............. .............+.++.+++.+|+..||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000000000000 00000011112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=299.86 Aligned_cols=265 Identities=22% Similarity=0.318 Sum_probs=193.2
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC------C
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD------H 807 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 807 (1029)
.++|...+.||+|+||.||+|+.. +|+.||+|.+.... ......+.+|+++++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999865 78999999987542 22345688999999999999999999998654 3
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
..++||||+. .++.++. ...+++..+..++.|++.|++||| +.||+||||||+||+++.++.+|++|||+++.
T Consensus 94 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 4689999995 4777654 345889999999999999999999 77899999999999999999999999999875
Q ss_pred cCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch--hccchhhhhh
Q 036879 888 LGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN--DSLHGKIINV 960 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~ 960 (1029)
.... .....++..|+|||.+ ++.++|||||||++|||++|+.||....... .+..... ......+.+.
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHH
Confidence 4322 1234578899999974 4668999999999999999999997532110 0000000 0000000000
Q ss_pred hhhhhhhh---------hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH--HHHhHH
Q 036879 961 VDINLLQK---------EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK--LLKIRN 1013 (1029)
Q Consensus 961 ~d~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~i~~ 1013 (1029)
.+...... ...........+..+.+++.+||+.||++||+++|++++ ++...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000000 000000011235668899999999999999999999965 666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=298.63 Aligned_cols=263 Identities=22% Similarity=0.305 Sum_probs=194.7
Q ss_pred HHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC--
Q 036879 733 LFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH-- 807 (1029)
Q Consensus 733 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 807 (1029)
++...++|++.+.||+|+||.||+|... ++..||||++.... ......+.+|++++++++||||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3446788999999999999999999865 78999999986532 223456889999999999999999999987643
Q ss_pred ----eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccC
Q 036879 808 ----FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFG 883 (1029)
Q Consensus 808 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg 883 (1029)
..++||||+ +++|.+++. ...+++..+..++.|+++|++||| +.||+||||||+||+++.++.+|++|||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 779988874 356899999999999999999999 7789999999999999999999999999
Q ss_pred CceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh--ccchh
Q 036879 884 ISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND--SLHGK 956 (1029)
Q Consensus 884 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~ 956 (1029)
++....... ....+++.|+|||.+ ++.++|+||+||++|++++|+.||........ +...... .....
T Consensus 164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHH
Confidence 997653321 223578899999973 56789999999999999999999975321100 0000000 00000
Q ss_pred hhhhhhhh----h-----hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 036879 957 IINVVDIN----L-----LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 957 ~~~~~d~~----~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1006 (1029)
+...+... . .............++..+.+++.+|+..||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 0 00000001111234567899999999999999999999995
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=302.39 Aligned_cols=262 Identities=23% Similarity=0.282 Sum_probs=195.6
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCe---
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHF--- 808 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 808 (1029)
...++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++|||++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999976 68899999986532 2234567789999999999999999998866554
Q ss_pred ---EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 809 ---KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 809 ---~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
.++|+||+ +++|.+++.. ..+++..+..++.|+++|++||| +.||+||||||+||+++.++.+||+|||.+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 6799998854 46899999999999999999999 778999999999999999999999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccch-----------hc
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKS-----------RV 949 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~-----------~~ 949 (1029)
...... .....++..|+|||.. .+.++||||+||++||+++|+.||......+. +.. +.
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCHHHH
Confidence 865432 1234578899999973 46789999999999999999999965321100 000 00
Q ss_pred hhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 950 NDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 950 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...........+.................++..+.+++.+|+..+|++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000000100000000000111112346789999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=297.48 Aligned_cols=267 Identities=19% Similarity=0.255 Sum_probs=192.8
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccch--hhHHHHHHHHHHhcCCCCceEEEEEEEecC-------
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG--TLRSFDAECEILGSIRHRNLVKIISTCSSD------- 806 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 806 (1029)
.++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999875 6899999998754322 234677899999999999999999987443
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 807 -HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 807 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
...++||||+. +++.+++......+++..+..++.|+++||+||| ++||+||||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 34699999995 4787777666667999999999999999999999 778999999999999999999999999999
Q ss_pred eecCCCCCc----------eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCccccccc--ccchh
Q 036879 886 KLLGDETSM----------TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI--SLKSR 948 (1029)
Q Consensus 886 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~--~~~~~ 948 (1029)
......... ..+...+++.|+|||.. ++.++|||||||++|||++|++||........ .+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 765432111 11223567889999973 46789999999999999999999865321100 00000
Q ss_pred chhccchh------hhhhhhhhhhh-hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 949 VNDSLHGK------IINVVDINLLQ-KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 949 ~~~~~~~~------~~~~~d~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
........ .....+..... ...............+.+++.+|+..+|++|||+.|++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000000 00000000000 0000000111234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=292.89 Aligned_cols=245 Identities=25% Similarity=0.396 Sum_probs=197.4
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIR-HRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 812 (1029)
++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999875 79999999987532 233467889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++++|.+++.+. ..+++..+..++.|++.|++||| +.|++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999998654 46999999999999999999999 7789999999999999999999999999998664322
Q ss_pred C-------------------ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhc
Q 036879 893 S-------------------MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV 949 (1029)
Q Consensus 893 ~-------------------~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 949 (1029)
. .......++..|+|||.. .+.++||||+|++++++++|+.||...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~----- 230 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-LT----- 230 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-HH-----
Confidence 1 122234578899999974 567899999999999999999998753210 00
Q ss_pred hhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCH----HHHHHH
Q 036879 950 NDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINI----KEALTK 1007 (1029)
Q Consensus 950 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~----~evl~~ 1007 (1029)
...... .....+...+..+.+++.+||+.+|++||++ ++++++
T Consensus 231 -------~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 231 -------FQKILK--------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -------HHHHHh--------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 000000 0011122336678999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=287.45 Aligned_cols=261 Identities=22% Similarity=0.323 Sum_probs=190.9
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcC---CCCceEEEEEEEecCCe-----
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSI---RHRNLVKIISTCSSDHF----- 808 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 808 (1029)
|++.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 667889999999999999986 589999999975432 2234566788777666 59999999999988776
Q ss_pred EEEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 809 KALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
.++||||+. ++|.+++.... ..+++..+..++.|+++||+||| +.+++|+||+|+||+++.++.+||+|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 58988886543 36899999999999999999999 77899999999999999999999999999987
Q ss_pred cCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc---chhhhhh
Q 036879 888 LGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL---HGKIINV 960 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 960 (1029)
+...... ....++..|+|||.. .+.++|||||||++|||++|++||...... ..+........ ...+...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCCC
Confidence 6443221 223478899999984 567899999999999999999998753211 11111100000 0000000
Q ss_pred h--hhh-hhh-hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 961 V--DIN-LLQ-KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 961 ~--d~~-~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. ... ... ............+..+.+++.+||+.||++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 000 000 0000111122345778899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=296.56 Aligned_cols=265 Identities=22% Similarity=0.295 Sum_probs=192.6
Q ss_pred hCCCCC-CceeccCcceEEEEEEec-CCcEEEEEEeecccchh--------------hHHHHHHHHHHhcCCCCceEEEE
Q 036879 737 TDGFSE-NNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGT--------------LRSFDAECEILGSIRHRNLVKII 800 (1029)
Q Consensus 737 ~~~~~~-~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~ 800 (1029)
.++|.. .+.||+|+||+||+|+.. +++.||||.+....... ...+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345653 577999999999999865 78999999986542211 12477899999999999999999
Q ss_pred EEEecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEE
Q 036879 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLS 880 (1029)
Q Consensus 801 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~ 880 (1029)
+++...+..++||||++ ++|.+++. ....+++.....++.|++.|++||| +.||+||||+|+||+++.++.++++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence 99999999999999996 68999885 3456899999999999999999999 7889999999999999999999999
Q ss_pred ccCCceecCCCC-------------CceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccc
Q 036879 881 DFGISKLLGDET-------------SMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGE 942 (1029)
Q Consensus 881 Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~ 942 (1029)
|||.+....... ........++..|+|||.+ ++.++||||+||++|||++|+.||......+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999997664110 1111223467889999984 4668999999999999999999997532211
Q ss_pred cccchhc---hhccchhhhhhhhhhh-----hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 943 ISLKSRV---NDSLHGKIINVVDINL-----LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 943 ~~~~~~~---~~~~~~~~~~~~d~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. +.... .......+.+..+... .............++..+.+++.+|++.+|++||+++|++.+
T Consensus 242 ~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 Q-LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred H-HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 0 00000 0000000000000000 000000011112345678999999999999999999999974
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=296.84 Aligned_cols=268 Identities=21% Similarity=0.293 Sum_probs=196.3
Q ss_pred HHHHHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC
Q 036879 730 YQELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD 806 (1029)
Q Consensus 730 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 806 (1029)
..++....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3456678899999999999999999999864 78999999987542 22345678899999999999999999988543
Q ss_pred ------CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEE
Q 036879 807 ------HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLS 880 (1029)
Q Consensus 807 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~ 880 (1029)
...++|++++ +++|.+++.. ..+++..+..++.|+++|++||| +.||+||||||+||++++++.+||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEe
Confidence 3467888887 7899887743 35899999999999999999999 7789999999999999999999999
Q ss_pred ccCCceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc--c
Q 036879 881 DFGISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS--L 953 (1029)
Q Consensus 881 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--~ 953 (1029)
|||++...... .....++..|+|||.. ++.++||||+||++|||++|+.||....... .+....... .
T Consensus 163 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~ 237 (345)
T cd07877 163 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTP 237 (345)
T ss_pred ccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 99998764322 1234578899999973 4678999999999999999999986422110 000000000 0
Q ss_pred chhhhhhhhhhhhhh--------hhh-hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 954 HGKIINVVDINLLQK--------EDA-YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 954 ~~~~~~~~d~~~~~~--------~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
...+...+....... ... ........+..+.+++.+|++.||++||++.+++++=
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 000000000000000 000 0000012356789999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=289.04 Aligned_cols=262 Identities=21% Similarity=0.287 Sum_probs=193.5
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEEEEEecc
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECEILGSIR-HRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
|++.+.||+|+||+||+|+.. +++.||+|.+..... .......+|+..+++++ |||++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999976 588999999875432 22234567899999998 999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 817 PNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 817 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+|++.+++.... ..+++..+..++.|++.+++||| +.+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889998886654 46899999999999999999999 67899999999999999999999999999986643222
Q ss_pred eccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCccccccccc--chhchhccchh------hhhhhh
Q 036879 896 QTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISL--KSRVNDSLHGK------IINVVD 962 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~------~~~~~d 962 (1029)
.....++..|+|||+. .+.++|+||||++++||++|++||......+... ........... .....+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 2234578899999974 4678999999999999999999986532111100 00000000000 000000
Q ss_pred hhhhhhhhh-hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 963 INLLQKEDA-YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 963 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
......... ........+..+.+++++||+.+|++|||++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 000011124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=300.47 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=207.2
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEec-----C
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSS-----D 806 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~ 806 (1029)
...++.|++.+.||.|.+|.||+++. ++++.+|+|+.....+ ..+++..|.++++.. .|||++.++|+|.. +
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 34567899999999999999999985 4799999999876643 336677889998888 69999999999853 6
Q ss_pred CeEEEEEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 807 HFKALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
+..+||||||.+|+..|.++.- +..+.|..+..|++.++.|+.+||..+ ++|||||..|||++..+.||++|||.+
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeee
Confidence 7899999999999999988643 557899999999999999999999554 999999999999999999999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGK 956 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 956 (1029)
..+... .......+||+.|||||++ ++.++|+||+|++..||.-|.+|+.++.+....+.
T Consensus 171 aQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~---------- 239 (953)
T KOG0587|consen 171 AQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---------- 239 (953)
T ss_pred eeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc----------
Confidence 876432 2333457899999999995 56689999999999999999999877543322211
Q ss_pred hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 957 IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 957 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
+...+.+....++.+...|.++|..|+.+|-++||++.+++++
T Consensus 240 --------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 240 --------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1223334444567789999999999999999999999999864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=294.41 Aligned_cols=263 Identities=20% Similarity=0.248 Sum_probs=189.1
Q ss_pred CCCCCceeccCcceEEEEEEec-C--CcEEEEEEeeccc--chhhHHHHHHHHHHhcC-CCCceEEEEEEEec----CCe
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-D--GMQIAVKVFNLEL--EGTLRSFDAECEILGSI-RHRNLVKIISTCSS----DHF 808 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 808 (1029)
+|++.+.||+|+||.||+|+.. + +..||+|.+.... ....+.+.+|+++++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999875 4 7899999987532 22345678899999999 59999999987533 245
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.++++||++ ++|.+++. ....+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 789999985 68998884 3456899999999999999999999 778999999999999999999999999999865
Q ss_pred CCCCCc---eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhh
Q 036879 889 GDETSM---TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKI 957 (1029)
Q Consensus 889 ~~~~~~---~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~ 957 (1029)
...... ......|+..|+|||+. ++.++||||+||++|+|++|++||....... .+...+. ....+.+
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 432211 11234688999999973 4678999999999999999999986532110 0000000 0000000
Q ss_pred hhhhhhh-------hhhhh-hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 958 INVVDIN-------LLQKE-DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 958 ~~~~d~~-------~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+.. ..... ..........+..+.+++.+|++.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 00000 00000111235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=286.54 Aligned_cols=241 Identities=24% Similarity=0.394 Sum_probs=192.0
Q ss_pred CceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCC
Q 036879 743 NNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNG 819 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 819 (1029)
.+.+|.|-||+||-|+.. +|+.||||++.+.. .....++.+|+.|++.++||.||.+...|++.+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 468999999999999865 89999999997642 233478999999999999999999999999999999999999554
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC---CCcEEEEccCCceecCCCCCcee
Q 036879 820 SLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE---SMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 820 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
=|.-.+....+.+++.....++.||+.||.||| -++|||+|+||+|||+.+ -.++||||||+|+++++.. . .
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-F-R 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-F-R 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh-h-h
Confidence 444445556678999999999999999999999 677999999999999963 4689999999999987642 2 3
Q ss_pred ccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
...+||+.|+|||++ |.+.-|+||.|||+|--++|..||.+.. ++ .+.+..+-+. ..
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dI--------------ndQIQNAaFM---yP 784 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DI--------------NDQIQNAAFM---YP 784 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--ch--------------hHHhhccccc---cC
Confidence 457899999999995 6677899999999999999999997631 11 1111000000 01
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+.+.+....++|...++..=.+|-+....+.+
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 12234567788999999999999999988876643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=274.56 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=210.2
Q ss_pred HHHHHHhCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEE
Q 036879 731 QELFRATDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTC 803 (1029)
Q Consensus 731 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~ 803 (1029)
+++....++++....+-+|.||+||.|.+. +.+.|-+|.++..+.. ....+..|.-.+..+.|||+..+.+.+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 355556677888899999999999999764 3456777877655432 356688888899999999999999988
Q ss_pred ec-CCeEEEEEeccCCCCHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC
Q 036879 804 SS-DHFKALVLEYMPNGSLENWMYNK-------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM 875 (1029)
Q Consensus 804 ~~-~~~~~lV~E~~~~gsL~~~l~~~-------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~ 875 (1029)
.+ .+.++.++.++.-|+|..|+... .+..+..+...++.|++.|++||| ++||||.||.++|.+||+.-
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence 65 56778899999999999999722 234777888999999999999999 88899999999999999999
Q ss_pred cEEEEccCCceec-CCCCCceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhc
Q 036879 876 VACLSDFGISKLL-GDETSMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRV 949 (1029)
Q Consensus 876 ~~kl~Dfg~a~~~-~~~~~~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 949 (1029)
++||+|=.+++.+ +.++.........+..||+||. .++.++|||||||++|||+| |+.|+.+..+-+.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm------ 507 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM------ 507 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH------
Confidence 9999999999865 3444444555567889999998 47899999999999999999 8899876422111
Q ss_pred hhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 950 NDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 950 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.+++ ..+.+...|..||.++..+|.-||...|++||++++++.-|.++...
T Consensus 508 --------~~yl------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 508 --------EHYL------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred --------HHHH------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 1111 12334556778999999999999999999999999999999876543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=288.55 Aligned_cols=263 Identities=25% Similarity=0.335 Sum_probs=196.1
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|+++++.++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999876 59999999998653 333467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
+ ++|.+++......+++..+..++.|+++|++||| +.||+||||+|+||++++++.++|+|||.+........ ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 7 5999999766567999999999999999999999 67899999999999999999999999999986643321 22
Q ss_pred ccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCccccccc--ccchhchhccchhhhhhhhh-----h
Q 036879 897 TQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI--SLKSRVNDSLHGKIINVVDI-----N 964 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~-----~ 964 (1029)
....++..|+|||.. .+.++||||+||++||+++|++||......+. .+...........+.+..+. .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 233467789999973 56689999999999999999999865321100 00000000000001111000 0
Q ss_pred hhhhh-hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 965 LLQKE-DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 965 ~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..... ..........+..+.+++.+||+.+|++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000 00001111235679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=278.48 Aligned_cols=239 Identities=21% Similarity=0.282 Sum_probs=192.7
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeE
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 809 (1029)
....+|..+..||+|+||.|..|..+ +.+.+|||+++++. .+..+--+.|-+++.-. +-|.+++++.+|++-+..
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34567999999999999999999765 57789999998764 33445556677777665 678999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
|+||||+.||+|--++++ -+.+.+..+..+|.+||-||-+|| ++||+.||+|.+||++|.+|++||+|||+++.--
T Consensus 426 yFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999888754 456788889999999999999999 9999999999999999999999999999998543
Q ss_pred CCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
.+.. ......|||.|+|||++ |+..+|+||+||++|||+.|++||++....+. +..+.+.
T Consensus 502 ~~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-------------F~aI~eh-- 565 (683)
T KOG0696|consen 502 FDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------------FQAIMEH-- 565 (683)
T ss_pred cCCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-------------HHHHHHc--
Confidence 3322 23346799999999985 68899999999999999999999987322111 1111111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCC
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI 999 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 999 (1029)
....|...+.+..+++...+.+.|.+|.
T Consensus 566 ------nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 ------NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ------cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1122455678889999999999999996
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=284.07 Aligned_cols=244 Identities=23% Similarity=0.295 Sum_probs=189.7
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-----chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-----EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
+|.+.+.||+|+||.||+|+.. .+..+++|.++... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5788899999999999999865 34556666655321 22334577899999999999999999999998899999
Q ss_pred EeccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 813 LEYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
|||+++++|.+++.. ....+++..+..++.|+++|++||| +.|++|+||||+||+++. +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 3456899999999999999999999 778999999999999975 569999999997664
Q ss_pred CCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
.... ......+++.|+|||.. ++.++|+||+|+++|+|++|..||..... ..... ....
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~--------~~~~--- 219 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVL--------RIVE--- 219 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHH--------HHHc---
Confidence 3322 22234578899999974 46689999999999999999999864210 00000 0000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
......+..++..+.+++.+||+.+|++||++.|++++
T Consensus 220 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 ----GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ----CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 00011123456788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=252.04 Aligned_cols=213 Identities=28% Similarity=0.340 Sum_probs=174.6
Q ss_pred HHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHH-HhcCCCCceEEEEEEEecCCeE
Q 036879 733 LFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEI-LGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 733 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
+....+.......||+|++|.|-+.++. +|+..|+|.+.... .+..++...|+.+ ++...+|.+|.++|.+......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 4445556666788999999999988865 89999999998664 3345667778877 4556899999999999999999
Q ss_pred EEEEeccCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 810 ALVLEYMPNGSLENWMY---NKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
++.||.| ..+|..+-. +++...++.-.-+|+..+.+||.|||+ +..|+|||+||+|||++.+|++|+||||.+.
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 457766543 457789999999999999999999996 4569999999999999999999999999998
Q ss_pred ecCCCCCceeccccCCccccCccCC--------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK--------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN 950 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~--------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 950 (1029)
.+.+ +...+...|...|||||.+ |+.|+||||+|++++||.+++.||+.+...-..+.+.+.
T Consensus 198 ~L~d--SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 198 YLVD--SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred eehh--hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 7754 3334445688999999984 677999999999999999999999887655555555443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=256.66 Aligned_cols=273 Identities=18% Similarity=0.282 Sum_probs=200.6
Q ss_pred ccccccCHHHHHHHhCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeecccchhhHHHHHHHHHHhcCC-CCceEEEE
Q 036879 723 VTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKII 800 (1029)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~ 800 (1029)
.-|..-++.......++|++.+++|+|.|++||.|.. .+.+.++||+++.- ..+.+.+|++|++.+. ||||++++
T Consensus 23 eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~ 99 (338)
T KOG0668|consen 23 EYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLL 99 (338)
T ss_pred hhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehh
Confidence 3344333333344678899999999999999999984 47888999998743 3467889999999996 99999999
Q ss_pred EEEecC--CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC-CCCcE
Q 036879 801 STCSSD--HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN-ESMVA 877 (1029)
Q Consensus 801 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~-~~~~~ 877 (1029)
+...++ ..+.+|+||+.+.+....- ..++..++..++.++++||.|+| ++||+|||+||+|++|| +.-.+
T Consensus 100 DiV~Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkL 172 (338)
T KOG0668|consen 100 DIVKDPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKL 172 (338)
T ss_pred hhhcCccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhcee
Confidence 999764 5678999999888776543 45677788899999999999999 99999999999999999 45679
Q ss_pred EEEccCCceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc
Q 036879 878 CLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS 952 (1029)
Q Consensus 878 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 952 (1029)
+++|||+|.++.+...+. ..+.+..|..||.+ ++..-|+|||||++..|+..+.||........++...+.-.
T Consensus 173 rlIDWGLAEFYHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 173 RLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL 250 (338)
T ss_pred eeeecchHhhcCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence 999999999987654433 34678899999985 56678999999999999999999854322222222221111
Q ss_pred cchhhhhh-------hhhhhhhhhhhhh----------HHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 953 LHGKIINV-------VDINLLQKEDAYL----------TAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 953 ~~~~~~~~-------~d~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
-.+++... +|+......+... +...-..+++.+++.+.+..|.++|+||+|++++
T Consensus 251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 251 GTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11111111 1222111000000 0011134789999999999999999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=307.38 Aligned_cols=262 Identities=21% Similarity=0.228 Sum_probs=169.3
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-C----CcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEE------Ee
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-D----GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIIST------CS 804 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 804 (1029)
..++|+..+.||+|+||.||+|++. + +..||+|++...... +....| .++...+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999875 4 789999987643211 111111 1112222222222211 24
Q ss_pred cCCeEEEEEeccCCCCHHHHHhcCCCCC-------------------CHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCC
Q 036879 805 SDHFKALVLEYMPNGSLENWMYNKNRSF-------------------DILQRLNMVIDVASALEYLHYDHPTPIIHCDLN 865 (1029)
Q Consensus 805 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk 865 (1029)
.+...++||||+++++|.+++......+ ....+..++.|++.||+||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 5667899999999999999986543221 12345679999999999999 7789999999
Q ss_pred CCCEEECC-CCcEEEEccCCceecCCCCCceeccccCCccccCccCC--------------------------CCCCcch
Q 036879 866 PSNILLNE-SMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK--------------------------LSRKGDV 918 (1029)
Q Consensus 866 ~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~--------------------------~~~~~Dv 918 (1029)
|+|||++. ++.+||+|||+|+.+............+++.|+|||.+ ++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 68999999999986644433334456789999999952 1235699
Q ss_pred hHHHHHHHHHhcCCCCCCcccccccccchhchhcc--chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHccccccc
Q 036879 919 YSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL--HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAE 996 (1029)
Q Consensus 919 wSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 996 (1029)
||+||++|||+++..|++... ..+........ ...+................+..........+++.+|++.||+
T Consensus 363 wSlGviL~el~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNL---IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHH---HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 999999999999877654311 00000000000 0001111111100000000000011123456899999999999
Q ss_pred CCCCHHHHHHH
Q 036879 997 ERINIKEALTK 1007 (1029)
Q Consensus 997 ~Rpt~~evl~~ 1007 (1029)
+|||++|++++
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=267.68 Aligned_cols=268 Identities=21% Similarity=0.333 Sum_probs=196.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecc--cchhhHHHHHHHHHHhcCCCCceEEEEEEEec--------
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLE--LEGTLRSFDAECEILGSIRHRNLVKIISTCSS-------- 805 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 805 (1029)
...|+...+||+|.||+||+|+.. +|+.||+|++-.+ ..+-.....+|++++..++|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 455777789999999999999865 6888999876543 23345567889999999999999999988843
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 806 DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 806 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
....|+||.+|++ +|.-.+......++..++..++.++..||.|+| ...|+|||+||.|+||+.+|.+||+|||+|
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 2457999999965 888888666678999999999999999999999 555999999999999999999999999999
Q ss_pred eecCCC---CCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCccccccc-c-cchhchhccch
Q 036879 886 KLLGDE---TSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI-S-LKSRVNDSLHG 955 (1029)
Q Consensus 886 ~~~~~~---~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~-~-~~~~~~~~~~~ 955 (1029)
+.+... .....+..+.|..|++||.+ ++++.|||+-||||.||+||.+-+++...... . +.+.......+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 866432 22234556779999999984 67889999999999999999998876422111 0 11111111111
Q ss_pred hhhhhhhhhhhhhh------hhhhHHHHH------HHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 956 KIINVVDINLLQKE------DAYLTAKEQ------CVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 956 ~~~~~~d~~~~~~~------~~~~~~~~~------~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.|..+....+.+.- .......+. -..+..+++.+++..||.+|+++++++.+-
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 12222211111000 000000011 134678999999999999999999998653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=291.16 Aligned_cols=239 Identities=25% Similarity=0.299 Sum_probs=191.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
++.|+....+|.|+|+.|-.+... +++..|||++.+.. .+-.+|+.++... +||||+++.+.+.++...|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 456777788999999999988764 78999999997662 3345677666555 79999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE-CCCCcEEEEccCCceecCCCCC
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL-NESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
++.++-+.+.+.... .+. ..+..|+.+|+.|+.||| ++||||||+||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 999999888775433 233 677789999999999999 7789999999999999 69999999999999876554
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
.....-|..|.|||+. +++++|+||+|+++|+|++|+.||.....+ ..+..++.
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~------------------- 527 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQ------------------- 527 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhc-------------------
Confidence 2223568899999983 789999999999999999999999875333 11111110
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
..+.....+..+.+++.+|++.||.+||+|+++..+=..
T Consensus 528 --~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 528 --MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred --CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 001114557889999999999999999999999876544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=277.25 Aligned_cols=232 Identities=29% Similarity=0.344 Sum_probs=187.0
Q ss_pred eccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 746 LGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 746 lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
||+|+||.||++... +++.||+|.+..... ...+.+..|+++++.++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 689999999876532 2456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccC
Q 036879 822 ENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA 901 (1029)
Q Consensus 822 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 901 (1029)
.+++... ..+++..+..++.|+++|+.|+| +.+++|+||+|+||+++.++.++|+|||.+....... .......+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 9998544 46899999999999999999999 6789999999999999999999999999997654331 12233457
Q ss_pred CccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHH
Q 036879 902 TIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKE 977 (1029)
Q Consensus 902 t~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 977 (1029)
+..|+|||.. .+.++|+||||+++||+++|+.||..... .... . .... .....+.
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~---~--------~~~~--------~~~~~~~ 214 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIY---E--------KILK--------DPLRFPE 214 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHH---H--------HHhc--------CCCCCCC
Confidence 8899999984 46689999999999999999999865321 0000 0 0000 0011122
Q ss_pred HHHHHHHHHHHHcccccccCCCCHHH
Q 036879 978 QCVSSVLSLAMQCTRESAEERINIKE 1003 (1029)
Q Consensus 978 ~~~~~l~~li~~cl~~dP~~Rpt~~e 1003 (1029)
..+..+.+++.+||..||++||++++
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 33567899999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=311.03 Aligned_cols=146 Identities=30% Similarity=0.441 Sum_probs=131.2
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|.+.+.||+|+||.||+|++. +++.||||+++... ......+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367889999999999999999976 78999999987542 23346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
|||+.+++|.+++.. ...+++..++.++.||+.||+||| ..+||||||||+||+++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999854 345788999999999999999999 6789999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=276.39 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=196.3
Q ss_pred HhCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeeccc--c-----hhhHHHHHHHHHHhcCCCCceEEEEEEEec-C
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLEL--E-----GTLRSFDAECEILGSIRHRNLVKIISTCSS-D 806 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 806 (1029)
..++|-.+..||+|+|+.||+|.+ ...+.||||+-.... + .-.+...+|.+|-+.+.||.||++|+++.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 345677788999999999999974 467889999865331 1 223457789999999999999999999975 4
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC---CCCcEEEEccC
Q 036879 807 HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN---ESMVACLSDFG 883 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~---~~~~~kl~Dfg 883 (1029)
+..+-|+|||+|.+|.-|+++ .+.+++.++..|++||..||.||.+. +.+|||-|+||.|||+- ..|.+||.|||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 567899999999999999854 45689999999999999999999976 57899999999999984 56899999999
Q ss_pred CceecCCCCCc------eeccccCCccccCccCC--------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhc
Q 036879 884 ISKLLGDETSM------TQTQTLATIGYMAPEWK--------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV 949 (1029)
Q Consensus 884 ~a~~~~~~~~~------~~~~~~gt~~y~aPE~~--------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 949 (1029)
+++.+.++... ......||.+|++||.+ .+.|+||||+|||+|.++.|+.||+..... .++.+.-
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-QdILqeN 697 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-QDILQEN 697 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-HHHHhhh
Confidence 99987554322 22346799999999985 355899999999999999999999763221 1111100
Q ss_pred hhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 036879 950 NDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 950 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1006 (1029)
.+....+ ...+..+..+.+...+|++|+.+.-++|.+..++..
T Consensus 698 ------TIlkAtE--------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 698 ------TILKATE--------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ------chhccee--------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 0100001 011112345778899999999999999999888875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=272.55 Aligned_cols=216 Identities=22% Similarity=0.156 Sum_probs=172.1
Q ss_pred CcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCHHHHHhc
Q 036879 749 GSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYN 827 (1029)
Q Consensus 749 G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 827 (1029)
|.||.||++++. +++.||+|.++... .+.+|...+....||||+++++++...+..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 78999999987542 233455555566799999999999999999999999999999999865
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccCCccccC
Q 036879 828 KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMA 907 (1029)
Q Consensus 828 ~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~a 907 (1029)
. ..+++..+..++.|+++|++|+| ++||+||||||+||+++.++.++++|||.+....... ....++..|+|
T Consensus 79 ~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~a 150 (237)
T cd05576 79 F-LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCA 150 (237)
T ss_pred h-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccC
Confidence 3 45899999999999999999999 7789999999999999999999999999886554321 12345778999
Q ss_pred ccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHH
Q 036879 908 PEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSV 983 (1029)
Q Consensus 908 PE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l 983 (1029)
||.. ++.++||||+||++|||++|+.|+........ .... ...+..++..+
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------~~~~----------~~~~~~~~~~~ 205 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------THTT----------LNIPEWVSEEA 205 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------cccc----------cCCcccCCHHH
Confidence 9984 56789999999999999999988753211000 0000 01112345678
Q ss_pred HHHHHHcccccccCCCCHH
Q 036879 984 LSLAMQCTRESAEERINIK 1002 (1029)
Q Consensus 984 ~~li~~cl~~dP~~Rpt~~ 1002 (1029)
.+++.+|++.||++||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 9999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=290.88 Aligned_cols=261 Identities=19% Similarity=0.272 Sum_probs=180.7
Q ss_pred HhCCCCCCceeccCcceEEEEEEe-----------------cCCcEEEEEEeecccchhh--------------HHHHHH
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL-----------------SDGMQIAVKVFNLELEGTL--------------RSFDAE 784 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~-----------------~~~~~vAvK~~~~~~~~~~--------------~~~~~E 784 (1029)
..++|++.++||+|+||+||+|.. ..++.||||.+........ +....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2356899999875432222 233457
Q ss_pred HHHHhcCCCCce-----EEEEEEEec--------CCeEEEEEeccCCCCHHHHHhcCCC---------------------
Q 036879 785 CEILGSIRHRNL-----VKIISTCSS--------DHFKALVLEYMPNGSLENWMYNKNR--------------------- 830 (1029)
Q Consensus 785 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 830 (1029)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777876654 677777753 3567999999999999999864321
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccCCccccCc
Q 036879 831 --SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAP 908 (1029)
Q Consensus 831 --~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aP 908 (1029)
..++..+..++.|+++|++|+| +.+|+||||||+||+++.++.+||+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 2356778889999999999999 77899999999999999999999999999976543322222223458899999
Q ss_pred cCCCC--------------------------CCcchhHHHHHHHHHhcCCC-CCCcccccccccchhchhccchhhhhhh
Q 036879 909 EWKLS--------------------------RKGDVYSYGIILMETFTKKK-PTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 909 E~~~~--------------------------~~~DvwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
|.+.. .+.||||+||+++||++|.. ||.....-...+..+-.. ...+..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~--~~~~r~-- 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDND--LNRWRM-- 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccch--HHHHHh--
Confidence 97421 24699999999999999875 664321111111000000 000000
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccc---cCCCCHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESA---EERINIKEALTK 1007 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rpt~~evl~~ 1007 (1029)
..............+....+++.+|+..+| .+|+|++|+++|
T Consensus 456 ----~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 ----YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ----hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000000011122346678999999998766 689999999975
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=268.40 Aligned_cols=261 Identities=22% Similarity=0.276 Sum_probs=194.2
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCC-C-C----ceEEEEEEEecCCe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIR-H-R----NLVKIISTCSSDHF 808 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~ 808 (1029)
...+|.+...+|+|.||.|..+.+. .+..||||+++.- ..-.+..+-|++++.++. + | -+|.+.++|.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 4789999999999999999999765 5789999998643 233345667899999993 2 2 37788888999999
Q ss_pred EEEEEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC--------------
Q 036879 809 KALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-------------- 873 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-------------- 873 (1029)
.++|+|.+ |.++.+++... ..+++...+..|+.|++++++||| +.+++|-|+||+||++-+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999998 77999999764 457999999999999999999999 777999999999999831
Q ss_pred ------CCcEEEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCccccccc
Q 036879 874 ------SMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI 943 (1029)
Q Consensus 874 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~ 943 (1029)
...+|++|||.|.+-.+.. ...+.|..|+|||++ .+.++||||+|||++|+.||...|+.....+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 3468999999998754433 345789999999996 57899999999999999999999876432211
Q ss_pred ccchhchhccchhhhhhhhhh------------------------hhhhhhh---hhHHHHHHHHHHHHHHHHccccccc
Q 036879 944 SLKSRVNDSLHGKIINVVDIN------------------------LLQKEDA---YLTAKEQCVSSVLSLAMQCTRESAE 996 (1029)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~d~~------------------------~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~ 996 (1029)
+ .+...........++... ..+.+.+ ...........+.++++.|+..||.
T Consensus 318 -L-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 318 -L-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred -H-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 1 111111111111111111 0000000 0111122355799999999999999
Q ss_pred CCCCHHHHHHH
Q 036879 997 ERINIKEALTK 1007 (1029)
Q Consensus 997 ~Rpt~~evl~~ 1007 (1029)
+|+|++|++.+
T Consensus 396 ~RiTl~EAL~H 406 (415)
T KOG0671|consen 396 RRITLREALSH 406 (415)
T ss_pred ccccHHHHhcC
Confidence 99999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=289.65 Aligned_cols=239 Identities=25% Similarity=0.390 Sum_probs=184.3
Q ss_pred CCCCceeccCcce-EEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEeccC
Q 036879 740 FSENNLLGKGSFG-SVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMP 817 (1029)
Q Consensus 740 ~~~~~~lg~G~fg-~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~ 817 (1029)
|.-.+++|.|+-| .||+|.. +|++||||++- ....+-.++|+..++.- +|||||++++.-+++...|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 4445679999998 6799988 67899999874 33445678999999888 7999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCC---HHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC-----CCcEEEEccCCceecC
Q 036879 818 NGSLENWMYNKNRSFD---ILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-----SMVACLSDFGISKLLG 889 (1029)
Q Consensus 818 ~gsL~~~l~~~~~~~~---~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-----~~~~kl~Dfg~a~~~~ 889 (1029)
..+|++++........ ....+.+..|++.|++||| +-+|||||+||.||||+. ...++|+|||+++++.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5699999976422211 1445778999999999999 666999999999999975 3579999999999886
Q ss_pred CCCCc--eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcC-CCCCCcccccccccchhchhccchhhhhhhh
Q 036879 890 DETSM--TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTK-KKPTDELFVGEISLKSRVNDSLHGKIINVVD 962 (1029)
Q Consensus 890 ~~~~~--~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 962 (1029)
.+... ......||-+|+|||+. -+.++||||+||++|+.++| .+||++....+.++..-.....
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~--------- 733 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLV--------- 733 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcccee---------
Confidence 54322 23446799999999994 35578999999999999996 9999875444443322111000
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1006 (1029)
. .....++ ++.++|.+|+.++|..||+|.+|+.
T Consensus 734 --~-------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 --H-------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --e-------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 0001112 6889999999999999999999984
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=271.97 Aligned_cols=204 Identities=24% Similarity=0.343 Sum_probs=171.6
Q ss_pred CCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.-|..++.||-|+||+|..++. ++...+|+|.+++.+ +..+..++.|-.|+...+.+=||++|..|++.+..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 3477789999999999999964 466778999998764 455677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec-----
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL----- 888 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~----- 888 (1029)
+|++||++-..+.+. +-|++..+..++.+++.|+++.| ++|+|||||||+|||||.+|++||.|||++.-+
T Consensus 709 dYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 999999999988654 45888888899999999999999 999999999999999999999999999998532
Q ss_pred ----CCCC-----Cc---------------------------eeccccCCccccCccCC----CCCCcchhHHHHHHHHH
Q 036879 889 ----GDET-----SM---------------------------TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMET 928 (1029)
Q Consensus 889 ----~~~~-----~~---------------------------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~el 928 (1029)
..+. ++ .....+||+-|+|||++ ++.-+|+||.|||+|||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 1110 00 01124699999999995 56679999999999999
Q ss_pred hcCCCCCCccccccccc
Q 036879 929 FTKKKPTDELFVGEISL 945 (1029)
Q Consensus 929 ltg~~p~~~~~~~~~~~ 945 (1029)
+.|++||-+...++..+
T Consensus 865 ~~g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQY 881 (1034)
T ss_pred hhCCCCccCCCCCccee
Confidence 99999998766555543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=253.52 Aligned_cols=246 Identities=21% Similarity=0.272 Sum_probs=196.9
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 810 (1029)
...+|...+.||+|+|++|..+++. +.+.+|+|++++.. ......++.|-.+..+. .||.+|.++.+|+++...+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 4567999999999999999999875 78889999998753 44567788898888777 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+|.||++||+|--+++ ..+.++++.+..+...|.-||.||| ++||+.||+|.+|||+|..|++|+.|+|+++.--.
T Consensus 328 fvieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999999987764 5567899999999999999999999 89999999999999999999999999999985432
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
... ..+...|||.|.|||.+ |+..+|+|++||+|+||+.|+.||+-......+. ...+.+=..+.
T Consensus 404 ~gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~----------ntedylfqvil 472 (593)
T KOG0695|consen 404 PGD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDM----------NTEDYLFQVIL 472 (593)
T ss_pred CCc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCccc----------chhHHHHHHHh
Confidence 222 33457899999999995 6778999999999999999999998543211110 01111111111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCC
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI 999 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 999 (1029)
...+..|+..+.....+++.-+.+||.+|.
T Consensus 473 ---ekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 473 ---EKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---hhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 111233455667788899999999999996
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=273.78 Aligned_cols=247 Identities=24% Similarity=0.310 Sum_probs=200.9
Q ss_pred hCCCCCCceeccCcceEEEEEEecCC-cEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDG-MQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~-~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
..+++++..||-|+||.|-.++.++. ..+|+|++++.. ....+.+..|-.+|...+.|.||++|-.|.+....|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 34566677899999999999987643 348999887653 33455678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
||-|-||.+...+ ++++.|+..+...++..+.+|++||| ++|||.||+||+|.+++.+|-+||.|||+|+.++...
T Consensus 499 mEaClGGElWTiL-rdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 499 MEACLGGELWTIL-RDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HHhhcCchhhhhh-hhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 9999999999988 45677999999999999999999999 8889999999999999999999999999999987764
Q ss_pred CceeccccCCccccCccCCC----CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWKL----SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~~----~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
... ...||+.|.|||++. +..+|.||+|+++||+++|.+||.+...... +.. +. +
T Consensus 575 KTw--TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-Yn~---------IL---------k 633 (732)
T KOG0614|consen 575 KTW--TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-YNL---------IL---------K 633 (732)
T ss_pred cee--eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-HHH---------HH---------h
Confidence 433 467999999999974 5589999999999999999999987421111 110 11 1
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCC-----HHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERIN-----IKEALTKL 1008 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~~L 1008 (1029)
.-.....|........++|++..+..|.+|.- +.++.+|-
T Consensus 634 Gid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 634 GIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred hhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 11223445556777899999999999999984 66776654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=261.17 Aligned_cols=234 Identities=29% Similarity=0.379 Sum_probs=187.7
Q ss_pred cceEEEEEEec-CCcEEEEEEeecccchh-hHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCHHHHHhc
Q 036879 750 SFGSVYKGTLS-DGMQIAVKVFNLELEGT-LRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYN 827 (1029)
Q Consensus 750 ~fg~V~~~~~~-~~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 827 (1029)
+||.||+|+.. +|+.||+|++....... .+.+.+|++.+++++|+|++++++++......++||||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 58999999998665444 67899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccCCccccC
Q 036879 828 KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMA 907 (1029)
Q Consensus 828 ~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~a 907 (1029)
... +++..+..++.+++++++||| +.+++|+||+|+||+++.++.++++|||.+....... ......++..|+|
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 433 889999999999999999999 6789999999999999999999999999998765432 2233457889999
Q ss_pred ccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHH
Q 036879 908 PEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSV 983 (1029)
Q Consensus 908 PE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l 983 (1029)
||.. .+.++||||+|++++++++|+.||........ +.+.... ...........++.++
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-------------~~~~~~~----~~~~~~~~~~~~~~~~ 217 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-------------LFKKIGK----PKPPFPPPEWKISPEA 217 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-------------HHHHHhc----cCCCCccccccCCHHH
Confidence 9973 57799999999999999999999865211100 0000000 0000000000156778
Q ss_pred HHHHHHcccccccCCCCHHHHHH
Q 036879 984 LSLAMQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 984 ~~li~~cl~~dP~~Rpt~~evl~ 1006 (1029)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 99999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=255.08 Aligned_cols=269 Identities=21% Similarity=0.315 Sum_probs=196.2
Q ss_pred CceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC-----CeEEEEEe
Q 036879 743 NNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD-----HFKALVLE 814 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~E 814 (1029)
.+.||.|+||.||.+.+. +|+.||.|++..-. -...+.+-+|++++..++|.||...+++.+-. .++|+|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 356999999999999875 89999999876432 23456788999999999999999999887654 35678889
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
.+ ..+|+..| .....++...+..++.||.+||.||| +.+|.||||||.|.+++++..+||||||+|+....++..
T Consensus 138 Lm-QSDLHKII-VSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 138 LM-QSDLHKII-VSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HH-Hhhhhhee-ccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 88 46777766 34556788888999999999999999 888999999999999999999999999999987666666
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc----chhh--------
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL----HGKI-------- 957 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~-------- 957 (1029)
..+..+.|.+|+|||.+ |+.+.||||.||++.|++.++..|+.... +.-.+.+.+.. .+.+
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 66677889999999984 67789999999999999999988875321 11111111111 0110
Q ss_pred hhhhhhhhhhhhhhh---hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccc
Q 036879 958 INVVDINLLQKEDAY---LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTN 1018 (1029)
Q Consensus 958 ~~~~d~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~ 1018 (1029)
.+++........... ...+..-..+...+..+++..||+.|.+..+++.+.-.=+.++.+.
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~ 354 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFH 354 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceeee
Confidence 011100000000000 0001122345678889999999999999999998875555554433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-29 Score=277.00 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=204.0
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
..++|+....+|.|.||.||||++. +++..|+|+++.........+++|+-+++..+|||||.++|.|...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3567889999999999999999976 799999999999888888999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
||.+|+|++.- .-...+++.++..+.+...+|++||| ++|-+|||||..||++++.|.+|++|||.+..+...-.
T Consensus 93 ycgggslQdiy-~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~- 167 (829)
T KOG0576|consen 93 YCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA- 167 (829)
T ss_pred ecCCCccccee-eecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhh-
Confidence 99999999853 44567899999999999999999999 88899999999999999999999999999876654322
Q ss_pred eeccccCCccccCccC-------CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEW-------KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~-------~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
......||++|||||+ -+..++|||+.|++..|+..-++|..+.......+ .+. ....++.
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~------LmT---kS~~qpp--- 235 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF------LMT---KSGFQPP--- 235 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH------Hhh---ccCCCCC---
Confidence 2334679999999998 26778999999999999999888854322111100 000 0000111
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1006 (1029)
....+..+.+.|.++++.|+-.+|++||++..+++
T Consensus 236 ----~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 ----TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ----cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11112345778999999999999999999988765
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=261.80 Aligned_cols=196 Identities=21% Similarity=0.364 Sum_probs=168.1
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chh-----hHHHHHHHHHHhcCC---CCceEEEEEE
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGT-----LRSFDAECEILGSIR---HRNLVKIIST 802 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~-----~~~~~~E~~~l~~l~---h~niv~l~~~ 802 (1029)
....+|...+.+|+|+||.|+.|.++ +..+|+||.+.+.. ..+ ...+-.|+.||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34456899999999999999999986 56789999987652 111 223567999999997 9999999999
Q ss_pred EecCCeEEEEEecc-CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEc
Q 036879 803 CSSDHFKALVLEYM-PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSD 881 (1029)
Q Consensus 803 ~~~~~~~~lV~E~~-~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~D 881 (1029)
|++++..|++||.. ++.+|.+|| +....+++.++..|++|++.|+++|| +.||||||||-+||.++.+|-+||+|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~I-E~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFI-EFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhh-hccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEee
Confidence 99999999999986 466999998 45667999999999999999999999 88899999999999999999999999
Q ss_pred cCCceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCc
Q 036879 882 FGISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDE 937 (1029)
Q Consensus 882 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~ 937 (1029)
||.|.+...+. ....+||.+|.|||++ .++..|||++|+++|-++....||..
T Consensus 714 fgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99998765443 3456799999999995 46679999999999999999999863
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-28 Score=243.89 Aligned_cols=258 Identities=19% Similarity=0.237 Sum_probs=190.8
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC-----
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD----- 806 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 806 (1029)
....+|.....+|.|+- .|..|.+. .+++||+|+..... ....+...+|...+..++|+||++++.+|.-.
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 34567788888999998 66666554 78999999876542 33456788999999999999999999998543
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 807 -HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 807 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
...|+|||+| ..+|.+.+. -..+-.++..+..|++.|++|+| +.||+|||+||+||++..+..+||.|||+|
T Consensus 93 ~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 93 FQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhh
Confidence 3568999999 578888775 33566788899999999999999 888999999999999999999999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc--------
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL-------- 953 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 953 (1029)
+..... ...+..+.|+.|+|||++ +.+.+||||+||++.||++|+.-|.+ +..+.+|.....
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g----~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG----KDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC----chHHHHHHHHHHHhcCCCHH
Confidence 865433 456678899999999996 45689999999999999999998764 222222211110
Q ss_pred -chhhhhhhhhh--hhhhhhhhhHH---------------HHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 954 -HGKIINVVDIN--LLQKEDAYLTA---------------KEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 954 -~~~~~~~~d~~--~~~~~~~~~~~---------------~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..++......- ....+.. ... ...-..-+.+++.+|+..+|++|.++++++++
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00000000000 0000000 000 01123457889999999999999999999975
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=244.04 Aligned_cols=131 Identities=23% Similarity=0.367 Sum_probs=111.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCC-----C---CceEEEEEEEec--
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIR-----H---RNLVKIISTCSS-- 805 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 805 (1029)
..+|-+.++||.|-|++||.|.+. +.+.||+|+.+.. ..-.+....|++++++++ | .+||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 478999999999999999999865 6788999998754 344466778999999983 2 479999999964
Q ss_pred --CCeEEEEEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE
Q 036879 806 --DHFKALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL 871 (1029)
Q Consensus 806 --~~~~~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill 871 (1029)
+.+.++|+|++ |.+|..+|... .+.++...+..|++||+.||.|||... ||||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56889999999 77888888654 456999999999999999999999755 89999999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=234.48 Aligned_cols=206 Identities=35% Similarity=0.548 Sum_probs=179.3
Q ss_pred eccCcceEEEEEEec-CCcEEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCHHH
Q 036879 746 LGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLEN 823 (1029)
Q Consensus 746 lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 823 (1029)
||+|++|.||++... +++.+++|++...... ..+.+.+|++.++.++|++++++++++......++||||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999986 4899999998866432 35679999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC-CCcEEEEccCCceecCCCCCceeccccCC
Q 036879 824 WMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-SMVACLSDFGISKLLGDETSMTQTQTLAT 902 (1029)
Q Consensus 824 ~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 902 (1029)
++.......++..+..++.++++++++|| +.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 98665457899999999999999999999 778999999999999999 89999999999987654321 12234578
Q ss_pred ccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHH
Q 036879 903 IGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKE 977 (1029)
Q Consensus 903 ~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 977 (1029)
..|++||.. .+.++|+|++|++++++
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 899999984 34789999999999999
Q ss_pred HHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 978 QCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 978 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..+.+++..|++.+|++||++.+++++
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 346889999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-27 Score=249.42 Aligned_cols=270 Identities=21% Similarity=0.264 Sum_probs=199.2
Q ss_pred CHHHHHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCC------CCceEEEEE
Q 036879 729 SYQELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIR------HRNLVKIIS 801 (1029)
Q Consensus 729 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~ 801 (1029)
.+.-.+.-..+|.+....|+|-|++|..|.+. -|+.||||+|... +...+.=..|++|+++|. --|+++++.
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 33444457789999999999999999999865 5889999999765 333345568999999994 347899999
Q ss_pred EEecCCeEEEEEeccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC-CCcEE
Q 036879 802 TCSSDHFKALVLEYMPNGSLENWMYNKNR--SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-SMVAC 878 (1029)
Q Consensus 802 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-~~~~k 878 (1029)
.|....+.++|+|.+ ..+|.+.+...++ .+....+..++.|+.-||..|- .-||+|.||||+|||+++ ...+|
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceee
Confidence 999999999999998 6799999977654 4677889999999999999999 566999999999999985 56789
Q ss_pred EEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccc---------c
Q 036879 879 LSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEIS---------L 945 (1029)
Q Consensus 879 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~---------~ 945 (1029)
|||||.|.+.+..+- +.+..+..|.|||++ |+...|+||+||++||+.||+..|.+....+.. +
T Consensus 578 LCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 578 LCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred eccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 999999987765433 334577889999996 567899999999999999999988753211110 0
Q ss_pred c-----------hhch----------hccch----hhhhhhhh------hhhhhhhhhhHHHHHHHHHHHHHHHHccccc
Q 036879 946 K-----------SRVN----------DSLHG----KIINVVDI------NLLQKEDAYLTAKEQCVSSVLSLAMQCTRES 994 (1029)
Q Consensus 946 ~-----------~~~~----------~~~~~----~~~~~~d~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 994 (1029)
+ +... ..+.+ .+...+.+ .+.. ..............+.+++.+|+..|
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~-~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA-VQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc-cCCCCchhHHHHHHHHHHHHHHhccC
Confidence 0 0000 00000 00000100 0111 00112223345677999999999999
Q ss_pred ccCCCCHHHHHHH
Q 036879 995 AEERINIKEALTK 1007 (1029)
Q Consensus 995 P~~Rpt~~evl~~ 1007 (1029)
|++|.|..+++++
T Consensus 734 P~KRit~nqAL~H 746 (752)
T KOG0670|consen 734 PEKRITVNQALKH 746 (752)
T ss_pred hhhcCCHHHHhcC
Confidence 9999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=225.26 Aligned_cols=250 Identities=20% Similarity=0.267 Sum_probs=187.5
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEE-EEecCCeEEEEEe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIIS-TCSSDHFKALVLE 814 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~lV~E 814 (1029)
+.|.+.+.+|+|.||.+-.+.+. +.+.+|+|.++.. ....++|.+|...--.+ .|.||+.-++ .|++.+...+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45888899999999999999876 6788999998765 34567899988775556 5899997765 5677888899999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC--CCCcEEEEccCCceecCCCC
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN--ESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|++.|+|..-+.. ..+-+.....++.|++.|+.|+| ++.+||||||.+||||- +...+|+||||..+..+.--
T Consensus 103 ~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred cCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 9999999886633 44677788899999999999999 77799999999999983 45689999999987654321
Q ss_pred CceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
. ..-.+-.|.|||.. ..+.+|||.||+++|.++||+.||+.....+..++.|..=. ++ ...
T Consensus 178 ~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~--~r----k~~ 247 (378)
T KOG1345|consen 178 K----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL--KR----KNP 247 (378)
T ss_pred h----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh--cc----cCc
Confidence 1 11234568899872 45679999999999999999999997666666555543211 11 000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
+. +..-...++.+..+.++-+.++|++|--..++.+....
T Consensus 248 ~~-------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 248 AL-------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred cC-------chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 11 11112245677889999999999999655565554443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=239.74 Aligned_cols=266 Identities=22% Similarity=0.306 Sum_probs=194.5
Q ss_pred HHHHhCCCCCCceeccCcceEEEEEEec----CCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCC
Q 036879 733 LFRATDGFSENNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDH 807 (1029)
Q Consensus 733 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 807 (1029)
+....+.|...++||+|.|++||+|.+. .++.||+|.+... .....+..|++++..+ -+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445677899999999999999999753 4678999998654 3346688999999999 5999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC-CCCcEEEEccCCce
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN-ESMVACLSDFGISK 886 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~-~~~~~kl~Dfg~a~ 886 (1029)
...+|+||+++....++.. .++...+..+++.+.+||+++| ..|||||||||.|++.+ ..+.-.|+|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999999888774 3567888999999999999999 88899999999999998 56788999999997
Q ss_pred ecCC--------C------C-------------------Cce----------eccccCCccccCccCC-----CCCCcch
Q 036879 887 LLGD--------E------T-------------------SMT----------QTQTLATIGYMAPEWK-----LSRKGDV 918 (1029)
Q Consensus 887 ~~~~--------~------~-------------------~~~----------~~~~~gt~~y~aPE~~-----~~~~~Dv 918 (1029)
.... . . .+. .....||+||+|||+. .+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 2100 0 0 000 0124699999999994 4678999
Q ss_pred hHHHHHHHHHhcCCCCCCcccccccccchhchhcc----------chh------------------hhhhhhhhhhhhhh
Q 036879 919 YSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL----------HGK------------------IINVVDINLLQKED 970 (1029)
Q Consensus 919 wSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----------~~~------------------~~~~~d~~~~~~~~ 970 (1029)
||.|||++-+++++.||.....+-..+.+.+..-- ++. +....-........
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999998654332222211110000 000 00000000000000
Q ss_pred ---hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 971 ---AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 971 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
......+..+..+.+++.+|+..+|.+|.||+|++++
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0011112235588999999999999999999999974
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=230.69 Aligned_cols=195 Identities=30% Similarity=0.454 Sum_probs=168.6
Q ss_pred CCCCceeccCcceEEEEEEecC-CcEEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccC
Q 036879 740 FSENNLLGKGSFGSVYKGTLSD-GMQIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMP 817 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~~-~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 817 (1029)
|...+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.++.++|+|++++++++......++|+||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999874 899999999876544 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceec
Q 036879 818 NGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897 (1029)
Q Consensus 818 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 897 (1029)
+++|.+++.......++..+..++.+++.++++|| +.+++|+|++|+||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 99999998654443889999999999999999999 668999999999999999999999999999877544211222
Q ss_pred cccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCc
Q 036879 898 QTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDE 937 (1029)
Q Consensus 898 ~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~ 937 (1029)
...++..|++||.. .+.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34577889999974 35589999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-27 Score=246.10 Aligned_cols=400 Identities=23% Similarity=0.227 Sum_probs=239.5
Q ss_pred cchhccccccccCCCCcccccccccceEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCC
Q 036879 204 LAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVI 283 (1029)
Q Consensus 204 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~ 283 (1029)
.++++|..|+|+...|.+|..+++|++||||+|+|+..-|++|..+.+|.+ .+++++|+|+.+.
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~----------------Lvlyg~NkI~~l~ 132 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLS----------------LVLYGNNKITDLP 132 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhH----------------HHhhcCCchhhhh
Confidence 456778888888778888888899999999999988888888888877653 3455667777766
Q ss_pred CCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCC
Q 036879 284 PPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFC 363 (1029)
Q Consensus 284 p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~ 363 (1029)
...|.+|..|+.|.+..|++. -++...+..|++|..|.|.+|.+..+--.+|..+..++.+.+..|.+--... +.+.
T Consensus 133 k~~F~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCn--L~wl 209 (498)
T KOG4237|consen 133 KGAFGGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCN--LPWL 209 (498)
T ss_pred hhHhhhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccc--cchh
Confidence 677777777777777777775 5666666667777777777777775555577777777777777776421100 0000
Q ss_pred CCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccc-cccCCcCcCcEEEecCccccc
Q 036879 364 HPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIP-SEIGNLNNLTTLHLETNELTG 442 (1029)
Q Consensus 364 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~ 442 (1029)
..+ .......+.......-..+.++++..+-+..|......+..=..+.+.+.+..| ..|.++++|+.|+|++|+|++
T Consensus 210 a~~-~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~ 288 (498)
T KOG4237|consen 210 ADD-LAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITR 288 (498)
T ss_pred hhH-HhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccch
Confidence 000 000011122333344444555555544444443322212222223333333444 468888888888888888887
Q ss_pred cccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCC-----C-
Q 036879 443 SIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSV-----I- 516 (1029)
Q Consensus 443 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----~- 516 (1029)
+-+.+|.++..+++|.|..|+|..+....|.++..|+.|+|++|+|+...|.+|..+..|.+|.|-.|.+--- .
T Consensus 289 i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~ 368 (498)
T KOG4237|consen 289 IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLG 368 (498)
T ss_pred hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHH
Confidence 7788888888888888888888877777888888888888888888888888888888888888877765210 0
Q ss_pred ----------CCCccCCCCCcEEEccCCcccC---cCCccc---------cccccccE-EEccCCcCCCCCCccccCccc
Q 036879 517 ----------PSSLWSLRDILNVNLSSNSLNG---TLPVEI---------GNLKVVTK-IDLSRNDLSGEIPSSIGDLKN 573 (1029)
Q Consensus 517 ----------~~~~~~l~~L~~L~Ls~N~l~~---~~p~~~---------~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~ 573 (1029)
...-.....++.+.++++.+.. ..|++. ..++-+.+ ...|++.++ .+|..+. ..
T Consensus 369 ~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d 445 (498)
T KOG4237|consen 369 EWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VD 445 (498)
T ss_pred HHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--ch
Confidence 0001112234444444443331 112111 11122222 223333333 3333332 23
Q ss_pred ccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCC
Q 036879 574 MQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFN 630 (1029)
Q Consensus 574 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 630 (1029)
-..|++.+|.++ .+|.. .+.+| .+|+|+|+++..--..|.+++.|.+|-+++|
T Consensus 446 ~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 446 VTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 445566666665 45544 33455 5666666665444455556666665555544
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-26 Score=236.85 Aligned_cols=390 Identities=22% Similarity=0.227 Sum_probs=224.3
Q ss_pred CCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceecccc-ccccCCCcccccCccccCeEec
Q 036879 74 LSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDG-NSFIGTIPPSICNISSLLTLDL 152 (1029)
Q Consensus 74 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L 152 (1029)
-..++|..|+|+...|.+|..+++|+.||||+|+|+.|. |+.|..+++|..|-+.+ |+|+...-..|+.|.+|+.|.+
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~-p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIA-PDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcC-hHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 345666666666444555666666666666666666554 56666666655555554 5665333345566666666666
Q ss_pred cCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCC-CCCcccccccccccchhccccccc------------cCCCC
Q 036879 153 SFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYN-TSPLQNIDMQYNSLAELHLAYNQL------------SGQIP 219 (1029)
Q Consensus 153 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~-~~~l~~l~l~~~~L~~L~Ls~N~l------------~~~~p 219 (1029)
.-|++.-.....|..+++|..|.+.+|.+..+....|. .. .++.++++.|.+ ....|
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~----------~i~tlhlA~np~icdCnL~wla~~~a~~~ 217 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLA----------AIKTLHLAQNPFICDCNLPWLADDLAMNP 217 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchh----------ccchHhhhcCccccccccchhhhHHhhch
Confidence 66666544455566666666666666665544332221 11 334444444431 11223
Q ss_pred cccccccccceEEcccccccCCCCccccc-cccccceeecccccc--------cccCcccEEEccCCcccCCCCCCcccC
Q 036879 220 STLFECKQLKILSLSVNNFIGSIPREIGN-ITMLKGLYLVYTNLT--------GEIQGLQVLALSSNRLTGVIPPEIINI 290 (1029)
Q Consensus 220 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~l~~n~l~--------~~l~~L~~L~Ls~N~l~~~~p~~~~~l 290 (1029)
..++...-..-..|.++++...-+..|.. +..+..-..+.+... ..+++|+.|+|++|+|+++-+.+|.++
T Consensus 218 ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~ 297 (498)
T KOG4237|consen 218 IETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGA 297 (498)
T ss_pred hhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcch
Confidence 33444433333344444433222222221 111111111111111 356788899999999999999999999
Q ss_pred CCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCC-----CCCCCCCC
Q 036879 291 SSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIP-----NSLGFCHP 365 (1029)
Q Consensus 291 ~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p-----~~~~~~~~ 365 (1029)
.++++|.|..|+|. .+...+|.++..|+.|+|.+|+|+...|..|..+..|.+|.+-.|.+.=..- +++....
T Consensus 298 a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~- 375 (498)
T KOG4237|consen 298 AELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKS- 375 (498)
T ss_pred hhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCC-
Confidence 99999999999996 8889999999999999999999999999999999999999998887621000 0000000
Q ss_pred CcccccccccccccccceeeccCCcCCC---CCCccccCch---------hhhcceeccccccccccccccCCcCcCcEE
Q 036879 366 YDELGFLTSLTNCKDLRKLILSENPLSG---VLPISIGNLS---------NAMDVLYLSACNIKGSIPSEIGNLNNLTTL 433 (1029)
Q Consensus 366 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~---~~p~~~~~l~---------~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 433 (1029)
...-.--..-..++.+.++++.+.. ..|+..+-.. -.-++...|+..++ .+|..+- ..-.+|
T Consensus 376 ---~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~tel 449 (498)
T KOG4237|consen 376 ---VVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTEL 449 (498)
T ss_pred ---CCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHH
Confidence 0000000111234455555544331 1222221111 11233444554554 3443332 245667
Q ss_pred EecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCC
Q 036879 434 HLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGN 486 (1029)
Q Consensus 434 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 486 (1029)
++.+|.++ .+|.. .+.+| .+|+++|++.......|.++..|..|.++.|
T Consensus 450 yl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 450 YLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 77777777 55655 55566 7778888777666677777777777777654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.7e-23 Score=207.45 Aligned_cols=266 Identities=18% Similarity=0.245 Sum_probs=210.7
Q ss_pred hCCCCCCceeccCcceEEEEEE-ecCCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.-.|.+.++||+|.||+++.|+ +-++++||||.-... ..+.++..|.++++.| ..++|...+.+-+++.+-.+|||
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3468899999999999999998 458999999975433 3457889999999998 57999999988888888899999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC-----CCcEEEEccCCceecC
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-----SMVACLSDFGISKLLG 889 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-----~~~~kl~Dfg~a~~~~ 889 (1029)
.+ |.+|+|...-.++.|+..++.-+|.|+..-++|+| ++..|.|||||+|+||+. ...+.|+|||+|+.+.
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99 89999988778899999999999999999999999 555999999999999974 4568999999999887
Q ss_pred CCCCcee------ccccCCccccCccCCC----CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhh
Q 036879 890 DETSMTQ------TQTLATIGYMAPEWKL----SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959 (1029)
Q Consensus 890 ~~~~~~~------~~~~gt~~y~aPE~~~----~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1029)
+...... ....||.+||+-.... +++.|+-|+|-|+++.+-|..||++.-.. ...+. ...
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~--tnK~k--------YeK 250 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD--TNKEK--------YEK 250 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc--chHHH--------HHH
Confidence 6543221 2245899999988754 56899999999999999999999874221 11111 122
Q ss_pred hhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcccccC
Q 036879 960 VVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIEN 1021 (1029)
Q Consensus 960 ~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~~ 1021 (1029)
+-+.+ ...+.....+.+|.+|...++-.-+.+-++-|+++-+...+..+.++..++-+-
T Consensus 251 IGe~K---r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg 309 (449)
T KOG1165|consen 251 IGETK---RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDG 309 (449)
T ss_pred hcccc---ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccc
Confidence 22211 112223344556788888888888889999999999999999988887766553
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=259.76 Aligned_cols=127 Identities=26% Similarity=0.331 Sum_probs=71.3
Q ss_pred ccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccc
Q 036879 499 LISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLS 578 (1029)
Q Consensus 499 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 578 (1029)
.++|+.|+|++|.....+|..+.++++|+.|++++|..-+.+|..+ ++++|+.|+|++|.....+|.. ..+|+.|+
T Consensus 777 ~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~ 852 (1153)
T PLN03210 777 SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLN 852 (1153)
T ss_pred cccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeE
Confidence 3455666666655544555556666666666666553333445443 4566666666665433333332 24566666
Q ss_pred cccccccccCCccccCCCCCCEEeCcCC-cccCcCchhhhcccccceeeccCCC
Q 036879 579 LADNKFQGSIPDSLGGLTSLNFLDMSSN-NLSGEIPNSLKALSLLKFLNLSFNG 631 (1029)
Q Consensus 579 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~l~~N~ 631 (1029)
|++|.|+ .+|.++..+++|++|+|++| +++ .+|..+..+++|+.+++++|.
T Consensus 853 Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 853 LSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 6666665 45666666666666666663 444 345555566666666666653
|
syringae 6; Provisional |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=199.87 Aligned_cols=265 Identities=20% Similarity=0.253 Sum_probs=207.2
Q ss_pred HHhCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeecccchhhHHHHHHHHHHhcCCC-CceEEEEEEEecCCeEEEE
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRH-RNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV 812 (1029)
....+|..+++||.|+||.+|.|.. .+|.+||||.-...+. ..++..|.++++.++| ..|..+..+..+...-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 4567899999999999999999974 5899999998665543 3567889999999964 7888888888888889999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC---CCCcEEEEccCCceecC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN---ESMVACLSDFGISKLLG 889 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~---~~~~~kl~Dfg~a~~~~ 889 (1029)
|+.+ |.+|.+...-..+.++..+++-.+-|+..-++|+| .+++|||||||+|+|.+ ....+.++|||+|+.+.
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9998 89999998878889999999999999999999999 77799999999999986 55679999999999875
Q ss_pred CCCCc------eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhh
Q 036879 890 DETSM------TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959 (1029)
Q Consensus 890 ~~~~~------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1029)
+.... ......||.+|.+-... .+.+.|+-|+|.++.++--|..||++...... .+. ...
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk--~QK--------yEk 235 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK--KQK--------YEK 235 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH--HHH--------HHH
Confidence 43221 12234688999887764 46789999999999999999999987532211 111 111
Q ss_pred hhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccc
Q 036879 960 VVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTN 1018 (1029)
Q Consensus 960 ~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~ 1018 (1029)
..+.++.. +.......+|.++.-.+.-|-..--++-|+..-+-+.+..+.+.+...
T Consensus 236 I~EkK~s~---~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~ 291 (341)
T KOG1163|consen 236 ISEKKMST---PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQ 291 (341)
T ss_pred HHHhhcCC---CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcccc
Confidence 11111111 112223456788888999999999999999999988888877766543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-24 Score=263.55 Aligned_cols=193 Identities=19% Similarity=0.246 Sum_probs=135.4
Q ss_pred cCCC-CceEEEEEEE-------ecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEE
Q 036879 790 SIRH-RNLVKIISTC-------SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIH 861 (1029)
Q Consensus 790 ~l~h-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH 861 (1029)
.++| +||++++++| ...+..+.+|||+ +++|.+++......+++.++..++.||++||+||| ++||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 4455 5777888877 2234566788887 67999999766677999999999999999999999 788999
Q ss_pred cCCCCCCEEECC-------------------CCcEEEEccCCceecCCCC---------------CceeccccCCccccC
Q 036879 862 CDLNPSNILLNE-------------------SMVACLSDFGISKLLGDET---------------SMTQTQTLATIGYMA 907 (1029)
Q Consensus 862 ~Dlk~~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~---------------~~~~~~~~gt~~y~a 907 (1029)
|||||+|||++. ++.+|++|||+++...... ........||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 4456666666665321100 000112357889999
Q ss_pred ccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHH
Q 036879 908 PEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSV 983 (1029)
Q Consensus 908 PE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l 983 (1029)
||++ ++.++|||||||++|||++|.+|+...... . ... ..... + ..........
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~---~------------~~~-~~~~~--~----~~~~~~~~~~ 241 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT---M------------SSL-RHRVL--P----PQILLNWPKE 241 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH---H------------HHH-HHhhc--C----hhhhhcCHHH
Confidence 9984 678999999999999999998886431100 0 000 00000 0 0001112345
Q ss_pred HHHHHHcccccccCCCCHHHHHHHH
Q 036879 984 LSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 984 ~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
..++.+||+++|.+||+|.|++++-
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhch
Confidence 6788899999999999999998743
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=257.41 Aligned_cols=235 Identities=24% Similarity=0.295 Sum_probs=106.6
Q ss_pred hcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCC
Q 036879 406 MDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485 (1029)
Q Consensus 406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 485 (1029)
|+.|+|++|.....+|..+.++++|+.|++++|..-+.+|..+ ++++|+.|++++|......|. ...+|++|++++
T Consensus 659 Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~---~~~nL~~L~L~~ 734 (1153)
T PLN03210 659 LETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPD---ISTNISWLDLDE 734 (1153)
T ss_pred ccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcccccc---ccCCcCeeecCC
Confidence 4444444443333444444444444444444432222333322 344444444444432222221 123444444444
Q ss_pred CcccCccccccccccccceeeccCccc-------cCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCC
Q 036879 486 NELNGSLPQCLDSLISLRTLSLGFNRL-------TSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRN 558 (1029)
Q Consensus 486 N~l~~~~~~~~~~l~~L~~L~Ls~N~l-------~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 558 (1029)
|.+. .+|..+ .+++|++|++.++.. ....+..+...++|+.|+|++|...+.+|..++++++|+.|++++|
T Consensus 735 n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C 812 (1153)
T PLN03210 735 TAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENC 812 (1153)
T ss_pred Cccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCC
Confidence 4443 233322 344444444444221 1111112223345666666666555455656666666666666655
Q ss_pred cCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccC-CCCcCCCC
Q 036879 559 DLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSF-NGLQGQVP 637 (1029)
Q Consensus 559 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~ 637 (1029)
...+.+|..+ .+++|+.|+|++|.....+|.. ..+|++|+|++|.++ .+|..+..+++|+.|++++ |++.+.++
T Consensus 813 ~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~ 887 (1153)
T PLN03210 813 INLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSL 887 (1153)
T ss_pred CCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCc
Confidence 4333445443 4556666666655433333332 245556666666665 4555556666666666655 34444333
Q ss_pred CCCCCCccCccccc
Q 036879 638 HGGPFTNLSSQSFV 651 (1029)
Q Consensus 638 ~~~~~~~l~~~~~~ 651 (1029)
....+..+..+.+.
T Consensus 888 ~~~~L~~L~~L~l~ 901 (1153)
T PLN03210 888 NISKLKHLETVDFS 901 (1153)
T ss_pred ccccccCCCeeecC
Confidence 33334444444443
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=243.43 Aligned_cols=266 Identities=29% Similarity=0.376 Sum_probs=198.8
Q ss_pred EEEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceecccc
Q 036879 51 TALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDG 130 (1029)
Q Consensus 51 ~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~ 130 (1029)
..|++++++|. ++|+++. ++|+.|++++|+|+ .+|.. +++|++|+|++|+|+. +|.. .++|+.|+|++
T Consensus 204 ~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts--LP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 204 AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS--LPVL---PPGLLELSIFS 271 (788)
T ss_pred cEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc--ccCc---ccccceeeccC
Confidence 35799999998 8999886 48999999999998 67753 5889999999999995 4643 46899999999
Q ss_pred ccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccc
Q 036879 131 NSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLA 210 (1029)
Q Consensus 131 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls 210 (1029)
|.|+ .+|..+ ++|+.|+|++|+++ .+|.. +++|+.|+|++|+|+++++. . .+|+.|+++
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~Lp~l-p------------~~L~~L~Ls 330 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASLPAL-P------------SELCKLWAY 330 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCccccCCCC-c------------ccccccccc
Confidence 9998 566533 67889999999998 56753 47899999999999976432 1 146678888
Q ss_pred cccccCCCCcccccccccceEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccC
Q 036879 211 YNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINI 290 (1029)
Q Consensus 211 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 290 (1029)
+|+|++ +|.. ..+|++|+|++|+|++ +|... .+|+.|++++|+|+. +|.. .
T Consensus 331 ~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~lp--------------------~~L~~L~Ls~N~L~~-LP~l---~ 381 (788)
T PRK15387 331 NNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTLP--------------------SELYKLWAYNNRLTS-LPAL---P 381 (788)
T ss_pred cCcccc-cccc---ccccceEecCCCccCC-CCCCC--------------------cccceehhhcccccc-Cccc---c
Confidence 888875 5532 2578999999999884 55432 234466777777774 4543 2
Q ss_pred CCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccc
Q 036879 291 SSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELG 370 (1029)
Q Consensus 291 ~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~ 370 (1029)
.+|+.|+|++|++. .+|.. .++|+.|++++|+|++ +|..+ .+|+.|++++|+++ .+|..
T Consensus 382 ~~L~~LdLs~N~Lt-~LP~l----~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~s----------- 440 (788)
T PRK15387 382 SGLKELIVSGNRLT-SLPVL----PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPES----------- 440 (788)
T ss_pred cccceEEecCCccc-CCCCc----ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChH-----------
Confidence 46788888888886 56643 3578888888888875 45433 45777888888887 45543
Q ss_pred cccccccccccceeeccCCcCCCCCCccccCch
Q 036879 371 FLTSLTNCKDLRKLILSENPLSGVLPISIGNLS 403 (1029)
Q Consensus 371 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 403 (1029)
+.++++|+.|+|++|++++..|..+..+.
T Consensus 441 ----l~~L~~L~~LdLs~N~Ls~~~~~~L~~l~ 469 (788)
T PRK15387 441 ----LIHLSSETTVNLEGNPLSERTLQALREIT 469 (788)
T ss_pred ----HhhccCCCeEECCCCCCCchHHHHHHHHh
Confidence 34678888999999999988888887654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=206.08 Aligned_cols=166 Identities=21% Similarity=0.206 Sum_probs=124.1
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|+|.+++...+..+++..++.++.|+++||+||| +.+ ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999776778999999999999999999999 554 999999999999999 99998654322
Q ss_pred ccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhH
Q 036879 899 TLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLT 974 (1029)
Q Consensus 899 ~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 974 (1029)
..|++.|||||++ ++.++|||||||++|||++|+.||.........+...... .. ..... ...
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~----~~~~~-~~~ 130 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG--------MP----ADDPR-DRS 130 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH--------hc----cCCcc-ccc
Confidence 2588999999984 6779999999999999999999986532111111111000 00 00000 000
Q ss_pred HHHHHHH--HHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 975 AKEQCVS--SVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 975 ~~~~~~~--~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.+..... .+.+++..||..+|++||++.|+++++..+...
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 1122233 689999999999999999999999999877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=222.41 Aligned_cols=164 Identities=21% Similarity=0.210 Sum_probs=127.4
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEec--CCcEEEEEEeecc-----cchhhHHHHHHHHHHhcCCCCceEEEEEEEecC
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLS--DGMQIAVKVFNLE-----LEGTLRSFDAECEILGSIRHRNLVKIISTCSSD 806 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 806 (1029)
....++|+..+.||+|+||+||+|++. +++.||||++... .....+.+.+|++++++++|+|+++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345678999999999999999999864 5778899987533 122356689999999999999998533222
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC-CCCCEEECCCCcEEEEccCCc
Q 036879 807 HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL-NPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dl-k~~Nill~~~~~~kl~Dfg~a 885 (1029)
+..++||||++|++|.. . ... . ...++.|+++|++|+| ++||+|||| ||+||+++.++.+||+|||+|
T Consensus 91 ~~~~LVmE~~~G~~L~~-~-~~~---~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-A-RPH---G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CCcEEEEEccCCCCHHH-h-Ccc---c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 45799999999999963 2 111 1 1467889999999999 788999999 999999999999999999999
Q ss_pred eecCCCCCcee-------ccccCCccccCccCC
Q 036879 886 KLLGDETSMTQ-------TQTLATIGYMAPEWK 911 (1029)
Q Consensus 886 ~~~~~~~~~~~-------~~~~gt~~y~aPE~~ 911 (1029)
+.+........ +...+++.|+|||+.
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~ 192 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL 192 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence 87654321111 234578889999983
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=237.34 Aligned_cols=263 Identities=29% Similarity=0.365 Sum_probs=134.8
Q ss_pred ccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCC
Q 036879 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMP 348 (1029)
Q Consensus 269 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls 348 (1029)
-..|+|++|.|+ .+|..+. ++|+.|++++|+++ .+|.. +++|++|+|++|+|+.. |.. .++|+.|+++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l----p~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls 270 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL----PPELRTLEVSGNQLTSL-PVL---PPGLLELSIF 270 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC----CCCCcEEEecCCccCcc-cCc---ccccceeecc
Confidence 457888888888 5666664 37888888888886 56642 46788888888888743 322 2345555555
Q ss_pred CccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcC
Q 036879 349 YNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLN 428 (1029)
Q Consensus 349 ~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~ 428 (1029)
+|.+.. +|. -..+|+.|++++|+++ .+|.. .+
T Consensus 271 ~N~L~~-Lp~------------------lp~~L~~L~Ls~N~Lt-~LP~~----------------------------p~ 302 (788)
T PRK15387 271 SNPLTH-LPA------------------LPSGLCKLWIFGNQLT-SLPVL----------------------------PP 302 (788)
T ss_pred CCchhh-hhh------------------chhhcCEEECcCCccc-ccccc----------------------------cc
Confidence 555542 111 0123444444554444 22221 23
Q ss_pred cCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeecc
Q 036879 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLG 508 (1029)
Q Consensus 429 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 508 (1029)
+|+.|+|++|+|++ +|.. ..+|+.|++++|.|++++. ...+|+.|++++|+|+. +|.. ..+|+.|+++
T Consensus 303 ~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~LP~----lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls 370 (788)
T PRK15387 303 GLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTSLPT----LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAY 370 (788)
T ss_pred ccceeECCCCcccc-CCCC---cccccccccccCccccccc----cccccceEecCCCccCC-CCCC---Ccccceehhh
Confidence 44444444444442 2221 1234444444444432211 01233333444443332 2221 1345555555
Q ss_pred CccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccC
Q 036879 509 FNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI 588 (1029)
Q Consensus 509 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 588 (1029)
+|+|++ +|.. ..+|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|..+ .+|+.|+|++|+|+ .+
T Consensus 371 ~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~L 437 (788)
T PRK15387 371 NNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RL 437 (788)
T ss_pred cccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-cc
Confidence 555553 2322 2345566666666653 3322 2356666666666653 44322 34556666666666 45
Q ss_pred CccccCCCCCCEEeCcCCcccCcCchhh
Q 036879 589 PDSLGGLTSLNFLDMSSNNLSGEIPNSL 616 (1029)
Q Consensus 589 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 616 (1029)
|..+..+++|+.|+|++|+|++..+..+
T Consensus 438 P~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 438 PESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred ChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 6666666666666666666665555544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-21 Score=216.93 Aligned_cols=257 Identities=20% Similarity=0.273 Sum_probs=193.8
Q ss_pred CCCCCceeccCcceEEEEEEecC--CcEEEEEEeecccchhhHHHHHHHHHHhcCCC----CceEEEEEEE-ecCCeEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLSD--GMQIAVKVFNLELEGTLRSFDAECEILGSIRH----RNLVKIISTC-SSDHFKAL 811 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 811 (1029)
+|.+.+.||+|+||.||.|.... ...+|+|............+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999998764 35789998776543333378889999988863 6899999998 57888999
Q ss_pred EEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC-----CcEEEEccCCc
Q 036879 812 VLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES-----MVACLSDFGIS 885 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~-----~~~kl~Dfg~a 885 (1029)
||+.+ |.+|.+...... +.++..++.+++.|+..+|+++| +.|++||||||.|+.++.. ..+.+.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99998 889999875554 78999999999999999999999 8889999999999999854 46999999999
Q ss_pred e--ecCCCCC----ce---eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc
Q 036879 886 K--LLGDETS----MT---QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS 952 (1029)
Q Consensus 886 ~--~~~~~~~----~~---~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 952 (1029)
+ .+..... .. .....||..|+++... .+++.|+||++.++.|+..|..||........ ...
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~---- 248 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSK---- 248 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHH----
Confidence 8 3321111 11 1235699999999973 67899999999999999999999965321111 000
Q ss_pred cchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 953 LHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 953 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
+........... .....+..+.++...+-+.+..++|.+..+.+.+++....-
T Consensus 249 ----~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 249 ----FEKDPRKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ----HHHHhhhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000000000000 11123456677777777789999999999999988877664
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.6e-22 Score=236.48 Aligned_cols=360 Identities=20% Similarity=0.320 Sum_probs=240.0
Q ss_pred CCchhHHHHHHHHHHhccCCCC-CcccCCCCCCCCCCceee----------------EEEcCCCCceEEEecccccccc-
Q 036879 1 TNVGRDQSALLALKAHVTNDPL-NVLASNWSTNTSVCNWFG----------------VTCSPRHRRVTALNLAYMGLLG- 62 (1029)
Q Consensus 1 ~~~~~~~~al~~~~~~~~~~~~-~~~~~~w~~~~~~c~w~g----------------v~c~~~~~~v~~l~l~~~~l~~- 62 (1029)
|+-..+.+.+..+.+.+...++ +-.++.|+.++|.|.=.. |.|. .+.||.+..-+.....
T Consensus 59 ~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~~~~~~ 136 (754)
T PRK15370 59 TASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTESEQASS 136 (754)
T ss_pred CCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecC--CCccccccccccccccc
Confidence 3456788999999999964332 333345998999997544 5664 3456655543321110
Q ss_pred -------------------cCCc-c------------CCCCcCCCeEeccCcccccCCccccccccCCceeecccccccC
Q 036879 63 -------------------TIPP-E------------LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSS 110 (1029)
Q Consensus 63 -------------------~~p~-~------------~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 110 (1029)
.-|+ + -+-..+.+.|++++++++ .+|..+. ++|+.|+|++|+|+.
T Consensus 137 ~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts 213 (754)
T PRK15370 137 ASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS 213 (754)
T ss_pred CCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc
Confidence 0110 0 012245789999999998 6887663 589999999999994
Q ss_pred CCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCC
Q 036879 111 IEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYN 190 (1029)
Q Consensus 111 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~ 190 (1029)
+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|++++|+|+.++..++
T Consensus 214 --LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~LP~~l~- 282 (754)
T PRK15370 214 --LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISCLPENLP- 282 (754)
T ss_pred --CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccCccccccC-
Confidence 676554 68999999999998 6787664 48999999999998 7887765 589999999999996554332
Q ss_pred CCCcccccccccccchhccccccccCCCCcccccccccceEEcccccccCCCCccccccccccceeecccccccccCccc
Q 036879 191 TSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQ 270 (1029)
Q Consensus 191 ~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~ 270 (1029)
.+|+.|++++|+|++ +|..+. ++|+.|++++|++++ +|..+. ++|+
T Consensus 283 -----------~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~-------------------~sL~ 328 (754)
T PRK15370 283 -----------EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP-------------------PGLK 328 (754)
T ss_pred -----------CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc-------------------ccce
Confidence 257788888888885 455443 579999999999884 554332 2455
Q ss_pred EEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCc
Q 036879 271 VLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYN 350 (1029)
Q Consensus 271 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N 350 (1029)
.|++++|.+++ +|..+. ++|+.|+|++|++. .+|..+. ++|+.|+|++|+++. +|..+. ..|+.|++++|
T Consensus 329 ~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp---~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N 398 (754)
T PRK15370 329 TLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP---PTITTLDVSRNALTN-LPENLP--AALQIMQASRN 398 (754)
T ss_pred eccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc---CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccC
Confidence 67777777774 555443 67888888888886 6776653 578888888888884 454443 36888888888
Q ss_pred cccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceecccccccc-ccccccCCcCc
Q 036879 351 LFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKG-SIPSEIGNLNN 429 (1029)
Q Consensus 351 ~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~-~~p~~~~~l~~ 429 (1029)
++. .+|..+. ..+..++.+..|++.+|+++. . .+.+ ++.| ++.+.+.| .++...+.+.+
T Consensus 399 ~L~-~LP~sl~-----------~~~~~~~~l~~L~L~~Npls~---~---tl~~-L~~L-l~s~~~~gp~i~~~~~~~~~ 458 (754)
T PRK15370 399 NLV-RLPESLP-----------HFRGEGPQPTRIIVEYNPFSE---R---TIQN-MQRL-MSSVGYQGPRVLFAMGDFSI 458 (754)
T ss_pred Ccc-cCchhHH-----------HHhhcCCCccEEEeeCCCccH---H---HHHH-HHHh-hhcccccCCccccccccccc
Confidence 887 4454332 122345788899999999872 1 2222 4455 34444433 33334444455
Q ss_pred CcEEEecCccc
Q 036879 430 LTTLHLETNEL 440 (1029)
Q Consensus 430 L~~L~L~~N~l 440 (1029)
++....-.+.+
T Consensus 459 l~~~~~l~~a~ 469 (754)
T PRK15370 459 VRVTRPLHQAV 469 (754)
T ss_pred ccccchHHHHH
Confidence 54443333333
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-22 Score=196.81 Aligned_cols=245 Identities=23% Similarity=0.334 Sum_probs=186.5
Q ss_pred CCCceeccCcceEEEEEEecCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 741 SENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 741 ~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
....+|.+...|+.|+|++.. ..+++|++.... ....+.|.+|.-.++-+.||||..++|.|..+....++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 445678899999999999964 455667765432 23346899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceec
Q 036879 819 GSLENWMYNKNR-SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897 (1029)
Q Consensus 819 gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 897 (1029)
|+|...+++... -.+..++.+++.+||+|++|||+.. +-|.---+..+.|++|++.+++|.- +-+++ +....
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf-----sfqe~ 344 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQEV 344 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee-----eeecc
Confidence 999999976533 4677889999999999999999764 2233445889999999999988751 11111 11112
Q ss_pred cccCCccccCccCCC-------CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 898 QTLATIGYMAPEWKL-------SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 898 ~~~gt~~y~aPE~~~-------~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
.....+.||+||.+. -+.+|+|||++++||+.|...||.+....+....- .-++
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-------------------aleg 405 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-------------------ALEG 405 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-------------------hhcc
Confidence 234578999999843 23689999999999999999999886544432221 0112
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
-+...|+..+..+..++.-|+..||.+||.++.++-.|++..
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 223344556778899999999999999999999999888653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-21 Score=226.10 Aligned_cols=249 Identities=20% Similarity=0.234 Sum_probs=184.4
Q ss_pred CCceeccCcceEEEEEEec-CCcEEEEEEeec---c--cch-hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 742 ENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNL---E--LEG-TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 742 ~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~---~--~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
....+|.|++|.|+.+... .....+.|.... . ... ....+..|+-+-.+++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3578999999988877643 344444444331 1 111 12236678888889999999988888877766666699
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC-
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS- 893 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 893 (1029)
||++ +|..++... ..+...++..+.+|+..|++|+| +.||.|||+|++|+++..+|.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9999 999988543 46788889999999999999999 88999999999999999999999999999976643322
Q ss_pred --ceeccccCCccccCccCC----C-CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 894 --MTQTQTLATIGYMAPEWK----L-SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 894 --~~~~~~~gt~~y~aPE~~----~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
......+|+.+|+|||+. + ....||||.|++++.|.+|+.||......+..+.+... ..-.
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~------------~~~~ 544 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY------------SDQR 544 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc------------cccc
Confidence 344556799999999994 3 33589999999999999999999765444333211100 0001
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....+.......+.....++..|++.+|.+|.|+++|++.
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 11112233345567778999999999999999999999873
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=226.47 Aligned_cols=246 Identities=30% Similarity=0.448 Sum_probs=144.1
Q ss_pred ceEEEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceecc
Q 036879 49 RVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYL 128 (1029)
Q Consensus 49 ~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~L 128 (1029)
.++.|+++++++. .+|..+. +.|+.|+|++|+|+ .+|..+. ++|++|++++|+|+. +|..+. ++|+.|+|
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts--LP~~l~--~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS--IPATLP--DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc--CChhhh--ccccEEEC
Confidence 4556666666666 5665543 45667777777776 5555443 467777777777663 454332 35677777
Q ss_pred ccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhc
Q 036879 129 DGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELH 208 (1029)
Q Consensus 129 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~ 208 (1029)
++|++. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|+|++.+..+. .+|+.|+
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp------------~sL~~L~ 310 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHLP------------SGITHLN 310 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccccCcccch------------hhHHHHH
Confidence 777766 5665553 46677777777776 4565443 366777777777665433211 2456666
Q ss_pred cccccccCCCCcccccccccceEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcc
Q 036879 209 LAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEII 288 (1029)
Q Consensus 209 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~ 288 (1029)
+++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+.
T Consensus 311 Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~-------------------~sL~~L~Ls~N~L~-~LP~~lp 366 (754)
T PRK15370 311 VQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP-------------------PELQVLDVSKNQIT-VLPETLP 366 (754)
T ss_pred hcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc-------------------CcccEEECCCCCCC-cCChhhc
Confidence 66666663 343332 466677777776663 444321 23456666666665 3444432
Q ss_pred cCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCccc----ccccccceecCCCcccc
Q 036879 289 NISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSI----SNASMLTLIDMPYNLFS 353 (1029)
Q Consensus 289 ~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l----~~l~~L~~L~ls~N~l~ 353 (1029)
++|++|+|++|++. .+|..+. ..|+.|++++|+++ .+|..+ +.++.+..+++.+|.++
T Consensus 367 --~~L~~LdLs~N~Lt-~LP~~l~---~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 367 --PTITTLDVSRNALT-NLPENLP---AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred --CCcCEEECCCCcCC-CCCHhHH---HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 46677777777765 5666554 25666777777766 333332 33456666777777664
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.5e-19 Score=199.84 Aligned_cols=253 Identities=31% Similarity=0.418 Sum_probs=191.9
Q ss_pred CCCCceeccCcceEEEEEEecCCcEEEEEEeecccch---hhHHHHHHHHHHhcCCCC-ceEEEEEEEecCCeEEEEEec
Q 036879 740 FSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEG---TLRSFDAECEILGSIRHR-NLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~E~ 815 (1029)
|...+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++|+||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999876 78999998766433 367899999999999988 799999999877778999999
Q ss_pred cCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC-cEEEEccCCceecCCCC
Q 036879 816 MPNGSLENWMYNKN--RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM-VACLSDFGISKLLGDET 892 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~ 892 (1029)
+.++++.+++.... ..+.......++.|++.+++|+| +.+++|||+||+||+++..+ .++++|||.+..+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997775444 27889999999999999999999 77799999999999999988 79999999998664432
Q ss_pred Cc-----eeccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCccccc--ccccchhchhccchhhh
Q 036879 893 SM-----TQTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVG--EISLKSRVNDSLHGKII 958 (1029)
Q Consensus 893 ~~-----~~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 958 (1029)
.. ......|+..|+|||.. .+...|+||+|++++++++|..||...... .......+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 21 23456799999999964 344689999999999999999997653221 00000000000000
Q ss_pred hhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 959 NVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 959 ~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....... ..........+.+++..|+..+|..|.++.+....
T Consensus 234 -----~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -----SLASPLS--PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -----ccccccC--ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000 00001223568899999999999999999988775
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=184.99 Aligned_cols=139 Identities=17% Similarity=0.204 Sum_probs=108.5
Q ss_pred CceeccCcceEEEEEEecCCcEEEEEEeecccch--h------------------------hHHHHHHHHHHhcCCCCce
Q 036879 743 NNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEG--T------------------------LRSFDAECEILGSIRHRNL 796 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 796 (1029)
...||+|+||.||+|...+|+.||||+++..... . ......|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999888999999999754211 0 1123459999999987776
Q ss_pred EEEEEEEecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEEcCCCCCCEEECCCC
Q 036879 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL-HYDHPTPIIHCDLNPSNILLNESM 875 (1029)
Q Consensus 797 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L-h~~~~~givH~Dlk~~Nill~~~~ 875 (1029)
.....+... ..++||||++++++..... ....++......++.|++.+++|+ | +.||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 443332222 2379999999887765432 235688999999999999999999 6 66899999999999998 47
Q ss_pred cEEEEccCCceec
Q 036879 876 VACLSDFGISKLL 888 (1029)
Q Consensus 876 ~~kl~Dfg~a~~~ 888 (1029)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.4e-20 Score=187.63 Aligned_cols=173 Identities=13% Similarity=0.144 Sum_probs=132.4
Q ss_pred HHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhH---------HHHHHHHHHhcCCCCceEEEEEEEec
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLR---------SFDAECEILGSIRHRNLVKIISTCSS 805 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~ 805 (1029)
...++|...+.+|.|+||.||.+.. ++..+|+|.+........+ .+.+|++.+.++.||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3578899999999999999999765 5778999999755432222 26899999999999999999988654
Q ss_pred C--------CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcE
Q 036879 806 D--------HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVA 877 (1029)
Q Consensus 806 ~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~ 877 (1029)
. ...++||||++|.+|.++.. .+. ....+++.++..+| ..|++|||+||.||+++.++ +
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-E
Confidence 3 35789999999999988631 222 34568999999999 78899999999999999988 9
Q ss_pred EEEccCCceecCCCCCceeccccCCccccCccCCCCCCcchhHHHHHHHHHhc
Q 036879 878 CLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKGDVYSYGIILMETFT 930 (1029)
Q Consensus 878 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~DvwSlGvil~ellt 930 (1029)
+++|||.......... ... ..-|..++.++|+||||+++.....
T Consensus 174 ~liDfg~~~~~~e~~a--~d~-------~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 174 RIIDLSGKRCTAQRKA--KDR-------IDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEECCCcccccchhh--HHH-------HHHHhHhcccccccceeEeehHHHH
Confidence 9999998865532211 110 1112234568999999998765543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=174.27 Aligned_cols=181 Identities=14% Similarity=0.113 Sum_probs=137.1
Q ss_pred CCCceeccCcceEEEEEEecCCcEEEEEEeecccc---hh-hHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEEEEEec
Q 036879 741 SENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE---GT-LRSFDAECEILGSIR-HRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 741 ~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~---~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.+...|++|+||+||.+.. .+..++.+.+..... .. ...+.+|+++++++. |+++++++++ +..++||||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3557899999999997766 677888777654422 11 225789999999995 5889999886 346899999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC-CCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL-NPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+.|.+|.+.... ....++.|++++++++| +.||+|||| ||.||+++.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998754311 12357789999999999 788999999 799999999999999999999865433210
Q ss_pred ----e--------eccccCCccccCccC--CCC----CCcchhHHHHHHHHHhcCCCCCCc
Q 036879 895 ----T--------QTQTLATIGYMAPEW--KLS----RKGDVYSYGIILMETFTKKKPTDE 937 (1029)
Q Consensus 895 ----~--------~~~~~gt~~y~aPE~--~~~----~~~DvwSlGvil~elltg~~p~~~ 937 (1029)
. ......++.|++|+. +.. .+.+.++-|..+|.++||+.|+-.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 011236778888886 222 246889999999999999998643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.9e-20 Score=214.94 Aligned_cols=243 Identities=20% Similarity=0.250 Sum_probs=174.4
Q ss_pred CCCCCceeccCcceEEEEEEecCCcEEEEEEeeccc-chhhHHHHH---HHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 739 GFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL-EGTLRSFDA---ECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.|...+.+|++.|=+|.+|+++.|. |+||++-+.. .-..+.|.+ |++ ...++|||++++.-....+...|+|=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5667788999999999999998887 8999987654 223344443 444 555699999999888777888889999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee--cCCCC
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL--LGDET 892 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~--~~~~~ 892 (1029)
|+. -+|.|.+ ..+.-+...+...|+.|+..|+.-+| ..||+|||||.+|||++.=+-+.|+||..-+. ++.+.
T Consensus 102 yvk-hnLyDRl-STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVK-HNLYDRL-STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHh-hhhhhhh-ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 985 4888877 34445667778889999999999999 88899999999999999999999999986542 22221
Q ss_pred Ccee----ccccCCccccCccCC---------------CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhc
Q 036879 893 SMTQ----TQTLATIGYMAPEWK---------------LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDS 952 (1029)
Q Consensus 893 ~~~~----~~~~gt~~y~aPE~~---------------~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 952 (1029)
.... .....-..|.|||.+ .+++.||||+||+++|+++ |++||.-.. +-.+-..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-----L~aYr~~- 250 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-----LLAYRSG- 250 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-----HHhHhcc-
Confidence 1111 112223469999984 3457899999999999998 677775310 0000000
Q ss_pred cchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 953 LHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 953 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
+ .+....-+ ..-....+++++..|++.||++|.+|++.++.-
T Consensus 251 --~--~~~~e~~L----------e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 251 --N--ADDPEQLL----------EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred --C--ccCHHHHH----------HhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 0 00000001 111133578999999999999999999999863
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=177.69 Aligned_cols=141 Identities=18% Similarity=0.221 Sum_probs=111.0
Q ss_pred CceeccCcceEEEEEEecCCcEEEEEEeecccch--------------------------hhHHHHHHHHHHhcCCCCce
Q 036879 743 NNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEG--------------------------TLRSFDAECEILGSIRHRNL 796 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 796 (1029)
...||+|+||.||+|+..+|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999998764211 01224678999999999987
Q ss_pred EEEEEEEecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCEEECCCC
Q 036879 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP-TPIIHCDLNPSNILLNESM 875 (1029)
Q Consensus 797 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~givH~Dlk~~Nill~~~~ 875 (1029)
.....+.... .++||||++++++..... .....+......++.|++.++.++| . .||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CC
Confidence 5444433332 479999998886544322 2345778889999999999999999 5 7899999999999999 89
Q ss_pred cEEEEccCCceecCC
Q 036879 876 VACLSDFGISKLLGD 890 (1029)
Q Consensus 876 ~~kl~Dfg~a~~~~~ 890 (1029)
.++|+|||+|.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.4e-19 Score=185.57 Aligned_cols=192 Identities=21% Similarity=0.297 Sum_probs=137.8
Q ss_pred CCCceEEEEEEEec---------------------------CCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHH
Q 036879 792 RHRNLVKIISTCSS---------------------------DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDV 844 (1029)
Q Consensus 792 ~h~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i 844 (1029)
+|||||++.++|.+ +...|+||..++ .+|.+|+... ..+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC--CCchHHHHHHHHHH
Confidence 59999999876522 346789999884 5999999543 35566777899999
Q ss_pred HHHHHHHHhcCCCCcEEcCCCCCCEEEC--CC--CcEEEEccCCceecCC-----CCCceeccccCCccccCccCC----
Q 036879 845 ASALEYLHYDHPTPIIHCDLNPSNILLN--ES--MVACLSDFGISKLLGD-----ETSMTQTQTLATIGYMAPEWK---- 911 (1029)
Q Consensus 845 ~~~l~~Lh~~~~~givH~Dlk~~Nill~--~~--~~~kl~Dfg~a~~~~~-----~~~~~~~~~~gt~~y~aPE~~---- 911 (1029)
.+|+.||| +.||.|||+|.+|||+. +| ..+.|+|||.+---.. ......-...|.-.-||||+.
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 78899999999999983 33 4578899997642111 011111123466778999983
Q ss_pred ------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHH
Q 036879 912 ------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLS 985 (1029)
Q Consensus 912 ------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~ 985 (1029)
--.|.|.|+.|.+.||+++...||+. .++..+...- .+ +..-+..++.+++.+.+
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGem~L~~r~----------------Yq-e~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGEMLLDTRT----------------YQ-ESQLPALPSRVPPVARQ 488 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccc--cchheechhh----------------hh-hhhCCCCcccCChHHHH
Confidence 23489999999999999999999986 2222222111 00 01112335667888999
Q ss_pred HHHHcccccccCCCCHHHHHHHH
Q 036879 986 LAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 986 li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
++...++.||.+|+++.-+...+
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 99999999999999877666544
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-20 Score=174.67 Aligned_cols=157 Identities=31% Similarity=0.545 Sum_probs=107.1
Q ss_pred CCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCcccc
Q 036879 68 LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSL 147 (1029)
Q Consensus 68 ~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 147 (1029)
+.++++++.|.||+|+++ .+|..++.+.+|+.|++++|+++ ++|..+.++++|+.|+++-|++. .+|..|+.++.|
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie--~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE--ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh--hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 446677777777777777 66667777777777777777776 46777777777777777777766 667777777777
Q ss_pred CeEeccCCcCc-ccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCccccccc
Q 036879 148 LTLDLSFNQLQ-GHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECK 226 (1029)
Q Consensus 148 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~ 226 (1029)
+.|||++|.+. ..+|..|..++.|+.|+|++|.+. .+|..++.++
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe----------------------------------~lp~dvg~lt 150 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE----------------------------------ILPPDVGKLT 150 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc----------------------------------cCChhhhhhc
Confidence 77777776664 245666666666655555555554 4566677777
Q ss_pred ccceEEcccccccCCCCccccccccccceeecccccc
Q 036879 227 QLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT 263 (1029)
Q Consensus 227 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~ 263 (1029)
+|+.|.+..|.+. .+|..++.++.|++|++.+|+++
T Consensus 151 ~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 151 NLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 7888888887776 67777777777775555544444
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-20 Score=173.40 Aligned_cols=162 Identities=35% Similarity=0.596 Sum_probs=102.8
Q ss_pred cCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceee
Q 036879 427 LNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLS 506 (1029)
Q Consensus 427 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 506 (1029)
+.+++.|.|++|+++ .+|..+..+.+|+.|++++|+|+ .+|..+..+++|+.|+
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-------------------------~lp~~issl~klr~ln 85 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-------------------------ELPTSISSLPKLRILN 85 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-------------------------hcChhhhhchhhhhee
Confidence 444455555555555 34444555555555555555553 4455555556666666
Q ss_pred ccCccccCCCCCCccCCCCCcEEEccCCcccC-cCCccccccccccEEEccCCcCCCCCCccccCccccccccccccccc
Q 036879 507 LGFNRLTSVIPSSLWSLRDILNVNLSSNSLNG-TLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQ 585 (1029)
Q Consensus 507 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 585 (1029)
++.|++. +.|..|+.++.|+.|||++|++.. .+|..|..++.|+.|+|++|.+. .+|..++++++||.|.+..|.+-
T Consensus 86 vgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll 163 (264)
T KOG0617|consen 86 VGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL 163 (264)
T ss_pred cchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh
Confidence 6666654 455666666666666666665553 46667777777777777777776 67777777777777777777776
Q ss_pred ccCCccccCCCCCCEEeCcCCcccCcCchhhhc
Q 036879 586 GSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKA 618 (1029)
Q Consensus 586 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 618 (1029)
..|..++.++.|++|++.+|+++ .+|..+++
T Consensus 164 -~lpkeig~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 164 -SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred -hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence 57777777777777777777777 44544444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.4e-18 Score=177.70 Aligned_cols=226 Identities=19% Similarity=0.270 Sum_probs=144.4
Q ss_pred CCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCC----------CceEEEEEEE--
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRH----------RNLVKIISTC-- 803 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~-- 803 (1029)
+...+.||.|+++.||.+++. +++++|||++.... ....+.+.+|.-....+.+ -.++..++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999986 69999999987554 2345667777655544322 1222222221
Q ss_pred -------ecC---C-----eEEEEEeccCCCCHHHHHhc---CCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCcEEc
Q 036879 804 -------SSD---H-----FKALVLEYMPNGSLENWMYN---KNRS---FDILQRLNMVIDVASALEYLHYDHPTPIIHC 862 (1029)
Q Consensus 804 -------~~~---~-----~~~lV~E~~~~gsL~~~l~~---~~~~---~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~ 862 (1029)
... . ..+++|+-+ .++|.+.+.. .... .....+..+..|+.+.+++|| ..|+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence 111 1 125677777 5688877532 2221 233445667799999999999 8889999
Q ss_pred CCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccCCccccCccCC------------CCCCcchhHHHHHHHHHhc
Q 036879 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK------------LSRKGDVYSYGIILMETFT 930 (1029)
Q Consensus 863 Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~------------~~~~~DvwSlGvil~ellt 930 (1029)
||||+|++++.+|.++|+||+.....+..... ...+..|.+||.. ++.+.|.|++|+++|.|++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999988765432211 3355788999862 4668899999999999999
Q ss_pred CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCC
Q 036879 931 KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEER 998 (1029)
Q Consensus 931 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 998 (1029)
|+.||+.......... ....+ ...++.+..+|..+++++|++|
T Consensus 246 ~~lPf~~~~~~~~~~~------------------~f~~C-------~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW------------------DFSRC-------RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG------------------GGTTS-------S---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc------------------cchhc-------CCcCHHHHHHHHHHccCCcccC
Confidence 9999986422211110 11111 1457789999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.7e-19 Score=198.15 Aligned_cols=222 Identities=27% Similarity=0.286 Sum_probs=177.5
Q ss_pred eccCcceEEEEEEe----cCCcEEEEEEeecccch--hhHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEEEEEeccCC
Q 036879 746 LGKGSFGSVYKGTL----SDGMQIAVKVFNLELEG--TLRSFDAECEILGSIR-HRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 746 lg~G~fg~V~~~~~----~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+|+|+||.|+.++. +.|.-+|+|..++.... .......|..++..++ ||.+|+++..++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 69999999997742 35777899988765311 1124566788888886 99999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
|.+...+. +...+.+.....+...++-+++++| +.+|+|||+|++||+++.+|++++.|||+++..-..+..
T Consensus 82 g~lft~l~-~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 82 GDLFTRLS-KEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred chhhhccc-cCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 99988763 4456778888888899999999999 888999999999999999999999999999876443322
Q ss_pred ccCCccccCccCC--CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHH
Q 036879 899 TLATIGYMAPEWK--LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAK 976 (1029)
Q Consensus 899 ~~gt~~y~aPE~~--~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 976 (1029)
.||..|||||++ ....+|.||||++++||+||..||... . . ..........|
T Consensus 154 -cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~~----~-----~----------------~~Il~~~~~~p 207 (612)
T KOG0603|consen 154 -CGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGGD----T-----M----------------KRILKAELEMP 207 (612)
T ss_pred -ccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCchH----H-----H----------------HHHhhhccCCc
Confidence 689999999996 467899999999999999999998751 0 0 00111123345
Q ss_pred HHHHHHHHHHHHHcccccccCCCCH
Q 036879 977 EQCVSSVLSLAMQCTRESAEERINI 1001 (1029)
Q Consensus 977 ~~~~~~l~~li~~cl~~dP~~Rpt~ 1001 (1029)
.+....+.+++..+...+|..|.-.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 5667788889999999999998744
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=169.45 Aligned_cols=136 Identities=18% Similarity=0.300 Sum_probs=105.8
Q ss_pred CCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcC-----CCCceEEEEEEEecCC---eEE-E
Q 036879 741 SENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSI-----RHRNLVKIISTCSSDH---FKA-L 811 (1029)
Q Consensus 741 ~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l 811 (1029)
...+.||+|+||.||. +......+||++........+.+.+|+++++.+ .||||++++|+++++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 433333479988765455567899999999999 5799999999998863 333 7
Q ss_pred EEec--cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCcEEcCCCCCCEEECC----CCcEEEEccCC
Q 036879 812 VLEY--MPNGSLENWMYNKNRSFDILQRLNMVIDVASAL-EYLHYDHPTPIIHCDLNPSNILLNE----SMVACLSDFGI 884 (1029)
Q Consensus 812 V~E~--~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~Lh~~~~~givH~Dlk~~Nill~~----~~~~kl~Dfg~ 884 (1029)
|||| +.+++|.+++.+. .+++. ..++.|++.++ +||| +.+||||||||+||+++. .+.++|+||+-
T Consensus 83 I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 8999 5579999999543 35554 35677888777 9999 677999999999999973 34899999543
Q ss_pred c
Q 036879 885 S 885 (1029)
Q Consensus 885 a 885 (1029)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6e-18 Score=189.54 Aligned_cols=214 Identities=28% Similarity=0.391 Sum_probs=160.9
Q ss_pred HhcCCCCceEEEEEEEecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCC
Q 036879 788 LGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPS 867 (1029)
Q Consensus 788 l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~ 867 (1029)
|+.+.|.|+.+++|.+..+...+.|.+||..|+|.+.+.......++.....++++|++|++|+|. +....|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 357899999999999999999999999999999999998878889999999999999999999993 233399999999
Q ss_pred CEEECCCCcEEEEccCCceecCCC-CCceeccccCCccccCccCC-----------CCCCcchhHHHHHHHHHhcCCCCC
Q 036879 868 NILLNESMVACLSDFGISKLLGDE-TSMTQTQTLATIGYMAPEWK-----------LSRKGDVYSYGIILMETFTKKKPT 935 (1029)
Q Consensus 868 Nill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~-----------~~~~~DvwSlGvil~elltg~~p~ 935 (1029)
|.++|..+.+|++|||+....... .........-..-|.|||.+ .+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998765321 11111112234568999973 356799999999999999999999
Q ss_pred Ccccccccc--cchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 936 DELFVGEIS--LKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 936 ~~~~~~~~~--~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
+........ +..++.. +... ...+......+..+++..++.+||..+|++||+++.+-..++.+.+
T Consensus 159 ~~~~~~~~~~eii~~~~~----------~~~~--~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK----------GGSN--PFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCChHHHHHHHHh----------cCCC--CcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 763322221 1111111 0000 0001111111445578999999999999999999999998887766
Q ss_pred hh
Q 036879 1014 TL 1015 (1029)
Q Consensus 1014 ~~ 1015 (1029)
..
T Consensus 227 ~~ 228 (484)
T KOG1023|consen 227 GG 228 (484)
T ss_pred cc
Confidence 43
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-19 Score=200.42 Aligned_cols=283 Identities=23% Similarity=0.282 Sum_probs=170.2
Q ss_pred eEeecCcccC-CCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCcc
Q 036879 320 QLILGGNRLT-GPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPIS 398 (1029)
Q Consensus 320 ~L~L~~N~l~-~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 398 (1029)
+|+|+++.++ +..+..+..+..|+.++++++.++..... .+...+...++|++|+++++.+.+ .+..
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~-----------~i~~~l~~~~~l~~l~l~~~~~~~-~~~~ 69 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAK-----------ALASALRPQPSLKELCLSLNETGR-IPRG 69 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHH-----------HHHHHHhhCCCceEEeccccccCC-cchH
Confidence 5778888887 45566666777777777777766421100 111223455567777777666542 1111
Q ss_pred ccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCC---CCEEEeccccccCc----cccc
Q 036879 399 IGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQK---LQGLYLQHNKLQGS----ITTD 471 (1029)
Q Consensus 399 ~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~----~~~~ 471 (1029)
+ ..++..+..+++|+.|+|++|.+.+..+..+..+.+ |++|++++|+++.. ....
T Consensus 70 ~------------------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~ 131 (319)
T cd00116 70 L------------------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKG 131 (319)
T ss_pred H------------------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHH
Confidence 0 123344555667777777777776544555544444 77777777776532 1223
Q ss_pred ccCC-CCCcEEecCCCcccC----ccccccccccccceeeccCccccCC----CCCCccCCCCCcEEEccCCcccCc---
Q 036879 472 LCGL-RSLSEFYSDGNELNG----SLPQCLDSLISLRTLSLGFNRLTSV----IPSSLWSLRDILNVNLSSNSLNGT--- 539 (1029)
Q Consensus 472 ~~~l-~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~--- 539 (1029)
+..+ ++|++|++++|.+++ ..+..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++.
T Consensus 132 l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 211 (319)
T cd00116 132 LKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS 211 (319)
T ss_pred HHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH
Confidence 3444 666777777776663 2334456666778888887777632 223344556788888888877643
Q ss_pred -CCccccccccccEEEccCCcCCCCCCccccC-----cccccccccccccccc----cCCccccCCCCCCEEeCcCCccc
Q 036879 540 -LPVEIGNLKVVTKIDLSRNDLSGEIPSSIGD-----LKNMQHLSLADNKFQG----SIPDSLGGLTSLNFLDMSSNNLS 609 (1029)
Q Consensus 540 -~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~ 609 (1029)
++..+..+++|+.|++++|.+++.....+.. .+.|+.|++++|.+++ .+...+..+++|+++++++|.++
T Consensus 212 ~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 212 ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 2334556777888888888877533333322 3678888888888762 23344556678888888888887
Q ss_pred Cc----Cchhhhcc-cccceeeccCCCC
Q 036879 610 GE----IPNSLKAL-SLLKFLNLSFNGL 632 (1029)
Q Consensus 610 ~~----~~~~~~~l-~~L~~L~l~~N~l 632 (1029)
.. ....+... +.|+.+++.+|++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 292 EEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 54 33344444 6777787777764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.4e-19 Score=200.74 Aligned_cols=285 Identities=25% Similarity=0.299 Sum_probs=162.7
Q ss_pred EEEccCcccCCCCCchhhhcccccceEeecCcccCCC----CCcccccccccceecCCCccccCCCCCCCCCCCCCcccc
Q 036879 295 VLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGP----IPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELG 370 (1029)
Q Consensus 295 ~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~ 370 (1029)
.|+|..+.+.+.--..++..+.+|+.|+++++.++.. ++..+...+.++.++++++.+.+ .+..+ ..
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~--------~~ 72 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGL--------QS 72 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHH--------HH
Confidence 5788888887443345556788999999999998643 56667788889999999998763 11111 01
Q ss_pred cccccccccccceeeccCCcCCCCCCccccCchh--hhcceecccccccc----ccccccCCc-CcCcEEEecCcccccc
Q 036879 371 FLTSLTNCKDLRKLILSENPLSGVLPISIGNLSN--AMDVLYLSACNIKG----SIPSEIGNL-NNLTTLHLETNELTGS 443 (1029)
Q Consensus 371 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--~L~~L~L~~n~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~ 443 (1029)
....+..+++|+.|++++|.+.+..+..+..+.. .|++|++++|++++ .+...+..+ ++|+.|+|++|.+++.
T Consensus 73 ~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~ 152 (319)
T cd00116 73 LLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGA 152 (319)
T ss_pred HHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCch
Confidence 1233456778888888888887544444433322 15555555555542 112223333 4455555555554421
Q ss_pred ----ccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCC----
Q 036879 444 ----IPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSV---- 515 (1029)
Q Consensus 444 ----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---- 515 (1029)
++..+..+++|++|++++|.+++... ..++..+..+++|+.|+|++|.+++.
T Consensus 153 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~--------------------~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 212 (319)
T cd00116 153 SCEALAKALRANRDLKELNLANNGIGDAGI--------------------RALAEGLKANCNLEVLDLNNNGLTDEGASA 212 (319)
T ss_pred HHHHHHHHHHhCCCcCEEECcCCCCchHHH--------------------HHHHHHHHhCCCCCEEeccCCccChHHHHH
Confidence 12233344445555555544432111 11223334445666666666665432
Q ss_pred CCCCccCCCCCcEEEccCCcccCcCCcccc-----ccccccEEEccCCcCCC----CCCccccCcccccccccccccccc
Q 036879 516 IPSSLWSLRDILNVNLSSNSLNGTLPVEIG-----NLKVVTKIDLSRNDLSG----EIPSSIGDLKNMQHLSLADNKFQG 586 (1029)
Q Consensus 516 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~ 586 (1029)
.+..+..+++|+.|++++|.+++.....+. ..+.|+.|++++|.++. .++..+..+++|+.+++++|.++.
T Consensus 213 l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 213 LAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred HHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 223445566677777777766642222222 23677777777777752 223344556778888888888874
Q ss_pred c----CCccccCC-CCCCEEeCcCCcc
Q 036879 587 S----IPDSLGGL-TSLNFLDMSSNNL 608 (1029)
Q Consensus 587 ~----~~~~~~~l-~~L~~L~Ls~N~l 608 (1029)
. ....+... +.|++|++.+|.+
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 293 EGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 4 33344444 6788888877754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.8e-16 Score=164.40 Aligned_cols=134 Identities=21% Similarity=0.327 Sum_probs=112.6
Q ss_pred ceeccCcceEEEEEEecCCcEEEEEEeecccc--------hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE--------GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
+.||+|++|.||+|.. .|..|++|....... .....+.+|++++..++|++++....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677899998654321 1124578899999999999988777777777778999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
++|++|.+++.... . .+..++.+++.+++++| +.|++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999885432 2 78889999999999999 77899999999999999 78999999998864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=168.10 Aligned_cols=144 Identities=19% Similarity=0.164 Sum_probs=112.2
Q ss_pred hCCCCCCceeccCcceEEEEEE--ecCCcEEEEEEeecccch------------------------hhHHHHHHHHHHhc
Q 036879 737 TDGFSENNLLGKGSFGSVYKGT--LSDGMQIAVKVFNLELEG------------------------TLRSFDAECEILGS 790 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~--~~~~~~vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~ 790 (1029)
..-|++.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|++++++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3457888999999999999998 458999999998754210 01235689999999
Q ss_pred CCCC--ceEEEEEEEecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEEcCCCCC
Q 036879 791 IRHR--NLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP-IIHCDLNPS 867 (1029)
Q Consensus 791 l~h~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~g-ivH~Dlk~~ 867 (1029)
+.+. .+.+++++ ...++||||++++++..+.. ............++.|++.++++|| +.| |+||||||+
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~ 178 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEY 178 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChh
Confidence 9753 34455543 23479999999988876542 2334566667889999999999999 888 999999999
Q ss_pred CEEECCCCcEEEEccCCceecC
Q 036879 868 NILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 868 Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
||+++ ++.++++|||.|...+
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999987543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=189.81 Aligned_cols=194 Identities=24% Similarity=0.285 Sum_probs=151.7
Q ss_pred HHHHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCC---CCceEEEEEEEecCCeE
Q 036879 733 LFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIR---HRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 733 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~ 809 (1029)
.+...+.|.+.+.||+|+||.||+|...+|+.||+|+-+....-. |.--.+++.+|+ -+.|+.+..++.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 344567889999999999999999998889999999866543211 111123344444 24455566666667778
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC-------CCCcEEEEcc
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN-------ESMVACLSDF 882 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~-------~~~~~kl~Df 882 (1029)
++|+||.+.|+|.+++. ..+..++..++.++.|+++.+++|| ..+||||||||+|+++. ....++|+||
T Consensus 770 ~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 89999999999999985 6677999999999999999999999 77799999999999995 3457999999
Q ss_pred CCceecCC-CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCC
Q 036879 883 GISKLLGD-ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKK 933 (1029)
Q Consensus 883 g~a~~~~~-~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~ 933 (1029)
|.+..+.- .........++|-.+-.+|+. .+...|.|.++.+++-|+.|+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99864421 122344556788899999996 4567999999999999999985
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.2e-16 Score=160.91 Aligned_cols=145 Identities=21% Similarity=0.179 Sum_probs=112.6
Q ss_pred HHHHHHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccch----------------------hhHHHHHHHHHH
Q 036879 731 QELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEG----------------------TLRSFDAECEIL 788 (1029)
Q Consensus 731 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~----------------------~~~~~~~E~~~l 788 (1029)
.++.....-|.+.+.||+|+||.||+|...+|+.||||++...... ....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444458888999999999999999888999999987643210 112367788899
Q ss_pred hcCCCC--ceEEEEEEEecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCC
Q 036879 789 GSIRHR--NLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNP 866 (1029)
Q Consensus 789 ~~l~h~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~ 866 (1029)
..+.|+ .+++.++. ...++||||+++++|.+.... .....++.+++.++.++| ..||+||||||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p 153 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSE 153 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCc
Confidence 988777 44444442 345899999999998765321 345678899999999999 67899999999
Q ss_pred CCEEECCCCcEEEEccCCceecC
Q 036879 867 SNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 867 ~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
+||++++++.++|+|||.+....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=182.33 Aligned_cols=139 Identities=22% Similarity=0.284 Sum_probs=112.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEe-ecccc-------hhhHHHHHHHHHHhcCCCCceEEEEEEEecCC
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVF-NLELE-------GTLRSFDAECEILGSIRHRNLVKIISTCSSDH 807 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~-~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 807 (1029)
....|...+.||+|+||+||+|.+... .+++|+. .+... ...+.+.+|+++++.++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 345566789999999999999987544 3444432 21111 12356889999999999999998887777777
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
..++||||+++++|.+++. ....++.|++++++||| +.||+|||+||+||++ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 7899999999999999874 45678999999999999 7789999999999999 678999999999975
Q ss_pred c
Q 036879 888 L 888 (1029)
Q Consensus 888 ~ 888 (1029)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.5e-16 Score=187.80 Aligned_cols=151 Identities=28% Similarity=0.477 Sum_probs=120.9
Q ss_pred CchhHHHHHHHHHHhccCCCCCcccCCCCCCCCCC----ceeeEEEcC--CC--CceEEEecccccccccCCccCCCCcC
Q 036879 2 NVGRDQSALLALKAHVTNDPLNVLASNWSTNTSVC----NWFGVTCSP--RH--RRVTALNLAYMGLLGTIPPELGNLSF 73 (1029)
Q Consensus 2 ~~~~~~~al~~~~~~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~--~~--~~v~~l~l~~~~l~~~~p~~~~~l~~ 73 (1029)
+.+.|++||++||+++. +|.. . +|.. ..|| .|.||+|+. .. .+|+.|+|+++++.|.+|++++.|++
T Consensus 369 t~~~~~~aL~~~k~~~~-~~~~--~-~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 369 TLLEEVSALQTLKSSLG-LPLR--F-GWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred cCchHHHHHHHHHHhcC-Cccc--C-CCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 45679999999999995 4432 2 4963 3342 799999953 22 25899999999999999999999999
Q ss_pred CCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCc-cccCeEec
Q 036879 74 LSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNI-SSLLTLDL 152 (1029)
Q Consensus 74 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L 152 (1029)
|+.|+|++|.++|.+|..++.+++|++|+|++|++++ .+|..++.+++|++|+|++|+++|.+|..++.+ .++..+++
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg-~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~ 522 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG-SIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCC-CCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEe
Confidence 9999999999999999989999999988888888886 568888888888888888888888888877654 45667777
Q ss_pred cCCcCc
Q 036879 153 SFNQLQ 158 (1029)
Q Consensus 153 s~N~l~ 158 (1029)
++|...
T Consensus 523 ~~N~~l 528 (623)
T PLN03150 523 TDNAGL 528 (623)
T ss_pred cCCccc
Confidence 777643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=157.83 Aligned_cols=130 Identities=23% Similarity=0.339 Sum_probs=105.3
Q ss_pred eeccCcceEEEEEEecCCcEEEEEEeecccc--------hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 745 LLGKGSFGSVYKGTLSDGMQIAVKVFNLELE--------GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 745 ~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.||+|+||.||+|.+ +|..|++|....... .....+.+|+++++.++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 678899998654311 11356778999999999887655555555566678999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
+|++|.+++..... .++.+++++++++| +.|++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988743211 78999999999999 78899999999999999 89999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.7e-16 Score=183.55 Aligned_cols=204 Identities=25% Similarity=0.309 Sum_probs=139.8
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..+|+.++.|..|+||.||.++++ ..+++|+|+=+... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee------------------
Confidence 467888999999999999999876 57788985422110 1110 23333444444
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC---
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET--- 892 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--- 892 (1029)
|+....+. .-+..+... +.+++|+| +.||+|||+||+|.+|+.-|++|+.|||+++...+..
T Consensus 136 ---gDc~tllk-~~g~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ---GDCATLLK-NIGPLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ---chhhhhcc-cCCCCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 34444332 222333222 67899999 8999999999999999999999999999987543211
Q ss_pred -----------CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhh
Q 036879 893 -----------SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKI 957 (1029)
Q Consensus 893 -----------~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 957 (1029)
.....+.+||+.|+|||++ |++.+|+|++|+++||.+.|+.||.+...++. +.+.+...
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~visd~----- 274 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDD----- 274 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhhhhhhh-----
Confidence 1112235799999999995 78899999999999999999999977422211 22211111
Q ss_pred hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCC
Q 036879 958 INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI 999 (1029)
Q Consensus 958 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 999 (1029)
.. +.+..+..+.++.+++.+.++.+|..|.
T Consensus 275 -------i~-----wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 275 -------IE-----WPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -------cc-----ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 10 1111234567889999999999999997
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.6e-15 Score=145.60 Aligned_cols=135 Identities=21% Similarity=0.268 Sum_probs=115.5
Q ss_pred CCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCC--CceEEEEEEEecCCeEEEEEeccCCC
Q 036879 742 ENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRH--RNLVKIISTCSSDHFKALVLEYMPNG 819 (1029)
Q Consensus 742 ~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~g 819 (1029)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| ..+++++++...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999754 7899999865533 4678899999999976 58999999988888899999999887
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 820 SLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 820 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
.+..+ +......++.+++++++++|..+..+++|||++|+||+++..+.++++|||.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 5567778899999999999966557899999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.6e-15 Score=166.09 Aligned_cols=169 Identities=25% Similarity=0.404 Sum_probs=124.2
Q ss_pred eEEEEEeccCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 808 FKALVLEYMPNGSLENWMYNK--NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
..|+.|++|+-.+|.+|+... ....++.....++.|++.|++| ++.+|||+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 568999999999999999543 3457788899999999999998 57999999999999999999999999998
Q ss_pred eecCCCC-----CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccch
Q 036879 886 KLLGDET-----SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHG 955 (1029)
Q Consensus 886 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 955 (1029)
....... ....+..+||..||+||.+ ++.|+||||+|++++|+++ -..+|+.. .
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------------~ 467 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------------A 467 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------------H
Confidence 7665443 2344567899999999984 7889999999999999998 23332211 0
Q ss_pred hhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHH
Q 036879 956 KIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005 (1029)
Q Consensus 956 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl 1005 (1029)
.+.++-|-.+... .... -+.-..++.+++.+.|.+||++.++.
T Consensus 468 t~~d~r~g~ip~~------~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 468 TLTDIRDGIIPPE------FLQD-YPEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhhhhhcCCCChH------Hhhc-CcHHHHHHHHhcCCCcccCchHHHHh
Confidence 0111111111100 0000 12235789999999999999655544
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.2e-14 Score=146.85 Aligned_cols=131 Identities=19% Similarity=0.226 Sum_probs=97.0
Q ss_pred CceeccCcceEEEEEEecCCcEEEEEEeecccchh--hHH----------------------HHHHHHHHhcCCCC--ce
Q 036879 743 NNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGT--LRS----------------------FDAECEILGSIRHR--NL 796 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~--ni 796 (1029)
.+.||+|+||+||+|...+|+.||||++....... ... ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987542111 111 13566666666433 24
Q ss_pred EEEEEEEecCCeEEEEEeccCCCC-----HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCEE
Q 036879 797 VKIISTCSSDHFKALVLEYMPNGS-----LENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP-TPIIHCDLNPSNIL 870 (1029)
Q Consensus 797 v~l~~~~~~~~~~~lV~E~~~~gs-----L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~givH~Dlk~~Nil 870 (1029)
.+.+++. ..++||||++++. +.+... . .....++.+++.++.++| . .+|+||||||+||+
T Consensus 82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~~------~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVRL------L-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNIL 147 (187)
T ss_pred CceEecC----CCEEEEEEeCCCCccChhhhhhhh------c-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEE
Confidence 4444432 3589999999854 333221 1 567789999999999999 5 78999999999999
Q ss_pred ECCCCcEEEEccCCceec
Q 036879 871 LNESMVACLSDFGISKLL 888 (1029)
Q Consensus 871 l~~~~~~kl~Dfg~a~~~ 888 (1029)
++ ++.++++|||.+...
T Consensus 148 i~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EE-CCcEEEEECcccccc
Confidence 99 999999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.8e-15 Score=178.66 Aligned_cols=253 Identities=24% Similarity=0.267 Sum_probs=193.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec--CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS--DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIR-HRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 811 (1029)
...|...+.||+|+|+.|-.+... ....+|+|.+.... .........|..+-+.+. |+|++++++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 445777788999999999888654 34456777665442 333455566888877776 9999999999999999999
Q ss_pred EEeccCCCCHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC-cEEEEccCCceecC
Q 036879 812 VLEYMPNGSLENWM-YNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM-VACLSDFGISKLLG 889 (1029)
Q Consensus 812 V~E~~~~gsL~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~ 889 (1029)
++||..++++.+-+ .......+......+..|+..++.|+|. ..++.|||+||+|.+++..+ ..+++|||+|..+.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999998877 4443367777888899999999999994 44699999999999999999 99999999998775
Q ss_pred C--CCCceeccccC-CccccCccCCC-----CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhh
Q 036879 890 D--ETSMTQTQTLA-TIGYMAPEWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 890 ~--~~~~~~~~~~g-t~~y~aPE~~~-----~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
. +.........| ++.|+|||... .+..|+||.|+++.-+++|..||+........+..|.....+..
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 251 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT----- 251 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc-----
Confidence 5 33334445667 99999999854 56799999999999999999999887666555444443321100
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
............++..+++..+|..|.+.+++...
T Consensus 252 -----------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 252 -----------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred -----------cCccccCChhhhhcccccccCCchhcccccccccc
Confidence 00111224456788889999999999998887653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.8e-14 Score=170.37 Aligned_cols=118 Identities=42% Similarity=0.743 Sum_probs=91.8
Q ss_pred cccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeecc
Q 036879 549 VVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLS 628 (1029)
Q Consensus 549 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 628 (1029)
.++.|+|++|.+++.+|..++.+++|+.|+|++|.|+|.+|..++.+++|+.|||++|++++.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36777888888888888888888888888888888887888778888888888888888888888888888888888888
Q ss_pred CCCCcCCCCCC--CCCCccCcccccCCCCCCCCCCCCCCCCC
Q 036879 629 FNGLQGQVPHG--GPFTNLSSQSFVGNKGLCGAPELKFPACK 668 (1029)
Q Consensus 629 ~N~l~~~~~~~--~~~~~l~~~~~~~n~~~c~~~~~~~~~~~ 668 (1029)
+|+++|.+|.. ..+..+..+.+.+|+++|+.|. .+.|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence 88888877753 1223445677899999999875 35775
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.9e-13 Score=144.27 Aligned_cols=135 Identities=17% Similarity=0.198 Sum_probs=104.4
Q ss_pred ceec-cCcceEEEEEEecCCcEEEEEEeeccc------c-------hhhHHHHHHHHHHhcCCCCce--EEEEEEEecC-
Q 036879 744 NLLG-KGSFGSVYKGTLSDGMQIAVKVFNLEL------E-------GTLRSFDAECEILGSIRHRNL--VKIISTCSSD- 806 (1029)
Q Consensus 744 ~~lg-~G~fg~V~~~~~~~~~~vAvK~~~~~~------~-------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~- 806 (1029)
..|| .|+.|+||.+... +..+|||.+.... . .....+.+|++++..++|+++ ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8999999998874 7789999885421 1 123467889999999998774 6777765432
Q ss_pred C---eEEEEEeccCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEcc
Q 036879 807 H---FKALVLEYMPN-GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDF 882 (1029)
Q Consensus 807 ~---~~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Df 882 (1029)
. ..++|||+++| .+|.+++.. ..++.. .+.+++++++++| +.||+||||||.|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 2 23599999997 699988743 234433 3578999999999 888999999999999999999999999
Q ss_pred CCceec
Q 036879 883 GISKLL 888 (1029)
Q Consensus 883 g~a~~~ 888 (1029)
|.+...
T Consensus 187 g~~~~~ 192 (239)
T PRK01723 187 DRGELR 192 (239)
T ss_pred CCcccC
Confidence 988753
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.5e-15 Score=162.18 Aligned_cols=173 Identities=30% Similarity=0.525 Sum_probs=97.7
Q ss_pred cCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeecc
Q 036879 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLG 508 (1029)
Q Consensus 429 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 508 (1029)
.-...||+.|++. .+|..++.+..|+.+.|.+|.+. .+|.+++++..|.+|||+
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-------------------------~ip~~i~~L~~lt~l~ls 129 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-------------------------TIPEAICNLEALTFLDLS 129 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-------------------------ecchhhhhhhHHHHhhhc
Confidence 3344555555555 45555555555555555555553 445555555555555555
Q ss_pred CccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccC
Q 036879 509 FNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI 588 (1029)
Q Consensus 509 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 588 (1029)
.|+++ ..|..++.++ |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+
T Consensus 130 ~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~l 204 (722)
T KOG0532|consen 130 SNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DL 204 (722)
T ss_pred cchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hC
Confidence 55554 3444444443 555556666665 45555565566666666666665 45555666666666666666665 34
Q ss_pred CccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcC
Q 036879 589 PDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 589 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 634 (1029)
|..+..| .|..||+|.|+++ .+|-.|.+|..|++|-|.+|+|+.
T Consensus 205 p~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 205 PEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred CHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence 5555533 3566666666665 556666666666666666666654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.7e-15 Score=162.81 Aligned_cols=147 Identities=31% Similarity=0.445 Sum_probs=76.9
Q ss_pred eEeccCcccccCCcccc--ccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEecc
Q 036879 76 LLNVTNNSFSGTLPIQL--SNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLS 153 (1029)
Q Consensus 76 ~L~l~~n~l~~~~p~~~--~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 153 (1029)
.|.|++-++. ..|..- ..+.--...||+.|++. ++|..++.+..|+.|.|+.|.+. .+|..++++..|++|||+
T Consensus 54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~--elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls 129 (722)
T KOG0532|consen 54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS--ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLS 129 (722)
T ss_pred ccccccchhh-cCCCccccccccchhhhhccccccc--cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhc
Confidence 4566666655 444221 23444445566666666 45566666666666666666655 566666666666666666
Q ss_pred CCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEc
Q 036879 154 FNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSL 233 (1029)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 233 (1029)
.|+++ .+|..+..|+ |+.|-+++|+++.+++++.... .|..||.+.|++. .+|..++++.+|+.|.+
T Consensus 130 ~NqlS-~lp~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~----------tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 130 SNQLS-HLPDGLCDLP-LKVLIVSNNKLTSLPEEIGLLP----------TLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred cchhh-cCChhhhcCc-ceeEEEecCccccCCcccccch----------hHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 66665 5565555554 5555555555554444333111 2333344444443 23444444444444444
Q ss_pred cccccc
Q 036879 234 SVNNFI 239 (1029)
Q Consensus 234 s~N~l~ 239 (1029)
+.|++.
T Consensus 197 rRn~l~ 202 (722)
T KOG0532|consen 197 RRNHLE 202 (722)
T ss_pred hhhhhh
Confidence 444443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.5e-13 Score=151.57 Aligned_cols=142 Identities=22% Similarity=0.292 Sum_probs=101.1
Q ss_pred CceeccCcceEEEEEEecCCcEEEEEEeecccchhh----------------------------------------HHHH
Q 036879 743 NNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL----------------------------------------RSFD 782 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~----------------------------------------~~~~ 782 (1029)
.+.||.|++|+||+|++.+|+.||||+.+....... -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999865421110 0244
Q ss_pred HHHHHHhcC----CCCceEEEEEEEe-cCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 036879 783 AECEILGSI----RHRNLVKIISTCS-SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVAS-ALEYLHYDHP 856 (1029)
Q Consensus 783 ~E~~~l~~l----~h~niv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~Lh~~~~ 856 (1029)
+|++.+.++ +|.+-+.+-..+. .....++||||++|+++.++........ .+..++.+++. .+..+| .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH---h
Confidence 566655555 3333344333332 2345689999999999988764322222 23456666665 467777 7
Q ss_pred CCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 857 ~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
.|++|+|++|.||+++.++.++++|||++..+..
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7899999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2e-12 Score=145.23 Aligned_cols=245 Identities=22% Similarity=0.192 Sum_probs=182.7
Q ss_pred CCCCCCceecc--CcceEEEEEEe--c-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeE
Q 036879 738 DGFSENNLLGK--GSFGSVYKGTL--S-DGMQIAVKVFNLELE--GTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 738 ~~~~~~~~lg~--G~fg~V~~~~~--~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 809 (1029)
..|.....+|. |.+|.||++.. . ++..+|+|.-+.... .....=.+|+...+.+ .|++.++.+..+.+.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566778999 99999999987 3 688899998554432 2233344566666666 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCcEEcCCCCCCEEECCC-CcEEEEccCC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVAS----ALEYLHYDHPTPIIHCDLNPSNILLNES-MVACLSDFGI 884 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~Lh~~~~~givH~Dlk~~Nill~~~-~~~kl~Dfg~ 884 (1029)
++-+|++ +.++.++.......++....+....+..+ |+.++| +..++|-|+||.||+...+ ...+++|||+
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence 9999999 58999998777777888889999999999 999999 6779999999999999999 8899999999
Q ss_pred ceecCCCCCce----eccccCCccccCccC---CCCCCcchhHHHHHHHHHhcCCCCCCcc-cccccccchhchhccchh
Q 036879 885 SKLLGDETSMT----QTQTLATIGYMAPEW---KLSRKGDVYSYGIILMETFTKKKPTDEL-FVGEISLKSRVNDSLHGK 956 (1029)
Q Consensus 885 a~~~~~~~~~~----~~~~~gt~~y~aPE~---~~~~~~DvwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~ 956 (1029)
...++...... .....|...|++||. .++..+|+|++|.++.+..++..++-.. ......+.++.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------- 342 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------- 342 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-------
Confidence 98887653111 111257778999998 5788999999999999999987654221 01111111110
Q ss_pred hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 957 IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 957 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
+ ..+..+....++...+..|++.+|-.|++++++...
T Consensus 343 -----i---------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 343 -----I---------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred -----C---------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 0 000111124455568899999999999999888753
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2e-12 Score=148.97 Aligned_cols=200 Identities=32% Similarity=0.492 Sum_probs=152.2
Q ss_pred eEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCC-ccceeccccccccCCCcccccCccccCeEeccC
Q 036879 76 LLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFP-KLEHLYLDGNSFIGTIPPSICNISSLLTLDLSF 154 (1029)
Q Consensus 76 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 154 (1029)
.|+++.|.+. .-+..+..++.++.|++.+|.++ .+|+..+.++ +|++|++++|++. .+|..++++++|+.|++++
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~--~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT--DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc--cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 5888888875 33445666788999999999998 4678778774 8999999999988 7778888999999999999
Q ss_pred CcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcc
Q 036879 155 NQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLS 234 (1029)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 234 (1029)
|+++ .+|...+.++.|+.|++++|+++.+++.... .+.|++|.+++|.+. .++..+..+.++..|.+.
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~----------~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~ 240 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIEL----------LSALEELDLSNNSII-ELLSSLSNLKNLSGLELS 240 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccccCchhhhh----------hhhhhhhhhcCCcce-ecchhhhhcccccccccC
Confidence 9998 7787777888999999999999876664321 134777888888533 467788889999999999
Q ss_pred cccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchh
Q 036879 235 VNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNI 311 (1029)
Q Consensus 235 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~ 311 (1029)
+|++. .++..++.+.++ +.|++++|+++.+.+ +..+.+|+.|++++|.+...+|...
T Consensus 241 ~n~~~-~~~~~~~~l~~l-----------------~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 241 NNKLE-DLPESIGNLSNL-----------------ETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred Cceee-eccchhcccccc-----------------ceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence 99876 335556555544 467777777774433 7788888888888888875555444
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=8.7e-11 Score=136.13 Aligned_cols=146 Identities=18% Similarity=0.212 Sum_probs=95.5
Q ss_pred CCCCCCceeccCcceEEEEEEecC-CcEEEEEEeecccchh----------------------------------hH---
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLSD-GMQIAVKVFNLELEGT----------------------------------LR--- 779 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vAvK~~~~~~~~~----------------------------------~~--- 779 (1029)
..|+. +.||+|++|+||+|++++ |+.||||+.+...... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999986 9999999997542110 01
Q ss_pred ---HHHHHHHHHhcC----CCCceEEEEEEEec-CCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHH
Q 036879 780 ---SFDAECEILGSI----RHRNLVKIISTCSS-DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVAS-ALEY 850 (1029)
Q Consensus 780 ---~~~~E~~~l~~l----~h~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~ 850 (1029)
.+.+|+..+.++ ++...+.+-..+.+ ....++||||++|+.+.++-.-.....+... ++...++ -+.-
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~Q 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFTQ 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHHH
Confidence 244455555444 24444555444433 3456799999999999875321122222111 1111111 1222
Q ss_pred HHhcCCCCcEEcCCCCCCEEECCCC----cEEEEccCCceecCC
Q 036879 851 LHYDHPTPIIHCDLNPSNILLNESM----VACLSDFGISKLLGD 890 (1029)
Q Consensus 851 Lh~~~~~givH~Dlk~~Nill~~~~----~~kl~Dfg~a~~~~~ 890 (1029)
+. ..|++|+|+||.||+++.++ .++++|||++..+..
T Consensus 276 if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 23 56899999999999999888 999999999976643
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.27 E-value=9.8e-13 Score=132.87 Aligned_cols=205 Identities=27% Similarity=0.247 Sum_probs=143.5
Q ss_pred cCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCC-CcccCcccccccccccc
Q 036879 424 IGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG-NELNGSLPQCLDSLISL 502 (1029)
Q Consensus 424 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L 502 (1029)
+.-+++|+.+.++.+.-.. +-+.-..-|.|+.+...+.-++... .+-....+....-+. .-..|..-..+...+.|
T Consensus 210 l~~f~~l~~~~~s~~~~~~-i~~~~~~kptl~t~~v~~s~~~~~~--~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~L 286 (490)
T KOG1259|consen 210 LNAFRNLKTLKFSALSTEN-IVDIELLKPTLQTICVHNTTIQDVP--SLLPETILADPSGSEPSTSNGSALVSADTWQEL 286 (490)
T ss_pred hHHhhhhheeeeeccchhh-eeceeecCchhheeeeecccccccc--cccchhhhcCccCCCCCccCCceEEecchHhhh
Confidence 3334556666666654331 1122223467788877776654221 111122222222111 11233344445566789
Q ss_pred ceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccc
Q 036879 503 RTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADN 582 (1029)
Q Consensus 503 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 582 (1029)
++||||+|.|+ .+.++..-++.++.|++|+|.|+.. ..+..+++|+.||||+|.++ .+.++-..+.+++.|.|++|
T Consensus 287 telDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N 362 (490)
T KOG1259|consen 287 TELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQN 362 (490)
T ss_pred hhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhh
Confidence 99999999998 4677888899999999999999843 34889999999999999998 66677778999999999999
Q ss_pred cccccCCccccCCCCCCEEeCcCCcccCcC-chhhhcccccceeeccCCCCcCCCC
Q 036879 583 KFQGSIPDSLGGLTSLNFLDMSSNNLSGEI-PNSLKALSLLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 583 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~ 637 (1029)
.|... ..+..+-+|..||+++|+|.... ...++++|-|+.+.|.+|++.+.+-
T Consensus 363 ~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 363 KIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 99732 45777889999999999998432 2467899999999999999997543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.5e-12 Score=147.05 Aligned_cols=181 Identities=41% Similarity=0.646 Sum_probs=102.3
Q ss_pred CcCcCcEEEecCccccccccccccCCC-CCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccce
Q 036879 426 NLNNLTTLHLETNELTGSIPKAIGRLQ-KLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRT 504 (1029)
Q Consensus 426 ~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 504 (1029)
.++.++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..++.+++|+.
T Consensus 114 ~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-------------------------~l~~~~~~l~~L~~ 167 (394)
T COG4886 114 ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-------------------------SLPSPLRNLPNLKN 167 (394)
T ss_pred cccceeEEecCCcccc-cCccccccchhhcccccccccchh-------------------------hhhhhhhccccccc
Confidence 3455666666666666 3444444443 5666666666654 22344555555555
Q ss_pred eeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccc
Q 036879 505 LSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKF 584 (1029)
Q Consensus 505 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 584 (1029)
|++++|+++. +|......++|+.|++++|+++ .+|........|+.|++++|++. ..+..+..+.++..|.+++|++
T Consensus 168 L~l~~N~l~~-l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~ 244 (394)
T COG4886 168 LDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL 244 (394)
T ss_pred cccCCchhhh-hhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCcee
Confidence 5555555553 2333335555666666666665 34444444455666666666433 3455566666666666666666
Q ss_pred cccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCC
Q 036879 585 QGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 585 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 638 (1029)
. ..+..++.++.|++|++++|.++...+ +..+.+++.|++++|.+....|.
T Consensus 245 ~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 245 E-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred e-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence 5 335556666666666666666663332 66666666666666666654443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.7e-11 Score=133.41 Aligned_cols=165 Identities=17% Similarity=0.187 Sum_probs=128.5
Q ss_pred ecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHH
Q 036879 759 LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRL 838 (1029)
Q Consensus 759 ~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~ 838 (1029)
..++.+|.|+..+...........+-++.++.++||+|+++++.+++.+..|+|+|.+. .|..++.+.. ...+.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 44788999988877655455667788899999999999999999999999999999985 5666765433 55667
Q ss_pred HHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccCCccccCccCCCCC--Cc
Q 036879 839 NMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR--KG 916 (1029)
Q Consensus 839 ~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~ 916 (1029)
..+.||+.||.|||. +.+++|++|.-.-|++++.|+.||++|.++........ .....+--..|..|+.+... ..
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~~s~ 184 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSEWSI 184 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccccch
Confidence 788999999999984 45799999999999999999999999998865432211 11112223346667654333 46
Q ss_pred chhHHHHHHHHHhcCC
Q 036879 917 DVYSYGIILMETFTKK 932 (1029)
Q Consensus 917 DvwSlGvil~elltg~ 932 (1029)
|.|.|||+++|++.|.
T Consensus 185 D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNGS 200 (690)
T ss_pred hhhhHHHHHHHHhCcc
Confidence 9999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.8e-11 Score=119.40 Aligned_cols=130 Identities=19% Similarity=0.151 Sum_probs=95.7
Q ss_pred CceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceE-EEEEEEecCCeEEEEEeccCCCCH
Q 036879 743 NNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLV-KIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
.+.++.|.++.||+++.. +..|++|....... ....+..|+++++.+.+.+++ +++++.. ...++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 356899999999999874 77899998764432 234567899999988655543 4555443 234799999999887
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 822 ENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH--PTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 822 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
.+. ......++.+++++++.||... ..+++|||++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 542 0112345678999999999433 22359999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.3e-12 Score=135.87 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=129.0
Q ss_pred CcccEEEccCCcccCC----CCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCccccccccc
Q 036879 267 QGLQVLALSSNRLTGV----IPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASML 342 (1029)
Q Consensus 267 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 342 (1029)
..++.++||+|.+... +...+.+.++|+..++| +-++|.+-..+...|.. +-..+-..++|
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~s-d~ftGR~~~Ei~e~L~~--------------l~~aL~~~~~L 94 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLS-DMFTGRLKDEIPEALKM--------------LSKALLGCPKL 94 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehH-hhhcCCcHHHHHHHHHH--------------HHHHHhcCCce
Confidence 3455666666666422 23334445566666665 23333333333221110 11233344456
Q ss_pred ceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceecccccccccccc
Q 036879 343 TLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPS 422 (1029)
Q Consensus 343 ~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~ 422 (1029)
+.+|||+|.|.-.-+..+. .-+..+.+|++|.|.+|.+. |..=..+...|..|. .+..
T Consensus 95 ~~ldLSDNA~G~~g~~~l~-----------~ll~s~~~L~eL~L~N~Glg---~~ag~~l~~al~~l~--~~kk------ 152 (382)
T KOG1909|consen 95 QKLDLSDNAFGPKGIRGLE-----------ELLSSCTDLEELYLNNCGLG---PEAGGRLGRALFELA--VNKK------ 152 (382)
T ss_pred eEeeccccccCccchHHHH-----------HHHHhccCHHHHhhhcCCCC---hhHHHHHHHHHHHHH--HHhc------
Confidence 6666666665432222211 12344566666666666543 332222333333333 1111
Q ss_pred ccCCcCcCcEEEecCcccccc----ccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCcccccccc
Q 036879 423 EIGNLNNLTTLHLETNELTGS----IPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDS 498 (1029)
Q Consensus 423 ~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 498 (1029)
...-+.|+++..++|++... +...|...+.|+.+.++.|.|..... ......|..
T Consensus 153 -~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~--------------------~al~eal~~ 211 (382)
T KOG1909|consen 153 -AASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGV--------------------TALAEALEH 211 (382)
T ss_pred -cCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchh--------------------HHHHHHHHh
Confidence 12235677777777776632 12335555666677776666642111 133456777
Q ss_pred ccccceeeccCccccCC----CCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccc-cCccc
Q 036879 499 LISLRTLSLGFNRLTSV----IPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSI-GDLKN 573 (1029)
Q Consensus 499 l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 573 (1029)
+++|+.|||.+|-++.. +...++.++.|+.|+++++.+......+|.. .+ ...++
T Consensus 212 ~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~--------------------al~~~~p~ 271 (382)
T KOG1909|consen 212 CPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVD--------------------ALKESAPS 271 (382)
T ss_pred CCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHH--------------------HHhccCCC
Confidence 77888888888877632 2334444555555555555554322222210 01 12455
Q ss_pred cccccccccccccc----CCccccCCCCCCEEeCcCCccc
Q 036879 574 MQHLSLADNKFQGS----IPDSLGGLTSLNFLDMSSNNLS 609 (1029)
Q Consensus 574 L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~ 609 (1029)
|+.|.|++|.|+.. +...+...+.|+.|+|++|++.
T Consensus 272 L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 272 LEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred CceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 66666666655531 2233444566777777777763
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.2e-11 Score=123.12 Aligned_cols=198 Identities=20% Similarity=0.265 Sum_probs=134.4
Q ss_pred HHhcCCCCceEEEEEEEecC-----CeEEEEEeccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 036879 787 ILGSIRHRNLVKIISTCSSD-----HFKALVLEYMPNGSLENWMYNK---NRSFDILQRLNMVIDVASALEYLHYDHPTP 858 (1029)
Q Consensus 787 ~l~~l~h~niv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~g 858 (1029)
-+-.+.|.|+|+++.|+.+. ....++.||+..|++.+++++. ..........+|+.||..||.|||.. +..
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 34556799999999998653 3567899999999999999753 34567778889999999999999976 578
Q ss_pred cEEcCCCCCCEEECCCCcEEEEccCCceecCCC---CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcC
Q 036879 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDE---TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTK 931 (1029)
Q Consensus 859 ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg 931 (1029)
|+|+++.-+-|++..+|-+|++--.-...-... .........+-++|.|||.- .+.++|||+||+...||..|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999999988522111100000 00011122366899999983 45689999999999999987
Q ss_pred CCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 932 KKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 932 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
..--... +..+ .+. ..+. .......+ ..=..++.+|++..|..||+|++++.+.
T Consensus 279 Eiq~tns---eS~~--~~e----e~ia----~~i~~len----------~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 279 EIQSTNS---ESKV--EVE----ENIA----NVIIGLEN----------GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eeccCCC---ccee--ehh----hhhh----hheeeccC----------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 6432111 0000 000 0010 01111110 0124578899999999999999998754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.6e-10 Score=111.71 Aligned_cols=136 Identities=16% Similarity=0.181 Sum_probs=98.4
Q ss_pred ceeccCcceEEEEEEecC-------CcEEEEEEeeccc----------------------chhhHH----HHHHHHHHhc
Q 036879 744 NLLGKGSFGSVYKGTLSD-------GMQIAVKVFNLEL----------------------EGTLRS----FDAECEILGS 790 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~-------~~~vAvK~~~~~~----------------------~~~~~~----~~~E~~~l~~ 790 (1029)
..||.|.=+.||.|...+ +..+|||+.+... ....+. ..+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999998653 4799999875310 011222 3489999999
Q ss_pred CC--CCceEEEEEEEecCCeEEEEEeccCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEEcCCCC
Q 036879 791 IR--HRNLVKIISTCSSDHFKALVLEYMPNGSLEN-WMYNKNRSFDILQRLNMVIDVASALEYL-HYDHPTPIIHCDLNP 866 (1029)
Q Consensus 791 l~--h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~L-h~~~~~givH~Dlk~ 866 (1029)
+. .-++.+.+++ ...++||||+.+..+.. .+. ....+..+...+..+++.++..+ | ..||||||+++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence 84 3466666664 34579999997654322 121 22344556677889999999999 7 67899999999
Q ss_pred CCEEECCCCcEEEEccCCceecC
Q 036879 867 SNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 867 ~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
.||+++ ++.++++|||.|....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 4689999999887553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.2e-11 Score=130.02 Aligned_cols=209 Identities=27% Similarity=0.345 Sum_probs=117.4
Q ss_pred ccccCCceeecccccccCCCCCCcCCCCCccceeccccccccC--CCcccccCccccCeEeccCCcCcccCCcc-ccCCC
Q 036879 93 SNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIG--TIPPSICNISSLLTLDLSFNQLQGHVPSS-ILNIP 169 (1029)
Q Consensus 93 ~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~ 169 (1029)
.++++|+...|.+..+.....-.....+++++.||||.|-|.. .+-.-..+|++|+.|+||.|++.-...+. -..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 4677888888888777643222356677888888888887763 12233456788888888888886222221 22456
Q ss_pred cCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcccccccCCCC--cccc
Q 036879 170 SLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIP--REIG 247 (1029)
Q Consensus 170 ~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~ 247 (1029)
+|+.|.|+.|.|+. ...+.+-+...+|..|+|..|.....-.....-+..|+.|||++|++.. .+ ...+
T Consensus 198 ~lK~L~l~~CGls~--------k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~ 268 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSW--------KDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVG 268 (505)
T ss_pred hhheEEeccCCCCH--------HHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccc
Confidence 77788888887762 1122223344566666776664322223334446667777777777652 22 1233
Q ss_pred ccccccceeecccccccccCcccEEEccCCcccCCC-CCC-----cccCCCCcEEEccCcccCCCCCc--hhhhcccccc
Q 036879 248 NITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVI-PPE-----IINISSLTVLSLTANNLLGNLPS--NIGHSLPNLQ 319 (1029)
Q Consensus 248 ~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~-p~~-----~~~l~~L~~L~Ls~N~l~~~lp~--~~~~~l~~L~ 319 (1029)
. +++|..|+++.+.|+.+- |+. ...+++|++|+++.|++. ..++ .+. .+++|+
T Consensus 269 ~-----------------l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~-~l~nlk 329 (505)
T KOG3207|consen 269 T-----------------LPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLR-TLENLK 329 (505)
T ss_pred c-----------------ccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhh-ccchhh
Confidence 3 344555666666665432 222 244566777777777663 2221 111 244555
Q ss_pred eEeecCcccC
Q 036879 320 QLILGGNRLT 329 (1029)
Q Consensus 320 ~L~L~~N~l~ 329 (1029)
.|....|.++
T Consensus 330 ~l~~~~n~ln 339 (505)
T KOG3207|consen 330 HLRITLNYLN 339 (505)
T ss_pred hhhccccccc
Confidence 5555555554
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.8e-12 Score=131.58 Aligned_cols=186 Identities=22% Similarity=0.256 Sum_probs=129.6
Q ss_pred ccCCCCCCEEEeccccccCcccccc----cCCCCCcEEecCCCcccCccccc-------------cccccccceeeccCc
Q 036879 448 IGRLQKLQGLYLQHNKLQGSITTDL----CGLRSLSEFYSDGNELNGSLPQC-------------LDSLISLRTLSLGFN 510 (1029)
Q Consensus 448 ~~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~~~~~~~-------------~~~l~~L~~L~Ls~N 510 (1029)
+...++|++|+||+|-+....+..| .....|++|+|.+|.+....... .+.-++|+++..++|
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN 167 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN 167 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence 3445566666777666654443333 34566777777777665332222 334578999999999
Q ss_pred cccCC----CCCCccCCCCCcEEEccCCcccC----cCCccccccccccEEEccCCcCCCC----CCccccCcccccccc
Q 036879 511 RLTSV----IPSSLWSLRDILNVNLSSNSLNG----TLPVEIGNLKVVTKIDLSRNDLSGE----IPSSIGDLKNMQHLS 578 (1029)
Q Consensus 511 ~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ 578 (1029)
++... ....|...+.|+.+.++.|.|.. .+...|..++.|+.|||.+|-++.. +...+..+++|+.|+
T Consensus 168 rlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~ 247 (382)
T KOG1909|consen 168 RLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELN 247 (382)
T ss_pred ccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeec
Confidence 98754 23356677889999999998873 1234577899999999999998843 234566688999999
Q ss_pred cccccccccCCcccc-----CCCCCCEEeCcCCcccCc----CchhhhcccccceeeccCCCCc
Q 036879 579 LADNKFQGSIPDSLG-----GLTSLNFLDMSSNNLSGE----IPNSLKALSLLKFLNLSFNGLQ 633 (1029)
Q Consensus 579 L~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~ 633 (1029)
++++.+......+|. ..++|+.|.|.+|.++.. +...+...+.|..|+|++|.+.
T Consensus 248 l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 248 LGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 999999865544432 358899999999999842 2233456788999999999884
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.1e-11 Score=139.21 Aligned_cols=215 Identities=29% Similarity=0.348 Sum_probs=155.1
Q ss_pred hcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCC
Q 036879 406 MDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485 (1029)
Q Consensus 406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 485 (1029)
++.+.++.|.|+. +-..+..+++|+.|++.+|+|.. +...+..+++|++|+|++|.|+.+ ..+..++.|+.|++.+
T Consensus 74 l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 74 LKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSG 149 (414)
T ss_pred HHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhheecc
Confidence 6666777777773 34456777888888888888883 444477788888888888888643 3445556688888888
Q ss_pred CcccCccccccccccccceeeccCccccCCCC-CCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCC
Q 036879 486 NELNGSLPQCLDSLISLRTLSLGFNRLTSVIP-SSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEI 564 (1029)
Q Consensus 486 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 564 (1029)
|.|... ..+..++.|+.+++++|+++.+.+ . ...+.+++.+++.+|.+. ....+..+..+..+++..|.++..-
T Consensus 150 N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~ 224 (414)
T KOG0531|consen 150 NLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLE 224 (414)
T ss_pred Ccchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceecc
Confidence 888632 445568889999999999886544 2 577888888899999887 3445566667777788888887332
Q ss_pred CccccCccc--ccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcC
Q 036879 565 PSSIGDLKN--MQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 565 p~~~~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 634 (1029)
+ +..+.. |+.+++++|++. ..+..+..+.++..|++++|++...- .+...+.+..+.+..|++..
T Consensus 225 ~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~ 291 (414)
T KOG0531|consen 225 G--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLAL 291 (414)
T ss_pred C--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcchhcc
Confidence 2 233333 889999999988 45466777888899999999887442 34556667777777777663
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.6e-10 Score=113.74 Aligned_cols=125 Identities=26% Similarity=0.379 Sum_probs=43.4
Q ss_pred cccccceeeccCccccCCCCCCcc-CCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccc-cCccccc
Q 036879 498 SLISLRTLSLGFNRLTSVIPSSLW-SLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSI-GDLKNMQ 575 (1029)
Q Consensus 498 ~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~ 575 (1029)
+..++++|+|++|+|+.+ +.+. .+.+|+.|+|++|.|+.. ..+..++.|+.|++++|+|+. ++..+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred cccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCC
Confidence 334567777777777643 2343 466777777777777742 246667777788888888774 33333 3577788
Q ss_pred ccccccccccccCC-ccccCCCCCCEEeCcCCcccCcCc---hhhhcccccceeec
Q 036879 576 HLSLADNKFQGSIP-DSLGGLTSLNFLDMSSNNLSGEIP---NSLKALSLLKFLNL 627 (1029)
Q Consensus 576 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~l 627 (1029)
.|+|++|+|....- ..+..+++|+.|+|.+|.++...- ..+..+|+|+.||-
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 88888887764321 345667888888888888874321 13456777777754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=7.4e-09 Score=110.48 Aligned_cols=270 Identities=14% Similarity=0.119 Sum_probs=168.8
Q ss_pred CCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEE-------ecCCeEEEEE
Q 036879 742 ENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTC-------SSDHFKALVL 813 (1029)
Q Consensus 742 ~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~-------~~~~~~~lV~ 813 (1029)
....+|+|+-+.+|..- +-...+.|+.+........ +.++.|... .||-+-.=+.+= ..+....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45679999999999642 1122356777655332222 223333333 566443312221 1233467888
Q ss_pred eccCCCC-HHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 814 EYMPNGS-LENWMY-----NKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 814 E~~~~gs-L~~~l~-----~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
..+.+.. ...+.. +......|...+++++.+|.+.+.|| ..|.+-+|+.++|+|+++++.+.+.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 8876542 222221 12234789999999999999999999 77899999999999999999999998654332
Q ss_pred cCCCCCceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcC-CCCCCcccccccccchhchhccchhh
Q 036879 888 LGDETSMTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTK-KKPTDELFVGEISLKSRVNDSLHGKI 957 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 957 (1029)
-. ........+|...|.+||.. .+...|-|.+||++++++.| ++||.+.......-...-..+-++.+
T Consensus 167 ~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 167 NA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred cc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 22 22233446788999999983 25579999999999999887 99997642211100000011112222
Q ss_pred hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHccccc--ccCCCCHHHHHHHHHHhHHhhcccccC
Q 036879 958 INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRES--AEERINIKEALTKLLKIRNTLLTNIEN 1021 (1029)
Q Consensus 958 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~Rpt~~evl~~L~~i~~~~~~~~~~ 1021 (1029)
...-|...--+..+........++++.-+..+|+... +.-|||++.++..|..+...+.+-+-+
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~ 310 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVS 310 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhc
Confidence 2222222111222222223445778888899998544 568999999999999999988654443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.5e-11 Score=127.68 Aligned_cols=110 Identities=23% Similarity=0.325 Sum_probs=48.1
Q ss_pred ccccceeeccCccccCC-CCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCC--ccccCccccc
Q 036879 499 LISLRTLSLGFNRLTSV-IPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIP--SSIGDLKNMQ 575 (1029)
Q Consensus 499 l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~ 575 (1029)
+++|+.|.|+.|.|+.. +......+++|+.|+|++|....+-......+..|+.|||++|++-. .+ ...+.++.|.
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLN 274 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchh
Confidence 34445555555544311 11123334555555555553222222333344455555555555442 22 2234455555
Q ss_pred cccccccccccc-CCcc-----ccCCCCCCEEeCcCCccc
Q 036879 576 HLSLADNKFQGS-IPDS-----LGGLTSLNFLDMSSNNLS 609 (1029)
Q Consensus 576 ~L~L~~N~l~~~-~~~~-----~~~l~~L~~L~Ls~N~l~ 609 (1029)
.|+++.+.+... +|+. ...+++|++|+++.|++.
T Consensus 275 ~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 275 QLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred hhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 555555555432 1221 122345555555555553
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.6e-10 Score=85.38 Aligned_cols=40 Identities=48% Similarity=0.980 Sum_probs=31.2
Q ss_pred hhHHHHHHHHHHhccCCCCCcccCCCCCC--CCCCceeeEEEc
Q 036879 4 GRDQSALLALKAHVTNDPLNVLASNWSTN--TSVCNWFGVTCS 44 (1029)
Q Consensus 4 ~~~~~al~~~~~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~ 44 (1029)
+.|++||++||+++..+|.+.+++ |+.+ .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~-W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSS-WNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT---TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCccccc-CCCcCCCCCeeeccEEeC
Confidence 579999999999998778888888 9877 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.4e-09 Score=114.75 Aligned_cols=142 Identities=17% Similarity=0.236 Sum_probs=110.8
Q ss_pred ceeccCcceEEEEEEecCCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCC--CceEEEEEEEecC---CeEEEEEeccC
Q 036879 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE-GTLRSFDAECEILGSIRH--RNLVKIISTCSSD---HFKALVLEYMP 817 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lV~E~~~ 817 (1029)
+.++.|.++.||++...+|..+++|....... .....+..|+++++.+++ ..+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999999765432 134578899999999965 3457777777654 35689999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 036879 818 NGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH------------------------------------------ 855 (1029)
Q Consensus 818 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~------------------------------------------ 855 (1029)
|.++.+.+.. ..++..+...++.++++++++||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888764421 35677778888889999999888421
Q ss_pred -----------CCCcEEcCCCCCCEEECC--CCcEEEEccCCcee
Q 036879 856 -----------PTPIIHCDLNPSNILLNE--SMVACLSDFGISKL 887 (1029)
Q Consensus 856 -----------~~givH~Dlk~~Nill~~--~~~~kl~Dfg~a~~ 887 (1029)
..+++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 356799999999999998 67789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.5e-09 Score=103.00 Aligned_cols=131 Identities=23% Similarity=0.312 Sum_probs=99.5
Q ss_pred ceeccCcceEEEEEEecCCcEEEEEEeeccc-c-------hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL-E-------GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~-~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..+++|+=+.+|.+.+. |.++++|.-.++. + -....-.+|++++.+++--.|...+=+..+.....+||||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999764 4446666432221 1 1234567899999998765655555555566667799999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
++|..|.+++... ...++..+-.-+.-|| ..||||+|+.++||+++.+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888554 3567777888889999 88899999999999998776 89999999974
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.02 E-value=5.6e-11 Score=120.33 Aligned_cols=130 Identities=25% Similarity=0.333 Sum_probs=86.0
Q ss_pred CCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEcc
Q 036879 477 SLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLS 556 (1029)
Q Consensus 477 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 556 (1029)
.|++++|++|.|+ .+.+...-+|.++.|++|+|.|+.+. .+..+++|+.||||+|.++. +-.+=..+.+++.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhHh-hhhhHhhhcCEeeeehh
Confidence 3344444444443 34445555677777777777776442 36667777777777777763 33444566777888888
Q ss_pred CCcCCCCCCccccCcccccccccccccccccC-CccccCCCCCCEEeCcCCcccCcC
Q 036879 557 RNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI-PDSLGGLTSLNFLDMSSNNLSGEI 612 (1029)
Q Consensus 557 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~ 612 (1029)
.|.|... ..++.+-+|..||+++|+|.... -..+++++-|+.|.|.+|.|.+.+
T Consensus 361 ~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 361 QNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 8887622 44667778888888888887321 256788888999999999988543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=8.3e-11 Score=135.69 Aligned_cols=201 Identities=26% Similarity=0.312 Sum_probs=106.0
Q ss_pred cCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccc-ccccccccc
Q 036879 424 IGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLP-QCLDSLISL 502 (1029)
Q Consensus 424 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L 502 (1029)
+..+++|++|+|++|+|+.+.+ +..++.|+.|++++|.|+.+ ..+..+.+|+.+++++|++....+ . ...+.+|
T Consensus 114 l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l 188 (414)
T KOG0531|consen 114 LSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISL 188 (414)
T ss_pred hhhhhcchheeccccccccccc--hhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccch
Confidence 3344455555555555543211 33444455555555555321 222334555555555555543333 2 3555566
Q ss_pred ceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccc--cccEEEccCCcCCCCCCccccCcccccccccc
Q 036879 503 RTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLK--VVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLA 580 (1029)
Q Consensus 503 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 580 (1029)
+.+++.+|.+..+ ..+..+..+..+++..|.++...+ +..+. .|+.+++++|++. ..+..+..+..+..|++.
T Consensus 189 ~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~ 263 (414)
T KOG0531|consen 189 EELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLS 263 (414)
T ss_pred HHHhccCCchhcc--cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchh
Confidence 6666666666532 333344444445666666653222 12222 3677777777776 333556667777777777
Q ss_pred cccccccCCccccCCCCCCEEeCcCCcccCc---Cchh-hhcccccceeeccCCCCcCCC
Q 036879 581 DNKFQGSIPDSLGGLTSLNFLDMSSNNLSGE---IPNS-LKALSLLKFLNLSFNGLQGQV 636 (1029)
Q Consensus 581 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~-~~~l~~L~~L~l~~N~l~~~~ 636 (1029)
+|++... ..+.....+..+.++.|.+... .... ....+.+..+.+.+|+.....
T Consensus 264 ~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
T KOG0531|consen 264 SNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKIS 321 (414)
T ss_pred hcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccc
Confidence 7777643 2344556677777777776521 1111 345566777777777776543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.7e-10 Score=127.22 Aligned_cols=247 Identities=21% Similarity=0.196 Sum_probs=170.1
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec--CCcEEEEEEeecccchhhHH--HHHHHHHHhcC-CCCceEEEEEEEecCCeE
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS--DGMQIAVKVFNLELEGTLRS--FDAECEILGSI-RHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vAvK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 809 (1029)
....+|..+..||.|.|+.|++.... ++..+|+|...........+ -..|+-+...+ .|.++++++..+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 35667888999999999999998643 67889999876554332222 23344444444 688999988888877788
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC-CcEEEEccCCceec
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES-MVACLSDFGISKLL 888 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~-~~~kl~Dfg~a~~~ 888 (1029)
|+--||+++++....+ .....+++..++++..|++.++.++| ++.++|+|+||+||++..+ +.-+++|||.+..+
T Consensus 342 ~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence 8999999999987765 33344777788999999999999999 8889999999999999876 88899999988643
Q ss_pred CCCCCceeccccCCccc-cCccC----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 889 GDETSMTQTQTLATIGY-MAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y-~aPE~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
...... ....+..| .+|+. .+..+.|+||||..+.|.++|..--.. +...+. +. .+.
T Consensus 418 ~~~~~~---~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~~~~~~--i~---~~~------- 479 (524)
T KOG0601|consen 418 AFSSGV---FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---GVQSLT--IR---SGD------- 479 (524)
T ss_pred ceeccc---ccccccccccchhhccccccccccccccccccccccccCcccCcc---ccccee--ee---ccc-------
Confidence 221111 11123333 23332 367799999999999999998653211 000000 00 000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
..........+..+.+.+..+++..||.+.+...+.+-..
T Consensus 480 ---------~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 480 ---------TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ---------ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0000111245677888888999999999998877665443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.2e-10 Score=110.15 Aligned_cols=82 Identities=27% Similarity=0.355 Sum_probs=15.2
Q ss_pred CcCcEEEecCcccccccccccc-CCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceee
Q 036879 428 NNLTTLHLETNELTGSIPKAIG-RLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLS 506 (1029)
Q Consensus 428 ~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 506 (1029)
.++++|+|++|+|+. +. .+. .+.+|+.|+|++|.|+.. ..+..+++|++|++++|+|+...+.....+++|++|+
T Consensus 19 ~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 19 VKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY 94 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc-cc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence 345555555555552 22 232 345555555555555422 1233344444444444444422221112345555555
Q ss_pred ccCcccc
Q 036879 507 LGFNRLT 513 (1029)
Q Consensus 507 Ls~N~l~ 513 (1029)
|++|+|.
T Consensus 95 L~~N~I~ 101 (175)
T PF14580_consen 95 LSNNKIS 101 (175)
T ss_dssp -TTS---
T ss_pred CcCCcCC
Confidence 5555554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.3e-08 Score=97.25 Aligned_cols=142 Identities=20% Similarity=0.288 Sum_probs=103.4
Q ss_pred CCceeccCcceEEEEEEecCCcEEEEEE-eecccc-------hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 742 ENNLLGKGSFGSVYKGTLSDGMQIAVKV-FNLELE-------GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 742 ~~~~lg~G~fg~V~~~~~~~~~~vAvK~-~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
....+-+|+=+.|+++.+ .|+.+.||. +.+.-+ -..+...+|++.+.+++--.|....-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567889999999999987 567767774 322211 12456788999998886545544444455555556999
Q ss_pred eccCC-CCHHHHHhcCCCCCCHHHH-HHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC---cEEEEccCCcee
Q 036879 814 EYMPN-GSLENWMYNKNRSFDILQR-LNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM---VACLSDFGISKL 887 (1029)
Q Consensus 814 E~~~~-gsL~~~l~~~~~~~~~~~~-~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~---~~kl~Dfg~a~~ 887 (1029)
||++| .++.+|+......-..... ...++.|-+.+.-|| ..+|||||+..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 4788888765443333333 788999999999999 66699999999999986443 458999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=8.5e-10 Score=130.18 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=165.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecc---cchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLE---LEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
..+.+.+.+-+-+|+++.++-++-. .|...+.|..... .....+....+-.+.-..+||-+++...-+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4566777788889999999987643 4444444433221 12223333334444444567888877766666778899
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
|++|..++++..-++... ..+..........+.++.+||| +..+.|||++|.|.++..++..++.|||.....+.-
T Consensus 882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence 999999999988775544 3444444455666788999999 666899999999999999999999999844322110
Q ss_pred ------------------------------CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCc
Q 036879 892 ------------------------------TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDE 937 (1029)
Q Consensus 892 ------------------------------~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~ 937 (1029)
.........+|+.|.|||.. .+..+|+|+.|++++|.++|.+||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 00112335689999999984 46679999999999999999999987
Q ss_pred ccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHH
Q 036879 938 LFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIK 1002 (1029)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 1002 (1029)
.....+. . .+....+ .....+...+..+.+++...+..+|.+|..|.
T Consensus 1038 ~tpq~~f-~------------ni~~~~~-----~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIF-E------------NILNRDI-----PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhhh-h------------ccccCCC-----CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 5433221 0 0111111 11222334456678888888888899888776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.4e-08 Score=99.12 Aligned_cols=126 Identities=21% Similarity=0.249 Sum_probs=81.8
Q ss_pred EEEEEEecCCcEEEEEEeeccc--------------c------------hhhHHHHHHHHHHhcCCCC--ceEEEEEEEe
Q 036879 753 SVYKGTLSDGMQIAVKVFNLEL--------------E------------GTLRSFDAECEILGSIRHR--NLVKIISTCS 804 (1029)
Q Consensus 753 ~V~~~~~~~~~~vAvK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 804 (1029)
.||.|...+|..+|||+.+... + .......+|++.|.++... ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999899999999875310 0 0123567899999999755 566666553
Q ss_pred cCCeEEEEEeccC--CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCcEEcCCCCCCEEECCCCcEEEEc
Q 036879 805 SDHFKALVLEYMP--NGSLENWMYNKNRSFDILQRLNMVIDVASALEY-LHYDHPTPIIHCDLNPSNILLNESMVACLSD 881 (1029)
Q Consensus 805 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-Lh~~~~~givH~Dlk~~Nill~~~~~~kl~D 881 (1029)
...+||||++ |..+....... ++......++.++...+.. +| ..||||||+.+.||+++++ .+.|+|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 2369999998 55554432211 1123445567777775544 56 7789999999999999988 999999
Q ss_pred cCCceecC
Q 036879 882 FGISKLLG 889 (1029)
Q Consensus 882 fg~a~~~~ 889 (1029)
||.|....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.6e-07 Score=100.34 Aligned_cols=140 Identities=14% Similarity=0.113 Sum_probs=99.6
Q ss_pred ceeccCcceEEEEEEecCCcEEEEEEeecccch-----------hhHHHHHHHHHHhcCCC--CceEEEEEEEec-----
Q 036879 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEG-----------TLRSFDAECEILGSIRH--RNLVKIISTCSS----- 805 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~h--~niv~l~~~~~~----- 805 (1029)
+.+-+.....|+++.. +|+.|.||........ ....+.+|.+.+.++.. -.+++.+++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455667655 6788999976433211 11147789988888842 233444555543
Q ss_pred CCeEEEEEeccCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC-------CCc
Q 036879 806 DHFKALVLEYMPNG-SLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-------SMV 876 (1029)
Q Consensus 806 ~~~~~lV~E~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-------~~~ 876 (1029)
....++|||++++. +|.+++... ....+......++.++++.+.-|| ..||+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23568999999876 899987532 234556677789999999999999 888999999999999975 578
Q ss_pred EEEEccCCcee
Q 036879 877 ACLSDFGISKL 887 (1029)
Q Consensus 877 ~kl~Dfg~a~~ 887 (1029)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998853
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.6e-09 Score=84.46 Aligned_cols=59 Identities=36% Similarity=0.621 Sum_probs=27.6
Q ss_pred cccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCc
Q 036879 549 VVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNN 607 (1029)
Q Consensus 549 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 607 (1029)
+|++|++++|+++...+..|.++++|+.|++++|+++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333444444444444444444444444444444444444444444
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.1e-08 Score=82.65 Aligned_cols=59 Identities=34% Similarity=0.511 Sum_probs=25.9
Q ss_pred ccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCc
Q 036879 501 SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRND 559 (1029)
Q Consensus 501 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 559 (1029)
+|++|++++|+|+.+.+..|.++++|++|++++|.++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444444444444444444444444444444333444444444444444443
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.6e-10 Score=128.43 Aligned_cols=130 Identities=32% Similarity=0.297 Sum_probs=96.9
Q ss_pred ccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccc
Q 036879 501 SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLA 580 (1029)
Q Consensus 501 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 580 (1029)
.|...+.++|+++ ....++.-++.|+.|||++|+++.. ..+..++.|++|||++|.++.+.--...++. |+.|+|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 5777788888887 4566777788888888888888743 2777888888888888888843323344444 8888999
Q ss_pred cccccccCCccccCCCCCCEEeCcCCcccCcCc-hhhhcccccceeeccCCCCcCCC
Q 036879 581 DNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIP-NSLKALSLLKFLNLSFNGLQGQV 636 (1029)
Q Consensus 581 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~ 636 (1029)
+|.++.. ..+.++++|+.|||++|-|.+.-. ..++.|..|+.|+|.||++.+.+
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 9988733 347788888899999998875432 34677888888999999987644
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.7e-08 Score=124.10 Aligned_cols=82 Identities=28% Similarity=0.330 Sum_probs=48.5
Q ss_pred ccEEEccCCcccCCCCCCcccCCCCcEEEccCcc--cCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceec
Q 036879 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANN--LLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLID 346 (1029)
Q Consensus 269 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 346 (1029)
.+...+-+|++. .++.... .++|++|-+..|. + ..++..+|..++.|+.|||++|.=-+.+|+.++++-+|++|+
T Consensus 525 ~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l-~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 525 VRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWL-LEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred eeEEEEeccchh-hccCCCC-CCccceEEEeecchhh-hhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 455566666655 2333322 2356677776665 3 366666666677777777777665556666666666666655
Q ss_pred CCCcccc
Q 036879 347 MPYNLFS 353 (1029)
Q Consensus 347 ls~N~l~ 353 (1029)
+++..++
T Consensus 602 L~~t~I~ 608 (889)
T KOG4658|consen 602 LSDTGIS 608 (889)
T ss_pred ccCCCcc
Confidence 5555554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.7e-07 Score=99.10 Aligned_cols=166 Identities=19% Similarity=0.255 Sum_probs=126.9
Q ss_pred ceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEec----CCeEEEEEeccCC-CCHHHH
Q 036879 751 FGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS----DHFKALVLEYMPN-GSLENW 824 (1029)
Q Consensus 751 fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~~~~-gsL~~~ 824 (1029)
-.+.||+... ||..|++|+++.........-..-++.++++.|+|||++.+++.. +....+||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3478899765 899999999965543333344456788999999999999998863 4567899999874 477765
Q ss_pred HhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 825 MYNK--------------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 825 l~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
-... +...++...|.++.|++.||.++| +.|..-+=+.+.+|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4322 223567889999999999999999 78899999999999999999999998887765544
Q ss_pred CCCceeccccCCccccCccCCCCCCcchhHHHHHHHHHhcCCC
Q 036879 891 ETSMTQTQTLATIGYMAPEWKLSRKGDVYSYGIILMETFTKKK 933 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~~~~~~DvwSlGvil~elltg~~ 933 (1029)
+.... +..-.+-|.=.||.+++.+.||..
T Consensus 446 d~~~~--------------le~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPTEP--------------LESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCcc--------------hhHHhhhhHHHHHHHHHHHhhccc
Confidence 32000 011236789999999999999964
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=7.9e-09 Score=127.01 Aligned_cols=128 Identities=21% Similarity=0.278 Sum_probs=81.7
Q ss_pred ceEEEecccccccccCCccCCCCcCCCeEeccCcc--cccCCccccccccCCceeecccccccCCCCCCcCCCCCcccee
Q 036879 49 RVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNS--FSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHL 126 (1029)
Q Consensus 49 ~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~--l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L 126 (1029)
+|....+-++.+. .++....+ +.|+.|-+..|. +....+..|..++.|++|||++|. +...+|..++.|-+|++|
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~-~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNS-SLSKLPSSIGELVHLRYL 600 (889)
T ss_pred heeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCC-ccCcCChHHhhhhhhhcc
Confidence 3444444444443 33333322 257777777775 442333346667777888887754 333677777777788888
Q ss_pred ccccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCc
Q 036879 127 YLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQ 180 (1029)
Q Consensus 127 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 180 (1029)
+|++..+. .+|..+++|..|.+|++..+.-...+|..+..|++|++|.+..-.
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 88877777 677777777788888877776554556666667777777765544
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.3e-09 Score=122.94 Aligned_cols=176 Identities=28% Similarity=0.317 Sum_probs=105.6
Q ss_pred ccccccceeeccCCcCCCCCCccccCchhhhcceeccccccc----------cccccccCCcCcCcEEEecCcccccccc
Q 036879 376 TNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIK----------GSIPSEIGNLNNLTTLHLETNELTGSIP 445 (1029)
Q Consensus 376 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~----------~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 445 (1029)
..+++|+.|.|.++.+.. ...+..+...|+.|-..+ .++ |.+...+. +..|...+.+.|.+. .+.
T Consensus 106 fpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~-Sl~Al~~v~ascggd~~ns~~-Wn~L~~a~fsyN~L~-~mD 180 (1096)
T KOG1859|consen 106 FPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHN-SLDALRHVFASCGGDISNSPV-WNKLATASFSYNRLV-LMD 180 (1096)
T ss_pred ccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhc-cHHHHHHHHHHhccccccchh-hhhHhhhhcchhhHH-hHH
Confidence 355667777777776653 222333333344443221 111 11111111 235666666666666 455
Q ss_pred ccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCC
Q 036879 446 KAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRD 525 (1029)
Q Consensus 446 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 525 (1029)
..+.-++.|+.|+|++|+++ .. +.+..+++|++|||++|.++.+.--...++.
T Consensus 181 ~SLqll~ale~LnLshNk~~------------------------~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~- 233 (1096)
T KOG1859|consen 181 ESLQLLPALESLNLSHNKFT------------------------KV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK- 233 (1096)
T ss_pred HHHHHHHHhhhhccchhhhh------------------------hh--HHHHhcccccccccccchhccccccchhhhh-
Confidence 55666666666666666664 12 3567778888888888888754333333444
Q ss_pred CcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCC-ccccCccccccccccccccc
Q 036879 526 ILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIP-SSIGDLKNMQHLSLADNKFQ 585 (1029)
Q Consensus 526 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 585 (1029)
|..|++.+|.++. -..+.++++|+.||+++|-|.+.-. ..++.|..|+.|+|.||++-
T Consensus 234 L~~L~lrnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 234 LQLLNLRNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred heeeeecccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 8888888888873 2456778888888888888774321 23566778888888888886
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.9e-07 Score=92.14 Aligned_cols=135 Identities=21% Similarity=0.210 Sum_probs=94.4
Q ss_pred CCCCceeccCcceEEEEEEecCCcEEEEEEeeccc----------------------chhhHHHHHHHHHHhcCCCC--c
Q 036879 740 FSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL----------------------EGTLRSFDAECEILGSIRHR--N 795 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n 795 (1029)
+.+.+.||.|.=|.||.|....|.++|||.=+... .-+....++|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 44568899999999999999999999999532110 01123567899999998654 5
Q ss_pred eEEEEEEEecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC
Q 036879 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM 875 (1029)
Q Consensus 796 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~ 875 (1029)
|.+.+++ +...+||||++|-.|...- ++....-.++..|.+-+.-.- ..||||+|+.+-||+++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence 6666554 3457999999886664321 122223333334444444443 45699999999999999999
Q ss_pred cEEEEccCCcee
Q 036879 876 VACLSDFGISKL 887 (1029)
Q Consensus 876 ~~kl~Dfg~a~~ 887 (1029)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.1e-09 Score=94.03 Aligned_cols=133 Identities=23% Similarity=0.355 Sum_probs=83.2
Q ss_pred ccceeeccCccccCCCCCC---ccCCCCCcEEEccCCcccCcCCccc-cccccccEEEccCCcCCCCCCccccCcccccc
Q 036879 501 SLRTLSLGFNRLTSVIPSS---LWSLRDILNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQH 576 (1029)
Q Consensus 501 ~L~~L~Ls~N~l~~~~~~~---~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 576 (1029)
.+..++|+.++|.. +++. +.....|+..+|++|.+.. .|..| ...+.++.|+|++|.|+ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred HhhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 45566677776642 3333 3334455666777777774 34433 34457777777777777 56777777777888
Q ss_pred cccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCC
Q 036879 577 LSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 577 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 638 (1029)
|+++.|+|. ..|..+..+.+|..||..+|.+. .+|..+-.-+.....++.+++|.+..+.
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 888888777 66777777777777777777776 4443333333334445566666655544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=8.2e-07 Score=102.61 Aligned_cols=141 Identities=21% Similarity=0.237 Sum_probs=95.6
Q ss_pred ceeccCcceEEEEEEecCCcEEEEEEeecccchh------------------------------hH----------HHHH
Q 036879 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGT------------------------------LR----------SFDA 783 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~------------------------------~~----------~~~~ 783 (1029)
+.|+.++-|+||+|++++|+.||||+.+...+.. .+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 7899999999999999999999999986432111 00 2445
Q ss_pred HHHHHhcC----CCCceEEEEEEEe-cCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHH-HHHHHhcCCC
Q 036879 784 ECEILGSI----RHRNLVKIISTCS-SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASA-LEYLHYDHPT 857 (1029)
Q Consensus 784 E~~~l~~l----~h~niv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~-l~~Lh~~~~~ 857 (1029)
|+..+.++ +...-+++-..|. -.....++|||++|..+.+...-+....+...+ +..++++ +..+- ..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~i---a~~~~~~f~~q~~---~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKEL---AELLVRAFLRQLL---RD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHH---HHHHHHHHHHHHH---hc
Confidence 66555555 2333333333333 245567999999999998875333344553333 3222222 22222 34
Q ss_pred CcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 858 givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
|+.|.|..|.||+++.+|.+.+.|||+...+.+
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 799999999999999999999999999887654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.9e-06 Score=89.17 Aligned_cols=106 Identities=24% Similarity=0.265 Sum_probs=82.2
Q ss_pred HHHHHHHHHHhcCC--CCceEEEEEEEecC----CeEEEEEeccCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 036879 779 RSFDAECEILGSIR--HRNLVKIISTCSSD----HFKALVLEYMPNG-SLENWMYNKNRSFDILQRLNMVIDVASALEYL 851 (1029)
Q Consensus 779 ~~~~~E~~~l~~l~--h~niv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L 851 (1029)
....+|.+.+..+. .=.+.+.+++.+.. ...++|+|++++. +|.+++..... .+......++.++++.++-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 45777888777774 33345566665542 2458999999874 79998865333 56667888999999999999
Q ss_pred HhcCCCCcEEcCCCCCCEEECCCC---cEEEEccCCceec
Q 036879 852 HYDHPTPIIHCDLNPSNILLNESM---VACLSDFGISKLL 888 (1029)
Q Consensus 852 h~~~~~givH~Dlk~~Nill~~~~---~~kl~Dfg~a~~~ 888 (1029)
| ..||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9 78899999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.8e-06 Score=82.84 Aligned_cols=138 Identities=18% Similarity=0.145 Sum_probs=100.7
Q ss_pred eccCcceEEEEEEecCCcEEEEEEeeccc------chhhHHHHHHHHHHhcCC--CCceEEEEEEEec----CCeEEEEE
Q 036879 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLEL------EGTLRSFDAECEILGSIR--HRNLVKIISTCSS----DHFKALVL 813 (1029)
Q Consensus 746 lg~G~fg~V~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~----~~~~~lV~ 813 (1029)
-|+||-+.|+..... |..+-+|.-.... ......|.+|...+.++. .-.+.+.+.+... .-..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467999999997764 4468888765221 123467999999998884 2235555522211 22457999
Q ss_pred eccCC-CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc--EEEEccCCcee
Q 036879 814 EYMPN-GSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV--ACLSDFGISKL 887 (1029)
Q Consensus 814 E~~~~-gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~--~kl~Dfg~a~~ 887 (1029)
|-+++ .+|.+++.+.. .+.+......+..++++.++-|| ..|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 58988885432 35677778899999999999999 888999999999999986666 99999986653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.3e-07 Score=106.24 Aligned_cols=147 Identities=18% Similarity=0.255 Sum_probs=97.7
Q ss_pred HHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceec--------cccCCccccCccCC-
Q 036879 841 VIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT--------QTLATIGYMAPEWK- 911 (1029)
Q Consensus 841 ~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~--------~~~gt~~y~aPE~~- 911 (1029)
+.+++.|+.|+|. +.++||++|.|++|.++..+..||+.|+++........+... .......|.|||++
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4455589999994 668999999999999999999999999988654332111111 11234579999994
Q ss_pred ---CCCCcchhHHHHHHHHHhcCCCC-CCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHH
Q 036879 912 ---LSRKGDVYSYGIILMETFTKKKP-TDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLA 987 (1029)
Q Consensus 912 ---~~~~~DvwSlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li 987 (1029)
.+.++|+||+||.+|.+..|..+ +.. ......+...... .+... .......+.++.+-+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~~~~~~~~---------~~~~~-------~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAA-NGGLLSYSFSRNL---------LNAGA-------FGYSNNLPSELRESL 245 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhc-cCCcchhhhhhcc---------ccccc-------ccccccCcHHHHHHH
Confidence 46789999999999999955444 332 1111111110000 00000 011134577889999
Q ss_pred HHcccccccCCCCHHHHHH
Q 036879 988 MQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 988 ~~cl~~dP~~Rpt~~evl~ 1006 (1029)
.+++..++..||++.++..
T Consensus 246 ~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHhcCCcccCcchhhhhc
Confidence 9999999999997777653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1029 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-48 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-48 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-35 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-30 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-30 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-23 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-20 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-20 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 7e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 527 bits (1360), Expect = e-174
Identities = 202/658 (30%), Positives = 303/658 (46%), Gaps = 52/658 (7%)
Query: 53 LNLAYMGLLGTIP-PELGNLSFLSLLNVTNNSFSGTLPIQL---SNLRRLKYLSFRSNNF 108
LN++ L L+ L +L+++ NS SG + LK+L+ N
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190
Query: 109 SSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNI 168
S ++ + LE L + N+F IP + + S+L LD+S N+L G +I
Sbjct: 191 SG-DVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTC 246
Query: 169 PSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLF-ECKQ 227
L +++S+NQF GP+P PL++ L L LA N+ +G+IP L C
Sbjct: 247 TELKLLNISSNQFVGPIPP----LPLKS-------LQYLSLAENKFTGEIPDFLSGACDT 295
Query: 228 LKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEI--------QGLQVLALSSNRL 279
L L LS N+F G++P G+ ++L+ L L N +GE+ +GL+VL LS N
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 355
Query: 280 TGVIPPEIINIS-SLTVLSLTANNLLGNLPSNIGHS-LPNLQQLILGGNRLTGPIPSSIS 337
+G +P + N+S SL L L++NN G + N+ + LQ+L L N TG IP ++S
Sbjct: 356 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415
Query: 338 NASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFL------------TSLTNCKDLRKLI 385
N S L + + +N SG IP+SLG +L L L K L LI
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLS---KLRDLKLWLNMLEGEIPQELMYVKTLETLI 472
Query: 386 LSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIP 445
L N L+G +P + N +N ++ + LS + G IP IG L NL L L N +G+IP
Sbjct: 473 LDFNDLTGEIPSGLSNCTN-LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531
Query: 446 KAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTL 505
+G + L L L N G+I + N + G + + +
Sbjct: 532 AELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI----AANFIAGKRYVYIKNDGMKKEC 587
Query: 506 SLGFN--RLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGE 563
N + L L N++S G N + +D+S N LSG
Sbjct: 588 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647
Query: 564 IPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLK 623
IP IG + + L+L N GSIPD +G L LN LD+SSN L G IP ++ AL++L
Sbjct: 648 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707
Query: 624 FLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPELKFPACKAKSNKIARKTDKN 681
++LS N L G +P G F F+ N GLCG P + A +++ +
Sbjct: 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRSHHH 765
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 465 bits (1198), Expect = e-150
Identities = 173/669 (25%), Positives = 282/669 (42%), Gaps = 91/669 (13%)
Query: 5 RDQSALLALKAHVTNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGL---L 61
R+ L++ K + + L +WS+N + C + GVTC +VT+++L+ L
Sbjct: 12 REIHQLISFKDVLPDKNL---LPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGF 66
Query: 62 GTIP-----------------------PELGNLSFLSLLNVTNNSFSGTLP--IQLSNLR 96
+ + L+ L+++ NS SG + L +
Sbjct: 67 SAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCS 126
Query: 97 RLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSIC---NISSLLTLDLS 153
LK+L+ SN LE L L NS G L L +S
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186
Query: 154 FNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQ 213
N++ G V + +L +D+S+N FS +P + + S +L L ++ N+
Sbjct: 187 GNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCS----------ALQHLDISGNK 234
Query: 214 LSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLA 273
LSG + C +LK+L++S N F+G IP ++ LQ L+
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPLP-------------------LKSLQYLS 275
Query: 274 LSSNRLTGVIPPEII-NISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPI 332
L+ N+ TG IP + +LT L L+ N+ G +P G L+ L L N +G +
Sbjct: 276 LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS-CSLLESLALSSNNFSGEL 334
Query: 333 P-SSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPL 391
P ++ L ++D+ +N FSG +P SL L L LS N
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNL--------------SASLLTLDLSSNNF 380
Query: 392 SGVLPISIGNLS-NAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGR 450
SG + ++ N + LYL G IP + N + L +LHL N L+G+IP ++G
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS 440
Query: 451 LQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFN 510
L KL+ L L N L+G I +L +++L D N+L G +P L + +L +SL N
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500
Query: 511 RLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGD 570
RLT IP + L ++ + LS+NS +G +P E+G+ + + +DL+ N +G IP+++
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 571 LKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSN--NLSGEIPNSLKALSLLKFLNLS 628
+A N G + + N G L LS N++
Sbjct: 561 QSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616
Query: 629 FNGLQGQVP 637
G
Sbjct: 617 SRVYGGHTS 625
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = 2e-95
Identities = 120/459 (26%), Positives = 195/459 (42%), Gaps = 54/459 (11%)
Query: 202 NSLAELHLAYNQLS---GQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLV 258
+ + + L+ L+ + S+L L+ L LS ++ GS+ L
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASL------ 102
Query: 259 YTNLTGEIQGLQVLALSSNRLTGVIPP--EIINISSLTVLSLTANNLLGNLPSNIGHSLP 316
L LS N L+G + + + S L L++++N L + G L
Sbjct: 103 -----------TSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLN 151
Query: 317 NLQQLILGGNRLTGPIPSSI---SNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLT 373
+L+ L L N ++G L + + N SG +
Sbjct: 152 SLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD---------------- 195
Query: 374 SLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTL 433
++ C +L L +S N S +P +G+ S + L +S + G I L L
Sbjct: 196 -VSRCVNLEFLDVSSNNFSTGIP-FLGDCSA-LQHLDISGNKLSGDFSRAISTCTELKLL 252
Query: 434 HLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCG-LRSLSEFYSDGNELNGSL 492
++ +N+ G IP L+ LQ L L NK G I L G +L+ GN G++
Sbjct: 253 NISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAV 310
Query: 493 PQCLDSLISLRTLSLGFNRLTSVIP-SSLWSLRDILNVNLSSNSLNGTLPVEIGNLKV-V 550
P S L +L+L N + +P +L +R + ++LS N +G LP + NL +
Sbjct: 311 PPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASL 370
Query: 551 TKIDLSRNDLSGEIPSSIGD--LKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNL 608
+DLS N+ SG I ++ +Q L L +N F G IP +L + L L +S N L
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430
Query: 609 SGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
SG IP+SL +LS L+ L L N L+G++P + +
Sbjct: 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE--LMYVKT 467
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 3e-65
Identities = 91/324 (28%), Positives = 148/324 (45%), Gaps = 24/324 (7%)
Query: 48 RRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNN 107
+ +L+L++ L GTIP LG+LS L L + N G +P +L ++ L+ L N+
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 108 FSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILN 167
+ EIP L + L + L N G IP I + +L L LS N G++P+ + +
Sbjct: 478 LTG-EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
Query: 168 IPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQ 227
SL+ +DL+ N F+G +P+ +A N ++G+ +
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQS-------------GKIAANFIAGKRYVYIKNDGM 583
Query: 228 LKILSLSVN--NFIGSIPREIGNITMLKGLYLVYTNLTGEI-------QGLQVLALSSNR 278
K + N F G ++ ++ + G + L +S N
Sbjct: 584 KKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNM 643
Query: 279 LTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISN 338
L+G IP EI ++ L +L+L N++ G++P +G L L L L N+L G IP ++S
Sbjct: 644 LSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVG-DLRGLNILDLSSNKLDGRIPQAMSA 702
Query: 339 ASMLTLIDMPYNLFSGFIPNSLGF 362
+MLT ID+ N SG IP F
Sbjct: 703 LTMLTEIDLSNNNLSGPIPEMGQF 726
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 328 bits (843), Expect = e-100
Identities = 129/656 (19%), Positives = 210/656 (32%), Gaps = 62/656 (9%)
Query: 48 RRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNN 107
+T LNL + L S L+ L+V N+ S P L LK L+ + N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 108 FSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILN 167
S + L L+L NS +L+TLDLS N L + +
Sbjct: 85 LSQL-SDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 168 IPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQ 227
+ +L + LSNN+ + SL +L L+ NQ+ P +
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANS-------SLKKLELSSNQIKEFSPGCFHAIGR 196
Query: 228 LKILSLSVNNFIGSIPREIG---NITMLKGLYLVYTNLTGEIQG---------LQVLALS 275
L L L+ S+ ++ T ++ L L + L+ L +L LS
Sbjct: 197 LFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLS 256
Query: 276 SNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGN--------- 326
N L V + L L NN+ ++ H L N++ L L +
Sbjct: 257 YNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL-HGLFNVRYLNLKRSFTKQSISLA 315
Query: 327 RLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLIL 386
L S L ++M N G N +L+ L L
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFT---------------GLINLKYLSL 360
Query: 387 SENPLSGVLPISIGNLSNAMD----VLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTG 442
S + S ++ + +L L+ I L +L L L NE+
Sbjct: 361 SNSFTSL-RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQ 419
Query: 443 SIP-KAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNG--SLPQCLDSL 499
+ + L+ + +YL +NK + SL L S P L
Sbjct: 420 ELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPL 479
Query: 500 ISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLN--------GTLPVEIGNLKVVT 551
+L L L N + ++ L L + ++L N+L G + L +
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 552 KIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGE 611
++L N DL ++ + L N SL L++ N ++
Sbjct: 540 ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSV 599
Query: 612 IPNSL-KALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPELKFPA 666
A L L++ FN F N +++ L P
Sbjct: 600 EKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 1e-86
Identities = 125/617 (20%), Positives = 215/617 (34%), Gaps = 62/617 (10%)
Query: 53 LNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIE 112
+ +++ L +P +L + +++LN+T+N + +L L N S +E
Sbjct: 9 ADCSHLKL-TQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65
Query: 113 IPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLL 172
P P L+ L L N + ++L L L N +Q + + +L+
Sbjct: 66 -PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLI 124
Query: 173 AIDLSNNQFSG-PMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTL--FECKQLK 229
+DLS+N S + + LQ EL L+ N++ L F LK
Sbjct: 125 TLDLSHNGLSSTKLGTQVQLENLQ----------ELLLSNNKIQALKSEELDIFANSSLK 174
Query: 230 ILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEI-- 287
L LS N P I L GL+ L++ +L + ++
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLFGLF-----------------LNNVQLGPSLTEKLCL 217
Query: 288 -INISSLTVLSLTANNLLGNLPSNIGH-SLPNLQQLILGGNRLTGPIPSSISNASMLTLI 345
+ +S+ LSL+ + L + NL L L N L S + L
Sbjct: 218 ELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYF 277
Query: 346 DMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNA 405
+ YN +SL L + L + K +S L + S L
Sbjct: 278 FLEYNNIQHLFSHSLH------GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKC- 330
Query: 406 MDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIG----RLQKLQGLYLQH 461
++ L + +I G + L NL L L + + L L L
Sbjct: 331 LEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTK 390
Query: 462 NKLQGSITTDLCGLRSLSEFYSDGNELNGSLP-QCLDSLISLRTLSLGFNRLTSVIPSSL 520
NK+ + L L NE+ L Q L ++ + L +N+ + +S
Sbjct: 391 NKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSF 450
Query: 521 WSLRDILNVNLSSNSLNG--TLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLS 578
+ + + L +L + P L+ +T +DLS N+++ + L+ ++ L
Sbjct: 451 ALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILD 510
Query: 579 LADNKFQGSIPDSLGGL--------TSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFN 630
L N + G + L+ L++ SN K L LK ++L N
Sbjct: 511 LQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLN 570
Query: 631 GLQGQVPHGGPFTNLSS 647
L F N S
Sbjct: 571 NLNT--LPASVFNNQVS 585
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 5e-43
Identities = 59/274 (21%), Positives = 104/274 (37%), Gaps = 13/274 (4%)
Query: 381 LRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNEL 440
S L+ V +L + VL L+ ++ + + LT+L + N +
Sbjct: 6 HEVADCSHLKLTQVPD----DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 441 TGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLI 500
+ P+ +L L+ L LQHN+L +L+E + N +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 501 SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVV--TKIDLSRN 558
+L TL L N L+S + L ++ + LS+N + E+ K++LS N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 559 DLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLG---GLTSLNFLDMSSNNLSGEIPNS 615
+ P + + L L + + S+ + L TS+ L +S++ LS +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 616 LKALSL--LKFLNLSFNGLQGQVPHGGPFTNLSS 647
L L L+LS+N L F L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGN--DSFAWLPQ 273
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 26/141 (18%), Positives = 50/141 (35%), Gaps = 5/141 (3%)
Query: 48 RRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNN 107
+ LNL G +L L ++++ N+ + +N LK L+ + N
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 108 FSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHV----PS 163
+S+E + +F L L + N F T ++ + + +L H P
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
Query: 164 SILNIPSLLAIDLSNNQFSGP 184
+ D S+ + S
Sbjct: 656 HYHGF-PVRLFDTSSCKDSAH 675
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = 2e-99
Identities = 87/634 (13%), Positives = 197/634 (31%), Gaps = 88/634 (13%)
Query: 24 VLASNWSTNTSVCNW---FGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVT 80
+NW+ N + W GV+ + + RVT L+L G G +P +G L+ L +L +
Sbjct: 55 QPGANWNFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALG 113
Query: 81 NNSFSG----TLPIQLSNLRRLKYLSFRSNNFSSIEIPP-WLDSFPKLEHLYLDGNSFIG 135
++ P +S + ++ + + F L ++ +
Sbjct: 114 SHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQK 173
Query: 136 TIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQ 195
+I S + N + V +++ + L + N+ F
Sbjct: 174 SIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENIC-------- 224
Query: 196 NIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGL 255
+ + Y Q K L + + + +P + + ++ +
Sbjct: 225 ------EAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI 278
Query: 256 YLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLL-GNLPSNIGHS 314
+ + + + ++ + NNL + +++
Sbjct: 279 NVACNRGIS---------GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK- 328
Query: 315 LPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTS 374
+ L L N+L G +P+ + L +++ YN + N G
Sbjct: 329 MKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCG------------- 374
Query: 375 LTNCKDLRKLILSENPLSGVLP-ISIGNLSNAMDVLYLSACNIKG-------SIPSEIGN 426
+ + L + N L + ++S M + S I +
Sbjct: 375 --FTEQVENLSFAHNKLKYIPNIFDAKSVSV-MSAIDFSYNEIGSVDGKNFDPLDPTPFK 431
Query: 427 LNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGN 486
N+++++L N+++ + L + L N L
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIP-----------------K 474
Query: 487 ELNGSLPQCLDSLISLRTLSLGFNRLTSVIPS-SLWSLRDILNVNLSSNSLNGTLPVEIG 545
+ + L ++ L FN+LT + +L ++ ++LS NS + P +
Sbjct: 475 NSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPL 533
Query: 546 NLKVVTKI------DLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLN 599
N + D N E P I ++ L + N + + + + +++
Sbjct: 534 NSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNIS 590
Query: 600 FLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQ 633
LD+ N + + L ++ Q
Sbjct: 591 VLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 2e-69
Identities = 73/507 (14%), Positives = 163/507 (32%), Gaps = 62/507 (12%)
Query: 53 LNLAYMGLLGTIPPELGNLSFLSL--LNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSS 110
M T F L + ++ ++ + + SNN +
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
Query: 111 IEIPPWLDSFPKLEHLYLDGN-------------------SFIGTIPPSICNISSLLTLD 151
+ + KL Y+ + T N+ L ++
Sbjct: 198 V--SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255
Query: 152 LSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAY 211
+ +P+ + +P + I+++ N+ + L + + + +++ Y
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK-IQIIYIGY 314
Query: 212 NQL-SGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTG---EIQ 267
N L + + ++L + K+L +L N G +P G+ L L L Y +T
Sbjct: 315 NNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFC 373
Query: 268 G----LQVLALSSNRLTGVIPP-EIINISSLTVLSLTANNL-------LGNLPSNIGHSL 315
G ++ L+ + N+L + + ++S ++ + + N + L
Sbjct: 374 GFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF-KG 432
Query: 316 PNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSL 375
N+ + L N+++ S S L+ I++ N+ + NSL +
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK--------DENENF 484
Query: 376 TNCKDLRKLILSENPLSGVLP-ISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLH 434
N L + L N L+ + L + + LS + P++ N + L
Sbjct: 485 KNTYLLTSIDLRFNKLTKLSDDFRATTLPY-LVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542
Query: 435 LET------NELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNEL 488
+ N P+ I L L + N ++ + + ++S N
Sbjct: 543 IRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPN 599
Query: 489 NGSLPQCLDSLISLRTLSLGFNRLTSV 515
+ I L +++ +
Sbjct: 600 ISIDLSYVCPYIEAGMYMLFYDKTQDI 626
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 7e-61
Identities = 60/397 (15%), Positives = 124/397 (31%), Gaps = 39/397 (9%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPN---LQQLILGG 325
+ L+L +G +P I ++ L VL+L ++ N + +Q
Sbjct: 83 VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR 142
Query: 326 NRLTGPIPSSISNASMLTLI--DMPYNLFSGFIPNSLGFCHPYDELGFLT--------SL 375
LI + + I S ++G L+ ++
Sbjct: 143 MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAV 202
Query: 376 TNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHL 435
LR+ + +P N + + NL +LT + +
Sbjct: 203 MRLTKLRQFYMGNSPFVAENICEAWENEN------SEYAQQYKTEDLKWDNLKDLTDVEV 256
Query: 436 ETNELTGSIPKAIGRLQKLQGLYLQHNKL--------QGSITTDLCGLRSLSEFYSDGNE 487
+P + L ++Q + + N+ D + Y N
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 488 L-NGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGN 546
L + L + L L +N+L +P + S + ++NL+ N + G
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGF 375
Query: 547 LKVVTKIDLSRNDLSGEIPS--SIGDLKNMQHLSLADNKFQG-------SIPDSLGGLTS 597
+ V + + N L IP+ + M + + N+ + + +
Sbjct: 376 TEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434
Query: 598 LNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQG 634
++ +++S+N +S S L +NL N L
Sbjct: 435 VSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-37
Identities = 30/270 (11%), Positives = 76/270 (28%), Gaps = 22/270 (8%)
Query: 392 SGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTG----SIPKA 447
+S+ + + L L G +P IG L L L L ++ PK
Sbjct: 70 GAQPGVSLNSNGR-VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKG 128
Query: 448 IGRLQKLQGLYLQHNKLQGSITTDLCGLR--SLSEFYSDGNELNGSLPQCLDSLISLRTL 505
I + Q + L + + + S+ + + +
Sbjct: 129 ISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188
Query: 506 SLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIP 565
N +T + ++ L + + ++ E + +
Sbjct: 189 GQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE-----NSEYAQQYKTED 242
Query: 566 SSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNL--------SGEIPNSLK 617
+LK++ + + + +P L L + ++++ N +
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302
Query: 618 ALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
++ + + +N L+ P +
Sbjct: 303 VGEKIQIIYIGYNNLKT-FPVETSLQKMKK 331
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-35
Identities = 31/248 (12%), Positives = 72/248 (29%), Gaps = 12/248 (4%)
Query: 412 SACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQG----S 467
+ + +T L LE +G +P AIG+L +L+ L L + +
Sbjct: 65 ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124
Query: 468 ITTDLCGLRSLSEFYSDGNELNGSLPQCLD--SLISLRTLSLGFNRLTSVIPSSLWSLRD 525
+ S + + L + + I S
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184
Query: 526 ILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQ 585
+ SN++ + + L + + + + E + + +
Sbjct: 185 DTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQY 238
Query: 586 GSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNL 645
+ L L +++ + ++P LKAL ++ +N++ N + L
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 646 SSQSFVGN 653
+
Sbjct: 299 ADAPVGEK 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 2e-85
Identities = 102/317 (32%), Positives = 147/317 (46%), Gaps = 17/317 (5%)
Query: 362 FCHPYDE---LGFLTSLTNCKDLR----KLILSENPLSGVLPISIGNLSNAMDVLYLSAC 414
C+P D+ L L N L GVL + ++ L LS
Sbjct: 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYR-VNNLDLSGL 60
Query: 415 NIKGS--IPSEIGNLNNLTTLHL-ETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
N+ IPS + NL L L++ N L G IP AI +L +L LY+ H + G+I
Sbjct: 61 NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
Query: 472 LCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNV-N 530
L +++L N L+G+LP + SL +L ++ NR++ IP S S +
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180
Query: 531 LSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPD 590
+S N L G +P NL + +DLSRN L G+ G KN Q + LA N +
Sbjct: 181 ISRNRLTGKIPPTFANLNLAF-VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG- 238
Query: 591 SLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSF 650
+G +LN LD+ +N + G +P L L L LN+SFN L G++P GG ++
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 651 VGNKGLCGAPELKFPAC 667
NK LCG+P PAC
Sbjct: 299 ANNKCLCGSP---LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 2e-72
Identities = 92/345 (26%), Positives = 151/345 (43%), Gaps = 56/345 (16%)
Query: 6 DQSALLALKAHVTNDPLNVLASNWSTNTSVCN--WFGVTCSPRHR--RVTALNLAYMGLL 61
D+ ALL +K + N S+W T CN W GV C + RV L+L+ + L
Sbjct: 7 DKQALLQIKKDLGNPTT---LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 62 GT--IPPELGNLSFLSLLNVTN-NSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLD 118
IP L NL +L+ L + N+ G +P ++ L
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL----------------------- 100
Query: 119 SFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSN 178
+L +LY+ + G IP + I +L+TLD S+N L G +P SI ++P+L+ I
Sbjct: 101 --TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 179 NQFSGPMP-SIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNN 237
N+ SG +P S + S L + ++ N+L+G+IP T L + LS N
Sbjct: 159 NRISGAIPDSYGSFSKLFTS---------MTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208
Query: 238 FIGSIPREIGNITMLKGLYLVYTNLTGEI------QGLQVLALSSNRLTGVIPPEIINIS 291
G G+ + ++L +L ++ + L L L +NR+ G +P + +
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268
Query: 292 SLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLT--GPIPS 334
L L+++ NNL G +P G +L N+ P+P+
Sbjct: 269 FLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-61
Identities = 79/329 (24%), Positives = 129/329 (39%), Gaps = 55/329 (16%)
Query: 149 TLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPM---PSIYNTSPLQNIDMQYNSLA 205
T D G + + + +DLS P S+ N L + +
Sbjct: 30 TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGG---- 85
Query: 206 ELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGE 265
N L G IP + + QL L ++ N G+IP + I L
Sbjct: 86 -----INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL------------- 127
Query: 266 IQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGG 325
L S N L+G +PP I ++ +L ++ N + G +P + G + +
Sbjct: 128 ----VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 326 NRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLI 385
NRLTG IP + +N + L +D+ N+ G G + K+ +K+
Sbjct: 184 NRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFG---------------SDKNTQKIH 227
Query: 386 LSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIP 445
L++N L+ L +G N ++ L L I G++P + L L +L++ N L G IP
Sbjct: 228 LAKNSLAFDLG-KVGLSKN-LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 446 KAIGRLQKLQGLYLQHNKLQGSITTDLCG 474
+ G LQ+ +NK LCG
Sbjct: 286 Q-GGNLQRFDVSAYANNKC-------LCG 306
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 4e-83
Identities = 101/594 (17%), Positives = 194/594 (32%), Gaps = 75/594 (12%)
Query: 50 VTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFS 109
L+L++ L + L +L+++ +L L L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 110 SIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQG-HVPSSILNI 168
S+ L+ L + I ++ +L L+++ N +Q +P N+
Sbjct: 90 SL-ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 169 PSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQL 228
+L +DLS+N+ + + L + + L L+ N ++ I F+ +L
Sbjct: 149 TNLEHLDLSSNKIQSIYCT--DLRVLHQMPLL---NLSLDLSLNPMNF-IQPGAFKEIRL 202
Query: 229 KILSLSVNNFIGSIPRE-IGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEI 287
L+L N ++ + I + L+ LV + L +
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR-----------NEGNLEKFDKSAL 251
Query: 288 INISSLTV--LSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLI 345
+ +LT+ L + + ++ + L N+ L +
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--------------- 296
Query: 346 DMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNA 405
+ + + L L + + +L
Sbjct: 297 --------------------------VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR- 329
Query: 406 MDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELT--GSIPKAIGRLQKLQGLYLQHNK 463
L+ + KG +L +L L L N L+ G ++ L+ L L N
Sbjct: 330 -----LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 464 LQGSITTDLCGLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSVIPSSLWS 522
+ ++++ GL L + L SL +L L +
Sbjct: 385 VIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443
Query: 523 LRDILNVNLSSNSLNGTL-PVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLAD 581
L + + ++ NS P L+ +T +DLS+ L P++ L ++Q L+++
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503
Query: 582 NKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKAL-SLLKFLNLSFNGLQG 634
N F L SL LD S N++ L+ S L FLNL+ N
Sbjct: 504 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 5e-72
Identities = 100/591 (16%), Positives = 177/591 (29%), Gaps = 93/591 (15%)
Query: 53 LNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIE 112
L L + LS L L + + + +L+ LK L+ N S +
Sbjct: 81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 113 IPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSL----LTLDLSFNQLQGHVPSSILNI 168
+P + + LEHL L N + + + L+LDLS N + +
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKE 199
Query: 169 PSLLAIDLSNNQFSGPMP--SIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECK 226
L + L NN S + I + L+ + L S L
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN----EGNLEKFDKSALEGLC 255
Query: 227 QLKILSLS---VNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQ-----GLQVLALSSNR 278
L I ++ ++ I +T + LV + G Q L L + +
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCK 315
Query: 279 LTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLT--GPIPSSI 336
++ ++ LT S N + LP+L+ L L N L+ G S
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEV------DLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 337 SNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLP 396
+ L +D+ +N N + L L + L +
Sbjct: 370 FGTTSLKYLDLSFNGVITMSSN----------------FLGLEQLEHLDFQHSNLKQMSE 413
Query: 397 ISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQG 456
S+ +L NL L + + L L+
Sbjct: 414 FSV------------------------FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 449
Query: 457 LYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVI 516
L + N Q + LP L +L L L +L +
Sbjct: 450 LKMAGNSFQENF-----------------------LPDIFTELRNLTFLDLSQCQLEQLS 486
Query: 517 PSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDL-KNMQ 575
P++ SL + +N+S N+ L + +D S N + + ++
Sbjct: 487 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 546
Query: 576 HLSLADNKFQGSIP--DSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKF 624
L+L N F + L + L + + P+ + + +L
Sbjct: 547 FLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 2e-64
Identities = 103/553 (18%), Positives = 183/553 (33%), Gaps = 83/553 (15%)
Query: 105 SNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSS 164
NF I P L ++L L N S + L LDLS ++Q +
Sbjct: 16 ELNFYKI--PDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 165 ILNIPSLLAIDLSNNQFSG-PMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLF 223
++ L + L+ N + + S LQ +L L+ +
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ----------KLVAVETNLASLENFPIG 121
Query: 224 ECKQLKILSLSVNNFIG-SIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGV 282
K LK L+++ N +P N+T L+ L LSSN++ +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLT-----------------NLEHLDLSSNKIQSI 164
Query: 283 IPPEIINISSLTVLSLT---ANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPS-SISN 338
++ + + +L+L+ + N + + + L +L L N + + I
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQG 223
Query: 339 ASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPIS 398
+ L + + F + + L L + E L+ +
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEK------------FDKSALEGLCNLTIEEFRLAYLD--- 268
Query: 399 IGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLY 458
I L N+++ L + + Q L
Sbjct: 269 ----------------YYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLE 310
Query: 459 LQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLT--SVI 516
L + K T L L+ L G L SL L L N L+
Sbjct: 311 LVNCKFGQFPTLKLKSLKRL-----TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC 365
Query: 517 PSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSI-GDLKNMQ 575
S + + ++LS N + T+ L+ + +D ++L S+ L+N+
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424
Query: 576 HLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEI-PNSLKALSLLKFLNLSFNGLQG 634
+L ++ + + GL+SL L M+ N+ P+ L L FL+LS L+
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 635 QVPHGGPFTNLSS 647
P F +LSS
Sbjct: 485 LSPT--AFNSLSS 495
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 7e-47
Identities = 64/416 (15%), Positives = 131/416 (31%), Gaps = 49/416 (11%)
Query: 49 RVTALNLAYMGLLGTIPPE-LGNLSFLSLLNVTNNSFSGTLPIQ------LSNLRRL--K 99
R+ L L + + L+ L + + F ++ L L L +
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 100 YLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQG 159
++ +I + + L + L+L +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQ 318
Query: 160 HVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIP 219
+ ++ L ++N+ S + L+ +D+ N L G
Sbjct: 319 FPTLKLKSLKRL---TFTSNKGGNA-FSEVDLPSLEFLDLSRNGL--------SFKGCCS 366
Query: 220 STLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEI--------QGLQV 271
+ F LK L LS N + ++ + L+ L ++NL + L
Sbjct: 367 QSDFGTTSLKYLDLS-FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 272 LALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGP 331
L +S +SSL VL + N+ N +I L NL L L +L
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 332 IPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPL 391
P++ ++ S L +++M +N F L+ L S N +
Sbjct: 486 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYK---------------CLNSLQVLDYSLNHI 530
Query: 392 SGVLPISIGNLSNAMDVLYLSACNIKGSIPSE--IGNLNNLTTLHLETNELTGSIP 445
+ + +++ L L+ + + + + + + L +E + + P
Sbjct: 531 MTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 586
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-46
Identities = 85/403 (21%), Positives = 144/403 (35%), Gaps = 42/403 (10%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
+ L LS N L + + L VL L+ + L +L LIL GN +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS-LSHLSTLILTGNPI 88
Query: 329 TGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE 388
+ S S L + + +G + K L++L ++
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIG---------------HLKTLKELNVAH 133
Query: 389 NPLSGV-LPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLT----TLHLETNELTGS 443
N + LP NL+N ++ L LS+ I+ +++ L+ + +L L N +
Sbjct: 134 NLIQSFKLPEYFSNLTN-LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192
Query: 444 IPKAIGRLQKLQGLYLQHNKLQGSITTD----LCGLRSLSEFYSDGNELNGSLPQCLDSL 499
P A + +L L L++N ++ L GL + +L
Sbjct: 193 QPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251
Query: 500 ISLRTLSLGFNRLTSV------IPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKI 553
L L++ RL + I L ++ + +L S ++ +
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHL 309
Query: 554 DLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS--GE 611
+L LK+++ L+ NK G S L SL FLD+S N LS G
Sbjct: 310 ELVNCKFGQFPTLK---LKSLKRLTFTSNK--GGNAFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 612 IPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNK 654
S + LK+L+LSFNG+ + L F +
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 407
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-39
Identities = 66/392 (16%), Positives = 126/392 (32%), Gaps = 54/392 (13%)
Query: 285 PEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTL 344
P + + ++T N +P N+ + + L L N L S + L +
Sbjct: 2 PCVEVVPNITYQ-CMELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQV 56
Query: 345 IDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSN 404
+D+ + + L LIL+ NP+ + + LS+
Sbjct: 57 LDLSRCEIQTIEDGAYQ---------------SLSHLSTLILTGNPIQSLALGAFSGLSS 101
Query: 405 AMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTG-SIPKAIGRLQKLQGLYLQHNK 463
+ L N+ IG+L L L++ N + +P+ L L+ L L NK
Sbjct: 102 -LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160
Query: 464 LQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSL 523
+Q TDL L + + +L L N + + P + +
Sbjct: 161 IQSIYCTDLRVLHQMP--------------------LLNLSLDLSLNPMNFIQPGAFKEI 200
Query: 524 RDILNVNLSSNSLNGTLP-VEIGNLKVVTKIDLSRNDLSGEI---PSSIGDLKNMQHLSL 579
R + + L +N + + I L + L + E L+ + +L++
Sbjct: 201 R-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 580 ADNK------FQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNS-LKALSLLKFLNLSFNGL 632
+ + + I D LT+++ + S + S L+ +N F
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF 319
Query: 633 QGQVPHGGPFTNLSSQSFVGNKGLCGAPELKF 664
+S P L+F
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEF 351
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-24
Identities = 39/205 (19%), Positives = 66/205 (32%), Gaps = 11/205 (5%)
Query: 51 TALNLAYMGLLGTIPPE-LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFS 109
L+ + L +L L L++++ + L L+ L N+F
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 110 SIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIP 169
+P L L L P + ++SSL L++S N +
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518
Query: 170 SLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFE--CKQ 227
SL +D S N P +SLA L+L N + F K
Sbjct: 519 SLQVLDYSLNHIMTSKKQELQHFP--------SSLAFLNLTQNDFACTCEHQSFLQWIKD 570
Query: 228 LKILSLSVNNFIGSIPREIGNITML 252
+ L + V + P + + +L
Sbjct: 571 QRQLLVEVERMECATPSDKQGMPVL 595
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-11
Identities = 29/132 (21%), Positives = 55/132 (41%), Gaps = 3/132 (2%)
Query: 48 RRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNN 107
R +T L+L+ L P +LS L +LN+++N+F L L+ L + N+
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 108 FSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPS--ICNISSLLTLDLSFNQLQGHVPSSI 165
+ + L L L N F T + I L + +++ PS
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
Query: 166 LNIPSLLAIDLS 177
+P +L+++++
Sbjct: 590 QGMP-VLSLNIT 600
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 2e-80
Identities = 101/674 (14%), Positives = 208/674 (30%), Gaps = 99/674 (14%)
Query: 5 RDQSALLALKAHVTNDPLN---------VLASNWSTNTSVCNWFGVTCS--PRHRRVTAL 53
+D AL A+ + + + NW+ N + W + RVT L
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328
Query: 54 NLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEI 113
+LA G G +P +G L+ L +L+ +S + + + R +
Sbjct: 329 SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK 388
Query: 114 PPWLDSFPKLEHLYLDGNSF-----IGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNI 168
+LD +L L ++ + I + N++ + +I +
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRL 447
Query: 169 PSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQL 228
L I +N+ F+ ++ + + Y + + K L
Sbjct: 448 TKLQIIYFANSPFTYDNIAV--------------DWEDANSDYAKQYENEELSWSNLKDL 493
Query: 229 KILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEII 288
+ L + +P + ++ L+ L + Q + +
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW--------TRLADDED 545
Query: 289 NISSLTVLSLTANNLLGNLPSNIG-HSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDM 347
+ + + N L P++ + L L N++ + LT + +
Sbjct: 546 TGPKIQIFYM-GYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKL 602
Query: 348 PYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLP-ISIGNLSNAM 406
YN IP + L S N L + + ++ M
Sbjct: 603 DYNQIEE-IPEDFC--------------AFTDQVEGLGFSHNKLKYIPNIFNAKSVYV-M 646
Query: 407 DVLYLSACNIKGSIPSEIG------NLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQ 460
+ S I GS I N +T+ L NE+ + + + L
Sbjct: 647 GSVDFSYNKI-GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILS 705
Query: 461 HNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPS-S 519
+N + S+ E + L T+ L FN+LTS+
Sbjct: 706 NNLMT-----------SIPE------NSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFR 748
Query: 520 LWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSR------NDLSGEIPSSIGDLKN 573
+L + N+++S N + + P + N + + N + + P+ I +
Sbjct: 749 ATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPS 807
Query: 574 MQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNL-SGEIPNSLKALSLLKFLNLSFNGL 632
+ L + N + + + L L LD++ N S ++ + + L ++
Sbjct: 808 LIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGM-YVLLYDKT 863
Query: 633 QGQVPHGGPFTNLS 646
Q G +
Sbjct: 864 QDIR--GCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-33
Identities = 42/271 (15%), Positives = 83/271 (30%), Gaps = 23/271 (8%)
Query: 392 SGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRL 451
+ + N + L L+ KG +P IG L L L T+ T S
Sbjct: 312 GDQPGVDLDNNGR-VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEE 370
Query: 452 QKLQGLYLQHNKLQGSITTD----LCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSL 507
+ ++++ L N P DS ISL+ +
Sbjct: 371 LTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQI 430
Query: 508 G--FNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIP 565
G NR+T I ++ L + + +++ + + +
Sbjct: 431 GNLTNRITF-ISKAIQRLTKLQIIYFANSPFTY-DNIAVDWED----ANSDYAKQYENEE 484
Query: 566 SSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSG---------EIPNSL 616
S +LK++ + L + +PD L L L L+++ N + +
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDE 544
Query: 617 KALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
++ + +N L+ P +
Sbjct: 545 DTGPKIQIFYMGYNNLEE-FPASASLQKMVK 574
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-12
Identities = 22/123 (17%), Positives = 41/123 (33%), Gaps = 2/123 (1%)
Query: 528 NVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGS 587
N N + V++ N VT + L+ G +P +IG L ++ LS + S
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 588 IPDSLGGLTSLNFLDMSSNNLSGEIPN-SLKALSLLKFLNLSFNGLQGQVPHGGPFTNLS 646
+ + + + + L L +L + + + P P S
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPEMKPIKKDS 421
Query: 647 SQS 649
S
Sbjct: 422 RIS 424
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 7e-79
Identities = 96/303 (31%), Positives = 151/303 (49%), Gaps = 21/303 (6%)
Query: 717 EEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEG 776
R+ +L AT+ F L+G G FG VYKG L DG ++A+K E
Sbjct: 18 SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ 77
Query: 777 TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDIL- 835
+ F+ E E L RH +LV +I C + L+ +YM NG+L+ +Y + +
Sbjct: 78 GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 836 --QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL--GDE 891
QRL + I A L YLH IIH D+ NILL+E+ V ++DFGISK D+
Sbjct: 138 WEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 892 TSMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDE-LFVGEISLK 946
T ++ T T+GY+ PE+ +L+ K DVYS+G++L E + + L ++L
Sbjct: 195 THLS-TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
Query: 947 SRVNDSLH-GKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
+S + G++ +VD NL D + + + A++C S+E+R ++ + L
Sbjct: 254 EWAVESHNNGQLEQIVDPNL---ADKI---RPESLRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 1006 TKL 1008
KL
Sbjct: 308 WKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 6e-78
Identities = 100/299 (33%), Positives = 154/299 (51%), Gaps = 21/299 (7%)
Query: 715 IDEEMSPEV---TWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFN 771
+ E PEV +R S +EL A+D FS N+LG+G FG VYKG L+DG +AVK
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK 63
Query: 772 LE-LEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNR 830
E +G F E E++ HRNL+++ C + + LV YM NGS+ + + +
Sbjct: 64 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 831 SFDIL---QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887
S L +R + + A L YLH IIH D+ +NILL+E A + DFG++KL
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 888 LGDETSMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGE- 942
+ + + T TIG++APE+ K S K DV+ YG++L+E T ++ D +
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 943 --ISLKSRVNDSL-HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEER 998
+ L V L K+ +VD++L ++ V ++ +A+ CT+ S ER
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYK------DEEVEQLIQVALLCTQSSPMER 296
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 1e-76
Identities = 116/582 (19%), Positives = 200/582 (34%), Gaps = 60/582 (10%)
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSF 120
L IP L + L + N S L L +L I S
Sbjct: 24 LNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH-EDTFQSQ 80
Query: 121 PKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQ 180
+L+ L L N I ++ +L L + + N +L ++ L +N
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 181 FSG-PMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVN-NF 238
S +P + T L+ L N + + +Q LSL++N N
Sbjct: 141 ISSIKLPKGFPTEKLK----------VLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190
Query: 239 IGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIIN--ISSLTVL 296
I I + + Q L + VI + N I SL +
Sbjct: 191 IAGIEPGAFDSAV-----------------FQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233
Query: 297 SLTANNLLGNLPSNI-GHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGF 355
+ + P+ G +++ + L + ++ S L +D+ S
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE- 292
Query: 356 IPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACN 415
+P+ L L+KL+LS N + IS N + + L +
Sbjct: 293 LPSGLV---------------GLSTLKKLVLSANKFENLCQISASNFPS-LTHLSIKGNT 336
Query: 416 IKGSIPSE-IGNLNNLTTLHLETNELTGS--IPKAIGRLQKLQGLYLQHNKLQGSITTDL 472
+ + + + NL NL L L +++ S + L LQ L L +N+ T
Sbjct: 337 KRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396
Query: 473 CGLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNL 531
L L Q +L L+ L+L + L L + ++NL
Sbjct: 397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456
Query: 532 SSNSLNGTLPVEIG---NLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI 588
N + L + + LS DLS + LK M H+ L+ N+ S
Sbjct: 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516
Query: 589 PDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFN 630
++L L + +L+++SN++S +P+ L LS + +NL N
Sbjct: 517 IEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 8e-68
Identities = 101/541 (18%), Positives = 190/541 (35%), Gaps = 47/541 (8%)
Query: 124 EHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSG 183
+ + + IP ++ +S L+ SFN L ++ + +L +DL+ Q
Sbjct: 15 KTYNCENLG-LNEIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 184 PMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIP 243
+ + L L L N L + L K LK L
Sbjct: 72 IHEDTFQSQH---------RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF 122
Query: 244 REIGNITMLKGLYLVYTNLTGEIQG-------LQVLALSSNRLTGVIPPEIINISSLTVL 296
+ N L+ LYL +++ L+VL +N + + ++ ++ T L
Sbjct: 123 IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL 182
Query: 297 SL-TANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASM--LTLIDMPYNLFS 353
SL N + + Q L GG + I + N+++ L L
Sbjct: 183 SLNLNGNDIAGIEPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241
Query: 354 GFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSA 413
P + + L ++ + + S + L L+A
Sbjct: 242 DISPAVFEGLCEMS-------------VESINLQKHYFFNISSNTFHCFSG-LQELDLTA 287
Query: 414 CNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD-L 472
++ +PS + L+ L L L N+ + L L ++ N + + T L
Sbjct: 288 THLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL 346
Query: 473 CGLRSLSEFYSDGNELNGS--LPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVN 530
L +L E +++ S L +L L++L+L +N S+ + + ++
Sbjct: 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLD 406
Query: 531 LSSNSLNGTLP-VEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI- 588
L+ L NL ++ ++LS + L L +QHL+L N F
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466
Query: 589 --PDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLS 646
+SL L L L +S +LS ++ +L ++ ++LS N L ++L
Sbjct: 467 QKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI--EALSHLK 524
Query: 647 S 647
Sbjct: 525 G 525
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-61
Identities = 101/541 (18%), Positives = 181/541 (33%), Gaps = 56/541 (10%)
Query: 53 LNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIE 112
L G+ L N L L + +N S + +LK L F++N +
Sbjct: 110 LFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169
Query: 113 IPPWLDSFPKLEHLYLDGNS-FIGTIPPSICNISSLLTLDLSFNQLQGHVPSSI--LNIP 169
+ S + +L L+ N I I P + + +L+ Q + + I
Sbjct: 170 -KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
Query: 170 SLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLK 229
SL + P+++ + S+ ++L + +T L+
Sbjct: 229 SLWLGTFEDMDDEDISPAVFE-------GLCEMSVESINLQKHYFFNISSNTFHCFSGLQ 281
Query: 230 ILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIIN 289
L L+ + +P + ++ L+ L LS+N+ + N
Sbjct: 282 ELDLT-ATHLSELPSGLVGLS-----------------TLKKLVLSANKFENLCQISASN 323
Query: 290 ISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLT--GPIPSSISNASMLTLIDM 347
SLT LS+ N L + +L NL++L L + + + N S L +++
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383
Query: 348 PYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISI-GNLSNAM 406
YN + C L L L+ L S NL +
Sbjct: 384 SYNEPLSLKTEAFK---------------ECPQLELLDLAFTRLKVKDAQSPFQNLHL-L 427
Query: 407 DVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIG---RLQKLQGLYLQHNK 463
VL LS + S L L L+L+ N + L +L+ L L
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487
Query: 464 LQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSL 523
L L+ ++ N L S + L L + L+L N ++ ++PS L L
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPIL 546
Query: 524 RDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNK 583
+NL N L+ T N+ + + L + + ++ + L+D
Sbjct: 547 SQQRTINLRQNPLDCT----CSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVT 602
Query: 584 F 584
Sbjct: 603 L 603
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 7e-51
Identities = 89/490 (18%), Positives = 165/490 (33%), Gaps = 48/490 (9%)
Query: 53 LNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIE 112
L L + P+ L +L+ NN+ +S+L++ LS N
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 113 IPPWLDSFPKLEHLYLDGNSFIGTIPPSI--CNISSLLTLDLSFNQLQGHVPSSILNIP- 169
I P + L G + I + I SL + P+ +
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 170 -SLLAIDLSNNQFSGPMP-SIYNTSPLQNIDMQYN-------------SLAELHLAYNQL 214
S+ +I+L + F + + S LQ +D+ +L +L L+ N+
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKF 313
Query: 215 SGQIPSTLFECKQLKILSLSVNNFIGSIPRE-IGNITMLKGLYLVYTNLT------GEIQ 267
+ L LS+ N + + N+ L+ L L + ++ +++
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
Query: 268 G---LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILG 324
LQ L LS N + L +L L L + +L L+ L L
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS 433
Query: 325 GNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKL 384
+ L L +++ N F SL L L
Sbjct: 434 HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTN------------SLQTLGRLEIL 481
Query: 385 ILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSI 444
+LS LS + + +L M+ + LS + S + +L + L+L +N ++ +
Sbjct: 482 VLSFCDLSSIDQHAFTSLKM-MNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIIL 539
Query: 445 PKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCL-DSLISLR 503
P + L + + + L+ N L + C E+Y + + L ++ LR
Sbjct: 540 PSLLPILSQQRTINLRQNPLDCT-----CSNIYFLEWYKENMQKLEDTEDTLCENPPLLR 594
Query: 504 TLSLGFNRLT 513
+ L L+
Sbjct: 595 GVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-22
Identities = 38/232 (16%), Positives = 68/232 (29%), Gaps = 29/232 (12%)
Query: 432 TLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGS 491
T + E L IP + + L N L T L +L
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINL------------- 59
Query: 492 LPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVT 551
L L ++ + + S + + L++N L + K +
Sbjct: 60 -----------TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALK 108
Query: 552 KIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGE 611
+ + +S + + K ++ L L N L LD +N +
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168
Query: 612 IPNSLKALSLLK--FLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPE 661
+ +L LNL+ N + G P S +F G + L +
Sbjct: 169 SKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFK 220
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 9e-69
Identities = 105/593 (17%), Positives = 174/593 (29%), Gaps = 83/593 (13%)
Query: 50 VTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFS 109
++L++ L N S L L+++ L L L N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 110 SIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQG-HVPSSILNI 168
S P LE+L I + +L L+++ N + +P+ N+
Sbjct: 94 SF-SPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 169 PSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQL 228
+L+ +DLS N + LQ + L ++ N + I F+ +L
Sbjct: 153 TNLVHVDLSYNYIQTITVND-----LQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKL 206
Query: 229 KILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEII 288
L+L N +I + + GL V L EI
Sbjct: 207 HELTLRGNFNSSNIMKTCLQ----------------NLAGLHVHRLILGEFKDERNLEIF 250
Query: 289 NIS--------SLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNAS 340
S ++ LT N + L N+ + L G + +
Sbjct: 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHC-LANVSAMSLAGVSIKYL--EDVPKHF 307
Query: 341 MLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIG 400
+ + F L F L+ L L+ N S +
Sbjct: 308 KWQSLSIIRCQLKQFPTLDLPF------------------LKSLTLTMNKGS--ISFKKV 347
Query: 401 NLSNAMDVLYLSACNIKGSIPS--EIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLY 458
L + + L LS + S N+L L L N + L++LQ L
Sbjct: 348 ALPS-LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLD 405
Query: 459 LQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPS 518
QH+ L+ SL L L + +
Sbjct: 406 FQHSTLKRVTE-----------------------FSAFLSLEKLLYLDISYTNTKIDFDG 442
Query: 519 SLWSLRDILNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHL 577
L + + ++ NS + N +T +DLS+ L L +Q L
Sbjct: 443 IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502
Query: 578 SLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFN 630
+++ N L SL+ LD S N + L F NL+ N
Sbjct: 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 7e-55
Identities = 88/522 (16%), Positives = 161/522 (30%), Gaps = 58/522 (11%)
Query: 53 LNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIE 112
L L + P L+ L L + + L LK L+ N S +
Sbjct: 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK 144
Query: 113 IPPWLDSFPKLEHLYLDGNSFIGTIPPSICNIS----SLLTLDLSFNQLQGHVPSSILNI 168
+P + + L H+ L N + + L+LD+S N + +
Sbjct: 145 LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQG 203
Query: 169 PSLLAIDLSNNQFSGPMP--SIYNTSPLQNIDMQYNSLA--------------------- 205
L + L N S + + N + L +
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263
Query: 206 -ELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTG 264
E L Y + +SL+ I + ++ + L ++ L
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLA-GVSIKYLE-DVPKHFKWQSLSIIRCQLKQ 321
Query: 265 ----EIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSL--PNL 318
++ L+ L L+ N+ + I + + + SL+ L L+ N L L +L
Sbjct: 322 FPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLS-RNALSFSGCCSYSDLGTNSL 378
Query: 319 QQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNC 378
+ L L N + ++ L +D ++ S +
Sbjct: 379 RHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSA--------------FLSL 423
Query: 379 KDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLET 437
+ L L +S L++ ++ L ++ + K + S + N NLT L L
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTS-LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482
Query: 438 NELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLD 497
+L L +LQ L + HN L ++ L SLS N + S
Sbjct: 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQH 542
Query: 498 SLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGT 539
SL +L N + I L+ + ++
Sbjct: 543 FPKSLAFFNLTNNSVAC-ICEHQKFLQWVKEQKQFLVNVEQM 583
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-39
Identities = 88/395 (22%), Positives = 143/395 (36%), Gaps = 44/395 (11%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
+ + LS N L + N S L L L+ + + H L +L LIL GN +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLS-RCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 329 TGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE 388
P S S + L + + +G L+KL ++
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIG---------------QLITLKKLNVAH 137
Query: 389 NPLSGV-LPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLT----TLHLETNELTGS 443
N + LP NL+N + + LS I+ +++ L +L + N +
Sbjct: 138 NFIHSCKLPAYFSNLTN-LVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-F 195
Query: 444 IPKAIGRLQKLQGLYLQHNKLQGSIT----TDLCGLRSLS---EFYSDGNELNGSLPQCL 496
I + KL L L+ N +I +L GL + D L P +
Sbjct: 196 IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255
Query: 497 DSLISLRT--LSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKID 554
+ L + L + S L ++ ++L+ S+ ++ +
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLS 313
Query: 555 LSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPN 614
+ R L + P+ DL ++ L+L NK GSI L SL++LD+S N LS
Sbjct: 314 IIRCQLK-QFPTL--DLPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCC 368
Query: 615 SLKALSL--LKFLNLSFNGLQGQVPHGGPFTNLSS 647
S L L+ L+LSFNG F L
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAII---MSANFMGLEE 400
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-21
Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 11/161 (6%)
Query: 490 GSLPQCLDSLISLRTLSLGFNRLTSV---IPSSLWSLRDILNVNLSSNSLNGTLPVEIGN 546
GSL C++ + ++ T +L+ V IPSS ++ +LS N L N
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLSKVPDDIPSSTKNI------DLSFNPLKILKSYSFSN 54
Query: 547 LKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSN 606
+ +DLSR ++ + L ++ +L L N Q P S GLTSL L
Sbjct: 55 FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114
Query: 607 NLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
L+ + L LK LN++ N + F+NL++
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLTN 154
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-65
Identities = 88/310 (28%), Positives = 143/310 (46%), Gaps = 48/310 (15%)
Query: 726 RRISYQELFRATDGFSE------NNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGT-- 777
S+ EL T+ F E N +G+G FG VYKG + + +AVK ++ T
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 778 --LRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSF--D 833
+ FD E +++ +H NLV+++ S LV YMPNGSL + + + +
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 834 ILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL--GDE 891
R + A+ + +LH + IH D+ +NILL+E+ A +SDFG+++ +
Sbjct: 132 WHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 892 TSMTQTQTLATIGYMAPEW---KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSR 948
T MT ++ + T YMAPE +++ K D+YS+G++L+E T D + R
Sbjct: 189 TVMT-SRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVD---------EHR 238
Query: 949 VNDSL----------HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEER 998
L I + +D + DA T+ E S+A QC E +R
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKM---NDADSTSVEAMY----SVASQCLHEKKNKR 291
Query: 999 INIKEALTKL 1008
+IK+ L
Sbjct: 292 PDIKKVQQLL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 4e-58
Identities = 69/315 (21%), Positives = 133/315 (42%), Gaps = 36/315 (11%)
Query: 728 ISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEI 787
+ + L+ + + +G FG V+K L +AVK+F ++ + +S+ E E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK---QSWQNEYEV 69
Query: 788 --LGSIRHRNLVKIISTCSSDHFKA----LVLEYMPNGSLENWMYNKNRSFDILQRLNMV 841
L ++H N+++ I L+ + GSL +++ K + ++
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIA 127
Query: 842 IDVASALEYLHYDHPT-------PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894
+A L YLH D P I H D+ N+LL ++ AC++DFG++ S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 895 TQTQTLA-TIGYMAPE---------WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEIS 944
T T YMAPE + D+Y+ G++L E ++ D V E
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP-VDEYM 246
Query: 945 LKSRVNDSLHGKIINVVDINLLQKEDAYL---TAKEQCVSSVLSLAMQCTRESAEERIN- 1000
L H + ++ ++ + +K+ L K ++ + +C AE R++
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 1001 --IKEALTKLLKIRN 1013
+ E +T++ ++ N
Sbjct: 307 GCVGERITQMQRLTN 321
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 7e-54
Identities = 71/295 (24%), Positives = 121/295 (41%), Gaps = 41/295 (13%)
Query: 728 ISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEI 787
I Y+E+ ++G+G+FG V K +A+K E E ++F E
Sbjct: 5 IDYKEIE-------VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQ 54
Query: 788 LGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNR--SFDILQRLNMVIDVA 845
L + H N+VK+ C + LV+EY GSL N ++ + ++ + +
Sbjct: 55 LSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 846 SALEYLHYDHPTPIIHCDLNPSNILLNESMVAC-LSDFGISKLLGDETSMTQTQTLATIG 904
+ YLH P +IH DL P N+LL + DFG + + T +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAA 168
Query: 905 YMAPE----WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960
+MAPE S K DV+S+GIIL E T++KP DE+ + V++ +I
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI-- 226
Query: 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015
+ + SL +C + +R +++E + + +
Sbjct: 227 ----------------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-52
Identities = 69/310 (22%), Positives = 127/310 (40%), Gaps = 50/310 (16%)
Query: 721 PEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVF-------NL 772
P+ ++ E+ +GKG FG V+KG + D +A+K
Sbjct: 9 PKSRLPTLADNEIE-------YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61
Query: 773 ELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSF 832
E+ + F E I+ ++ H N+VK+ + +V+E++P G L + + +K
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPI 119
Query: 833 DILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES-----MVACLSDFGISKL 887
+L +++D+A +EY+ +P PI+H DL NI L + A ++DFG+S+
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
Query: 888 LGDETSMTQTQTLATIGYMAPE------WKLSRKGDVYSYGIILMETFTKKKPTDELFVG 941
+ +MAPE + K D YS+ +IL T + P DE G
Sbjct: 179 S-VHSVSGLLGNFQ---WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234
Query: 942 EISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINI 1001
+I + + + E T E C + ++ C ++R +
Sbjct: 235 KIKFINMIRE-----------------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHF 277
Query: 1002 KEALTKLLKI 1011
+ +L ++
Sbjct: 278 SYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-52
Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 728 ISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNL----ELEGTLRSFDA 783
I + EL ++G G FG VY+ G ++AVK ++ T+ +
Sbjct: 4 IDFAELT-------LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 784 ECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVID 843
E ++ ++H N++ + C + LV+E+ G L + + +N +
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQ 113
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC--------LSDFGISKLLGDETSMT 895
+A + YLH + PIIH DL SNIL+ + + ++DFG+++ T M+
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS 173
Query: 896 QTQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFTKKKPTDEL 938
+MAPE S+ DV+SYG++L E T + P +
Sbjct: 174 AA---GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 4e-52
Identities = 72/304 (23%), Positives = 124/304 (40%), Gaps = 37/304 (12%)
Query: 728 ISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLE--LEGTLRSFDAEC 785
I + +L +G GSFG+V++ G +AVK+ + + F E
Sbjct: 34 IPWCDLN-------IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREV 85
Query: 786 EILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKN--RSFDILQRLNMVID 843
I+ +RH N+V + + ++V EY+ GSL ++ D +RL+M D
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATI 903
VA + YLH +P PI+H +L N+L+++ + DFG+S+L T ++ T
Sbjct: 146 VAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTP 203
Query: 904 GYMAPE----WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959
+MAPE + K DVYS+G+IL E T ++P L ++ +
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV-------------VAA 250
Query: 960 VVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNI 1019
V L V ++ C +R + + L + + +
Sbjct: 251 VGFKCKR------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
Query: 1020 ENSS 1023
S
Sbjct: 305 NRSD 308
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 9e-52
Identities = 102/545 (18%), Positives = 178/545 (32%), Gaps = 58/545 (10%)
Query: 98 LKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSIC-NISSLLTLDLSFNQ 156
K L N + SFP+L+ L L I TI ++S L TL L+ N
Sbjct: 30 TKNLDLSFNPLRHLG-SYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNP 87
Query: 157 LQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQL-S 215
+Q + + SL + + +L EL++A+N + S
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK---------TLKELNVAHNLIQS 138
Query: 216 GQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALS 275
++P L+ L LS +N I SI L L LS
Sbjct: 139 FKLPEYFSNLTNLEHLDLS-SNKIQSIYCT------------DLRVLHQMPLLNLSLDLS 185
Query: 276 SNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLIL------GGNRLT 329
N + I P L L+L N N+ L L+ L L
Sbjct: 186 LNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 330 GPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSEN 389
S++ LT+ + ++ + + ++ L
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIID------------LFNCLTNVSSFSLVSV 292
Query: 390 PLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIG 449
+ V S ++++ L +L L +N+ + +
Sbjct: 293 TIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNAFSEV-- 344
Query: 450 RLQKLQGLYLQHNKLQ--GSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSL 507
L L+ L L N L G + G SL N + ++ L L L
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 403
Query: 508 GFNRLTSVIPSSLW-SLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPS 566
+ L + S++ SLR+++ +++S L + + ++ N
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
Query: 567 SI-GDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFL 625
I +L+N+ L L+ + + P + L+SL L+M+SN L L+ L+ +
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI 523
Query: 626 NLSFN 630
L N
Sbjct: 524 WLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-51
Identities = 101/573 (17%), Positives = 191/573 (33%), Gaps = 74/573 (12%)
Query: 50 VTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFS 109
L+L++ L + L +L+++ +L L L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 110 SIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQ-GHVPSSILNI 168
S+ L+ L + I ++ +L L+++ N +Q +P N+
Sbjct: 90 SLA-LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 169 PSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQL 228
+L +DLS+N+ + L + + L L+ N ++ I F+ +L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTD--LRVLHQMPL---LNLSLDLSLNPMN-FIQPGAFKEIRL 202
Query: 229 KILSLSVNNFIGSIPRE-IGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEI 287
L+L N ++ + I + L+ LV + L +
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF-----------RNEGNLEKFDKSAL 251
Query: 288 INISSLTV--LSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASM--LT 343
+ +LT+ L + + ++ + L N+ L + + N L
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLE 310
Query: 344 LIDMPYNLFSGFIPNSLGFCH-PYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNL 402
L++ + F SL ++ G S + L L LS N LS
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS---------- 360
Query: 403 SNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHN 462
KG +L L L N + ++ L++L+ L QH+
Sbjct: 361 -------------FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 406
Query: 463 KLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWS 522
L+ +SEF SL +L L +
Sbjct: 407 NLK-----------QMSEFSV------------FLSLRNLIYLDISHTHTRVAFNGIFNG 443
Query: 523 LRDILNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLAD 581
L + + ++ NS +I L+ +T +DLS+ L P++ L ++Q L++A
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503
Query: 582 NKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPN 614
N+ + LTSL + + +N P
Sbjct: 504 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 56/270 (20%), Positives = 96/270 (35%), Gaps = 17/270 (6%)
Query: 401 NLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQ 460
NL + L LS ++ + L L L E+ A L L L L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 461 HNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSV-IPSS 519
N +Q GL SL + + L + L +L+ L++ N + S +P
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 520 LWSLRDILNVNLSSNSLNGTLPVEIGNLK----VVTKIDLSRNDLSGEIPSSIGDLKNMQ 575
+L ++ +++LSSN + ++ L + +DLS N ++ I +
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLH 203
Query: 576 HLSLADNKFQGSIPD-SLGGLTSLNFLD------MSSNNLSGEIPNSLKALSLLKFLNLS 628
L+L +N ++ + GL L + NL ++L+ L L
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 629 FNGLQGQVPHG----GPFTNLSSQSFVGNK 654
L + TN+SS S V
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-51
Identities = 80/329 (24%), Positives = 126/329 (38%), Gaps = 51/329 (15%)
Query: 728 ISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEI 787
+ E D L+G+G +G+VYKG+L D +AVKVF+ ++F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58
Query: 788 --LGSIRHRNLVKIISTC-----SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNM 840
+ + H N+ + I LV+EY PNGSL ++ + D + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRL 116
Query: 841 VIDVASALEYLHYDHPT------PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894
V L YLH + P I H DLN N+L+ +SDFG+S L +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 895 TQTQTLA-------TIGYMAPE-----------WKLSRKGDVYSYGIILMETFTKKKPTD 936
+ TI YMAPE ++ D+Y+ G+I E F +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD-- 234
Query: 937 ELFVGEISLKSRV--------NDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAM 988
LF GE + ++ + + + V K V S+
Sbjct: 235 -LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 989 QCTRESAEERIN---IKEALTKLLKIRNT 1014
C + AE R+ +E + +L+ I
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWER 322
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-51
Identities = 67/298 (22%), Positives = 113/298 (37%), Gaps = 46/298 (15%)
Query: 728 ISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAEC 785
I +++L + L + G ++KG G I VKV + R F+ EC
Sbjct: 7 IDFKQL-------NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 786 EILGSIRHRNLVKIISTCSSDHFK--ALVLEYMPNGSLENWMY-NKNRSFDILQRLNMVI 842
L H N++ ++ C S L+ +MP GSL N ++ N D Q + +
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 843 DVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT 902
D+A + +LH P I LN +++++E M A +S + S +
Sbjct: 119 DMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYA 171
Query: 903 IGYMAPE-------WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG 955
++APE R D++S+ ++L E T++ P +L EI +K
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK--------- 222
Query: 956 KIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013
V L T V L C E +R + L K+++
Sbjct: 223 ----VALEGLR------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-50
Identities = 126/638 (19%), Positives = 221/638 (34%), Gaps = 85/638 (13%)
Query: 42 TCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYL 101
+CS R + L +P L L L + N L +L+ L
Sbjct: 1 SCSFDGRIA---FYRFCNL-TQVPQVLNTTERLLL---SFNYIRTVTASSFPFLEQLQLL 53
Query: 102 SFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQLQGH 160
S + P L L L + I + P + L L L F L
Sbjct: 54 ELGSQYTPLTIDKEAFRNLPNLRILDLGSSK-IYFLHPDAFQGLFHLFELRLYFCGLSDA 112
Query: 161 V--PSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQI 218
V N+ +L +DLS NQ S+Y + NSL + + NQ+
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIR----SLYLHPSFGKL----NSLKSIDFSSNQIFLVC 164
Query: 219 PSTL--FECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSS 276
L + K L SL+ N+ + + G + N+ L++L +S
Sbjct: 165 EHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP------FRNMV-----LEILDVSG 213
Query: 277 NRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSI 336
N T I +N + + ++ G + + P ++
Sbjct: 214 NGWTVDITG-------------NFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTF 260
Query: 337 SNASMLTL--IDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGV 394
+ + ++ +D+ + KDL+ L L+ N ++ +
Sbjct: 261 AGLARSSVRHLDLSHGFVFSLNSR---------------VFETLKDLKVLNLAYNKINKI 305
Query: 395 LPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKL 454
+ L N + VL LS + S L + + L+ N + + L+KL
Sbjct: 306 ADEAFYGLDN-LQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL 364
Query: 455 QGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSL-ISLRTLSLGFNRLT 513
Q L L+ N L T + + S+ + + GN+L L + ++ + L NRL
Sbjct: 365 QTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-----TLPKINLTANLIHLSENRLE 414
Query: 514 SV-IPSSLWSLRDILNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRNDLSGEIPSSI--- 568
++ I L + + + L+ N + + + ++ L N L + +
Sbjct: 415 NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474
Query: 569 --GDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLN 626
L ++Q L L N P LT+L L ++SN L+ N L + L+ L+
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILD 532
Query: 627 LSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPELKF 664
+S N L P+ F +LS NK +C F
Sbjct: 533 ISRNQL--LAPNPDVFVSLSVLDITHNKFICECELSTF 568
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-50
Identities = 69/278 (24%), Positives = 122/278 (43%), Gaps = 34/278 (12%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTC 803
+G GSFG+VYKG +AVK+ N+ L++F E +L RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
++ A+V ++ SL + ++ F++ + +++ A ++YL H IIH D
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRD 145
Query: 864 LNPSNILLNESMVACLSDFGISKLLGD-ETSMTQTQTLATIGYMAPE-------WKLSRK 915
L +NI L+E + DFG++ S Q +I +MAPE S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 916 GDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTA 975
DVY++GI+L E T + P + + +II +V L +
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNI-------------NNRDQIIEMVGRGSLSPD--LSKV 250
Query: 976 KEQCVSSVLSLAMQCTRESAEER---INIKEALTKLLK 1010
+ C + L +C ++ +ER I + +L +
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-50
Identities = 69/299 (23%), Positives = 118/299 (39%), Gaps = 39/299 (13%)
Query: 746 LGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
LGKG FG K T G + +K E T R+F E +++ + H N++K I
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864
D + EY+ G+L + + + + QR++ D+AS + YLH + IIH DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDL 134
Query: 865 NPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA-------------TIGYMAPE-- 909
N N L+ E+ ++DFG+++L+ DE + + +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 910 --WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967
K DV+S+GI+L E + + + +D L
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDY------------------LPRTMDFGLNV 236
Query: 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIENSSDKR 1026
+ C S + ++C E+R + + L +R L ++
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLE 295
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-49
Identities = 68/297 (22%), Positives = 123/297 (41%), Gaps = 31/297 (10%)
Query: 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEI--LGSIRHRNLVKIIS 801
+GKG +G V+ G G ++AVKVF E S+ E EI +RH N++ I+
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIA 98
Query: 802 TCSSDHFK----ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
L+ +Y NGSL +++ K+ + D L + S L +LH + +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 858 -----PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPE 909
I H DL NIL+ ++ C++D G++ +T+ +G YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 910 ----------WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV-NDSLHGKII 958
++ D+YS+G+IL E + + ++ V +D + +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 959 NVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015
+V I L+ + ++C+ + L +C + R+ L K+ +
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 7e-49
Identities = 100/503 (19%), Positives = 167/503 (33%), Gaps = 64/503 (12%)
Query: 137 IPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMP----SIYNTS 192
I P + + L + L +P N+ S + +++ P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 193 PLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITML 252
+ D EL L LS +P L+ L S N + +P ++ L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPE---LPPHLESLVAS-CNSLTELPELPQSLKSL 116
Query: 253 KGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIG 312
L+ L+ L +S+N+L + PE+ N S L ++ + NN L LP
Sbjct: 117 LVDNNNLKALSDLPPLLEYLGVSNNQLEKL--PELQNSSFLKIIDVD-NNSLKKLPD--- 170
Query: 313 HSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCH----PYDE 368
P+L+ + G N+L + N LT I N +P+ +
Sbjct: 171 -LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLPDLPLSLESIVAGNNI 226
Query: 369 LGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLN 428
L L L N L + N L LP +L L + + +P +L
Sbjct: 227 LEELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA----LNVRDNYLT-DLPELPQSLT 280
Query: 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCG-LRSLSEFYSDGNE 487
L + L+ P L L N++ LC SL E N+
Sbjct: 281 FLDVSENIFSGLSELPP-------NLYYLNASSNEI-----RSLCDLPPSLEELNVSNNK 328
Query: 488 LNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNL 547
L LP L L FN L +P +L+ + ++ N L P ++
Sbjct: 329 LI-ELP---ALPPRLERLIASFNHLAE-VPELPQNLKQL---HVEYNPLR-EFPDIPESV 379
Query: 548 KVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNN 607
+ DL N E+P N++ L + N + PD + L M+S
Sbjct: 380 E-----DLRMNSHLAEVPELPQ---NLKQLHVETNPLR-EFPDIPESVED---LRMNSER 427
Query: 608 LSGEIPNSLKALSLLKFLNLSFN 630
+ + + L+ +
Sbjct: 428 VVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-41
Identities = 99/514 (19%), Positives = 178/514 (34%), Gaps = 100/514 (19%)
Query: 51 TALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSS 110
T A+ PP G +++ + + R+ L + SS
Sbjct: 37 TEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL-----------DRQAHELELNNLGLSS 85
Query: 111 IEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPS 170
+ + P LE L NS + +P ++ SLL + + L P
Sbjct: 86 LP-----ELPPHLESLVASCNS-LTELPELPQSLKSLLVDNNNLKALSD-------LPPL 132
Query: 171 LLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKI 230
L + +SNNQ +P + N+S L+ ID+ NSL +L P L+
Sbjct: 133 LEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKKL-----------PDLP---PSLEF 177
Query: 231 LSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT---GEIQGLQVLALSSNRLTGVIPPEI 287
++ NN + +P E+ N+ L +Y +L L+ + +N L PE+
Sbjct: 178 IAAG-NNQLEELP-ELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILE--ELPEL 233
Query: 288 INISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDM 347
N+ LT + NNLL LP P+L+ L + N LT +P + + L + +
Sbjct: 234 QNLPFLTTIYAD-NNLLKTLPD----LPPSLEALNVRDNYLTD-LPELPQSLTFLDVSEN 287
Query: 348 PYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMD 407
++ S PN L L S N + L +L
Sbjct: 288 IFSGLSELPPN----------------------LYYLNASSNEIR-SLCDLPPSLE---- 320
Query: 408 VLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGS 467
L +S + +P+ L L N L +P+ L++ L++++N L+
Sbjct: 321 ELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLKQ---LHVEYNPLR-E 371
Query: 468 ITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDIL 527
+ L +N L + + +L+ L + N L P S+
Sbjct: 372 FPDIPESVEDL--------RMNSHLAEVPELPQNLKQLHVETNPLRE-FPDIPESVE--- 419
Query: 528 NVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLS 561
++ ++S + + +
Sbjct: 420 DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-39
Identities = 89/436 (20%), Positives = 160/436 (36%), Gaps = 72/436 (16%)
Query: 198 DMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYL 257
++ L E + L+ ++P K + + + + P G + L
Sbjct: 7 NVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRL 65
Query: 258 VYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPN 317
L L++ L+ +P ++ SL + N L LP SL +
Sbjct: 66 RDCLDRQ----AHELELNNLGLS-SLPELPPHLESLVA----SCNSLTELPELPQ-SLKS 115
Query: 318 LQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTN 377
L L+ P L + + N +L L L N
Sbjct: 116 LLVDNNNLKALSDLPPL-------LEYLGVSNN-----------------QLEKLPELQN 151
Query: 378 CKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLET 437
L+ + + N L LP +L + ++ +P E+ NL LT ++ +
Sbjct: 152 SSFLKIIDVDNNSLK-KLPDLPPSLEF----IAAGNNQLE-ELP-ELQNLPFLTAIYADN 204
Query: 438 NELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLD 497
N L +P L+ + +N L +L L L+ Y+D N L +LP D
Sbjct: 205 NSLK-KLPDLPLSLESI---VAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLP---D 254
Query: 498 SLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSR 557
SL L++ N LT +P SL + ++S N + L NL ++ S
Sbjct: 255 LPPSLEALNVRDNYLTD-LPELPQSLTFL---DVSENIFS-GLSELPPNLY---YLNASS 306
Query: 558 NDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLK 617
N++ + +++ L++++NK +P L L S N+L+ E+P +
Sbjct: 307 NEIR-SLCDL---PPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQ 357
Query: 618 ALSLLKFLNLSFNGLQ 633
L K L++ +N L+
Sbjct: 358 NL---KQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-31
Identities = 65/356 (18%), Positives = 124/356 (34%), Gaps = 60/356 (16%)
Query: 283 IPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASML 342
I P ++ + L ++NL +P + + + + + P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNL-TEMPVEAEN-VKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 343 TLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNL 402
+ + L + +L L+ LS LP +L
Sbjct: 61 AVSRLRDCL--------------------------DRQAHELELNNLGLS-SLPELPPHL 93
Query: 403 SNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHN 462
+ L S ++ +P +L +L + L+ P L+ L + +N
Sbjct: 94 ES----LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNN 141
Query: 463 KLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWS 522
+L+ +L L D N L LP D SL ++ G N+L + L +
Sbjct: 142 QLEKL--PELQNSSFLKIIDVDNNSLK-KLP---DLPPSLEFIAAGNNQLEEL--PELQN 193
Query: 523 LRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADN 582
L + + +NSL LP +L+ I N L + +L + + +N
Sbjct: 194 LPFLTAIYADNNSLK-KLPDLPLSLE---SIVAGNNILE--ELPELQNLPFLTTIYADNN 247
Query: 583 KFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH 638
+ ++PD L +LN +N ++P ++L+ L F+GL P+
Sbjct: 248 LLK-TLPDLPPSLEALNV----RDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 298
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-22
Identities = 54/267 (20%), Positives = 104/267 (38%), Gaps = 30/267 (11%)
Query: 397 ISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQG 456
I+ N+SN L + +P E N+ + T + +E + P G +++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 457 LYLQHNKLQGSITTDLCG---------LRSLSEFYSDGNELNGSLPQCLDSLISLRTLSL 507
L+ + + +L L + N L LP+ SL SL +
Sbjct: 63 SRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNN 121
Query: 508 GFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSS 567
L+ +P L L +S+N L LP E+ N + ID+ N L ++P
Sbjct: 122 NLKALSD-LPPLLEYL------GVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDL 171
Query: 568 IGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNL 627
L + ++ +N+ + +P+ L L L + +N+L ++P+ + L+ +
Sbjct: 172 PPSL---EFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVA 222
Query: 628 SFNGLQGQVPHGGPFTNLSSQSFVGNK 654
N L+ ++P L++ N
Sbjct: 223 GNNILE-ELPELQNLPFLTTIYADNNL 248
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 8e-49
Identities = 62/297 (20%), Positives = 124/297 (41%), Gaps = 39/297 (13%)
Query: 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEI--LGSIRHRNLVKIIS 801
+GKG +G V++G+ G +AVK+F+ E +S+ E E+ +RH N++ I+
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 69
Query: 802 TCSSDHFKA----LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
+ + + L+ Y GSL +++ + + D + L +V+ +AS L +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 858 -----PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPE 909
I H DL NIL+ ++ C++D G++ + T+ +G YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 910 ----------WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEI--SLKSRVNDSLHGKI 957
+ ++ D++++G++L E + + + + S
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 958 INVVDINL---LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011
V + + ++S+ L +C ++ R+ L KI
Sbjct: 248 KVVCVDQQRPNIPNR----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-48
Identities = 67/339 (19%), Positives = 123/339 (36%), Gaps = 62/339 (18%)
Query: 699 LSVVLIRRQKRNTGLQIDEEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGT 758
LS R+ T + + E W I +++L L+GKG FG VY G
Sbjct: 9 LSARSFPRKASQTSIFLQE-------WD-IPFEQLE-------IGELIGKGRFGQVYHGR 53
Query: 759 LSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816
++A+++ ++E E L++F E RH N+V + C S A++
Sbjct: 54 WHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111
Query: 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV 876
+L + + + D+ + + ++ + YLH I+H DL N+ + V
Sbjct: 112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDNGKV 168
Query: 877 ACLSDFGISKLLGDETSMTQTQTLA----TIGYMAPE---WKL----------SRKGDVY 919
++DFG+ + G + + L + ++APE S+ DV+
Sbjct: 169 V-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227
Query: 920 SYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQC 979
+ G I E ++ P II + + ++
Sbjct: 228 ALGTIWYELHAREWPFKTQPAEA--------------IIWQMGTGMKP-----NLSQIGM 268
Query: 980 VSSVLSLAMQCTRESAEER---INIKEALTKLLKIRNTL 1015
+ + + C EER + + L KL K L
Sbjct: 269 GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-48
Identities = 108/525 (20%), Positives = 202/525 (38%), Gaps = 80/525 (15%)
Query: 68 LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLY 127
L+ + + + T+ ++L ++ L SI+ ++ L +
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG---VEYLNNLTQIN 74
Query: 128 LDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPS 187
N + I P + N++ L+ + ++ NQ+ + + N+ +L + L NNQ +
Sbjct: 75 FSNNQ-LTDITP-LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDI--- 127
Query: 188 IYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIG 247
PL+N +L L L+ N +S S L L+ LS N P +
Sbjct: 128 ----DPLKN----LTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LA 174
Query: 248 NITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNL 307
N+T L+ L +SSN+++ + +++L L T N +
Sbjct: 175 NLT-----------------TLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-- 213
Query: 308 PSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYD 367
+ +G L NL +L L GN+L ++++ + LT +D+ N S P
Sbjct: 214 ITPLGI-LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP---------- 260
Query: 368 ELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNL 427
L+ L +L L N +S + + L+ + L L+ ++ P I NL
Sbjct: 261 -------LSGLTKLTELKLGANQISNI--SPLAGLTA-LTNLELNENQLEDISP--ISNL 308
Query: 428 NNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNE 487
NLT L L N ++ P + L KLQ L+ +NK+ + L L +++ + N+
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQ 364
Query: 488 LNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNL 547
++ P L +L + L L T+ + ++ I N + P I +
Sbjct: 365 ISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS-IPNTVKNVTGAL-IAPATISDG 420
Query: 548 KVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSL 592
T+ D++ N L + F G++ L
Sbjct: 421 GSYTEPDITWN-LPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-46
Identities = 104/550 (18%), Positives = 195/550 (35%), Gaps = 84/550 (15%)
Query: 69 GNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYL 128
G L ++ + + + L N + ++ L
Sbjct: 1 GPLGSATITQ--DTPINQIFT--DTALAEKMKTVLGKTNVTDT---VSQTDLDQVTTLQA 53
Query: 129 DGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSI 188
D + +++L ++ S NQL + + N+ L+ I ++NNQ +
Sbjct: 54 DRLGI--KSIDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADI---- 105
Query: 189 YNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGN 248
+PL N+ +L L L NQ++ L L L LS +N I I +
Sbjct: 106 ---TPLANL----TNLTGLTLFNNQITD--IDPLKNLTNLNRLELS-SNTISDIS-ALSG 154
Query: 249 ITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLP 308
+T L+ L N++T + P + N+++L L +++N +
Sbjct: 155 LTSLQQLSF------------------GNQVTDLKP--LANLTTLERLDISSNKVSD--I 192
Query: 309 SNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDE 368
S + L NL+ LI N+++ P + + L + + N
Sbjct: 193 SVLAK-LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-------------- 235
Query: 369 LGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLN 428
+ +L + +L L L+ N +S + + L+ + L L A I P + L
Sbjct: 236 ---IGTLASLTNLTDLDLANNQISNL--APLSGLTK-LTELKLGANQISNISP--LAGLT 287
Query: 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNEL 488
LT L L N+L P I L+ L L L N + + L L + N++
Sbjct: 288 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFYNNKV 343
Query: 489 NGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLK 548
+ L +L ++ LS G N+++ + P L +L I + L+ + PV
Sbjct: 344 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNYKANV 398
Query: 549 VVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNL 608
+ + P++I D + + N + + + +
Sbjct: 399 SIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTF 456
Query: 609 SGEIPNSLKA 618
SG + LKA
Sbjct: 457 SGTVTQPLKA 466
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-45
Identities = 94/516 (18%), Positives = 193/516 (37%), Gaps = 89/516 (17%)
Query: 123 LEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFS 182
L + ++ I I ++ + L + S ++ + +
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK 59
Query: 183 GPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSI 242
++ + N+L +++ + NQL+ P L +L + ++ N
Sbjct: 60 SI-------DGVEYL----NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT 106
Query: 243 PREIGNITMLKGLYLVYTNLT-----GEIQGLQVLALSSNRLTGVIPPEIINISSLTVLS 297
P + N+T L GL L +T + L L LSSN ++ + + ++SL LS
Sbjct: 107 P--LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLS 162
Query: 298 LTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIP 357
N + + + L L++L + N+++
Sbjct: 163 F-GNQVTD--LKPLAN-LTTLERLDISSNKVSD--------------------------- 191
Query: 358 NSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIK 417
++ L +L LI + N +S + +G L+N +D L L+ +K
Sbjct: 192 --------------ISVLAKLTNLESLIATNNQISDI--TPLGILTN-LDELSLNGNQLK 234
Query: 418 GSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRS 477
+ +L NLT L L N+++ P + L KL L L N++ L GL +
Sbjct: 235 D--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTA 288
Query: 478 LSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLN 537
L+ + N+L P + +L +L L+L FN ++ + P + SL + + +N ++
Sbjct: 289 LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS 344
Query: 538 GTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTS 597
+ NL + + N +S P + +L + L L D + + + ++
Sbjct: 345 D--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSI 400
Query: 598 LNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQ 633
N + + L P ++ ++++N
Sbjct: 401 PNTVKNVTGALI--APATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-40
Identities = 97/492 (19%), Positives = 189/492 (38%), Gaps = 78/492 (15%)
Query: 50 VTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFS 109
VT L +G+ + L+ L+ +N +NN + P L NL +L + +N +
Sbjct: 48 VTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 103
Query: 110 SIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIP 169
I L + L L L N T + N+++L L+LS N + S++ +
Sbjct: 104 DITP---LANLTNLTGLTLFNNQI--TDIDPLKNLTNLNRLELSSNTISD--ISALSGLT 156
Query: 170 SLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLK 229
SL + N + + PL N+ +L L ++ N++S S L + L+
Sbjct: 157 SLQQLSFGNQ--------VTDLKPLANL----TTLERLDISSNKVSD--ISVLAKLTNLE 202
Query: 230 ILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIIN 289
L + NN I I +G +T L L L+ N+L + + +
Sbjct: 203 SLIAT-NNQISDIT-PLGILTNLDELS-----------------LNGNQLKDI--GTLAS 241
Query: 290 ISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPY 349
+++LT L L N + + + L L +L LG N+++ P ++ + LT +++
Sbjct: 242 LTNLTDLDLANNQISN--LAPLSG-LTKLTELKLGANQISNISP--LAGLTALTNLELNE 296
Query: 350 NLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVL 409
N P ++N K+L L L N +S + P+S +L+ + L
Sbjct: 297 NQLEDISP-----------------ISNLKNLTYLTLYFNNISDISPVS--SLTK-LQRL 336
Query: 410 YLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSIT 469
+ + S + NL N+ L N+++ P + L ++ L L +
Sbjct: 337 FFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPV 392
Query: 470 TDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNV 529
+ + + L P + S + +N + ++ + +
Sbjct: 393 NYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTI 449
Query: 530 NLSSNSLNGTLP 541
+ + +GT+
Sbjct: 450 GKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-28
Identities = 62/283 (21%), Positives = 122/283 (43%), Gaps = 23/283 (8%)
Query: 372 LTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLT 431
+ + T + K +L + ++ + + +L + L I + LNNLT
Sbjct: 17 IFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQ-VTTLQADRLGI--KSIDGVEYLNNLT 71
Query: 432 TLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGS 491
++ N+LT P + L KL + + +N++ L L +L+ N++
Sbjct: 72 QINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDI 127
Query: 492 LPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVT 551
P L +L +L L L N ++ + S+L L + ++ + + + NL +
Sbjct: 128 DP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFGNQVTD---LKPLANLTTLE 180
Query: 552 KIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGE 611
++D+S N +S S + L N++ L +N+ P LG LT+L+ L ++ N L
Sbjct: 181 RLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD- 235
Query: 612 IPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNK 654
+L +L+ L L+L+ N + + T L+ N+
Sbjct: 236 -IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQ 276
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-46
Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEI--LGSIRHRNLVKIIS 801
+GKG FG V++G G ++AVK+F+ E RS+ E EI +RH N++ I+
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA 103
Query: 802 TCSSDHFKA----LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
+ D+ LV +Y +GSL +++ + + + + + AS L +LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 858 -----PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPE 909
I H DL NIL+ ++ C++D G++ T +G YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 910 ----------WKLSRKGDVYSYGIILMETFTKKKPTD 936
++ ++ D+Y+ G++ E +
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-45
Identities = 97/540 (17%), Positives = 183/540 (33%), Gaps = 52/540 (9%)
Query: 101 LSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPP-SICNISSLLTLDLSFNQLQG 159
RS +F+SI P L ++ L L N I I + ++L L L +++
Sbjct: 10 CDGRSRSFTSI--PSGL--TAAMKSLDLSFNK-ITYIGHGDLRACANLQVLILKSSRINT 64
Query: 160 HVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIP 219
+ ++ SL +DLS+N S S+ ++S + +SL L+L N
Sbjct: 65 IEGDAFYSLGSLEHLDLSDNHLS----SL-SSSWFGPL----SSLKYLNLMGNPYQTLGV 115
Query: 220 STLFE-CKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNR 278
++LF L+ L + I R GL L L + +
Sbjct: 116 TSLFPNLTNLQTLRIGNVETFSEIRRI-----DFAGL-----------TSLNELEIKALS 159
Query: 279 LTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISN 338
L + +I + L+L + L L +++ L L L S +
Sbjct: 160 LRNYQSQSLKSIRDIHHLTL-HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV 218
Query: 339 ASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTS---LTNCKDLRKLILSENPLSGVL 395
+ + + S S S +C + + V
Sbjct: 219 DEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVS 278
Query: 396 PISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQ 455
+ + L++ + + + L + + +E +++ L+ L+
Sbjct: 279 ELGKVETVT-IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLE 337
Query: 456 GLYLQHNKLQGSI---TTDLCGLRSLSEFYSDGNELN--GSLPQCLDSLISLRTLSLGFN 510
L L N + + SL N L + L +L +L +L + N
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN 397
Query: 511 RLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGD 570
+P S + +NLSS + + I + + +D+S N+L
Sbjct: 398 TFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSL---F 449
Query: 571 LKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFN 630
L +Q L ++ NK + ++PD+ L + +S N L L+ L+ + L N
Sbjct: 450 LPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-38
Identities = 76/498 (15%), Positives = 164/498 (32%), Gaps = 46/498 (9%)
Query: 61 LGTIPPE-LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDS 119
+ I L + L +L + ++ + +L L++L N+ SS+ W
Sbjct: 38 ITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLS-SSWFGP 96
Query: 120 FPKLEHLYLDGNSFIG-TIPPSICNISSLLTLDLSFNQLQGHVPSSIL-NIPSLLAIDLS 177
L++L L GN + + N+++L TL + + + + SL +++
Sbjct: 97 LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156
Query: 178 NNQFSG-PMPSIYNTSPLQNIDMQYN--------------SLAELHLAYNQLSGQIPSTL 222
S+ + + ++ + + S+ L L L+ S L
Sbjct: 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL 216
Query: 223 FECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT-GEIQGLQVLALSSNRLTG 281
+ + + L L + + + + + +
Sbjct: 217 PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDV 276
Query: 282 VIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASM 341
V + ++ L + L S + L ++++ + +++ S +
Sbjct: 277 VSELGKVETVTIRRLHIP-QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKS 335
Query: 342 LTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGN 401
L +D+ NL + L+ L+LS+N L + +
Sbjct: 336 LEFLDLSENLMVEEYLKNSACKG------------AWPSLQTLVLSQNHLR-SMQKTGEI 382
Query: 402 LSNAMD--VLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYL 459
L + L +S +P + L+L + + + I Q L+ L +
Sbjct: 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDV 438
Query: 460 QHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSS 519
+N L S + L L+ L Y N+L +LP L + + N+L SV
Sbjct: 439 SNNNLD-SFSLFLPRLQEL---YISRNKLK-TLPDAS-LFPVLLVMKISRNQLKSVPDGI 492
Query: 520 LWSLRDILNVNLSSNSLN 537
L + + L +N +
Sbjct: 493 FDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-33
Identities = 67/393 (17%), Positives = 138/393 (35%), Gaps = 46/393 (11%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
++ L LS N++T + ++ ++L VL L ++ + + + +SL +L+ L L N L
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLIL-KSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 329 TGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILS- 387
+ S S L +++ N + SL N +L+ L +
Sbjct: 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL--------------FPNLTNLQTLRIGN 132
Query: 388 ENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKA 447
S + I L++ ++ L + A +++ + ++ ++ L L +E +
Sbjct: 133 VETFSEIRRIDFAGLTS-LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191
Query: 448 IGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNG----------SLPQCLD 497
L ++ L L+ L + L S + L + +
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251
Query: 498 SLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSR 557
L + N L PS + ++ V + + +
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRL----------------HIPQ 295
Query: 558 NDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEI---PN 614
L ++ + L+ ++ +++ ++K L SL FLD+S N + E
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355
Query: 615 SLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
A L+ L LS N L+ G L +
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 33/119 (27%), Positives = 53/119 (44%), Gaps = 4/119 (3%)
Query: 529 VNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI 588
+ S S ++P + + +DLS N ++ + N+Q L L ++
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66
Query: 589 PDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
D+ L SL LD+S N+LS + LS LK+LNL N Q + F NL++
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTN 124
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-45
Identities = 55/350 (15%), Positives = 115/350 (32%), Gaps = 40/350 (11%)
Query: 281 GVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNAS 340
G + S L + L + Q+ +N++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLS----QWQRHYNADRNRWHS-AWRQANSN 56
Query: 341 MLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIG 400
+ + L L L PL P
Sbjct: 57 NPQIETRTGRALKA-TADLLEDA-------------TQPGRVALELRSVPLP-QFPDQAF 101
Query: 401 NLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQ 460
LS+ + + + A + +P + L TL L N L ++P +I L +L+ L ++
Sbjct: 102 RLSH-LQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR 158
Query: 461 HNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSL 520
+ L + L++L++L L + + S +P+S+
Sbjct: 159 ACPELTELPEPLA---------------STDASGEHQGLVNLQSLRLEWTGIRS-LPASI 202
Query: 521 WSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLA 580
+L+++ ++ + ++ L+ L I +L + ++DL P G ++ L L
Sbjct: 203 ANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILK 261
Query: 581 DNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFN 630
D ++P + LT L LD+ +P+ + L + + +
Sbjct: 262 DCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-40
Identities = 58/350 (16%), Positives = 106/350 (30%), Gaps = 58/350 (16%)
Query: 123 LEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFS 182
E+LY G++ + + D + N + +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALK 69
Query: 183 GPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSI 242
+ + L L L Q P F L+ +++ + +
Sbjct: 70 ATADLLED--------ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTID-AAGLMEL 119
Query: 243 PREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANN 302
P + GL+ L L+ N L +P I +++ L LS+ A
Sbjct: 120 PDTMQQFA-----------------GLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161
Query: 303 LLGNLPSNIG--------HSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSG 354
L LP + L NLQ L L + +P+SI+N L + + + S
Sbjct: 162 ELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA 220
Query: 355 FIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSAC 414
+ ++ + L +L L P G + + L L C
Sbjct: 221 -LGPAIH---------------HLPKLEELDLRGCTALRNYPPIFGGRAP-LKRLILKDC 263
Query: 415 NIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKL 464
+ ++P +I L L L L +P I +L + + +
Sbjct: 264 SNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-39
Identities = 56/329 (17%), Positives = 101/329 (30%), Gaps = 25/329 (7%)
Query: 203 SLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNL 262
L+ + L + ++ + + N + L
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRAL 68
Query: 263 T--------GEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHS 314
G L L S L P + +S L +++ L LP +
Sbjct: 69 KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTI-DAAGLMELPDTMQQ- 125
Query: 315 LPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTS 374
L+ L L N L +P+SI++ + L + + +P L E L +
Sbjct: 126 FAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN 184
Query: 375 LTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLH 434
L L L + LP SI NL N + L + + ++ I +L L L
Sbjct: 185 LQ------SLRLEWTGIR-SLPASIANLQN-LKSLKIRNSPLS-ALGPAIHHLPKLEELD 235
Query: 435 LETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQ 494
L + P G L+ L L+ ++ D+ L L + G LP
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
Query: 495 CLDSLISLRTLSLGFNRLTSVIPSSLWSL 523
+ L + + + + + +
Sbjct: 296 LIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-37
Identities = 63/384 (16%), Positives = 113/384 (29%), Gaps = 73/384 (19%)
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSF 120
+G+ + S L ++ LS +R N + S +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNAD--RNRWHSAWRQANSN-- 56
Query: 121 PKLEHLYLDGNSFIGTIPPSI--CNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSN 178
+ G + + + + L+L L P + L + +
Sbjct: 57 -NPQIETRTGRA-LKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA 113
Query: 179 NQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNF 238
++ L L LA N L +P+++ +L+ LS+
Sbjct: 114 AGLMELPDTMQQ---FAG-------LETLTLARNPLR-ALPASIASLNRLRELSIRACPE 162
Query: 239 IGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSL 298
+ +P + + + LQ L L + +P I N+ +L L +
Sbjct: 163 LTELPEPLASTDASGEH--------QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI 213
Query: 299 TANNLLGNLPSNIGHSLPNLQQLILGG-NRLTGPIPSSISNASMLTLIDMPYNLFSGFIP 357
N+ L L I H LP L++L L G L P
Sbjct: 214 R-NSPLSALGPAIHH-LPKLEELDLRGCTALRN-------------------------YP 246
Query: 358 NSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIK 417
G L++LIL + LP+ I L+ ++ L L C
Sbjct: 247 PIFG---------------GRAPLKRLILKDCSNLLTLPLDIHRLTQ-LEKLDLRGCVNL 290
Query: 418 GSIPSEIGNLNNLTTLHLETNELT 441
+PS I L + + +
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 48/265 (18%), Positives = 95/265 (35%), Gaps = 41/265 (15%)
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSF 120
L P + LS L + + LP + L+ L+ N ++ P + S
Sbjct: 93 LPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRAL--PASIASL 149
Query: 121 PKLEHLYLDGNSFIGTIPPSICNIS---------SLLTLDLSFNQLQGHVPSSILNIPSL 171
+L L + + +P + + +L +L L + ++ +P+SI N+ +L
Sbjct: 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL 208
Query: 172 LAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKIL 231
++ + N+ S P+I++ L L EL L P LK L
Sbjct: 209 KSLKIRNSPLSALGPAIHH---LPK-------LEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 232 SLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINIS 291
L + + ++P +I +T L+ L L +P I +
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLD-----------------LRGCVNLSRLPSLIAQLP 301
Query: 292 SLTVLSLTANNLLGNLPSNIGHSLP 316
+ ++ + +L L + + P
Sbjct: 302 ANCIILVP-PHLQAQLDQHRPVARP 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-43
Identities = 89/394 (22%), Positives = 169/394 (42%), Gaps = 55/394 (13%)
Query: 241 SIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTA 300
++P I I L L +T V+ E + S+T L +
Sbjct: 7 TLPAPINQIFPDADL-----------AEGIRAVLQKASVTDVVTQE--ELESITKLVVAG 53
Query: 301 NNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSL 360
+ I + L NL+ L L GN++T P +SN LT + + N +
Sbjct: 54 EKVAS--IQGIEY-LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD------ 102
Query: 361 GFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSI 420
+++L N +LR+L L+E+ +S + + NL+ M L L A N S
Sbjct: 103 -----------ISALQNLTNLRELYLNEDNISDI--SPLANLTK-MYSLNLGA-NHNLSD 147
Query: 421 PSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSE 480
S + N+ L L + +++ P I L L L L +N+++ L L SL
Sbjct: 148 LSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHY 203
Query: 481 FYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIP-SSLWSLRDILNVNLSSNSLNGT 539
F + N++ P + ++ L +L +G N++T + P ++L L + + +N + +
Sbjct: 204 FTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWL---EIGTNQI--S 256
Query: 540 LPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLN 599
+ +L + +++ N +S S + +L + L L +N+ + +GGLT+L
Sbjct: 257 DINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314
Query: 600 FLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQ 633
L +S N+++ P L +LS + + + ++
Sbjct: 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-41
Identities = 73/367 (19%), Positives = 149/367 (40%), Gaps = 42/367 (11%)
Query: 268 GLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNR 327
G LA + + P +++ L ++ L ++ +L++ G +
Sbjct: 1 GAATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEE-LESITKLVVAGEK 55
Query: 328 LTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILS 387
+ I + L +++ N + P L+N L L +
Sbjct: 56 VASI--QGIEYLTNLEYLNLNGNQITDISP-----------------LSNLVKLTNLYIG 96
Query: 388 ENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKA 447
N ++ + + NL+N + LYL+ NI P + NL + +L+L N S
Sbjct: 97 TNKITDISALQ--NLTN-LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSP 150
Query: 448 IGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSL 507
+ + L L + +K++ + L L + N++ P L SL SL +
Sbjct: 151 LSNMTGLNYLTVTESKVKDVT--PIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTA 206
Query: 508 GFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSS 567
N++T + P + ++ + ++ + +N + P + NL +T +++ N +S ++
Sbjct: 207 YVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INA 260
Query: 568 IGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNL 627
+ DL ++ L++ N+ S L L+ LN L +++N L E + L+ L L L
Sbjct: 261 VKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318
Query: 628 SFNGLQG 634
S N +
Sbjct: 319 SQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-41
Identities = 81/398 (20%), Positives = 155/398 (38%), Gaps = 69/398 (17%)
Query: 68 LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLY 127
+L+ + S + + L + L +SI ++ LE+L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI---QGIEYLTNLEYLN 72
Query: 128 LDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPS 187
L+GN I I P + N+ L L + N++ S++ N+ +L + L+ + S
Sbjct: 73 LNGNQ-ITDISP-LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDI--- 125
Query: 188 IYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIG 247
SPL N + L+L N S L L L+++ + + + I
Sbjct: 126 ----SPLAN----LTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVT-ESKVKDVT-PIA 174
Query: 248 NITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNL 307
N+T L L L+ N++ + P + +++SL + N +
Sbjct: 175 NLTDLYSLS-----------------LNYNQIEDISP--LASLTSLHYFTAYVNQITD-- 213
Query: 308 PSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYD 367
+ + + + L L +G N++T P ++N S LT +++ N S
Sbjct: 214 ITPVAN-MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD------------- 257
Query: 368 ELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNL 427
+ ++ + L+ L + N +S + + NLS ++ L+L+ + IG L
Sbjct: 258 ----INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQ-LNSLFLNNNQLGNEDMEVIGGL 310
Query: 428 NNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQ 465
NLTTL L N +T P + L K+ + ++
Sbjct: 311 TNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-40
Identities = 79/415 (19%), Positives = 155/415 (37%), Gaps = 71/415 (17%)
Query: 74 LSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSF 133
+ L + P ++L + + + + + + L + G
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDV---VTQEELESITKLVVAGEK- 55
Query: 134 IGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSP 193
+ +I I +++L L+L+ NQ+ S + N+ L + + N+ + S
Sbjct: 56 VASIQG-IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITDI-------SA 105
Query: 194 LQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLK 253
LQN+ +L EL+L + +S S L ++ L+L N+ + + + N+T L
Sbjct: 106 LQNL----TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLN 158
Query: 254 GLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGH 313
L + + +++ V P I N++ L LSL N + S +
Sbjct: 159 YLTV-----------------TESKVKDVTP--IANLTDLYSLSLNYNQIED--ISPLAS 197
Query: 314 SLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLT 373
L +L N++T P ++N + L + + N + P
Sbjct: 198 -LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP---------------- 238
Query: 374 SLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTL 433
L N L L + N +S + ++ +L+ + +L + + I S + NL+ L +L
Sbjct: 239 -LANLSQLTWLEIGTNQISDI--NAVKDLTK-LKMLNVGSNQISD--ISVLNNLSQLNSL 292
Query: 434 HLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNEL 488
L N+L + IG L L L+L N + L L + +
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR--PLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-33
Identities = 70/350 (20%), Positives = 132/350 (37%), Gaps = 52/350 (14%)
Query: 48 RRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNN 107
+T L +A + + L+ L LN+ N + P LSNL +L L +N
Sbjct: 44 ESITKLVVAGEKV--ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNK 99
Query: 108 FSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILN 167
I L + L LYL+ ++ I I P + N++ + +L+L N S + N
Sbjct: 100 ---ITDISALQNLTNLRELYLNEDN-ISDISP-LANLTKMYSLNLGANHNLSD-LSPLSN 153
Query: 168 IPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQ 227
+ L + ++ ++ +P+ N+ L L L YNQ+ P L
Sbjct: 154 MTGLNYLTVTESKVKDV-------TPIANL----TDLYSLSLNYNQIEDISP--LASLTS 200
Query: 228 LKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT-----GEIQGLQVLALSSNRLTGV 282
L + VN P + N+T L L + +T + L L + +N+++ +
Sbjct: 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDI 258
Query: 283 IPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASML 342
+ +++ L +L++ +N + S + + L L L L N+L I + L
Sbjct: 259 --NAVKDLTKLKMLNVGSNQISD--ISVLNN-LSQLNSLFLNNNQLGNEDMEVIGGLTNL 313
Query: 343 TLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLS 392
T + + N + P L + + + +
Sbjct: 314 TTLFLSQNHITDIRP-----------------LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 34/177 (19%), Positives = 69/177 (38%), Gaps = 12/177 (6%)
Query: 478 LSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLN 537
+ + +N P L L +T V+ L I + ++ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA 57
Query: 538 GTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTS 597
++ I L + ++L+ N ++ P + +L + +L + NK + +L LT+
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 598 LNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNK 654
L L ++ +N+S P L L+ + LNL N + T L+ + +K
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESK 166
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 76/282 (26%), Positives = 128/282 (45%), Gaps = 22/282 (7%)
Query: 746 LGKGSFGSVYKGTL-----SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKII 800
LGKG+FGSV + G +AVK E LR F+ E EIL S++H N+VK
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 801 STCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
C S + L++EY+P GSL +++ D ++ L + +EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT--IGYMAPE----WKL 912
IH DL NIL+ + DFG++K+L + + + I + APE K
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 913 SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972
S DV+S+G++L E FT + + + + G++I I LL ++
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK---QGQMIVFHLIELL--KNNG 249
Query: 973 -LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013
L + C + + +C + +R + ++ ++ +IR+
Sbjct: 250 RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 68/288 (23%), Positives = 108/288 (37%), Gaps = 43/288 (14%)
Query: 746 LGKGSFGSVYKGTL----SDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVK 798
LG GSFG V +G + +AVK L + F E + S+ HRNL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDH 855
+ + K +V E P GSL + + F + + VA + YL +
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT--IGYMAPE---- 909
IH DL N+LL + + DFG+ + L Q + APE
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 910 WKLSRKGDVYSYGIILMETFTK-KKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968
S D + +G+ L E FT ++P L +I ++ + K
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-------------------LHKIDK 239
Query: 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016
E L E C + ++ +QC E+R LL+ + T +
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-38
Identities = 76/284 (26%), Positives = 129/284 (45%), Gaps = 22/284 (7%)
Query: 746 LGKGSFGSVYKGTL-----SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKII 800
LGKG+FGSV + G +AVK E LR F+ E EIL S++H N+VK
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 801 STCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
C S + L++EY+P GSL +++ D ++ L + +EYL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 165
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT--IGYMAPE----WKL 912
IH DL NIL+ + DFG++K+L + + + I + APE K
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225
Query: 913 SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972
S DV+S+G++L E FT + + + + G++I I LL ++
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK---QGQMIVFHLIELL--KNNG 280
Query: 973 -LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015
L + C + + +C + +R + ++ ++ +IR+ +
Sbjct: 281 RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 43/297 (14%)
Query: 746 LGKGSFGSVYKGTLSDG---MQIAVKVFNLELEGTLRS-FDAECEILGSIRHRNLVKIIS 801
LG G+FGSV +G + +A+KV E E +I+ + + +V++I
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDHPTP 858
C ++ LV+E G L ++ K + ++ V+ ++YL ++
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT--IGYMAPE----WKL 912
+H DL N+LL A +SDFG+SK LG + S ++ + + APE K
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 913 SRKGDVYSYGIILMETFTK-KKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971
S + DV+SYG+ + E + +KP ++ E ++ + E
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------------VMAFI-------EQG 229
Query: 972 Y-LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIENSSDKRY 1027
+ +C + +L C E+R + ++ +L + +E +
Sbjct: 230 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHHH 286
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 71/282 (25%), Positives = 120/282 (42%), Gaps = 41/282 (14%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTC 803
+G G FG V+ G + ++A+K EG + F E E++ + H LV++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDHPTPII 860
LV E+M +G L +++ + F L M +DV + YL I
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------I 126
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKG 916
H DL N L+ E+ V +SDFG+++ + D+ + T T + + +PE + S K
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 917 DVYSYGIILMETFTK-KKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY-LT 974
DV+S+G+++ E F++ K P + E VV+ + L
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSE-----------------VVE----DISTGFRLY 225
Query: 975 AKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016
+ V + C RE E+R L +L +I + L
Sbjct: 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTC 803
LG G FG V G +AVK+ EG++ F E + + + H LVK C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDHPTPII 860
S ++ +V EY+ NG L N++ + + + Q L M DV + +L + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------I 126
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKG 916
H DL N L++ + +SDFG+++ + D+ ++ T + + APE +K S K
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 917 DVYSYGIILMETFTK-KKP 934
DV+++GI++ E F+ K P
Sbjct: 187 DVWAFGILMWEVFSLGKMP 205
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 68/283 (24%), Positives = 116/283 (40%), Gaps = 27/283 (9%)
Query: 746 LGKGSFGSVYKGTL-----SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKI 799
LG+G FG V + G Q+AVK E + E EIL ++ H N+VK
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 800 ISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
C+ D L++E++P+GSL+ ++ ++ Q+L + + ++YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ-- 146
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT--IGYMAPE----WK 911
+H DL N+L+ + DFG++K + + + + + APE K
Sbjct: 147 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205
Query: 912 LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971
DV+S+G+ L E T ++L ++ HG++ +N L ++
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSS----PMALFLKMIGPTHGQMTVTRLVNTL--KEG 259
Query: 972 Y-LTAKEQCVSSVLSLAMQCTRESAEERI---NIKEALTKLLK 1010
L C V L +C R N+ E LLK
Sbjct: 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 746 LGKGSFGSVYKGTL---SDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKII 800
LG G+FG+V KG +AVK+ E AE ++ + + +V++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDHPT 857
C ++ + LV+E G L ++ +NR + +V V+ ++YL ++
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF---- 138
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT--IGYMAPE----WK 911
+H DL N+LL A +SDFG+SK L + + + QT + + APE +K
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 912 LSRKGDVYSYGIILMETFTK-KKP 934
S K DV+S+G+++ E F+ +KP
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 45/202 (22%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 746 LGKGSFGSVYKGTLSDG----MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKII 800
+G+G FG V++G + +A+K + F E + H ++VK+I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDHPT 857
+ + +++E G L +++ + S D+ + +++AL YL +
Sbjct: 83 GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLS 913
+H D+ N+L++ + L DFG+S+ + D T ++ I +MAPE + +
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 914 RKGDVYSYGIILMETFTK-KKP 934
DV+ +G+ + E KP
Sbjct: 196 SASDVWMFGVCMWEILMHGVKP 217
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-37
Identities = 57/193 (29%), Positives = 103/193 (53%), Gaps = 10/193 (5%)
Query: 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
LG+G FG V+ GT + ++A+K + +F E +++ +RH LV++ +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRL-NMVIDVASALEYLHYDHPTPIIHC 862
S + +V EYM GSL +++ + + L +L +M +AS + Y+ + +H
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGDV 918
DL +NIL+ E++V ++DFG+++L+ D + I + APE + + K DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 919 YSYGIILMETFTK 931
+S+GI+L E TK
Sbjct: 365 WSFGILLTELTTK 377
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-37
Identities = 50/193 (25%), Positives = 100/193 (51%), Gaps = 10/193 (5%)
Query: 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
LG G FG V+ T + ++AVK ++ +F AE ++ +++H LVK+ +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 804 SSDHFKALVLEYMPNGSLENWMY-NKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
+ + ++ E+M GSL +++ ++ + + ++ +A + ++ + IH
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHR 308
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGDV 918
DL +NIL++ S+V ++DFG+++++ D + I + APE + K DV
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 919 YSYGIILMETFTK 931
+S+GI+LME T
Sbjct: 369 WSFGILLMEIVTY 381
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-37
Identities = 70/447 (15%), Positives = 129/447 (28%), Gaps = 41/447 (9%)
Query: 194 LQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLK 253
+ I N + + L + S +K L LS N ++ T L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 254 GLYLVYTNLT-----GEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLP 308
L L L + L+ L L++N + E++ S+ L ANN + +
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHA-ANNNISRVS 115
Query: 309 SNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDE 368
+ + + L N++T S + +D+ N
Sbjct: 116 CSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID--------------T 158
Query: 369 LGFLTSLTNCKDLRKLILSENPLSGVLP-ISIGNLSNAMDVLYLSACNIKGSIPSEIGNL 427
+ F + L L L N + V + L L LS+ + + E +
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLK----TLDLSSNKLA-FMGPEFQSA 213
Query: 428 NNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNE 487
+T + L N+L I KA+ Q L+ L+ N D ++
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQT 271
Query: 488 LNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNG----TLPVE 543
+ Q + G + L + + S G L E
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECE 331
Query: 544 IGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDM 603
N +ID + I + L + + L+
Sbjct: 332 RENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQ 391
Query: 604 SSNNLSGEIPNSLKALSLLKFLNLSFN 630
+ E+ ++ + S L+ L
Sbjct: 392 QAVGQ-IELQHATEEQSPLQLLRAIVK 417
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-34
Identities = 74/534 (13%), Positives = 153/534 (28%), Gaps = 62/534 (11%)
Query: 69 GNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYL 128
N + + VT++S L + +K L N S I L F KLE L L
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQIS-AADLAPFTKLELLNL 65
Query: 129 DGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSI 188
N + ++S+L TLDL+ N + +L PS+ + +NN S S
Sbjct: 66 SSNVL--YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSR 118
Query: 189 YNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGN 248
++LA N+++ +++ L L N I ++
Sbjct: 119 GQ------------GKKNIYLANNKITMLRDLDEGCRSRVQYLDLK-LNEIDTVNFA--- 162
Query: 249 ITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLP 308
L L+ L L N + V + + L L L ++N L +
Sbjct: 163 ------------ELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDL-SSNKLAFMG 207
Query: 309 SNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDE 368
+ + L N+L I ++ + L D+ N F
Sbjct: 208 PEFQS-AAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF-------- 257
Query: 369 LGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLN 428
K+ R +++ + + + + + + A + L
Sbjct: 258 --------FSKNQRVQTVAKQTVKKLTGQNEEECTV-PTLGHYGAYCCEDLPAPFADRLI 308
Query: 429 NLTTLHLETNELTGS----IPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSD 484
L GS + + + + + + I ++
Sbjct: 309 ALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQK 368
Query: 485 GNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEI 544
L+ + + L + ++ L + + +
Sbjct: 369 KKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQS 428
Query: 545 GNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSL 598
+ D+ ++ + + K LA ++ + + +L
Sbjct: 429 VQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNL 482
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-34
Identities = 61/411 (14%), Positives = 121/411 (29%), Gaps = 44/411 (10%)
Query: 241 SIPREIGNITMLKGLYLVYTNLTGEIQG-------LQVLALSSNRLTGVIPPEIINISSL 293
+I N K + ++L + ++ L LS N L+ + ++ + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 294 TVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFS 353
+L+L ++N+L SL L+ L L N + + + + N S
Sbjct: 61 ELLNL-SSNVLYETLDL--ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 354 GFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSA 413
+ + + + L+ N ++ + + G S + L L
Sbjct: 113 RVSCSRG------------------QGKKNIYLANNKITMLRDLDEGCRSR-VQYLDLKL 153
Query: 414 CNIKG-SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDL 472
I + + + L L+L+ N + + + KL+ L L NKL + +
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEF 210
Query: 473 CGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLS 532
++ N+L + + L +L L N +S + ++
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ-TVA 268
Query: 533 SNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGS----I 588
++ V T L ++ A QGS +
Sbjct: 269 KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERL 328
Query: 589 PDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHG 639
+D I L L QV +G
Sbjct: 329 ECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNG 379
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-33
Identities = 77/529 (14%), Positives = 149/529 (28%), Gaps = 58/529 (10%)
Query: 49 RVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNF 108
R + L + + + L+++ N S L+ +L+ L+ SN
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 109 SSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNI 168
L+S L L L+ N + + S+ TL + N + V S
Sbjct: 71 YET---LDLESLSTLRTLDLNNNY-VQELLVG----PSIETLHAANNNIS-RVSCSRG-- 119
Query: 169 PSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFE-CKQ 227
I L+NN+ + + + L L N++ + L
Sbjct: 120 QGKKNIYLANNKITMLRDLDEG---------CRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 228 LKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEI 287
L+ L+L NFI + ++ L+ L LSSN+L + PE
Sbjct: 171 LEHLNLQ-YNFIYDVKGQVV------------------FAKLKTLDLSSNKLA-FMGPEF 210
Query: 288 INISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDM 347
+ + +T +SL NN L + + NL+ L GN + + +
Sbjct: 211 QSAAGVTWISL-RNNKLVLIEKALRF-SQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTV 267
Query: 348 PYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMD 407
+ C C+DL ++ +
Sbjct: 268 AKQTVKKLTGQNEEECTVPTLG--HYGAYCCEDLPAPFADRLIALKRKEHALLSGQG--- 322
Query: 408 VLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGS 467
+ + E N + + I + R Q L + L
Sbjct: 323 -------SETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQ 375
Query: 468 ITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLT-SVIPSSLWSLRDI 526
++ L L + L+ L R + I
Sbjct: 376 VSNGRRAHAELDGTLQQAVGQI-ELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAI 434
Query: 527 LNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQ 575
+ ++ + K+ + DL+ + + + +N+
Sbjct: 435 RDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLA 483
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-29
Identities = 49/283 (17%), Positives = 94/283 (33%), Gaps = 34/283 (12%)
Query: 408 VLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGS 467
+ ++ ++K ++ S + N+ L L N L+ + KL+ L L N L +
Sbjct: 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET 73
Query: 468 ITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDIL 527
DL L +L + N + Q L S+ TL N ++ V S +
Sbjct: 74 --LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQGKK--- 123
Query: 528 NVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSG-EIPSSIGDLKNMQHLSLADNKFQG 586
N+ L++N + ++ G V +DL N++ ++HL+L N
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183
Query: 587 ---------------------SIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFL 625
+ + ++ + +N L I +L+ L+
Sbjct: 184 VKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 626 NLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPELKFPACK 668
+L NG F+ V + + C
Sbjct: 243 DLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 48/359 (13%), Positives = 92/359 (25%), Gaps = 36/359 (10%)
Query: 45 PRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFR 104
+ L+ A + + + + NN + + R++YL +
Sbjct: 96 LVGPSIETLHAANN-NISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152
Query: 105 SNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSS 164
N ++ S LEHL L N I + + + L TLDLS N+L +
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNF-IYDVKGQV-VFAKLKTLDLSSNKLA-FMGPE 209
Query: 165 ILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFE 224
+ + I L NN+ ++ +L L N F
Sbjct: 210 FQSAAGVTWISLRNNKLVL----------IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
Query: 225 CKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT----GEIQGLQVLALSSNRLT 280
K ++ +++ + T+ + L L + L
Sbjct: 260 -KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL 318
Query: 281 GV-------IPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIP 333
+ E N + + + + L L
Sbjct: 319 SGQGSETERLECERENQARQREIDA-LKEQYRTVIDQVTLRKQAKITLEQKKKALD---- 373
Query: 334 SSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLS 392
+ ++ L L H +E L L + + E
Sbjct: 374 -EQVSNGRRAHAELDGTLQQAVGQIELQ--HATEEQSPLQLLRAIVKRYEEMYVEQQSV 429
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 17/82 (20%), Positives = 31/82 (37%), Gaps = 1/82 (1%)
Query: 564 IPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLK 623
I + + + D+ + ++ ++ LD+S N LS L + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 624 FLNLSFNGLQGQVPHGGPFTNL 645
LNLS N L + + L
Sbjct: 62 LLNLSSNVLY-ETLDLESLSTL 82
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-37
Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 47/284 (16%)
Query: 746 LGKGSFGSVYKGTLSDG-----MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKI 799
LG G+FG+VYKG + +A+K + E ++ S+ + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDHP 856
+ C + + L+ + MP G L +++ + LN + +A + YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT-IGYMAPE----WK 911
+H DL N+L+ ++DFG++KLLG E + I +MA E
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 912 LSRKGDVYSYGIILMETFTK-KKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970
+ + DV+SYG+ + E T KP D + EI ++L E
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------------------SSIL--EK 234
Query: 971 AY-LTAKEQCVSSVLSLAMQCTRESAEER---INIKEALTKLLK 1010
L C V + +C A+ R + +K+ +
Sbjct: 235 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 18/194 (9%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTC 803
LG G FG V G +A+K+ EG++ F E +++ ++ H LV++ C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDHPTPII 860
+ ++ EYM NG L N++ F Q L M DV A+EYL + +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------L 142
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKG 916
H DL N L+N+ V +SDFG+S+ + D+ + + + + PE K S K
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 917 DVYSYGIILMETFT 930
D++++G+++ E ++
Sbjct: 203 DIWAFGVLMWEIYS 216
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 746 LGKGSFGSVYKGTL----SDGMQIAVKVFNLE-LEGTLRSFDAECEILGSIRHRNLVKII 800
LG+G FG VY+G + + +AVK + F +E I+ ++ H ++VK+I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDHPT 857
+ +++E P G L +++ S +L + + + A+ YL +
Sbjct: 80 GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLS 913
+H D+ NIL+ L DFG+S+ + DE + T I +M+PE + +
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 914 RKGDVYSYGIILMETFTK-KKP 934
DV+ + + + E + K+P
Sbjct: 193 TASDVWMFAVCMWEILSFGKQP 214
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 746 LGKGSFGSVYKGTL----SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKII 800
+G G G V G L + +A+K E R F +E I+G H N++++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDHPT 857
+ +V EYM NGSL+ ++ + F I+Q + M+ V + + YL Y
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT--IGYMAPE----WK 911
+H DL N+L++ ++V +SDFG+S++L D+ T T I + APE
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 912 LSRKGDVYSYGIILMETFTK-KKP 934
S DV+S+G+++ E ++P
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERP 254
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 71/282 (25%), Positives = 113/282 (40%), Gaps = 28/282 (9%)
Query: 746 LGKGSFGSVYKGTL-----SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKII 800
LGKG+FGSV + G +AVK R F E +IL ++ +VK
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 801 STCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
++ LV+EY+P+G L +++ D + L + +EYL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--- 147
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT--IGYMAPE----WKL 912
+H DL NIL+ ++DFG++KLL + + I + APE
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 913 SRKGDVYSYGIILMETFTK-KKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971
SR+ DV+S+G++L E FT K + ++ + + LL E+
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPALSRL-LELL--EEG 260
Query: 972 Y-LTAKEQCVSSVLSLAMQCTRESAEER---INIKEALTKLL 1009
L A C + V L C S ++R + L L
Sbjct: 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-36
Identities = 57/193 (29%), Positives = 103/193 (53%), Gaps = 10/193 (5%)
Query: 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
LG+G FG V+ GT + ++A+K + +F E +++ +RH LV++ +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRL-NMVIDVASALEYLHYDHPTPIIHC 862
S + +V EYM GSL +++ + + L +L +M +AS + Y+ + +H
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 387
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGDV 918
DL +NIL+ E++V ++DFG+++L+ D + I + APE + + K DV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 919 YSYGIILMETFTK 931
+S+GI+L E TK
Sbjct: 448 WSFGILLTELTTK 460
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-36
Identities = 76/387 (19%), Positives = 135/387 (34%), Gaps = 68/387 (17%)
Query: 141 ICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQ 200
C + L++ + L +P + + + + +N L ++
Sbjct: 36 ACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNN-------------LTSLPAL 79
Query: 201 YNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYT 260
L L ++ NQL+ +P +L I S + +P + L T
Sbjct: 80 PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT----HLPALPSGLCKLWIFGNQLT 134
Query: 261 NLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQ 320
+L GLQ L++S N+L +P + L NN L +LP LQ+
Sbjct: 135 SLPVLPPGLQELSVSDNQLA-SLPALPSELCKLWAY----NNQLTSLPMLPS----GLQE 185
Query: 321 LILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKD 380
L + N+L +P+ S L + N + +P
Sbjct: 186 LSVSDNQLAS-LPTLPSE---LYKLWAYNNRLT-SLPALPS------------------G 222
Query: 381 LRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNEL 440
L++LI+S N L+ LP+ L L +S + S+P L +L + N+L
Sbjct: 223 LKELIVSGNRLTS-LPVLPSELKE----LMVSGNRLT-SLPMLPS---GLLSLSVYRNQL 273
Query: 441 TGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYS----DGNELNGSLPQCL 496
T +P+++ L + L+ N L T + + YS + S P+
Sbjct: 274 T-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRET 331
Query: 497 DSLISLRTLSLGFNRLTSVIPSSLWSL 523
+L L R P+ W +
Sbjct: 332 RALHLAAADWLVPAREGEPAPADRWHM 358
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-31
Identities = 87/440 (19%), Positives = 151/440 (34%), Gaps = 57/440 (12%)
Query: 50 VTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFS 109
+T L + L ++P L L V+ N + +LP+ L L S +
Sbjct: 63 ITTLVIPDNNLT-SLPALPPELRT---LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP 117
Query: 110 SIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIP 169
++ L L++ GN + ++P L L +S NQL +P+ +
Sbjct: 118 AL--------PSGLCKLWIFGNQ-LTSLPVLPPG---LQELSVSDNQLA-SLPALPSELC 164
Query: 170 SLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLK 229
L NNQ L ++ M + L EL ++ NQL+ +P+ E +L
Sbjct: 165 KL---WAYNNQ-------------LTSLPMLPSGLQELSVSDNQLA-SLPTLPSELYKLW 207
Query: 230 ILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIIN 289
NN + S+P + L T+L L+ L +S NRLT +P
Sbjct: 208 AY----NNRLTSLPALPSGLKELIVSGNRLTSLPVLPSELKELMVSGNRLTS-LPML--- 259
Query: 290 ISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPY 349
S L LS+ N L LP ++ H L + + L GN L+ ++ + P
Sbjct: 260 PSGLLSLSV-YRNQLTRLPESLIH-LSSETTVNLEGNPLSERTLQALREITSAPGYSGPI 317
Query: 350 NLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLI-----LSENPLSGVLPISIGNLSN 404
F ++ + + + + + + LS
Sbjct: 318 IRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSE 377
Query: 405 AMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPK-----AIGRLQKLQGLYL 459
+ ++ K I S + L L T + L +++ + L
Sbjct: 378 TEN--FIKDAGFKAQISSWLAQLAEDEALRANTFAMATEATSSCEDRVTFFLHQMKNVQL 435
Query: 460 QHNKLQGSITTDLCGLRSLS 479
HN +G DL L +
Sbjct: 436 VHNAEKGQYDNDLAALVATG 455
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-31
Identities = 85/448 (18%), Positives = 148/448 (33%), Gaps = 119/448 (26%)
Query: 74 LSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSF 133
++LNV + + TLP L + L NN +S+ P+L L + GN
Sbjct: 42 NAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTSLP-----ALPPELRTLEVSGNQ- 92
Query: 134 IGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSP 193
+ ++P + L L L + + NQ
Sbjct: 93 LTSLPVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQ------------- 132
Query: 194 LQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLK 253
L ++ + L EL ++ NQL+ +P+ E +L NN + S+P
Sbjct: 133 LTSLPVLPPGLQELSVSDNQLA-SLPALPSELCKLWAY----NNQLTSLPMLPSG----- 182
Query: 254 GLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGH 313
LQ L++S N+L +P + L NN L +LP+
Sbjct: 183 ---------------LQELSVSDNQLA-SLPTLPSELYKLWAY----NNRLTSLPALPS- 221
Query: 314 SLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLT 373
L++LI+ GNRLT +P S
Sbjct: 222 ---GLKELIVSGNRLTS-LPVLPSE----------------------------------- 242
Query: 374 SLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTL 433
L++L++S N L+ LP+ L L + + +P + +L++ TT+
Sbjct: 243 -------LKELMVSGNRLTS-LPMLPSGLL----SLSVYRNQLT-RLPESLIHLSSETTV 289
Query: 434 HLETNELTGSIPKAIGRLQKLQGLYLQ---HNKLQGSITTDLCGLRSLSEFYSDGNELNG 490
+LE N L+ +A+ + G + S + L + +
Sbjct: 290 NLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGE 349
Query: 491 SLP----QCLDSLISLRTLSLGFNRLTS 514
P + SL +RL+
Sbjct: 350 PAPADRWHMFGQEDNADAFSLFLDRLSE 377
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-36
Identities = 77/290 (26%), Positives = 128/290 (44%), Gaps = 44/290 (15%)
Query: 746 LGKGSFGSVYKGTL----SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKII 800
+G G FG V G L + +A+K + E R F E I+G H N++++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDHPT 857
+ +V EYM NGSL++++ + F ++Q + M+ +AS ++YL Y
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGD--ETSMTQTQTLATIGYMAPE----WK 911
+H DL NIL+N ++V +SDFG+ ++L D E + T I + +PE K
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 912 LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971
+ DV+SYGI+L E + GE N +I V ++
Sbjct: 227 FTSASDVWSYGIVLWEVMSY---------GERPYWEMSNQ----DVIKAV-------DEG 266
Query: 972 Y-LTAKEQCVSSVLSLAMQCTRESAEER---INIKEALTKLLKIRNTLLT 1017
Y L C +++ L + C ++ R I L KL++ +L
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKI 316
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 53/193 (27%), Positives = 101/193 (52%), Gaps = 14/193 (7%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIISTC 803
LG G FG V+ G + ++AVK +G++ +F AE ++ ++H+ LV++ +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 804 SSDHFKALVLEYMPNGSLENWM-YNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
+ + ++ EYM NGSL +++ I + L+M +A + ++ + IH
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKGDV 918
DL +NIL+++++ ++DFG+++L+ D + I + APE + K DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 919 YSYGIILMETFTK 931
+S+GI+L E T
Sbjct: 194 WSFGILLTEIVTH 206
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-36
Identities = 59/193 (30%), Positives = 92/193 (47%), Gaps = 12/193 (6%)
Query: 746 LGKGSFGSVYKGTL-SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTC 803
+G+G+FG V+ G L +D +AVK L F E IL H N+V++I C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
+ +V+E + G ++ + + L MV D A+ +EYL IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 864 LNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT--IGYMAPE----WKLSRKGD 917
L N L+ E V +SDFG+S+ + + L + + APE + S + D
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 918 VYSYGIILMETFT 930
V+S+GI+L ETF+
Sbjct: 298 VWSFGILLWETFS 310
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-36
Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 10/194 (5%)
Query: 744 NLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIIST 802
+ LG G +G VY+G + +AVK E + F E ++ I+H NLV+++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRS-FDILQRLNMVIDVASALEYLHYDHPTPIIH 861
C+ + ++ E+M G+L +++ NR + L M ++SA+EYL + IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 862 CDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGD 917
+L N L+ E+ + ++DFG+S+L+ +T I + APE K S K D
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 918 VYSYGIILMETFTK 931
V+++G++L E T
Sbjct: 402 VWAFGVLLWEIATY 415
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-35
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 746 LGKGSFGSVYKGTLSDG---MQIAVKVFNLELEGTLRS-FDAECEILGSIRHRNLVKIIS 801
LG G+FGSV +G + +A+KV E E +I+ + + +V++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDHPTP 858
C ++ LV+E G L ++ K + ++ V+ ++YL ++
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT--IGYMAPE----WKL 912
+H +L N+LL A +SDFG+SK LG + S ++ + + APE K
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 913 SRKGDVYSYGIILMETFTK-KKP 934
S + DV+SYG+ + E + +KP
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP 539
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 28/208 (13%)
Query: 746 LGKGSFGSVYKGTL-----SDGMQIAVKVFNLELEGT----LRSFDAECEILGSIRHRNL 796
+G G FG VYKG L + +A+K G F E I+G H N+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HY 853
+++ S ++ EYM NG+L+ ++ K+ F +LQ + M+ +A+ ++YL +Y
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY 168
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD--ETSMTQTQTLATIGYMAPE-- 909
+H DL NIL+N ++V +SDFG+S++L D E + T + I + APE
Sbjct: 169 ------VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 910 --WKLSRKGDVYSYGIILMETFTK-KKP 934
K + DV+S+GI++ E T ++P
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 67/283 (23%), Positives = 110/283 (38%), Gaps = 29/283 (10%)
Query: 746 LGKGSFGSVYKGTL-----SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKI 799
LG+G FG V G +AVK + + E +IL ++ H +++K
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 800 ISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
C + LV+EY+P GSL + Y S + Q L + + YLH H
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHAQH-- 154
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT--IGYMAPE----WK 911
IH DL N+LL+ + + DFG++K + + + + + + APE +K
Sbjct: 155 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213
Query: 912 LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971
DV+S+G+ L E T + + L + + LL E
Sbjct: 214 FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL----TELL--ERG 267
Query: 972 Y-LTAKEQCVSSVLSLAMQCTRESAEER---INIKEALTKLLK 1010
L ++C + V L C A R N+ L + +
Sbjct: 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 20/196 (10%)
Query: 746 LGKGSFGSVYKGTLSDG-MQIAVKVFNLELEGTL--RSFDAECEILGSIRHRNLVKIIST 802
LG G +G VY+G + +AVK E T+ F E ++ I+H NLV+++
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNR-SFDILQRLNMVIDVASALEYL---HYDHPTP 858
C+ + ++ E+M G+L +++ NR + L M ++SA+EYL ++
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----- 132
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSR 914
IH DL N L+ E+ + ++DFG+S+L+ +T I + APE K S
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 915 KGDVYSYGIILMETFT 930
K DV+++G++L E T
Sbjct: 192 KSDVWAFGVLLWEIAT 207
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-35
Identities = 77/431 (17%), Positives = 148/431 (34%), Gaps = 68/431 (15%)
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSF 120
I L +++ + + L K ++F+++ + LDSF
Sbjct: 10 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP-AALLDSF 68
Query: 121 PKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNN 179
++E L L+ I I ++ L + FN ++ P N+P L + L N
Sbjct: 69 RQVELLNLNDLQ-IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 127
Query: 180 QFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSVNNF 238
S I++ +P L L ++ N L +I F+ L+ L LS +N
Sbjct: 128 DLSSLPRGIFHNTP---------KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS-SNR 176
Query: 239 IGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSL 298
+ + I L +S N L+ + ++ L
Sbjct: 177 LTHVDL-------------------SLIPSLFHANVSYNLLS-----TLAIPIAVEELDA 212
Query: 299 TANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPN 358
++N + + + L L L N LT + + N L +D+ YN + +
Sbjct: 213 -SHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYH 266
Query: 359 SLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKG 418
+ L +L +S N L L + + + VL LS ++
Sbjct: 267 PFV---------------KMQRLERLYISNNRLV-ALNLYGQPIPT-LKVLDLSHNHLL- 308
Query: 419 SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSL 478
+ + L L+L+ N + ++ + L+ L L HN + L R++
Sbjct: 309 HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNV 363
Query: 479 SEFYSDGNELN 489
+ D + +
Sbjct: 364 ARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-34
Identities = 75/409 (18%), Positives = 144/409 (35%), Gaps = 65/409 (15%)
Query: 131 NSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYN 190
I ++ + + + + + + + N+ ++ +
Sbjct: 7 QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLD 66
Query: 191 TSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSVNNFIGSIPREIGNI 249
+ + L+L Q+ +I + F ++ L + N I +P +
Sbjct: 67 ---------SFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMG-FNAIRYLPPHV--- 112
Query: 250 TMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEI-INISSLTVLSLTANNLLGNLP 308
+ + L VL L N L+ +P I N LT LS+ +NN L +
Sbjct: 113 --FQNV-----------PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSM-SNNNLERIE 157
Query: 309 SNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDE 368
+ + +LQ L L NRLT S I + L ++ YN
Sbjct: 158 DDTFQATTSLQNLQLSSNRLTHVDLSLIPS---LFHANVSYN------------------ 196
Query: 369 LGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLN 428
L++L + +L S N ++ V L+ L L N+ + N
Sbjct: 197 --LLSTLAIPIAVEELDASHNSINVVRGPVNVELTI----LKLQHNNLT-DTAW-LLNYP 248
Query: 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNEL 488
L + L NEL + ++Q+L+ LY+ +N+L ++ + +L N L
Sbjct: 249 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307
Query: 489 NGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLN 537
+ + L L L N + ++ S+ +L+ N+ LS N +
Sbjct: 308 L-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLK---NLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-33
Identities = 53/341 (15%), Positives = 126/341 (36%), Gaps = 35/341 (10%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
+++ ++ + + + + + +L+L + + + + +Q+L +G N +
Sbjct: 47 QKIVTFKNSTMRKLPAALLDSFRQVELLNL-NDLQIEEIDTYAFAYAHTIQKLYMGFNAI 105
Query: 329 TGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE 388
P N +LT++ + N S +P + N L L +S
Sbjct: 106 RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGI--------------FHNTPKLTTLSMSN 150
Query: 389 NPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAI 448
N L + + ++ + L LS+ + + + + +L ++ N L+ +
Sbjct: 151 NNLERIEDDTFQATTS-LQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TL 201
Query: 449 GRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLG 508
++ L HN + + + L+ N L L + L + L
Sbjct: 202 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLS 256
Query: 509 FNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSI 568
+N L ++ ++ + + +S+N L L + + + +DLS N L + +
Sbjct: 257 YNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 314
Query: 569 GDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS 609
+++L L N ++ L +L L +S N+
Sbjct: 315 PQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 66/366 (18%), Positives = 127/366 (34%), Gaps = 58/366 (15%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
+ + E I +++ +++ N+ + LP+ + S ++ L L ++
Sbjct: 23 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFK-NSTMRKLPAALLDSFRQVELLNLNDLQI 81
Query: 329 TGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE 388
++ F+ ++KL +
Sbjct: 82 E----------------EIDTYAFAY-----------------------AHTIQKLYMGF 102
Query: 389 NPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELTGSIPKA 447
N + + P N+ + VL L ++ S+P I N LTTL + N L
Sbjct: 103 NAIRYLPPHVFQNVPL-LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160
Query: 448 IGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSL 507
LQ L L N+L DL + SL N L L I++ L
Sbjct: 161 FQATTSLQNLQLSSNRLT---HVDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDA 212
Query: 508 GFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSS 567
N + V L + L N+L + N + ++DLS N+L +
Sbjct: 213 SHNSINVVRGPVNVELTIL---KLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHP 267
Query: 568 IGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNL 627
++ ++ L +++N+ ++ + +L LD+S N+L + + L+ L L
Sbjct: 268 FVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325
Query: 628 SFNGLQ 633
N +
Sbjct: 326 DHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-29
Identities = 75/359 (20%), Positives = 129/359 (35%), Gaps = 51/359 (14%)
Query: 53 LNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIE 112
+++ E L+ ++ N++ L + R+++ L+ I+
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 113 IPPWLDSFPKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQLQGHVPSSIL-NIPS 170
++ LY+ N+ I +PP + N+ L L L N L +P I N P
Sbjct: 86 -TYAFAYAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPK 142
Query: 171 LLAIDLSNNQFSG-PMPSIYNTSPLQNIDMQYN-----------SLAELHLAYNQLSGQI 218
L + +SNN + T+ LQN+ + N SL +++YN L
Sbjct: 143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLL---- 198
Query: 219 PSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT-----GEIQGLQVLA 273
STL ++ L S +N I + + L L L + NLT GL +
Sbjct: 199 -STLAIPIAVEELDAS-HNSINVVRGPV--NVELTILKLQHNNLTDTAWLLNYPGLVEVD 254
Query: 274 LSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIP 333
LS N L ++ + + L L + +NN L L +P L+ L L N L +
Sbjct: 255 LSYNELEKIMYHPFVKMQRLERLYI-SNNRLVALNLYG-QPIPTLKVLDLSHNHLLH-VE 311
Query: 334 SSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLS 392
+ L + + +N ++ L+ L LS N
Sbjct: 312 RNQPQFDRLENLYLDHNSIVTLKLSTH------------------HTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 48/277 (17%), Positives = 107/277 (38%), Gaps = 21/277 (7%)
Query: 372 LTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNL 430
L D+ + +++ G I++ N ++ ++ +P+ + + +
Sbjct: 17 LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQK----IVTFKNSTMR-KLPAALLDSFRQV 71
Query: 431 TTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNG 490
L+L ++ A +Q LY+ N ++ + L+ + N+L+
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 491 SLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVV 550
+ L TLS+ N L + + + + N+ LSSN L V++ + +
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSL 188
Query: 551 TKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSG 610
++S N L S++ ++ L + N + + L L + NNL+
Sbjct: 189 FHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT- 239
Query: 611 EIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
+ L L ++LS+N L+ ++ + PF +
Sbjct: 240 DTA-WLLNYPGLVEVDLSYNELE-KIMY-HPFVKMQR 273
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-16
Identities = 42/217 (19%), Positives = 83/217 (38%), Gaps = 31/217 (14%)
Query: 419 SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSL 478
I S + +H++ L + + +++ ++ + L
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL------ 64
Query: 479 SEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNG 538
LDS + L+L ++ + + I + + N++
Sbjct: 65 -----------------LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR- 106
Query: 539 TLPVEI-GNLKVVTKIDLSRNDLSGEIPSSI-GDLKNMQHLSLADNKFQGSIPDSLGGLT 596
LP + N+ ++T + L RNDLS +P I + + LS+++N + D+ T
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 165
Query: 597 SLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQ 633
SL L +SSN L+ + S + L N+S+N L
Sbjct: 166 SLQNLQLSSNRLT-HVDLS--LIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 32/189 (16%), Positives = 66/189 (34%), Gaps = 4/189 (2%)
Query: 467 SITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDI 526
I ++L + + D + +L + + ++ + + + + L S R +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 527 LNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQ 585
+NL+ + + + K+ + N + P ++ + L L N
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 586 GSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNL 645
L L MS+NNL ++ +A + L+ L LS N L V +L
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL-IPSL 188
Query: 646 SSQSFVGNK 654
+ N
Sbjct: 189 FHANVSYNL 197
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-35
Identities = 62/284 (21%), Positives = 116/284 (40%), Gaps = 47/284 (16%)
Query: 746 LGKGSFGSVYKGTLSDG-----MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKI 799
LG G FG+V+KG + + +KV + + ++ +GS+ H ++V++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDHP 856
+ C + LV +Y+P GSL + + + LN + +A + YL
Sbjct: 81 LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM--- 136
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLL-GDETSMTQTQTLATIGYMAPE----WK 911
+H +L N+LL ++DFG++ LL D+ + ++ I +MA E K
Sbjct: 137 ---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 912 LSRKGDVYSYGIILMETFTK-KKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970
+ + DV+SYG+ + E T +P L + E+ +LL E
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-------------------PDLL--EK 232
Query: 971 AY-LTAKEQCVSSVLSLAMQCTRESAEER---INIKEALTKLLK 1010
L + C V + ++C R + T++ +
Sbjct: 233 GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 63/291 (21%), Positives = 114/291 (39%), Gaps = 47/291 (16%)
Query: 746 LGKGSFGSVYKGTLSDG-----MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKI 799
LG G+FG+VYKG + +A+K + E ++ S+ + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDHP 856
+ C + + L+ + MP G L +++ + LN + +A + YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT-IGYMAPE----WK 911
+H DL N+L+ ++DFG++KLLG E + I +MA E
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 912 LSRKGDVYSYGIILMETFTK-KKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970
+ + DV+SYG+ + E T KP D + EI ++L E
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------------------SSIL--EK 234
Query: 971 AY-LTAKEQCVSSVLSLAMQCTRESAEER---INIKEALTKLLKIRNTLLT 1017
L C V + ++C A+ R + +K+ + L
Sbjct: 235 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 285
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 65/192 (33%), Positives = 106/192 (55%), Gaps = 16/192 (8%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS 805
+GKG FG V G G ++AVK ++ + T ++F AE ++ +RH NLV+++
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 806 DHFKA-LVLEYMPNGSLENWMYNKNRS-FDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
+ +V EYM GSL +++ ++ RS L +DV A+EYL ++ +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 314
Query: 864 LNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGDVY 919
L N+L++E VA +SDFG++K + +S T L + + APE K S K DV+
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLP-VKWTAPEALREKKFSTKSDVW 370
Query: 920 SYGIILMETFTK 931
S+GI+L E ++
Sbjct: 371 SFGILLWEIYSF 382
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-34
Identities = 46/202 (22%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 746 LGKGSFGSVYKGTLSDG----MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKII 800
+G+G FG V++G M +A+K + F E + H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYDHPT 857
+ + +++E G L +++ + S D+ + +++AL YL +
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLS 913
+H D+ N+L++ + L DFG+S+ + D T ++ I +MAPE + +
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 914 RKGDVYSYGIILMETFTK-KKP 934
DV+ +G+ + E KP
Sbjct: 571 SASDVWMFGVCMWEILMHGVKP 592
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 55/232 (23%), Positives = 95/232 (40%), Gaps = 30/232 (12%)
Query: 718 EMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL-- 774
MS + + + + +G+GSF +VYKG +++A
Sbjct: 20 GMSNDGRFLKF--------------DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT 65
Query: 775 EGTLRSFDAECEILGSIRHRNLVKII----STCSSDHFKALVLEYMPNGSLENWMYNKNR 830
+ + F E E+L ++H N+V+ ST LV E M +G+L+ + +
Sbjct: 66 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFK 124
Query: 831 SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC-LSDFGISKLLG 889
I + + L++LH PIIH DL NI + + + D G++ L
Sbjct: 125 VMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183
Query: 890 DETSMTQTQTLATIGYMAPEW---KLSRKGDVYSYGIILMETFTKKKPTDEL 938
+ + T +MAPE K DVY++G+ ++E T + P E
Sbjct: 184 ASFAKA---VIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSEC 232
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-34
Identities = 93/507 (18%), Positives = 170/507 (33%), Gaps = 62/507 (12%)
Query: 145 SSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSL 204
L++S N + S IL++ L + +S+N+ S++ Q L
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVF--KFNQE-------L 71
Query: 205 AELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTG 264
L L++N+L I LK L LS N ++P + N++
Sbjct: 72 EYLDLSHNKLVK-ISCHPT--VNLKHLDLS-FNAFDALPICK-----------EFGNMSQ 116
Query: 265 EIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILG 324
L+ L LS+ L I +++ VL + L + L
Sbjct: 117 ----LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG---EKEDPEGLQDFNTESLH 169
Query: 325 GNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKL 384
T I + S+ T+ ++ + I L L L L L L
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLELSN----IKCVLEDNKCSYFLSILAKLQTNPKLSNL 225
Query: 385 ILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSI 444
L+ + I I L V Y +++ + L+
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYF-----------------SISNVKLQGQLDFRDF 268
Query: 445 PKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRT 504
+ L+ L + + + +++ + C +
Sbjct: 269 DYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLH 328
Query: 505 LSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIG---NLKVVTKIDLSRNDLS 561
L N LT + + L ++ + L N L L +K + ++D+S+N +S
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVS 387
Query: 562 GEIPSSIGD-LKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALS 620
+ K++ L+++ N +I L + LD+ SN + IP + L
Sbjct: 388 YDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLE 444
Query: 621 LLKFLNLSFNGLQGQVPHGGPFTNLSS 647
L+ LN++ N L+ VP G F L+S
Sbjct: 445 ALQELNVASNQLK-SVPD-GIFDRLTS 469
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 98/521 (18%), Positives = 183/521 (35%), Gaps = 64/521 (12%)
Query: 104 RSNNFSSI--EIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHV 161
N + ++ K L + N I ++S L L +S N++Q
Sbjct: 8 SKNGLIHVPKDLSQ------KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 162 PSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQ-YNSLAELHLAYNQLSGQIPS 220
S L +DLS+N+ L I +L L L++N
Sbjct: 62 ISVFKFNQELEYLDLSHNK-------------LVKISCHPTVNLKHLDLSFNAFDALPIC 108
Query: 221 TLFEC-KQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEI-----QGLQVLAL 274
F QLK L LS + S I ++ + K L ++ + Q +L
Sbjct: 109 KEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESL 168
Query: 275 SSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPS 334
T I+++S TV +L +N+ L N ++ + +L+ +
Sbjct: 169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLN 228
Query: 335 --SISNASMLTLIDMPYNLFSGFIP-NSLGFCHPYDELGFLTSLTNCKDLRKLILSENPL 391
+ S + ++ + ++ + +++ D F S T+ K L + +
Sbjct: 229 NIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF 288
Query: 392 SGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRL 451
SN M++ + + ++ L N LT ++ + G L
Sbjct: 289 GFPQSYIYEIFSN-MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
Query: 452 QKLQGLYLQHNKLQ--GSITTDLCGLRSLSEFYSDGNELNGSLPQCL-DSLISLRTLSLG 508
+L+ L LQ N+L+ I ++SL + N ++ + SL +L++
Sbjct: 348 TELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407
Query: 509 FNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSI 568
N LT I L + +DL N + IP +
Sbjct: 408 SNILTDTIFRCLPPR--------------------------IKVLDLHSNKIK-SIPKQV 440
Query: 569 GDLKNMQHLSLADNKFQGSIPD-SLGGLTSLNFLDMSSNNL 608
L+ +Q L++A N+ + S+PD LTSL + + +N
Sbjct: 441 VKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-29
Identities = 79/483 (16%), Positives = 163/483 (33%), Gaps = 49/483 (10%)
Query: 77 LNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGT 136
LN++ N S + +L +L+ L N ++ +LE+L L N +
Sbjct: 26 LNISQNYISELWTSDILSLSKLRILIISHNRIQYLD-ISVFKFNQELEYLDLSHNK-LVK 83
Query: 137 IPPSICNISSLLTLDLSFNQLQG-HVPSSILNIPSLLAIDLSNNQF-SGPMPSIYNTSPL 194
I +L LDLSFN + N+ L + LS + I + +
Sbjct: 84 ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNIS 141
Query: 195 QNIDMQYNS------------LAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSI 242
+ + + + L + + + + + +L ++N I +
Sbjct: 142 KVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN-IKCV 200
Query: 243 PREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANN 302
+ L L + TN L + + N + +++ +++ S++
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI--LQLVWHTTVWYFSISNVK 258
Query: 303 LLGNLPSN----IGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPN 358
L G L G SL L + + P S + + + +
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVS-------- 310
Query: 359 SLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKG 418
H + + L S N L+ + + G+L+ ++ L L +K
Sbjct: 311 GTRMVH-------MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE-LETLILQMNQLK- 361
Query: 419 SIPSEIG---NLNNLTTLHLETNELTGSIPKAI-GRLQKLQGLYLQHNKLQGSITTDLCG 474
+ + +L L + N ++ K + L L + N L +I C
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR--CL 419
Query: 475 LRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSN 534
+ N++ S+P+ + L +L+ L++ N+L SV L + + L +N
Sbjct: 420 PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
Query: 535 SLN 537
+
Sbjct: 479 PWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-17
Identities = 55/262 (20%), Positives = 96/262 (36%), Gaps = 33/262 (12%)
Query: 70 NLSFLSLLNVTNNSFSGTLPIQLSNLR--RLKYLSFRSNNFSSIEIPP--WLDSFPKLEH 125
+ + +++N G L + + LK LS P + F +
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 126 LYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPM 185
+ IS L LD S N L V + ++ L + L NQ
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK--- 361
Query: 186 PSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFEC-KQLKILSLSVNNFIGSIPR 244
S + + Q SL +L ++ N +S K L L++S N +I R
Sbjct: 362 ----ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417
Query: 245 EIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLL 304
+ ++VL L SN++ IP +++ + +L L++ A+N L
Sbjct: 418 CLP-------------------PRIKVLDLHSNKIK-SIPKQVVKLEALQELNV-ASNQL 456
Query: 305 GNLPSNIGHSLPNLQQLILGGN 326
++P I L +LQ++ L N
Sbjct: 457 KSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 6e-14
Identities = 47/267 (17%), Positives = 87/267 (32%), Gaps = 17/267 (6%)
Query: 401 NLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQ 460
+LS +L +S I S+I +L+ L L + N + Q+L+ L L
Sbjct: 18 DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77
Query: 461 HNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQC--LDSLISLRTLSLGFNRLTSVIPS 518
HNKL I+ +L N + +LP C ++ L+ L L L
Sbjct: 78 HNKLV-KISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133
Query: 519 SLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLS 578
+ L + + + + L+ L + + I D+ +
Sbjct: 134 PIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 579 L---------ADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSF 629
L DNK + T+ +++ NN+ + ++ L L+ + +
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251
Query: 630 NGLQGQVPHGGPFTNLSSQSFVGNKGL 656
+ G S K L
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKAL 278
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-34
Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 740 FSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEIL-GSIRHRNLVK 798
F ++LG G+ G++ + D +AVK E E ++L S H N+++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIR 82
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
T F+ + +E +L+ ++ K+ + L+ + ++ S L +LH +
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--- 138
Query: 859 IIHCDLNPSNILL-----NESMVACLSDFGISKLL-GDETSMTQTQTLA-TIGYMAPE-- 909
I+H DL P NIL+ + + A +SDFG+ K L S ++ + T G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 910 -----WKLSRKGDVYSYGIILMETFTKKKP 934
+ D++S G + ++
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-34
Identities = 94/555 (16%), Positives = 183/555 (32%), Gaps = 82/555 (14%)
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSF 120
I L +++ + + L K ++F+++ + LDSF
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP-AALLDSF 74
Query: 121 PKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNN 179
++E L L+ I I ++ L + FN ++ P N+P L + L N
Sbjct: 75 RQVELLNLNDLQ-IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133
Query: 180 QFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSVNNF 238
S I++ +P L L ++ N L +I F+ L+ L LS +N
Sbjct: 134 DLSSLPRGIFHNTP---------KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS-SNR 182
Query: 239 IGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSL 298
+ + I L +S N L+ + ++ L
Sbjct: 183 LTHVDL-------------------SLIPSLFHANVSYNLLS-----TLAIPIAVEELDA 218
Query: 299 TANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPN 358
++N + + + L L L N LT + + N L +D+ YN + +
Sbjct: 219 -SHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYH 272
Query: 359 SLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKG 418
+ L +L +S N L L + + + VL LS ++
Sbjct: 273 PFV---------------KMQRLERLYISNNRLV-ALNLYGQPIPT-LKVLDLSHNHLL- 314
Query: 419 SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSL 478
+ + L L+L+ N + ++ + L+ L L HN + L R++
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNV 369
Query: 479 SEFYSDGNELNGSLPQ-------CLDSLISLRTLSLGFNRLTSVI---PSSLWSLRDILN 528
+ D + + + C +S L + LTSV+ +
Sbjct: 370 ARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDT 429
Query: 529 VNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPS----SIGDLKNMQHLSLADNKF 584
+N + + L+ +++ N+L E+ I + +Q L +
Sbjct: 430 INSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTN 489
Query: 585 QGSIPDSLGGLTSLN 599
GL +
Sbjct: 490 LRRYRLPKDGLARSS 504
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 88/515 (17%), Positives = 173/515 (33%), Gaps = 73/515 (14%)
Query: 134 IGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSP 193
I ++ + + + + + + + N+ ++ +
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLD--- 72
Query: 194 LQNIDMQYNSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSVNNFIGSIPREIGNITML 252
+ + L+L Q+ +I + F ++ L + N I +P +
Sbjct: 73 ------SFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMG-FNAIRYLPPHV-----F 119
Query: 253 KGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEI-INISSLTVLSLTANNLLGNLPSNI 311
+ + L VL L N L+ +P I N LT LS+ +NN L + +
Sbjct: 120 QNV-----------PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSM-SNNNLERIEDDT 166
Query: 312 GHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGF 371
+ +LQ L L NRLT S I + L ++ YNL
Sbjct: 167 FQATTSLQNLQLSSNRLTHVDLSLIPS---LFHANVSYNL-------------------- 203
Query: 372 LTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLT 431
L++L + +L S N ++ V L+ +L L N+ + N L
Sbjct: 204 LSTLAIPIAVEELDASHNSINVVRGPVNVELT----ILKLQHNNLT-DTAW-LLNYPGLV 257
Query: 432 TLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGS 491
+ L NEL + ++Q+L+ LY+ +N+L ++ + +L N L
Sbjct: 258 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-H 315
Query: 492 LPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGT----LPVEIGNL 547
+ + L L L N + ++ S+ +L+ N+ LS N + L +
Sbjct: 316 VERNQPQFDRLENLYLDHNSIVTLKLSTHHTLK---NLTLSHNDWDCNSLRALFRNVARP 372
Query: 548 KVVTKIDLSRNDLSGE----IPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDM 603
V + D E S + +A + + G ++ + ++
Sbjct: 373 AVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINS 432
Query: 604 SSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH 638
+ L + L N L+ +V
Sbjct: 433 VQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQ 467
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 68/486 (13%), Positives = 146/486 (30%), Gaps = 103/486 (21%)
Query: 176 LSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSV 235
+ Q P + + ++H+ KI++
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFK- 59
Query: 236 NNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEII-NISSLT 294
N+ + +P + L + +++L L+ ++ I ++
Sbjct: 60 NSTMRKLPAAL-----LDSF-----------RQVELLNLNDLQIE-EIDTYAFAYAHTIQ 102
Query: 295 VLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSG 354
L + N + LP ++ ++P L L+L N L+ +P +F
Sbjct: 103 KLYM-GFNAIRYLPPHVFQNVPLLTVLVLERNDLS----------------SLPRGIFHN 145
Query: 355 FIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSAC 414
L L +S N L + + ++ + L LS+
Sbjct: 146 --------------------TPK---LTTLSMSNNNLERIEDDTFQATTS-LQNLQLSSN 181
Query: 415 NIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCG 474
+ + + + +L ++ N L+ + ++ L HN +
Sbjct: 182 RLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN--------- 224
Query: 475 LRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSN 534
+ + L L L N LT + L + ++ V+LS N
Sbjct: 225 ----------------VVRG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYN 264
Query: 535 SLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGG 594
L + ++ + ++ +S N L + + ++ L L+ N + +
Sbjct: 265 ELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 322
Query: 595 LTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNK 654
L L + N++ + L LK L LS N F N++ +
Sbjct: 323 FDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDC-NSLRALFRNVARPAVDDAD 378
Query: 655 GLCGAP 660
C
Sbjct: 379 QHCKID 384
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
+LGKG++G VY G LS+ ++IA+K + E + ++H+N+V+ + +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRL--NMVIDVASALEYLHYDHPTPIIH 861
S + F + +E +P GSL + +K ++ + L+YLH + I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 862 CDLNPSNILLNESMVAC-LSDFGISKLLGDETSMTQTQTLATIGYMAPE------WKLSR 914
D+ N+L+N +SDFG SK L T+T T T+ YMAPE +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGYGK 204
Query: 915 KGDVYSYGIILMETFTKKKP 934
D++S G ++E T K P
Sbjct: 205 AADIWSLGCTIIEMATGKPP 224
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 65/298 (21%), Positives = 117/298 (39%), Gaps = 34/298 (11%)
Query: 738 DGFSENNLLGKGSFGSVYKGT-LSDGMQIAVK---VFNLELEGTLRSFDAECEILGSIRH 793
F +G+G F VY+ L DG+ +A+K +F+L E ++L + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 794 RNLVKIISTCSSDHFKALVLEYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEY 850
N++K ++ D+ +VLE G L + + + R + + SALE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE- 909
+H ++H D+ P+N+ + + V L D G+ + +T+ + T YM+PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 910 WKL---SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966
+ K D++S G +L E + P F G+ SL KI
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP----FYGD----KMNLYSLCKKIEQ------- 252
Query: 967 QKEDAYLTAKEQCVSSVL-SLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIENSS 1023
Y S L L C E+R ++ ++ +++E+
Sbjct: 253 ---CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 744 NLLGKGSFGSVYKGTLSDG----MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVK 798
++G+G FG VY GTL D + AVK N G + F E I+ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 799 IISTCSSDHFKAL-VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
++ C L VL YM +G L N++ N+ + + + + VA ++YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-- 148
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT---IGYMAPE----W 910
+H DL N +L+E ++DFG+++ + D+ + + +MA E
Sbjct: 149 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 911 KLSRKGDVYSYGIILMETFT 930
K + K DV+S+G++L E T
Sbjct: 208 KFTTKSDVWSFGVLLWELMT 227
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 51/208 (24%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 742 ENNLLGKGSFGSVYKGTLSDG----MQIAVKVFNLELEGT----LRSFDAECEILGSIRH 793
+ ++GKG FG VY G D +Q A+K + T + +F E ++ + H
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNH 81
Query: 794 RNLVKIISTCS-SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL- 851
N++ +I + ++L YM +G L ++ + R+ + ++ + VA +EYL
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 852 --HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT---IGYM 906
+ +H DL N +L+ES ++DFG+++ + D + Q + +
Sbjct: 142 EQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 907 APE----WKLSRKGDVYSYGIILMETFT 930
A E ++ + K DV+S+G++L E T
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 36/214 (16%)
Query: 746 LGKGSFGSVYKGTL--------SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLV 797
LG+G+F ++KG ++ +KV + SF ++ + H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL---HYD 854
C LV E++ GSL+ ++ +IL +L + +A+A+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134
Query: 855 HPTPIIHCDLNPSNILLN--------ESMVACLSDFGISKLLGDETSMTQTQTLATIGYM 906
IH ++ NILL LSD GIS + + I ++
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-----LQERIPWV 184
Query: 907 APE-----WKLSRKGDVYSYGIILMETFTK-KKP 934
PE L+ D +S+G L E + KP
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 65/196 (33%), Positives = 106/196 (54%), Gaps = 22/196 (11%)
Query: 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
+GKG FG V G G ++AVK ++ + T ++F AE ++ +RH NLV+++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 804 SSDHFKA-LVLEYMPNGSLENWMYNKNRS-FDILQRLNMVIDVASALEYL---HYDHPTP 858
+ +V EYM GSL +++ ++ RS L +DV A+EYL ++
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----- 138
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSR 914
+H DL N+L++E VA +SDFG++K + +S T L + + APE K S
Sbjct: 139 -VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLP-VKWTAPEALREKKFST 193
Query: 915 KGDVYSYGIILMETFT 930
K DV+S+GI+L E ++
Sbjct: 194 KSDVWSFGILLWEIYS 209
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 31/222 (13%)
Query: 735 RATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRH 793
R F E L+G G FG V+K DG +K E R E + L + H
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDH 63
Query: 794 RNLVK----------------IISTCSSDHFKALVLEYMPNGSLENWM-YNKNRSFDILQ 836
N+V S+ S + +E+ G+LE W+ + D +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 837 RLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896
L + + ++Y+H +I+ DL PSNI L ++ + DFG+ L ++
Sbjct: 124 ALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178
Query: 897 TQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFTKKKP 934
T++ T+ YM+PE ++ D+Y+ G+IL E
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIIS 801
+G+GSFG DG Q +K N+ E +L +++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 802 TCSSDHFKALVLEYMPNGSLENWM-YNKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
+ + +V++Y G L + K F Q L+ + + AL+++H I+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---IL 147
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE-WKL---SRKG 916
H D+ NI L + L DFGI+++L + + T Y++PE + + K
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNKS 206
Query: 917 DVYSYGIILMETFTKKKP 934
D+++ G +L E T K
Sbjct: 207 DIWALGCVLYELCTLKHA 224
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNL--VKI 799
+G G V++ A+K NLE TL S+ E L ++ + +++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
+D + +V+E N L +W+ K +S D +R + ++ A+ +H I
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 148
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA-TIGYMAPE--------- 909
+H DL P+N L+ + M+ L DFGI+ + +T+ + T+ YM PE
Sbjct: 149 VHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 910 ------WKLSRKGDVYSYGIILMETFTKKKP 934
K+S K DV+S G IL K P
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIIS 801
+G GS+G K SDG + K + E + +E +L ++H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 802 TCSSDHFKAL--VLEYMPNGSLENW---MYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
L V+EY G L + + + D L ++ + AL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 857 TP--IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE-WK-- 911
++H DL P+N+ L+ L DFG++++L +TS +T + T YM+PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMSPEQMNRM 191
Query: 912 -LSRKGDVYSYGIILMETFTKKKP 934
+ K D++S G +L E P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-32
Identities = 70/342 (20%), Positives = 130/342 (38%), Gaps = 43/342 (12%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
++L L NR+ + E + L L L N++ + ++L NL+ L L NRL
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELN-ENIVSAVEPGAFNNLFNLRTLGLRSNRL 92
Query: 329 TGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE 388
+ S LT +D+ N + L N L+ L + +
Sbjct: 93 KLIPLGVFTGLSNLTKLDISENKIVILLDYMF------------QDLYN---LKSLEVGD 137
Query: 389 NPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELTGSIPKA 447
N L + + L++ ++ L L CN+ SIP+E +L+ L L L + +
Sbjct: 138 NDLVYISHRAFSGLNS-LEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYS 195
Query: 448 IGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSL 507
RL +L+ L + H ++T + +L+ L + L+ LR L+L
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNL 255
Query: 508 GFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSS 567
+N ++++ S L L + +I L L+ P +
Sbjct: 256 SYNPISTIEGSML------------------------HELLRLQEIQLVGGQLAVVEPYA 291
Query: 568 IGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS 609
L ++ L+++ N+ + +L L + SN L+
Sbjct: 292 FRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-29
Identities = 62/277 (22%), Positives = 113/277 (40%), Gaps = 9/277 (3%)
Query: 374 SLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTT 432
+ L +L L+EN +S V P + NL N + L L + +K IP + L+NLT
Sbjct: 51 EFASFPHLEELELNENIVSAVEPGAFNNLFN-LRTLGLRSNRLK-LIPLGVFTGLSNLTK 108
Query: 433 LHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD-LCGLRSLSEFYSDGNELNGS 491
L + N++ + L L+ L + N L I+ GL SL + + L
Sbjct: 109 LDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSI 167
Query: 492 LPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVT 551
+ L L L L L + ++ S L + + +S T+ +T
Sbjct: 168 PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227
Query: 552 KIDLSRNDLSGEIPS-SIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSG 610
+ ++ +L+ +P ++ L ++ L+L+ N L L L + + L+
Sbjct: 228 SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV 286
Query: 611 EIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
P + + L+ L+ LN+S N L F ++ +
Sbjct: 287 VEPYAFRGLNYLRVLNVSGNQL--TTLEESVFHSVGN 321
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 61/337 (18%), Positives = 128/337 (37%), Gaps = 36/337 (10%)
Query: 42 TCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYL 101
CS + R V + +P + + LL++ N + ++ L+ L
Sbjct: 8 ECSAQDRAV---LCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEEL 61
Query: 102 SFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQLQGH 160
N S++E P ++ L L L N + IP + +S+L LD+S N++
Sbjct: 62 ELNENIVSAVE-PGAFNNLFNLRTLGLRSNR-LKLIPLGVFTGLSNLTKLDISENKIV-I 118
Query: 161 VPSSIL-NIPSLLAIDLSNNQFSG-PMPSIYNTSPLQNIDMQYN--------------SL 204
+ + ++ +L ++++ +N + + L+ + ++ L
Sbjct: 119 LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGL 178
Query: 205 AELHLAYNQLSGQIPSTLFE-CKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT 263
L L + ++ I F+ +LK+L +S ++ ++ L L + + NLT
Sbjct: 179 IVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT 237
Query: 264 -------GEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLP 316
+ L+ L LS N ++ + + + L + L L + L
Sbjct: 238 AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLV-GGQLAVVEPYAFRGLN 296
Query: 317 NLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFS 353
L+ L + GN+LT S + L + + N +
Sbjct: 297 YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-28
Identities = 57/270 (21%), Positives = 103/270 (38%), Gaps = 7/270 (2%)
Query: 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETN 438
+ R L L +N + + + + ++ L L+ + ++ NL NL TL L +N
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPH-LEELELNENIVS-AVEPGAFNNLFNLRTLGLRSN 90
Query: 439 ELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDS 498
L L L L + NK+ + L +L N+L +
Sbjct: 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150
Query: 499 LISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRN 558
L SL L+L LTS+ +L L ++ + L ++N L + +++S
Sbjct: 151 LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 559 DLSGEIPSSIGDLKNMQHLSLADNKFQGSIP-DSLGGLTSLNFLDMSSNNLSGEIPNSLK 617
+ + N+ LS+ ++P ++ L L FL++S N +S + L
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLH 269
Query: 618 ALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
L L+ + L L V F L+
Sbjct: 270 ELLRLQEIQLVGGQL--AVVEPYAFRGLNY 297
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 65/348 (18%), Positives = 127/348 (36%), Gaps = 42/348 (12%)
Query: 217 QIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSS 276
+P + + ++L L N I ++ ++ L+ L L+
Sbjct: 25 AVPEGIPT--ETRLLDLG-KNRIKTLNQD-----EFASF-----------PHLEELELNE 65
Query: 277 NRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSI 336
N ++ V P N+ +L L L +N L +P + L NL +L + N++ +
Sbjct: 66 NIVSAVEPGAFNNLFNLRTLGL-RSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMF 124
Query: 337 SNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLP 396
+ L +++ N +I + + L + L +L L + L+ +
Sbjct: 125 QDLYNLKSLEVGDNDLV-YISH-----------RAFSGLNS---LEQLTLEKCNLTSIPT 169
Query: 397 ISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELTGSIPKAIGRLQKLQ 455
++ +L + VL L NI +I L L L + ++ L
Sbjct: 170 EALSHLHG-LIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227
Query: 456 GLYLQHNKLQGSITTDLC-GLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTS 514
L + H L ++ L L N ++ L L+ L+ + L +L
Sbjct: 228 SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV 286
Query: 515 VIPSSLWSLRDILNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRNDLS 561
V P + L + +N+S N L TL + ++ + + L N L+
Sbjct: 287 VEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 48/248 (19%), Positives = 84/248 (33%), Gaps = 28/248 (11%)
Query: 401 NLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQ 460
+ +L L IK E + +L L L N ++ P A L L+ L L+
Sbjct: 29 GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR 88
Query: 461 HNKLQGSITTD-LCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSS 519
N+L+ I GL +L++ N++ L L +L++L +G N L + +
Sbjct: 89 SNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRA 147
Query: 520 LWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSL 579
L + + L +L T I ++ L + L L
Sbjct: 148 FSGLNSLEQLTLEKCNL--------------TSIP----------TEALSHLHGLIVLRL 183
Query: 580 ADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHG 639
S L L L++S + + L L+++ L VP+
Sbjct: 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYL 242
Query: 640 GPFTNLSS 647
+L
Sbjct: 243 A-VRHLVY 249
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 9e-20
Identities = 43/217 (19%), Positives = 82/217 (37%), Gaps = 6/217 (2%)
Query: 431 TTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNG 490
+ ++P+ I + + L L N+++ + L E + N ++
Sbjct: 14 RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA 70
Query: 491 SLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVV 550
P ++L +LRTL L NRL + L ++ +++S N + L +L +
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNL 130
Query: 551 TKIDLSRNDLSGEIPSSI-GDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS 609
+++ NDL I L +++ L+L ++L L L L + N++
Sbjct: 131 KSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189
Query: 610 GEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLS 646
S K L LK L +S L+
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYL-DTMTPNCLYGLN 225
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 744 NLLGKGSFGSVYKGTLSDG----MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVK 798
++G+G FG VY GTL D + AVK N G + F E I+ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 799 IISTCSSDHFKAL-VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
++ C L VL YM +G L N++ N+ + + + + VA +++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-- 212
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT---IGYMAPE----W 910
+H DL N +L+E ++DFG+++ + D+ + + +MA E
Sbjct: 213 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 911 KLSRKGDVYSYGIILMETFT 930
K + K DV+S+G++L E T
Sbjct: 272 KFTTKSDVWSFGVLLWELMT 291
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 66/282 (23%), Positives = 117/282 (41%), Gaps = 44/282 (15%)
Query: 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNL--VKI 799
+G G V++ A+K NLE TL S+ E L ++ + +++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
+D + +V+E N L +W+ K +S D +R + ++ A+ +H I
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 129
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA-TIGYMAPE--------- 909
+H DL P+N L+ + M+ L DFGI+ + +T+ + T+ YM PE
Sbjct: 130 VHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 910 ------WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963
K+S K DV+S G IL K P F I+ S+++ II+
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLH-----AIID---- 235
Query: 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
+ + + + + C + ++RI+I E L
Sbjct: 236 -----PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 38/226 (16%)
Query: 735 RATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRH 793
R F E +LG+G+FG V K D A+K E L + +E +L S+ H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNH 61
Query: 794 RNLVKI-------------ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNM 840
+ +V+ ++ + +EY NG+L + ++++N + + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 841 VIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL 900
+ AL Y+H IIH DL P NI ++ES + DFG++K + + + +
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 901 ATIG-------------YMAPEWKLSRKG------DVYSYGIILME 927
G Y+A E L G D+YS GII E
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFE 223
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 50/241 (20%), Positives = 87/241 (36%), Gaps = 22/241 (9%)
Query: 704 IRRQKRNTGLQIDEEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGT-LSDG 762
++R T ++ ++ Y+E + +G+GSFG V++ G
Sbjct: 27 LQRLGPETEDNEGVLLTEKLKPVDYEYREEVH---WMTHQPRVGRGSFGEVHRMKDKQTG 83
Query: 763 MQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLE 822
Q AVK LE E + +V + + + +E + GSL
Sbjct: 84 FQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138
Query: 823 NWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC-LSD 881
+ + + L + LEYLH I+H D+ N+LL+ L D
Sbjct: 139 Q-LIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCD 194
Query: 882 FGISKLLGDE---TSMTQTQTLA-TIGYMAPE----WKLSRKGDVYSYGIILMETFTKKK 933
FG + L + S+ + T +MAPE K D++S +++
Sbjct: 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
Query: 934 P 934
P
Sbjct: 255 P 255
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 746 LGKGSFGSVYKGTLSDG----MQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKI 799
LG+G FGSV +G L +++AVK L+ + + F +E + H N++++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 800 ISTCSSDHFKA-----LVLEYMPNGSL-----ENWMYNKNRSFDILQRLNMVIDVASALE 849
+ C + ++L +M G L + + + + L ++D+A +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 850 YLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL--GDETSMTQTQTLATIGYMA 907
YL + +H DL N +L + M C++DFG+SK + GD + ++A
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG-RIAKMPVKWIA 217
Query: 908 PE----WKLSRKGDVYSYGIILMETFT 930
E + K DV+++G+ + E T
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-31
Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNL--VKI 799
+G G V++ A+K NLE TL S+ E L ++ + +++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
+D + +V+E N L +W+ K D +R + ++ A+ +H I
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHG---I 176
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA-TIGYMAPE--------- 909
+H DL P+N L+ + M+ L DFGI+ + +T+ + + YM PE
Sbjct: 177 VHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 910 ------WKLSRKGDVYSYGIILMETFTKKKP 934
K+S K DV+S G IL K P
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 71/330 (21%), Positives = 119/330 (36%), Gaps = 34/330 (10%)
Query: 64 IPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKL 123
I N + + VT++S L + +K L N S I L F KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQIS-AADLAPFTKL 60
Query: 124 EHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSG 183
E L L N + ++S+L TLDL+ N + +L PS+ + +NN S
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 184 PMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIP 243
S ++LA N+++ +++ L L N I ++
Sbjct: 114 VSCSR------------GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK-LNEIDTVN 160
Query: 244 RE--IGNITMLKGLYLVY---TNLTGEI--QGLQVLALSSNRLTGVIPPEIINISSLTVL 296
+ L+ L L Y ++ G++ L+ L LSSN+L + PE + + +T +
Sbjct: 161 FAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 297 SLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFI 356
SL NN L + + NL+ L GN + + +
Sbjct: 220 SL-RNNKLVLIEKALRF-SQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLT 276
Query: 357 PNSLGFCHPYDELGFLTSLTNCKDLRKLIL 386
+ C LG + C+DL
Sbjct: 277 GQNEEEC-TVPTLGHYGAYC-CEDLPAPFA 304
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 55/344 (15%), Positives = 108/344 (31%), Gaps = 56/344 (16%)
Query: 311 IGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELG 370
I + + + + L + S +A + +D+ N S L
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLA--------- 55
Query: 371 FLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNL 430
L L LS N L L + +LS + L L+ + E+ ++
Sbjct: 56 ------PFTKLELLNLSSNVLYETLDL--ESLST-LRTLDLNNNYV-----QELLVGPSI 101
Query: 431 TTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNG 490
TLH N ++ + + Q + +YL +NK+ D + NE++
Sbjct: 102 ETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158
Query: 491 -SLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKV 549
+ + S +L L+L +N + V +++ LK
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIYDVKGQVVFA-----------------------KLK- 194
Query: 550 VTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS 609
+DLS N L+ + + +SL +NK I +L +L D+ N
Sbjct: 195 --TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
Query: 610 GEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGN 653
+ ++ ++ + + G
Sbjct: 251 CGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 51/284 (17%), Positives = 94/284 (33%), Gaps = 33/284 (11%)
Query: 194 LQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLK 253
+ I N + + L + S +K L LS N ++ T L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 254 GLYLVYTNLT-----GEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLP 308
L L L + L+ L L++N + E++ S+ L ANN + +
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHA-ANNNISRVS 115
Query: 309 SNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDE 368
+ + + L N++T S + +D+ N
Sbjct: 116 CSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID--------------T 158
Query: 369 LGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLN 428
+ F + L L L N + + + + + L LS+ + + E +
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAK-LKTLDLSSNKLA-FMGPEFQSAA 214
Query: 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDL 472
+T + L N+L I KA+ Q L+ L+ N D
Sbjct: 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 52/349 (14%), Positives = 113/349 (32%), Gaps = 42/349 (12%)
Query: 241 SIPREIGNITMLKGLYLVYTNLTGEIQG-------LQVLALSSNRLTGVIPPEIINISSL 293
+I N K + ++L + ++ L LS N L+ + ++ + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 294 TVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFS 353
+L+L ++N+L SL L+ L L N + + + + N S
Sbjct: 61 ELLNL-SSNVLYETLDL--ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 354 GFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSA 413
+ + + + L+ N ++ + + G S + L L
Sbjct: 113 RVSCSRG------------------QGKKNIYLANNKITMLRDLDEGCRSR-VQYLDLKL 153
Query: 414 CNIKG-SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDL 472
I + + + L L+L+ N + + + KL+ L L NKL + +
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEF 210
Query: 473 CGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLS 532
++ N+L + + L +L L N +S + ++
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ-TVA 268
Query: 533 SNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIG-DLKNMQHLSLA 580
++ L + V + ++P+ L + H
Sbjct: 269 KQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 57/362 (15%), Positives = 115/362 (31%), Gaps = 81/362 (22%)
Query: 121 PKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQ 180
+ + + +S + + ++ LDLS N L + + L ++LS+N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 181 FSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIG 240
+Y T L+++ ++L L L N + L ++ L + NN I
Sbjct: 70 -------LYETLDLESL----STLRTLDLNNNYVQ-----ELLVGPSIETLHAA-NNNIS 112
Query: 241 SIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTA 300
+ G QG + + L++N++T + + S + L L
Sbjct: 113 RVSCSRG-------------------QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL 153
Query: 301 NNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSL 360
N + + + S L+ L L N +
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIYD------------------------------ 183
Query: 361 GFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSI 420
+ L+ L LS N L+ + + + + + L + I
Sbjct: 184 -----------VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAG-VTWISLRNNKLV-LI 229
Query: 421 PSEIGNLNNLTTLHLETNELT-GSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLS 479
+ NL L N G++ + Q++Q + Q K + C + +L
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289
Query: 480 EF 481
+
Sbjct: 290 HY 291
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 44/232 (18%), Positives = 80/232 (34%), Gaps = 24/232 (10%)
Query: 419 SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSL 478
+I N N + + L ++ ++ L L N L DL L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 479 SEFYSDGNELNGSLP-----------------QCLDSLISLRTLSLGFNRLTSVIPSSLW 521
N L +L Q L S+ TL N ++ V S
Sbjct: 61 ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQ 120
Query: 522 SLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSG-EIPSSIGDLKNMQHLSLA 580
+ N+ L++N + ++ G V +DL N++ ++HL+L
Sbjct: 121 GKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 581 DNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGL 632
N + + L LD+SSN L+ + ++ + + +++L N L
Sbjct: 178 YNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 49/285 (17%), Positives = 91/285 (31%), Gaps = 30/285 (10%)
Query: 53 LNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIE 112
L+L+ L +L + L LLN+++N TL + +L L+ L +N +
Sbjct: 39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDL--ESLSTLRTLDLNNNYVQELL 96
Query: 113 IPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLL 172
+ P +E L+ N+ I + S + L+ N++ +
Sbjct: 97 VG------PSIETLHAANNN-ISRVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQ 147
Query: 173 AIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILS 232
+DL N+ T + ++L L+L YN + + + +LK L
Sbjct: 148 YLDLKLNEID--------TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLD 197
Query: 233 LSVNNFIGSIPREIGNITMLKGLYLVYTNLT------GEIQGLQVLALSSNRLTGVIPPE 286
LS +N + + E + + + L L Q L+ L N +
Sbjct: 198 LS-SNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRD 256
Query: 287 IINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGP 331
S + A + L G
Sbjct: 257 F--FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 17/82 (20%), Positives = 31/82 (37%), Gaps = 1/82 (1%)
Query: 564 IPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLK 623
I + + + D+ + ++ ++ LD+S N LS L + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 624 FLNLSFNGLQGQVPHGGPFTNL 645
LNLS N L + + L
Sbjct: 62 LLNLSSNVLY-ETLDLESLSTL 82
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 67/393 (17%), Positives = 137/393 (34%), Gaps = 50/393 (12%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
+ + LS N + + + L L + + +N L +L L L N+
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 329 TGPIPSSI-SNASMLTLIDMPYN-LFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLIL 386
+ + + + L ++ + L + F LT+ L L+L
Sbjct: 92 LQ-LETGAFNGLANLEVLTLTQCNLDGAVLSG-----------NFFKPLTS---LEMLVL 136
Query: 387 SENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-----------GNLNNLTTLHL 435
+N + + P S VL L+ +K SI E L+++T +
Sbjct: 137 RDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDM 195
Query: 436 ETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQC 495
L + + L L N + S+ + ++ S + ++
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 496 LDSLI---------------SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTL 540
++T L +++ +++ S D+ + L+ N +N +
Sbjct: 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KI 314
Query: 541 PVEI-GNLKVVTKIDLSRNDLSGEIPSSIGD-LKNMQHLSLADNKFQGSIP-DSLGGLTS 597
L + K++LS+N L I S + + L ++ L L+ N + ++ S GL +
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPN 372
Query: 598 LNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFN 630
L L + +N L L+ L+ + L N
Sbjct: 373 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-30
Identities = 75/445 (16%), Positives = 150/445 (33%), Gaps = 73/445 (16%)
Query: 98 LKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSIC-NISSLLTLDLSFNQ 156
+ Y+ N+ + + L+ L ++ + I + +SSL+ L L +NQ
Sbjct: 32 VNYVDLSLNSIAELN-ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 157 LQGHVPSSIL-NIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLS 215
+ + + +L + L+ G + S PL + L L L N +
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS-------LEMLVLRDNNIK 142
Query: 216 GQIPSTLFEC-KQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLAL 274
P++ F ++ +L L+ N + SI E + +G + L + + +
Sbjct: 143 KIQPASFFLNMRRFHVLDLT-FNKVKSICEED--LLNFQGKHFTLLRL----SSITLQDM 195
Query: 275 SSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPS 334
+ L +S+T L L+ N ++ ++ + L + S
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 335 SISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGV 394
D F G + + + LS++ + +
Sbjct: 256 FGHTN----FKDPDNFTFKGLEASGV---------------------KTCDLSKSKIFAL 290
Query: 395 LPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELTGSIPKAI-GRLQ 452
L + ++ ++ L L+ I I L +L L+L N L SI + L
Sbjct: 291 LKSVFSHFTD-LEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLD 347
Query: 453 KLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRL 512
KL+ L L +N ++ ++ L +L+ L+L N+L
Sbjct: 348 KLEVLDLSYNHIR-ALGDQS-----------------------FLGLPNLKELALDTNQL 383
Query: 513 TSVIPSSLWSLRDILNVNLSSNSLN 537
SV L + + L +N +
Sbjct: 384 KSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 86/428 (20%), Positives = 146/428 (34%), Gaps = 63/428 (14%)
Query: 50 VTALNLAYMGLLGTIPPE-LGNLSFLSLLNVTNNSFSGTLPIQL-SNLRRLKYLSFRSNN 107
V ++L+ + + L L L V + + L L L N
Sbjct: 32 VNYVDLSLNSI-AELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 108 FSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSIC--NISSLLTLDLSFNQLQGHVPSSI 165
F +E + LE L L + G + ++SL L L N ++ P+S
Sbjct: 91 FLQLE-TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 166 L-NIPSLLAIDLSNNQFSG-PMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLF 223
N+ +DL+ N+ + N ++ +S+ + L + F
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 224 ECKQLKILSLSVNNFIGSIPREI-GNITMLKGLYLVYTNLTGEIQGL---QVLALSSNRL 279
+ + L LS N F S+ + I K L+ +N +
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 280 TGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNA 339
G + S + L+ + + L ++ +L+QL L N +
Sbjct: 270 KG------LEASGVKTCDLS-KSKIFALLKSVFSHFTDLEQLTLAQNEIN---------- 312
Query: 340 SMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISI 399
+ N F G LT+ L KL LS+N L +
Sbjct: 313 ------KIDDNAFWG--------------------LTH---LLKLNLSQNFLGSIDSRMF 343
Query: 400 GNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELTGSIPK-AIGRLQKLQGL 457
NL ++VL LS +I+ ++ + L NL L L+TN+L S+P RL LQ +
Sbjct: 344 ENLDK-LEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKI 400
Query: 458 YLQHNKLQ 465
+L N
Sbjct: 401 WLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 72/437 (16%), Positives = 134/437 (30%), Gaps = 91/437 (20%)
Query: 203 SLAELHLAYNQLSGQIPSTLFEC-KQLKILSLSVNNFIGSIPREI-GNITMLKGLYLVYT 260
+ + L+ N ++ ++ T F + L+ L + I ++ L L L Y
Sbjct: 31 HVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 261 NLT-------GEIQGLQVLALSSNRLTGVIPPEII--NISSLTVLSLTANNLLGNLPSNI 311
+ L+VL L+ L G + ++SL +L L NN+ P++
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 312 GHSLPNLQQLILGGNRLTGPIPSSI---SNASMLTLIDMPYNLFSGFIPNSLGFCHPYDE 368
++ L L N++ I TL+ + LG+
Sbjct: 150 FLNMRRFHVLDLTFNKVKS-ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC--- 205
Query: 369 LGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGN-- 426
+ + L LS N + + + L N S
Sbjct: 206 ----GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNF 261
Query: 427 ------------LNNLTTLHLETNELTGSIPKAI-GRLQKLQGLYLQHNKLQGSITTDLC 473
+ + T L +++ ++ K++ L+ L L N++
Sbjct: 262 KDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-------- 312
Query: 474 GLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSS 533
+ L L L+L N L S+ +L L
Sbjct: 313 ---KID-------------DNAFWGLTHLLKLNLSQNFLGSIDSRMFENL-----DKL-- 349
Query: 534 NSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGD-LKNMQHLSLADNKFQGSIPDS- 591
+DLS N + + L N++ L+L N+ + S+PD
Sbjct: 350 -----------------EVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGI 390
Query: 592 LGGLTSLNFLDMSSNNL 608
LTSL + + +N
Sbjct: 391 FDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 48/263 (18%), Positives = 91/263 (34%), Gaps = 23/263 (8%)
Query: 398 SIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPK-AIGRLQKLQG 456
+ L ++ + LS +I + L +L L +E I L L
Sbjct: 24 QVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII 83
Query: 457 LYLQHNKLQGSITTD-LCGLRSLSEFYSDGNELNGSL--PQCLDSLISLRTLSLGFNRLT 513
L L +N+ + T GL +L L+G++ L SL L L N +
Sbjct: 84 LKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142
Query: 514 SVIPSSLW-SLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLK 572
+ P+S + ++R ++L+ N + ++ N + L L
Sbjct: 143 KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL--------------RLS 188
Query: 573 NMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPN---SLKALSLLKFLNLSF 629
++ + + + TS+ LD+S N + A + ++ L LS
Sbjct: 189 SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248
Query: 630 NGLQGQVPHGGPFTNLSSQSFVG 652
+ G F + + +F G
Sbjct: 249 SYNMGSSFGHTNFKDPDNFTFKG 271
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 46/207 (22%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 746 LGKGSFGSVYKGTLSDG----MQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKI 799
LGKG FGSV + L +++AVK+ ++ + F E + H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 800 ISTCSSDHFKA------LVLEYMPNGSLENWM-----YNKNRSFDILQRLNMVIDVASAL 848
+ K ++L +M +G L ++ + + + ++D+A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL-GDETSMTQTQTLATIGYMA 907
EYL + IH DL N +L E M C++DFG+S+ + + + + ++A
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 908 PE----WKLSRKGDVYSYGIILMETFT 930
E + DV+++G+ + E T
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 50/208 (24%), Positives = 72/208 (34%), Gaps = 15/208 (7%)
Query: 735 RATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGT--LRSFDAECEILGSI 791
F + LG GS+G V+K DG AVK G AE +
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 792 -RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEY 850
+H V++ L E SL+ S Q + D AL +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA-TIGYMAPE 909
LH ++H D+ P+NI L L DFG+ L + + YMAPE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL---GTAGAGEVQEGDPRYMAPE 226
Query: 910 ---WKLSRKGDVYSYGIILMETFTKKKP 934
DV+S G+ ++E +
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 68/258 (26%), Positives = 115/258 (44%), Gaps = 35/258 (13%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKII 800
LG G +VY +++A+K + E TL+ F+ E + H+N+V +I
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
D LV+EY+ +L ++ + + +N + +++ H I+
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAHDMR---IV 133
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT-LATIGYMAPE----WKLSRK 915
H D+ P NIL++ + + DFGI+K L ETS+TQT L T+ Y +PE
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 916 GDVYSYGIILMETFTKKKPTDELFVGE----ISLK----------SRVNDSLHGKIINVV 961
D+YS GI+L E + P F GE I++K + V + + NV+
Sbjct: 193 TDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVI 248
Query: 962 DINLLQK--EDAYLTAKE 977
+ +K + Y T +E
Sbjct: 249 -LRATEKDKANRYKTIQE 265
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 50/224 (22%), Positives = 84/224 (37%), Gaps = 34/224 (15%)
Query: 735 RATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNL-ELEGTLRSFDAECEILGSIR 792
R F LG+G FG V++ D A+K L E E + L +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 793 HRNLVKIISTCSSDHFKA------------LVLEYMPNGSLENWMYNKNRS--FDILQRL 838
H +V+ + + + ++ +L++WM + + L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 839 NMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898
++ + +A A+E+LH ++H DL PSNI V + DFG+ + +
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 899 TLATIG-----------YMAPE----WKLSRKGDVYSYGIILME 927
T YM+PE S K D++S G+IL E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 746 LGKGSFGSVYKGTLSDG------MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVK 798
LG G+FG VY+G +S +Q+AVK E F E I+ H+N+V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWM------YNKNRSFDILQRLNMVIDVASALEYLH 852
I + +++E M G L++++ ++ S +L L++ D+A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 853 YDHPTPIIHCDLNPSNILLN---ESMVACLSDFGISKLL-GDETSMTQTQTLATIGYMAP 908
+H IH D+ N LL VA + DFG+++ + + + +M P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 909 E----WKLSRKGDVYSYGIILMETFT 930
E + K D +S+G++L E F+
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 18/207 (8%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKII 800
L+G+G G VY+ +A+K+ + L E G ++ ++V I
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
D + + + L + + + + +V + SAL+ H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAHAAG---AT 156
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT-LATIGYMAPE----WKLSRK 915
H D+ P NIL++ A L DFGI+ D +TQ + T+ YMAPE + +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTD-EKLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 916 GDVYSYGIILMETFTKKKPTDELFVGE 942
D+Y+ +L E T P + G+
Sbjct: 216 ADIYALTCVLYECLTGSPP----YQGD 238
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 746 LGKGSFGSVYKGTLSDG------MQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKI 799
LG+G+FG V+ + M +AVK E + F E E+L ++H+++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 800 ISTCSSDHFKALVLEYMPNGSL--------------ENWMYNKNRSFDILQRLNMVIDVA 845
C+ +V EYM +G L + Q L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 846 SALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL--GDETSMTQTQTLATI 903
+ + YL H +H DL N L+ + +V + DFG+S+ + D + +T+ I
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV-GGRTMLPI 224
Query: 904 GYMAPE----WKLSRKGDVYSYGIILMETFT 930
+M PE K + + DV+S+G++L E FT
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 746 LGKGSFGSVYKGTL------SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKI 799
LG+G+FG V+ D M +AVK + F E E+L +++H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 800 ISTCSSDHFKALVLEYMPNGSL---------------ENWMYNKNRSFDILQRLNMVIDV 844
C +V EYM +G L + + Q L++ +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 845 ASALEYL---HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL--GDETSMTQTQT 899
AS + YL H+ +H DL N L+ +++ + DFG+S+ + D + T
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV-GGHT 195
Query: 900 LATIGYMAPE----WKLSRKGDVYSYGIILMETFT 930
+ I +M PE K + + DV+S+G+IL E FT
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 63/251 (25%), Positives = 106/251 (42%), Gaps = 47/251 (18%)
Query: 707 QKRNTGLQIDEEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDG---M 763
+ D + P + W I +Q++ +G+G+FG V K + M
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQDV------------IGEGNFGQVLKARIKKDGLRM 53
Query: 764 QIAVKVFNLELEGT----LRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPN 818
A+K E R F E E+L + H N++ ++ C + L +EY P+
Sbjct: 54 DAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 110
Query: 819 GSLENW---------------MYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
G+L ++ + + Q L+ DVA ++YL IH D
Sbjct: 111 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 167
Query: 864 LNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKGDVY 919
L NIL+ E+ VA ++DFG+S+ G E + +T + +MA E + DV+
Sbjct: 168 LAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 225
Query: 920 SYGIILMETFT 930
SYG++L E +
Sbjct: 226 SYGVLLWEIVS 236
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 44/206 (21%), Positives = 85/206 (41%), Gaps = 24/206 (11%)
Query: 746 LGKGSFGSVYKGTLSDG------MQIAVKVFNLELEGTLRS-FDAECEILGSIRHRNLVK 798
LG+GSFG VY+G ++A+K N R F E ++ ++V+
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 799 IISTCSSDHFKALVLEYMPNGSL---------ENWMYNKNRSFDILQRLNMVIDVASALE 849
++ S +++E M G L + + + M ++A +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 850 YLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL-GDETSMTQTQTLATIGYMAP 908
YL+ + +H DL N ++ E + DFG+++ + + + L + +M+P
Sbjct: 153 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 909 E----WKLSRKGDVYSYGIILMETFT 930
E + DV+S+G++L E T
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 746 LGKGSFGSVYKGTLSDG------MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVK 798
LG G+FG VY+G +S +Q+AVK E F E I+ H+N+V+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWM------YNKNRSFDILQRLNMVIDVASALEYLH 852
I + ++LE M G L++++ ++ S +L L++ D+A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 853 YDHPTPIIHCDLNPSNILLN---ESMVACLSDFGISKLL--GDETSMTQTQTLATIGYMA 907
+H IH D+ N LL VA + DFG+++ + + + +M
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK-GGCAMLPVKWMP 254
Query: 908 PE----WKLSRKGDVYSYGIILMETFT 930
PE + K D +S+G++L E F+
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-28
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 740 FSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILG-SIRHRNLVK 798
+LG GS G+V G +AVK ++ E ++L S H N+++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIR 73
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRL------NMVIDVASALEYLH 852
+ ++D F + LE N +L++ + +KN S + L+ +++ +AS + +LH
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 853 YDHPTPIIHCDLNPSNILLNESMVAC-------------LSDFGISKLLGDETS--MTQT 897
IIH DL P NIL++ S +SDFG+ K L S T
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 898 QTLA-TIGYMAPE-----------WKLSRKGDVYSYGIIL 925
+ T G+ APE +L+R D++S G +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 746 LGKGSFGSVYKGTLSDG------MQIAVKVFNLELEGTLRS-FDAECEILGSIRHRNLVK 798
LG+ FG VYKG L +A+K + EG LR F E + ++H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 799 IISTCSSDHFKALVLEYMPNGSL---------------ENWMYNKNRSFDILQRLNMVID 843
++ + D +++ Y +G L + + + +++V
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 844 VASALEYL---HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL-GDETSMTQTQT 899
+A+ +EYL H +H DL N+L+ + + +SD G+ + + + +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 900 LATIGYMAPE----WKLSRKGDVYSYGIILMETFT 930
L I +MAPE K S D++SYG++L E F+
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 31/212 (14%)
Query: 738 DGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLE-LEGTLRSFDAECEILGSIRHRN 795
+ +++LG+G+ +V++G G A+KVFN + E E+L + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 796 LVK---IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQR--LNMVIDVASALEY 850
+VK I ++ H L++E+ P GSL + + ++ + + L ++ DV + +
Sbjct: 69 IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 851 LHYDHPTPIIHCDLNPSNILL----NESMVACLSDFGISKLLGDETSMTQTQTLA-TIGY 905
L + I+H ++ P NI+ + V L+DFG ++ L D+ +L T Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEY 181
Query: 906 MAPE-------WKLSRKG-----DVYSYGIIL 925
+ P+ K +K D++S G+
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 52/229 (22%), Positives = 85/229 (37%), Gaps = 26/229 (11%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
LG+G F V L DG A+K + E ++ H N++++++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 804 SSDHFKA----LVLEYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHP 856
+ L+L + G+L N + K Q L +++ + LE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA--------TIGYMAP 908
H DL P+NILL + L D G ++ TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 909 E-WKLSR------KGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN 950
E + + + DV+S G +L + P D +F S+ V
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 75/503 (14%), Positives = 153/503 (30%), Gaps = 88/503 (17%)
Query: 74 LSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSF 133
+ T I L L L +++ + + ++ L L N+
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM---TGIEKLTGLTKLICTSNN- 75
Query: 134 IGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSP 193
I T+ S ++L L N+L + + L ++ N+ + S
Sbjct: 76 ITTLDLSQN--TNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKLDVS------ 124
Query: 194 LQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLK 253
Q L L+ A N L+ +I + QL L +N I + + T L
Sbjct: 125 ------QNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLT 173
Query: 254 GLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGH 313
L S N++T + ++ L L+ N + L N
Sbjct: 174 TLDC-----------------SFNKITEL---DVSQNKLLNRLNC-DTNNITKLDLN--- 209
Query: 314 SLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLT 373
L L N+LT ++ + LT D N +
Sbjct: 210 QNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLTEL------------------ 248
Query: 374 SLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTL 433
++ L L + L + +L++ ++Y A + ++ + L L
Sbjct: 249 DVSTLSKLTTLHCIQTDLLEI------DLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLL 302
Query: 434 HLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLP 493
+ +T + + + KL LYL + +L D+ L +
Sbjct: 303 DCQAAGIT-ELD--LSQNPKLVYLYLNNTELT---ELDVSHNTKLKSLSCVNAHIQ-DFS 355
Query: 494 QCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNG---TLPVEIGNLKVV 550
+ + +L + ++ +L + + V+ G + G +
Sbjct: 356 -SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQ 414
Query: 551 TKIDLSRNDLSGEIPSSIGDLKN 573
++ +LS + P+ +
Sbjct: 415 ATNTITWENLSTDNPAVTYTFTS 437
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 77/436 (17%), Positives = 145/436 (33%), Gaps = 61/436 (13%)
Query: 204 LAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT 263
A A ++ + + L L N+ I + I +T L L N+T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCH-NSSITDMT-GIEKLTGLTKLICTSNNIT 77
Query: 264 ----GEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQ 319
+ L LA SN+LT + ++ ++ LT L+ N L L + P L
Sbjct: 78 TLDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCD-TNKLTKLDVS---QNPLLT 130
Query: 320 QLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCK 379
L N LT +S+ + LT +D N + +T
Sbjct: 131 YLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD-----------------VTPQT 170
Query: 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNE 439
L L S N ++ + + ++ L NI + + LT L +N+
Sbjct: 171 QLTTLDCSFNKITE---LDVSQNKL-LNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNK 223
Query: 440 LTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSL 499
LT I + L +L N L D+ L L+ + +L + L
Sbjct: 224 LT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EID--LTHN 274
Query: 500 ISLRTLSL-GFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRN 558
L G ++ + + L + + + + +++ + + L+
Sbjct: 275 TQLIYFQAEGCRKIKELDVTHNTQLYLL---DCQAAGIT---ELDLSQNPKLVYLYLNNT 328
Query: 559 DLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKA 618
+L+ E+ + ++ LS + Q S+G + +LN + +L
Sbjct: 329 ELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTN 383
Query: 619 LSLLKFLNLSFNGLQG 634
SL ++ G
Sbjct: 384 NSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-24
Identities = 79/501 (15%), Positives = 158/501 (31%), Gaps = 76/501 (15%)
Query: 53 LNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIE 112
A + T L+ L+ L+ N+S + I L L L SNN ++++
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGI--EKLTGLTKLICTSNNITTLD 80
Query: 113 IPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLL 172
L L +L D N + + + ++ L L+ N+L + P L
Sbjct: 81 ----LSQNTNLTYLACDSNK-LTNLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLT 130
Query: 173 AIDLSNNQFSGPMPSIYNTSPLQNIDMQYN-SLAELHLAYNQLSGQIPSTLFECKQLKIL 231
++ + N L ID+ +N L EL N+ ++ + QL L
Sbjct: 131 YLNCARNT-------------LTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTL 175
Query: 232 SLSVNNFIGSIPREIGNITMLKGLYLVYTNLT----GEIQGLQVLALSSNRLTGVIPPEI 287
S N I + + +L L N+T + L L SSN+LT + ++
Sbjct: 176 DCS-FNKITELD--VSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTEI---DV 229
Query: 288 INISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDM 347
++ LT + N L L + +L L L L +++ + L
Sbjct: 230 TPLTQLTYFDC-SVNPLTELDVS---TLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQA 282
Query: 348 PYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMD 407
+ +T+ L L ++ + + +
Sbjct: 283 EGCRKIKELD-----------------VTHNTQLYLLDCQAAGIT---ELDLSQNPK-LV 321
Query: 408 VLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGS 467
LYL+ + + + + L +L + ++G++ L + +
Sbjct: 322 YLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITM 376
Query: 468 IT-----TDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWS 522
L S GN +N + T++ + + ++
Sbjct: 377 PKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFT 436
Query: 523 LRDILNVNLSSNSLNGTLPVE 543
+ V + P++
Sbjct: 437 SENGAIVGTVTTPFEAPQPIK 457
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 55/318 (17%), Positives = 109/318 (34%), Gaps = 49/318 (15%)
Query: 316 PNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSL 375
N + + S + LT +D + + +T +
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-----------------MTGI 60
Query: 376 TNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHL 435
L KLI + N ++ + + +N + L + + ++ + L LT L+
Sbjct: 61 EKLTGLTKLICTSNNITT---LDLSQNTN-LTYLACDSNKLT-NLD--VTPLTKLTYLNC 113
Query: 436 ETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQC 495
+TN+LT + + + L L N L D+ L+E N+ L
Sbjct: 114 DTNKLT-KLD--VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD-- 165
Query: 496 LDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDL 555
+ L TL FN++T + S L + N +N++ +++ +T +D
Sbjct: 166 VTPQTQLTTLDCSFNKITELDVSQNKLLNRL---NCDTNNITK---LDLNQNIQLTFLDC 219
Query: 556 SRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNS 615
S N L+ EI + L + + + N + S L+ L L +L
Sbjct: 220 SSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-----E 268
Query: 616 LKALSLLKFLNLSFNGLQ 633
+ + + G +
Sbjct: 269 IDLTHNTQLIYFQAEGCR 286
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-27
Identities = 93/519 (17%), Positives = 177/519 (34%), Gaps = 74/519 (14%)
Query: 137 IPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQN 196
+P + L LS N + I + L + LS+N+ +++
Sbjct: 46 VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNR-------------IRS 90
Query: 197 IDM----QYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITML 252
+D L L +++N+L I L+ L LS N+F +P
Sbjct: 91 LDFHVFLFNQDLEYLDVSHNRLQN-ISCCPM--ASLRHLDLSFNDFD-VLPVCK------ 140
Query: 253 KGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIG 312
+ NLT L L LS+ + + +++ ++ L + + + + ++
Sbjct: 141 -----EFGNLT----KLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGET 188
Query: 313 HSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFL 372
SL +L + S N S+ L + L + + FL
Sbjct: 189 ESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHL------QLSNIKLNDENCQRLMTFL 242
Query: 373 TSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTT 432
+ LT L + L + + + V YL+ N+ +E + T
Sbjct: 243 SELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI---TERIDREEFTY 299
Query: 433 LHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSL 492
L+ L ++++ S ++ ++
Sbjct: 300 SETA--------------LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH 345
Query: 493 PQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIG---NLKV 549
C S S L+ N T + +L+ + + L N L N+
Sbjct: 346 MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSS 404
Query: 550 VTKIDLSRNDL-SGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNL 608
+ +D+S N L S + +++ L+L+ N GS+ L + LD+ +N +
Sbjct: 405 LETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRI 462
Query: 609 SGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
IP + L L+ LN++ N L+ VP G F L+S
Sbjct: 463 M-SIPKDVTHLQALQELNVASNQLKS-VPD-GVFDRLTS 498
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-26
Identities = 94/517 (18%), Positives = 177/517 (34%), Gaps = 69/517 (13%)
Query: 98 LKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSIC-NISSLLTLDLSFNQ 156
K LS N+ S + P + +L L L N I ++ + L LD+S N+
Sbjct: 54 TKALSLSQNSISELR-MPDISFLSELRVLRLSHNR-IRSLDFHVFLFNQDLEYLDVSHNR 111
Query: 157 LQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSG 216
LQ ++ + SL +DLS N F + N+ L L L+ +
Sbjct: 112 LQ-NISCCPM--ASLRHLDLSFNDFD----VLPVCKEFGNL----TKLTFLGLSAAKFR- 159
Query: 217 QIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSS 276
Q+ L + + ++ I + +I VL L
Sbjct: 160 QLDLLPV--AHLHLSCILLDLVSYHIKG--------------GETESLQIPNTTVLHLVF 203
Query: 277 NRLTGVIPPEIINISSLTVLSLTANNLLGN----LPSNIGHSLPNLQQLILGGNRLTGPI 332
+ + +++++L L L+ L L + + L + +
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263
Query: 333 PSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLS 392
S+ + Y + + ++ +
Sbjct: 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL----- 318
Query: 393 GVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQ 452
++ ++ M++ LS + + ++ T L+ N T S+ + L+
Sbjct: 319 -FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLK 377
Query: 453 KLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRL 512
+LQ L LQ N L+ + + ++ SL TL + N L
Sbjct: 378 RLQTLILQRNGLK-----------NFF-----------KVALMTKNMSSLETLDVSLNSL 415
Query: 513 TSVIPSSLWSLRDILNV-NLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDL 571
S + + + V NLSSN L G++ + V +DL N + IP + L
Sbjct: 416 NSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIPKDVTHL 472
Query: 572 KNMQHLSLADNKFQGSIPD-SLGGLTSLNFLDMSSNN 607
+ +Q L++A N+ + S+PD LTSL ++ + N
Sbjct: 473 QALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 1e-21
Identities = 76/443 (17%), Positives = 148/443 (33%), Gaps = 64/443 (14%)
Query: 61 LGTIPPEL-GNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDS 119
+ ++ + L L+V++N I + L++L N+F + + +
Sbjct: 88 IRSLDFHVFLFNQDLEYLDVSHNRLQN---ISCCPMASLRHLDLSFNDFDVLPVCKEFGN 144
Query: 120 FPKLEHLYLDGNSFIGTIPPSICNIS-SLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSN 178
KL L L F + ++ S + LDL ++G S+ + + + +
Sbjct: 145 LTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH 204
Query: 179 NQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPST----------------- 221
+ + + L ++ + L + + +
Sbjct: 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264
Query: 222 -------LFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGE--------- 265
F + ++ L++ I RE + L+ ++ +
Sbjct: 265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324
Query: 266 ---IQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLI 322
+ + LS + + + SS T L+ T N+ + +L LQ LI
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFT-QNVFTDSVFQGCSTLKRLQTLI 383
Query: 323 LGGNRLT--GPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKD 380
L N L + N S L +D+ N + +
Sbjct: 384 LQRNGLKNFFKVALMTKNMSSLETLDVSLN------------SLNSHAYDRTCAWA--ES 429
Query: 381 LRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNEL 440
+ L LS N L+G + L + VL L I SIP ++ +L L L++ +N+L
Sbjct: 430 ILVLNLSSNMLTGSVFRC---LPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
Query: 441 TGSIPK-AIGRLQKLQGLYLQHN 462
S+P RL LQ ++L N
Sbjct: 486 K-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-19
Identities = 70/386 (18%), Positives = 129/386 (33%), Gaps = 28/386 (7%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
+ L+LS N ++ + P+I +S L VL L ++N + +L ++ +L+ L + NRL
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRL-SHNRIRSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 329 TGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE 388
I + L +D+ +N +D L N L L LS
Sbjct: 113 QN-ISCC--PMASLRHLDLSFN--------------DFDVLPVCKEFGNLTKLTFLGLSA 155
Query: 389 NPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAI 448
+ + + +L + +L L + +IKG + N T LHL + + +
Sbjct: 156 AKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-TTVLHLVFHPNSLFSVQVN 214
Query: 449 GRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLG 508
+ L L L + KL + + +EL +L + T
Sbjct: 215 MSVNALGHLQLSNIKLND---------ENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC 265
Query: 509 FNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSI 568
+L +I N+ ++ LK + + +
Sbjct: 266 SVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALY 325
Query: 569 GDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLS 628
M L+ + +S FL+ + N + + L L+ L L
Sbjct: 326 SVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQ 385
Query: 629 FNGLQGQVPHGGPFTNLSSQSFVGNK 654
NGL+ N+SS +
Sbjct: 386 RNGLKNFFKVALMTKNMSSLETLDVS 411
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 51/218 (23%), Positives = 79/218 (36%), Gaps = 37/218 (16%)
Query: 419 SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSL 478
+P ++ L L N ++ I L +L+ L L HN+++
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR------------- 89
Query: 479 SEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLN 537
SL L L + NRL ++ + SLR + +LS N +
Sbjct: 90 ------------SLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLRHL---DLSFNDFD 134
Query: 538 GTLPV--EIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQ-HLSLADNKFQGSIPDSLGG 594
LPV E GNL +T + LS + L L L +G +SL
Sbjct: 135 -VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQI 193
Query: 595 L-TSLNFLDMSSNNLSGEIPN-SLKALSLLKFLNLSFN 630
T++ L N+L N S+ AL L+ N+ N
Sbjct: 194 PNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN 231
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 32/166 (19%), Positives = 59/166 (35%), Gaps = 8/166 (4%)
Query: 41 VTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPI---QLSNLRR 97
+ C P T LN ++ L L L + N N+
Sbjct: 346 MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSS 404
Query: 98 LKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQL 157
L+ L N+ +S + L L N G++ + + LDL N++
Sbjct: 405 LETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRI 462
Query: 158 QGHVPSSILNIPSLLAIDLSNNQF-SGPMPSIYNTSPLQNIDMQYN 202
+P + ++ +L +++++NQ S P + LQ I + N
Sbjct: 463 M-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 32/116 (27%), Positives = 55/116 (47%), Gaps = 7/116 (6%)
Query: 68 LGNLSFLSLLNVTNNSF-SGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHL 126
N+S L L+V+ NS S + + L+ SN + + L PK++ L
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS-VFRCL--PPKVKVL 455
Query: 127 YLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSIL-NIPSLLAIDLSNNQF 181
L N I +IP + ++ +L L+++ NQL+ VP + + SL I L +N +
Sbjct: 456 DLHNNR-IMSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-27
Identities = 76/469 (16%), Positives = 144/469 (30%), Gaps = 89/469 (18%)
Query: 142 CNISSLLTLDLSFNQLQGHVPSSILNIPSLLAI----DLSNNQFSGPMPSIYNTSPLQNI 197
N + L+ + +N + G + + + N+ +
Sbjct: 7 INNNFSLSQNSFYNTISG-TYADYFSAWDKWEKQALPGENRNEAVSLLKEC--------- 56
Query: 198 DMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYL 257
N +EL L LS +P L Q+ +L ++ N + S+P ++ L
Sbjct: 57 --LINQFSELQLNRLNLS-SLPDNLP--PQITVLEIT-QNALISLPELPASLEYLDACDN 110
Query: 258 VYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPN 317
+ L L+ L + +N+LT ++P + L ++ NN L LP +
Sbjct: 111 RLSTLPELPASLKHLDVDNNQLT-MLPEL---PALLEYINAD-NNQLTMLPE----LPTS 161
Query: 318 LQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTN 377
L+ L + N+LT +P +
Sbjct: 162 LEVLSVRNNQLTF-LPELPES--------------------------------------- 181
Query: 378 CKDLRKLILSENPLSGVLPISIGNLSN---AMDVLYLSACNIKGSIPSEIGNLNNLTTLH 434
L L +S N L LP + I IP I +L+ T+
Sbjct: 182 ---LEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTII 236
Query: 435 LETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQ 494
LE N L+ I +++ + + S R L++ + P+
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLAD------AVTAWFPE 290
Query: 495 CLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKID 554
S +S + + + L L D ++ +S + L ++
Sbjct: 291 NKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAW-LEKLSASAELR 349
Query: 555 LSRNDLSGEIPSSIGD-----LKNMQHLSLADNKFQGSIPDSLGGLTSL 598
++ + S D N++ L +G + G L SL
Sbjct: 350 QQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-27
Identities = 57/294 (19%), Positives = 100/294 (34%), Gaps = 42/294 (14%)
Query: 344 LIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLP-ISIGNL 402
+ N F I + D + N +L I
Sbjct: 10 NFSLSQNSFYNTISGT-----YADYFSAWDKWEK---QALPGENRNEAVSLLKECLINQF 61
Query: 403 SNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHN 462
S L L+ N+ S+P + +T L + N L S+P+ L+ L N
Sbjct: 62 S----ELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPASLEYL---DACDN 110
Query: 463 KLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWS 522
+L ++ L+ L D N+L LP + L ++ N+LT +P S
Sbjct: 111 RLS-TLPELPASLKHL---DVDNNQLT-MLP---ELPALLEYINADNNQLTM-LPELPTS 161
Query: 523 LRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQ----HLS 578
L + ++ +N L LP +L +D+S N L +P+ + +
Sbjct: 162 LEVL---SVRNNQLT-FLPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFR 213
Query: 579 LADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGL 632
+N+ IP+++ L + + N LS I SL + +
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-25
Identities = 72/419 (17%), Positives = 138/419 (32%), Gaps = 47/419 (11%)
Query: 87 TLPIQLSNLRRLKYLSFRSNNFSSI--EIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNI 144
++ + ++N L SF N S + D + K + N + + C I
Sbjct: 2 SIMLPINNNFSLSQNSF-YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLI 58
Query: 145 SSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYN-- 202
+ L L+ L +P ++ P + ++++ N + L+ +D N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALISLPELPAS---LEYLDACDNRL 112
Query: 203 --------SLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKG 254
SL L + NQL+ +P L+ ++ NN + +P + L+
Sbjct: 113 STLPELPASLKHLDVDNNQLT-MLPELP---ALLEYINAD-NNQLTMLPELPTS---LEV 164
Query: 255 LYLVYTNLTG---EIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLT---ANNLLGNLP 308
L + LT + L+ L +S+N L +P + + N + ++P
Sbjct: 165 LSVRNNQLTFLPELPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRITHIP 223
Query: 309 SNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDE 368
NI L +IL N L+ I S+S + P FS P +
Sbjct: 224 ENILS-LDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLAD 282
Query: 369 LGFLTSLTNCKDLRKLI---LSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIG 425
N + I + + LS+ + S + + + +
Sbjct: 283 AVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSG--FREQVAAWLE 340
Query: 426 NLNNLTTLHLETNELTGSIPKAIG-----RLQKLQGLYLQHNKLQGSITTDLCGLRSLS 479
L+ L ++ + ++ L+ L H +G D L SL
Sbjct: 341 KLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLG 399
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 55/250 (22%), Positives = 95/250 (38%), Gaps = 32/250 (12%)
Query: 372 LTSLTNC--KDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNN 429
++ L C +L L+ LS LP ++ + VL ++ + S+P +L
Sbjct: 50 VSLLKECLINQFSELQLNRLNLS-SLPDNLPPQ---ITVLEITQNALI-SLPELPASL-- 102
Query: 430 LTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELN 489
L N L+ ++P+ L+ L + +N+L + L + +D N+L
Sbjct: 103 -EYLDACDNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPALLEYI---NADNNQLT 153
Query: 490 GSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNL-- 547
LP + SL LS+ N+LT +P SL + ++S+N L +LP
Sbjct: 154 -MLP---ELPTSLEVLSVRNNQLTF-LPELPESLEAL---DVSTNLLE-SLPAVPVRNHH 204
Query: 548 --KVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSS 605
+ N ++ IP +I L + L DN I +SL T+
Sbjct: 205 SEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPR 263
Query: 606 NNLSGEIPNS 615
S
Sbjct: 264 IYFSMSDGQQ 273
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 2e-21
Identities = 49/264 (18%), Positives = 92/264 (34%), Gaps = 48/264 (18%)
Query: 395 LPISIGNLSN-AMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQK 453
+ + I N + + + Y + S NE + + + + +
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQ 60
Query: 454 LQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLT 513
L L L S+ +L ++ N L SLP + SL L NRL+
Sbjct: 61 FSELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLP---ELPASLEYLDACDNRLS 113
Query: 514 SVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKN 573
+ +P SL+ ++++ +N L LP L+ I+ N L+ +P L
Sbjct: 114 T-LPELPASLK---HLDVDNNQLT-MLPELPALLE---YINADNNQLT-MLPELPTSL-- 162
Query: 574 MQHLSLADNKFQGSIPDSLGGLTSLN------------------------FLDMSSNNLS 609
+ LS+ +N+ +P+ L +L+ F N ++
Sbjct: 163 -EVLSVRNNQLT-FLPELPESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRIT 220
Query: 610 GEIPNSLKALSLLKFLNLSFNGLQ 633
IP ++ +L + L N L
Sbjct: 221 -HIPENILSLDPTCTIILEDNPLS 243
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 4e-16
Identities = 39/210 (18%), Positives = 73/210 (34%), Gaps = 28/210 (13%)
Query: 48 RRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNN 107
++T L + L ++P +L +L +N S TLP ++L+ L + +N
Sbjct: 80 PQITVLEITQN-ALISLPELPASLEYLDAC---DNRLS-TLPELPASLKHL-DVD--NNQ 131
Query: 108 FSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILN 167
+ +P + LE++ D N + +P + L L + NQL +P
Sbjct: 132 LTM--LP---ELPALLEYINADNNQ-LTMLPELPTS---LEVLSVRNNQLT-FLPEL--- 178
Query: 168 IPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQ 227
SL A+D+S N + + N+++ IP +
Sbjct: 179 PESLEALDVSTNLLESLPAVPVRNHHSE------ETEIFFRCRENRIT-HIPENILSLDP 231
Query: 228 LKILSLSVNNFIGSIPREIGNITMLKGLYL 257
+ L N I + T +
Sbjct: 232 TCTIILEDNPLSSRIRESLSQQTAQPDYHG 261
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 29/149 (19%), Positives = 44/149 (29%), Gaps = 11/149 (7%)
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSI--EIPPWLD 118
L +P +L LS+ NN + LP +L L +S +N S+
Sbjct: 152 LTMLPELPTSLEVLSV---RNNQLT-FLPELPESLEAL-DVS--TNLLESLPAVPVRNHH 204
Query: 119 SFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSN 178
S N I IP +I ++ T+ L N L L+ +
Sbjct: 205 SEETEIFFRCRENR-ITHIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGP 262
Query: 179 NQFSGPMPSIYNTSPLQNIDMQYNSLAEL 207
+ NT D E
Sbjct: 263 RIYFSMSDGQQNTLHRPLADAVTAWFPEN 291
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 54/280 (19%), Positives = 101/280 (36%), Gaps = 22/280 (7%)
Query: 379 KDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLET 437
D L L N ++ + NL N + L L I I L L L+L
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKIS-KISPGAFAPLVKLERLYLSK 109
Query: 438 NELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD-LCGLRSLSEFYSDGNELNGSL--PQ 494
N+L +P+ + LQ L + N++ + GL + N L S
Sbjct: 110 NQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 495 CLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKID 554
+ L + + +T++ SL ++ +L N + + L + K+
Sbjct: 166 AFQGMKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLG 222
Query: 555 LSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPN 614
LS N +S S+ + +++ L L +NK +P L + + + +NN+S I +
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGS 280
Query: 615 S-------LKALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
+ + ++L N +Q F +
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 320
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 70/350 (20%), Positives = 127/350 (36%), Gaps = 65/350 (18%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
L+V+ S L +P ++ +L L NN + + +L NL LIL N++
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQ-NNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 329 TGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE 388
+ + F+ L L +L LS+
Sbjct: 89 S----------------KISPGAFAP--------------------LVK---LERLYLSK 109
Query: 389 NPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELTGSI--P 445
N L + L L + I + + LN + + L TN L S
Sbjct: 110 NQLKELPEKMPKTLQE----LRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIEN 164
Query: 446 KAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTL 505
A ++KL + + + +I L SL+E + DGN++ L L +L L
Sbjct: 165 GAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKL 221
Query: 506 SLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIP 565
L FN +++V SL + + ++L++N L +P + + K + + L N++S I
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIG 279
Query: 566 SS-------IGDLKNMQHLSLADNKFQGSI--PDSLGGLTSLNFLDMSSN 606
S+ + +SL N Q P + + + + +
Sbjct: 280 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 55/254 (21%), Positives = 103/254 (40%), Gaps = 15/254 (5%)
Query: 401 NLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQ 460
+L +L L I + NL NL TL L N+++ P A L KL+ LYL
Sbjct: 49 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108
Query: 461 HNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVI--PS 518
N+L+ + + ++L E NE+ + L + + LG N L S
Sbjct: 109 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 519 SLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPS-SIGDLKNMQHL 577
+ ++ + + ++ ++ + G +T++ L N ++ ++ + S+ L N+ L
Sbjct: 166 AFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKL 221
Query: 578 SLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQ---- 633
L+ N SL L L +++N L ++P L ++ + L N +
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 280
Query: 634 GQVPHGGPFTNLSS 647
G T +S
Sbjct: 281 NDFCPPGYNTKKAS 294
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 61/297 (20%), Positives = 113/297 (38%), Gaps = 39/297 (13%)
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSF 120
L +P +L +LL++ NN + NL+ L L +N S I P
Sbjct: 43 LEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS-PGAFAPL 99
Query: 121 PKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSIL-NIPSLLAIDLSNN 179
KLE LYL N + +P + +L L + N++ V S+ + ++ ++L N
Sbjct: 100 VKLERLYLSKNQ-LKELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTN 155
Query: 180 QFSG---PMPSIYNTSPLQNIDMQYN-----------SLAELHLAYNQLSGQIPSTLFE- 224
+ L I + SL ELHL N+++ ++ + +
Sbjct: 156 PLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKIT-KVDAASLKG 214
Query: 225 CKQLKILSLSVNNFIGSIPREI-GNITMLKGLYLVYTNLT------GEIQGLQVLALSSN 277
L L LS N I ++ N L+ L+L L + + +QV+ L +N
Sbjct: 215 LNNLAKLGLS-FNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN 273
Query: 278 RLTGV------IPPEIINISSLTVLSLTANNL-LGNLPSNIGHSLPNLQQLILGGNR 327
++ + P +S + +SL +N + + + + + LG +
Sbjct: 274 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 61/320 (19%), Positives = 113/320 (35%), Gaps = 46/320 (14%)
Query: 268 GLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNR 327
+L L +N++T + + N+ +L L L NN + + L L++L L N+
Sbjct: 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILI-NNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 328 LTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILS 387
L +P + L + + N + + S+ L + + L
Sbjct: 112 LKE-LPEKM--PKTLQELRVHENEIT-KVRKSV-----------FNGLNQ---MIVVELG 153
Query: 388 ENPLSGVLPISIGNLSN--AMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIP 445
NPL I G + + ++ NI +IP G +LT LHL+ N++T
Sbjct: 154 TNPLKSS-GIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDA 209
Query: 446 KAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTL 505
++ L L L L N + L L E + + N+L +P L ++ +
Sbjct: 210 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 268
Query: 506 SLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLS-GEI 564
L N ++++ + P + + L N + EI
Sbjct: 269 YLHNNNISAIGSNDFCP------------------PGYNTKKASYSGVSLFSNPVQYWEI 310
Query: 565 PSSI-GDLKNMQHLSLADNK 583
S + + L + K
Sbjct: 311 QPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 59/353 (16%), Positives = 113/353 (32%), Gaps = 67/353 (18%)
Query: 123 LEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFS 182
L + +P + LDL N++ N+ +L + L NN+ S
Sbjct: 33 LRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 183 GPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSI 242
P + L L+L+ NQL ++P + K L+ L + N I +
Sbjct: 90 KISPGAFAPLV---------KLERLYLSKNQLK-ELPEKMP--KTLQELRVH-ENEITKV 136
Query: 243 PREI-GNITMLKGLYLVYTNLTGEI---------QGLQVLALSSNRLTGVIPPEIINISS 292
+ + + + + L L + L + ++ +T IP + S
Sbjct: 137 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PS 193
Query: 293 LTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLF 352
LT L L N + + + L NL +L L N ++ S++N L + + N
Sbjct: 194 LTELHL-DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
Query: 353 SGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLS 412
+P L + K ++ + L N +S +
Sbjct: 253 V-KVPG---------------GLADHKYIQVVYLHNNNISAIGSNDFCP----------- 285
Query: 413 ACNIKGSIPSEIGNLNNLTTLHLETNELTGSI--PKAIGRLQKLQGLYLQHNK 463
P + + + L +N + P + + L + K
Sbjct: 286 --------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 55/243 (22%), Positives = 98/243 (40%), Gaps = 34/243 (13%)
Query: 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNEL 488
+L + L +PK + L LQ+NK+ D L++L N++
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 489 NGSLPQCLDSLISLRTLSLGFNRLTSV--------------------IPSSLWS-LRDIL 527
+ P L+ L L L N+L + + S+++ L ++
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 148
Query: 528 NVNLSSNSLNGTLPVEIG---NLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKF 584
V L +N L + +E G +K ++ I ++ +++ IP + ++ L L NK
Sbjct: 149 VVELGTNPLK-SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKI 204
Query: 585 QGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTN 644
SL GL +L L +S N++S SL L+ L+L+ N L +VP G +
Sbjct: 205 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG--LAD 261
Query: 645 LSS 647
Sbjct: 262 HKY 264
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 53/193 (27%), Positives = 85/193 (44%), Gaps = 17/193 (8%)
Query: 744 NLLGKGSFGSVYKGT-LSDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVKI 799
LGKG FG+VY +A+KV LE G E EI +RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
L+LEY P G++ + ++ FD + + ++A+AL Y H +
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR---V 130
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG--- 916
IH D+ P N+LL + ++DFG S TL Y+ PE + +
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLD---YLPPE-MIEGRMHDE 186
Query: 917 --DVYSYGIILME 927
D++S G++ E
Sbjct: 187 KVDLWSLGVLCYE 199
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 48/262 (18%), Positives = 78/262 (29%), Gaps = 31/262 (11%)
Query: 737 TDGFSENNLLGKGSFGSVYKGTLSD------GMQIAVKVFNLELEGTLRSFDAECEILGS 790
+ ++LLG+G+F VY+ T D + +KV E L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 791 IRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWM----YNKNRSFDILQRLNMVIDVAS 846
+K S + LV E G+L N + + ++ + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 847 ALEYLHYDHPTPIIHCDLNPSNILLNESMVA-----------CLSDFGISKLLGDETSMT 895
+E +H IIH D+ P N +L + L D G S + T
Sbjct: 184 MIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 896 QTQTLA-TIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKPTDELFVGEISLKSRV 949
T G+ E LS K D + + + GE +
Sbjct: 241 IFTAKCETSGFQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 950 NDSLHGKIINVVDINLLQKEDA 971
H + N +L D
Sbjct: 300 RRLPHLDMWNEFFHVMLNIPDC 321
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 35/240 (14%)
Query: 713 LQIDEEMSPEVTWRRISYQELFRAT-DGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVF 770
L++DE+ + Q++ D F + + LG G+ G V+K + G+ +A K+
Sbjct: 7 LELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI 66
Query: 771 NLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDH--------FKA----LVLEYMPN 818
+LE++ +R+ +I+ + +++ C+S + + + +E+M
Sbjct: 67 HLEIKPAIRN-----QIIREL------QVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC 878
GSL+ + K + I V L YL H I+H D+ PSNIL+N
Sbjct: 116 GSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIK 172
Query: 879 LSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFTKKKP 934
L DFG+S L D SM + + T YM+PE S + D++S G+ L+E + P
Sbjct: 173 LCDFGVSGQLID--SMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 31/205 (15%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFN-LELEGTLRSFDAECEILGSIRHRNLVK---I 799
+LG+G+ +V++G G A+KVFN + + E E+L + H+N+VK I
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQR--LNMVIDVASALEYLHYDHPT 857
++ H L++E+ P GSL + + ++ + + L ++ DV + +L +
Sbjct: 76 EEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 858 PIIHCDLNPSNILL----NESMVACLSDFGISKLLGDETSMTQTQTLA-TIGYMAPE--- 909
I+H ++ P NI+ + V L+DFG ++ L D+ +L T Y+ P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEYLHPDMYE 188
Query: 910 ----WKLSRKG-----DVYSYGIIL 925
K +K D++S G+
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 37/200 (18%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
+LG G+F V+ G A+K S + E +L I+H N+V +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVASALEYLHYD 854
S LV++ + G L FD IL+R ++ V SA++YLH +
Sbjct: 76 ESTTHYYLVMQLVSGGEL----------FDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 855 HPTPIIHCDLNPSNILL----NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW 910
I+H DL P N+L S + ++DFG+SK+ + T T GY+APE
Sbjct: 126 G---IVHRDLKPENLLYLTPEENSKIM-ITDFGLSKMEQNGIMST---ACGTPGYVAPE- 177
Query: 911 KLSRKG-----DVYSYGIIL 925
L++K D +S G+I
Sbjct: 178 VLAQKPYSKAVDCWSIGVIT 197
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-26
Identities = 43/210 (20%), Positives = 79/210 (37%), Gaps = 29/210 (13%)
Query: 745 LLGKGSFGSVYKG--TLSDGMQIAVKVFNLELEGTLRS-FDAECEILGSIRHRNLVKII- 800
+ G G +Y +G + +K + ++ AE + L + H ++V+I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 801 ----STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
+ D +V+EY+ SL+ K + + + + ++++ AL YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRS---KGQKLPVAEAIAYLLEILPALSYLHSIG- 202
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT-LATIGYMAPE---WKL 912
+++ DL P NI+L E + L D G + T G+ APE
Sbjct: 203 --LVYNDLKPENIMLTEEQLK-LIDLGAVS------RINSFGYLYGTPGFQAPEIVRTGP 253
Query: 913 SRKGDVYSYGIILMETFTKKKPTDELFVGE 942
+ D+Y+ G L G
Sbjct: 254 TVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 49/225 (21%)
Query: 735 RATDGFSEN----NLLGKGSFGSVYKGT-LSDGMQIAVKVFN---------LELEGTLRS 780
+T GF EN +LG+G V + + AVK+ + E++ +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 781 FDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR- 837
E +IL + H N++++ T ++ F LV + M G L FD + ++
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----------FDYLTEKV 119
Query: 838 -------LNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890
++ + + LH + I+H DL P NILL++ M L+DFG S L
Sbjct: 120 TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 891 ETSMTQTQTLATIGYMAPE-----WKLSRKG-----DVYSYGIIL 925
+ + T Y+APE + G D++S G+I+
Sbjct: 177 GEKL--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 65/264 (24%), Positives = 116/264 (43%), Gaps = 42/264 (15%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKI- 799
+LG G V+ L D +AVKV +L F E + ++ H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 800 -----ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD 854
+ + +V+EY+ +L + + + + + ++ D AL + H +
Sbjct: 79 DTGEAETPAGPLPY--IVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET-SMTQTQT-LATIGYMAPE--- 909
IIH D+ P+NI+++ + + DFGI++ + D S+TQT + T Y++PE
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 910 -WKLSRKGDVYSYGIILMETFTKKKPTDELFVGE----ISLK---------SRVNDSLHG 955
+ + DVYS G +L E T + P F G+ ++ + S ++ L
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPSARHEGLSA 248
Query: 956 KIINVVDINLLQK--EDAYLTAKE 977
+ VV + L K E+ Y TA E
Sbjct: 249 DLDAVV-LKALAKNPENRYQTAAE 271
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 28/197 (14%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVKII 800
LLGKGSF VY+ + G+++A+K+ + + G ++ E +I ++H +++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-------ILQRLNMVIDVASALEYLHY 853
+ ++ LVLE NG + ++ N+ + F + Q + + + YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ-------IITGMLYLHS 130
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLS 913
I+H DL SN+LL +M ++DFG++ L T T Y++PE +
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE-IAT 185
Query: 914 RKG-----DVYSYGIIL 925
R DV+S G +
Sbjct: 186 RSAHGLESDVWSLGCMF 202
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 44/223 (19%)
Query: 746 LGKGSFGSVYKGTLSDG------MQIAVKVFNLELEGT----LRSFDAECEILGSIRHRN 795
LG+G FG V K T +AVK+ E LR +E +L + H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPH 87
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENW-----------------------MYNKNRSF 832
++K+ CS D L++EY GSL + + R+
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 833 DILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892
+ ++ ++ ++YL ++H DL NIL+ E +SDFG+S+ + +E
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 893 SMT-QTQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFT 930
S ++Q + +MA E + + DV+S+G++L E T
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 730 YQELFRATD---GFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAEC 785
Y+ + R D + LG G+FG VYK G A KV + E L + E
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI 67
Query: 786 EILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVA 845
EIL + H +VK++ D +++E+ P G+++ M +R Q + +
Sbjct: 68 EILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML 127
Query: 846 SALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG- 904
AL +LH IIH DL N+L+ L+DFG+S ++ + + IG
Sbjct: 128 EALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TLQKRDSF--IGT 180
Query: 905 --YMAPEWKLSR---------KGDVYSYGIILME 927
+MAPE + K D++S GI L+E
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 48/218 (22%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 746 LGKGSFGSVYKGTLSD--------GMQIAVKVFNLELEGT----LRSFDAECEILGSI-R 792
LG+G+FG V + +AVK+ + L +E E++ I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSL---------------ENWMYNKNRSFDILQR 837
H+N++ ++ C+ D +++EY G+L +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 838 LNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT-Q 896
++ +A +EYL IH DL N+L+ E+ V ++DFG+++ + +
Sbjct: 160 VSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 897 TQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFT 930
T + +MAPE + + DV+S+G+++ E FT
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 746 LGKGSFGSVYKGTL--------SDGMQIAVKVFNLELEGT----LRSFDAECEILGSI-R 792
LG+G+FG V + ++AVK+ L +E E++ I +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSL---------------ENWMYNKNRSFDILQR 837
H+N++ ++ C+ D +++EY G+L N +N
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 838 LNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT-Q 896
++ VA +EYL IH DL N+L+ E V ++DFG+++ +
Sbjct: 194 VSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 897 TQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFT 930
T + +MAPE + + DV+S+G++L E FT
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 746 LGKGSFGSVYKGTLSD------GMQIAVKVFNLELEGT----LRSFDAECEILGSI-RHR 794
LG G+FG V + T M +AVK+ + +E ++L + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 795 NLVKIISTCSSDHFKALVLEYMPNGSLENW-----------------MYNKNRSFDILQR 837
N+V ++ C+ ++ EY G L N+ M + + D+
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 838 LNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT-Q 896
L+ VA + +L + IH DL NILL + + DFG+++ + ++++ +
Sbjct: 148 LSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 897 TQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFT 930
+ +MAPE + + DV+SYGI L E F+
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 48/218 (22%), Positives = 91/218 (41%), Gaps = 39/218 (17%)
Query: 746 LGKGSFGSVYKGTLSD--------GMQIAVKVFNLELEGT----LRSFDAECEILGSI-R 792
LG+G FG V + +AVK+ + L +E E++ I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 145
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSL---------------ENWMYNKNRSFDILQR 837
H+N++ ++ C+ D +++EY G+L +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 838 LNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL-GDETSMTQ 896
++ +A +EYL IH DL N+L+ E+ V ++DFG+++ + +
Sbjct: 206 VSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 897 TQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFT 930
T + +MAPE + + DV+S+G+++ E FT
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 54/195 (27%), Positives = 84/195 (43%), Gaps = 23/195 (11%)
Query: 745 LLGKGSFGSVYKG-TLSDGMQIAVKVFN------LELEGTLRSFDAECEILGSIRHRNLV 797
LGKG FG+VY + +A+KV +E LR E EI +RH N++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR---EIEIQSHLRHPNIL 77
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
++ + L+LE+ P G L + R FD + + ++A AL Y H
Sbjct: 78 RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCHERK-- 134
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG- 916
+IH D+ P N+L+ ++DFG S T TL Y+ PE + K
Sbjct: 135 -VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLD---YLPPE-MIEGKTH 189
Query: 917 ----DVYSYGIILME 927
D++ G++ E
Sbjct: 190 DEKVDLWCAGVLCYE 204
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 38/217 (17%)
Query: 746 LGKGSFGSVYKGTL------SDGMQIAVKVFNLELEGT----LRSFDAECEILGSI-RHR 794
LG+G+FG V + + +AVK+ EG R+ +E +IL I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 795 NLVKIISTCS-SDHFKALVLEYMPNGSL------------ENWMYNKNRSFDIL---QRL 838
N+V ++ C+ +++E+ G+L + ++ D L +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 839 NMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT-QT 897
VA +E+L IH DL NILL+E V + DFG+++ + + +
Sbjct: 152 CYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 898 QTLATIGYMAPE----WKLSRKGDVYSYGIILMETFT 930
+ +MAPE + + DV+S+G++L E F+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 49/220 (22%), Positives = 89/220 (40%), Gaps = 38/220 (17%)
Query: 746 LGKGSFGSVYKGTLSDG------MQIAVKVFNLELEGTLRS-FDAECEILGSIRHRNLVK 798
+G+G+FG V++ +AVK+ E +++ F E ++ + N+VK
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 799 IISTCSSDHFKALVLEYMPNGSL-----------------------ENWMYNKNRSFDIL 835
++ C+ L+ EYM G L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 836 QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS-KLLGDETSM 894
++L + VA+ + YL +H DL N L+ E+MV ++DFG+S + +
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 895 TQTQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFT 930
I +M PE + + + DV++YG++L E F+
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 48/226 (21%), Positives = 91/226 (40%), Gaps = 29/226 (12%)
Query: 735 RATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDA--ECEILGSI 791
R T F E +G G FGSV+K DG A+K L G++ +A E +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 792 -RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDIL---QRLNMVIDVASA 847
+H ++V+ S + D + EY GSL + + R + ++++ V
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 848 LEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS-----------KL--LGDETSM 894
L Y+H ++H D+ PSNI ++ + + + K+ LG T +
Sbjct: 128 LRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 895 TQTQTLA-TIGYMAPE-WKLSR----KGDVYSYGIILMETFTKKKP 934
+ Q ++A E + + K D+++ + ++ +
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 46/205 (22%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFN------LELEGTLRSFDAECEILGSIRHRNLVK 798
LGKG+F V + + G++ A K+ N + + R E I ++H N+V+
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER----EARICRKLQHPNIVR 69
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVASALE 849
+ + + F LV + + G L F+ I+ R + + + ++
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGEL----------FEDIVAREFYSEADASHCIQQILESIA 119
Query: 850 YLHYDHPTPIIHCDLNPSNILL----NESMVACLSDFGISKLLGDETSMTQTQTLATIGY 905
Y H + I+H +L P N+LL + V L+DFG++ + D + T GY
Sbjct: 120 YCHSNG---IVHRNLKPENLLLASKAKGAAVK-LADFGLAIEVNDSEAW--HGFAGTPGY 173
Query: 906 MAPEWKLSRKG-----DVYSYGIIL 925
++PE L + D+++ G+IL
Sbjct: 174 LSPE-VLKKDPYSKPVDIWACGVIL 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 42/207 (20%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDA-----ECEILGSIRHRNLVKI 799
+GKG F V + G Q AVK+ ++ + E I ++H ++V++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRLN------------MVIDVAS 846
+ T SSD +V E+M L I++R + + +
Sbjct: 92 LETYSSDGMLYMVFEFMDGADL----------CFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 847 ALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLATI 903
AL Y H ++ IIH D+ P +LL S L FG++ LG+ + + T
Sbjct: 142 ALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-RVGTP 197
Query: 904 GYMAPEWKLSRKG-----DVYSYGIIL 925
+MAPE + R+ DV+ G+IL
Sbjct: 198 HFMAPE-VVKREPYGKPVDVWGCGVIL 223
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 35/216 (16%)
Query: 744 NLLGKGSFGSVYKGTLSD------GMQIAVKVFNLELEGT----LRSFDAECEILGSI-R 792
LG G+FG V + T +++AVK+ + +E +I+ + +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQ 108
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENW-------------MYNKNRSFDILQRLN 839
H N+V ++ C+ ++ EY G L N+ N + L+
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 840 MVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS-KLLGDETSMTQTQ 898
VA + +L + IH D+ N+LL VA + DFG++ ++ D + +
Sbjct: 169 FSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 899 TLATIGYMAPE----WKLSRKGDVYSYGIILMETFT 930
+ +MAPE + + DV+SYGI+L E F+
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 9/256 (3%)
Query: 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNE 439
K++ + LS V P + + L L NI+ +L++L L L N
Sbjct: 55 QFSKVVCTRRGLSEV-P---QGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 440 LTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD-LCGLRSLSEFYSDGNELNGSLPQCLDS 498
+ A L L L L N L I + L L E + N + +
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169
Query: 499 LISLRTLSLG-FNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSR 557
+ SL L LG +L + + L ++ +NL ++ +P + L + ++++S
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSG 227
Query: 558 NDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLK 617
N P S L +++ L + +++ ++ GL SL L+++ NNLS +
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT 287
Query: 618 ALSLLKFLNLSFNGLQ 633
L L L+L N
Sbjct: 288 PLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 65/328 (19%), Positives = 104/328 (31%), Gaps = 78/328 (23%)
Query: 139 PSICN-ISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNI 197
PS+C+ + + + L VP I + ++L N I + ++
Sbjct: 47 PSVCSCSNQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQ----MIQADT-FRH- 97
Query: 198 DMQYNSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSVNNFIGSIPREIGNITMLKGLY 256
+ L L L N + QI F L L L +N++ IP + L
Sbjct: 98 ---LHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELF-DNWLTVIPSG-----AFEYL- 146
Query: 257 LVYTNLTGEIQGLQVLALSSNRLTGVIPPEI-INISSLTVLSLTANNLLGNLPSNIGHSL 315
L+ L L +N + IP + SL L L L + L
Sbjct: 147 ----------SKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL 195
Query: 316 PNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSL 375
NL+ L LG + + +L
Sbjct: 196 FNLKYLNLGMCNIK-----------------------------------------DMPNL 214
Query: 376 TNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSE-IGNLNNLTTLH 434
T L +L +S N + P S LS+ + L++ + I L +L L+
Sbjct: 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSS-LKKLWVMNSQVS-LIERNAFDGLASLVELN 272
Query: 435 LETNELTGSIPKAIGRLQKLQGLYLQHN 462
L N L+ L+ L L+L HN
Sbjct: 273 LAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-21
Identities = 61/288 (21%), Positives = 105/288 (36%), Gaps = 41/288 (14%)
Query: 42 TCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYL 101
+CS + +V GL +P + S LN+ N+ +L L+ L
Sbjct: 51 SCSNQFSKV---VCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVL 104
Query: 102 SFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQLQGH 160
N+ IE + L L L N + IP +S L L L N ++
Sbjct: 105 QLGRNSIRQIE-VGAFNGLASLNTLELFDNW-LTVIPSGAFEYLSKLRELWLRNNPIE-S 161
Query: 161 VPSSIL-NIPSLLAIDLS-NNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQI 218
+PS +PSL+ +DL + + + +L L+L + +
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGA-----FEGLF----NLKYLNLGMCNIK-DM 211
Query: 219 PSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNR 278
P L L+ L +S N I GL L+ L + +++
Sbjct: 212 P-NLTPLVGLEELEMS-GNHFPEIRPG-----SFHGL-----------SSLKKLWVMNSQ 253
Query: 279 LTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGN 326
++ + ++SL L+L +N L +LP ++ L L +L L N
Sbjct: 254 VSLIERNAFDGLASLVELNLA-HNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-14
Identities = 45/196 (22%), Positives = 78/196 (39%), Gaps = 22/196 (11%)
Query: 61 LGTIPPE-LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDS 119
+ I L+ L+ L + +N + L +L+ L R+N SI +
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIP-SYAFNR 169
Query: 120 FPKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSN 178
P L L L + I + +L L+L ++ +P+ + + L +++S
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSG 227
Query: 179 NQFSGPMP-SIYNTSPLQNIDMQYN--------------SLAELHLAYNQLSGQIPSTLF 223
N F P S + S L+ + + + SL EL+LA+N LS +P LF
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLF 286
Query: 224 E-CKQLKILSLSVNNF 238
+ L L L N +
Sbjct: 287 TPLRYLVELHLHHNPW 302
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 49/263 (18%), Positives = 93/263 (35%), Gaps = 16/263 (6%)
Query: 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETN 438
++ L LS N ++ + + N + L L++ I +I + +L +L L L N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVN-LQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 439 ELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD--LCGLRSLSEFYSDGNELNGSLP-QC 495
L+ L L L L N + ++ L L + + +
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 496 LDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDL 555
L L L + + L S P SL S++++ ++ L L + + V ++L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229
Query: 556 SRNDLSGEIPSSI--------GDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNN 607
DL S + +++ + D + L ++ L L+ S N
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQ 288
Query: 608 LSGEIPNSLKALSLLKFLNLSFN 630
L L+ L+ + L N
Sbjct: 289 LKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 54/338 (15%), Positives = 109/338 (32%), Gaps = 45/338 (13%)
Query: 132 SFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNT 191
S + + + S L +PS + ++ ++DLSNN+ + S
Sbjct: 18 SKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQ- 73
Query: 192 SPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFEC-KQLKILSLSVNNFIGSIPREIGNIT 250
+ +L L L N ++ I F L+ L LS N++ ++
Sbjct: 74 --------RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLS-YNYLSNLSSS----- 118
Query: 251 MLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEI-INISSLTVLSLTANNLLGNLPS 309
+ L+ L L L N + + +++ L +L + + +
Sbjct: 119 -------WFKPLSS----LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
Query: 310 NIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDEL 369
L L++L + + L P S+ + ++ + + + D
Sbjct: 168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF-----VDVT 221
Query: 370 GFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLS-ACNIKGSIPSEIGNLN 428
+ L +LR L S + +L + + + ++
Sbjct: 222 SSVECL----ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQIS 277
Query: 429 NLTTLHLETNELTGSIPK-AIGRLQKLQGLYLQHNKLQ 465
L L N+L S+P RL LQ ++L N
Sbjct: 278 GLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 4e-22
Identities = 57/320 (17%), Positives = 118/320 (36%), Gaps = 60/320 (18%)
Query: 268 GLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNR 327
++ L LS+NR+T + ++ +L L LT +N + + + SL +L+ L L N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLT-SNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 328 LTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILS 387
L+ ++ + F L++ L L L
Sbjct: 112 LS----------------NLSSSWFKP--------------------LSS---LTFLNLL 132
Query: 388 ENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELTGSIPK 446
NP + S+ + + +L + + I + L L L ++ ++L PK
Sbjct: 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192
Query: 447 AIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLS 506
++ +Q + L L + + + S+ +L+ +
Sbjct: 193 SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD----------------T 236
Query: 507 LGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPS 566
F+ L++ +SL NV ++ SL + + + + +++ SRN L +P
Sbjct: 237 FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPD 294
Query: 567 SI-GDLKNMQHLSLADNKFQ 585
I L ++Q + L N +
Sbjct: 295 GIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 52/288 (18%), Positives = 101/288 (35%), Gaps = 35/288 (12%)
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSF 120
L +IP L + L+++NN + L L+ L SN ++IE S
Sbjct: 43 LNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE-EDSFSSL 99
Query: 121 PKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQLQGHVPSSIL-NIPSLLAIDLSN 178
LEHL L N + + S +SSL L+L N + +S+ ++ L + + N
Sbjct: 100 GSLEHLDLSYNY-LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158
Query: 179 NQFSGPMPS--IYNTSPLQNIDMQYN--------------SLAELHLAYNQLSGQIPSTL 222
+ + L+ +++ + +++ L L Q +
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF 217
Query: 223 FEC-KQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTG 281
+ ++ L L + E+ + + + ++ L
Sbjct: 218 VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT---------FRNVKITDESLF- 267
Query: 282 VIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLT 329
+ + IS L L + N L ++P I L +LQ++ L N
Sbjct: 268 QVMKLLNQISGLLELEF-SRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 49/239 (20%), Positives = 94/239 (39%), Gaps = 16/239 (6%)
Query: 419 SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDL-CGLRS 477
SIPS + + +L L N +T + R LQ L L N + +I D L S
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101
Query: 478 LSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWS-LRDILNVNLSSNSL 536
L N L+ L SL L+L N ++ +SL+S L + + + +
Sbjct: 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161
Query: 537 NGTLPVEI-GNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPD-SLGG 594
+ + L + ++++ +DL P S+ ++N+ HL L + + + +
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDV 220
Query: 595 LTSLNFLDMSSNNLSG----EIP----NSLKALSLLKFLNLSFNGLQGQVPHGGPFTNL 645
+S+ L++ +L E+ NSL + + ++ L + + L
Sbjct: 221 TSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGL 279
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 48/261 (18%), Positives = 100/261 (38%), Gaps = 28/261 (10%)
Query: 48 RRVTALNLAYMGLLGTIPPEL-GNLSFLSLLNVTNNSFSGTLPIQL-SNLRRLKYLSFRS 105
+ AL L + TI + +L L L+++ N S L L L +L+
Sbjct: 76 VNLQALVLTS-NGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLG 133
Query: 106 NNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQLQGHVPSS 164
N + ++ KL+ L + I ++ L L++ + LQ + P S
Sbjct: 134 NPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS 193
Query: 165 ILNIPSLLAIDLSNNQFSG-PMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLF 223
+ +I ++ + L Q + TS ++ ++++ L H ++LS ++L
Sbjct: 194 LKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF--SELSTGETNSLI 251
Query: 224 ECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVI 283
+ + + ++ + + + + + I+ GL L S N+L +
Sbjct: 252 KKFTFRNVKIT-DESLFQVMKLLNQIS-----------------GLLELEFSRNQLKS-V 292
Query: 284 PPEII-NISSLTVLSLTANNL 303
P I ++SL + L N
Sbjct: 293 PDGIFDRLTSLQKIWLHTNPW 313
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 48/201 (23%), Positives = 78/201 (38%), Gaps = 37/201 (18%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVKII 800
LGKG F ++ + A K+ L E I S+ H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRL---------NMVIDVASALEYL 851
+ F +VLE SL ++ +R + + +YL
Sbjct: 82 GFFEDNDFVFVVLELCRRRSL----------LELHKRRKALTEPEARYYLRQIVLGCQYL 131
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ--TLATIGYMAPE 909
H + +IH DL N+ LNE + + DFG++ + + + T Y+APE
Sbjct: 132 HRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---YIAPE 185
Query: 910 WKLSRKG-----DVYSYGIIL 925
LS+KG DV+S G I+
Sbjct: 186 -VLSKKGHSFEVDVWSIGCIM 205
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 45/220 (20%)
Query: 731 QELFRATDGFSEN----NLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAEC 785
Q+L R + F++ +G GS+ + + M+ AVK+ + E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EI 66
Query: 786 EILG-SIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRLN---- 839
EIL +H N++ + + +V E M G L D IL++
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----------LDKILRQKFFSER 116
Query: 840 ----MVIDVASALEYLHYDHPTPIIHCDLNPSNILL-----NESMVACLSDFGISKLLGD 890
++ + +EYLH ++H DL PSNIL N + + DFG +K L
Sbjct: 117 EASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESI-RICDFGFAKQLRA 172
Query: 891 ETSMTQTQTLATIGYMAPEWKLSRKG-----DVYSYGIIL 925
E + T T ++APE L R+G D++S G++L
Sbjct: 173 ENGLLMT-PCYTANFVAPE-VLERQGYDAACDIWSLGVLL 210
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 50/226 (22%)
Query: 734 FRATDGFSEN----NLLGKGSFGSVYKGT-LSDGMQIAVKVFNL--------ELEGTLRS 780
+ A F + +++G+G V + + G + AVK+ + +LE +
Sbjct: 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 781 FDAECEILGSIR-HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRL 838
E IL + H +++ +I + S F LV + M G L FD + +++
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----------FDYLTEKV 195
Query: 839 --------NMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890
+++ + A+ +LH ++ I+H DL P NILL+++M LSDFG S L
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
Query: 891 ETSMTQTQTLA-TIGYMAPE-----WKLSRKG-----DVYSYGIIL 925
+ L T GY+APE + G D+++ G+IL
Sbjct: 253 GEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 52/194 (26%), Positives = 78/194 (40%), Gaps = 17/194 (8%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLEL-EGTLRSFDAECEIL-GSIRHRNLVKIIST 802
+G G+ G V+K G IAVK + + + +++ S +V+ T
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
++ + +E M E M + + AL YL H +IH
Sbjct: 93 FITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHR 149
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE---------WKLS 913
D+ PSNILL+E L DFGIS L D + ++ YMAPE
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 914 RKGDVYSYGIILME 927
+ DV+S GI L+E
Sbjct: 208 IRADVWSLGISLVE 221
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-24
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 26/199 (13%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLR-SFDAECEILGSIRHRNLVKII--- 800
LG G FG V + G Q+A+K EL R + E +I+ + H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 801 ---STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDIL---QRLNMVIDVASALEYLHYD 854
+ + L +EY G L ++ N+ + L ++ D++SAL YLH +
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 855 HPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK 911
IIH DL P NI+L + ++ + D G +K L T+ + T+ Y+APE
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLAPEL- 194
Query: 912 LSRKG-----DVYSYGIIL 925
L +K D +S+G +
Sbjct: 195 LEQKKYTVTVDYWSFGTLA 213
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 58/296 (19%), Positives = 110/296 (37%), Gaps = 38/296 (12%)
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSF 120
L +P E+ +LL++ NN S L+ L L +N S I
Sbjct: 45 LKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIH-EKAFSPL 101
Query: 121 PKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQ 180
KL+ LY+ N + IPP++ SSL+ L + N+++ + ++ I++ N
Sbjct: 102 RKLQKLYISKNH-LVEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNP 158
Query: 181 FSGPM--PSIYNTSPLQNIDMQYN-----------SLAELHLAYNQLSGQIPSTLFE-CK 226
P ++ L + + +L ELHL +N++ I
Sbjct: 159 LENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQ-AIELEDLLRYS 217
Query: 227 QLKILSLSVNNFIGSIPREI-GNITMLKGLYLVYTNLT------GEIQGLQVLALSSNRL 279
+L L L +N I I + L+ L+L L+ +++ LQV+ L +N +
Sbjct: 218 KLYRLGLG-HNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNI 276
Query: 280 TGVIPPEI-------INISSLTVLSLTANNL-LGNLPSNIGHSLPNLQQLILGGNR 327
T + + + +SL N + + + + + G +
Sbjct: 277 T-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 55/266 (20%), Positives = 93/266 (34%), Gaps = 20/266 (7%)
Query: 401 NLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQ 460
+S +L L +I + L +L L L N+++ KA L+KLQ LY+
Sbjct: 51 EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110
Query: 461 HNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSV-IPSS 519
N L I +L SL E N + L ++ + +G N L +
Sbjct: 111 KNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167
Query: 520 LWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPS-SIGDLKNMQHLS 578
+ + + +S L G + + + ++ L N + I + + L
Sbjct: 168 AFDGLKLNYLRISEAKLTG---IPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLG 223
Query: 579 LADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH 638
L N+ + SL L +L L + +N LS +P L L LL+ + L N
Sbjct: 224 LGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN-------- 274
Query: 639 GGPFTNLSSQSFVGNKGLCGAPELKF 664
T + F
Sbjct: 275 --NITKVGVNDFCPVGFGVKRAYYNG 298
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 57/284 (20%), Positives = 104/284 (36%), Gaps = 31/284 (10%)
Query: 379 KDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLET 437
D L L N +S + L + + L L I I + L L L++
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQH-LYALVLVNNKIS-KIHEKAFSPLRKLQKLYISK 111
Query: 438 NELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD-LCGLRSLSEFYSDGNELNGSL--PQ 494
N L IP + L L + N+++ + GLR+++ GN L S P
Sbjct: 112 NHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167
Query: 495 CLDSLISLRTLSLGFNRLTSV---IPSSLWSLRDILNVNLSSNSLNGTLPVEI-GNLKVV 550
D L L L + +LT + +P +L L L N + + +E +
Sbjct: 168 AFDGL-KLNYLRISEAKLTGIPKDLPETLNELH------LDHNKIQ-AIELEDLLRYSKL 219
Query: 551 TKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSG 610
++ L N + S+ L ++ L L +NK +P L L L + + +NN++
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT- 277
Query: 611 EIPNS-------LKALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
++ + + ++L N + F ++
Sbjct: 278 KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD 321
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 70/349 (20%), Positives = 127/349 (36%), Gaps = 64/349 (18%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
L+V+ S L +P EI T+L L NN + L + L +L L+L N++
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQ-NNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 329 TGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE 388
+ + FS L L+KL +S+
Sbjct: 91 S----------------KIHEKAFSP--------------------LRK---LQKLYISK 111
Query: 389 NPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELT-GSIPK 446
N L + P +L L + I+ +P + L N+ + + N L
Sbjct: 112 NHLVEIPPNLPSSLVE----LRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166
Query: 447 AIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLS 506
KL L + KL I DL +L+E + D N++ + L L L
Sbjct: 167 GAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLG 223
Query: 507 LGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPS 566
LG N++ + SL L + ++L +N L+ +P + +LK++ + L N+++ ++
Sbjct: 224 LGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGV 281
Query: 567 SI-------GDLKNMQHLSLADNKFQGSI--PDSLGGLTSLNFLDMSSN 606
+ +SL +N P + +T + +
Sbjct: 282 NDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 62/320 (19%), Positives = 115/320 (35%), Gaps = 47/320 (14%)
Query: 268 GLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNR 327
+L L +N ++ + + + L L L NN + + L LQ+L + N
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLV-NNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 328 LTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILS 387
L IP ++ ++ L + + N +P + + L N + + +
Sbjct: 114 LVE-IPPNLPSS--LVELRIHDNRIR-KVPKGV-----------FSGLRN---MNCIEMG 155
Query: 388 ENPLSGVLPISIGNLSN-AMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPK 446
NPL G ++ L +S + IP L LHL+ N++ +I
Sbjct: 156 GNPLENS-GFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIEL 210
Query: 447 -AIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTL 505
+ R KL L L HN+++ L L +L E + D N+L+ +P L L L+ +
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVV 269
Query: 506 SLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLS-GEI 564
L N +T V + + + I L N + E+
Sbjct: 270 YLHTNNITKVGVNDFCPVGFGV------------------KRAYYNGISLFNNPVPYWEV 311
Query: 565 PSSI-GDLKNMQHLSLADNK 583
+ + + + + K
Sbjct: 312 QPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 62/353 (17%), Positives = 112/353 (31%), Gaps = 90/353 (25%)
Query: 123 LEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFS 182
L + +P I LDL N + + L A+ L NN+ S
Sbjct: 35 LRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 183 GPMPSIYNT--SPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIG 240
I+ SPL+ L +L+++ N L +IP L L L + +N I
Sbjct: 92 ----KIHEKAFSPLRK-------LQKLYISKNHLV-EIPPNLP--SSLVELRIH-DNRIR 136
Query: 241 SIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGV-IPPEIINISSLTVLSLT 299
+P+ + GL + + + + N L P + L L +
Sbjct: 137 KVPKG-----VFSGL-----------RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRI- 179
Query: 300 ANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNS 359
+ L +P ++ L +L L N++ I
Sbjct: 180 SEAKLTGIPKDL---PETLNELHLDHNKIQ-------------------------AIELE 211
Query: 360 LGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGS 419
L L +L L N + + S+ L + L+L +
Sbjct: 212 --------------DLLRYSKLYRLGLGHNQIRMIENGSLSFLPT-LRELHLDNNKLS-R 255
Query: 420 IPSEIGNLNNLTTLHLETNELTGSIP-------KAIGRLQKLQGLYLQHNKLQ 465
+P+ + +L L ++L TN +T + + G+ L +N +
Sbjct: 256 VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 48/201 (23%), Positives = 78/201 (38%), Gaps = 37/201 (18%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVKII 800
LGKG F ++ + A K+ L E I S+ H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQ---RLN------MVIDVASALEYL 851
+ F +VLE SL ++ + L + + +YL
Sbjct: 108 GFFEDNDFVFVVLELCRRRSL----------LELHKRRKALTEPEARYYLRQIVLGCQYL 157
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ--TLATIGYMAPE 909
H + +IH DL N+ LNE + + DFG++ + + + T Y+APE
Sbjct: 158 HRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---YIAPE 211
Query: 910 WKLSRKG-----DVYSYGIIL 925
LS+KG DV+S G I+
Sbjct: 212 -VLSKKGHSFEVDVWSIGCIM 231
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 44/204 (21%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFN------LELEGTLRSFDAECEILGSIRHRNLVK 798
LGKG+F V + + G++ A K+ N + + R E I ++H N+V+
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER----EARICRKLQHPNIVR 92
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVASALE 849
+ + + F LV + + G L F+ I+ R + + + ++
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGEL----------FEDIVAREFYSEADASHCIQQILESIA 142
Query: 850 YLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLATIGYM 906
Y H + I+H +L P N+LL + L+DFG++ + D + T GY+
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYL 197
Query: 907 APEWKLSRKG-----DVYSYGIIL 925
+PE L + D+++ G+IL
Sbjct: 198 SPE-VLKKDPYSKPVDIWACGVIL 220
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 39/205 (19%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVFN-------LELEGTLRSFDAECEILGSIRHRNL 796
+LG+GSF +V + A+K+ ++ E +++ + H
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT----RERDVMSRLDHPFF 92
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVA--------SAL 848
VK+ T D L Y NG L ++ K SFD SAL
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDE--------TCTRFYTAEIVSAL 143
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYMA 907
EYLH IIH DL P NILLNE M ++DFG +K+L E+ + + T Y++
Sbjct: 144 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 908 PEWKLSRKG-----DVYSYGIILME 927
PE L+ K D+++ G I+ +
Sbjct: 201 PE-LLTEKSACKSSDLWALGCIIYQ 224
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 5/235 (2%)
Query: 401 NLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQ 460
+S +L L I+ + +L +L L L N + A L L L L
Sbjct: 61 GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120
Query: 461 HNKLQGSITTD-LCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLG-FNRLTSVIPS 518
N+L +I L L E + N + + + SLR L LG RL+ +
Sbjct: 121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG 179
Query: 519 SLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLS 578
+ L ++ +NL+ +L +P + L + ++DLS N LS P S L ++Q L
Sbjct: 180 AFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237
Query: 579 LADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQ 633
+ ++ Q ++ L SL ++++ NNL+ + L L+ ++L N
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-21
Identities = 72/328 (21%), Positives = 106/328 (32%), Gaps = 78/328 (23%)
Query: 139 PSICN-ISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNI 197
PS+C+ + + L+ VP I + ++L NQ I S ++
Sbjct: 36 PSVCSCSNQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQ----IIKVNS-FKH- 86
Query: 198 DMQYNSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSVNNFIGSIPREIGNITMLKGLY 256
L L L+ N + I F L L L +N + +IP L
Sbjct: 87 ---LRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELF-DNRLTTIPNG-----AFVYL- 135
Query: 257 LVYTNLTGEIQGLQVLALSSNRLTGVIPPEI-INISSLTVLSLTANNLLGNLPSNIGHSL 315
L+ L L +N + IP I SL L L L + L
Sbjct: 136 ----------SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184
Query: 316 PNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSL 375
NL+ L L L E+ LT L
Sbjct: 185 SNLRYLNLAMCNLR--------------------------------------EIPNLTPL 206
Query: 376 TNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSE-IGNLNNLTTLH 434
L +L LS N LS + P S L + + L++ I+ I NL +L ++
Sbjct: 207 IK---LDELDLSGNHLSAIRPGSFQGLMH-LQKLWMIQSQIQ-VIERNAFDNLQSLVEIN 261
Query: 435 LETNELTGSIPKAIGRLQKLQGLYLQHN 462
L N LT L L+ ++L HN
Sbjct: 262 LAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 53/249 (21%), Positives = 89/249 (35%), Gaps = 39/249 (15%)
Query: 61 LGTIPPE-LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDS 119
+ I +L L +L ++ N + L L L N ++I
Sbjct: 76 IQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIP-NGAFVY 134
Query: 120 FPKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLS-FNQLQGHVPSSIL-NIPSLLAIDL 176
KL+ L+L N I +IP I SL LDL +L ++ + +L ++L
Sbjct: 135 LSKLKELWLRNNP-IESIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNL 192
Query: 177 SNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSV 235
+ +P++ L EL L+ N LS I F+ L+ L +
Sbjct: 193 AMCNLRE-IPNLTPLI----------KLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMI- 239
Query: 236 NNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEII-NISSLT 294
+ I I R + NL L + L+ N LT ++P ++ + L
Sbjct: 240 QSQIQVIERN------------AFDNLQS----LVEINLAHNNLT-LLPHDLFTPLHHLE 282
Query: 295 VLSLTANNL 303
+ L N
Sbjct: 283 RIHLHHNPW 291
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 52/235 (22%), Positives = 90/235 (38%), Gaps = 11/235 (4%)
Query: 419 SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLC--GLR 476
S+P+ I ++ T L LE+N+L +L +L L L N L G
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 477 SLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSL-WSLRDILNVNLSSNS 535
SL N + ++ L L L + L + S+ SLR+++ +++S
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 536 LNGTLPVEI-GNLKVVTKIDLSRNDLSGEIPSSI-GDLKNMQHLSLADNKFQGSIPDSLG 593
I L + + ++ N I +L+N+ L L+ + + P +
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196
Query: 594 GLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQ 648
L+SL L+MS NN K L+ L+ L+ S N + + S
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQE-LQHFPSS 249
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 54/272 (19%), Positives = 90/272 (33%), Gaps = 34/272 (12%)
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPW-LDS 119
L ++P + S + L + +N L +L LS SN S
Sbjct: 19 LTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFG 76
Query: 120 FPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSIL-NIPSLLAIDLSN 178
L++L L N + T+ + + L LD + L+ S+ ++ +L+ +D+S+
Sbjct: 77 TTSLKYLDLSFNG-VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135
Query: 179 NQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSVNN 237
I+N SL L +A N +F + L L LS
Sbjct: 136 THTRVAFNGIFNGLS---------SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS-QC 185
Query: 238 FIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLS 297
+ + L LQVL +S N + ++SL VL
Sbjct: 186 QLEQLSPTA-----FNSL-----------SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 229
Query: 298 LTANNLLGNLPSNIGHSLP-NLQQLILGGNRL 328
+ N + P +L L L N
Sbjct: 230 Y-SLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 56/290 (19%), Positives = 102/290 (35%), Gaps = 44/290 (15%)
Query: 124 EHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSG 183
+ + ++P I SS L+L N+LQ + L + LS+N
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG--- 63
Query: 184 PMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIP 243
+ D SL L L++N + + S +QL+ L ++ + +
Sbjct: 64 ----LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQ-HSNLKQMS 117
Query: 244 REIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEI-INISSLTVLSLTANN 302
++ L + L L +S V I +SSL VL + N+
Sbjct: 118 EF----SVFLSL-----------RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNS 161
Query: 303 LLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGF 362
N +I L NL L L +L P++ ++ S L +++M +N F
Sbjct: 162 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT----- 216
Query: 363 CHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLS 412
L + L+ L S N + + + +++ L L+
Sbjct: 217 -------FPYKCLNS---LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 256
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 53/274 (19%), Positives = 98/274 (35%), Gaps = 24/274 (8%)
Query: 292 SLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNL 351
S T + + L ++P+ I + +L L N+L + LT + + N
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63
Query: 352 FSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYL 411
S S T+ L+ L LS N + + + L ++ L
Sbjct: 64 LSFKGCCSQSD----------FGTTS---LKYLDLSFNGVI-TMSSNFLGLEQ-LEHLDF 108
Query: 412 SACNIKGSIPSEI-GNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITT 470
N+K + +L NL L + + L L+ L + N Q +
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 168
Query: 471 D-LCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNV 529
D LR+L+ +L P +SL SL+ L++ N S+ L + +
Sbjct: 169 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228
Query: 530 NLSSNSLNGTLPVEI--GNLKVVTKIDLSRNDLS 561
+ S N + T + + ++L++ND +
Sbjct: 229 DYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 25/111 (22%), Positives = 40/111 (36%), Gaps = 5/111 (4%)
Query: 51 TALNLAYMGLLGTIPPE-LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFS 109
L +A P+ L L+ L+++ P ++L L+ L+ NNF
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 212
Query: 110 SIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICN--ISSLLTLDLSFNQLQ 158
S++ L+ L N I T SSL L+L+ N
Sbjct: 213 SLD-TFPYKCLNSLQVLDYSLNH-IMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 24/199 (12%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLEL-EGTLRSFDAECEI-LGSIRHRNLVKIIST 802
+G+G++GSV K G +AVK + E + + ++ + S +V+
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLN------MVIDVASALEYLHYDHP 856
+ + +E M + S + + K + + + + AL +L +
Sbjct: 90 LFREGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE------- 909
IIH D+ PSNILL+ S L DFGIS L D S+ +T+ YMAPE
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPERIDPSAS 202
Query: 910 -WKLSRKGDVYSYGIILME 927
+ DV+S GI L E
Sbjct: 203 RQGYDVRSDVWSLGITLYE 221
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 53/247 (21%), Positives = 89/247 (36%), Gaps = 49/247 (19%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFN-----------------LELEGTLRSFDAECEIL 788
L +G F + D A+K + + ++ F E +I+
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 789 GSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVA--- 845
I++ + ++ ++ EYM N S+ + D + I V
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV-LDKNYTCFIPIQVIKCI 156
Query: 846 -----SALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL 900
++ Y+H + I H D+ PSNIL++++ LSDFG S+ + D+ T
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTY 214
Query: 901 ATIGYMAPEWKLSRKG-------DVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL 953
+M PE S + D++S GI L F P F +ISL L
Sbjct: 215 E---FMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLV-----EL 261
Query: 954 HGKIINV 960
I
Sbjct: 262 FNNIRTK 268
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 37/199 (18%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKIISTC 803
LG+GSF K AVK+ + +E + E L H N+VK+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRLN--------MVIDVASALEYLHYD 854
LV+E + G L F+ I ++ + ++ + SA+ ++H
Sbjct: 76 HDQLHTFLVMELLNGGEL----------FERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125
Query: 855 HPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK 911
++H DL P N+L N+++ + DFG ++L + +T T+ Y APE
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPE-L 180
Query: 912 LSRKG-----DVYSYGIIL 925
L++ G D++S G+IL
Sbjct: 181 LNQNGYDESCDLWSLGVIL 199
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-24
Identities = 45/204 (22%), Positives = 85/204 (41%), Gaps = 43/204 (21%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFN------LELEGTLRSFDAECEILGSIRHRNLVK 798
LGKG+F V + + G + A + N + + R E I ++H N+V+
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER----EARICRLLKHPNIVR 74
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVASALE 849
+ + S + L+ + + G L F+ I+ R + + + A+
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGEL----------FEDIVAREYYSEADASHCIQQILEAVL 124
Query: 850 YLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLATIGYM 906
+ H ++H +L P N+LL + L+DFG++ + E T GY+
Sbjct: 125 HCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGYL 180
Query: 907 APEWKLSRKG-----DVYSYGIIL 925
+PE L + D+++ G+IL
Sbjct: 181 SPE-VLRKDPYGKPVDLWACGVIL 203
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 64/306 (20%), Positives = 108/306 (35%), Gaps = 55/306 (17%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKIIST 802
+L +G F VY+ + G + A+K E R+ E + + H N+V+ S
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 803 CS-------SDHFKALVLEYMPNGSLENWMYNK--NRSFDILQRLNMVIDVASALEYLHY 853
S + + L+L + G L ++ L + A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA-----------T 902
P PIIH DL N+LL+ L DFG + + + + T
Sbjct: 155 QKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 903 IGYMAPE-WKLSR------KGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG 955
Y PE L K D+++ G IL ++ P F D
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----F----------EDGAKL 259
Query: 956 KIINVVDINLLQKEDAYLTAKEQCVSSVL-SLAMQCTRESAEERINIKEALTKLLKIRNT 1014
+I+N Y +V SL + + EER++I E + +L +I
Sbjct: 260 RIVNG----------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309
Query: 1015 LLTNIE 1020
N +
Sbjct: 310 RNVNPK 315
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 48/210 (22%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFN--------LELEGTLRSFDAECEILGSIRHRNL 796
LG G+ G V ++A+K+ + + + E EIL + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 797 VKIISTC-SSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVAS 846
+KI + + D++ +VLE M G L FD ++ +
Sbjct: 78 IKIKNFFDAEDYY--IVLELMEGGEL----------FDKVVGNKRLKEATCKLYFYQMLL 125
Query: 847 ALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLA-T 902
A++YLH + IIH DL P N+LL E + ++DFG SK+LG+ + M TL T
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---TLCGT 179
Query: 903 IGYMAPE--WKLSRKG-----DVYSYGIIL 925
Y+APE + G D +S G+IL
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 740 FSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVK 798
++ +G+G+ G+VY ++ G ++A++ NL+ + E ++ ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
+ + +V+EY+ GSL + + D Q + + ALE+LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ--- 136
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPEWKLSRK 915
+IH D+ NILL L+DFG + E ++ T+ +G +MAPE ++RK
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTM--VGTPYWMAPE-VVTRK 191
Query: 916 G-----DVYSYGIILME 927
D++S GI+ +E
Sbjct: 192 AYGPKVDIWSLGIMAIE 208
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 19/197 (9%)
Query: 740 FSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVK 798
+G+GS G V G Q+AVK+ +L + E I+ +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
+ + +++E++ G+L + + + Q + V AL YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQG--- 161
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPEWKLSRK 915
+IH D+ +ILL LSDFG + + + + ++L +G +MAPE +SR
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSL--VGTPYWMAPE-VISRS 216
Query: 916 G-----DVYSYGIILME 927
D++S GI+++E
Sbjct: 217 LYATEVDIWSLGIMVIE 233
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 51/223 (22%), Positives = 88/223 (39%), Gaps = 44/223 (19%)
Query: 746 LGKGSFGSVYKGTLSDG------MQIAVKVFNLELEGT----LRSFDAECEILGSI-RHR 794
LG G+FG V T +Q+AVK+ E + +E +++ + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHE 109
Query: 795 NLVKIISTCSSDHFKALVLEYMPNGSLENW----------------------MYNKNRSF 832
N+V ++ C+ L+ EY G L N+
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 833 DILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892
L VA +E+L + +H DL N+L+ V + DFG+++ + ++
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 893 SMT-QTQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFT 930
+ + + +MAPE + K DV+SYGI+L E F+
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 59/198 (29%), Positives = 82/198 (41%), Gaps = 33/198 (16%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGT--LRSFDAECEILGSIRHRNLVKIIST 802
LGKGSFG V K + AVKV N + E E+L + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVASALEYLHY 853
+V E G L FD I++R ++ V S + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGEL----------FDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 854 DHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE- 909
+ I+H DL P NILL + + DFG+S T M + T Y+APE
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEV 194
Query: 910 --WKLSRKGDVYSYGIIL 925
K DV+S G+IL
Sbjct: 195 LRGTYDEKCDVWSAGVIL 212
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 36/201 (17%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFN-LELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
LG G+FG V+ S G++ +K N + + +AE E+L S+ H N++KI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRL------------NMVIDVASALEY 850
H +V+E G L + I+ ++ + +AL Y
Sbjct: 90 EDYHNMYIVMETCEGGEL----------LERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 851 LHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMA 907
H H ++H DL P NIL + + DFG+++L + T T YMA
Sbjct: 140 FHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMA 194
Query: 908 PE---WKLSRKGDVYSYGIIL 925
PE ++ K D++S G+++
Sbjct: 195 PEVFKRDVTFKCDIWSAGVVM 215
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 40/201 (19%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFN-LELEGTLRSFDAECEILGSIRHRNLVKIIST 802
LG+G+ VY+ A+KV + +R+ E +L + H N++K+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLLRLSHPNIIKLKEI 116
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVASALEYLHY 853
+ +LVLE + G L FD I+++ + V + A+ YLH
Sbjct: 117 FETPTEISLVLELVTGGEL----------FDRIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 854 DHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLA-TIGYMAPE 909
+ I+H DL P N+L ++DFG+SK++ + M T+ T GY APE
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---TVCGTPGYCAPE 220
Query: 910 WKLSRKG-----DVYSYGIIL 925
L D++S GII
Sbjct: 221 -ILRGCAYGPEVDMWSVGIIT 240
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 49/196 (25%), Positives = 85/196 (43%), Gaps = 19/196 (9%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLEL-EGTLRSFDAECEI-LGSIRHRNLVKIIST 802
LG+G++G V K + G +AVK + + + +I + ++ V
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 803 CSSDHFKALVLEYMPNGSLEN---WMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
+ + +E M + SL+ + +K ++ + + + ALE+LH +
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE--------WK 911
IH D+ PSN+L+N + DFGIS L D + + YMAPE
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 912 LSRKGDVYSYGIILME 927
S K D++S GI ++E
Sbjct: 190 YSVKSDIWSLGITMIE 205
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 44/196 (22%), Positives = 79/196 (40%), Gaps = 31/196 (15%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS 804
+G+GS+G V ++ A K + F E EI+ S+ H N++++ T
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 805 SDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVASALEYLHYDH 855
+ LV+E G L F+ ++ + ++ DV SA+ Y H +
Sbjct: 77 DNTDIYLVMELCTGGEL----------FERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 856 PTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE--- 909
+ H DL P N L + L DFG++ M + T Y++P+
Sbjct: 127 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLE 181
Query: 910 WKLSRKGDVYSYGIIL 925
+ D +S G+++
Sbjct: 182 GLYGPECDEWSAGVMM 197
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-23
Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 16/190 (8%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVKIIS 801
LGKGSFG V G + AVKV + ++ + S E ++L + H N++K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIH 861
+ LV E G L + + ++ R F + ++ V S + Y+H + I+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNK---IVH 149
Query: 862 CDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE---WKLSRK 915
DL P N+LL ++ + DFG+S M + T Y+APE K
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPEVLHGTYDEK 207
Query: 916 GDVYSYGIIL 925
DV+S G+IL
Sbjct: 208 CDVWSTGVIL 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-23
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 48/210 (22%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFN--------LELEGTLRSFDAECEILGSIRHRNL 796
LG G+ G V ++A+++ + + + E EIL + H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 797 VKIISTC-SSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVAS 846
+KI + + D++ +VLE M G L FD ++ +
Sbjct: 203 IKIKNFFDAEDYY--IVLELMEGGEL----------FDKVVGNKRLKEATCKLYFYQMLL 250
Query: 847 ALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLA-T 902
A++YLH + IIH DL P N+LL E + ++DFG SK+LG+ + M TL T
Sbjct: 251 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---TLCGT 304
Query: 903 IGYMAPE--WKLSRKG-----DVYSYGIIL 925
Y+APE + G D +S G+IL
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 25/231 (10%), Positives = 53/231 (22%), Gaps = 48/231 (20%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVKII 800
L G V+ + A+KVF L + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 801 STC----------------------SSDHFKA----LVLEYM-----PNGSLENWMYNKN 829
D + L++ S +++Y
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 830 RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889
IL + + L ++H P N+ + L D +G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 890 DETSMTQTQTLATIGYMAPEWKLSRKG------DVYSYGIILMETFTKKKP 934
+ + Y E+ + + + G+ + + P
Sbjct: 246 TRGPASSV----PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 61/268 (22%), Positives = 84/268 (31%), Gaps = 57/268 (21%)
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSF 120
L +P + + + + N S R L L SN + I+
Sbjct: 23 LQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID-AAAFTGL 79
Query: 121 PKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNN 179
LE L L N+ + ++ P+ + L TL L LQ +L
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ----------------ELGPG 123
Query: 180 QFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSVNNF 238
F G +L L+L N L +P F L L L N
Sbjct: 124 LFRGL-----------------AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLH-GNR 164
Query: 239 IGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSL 298
I S+P +GL L L L NR+ V P ++ L L L
Sbjct: 165 ISSVPER-----AFRGL-----------HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 299 TANNLLGNLPSNIGHSLPNLQQLILGGN 326
N L LP+ L LQ L L N
Sbjct: 209 F-ANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 56/231 (24%), Positives = 83/231 (35%), Gaps = 25/231 (10%)
Query: 401 NLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQ 460
+ A ++L I + NLT L L +N L A L L+ L L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 461 HNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSL 520
N LRS+ P L L TL L L + P
Sbjct: 89 DNAQ----------LRSVD-------------PATFHGLGRLHTLHLDRCGLQELGPGLF 125
Query: 521 WSLRDILNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSL 579
L + + L N+L LP + +L +T + L N +S + L ++ L L
Sbjct: 126 RGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 580 ADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFN 630
N+ P + L L L + +NNLS +L L L++L L+ N
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 50/238 (21%), Positives = 78/238 (32%), Gaps = 33/238 (13%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
C +G ++P I + L N ++ + + L L+L N L
Sbjct: 18 CPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 472 LCGLRSLSEFYSDGNELNGSLP-QCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVN 530
GL L + N S+ L L TL L L + P L + +
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135
Query: 531 LSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSI-GDLKNMQHLSLADNKFQGSIP 589
L N+L +P DL N+ HL L N+
Sbjct: 136 LQDNALQ-------------------------ALPDDTFRDLGNLTHLFLHGNRISSVPE 170
Query: 590 DSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
+ GL SL+ L + N ++ P++ + L L L L N L +P L +
Sbjct: 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEA-LAPLRA 226
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 52/249 (20%), Positives = 86/249 (34%), Gaps = 41/249 (16%)
Query: 217 QIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSS 276
+P + + + L N I +P + + L +L L S
Sbjct: 25 AVPVGIPA--ASQRIFLH-GNRISHVPAA-----SFRAC-----------RNLTILWLHS 65
Query: 277 NRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSI 336
N L + ++ L L L+ N L ++ H L L L L L + +
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGL 124
Query: 337 -SNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVL 395
+ L + + N +P+ L N L L L N +S V
Sbjct: 125 FRGLAALQYLYLQDNALQ-ALPD-----------DTFRDLGN---LTHLFLHGNRISSVP 169
Query: 396 PISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELTGSIPK-AIGRLQK 453
+ L + +D L L + + +L L TL+L N L+ ++P A+ L+
Sbjct: 170 ERAFRGLHS-LDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRA 226
Query: 454 LQGLYLQHN 462
LQ L L N
Sbjct: 227 LQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 38/182 (20%), Positives = 70/182 (38%), Gaps = 16/182 (8%)
Query: 61 LGTIPPE-LGNLSFLSLLNVTNNSFSGTLPIQ-LSNLRRLKYLSFRSNNFSSIEIPPWLD 118
L I L+ L L++++N+ ++ L RL L + P
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG-PGLFR 126
Query: 119 SFPKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLS 177
L++LYL N+ + +P ++ +L L L N++ + + SL + L
Sbjct: 127 GLAALQYLYLQDNA-LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 178 NNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSVN 236
N+ + P + L L L+L N LS +P+ + L+ L L+ N
Sbjct: 186 QNRVAHVHPHAF--RDLGR-------LMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
Query: 237 NF 238
+
Sbjct: 236 PW 237
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 18/197 (9%)
Query: 740 FSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLE-LEGTLRSFDAECEILGSIRHRNLV 797
F++ +GKGSFG V+KG +A+K+ +LE E + E +L +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
K + D +++EY+ GS + + + D Q ++ ++ L+YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEK-- 139
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPE----W 910
IH D+ +N+LL+E L+DFG++ L D + + T +G +MAPE
Sbjct: 140 -KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTF--VGTPFWMAPEVIKQS 194
Query: 911 KLSRKGDVYSYGIILME 927
K D++S GI +E
Sbjct: 195 AYDSKADIWSLGITAIE 211
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 54/198 (27%), Positives = 84/198 (42%), Gaps = 33/198 (16%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGT--LRSFDAECEILGSIRHRNLVKIIST 802
LG G++G V ++ A+K+ T E +L + H N++K+
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVASALEYLHY 853
LV+E G L FD I+ R ++ V S + YLH
Sbjct: 105 FEDKRNYYLVMECYKGGEL----------FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 854 DHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE- 909
+ I+H DL P N+LL + + + DFG+S + ++ M + L T Y+APE
Sbjct: 155 HN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPEV 209
Query: 910 --WKLSRKGDVYSYGIIL 925
K K DV+S G+IL
Sbjct: 210 LRKKYDEKCDVWSIGVIL 227
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 61/228 (26%), Positives = 91/228 (39%), Gaps = 51/228 (22%)
Query: 736 ATDGFSEN---------NLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAEC 785
+TD FS ++LG+G+ V L + AVK+ + E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 786 EILGSIR-HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRLN---- 839
E+L + HRN++++I + LV E M GS+ I +R +
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----------LSHIHKRRHFNEL 111
Query: 840 ----MVIDVASALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLL--GD 890
+V DVASAL++LH I H DL P NIL N+ + DF + +
Sbjct: 112 EASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
Query: 891 ETSMTQTQTLATI----GYMAPE----WKLSRKG-----DVYSYGIIL 925
+ S T L T YMAPE + D++S G+IL
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 59/198 (29%), Positives = 82/198 (41%), Gaps = 33/198 (16%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGT--LRSFDAECEILGSIRHRNLVKIIST 802
LGKGSFG V K + AVKV N + E E+L + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVASALEYLHY 853
+V E G L FD I++R ++ V S + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGEL----------FDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 854 DHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE- 909
+ I+H DL P NILL + + DFG+S T M + T Y+APE
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEV 194
Query: 910 --WKLSRKGDVYSYGIIL 925
K DV+S G+IL
Sbjct: 195 LRGTYDEKCDVWSAGVIL 212
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 48/205 (23%), Positives = 77/205 (37%), Gaps = 41/205 (20%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNL-ELEGTLRSFDA-----ECEILGSIRHRNLVK 798
LG G F V K S G++ A K + + R E IL + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVASALE 849
+ + L+LE + G L FD + Q+ + + + +
Sbjct: 80 LHDVYENRTDVVLILELVSGGEL----------FDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 850 YLHYDHPTPIIHCDLNPSNILL----NESMVACLSDFGISKLLGDETSMTQTQTLATIGY 905
YLH I H DL P NI+L L DFG++ + D T +
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEF 184
Query: 906 MAPEWKLSRKG-----DVYSYGIIL 925
+APE ++ + D++S G+I
Sbjct: 185 VAPE-IVNYEPLGLEADMWSIGVIT 208
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 5e-22
Identities = 29/232 (12%), Positives = 70/232 (30%), Gaps = 59/232 (25%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRS----------------------- 780
+LG+ + + T G V V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 781 -----FDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM-PNGSLENW------MYNK 828
F +++ + + ++++ + Y +L+ + +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 829 NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888
++S RL + + V L LH+ ++H L P +I+L++ L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 889 GDETSMTQTQTLATIGYMAPEW---------------KLSRKGDVYSYGIIL 925
G + + G+ PE ++ D ++ G+++
Sbjct: 257 GARVVSS-----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 60/226 (26%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFN--------------------LELEGTLRSFDA 783
+GKGS+G V +D A+KV + G ++
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 784 ------ECEILGSIRHRNLVK---IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDI 834
E IL + H N+VK ++ + DH +V E + G + ++
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPV----------MEV 128
Query: 835 LQRLNMVIDVA--------SALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886
+ D A +EYLHY IIH D+ PSN+L+ E ++DFG+S
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 887 LLGDETSMTQTQTLATIGYMAPE-WKLSRKG------DVYSYGIIL 925
++ T+ T +MAPE +RK DV++ G+ L
Sbjct: 186 EFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 49/205 (23%), Positives = 75/205 (36%), Gaps = 41/205 (20%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNL-ELEGTLRSFDA-----ECEILGSIRHRNLVK 798
LG G F V K G + A K L + R E IL IRH N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVASALE 849
+ + L+LE + G L FD + ++ + + +
Sbjct: 73 LHDIFENKTDVVLILELVSGGEL----------FDFLAEKESLTEDEATQFLKQILDGVH 122
Query: 850 YLHYDHPTPIIHCDLNPSNILL----NESMVACLSDFGISKLLGDETSMTQTQTLATIGY 905
YLH I H DL P NI+L + L DFGI+ + T +
Sbjct: 123 YLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEF 177
Query: 906 MAPEWKLSRKG-----DVYSYGIIL 925
+APE ++ + D++S G+I
Sbjct: 178 VAPE-IVNYEPLGLEADMWSIGVIT 201
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 8e-22
Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 17/196 (8%)
Query: 740 FSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVK 798
F LG+GS+GSVYK G +A+K +E + L+ E I+ ++VK
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
+ + +V+EY GS+ + + +N++ + ++ LEYLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPE----WK 911
IH D+ NILLN A L+DFG++ L D +M + T+ IG +MAPE
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--TMAKRNTV--IGTPFWMAPEVIQEIG 201
Query: 912 LSRKGDVYSYGIILME 927
+ D++S GI +E
Sbjct: 202 YNCVADIWSLGITAIE 217
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 9e-22
Identities = 40/200 (20%), Positives = 75/200 (37%), Gaps = 21/200 (10%)
Query: 746 LGKG--SFGSVYKGT-LSDGMQIAVKVFNLELEGT--LRSFDAECEILGSIRHRNLVKII 800
+GKG +V G + V+ NLE + E + H N+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 801 STCSSDHFKALVLEYMPNGSLENWM-YNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
+T +D+ +V +M GS ++ + + + L ++ V AL+Y+H+
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---Y 149
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT---IG---YMAPE---- 909
+H + S+IL++ LS + + + + +++PE
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 910 --WKLSRKGDVYSYGIILME 927
K D+YS GI E
Sbjct: 210 NLQGYDAKSDIYSVGITACE 229
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 1e-21
Identities = 33/235 (14%), Positives = 66/235 (28%), Gaps = 48/235 (20%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGT---LRSFDAECEILGSIR-------- 792
+LG+ + + T G V V ++ E L +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 793 --------------HRNLVKIISTCSSDH----FKALVLEYMPNGSLENWM------YNK 828
K+I + L +L+ + +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 829 NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888
++S RL + + V L LH+ ++H L P +I+L++ L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 889 GDETSMTQTQTLATIGYMAPE---------WKLSRKGDVYSYGIILMETFTKKKP 934
G + A A ++ D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-21
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 44/211 (20%)
Query: 744 NLLGKGSFGSVYKGT-LSDGMQIAVKV-------------FNLELEGTLRSFDAECEILG 789
LG G++G V + + A+KV N +E E +L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 790 SIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNM 840
S+ H N++K+ + LV E+ G L F+ I+ R N+
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----------FEQIINRHKFDECDAANI 151
Query: 841 VIDVASALEYLHYDHPTPIIHCDLNPSNILL-NESMVACL--SDFGISKLLGDETSMTQT 897
+ + S + YLH + I+H D+ P NILL N++ + + DFG+S + +
Sbjct: 152 MKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--R 206
Query: 898 QTLATIGYMAPE---WKLSRKGDVYSYGIIL 925
L T Y+APE K + K DV+S G+I+
Sbjct: 207 DRLGTAYYIAPEVLKKKYNEKCDVWSCGVIM 237
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 47/205 (22%), Positives = 75/205 (36%), Gaps = 41/205 (20%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFN------LELEGTLRSFDAECEILGSIRHRNLVK 798
LG G F V K S G++ A K + E IL + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVASALE 849
+ + L+LE + G L FD + Q+ + + + +
Sbjct: 80 LHDVYENRTDVVLILELVSGGEL----------FDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 850 YLHYDHPTPIIHCDLNPSNILL----NESMVACLSDFGISKLLGDETSMTQTQTLATIGY 905
YLH I H DL P NI+L L DFG++ + D T +
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEF 184
Query: 906 MAPEWKLSRKG-----DVYSYGIIL 925
+APE ++ + D++S G+I
Sbjct: 185 VAPE-IVNYEPLGLEADMWSIGVIT 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 46/232 (19%), Positives = 93/232 (40%), Gaps = 18/232 (7%)
Query: 706 RQKRNTGLQIDEEMSPEVTWRRISYQELFRATDGFSEN----NLLGKGSFGSVYKGT-LS 760
R K + D + E W++ Q + + LG G+FG V++ +
Sbjct: 15 RGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKA 74
Query: 761 DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGS 820
G K N + E I+ + H L+ + + L+LE++ G
Sbjct: 75 TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134
Query: 821 LENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL--NESMVAC 878
L + + ++ + +N + L+++H I+H D+ P NI+ ++
Sbjct: 135 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVK 191
Query: 879 LSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-----DVYSYGIIL 925
+ DFG++ L + + T AT + APE + R+ D+++ G++
Sbjct: 192 IIDFGLATKLNPDEIV--KVTTATAEFAAPE-IVDREPVGFYTDMWAIGVLG 240
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 738 DGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLE-LEGTLRSFDAECEILGSIRHRN 795
D + ++G G+ V ++A+K NLE + ++ E + + H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWM-YNKNRSFDILQRLN------MVIDVASAL 848
+V ++ LV++ + GS+ + + + + L+ ++ +V L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT-IG--- 904
EYLH + IH D+ NILL E ++DFG+S L +T+ + T +G
Sbjct: 135 EYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 905 YMAPEWKLSRKG-----DVYSYGIILME 927
+MAPE +G D++S+GI +E
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 47/205 (22%), Positives = 77/205 (37%), Gaps = 41/205 (20%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFN-LELEGTLRSFDA-----ECEILGSIRHRNLVK 798
LG G F V K S G+Q A K + + R E IL I+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR--------LNMVIDVASALE 849
+ + L+LE + G L FD + ++ + + + +
Sbjct: 79 LHEVYENKTDVILILELVAGGEL----------FDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 850 YLHYDHPTPIIHCDLNPSNILL----NESMVACLSDFGISKLLGDETSMTQTQTLATIGY 905
YLH I H DL P NI+L + DFG++ + T +
Sbjct: 129 YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 906 MAPEWKLSRKG-----DVYSYGIIL 925
+APE ++ + D++S G+I
Sbjct: 184 VAPE-IVNYEPLGLEADMWSIGVIT 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 51/231 (22%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 706 RQKRNTGLQIDEEMSPEVTWRRI--SYQELFRATDGFSENNLLGKGSFGSVYKGT-LSDG 762
+ KR + L +D P RI + Q + S+ +LG G FG V+K + G
Sbjct: 55 KSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATG 114
Query: 763 MQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLE 822
+++A K+ E ++ + H NL+++ S + LV+EY+ G L
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 823 NWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL---NESMVACL 879
+ + +++ + L + + + + ++H + I+H DL P NIL + + +
Sbjct: 175 DRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIK-I 230
Query: 880 SDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-----DVYSYGIIL 925
DFG+++ + T ++APE ++ D++S G+I
Sbjct: 231 IDFGLARRYKPREKL--KVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIA 278
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 32/233 (13%)
Query: 719 MSPEVTWRRISYQELFRATD---GFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL 774
M+ + R + +L D F L+G G++G VYKG + G A+KV ++
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT- 60
Query: 775 EGTLRSFDAECEILGSI-RHRNLVKII------STCSSDHFKALVLEYMPNGSLENWMYN 827
E +L HRN+ + D LV+E+ GS+ + + N
Sbjct: 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120
Query: 828 -KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886
K + + ++ L +LH +IH D+ N+LL E+ L DFG+S
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 887 LLGDETSMTQTQTLATIG---YMAPEWKLSR---------KGDVYSYGIILME 927
L ++ + T IG +MAPE K D++S GI +E
Sbjct: 178 QLDR--TVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 48/208 (23%), Positives = 82/208 (39%), Gaps = 51/208 (24%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDA--ECEILGSI-RHRNLVKII 800
+LG G G V + G + A+K+ S A E + ++V I+
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88
Query: 801 STCSSDHFKA----LVLEYMPNGSLENWMYNKNRSFD-ILQRLN----------MVIDVA 845
+ H +++E M G L F I +R + ++ D+
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138
Query: 846 SALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLAT 902
+A+++LH + I H D+ P N+L + V L+DFG +K T T
Sbjct: 139 TAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT---PCYT 192
Query: 903 IGYMAPEWKLSRKG-----DVYSYGIIL 925
Y+APE L + D++S G+I+
Sbjct: 193 PYYVAPE-VLGPEKYDKSCDMWSLGVIM 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 26/202 (12%)
Query: 740 FSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGT---LRSFDAECEILGSIRHRN 795
FS+ +G GSFG+VY + + +A+K + + + + E L +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH 855
++ +H LV+EY GS + + + ++ + L YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG---YMAPE--W 910
+IH D+ NILL+E + L DFG + + M + +G +MAPE
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSF--VGTPYWMAPEVIL 223
Query: 911 KLSRKG-----DVYSYGIILME 927
+ DV+S GI +E
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIE 245
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 56/280 (20%), Positives = 84/280 (30%), Gaps = 26/280 (9%)
Query: 69 GNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLD--SFPKLEHL 126
G S LL + + LK L+ R+ S + L L+ L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 127 YLDGNSFIGTIPPSICNI--SSLLTLDLSFNQLQGHVPS----SILNIPSLLAIDLSNNQ 180
L+ GT PP + L L+L P L + ++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 181 FSG-PMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFI 239
+ L +D+ N + L TL + L + + +
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL---QVLALRNAGMETPS 217
Query: 240 GSIPREIGNITMLKGLYLVYTNLTGEI--------QGLQVLALSSNRLTGVIPPEIINIS 291
G L+GL L + +L L L LS L V P + +
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV-PKGL--PA 274
Query: 292 SLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGP 331
L+VL L + N L PS LP + L L GN
Sbjct: 275 KLSVLDL-SYNRLDRNPSPDE--LPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 6e-19
Identities = 60/297 (20%), Positives = 90/297 (30%), Gaps = 38/297 (12%)
Query: 19 NDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLN 78
L L T + + + S +R+T + + +S L L
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 79 VTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSF-----PKLEHLYLDGNSF 133
+ N +GT P L N S WL P L+ L +
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 134 IGTIPPSICNISSLLTLDLSFNQLQGHVPSSI----LNIPSLLAIDLSNNQFSGPMPSIY 189
+ + +L TLDLS N G L P+L + L N P
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 190 NTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSVNNFIGSIPREIGN 248
+ + L L L++N L + + QL L+LS + +P+ +
Sbjct: 222 ALAAAR------VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS-FTGLKQVPKGLP- 273
Query: 249 ITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLG 305
L VL LS NRL P + + LSL N L
Sbjct: 274 ------------------AKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 54/322 (16%), Positives = 99/322 (30%), Gaps = 41/322 (12%)
Query: 327 RLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLIL 386
+ P P S + L D+ + L +LG T + L++L +
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75
Query: 387 SENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPK 446
+ + + ++ L L LE E+TG+ P
Sbjct: 76 RAARIPSRILFGA----------------------LRVLGISGLQELTLENLEVTGTAPP 113
Query: 447 AIGRLQ--KLQGLYLQHNKLQG--SITTDL--CGLRSLSEFYSDGNELNGSLPQCLDSLI 500
+ L L L++ + +L L + +
Sbjct: 114 PLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173
Query: 501 SLRTLSLGFNRLT-------SVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKI 553
+L TL L N ++ P +L+ + N + +G + +
Sbjct: 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGL 233
Query: 554 DLSRNDLSGEIPSSIGD-LKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEI 612
DLS N L + D + L+L+ + +P L L+ LD+S N L
Sbjct: 234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RN 289
Query: 613 PNSLKALSLLKFLNLSFNGLQG 634
P+ + L + L+L N
Sbjct: 290 PSPDE-LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 40/196 (20%), Positives = 73/196 (37%), Gaps = 11/196 (5%)
Query: 18 TNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLL 77
T LN+L + + W + L++A L ++ LS L
Sbjct: 119 TGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178
Query: 78 NVTNNSFSGTLPIQLS----NLRRLKYLSFRSNNFSSI--EIPPWLDSFPKLEHLYLDGN 131
++++N G + + L+ L+ R+ + + +L+ L L N
Sbjct: 179 DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238
Query: 132 SFIGTIPPSICNI-SSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYN 190
S C+ S L +L+LSF L+ VP + L +DLS N+ PS
Sbjct: 239 SLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NPSPDE 294
Query: 191 TSPLQNIDMQYNSLAE 206
+ N+ ++ N +
Sbjct: 295 LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 57/312 (18%), Positives = 96/312 (30%), Gaps = 42/312 (13%)
Query: 181 FSGPMP---SIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFEC-KQLKILSLSVN 236
FS P P S +N ++++ + +L + + K L + L+V
Sbjct: 17 FSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVR 76
Query: 237 NFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVL 296
G + +L GLQ L L + +TG PP ++ + +
Sbjct: 77 AARIPSRILFGALRVLGIS------------GLQELTLENLEVTGTAPPPLLEATGPDLN 124
Query: 297 SLTANNLLGN-----LPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNL 351
L N+ L P L+ L + + L+ +D+ N
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 352 FSGFIPNSLGFC-HPYDELGFLT---------------SLTNCKDLRKLILSENPLSGVL 395
G C + L L L+ L LS N L
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244
Query: 396 PISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQ 455
+ + ++ L LS +K +P + L+ L L N L P L ++
Sbjct: 245 GAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPS-PDELPQVG 299
Query: 456 GLYLQHNKLQGS 467
L L+ N S
Sbjct: 300 NLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 45/329 (13%), Positives = 93/329 (28%), Gaps = 39/329 (11%)
Query: 288 INISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDM 347
N S +A N LG + +L+ L+ + ++ + +
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQF----TDIIKSLSL 70
Query: 348 PYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSN-AM 406
S + L++L L ++G P + + +
Sbjct: 71 KRLTVRAARIPSRILFG-------ALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL 123
Query: 407 DVLYLSACNIKG--SIPSEIGNL--NNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHN 462
++L L + + +E+ L L + + + L L L N
Sbjct: 124 NILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183
Query: 463 KLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWS 522
G ++ P +L L + G + V + +
Sbjct: 184 PELGERG-----------------LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226
Query: 523 LRDILNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLAD 581
+ ++LS NSL + ++LS L ++P + + L L+
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSY 283
Query: 582 NKFQGSIPDSLGGLTSLNFLDMSSNNLSG 610
N+ P L + L + N
Sbjct: 284 NRLD-RNPSPDE-LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 55/302 (18%), Positives = 85/302 (28%), Gaps = 69/302 (22%)
Query: 269 LQVLALSSNRLTGVIPP---EIINISSLTVLSLTANNLLGNLPSNIG-HSLPNLQQLILG 324
L+ L + + R+ I ++ IS L L+L + G P + + P+L L L
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 325 GNRLTG--PIPSSISNASMLTL--IDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKD 380
+ + L + + F +
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVR---------------VFPA 174
Query: 381 LRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNEL 440
L L LS+NP G + I P + L L +
Sbjct: 175 LSTLDLSDNPELGERGL------------------ISALCPLKFPTLQVLALRNAGMETP 216
Query: 441 TGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLI 500
+G +LQGL L HN L+ + C S
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS----------------------- 253
Query: 501 SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDL 560
L +L+L F L V L ++LS N L+ P L V + L N
Sbjct: 254 QLNSLNLSFTGLKQVPKGLPAKLS---VLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPF 308
Query: 561 SG 562
Sbjct: 309 LD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 28/121 (23%), Positives = 45/121 (37%), Gaps = 5/121 (4%)
Query: 64 IPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKL 123
P + L L+L N + SG + +L+ L N+ P D +L
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255
Query: 124 EHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSG 183
L L + +P + + L LDLS+N+L S +P + + L N F
Sbjct: 256 NSLNLSFTG-LKQVPKGL--PAKLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLD 310
Query: 184 P 184
Sbjct: 311 S 311
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 46/237 (19%), Positives = 81/237 (34%), Gaps = 61/237 (25%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDA-----ECEILGSIRHRNLVKI 799
+G+GS+G V A+K+ N + D E ++ + H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRL--------------------- 838
+ + LV+E G L + + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 839 ------------------NMVIDVASALEYLHYDHPTPIIHCDLNPSNILL--NESMVAC 878
N++ + SAL YLH I H D+ P N L N+S
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 879 LSDFGISKLLGDETSMTQTQTLATI----GYMAPE-WKLSRKG-----DVYSYGIIL 925
L DFG+SK + + + + T ++APE + + D +S G++L
Sbjct: 211 LVDFGLSKEF-YKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 47/203 (23%), Positives = 77/203 (37%), Gaps = 39/203 (19%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGT--LRSFDAECEILGSIRHR-NLVKIIS 801
LG+G F V + S G + A K G E +L + ++ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRL----------NMVIDVASALEY 850
+ L+LEY G + F L L ++ + + Y
Sbjct: 97 VYENTSEIILILEYAAGGEI----------FSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 851 LHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMA 907
LH ++ I+H DL P NILL + DFG+S+ +G + + + T Y+A
Sbjct: 147 LHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLA 201
Query: 908 PEWKLSRKG-----DVYSYGIIL 925
PE L+ D+++ GII
Sbjct: 202 PE-ILNYDPITTATDMWNIGIIA 223
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 94.4 bits (234), Expect = 6e-20
Identities = 50/250 (20%), Positives = 104/250 (41%), Gaps = 19/250 (7%)
Query: 381 LRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNEL 440
+ + I P+ + P + + L ++ ++ LN++ + +++
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETI-KDNLKKKSVTDAVT--QNELNSIDQIIANNSDI 55
Query: 441 TGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLI 500
S+ + I L + L+L NKL I L L++L + D N++ L L
Sbjct: 56 K-SV-QGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKI--KDLSSLKDLK 109
Query: 501 SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDL 560
L++LSL N ++ + + L L + ++ L +N + + L + + L N +
Sbjct: 110 KLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQI 165
Query: 561 SGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALS 620
S +I + L +Q+L L+ N S +L GL +L+ L++ S + N L
Sbjct: 166 S-DI-VPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLV 221
Query: 621 LLKFLNLSFN 630
+ + +
Sbjct: 222 VPNTVKNTDG 231
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 89.4 bits (221), Expect = 2e-18
Identities = 56/244 (22%), Positives = 106/244 (43%), Gaps = 17/244 (6%)
Query: 372 LTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLT 431
+ + K L + ++ + + L++ +D + + +IK S+ I L N+T
Sbjct: 14 IFPDDAFAETIKDNLKKKSVTDAVTQN--ELNS-IDQIIANNSDIK-SV-QGIQYLPNVT 68
Query: 432 TLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGS 491
L L N+LT I K + L+ L L+L NK+ + L L+ L + N + S
Sbjct: 69 KLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKI--KDLSSLKDLKKLKSLSLEHNGI--S 122
Query: 492 LPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVT 551
L L L +L LG N++T + + L L + ++L N ++ +P+ L +
Sbjct: 123 DINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQ 178
Query: 552 KIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGE 611
+ LS+N +S ++ ++ LKN+ L L + + L N + + +L
Sbjct: 179 NLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 236
Query: 612 IPNS 615
S
Sbjct: 237 EIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 2e-16
Identities = 47/268 (17%), Positives = 93/268 (34%), Gaps = 44/268 (16%)
Query: 92 LSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLD 151
+ + + + + ++ + + + I ++ I + ++ L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSD-IKSVQG-IQYLPNVTKLF 71
Query: 152 LSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAY 211
L+ N+L + N+ +L + L N+ I + S L++ L L L +
Sbjct: 72 LNGNKLT--DIKPLTNLKNLGWLFLDENK-------IKDLSSLKD----LKKLKSLSLEH 118
Query: 212 NQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQV 271
N +S I + L QL+ L L N I +IT+L L L
Sbjct: 119 NGIS-DI-NGLVHLPQLESLYLGNNK--------ITDITVLSRL-----------TKLDT 157
Query: 272 LALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGP 331
L+L N+++ + + ++ L L L + N + +L + L NL L L
Sbjct: 158 LSLEDNQISDI--VPLAGLTKLQNLYL-SKNHISDLRAL--AGLKNLDVLELFSQECLNK 212
Query: 332 IPSSISNASMLTLIDMPYNLFSGFIPNS 359
+ SN + + S
Sbjct: 213 PINHQSNLVVPNTVKNTDGSLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.8 bits (196), Expect = 2e-15
Identities = 52/263 (19%), Positives = 103/263 (39%), Gaps = 22/263 (8%)
Query: 372 LTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLT 431
+ + ++I + + + V I L N + L+L+ + I + NL NL
Sbjct: 36 AVTQNELNSIDQIIANNSDIKSVQGIQ--YLPN-VTKLFLNGNKLT-DI-KPLTNLKNLG 90
Query: 432 TLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGS 491
L L+ N++ + ++ L+KL+ L L+HN + S L L L Y N++ +
Sbjct: 91 WLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKI--T 144
Query: 492 LPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVT 551
L L L TLSL N+++ + L L + N+ LS N ++ + LK +
Sbjct: 145 DITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLD 200
Query: 552 KIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGE 611
++L + + + +L + D S + D N+
Sbjct: 201 VLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS-------DDGDYEKPNVKWH 253
Query: 612 IPNSLKALSLLKFLNLSFNGLQG 634
+P +S + + ++ +
Sbjct: 254 LPEFTNEVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 78.2 bits (192), Expect = 7e-15
Identities = 49/270 (18%), Positives = 95/270 (35%), Gaps = 44/270 (16%)
Query: 204 LAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT 263
+ E + QI + +L + + + + + +++
Sbjct: 1 MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKS-VTDAV-TQNELNSIDQIIANNSDIK 56
Query: 264 GEIQG------LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNL--LGNLPSNIGHSL 315
+QG + L L+ N+LT + P + N+ +L L L N + L +L L
Sbjct: 57 -SVQGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSSL-----KDL 108
Query: 316 PNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSL 375
L+ L L N ++ + + + L + + N ++ +T L
Sbjct: 109 KKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNN-----------------KITDITVL 149
Query: 376 TNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHL 435
+ L L L +N +S ++P++ L+ + LYLS +I S + L NL L L
Sbjct: 150 SRLTKLDTLSLEDNQISDIVPLA--GLTK-LQNLYLSKNHI--SDLRALAGLKNLDVLEL 204
Query: 436 ETNELTGSIPKAIGRLQKLQGLYLQHNKLQ 465
+ E L + L
Sbjct: 205 FSQECLNKPINHQSNLVVPNTVKNTDGSLV 234
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 8e-12
Identities = 42/196 (21%), Positives = 67/196 (34%), Gaps = 22/196 (11%)
Query: 68 LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLY 127
L NL L L + N L +L++LK LS N S I L P+LE LY
Sbjct: 83 LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGISDIN---GLVHLPQLESLY 137
Query: 128 LDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPS 187
L N I I + ++ L TL L NQ+ + + L + LS N
Sbjct: 138 LGNNK-ITDITV-LSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNH------- 186
Query: 188 IYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIG 247
I + L + +L L L + + + + + + P I
Sbjct: 187 ISDLRALAGL----KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIIS 240
Query: 248 NITMLKGLYLVYTNLT 263
+ + + +
Sbjct: 241 DDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 4e-04
Identities = 23/123 (18%), Positives = 43/123 (34%), Gaps = 5/123 (4%)
Query: 68 LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLY 127
L L+ L L++ +N S +P L+ L +L+ L N+ S + L L+ L
Sbjct: 149 LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRA---LAGLKNLDVLE 203
Query: 128 LDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPS 187
L + N+ T+ + L S + +F+ +
Sbjct: 204 LFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSF 263
Query: 188 IYN 190
I+
Sbjct: 264 IFY 266
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-20
Identities = 42/202 (20%), Positives = 74/202 (36%), Gaps = 43/202 (21%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVKIIS 801
LG+G FG V++ S K + + E IL RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK----EISILNIARHRNILHLHE 68
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQR---------LNMVIDVASALEYL 851
+ S ++ E++ + F+ I ++ V V AL++L
Sbjct: 69 SFESMEELVMIFEFISGLDI----------FERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 852 HYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAP 908
H + I H D+ P NI+ S + + +FG ++ L + Y AP
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIK-IIEFGQARQLKPGDNF--RLLFTAPEYYAP 172
Query: 909 EWKLSRKG-----DVYSYGIIL 925
E D++S G ++
Sbjct: 173 E-VHQHDVVSTATDMWSLGTLV 193
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 8e-20
Identities = 39/172 (22%), Positives = 67/172 (38%), Gaps = 20/172 (11%)
Query: 784 ECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNR--SFDILQRLNMV 841
+ + +N V + S + + ++ +L++WM + + L++
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170
Query: 842 IDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA 901
I +A A+E+LH ++H DL PSNI V + DFG+ + + T
Sbjct: 171 IQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 227
Query: 902 -----------TIGYMAPE----WKLSRKGDVYSYGIILMETFTKKKPTDEL 938
T YM+PE S K D++S G+IL E E
Sbjct: 228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER 279
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-19
Identities = 48/233 (20%), Positives = 93/233 (39%), Gaps = 18/233 (7%)
Query: 705 RRQKRNTGLQIDEEMSPEVTWRRISYQELFRATDGFSE----NNLLGKGSFGSVYKGT-L 759
+ + + + + W++ Q + D + + LG G+FG V++ T
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179
Query: 760 SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNG 819
+ G A K E + E + + +RH LV + D+ ++ E+M G
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239
Query: 820 SLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACL 879
L + +++ + + + V L ++H ++ +H DL P NI+ L
Sbjct: 240 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNEL 296
Query: 880 --SDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-----DVYSYGIIL 925
DFG++ L + S+ T T + APE K D++S G++
Sbjct: 297 KLIDFGLTAHLDPKQSV--KVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLS 346
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 59/201 (29%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVFN-------LELEGTLRSFDAECEILGSIRHRNL 796
+GKGSFG V +D ++ A+K N E+ + E +I+ + H L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK----ELQIMQGLEHPFL 77
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMY--NKNRSFDILQRLNMVIDVASALEYLHYD 854
V + + + +V++ + G L Y +N F + ++ AL+YL
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDL---RYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA-TIGYMAPEWKLS 913
IIH D+ P NILL+E ++DF I+ +L ET T+A T YMAPE S
Sbjct: 135 R---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSS 188
Query: 914 RKGDVY-------SYGIILME 927
RKG Y S G+ E
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYE 209
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEG------TLRSFDAECEILGSIRHRNLVK 798
+G+G++G+V+K +A+K L+ + LR E +L ++H+N+V+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 65
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
+ SD LV E+ L+ + + N D + + + L + H +
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL-----S 913
++H DL P N+L+N + L++FG+++ G + + T+ Y P+ S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 914 RKGDVYSYGIILMETFTKKKPTDELFVGE 942
D++S G I E +P LF G
Sbjct: 181 TSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 47/207 (22%), Positives = 81/207 (39%), Gaps = 50/207 (24%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDA--ECEILGSI-RHRNLVKIIS 801
LG G G V + + A+K+ A E E+ + ++V+I+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122
Query: 802 TC----SSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRLN----------MVIDVAS 846
+ +V+E + G L F I R + ++ +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 847 ALEYLHYDHPTPIIHCDLNPSNILL-NESMVACL--SDFGISKLLGDETSMTQTQTLATI 903
A++YLH + I H D+ P N+L ++ A L +DFG +K S+ T T
Sbjct: 173 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTP 227
Query: 904 GYMAPEWKLSRKG-----DVYSYGIIL 925
Y+APE L + D++S G+I+
Sbjct: 228 YYVAPE-VLGPEKYDKSCDMWSLGVIM 253
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 9e-19
Identities = 50/251 (19%), Positives = 92/251 (36%), Gaps = 38/251 (15%)
Query: 714 QIDEEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQI-AVKVF-- 770
++ + W+ + D FS + ++G+G FG VY +D ++ A+K
Sbjct: 166 IESDKFTRFCQWKNVELNIHLTMND-FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK 224
Query: 771 -----NLELEGTLRSFDAECEIL---GSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLE 822
L E +L + +V + + + +L+ M G L
Sbjct: 225 KRIKMKQGETLAL----NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 823 NWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDF 882
+ ++ F ++ LE++H +++ DL P+NILL+E +SD
Sbjct: 281 YHLS-QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 336
Query: 883 GISKLLGDETSMTQTQTLA-TIGYMAPEWKLSRKG-----DVYSYGIILMETFT------ 930
G++ + + T GYMAPE D +S G +L +
Sbjct: 337 GLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392
Query: 931 --KKKPTDELF 939
K K E+
Sbjct: 393 QHKTKDKHEID 403
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 53/202 (26%), Positives = 82/202 (40%), Gaps = 38/202 (18%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLE-LEGTLRSFDAECEILGSIRHRNLVK---I 799
LG+G++G V +AVK+ +++ + E I + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRLNMVIDVA--------SALEY 850
+ + L LEY G L FD I + M A + + Y
Sbjct: 74 RRE-GNIQY--LFLEYCSGGEL----------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYMAPE 909
LH I H D+ P N+LL+E +SDFG++ + + T+ Y+APE
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 910 WKLSRKG------DVYSYGIIL 925
L R+ DV+S GI+L
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVL 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 24/219 (10%)
Query: 735 RATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEG------TLRSFDAECEIL 788
+ + + +G+G++G VYK S G +A+K L+ E +R E +L
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLL 73
Query: 789 GSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASAL 848
+ H N+V +I S+ LV E+M L+ + Q + + +
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAP 908
+ H I+H DL P N+L+N L+DFG+++ G + T + T+ Y AP
Sbjct: 133 AHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAP 188
Query: 909 EWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVGE 942
+ + S D++S G I E T KP LF G
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMIT-GKP---LFPGV 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 45/207 (21%), Positives = 76/207 (36%), Gaps = 41/207 (19%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFN----LELEGTLRSFDAECEILGSIRHRNLVK- 798
LLG+GS+G V + + AVK+ + + E ++L +RH+N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 799 --IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVA--------SAL 848
++ +V+EY G E D + + A L
Sbjct: 72 VDVLYNEEKQKM-YMVMEYCVCGMQE--------MLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATI----G 904
EYLH I+H D+ P N+LL +S G+++ L T T
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPF---AADDTCRTSQGSPA 176
Query: 905 YMAPEWKLSRKG------DVYSYGIIL 925
+ PE D++S G+ L
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 46/206 (22%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVFN-------LELEGTLRSFDAECEILGSIRHRNL 796
LG GSFG V+ + A+KV ++E T E +L + H +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN----DERLMLSIVTHPFI 68
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVID---------VASA 847
+++ T ++++Y+ G L F +L++ + V A
Sbjct: 69 IRMWGTFQDAQQIFMIMDYIEGGEL----------FSLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 848 LEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYM 906
LEYLH II+ DL P NILL+++ ++DFG +K + D T TL T Y+
Sbjct: 119 LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYI 170
Query: 907 APEWKLSRKG-----DVYSYGIILME 927
APE +S K D +S+GI++ E
Sbjct: 171 APE-VVSTKPYNKSIDWWSFGILIYE 195
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 53/202 (26%), Positives = 82/202 (40%), Gaps = 38/202 (18%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLE-LEGTLRSFDAECEILGSIRHRNLVK---I 799
LG+G++G V +AVK+ +++ + E I + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRLNMVIDVA--------SALEY 850
+ + L LEY G L FD I + M A + + Y
Sbjct: 74 RRE-GNIQY--LFLEYCSGGEL----------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYMAPE 909
LH I H D+ P N+LL+E +SDFG++ + + T+ Y+APE
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 910 WKLSRKG------DVYSYGIIL 925
L R+ DV+S GI+L
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVL 198
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 49/207 (23%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVK-- 798
LG G+FG V G G ++AVK+ N + + E + L RH +++K
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 799 -IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRLNMVIDVA--------SAL 848
+IST +D F +V+EY+ G L FD I + + A SA+
Sbjct: 78 QVIST-PTDFF--MVMEYVSGGEL----------FDYICKHGRVEEMEARRLFQQILSAV 124
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATI----G 904
+Y H ++H DL P N+LL+ M A ++DFG+S + M+ + L T
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM------MSDGEFLRTSCGSPN 175
Query: 905 YMAPEWKLSRKG------DVYSYGIIL 925
Y APE +S + D++S G+IL
Sbjct: 176 YAAPE-VISGRLYAGPEVDIWSCGVIL 201
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 54/232 (23%), Positives = 89/232 (38%), Gaps = 31/232 (13%)
Query: 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETN 438
+ L LS NPL + S + + VL LS C I+ +I +L++L+TL L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPE-LQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 439 ELTGSIPKAI-GRLQKLQGLYLQHNKLQGSITTDL-CGLRSLSEFYSDGNELNGSLPQ-- 494
+ S+ L LQ L L S+ L++L E N + S
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPE 143
Query: 495 CLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKID 554
+L +L L L N++ S+ + L L + +L +D
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVL-----HQMPLLNL---------------SLD 183
Query: 555 LSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSN 606
LS N ++ I ++ L+L N+ + LTSL + + +N
Sbjct: 184 LSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 59/243 (24%), Positives = 93/243 (38%), Gaps = 40/243 (16%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
C IP + + L L N L + +LQ L L ++Q
Sbjct: 14 CMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ------ 65
Query: 472 LCGLRSLSEFYSDGNELNGSLP-QCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVN 530
++ SL L TL L N + S+ + L + +
Sbjct: 66 -------------------TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106
Query: 531 LSSNSLNGTLPVEIGNLKVVTKIDLSRNDL-SGEIPSSIGDLKNMQHLSLADNKFQGSIP 589
+L IG+LK + +++++ N + S ++P +L N++HL L+ NK Q SI
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIY 165
Query: 590 ----DSLGGLTSLNF-LDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTN 644
L + LN LD+S N ++ I LK L L N L+ VP G F
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGI-FDR 222
Query: 645 LSS 647
L+S
Sbjct: 223 LTS 225
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 57/273 (20%), Positives = 86/273 (31%), Gaps = 75/273 (27%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
+ L LS N L + + L VL L+ + + SL +L LIL GN +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPI 88
Query: 329 TGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE 388
S+ FSG L+SL
Sbjct: 89 Q-----SL-----------ALGAFSG-----------------LSSLQK----------- 104
Query: 389 NPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELTGSIP-- 445
L N+ S+ + G+L L L++ N + S
Sbjct: 105 --------------------LVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLP 142
Query: 446 KAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYS----DGNELNGSLPQCLDSLIS 501
+ L L+ L L NK+Q TDL L + N +N + I
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIR 201
Query: 502 LRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSN 534
L+ L+L N+L SV L + + L +N
Sbjct: 202 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 54/252 (21%), Positives = 82/252 (32%), Gaps = 52/252 (20%)
Query: 77 LNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGT 136
L+++ N + L+ L +IE S L L L GN I +
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE-DGAYQSLSHLSTLILTGNP-IQS 90
Query: 137 IPPSI-CNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQ 195
+ +SSL L L ++ + L
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLA--------SLENFPIGHLKT----------------- 125
Query: 196 NIDMQYNSLAELHLAYNQL-SGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKG 254
L EL++A+N + S ++P L+ L LS N I SI L+
Sbjct: 126 --------LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK-IQSIYCTD-----LRV 171
Query: 255 LYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHS 314
L + L LS N + I P L L+L N L ++P I
Sbjct: 172 L----HQMPLLNLSLD---LSLNPMN-FIQPGAFKEIRLKELALDTNQ-LKSVPDGIFDR 222
Query: 315 LPNLQQLILGGN 326
L +LQ++ L N
Sbjct: 223 LTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 52/256 (20%), Positives = 87/256 (33%), Gaps = 58/256 (22%)
Query: 145 SSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNID----MQ 200
S LDLSFN L+ S + P L +DLS + +Q I+
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE-------------IQTIEDGAYQS 74
Query: 201 YNSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVY 259
+ L+ L L N + + F L+ L V + S+
Sbjct: 75 LSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA-VETNLASLENF------------PI 120
Query: 260 TNLTGEIQGLQVLALSSNRLTGVIPPEI-INISSLTVLSLTANNLLGNLPSNIGHSLPNL 318
+L L+ L ++ N + PE N+++L L L ++N + ++ L +
Sbjct: 121 GHLK----TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL-SSNKIQSIYCTDLRVLHQM 175
Query: 319 Q----QLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTS 374
L L N + I L + + N +P+ G
Sbjct: 176 PLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPD-----------GIFDR 222
Query: 375 LTNCKDLRKLILSENP 390
LT+ L+K+ L NP
Sbjct: 223 LTS---LQKIWLHTNP 235
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 34/149 (22%), Positives = 58/149 (38%), Gaps = 9/149 (6%)
Query: 61 LGTIPPEL-GNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDS 119
+ ++ LS L L + + + +L+ LK L+ N S ++P + +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 120 FPKLEHLYLDGNSFIGTIPPSI-CNISSL----LTLDLSFNQLQGHVPSSILNIPSLLAI 174
LEHL L N I +I + + + L+LDLS N + + L +
Sbjct: 148 LTNLEHLDLSSNK-IQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL 205
Query: 175 DLSNNQFSGPMPSIY-NTSPLQNIDMQYN 202
L NQ I+ + LQ I + N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 61/289 (21%), Positives = 123/289 (42%), Gaps = 34/289 (11%)
Query: 68 LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLY 127
L+ + ++ + T+ ++L + LS ++IE + L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG---VQYLNNLIGLE 69
Query: 128 LDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPS 187
L N I + P + N++ + L+LS N L+ S+I + S+ +DL++ Q
Sbjct: 70 LKDNQ-ITDLAP-LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQ------- 118
Query: 188 IYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIG 247
I + +PL ++L L+L NQ++ P L L+ LS+ N + + +
Sbjct: 119 ITDVTPLAG----LSNLQVLYLDLNQITNISP--LAGLTNLQYLSIG-NAQVSDLT-PLA 170
Query: 248 NITMLKGLYLVYTNLT-----GEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANN 302
N++ L L ++ + L + L +N+++ V P + N S+L +++LT N
Sbjct: 171 NLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227
Query: 303 LLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNL 351
+ N P ++L + P++IS+ ++ +NL
Sbjct: 228 TITNQPVFYNNNLVVPNVVKGPSGAPI--APATISDNGTYASPNLTWNL 274
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 59/318 (18%), Positives = 123/318 (38%), Gaps = 34/318 (10%)
Query: 314 SLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLT 373
+L N ++ G + +T + ++ +T + + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-----------------IE 57
Query: 374 SLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTL 433
+ +L L L +N ++ + P+ NL+ + L LS +K S I L ++ TL
Sbjct: 58 GVQYLNNLIGLELKDNQITDLAPLK--NLTK-ITELELSGNPLK--NVSAIAGLQSIKTL 112
Query: 434 HLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLP 493
L + ++T P + L LQ LYL N++ + + L GL +L +++ P
Sbjct: 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVSDLTP 168
Query: 494 QCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKI 553
L +L L TL N+++ + S L SL +++ V+L +N ++ P + N + +
Sbjct: 169 --LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 554 DLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIP 613
L+ ++ + +L + S G + L + + +
Sbjct: 223 TLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVS 282
Query: 614 NSLKALSLLKFLNLSFNG 631
+ K + F+G
Sbjct: 283 YTFNQSVTFKNTTVPFSG 300
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 55/246 (22%), Positives = 99/246 (40%), Gaps = 21/246 (8%)
Query: 385 ILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSI 444
I ++ + P L+NA+ + N+ +L+ +TTL +T +I
Sbjct: 3 ITQPTAINVIFPDP--ALANAIK-IAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI 56
Query: 445 PKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRT 504
+ L L GL L+ N++ + L L ++E GN L + L S++T
Sbjct: 57 E-GVQYLNNLIGLELKDNQI--TDLAPLKNLTKITELELSGNPLKN--VSAIAGLQSIKT 111
Query: 505 LSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEI 564
L L ++T V P L L ++ + L N + P + L + + + +S
Sbjct: 112 LDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL- 166
Query: 565 PSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKF 624
+ + +L + L DNK I L L +L + + +N +S P L S L
Sbjct: 167 -TPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 625 LNLSFN 630
+ L+
Sbjct: 222 VTLTNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 51/247 (20%), Positives = 92/247 (37%), Gaps = 24/247 (9%)
Query: 66 PELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEH 125
+ L+ L L + +N + P L NL ++ L N ++ + ++
Sbjct: 57 EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVSA---IAGLQSIKT 111
Query: 126 LYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPM 185
L L I + P + +S+L L L NQ+ S + + +L + + N Q
Sbjct: 112 LDLTSTQ-ITDVTP-LAGLSNLQVLYLDLNQIT--NISPLAGLTNLQYLSIGNAQ----- 162
Query: 186 PSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPRE 245
+ + +PL N+ + L L N++S S L L + L NN I +
Sbjct: 163 --VSDLTPLANL----SKLTTLKADDNKISD--ISPLASLPNLIEVHLK-NNQISDVS-P 212
Query: 246 IGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLG 305
+ N + L + L +T + + N + G I + + + NL
Sbjct: 213 LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTW 272
Query: 306 NLPSNIG 312
NL S I
Sbjct: 273 NLTSFIN 279
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 34/166 (20%), Positives = 75/166 (45%), Gaps = 12/166 (7%)
Query: 467 SITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDI 526
++ L + + + + + ++ L + TLS +T++ + L ++
Sbjct: 10 NVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNL 65
Query: 527 LNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQG 586
+ + L N + P + NL +T+++LS N L S+I L++++ L L +
Sbjct: 66 IGLELKDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITD 121
Query: 587 SIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGL 632
P L GL++L L + N ++ I L L+ L++L++ +
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQV 163
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 28/145 (19%), Positives = 57/145 (39%), Gaps = 11/145 (7%)
Query: 510 NRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIG 569
+ + P +L + + + +++ V +L +T + ++ I +
Sbjct: 7 TAINVIFP--DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI-EGVQ 60
Query: 570 DLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSF 629
L N+ L L DN+ + L LT + L++S N L + + L +K L+L+
Sbjct: 61 YLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTS 116
Query: 630 NGLQGQVPHGGPFTNLSSQSFVGNK 654
+ P G +NL N+
Sbjct: 117 TQITDVTPLAG-LSNLQVLYLDLNQ 140
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-18
Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 30/198 (15%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVFNL-------ELEGTLRSFDAECEILGSIRHRNL 796
LG GSFG V + A+K+ + ++E TL E IL ++ L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQAVNFPFL 103
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMY-NKNRSFDILQRLNMVIDVASALEYLHYDH 855
VK+ + + +V+EY+ G + + + + F + EYLH
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYMAPEWKLSR 914
+I+ DL P N+L+++ ++DFG +K + T TL T +APE +
Sbjct: 162 ---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-----TLCGTPEALAPE-IILS 212
Query: 915 KG-----DVYSYGIILME 927
KG D ++ G+++ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
C+ + ++P ++ + T LHL N L + +L L L +L
Sbjct: 17 CDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG 74
Query: 472 LCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNL 531
L L N+L SLP +L +L L + FNRLTS+ +L L ++ + L
Sbjct: 75 --TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131
Query: 532 SSNSLNGTLPVEI-GNLKVVTKIDLSRNDLSGEIPSSIGD-LKNMQHLSLADNKFQGSIP 589
N L TLP + + K+ L+ N+L+ E+P+ + + L+N+ L L +N +IP
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188
Query: 590 DSLGGLTSLNFLDMSSN 606
G L F + N
Sbjct: 189 KGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 49/178 (27%), Positives = 75/178 (42%), Gaps = 8/178 (4%)
Query: 407 DVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQG 466
+L+LS + + + LT L+L+ ELT + G L L L L HN+LQ
Sbjct: 34 TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ- 90
Query: 467 SITTDLCGLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSVIPSSLWSLRD 525
S+ L +L+ N L SLP L L L+ L L N L ++ P L
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149
Query: 526 ILNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADN 582
+ ++L++N+L LP + L+ + + L N L IP + L N
Sbjct: 150 LEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 52/223 (23%), Positives = 83/223 (37%), Gaps = 36/223 (16%)
Query: 426 NLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485
+ + ++ + LT ++P + + L+L N L L L++ D
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 486 NELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIG 545
EL L +L L TL L N+L S LP+
Sbjct: 65 AELT-KLQ-VDGTLPVLGTLDLSHNQLQS-------------------------LPLLGQ 97
Query: 546 NLKVVTKIDLSRNDLSGEIPSSIGD-LKNMQHLSLADNKFQGSIPDSL-GGLTSLNFLDM 603
L +T +D+S N L+ +P L +Q L L N+ + ++P L L L +
Sbjct: 98 TLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSL 155
Query: 604 SSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLS 646
++NNL+ L L L L L N L +P G F +
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGF-FGSHL 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 66/267 (24%), Positives = 90/267 (33%), Gaps = 79/267 (29%)
Query: 203 SLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREI-GNITMLKGLYLVYTN 261
S E++ L+ +P L K IL LS N + + T L L L
Sbjct: 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENL-LYTFSLATLMPYTRLTQLNLDRAE 66
Query: 262 LT-----GEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLP 316
LT G + L L LS N+L +P + +LTVL ++ N L +LP L
Sbjct: 67 LTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS-FNRLTSLPLGALRGLG 124
Query: 317 NLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLT 376
LQ+L L GN L +P G LT
Sbjct: 125 ELQELYLKGNELK-------------------------TLPP-----------GLLTPTP 148
Query: 377 NCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHL 435
L KL L+ N L+ +P+ + L NL TL L
Sbjct: 149 K---LEKLSLANNNLT--------------------------ELPAGLLNGLENLDTLLL 179
Query: 436 ETNELTGSIPKAIGRLQKLQGLYLQHN 462
+ N L +IPK L +L N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 62/269 (23%), Positives = 86/269 (31%), Gaps = 78/269 (28%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
+ LT +PP++ T+L L+ NLL L QL L L
Sbjct: 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLS-ENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 329 TGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE 388
T +L +L L L LS
Sbjct: 68 T--------------------------------------KLQVDGTLPV---LGTLDLSH 86
Query: 389 NPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIP-KA 447
N L S+P L LT L + N LT S+P A
Sbjct: 87 NQLQ--------------------------SLPLLGQTLPALTVLDVSFNRLT-SLPLGA 119
Query: 448 IGRLQKLQGLYLQHNKLQGSITTDLC-GLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTL 505
+ L +LQ LYL+ N+L+ ++ L L + N L LP L+ L +L TL
Sbjct: 120 LRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTL 177
Query: 506 SLGFNRLTSVIPSSLWSLRDILNVNLSSN 534
L N L + IP + + L N
Sbjct: 178 LLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 52/243 (21%), Positives = 77/243 (31%), Gaps = 61/243 (25%)
Query: 61 LGTIPPEL-GNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDS 119
L +PP+L + + L L + N L RL L+ + + +
Sbjct: 22 LTALPPDLPKDTTILHL---SENLLYTFSLATLMPYTRLTQLNLDRAELTKL---QVDGT 75
Query: 120 FPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNN 179
P L L L N + ++P + +L LD+SFN+L L
Sbjct: 76 LPVLGTLDLSHNQ-LQSLPLLGQTLPALTVLDVSFNRLT----------------SLPLG 118
Query: 180 QFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFEC-KQLKILSLSVNNF 238
G L EL+L N+L +P L +L+ LSL+ NN
Sbjct: 119 ALRGL-----------------GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNN- 159
Query: 239 IGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSL 298
+ +P + L L L L N L IP L L
Sbjct: 160 LTELPAG------------LLNGLE----NLDTLLLQENSLYT-IPKGFFGSHLLPFAFL 202
Query: 299 TAN 301
N
Sbjct: 203 HGN 205
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 738 DGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEG------TLRSFDAECEILGSI 791
+ + +G+G++G VYK + G A+K LE E T+R E IL +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKEL 57
Query: 792 RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL 851
+H N+VK+ + LV E++ L+ + + + + ++ + + + Y
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK 911
H ++H DL P N+L+N ++DFG+++ G T + T+ Y AP+
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVL 172
Query: 912 L-----SRKGDVYSYGIILMETFTKKKPTDELFVGE 942
+ S D++S G I E P LF G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVN-GTP---LFPGV 204
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 32/206 (15%)
Query: 740 FSENNLLGKGSFGSVY----KGTLSDGMQIAVKVF-------NLELEGTLRSFDAECEIL 788
F + +LGKG FG V + T G A K L E +IL
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMAL----NEKQIL 238
Query: 789 GSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRS-FDILQRLNMVIDVASA 847
+ R +V + + LVL M G L+ +Y+ ++ F + + ++
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298
Query: 848 LEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA-TIGYM 906
LE LH + I++ DL P NILL++ +SD G++ + + + + T+GYM
Sbjct: 299 LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYM 352
Query: 907 APEWKLSRKG-----DVYSYGIILME 927
APE + + D ++ G +L E
Sbjct: 353 APE-VVKNERYTFSPDWWALGCLLYE 377
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 1e-17
Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 40/230 (17%)
Query: 738 DGFSENNLLGKGSFGSVY----KGTLSDGMQIAVKVF-------NLELEGTLRSFDAECE 786
D F + +LG+G FG V+ K T G A K +G + E +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAM----VEKK 237
Query: 787 ILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYN---KNRSFDILQRLNMVID 843
IL + R +V + + LV+ M G + +YN N F + +
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATI 903
+ S LE+LH + II+ DL P N+LL++ +SD G++ L + T+ T
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTP 353
Query: 904 GYMAPEWKLSRKG-----DVYSYGIILMETFT---------KKKPTDELF 939
G+MAPE L + D ++ G+ L E +K EL
Sbjct: 354 GFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 58/278 (20%), Positives = 100/278 (35%), Gaps = 61/278 (21%)
Query: 730 YQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVK--VFNLELEGTLRSFDA---- 783
EL ++ + GS+G+V G S+G+ +A+K + T+
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 784 -----ECEILGSIRHRNLVK---IISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFD 833
E +L H N++ I LV E M L ++++
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS 132
Query: 834 -------ILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886
+ L L LH ++H DL+P NILL ++ + DF +++
Sbjct: 133 PQHIQYFMYHILL-------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 887 LLGDETSMTQTQTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKPTDELFVG 941
+ + T + Y APE + KG D++S G ++ E F +K LF G
Sbjct: 183 EDTADANK--THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK----ALFRG 236
Query: 942 EISLKSRVNDSLH--GKIINVV------DINLLQKEDA 971
+ + KI+ VV D+ + A
Sbjct: 237 --------STFYNQLNKIVEVVGTPKIEDVVMFSSPSA 266
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 37/218 (16%)
Query: 745 LLGKGSFGSVY----KGTLSDGMQIAVKVF-------NLELEGTLRSFDAECEILGSIRH 793
LLGKG+FG V K T G A+K+ E+ TL E +L + RH
Sbjct: 155 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTL----TENRVLQNSRH 207
Query: 794 RNLVKIISTCSSDHFKALVLEYMPNGSLENWMY--NKNRSFDILQRLNMVIDVASALEYL 851
L + + + V+EY G L + ++ R F + ++ SAL+YL
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK 911
H + +++ DL N++L++ ++DFG+ K + + +T T Y+APE
Sbjct: 265 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPE-V 320
Query: 912 LSRKG-----DVYSYGIILMETFTKKKP-----TDELF 939
L D + G+++ E + P ++LF
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 49/207 (23%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVK-- 798
LG G+FG V G G ++AVK+ N + + E + L RH +++K
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 799 -IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRLNMVIDVA--------SAL 848
+IST SD F +V+EY+ G L FD I + + + S +
Sbjct: 83 QVIST-PSDIF--MVMEYVSGGEL----------FDYICKNGRLDEKESRRLFQQILSGV 129
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATI----G 904
+Y H ++H DL P N+LL+ M A ++DFG+S + M+ + L T
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM------MSDGEFLRTSCGSPN 180
Query: 905 YMAPEWKLSRKG------DVYSYGIIL 925
Y APE +S + D++S G+IL
Sbjct: 181 YAAPE-VISGRLYAGPEVDIWSSGVIL 206
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 36/195 (18%)
Query: 745 LLGKGSFGSVY----KGTLSDGMQIAVKVFN----LELEGTLRSFDAECEILGSIRHRNL 796
++G+G+FG V K T A+K+ + ++ + F E +I+ +
Sbjct: 76 VIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWV 131
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVA--------SAL 848
V++ D + +V+EYMP G L +++ ++ A AL
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLAL 181
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYMA 907
+ +H IH D+ P N+LL++S L+DFG + E M + T T Y++
Sbjct: 182 DAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYIS 237
Query: 908 PEWKLSRKGDVYSYG 922
PE L +G YG
Sbjct: 238 PE-VLKSQGGDGYYG 251
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 48/209 (22%), Positives = 78/209 (37%), Gaps = 49/209 (23%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFN---LELEGTLRSFDA-----ECEILGSIRHRNL 796
LG G+FG V+ ++ VK + + + E IL + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 797 VKIISTCSSDHFKALVLEYMPNGS-LENWMYNKNRSFD-ILQRLNMVIDVA--------S 846
+K++ + F LV+E +G L F I + + +A S
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDL----------FAFIDRHPRLDEPLASYIFRQLVS 141
Query: 847 ALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT---- 902
A+ YL IIH D+ NI++ E L DFG + + + + T
Sbjct: 142 AVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY------LERGKLFYTFCGT 192
Query: 903 IGYMAPEWKLSRKG------DVYSYGIIL 925
I Y APE L +++S G+ L
Sbjct: 193 IEYCAPE-VLMGNPYRGPELEMWSLGVTL 220
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-17
Identities = 48/238 (20%), Positives = 94/238 (39%), Gaps = 25/238 (10%)
Query: 710 NTGLQIDEEMSPEVTWRRISYQELFRAT---DGFSENNLLGKGSFGSVYKGTLSDGMQI- 765
+ L D+ ++ + W L D F ++G+G+F V + Q+
Sbjct: 30 ASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVY 89
Query: 766 AVKVFN---LELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLE 822
A+K+ N + G + F E ++L + R + ++ +++ LV+EY G L
Sbjct: 90 AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149
Query: 823 NWMYNKNRSFDILQRLNMVI-DVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSD 881
+ + + ++ A++ +H +H D+ P NILL+ L+D
Sbjct: 150 TLLSKFGERIP-AEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205
Query: 882 FGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG------------DVYSYGIILME 927
FG L + ++ + T Y++PE L G D ++ G+ E
Sbjct: 206 FGSCLKLRADGTVRSLVAVGTPDYLSPE-ILQAVGGGPGTGSYGPECDWWALGVFAYE 262
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 7e-17
Identities = 52/241 (21%), Positives = 100/241 (41%), Gaps = 27/241 (11%)
Query: 693 ILLVLSLSVVLIRRQKR-NTGLQIDEEMSPEVTWRRISYQELFRATDGFSENNLLGKGSF 751
I L + +RR+K L+ + + +V R+ ++ F ++G+G+F
Sbjct: 35 ICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHRED-------FEILKVIGRGAF 87
Query: 752 GSVYKGTLSDGMQI-AVKVFN----LELEGTLRSFDAECEILGSIRHRNLVKIISTCSSD 806
G V L + ++ A+K+ N L+ T F E ++L + + + + D
Sbjct: 88 GEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGDSKWITTLHYAFQDD 146
Query: 807 HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVI----DVASALEYLHYDHPTPIIHC 862
+ LV++Y G L + M ++ A++ +H H +H
Sbjct: 147 NNLYLVMDYYVGGDLLTLLSKFEDRLP----EEMARFYLAEMVIAIDSVHQLH---YVHR 199
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTL-ATIGYMAPEWKLSRKGDVYSY 921
D+ P NIL++ + L+DFG L ++ Q+ T Y++PE + +G Y
Sbjct: 200 DIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRY 258
Query: 922 G 922
G
Sbjct: 259 G 259
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-17
Identities = 51/206 (24%), Positives = 70/206 (33%), Gaps = 49/206 (23%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVKII 800
+G G+FG +AVK E R E S+RH N+V+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRLNMVIDVA--------SALEYL 851
+ A+++EY G L ++ I D A S + Y
Sbjct: 83 EVILTPTHLAIIMEYASGGEL----------YERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACL--SDFGISKLLGDETSMTQTQTLATI----GY 905
H I H DL N LL+ S L DFG SK + Y
Sbjct: 133 HSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAY 183
Query: 906 MAPEWKLSRKG------DVYSYGIIL 925
+APE L R+ DV+S G+ L
Sbjct: 184 IAPE-VLLRQEYDGKIADVWSCGVTL 208
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 58/259 (22%), Positives = 112/259 (43%), Gaps = 19/259 (7%)
Query: 372 LTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLT 431
+ S + K L + ++ + + L++ +D + + +IK S+ I L N+T
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVTQN--ELNS-IDQIIANNSDIK-SV-QGIQYLPNVT 71
Query: 432 TLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGS 491
L L N+LT I K + L+ L L+L NK+ + L L+ L + N + S
Sbjct: 72 KLFLNGNKLT-DI-KPLANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNGI--S 125
Query: 492 LPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVT 551
L L L +L LG N++T + + L L + ++L N + + V + L +
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQ 181
Query: 552 KIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGE 611
+ LS+N +S ++ ++ LKN+ L L + + L N + + +L
Sbjct: 182 NLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT- 238
Query: 612 IPNSLKALSLLKFLNLSFN 630
P + + N+ ++
Sbjct: 239 -PEIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 50/265 (18%), Positives = 100/265 (37%), Gaps = 32/265 (12%)
Query: 92 LSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLD 151
+ + + + + ++ + + + I ++ I + ++ L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSD-IKSVQG-IQYLPNVTKLF 74
Query: 152 LSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAY 211
L+ N+L + N+ +L + L N+ + + S L+++ L L L +
Sbjct: 75 LNGNKLT--DIKPLANLKNLGWLFLDENK-------VKDLSSLKDLK----KLKSLSLEH 121
Query: 212 NQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT-----GEI 266
N +S + L QL+ L L NN I I + +T L L L ++ +
Sbjct: 122 NGIS--DINGLVHLPQLESLYLG-NNKITDIT-VLSRLTKLDTLSLEDNQISDIVPLAGL 177
Query: 267 QGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGN 326
LQ L LS N ++ + + + +L VL L + L N P N +L +
Sbjct: 178 TKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTDG 234
Query: 327 RLTGPIPSSISNASMLTLIDMPYNL 351
L P IS+ ++ ++L
Sbjct: 235 SLVT--PEIISDDGDYEKPNVKWHL 257
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 54/299 (18%), Positives = 108/299 (36%), Gaps = 56/299 (18%)
Query: 314 SLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLT 373
+ + L +T + + + + I + ++ +
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS-----------------DIKSVQ 62
Query: 374 SLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTL 433
+ ++ KL L+ N L+ + P++ NL N + L+L +K + S + +L L +L
Sbjct: 63 GIQYLPNVTKLFLNGNKLTDIKPLA--NLKN-LGWLFLDENKVK-DL-SSLKDLKKLKSL 117
Query: 434 HLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLP 493
LE N ++ I + L +L+ LYL +NK+ TD+ L
Sbjct: 118 SLEHNGIS-DIN-GLVHLPQLESLYLGNNKI-----TDITVL------------------ 152
Query: 494 QCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKI 553
L L TLSL N+++ + L L + N+ LS N ++ + LK + +
Sbjct: 153 ---SRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVL 205
Query: 554 DLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEI 612
+L + + + +L + D S G + + E+
Sbjct: 206 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 40/207 (19%), Positives = 82/207 (39%), Gaps = 38/207 (18%)
Query: 426 NLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485
+L+ +T ++ L + + ++ + + G+
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-----KSVQGI---------- 64
Query: 486 NELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIG 545
L ++ L L N+LT + L +L+++ + L N + ++
Sbjct: 65 -----------QYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSSLK-- 109
Query: 546 NLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSS 605
+LK + + L N +S +I + + L ++ L L +NK + L LT L+ L +
Sbjct: 110 DLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLED 165
Query: 606 NNLSGEIPNSLKALSLLKFLNLSFNGL 632
N +S +I L L+ L+ L LS N +
Sbjct: 166 NQIS-DIVP-LAGLTKLQNLYLSKNHI 190
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 51/282 (18%), Positives = 103/282 (36%), Gaps = 56/282 (19%)
Query: 187 SIYNTSPLQNI--DMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPR 244
+I +P++ I D + + +L ++ T E + + + ++
Sbjct: 7 TITVPTPIKQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSD------- 57
Query: 245 EIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNL- 303
I ++ ++ L + L L+ N+LT + P + N+ +L L L N +
Sbjct: 58 -IKSVQGIQYL-----------PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK 103
Query: 304 -LGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGF 362
L +L L L+ L L N ++ + + + L + + N
Sbjct: 104 DLSSLKD-----LKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNN------------ 144
Query: 363 CHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPS 422
++ +T L+ L L L +N +S ++P++ L+ + LYLS +I +
Sbjct: 145 -----KITDITVLSRLTKLDTLSLEDNQISDIVPLA--GLTK-LQNLYLSKNHIS-DL-R 194
Query: 423 EIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKL 464
+ L NL L L + E L + L
Sbjct: 195 ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 36/176 (20%), Positives = 67/176 (38%), Gaps = 14/176 (7%)
Query: 457 LYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVI 516
+ + + + L S+ + + + SV
Sbjct: 7 TITVPTPI--KQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSV- 61
Query: 517 PSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQH 576
+ L ++ + L+ N L P + NLK + + L N + ++ SS+ DLK ++
Sbjct: 62 -QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKS 116
Query: 577 LSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGL 632
LSL N S + L L L L + +N ++ +I L L+ L L+L N +
Sbjct: 117 LSLEHNGI--SDINGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQI 168
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 40/172 (23%), Positives = 62/172 (36%), Gaps = 20/172 (11%)
Query: 68 LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLY 127
L NL L L + N L +L++LK LS N S I L P+LE LY
Sbjct: 86 LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISDIN---GLVHLPQLESLY 140
Query: 128 LDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPS 187
L N I I + ++ L TL L NQ+ + + L + LS N
Sbjct: 141 LGNNK-ITDITV-LSRLTKLDTLSLEDNQIS--DIVPLAGLTKLQNLYLSKNH------- 189
Query: 188 IYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFI 239
I + L + +L L L + + + + + + +
Sbjct: 190 ISDLRALAGL----KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 34/138 (24%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 496 LDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDL 555
D+ +L +T + + L I + +++ + ++ L VTK+ L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFL 75
Query: 556 SRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNS 615
+ N L+ +I + +LKN+ L L +NK + + SL L L L + N +S +I
Sbjct: 76 NGNKLT-DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING- 129
Query: 616 LKALSLLKFLNLSFNGLQ 633
L L L+ L L N +
Sbjct: 130 LVHLPQLESLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 29/140 (20%), Positives = 53/140 (37%), Gaps = 8/140 (5%)
Query: 68 LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLY 127
L +L L L + NN + LS L +L LS N S I L KL++LY
Sbjct: 130 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP---LAGLTKLQNLY 184
Query: 128 LDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPS 187
L N I + + + +L L+L + + N+ + ++ P
Sbjct: 185 LSKNH-ISDLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP-EI 241
Query: 188 IYNTSPLQNIDMQYNSLAEL 207
I + + +++++
Sbjct: 242 ISDDGDYEKPNVKWHLPEFT 261
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 52/207 (25%), Positives = 80/207 (38%), Gaps = 43/207 (20%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFN---LELEGTLRSFDA---ECEILGSIRHR--N 795
LLG G FGSVY G +SD + +A+K + G L + E +L +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 796 LVKIISTCSSDHFKALVLEY-MPNGSLENWMYNKNRSFD-ILQRLNMVIDVA-------- 845
+++++ L+LE P L FD I +R + ++A
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDL----------FDFITERGALQEELARSFFWQVL 159
Query: 846 SALEYLHYDHPTPIIHCDLNPSNILLN-ESMVACLSDFGISKLLGDETSMTQTQTLATIG 904
A+ + H ++H D+ NIL++ L DFG LL D T
Sbjct: 160 EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD---FDGTRV 213
Query: 905 YMAPEWKLSRKG------DVYSYGIIL 925
Y PEW + V+S GI+L
Sbjct: 214 YSPPEW-IRYHRYHGRSAAVWSLGILL 239
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 55/209 (26%), Positives = 83/209 (39%), Gaps = 56/209 (26%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFN------LELEGTLRSFDAECEILGSIRHRNLVK 798
+GKG+F V + G ++A+K+ + L+ R E I+ + H N+VK
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 799 ---IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRLNMVIDVA--------S 846
+I T + L++EY G + FD ++ M A S
Sbjct: 79 LFEVIET-EKTLY--LIMEYASGGEV----------FDYLVAHGRMKEKEARSKFRQIVS 125
Query: 847 ALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATI--- 903
A++Y H I+H DL N+LL+ M ++DFG S T L
Sbjct: 126 AVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCGA 176
Query: 904 -GYMAPEWKLSRKG------DVYSYGIIL 925
Y APE K DV+S G+IL
Sbjct: 177 PPYAAPE-LFQGKKYDGPEVDVWSLGVIL 204
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 738 DGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL-EG----TLRSFDAECEILGSI 791
+ + + + LG+G++ +VYKG +A+K LE EG +R E +L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 792 RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYL 851
+H N+V + ++ LV EY+ L+ ++ + ++ + + L Y
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK 911
H ++H DL P N+L+NE L+DFG+++ T T + T+ Y P+
Sbjct: 117 HRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYDNEVVTLWYRPPDIL 172
Query: 912 L-----SRKGDVYSYGIILMETFTKKKPTDELFVGE 942
L S + D++ G I E T +P LF G
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMAT-GRP---LFPGS 204
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 51/212 (24%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFN---------LELEGTLRSFDAECEILGSIR-- 792
LLGKG FG+V+ G L+D +Q+A+KV L T E +L +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL---EVALLWKVGAG 94
Query: 793 --HRNLVKIISTCSSDHFKALVLEY-MPNGSLENWMYNKNRSFD-ILQRLNMVIDVA--- 845
H +++++ + LVLE +P L FD I ++ + +
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPAQDL----------FDYITEKGPLGEGPSRCF 144
Query: 846 -----SALEYLHYDHPTPIIHCDLNPSNILLN-ESMVACLSDFGISKLLGDETSMTQTQT 899
+A+++ H ++H D+ NIL++ A L DFG LL DE
Sbjct: 145 FGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD---F 198
Query: 900 LATIGYMAPEWKLSRKG------DVYSYGIIL 925
T Y PEW +SR V+S GI+L
Sbjct: 199 DGTRVYSPPEW-ISRHQYHALPATVWSLGILL 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 27/206 (13%), Positives = 60/206 (29%), Gaps = 52/206 (25%)
Query: 745 LLGKGSFGSVYKGTLSD---GMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVK 798
G ++ D Q+A+ + + + L+ + L I + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQR-------LNMVIDVASALEYL 851
++ + +V E++ GSL+ ++ + + +A+A +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQ----------EVADTSPSPVGAIRAMQSLAAAADAA 145
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK 911
H + +PS + +S G LA M
Sbjct: 146 HRAG---VALSIDHPSRVR--------VSIDGDVV-------------LAYPATMPDA-- 179
Query: 912 LSRKGDVYSYGIILMETFTKKKPTDE 937
+ + D+ G L + P E
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPE 204
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 4e-16
Identities = 49/253 (19%), Positives = 83/253 (32%), Gaps = 46/253 (18%)
Query: 96 RRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLS- 153
R L F I+ F LE + + N + I + N+ L + +
Sbjct: 30 RNAIELRFVLTKLRVIQ-KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 154 FNQLQGHVPSSIL-NIPSLLAIDLSNNQFSG-PMPSIYNTSPLQNIDMQYNS-------- 203
N L ++ N+P+L + +SN P ++ +D+Q N
Sbjct: 89 ANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN 147
Query: 204 --------LAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGL 255
L L N + +I ++ F QL L+LS NN + +P ++ G
Sbjct: 148 SFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDV-----FHGA 201
Query: 256 YLVYTNLTGEIQGLQVLALSSNRLTGVIPPEII-NISSLTVLSLTANNLLGNLPSNIGHS 314
G +L +S R+ +P + N+ L S L L
Sbjct: 202 -----------SGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLPTL-----EK 244
Query: 315 LPNLQQLILGGNR 327
L L + L
Sbjct: 245 LVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 6e-16
Identities = 41/215 (19%), Positives = 76/215 (35%), Gaps = 8/215 (3%)
Query: 419 SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD-LCGLRS 477
IPS++ N L +L A L+ + + N + I D L
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 478 LSEFY-SDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSL 536
L E N L P+ +L +L+ L + + + + +++ N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140
Query: 537 NGTLPVEI--GNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIP-DSLG 593
T+ G + L++N + EI +S + + L+L+DN +P D
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199
Query: 594 GLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLS 628
G + LD+S + L+ L L+ +
Sbjct: 200 GASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 8e-14
Identities = 49/312 (15%), Positives = 96/312 (30%), Gaps = 67/312 (21%)
Query: 203 SLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNL 262
S ++++ +IPS L + L + I + G
Sbjct: 10 SNRVFLCQESKVT-EIPSDLP--RNAIELRFV-LTKLRVIQK-----GAFSGF------- 53
Query: 263 TGEIQGLQVLALSSNRLTGVIPPEI-INISSLTVLSLTANNLLGNLPSNIGHSLPNLQQL 321
L+ + +S N + VI ++ N+ L + + N L + +LPNLQ L
Sbjct: 54 ----GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109
Query: 322 ILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDL 381
++ + +P+ + SL
Sbjct: 110 LISNTGIK-------------------------HLPDVH----------KIHSLQ----K 130
Query: 382 RKLILSENP-LSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNE 439
L + +N + + S LS +L+L+ I+ I + + N
Sbjct: 131 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNN 189
Query: 440 LTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSL 499
L L + ++ S+ + GL +L + + LP L+ L
Sbjct: 190 LEELPNDVFHGASGPVILDISRTRIH-SLPSY--GLENLKKLRARSTYNLKKLPT-LEKL 245
Query: 500 ISLRTLSLGFNR 511
++L SL +
Sbjct: 246 VALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 9e-13
Identities = 38/224 (16%), Positives = 73/224 (32%), Gaps = 38/224 (16%)
Query: 124 EHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSG 183
+ + IP + + + L +L+ + L I++S N
Sbjct: 12 RVFLCQESK-VTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 184 PMPS-------------IYNTSPLQNID----MQYNSLAELHLAYNQLSGQIPSTLF-EC 225
+ + I + L I+ +L L ++ + +P
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127
Query: 226 KQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPP 285
Q +L + N I +I R + L+ E +L L+ N + I
Sbjct: 128 LQKVLLDIQDNINIHTIERN------------SFVGLSFE---SVILWLNKNGIQ-EIHN 171
Query: 286 EIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLT 329
N + L L+L+ NN L LP+++ H L + R+
Sbjct: 172 SAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 48/270 (17%), Positives = 89/270 (32%), Gaps = 26/270 (9%)
Query: 292 SLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNL 351
S V + + +PS++ N +L +L + S L I++ N
Sbjct: 10 SNRVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 65
Query: 352 FSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYL 411
I ++L ++R I N L + P + NL N + L +
Sbjct: 66 VLEVIEA-----------DVFSNLPKLHEIR--IEKANNLLYINPEAFQNLPN-LQYLLI 111
Query: 412 SACNIKGSIPSEI-GNLNNLTTLHLETNELTGSIPKAI--GRLQKLQGLYLQHNKLQGSI 468
S IK +P + L ++ N +I + G + L+L N +Q
Sbjct: 112 SNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIH 170
Query: 469 TTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILN 528
+ G + SD N L L + R+ S+ L +L+ +
Sbjct: 171 NSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA 230
Query: 529 VNLSSNSLNGTLPVEIGNLKVVTKIDLSRN 558
+ + LP + L + + L+
Sbjct: 231 RSTYNLK---KLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 39/220 (17%), Positives = 75/220 (34%), Gaps = 26/220 (11%)
Query: 48 RRVTALNLAYMGLLGTIPPE----LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSF 103
+ + ++ +L I + L L + + N+ P NL L+YL
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK--ANNLLYINPEAFQNLPNLQYLLI 111
Query: 104 RSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPP-SICNISSLL-TLDLSFNQLQGHV 161
+ + + L + N I TI S +S L L+ N +Q +
Sbjct: 112 SNTGIKHLP-DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EI 169
Query: 162 PSSILNIPSLLAIDLS-NNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPS 220
+S N L ++LS NN +++ + L ++ ++ +PS
Sbjct: 170 HNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS---------GPVILDISRTRIH-SLPS 219
Query: 221 TLFEC-KQLKILSLSVNNFIGSIPREIGNITMLKGLYLVY 259
E K+L+ S + + + + L L Y
Sbjct: 220 YGLENLKKLRARSTYNLKKLPT----LEKLVALMEASLTY 255
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 734 FRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEG------TLRSFDAECE 786
F++ + + L+G+GS+G V K G +A+K F + +R E +
Sbjct: 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIK 76
Query: 787 ILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVAS 846
+L +RH NLV ++ C LV E++ + ++ + + D + + +
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 847 ALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYM 906
+ + H + IIH D+ P NIL+++S V L DFG ++ L +AT Y
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDDEVATRWYR 191
Query: 907 APEWKLSRKG-----DVYSYGIILMETFTKKKPTDELFVGE 942
APE + DV++ G ++ E F +P LF G+
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFM-GEP---LFPGD 228
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 33/229 (14%)
Query: 731 QELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGS 790
+ + ++ ++G GSFG V++ L + ++A+K + R E +I+
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRI 88
Query: 791 IRHRNLVK----IISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDV 844
++H N+V S LVLEY+P E +Y +R + + M + +
Sbjct: 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ET-VYRASRHYA-KLKQTMPMLL 142
Query: 845 ASALEY-----LHYDHPTPIIHCDLNPSNILLNESMVAC-LSDFGISKLLGDETSMTQTQ 898
Y L Y H I H D+ P N+LL+ L DFG +K+L
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN--VS 200
Query: 899 TLATIGYMAPEWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVGE 942
+ + Y APE + D++S G ++ E +P LF GE
Sbjct: 201 YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ-GQP---LFPGE 245
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 82.2 bits (202), Expect = 6e-16
Identities = 101/677 (14%), Positives = 205/677 (30%), Gaps = 190/677 (28%)
Query: 366 YDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIG 425
D S+ + +++ +I+S++ +SG L + L + E+
Sbjct: 36 KDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL--------FWTLLSKQEEMVQKFVEEVL 87
Query: 426 NLNN---LTTLHLETNELTGSIPKAIGRLQKLQG---LYLQHN----KLQGSITTDLCGL 475
+N ++ + E + + I + +L ++ ++N + + L L
Sbjct: 88 RINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLEL 147
Query: 476 RSLSEFYSDGNELNGSLPQCL--DSLISLRT----------LSLGFNRLTSVIPSSLWSL 523
R DG + GS + D +S + L+L + L L
Sbjct: 148 RPAKNVLIDG--VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL 205
Query: 524 RDILNVNLSSNSLNG-TLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADN 582
++ N +S S + + + I +++ + L + + L N+Q+ +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY----ENCLLVLLNVQNAKAWN- 260
Query: 583 KF-----------QGSIPDSLGGLTSLNF-LDMSSNNLSGEIPNSLKALSLL-KFLNLSF 629
F + D L T+ + LD S L+ + + SLL K+L+
Sbjct: 261 AFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD-----EVKSLLLKYLDCRP 315
Query: 630 NGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPELK-FPA---------CKAKSNKIARKTD 679
L +V P LS + ++ A C + I +
Sbjct: 316 QDLPREVLTTNPRR-LS---------IIAE-SIRDGLATWDNWKHVNCDKLTTIIESSLN 364
Query: 680 -------KNIFIY--VFP----IAASILLVLSLSVVLIRRQKRNTGLQIDEEMSPEVTWR 726
+ +F VFP I +L ++ W
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSAHIPTILLSLI---------------------------WF 397
Query: 727 RISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECE 786
+ ++ + + +L+ K S + + E
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTI-----------------SIPSIYLELKVKLE 440
Query: 787 ILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVAS 846
++ HR++V DH YN ++FD + +D
Sbjct: 441 NEYAL-HRSIV--------DH------------------YNIPKTFDSDDLIPPYLD--- 470
Query: 847 ALEYLHYDHPTPII--HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG 904
+Y Y H I H L N ++ F + D + Q +
Sbjct: 471 --QYF-YSH----IGHH--------LKNIEHPERMTLF--RMVFLDFRFLEQKIRHDSTA 513
Query: 905 YMAPEWKLSRKGDVYSYGIILMETFTKKKPTDELFVGEIS--LKSRVNDSLHGKIINVVD 962
+ A L+ + Y P E V I L + + K +++
Sbjct: 514 WNASGSILNTLQQLKFYK----PYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLR 569
Query: 963 INLLQKEDA-YLTAKEQ 978
I L+ +++A + A +Q
Sbjct: 570 IALMAEDEAIFEEAHKQ 586
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 9e-11
Identities = 86/518 (16%), Positives = 154/518 (29%), Gaps = 127/518 (24%)
Query: 521 WSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQH---- 576
+ +DIL+V + N D+ ++ LS E I K+
Sbjct: 16 YQYKDILSVFE---------DAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR 66
Query: 577 -----LSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNG 631
LS + Q + + L + FL MS P S+ ++ + +N
Sbjct: 67 LFWTLLSKQEEMVQKFVEEVLR--INYKFL-MSPIKTEQRQP-SMMTRMYIEQRDRLYND 122
Query: 632 LQ----GQVPHGGPFT-------NLSSQSFV---GNKGLCGAPELKFPACKAKSNKIARK 677
Q V P+ L V G G G + C S K+ K
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG-SGKTWVALDVCL--SYKVQCK 179
Query: 678 TDKNIFIYVFPIAASILLVLSLSVVLIRRQKRNTGLQIDEEMSPEVT--WRRISYQELFR 735
D IF S VL + L+ + N + D + ++ + + L +
Sbjct: 180 MDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK 239
Query: 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRN 795
+ EN LL L + V N + +F+ C+IL + R +
Sbjct: 240 SKPY--ENCLL-----------VLLN-------VQNAK---AWNAFNLSCKILLTTRFKQ 276
Query: 796 LVKIISTCSSDHFKALVLEYMPNG-----SLE---NWMYNKNRSFD----ILQRLNMVID 843
+ + S+ + L++ ++ R D +L +
Sbjct: 277 VTDFL---SAATTTHISLDHHSMTLTPDEVKSLLLKYL--DCRPQDLPREVLTTNPRRLS 331
Query: 844 VASAL---------EYLHYDHP--TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892
+ + + H + T II L N+L +
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSL---NVLEPAEYRKMFDRLSV---FPPSA 385
Query: 893 SMTQTQTLATIGYMAPEWKLSRKGDVYSYGIILMETFTKK----KPTDELFVG------E 942
+ T L+ I W K DV ++++ K K E + E
Sbjct: 386 HIP-TILLSLI------WFDVIKSDV----MVVVNKLHKYSLVEKQPKESTISIPSIYLE 434
Query: 943 ISLKSRVNDSLHGKIINVVDIN--------LLQKEDAY 972
+ +K +LH I++ +I + D Y
Sbjct: 435 LKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY 472
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 2e-09
Identities = 80/549 (14%), Positives = 157/549 (28%), Gaps = 150/549 (27%)
Query: 165 ILNIPS-------LLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAE-LHLAYNQLSG 216
I+ L LS + + + + + Y L + Q S
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQE------EMVQKFVEEVLRINYKFLMSPIKTEQRQPSM 107
Query: 217 QIPSTLFECKQLKILSLSVNNFI-GSIPRE--IGNI-TMLKGL----YLVYTNLTGEIQG 268
+ ++ +Q L F ++ R + L L ++ + G G
Sbjct: 108 --MTRMYI-EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG--SG 162
Query: 269 LQVLA---LSSNRLTGVIPPEI--INISSLTVLSLTANNLLGNLPSNIGHSL-PNLQQLI 322
+A S ++ + +I +N+ + + +L L + + + PN
Sbjct: 163 KTWVALDVCLSYKVQCKMDFKIFWLNLKNCN----SPETVLEML-QKLLYQIDPNWTSRS 217
Query: 323 LGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSL----GFCHP--YDELGFLTSLT 376
+ + I S + L L PY N L + ++
Sbjct: 218 DHSSNIKLRIHSIQAELRRL-LKSKPY-------ENCLLVLLNVQNAKAWNAFNL----- 264
Query: 377 NCKDL----------------RKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIK-GS 419
+CK L I ++ + P +L L + +
Sbjct: 265 SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP------DEVKSLL-LKYLDCRPQD 317
Query: 420 IPSEIGNLNNLTTLHLETNELTG-SIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRS- 477
+P E+ N L + SI + + ++ +KL I + L L
Sbjct: 318 LPREVLTTN---PRRLS---IIAESIRDGLATWDNWK--HVNCDKLTTIIESSLNVLEPA 369
Query: 478 -LSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWS------LRDILNVN 530
+ + L P + I LSL +W + ++N
Sbjct: 370 EYRKMFDR---L-SVFPP--SAHIPTILLSL------------IWFDVIKSDVMVVVN-K 410
Query: 531 LSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLAD--NKFQGSI 588
L SL VE + I + E+ + + + H S+ D N +
Sbjct: 411 LHKYSL-----VEKQPKESTISI----PSIYLELKVKLENEYAL-HRSIVDHYNIPKTFD 460
Query: 589 PDSLGGLTSLNFLD----------MSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH 638
D L +LD + + + +L + + L F L+ ++ H
Sbjct: 461 SDDL----IPPYLDQYFYSHIGHHLKNIEHPERM-------TLFRMVFLDFRFLEQKIRH 509
Query: 639 GGPFTNLSS 647
N S
Sbjct: 510 DSTAWNASG 518
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 4e-05
Identities = 65/381 (17%), Positives = 120/381 (31%), Gaps = 99/381 (25%)
Query: 77 LNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSF-PKLEHLYLDGNSFIG 135
LN+ N + T+ L L ++ S + S I + S +L L
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS------ 240
Query: 136 TIPPSICNISSLLTLDLSFNQLQGHVPSS-ILNIPSLLAIDLSNNQFSGPMPSIYNTSPL 194
N LL L +V ++ N A +LS + T
Sbjct: 241 ---KPYEN--CLLVLL--------NVQNAKAWN-----AFNLS-------CKILLTTRFK 275
Query: 195 QNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREI--GN---I 249
Q D ++ H++ + S TL + +L ++ +PRE+ N +
Sbjct: 276 QVTD-FLSAATTTHISLDHHS----MTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL 330
Query: 250 TMLKGL------------YLVYTNLTGEIQ-GLQVLALSSNR-----LTGVIPPEIINIS 291
+++ ++ LT I+ L VL + R L + P +I
Sbjct: 331 SIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL--SVFPPSAHIP 388
Query: 292 SLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPS-------SISNASML-- 342
+ +LSL +++ + + + L + T IPS + N L
Sbjct: 389 T-ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR 447
Query: 343 TLIDMPYNLFSGFIPNSLG--------FCH---------PYDELGFLTSLTNCKDLR--- 382
+++D YN+ F + L + H + + + D R
Sbjct: 448 SIVDH-YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVF--LDFRFLE 504
Query: 383 -KLILSENPLSGVLPISIGNL 402
K+ + SI N
Sbjct: 505 QKIRHDSTAWNA--SGSILNT 523
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 50/207 (24%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRHRNLVK-- 798
LG+GSFG V T ++A+K + L+ + E L +RH +++K
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 799 -IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRLNMVIDVA--------SAL 848
+I+T +D +V+EY G L FD I+++ M D A+
Sbjct: 76 DVITT-PTDIV--MVIEYA-GGEL----------FDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATI----G 904
EY H I+H DL P N+LL++++ ++DFG+S + MT L T
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNI------MTDGNFLKTSCGSPN 172
Query: 905 YMAPEWKLSRKG------DVYSYGIIL 925
Y APE ++ K DV+S GI+L
Sbjct: 173 YAAPE-VINGKLYAGPEVDVWSCGIVL 198
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-16
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 31/225 (13%)
Query: 735 RATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEG------TLRSFDAECEI 787
+ D + LG+G++G VYK +A+K LE E +R E +
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSL 86
Query: 788 LGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASA 847
L ++HRN++++ S +H L+ EY N L+ +M +KN + + + + +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLING 144
Query: 848 LEYLHYDHPTPIIHCDLNPSNILLNESMVAC-----LSDFGISKLLGDETSMTQTQTLAT 902
+ + H +H DL P N+LL+ S + + DFG+++ G T + T
Sbjct: 145 VNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIIT 200
Query: 903 IGYMAPEWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVGE 942
+ Y PE L S D++S I E K P LF G+
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTP---LFPGD 241
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-16
Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 25/209 (11%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEG------TLRSFDAECEILGSIRHRNLVK 798
+G+GS+G V+K G +A+K F + LR E +L ++H NLV
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
++ LV EY + ++ + + R ++ A+ + H +
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--- 122
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-- 916
IH D+ P NIL+ + V L DFG ++LL + +AT Y +PE +
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYDDEVATRWYRSPELLVGDTQYG 181
Query: 917 ---DVYSYGIILMETFTKKKPTDELFVGE 942
DV++ G + E + P L+ G+
Sbjct: 182 PPVDVWAIGCVFAELLS-GVP---LWPGK 206
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 8e-16
Identities = 53/231 (22%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 735 RATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNL--ELEG----TLRSFDAECEI 787
+ + +G+G+FG V+K G ++A+K + E EG LR E +I
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKI 69
Query: 788 LGSIRHRNLVKIISTCSSDHFKA--------LVLEYMPNGSLENWMYNKNRSFDILQRLN 839
L ++H N+V +I C + LV ++ + L + N F + +
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128
Query: 840 MVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ--- 896
++ + + L Y+H + I+H D+ +N+L+ V L+DFG+++ +
Sbjct: 129 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 897 TQTLATIGYMAPEWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVGE 942
T + T+ Y PE L D++ G I+ E +T + P + G
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSP---IMQGN 232
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 80.6 bits (198), Expect = 1e-15
Identities = 42/213 (19%), Positives = 81/213 (38%), Gaps = 14/213 (6%)
Query: 421 PSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSE 480
+ L L + T + + ++LQ L ++ + + T + +R+L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPEN---KWCLLTIILLMRALDP 397
Query: 481 FYSDGNELNGSLPQCLDSLISLRTLSLGFNR--LTSVIPSSLWSLRDILNVNLSSNSLNG 538
+ L L ++ +R L R D+ ++L+ L
Sbjct: 398 LLYEKETLQ--YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL-- 453
Query: 539 TLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSL 598
T+ + L +VT +DLS N L +P ++ L+ ++ L +DN + ++ + L L
Sbjct: 454 TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRL 510
Query: 599 NFLDMSSNNLSG-EIPNSLKALSLLKFLNLSFN 630
L + +N L L + L LNL N
Sbjct: 511 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.6 bits (172), Expect = 1e-12
Identities = 43/253 (16%), Positives = 80/253 (31%), Gaps = 29/253 (11%)
Query: 97 RLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQ 156
L S W S + E + L L +LS +
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE--CWCRDSATDEQLFRCELSVEK 360
Query: 157 LQGHVPSSILNIPSLLAIDLSNNQFS----GPMPSIYNTSPLQNIDMQYNSLAEL----- 207
+ S + + L ++ N M ++ + +++L +
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRA 419
Query: 208 ---HLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT- 263
++ + E +++L L+ + + + + + ++ L L + L
Sbjct: 420 AYLDDLRSKFLLENSVLKMEYADVRVLHLA-HKDLTVLC-HLEQLLLVTHLDLSHNRLRA 477
Query: 264 -----GEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGH--SLP 316
++ L+VL S N L V + N+ L L L NN L + I S P
Sbjct: 478 LPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLL-CNNRLQQSAA-IQPLVSCP 533
Query: 317 NLQQLILGGNRLT 329
L L L GN L
Sbjct: 534 RLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 2e-12
Identities = 55/301 (18%), Positives = 98/301 (32%), Gaps = 20/301 (6%)
Query: 371 FLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGN---- 426
LT + L ++ N + + + L A ++ +P
Sbjct: 264 PLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWT 323
Query: 427 LNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQG--SITTDLCGLRSLSEFYSD 484
++ + + + ++L L K S L+ L
Sbjct: 324 GSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKW 383
Query: 485 GNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEI 544
L + LD L+ + F+ L +V P +R +L S L V
Sbjct: 384 CLLTIILLMRALDPLLYEKETLQYFSTLKAVDP-----MRAAYLDDLRSKFLLEN-SVLK 437
Query: 545 GNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMS 604
V + L+ DL+ + + L + HL L+ N+ + ++P +L L L L S
Sbjct: 438 MEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQAS 494
Query: 605 SNNLSGEIPNSLKALSLLKFLNLSFNGLQG--QVPHGGPFTNLSSQSFVGNKGLCGAPEL 662
N L + + L L+ L L N LQ + L + GN LC +
Sbjct: 495 DNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS-LCQEEGI 551
Query: 663 K 663
+
Sbjct: 552 Q 552
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 1e-09
Identities = 44/267 (16%), Positives = 84/267 (31%), Gaps = 66/267 (24%)
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIE--IPPWLD 118
+ EL + L L N T+ + + L L Y FS+++ P
Sbjct: 361 STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA 420
Query: 119 SFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSN 178
L +L N + + L L+ L V + + + +DLS+
Sbjct: 421 YLDDLRSKFLLEN------SVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSH 472
Query: 179 NQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNF 238
N+ +P L + L++L S +N
Sbjct: 473 NRLR----------------------------------ALPPALAALRCLEVLQAS-DNA 497
Query: 239 IGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGV-IPPEIINISSLTVLS 297
+ ++ + L LQ L L +NRL +++ L +L+
Sbjct: 498 LENVD----GVANL--------------PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539
Query: 298 LTANNL--LGNLPSNIGHSLPNLQQLI 322
L N+L + + LP++ ++
Sbjct: 540 LQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 4e-09
Identities = 49/336 (14%), Positives = 98/336 (29%), Gaps = 28/336 (8%)
Query: 256 YLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSL 315
+L+ ++ ++ L+ + S + L L + ++
Sbjct: 234 WLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGR 293
Query: 316 P---NLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDE--LG 370
++ L L +P + P DE
Sbjct: 294 NRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFR 353
Query: 371 FLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNL 430
S+ L+ + S L + P + L +L + A + + + L
Sbjct: 354 CELSVEKSTVLQSELESCKELQELEPENKWCLL--TIILLMRALDPLLYEKETLQYFSTL 411
Query: 431 TTL--------HLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLS--- 479
+ ++ ++ L+L H L T LC L L
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL-----TVLCHLEQLLLVT 466
Query: 480 EFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGT 539
N L +LP L +L L L N L +V + +L + + L +N L +
Sbjct: 467 HLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQQS 523
Query: 540 LPVE-IGNLKVVTKIDLSRNDLSGEIPSSIGDLKNM 574
++ + + + ++L N L + L M
Sbjct: 524 AAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 1e-06
Identities = 33/153 (21%), Positives = 54/153 (35%), Gaps = 32/153 (20%)
Query: 20 DPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGL------------------- 60
DP+ + + + + RV L+LA+ L
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRV--LHLAHKDLTVLCHLEQLLLVTHLDLSH 472
Query: 61 --LGTIPPELGNLSFLSLLNVTNN---SFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPP 115
L +PP L L L +L ++N + G ++NL RL+ L +N
Sbjct: 473 NRLRALPPALAALRCLEVLQASDNALENVDG-----VANLPRLQELLLCNNRLQQSAAIQ 527
Query: 116 WLDSFPKLEHLYLDGNSFIGTIPPSICNISSLL 148
L S P+L L L GNS + ++ +L
Sbjct: 528 PLVSCPRLVLLNLQGNS-LCQEEGIQERLAEML 559
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 53/238 (22%), Positives = 94/238 (39%), Gaps = 50/238 (21%)
Query: 734 FRATDGFSENNLLGKGSFGSVYKGTLSD-GMQIAVK-VF------NLELEGTLRSFDAEC 785
+ D F + G+G+FG+V G GM +A+K V N EL+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ--------IM 70
Query: 786 EILGSIRHRNLVK---IISTCSSDHFK----ALVLEYMPNGSLENWMYNKNRSFDILQRL 838
+ L + H N+V+ T + +V+EY+P + ++ R++ +++
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DT-LHRCCRNY-YRRQV 124
Query: 839 NMVID--------VASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC-LSDFGISKLLG 889
+ ++ LH + H D+ P N+L+NE+ L DFG +K L
Sbjct: 125 APPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 890 DETSMTQTQTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKPTDELFVGE 942
+ + Y APE + D++S G I E +P +F G+
Sbjct: 184 PSEPN--VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML-GEP---IFRGD 235
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 33/216 (15%), Positives = 67/216 (31%), Gaps = 23/216 (10%)
Query: 300 ANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNS 359
L N+ + + G + + + + LT I + +
Sbjct: 4 EQTGLKASQDNVNIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD----- 58
Query: 360 LGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGS 419
LT + +++ L ++ + PIS LSN ++ L + ++
Sbjct: 59 ------------LTGIEYAHNIKDLTINNIHATNYNPIS--GLSN-LERLRIMGKDVTSD 103
Query: 420 IPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLS 479
+ L +LT L + + SI I L K+ + L +N I L L L
Sbjct: 104 KIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELK 162
Query: 480 EFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSV 515
+ ++ ++ L L +
Sbjct: 163 SLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 29/186 (15%), Positives = 66/186 (35%), Gaps = 10/186 (5%)
Query: 426 NLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485
L + ++ L + L + + + T + ++ + +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINN 75
Query: 486 NELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIG 545
P + L +L L + +TS +L L + +++S ++ + ++ +I
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 546 NLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSS 605
L V IDLS N +I + L ++ L++ + + LN L S
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 606 NNLSGE 611
+ G+
Sbjct: 191 QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 28/183 (15%), Positives = 74/183 (40%), Gaps = 8/183 (4%)
Query: 381 LRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNEL 440
+ + S I+ +++ + + L+ N+ + + I +N+ L +
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNS-LTYITLANINVT-DL-TGIEYAHNIKDLTINNIHA 78
Query: 441 TGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLI 500
T P I L L+ L + + +L GL SL+ + + S+ +++L
Sbjct: 79 TNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 501 SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDL 560
+ ++ L +N + I L +L ++ ++N+ + ++ I + + ++ +
Sbjct: 137 KVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
Query: 561 SGE 563
G+
Sbjct: 194 GGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 34/192 (17%), Positives = 75/192 (39%), Gaps = 18/192 (9%)
Query: 51 TALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSS 110
A +G T ++ L+ + + N + + I+ +K L+ + + ++
Sbjct: 23 KAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHATN 80
Query: 111 IEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPS 170
+ LE L + G P++ ++SL LD+S + + + I +P
Sbjct: 81 YNP---ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPK 137
Query: 171 LLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKI 230
+ +IDLS N +I + PL+ + L L++ ++ + + + +L
Sbjct: 138 VNSIDLSYNG------AITDIMPLKTL----PELKSLNIQFDGVHDYRG--IEDFPKLNQ 185
Query: 231 LSLSVNNFIGSI 242
L + IG
Sbjct: 186 LYAF-SQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 30/208 (14%), Positives = 72/208 (34%), Gaps = 32/208 (15%)
Query: 105 SNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSS 164
+ ++ IP +F + L +S T + ++SL + L+ + +
Sbjct: 9 KASQDNVNIP--DSTFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINV-----TD 58
Query: 165 ILNI---PSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPST 221
+ I ++ + ++N N +P+ + ++L L + ++
Sbjct: 59 LTGIEYAHNIKDLTINNIH-------ATNYNPISGL----SNLERLRIMGKDVTSDKIPN 107
Query: 222 LFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQG------LQVLALS 275
L L +L +S + SI +I + + + L Y +I L+ L +
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQ 167
Query: 276 SNRLTGVIPPEIINISSLTVLSLTANNL 303
+ + I + L L + +
Sbjct: 168 FDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 28/151 (18%), Positives = 58/151 (38%), Gaps = 7/151 (4%)
Query: 497 DSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLS 556
+ + LG + ++ + + SL I L++ ++ +E + + ++
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYI---TLANINVTDLTGIE--YAHNIKDLTIN 74
Query: 557 RNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSL 616
+ + I L N++ L + +L GLTSL LD+S + I +
Sbjct: 75 NIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 617 KALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
L + ++LS+NG + L S
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMPLKTLPELKS 163
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 8e-10
Identities = 25/212 (11%), Positives = 66/212 (31%), Gaps = 37/212 (17%)
Query: 143 NISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYN 202
+ L L + + + SL I L+N + + + ++ +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANIN-------VTDLTGIEY----AH 66
Query: 203 SLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNL 262
++ +L + + + + L+ L + + + +T L L +
Sbjct: 67 NIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI----- 119
Query: 263 TGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLI 322
S + I +I + + + L+ N + ++ + +LP L+ L
Sbjct: 120 ------------SHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLK-TLPELKSLN 165
Query: 323 LGGNRLTGPIPSSISNASMLTLIDMPYNLFSG 354
+ + + I + L + G
Sbjct: 166 IQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 44/223 (19%)
Query: 745 LLGKGSFGSVY---KGTLSDGMQI-AVKVF--------NLELEGTLRSFDAECEILGSIR 792
+LGKG +G V+ K T ++ +I A+KV + T AE IL ++
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK----AERNILEEVK 79
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMY--NKNRSFDILQRLNMVI----DVAS 846
H +V +I + L+LEY+ G L + F + +++
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFM----EDTACFYLAEISM 132
Query: 847 ALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYM 906
AL +LH II+ DL P NI+LN L+DFG+ K + ++T T TI YM
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYM 188
Query: 907 APEWKLSRKG-----DVYSYGIILMETFTKKKP-----TDELF 939
APE L R G D +S G ++ + T P +
Sbjct: 189 APE-ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 48/224 (21%)
Query: 745 LLGKGSFGSVY---KGTLSDGMQI-AVKVFNLEL------EGTLRSFDAECEILGSIRHR 794
+LG+GSFG V+ K + SD Q+ A+KV T E +IL + H
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK----MERDILVEVNHP 86
Query: 795 NLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNM---------VIDVA 845
+VK+ ++ L+L+++ G L F L + M + ++A
Sbjct: 87 FIVKLHYAFQTEGKLYLILDFLRGGDL----------FTRLSKEVMFTEEDVKFYLAELA 136
Query: 846 SALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGY 905
AL++LH II+ DL P NILL+E L+DFG+SK D + T+ Y
Sbjct: 137 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEY 192
Query: 906 MAPEWKLSRKG-----DVYSYGIILMETFTKKKP-----TDELF 939
MAPE ++R+G D +S+G+++ E T P E
Sbjct: 193 MAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 28/222 (12%), Positives = 73/222 (32%), Gaps = 39/222 (17%)
Query: 98 LKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQ 156
+ L + +I + P + +Y+ + + + N+S + +++ +
Sbjct: 33 TQTLKLIETHLRTIP-SHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 157 LQGHVPSSIL-NIPSLLAIDLSNNQFS--GPMPSIYNTSPLQNIDMQYNS---------- 203
++ L +P L + + N + +Y+T +++ N
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 204 ------LAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYL 257
L L N + + F +L + L+ N ++ I ++
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDA----------- 199
Query: 258 VYTNLTGEIQGLQVLALSSNRLTGVIPPEII-NISSLTVLSL 298
G G +L +S +T +P + + ++ L +
Sbjct: 200 ----FGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 40/208 (19%), Positives = 77/208 (37%), Gaps = 12/208 (5%)
Query: 429 NLTTLHLETNELTGSIPK-AIGRLQKLQGLYLQHNKLQGSITTDL-CGLRSLSEFY-SDG 485
+ TL L L +IP A L + +Y+ + + + L ++ +
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 486 NELNGSLPQCLDSLISLRTLSLGFNRLTSVIP-SSLWSLRDILNVNLSSNSLNGTLPVEI 544
L P L L L+ L + L + ++S + ++ N ++PV
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 545 --GNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIP-DSLGGLTS-LNF 600
G + L N + + + + + L NK+ I D+ GG+ S +
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209
Query: 601 LDMSSNNLSGEIP-NSLKALSLLKFLNL 627
LD+S +++ +P L+ L L N
Sbjct: 210 LDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 35/196 (17%), Positives = 69/196 (35%), Gaps = 24/196 (12%)
Query: 48 RRVTALNLAYMGLLGTIPPEL-GNLSFLSLLNVTNNSFSGTLPIQ-LSNLRRLKYLSFRS 105
++ + ++ L + NLS ++ + + N + L L LK+L +
Sbjct: 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114
Query: 106 NNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPP-SICNISSLL-TLDLSFNQLQGHVPS 163
+ S L + N ++ +IP + + + TL L N V
Sbjct: 115 TGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQG 173
Query: 164 SILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQ-----YNSLAELHLAYNQLSGQI 218
N L A+ L+ N++ L ID Y+ + L ++ ++ +
Sbjct: 174 YAFNGTKLDAVYLNKNKY------------LTVIDKDAFGGVYSGPSLLDVSQTSVT-AL 220
Query: 219 PSTLFE-CKQLKILSL 233
PS E K+L +
Sbjct: 221 PSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 35/216 (16%), Positives = 71/216 (32%), Gaps = 21/216 (9%)
Query: 268 GLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNR 327
Q L L L + N+ +++ + ++ + L L S+ ++L + + + R
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 328 LTGPIPSSI-SNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLIL 386
I +L + + F +L + S L +
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLKMF-----------PDLTKVYSTDI---FFILEI 137
Query: 387 SENPLSGVLPI-SIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIP 445
++NP +P+ + L N L L S+ N L ++L N+ I
Sbjct: 138 TDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVID 196
Query: 446 KAI--GRLQKLQGLYLQHNKLQGSITTD-LCGLRSL 478
K G L + + ++ + L L+ L
Sbjct: 197 KDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 30/202 (14%), Positives = 62/202 (30%), Gaps = 31/202 (15%)
Query: 145 SSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQY--- 201
S TL L L+ + N+P++ I +S + LQ ++
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSID------------VTLQQLESHSFYN 78
Query: 202 -NSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSVNNFIGSIP--REIGNITMLKGLYL 257
+ + + + + I + LK L + N + P ++ + + L +
Sbjct: 79 LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF-NTGLKMFPDLTKVYSTDIFFILEI 137
Query: 258 VYTNLTGEIQG---------LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLP 308
I L L +N T + N + L + L N L +
Sbjct: 138 TDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVID 196
Query: 309 SNIGHSLPN-LQQLILGGNRLT 329
+ + + L + +T
Sbjct: 197 KDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 29/139 (20%), Positives = 53/139 (38%), Gaps = 7/139 (5%)
Query: 501 SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRND 559
S +TL L L ++ + +L +I + +S + L NL VT I++
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 560 LSGEIPSSI-GDLKNMQHLSLADNKFQGSIPD--SLGGLTSLNFLDMSSNNLSGEIP-NS 615
I +L ++ L + + + PD + L+++ N IP N+
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 616 LKAL-SLLKFLNLSFNGLQ 633
+ L + L L NG
Sbjct: 151 FQGLCNETLTLKLYNNGFT 169
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 20/219 (9%)
Query: 735 RATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRS---FDA--ECEIL 788
+ + + LG+G F +VYK + +A+K L + A E ++L
Sbjct: 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL 66
Query: 789 GSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASAL 848
+ H N++ ++ +LV ++M LE + + + ++ L
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAP 908
EYLH I+H DL P+N+LL+E+ V L+DFG++K G T + T Y AP
Sbjct: 126 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAP 181
Query: 909 EWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVGE 942
E D+++ G IL E + P G+
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLL-RVP---FLPGD 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 41/234 (17%)
Query: 734 FRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEG---------TLRSFDA 783
AT + +G G++G+VYK G +A+K + G T+R
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR---- 60
Query: 784 ECEI-----LGSIRHRNLVKIISTCSSDHFKA-----LVLEYMPNGSLENWMYN-KNRSF 832
E+ L + H N+V+++ C++ LV E++ L ++
Sbjct: 61 --EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGL 117
Query: 833 DILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892
+++ L++LH + I+H DL P NIL+ L+DFG++++ +
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174
Query: 893 SMTQTQTLATIGYMAPEWKL-SRKG---DVYSYGIILMETFTKKKPTDELFVGE 942
++ T + T+ Y APE L S D++S G I E F +KP LF G
Sbjct: 175 AL--TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP---LFCGN 222
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 55/270 (20%), Positives = 96/270 (35%), Gaps = 55/270 (20%)
Query: 719 MSPEVTWRRISYQE-----LFRATDGFSENNLLGKGSFGSVYKGTLSD-GMQIAVK---- 768
M Y F + +G G+ G V + +A+K
Sbjct: 1 MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60
Query: 769 VFNLELEG--TLRSFDAECEILGSIRHRNLVKI----ISTCSSDHFKA--LVLEYMP--- 817
F + R E ++ + H+N++ + S + F+ +V+E M
Sbjct: 61 PFQNQTHAKRAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL 116
Query: 818 NGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVA 877
++ + ++ S+ + Q L +++LH IIH DL PSNI++
Sbjct: 117 CQVIQMELDHERMSYLLYQMLC-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTL 166
Query: 878 CLSDFGISKLLGDETSMTQTQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFTKKK 933
+ DFG+++ G M T + T Y APE D++S G I+ E
Sbjct: 167 KILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
Query: 934 PTDELFVGEISLKSRVNDSLH--GKIINVV 961
LF G D + K+I +
Sbjct: 225 ----LFPG--------TDHIDQWNKVIEQL 242
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELE-G----TLRSFDAECEILGSIRHRNLVKI 799
LG G++ +VYKG + G+ +A+K L+ E G +R E ++ ++H N+V++
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENIVRL 68
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWM-----YNKNRSFDILQRLNMVIDVASALEYLHYD 854
+++ LV E+M N L+ +M N R ++ + L + H +
Sbjct: 69 YDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL-- 912
I+H DL P N+L+N+ L DFG+++ G + T + + T+ Y AP+ +
Sbjct: 128 K---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMGS 183
Query: 913 ---SRKGDVYSYGIILMETFTKKKPTDELFVGE 942
S D++S G IL E T KP LF G
Sbjct: 184 RTYSTSIDIWSCGCILAEMIT-GKP---LFPGT 212
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 39/231 (16%)
Query: 735 RATDGFSENNLLGKGSFGSVYKG--TLSDGMQIAVKVFNLELEG------TLRSFDAECE 786
RA + +G+G++G V+K + G +A+K ++ T+R E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------E 61
Query: 787 I-----LGSIRHRNLVK---IISTCSSDHFKA--LVLEYMPNGSLENWMYN-KNRSFDIL 835
+ L + H N+V+ + + +D LV E++ L ++
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 836 QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895
+M+ + L++LH ++H DL P NIL+ S L+DFG++++ + M
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MA 175
Query: 896 QTQTLATIGYMAPEWKL-SRKG---DVYSYGIILMETFTKKKPTDELFVGE 942
T + T+ Y APE L S D++S G I E F +KP LF G
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRGS 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 48/278 (17%)
Query: 720 SPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVK---VFNLELE 775
+ + ++F ++ + +G+G++G V + +++A+K F +
Sbjct: 9 AAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY 68
Query: 776 G--TLRSFDAECEILGSIRHRNLVK---IISTCSSDHFKA--LVLEYMPNGSLENWMYNK 828
TLR E +IL RH N++ II + + K +V + M L + +
Sbjct: 69 CQRTLR----EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ 123
Query: 829 NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888
+ S D + I L L Y H ++H DL PSN+LLN + + DFG++++
Sbjct: 124 HLSNDHICYFLYQI-----LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178
Query: 889 GDETSMTQ--TQTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKPTDELFVG 941
+ T T+ +AT Y APE L+ KG D++S G IL E + + +F G
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR----PIFPG 234
Query: 942 EISLKSRVNDSLH--GKIINVV------DINLLQKEDA 971
L I+ ++ D+N + A
Sbjct: 235 --------KHYLDQLNHILGILGSPSQEDLNCIINLKA 264
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 54/254 (21%), Positives = 95/254 (37%), Gaps = 50/254 (19%)
Query: 730 YQELFRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVK----VFNLELEG--TLRSFD 782
F + +G G+ G V +A+K F + R
Sbjct: 54 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR--- 110
Query: 783 AECEILGSIRHRNLVKII----STCSSDHFKA--LVLEYMP---NGSLENWMYNKNRSFD 833
E ++ + H+N++ ++ + + F+ LV+E M ++ + ++ S+
Sbjct: 111 -ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 834 ILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893
+ Q L +++LH IIH DL PSNI++ + DFG+++ G
Sbjct: 170 LYQMLC-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219
Query: 894 MTQTQTLATIGYMAPE----WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV 949
M T + T Y APE D++S G I+ E K LF G
Sbjct: 220 M--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG-------- 265
Query: 950 NDSLH--GKIINVV 961
D + K+I +
Sbjct: 266 RDYIDQWNKVIEQL 279
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 67/268 (25%), Positives = 110/268 (41%), Gaps = 52/268 (19%)
Query: 730 YQELFRATDGFSENNLLGKGSFGSVYKGTLSD-GMQIAVK----VFNLELEG--TLRSFD 782
+ ++ + + + +G G++GSV + G+++AVK F + T R
Sbjct: 21 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR--- 77
Query: 783 AECEILGSIRHRNLVKI----ISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQ 836
E +L ++H N++ + S + F LV M L N + + + D +Q
Sbjct: 78 -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ 135
Query: 837 RLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896
L + L L Y H IIH DL PSN+ +NE + DFG+++ DE
Sbjct: 136 FL-----IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----M 186
Query: 897 TQTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKPTDELFVGEISLKSRVND 951
T +AT Y APE L+ D++S G I+ E T + LF G D
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TLFPG--------TD 234
Query: 952 SLH--GKIINVV------DINLLQKEDA 971
+ I+ +V + + E A
Sbjct: 235 HIDQLKLILRLVGTPGAELLKKISSESA 262
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 44/232 (18%)
Query: 734 FRATDGFSENNLLGKGSFGSVYKGTLSD-GMQIAVKVFNLELEGTLRSFDAECEILGSIR 792
+++ ++G GSFG VY+ L D G +A+K + R E +I+ +
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLD 105
Query: 793 HRNLVK----IISTCSSDHFKAL--VLEYMPNGSLENWMYNKNRSFDIL----------Q 836
H N+V+ S+ L VL+Y+P ++ + +R+ L Q
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 837 RLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC-LSDFGISKLLGDETSMT 895
+L Y+H I H D+ P N+LL+ L DFG +K L
Sbjct: 165 LF-------RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN- 213
Query: 896 QTQTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKPTDELFVGE 942
+ + Y APE DV+S G +L E +P +F G+
Sbjct: 214 -VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQP---IFPGD 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 60/271 (22%), Positives = 101/271 (37%), Gaps = 59/271 (21%)
Query: 730 YQELFRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVK----VFNLELEG--TLRSFD 782
+ + + +G G++GSV G ++A+K F E+ R
Sbjct: 16 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR--- 72
Query: 783 AECEILGSIRHRNLVKI----ISTCSSDHFKA--LVLEYMP---NGSLENWMYNKNRSFD 833
E +L ++H N++ + S +F LV+ +M + + +
Sbjct: 73 -ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL 131
Query: 834 ILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893
+ Q L L+Y+H ++H DL P N+ +NE + DFG+++ E
Sbjct: 132 VYQMLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 179
Query: 894 MTQTQTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKPTDELFVGEISLKSR 948
T + T Y APE LS D++S G I+ E T K LF G
Sbjct: 180 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKG------- 226
Query: 949 VNDSLH--GKIINVV------DINLLQKEDA 971
D L +I+ V + L + A
Sbjct: 227 -KDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
C+ K +IPS I + L L++N+L+ KA RL KL+ LYL NKLQ ++
Sbjct: 23 CSSKKLTAIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAG 79
Query: 472 LC-GLRSLSEFYSDGNELNGSLPQCL-DSLISLRTLSLGFNRLTSV---IPSSLWSLRDI 526
+ L++L + N+L +LP + D L++L L L N+L S+ + SL L +
Sbjct: 80 IFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYL 138
Query: 527 LNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRNDLSGEIPSSIGD-LKNMQHLSLADNKF 584
+L N L +LP + L + ++ L N L +P D L ++ L L +N+
Sbjct: 139 ---SLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQL 193
Query: 585 QGSIPDSLGGLTSLNFLDMSSN 606
+ + L L L + N
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 9/183 (4%)
Query: 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETN 438
D +KL L N LS + + L+ + +LYL+ ++ ++P+ I L NL TL + N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTK-LRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 439 ELTGSIPKAI-GRLQKLQGLYLQHNKLQGSITTDLC-GLRSLSEFYSDGNELNGSLPQCL 496
+L ++P + +L L L L N+L+ S+ + L L+ NEL SLP+ +
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152
Query: 497 -DSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDL 555
D L SL+ L L N+L V + L ++ + L +N L +L+ + + L
Sbjct: 153 FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 556 SRN 558
N
Sbjct: 213 QEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 56/218 (25%), Positives = 87/218 (39%), Gaps = 32/218 (14%)
Query: 275 SSNRLTGV---IPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGP 331
SS +LT + IP + L L +N L +LPS H L L+ L L N+L
Sbjct: 24 SSKKLTAIPSNIP------ADTKKLDL-QSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT- 75
Query: 332 IPSSI-SNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENP 390
+P+ I L + + N +P G L N L +L L N
Sbjct: 76 LPAGIFKELKNLETLWVTDNKLQA-LPI-----------GVFDQLVN---LAELRLDRNQ 120
Query: 391 LSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELTGSIPK-AI 448
L + P +L+ + L L ++ S+P + L +L L L N+L +P+ A
Sbjct: 121 LKSLPPRVFDSLTK-LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAF 177
Query: 449 GRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGN 486
+L +L+ L L +N+L+ L L N
Sbjct: 178 DKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 49/217 (22%), Positives = 83/217 (38%), Gaps = 33/217 (15%)
Query: 136 TIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQ 195
IP +I + LDL N+L + + L + L++N+ I+
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFK----- 82
Query: 196 NIDMQYNSLAELHLAYNQLSGQIPSTLFEC-KQLKILSLSVNNFIGSIPREIGNITMLKG 254
+ +L L + N+L +P +F+ L L L N + S+P
Sbjct: 83 ----ELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLD-RNQLKSLPPR--------- 127
Query: 255 LYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEII-NISSLTVLSLTANNLLGNLPSNIGH 313
V+ +LT L L+L N L +P + ++SL L L NN L +P
Sbjct: 128 ---VFDSLT----KLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLY-NNQLKRVPEGAFD 178
Query: 314 SLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYN 350
L L+ L L N+L + + L ++ + N
Sbjct: 179 KLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 501 SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRND 559
+ L L N+L+S+ + L + + L+ N L TLP I LK + + ++ N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 560 LSGEIPSSIGD-LKNMQHLSLADNKFQGSIPDSL-GGLTSLNFLDMSSNNLSGEIPNSL- 616
L +P + D L N+ L L N+ + S+P + LT L +L + N L +P +
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 617 KALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
L+ LK L L N L+ +VP G F L+
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGA-FDKLTE 182
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 48/228 (21%), Positives = 81/228 (35%), Gaps = 57/228 (25%)
Query: 77 LNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWL-DSFPKLEHLYLDGNSFIG 135
L++ +N S L +L+ L N + +P + LE L++ N +
Sbjct: 42 LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT--LPAGIFKELKNLETLWVTDNK-LQ 98
Query: 136 TIPPSI-CNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPL 194
+P + + +L L L NQL+ +P + + L+
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFD-------SLTK---------------- 134
Query: 195 QNIDMQYNSLAELHLAYNQLSGQIPSTLFEC-KQLKILSLSVNNFIGSIPREIGNITMLK 253
L L L YN+L +P +F+ LK L L NN + +P
Sbjct: 135 ---------LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLY-NNQLKRVPEG-------- 175
Query: 254 GLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTAN 301
+ LT L+ L L +N+L V ++ L +L L N
Sbjct: 176 ----AFDKLT----ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 32/123 (26%), Positives = 53/123 (43%), Gaps = 8/123 (6%)
Query: 61 LGTIPPEL-GNLSFLSLLNVTNNSFSGTLPIQL-SNLRRLKYLSFRSNNFSSIEIPPWL- 117
L +P + L L+ L + N +LP ++ +L +L YLS N S+ P +
Sbjct: 97 LQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSL--PKGVF 153
Query: 118 DSFPKLEHLYLDGNSFIGTIPPSIC-NISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDL 176
D L+ L L N + +P ++ L TL L NQL+ + ++ L + L
Sbjct: 154 DKLTSLKELRLYNNQ-LKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 177 SNN 179
N
Sbjct: 213 QEN 215
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 72/284 (25%), Positives = 114/284 (40%), Gaps = 57/284 (20%)
Query: 719 MSPEVTWRRISYQE-----LFRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVK---- 768
MS R Y++ + + + +G G++G+V G ++A+K
Sbjct: 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR 60
Query: 769 VFNLELEG--TLRSFDAECEILGSIRHRNLVKII----STCSSDHFKA--LVLEYMPNGS 820
F EL R E +L +RH N++ ++ + D F LV+ +M
Sbjct: 61 PFQSELFAKRAYR----ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-D 115
Query: 821 LENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLS 880
L M ++ D +Q L V L+ L Y H IIH DL P N+ +NE +
Sbjct: 116 LGKLMKHEKLGEDRIQFL-----VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 170
Query: 881 DFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKPT 935
DFG+++ E T + T Y APE L+ D++S G I+ E T K
Sbjct: 171 DFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK--- 223
Query: 936 DELFVGEISLKSRVNDSLH--GKIINVV------DINLLQKEDA 971
LF G +D L +I+ V + LQ ++A
Sbjct: 224 -TLFKG--------SDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 5e-14
Identities = 67/245 (27%), Positives = 108/245 (44%), Gaps = 44/245 (17%)
Query: 721 PEVTWRRISYQELFRATDGFSENNLLGKGSFGSV----YKGTLSDGMQIAVKVF------ 770
PE+ R S Q + D F + +LGKGSFG V +K T A+K
Sbjct: 1 PELNKERPSLQIKLKIED-FILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVL 56
Query: 771 -NLELEGTLRSFDAECEILG-SIRHRNLVKIIST-CSSDHFKALVLEYMPNGSLENWMYN 827
+ ++E T+ E +L + H L + T + ++ V+EY+ G L +
Sbjct: 57 MDDDVECTM----VEKRVLSLAWEHPFLTHMFCTFQTKENL-FFVMEYLNGGDLMYHIQ- 110
Query: 828 KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK- 886
FD+ + ++ L++LH I++ DL NILL++ ++DFG+ K
Sbjct: 111 SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167
Query: 887 -LLGDETSMTQTQTL-ATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKP----- 934
+LGD T T T Y+APE L + D +S+G++L E + P
Sbjct: 168 NMLGDAK----TNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222
Query: 935 TDELF 939
+ELF
Sbjct: 223 EEELF 227
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVF-------NLELEGTLRSFDAECEILGSIRHRNL 796
LLGKG+FG V + A+K+ E+ T+ E +L + RH L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----TESRVLQNTRHPFL 67
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMY--NKNRSFDILQRLNMVIDVASALEYLHYD 854
+ + V+EY G L + ++ R F + ++ SALEYLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR 914
+++ D+ N++L++ ++DFG+ K + + +T T Y+APE L
Sbjct: 125 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPE-VLED 179
Query: 915 KG-----DVYSYGIILMETFTKKKP-----TDELF 939
D + G+++ E + P + LF
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-14
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 47/212 (22%)
Query: 745 LLGKGSFGSVY---KGTLSDGMQI-AVKVF--------NLELEGTLRSFDAECEILGSIR 792
+LG G++G V+ K + D ++ A+KV E T E ++L IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR----TERQVLEHIR 116
Query: 793 HRN-LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNM---------VI 842
LV + ++ L+L+Y+ G L F L + V
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGEL----------FTHLSQRERFTEHEVQIYVG 166
Query: 843 DVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL-LGDETSMTQTQTLA 901
++ ALE+LH II+ D+ NILL+ + L+DFG+SK + DET
Sbjct: 167 EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCG 222
Query: 902 TIGYMAPE-WKLSRKG-----DVYSYGIILME 927
TI YMAP+ + G D +S G+++ E
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 68/280 (24%), Positives = 114/280 (40%), Gaps = 72/280 (25%)
Query: 734 FRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVK---VFNLELEG--TLRSFDAECEI 787
+ + F +LLG+G++G V T G +A+K F+ L TLR E +I
Sbjct: 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKI 62
Query: 788 LGSIRHRNLVK---IISTCSSDHFKA--LVLEYMP--------NGSLENWMYNKNRSFDI 834
L +H N++ I S ++F ++ E M L + + F I
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI---QYF-I 118
Query: 835 LQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894
Q L A++ LH + +IH DL PSN+L+N + + DFG+++++ + +
Sbjct: 119 YQTLR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 895 TQ---------TQTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKPTDELFV 940
+ +AT Y APE L+ DV+S G IL E F ++ +F
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP----IFP 224
Query: 941 GEISLKSRVNDSLH--GKIINVV-------DINLLQKEDA 971
G D H I ++ D+ ++ A
Sbjct: 225 G--------RDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 44/203 (21%), Positives = 81/203 (39%), Gaps = 22/203 (10%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
+ P + +L+ +T L + + ++ ++
Sbjct: 5 VSTPIKQIFPDDA--FAETIKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSVQGIQ 60
Query: 472 LCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNL 531
L ++ GN+L+ + L L +L L L N+L S+ L ++ + L
Sbjct: 61 --YLPNVRYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116
Query: 532 SSNSLNGTLPVEIGN-LKVVTKIDLSRNDLSGEIPSSIGD-LKNMQHLSLADNKFQGSIP 589
N L +LP + + L +T ++L+ N L +P + D L N+ L L+ N+ Q S+P
Sbjct: 117 VENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLP 173
Query: 590 DSLGG----LTSLNFLDMSSNNL 608
+ G LT L L + N L
Sbjct: 174 E---GVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 46/179 (25%), Positives = 64/179 (35%), Gaps = 57/179 (31%)
Query: 426 NLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485
L NLT L L N+L +L L+ L L N+LQ
Sbjct: 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-------------------- 122
Query: 486 NELNGSLPQ-CLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEI 544
SLP D L +L L+L N+L S+ L NL
Sbjct: 123 -----SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKL-----TNL------------- 159
Query: 545 GNLKVVTKIDLSRNDLSGEIPSSIGD-LKNMQHLSLADNKFQGSIP----DSLGGLTSL 598
T++DLS N L +P + D L ++ L L N+ + S+P D L L +
Sbjct: 160 ------TELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYI 210
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 56/199 (28%), Positives = 80/199 (40%), Gaps = 53/199 (26%)
Query: 269 LQVLALSSNRLT--GVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGN 326
++ LAL N+L + +++LT L LT N L +LP+ + L NL++L+L N
Sbjct: 65 VRYLALGGNKLHDISALK----ELTNLTYLILT-GNQLQSLPNGVFDKLTNLKELVLVEN 119
Query: 327 RLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLIL 386
+L SL G LTN L L L
Sbjct: 120 QLQ-----------------------------SL-------PDGVFDKLTN---LTYLNL 140
Query: 387 SENPLSGVLPISI-GNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELTGSI 444
+ N L LP + L+N + L LS N S+P + L L L L N+L S+
Sbjct: 141 AHNQLQ-SLPKGVFDKLTN-LTELDLS-YNQLQSLPEGVFDKLTQLKDLRLYQNQLK-SV 196
Query: 445 PK-AIGRLQKLQGLYLQHN 462
P RL LQ ++L N
Sbjct: 197 PDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 51/229 (22%), Positives = 94/229 (41%), Gaps = 41/229 (17%)
Query: 77 LNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGT 136
N+ S + + L + + +++ S+ + P + +L L GN
Sbjct: 24 ANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV---QGIQYLPNVRYLALGGNKL--H 76
Query: 137 IPPSICNISSLLTLDLSFNQLQGHVPSSILNIPS-LLAIDLSNNQFSGPMPSIYNTSPLQ 195
++ +++L L L+ NQLQ +P+ + + + L + L NQ +++
Sbjct: 77 DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFD----- 130
Query: 196 NIDMQYNSLAELHLAYNQLSGQIPSTLFEC-KQLKILSLSVNNFIGSIPREIGNITMLKG 254
+ +L L+LA+NQL +P +F+ L L LS N S+P
Sbjct: 131 ----KLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL-QSLPEG--------- 175
Query: 255 LYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEII--NISSLTVLSLTAN 301
V+ LT L+ L L N+L V P+ + ++SL + L N
Sbjct: 176 ---VFDKLT----QLKDLRLYQNQLKSV--PDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 29/135 (21%), Positives = 49/135 (36%), Gaps = 22/135 (16%)
Query: 511 RLTSV---IPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSS 567
+ + NL S+ + L + +I + +D+
Sbjct: 9 IKQIFPDDAFAET------IKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSV--QG 58
Query: 568 IGDLKNMQHLSLADNKFQGSIPDSLG---GLTSLNFLDMSSNNLSGEIPNSLKALSLLKF 624
I L N+++L+L NK + LT+L +L ++ N L L+ LK
Sbjct: 59 IQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE 113
Query: 625 LNLSFNGLQGQVPHG 639
L L N LQ +P G
Sbjct: 114 LVLVENQLQ-SLPDG 127
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 33/137 (24%), Positives = 57/137 (41%), Gaps = 14/137 (10%)
Query: 501 SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDL 560
+L +T + + L I + +++ + ++ I L V + L N L
Sbjct: 20 ETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKL 75
Query: 561 SGEIPSSIG---DLKNMQHLSLADNKFQGSIPDSL-GGLTSLNFLDMSSNNLSGEIPNSL 616
I +L N+ +L L N+ Q S+P+ + LT+L L + N L
Sbjct: 76 -----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVF 129
Query: 617 KALSLLKFLNLSFNGLQ 633
L+ L +LNL+ N LQ
Sbjct: 130 DKLTNLTYLNLAHNQLQ 146
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 40/200 (20%), Positives = 75/200 (37%), Gaps = 57/200 (28%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKII--- 800
LG G G V + + A+K+ + R E E+ + ++V+I+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80
Query: 801 -STCSSDHFKALVLEYMPNGSLENWMYNKNRSFD-ILQRLN----------MVIDVASAL 848
+ + +V+E + G L F I R + ++ + A+
Sbjct: 81 ENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 849 EYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDETSMTQTQTLATIGY 905
+YLH + I H D+ P N+L + + L+DFG +K +T Y
Sbjct: 131 QYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTGE-KY 175
Query: 906 MAPEWKLSRKGDVYSYGIIL 925
+ D++S G+I+
Sbjct: 176 -------DKSCDMWSLGVIM 188
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 36/163 (22%), Positives = 62/163 (38%), Gaps = 10/163 (6%)
Query: 401 NLSNAMDVLYLSACNIKGSIPSEI--GNLNNLTTLHLETNELTGSIPK-AIGRLQKLQGL 457
+L + +L LS N+ + +E L NL +L L N L I A + L+ L
Sbjct: 36 SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYL 93
Query: 458 YLQHNKLQGSITTD-LCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVI 516
L N L ++ L++L N + + + L+ L L N+++
Sbjct: 94 DLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152
Query: 517 P---SSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLS 556
L ++ ++LSSN L ++ L K L
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 40/209 (19%), Positives = 63/209 (30%), Gaps = 35/209 (16%)
Query: 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQG-SITTDLCGLRSLSEFYSDGNE 487
L +L ++P+++ L L HN L L +L N
Sbjct: 19 ASNILSCSKQQLP-NVPQSLPSY--TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH 75
Query: 488 LNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNL 547
LN + + +LR L L N L ++ L L
Sbjct: 76 LNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDL-----QAL---------------- 114
Query: 548 KVVTKIDLSRNDLSGEIPSSI-GDLKNMQHLSLADNKFQGSIP----DSLGGLTSLNFLD 602
+ L N + + + D+ +Q L L+ N+ P L L LD
Sbjct: 115 ---EVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLD 169
Query: 603 MSSNNLSGEIPNSLKALSLLKFLNLSFNG 631
+SSN L L+ L L +
Sbjct: 170 LSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 34/156 (21%), Positives = 57/156 (36%), Gaps = 19/156 (12%)
Query: 96 RRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSF 154
L NN S + L L L N + I + +L LDLS
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVPNLRYLDLSS 97
Query: 155 NQLQGHVPSSIL-NIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQ 213
N L + + ++ +L + L NN + + L +L+L+ NQ
Sbjct: 98 NHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMA---------QLQKLYLSQNQ 147
Query: 214 LSGQIPSTLFEC----KQLKILSLSVNNFIGSIPRE 245
+S + P L + +L +L LS +N + +P
Sbjct: 148 IS-RFPVELIKDGNKLPKLMLLDLS-SNKLKKLPLT 181
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 33/149 (22%), Positives = 57/149 (38%), Gaps = 13/149 (8%)
Query: 92 LSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSIC-NISSLLTL 150
+ L L L N+ + I P L +L L N + T+ + ++ +L L
Sbjct: 60 PTRLTNLHSLLLSHNHLNFIS-SEAFVPVPNLRYLDLSSNH-LHTLDEFLFSDLQALEVL 117
Query: 151 DLSFNQLQGHVPSSIL-NIPSLLAIDLSNNQFSG-PMPSIYNTSPLQNIDMQYNSLAELH 208
L N + V + ++ L + LS NQ S P+ I + + L L L
Sbjct: 118 LLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLP-------KLMLLD 169
Query: 209 LAYNQLSGQIPSTLFECKQLKILSLSVNN 237
L+ N+L + L + L ++N
Sbjct: 170 LSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 41/197 (20%), Positives = 66/197 (33%), Gaps = 34/197 (17%)
Query: 218 IPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSN 277
+P +L +L LS +N + + E L L L LS N
Sbjct: 33 VPQSLP--SYTALLDLS-HNNLSRLRAE----WTPTRL-----------TNLHSLLLSHN 74
Query: 278 RLTGVIPPEI-INISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSI 336
L I E + + +L L L+ +N L L + L L+ L+L N + ++
Sbjct: 75 HLN-FISSEAFVPVPNLRYLDLS-SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAF 132
Query: 337 SNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLP 396
+ + L + + N S F + L L LS N L +
Sbjct: 133 EDMAQLQKLYLSQNQISRFPV------------ELIKDGNKLPKLMLLDLSSNKLKKLPL 180
Query: 397 ISIGNLSN-AMDVLYLS 412
+ L + LYL
Sbjct: 181 TDLQKLPAWVKNGLYLH 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 22/95 (23%), Positives = 42/95 (44%), Gaps = 6/95 (6%)
Query: 554 DLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPD-SLGGLTSLNFLDMSSNNLSGEI 612
S+ L +P S+ L L+ N + + LT+L+ L +S N+L+
Sbjct: 24 SCSKQQLP-NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFIS 80
Query: 613 PNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
+ + L++L+LS N L + F++L +
Sbjct: 81 SEAFVPVPNLRYLDLSSNHLH-TLDEFL-FSDLQA 113
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 70/387 (18%), Positives = 118/387 (30%), Gaps = 79/387 (20%)
Query: 291 SSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYN 350
+ L + L + + L Q + L LT IS+A
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA----------- 51
Query: 351 LFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPL--SGVLPISIG--NLSNAM 406
L L +L L N L GV + G S +
Sbjct: 52 ------------------------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 87
Query: 407 DVLYLSACNIK----GSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQ-----KLQGL 457
L L C + G + S + L L LHL N L + + + +L+ L
Sbjct: 88 QKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKL 147
Query: 458 YLQHNKLQGSITTDLC----GLRSLSEFYSDGNELNGS----LPQCL-DSLISLRTLSLG 508
L++ L + L E N++N + L Q L DS L L L
Sbjct: 148 QLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLE 207
Query: 509 FNRLT----SVIPSSLWSLRDILNVNLSSNSLNGT-----LPVEIGNLKVVTKIDLSRND 559
+T + + S + + L SN L P + + + +
Sbjct: 208 SCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 267
Query: 560 LSGE----IPSSIGDLKNMQHLSLADNKFQGSIPDSLGGL-----TSLNFLDMSSNNLSG 610
++ + + + ++++ LSLA N+ L L L + S + +
Sbjct: 268 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTA 327
Query: 611 E----IPNSLKALSLLKFLNLSFNGLQ 633
+ L L L +S N L+
Sbjct: 328 ACCSHFSSVLAQNRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-12
Identities = 73/467 (15%), Positives = 137/467 (29%), Gaps = 111/467 (23%)
Query: 98 LKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSF----IGTIPPSICNISSLLTLDLS 153
++ L + S L + + + LD I ++ +L L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 154 FNQLQGHVPSSILNI-----PSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELH 208
N+L +L + + L N +G L + +L ELH
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA-----GCGVLSSTLRTLPTLQELH 119
Query: 209 LAYNQLSGQIPSTLFE-----CKQLKILSLSVNNF----IGSIPREIGNITMLKGLYLVY 259
L+ N L L E +L+ L L + + + K L +
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179
Query: 260 TNLTGE------------IQGLQVLALSSNRLT----GVIPPEIINISSLTVLSLTANNL 303
++ L+ L L S +T + + + +SL L+L +N L
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
Query: 304 ----LGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNS 359
+ L + H L+ L + +T +
Sbjct: 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV-------------------- 279
Query: 360 LGFCHPYDELGFLTSLTNCKDLRKLILSENPL--SGVLPIS--IGNLSNAMDVLYLSACN 415
L + L++L L+ N L G + + ++ L++ +C+
Sbjct: 280 ---------------LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCS 324
Query: 416 IKG----SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRL-----QKLQGLYLQHNKLQG 466
S + L L + N L + + + + L+ L+L
Sbjct: 325 FTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC---- 380
Query: 467 SITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLT 513
++ SL+ L + SLR L L N L
Sbjct: 381 DVSDS--SCSSLAA--------------TLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-11
Identities = 81/525 (15%), Positives = 160/525 (30%), Gaps = 154/525 (29%)
Query: 145 SSLLTLDLSFNQLQGHVPSSIL-NIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNS 203
+ +LD+ +L + +L + + L + + + +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT---------------EARCKD 47
Query: 204 LAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT 263
++ L L L+L +N +G G++ V L
Sbjct: 48 ISSA--------------LRVNPALAELNLR-SNELGD-----------VGVHCVLQGLQ 81
Query: 264 GEIQGLQVLALSSNRLT----GVIPPEIINISSLTVLSLTANNL----LGNLPSNIGHSL 315
+Q L+L + LT GV+ + + +L L L+ N L L L +
Sbjct: 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141
Query: 316 PNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSL 375
L++L L L+ +++ L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASV-----------------------------------L 166
Query: 376 TNCKDLRKLILSENPLS--GVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTL 433
D ++L +S N ++ GV + L S C L L
Sbjct: 167 RAKPDFKELTVSNNDINEAGVRVLC--------QGLKDSPC--------------QLEAL 204
Query: 434 HLETNELT----GSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELN 489
LE+ +T + + L+ L L NKL G+ L
Sbjct: 205 KLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV------GMAELCP--------- 249
Query: 490 GSLPQCLDSLISLRTLSLGFNRLTSV----IPSSLWSLRDILNVNLSSNSLNGTLPVEIG 545
L LRTL + +T+ + L + + ++L+ N L +
Sbjct: 250 ----GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC 305
Query: 546 NL-----KVVTKIDLSRNDLSGE----IPSSIGDLKNMQHLSLADNKFQGS----IPDSL 592
+ + + + S + + + L +++N+ + + + L
Sbjct: 306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGL 365
Query: 593 G-GLTSLNFLDMSSNNLSGE----IPNSLKALSLLKFLNLSFNGL 632
G + L L ++ ++S + +L A L+ L+LS N L
Sbjct: 366 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-06
Identities = 51/318 (16%), Positives = 95/318 (29%), Gaps = 71/318 (22%)
Query: 68 LGNLSFLSLLNVTNNSFSGT----LPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFP-- 121
L L L + S S L L K L+ +N+ + +
Sbjct: 138 LDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDS 197
Query: 122 --KLEHLYLDGNSF----IGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNI-----PS 170
+LE L L+ + + + +SL L L N+L + +
Sbjct: 198 PCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSR 257
Query: 171 LLAIDLSNNQFSGP-----MPSIYNTSPLQNIDMQYN-------------------SLAE 206
L + + + + L+ + + N L
Sbjct: 258 LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES 317
Query: 207 LHLAYNQLSGQ----IPSTLFECKQLKILSLSVNNFIGSIPREIG-----NITMLKGLYL 257
L + + S L + + L L +S N + RE+ ++L+ L+L
Sbjct: 318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL 377
Query: 258 VYTNLTGEIQGLQVLA--LSSNRLTGVIPPEIINISSLTVLSLTANNL----LGNLPSNI 311
+++ LA L +N SL L L+ N L + L ++
Sbjct: 378 ADCDVSDS--SCSSLAATLLANH-------------SLRELDLSNNCLGDAGILQLVESV 422
Query: 312 GHSLPNLQQLILGGNRLT 329
L+QL+L +
Sbjct: 423 RQPGCLLEQLVLYDIYWS 440
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 56/251 (22%), Positives = 94/251 (37%), Gaps = 47/251 (18%)
Query: 742 ENNLLGKGSFGSVYKG---TLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVK 798
E +G+G++G VYK D A+K E G S E +L ++H N++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRELKHPNVIS 82
Query: 799 IISTCSSDHFKA--LVLEYMPNGSLEN--WMYNKNRSFDILQRLNMVIDVA--------- 845
+ S + L+ +Y E+ W K + + +
Sbjct: 83 LQKVFLSHADRKVWLLFDYA-----EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 846 -SALEYLHYDHPTPIIHCDLNPSNILLNESMVAC----LSDFGISKLLGDET-SMTQ-TQ 898
+ YLH + ++H DL P+NIL+ ++D G ++L +
Sbjct: 138 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 899 TLATIGYMAPEWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVG--EISLKSRVN- 950
+ T Y APE L ++ D+++ G I E T +P +F E S
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEP---IFHCRQEDIKTSNPYH 250
Query: 951 -DSLHGKIINV 960
D L +I NV
Sbjct: 251 HDQLD-RIFNV 260
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 46/229 (20%), Positives = 93/229 (40%), Gaps = 35/229 (15%)
Query: 729 SYQELFRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELE-GTLRSFDAECE 786
S+ + D + LG+G + V++ +++ ++ VK+ + R E +
Sbjct: 27 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIK 82
Query: 787 ILGSIR-HRNLVKIISTCSSDHFK--ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVID 843
IL ++R N++ + + ALV E++ N + + Q L D
Sbjct: 83 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ----------LYQTLTD-YD 131
Query: 844 VAS----ALEYLHYDHPTPIIHCDLNPSNILLN-ESMVACLSDFGISKLLGDETSMTQTQ 898
+ L+ L Y H I+H D+ P N++++ E L D+G+++
Sbjct: 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NV 189
Query: 899 TLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKPTDELFVGE 942
+A+ + PE + + D++S G +L +K+P F G
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGH 235
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 1e-12
Identities = 62/261 (23%), Positives = 106/261 (40%), Gaps = 44/261 (16%)
Query: 706 RQKRNTGLQIDEEMSPEVTWRRISYQELFRAT-DGFSENNLLGKGSFGSVYKGTLSDGMQ 764
R K G + EE + + + R F+ +LGKGSFG V +
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367
Query: 765 I-AVKVF-------NLELEGTLRSFDAECEILGSI-RHRNLVKIIST--CSSDHFKALVL 813
+ AVK+ + ++E T+ E +L + L ++ S + V+
Sbjct: 368 LYAVKILKKDVVIQDDDVECTM----VEKRVLALPGKPPFLTQLHSCFQTMDRLY--FVM 421
Query: 814 EYMPNGSLENWMY--NKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL 871
EY+ G L MY + F + ++A L +L II+ DL N++L
Sbjct: 422 EYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVML 475
Query: 872 NESMVACLSDFGISK--LLGDETSMTQTQTLA-TIGYMAPEWKLSRKG-----DVYSYGI 923
+ ++DFG+ K + T T+T T Y+APE ++ + D +++G+
Sbjct: 476 DSEGHIKIADFGMCKENIWDGVT----TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGV 530
Query: 924 ILMETFTKKKP-----TDELF 939
+L E + P DELF
Sbjct: 531 LLYEMLAGQAPFEGEDEDELF 551
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 51/224 (22%), Positives = 86/224 (38%), Gaps = 57/224 (25%)
Query: 746 LGKGSFGSVYKGTLSD-GMQIAVK--VFNLELEG--TLRSFDAECEILGSIRHRNLVKII 800
LG G G V+ +D ++A+K V LR E +I+ + H N+VK+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74
Query: 801 ------------STCSSDHFKA--LVLEYMP--------NGSLENWMYNKNRSFDILQRL 838
S + +V EYM G L ++ + Q L
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE----EHARLFMYQLL 130
Query: 839 NMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC---LSDFGISKLLGDETSMT 895
L+Y+H + ++H DL P+N+ +N + DFG+++++ S
Sbjct: 131 R-------GLKYIHSAN---VLHRDLKPANLFINTE--DLVLKIGDFGLARIMDPHYSHK 178
Query: 896 Q--TQTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKK 932
++ L T Y +P LS D+++ G I E T K
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 66/247 (26%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 717 EEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQI-AVKVF----- 770
+E S E ++ + F +LGKGSFG V + + + AVKV
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDN-FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI 61
Query: 771 --NLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMY- 826
+ ++E T+ E IL H L ++ + V+E++ G L M+
Sbjct: 62 LQDDDVECTM----TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFH 114
Query: 827 -NKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885
K+R FD + ++ SAL +LH II+ DL N+LL+ L+DFG+
Sbjct: 115 IQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMC 171
Query: 886 K--LLGDETSMTQTQTL-ATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKP--- 934
K + T T T T Y+APE L D ++ G++L E P
Sbjct: 172 KEGICNGVT----TATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
Query: 935 --TDELF 939
D+LF
Sbjct: 227 ENEDDLF 233
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 39/219 (17%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVF-------NLELEGTLRSFDAECEILG-SIRHRN 795
++GKGSFG V AVKV E + + +E +L +++H
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM----SERNVLLKNVKHPF 100
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMY--NKNRSFDILQRLNMVIDVASALEYLHY 853
LV + + + VL+Y+ G L Y + R F + ++ASAL YLH
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAEIASALGYLHS 157
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISK--LLGDETSMTQTQTL-ATIGYMAPEW 910
+ I++ DL P NILL+ L+DFG+ K + + T T T T Y+APE
Sbjct: 158 LN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST----TSTFCGTPEYLAPE- 209
Query: 911 KLSRKG-----DVYSYGIILMETFTKKKP-----TDELF 939
L ++ D + G +L E P T E++
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 39/204 (19%), Positives = 73/204 (35%), Gaps = 15/204 (7%)
Query: 422 SEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEF 481
L N +L +T + L +Q ++ + + +L E
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKEL 68
Query: 482 YSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLP 541
+ N++ S L L L LS+ NRL ++ L + L +N L T
Sbjct: 69 HLSHNQI--SDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNELRDTDS 123
Query: 542 VEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFL 601
+ +LK + + + N L I +G L ++ L L N+ + L L +N++
Sbjct: 124 --LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWI 177
Query: 602 DMSSNNLSGEIPNSLKALSLLKFL 625
D++ E L + +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTV 201
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 41/241 (17%), Positives = 86/241 (35%), Gaps = 30/241 (12%)
Query: 68 LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLY 127
L+ N+ S + + L ++ + ++N S+ + F L+ L+
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLA---GMQFFTNLKELH 69
Query: 128 LDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPS 187
L N I + P + +++ L L ++ N+L+ + + L + L NN+
Sbjct: 70 LSHNQ-ISDLSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNE------- 117
Query: 188 IYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIG 247
+ +T L ++ +L L + N+L L +L++L L N I + +
Sbjct: 118 LRDTDSLIHL----KNLEILSIRNNKLKS--IVMLGFLSKLEVLDLH-GNEITNTG-GLT 169
Query: 248 NITMLKGLYLVYTNLTGEIQGLQVLALSSNRL-----TGVIPPEIINISSLTVLSLTANN 302
+ + + L E Q +N + + P I N S +
Sbjct: 170 RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWEL 229
Query: 303 L 303
Sbjct: 230 P 230
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 44/262 (16%), Positives = 87/262 (33%), Gaps = 42/262 (16%)
Query: 372 LTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLT 431
+ + K L + ++ ++ LS + NI+ S+ + + NL
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTDLVSQK--ELSG-VQNFNGDNSNIQ-SL-AGMQFFTNLK 66
Query: 432 TLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGS 491
LHL N+++ + + L KL+ L + N+L +L G+ S
Sbjct: 67 ELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRL-----KNLNGIPSAC------------ 107
Query: 492 LPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVT 551
L L L N L SL L+++ +++ +N L + +G L +
Sbjct: 108 ----------LSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLE 153
Query: 552 KIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGE 611
+DL N+++ + LK + + L K L N +
Sbjct: 154 VLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS- 210
Query: 612 IPNSLKALSLLKFLNLSFNGLQ 633
P + + +
Sbjct: 211 -PYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 42/278 (15%), Positives = 83/278 (29%), Gaps = 59/278 (21%)
Query: 286 EIINISSLTVLSLTANNLLGNLPSNIG--HSLPNLQQLILGGNRLTGPIPSSISNASMLT 343
++ L + NL +++ L +Q + + + + + L
Sbjct: 11 QVFPDPGLA--NAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLK 66
Query: 344 LIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLS 403
+ + +N ++ L+ L + L +L ++ N L + I LS
Sbjct: 67 ELHLSHN-----------------QISDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLS 109
Query: 404 NAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNK 463
L+L + + +L NL L + N+L SI +G L KL+ L L N+
Sbjct: 110 R----LFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNE 161
Query: 464 LQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSL 523
+ T+ GL L + + L + + L
Sbjct: 162 I-----TNTGGLTRLK---------------------KVNWIDLTGQKCVNEPVKYQPEL 195
Query: 524 RDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLS 561
+ + P I N +
Sbjct: 196 --YITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.4 bits (166), Expect = 2e-12
Identities = 36/263 (13%), Positives = 70/263 (26%), Gaps = 66/263 (25%)
Query: 734 FRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKV--------FNLELEGTLRSFDAEC 785
T+ +G+G FG V++ D +A+K+ N + T E
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 786 EIL---------GSIRHRNLVKIISTC------------------------------SSD 806
I R + + S D
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 807 HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNP 866
+VLE+ G M K S +++ + ++L H DL+
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLA--TAKSILHQLTASLAVAEASLR--FEHRDLHW 190
Query: 867 SNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKGDVYSYGIILM 926
N+LL ++ + L K + G + ++
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSC----------GLQVSIIDYTLSRLERDGIVVFC 240
Query: 927 ETFTKKKPTDELFVGEISLKSRV 949
+ + +LF G+ + +
Sbjct: 241 DVSMDE----DLFTGDGDYQFDI 259
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 6e-12
Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 33/216 (15%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVF-------NLELEGTLRSFDAECEILGSI-RHRN 795
+LGKGSFG V ++ AVK+ + ++E T+ E +L +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM----VEKRVLALPGKPPF 82
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMY--NKNRSFDILQRLNMVIDVASALEYLHY 853
L ++ S + V+EY+ G L MY + F + ++A L +L
Sbjct: 83 LTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 139
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLS 913
II+ DL N++L+ ++DFG+ K + T+T T Y+APE ++
Sbjct: 140 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPE-IIA 194
Query: 914 RKG-----DVYSYGIILMETFTKKKP-----TDELF 939
+ D +++G++L E + P DELF
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-12
Identities = 57/228 (25%), Positives = 89/228 (39%), Gaps = 59/228 (25%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDA-------ECEILGSIRHR-- 794
++GKGSFG V K +A+K+ +R+ E IL +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKM--------VRNEKRFHRQAAEEIRILEHLRKQDK 155
Query: 795 ----NLVKIISTCSSDHFK-----ALVLEYMPNGSLENWM-YNKNRSFDILQRLNMVIDV 844
N++ ++ ++F + E + + +L + NK + F + +
Sbjct: 156 DNTMNVIHML-----ENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 845 ASALEYLHYDHPTPIIHCDLNPSNILLNE--SMVACLSDFGISKLLGDETSMTQTQTLAT 902
L+ LH + IIHCDL P NILL + + DFG +S + Q + T
Sbjct: 210 LQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG--------SSCYEHQRVYT 258
Query: 903 I----GYMAPEWKL----SRKGDVYSYGIILMETFTKKKPTDELFVGE 942
Y APE L D++S G IL E T L GE
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY----PLLPGE 302
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 9e-12
Identities = 51/241 (21%), Positives = 81/241 (33%), Gaps = 54/241 (22%)
Query: 746 LGKGSFGSVYKGTLSD-GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIIS--- 801
LG GSFG V + + G + A+K + R E +I+ + H N++K++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEY----------- 850
T + K N N ++ + + +EY
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 851 -----------------------LHYDHPTPIIHCDLNPSNILLN-ESMVACLSDFGISK 886
+ + H I H D+ P N+L+N + L DFG +K
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAK 190
Query: 887 LLGDETSMTQTQTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTKKKPTDELFVG 941
L + + Y APE L D++S G + E KP LF G
Sbjct: 191 KLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL-GKP---LFSG 244
Query: 942 E 942
E
Sbjct: 245 E 245
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 35/135 (25%), Positives = 61/135 (45%), Gaps = 10/135 (7%)
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
S+ SS + L + +Y + + L + VA +E+L I
Sbjct: 161 SSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL--ICYSFQVAKGMEFLASRK---CI 215
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLL-GDETSMTQTQTLATIGYMAPE----WKLSRK 915
H DL NILL+E V + DFG+++ + D + + + +MAPE + +
Sbjct: 216 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 275
Query: 916 GDVYSYGIILMETFT 930
DV+S+G++L E F+
Sbjct: 276 SDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 32/150 (21%), Positives = 57/150 (38%), Gaps = 17/150 (11%)
Query: 746 LGKGSFGSVYKGTL------SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLV 797
LG+G+FG V + + +AVK+ R+ +E +IL I H N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 798 KIISTCSSDHFKALV-LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
++ C+ +V +E+ G+L ++ +K F + +Y+
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGA--RFRQGKDYVG---- 143
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISK 886
I DL + S + S F K
Sbjct: 144 --AIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 1e-11
Identities = 58/271 (21%), Positives = 92/271 (33%), Gaps = 85/271 (31%)
Query: 734 FRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVK----VFNLELEG--TLRSFDAECE 786
++ D + +L+G GS+G V + + +A+K VF ++ LR E
Sbjct: 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIA 104
Query: 787 ILGSIRHRNLVK---IISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQRLNMV 841
IL + H ++VK I+ + F +VLE + D +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS--------------D----FKKL 146
Query: 842 IDVASALEYLH-------------YDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888
L LH Y H I+H DL P+N L+N+ + DFG+++ +
Sbjct: 147 FRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206
Query: 889 GDETSMTQ--------------------------TQTLATIGYMAPEWKLSRKG-----D 917
+ T + T Y APE L ++ D
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAID 266
Query: 918 VYSYGIILMETFTKKKPTDE-------LFVG 941
V+S G I E K LF G
Sbjct: 267 VWSIGCIFAELLNMIKENVAYHADRGPLFPG 297
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 39/150 (26%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
C KG IP+ + +T + LE N + P A +KL+ + L +N++ + D
Sbjct: 18 CRGKGLTEIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPD 74
Query: 472 LC-GLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNV 529
GLRSL+ GN++ LP+ + L SL+ L L N++ + + L ++ +
Sbjct: 75 AFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLL 133
Query: 530 NLSSNSLNGTLPVEI-GNLKVVTKIDLSRN 558
+L N L T+ L+ + + L++N
Sbjct: 134 SLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 29/133 (21%), Positives = 63/133 (47%), Gaps = 6/133 (4%)
Query: 501 SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRND 559
++ + L N + + P + + + ++LS+N ++ L + L+ + + L N
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 560 LSGEIPSSIGD-LKNMQHLSLADNKFQGSIP-DSLGGLTSLNFLDMSSNNLSGEIPNSLK 617
++ E+P S+ + L ++Q L L NK + D+ L +LN L + N L +
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 618 ALSLLKFLNLSFN 630
L ++ ++L+ N
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 15/143 (10%)
Query: 510 NRLTSV---IPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPS 566
LT + +P ++ +R L N++ P K + +IDLS N +S E+
Sbjct: 21 KGLTEIPTNLPETITEIR------LEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAP 73
Query: 567 SIGD-LKNMQHLSLADNKFQGSIPDSL-GGLTSLNFLDMSSNNLSGEIPNSLKALSLLKF 624
L+++ L L NK +P SL GL SL L +++N ++ ++ + L L
Sbjct: 74 DAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNL 132
Query: 625 LNLSFNGLQGQVPHGGPFTNLSS 647
L+L N LQ + G F+ L +
Sbjct: 133 LSLYDNKLQ-TIAKGT-FSPLRA 153
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 34/158 (21%), Positives = 61/158 (38%), Gaps = 31/158 (19%)
Query: 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETN 438
+ ++ L +N + + P + + + LS I + + L +L +L L N
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKK-LRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 439 ELTGSIPKAI-GRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLP-QCL 496
++T +PK++ L LQ L L NK+ L
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKIN-------------------------CLRVDAF 124
Query: 497 DSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSN 534
L +L LSL N+L ++ + LR I ++L+ N
Sbjct: 125 QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 33/180 (18%), Positives = 63/180 (35%), Gaps = 55/180 (30%)
Query: 149 TLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELH 208
+ L N ++ + FS Y L +
Sbjct: 36 EIRLEQNTIK----------------VIPPGAFSP-----------------YKKLRRID 62
Query: 209 LAYNQLSGQIPSTLFEC-KQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQ 267
L+ NQ+S ++ F+ + L L L N I +P+ ++ L
Sbjct: 63 LSNNQIS-ELAPDAFQGLRSLNSLVLYGNK-ITELPKS------------LFEGLF---- 104
Query: 268 GLQVLALSSNRLTGVIPPEII-NISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGN 326
LQ+L L++N++ + + ++ +L +LSL +N L + L +Q + L N
Sbjct: 105 SLQLLLLNANKINC-LRVDAFQDLHNLNLLSLY-DNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 28/126 (22%), Positives = 49/126 (38%), Gaps = 10/126 (7%)
Query: 61 LGTIPPE-LGNLSFLSLLNVTNNSFSGTLPIQL-SNLRRLKYLSFRSNNFSSIEIPPW-- 116
+ IPP L ++++NN S L LR L L N + + P
Sbjct: 44 IKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL---PKSL 99
Query: 117 LDSFPKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQLQGHVPSSILNIPSLLAID 175
+ L+ L L+ N I + ++ +L L L N+LQ + + ++ +
Sbjct: 100 FEGLFSLQLLLLNANK-INCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMH 158
Query: 176 LSNNQF 181
L+ N F
Sbjct: 159 LAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 30/147 (20%), Positives = 55/147 (37%), Gaps = 22/147 (14%)
Query: 99 KYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICN-ISSLLTLDLSFNQL 157
+ N I P + KL + L N I + P + SL +L L N++
Sbjct: 35 TEIRLEQNTIKVIP-PGAFSPYKKLRRIDLSNNQ-ISELAPDAFQGLRSLNSLVLYGNKI 92
Query: 158 QGHVPSSIL-NIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQY----NSLAELHLAYN 212
+P S+ + SL + L+ N+ + + + ++L L L N
Sbjct: 93 T-ELPKSLFEGLFSLQLLLLNANK-------------INCLRVDAFQDLHNLNLLSLYDN 138
Query: 213 QLSGQIPSTLFECKQLKILSLSVNNFI 239
+L T + ++ + L+ N FI
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 35/187 (18%), Positives = 60/187 (32%), Gaps = 59/187 (31%)
Query: 206 ELHLAYNQLSGQIPSTLFEC-KQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTG 264
E+ L N + IP F K+L+ + LS NN I + + +L
Sbjct: 36 EIRLEQNTIK-VIPPGAFSPYKKLRRIDLS-NNQISELAP---------DAFQGLRSLN- 83
Query: 265 EIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILG 324
L L N++T LP ++ L +LQ L+L
Sbjct: 84 ------SLVLYGNKIT-------------------------ELPKSLFEGLFSLQLLLLN 112
Query: 325 GNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKL 384
N++ + + L L+ + N I G + L + +
Sbjct: 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAK-----------GTFSPLRAIQTMH-- 158
Query: 385 ILSENPL 391
L++NP
Sbjct: 159 -LAQNPF 164
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 69/289 (23%), Positives = 110/289 (38%), Gaps = 81/289 (28%)
Query: 734 FRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVK----VFNLELEG--TLRSFDAECE 786
+ LGKG++G V+K G +AVK F + T R E
Sbjct: 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIM 60
Query: 787 ILGSIR-HRNLVKIISTCSSDHFKA--LVLEYMP--------NGSLENWMYNKNRSFDIL 835
IL + H N+V +++ +D+ + LV +YM LE + +
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK---QYV-VY 116
Query: 836 QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895
Q + ++YLH ++H D+ PSNILLN ++DFG+S+ + +T
Sbjct: 117 QLIK-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 896 Q--------------------TQTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFT 930
T +AT Y APE L D++S G IL E
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
Query: 931 KKKPTDELFVGEISLKSRVNDSLH--GKIINVV------DINLLQKEDA 971
KP +F G + +++ +II V+ D+ +Q A
Sbjct: 227 -GKP---IFPG--------SSTMNQLERIIGVIDFPSNEDVESIQSPFA 263
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 59/304 (19%), Positives = 109/304 (35%), Gaps = 71/304 (23%)
Query: 730 YQELFRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVK----VFNLELEG--TLRSFD 782
+ D + +L+G+GS+G VY + +A+K +F ++ LR
Sbjct: 18 GIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR--- 74
Query: 783 AECEILGSIRHRNLVK---IISTCSSDHFKA--LVLEYMPNGSLENWMYNKNRSFDILQR 837
E IL ++ +++ +I F +VLE ++ + ++ L
Sbjct: 75 -EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTE 128
Query: 838 LNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ- 896
++ + + L ++ H + IIH DL P+N LLN+ + DFG+++ + E
Sbjct: 129 EHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 897 --------------------TQTLATIGYMAPEWKLSRKG-----DVYSYGIILMETFTK 931
T + T Y APE L ++ D++S G I E
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 932 KKPTDE-------LFVG---------EISLKSRVNDSLH--GKIINVV------DINLLQ 967
+ LF G S K + I N++ D+ +
Sbjct: 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN 308
Query: 968 KEDA 971
K +
Sbjct: 309 KPEV 312
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 56/234 (23%), Positives = 90/234 (38%), Gaps = 33/234 (14%)
Query: 712 GLQIDEEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQI-AVKVF 770
G I+EE T D F ++G+GS+ V L +I A++V
Sbjct: 27 GSGIEEEKEAMNTRESGKASSSLGLQD-FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV 85
Query: 771 -------NLELEGTLRSFDAECEILGSI-RHRNLVKIIST--CSSDHFKALVLEYMPNGS 820
+ +++ E + H LV + S S F V+EY+ G
Sbjct: 86 KKELVNDDEDIDWVQ----TEKHVFEQASNHPFLVGLHSCFQTESRLF--FVIEYVNGGD 139
Query: 821 LENWMY--NKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC 878
L M+ + R +++ AL YLH II+ DL N+LL+
Sbjct: 140 L---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIK 193
Query: 879 LSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSRKG-----DVYSYGIILME 927
L+D+G+ K T T T Y+APE L + D ++ G+++ E
Sbjct: 194 LTDYGMCKEGLRPGDTTST-FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFE 245
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-11
Identities = 50/201 (24%), Positives = 82/201 (40%), Gaps = 32/201 (15%)
Query: 745 LLGKGSFGSVYKGTLSDGMQI-AVKVF-------NLELEGTLRSFDAECEILGSI-RHRN 795
++G+GS+ V L +I A+KV + +++ E + H
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ----TEKHVFEQASNHPF 71
Query: 796 LVKIIST--CSSDHFKALVLEYMPNGSLENWMY--NKNRSFDILQRLNMVIDVASALEYL 851
LV + S S F V+EY+ G L M+ + R +++ AL YL
Sbjct: 72 LVGLHSCFQTESRLF--FVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 852 HYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK 911
H II+ DL N+LL+ L+D+G+ K T T T Y+APE
Sbjct: 127 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPE-I 181
Query: 912 LSRKG-----DVYSYGIILME 927
L + D ++ G+++ E
Sbjct: 182 LRGEDYGFSVDWWALGVLMFE 202
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 48/257 (18%), Positives = 91/257 (35%), Gaps = 67/257 (26%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDA-------ECEILGSIR---- 792
LG G F +V+ + + +A+K+ +R E ++L +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKI--------VRGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 793 -------HRNLVKIISTCSSDHFKA---------LVLEYMPNGSLENWM-YNKNRSFDIL 835
+++K++ DHF +V E + +L + ++R ++
Sbjct: 78 TKEDSMGANHILKLL-----DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLI 131
Query: 836 QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC------LSDFGISKLLG 889
+ + L+Y+H IIH D+ P N+L+ ++D G +
Sbjct: 132 YVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWY 188
Query: 890 DETSMTQTQTLATIGYMAPE------WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEI 943
DE QT Y +PE W D++S ++ E T D LF +
Sbjct: 189 DEHYTNSIQTRE---YRSPEVLLGAPW--GCGADIWSTACLIFELIT----GDFLFEPDE 239
Query: 944 SLKSRVNDSLHGKIINV 960
+D +II +
Sbjct: 240 GHSYTKDDDHIAQIIEL 256
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 35/153 (22%), Positives = 65/153 (42%), Gaps = 23/153 (15%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRH-RNLVKIISTC 803
+G G+FG + G L +A+K+ ++ E + + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 804 SSDHFKALVLEYMPNG-SLENWMYNKNRSFDILQRLNMVIDVA----SALEYLHYDHPTP 858
+ A+VLE + G SLE+ +R+F L V+ +A S +EY+H +
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFS----LKTVLMIAIQLISRMEYVHSKN--- 125
Query: 859 IIHCDLNPSNILL-----NESMVACLSDFGISK 886
+I+ D+ P N L+ V + DF ++K
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 33/154 (21%), Positives = 64/154 (41%), Gaps = 25/154 (16%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRH-RNLVKIISTC 803
+G+GSFG +++GT L + Q+A+K + E + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 804 SSDHFKALVLEYMPNG-SLENWMYNKNRSFDILQRLNMVIDVA----SALEYLHYDHPTP 858
LV++ + G SLE+ + R F + V A + ++ +H
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFS----VKTVAMAAKQMLARVQSIHEKS--- 126
Query: 859 IIHCDLNPSNILL------NESMVACLSDFGISK 886
+++ D+ P N L+ N +M+ + DFG+ K
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVV-DFGMVK 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 37/147 (25%), Positives = 72/147 (48%), Gaps = 13/147 (8%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRH-RNLVKIISTC 803
+G GSFG +Y GT ++ G ++A+K+ ++ + E +I ++ + I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 804 SSDHFKALVLEYMPNG-SLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
+ + +V+E + G SLE+ +R F + L + + S +EY+H + IH
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHR 129
Query: 863 DLNPSNILL---NESMVACLSDFGISK 886
D+ P N L+ + + + DFG++K
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 42/154 (27%), Positives = 66/154 (42%), Gaps = 4/154 (2%)
Query: 407 DVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQG 466
+ L L + + + L LT L+L+ N+L L +L L L +N+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 467 SITTDL-CGLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSVIPSSLWSLR 524
S+ + L L + Y GN+L SLP D L L+ L L N+L S+ + L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155
Query: 525 DILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRN 558
++ ++LS+N L L + I L N
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 55/225 (24%), Positives = 77/225 (34%), Gaps = 64/225 (28%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
C K S+PS I + L L++ L L KL L L +N+LQ
Sbjct: 21 CQGKSLDSVPSGIPA--DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ------ 72
Query: 472 LCGLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSV---IPSSLWSLRDIL 527
+L D L L TL L N+L S+ + L L
Sbjct: 73 -------------------TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQL---- 109
Query: 528 NVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGD-LKNMQHLSLADNKFQG 586
K+ L N L +PS + D L ++ L L N+ Q
Sbjct: 110 -----------------------DKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ- 144
Query: 587 SIPDSL-GGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFN 630
SIP LT+L L +S+N L + L L+ + L N
Sbjct: 145 SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 55/219 (25%), Positives = 68/219 (31%), Gaps = 69/219 (31%)
Query: 270 QVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLT 329
+ L L S L + ++ LT L+L N L L + + L L L L N+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLD-YNQLQTLSAGVFDDLTELGTLGLANNQLA 96
Query: 330 GPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSEN 389
SL LG LT L KL L N
Sbjct: 97 -----------------------------SL-------PLGVFDHLTQ---LDKLYLGGN 117
Query: 390 PLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELTGSIPK-A 447
L S+PS + L L L L TN+L SIP A
Sbjct: 118 QLK--------------------------SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGA 150
Query: 448 IGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGN 486
+L LQ L L N+LQ L L GN
Sbjct: 151 FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 30/180 (16%)
Query: 124 EHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIP-SLLAIDLSNNQFS 182
E L L + ++ L L+L +NQLQ + + + + L + L+NNQ +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 183 GPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFEC-KQLKILSLSVNNFIGS 241
+++ L L +L+L NQL +PS +F+ +LK L L+ N + S
Sbjct: 97 SLPLGVFD--HLTQ-------LDKLYLGGNQLKS-LPSGVFDRLTKLKELRLN-TNQLQS 145
Query: 242 IPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTAN 301
IP + LT LQ L+LS+N+L V + L ++L N
Sbjct: 146 IPAG------------AFDKLT----NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 30/161 (18%), Positives = 58/161 (36%), Gaps = 30/161 (18%)
Query: 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETN 438
+L L+ N + + I + + S I I + + + L +N
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSN 91
Query: 439 ELTGSIPKAI-GRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQ-CL 496
L ++ + L+ L+ L L+ N++ +
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRIT-------------------------CVGNDSF 125
Query: 497 DSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLN 537
L S+R LSL N++T+V P + +L + +NL +N N
Sbjct: 126 IGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 28/126 (22%), Positives = 55/126 (43%), Gaps = 21/126 (16%)
Query: 206 ELHLAYNQLSGQIPSTLF-ECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTG 264
EL L N+ + + +F + QL+ ++ S NN I I + +
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFS-NNKITDIEEG------------AFEGAS- 81
Query: 265 EIQGLQVLALSSNRLTGVIPPEII-NISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLIL 323
G+ + L+SNRL + ++ + SL L L +N + + ++ L +++ L L
Sbjct: 82 ---GVNEILLTSNRLEN-VQHKMFKGLESLKTLML-RSNRITCVGNDSFIGLSSVRLLSL 136
Query: 324 GGNRLT 329
N++T
Sbjct: 137 YDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 29/141 (20%), Positives = 52/141 (36%), Gaps = 15/141 (10%)
Query: 101 LSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQLQG 159
L +N F+ +E P+L + N I I S + + L+ N+L+
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNK-ITDIEEGAFEGASGVNEILLTSNRLEN 95
Query: 160 HVPSSIL-NIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQI 218
V + + SL + L +N+ + + S+ L L NQ++ +
Sbjct: 96 -VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLS---------SVRLLSLYDNQIT-TV 144
Query: 219 PSTLFEC-KQLKILSLSVNNF 238
F+ L L+L N F
Sbjct: 145 APGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 23/99 (23%), Positives = 43/99 (43%), Gaps = 3/99 (3%)
Query: 550 VTKIDLSRNDLSGEIPSSI-GDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNL 608
++ L+ N+ + + I L ++ ++ ++NK + G + +N + ++SN L
Sbjct: 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL 93
Query: 609 SGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
K L LK L L N + V + F LSS
Sbjct: 94 ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDS-FIGLSS 130
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 31/134 (23%), Positives = 56/134 (41%), Gaps = 7/134 (5%)
Query: 501 SLRTLSLGFNRLTSVIPSSLWS-LRDILNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRN 558
L L N T + + ++ L + +N S+N + + V +I L+ N
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSN 91
Query: 559 DLSGEIPSSIGD-LKNMQHLSLADNKFQGSIP-DSLGGLTSLNFLDMSSNNLSGEIPNSL 616
L + + L++++ L L N+ + DS GL+S+ L + N ++ P +
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAF 149
Query: 617 KALSLLKFLNLSFN 630
L L LNL N
Sbjct: 150 DTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 25/98 (25%), Positives = 41/98 (41%), Gaps = 13/98 (13%)
Query: 241 SIPREIGNITMLKGLYLVYTNLT--------GEIQGLQVLALSSNRLTGVIPPEIIN-IS 291
IP I T L L T ++ L+ + S+N++T I S
Sbjct: 25 KIPEHIPQYT--AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 292 SLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLT 329
+ + LT +N L N+ + L +L+ L+L NR+T
Sbjct: 82 GVNEILLT-SNRLENVQHKMFKGLESLKTLMLRSNRIT 118
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 45/214 (21%)
Query: 743 NNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDA-------ECEILGSIRHR 794
++L+GKGSFG V K + +A+K+ +++ A E +L +
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKI--------IKNKKAFLNQAQIEVRLLELMNKH 110
Query: 795 ------NLVKIISTCSSDHFK-----ALVLEYMPNGSLENWM-YNKNRSFDILQRLNMVI 842
+V + HF LV E + + +L + + R +
Sbjct: 111 DTEMKYYIVHLK-----RHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQ 164
Query: 843 DVASALEYLHYDHPTPIIHCDLNPSNILL--NESMVACLSDFGISKLLGDETSMTQTQTL 900
+ +AL +L + IIHCDL P NILL + + DFG S LG Q +
Sbjct: 165 QMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI----YQYI 219
Query: 901 ATIGYMAPEWKL----SRKGDVYSYGIILMETFT 930
+ Y +PE L D++S G IL+E T
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 32/147 (21%), Positives = 67/147 (45%), Gaps = 13/147 (8%)
Query: 746 LGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLV-KIISTC 803
+G GSFG +Y GT + ++A+K+ N++ + E +I ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 804 SSDHFKALVLEYMPNG-SLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
+ LV++ + G SLE+ +R + L + + + +E++H +H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHR 127
Query: 863 DLNPSNILL---NESMVACLSDFGISK 886
D+ P N L+ + + DFG++K
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 18/102 (17%), Positives = 35/102 (34%), Gaps = 1/102 (0%)
Query: 104 RSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPP-SICNISSLLTLDLSFNQLQGHVP 162
R +++ L L LY++ + + + + L L + + L+ P
Sbjct: 14 RCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73
Query: 163 SSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSL 204
+ P L ++LS N LQ + + N L
Sbjct: 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 1e-07
Identities = 25/110 (22%), Positives = 42/110 (38%), Gaps = 6/110 (5%)
Query: 551 TKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPD-SLGGLTSLNFLDMSSNNLS 609
+ + +R+ + + +N+ L + + + + L GL L L + + L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 610 GEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFV--GNKGLC 657
P++ L LNLSFN L+ LS Q V GN C
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALESL--SWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 5e-06
Identities = 18/102 (17%), Positives = 42/102 (41%), Gaps = 2/102 (1%)
Query: 533 SNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPS-SIGDLKNMQHLSLADNKFQGSIPDS 591
+ + + +T++ + + + L +++L++ + + PD+
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 592 LGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQ 633
L+ L++S N L +++ LS L+ L LS N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 9e-06
Identities = 22/103 (21%), Positives = 31/103 (30%), Gaps = 7/103 (6%)
Query: 36 CNWFGVTCSPRH----RRVTALNLAYMGLLGTIPPE-LGNLSFLSLLNVTNNSFSGTLPI 90
C G S H +T L + L + L L L L + + P
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74
Query: 91 QLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSF 133
RL L+ N S+ + L+ L L GN
Sbjct: 75 AFHFTPRLSRLNLSFNALESLS-WKTVQG-LSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 19/100 (19%), Positives = 33/100 (33%), Gaps = 9/100 (9%)
Query: 212 NQLSGQIPSTLFECKQLKILSLSVNNFIGSIPRE-IGNITMLKGLYLVYTNLT------- 263
+ L + L L + + + + + L+ L +V + L
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 264 GEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNL 303
L L LS N L + + + SL L L+ N L
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 7e-05
Identities = 23/113 (20%), Positives = 37/113 (32%), Gaps = 4/113 (3%)
Query: 378 CKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSE-IGNLNNLTTLHLE 436
L + + L + N + LY+ + + L L L +
Sbjct: 7 PHGSSGLRCTRDGALDSLH-HLPGAEN-LTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 437 TNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELN 489
+ L P A +L L L N L+ S++ SL E GN L+
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 20/116 (17%), Positives = 39/116 (33%), Gaps = 16/116 (13%)
Query: 276 SNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSS 335
+ + +LT L + L +L L L+ L + + L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 336 ISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPL 391
L+ +++ +N + L+ L++L+LS NPL
Sbjct: 76 FHFTPRLSRLNLSFNALESLSW------------KTVQGLS----LQELVLSGNPL 115
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 48/173 (27%), Positives = 68/173 (39%), Gaps = 33/173 (19%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
C K S+P+ I N L+L N++T P L L+ LYL N+L
Sbjct: 26 CRSKRHASVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG------ 77
Query: 472 LCGLRSLSEFYSDGNELNGSLPQCL-DSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVN 530
+LP + DSL L L LG N+LT + + L + +
Sbjct: 78 -------------------ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELF 118
Query: 531 LSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGD-LKNMQHLSLADN 582
+ N L LP I L +T + L +N L IP D L ++ H L N
Sbjct: 119 MCCNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 48/194 (24%), Positives = 67/194 (34%), Gaps = 68/194 (35%)
Query: 270 QVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLT 329
Q+L L N++T + P ++ +L L L +N LG LP + SL L L LG N+LT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYL-GSNQLGALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 330 GPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSEN 389
L L + L++L + N
Sbjct: 102 -----------------------------VL-------PSAVFDRLVH---LKELFMCCN 122
Query: 390 PLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPK-AI 448
L+ +P I L +LT L L+ N+L SIP A
Sbjct: 123 KLT--------------------------ELPRGIERLTHLTHLALDQNQLK-SIPHGAF 155
Query: 449 GRLQKLQGLYLQHN 462
RL L YL N
Sbjct: 156 DRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 34/108 (31%), Positives = 56/108 (51%), Gaps = 5/108 (4%)
Query: 503 RTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEI-GNLKVVTKIDLSRNDLS 561
+ L L N++T + P SL ++ + L SN L LPV + +L +T +DL N L+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 562 GEIPSSIGD-LKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNL 608
+PS++ D L +++ L + NK +P + LT L L + N L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 32/129 (24%), Positives = 54/129 (41%), Gaps = 7/129 (5%)
Query: 77 LNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWL-DSFPKLEHLYLDGNSFIG 135
L + +N + P +L LK L SN + +P + DS +L L L N +
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA--LPVGVFDSLTQLTVLDLGTNQ-LT 101
Query: 136 TIPPSICN-ISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQF-SGPMPSIYNTSP 193
+P ++ + + L L + N+L +P I + L + L NQ S P + S
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 194 LQNIDMQYN 202
L + + N
Sbjct: 161 LTHAYLFGN 169
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 47/236 (19%), Positives = 81/236 (34%), Gaps = 77/236 (32%)
Query: 745 LLGKGSFGSVYKG--TLSDGMQIAVKVFNLELEGTLRSFDA-------ECEILGSIRHR- 794
LG+G+FG V + Q+A+K+ +R+ E +L I+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKI--------IRNVGKYREAARLEINVLKKIKEKD 77
Query: 795 -----NLVKIISTCSSDHFK-----ALVLEYMPNGSLENWM-YNKNRSFDILQRLNMVID 843
V + D F + E + + ++ N + + + +M
Sbjct: 78 KENKFLCVLMS-----DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC-------------------LSDFGI 884
+ AL +LH + + H DL P NIL S ++DFG
Sbjct: 132 LCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG- 187
Query: 885 SKLLGDETSMTQTQTLATI----GYMAPE------WKLSRKGDVYSYGIILMETFT 930
++ + TI Y PE W ++ DV+S G IL E +
Sbjct: 188 -------SATFDHEHHTTIVATRHYRPPEVILELGW--AQPCDVWSIGCILFEYYR 234
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 34/165 (20%), Positives = 66/165 (40%), Gaps = 30/165 (18%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGT---------LRSFDAECEILGSIRHR 794
+G G FG +Y + + A V +E + + + I I +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 795 NLVKI---------ISTCSSDHFKALVLEYMPNG-SLENWMYNKNRSFDILQRLNMVIDV 844
L + ++ ++ +V+E + G L+ + +N +F L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRM 160
Query: 845 ASALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISK 886
LEY+H + +H D+ +N+LL N V L+D+G+S
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVY-LADYGLSY 201
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 37/273 (13%), Positives = 75/273 (27%), Gaps = 54/273 (19%)
Query: 399 IGNLSNAMDVLYLSACNIKG----SIPSEIGNLNNLTTLHLETNELTG----SIPKAIGR 450
+ S L I S+ + + +++ + L N + + + I
Sbjct: 1 MARFSIE--GKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS 58
Query: 451 LQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFN 510
+ L+ LR L + L L T+ L N
Sbjct: 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQ--------------ALLKCPKLHTVRLSDN 104
Query: 511 RLT----SVIPSSLWSLRDILNVNLSSNSL-------------NGTLPVEIGNLKVVTKI 553
+ L + ++ L +N L + + N + I
Sbjct: 105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 164
Query: 554 DLSRNDLSGE----IPSSIGDLKNMQHLSLADNKF-----QGSIPDSLGGLTSLNFLDMS 604
RN L + + + + + N + + + L L LD+
Sbjct: 165 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 224
Query: 605 SNNLSGE----IPNSLKALSLLKFLNLSFNGLQ 633
N + + +LK+ L+ L L+ L
Sbjct: 225 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 52/301 (17%), Positives = 98/301 (32%), Gaps = 54/301 (17%)
Query: 374 SLTNCKDLRKLILSENPLS--GVLPISIGNLSNA-MDVLYLSACNIKGSIPSEIG----- 425
L +++++LS N + +S S +++ S G + EI
Sbjct: 27 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT-GRVKDEIPEALRL 85
Query: 426 ------NLNNLTTLHLETNELTGSIPKAIGRL----QKLQGLYLQHNKLQGSITTDLCGL 475
L T+ L N + + + L+ LYL +N L +
Sbjct: 86 LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA-- 143
Query: 476 RSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLT----SVIPSSLWSLRDILNVNL 531
R+L E + N LR++ G NRL + S R + V +
Sbjct: 144 RALQELAVNKKAKNAP---------PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKM 194
Query: 532 SSNSLN-----GTLPVEIGNLKVVTKIDLSRNDLSGE----IPSSIGDLKNMQHLSLADN 582
N + L + + + +DL N + + ++ N++ L L D
Sbjct: 195 VQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC 254
Query: 583 KFQG----SIPDSLGGL--TSLNFLDMSSNNLSGE----IPNSLKA-LSLLKFLNLSFNG 631
++ D+ L L L + N + + + + + L FL L+ N
Sbjct: 255 LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314
Query: 632 L 632
Sbjct: 315 F 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 55/333 (16%), Positives = 103/333 (30%), Gaps = 54/333 (16%)
Query: 144 ISSLLTLDLSFNQLQG----HVPSSILNIPSLLAIDLSNNQFSGP-----MPSIYNTSPL 194
S+ L + + V + +L S+ I LS N +I + L
Sbjct: 3 RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 62
Query: 195 QNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNF----IGSIPREIGNIT 250
+ + + + + L +C +L + LS N F + + T
Sbjct: 63 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 122
Query: 251 MLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSN 310
L+ LYL L Q +A + L + + N L + N L
Sbjct: 123 PLEHLYLHNNGLG--PQAGAKIARALQELA--VNKKAKNAPPLRSIICGRNRLENGSMKE 178
Query: 311 IGHSL---PNLQQLILGGNRLT-----GPIPSSISNASMLTLIDMPYNLFSGFIPNSLGF 362
+ L + + N + + ++ L ++D+ N F+
Sbjct: 179 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT--------- 229
Query: 363 CHPYDE----LGFLTSLTNCKDLRKLILSENPLS--GVLPIS--IGNLSN-AMDVLYLSA 413
L +L + +LR+L L++ LS G + L N + L L
Sbjct: 230 ----HLGSSALA--IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 283
Query: 414 CNIKGSIPSEIG-----NLNNLTTLHLETNELT 441
I+ + + +L L L N +
Sbjct: 284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 51/330 (15%), Positives = 97/330 (29%), Gaps = 82/330 (24%)
Query: 68 LGNLSFLSLLNVTNNSFS--GTLPI--QLSNLRRLKYLSFRSNNFS---SIEIPPWLDSF 120
+ S ++ ++ + + L +K + N + + + S
Sbjct: 1 MARFSIEGK-SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 121 PKLEHLYLDGNSFIG-----------TIPPSICNISSLLTLDLSFNQLQG----HVPSSI 165
LE F G + ++ L T+ LS N + +
Sbjct: 60 KDLEIAEFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118
Query: 166 LNIPSLLAIDLSNNQFS--------------GPMPSIYNTSPLQNIDMQYN--------- 202
L + L NN N PL++I N
Sbjct: 119 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 178
Query: 203 ---------SLAELHLAYNQLSGQ-----IPSTLFECKQLKILSLSVNNFIG-----SIP 243
L + + N + + + L C++LK+L L +N ++
Sbjct: 179 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ-DNTFTHLGSSALA 237
Query: 244 REIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNL 303
+ + L+ L L L+ G + + ++L L L L N +
Sbjct: 238 IALKSWPNLRELGLNDCLLSAR--GAAAVVDAFSKLEN---------IGLQTLRLQYNEI 286
Query: 304 ----LGNLPSNIGHSLPNLQQLILGGNRLT 329
+ L + I +P+L L L GNR +
Sbjct: 287 ELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 49/351 (13%), Positives = 109/351 (31%), Gaps = 55/351 (15%)
Query: 290 ISSLTVLSLTANNLLGNLPSNIGHSL---PNLQQLILGGNRLTGP----IPSSISNASML 342
S+ SL + + ++ L ++++++L GN + + +I++ L
Sbjct: 3 RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 62
Query: 343 TLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLS--GVLPISIG 400
+ + FS + P L +L C L + LS+N P+
Sbjct: 63 EIAE-----FSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF 117
Query: 401 NLSNA-MDVLYLSACNI-------------KGSIPSEIGNLNNLTTLHLETNELTG---- 442
+ ++ LYL + + ++ + N L ++ N L
Sbjct: 118 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK 177
Query: 443 SIPKAIGRLQKLQGLYLQHNKL-----QGSITTDLCGLRSLSEFYSDGNELNG----SLP 493
K + L + + N + + + L + L N +L
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 237
Query: 494 QCLDSLISLRTLSLGFNRLTSV----IPSSL--WSLRDILNVNLSSNSLNGTLPVEIG-- 545
L S +LR L L L++ + + + + L N + +
Sbjct: 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297
Query: 546 ---NLKVVTKIDLSRNDLS--GEIPSSIGD-LKNMQHLSLADNKFQGSIPD 590
+ + ++L+ N S ++ I + L + + D
Sbjct: 298 IDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTD 348
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 51/232 (21%), Positives = 79/232 (34%), Gaps = 65/232 (28%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDA-------ECEILGSIRHR-- 794
+G G+FG V + + AVKV +R+ E +IL I++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKV--------VRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 795 ---NLVKIISTCSSDHFK-----ALVLEYMPNGSLENWM-YNKNRSFDILQRLNMVIDVA 845
N+VK F L+ E + SL + N F I I++
Sbjct: 94 NNNNIVKYH-----GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 846 SALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ--------- 896
AL YL + H DL P NILL++ G + + +
Sbjct: 148 KALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 897 --------TQTLATI----GYMAPE------WKLSRKGDVYSYGIILMETFT 930
+ +I Y APE W D++S+G +L E +T
Sbjct: 205 DFGCATFKSDYHGSIINTRQYRAPEVILNLGW--DVSSDMWSFGCVLAELYT 254
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 29/106 (27%), Positives = 50/106 (47%), Gaps = 9/106 (8%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
C+ KG +P I ++T L+L+ N+ T +PK + + L + L +N++ +++
Sbjct: 17 CSNKGLKVLPKGIPR--DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQ 72
Query: 472 LC-GLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSV 515
+ L N L +P D L SLR LSL N ++ V
Sbjct: 73 SFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVV 117
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 35/119 (29%), Positives = 52/119 (43%), Gaps = 19/119 (15%)
Query: 511 RLTSV---IPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSS 567
L + IP + L L N +P E+ N K +T IDLS N +S + +
Sbjct: 21 GLKVLPKGIPRDVTELY------LDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQ 72
Query: 568 IGD-LKNMQHLSLADNKFQGSIPDSL-GGLTSLNFLDMSSNNLSGEIP----NSLKALS 620
+ + L L+ N+ + IP GL SL L + N++S +P N L ALS
Sbjct: 73 SFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALS 129
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 38/122 (31%), Positives = 56/122 (45%), Gaps = 21/122 (17%)
Query: 206 ELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGE 265
EL+L NQ + +P L K L ++ LS NN I ++ + ++N+T
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLS-NNRISTLSNQ------------SFSNMTQ- 79
Query: 266 IQGLQVLALSSNRLTGVIPPEIIN-ISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILG 324
L L LS NRL IPP + + SL +LSL N + +P + L L L +G
Sbjct: 80 ---LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLH-GNDISVVPEGAFNDLSALSHLAIG 134
Query: 325 GN 326
N
Sbjct: 135 AN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 5/105 (4%)
Query: 480 EFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGT 539
E Y DGN+ +P+ L + L + L NR++++ S ++ +L + LS N L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 540 LPVEI-GNLKVVTKIDLSRNDLSGEIPSSIGD-LKNMQHLSLADN 582
+P LK + + L ND+S +P + L + HL++ N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 39/140 (27%), Positives = 54/140 (38%), Gaps = 39/140 (27%)
Query: 124 EHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSG 183
LYLDGN F +P + N L +DLS N++ LSN FS
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS----------------TLSNQSFS- 75
Query: 184 PMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSVNNFIGSI 242
L L L+YN+L IP F+ K L++LSL N I +
Sbjct: 76 ----------------NMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLH-GNDISVV 117
Query: 243 PREI-GNITMLKGLYLVYTN 261
P +++ L L + N
Sbjct: 118 PEGAFNDLSALSHLAI-GAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 20/60 (33%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 270 QVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLT 329
L L N+ T ++P E+ N LT++ L +NN + L + ++ L LIL NRL
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDL-SNNRISTLSNQSFSNMTQLLTLILSYNRLR 91
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 24/95 (25%), Positives = 41/95 (43%), Gaps = 11/95 (11%)
Query: 241 SIPREIGNITMLKGLYLVYTNLTGE------IQGLQVLALSSNRLTGVIPPEII-NISSL 293
+P+ I LYL T + L ++ LS+NR++ + + N++ L
Sbjct: 24 VLPKGIPRDV--TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80
Query: 294 TVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
L L+ N L +P L +L+ L L GN +
Sbjct: 81 LTLILS-YNRLRCIPPRTFDGLKSLRLLSLHGNDI 114
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 27/166 (16%), Positives = 58/166 (34%), Gaps = 31/166 (18%)
Query: 746 LGKGSFGSVYKGT---------LSDGMQIAVKV--FNLELEGTLRSFDAECEI------- 787
+ + G +Y+ + ++K+ + L F +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 788 -LGSIRHRNLVKII-STCSSDHFKALVLEYMPNG-SLEN-WMYNKNRSFDILQRLNMVID 843
L S + + D ++ LVL + G SL++ + L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISK 886
+ ALE+LH + +H ++ NI + ++S V L+ +G +
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVT-LAGYGFAF 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 48/236 (20%), Positives = 88/236 (37%), Gaps = 77/236 (32%)
Query: 745 LLGKGSFGSVYKG--TLSDGMQIAVKVFNLELEGTLRS----FDA---ECEILGSIRHR- 794
LG+G+FG V + + G +AVK+ +++ +A E ++L +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKI--------VKNVDRYCEAARSEIQVLEHLNTTD 72
Query: 795 -----NLVKIISTCSSDHFK-----ALVLEYMPNGSLENWM-YNKNRSFDILQRLNMVID 843
V+++ + F+ +V E + S +++ N F + M
Sbjct: 73 PNSTFRCVQML-----EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQ 126
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLS-------------------DFGI 884
+ ++ +LH + + H DL P NIL +S DFG
Sbjct: 127 ICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG- 182
Query: 885 SKLLGDETSMTQTQTLATI----GYMAPE------WKLSRKGDVYSYGIILMETFT 930
++ + +T+ Y APE W S+ DV+S G IL+E +
Sbjct: 183 -------SATYDDEHHSTLVSTRHYRAPEVILALGW--SQPCDVWSIGCILIEYYL 229
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 8e-08
Identities = 69/478 (14%), Positives = 142/478 (29%), Gaps = 71/478 (14%)
Query: 48 RRVTALNLAYMGLLGTIPPEL----GNLSFLSLLNVTNNSFS--GTLPIQLSNLRRLKYL 101
R NL G + P + NL L ++ S + + L+ L
Sbjct: 84 PRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL 143
Query: 102 SFRS-NNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNIS----SLLTLDLSFNQ 156
+ F++ + + K++ L ++ +SF + ++ SL L+ +
Sbjct: 144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTE 203
Query: 157 LQGHVPSSILNI----PSLLAIDLSNNQFSGPMPSIYNTSPLQNIDM-QYNSLAELHLAY 211
P + I SL+++ + + + + + L+ N + Y
Sbjct: 204 FAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKY 263
Query: 212 NQLSGQ---------------IPSTLFECKQLKILSLSVNNFIG-SIPREIGNITMLKGL 255
L +P Q++ L L I L+ L
Sbjct: 264 MNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVL 323
Query: 256 YLVYTNLTGEIQGLQVLALSSNRLTGV-------IPPEIINISSLTVLSLTANNLLGNLP 308
+ GL+VLA +L + ++ L A
Sbjct: 324 ETRNV-IGDR--GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIA-------- 372
Query: 309 SNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFS---GFIPNSLGFCHP 365
+ L+ + + + +T N S+ ++ NL +
Sbjct: 373 --LAQGCQELEYMAVYVSDIT--------NESLESIGTYLKNLCDFRLVLLDREERITDL 422
Query: 366 YDELGFLTSLTNCKDLRKLILSENP--LSGVLPISIGNLSNAMDVLYLSACNIK-GSIPS 422
+ G + L CK LR+ L+ + IG S + + L +
Sbjct: 423 PLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLME 482
Query: 423 EIGNLNNLTTLHLETNELT-GSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLS 479
NL L + + +I A+ +L L+ L++Q + + L ++
Sbjct: 483 FSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR----ASMTGQDLMQMA 536
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 65/438 (14%), Positives = 135/438 (30%), Gaps = 61/438 (13%)
Query: 225 CKQLKILSLS----VNNFIGSIPREIGNITMLKGLYLVY-TNLTGEIQGLQVLALSSNRL 279
+QLK + + + + + L+ L L + T + GL + ++
Sbjct: 111 LRQLKSVHFRRMIVSDLDLDRLAK--ARADDLETLKLDKCSGFTTD--GLLSIVTHCRKI 166
Query: 280 TGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNA 339
+ + + + L + +L+ L IS
Sbjct: 167 ------KTLLMEESSFSEKDGKWL-----HELAQHNTSLEVLNFYMTEFAK-----ISPK 210
Query: 340 SMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISI 399
+ T+ +L S +G + +GF + N ++ L+E+ +P
Sbjct: 211 DLETIARNCRSLVS----VKVGDFEILELVGFFKAAANLEEFCGGSLNEDIG---MPEKY 263
Query: 400 GNLSNAMDVLYLSACNI-KGSIPSEIGNLNNLTTLHLE-TNELTGSIPKAIGRLQKLQGL 457
NL + L + +P + L L T I + L+ L
Sbjct: 264 MNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVL 323
Query: 458 YLQH---NKLQGSITTDLCGLRSLS-EFYSDGNELNGSLPQCLD--------SLISLRTL 505
++ ++ + L+ L E +D + L +
Sbjct: 324 ETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYM 383
Query: 506 SLGFNRLTSV----IPSSLWSLRDILNVNLSSNSLNGTLPVEIG------NLKVVTKIDL 555
++ + +T+ I + L +L D V L LP++ G K + +
Sbjct: 384 AVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAF 443
Query: 556 SRN--DLSGEIPSSIGDL-KNMQHLSLADNKFQ-GSIPDSLGGLTSLNFLDMSSNNLSGE 611
L+ S IG N++ + L + + G +L L+M S
Sbjct: 444 YLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSER 503
Query: 612 -IPNSLKALSLLKFLNLS 628
I ++ L L++L +
Sbjct: 504 AIAAAVTKLPSLRYLWVQ 521
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 73/539 (13%), Positives = 146/539 (27%), Gaps = 81/539 (15%)
Query: 94 NLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLS 153
+ + FP L L L G N +T ++
Sbjct: 46 KIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVT 105
Query: 154 FNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAY-N 212
N+ L ++ + + + + + L L L +
Sbjct: 106 ---------EISNNLRQLKSVHFRRM-------IVSDLDLDRLAKARADDLETLKLDKCS 149
Query: 213 QLSGQIPSTLFE-CKQLKILSLSVNNFIGSIPREIGNI----TMLKGLYLVYTNLTG-EI 266
+ ++ C+++K L + ++F + + + T L+ L T
Sbjct: 150 GFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISP 209
Query: 267 QGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGN 326
+ L+ +A + L + + +L L + NL++ G
Sbjct: 210 KDLETIARNCRSL------VSVKVGDFEILELVG----------FFKAAANLEEFCGGSL 253
Query: 327 RLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLIL 386
+P N + LG + +RKL L
Sbjct: 254 NEDIGMPEKYMNLVFPRKL------------CRLGLSYMGPN-EMPILFPFAAQIRKLDL 300
Query: 387 SENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPK 446
L ++ ++VL + L L +E +
Sbjct: 301 LYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMED 360
Query: 447 AIGRL------------QKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELN-GSLP 493
G + Q+L+ + + + + T+ L S+ + + + L
Sbjct: 361 EEGLVSQRGLIALAQGCQELEYMAVYVSDI-----TNE-SLESIGTYLKNLCDFRLVLLD 414
Query: 494 QCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIG-NLKVVTK 552
+ I+ L G + LR L L IG V
Sbjct: 415 RE--ERITDLPLDNGV----RSLLIGCKKLRR-FAFYLRQGGLTDLGLSYIGQYSPNVRW 467
Query: 553 IDLSRNDLSGE-IPSSIGDLKNMQHLSLADNKF-QGSIPDSLGGLTSLNFLDMSSNNLS 609
+ L S E + N+Q L + F + +I ++ L SL +L + S
Sbjct: 468 MLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 29/167 (17%), Positives = 58/167 (34%), Gaps = 31/167 (18%)
Query: 745 LLGKGSFGSVYKGTLSDGMQIAVKVFN-----------LELEGTLRSFDAECEILGSIRH 793
+G+G FG +Y ++ + L E A+ E +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 794 RNLVKII----------STCSSDHFKALVLEYMPNG-SLENWMYNKNRSFDILQRLNMVI 842
+K + + ++ ++++ G L+ + F L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 843 DVASALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISK 886
+ LEY+H +H D+ SN+LL N V L D+G++
Sbjct: 160 RILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVY-LVDYGLAY 202
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 37/134 (27%), Positives = 56/134 (41%), Gaps = 29/134 (21%)
Query: 407 DVLYLSACNIKGSIPSE--IGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKL 464
L L+ N G I S+ G L +L L L+ N+LTG P A +Q L L NK+
Sbjct: 32 TELLLND-NELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90
Query: 465 QGSITTDLCGLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSVIPSSLWSL 523
+ + L L+TL+L N+++ V+P S L
Sbjct: 91 K-------------------------EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125
Query: 524 RDILNVNLSSNSLN 537
+ ++NL+SN N
Sbjct: 126 NSLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 27/100 (27%), Positives = 44/100 (44%), Gaps = 7/100 (7%)
Query: 551 TKIDLSRNDLSGEIPSSIGD-LKNMQHLSLADNKFQGSIPDSL-GGLTSLNFLDMSSNNL 608
T++ L+ N+L + L ++ L L N+ I + G + + L + N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 609 SGEIPNSL-KALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
EI N + L LK LNL N + V G F +L+S
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQISC-VMPGS-FEHLNS 127
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 33/139 (23%), Positives = 54/139 (38%), Gaps = 24/139 (17%)
Query: 194 LQNIDMQYNSLAELHLAYNQLS-GQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITML 252
L+ + ++ EL L + + G+I E L+ LSL N + + N+ L
Sbjct: 16 LELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLI-NVGL----ISVSNLPKL 70
Query: 253 KGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIG 312
L + L LS NR+ G + + +LT L+L+ N L S +
Sbjct: 71 PKL--------------KKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL--KDISTLE 114
Query: 313 H--SLPNLQQLILGGNRLT 329
L L+ L L +T
Sbjct: 115 PLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 28/141 (19%), Positives = 52/141 (36%), Gaps = 13/141 (9%)
Query: 94 NLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLS 153
++ L + + +I F LE L L + ++ + + L L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVG-LISVSN-LPKLPKLKKLELS 79
Query: 154 FNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQ 213
N++ G + +P+L ++LS N+ I PL+ + L L L +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK----DISTLEPLKKL----ECLKSLDLFNCE 131
Query: 214 LSGQI---PSTLFECKQLKIL 231
++ S QL L
Sbjct: 132 VTNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 16/64 (25%), Positives = 22/64 (34%)
Query: 68 LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLY 127
L L L L ++ N G L + L L +L+ N I L L+ L
Sbjct: 67 LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126
Query: 128 LDGN 131
L
Sbjct: 127 LFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 28/131 (21%), Positives = 47/131 (35%), Gaps = 22/131 (16%)
Query: 265 EIQGLQVLALSSNRLT-GVIPPEIINISSLTVLSLTANNL--LGNLPSNIGHSLPNLQQL 321
++ L L + + G I +L LSL L + NLP LP L++L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPK-----LPKLKKL 76
Query: 322 ILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDL 381
L NR+ G + LT +++ N ++ L L + L
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK--------------DISTLEPLKKLECL 122
Query: 382 RKLILSENPLS 392
+ L L ++
Sbjct: 123 KSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 26/138 (18%), Positives = 47/138 (34%), Gaps = 25/138 (18%)
Query: 377 NCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLE 436
+R+L+L + + ++ L L + S+ + + L L L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 437 TNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCL 496
N + G + +L L L L NKL+ +S + L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK-----------DISTL------------EPL 116
Query: 497 DSLISLRTLSLGFNRLTS 514
L L++L L +T+
Sbjct: 117 KKLECLKSLDLFNCEVTN 134
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 5/89 (5%)
Query: 544 IGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDM 603
+ + L L + S++ L ++ L L++N+ G + L +L L++
Sbjct: 45 TAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102
Query: 604 SSNNLS--GEIPNSLKALSLLKFLNLSFN 630
S N L + LK L LK L+L
Sbjct: 103 SGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 25/103 (24%), Positives = 43/103 (41%), Gaps = 5/103 (4%)
Query: 553 IDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEI 612
+D +++ G+I + N++ LSL + S+ +L L L L++S N + G +
Sbjct: 31 LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGL 87
Query: 613 PNSLKALSLLKFLNLSFNGLQ--GQVPHGGPFTNLSSQSFVGN 653
+ L L LNLS N L+ + L S
Sbjct: 88 DMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 8/108 (7%)
Query: 74 LSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSF 133
L L N +N G + + L++LS + S+ L PKL+ L L N
Sbjct: 29 LVLDNCKSND--GKIEGLTAEFVNLEFLSLINVGLISVSN---LPKLPKLKKLELSENRI 83
Query: 134 IGTIPPSICNISSLLTLDLSFNQLQ--GHVPSSILNIPSLLAIDLSNN 179
G + + +L L+LS N+L+ + + + L ++DL N
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 57/314 (18%), Positives = 108/314 (34%), Gaps = 62/314 (19%)
Query: 375 LTNCKDLRKLILSENPLS--GVLPISIGNLSNAMDV--LYLSACNIKGSIPSEIG----- 425
+ + L LS N L + + + V L LS ++ E+
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 426 NLNNLTTLHLETNELTGSIPKAIGRL-----QKLQGLYLQHNKLQGSITTDLCGL----- 475
N+T+L+L N L+ + + + L L N +++
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 476 RSLSEFYSDGNELNG----SLPQCLDSL-ISLRTLSLGFNRLTSV-----------IPSS 519
S++ GN+L L Q L ++ ++ +L+L N L S IP+S
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 520 LWSLRDILNVNLSSNSLNGTLPVEIG-----NLKVVTKIDLSRNDLSGE----IPSSIGD 570
+ SL +LS+N L E+ V ++L N L G +
Sbjct: 198 VTSL------DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDS 251
Query: 571 LKNMQHLSLADNKFQG-------SIPDSLGGLTSLNFLDMSSNNLSGE----IPNSLKAL 619
LK++Q + L + + ++ + + + +D + + I N ++ L
Sbjct: 252 LKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIREL 311
Query: 620 SL-LKFLNLSFNGL 632
S +L L
Sbjct: 312 SGKADVPSLLNQCL 325
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 56/359 (15%), Positives = 107/359 (29%), Gaps = 67/359 (18%)
Query: 291 SSLTVLSLTANNL----LGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLID 346
+T L L+ NNL L ++ ++ L L GN L + L
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQI----LAA 77
Query: 347 MPYNLFSGFIPNSLGFCHPYDE----LGFLTSLTNCKDLRKLILSENPLS--GVLPIS-- 398
+P N+ S +L + L + + L L N S
Sbjct: 78 IPANVTS----LNLSGNFLSYKSSDELVKTLAAIPFT-ITVLDLGWNDFSSKSSSEFKQA 132
Query: 399 IGNLSNAMDVLYLSACNIKG----SIPSEIGNLN-NLTTLHLETNELTGSIPKAIGRL-- 451
NL ++ L L ++ + + + N+ +L+L N L + +
Sbjct: 133 FSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLA 192
Query: 452 ---QKLQGLYLQHNKLQGSITTDLCGL-----RSLSEFYSDGNELNGS----LPQCLDSL 499
+ L L N L +L + + N L+G L DSL
Sbjct: 193 SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSL 252
Query: 500 ISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRND 559
L+T+ L ++ + ++ +L N++ + +D + +
Sbjct: 253 KHLQTVYLDYDIVKNMSKEQCKALGAAF-----------------PNIQKIILVDKNGKE 295
Query: 560 LSGEIPSSIGDL-----KNMQHLSLADN-----KFQGSIPDSLGGLTSLNFLDMSSNNL 608
+ I +L SL + + + + L L + L
Sbjct: 296 IHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 8e-07
Identities = 33/139 (23%), Positives = 57/139 (41%), Gaps = 24/139 (17%)
Query: 194 LQNIDMQYNSLAELHLAYNQLS-GQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITML 252
L+ + + + EL L ++ + G++ E ++L+ LS N + I N+ L
Sbjct: 9 LELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTI-NVGL----TSIANLPKL 63
Query: 253 KGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIG 312
L + L LS NR++G + +LT L+L+ N + S I
Sbjct: 64 NKL--------------KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI--KDLSTIE 107
Query: 313 H--SLPNLQQLILGGNRLT 329
L NL+ L L +T
Sbjct: 108 PLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 28/148 (18%), Positives = 59/148 (39%), Gaps = 13/148 (8%)
Query: 87 TLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISS 146
L ++ +K L ++ + ++ D F +LE L + +I ++ ++
Sbjct: 8 HLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG-LTSIA-NLPKLNK 65
Query: 147 LLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAE 206
L L+LS N++ G + P+L ++LS N+ + PL+ + +L
Sbjct: 66 LKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK----DLSTIEPLKKL----ENLKS 117
Query: 207 LHLAYNQLSGQI---PSTLFECKQLKIL 231
L L +++ + QL L
Sbjct: 118 LDLFNCEVTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 26/127 (20%), Positives = 47/127 (37%), Gaps = 22/127 (17%)
Query: 269 LQVLALSSNRLT-GVIPPEIINISSLTVLSLTANNL--LGNLPSNIGHSLPNLQQLILGG 325
++ L L ++R G + L LS L + NLP L L++L L
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK-----LNKLKKLELSD 73
Query: 326 NRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLI 385
NR++G + LT +++ N +L + L ++L+ L
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK--------------DLSTIEPLKKLENLKSLD 119
Query: 386 LSENPLS 392
L ++
Sbjct: 120 LFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 23/113 (20%), Positives = 44/113 (38%), Gaps = 3/113 (2%)
Query: 377 NCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLE 436
D+++L+L + + + + ++ L + SI + + LN L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 437 TNELTGSIPKAIGRLQKLQGLYLQHNKLQG-SITTDLCGLRSLSEFYSDGNEL 488
N ++G + + L L L NK++ S L L +L E+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 15/64 (23%), Positives = 24/64 (37%)
Query: 68 LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLY 127
L L+ L L +++N SG L + L +L+ N + L L+ L
Sbjct: 60 LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119
Query: 128 LDGN 131
L
Sbjct: 120 LFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 3/88 (3%)
Query: 544 IGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDM 603
+ + + L+ I +++ L ++ L L+DN+ G + +L L++
Sbjct: 38 TDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95
Query: 604 SSNNLSG-EIPNSLKALSLLKFLNLSFN 630
S N + LK L LK L+L
Sbjct: 96 SGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 25/103 (24%), Positives = 44/103 (42%), Gaps = 5/103 (4%)
Query: 553 IDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEI 612
+D SR++ G++ + + ++ LS + SI + L L L L++S N +SG +
Sbjct: 24 LDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGL 80
Query: 613 PNSLKALSLLKFLNLSFNGLQ--GQVPHGGPFTNLSSQSFVGN 653
+ L LNLS N ++ + NL S
Sbjct: 81 EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 48/193 (24%), Positives = 66/193 (34%), Gaps = 61/193 (31%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
C +G S+P+ I T L LETN L L L LYL NKLQ
Sbjct: 14 CYSQGRTSVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ------ 65
Query: 472 LCGLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVN 530
SLP + L SL L+L N+L S+ L
Sbjct: 66 -------------------SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKL-----TQ 101
Query: 531 LSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGD-LKNMQHLSLADNKFQGSIP 589
L ++ L+ N L +P + D L ++ L L N+ + S+P
Sbjct: 102 L-------------------KELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVP 140
Query: 590 ----DSLGGLTSL 598
D L L +
Sbjct: 141 DGVFDRLTSLQYI 153
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 45/195 (23%), Positives = 64/195 (32%), Gaps = 69/195 (35%)
Query: 270 QVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLT 329
L L +N L + ++SLT L L N L +LP+ + + L +L L L N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLG-GNKLQSLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 330 GPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSEN 389
SL G LT L++L L+ N
Sbjct: 90 -----------------------------SL-------PNGVFDKLTQ---LKELALNTN 110
Query: 390 PLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELTGSIPK-A 447
L S+P + L L L L N+L S+P
Sbjct: 111 QLQ--------------------------SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGV 143
Query: 448 IGRLQKLQGLYLQHN 462
RL LQ ++L N
Sbjct: 144 FDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 41/141 (29%), Positives = 65/141 (46%), Gaps = 16/141 (11%)
Query: 124 EHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIP-SLLAIDLSNNQFS 182
+L L+ NS ++SL L L N+LQ +P+ + N SL ++LS NQ
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 183 GPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFE-CKQLKILSLSVNNFIGS 241
+++ L L EL L NQL +P +F+ QLK L L N + S
Sbjct: 90 SLPNGVFDK--LTQ-------LKELALNTNQLQ-SLPDGVFDKLTQLKDLRLY-QNQLKS 138
Query: 242 IPREI-GNITMLKGLYLVYTN 261
+P + +T L+ ++L + N
Sbjct: 139 VPDGVFDRLTSLQYIWL-HDN 158
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 40/125 (32%), Positives = 60/125 (48%), Gaps = 8/125 (6%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
CN KG S+P+ I + + T L LE+N+L +L +L L L N++Q S+
Sbjct: 14 CNSKGLTSVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDG 70
Query: 472 LC-GLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNV 529
+ L L+ Y N+L SLP D L L+ L+L N+L SV L + +
Sbjct: 71 VFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKI 129
Query: 530 NLSSN 534
L +N
Sbjct: 130 WLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 9e-04
Identities = 47/190 (24%), Positives = 64/190 (33%), Gaps = 72/190 (37%)
Query: 275 SSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPS 334
+S LT V P I SS T L L +N L +LP + L L +L L N++
Sbjct: 15 NSKGLTSV-PTGIP--SSATRLELE-SNKLQSLPHGVFDKLTQLTKLSLSQNQIQ----- 65
Query: 335 SISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGV 394
+P +F LT L L L EN L
Sbjct: 66 -----------SLPDGVFD--------------------KLTK---LTILYLHENKLQ-- 89
Query: 395 LPISIGNLSNAMDVLYLSACNIKGSIPSEI-GNLNNLTTLHLETNELTGSIPK-AIGRLQ 452
S+P+ + L L L L+TN+L S+P RL
Sbjct: 90 ------------------------SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLT 124
Query: 453 KLQGLYLQHN 462
LQ ++L N
Sbjct: 125 SLQKIWLHTN 134
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 25/147 (17%), Positives = 53/147 (36%), Gaps = 21/147 (14%)
Query: 91 QLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLL-- 148
Q +N R + L R IE + + + + N + L
Sbjct: 14 QYTNAVRDRELDLRGYKIPVIEN--LGATLDQFDAIDFSDNEI-----RKLDGFPLLRRL 66
Query: 149 -TLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAEL 207
TL ++ N++ +P L + L+NN + + PL ++ SL L
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV----ELGDLDPLASL----KSLTYL 118
Query: 208 HLAYNQLSGQI---PSTLFECKQLKIL 231
+ N ++ + +++ Q+++L
Sbjct: 119 CILRNPVTNKKHYRLYVIYKVPQVRVL 145
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 28/132 (21%), Positives = 49/132 (37%), Gaps = 30/132 (22%)
Query: 203 SLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNL 262
EL L ++ I + Q + S +N I R++ +L+ L
Sbjct: 20 RDRELDLRGYKIP-VIENLGATLDQFDAIDFS-DNEI----RKLDGFPLLRRL------- 66
Query: 263 TGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGH-----SLPN 317
+ L +++NR+ + + LT L LT N+L +G SL +
Sbjct: 67 -------KTLLVNNNRICRIGEGLDQALPDLTELILTNNSL-----VELGDLDPLASLKS 114
Query: 318 LQQLILGGNRLT 329
L L + N +T
Sbjct: 115 LTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 31/145 (21%), Positives = 44/145 (30%), Gaps = 33/145 (22%)
Query: 373 TSLTNCKDLRKLILSENPLSGVLPISIGNLSNAM---DVLYLSACNIKGSIPSEIGNLNN 429
TN R+L L + I NL + D + S I+ + L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRR 65
Query: 430 LTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELN 489
L TL + N + L L L L +N L L +
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----------ELGDL-------- 106
Query: 490 GSLPQCLDSLISLRTLSLGFNRLTS 514
L SL SL L + N +T+
Sbjct: 107 ----DPLASLKSLTYLCILRNPVTN 127
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 25/126 (19%), Positives = 42/126 (33%), Gaps = 22/126 (17%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNL--LGNLPSNIGHSLPNLQQLILGGN 326
+ L L ++ VI + + + N + L P L L+ L++ N
Sbjct: 21 DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPL-----LRRLKTLLVNNN 74
Query: 327 RLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLIL 386
R+ LT + + N ELG L L + K L L +
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLV--------------ELGDLDPLASLKSLTYLCI 120
Query: 387 SENPLS 392
NP++
Sbjct: 121 LRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 24/137 (17%), Positives = 50/137 (36%), Gaps = 30/137 (21%)
Query: 496 LDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDL 555
+ + R L L ++ + +L TL ID
Sbjct: 15 YTNAVRDRELDLRGYKIPVI------------------ENLGATLD----QFDA---IDF 49
Query: 556 SRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS--GEIP 613
S N++ ++ L+ ++ L + +N+ L L L +++N+L G++
Sbjct: 50 SDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL- 106
Query: 614 NSLKALSLLKFLNLSFN 630
+ L +L L +L + N
Sbjct: 107 DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 15/64 (23%), Positives = 20/64 (31%)
Query: 68 LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLY 127
L L L V NN L L L +N+ + L S L +L
Sbjct: 60 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 119
Query: 128 LDGN 131
+ N
Sbjct: 120 ILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 24/127 (18%), Positives = 47/127 (37%), Gaps = 7/127 (5%)
Query: 529 VNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI 588
V L++ + + N ++DL + I + L + +DN+ + +
Sbjct: 2 VKLTAELIEQAA--QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 589 PDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQ--GQVPHGGPFTNLS 646
D L L L +++N + +AL L L L+ N L G + +L+
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 647 SQSFVGN 653
+ N
Sbjct: 117 YLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 21/139 (15%), Positives = 37/139 (26%), Gaps = 38/139 (27%)
Query: 117 LDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDL 176
+ + L L G I I + +D S N++ + P L
Sbjct: 15 YTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEI-----RKLDGFPLL----- 63
Query: 177 SNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVN 236
L L + N++ L L L+ N
Sbjct: 64 -------------------------RRLKTLLVNNNRICRIGEGLDQALPDLTELILT-N 97
Query: 237 NFIGSIPREIGNITMLKGL 255
N + + ++ + LK L
Sbjct: 98 NSLVEL-GDLDPLASLKSL 115
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 32/145 (22%), Positives = 65/145 (44%), Gaps = 15/145 (10%)
Query: 505 LSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKI---DLSRNDLS 561
L + + ++L +L+ ++ LS+N++ +I +L + + L RN +
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIK 83
Query: 562 GEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS--GEIPNSLKAL 619
+I + ++ L ++ N+ S+ + L +L L MS+N ++ GEI + L AL
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEI-DKLAAL 139
Query: 620 SLLKFLNLSFNGLQGQVPHGGPFTN 644
L+ L L+ N L +
Sbjct: 140 DKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 29/160 (18%), Positives = 65/160 (40%), Gaps = 16/160 (10%)
Query: 381 LRKLILSENPLSGVLPISIGNLSNAMDV-LYLSACNIKGSIPSEIGNLNNLTTLHLETNE 439
+ K ++ + + A V L+ I+ + + + L L L TN
Sbjct: 1 MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNN 59
Query: 440 LTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGL----RSLSEFYSDGNELNGSLPQC 495
+ I ++ ++ L+ L L N + + L +L E + N++ +
Sbjct: 60 IE-KI-SSLSGMENLRILSLGRNLI-----KKIENLDAVADTLEELWISYNQI--ASLSG 110
Query: 496 LDSLISLRTLSLGFNRLTSVIP-SSLWSLRDILNVNLSSN 534
++ L++LR L + N++T+ L +L + ++ L+ N
Sbjct: 111 IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 42/203 (20%), Positives = 69/203 (33%), Gaps = 56/203 (27%)
Query: 422 SEIGNLNNLTTLHLETNELTGSIPK------AIGRLQKLQGLYLQHNKLQGSITTDLCGL 475
++ E EL G IP + L+ + L L N + +
Sbjct: 12 RIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-----EKISS- 65
Query: 476 RSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNV-NLSSN 534
L + +LR LSLG N + + +L ++ D L +S N
Sbjct: 66 --------------------LSGMENLRILSLGRNLIKKI--ENLDAVADTLEELWISYN 103
Query: 535 ---SLNGTLPVEIGNLKVVTKIDLSRNDLS--GEIPSSIGDLKNMQHLSLADNKFQGSIP 589
SL+G I L + + +S N ++ GEI + L ++ L LA N
Sbjct: 104 QIASLSG-----IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYK 157
Query: 590 DSLGG----------LTSLNFLD 602
++ L +L LD
Sbjct: 158 ENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 29/169 (17%), Positives = 63/169 (37%), Gaps = 44/169 (26%)
Query: 92 LSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLD 151
+ +++ L ++ L + +HL L N+ I ++S +
Sbjct: 22 ATEAEKVE-LHGMIPPIEKMDAT--LSTLKACKHLALSTNNI-----EKISSLSGM---- 69
Query: 152 LSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAY 211
+L + L N ++N+D ++L EL ++Y
Sbjct: 70 -----------------ENLRILSLGRNLIKK----------IENLDAVADTLEELWISY 102
Query: 212 NQLSGQIPSTLFECKQLKILSLSVNNFIGSIP--REIGNITMLKGLYLV 258
NQ++ + S + + L++L +S NN I + ++ + L+ L L
Sbjct: 103 NQIA-SL-SGIEKLVNLRVLYMS-NNKITNWGEIDKLAALDKLEDLLLA 148
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 38/187 (20%), Positives = 64/187 (34%), Gaps = 62/187 (33%)
Query: 206 ELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGE 265
ELH + + +TL K K L+LS NN +I +++ ++ L
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-----EKISSLSGMENL---------- 72
Query: 266 IQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGG 325
++L+L N + I +L L + + N + +L S I L NL+ L +
Sbjct: 73 ----RILSLGRNLIK-KIENLDAVADTLEELWI-SYNQIASL-SGIEK-LVNLRVLYMSN 124
Query: 326 NRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLI 385
N++T G + L L L+
Sbjct: 125 NKIT--------------------------------------NWGEIDKLAALDKLEDLL 146
Query: 386 LSENPLS 392
L+ NPL
Sbjct: 147 LAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 27/121 (22%), Positives = 45/121 (37%), Gaps = 9/121 (7%)
Query: 64 IPPELGNLSFLSLLNVTNNSFSGTLPIQ-LSNLRRLKYLSFRSNNFSSIEIPPWLDSFPK 122
+ L L L ++ N+ I LS + L+ LS N IE
Sbjct: 40 MDATLSTLKACKHLALSTNNIEK---ISSLSGMENLRILSLGRNLIKKIE--NLDAVADT 94
Query: 123 LEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSIL-NIPSLLAIDLSNNQF 181
LE L++ N I ++ I + +L L +S N++ L + L + L+ N
Sbjct: 95 LEELWISYN-QIASLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152
Query: 182 S 182
Sbjct: 153 Y 153
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.0 bits (118), Expect = 3e-06
Identities = 27/160 (16%), Positives = 57/160 (35%), Gaps = 17/160 (10%)
Query: 489 NGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLK 548
L LD++ L L + S+ +L+ L + + + +L
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKS-LEIISGGLPDSVVEDILGSDLP 219
Query: 549 VVTKIDLSRNDLSGEIPSSIGDL---------KNMQHLSLADNKFQGSIPDSLGG---LT 596
+ K+ L + N++ L + D + Q + + L
Sbjct: 220 NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279
Query: 597 SLNFLDMSSNNLSGE----IPNSLKALSLLKFLNLSFNGL 632
L +D+S+ L+ E + + + + LKF+N+ +N L
Sbjct: 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 5e-05
Identities = 33/177 (18%), Positives = 60/177 (33%), Gaps = 25/177 (14%)
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDS- 119
+ P L + L+ L + + NL+ L+ S + L S
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLE---IISGGLPDSVVEDILGSD 217
Query: 120 FPKLEHLYLD-------GNSFIGTIPP--SICNISSLLTLDLSFNQLQGHVPSSILN--- 167
P LE L L + + P S +L L + + Q V L
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 168 IPSLLAIDLSNNQFS--GPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTL 222
+P L +D+S + G + + +++ L +++ YN LS ++ L
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKH-------LKFINMKYNYLSDEMKKEL 327
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 1e-04
Identities = 25/180 (13%), Positives = 62/180 (34%), Gaps = 18/180 (10%)
Query: 465 QGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLR--TLSLGFNRLTSVIPSSLWS 522
Q ++ L + L+ G + +L SL + L + + ++ S L +
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPN 220
Query: 523 LRDILNVNLSSNSLNGTLPVEI-------GNLKVVTKIDLSRNDLSGEIPSSIGD---LK 572
L L + + + + + + + + + + L
Sbjct: 221 LEK-LVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279
Query: 573 NMQHLSLADNKFQGS----IPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLS 628
++ + ++ + D + + L F++M N LS E+ L+ SL +++S
Sbjct: 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK-SLPMKIDVS 338
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 37/144 (25%), Positives = 58/144 (40%), Gaps = 24/144 (16%)
Query: 746 LGKGSFGSVYKG-TLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIR-----HRNLVKI 799
LG G F +V+ + +A+KV T + D E +L S+R N +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNREMV 103
Query: 800 ISTCSSDHFK---------ALVLEYMPNG-SLENWM-YNKNRSFDILQRLNMVIDVASAL 848
+ D FK +V E + G L W+ + + + ++ V L
Sbjct: 104 VQLL--DDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 849 EYLHYDHPTPIIHCDLNPSNILLN 872
+YLH IIH D+ P NILL+
Sbjct: 160 DYLHTK--CRIIHTDIKPENILLS 181
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 52/283 (18%), Positives = 104/283 (36%), Gaps = 32/283 (11%)
Query: 258 VYTNLTGEIQGLQVLALSSNR-LTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLP 316
++ ++TG + V+A R E + + + L+ + + + I
Sbjct: 59 LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCS 118
Query: 317 NLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLT 376
LQ L L G RL+ PI ++++ S L ++ L C + E T L+
Sbjct: 119 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLN-------------LSGCSGFSEFALQTLLS 165
Query: 377 NCKDLRKLILSENPL--SGVLPISIGNLSNAMDVLYLSACNIK---GSIPSEIGNLNNLT 431
+C L +L LS + +++ ++S + L LS + + + NL
Sbjct: 166 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 225
Query: 432 TLHL-ETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSIT-------TDLCGLRSLSEFYS 483
L L ++ L + +L LQ L L I ++ L++L F
Sbjct: 226 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD---IIPETLLELGEIPTLKTLQVFGI 282
Query: 484 DGNELNGSLPQCLDSL-ISLRTLS-LGFNRLTSVIPSSLWSLR 524
+ L + L L I+ + + + + +W ++
Sbjct: 283 VPDGTLQLLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGIK 325
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 28/105 (26%), Positives = 39/105 (37%), Gaps = 30/105 (28%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
C+ K S+P+ I L+L N++T P RL +L L L +N+L
Sbjct: 16 CSGKSLASVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT------ 67
Query: 472 LCGLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSV 515
LP D L L LSL N+L S+
Sbjct: 68 -------------------VLPAGVFDKLTQLTQLSLNDNQLKSI 93
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 26/105 (24%), Positives = 34/105 (32%), Gaps = 30/105 (28%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
C S+P+ I + L L N++T P L LQ LY NKL
Sbjct: 19 CQNIRLASVPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT------ 70
Query: 472 LCGLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSV 515
++P D L L L L N L S+
Sbjct: 71 -------------------AIPTGVFDKLTQLTQLDLNDNHLKSI 96
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 77/526 (14%), Positives = 160/526 (30%), Gaps = 86/526 (16%)
Query: 35 VC-NWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSL--------LNVTNNSFS 85
VC +W+ + R + + Y T+ + + L N+ + +
Sbjct: 33 VCKSWYEIERWCRRKV--FIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWG 90
Query: 86 G----TLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGT--IPP 139
G + S+ L+ + + + + SF + L L T +
Sbjct: 91 GYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAA 150
Query: 140 SICNISSLLTLDLSFNQLQGHVPSSILNI----PSLLAIDLSNNQFSGPMPSIYNTSPLQ 195
+L LDL + + + + SL+++++S S +
Sbjct: 151 IAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-----------SEVS 199
Query: 196 NIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGL 255
++ L C LK L L+ + + + L+ L
Sbjct: 200 FSALE-------RLVTR------------CPNLKSLKLNRAVPLEKLATLLQRAPQLEEL 240
Query: 256 YL----------VYTNLTGEIQGLQVLALSSNRLTGVIPPEIINI----SSLTVLSLTAN 301
VY+ L+ + G + L + +P + + S LT L+L+
Sbjct: 241 GTGGYTAEVRPDVYSGLSVALSGCKEL-RCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYA 299
Query: 302 NLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLG 361
+ + P LQ+L + + S L + + P +
Sbjct: 300 TVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRV-----FPSEPFVME 354
Query: 362 FCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKG--- 418
E G ++ C L ++ ++ I+I M L K
Sbjct: 355 PNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDY 414
Query: 419 --------SIPSEIGNLNNLTTLHLETNELTGSIPKAIGR-LQKLQGLYLQHNKL-QGSI 468
+ + + +L L L LT + + IG +K++ L + +
Sbjct: 415 LTLEPLDIGFGAIVEHCKDLRRLSLS-GLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGM 473
Query: 469 TTDLCGLRSLSEFY-SDGNELNGSLPQCLDSLISLRTLSLGFNRLT 513
L G SL + D + +L L ++R+L + ++
Sbjct: 474 HHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1029 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.59 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.45 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.4 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.38 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.29 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.26 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.26 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.26 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.25 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.01 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.99 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.97 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.93 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.85 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.84 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.83 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.76 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.43 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.38 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.32 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.25 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.07 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.78 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.78 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.76 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.68 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.53 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.29 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.24 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.08 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.08 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.05 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.99 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.92 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.86 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.63 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.53 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.27 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.26 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.21 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.14 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.1 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.3 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.07 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.24 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-87 Score=833.84 Aligned_cols=641 Identities=32% Similarity=0.490 Sum_probs=491.3
Q ss_pred chhHHHHHHHHHHhccCCCCCcccCCCCCCCCCCceeeEEEcCCCCceEEEeccccccccc---CCccCCCCcCCCeEec
Q 036879 3 VGRDQSALLALKAHVTNDPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGT---IPPELGNLSFLSLLNV 79 (1029)
Q Consensus 3 ~~~~~~al~~~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~---~p~~~~~l~~L~~L~l 79 (1029)
.+.|++||++||+++. ||. .++| |..++|||+|.||+|+ +++|+.|+|+++++.|. +|+.+++|++|+.+++
T Consensus 10 ~~~~~~all~~k~~~~-~~~-~l~~-W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~ 84 (768)
T 3rgz_A 10 LYREIHQLISFKDVLP-DKN-LLPD-WSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFL 84 (768)
T ss_dssp HHHHHHHHHHHHTTCS-CTT-SSTT-CCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEEC
T ss_pred CHHHHHHHHHHHhhCC-Ccc-cccC-CCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccccCC
Confidence 5789999999999997 787 8887 9888999999999998 68999999999999998 7765555555555555
Q ss_pred cCcccccCCccccccccCCceeecccccccCCCCCC--cCCCCCccceeccccccccCCCcccc-cCccccCeEeccCCc
Q 036879 80 TNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPP--WLDSFPKLEHLYLDGNSFIGTIPPSI-CNISSLLTLDLSFNQ 156 (1029)
Q Consensus 80 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~ 156 (1029)
+.|.+. .+|..|+++++|++|+|++|.+++ .+|. .++.+++|++|+|++|.+.+.+|..+ .++++|++|||++|+
T Consensus 85 ~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 85 SNSHIN-GSVSGFKCSASLTSLDLSRNSLSG-PVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp TTSCEE-ECCCCCCCCTTCCEEECCSSEEEE-EGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred cCCCcC-CCchhhccCCCCCEEECCCCcCCC-cCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 555543 344455555555555555555543 2344 45555555555555555555444443 455555555555555
Q ss_pred CcccCCcc---ccCCCcCcccccCCCcCcccCCCCCCCCCcccccccc-------------cccchhccccccccCCCCc
Q 036879 157 LQGHVPSS---ILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQY-------------NSLAELHLAYNQLSGQIPS 220 (1029)
Q Consensus 157 l~~~~p~~---~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~-------------~~L~~L~Ls~N~l~~~~p~ 220 (1029)
+++..|.. +.++++|++|++++|++++..+. ..+.+|+.|+++. .+|++|+|++|++++.+|.
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~ 241 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDV-SRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSR 241 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC-TTCTTCCEEECCSSCCCSCCCBCTTCCSCCEEECCSSCCCSCHHH
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCc-ccCCcCCEEECcCCcCCCCCcccccCCCCCEEECcCCcCCCcccH
Confidence 55444444 44555555555555555543332 2222222222222 2455666677777766677
Q ss_pred ccccccccceEEcccccccCCCCccccccccccceeecccccccc--------cCcccEEEccCCcccCCCCCCcccCCC
Q 036879 221 TLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGE--------IQGLQVLALSSNRLTGVIPPEIINISS 292 (1029)
Q Consensus 221 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~--------l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 292 (1029)
.+..+++|++|+|++|++++.+|.. .+++|+.|++++|++++. +++|++|+|++|++++.+|..|.++++
T Consensus 242 ~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~ 319 (768)
T 3rgz_A 242 AISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319 (768)
T ss_dssp HTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTT
T ss_pred HHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCC
Confidence 7777777777777777776666654 666777777777766521 256777777777777777777777777
Q ss_pred CcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCccccccc-ccceecCCCccccCCCCCCCCCCCCCccccc
Q 036879 293 LTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNAS-MLTLIDMPYNLFSGFIPNSLGFCHPYDELGF 371 (1029)
Q Consensus 293 L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~ 371 (1029)
|++|+|++|.+.+.+|...+..+++|++|+|++|++++.+|..+.+++ +|+.|++++|.+.+.+|..+..
T Consensus 320 L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~--------- 390 (768)
T 3rgz_A 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ--------- 390 (768)
T ss_dssp CCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTC---------
T ss_pred ccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhh---------
Confidence 777777777776677766444577777777777777777777777776 7777777777777666654431
Q ss_pred ccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCC
Q 036879 372 LTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRL 451 (1029)
Q Consensus 372 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 451 (1029)
..+++|++|++++|++++.+|..+.++.. |++|++++|++++.+|..|.++++|++|+|++|++++.+|..+..+
T Consensus 391 ----~~~~~L~~L~L~~n~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l 465 (768)
T 3rgz_A 391 ----NPKNTLQELYLQNNGFTGKIPPTLSNCSE-LVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV 465 (768)
T ss_dssp ----STTCCCCEEECCSSEEEEECCGGGGGCTT-CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred ----cccCCccEEECCCCccccccCHHHhcCCC-CCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCC
Confidence 12677889999999988888888888876 8899999999988888888889999999999999988888888888
Q ss_pred CCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEc
Q 036879 452 QKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNL 531 (1029)
Q Consensus 452 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 531 (1029)
++|++|+|++|++++..|..+..+++|++|++++|++++.+|..++.+++|++|+|++|++++.+|..+..+++|+.|++
T Consensus 466 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 545 (768)
T 3rgz_A 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDL 545 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEEC
T ss_pred CCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEEC
Confidence 99999999999998888888888999999999999998888989999999999999999998888888889999999999
Q ss_pred cCCcccCcCCcc--------------------------------------------------------------------
Q 036879 532 SSNSLNGTLPVE-------------------------------------------------------------------- 543 (1029)
Q Consensus 532 s~N~l~~~~p~~-------------------------------------------------------------------- 543 (1029)
++|.+++.+|..
T Consensus 546 s~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~ 625 (768)
T 3rgz_A 546 NTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625 (768)
T ss_dssp CSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECC
T ss_pred CCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCc
Confidence 998888766654
Q ss_pred --ccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccc
Q 036879 544 --IGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSL 621 (1029)
Q Consensus 544 --~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 621 (1029)
++.+++|+.|||++|+++|.+|..|+.+++|+.|+|++|+++|.+|..|+++++|++|||++|+++|.+|..+..++.
T Consensus 626 ~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~ 705 (768)
T 3rgz_A 626 PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTM 705 (768)
T ss_dssp CSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCC
T ss_pred hhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCC
Confidence 344678999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cceeeccCCCCcCCCCCCCCCCccCcccccCCCCCCCCCCCCCCCCCCc
Q 036879 622 LKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAPELKFPACKAK 670 (1029)
Q Consensus 622 L~~L~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~~~~~~~~~~~ 670 (1029)
|+.|++++|+++|.+|..++|.++...++.|||++||.|. +.|...
T Consensus 706 L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~~ 751 (768)
T 3rgz_A 706 LTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDPS 751 (768)
T ss_dssp CSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCSC
T ss_pred CCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCCC
Confidence 9999999999999999999999999999999999999985 367644
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-68 Score=664.67 Aligned_cols=568 Identities=31% Similarity=0.467 Sum_probs=521.8
Q ss_pred CCCeEeccCcccccC---CccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcc--cccCcccc
Q 036879 73 FLSLLNVTNNSFSGT---LPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPP--SICNISSL 147 (1029)
Q Consensus 73 ~L~~L~l~~n~l~~~---~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L 147 (1029)
.++.|+|+++.++|. +|..+.+++.|+.++++.|.+. ++|..++.+++|++|+|++|.++|.+|. .++++++|
T Consensus 51 ~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~--~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L 128 (768)
T 3rgz_A 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN--GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL 128 (768)
T ss_dssp EEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEE--ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTC
T ss_pred cEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcC--CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCC
Confidence 577999999999998 9999999999999999999886 5789999999999999999999999998 99999999
Q ss_pred CeEeccCCcCcccCCccc-cCCCcCcccccCCCcCcccCCC----CCCCCCccccccccc------------ccchhccc
Q 036879 148 LTLDLSFNQLQGHVPSSI-LNIPSLLAIDLSNNQFSGPMPS----IYNTSPLQNIDMQYN------------SLAELHLA 210 (1029)
Q Consensus 148 ~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~~~----~~~~~~l~~l~l~~~------------~L~~L~Ls 210 (1029)
++|+|++|.+++.+|..+ .++++|++|+|++|++++..+. +..+..|+.|+++.| +|++|+|+
T Consensus 129 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls 208 (768)
T 3rgz_A 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVS 208 (768)
T ss_dssp CEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECC
T ss_pred CEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECc
Confidence 999999999998888876 8999999999999999988764 456788999988865 57789999
Q ss_pred cccccCCCCcccccccccceEEcccccccCCCCccccccccccceeeccccccc-----ccCcccEEEccCCcccCCCCC
Q 036879 211 YNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTG-----EIQGLQVLALSSNRLTGVIPP 285 (1029)
Q Consensus 211 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~-----~l~~L~~L~Ls~N~l~~~~p~ 285 (1029)
+|++++.+|. ++.+++|++|+|++|++++.+|..|+++++|+.|++++|.+++ .+++|++|+|++|++++.+|.
T Consensus 209 ~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~ 287 (768)
T 3rgz_A 209 SNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPD 287 (768)
T ss_dssp SSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCC
T ss_pred CCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCH
Confidence 9999988887 9999999999999999999999999999999999999999985 356899999999999999999
Q ss_pred CcccC-CCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcc-cccccccceecCCCccccCCCCCCCCCC
Q 036879 286 EIINI-SSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSS-ISNASMLTLIDMPYNLFSGFIPNSLGFC 363 (1029)
Q Consensus 286 ~~~~l-~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~ls~N~l~~~~p~~~~~~ 363 (1029)
.+..+ ++|++|+|++|.+.+.+|..+. .+++|++|+|++|++++.+|.. +.++++|++|++++|.+.+.+|..+
T Consensus 288 ~~~~~~~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l--- 363 (768)
T 3rgz_A 288 FLSGACDTLTGLDLSGNHFYGAVPPFFG-SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL--- 363 (768)
T ss_dssp CSCTTCTTCSEEECCSSEEEECCCGGGG-GCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTH---
T ss_pred HHHhhcCcCCEEECcCCcCCCccchHHh-cCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHH---
Confidence 98875 9999999999999988888876 5999999999999999888866 9999999999999999998887654
Q ss_pred CCCccccccccccccc-ccceeeccCCcCCCCCCccccC--chhhhcceeccccccccccccccCCcCcCcEEEecCccc
Q 036879 364 HPYDELGFLTSLTNCK-DLRKLILSENPLSGVLPISIGN--LSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNEL 440 (1029)
Q Consensus 364 ~~~~~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~--l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 440 (1029)
..++ +|+.|++++|++++.+|..+.. +.. |++|++++|++++.+|..|.++++|++|+|++|++
T Consensus 364 ------------~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~-L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 430 (768)
T 3rgz_A 364 ------------TNLSASLLTLDLSSNNFSGPILPNLCQNPKNT-LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430 (768)
T ss_dssp ------------HHHTTTCSEEECCSSEEEEECCTTTTCSTTCC-CCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEE
T ss_pred ------------HhhhcCCcEEEccCCCcCCCcChhhhhcccCC-ccEEECCCCccccccCHHHhcCCCCCEEECcCCcc
Confidence 3565 8999999999999988888876 554 99999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCc
Q 036879 441 TGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSL 520 (1029)
Q Consensus 441 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 520 (1029)
++.+|..|..+++|++|++++|++++..+..+..+++|++|++++|++++..|..+..+++|++|+|++|++++.+|..+
T Consensus 431 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 510 (768)
T 3rgz_A 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510 (768)
T ss_dssp ESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGG
T ss_pred cCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccc--------------------------------
Q 036879 521 WSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSI-------------------------------- 568 (1029)
Q Consensus 521 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-------------------------------- 568 (1029)
..+++|+.|+|++|++++.+|..++.+++|+.|++++|++++.+|..+
T Consensus 511 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (768)
T 3rgz_A 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGA 590 (768)
T ss_dssp GGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSS
T ss_pred hcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccc
Confidence 999999999999999999999999999999999999999988777644
Q ss_pred --------------------------------------cCcccccccccccccccccCCccccCCCCCCEEeCcCCcccC
Q 036879 569 --------------------------------------GDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSG 610 (1029)
Q Consensus 569 --------------------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 610 (1029)
+.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|
T Consensus 591 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g 670 (768)
T 3rgz_A 591 GNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISG 670 (768)
T ss_dssp EEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCS
T ss_pred ccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCC
Confidence 335778999999999999999999999999999999999999
Q ss_pred cCchhhhcccccceeeccCCCCcCCCCCC-CCCCccCcccccCCCCCCCCC
Q 036879 611 EIPNSLKALSLLKFLNLSFNGLQGQVPHG-GPFTNLSSQSFVGNKGLCGAP 660 (1029)
Q Consensus 611 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~~ 660 (1029)
.+|..+.++++|+.|||++|+++|.+|.. ..++.+..+++++|+....-|
T Consensus 671 ~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP 721 (768)
T 3rgz_A 671 SIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721 (768)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECC
T ss_pred CCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCC
Confidence 99999999999999999999999999864 567788888899887554344
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-62 Score=609.35 Aligned_cols=588 Identities=22% Similarity=0.240 Sum_probs=493.0
Q ss_pred EecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceecccccc
Q 036879 53 LNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNS 132 (1029)
Q Consensus 53 l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~ 132 (1029)
++.+++++. ++|..+. +++++|+|++|.+++..|..|+++++|++|+|++|+++.+ .|..++.+++|++|+|++|+
T Consensus 9 ~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~L~~n~ 84 (680)
T 1ziw_A 9 ADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKL-EPELCQKLPMLKVLNLQHNE 84 (680)
T ss_dssp EECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCC-CTTHHHHCTTCCEEECCSSC
T ss_pred eECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCcc-CHHHHhcccCcCEEECCCCc
Confidence 455556665 6787765 7889999999999877777899999999999999998864 37778889999999999999
Q ss_pred ccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccc
Q 036879 133 FIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYN 212 (1029)
Q Consensus 133 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N 212 (1029)
+++..+..|+++++|++|+|++|++++..|..|.++++|++|++++|.+++.++..+.. ..+|++|++++|
T Consensus 85 l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~---------l~~L~~L~L~~n 155 (680)
T 1ziw_A 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ---------LENLQELLLSNN 155 (680)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSC---------CTTCCEEECCSS
T ss_pred cCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcc---------cccCCEEEccCC
Confidence 88544457889999999999999998766788899999999999999988877654421 235777888888
Q ss_pred cccCCCCcccc--cccccceEEcccccccCCCCccccccccccceeeccccccc----------ccCcccEEEccCCccc
Q 036879 213 QLSGQIPSTLF--ECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTG----------EIQGLQVLALSSNRLT 280 (1029)
Q Consensus 213 ~l~~~~p~~l~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~----------~l~~L~~L~Ls~N~l~ 280 (1029)
++++..+..+. .+++|++|++++|++++..|..|..+.+|+.|++.++.+.. ..++|+.|+|++|+++
T Consensus 156 ~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~ 235 (680)
T 1ziw_A 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235 (680)
T ss_dssp CCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCC
T ss_pred cccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCccc
Confidence 88877777665 45889999999999998888899999999999998888763 2368999999999999
Q ss_pred CCCCCCcccCCC--CcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCC
Q 036879 281 GVIPPEIINISS--LTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPN 358 (1029)
Q Consensus 281 ~~~p~~~~~l~~--L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~ 358 (1029)
+..|..|.+++. |++|+|++|.+.+..|..+ ..+++|++|+|++|++++..|..|..+++|+.|++++|...+.++.
T Consensus 236 ~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~ 314 (680)
T 1ziw_A 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF-AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314 (680)
T ss_dssp EECTTTTGGGGGSCCCEEECTTSCCCEECTTTT-TTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC----
T ss_pred ccChhHhhccCcCCCCEEECCCCCcCccCcccc-cCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccc
Confidence 999999998865 9999999999985555555 4699999999999999999999999999999999998876543321
Q ss_pred CCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceecccccccc--ccccccCCc--CcCcEEE
Q 036879 359 SLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKG--SIPSEIGNL--NNLTTLH 434 (1029)
Q Consensus 359 ~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~--~~p~~~~~l--~~L~~L~ 434 (1029)
. .+..+ ....+..+++|++|++++|++++..|..+..+.+ |++|++++|.+.. ..+..|..+ ++|+.|+
T Consensus 315 ~-----~lp~i-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~ 387 (680)
T 1ziw_A 315 A-----SLPKI-DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLIN-LKYLSLSNSFTSLRTLTNETFVSLAHSPLHILN 387 (680)
T ss_dssp -------CCEE-CTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTT-CCEEECTTCBSCCCEECTTTTGGGTTSCCCEEE
T ss_pred c-----ccccc-ChhhcccCCCCCEEECCCCccCCCChhHhccccC-CcEEECCCCchhhhhcchhhhcccccCcCceEE
Confidence 0 00000 0013567899999999999999988888998887 9999999998543 333445444 5899999
Q ss_pred ecCccccccccccccCCCCCCEEEeccccccCccc-ccccCCCCCcEEecCCCcccCccccccccccccceeeccCcccc
Q 036879 435 LETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSIT-TDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLT 513 (1029)
Q Consensus 435 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 513 (1029)
|++|++++..|..|..+++|++|+|++|.+.+..+ ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.++
T Consensus 388 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~ 467 (680)
T 1ziw_A 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467 (680)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCB
T ss_pred CCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccc
Confidence 99999998889999999999999999999986554 78999999999999999999999999999999999999999997
Q ss_pred --CCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCC--------ccccCccccccccccccc
Q 036879 514 --SVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIP--------SSIGDLKNMQHLSLADNK 583 (1029)
Q Consensus 514 --~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~L~~N~ 583 (1029)
+..|..|..+++|+.|++++|++++..+..|.++++|++|+|++|++++..+ ..|.++++|+.|+|++|+
T Consensus 468 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 547 (680)
T 1ziw_A 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547 (680)
T ss_dssp CTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSC
T ss_pred ccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCC
Confidence 5688999999999999999999998888889999999999999999986422 247889999999999999
Q ss_pred ccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCCC--CCCccCcccccCCCCCCCCCC
Q 036879 584 FQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGG--PFTNLSSQSFVGNKGLCGAPE 661 (1029)
Q Consensus 584 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~--~~~~l~~~~~~~n~~~c~~~~ 661 (1029)
|+...+..|.++++|++|+|++|+|++.++..|.++++|+.|++++|++++.+|... .+.++..+.+.+|||.|+|+.
T Consensus 548 l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred CCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 996555679999999999999999998888889999999999999999998776532 467888999999999999974
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-62 Score=600.77 Aligned_cols=578 Identities=22% Similarity=0.225 Sum_probs=500.8
Q ss_pred CceeeEEEcC---------CCCceEEEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccc
Q 036879 36 CNWFGVTCSP---------RHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSN 106 (1029)
Q Consensus 36 c~w~gv~c~~---------~~~~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N 106 (1029)
|.++-|.|+. -..+++.|+|+++++.+..|..++++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 5555667753 2247999999999999766678999999999999999999988999999999999999999
Q ss_pred cccCCCCCC-cCCCCCccceeccccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccC
Q 036879 107 NFSSIEIPP-WLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPM 185 (1029)
Q Consensus 107 ~l~~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 185 (1029)
+++. +|+ .|+.+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+.++++|++|++++|.+++.+
T Consensus 84 ~l~~--l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 161 (680)
T 1ziw_A 84 ELSQ--LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161 (680)
T ss_dssp CCCC--CCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred ccCc--cChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence 9995 555 6999999999999999999777789999999999999999999888999999999999999999998876
Q ss_pred CCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcccccccCCCCcccc---ccccccceeeccccc
Q 036879 186 PSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIG---NITMLKGLYLVYTNL 262 (1029)
Q Consensus 186 ~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~l~~n~l 262 (1029)
+..+.. +...+|++|++++|++++..|..|..+.+|+.|++++|.+.+.....+. ..++|+.|++++|.+
T Consensus 162 ~~~~~~-------~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l 234 (680)
T 1ziw_A 162 SEELDI-------FANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234 (680)
T ss_dssp HHHHGG-------GTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCC
T ss_pred HHHhhc-------cccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcc
Confidence 643221 1124788999999999999999999999999999999987643332222 347899999999998
Q ss_pred ccc-------c--CcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCC---
Q 036879 263 TGE-------I--QGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTG--- 330 (1029)
Q Consensus 263 ~~~-------l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~--- 330 (1029)
.+. + ++|++|+|++|++++..|..|.++++|++|+|++|++.+..|..+. .+++|++|++++|...+
T Consensus 235 ~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~~~~~~~~~ 313 (680)
T 1ziw_A 235 STTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH-GLFNVRYLNLKRSFTKQSIS 313 (680)
T ss_dssp CEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTT-TCTTCCEEECTTCBCCC---
T ss_pred cccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhc-CCCCccEEeccchhhhcccc
Confidence 743 2 3499999999999999999999999999999999999866666655 69999999999987654
Q ss_pred --CCCc----ccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCC--CCCccccCc
Q 036879 331 --PIPS----SISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSG--VLPISIGNL 402 (1029)
Q Consensus 331 --~~p~----~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~l 402 (1029)
.+|. .|..+++|+.|++++|.+.+..+..+ ..+++|++|++++|.+.. ..+..+..+
T Consensus 314 ~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---------------~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~ 378 (680)
T 1ziw_A 314 LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF---------------TGLINLKYLSLSNSFTSLRTLTNETFVSL 378 (680)
T ss_dssp ---CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTT---------------TTCTTCCEEECTTCBSCCCEECTTTTGGG
T ss_pred cccccccChhhcccCCCCCEEECCCCccCCCChhHh---------------ccccCCcEEECCCCchhhhhcchhhhccc
Confidence 2333 78899999999999999998766544 478999999999998543 222333333
Q ss_pred h-hhhcceeccccccccccccccCCcCcCcEEEecCcccccccc-ccccCCCCCCEEEeccccccCcccccccCCCCCcE
Q 036879 403 S-NAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIP-KAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSE 480 (1029)
Q Consensus 403 ~-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 480 (1029)
. ..++.|++++|++++..|.+|..+++|++|+|++|++++.+| ..|..+++|++|++++|++.+..+..|..+++|+.
T Consensus 379 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~ 458 (680)
T 1ziw_A 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQR 458 (680)
T ss_dssp TTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCE
T ss_pred ccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCccccc
Confidence 2 248999999999999999999999999999999999987555 78999999999999999999999999999999999
Q ss_pred EecCCCccc--CccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCC--------ccccccccc
Q 036879 481 FYSDGNELN--GSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLP--------VEIGNLKVV 550 (1029)
Q Consensus 481 L~l~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L 550 (1029)
|++++|.+. +..|..|..+++|++|+|++|+++++.+..|.++++|+.|+|++|++++..+ ..+.++++|
T Consensus 459 L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L 538 (680)
T 1ziw_A 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538 (680)
T ss_dssp EECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTC
T ss_pred chhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCC
Confidence 999999987 5789999999999999999999999999999999999999999999986432 247899999
Q ss_pred cEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhh-cccccceeeccC
Q 036879 551 TKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLK-ALSLLKFLNLSF 629 (1029)
Q Consensus 551 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~l~~ 629 (1029)
+.|+|++|+++...+..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..+. .+++|+.|++++
T Consensus 539 ~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~ 618 (680)
T 1ziw_A 539 HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTT
T ss_pred CEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccC
Confidence 9999999999966566799999999999999999977777889999999999999999998888888 899999999999
Q ss_pred CCCcCCCCC
Q 036879 630 NGLQGQVPH 638 (1029)
Q Consensus 630 N~l~~~~~~ 638 (1029)
|++.|.++.
T Consensus 619 N~~~c~c~~ 627 (680)
T 1ziw_A 619 NPFDCTCES 627 (680)
T ss_dssp CCCCBCCCC
T ss_pred CCcccCCcc
Confidence 999998764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-58 Score=559.04 Aligned_cols=531 Identities=21% Similarity=0.226 Sum_probs=419.8
Q ss_pred ecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccc
Q 036879 54 NLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSF 133 (1029)
Q Consensus 54 ~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 133 (1029)
+.++.++. ++|..+.. .+++|+|++|.+++..|..|+++++|++|+|++|+++.+ .|..|+.+++|++|+|++|++
T Consensus 18 ~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 18 NCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI-HEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp ECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEE-CTTTTTTCTTCCEEECTTCCC
T ss_pred ECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCcccee-ChhhccCccccCeeeCCCCcc
Confidence 44445555 67776653 689999999999988899999999999999999999864 478899999999999999999
Q ss_pred cCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccC-CCCCCCCCcccccccccccchhccccc
Q 036879 134 IGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPM-PSIYNTSPLQNIDMQYNSLAELHLAYN 212 (1029)
Q Consensus 134 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~-~~~~~~~~l~~l~l~~~~L~~L~Ls~N 212 (1029)
++..|..|+++++|++|+|++|++++..|..+.++++|++|++++|++++.. +.++.+ .+|++|++++|
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l----------~~L~~L~L~~n 163 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT----------EKLKVLDFQNN 163 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCC----------TTCCEEECCSS
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCC----------cccCEEEcccC
Confidence 9888999999999999999999999766888999999999999999998753 444433 25677788888
Q ss_pred cccCCCCcccccccccc--eEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccC
Q 036879 213 QLSGQIPSTLFECKQLK--ILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINI 290 (1029)
Q Consensus 213 ~l~~~~p~~l~~l~~L~--~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 290 (1029)
++++..|..|+.+++|+ .|++++|++++..|..+.. .+|+.|+ +++|. .++..+.++
T Consensus 164 ~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~-----------------l~~~~---~~~~~~~~l 222 (606)
T 3t6q_A 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLN-----------------FGGTQ---NLLVIFKGL 222 (606)
T ss_dssp CCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEE-----------------CTTCS---CHHHHHHHT
T ss_pred cccccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccc-----------------cCCch---hHHHHhhhc
Confidence 88877788888888888 8889999888777666544 3455444 44443 122233333
Q ss_pred CCCcEEEccCcccC----CCCCchhhhccc--ccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCC
Q 036879 291 SSLTVLSLTANNLL----GNLPSNIGHSLP--NLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCH 364 (1029)
Q Consensus 291 ~~L~~L~Ls~N~l~----~~lp~~~~~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~ 364 (1029)
.++....+..+.+. ..++...+..+. +|+.|++++|++++..+..|..+++|+.|++++|.++ .+|..
T Consensus 223 ~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~----- 296 (606)
T 3t6q_A 223 KNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG----- 296 (606)
T ss_dssp TTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSS-----
T ss_pred cccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChh-----
Confidence 33333322222111 123333333333 6888888888888877777888888888888888876 44443
Q ss_pred CCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceecccccccccccc-ccCCcCcCcEEEecCcccccc
Q 036879 365 PYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPS-EIGNLNNLTTLHLETNELTGS 443 (1029)
Q Consensus 365 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~ 443 (1029)
+..+++|++|++++|++.+..|..+..++. |++|++++|.+.+.+|. .|.++++|++|++++|.+++.
T Consensus 297 ----------l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 365 (606)
T 3t6q_A 297 ----------LVGLSTLKKLVLSANKFENLCQISASNFPS-LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365 (606)
T ss_dssp ----------CCSCTTCCEEECTTCCCSBGGGGCGGGCTT-CSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEE
T ss_pred ----------hcccccCCEEECccCCcCcCchhhhhccCc-CCEEECCCCCcccccchhhhhccCcCCEEECCCCccccc
Confidence 346778888888888888777777777776 88888888888755554 488888899999999988865
Q ss_pred c--cccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCcccc-ccccccccceeeccCccccCCCCCCc
Q 036879 444 I--PKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSVIPSSL 520 (1029)
Q Consensus 444 ~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~ 520 (1029)
. +..+..+++|++|++++|++.+..+..|..+++|++|++++|++.+..+. .+..+++|++|++++|.+++..|..+
T Consensus 366 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 445 (606)
T 3t6q_A 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF 445 (606)
T ss_dssp EESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTT
T ss_pred cCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHH
Confidence 5 67788888899999999988888888888888888888888888876554 48888999999999999988888888
Q ss_pred cCCCCCcEEEccCCcccCc---CCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCC
Q 036879 521 WSLRDILNVNLSSNSLNGT---LPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTS 597 (1029)
Q Consensus 521 ~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 597 (1029)
..+++|+.|++++|.+++. .+..+..+++|+.|++++|++++..|..|..+++|+.|+|++|++++..|..+..+++
T Consensus 446 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 525 (606)
T 3t6q_A 446 DGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525 (606)
T ss_dssp TTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCS
T ss_pred hCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCcccc
Confidence 8899999999999988762 3356888899999999999998888888899999999999999999888888999999
Q ss_pred CCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCC
Q 036879 598 LNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 598 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 637 (1029)
| +|+|++|++++.+|..+..+++|+.|++++|++.|.++
T Consensus 526 L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 526 I-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp C-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred c-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 9 99999999998888888888999999998888887555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-58 Score=560.23 Aligned_cols=512 Identities=18% Similarity=0.257 Sum_probs=284.6
Q ss_pred hhHHHHHHHHHHhccCCCCCccc------CCCCCCCCCCce---eeEEEcCCCCceEEEecccccccccCCccCCCCcCC
Q 036879 4 GRDQSALLALKAHVTNDPLNVLA------SNWSTNTSVCNW---FGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFL 74 (1029)
Q Consensus 4 ~~~~~al~~~~~~~~~~~~~~~~------~~w~~~~~~c~w---~gv~c~~~~~~v~~l~l~~~~l~~~~p~~~~~l~~L 74 (1029)
..|+.||.+||.++..+++..-+ .+|+.++|||.| .||+|+.. +||+.|+|+++++.|.+|+++++|++|
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~L 107 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTEL 107 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTTC
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCccc
Confidence 47999999999998654443222 249999999999 99999865 899999999999999999999999999
Q ss_pred CeEeccCccc------cc------CCccccccccCCceeecccccccCCCCCCcCCC-CCccceeccccccccCCCcccc
Q 036879 75 SLLNVTNNSF------SG------TLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDS-FPKLEHLYLDGNSFIGTIPPSI 141 (1029)
Q Consensus 75 ~~L~l~~n~l------~~------~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~ 141 (1029)
++|+|++|.+ .| .+|... +..|+ +++++|.+.. ..|..+.. +..+..+++....+..
T Consensus 108 ~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~-~~~~~~~~~~~~l~~~~l~~~~~~~------ 177 (636)
T 4eco_A 108 EVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDY-DPREDFSDLIKDCINSDPQQKSIKK------ 177 (636)
T ss_dssp CEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCC-CGGGGSCHHHHHHHHHCTTSCCCCC------
T ss_pred eEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhcc-CchhhHHHHHHHHhhcCcccccccc------
Confidence 9999999987 33 445444 56666 7777777665 33444432 2233333433222210
Q ss_pred cCccccCeEec--cCCcCcccCCccccCCCcCcccccCCCcCccc-CCCCCCCCCcccccccccccchhccccccccCCC
Q 036879 142 CNISSLLTLDL--SFNQLQGHVPSSILNIPSLLAIDLSNNQFSGP-MPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQI 218 (1029)
Q Consensus 142 ~~l~~L~~L~L--s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~ 218 (1029)
.....++.+.+ ..|++++ +|..++++++|++|+|++|++++. ++..+.. -+.+...+.+
T Consensus 178 ~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~-----------------~~~~~~~~~i 239 (636)
T 4eco_A 178 SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----------------ENSEYAQQYK 239 (636)
T ss_dssp CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC-----------------TTSHHHHHHT
T ss_pred ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccc-----------------cccchhcccC
Confidence 01112222222 2456665 566666666666666666666652 1100000 0001111224
Q ss_pred Ccccc--cccccceEEcccccccCCCCccccccccccceeecccc-ccc--------------ccCcccEEEccCCcccC
Q 036879 219 PSTLF--ECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTN-LTG--------------EIQGLQVLALSSNRLTG 281 (1029)
Q Consensus 219 p~~l~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~-l~~--------------~l~~L~~L~Ls~N~l~~ 281 (1029)
|+.++ ++++|++|+|++|++.+.+|..|+++++|+.|++++|+ +++ .+++|++|+|++|+++
T Consensus 240 p~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~- 318 (636)
T 4eco_A 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK- 318 (636)
T ss_dssp TSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-
T ss_pred chhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-
Confidence 44444 44445555555554444444444444433311111111 100 1123445555555555
Q ss_pred CCCC--CcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCC
Q 036879 282 VIPP--EIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNS 359 (1029)
Q Consensus 282 ~~p~--~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~ 359 (1029)
.+|. .+.++++|++|+|++|.+.|.+| .+. .+++|++|+|++|+++ .+|..+..+++
T Consensus 319 ~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~-~l~~L~~L~L~~N~l~-~lp~~l~~l~~------------------ 377 (636)
T 4eco_A 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG-SEIKLASLNLAYNQIT-EIPANFCGFTE------------------ 377 (636)
T ss_dssp SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCE-EEEEESEEECCSSEEE-ECCTTSEEECT------------------
T ss_pred ccCchhhhccCCCCCEEeCcCCcCccchh-hhC-CCCCCCEEECCCCccc-cccHhhhhhcc------------------
Confidence 4444 45555555555555555544555 222 3455555555555554 34444444444
Q ss_pred CCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCch-hhhcceeccccccccccccccC-------CcCcCc
Q 036879 360 LGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLS-NAMDVLYLSACNIKGSIPSEIG-------NLNNLT 431 (1029)
Q Consensus 360 ~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~~L~~L~L~~n~l~~~~p~~~~-------~l~~L~ 431 (1029)
+|++|++++|+++ .+|..+.... ..|++|++++|++++.+|..|. .+++|+
T Consensus 378 --------------------~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~ 436 (636)
T 4eco_A 378 --------------------QVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436 (636)
T ss_dssp --------------------TCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEE
T ss_pred --------------------cCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCC
Confidence 0555555555554 4444443322 0255555555555555555555 566788
Q ss_pred EEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCcc
Q 036879 432 TLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNR 511 (1029)
Q Consensus 432 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 511 (1029)
+|+|++|++++..+..+..+++|++|+|++|+++......+.... ..+.++++|++|+|++|+
T Consensus 437 ~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~-----------------~~~~~l~~L~~L~Ls~N~ 499 (636)
T 4eco_A 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN-----------------ENFKNTYLLTSIDLRFNK 499 (636)
T ss_dssp EEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETT-----------------EECTTGGGCCEEECCSSC
T ss_pred EEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhcccc-----------------ccccccCCccEEECcCCc
Confidence 888888888754444455678888888888887743333332211 112334467777777777
Q ss_pred ccCCCCCCcc--CCCCCcEEEccCCcccCcCCccccccccccEEEccCCc------CCCCCCccccCccccccccccccc
Q 036879 512 LTSVIPSSLW--SLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRND------LSGEIPSSIGDLKNMQHLSLADNK 583 (1029)
Q Consensus 512 l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~------l~~~~p~~~~~l~~L~~L~L~~N~ 583 (1029)
++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++|+ +.+.+|..+..+++|+.|+|++|+
T Consensus 500 l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 577 (636)
T 4eco_A 500 LT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577 (636)
T ss_dssp CC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSC
T ss_pred CC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCc
Confidence 76 3555554 67777777777777775 67777777777777775544 444444444444444444444444
Q ss_pred ccccCCccccCCCCCCEEeCcCCccc
Q 036879 584 FQGSIPDSLGGLTSLNFLDMSSNNLS 609 (1029)
Q Consensus 584 l~~~~~~~~~~l~~L~~L~Ls~N~l~ 609 (1029)
|+ .+|..+. ++|++|||++|+++
T Consensus 578 l~-~ip~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 578 IR-KVNEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp CC-BCCSCCC--TTCCEEECCSCTTC
T ss_pred CC-ccCHhHh--CcCCEEECcCCCCc
Confidence 42 3443333 34444444444443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-56 Score=542.03 Aligned_cols=535 Identities=20% Similarity=0.210 Sum_probs=456.2
Q ss_pred eEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCC
Q 036879 76 LLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFN 155 (1029)
Q Consensus 76 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 155 (1029)
.++.++..++ .+|..+.. ++++|+|++|+++.+. |..|+.+++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 16 ~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~-~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 91 (606)
T 3t6q_A 16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQ-NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEEC-TTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred eEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCC-hhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCC
Confidence 6888888888 78877754 7999999999999743 778999999999999999999888999999999999999999
Q ss_pred cCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEccc
Q 036879 156 QLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSV 235 (1029)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 235 (1029)
++++..|..|.++++|++|++++|++++..+..+.. ..+|++|+|++|++++..+..+..+++|++|++++
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~---------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 162 (606)
T 3t6q_A 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN---------QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQN 162 (606)
T ss_dssp CCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTT---------CTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCS
T ss_pred cccccChhhhcccccccEeeccccCcccCCcchhcc---------CCcccEEECCCCcccccCcccccCCcccCEEEccc
Confidence 999888999999999999999999999865433321 23577888888888875545555699999999999
Q ss_pred ccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcc
Q 036879 236 NNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSL 315 (1029)
Q Consensus 236 N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l 315 (1029)
|++++..|..|+.+++|+.+ .|++++|++++..|..+.. .+|++|++++|. .++..+. .+
T Consensus 163 n~l~~~~~~~~~~l~~L~~l---------------~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~-~l 222 (606)
T 3t6q_A 163 NAIHYLSKEDMSSLQQATNL---------------SLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFK-GL 222 (606)
T ss_dssp SCCCEECHHHHHTTTTCCSE---------------EEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHH-HT
T ss_pred CcccccChhhhhhhccccee---------------EEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhh-hc
Confidence 99988778888887766632 5788899998777776654 689999999986 2343332 35
Q ss_pred cccceEeecCcccC-----CCCCccccccc--ccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccC
Q 036879 316 PNLQQLILGGNRLT-----GPIPSSISNAS--MLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE 388 (1029)
Q Consensus 316 ~~L~~L~L~~N~l~-----~~~p~~l~~l~--~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 388 (1029)
.++....+.-+.+. ...+..+..+. .|+.|++++|.+.+..+..+ ..+++|++|++++
T Consensus 223 ~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~---------------~~l~~L~~L~l~~ 287 (606)
T 3t6q_A 223 KNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTF---------------HCFSGLQELDLTA 287 (606)
T ss_dssp TTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTT---------------TTCTTCSEEECTT
T ss_pred cccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHh---------------ccccCCCEEeccC
Confidence 55544444333222 23344455554 79999999999987666544 4789999999999
Q ss_pred CcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCcccccccc-ccccCCCCCCEEEeccccccCc
Q 036879 389 NPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIP-KAIGRLQKLQGLYLQHNKLQGS 467 (1029)
Q Consensus 389 N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~ 467 (1029)
|+++ .+|..+..+.. |++|++++|.+++..|..+.++++|++|++++|.+.+.+| ..+..+++|++|++++|.+++.
T Consensus 288 n~l~-~lp~~l~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 365 (606)
T 3t6q_A 288 THLS-ELPSGLVGLST-LKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365 (606)
T ss_dssp SCCS-CCCSSCCSCTT-CCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEE
T ss_pred CccC-CCChhhccccc-CCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccc
Confidence 9998 78888988887 9999999999998889999999999999999999986555 4589999999999999999887
Q ss_pred c--cccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCC-CccCCCCCcEEEccCCcccCcCCccc
Q 036879 468 I--TTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPS-SLWSLRDILNVNLSSNSLNGTLPVEI 544 (1029)
Q Consensus 468 ~--~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~ 544 (1029)
. +..+..+++|++|++++|++.+..|..|..+++|++|++++|++++..+. .+..+++|+.|++++|.+++..|..+
T Consensus 366 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 445 (606)
T 3t6q_A 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF 445 (606)
T ss_dssp EESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTT
T ss_pred cCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHH
Confidence 7 77899999999999999999999999999999999999999999987655 48999999999999999999899999
Q ss_pred cccccccEEEccCCcCCCC---CCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccc
Q 036879 545 GNLKVVTKIDLSRNDLSGE---IPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSL 621 (1029)
Q Consensus 545 ~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 621 (1029)
+.+++|++|++++|++++. .+..+..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..+.+++.
T Consensus 446 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 525 (606)
T 3t6q_A 446 DGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525 (606)
T ss_dssp TTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCS
T ss_pred hCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCcccc
Confidence 9999999999999999863 3367899999999999999999988999999999999999999999999999999999
Q ss_pred cceeeccCCCCcCCCCCC-CCCCccCcccccCCCCCCCCCC
Q 036879 622 LKFLNLSFNGLQGQVPHG-GPFTNLSSQSFVGNKGLCGAPE 661 (1029)
Q Consensus 622 L~~L~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~~~ 661 (1029)
| .|++++|++++.+|.. ..+..++.+.+.+|||.|+|+.
T Consensus 526 L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 526 I-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp C-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred c-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 9 9999999999877763 4567888999999999998864
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=555.69 Aligned_cols=528 Identities=21% Similarity=0.199 Sum_probs=349.0
Q ss_pred ecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCC-CCcCCCCCccceecccccc
Q 036879 54 NLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEI-PPWLDSFPKLEHLYLDGNS 132 (1029)
Q Consensus 54 ~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-p~~~~~l~~L~~L~Ls~N~ 132 (1029)
+.+++++. .+|. ..++|++|||++|.|++..|..|.++++|++|+|++|.+.. .+ |..|+.+++|++|+|++|+
T Consensus 10 dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~-~i~~~~f~~L~~L~~L~Ls~N~ 84 (844)
T 3j0a_A 10 FYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL-TIDKEAFRNLPNLRILDLGSSK 84 (844)
T ss_dssp EESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCC-EECTTTTSSCTTCCEEECTTCC
T ss_pred EccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCcc-ccCHHHhcCCCCCCEEECCCCc
Confidence 44455665 6776 45788899999999988888889999999999999986543 33 6778889999999999999
Q ss_pred ccCCCcccccCccccCeEeccCCcCcccCCcc--ccCCCcCcccccCCCcCcccCCC--CCCCCCcccccccccccchhc
Q 036879 133 FIGTIPPSICNISSLLTLDLSFNQLQGHVPSS--ILNIPSLLAIDLSNNQFSGPMPS--IYNTSPLQNIDMQYNSLAELH 208 (1029)
Q Consensus 133 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~ls~N~l~~~~~~--~~~~~~l~~l~l~~~~L~~L~ 208 (1029)
+++..|..|+++++|++|+|++|.+++.+|.. +.++++|++|+|++|.+++..+. +..+ .+|++|+
T Consensus 85 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L----------~~L~~L~ 154 (844)
T 3j0a_A 85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL----------NSLKSID 154 (844)
T ss_dssp CCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTC----------SSCCEEE
T ss_pred CcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhC----------CCCCEEE
Confidence 88877888999999999999999988766665 88888888888888888765432 1222 2455666
Q ss_pred cccccccCCCCcccccc--cccceEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCC
Q 036879 209 LAYNQLSGQIPSTLFEC--KQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPE 286 (1029)
Q Consensus 209 Ls~N~l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~ 286 (1029)
|++|++++..|..+..+ ++|+.|++++|.+.+..|..++.+.+.- ....|+.|+|++|++++..|..
T Consensus 155 Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~-----------~~~~L~~L~Ls~n~l~~~~~~~ 223 (844)
T 3j0a_A 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF-----------RNMVLEILDVSGNGWTVDITGN 223 (844)
T ss_dssp EESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTT-----------TTCCBSEEBCSSCCSSTTTTSG
T ss_pred CCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCcc-----------ccCceeEEecCCCcCchhHHHH
Confidence 66666666666777666 6777777777777776666665544210 0113678888888888777777
Q ss_pred cccC---CCCcEEEccCcccCC--------CCCchhhhcc--cccceEeecCcccCCCCCcccccccccceecCCCcccc
Q 036879 287 IINI---SSLTVLSLTANNLLG--------NLPSNIGHSL--PNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFS 353 (1029)
Q Consensus 287 ~~~l---~~L~~L~Ls~N~l~~--------~lp~~~~~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 353 (1029)
+... .+++.|+++.+.+.. ......+.++ ++|+.|+|++|.+.+..|..|..+++|+.|++++|.+.
T Consensus 224 ~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 303 (844)
T 3j0a_A 224 FSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303 (844)
T ss_dssp GGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCC
T ss_pred HHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCC
Confidence 6643 567778776433211 1111112222 56777777777777777777777777777777777776
Q ss_pred CCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEE
Q 036879 354 GFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTL 433 (1029)
Q Consensus 354 ~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 433 (1029)
+..|..+ ..+++|++|+|++|++++..|..+..+++ |++|++++|++++..+..|.++++|++|
T Consensus 304 ~~~~~~~---------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~i~~~~~~~~~~l~~L~~L 367 (844)
T 3j0a_A 304 KIADEAF---------------YGLDNLQVLNLSYNLLGELYSSNFYGLPK-VAYIDLQKNHIAIIQDQTFKFLEKLQTL 367 (844)
T ss_dssp EECTTTT---------------TTCSSCCEEEEESCCCSCCCSCSCSSCTT-CCEEECCSCCCCCCCSSCSCSCCCCCEE
T ss_pred CCChHHh---------------cCCCCCCEEECCCCCCCccCHHHhcCCCC-CCEEECCCCCCCccChhhhcCCCCCCEE
Confidence 6555433 35667777777777777666666766665 7777777777776666667777777777
Q ss_pred EecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCcc-ccccccccccceeeccCccc
Q 036879 434 HLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSL-PQCLDSLISLRTLSLGFNRL 512 (1029)
Q Consensus 434 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l 512 (1029)
+|++|.+++ ++ .+++|+.|++++|+++..... ..+++.|++++|++.+.. +..+..+++|++|+|++|++
T Consensus 368 ~Ls~N~l~~-i~----~~~~L~~L~l~~N~l~~l~~~----~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l 438 (844)
T 3j0a_A 368 DLRDNALTT-IH----FIPSIPDIFLSGNKLVTLPKI----NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRF 438 (844)
T ss_dssp EEETCCSCC-CS----SCCSCSEEEEESCCCCCCCCC----CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCC
T ss_pred ECCCCCCCc-cc----CCCCcchhccCCCCccccccc----ccccceeecccCccccCchhhhhhcCCccceeeCCCCcc
Confidence 777777763 22 256677777777777633221 345666667766666432 22244666666666666666
Q ss_pred cCCCCC-CccCCCCCcEEEccCCccc-----CcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccc
Q 036879 513 TSVIPS-SLWSLRDILNVNLSSNSLN-----GTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQG 586 (1029)
Q Consensus 513 ~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 586 (1029)
++..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++
T Consensus 439 ~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 518 (844)
T 3j0a_A 439 SSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV 518 (844)
T ss_dssp CCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSS
T ss_pred cccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCc
Confidence 654333 3445666666666666665 2333445666666666666666666666666666666666666666665
Q ss_pred cCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCC
Q 036879 587 SIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 587 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 637 (1029)
..|..+. ++|+.|||++|+|++.+|..| .+|+.|++++|++.|.++
T Consensus 519 l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 519 LSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECE 564 (844)
T ss_dssp CCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSS
T ss_pred cChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccc
Confidence 5544444 566666666666666665543 355666666666666554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-56 Score=541.41 Aligned_cols=525 Identities=19% Similarity=0.185 Sum_probs=380.2
Q ss_pred EEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccc
Q 036879 52 ALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGN 131 (1029)
Q Consensus 52 ~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N 131 (1029)
.++.+++++. .+|..+. ++|++|+|++|++++..|..|+++++|++|+|++|+++.+. |..|+.+++|++|+|++|
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~-~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE-DKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEEC-TTTTTTCTTCCEEECTTC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccC-HHHhhchhhcCEeECCCC
Confidence 3566666776 7888765 78999999999999888889999999999999999998643 678899999999999999
Q ss_pred cccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhcccc
Q 036879 132 SFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAY 211 (1029)
Q Consensus 132 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~ 211 (1029)
++++..|..|+++++|++|+|++|++++..|..++++++|++|++++|++++.
T Consensus 91 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--------------------------- 143 (606)
T 3vq2_A 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC--------------------------- 143 (606)
T ss_dssp CCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCC---------------------------
T ss_pred cccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccce---------------------------
Confidence 99987788999999999999999999876668899999999998888887641
Q ss_pred ccccCCCCcccccccccceEEcccccccCCCCcccccccccc----ceeecccccccc------cCcccEEEccCCccc-
Q 036879 212 NQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLK----GLYLVYTNLTGE------IQGLQVLALSSNRLT- 280 (1029)
Q Consensus 212 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~l~~n~l~~~------l~~L~~L~Ls~N~l~- 280 (1029)
.+|..|+++++|++|+|++|++++..|..|+.+.+|+ .|++++|.+++. ..+|+.|+|++|.++
T Consensus 144 -----~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~ 218 (606)
T 3vq2_A 144 -----KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSS 218 (606)
T ss_dssp -----CCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCH
T ss_pred -----echHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccch
Confidence 1244444455555555555555544444444444433 233333333210 114567777777765
Q ss_pred CCCCCCcccCCCCcEEEccCcccCC-----CCCchhhhccc--ccceEee-cCcccCCCCCcccccccccceecCCCccc
Q 036879 281 GVIPPEIINISSLTVLSLTANNLLG-----NLPSNIGHSLP--NLQQLIL-GGNRLTGPIPSSISNASMLTLIDMPYNLF 352 (1029)
Q Consensus 281 ~~~p~~~~~l~~L~~L~Ls~N~l~~-----~lp~~~~~~l~--~L~~L~L-~~N~l~~~~p~~l~~l~~L~~L~ls~N~l 352 (1029)
+..|..+.++++|+.+++..+.+.+ .++...+..+. .++.+++ ..|.+.+.+|. +..+++|+.|++++|.+
T Consensus 219 ~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~ 297 (606)
T 3vq2_A 219 NIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSI 297 (606)
T ss_dssp HHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCC
T ss_pred hHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccc
Confidence 3556677777777777776554431 12222222222 3555556 66777777776 78888888888888877
Q ss_pred cCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcE
Q 036879 353 SGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTT 432 (1029)
Q Consensus 353 ~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 432 (1029)
.. +| . +..+++|++|++++|++ +.+| .+ .++. |+.|++++|...+.. .+..+++|++
T Consensus 298 ~~-l~-~---------------l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~-L~~L~l~~n~~~~~~--~~~~l~~L~~ 354 (606)
T 3vq2_A 298 KY-LE-D---------------VPKHFKWQSLSIIRCQL-KQFP-TL-DLPF-LKSLTLTMNKGSISF--KKVALPSLSY 354 (606)
T ss_dssp CC-CC-C---------------CCTTCCCSEEEEESCCC-SSCC-CC-CCSS-CCEEEEESCSSCEEC--CCCCCTTCCE
T ss_pred hh-hh-h---------------ccccccCCEEEcccccC-cccc-cC-CCCc-cceeeccCCcCccch--hhccCCCCCE
Confidence 53 22 1 34667788888888888 4666 34 5554 788888888554333 5667788888
Q ss_pred EEecCcccccc--ccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccc-cccccccccceeeccC
Q 036879 433 LHLETNELTGS--IPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLP-QCLDSLISLRTLSLGF 509 (1029)
Q Consensus 433 L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~Ls~ 509 (1029)
|+|++|++++. .|..+..+++|++|++++|.+++. +..|..+++|+.|++++|++.+..| ..+..+++|++|++++
T Consensus 355 L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~ 433 (606)
T 3vq2_A 355 LDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISY 433 (606)
T ss_dssp EECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEE-CCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTT
T ss_pred EECcCCccCCCcchhhhhccCCcccEeECCCCccccc-hhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcC
Confidence 88888888754 267777888888888888887653 4677778888888888888877766 6777888888888888
Q ss_pred ccccCCCCCCccCCCCCcEEEccCCcccC-cCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccC
Q 036879 510 NRLTSVIPSSLWSLRDILNVNLSSNSLNG-TLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI 588 (1029)
Q Consensus 510 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 588 (1029)
|++++..|..+..+++|+.|++++|++++ ..|..++.+++|+.|+|++|++++..|..|..+++|+.|+|++|++++.+
T Consensus 434 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 513 (606)
T 3vq2_A 434 TNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLD 513 (606)
T ss_dssp SCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEE
T ss_pred CCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcC
Confidence 88887777788888888888888888876 46777788888888888888888777777888888888888888888777
Q ss_pred CccccCCCCCCEEeCcCCcccCcCchhhhccc-ccceeeccCCCCcCCCCC
Q 036879 589 PDSLGGLTSLNFLDMSSNNLSGEIPNSLKALS-LLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 589 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~ 638 (1029)
|..|..+++|++|+|++|+|+ .+|..+..++ +|+.|++++|++.|.++.
T Consensus 514 ~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 514 SSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp GGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred HHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 778888888888888888887 5555577776 488888888888776654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=545.37 Aligned_cols=533 Identities=19% Similarity=0.223 Sum_probs=302.5
Q ss_pred chhHHHHHHHHHHhccCCCCCcccCCCCCCC-----CC--Cce------------eeEEEcCCCCceEEEeccccccccc
Q 036879 3 VGRDQSALLALKAHVTNDPLNVLASNWSTNT-----SV--CNW------------FGVTCSPRHRRVTALNLAYMGLLGT 63 (1029)
Q Consensus 3 ~~~~~~al~~~~~~~~~~~~~~~~~~w~~~~-----~~--c~w------------~gv~c~~~~~~v~~l~l~~~~l~~~ 63 (1029)
...|++||++||+++. +| + |+.+. +| |+| .||+|+. .+||+.|+|+++++.|.
T Consensus 267 ~~~d~~ALl~~k~~l~-~~-----~-W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ 338 (876)
T 4ecn_A 267 YIKDYKALKAIWEALD-GK-----N-WRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGR 338 (876)
T ss_dssp HHHHHHHHHHHHHHTT-GG-----G-CCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEE
T ss_pred chHHHHHHHHHHHHcC-CC-----C-CCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCc
Confidence 3579999999999995 55 3 75443 55 999 9999987 68999999999999999
Q ss_pred CCccCCCCcCCCeEec-cCcccccCCccccccc----c-----CCceeecc-------ccccc----------CCCCCCc
Q 036879 64 IPPELGNLSFLSLLNV-TNNSFSGTLPIQLSNL----R-----RLKYLSFR-------SNNFS----------SIEIPPW 116 (1029)
Q Consensus 64 ~p~~~~~l~~L~~L~l-~~n~l~~~~p~~~~~l----~-----~L~~L~l~-------~N~l~----------~~~~p~~ 116 (1029)
+|+++++|++|+.|+| ++|.++|..|...... . .++...+. ...+. ....+..
T Consensus 339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~ 418 (876)
T 4ecn_A 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418 (876)
T ss_dssp ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence 9999999999999999 9999998755332111 0 00000000 00000 0000111
Q ss_pred CCCCCccceecccc--ccccCCCcccccCccccCeEeccCCcCcc-cCCccccCCCcCcccccCCCcCcccCCCCCCCCC
Q 036879 117 LDSFPKLEHLYLDG--NSFIGTIPPSICNISSLLTLDLSFNQLQG-HVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSP 193 (1029)
Q Consensus 117 ~~~l~~L~~L~Ls~--N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~ 193 (1029)
......++.+.+.. |++++ +|+.|+++++|++|+|++|++++ .+|..+. ..+.|.+++.+|..+....
T Consensus 419 ~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~--------~~s~n~~~g~iP~~l~f~~ 489 (876)
T 4ecn_A 419 KDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWE--------DANSDYAKQYENEELSWSN 489 (876)
T ss_dssp CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCS--------CTTSHHHHHHTTSCCCGGG
T ss_pred cccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccc--------ccccccccccCChhhhhcc
Confidence 12233444444443 66665 66666666666666666666664 1211110 0111222222221110000
Q ss_pred cccccccccccchhccccccccCCCCcccccccccceEEccccc-ccC-CCCccccccc-cccceeecccccccccCccc
Q 036879 194 LQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNN-FIG-SIPREIGNIT-MLKGLYLVYTNLTGEIQGLQ 270 (1029)
Q Consensus 194 l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~-~L~~L~l~~n~l~~~l~~L~ 270 (1029)
..+|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+++++ .+ ..+++|+
T Consensus 490 -------L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~-----------~~l~~L~ 551 (876)
T 4ecn_A 490 -------LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDE-----------DTGPKIQ 551 (876)
T ss_dssp -------CTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCT-----------TTTTTCC
T ss_pred -------CCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcc-----------cccCCcc
Confidence 0122333333333334445555555555555555554 544 4555444433 11 1223455
Q ss_pred EEEccCCcccCCCCC--CcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccc-cceecC
Q 036879 271 VLALSSNRLTGVIPP--EIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASM-LTLIDM 347 (1029)
Q Consensus 271 ~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~l 347 (1029)
.|+|++|+++ .+|. .+.++++|++|+|++|.+. .+| .+ ..+++|+.|+|++|+++ .+|..+..+++ |+.|++
T Consensus 552 ~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~-~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~L 626 (876)
T 4ecn_A 552 IFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AF-GTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGF 626 (876)
T ss_dssp EEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CC-CTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEEC
T ss_pred EEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hh-cCCCcceEEECcCCccc-cchHHHhhccccCCEEEC
Confidence 6666666666 5555 6666666666666666665 566 33 24666666666666666 55555665555 666666
Q ss_pred CCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccC--
Q 036879 348 PYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIG-- 425 (1029)
Q Consensus 348 s~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~-- 425 (1029)
++|.+. .+|..+.. ...++|+.|+|++|++.+.+|... ..+.
T Consensus 627 s~N~L~-~lp~~~~~-------------~~~~~L~~L~Ls~N~l~g~ip~l~----------------------~~l~~~ 670 (876)
T 4ecn_A 627 SHNKLK-YIPNIFNA-------------KSVYVMGSVDFSYNKIGSEGRNIS----------------------CSMDDY 670 (876)
T ss_dssp CSSCCC-SCCSCCCT-------------TCSSCEEEEECCSSCTTTTSSSCS----------------------SCTTTC
T ss_pred cCCCCC-cCchhhhc-------------cccCCCCEEECcCCcCCCccccch----------------------hhhccc
Confidence 655555 33433210 011235555555555544332111 1111
Q ss_pred CcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCcccccccccccccee
Q 036879 426 NLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTL 505 (1029)
Q Consensus 426 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 505 (1029)
.+++|+.|+|++|+|+...+..+..+++|+.|+|++|+++..+...+.... ..+.++++|+.|
T Consensus 671 ~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~-----------------~~l~nl~~L~~L 733 (876)
T 4ecn_A 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKD-----------------GNYKNTYLLTTI 733 (876)
T ss_dssp CCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTT-----------------SCCTTGGGCCEE
T ss_pred cCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhcccc-----------------ccccccCCccEE
Confidence 234788888888888843333445778888888888888744443333221 012233345555
Q ss_pred eccCccccCCCCCCcc--CCCCCcEEEccCCcccCcCCccccccccccEEEcc------CCcCCCCCCccccCccccccc
Q 036879 506 SLGFNRLTSVIPSSLW--SLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLS------RNDLSGEIPSSIGDLKNMQHL 577 (1029)
Q Consensus 506 ~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls------~N~l~~~~p~~~~~l~~L~~L 577 (1029)
+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|+ +|++.+.+|..|..+++|+.|
T Consensus 734 ~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L 811 (876)
T 4ecn_A 734 DLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811 (876)
T ss_dssp ECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEE
T ss_pred ECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEE
Confidence 55555554 2344443 45555555555555554 45555555555555554 477777888888888888888
Q ss_pred ccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCc
Q 036879 578 SLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQ 633 (1029)
Q Consensus 578 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 633 (1029)
+|++|+| +.+|..+. ++|+.|||++|++....+..+.....+..+.|.+|+++
T Consensus 812 ~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 812 QIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp ECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred ECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 8888888 46777665 58888888888887666666666666666777776655
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-55 Score=532.56 Aligned_cols=525 Identities=19% Similarity=0.174 Sum_probs=429.2
Q ss_pred CCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEecc
Q 036879 74 LSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLS 153 (1029)
Q Consensus 74 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 153 (1029)
...++.++++++ .+|..+. ++|++|+|++|+++.+. |..|..+++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 13 ~~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls 88 (606)
T 3vq2_A 13 NITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILK-SYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILT 88 (606)
T ss_dssp TTEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEEC-TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CCceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeC-hhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECC
Confidence 356888888888 7777654 77888888888888532 4578888888888888888887777788888888888888
Q ss_pred CCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEc
Q 036879 154 FNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSL 233 (1029)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 233 (1029)
+|++++..|..|.++++|++|++++|++++ ..|..++++++|++|+|
T Consensus 89 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~---------------------------------~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 89 GNPIQSFSPGSFSGLTSLENLVAVETKLAS---------------------------------LESFPIGQLITLKKLNV 135 (606)
T ss_dssp TCCCCCCCTTSSTTCTTCCEEECTTSCCCC---------------------------------SSSSCCTTCTTCCEEEC
T ss_pred CCcccccChhhcCCcccCCEEEccCCcccc---------------------------------ccccccCCCCCCCEEeC
Confidence 888887778888888888887777777653 33456788999999999
Q ss_pred ccccccC-CCCccccccccccceeecccccccccC-------c----ccEEEccCCcccCCCCCCcccCCCCcEEEccCc
Q 036879 234 SVNNFIG-SIPREIGNITMLKGLYLVYTNLTGEIQ-------G----LQVLALSSNRLTGVIPPEIINISSLTVLSLTAN 301 (1029)
Q Consensus 234 s~N~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~l~-------~----L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 301 (1029)
++|++++ .+|..|+++++|+.|++++|++++..+ + +.+|++++|+++++.+..+... +|++|++++|
T Consensus 136 ~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n 214 (606)
T 3vq2_A 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGN 214 (606)
T ss_dssp CSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESC
T ss_pred CCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCC
Confidence 9999986 679999999999998888888875322 2 3478888888886666555554 7888888888
Q ss_pred ccCCCCCchhhhcccccceEeecCcccCC------CCCccccccc--ccceecC-CCccccCCCCCCCCCCCCCcccccc
Q 036879 302 NLLGNLPSNIGHSLPNLQQLILGGNRLTG------PIPSSISNAS--MLTLIDM-PYNLFSGFIPNSLGFCHPYDELGFL 372 (1029)
Q Consensus 302 ~l~~~lp~~~~~~l~~L~~L~L~~N~l~~------~~p~~l~~l~--~L~~L~l-s~N~l~~~~p~~~~~~~~~~~~~~~ 372 (1029)
.+.+......+..+++|+.+++..+.+.+ ..+..+..+. .++.+++ ..|.+.+.+|.
T Consensus 215 ~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-------------- 280 (606)
T 3vq2_A 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-------------- 280 (606)
T ss_dssp CSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS--------------
T ss_pred ccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc--------------
Confidence 87643333334468888888876655442 1122222222 3445555 55666655443
Q ss_pred cccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCC
Q 036879 373 TSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQ 452 (1029)
Q Consensus 373 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 452 (1029)
+..+++|+.|++++|.+. .+| .+..+.+ |+.|++++|++ +.+| .+ .+++|++|++++|+..+.. .+..++
T Consensus 281 --~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~-L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~ 350 (606)
T 3vq2_A 281 --FHCLANVSAMSLAGVSIK-YLE-DVPKHFK-WQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALP 350 (606)
T ss_dssp --CGGGTTCSEEEEESCCCC-CCC-CCCTTCC-CSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCT
T ss_pred --cccCCCCCEEEecCccch-hhh-hcccccc-CCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCC
Confidence 457899999999999997 556 7777776 99999999999 5777 45 9999999999999665433 678999
Q ss_pred CCCEEEeccccccCcc--cccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCC-CCccCCCCCcEE
Q 036879 453 KLQGLYLQHNKLQGSI--TTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIP-SSLWSLRDILNV 529 (1029)
Q Consensus 453 ~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L 529 (1029)
+|++|++++|++++.. +..+..+++|++|++++|.+.+ .|..+..+++|++|++++|++++..| ..+..+++|+.|
T Consensus 351 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 429 (606)
T 3vq2_A 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429 (606)
T ss_dssp TCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEE
T ss_pred CCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEE
Confidence 9999999999998774 7888999999999999999985 56899999999999999999999887 789999999999
Q ss_pred EccCCcccCcCCccccccccccEEEccCCcCCC-CCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcc
Q 036879 530 NLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSG-EIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNL 608 (1029)
Q Consensus 530 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 608 (1029)
++++|.+++..|..++.+++|+.|++++|.+++ .+|..|+.+++|+.|+|++|++++..|..|..+++|++|+|++|++
T Consensus 430 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 509 (606)
T 3vq2_A 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509 (606)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred ECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcC
Confidence 999999999999999999999999999999997 4789999999999999999999999999999999999999999999
Q ss_pred cCcCchhhhcccccceeeccCCCCcCCCCCCCCCC-ccCcccccCCCCCCCCCC
Q 036879 609 SGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFT-NLSSQSFVGNKGLCGAPE 661 (1029)
Q Consensus 609 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-~l~~~~~~~n~~~c~~~~ 661 (1029)
++.+|..+.++++|+.|++++|+++..++....+. ++..+.+.+|||.|+|+.
T Consensus 510 ~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 510 LFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp SCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 99999999999999999999999996544444454 588899999999999975
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=537.69 Aligned_cols=529 Identities=20% Similarity=0.215 Sum_probs=447.4
Q ss_pred CceeeEEEcCCCCceEEEecccccccccCCccCCCCcCCCeEeccCcccccCC-ccccccccCCceeecccccccCCCCC
Q 036879 36 CNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTL-PIQLSNLRRLKYLSFRSNNFSSIEIP 114 (1029)
Q Consensus 36 c~w~gv~c~~~~~~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~p 114 (1029)
|+|.+|.+ -..+++.|+|++|.+.+..|..+.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|+++.+ .|
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~-~p 90 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFL-HP 90 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEE-CT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCccc-CH
Confidence 56777776 4568999999999999888999999999999999999776666 78899999999999999999974 48
Q ss_pred CcCCCCCccceeccccccccCCCccc--ccCccccCeEeccCCcCcccCC-ccccCCCcCcccccCCCcCcccCCCCCCC
Q 036879 115 PWLDSFPKLEHLYLDGNSFIGTIPPS--ICNISSLLTLDLSFNQLQGHVP-SSILNIPSLLAIDLSNNQFSGPMPSIYNT 191 (1029)
Q Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~ 191 (1029)
..|+.+++|++|+|++|++++.+|.. |+++++|++|+|++|++++..| ..|.++++|++|+|++|.+++..+..+.
T Consensus 91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~- 169 (844)
T 3j0a_A 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE- 169 (844)
T ss_dssp TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGH-
T ss_pred hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcc-
Confidence 89999999999999999999877765 9999999999999999987655 5899999999999999999877664332
Q ss_pred CCcccccccccccchhccccccccCCCCcccccccc------cceEEcccccccCCCCcccccc---ccccceeeccccc
Q 036879 192 SPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQ------LKILSLSVNNFIGSIPREIGNI---TMLKGLYLVYTNL 262 (1029)
Q Consensus 192 ~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~------L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~l~~n~l 262 (1029)
.+...+|+.|+|+.|.+.+..|..++.+.+ |+.|++++|++++.+|..+... .+++.|.+..+..
T Consensus 170 ------~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~ 243 (844)
T 3j0a_A 170 ------PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243 (844)
T ss_dssp ------HHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred ------cccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence 112257889999999999989888887776 9999999999999888887754 3445454443322
Q ss_pred ccccCcccEEEccCCcccCCCCCCcccC--CCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCccccccc
Q 036879 263 TGEIQGLQVLALSSNRLTGVIPPEIINI--SSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNAS 340 (1029)
Q Consensus 263 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 340 (1029)
.. +++.|.+.+..+..|.++ ++|+.|+|++|.+.+..|.. +..+++|+.|+|++|++++..|..|..++
T Consensus 244 ~~--------~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~n~i~~~~~~~~~~l~ 314 (844)
T 3j0a_A 244 GA--------GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRV-FETLKDLKVLNLAYNKINKIADEAFYGLD 314 (844)
T ss_dssp BC--------SSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCC-SSSCCCCCEEEEESCCCCEECTTTTTTCS
T ss_pred cc--------cccccccCCCChhhhhccccCCccEEECCCCcccccChhh-hhcCCCCCEEECCCCcCCCCChHHhcCCC
Confidence 21 223556665666667765 78999999999997544444 45799999999999999999999999999
Q ss_pred ccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceecccccccccc
Q 036879 341 MLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSI 420 (1029)
Q Consensus 341 ~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~ 420 (1029)
+|+.|++++|.+.+..|..+ ..+++|+.|++++|++.+..+..+..+++ |++|++++|.+++.
T Consensus 315 ~L~~L~Ls~N~l~~~~~~~~---------------~~l~~L~~L~L~~N~i~~~~~~~~~~l~~-L~~L~Ls~N~l~~i- 377 (844)
T 3j0a_A 315 NLQVLNLSYNLLGELYSSNF---------------YGLPKVAYIDLQKNHIAIIQDQTFKFLEK-LQTLDLRDNALTTI- 377 (844)
T ss_dssp SCCEEEEESCCCSCCCSCSC---------------SSCTTCCEEECCSCCCCCCCSSCSCSCCC-CCEEEEETCCSCCC-
T ss_pred CCCEEECCCCCCCccCHHHh---------------cCCCCCCEEECCCCCCCccChhhhcCCCC-CCEEECCCCCCCcc-
Confidence 99999999999987766554 47899999999999999888888888887 99999999999843
Q ss_pred ccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccc-cccCCCCCcEEecCCCcccCcccc-cccc
Q 036879 421 PSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITT-DLCGLRSLSEFYSDGNELNGSLPQ-CLDS 498 (1029)
Q Consensus 421 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~-~~~~ 498 (1029)
..+++|+.|++++|+++ .+|.. ..+++.|++++|++++.... .+..+++|+.|++++|++++..+. .+..
T Consensus 378 ----~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 449 (844)
T 3j0a_A 378 ----HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449 (844)
T ss_dssp ----SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCS
T ss_pred ----cCCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCccccccccccccc
Confidence 23789999999999999 45543 56899999999999876443 356899999999999999866544 4667
Q ss_pred ccccceeeccCcccc-----CCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccc
Q 036879 499 LISLRTLSLGFNRLT-----SVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKN 573 (1029)
Q Consensus 499 l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 573 (1029)
+++|+.|+|++|.++ +..+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..|..+. ++
T Consensus 450 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~ 527 (844)
T 3j0a_A 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--AN 527 (844)
T ss_dssp CTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SC
T ss_pred CCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--cc
Confidence 899999999999997 44567799999999999999999999999999999999999999999987777776 89
Q ss_pred ccccccccccccccCCccccCCCCCCEEeCcCCcccCcCc
Q 036879 574 MQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIP 613 (1029)
Q Consensus 574 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 613 (1029)
|+.|+|++|+|++..|..|. +|+.|++++|.+....+
T Consensus 528 L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 528 LEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICECE 564 (844)
T ss_dssp CCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCSSS
T ss_pred ccEEECCCCcCCCCChhHhC---CcCEEEecCCCcccccc
Confidence 99999999999998887764 78999999999986543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=496.42 Aligned_cols=529 Identities=19% Similarity=0.202 Sum_probs=402.6
Q ss_pred ccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccC
Q 036879 56 AYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIG 135 (1029)
Q Consensus 56 ~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 135 (1029)
++.++. +||..+. +.++.|+|++|++++..+..|.++++|++|+|++|+++.+. |..|+.+++|++|+|++|++++
T Consensus 15 ~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~-~~~~~~l~~L~~L~L~~n~l~~ 90 (570)
T 2z63_A 15 MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE-DGAYQSLSHLSTLILTGNPIQS 90 (570)
T ss_dssp CSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEEC-TTTTTTCTTCCEEECTTCCCCE
T ss_pred CCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccC-cccccCchhCCEEeCcCCcCCc
Confidence 344554 6777553 57899999999999777888999999999999999988642 5678889999999999999887
Q ss_pred CCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhcccccccc
Q 036879 136 TIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLS 215 (1029)
Q Consensus 136 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~ 215 (1029)
..|..|+++++|++|++++|++++..+..+.++++|++|++++|.+++.
T Consensus 91 ~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~------------------------------- 139 (570)
T 2z63_A 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF------------------------------- 139 (570)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCC-------------------------------
T ss_pred cCHhhhcCccccccccccccccccCCCccccccccccEEecCCCcccee-------------------------------
Confidence 7778889999999999999999855555688888888888887776531
Q ss_pred CCCCcccccccccceEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcE
Q 036879 216 GQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTV 295 (1029)
Q Consensus 216 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 295 (1029)
.+|..|+++++|++|++++|++++..|..++.+++|..+ .+.|++++|.++++.|..+..+ +|++
T Consensus 140 -~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~-------------~~~L~l~~n~l~~~~~~~~~~~-~L~~ 204 (570)
T 2z63_A 140 -KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL-------------NLSLDLSLNPMNFIQPGAFKEI-RLHK 204 (570)
T ss_dssp -CCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTC-------------CCEEECTTCCCCEECTTTTTTC-EEEE
T ss_pred -cChhhhcccCCCCEEeCcCCccceecHHHccchhccchh-------------hhhcccCCCCceecCHHHhccC-ccee
Confidence 246677788888888888888887777777777666311 1367777777777666666655 6788
Q ss_pred EEccCcccCC-CCCchhhhcccccceEeecCcccC------CCCCccccccc--ccceecCCCc-cccCCCCCCCCCCCC
Q 036879 296 LSLTANNLLG-NLPSNIGHSLPNLQQLILGGNRLT------GPIPSSISNAS--MLTLIDMPYN-LFSGFIPNSLGFCHP 365 (1029)
Q Consensus 296 L~Ls~N~l~~-~lp~~~~~~l~~L~~L~L~~N~l~------~~~p~~l~~l~--~L~~L~ls~N-~l~~~~p~~~~~~~~ 365 (1029)
|++++|.... .+|..+ ..+++++.+.+.-+.+. ......+..+. .++.++++++ .+.+..|..
T Consensus 205 L~l~~n~~~~~~~~~~~-~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~------ 277 (570)
T 2z63_A 205 LTLRNNFDSLNVMKTCI-QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL------ 277 (570)
T ss_dssp EEEESCCSCTTHHHHHH-HTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTT------
T ss_pred Eecccccccccchhhhh-cCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhh------
Confidence 8887774432 222222 34666666555433221 12223333333 2455666665 555554443
Q ss_pred CcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCcccccccc
Q 036879 366 YDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIP 445 (1029)
Q Consensus 366 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 445 (1029)
+..+++|+.|++++|.+. .+|..+..+ . |+.|++++|.+. .+|. ..+++|+.|++++|.+.+..+
T Consensus 278 ---------~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~-L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~ 342 (570)
T 2z63_A 278 ---------FNCLTNVSSFSLVSVTIE-RVKDFSYNF-G-WQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFS 342 (570)
T ss_dssp ---------TGGGTTCSEEEEESCEEC-SCCBCCSCC-C-CSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCC
T ss_pred ---------hcCcCcccEEEecCccch-hhhhhhccC-C-ccEEeeccCccc-ccCc--ccccccCEEeCcCCccccccc
Confidence 346788888888888887 577777777 3 888888888888 4554 467889999999998886555
Q ss_pred ccccCCCCCCEEEeccccccCcc--cccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCC-CCccC
Q 036879 446 KAIGRLQKLQGLYLQHNKLQGSI--TTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIP-SSLWS 522 (1029)
Q Consensus 446 ~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~ 522 (1029)
. ..+++|++|++++|++++.. +..+..+++|++|++++|.+.+..+. +..+++|++|++++|++++..+ ..+..
T Consensus 343 ~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 419 (570)
T 2z63_A 343 E--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLS 419 (570)
T ss_dssp C--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTT
T ss_pred c--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhc
Confidence 4 67889999999999987664 66788889999999999998866555 8999999999999999988766 57889
Q ss_pred CCCCcEEEccCCcccCcCCccccccccccEEEccCCcCC-CCCCccccCcccccccccccccccccCCccccCCCCCCEE
Q 036879 523 LRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLS-GEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFL 601 (1029)
Q Consensus 523 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 601 (1029)
+++|+.|++++|.+++..|..+..+++|+.|++++|.++ +.+|..|..+++|+.|+|++|++++..|..|..+++|++|
T Consensus 420 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 499 (570)
T 2z63_A 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499 (570)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEE
Confidence 999999999999999888889999999999999999997 5688899999999999999999998889999999999999
Q ss_pred eCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCCCCC-CccCc--ccccCCCCCCCCC
Q 036879 602 DMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPF-TNLSS--QSFVGNKGLCGAP 660 (1029)
Q Consensus 602 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~~l~~--~~~~~n~~~c~~~ 660 (1029)
+|++|++++.+|..+.++++|+.|++++|+++|.+|....+ .++.. ..+.+.+ .|..|
T Consensus 500 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~ 560 (570)
T 2z63_A 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGS 560 (570)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTTT
T ss_pred eCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhccccCCCch-hhCCC
Confidence 99999999888888999999999999999999988864333 22222 2344544 66655
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=490.91 Aligned_cols=499 Identities=20% Similarity=0.205 Sum_probs=346.3
Q ss_pred CCceeeEEEcCCCCceEEEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCC
Q 036879 35 VCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIP 114 (1029)
Q Consensus 35 ~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p 114 (1029)
.|.|.|| |+.. ++++. +||+.+. ++|++|+|++|++++..|..|+++++|++|+|++|+++.+ .|
T Consensus 3 ~C~~~~~-c~~~----------~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~ 67 (549)
T 2z81_A 3 SCDASGV-CDGR----------SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI-EG 67 (549)
T ss_dssp EECTTSE-EECT----------TSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEE-CT
T ss_pred cCCCCce-EECC----------CCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCcc-Ch
Confidence 5999999 9654 34454 7888765 7899999999999988889999999999999999999964 36
Q ss_pred CcCCCCCccceeccccccccCCCcccccCccccCeEeccCCcCcc-cCCccccCCCcCcccccCCCcC-cccCCCCCCCC
Q 036879 115 PWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQG-HVPSSILNIPSLLAIDLSNNQF-SGPMPSIYNTS 192 (1029)
Q Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l-~~~~~~~~~~~ 192 (1029)
..|+.+++|++|+|++|++++..|..|+++++|++|+|++|++++ ..|..+.++++|++|++++|.+ ...++..+..
T Consensus 68 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~- 146 (549)
T 2z81_A 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG- 146 (549)
T ss_dssp TTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTT-
T ss_pred hhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhc-
Confidence 789999999999999999997777779999999999999999986 3577889999999999888874 3332222210
Q ss_pred CcccccccccccchhccccccccCCCCcccccccccceEEcccccccCCCCccccccccccceeecccccccccCcccEE
Q 036879 193 PLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVL 272 (1029)
Q Consensus 193 ~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L 272 (1029)
..+|++|++++|++++.+|..+..+++|++|++++|.+. .+|..+. +.+++|++|
T Consensus 147 --------l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~----------------~~l~~L~~L 201 (549)
T 2z81_A 147 --------LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFA----------------DILSSVRYL 201 (549)
T ss_dssp --------CCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHH----------------HSTTTBSEE
T ss_pred --------ccccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhH----------------hhcccccEE
Confidence 123444444445554444555555555555555544433 2222211 123345566
Q ss_pred EccCCcccCCC--C-CCcccCCCCcEEEccCcccCCCCCchhh---hcccccceEeecCcccCCCCCcccccccccceec
Q 036879 273 ALSSNRLTGVI--P-PEIINISSLTVLSLTANNLLGNLPSNIG---HSLPNLQQLILGGNRLTGPIPSSISNASMLTLID 346 (1029)
Q Consensus 273 ~Ls~N~l~~~~--p-~~~~~l~~L~~L~Ls~N~l~~~lp~~~~---~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 346 (1029)
+|++|++++.. | .....+++|+.|++++|.+.+..+..+. ..+++|+.|++++|.+.+...-
T Consensus 202 ~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~------------ 269 (549)
T 2z81_A 202 ELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDF------------ 269 (549)
T ss_dssp EEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCC------------
T ss_pred EccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccc------------
Confidence 66666666432 1 1223455666666666666543333322 1234555555555554432100
Q ss_pred CCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCC
Q 036879 347 MPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGN 426 (1029)
Q Consensus 347 ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~ 426 (1029)
+. .....+..+.+|+.|+++++.+.... .+. .++..+..
T Consensus 270 ----------~~-----------~~~~~~~~l~~L~~L~l~~~~i~~~~--~~~------------------~l~~~~~~ 308 (549)
T 2z81_A 270 ----------NP-----------SESDVVSELGKVETVTIRRLHIPQFY--LFY------------------DLSTVYSL 308 (549)
T ss_dssp ----------CC-----------CTTTCCCCCTTCCEEEEESCBCSCGG--GSC------------------CCCHHHHH
T ss_pred ----------cc-----------cchhhhhhhcccccccccccccchhh--hcc------------------cchhhhhh
Confidence 00 00112345667788888877654211 000 11122233
Q ss_pred cCcCcEEEecCccccccccccc-cCCCCCCEEEeccccccCccc---ccccCCCCCcEEecCCCcccCccc--ccccccc
Q 036879 427 LNNLTTLHLETNELTGSIPKAI-GRLQKLQGLYLQHNKLQGSIT---TDLCGLRSLSEFYSDGNELNGSLP--QCLDSLI 500 (1029)
Q Consensus 427 l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~l~ 500 (1029)
..+|+.|++++|+++ .+|..+ ..+++|++|+|++|++++..+ ..+..+++|+.|++++|++++..+ ..+..++
T Consensus 309 ~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~ 387 (549)
T 2z81_A 309 LEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387 (549)
T ss_dssp STTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCT
T ss_pred cccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCC
Confidence 467888888888887 455554 568888888888888876553 336677888888888888876543 5688889
Q ss_pred ccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccc
Q 036879 501 SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLA 580 (1029)
Q Consensus 501 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 580 (1029)
+|++|++++|+++ .+|..+..+++|+.|++++|++++ +|..+ .++|+.|++++|++++.+ ..+++|+.|+|+
T Consensus 388 ~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls 459 (549)
T 2z81_A 388 NLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYIS 459 (549)
T ss_dssp TCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECC
T ss_pred CCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECC
Confidence 9999999999998 467788888999999999999884 44433 258999999999998642 578899999999
Q ss_pred cccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCC
Q 036879 581 DNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 581 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 638 (1029)
+|+|+ .+|. ...+++|++|+|++|++++.+|..+..+++|+.|++++|+++|.+|.
T Consensus 460 ~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 460 RNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp SSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred CCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 99998 6665 46789999999999999988888899999999999999999887764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=477.33 Aligned_cols=515 Identities=21% Similarity=0.219 Sum_probs=414.4
Q ss_pred CeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccC
Q 036879 75 SLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSF 154 (1029)
Q Consensus 75 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 154 (1029)
..++.++.+++ .+|..+. +++++|+|++|+++.+. +..|..+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 85 (570)
T 2z63_A 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLG-SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85 (570)
T ss_dssp TEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEEC-TTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred cEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccC-hhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcC
Confidence 45677777777 6776543 46788888888877542 45677788888888888887766666777788888888888
Q ss_pred CcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcc
Q 036879 155 NQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLS 234 (1029)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 234 (1029)
|++++..|..|.++++|++|++++|++++ ..+..++.+++|++|+++
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---------------------------------l~~~~~~~l~~L~~L~L~ 132 (570)
T 2z63_A 86 NPIQSLALGAFSGLSSLQKLVAVETNLAS---------------------------------LENFPIGHLKTLKELNVA 132 (570)
T ss_dssp CCCCEECTTTTTTCTTCCEEECTTSCCCC---------------------------------STTCSCTTCTTCCEEECC
T ss_pred CcCCccCHhhhcCcccccccccccccccc---------------------------------CCCccccccccccEEecC
Confidence 88876666777777777777777776653 223357789999999999
Q ss_pred cccccC-CCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCC----cEEEccCcccCCCCCc
Q 036879 235 VNNFIG-SIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSL----TVLSLTANNLLGNLPS 309 (1029)
Q Consensus 235 ~N~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L----~~L~Ls~N~l~~~lp~ 309 (1029)
+|++++ .+|..|+++++|+ +|++++|++++..|..+..+++| +.|++++|.+.+ ++.
T Consensus 133 ~n~l~~~~lp~~~~~l~~L~-----------------~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~-~~~ 194 (570)
T 2z63_A 133 HNLIQSFKLPEYFSNLTNLE-----------------HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQP 194 (570)
T ss_dssp SSCCCCCCCCGGGGGCTTCC-----------------EEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCE-ECT
T ss_pred CCccceecChhhhcccCCCC-----------------EEeCcCCccceecHHHccchhccchhhhhcccCCCCcee-cCH
Confidence 999987 4788888887665 78888888888888889999988 899999999974 444
Q ss_pred hhhhcccccceEeecCcccCC-CCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccC
Q 036879 310 NIGHSLPNLQQLILGGNRLTG-PIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE 388 (1029)
Q Consensus 310 ~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 388 (1029)
..+. ..+|+.|++++|.... .++..+..++.++.+.+..+.+..... +. .+. ...+..+..+ .++.+++++
T Consensus 195 ~~~~-~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~--l~---~~~-~~~~~~l~~l-~l~~l~l~~ 266 (570)
T 2z63_A 195 GAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN--LE---KFD-KSALEGLCNL-TIEEFRLAY 266 (570)
T ss_dssp TTTT-TCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSS--CE---ECC-TTTTGGGGGS-EEEEEEEEE
T ss_pred HHhc-cCcceeEecccccccccchhhhhcCccccceeeeccccccCchh--hh---hcc-hhhhcccccc-chhhhhhhc
Confidence 4454 3489999999986542 345666777777766665443322100 00 000 0011112222 367888888
Q ss_pred C-cCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCc
Q 036879 389 N-PLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGS 467 (1029)
Q Consensus 389 N-~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 467 (1029)
+ .+.+..|..+..+.+ ++.|++++|.++ .+|..+..+ +|++|++++|.+. .+|. ..+++|++|++++|.+.+.
T Consensus 267 ~~~~~~~~~~~~~~l~~-L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~ 340 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTN-VSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNA 340 (570)
T ss_dssp TTEEESCSTTTTGGGTT-CSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCB
T ss_pred chhhhhhchhhhcCcCc-ccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCccccc
Confidence 8 778888888888877 999999999999 688888888 9999999999999 5564 4788999999999999766
Q ss_pred ccccccCCCCCcEEecCCCcccCcc--ccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCC-ccc
Q 036879 468 ITTDLCGLRSLSEFYSDGNELNGSL--PQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLP-VEI 544 (1029)
Q Consensus 468 ~~~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~ 544 (1029)
.+. ..+++|++|++++|.+++.. +..+..+++|++|++++|++++..+. +..+++|+.|++++|.+++..| ..+
T Consensus 341 ~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~ 417 (570)
T 2z63_A 341 FSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVF 417 (570)
T ss_dssp CCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTT
T ss_pred ccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhh
Confidence 555 78899999999999998665 78899999999999999999976655 9999999999999999998766 578
Q ss_pred cccccccEEEccCCcCCCCCCccccCccccccccccccccc-ccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccc
Q 036879 545 GNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQ-GSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLK 623 (1029)
Q Consensus 545 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 623 (1029)
..+++|+.|++++|.+++..|..|..+++|+.|+|++|+++ +.+|..+..+++|++|+|++|++++..|..+..+++|+
T Consensus 418 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 497 (570)
T 2z63_A 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497 (570)
T ss_dssp TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCC
Confidence 99999999999999999989999999999999999999998 57899999999999999999999999899999999999
Q ss_pred eeeccCCCCcCCCCC-CCCCCccCcccccCCCCCCCCCC
Q 036879 624 FLNLSFNGLQGQVPH-GGPFTNLSSQSFVGNKGLCGAPE 661 (1029)
Q Consensus 624 ~L~l~~N~l~~~~~~-~~~~~~l~~~~~~~n~~~c~~~~ 661 (1029)
.|++++|++++.+|. ...+++++.+.+.+||+.|+||.
T Consensus 498 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred EEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 999999999998775 35678889999999999999985
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=491.07 Aligned_cols=538 Identities=16% Similarity=0.202 Sum_probs=365.7
Q ss_pred hHHHHHHHHHHhccCCCCCcccCCCCCCCCC----CceeeEEEcCCC---CceEEEecccccccccCCccCCCCcCCCeE
Q 036879 5 RDQSALLALKAHVTNDPLNVLASNWSTNTSV----CNWFGVTCSPRH---RRVTALNLAYMGLLGTIPPELGNLSFLSLL 77 (1029)
Q Consensus 5 ~~~~al~~~~~~~~~~~~~~~~~~w~~~~~~----c~w~gv~c~~~~---~~v~~l~l~~~~l~~~~p~~~~~l~~L~~L 77 (1029)
.+...-.|+++-+..-. ..+|....+. |+|..-+.-+.. .-|++- . -..++.|
T Consensus 27 ~~~~d~~aL~~~~~~~~----~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~---~-------------~~~V~~L 86 (636)
T 4eco_A 27 EYIKDYLALKEIWDALN----GKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN---S-------------NGRVTGL 86 (636)
T ss_dssp HHHHHHHHHHHHHHHTT----GGGCCCCC------CCCCCSSCGGGTTCCTTEEEC---T-------------TCCEEEE
T ss_pred hHHHHHHHHHHHHHHcC----CCCcccCCcCCccCCCCCCCCCcccccCCCCeEEc---C-------------CCCEEEE
Confidence 34456677777774322 2358744432 479643221222 345541 0 0457899
Q ss_pred eccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCCcC
Q 036879 78 NVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQL 157 (1029)
Q Consensus 78 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 157 (1029)
+|++|+++|.+|.+|++|++|++|+|++|.+... +..++.. .+.-.+|+.. +..|+ +++++|.+
T Consensus 87 ~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~--~~~~~~~-----------~~~~~~~~~~--~~~l~-l~l~~~~l 150 (636)
T 4eco_A 87 SLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN--ERLFGPK-----------GISANMSDEQ--KQKMR-MHYQKTFV 150 (636)
T ss_dssp ECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGT--CCSBSTT-----------SBCTTCCHHH--HHHHH-THHHHHHT
T ss_pred EecCcccCCcCChHHhcCccceEEECcCCccccC--Ccccccc-----------ccccCchHHH--HHHHH-hhHHHhhh
Confidence 9999999999999999999999999999987421 1111100 0001223222 33344 44444444
Q ss_pred cccCCccccC-CCcCcccccCCCcCcccCCCCCCCCCcccccccccccchh--ccccccccCCCCcccccccccceEEcc
Q 036879 158 QGHVPSSILN-IPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAEL--HLAYNQLSGQIPSTLFECKQLKILSLS 234 (1029)
Q Consensus 158 ~~~~p~~~~~-l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L--~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 234 (1029)
.+.+|..+.. +..+..+++....+.... . -.++.+ ....|++++ +|..|+++++|++|+|+
T Consensus 151 ~~~~~~~~~~~~~~l~~~~l~~~~~~~~~-----~----------~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls 214 (636)
T 4eco_A 151 DYDPREDFSDLIKDCINSDPQQKSIKKSS-----R----------ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMG 214 (636)
T ss_dssp CCCGGGGSCHHHHHHHHHCTTSCCCCCCC-----C----------CCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEE
T ss_pred ccCchhhHHHHHHHHhhcCcccccccccc-----c----------cchhhhhhccccCCCcc-CCHHHhcccCCCEEECc
Confidence 4444443332 122333333332222100 0 012222 334688988 89999999999999999
Q ss_pred cccccCC-----------------CCcccc--ccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcE
Q 036879 235 VNNFIGS-----------------IPREIG--NITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTV 295 (1029)
Q Consensus 235 ~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 295 (1029)
+|++++. +|..++ ++++|+ +|+|++|++.+.+|..+.++++|++
T Consensus 215 ~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~-----------------~L~L~~n~l~~~~p~~l~~l~~L~~ 277 (636)
T 4eco_A 215 NSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLT-----------------DVEVYNCPNLTKLPTFLKALPEMQL 277 (636)
T ss_dssp SCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCC-----------------EEEEECCTTCSSCCTTTTTCSSCCE
T ss_pred CCccccccccccccccccchhcccCchhhhhcccCCCC-----------------EEEecCCcCCccChHHHhcCCCCCE
Confidence 9999985 888877 776655 7888888888899999999999999
Q ss_pred EEccCcc-cCC-CCCchhhhcc------cccceEeecCcccCCCCCc--ccccccccceecCCCccccCCCCCCCCCCCC
Q 036879 296 LSLTANN-LLG-NLPSNIGHSL------PNLQQLILGGNRLTGPIPS--SISNASMLTLIDMPYNLFSGFIPNSLGFCHP 365 (1029)
Q Consensus 296 L~Ls~N~-l~~-~lp~~~~~~l------~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~ 365 (1029)
|+|++|+ +++ .+|..++. + ++|++|+|++|+++ .+|. .++++++|+.|++++|.+.|.+| .+
T Consensus 278 L~Ls~n~~l~~~~lp~~~~~-L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~----- 349 (636)
T 4eco_A 278 INVACNRGISGEQLKDDWQA-LADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AF----- 349 (636)
T ss_dssp EECTTCTTSCHHHHHHHHHH-HHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CC-----
T ss_pred EECcCCCCCccccchHHHHh-hhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hh-----
Confidence 9999998 877 78888764 4 88899999998888 6776 77777777777777776665554 22
Q ss_pred CcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCc-CcEEEecCccccccc
Q 036879 366 YDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNN-LTTLHLETNELTGSI 444 (1029)
Q Consensus 366 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~ 444 (1029)
..+++|++|++++|+++ .+|..|.++++ |++|+|++|+++ .+
T Consensus 350 ----------~~l~~L~~L~L~~N~l~--------------------------~lp~~l~~l~~~L~~L~Ls~N~l~-~l 392 (636)
T 4eco_A 350 ----------GSEIKLASLNLAYNQIT--------------------------EIPANFCGFTEQVENLSFAHNKLK-YI 392 (636)
T ss_dssp ----------EEEEEESEEECCSSEEE--------------------------ECCTTSEEECTTCCEEECCSSCCS-SC
T ss_pred ----------CCCCCCCEEECCCCccc--------------------------cccHhhhhhcccCcEEEccCCcCc-cc
Confidence 24455555555555544 44455555555 666666666666 45
Q ss_pred cccccCCC--CCCEEEeccccccCccccccc-------CCCCCcEEecCCCcccCccccccccccccceeeccCccccCC
Q 036879 445 PKAIGRLQ--KLQGLYLQHNKLQGSITTDLC-------GLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSV 515 (1029)
Q Consensus 445 ~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 515 (1029)
|..+..++ +|++|++++|++++..|..|. .+++|+.|++++|+++...+..+..+++|++|+|++|+++.+
T Consensus 393 p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i 472 (636)
T 4eco_A 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472 (636)
T ss_dssp CSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBC
T ss_pred chhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCc
Confidence 55554433 566666666666665555555 556677777777777755555666788888888888888855
Q ss_pred CCCCccCCC-------CCcEEEccCCcccCcCCcccc--ccccccEEEccCCcCCCCCCccccCccccccccc------c
Q 036879 516 IPSSLWSLR-------DILNVNLSSNSLNGTLPVEIG--NLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSL------A 580 (1029)
Q Consensus 516 ~~~~~~~l~-------~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------~ 580 (1029)
.+..+.... +|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+| +
T Consensus 473 ~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls 550 (636)
T 4eco_A 473 PKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQ 550 (636)
T ss_dssp CSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTT
T ss_pred CHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccc
Confidence 555554443 9999999999999 6888887 99999999999999997 8999999999999999 5
Q ss_pred cccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCCC-C--CCccCcccccCCCCCC
Q 036879 581 DNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGG-P--FTNLSSQSFVGNKGLC 657 (1029)
Q Consensus 581 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~-~--~~~l~~~~~~~n~~~c 657 (1029)
+|++.+.+|..+..+++|++|+|++|+++ .+|..+. ++|+.|++++|++.+...... + ......+.+..+...|
T Consensus 551 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 627 (636)
T 4eco_A 551 GNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIR 627 (636)
T ss_dssp CCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC--TTCCEEECCSCTTCEEECTTTHHHHHTTCCEEECCTTSEEE
T ss_pred cCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhHh--CcCCEEECcCCCCccccHHhcchhhhcccceeecCCccccC
Confidence 68888899999999999999999999995 7777665 799999999999886433211 0 1222233344555566
Q ss_pred CCCC
Q 036879 658 GAPE 661 (1029)
Q Consensus 658 ~~~~ 661 (1029)
|||.
T Consensus 628 ~C~~ 631 (636)
T 4eco_A 628 GCDA 631 (636)
T ss_dssp SCGG
T ss_pred CCcc
Confidence 7764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=441.30 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=210.6
Q ss_pred CCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
++|.+.+.||+|+||+||+|++. +++.||||+++.......+.|.+|++++++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45778899999999999999863 478899999987766667889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEE
Q 036879 812 VLEYMPNGSLENWMYNKN------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACL 879 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl 879 (1029)
|||||++|+|.++++..+ ..+++.++..|+.|||+||+||| +++||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997542 46999999999999999999999 677999999999999999999999
Q ss_pred EccCCceecCCCCCce-eccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhcc
Q 036879 880 SDFGISKLLGDETSMT-QTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSL 953 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 953 (1029)
+|||+|+......... .....||++|||||+ .++.++|||||||++|||+| |+.||.+....+. ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~--~~------ 241 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV--IE------ 241 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HH------
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HH------
Confidence 9999998764433222 223468999999998 47889999999999999999 8999976321110 00
Q ss_pred chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 954 HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 954 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
.+.. ....+.|..++.++.+++.+||+.||++|||++|+.+.|+.+.+.-.
T Consensus 242 -----~i~~-------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 242 -----CITQ-------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp -----HHHH-------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred -----HHHc-------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 0000 00112234578889999999999999999999999999998876543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=437.59 Aligned_cols=260 Identities=26% Similarity=0.440 Sum_probs=205.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
..+++++.++||+|+||+||+|++.+ .||||+++... ....+.|.+|++++++++|||||+++|++.+ +..++||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 34678888999999999999998753 69999987543 3445789999999999999999999999865 4579999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC-
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET- 892 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 892 (1029)
|||++|+|.+++......+++.++..|+.|||+||+||| +++||||||||+|||+++++.+||+|||+|+......
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999999887788999999999999999999999 6779999999999999999999999999998764322
Q ss_pred CceeccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
........||+.|||||++ ++.++|||||||++|||+||+.||.+...... +...+... ...+..
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~~~~~-------~~~p~~ 259 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFMVGRG-------YASPDL 259 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHTT-------CCCCCS
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHHHhcC-------CCCCCc
Confidence 2223346799999999984 56789999999999999999999975321111 00000000 000000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
...+..++.++.+++.+||+.||++||||+||+++|+.+...+.
T Consensus 260 -------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 260 -------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp -------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred -------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 11223567889999999999999999999999999998876653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=479.45 Aligned_cols=564 Identities=18% Similarity=0.180 Sum_probs=406.3
Q ss_pred CCCcccCCCCCCCCCCceeeEEEcCCCCceEEEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCce
Q 036879 21 PLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKY 100 (1029)
Q Consensus 21 ~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 100 (1029)
+-+.+++ |+... +..|+.+.|......|. =++.+|. +||+.+- +++++|||++|+|++..|.+|.++++|++
T Consensus 9 ~~~~~~~-~~~~~-p~~~~~c~~~~~~~~~~---c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~ 80 (635)
T 4g8a_A 9 DDDKLAA-ANSSI-PESWEPCVEVVPNITYQ---CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQV 80 (635)
T ss_dssp ------------------CCSEEEETTTEEE---CTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred Ccchhhc-ccCCC-CCCCCCccccCCCCEEE---CCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCE
Confidence 3355666 66443 34577777764444443 2344555 7777652 47899999999999777789999999999
Q ss_pred eecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCc
Q 036879 101 LSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQ 180 (1029)
Q Consensus 101 L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 180 (1029)
|+|++|+|+.++ |..|+.+++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|+++++|++|+|++|+
T Consensus 81 L~Ls~N~i~~i~-~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~ 159 (635)
T 4g8a_A 81 LDLSRCEIQTIE-DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 159 (635)
T ss_dssp EECTTCCCCEEC-TTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSC
T ss_pred EECCCCcCCCcC-hhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCc
Confidence 999999999653 5678999999999999999997666789999999999999999997666789999999999999888
Q ss_pred CcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcccccccCCCCccccccccccceeeccc
Q 036879 181 FSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYT 260 (1029)
Q Consensus 181 l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n 260 (1029)
+++. .+|..++.+++|++|+|++|++++..|..|..+.+++.+
T Consensus 160 l~~~--------------------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~----- 202 (635)
T 4g8a_A 160 IQSF--------------------------------KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL----- 202 (635)
T ss_dssp CCCC--------------------------------CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC-----
T ss_pred cccC--------------------------------CCchhhccchhhhhhcccCccccccccccccchhhhhhh-----
Confidence 7632 246677788889999999999888888888877766532
Q ss_pred ccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcc------cCCCCCc
Q 036879 261 NLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNR------LTGPIPS 334 (1029)
Q Consensus 261 ~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~------l~~~~p~ 334 (1029)
+..++++.|.++.+.+..+ ....++.+++++|.....++...+..+..++...+..+. +......
T Consensus 203 --------~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~ 273 (635)
T 4g8a_A 203 --------NLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 273 (635)
T ss_dssp --------CCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTT
T ss_pred --------hhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccccc
Confidence 2367788888875554444 344577888887766544555555567777766665433 2333445
Q ss_pred ccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceecccc
Q 036879 335 SISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSAC 414 (1029)
Q Consensus 335 ~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n 414 (1029)
.+.....+...++..+......... ...+..+.+++.+++.++.+....+ +..... ++.|++.+|
T Consensus 274 ~~~~~~~l~~~~l~~~~~~~~~~~~------------~~~~~~~~~l~~l~~~~~~~~~~~~--~~~~~~-L~~L~l~~~ 338 (635)
T 4g8a_A 274 ALEGLCNLTIEEFRLAYLDYYLDGI------------IDLFNCLTNVSSFSLVSVTIERVKD--FSYNFG-WQHLELVNC 338 (635)
T ss_dssp TTGGGGGSEEEEEEEECCCSCEEEC------------TTTTGGGTTCSEEEEESCEEEECGG--GGSCCC-CSEEEEESC
T ss_pred ccccccchhhhhhhhhhhcccccch------------hhhhhhhcccccccccccccccccc--cccchh-hhhhhcccc
Confidence 5555666666655554433221111 1223456677888888887764332 222233 778888888
Q ss_pred ccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCc--ccccccCCCCCcEEecCCCcccCcc
Q 036879 415 NIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGS--ITTDLCGLRSLSEFYSDGNELNGSL 492 (1029)
Q Consensus 415 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~l~~N~l~~~~ 492 (1029)
.+....+. .+..|+.+++..|.+... ..+..+++|+.|++++|.+... .+..+..+.+|+.+++..|.+.. .
T Consensus 339 ~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~ 412 (635)
T 4g8a_A 339 KFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-M 412 (635)
T ss_dssp EESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-E
T ss_pred cccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-c
Confidence 88755443 356788888888887632 2345678888888888887543 34556677888888888888763 4
Q ss_pred ccccccccccceeeccCccccCCCC-CCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCC-CCCCccccC
Q 036879 493 PQCLDSLISLRTLSLGFNRLTSVIP-SSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLS-GEIPSSIGD 570 (1029)
Q Consensus 493 ~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~ 570 (1029)
+..+..+++|+.++++.|......+ ..|..+++++.++++.|.+++..+..+..++.|+.|+|++|.+. +..|..|..
T Consensus 413 ~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~ 492 (635)
T 4g8a_A 413 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 492 (635)
T ss_dssp CSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred cccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhh
Confidence 5567788888888888877765543 46778888888888888888888888888888888888888743 456778888
Q ss_pred cccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCC-CCC-CccCcc
Q 036879 571 LKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHG-GPF-TNLSSQ 648 (1029)
Q Consensus 571 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~-~~l~~~ 648 (1029)
+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|++++.+|.. ..+ ++++.+
T Consensus 493 l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L 572 (635)
T 4g8a_A 493 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 572 (635)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEE
T ss_pred ccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEE
Confidence 888888888888888888888888888888999888888888888888888888899888888877763 233 567788
Q ss_pred cccCCCCCCCCC
Q 036879 649 SFVGNKGLCGAP 660 (1029)
Q Consensus 649 ~~~~n~~~c~~~ 660 (1029)
.+.+|||.|+|.
T Consensus 573 ~L~~Np~~C~C~ 584 (635)
T 4g8a_A 573 NLTQNDFACTCE 584 (635)
T ss_dssp ECTTCCBCCSGG
T ss_pred EeeCCCCcccCC
Confidence 888999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=443.22 Aligned_cols=256 Identities=26% Similarity=0.446 Sum_probs=204.5
Q ss_pred CCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
++|.+.++||+|+||+||+|++. +++.||||+++.......+.|.+|++++++++|||||+++|+|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34667789999999999999864 478899999987766667889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcE
Q 036879 812 VLEYMPNGSLENWMYNKN--------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVA 877 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~ 877 (1029)
|||||++|+|.++++... ..+++.++..|+.|||+||+||| +++||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 999999999999997542 35899999999999999999999 6779999999999999999999
Q ss_pred EEEccCCceecCCCCC-ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchh
Q 036879 878 CLSDFGISKLLGDETS-MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVND 951 (1029)
Q Consensus 878 kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 951 (1029)
||+|||+|+....... .......||+.|||||++ ++.++|||||||++|||+| |+.||.+....+. .
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~--~----- 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA--I----- 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH--H-----
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH--H-----
Confidence 9999999987643322 223346799999999984 6789999999999999999 8999976321110 0
Q ss_pred ccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 952 SLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 952 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
..+. . ....+.|..+++++.+++.+||+.||++||||+||+++|+.+.+...
T Consensus 271 -------~~i~---~---g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 271 -------DCIT---Q---GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp -------HHHH---H---TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred -------HHHH---c---CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 0000 0 01122344578889999999999999999999999999999887543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=471.61 Aligned_cols=491 Identities=19% Similarity=0.211 Sum_probs=374.8
Q ss_pred eEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCC
Q 036879 76 LLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFN 155 (1029)
Q Consensus 76 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 155 (1029)
..|.++|+++ .+|..+. ++|++|+|++|+++.+ .|..|..+++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 9 ~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 84 (549)
T 2z81_A 9 VCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYI-GHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84 (549)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEE-CSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred eEECCCCccc-cccccCC--CCccEEECcCCccCcc-ChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCC
Confidence 4577888887 7777654 6888888888888753 2567888888888888888888777778888888888888888
Q ss_pred cCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEccc
Q 036879 156 QLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSV 235 (1029)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 235 (1029)
++++..|..|.++++|++|++++|++++. ..|..++++++|++|++++
T Consensus 85 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~--------------------------------~~~~~~~~l~~L~~L~L~~ 132 (549)
T 2z81_A 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTL--------------------------------GVTSLFPNLTNLQTLRIGN 132 (549)
T ss_dssp CCCSCCHHHHTTCTTCCEEECTTCCCSSS--------------------------------CSSCSCTTCTTCCEEEEEE
T ss_pred ccCccCHHHhccCCCCcEEECCCCccccc--------------------------------chhhhhhccCCccEEECCC
Confidence 88866666688888888888887776632 1345677788888888888
Q ss_pred ccccCCCC-ccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhc
Q 036879 236 NNFIGSIP-REIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHS 314 (1029)
Q Consensus 236 N~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~ 314 (1029)
|++.+.+| ..|+++++| ++|+|++|++++..|..+.++++|++|+++.|.+. .+|..++..
T Consensus 133 n~~~~~~~~~~~~~l~~L-----------------~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~ 194 (549)
T 2z81_A 133 VETFSEIRRIDFAGLTSL-----------------NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADI 194 (549)
T ss_dssp SSSCCEECTTTTTTCCEE-----------------EEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHS
T ss_pred CccccccCHhhhhccccc-----------------CeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhh
Confidence 88555554 456665544 47777788888888888888999999999988884 777777667
Q ss_pred ccccceEeecCcccCCCC---CcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcC
Q 036879 315 LPNLQQLILGGNRLTGPI---PSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPL 391 (1029)
Q Consensus 315 l~~L~~L~L~~N~l~~~~---p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 391 (1029)
+++|++|++++|++++.. ......+++|+.|++++|.+.+..+..+ ...+..+++|+.|++++|.+
T Consensus 195 l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l-----------~~~~~~~~~L~~l~l~~~~~ 263 (549)
T 2z81_A 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL-----------LKLLRYILELSEVEFDDCTL 263 (549)
T ss_dssp TTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHH-----------HGGGGGCTTCCEEEEESCEE
T ss_pred cccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHH-----------HHHhhhhccccccccccccc
Confidence 889999999999988642 1223345666677777766654332211 12234456666666666665
Q ss_pred CCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCcccccc-----ccccccCCCCCCEEEeccccccC
Q 036879 392 SGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGS-----IPKAIGRLQKLQGLYLQHNKLQG 466 (1029)
Q Consensus 392 ~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~ 466 (1029)
.+... +. ......+..+.+|+.|++.++.+... ++..+...++|+.|++++|+++.
T Consensus 264 ~~~~~-----~~--------------~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ 324 (549)
T 2z81_A 264 NGLGD-----FN--------------PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL 324 (549)
T ss_dssp ECCSC-----CC--------------CCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCC
T ss_pred ccccc-----cc--------------ccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCcccc
Confidence 53211 00 01123355678889999999887632 22334456789999999999986
Q ss_pred cccccccCCCCCcEEecCCCcccCccc---cccccccccceeeccCccccCCCC--CCccCCCCCcEEEccCCcccCcCC
Q 036879 467 SITTDLCGLRSLSEFYSDGNELNGSLP---QCLDSLISLRTLSLGFNRLTSVIP--SSLWSLRDILNVNLSSNSLNGTLP 541 (1029)
Q Consensus 467 ~~~~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~p 541 (1029)
.+...+..+++|++|++++|++.+..| ..++.+++|++|+|++|+++++.+ ..+..+++|+.|++++|+++ .+|
T Consensus 325 ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp 403 (549)
T 2z81_A 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMP 403 (549)
T ss_dssp CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCC
T ss_pred CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCC
Confidence 555555789999999999999998764 447899999999999999987643 56899999999999999999 688
Q ss_pred ccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccc
Q 036879 542 VEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSL 621 (1029)
Q Consensus 542 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 621 (1029)
..+..+++|++|++++|+++ .+|..+. ++|+.|+|++|+|++.+ ..+++|++|+|++|+|+ .+|. ...+++
T Consensus 404 ~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~ 474 (549)
T 2z81_A 404 DSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPV 474 (549)
T ss_dssp SCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTT
T ss_pred hhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCcc
Confidence 88999999999999999998 4454442 68999999999999643 57899999999999999 5665 467999
Q ss_pred cceeeccCCCCcCCCCC-CCCCCccCcccccCCCCCCCCC
Q 036879 622 LKFLNLSFNGLQGQVPH-GGPFTNLSSQSFVGNKGLCGAP 660 (1029)
Q Consensus 622 L~~L~l~~N~l~~~~~~-~~~~~~l~~~~~~~n~~~c~~~ 660 (1029)
|+.|++++|++++.+|. ...+.++..+.+.+|||.|+||
T Consensus 475 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 99999999999998876 4667888999999999999887
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=436.49 Aligned_cols=250 Identities=24% Similarity=0.420 Sum_probs=204.1
Q ss_pred CCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
.+++.+.||+|+||+||+|++. +++.||||+++.... ...+.|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3556789999999999999862 568899999976543 345789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc
Q 036879 812 VLEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV 876 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~ 876 (1029)
|||||++|+|.+++.... ..+++.++..|+.|||+||+||| +++||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence 999999999999996532 35899999999999999999999 677999999999999999999
Q ss_pred EEEEccCCceecCCCC-CceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhch
Q 036879 877 ACLSDFGISKLLGDET-SMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVN 950 (1029)
Q Consensus 877 ~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 950 (1029)
+||+|||+|+...... ........||++|||||+ .++.++|||||||++|||+| |+.||.+....+ +.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~---- 257 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VV---- 257 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HH----
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HH----
Confidence 9999999998664322 222334579999999998 47889999999999999998 899997632111 11
Q ss_pred hccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 951 DSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 951 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
..+.. ....+.|..++..+.+++.+||+.||++||||+||+++|+.+
T Consensus 258 --------~~i~~------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 --------EMIRN------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --------HHHHT------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --------HHHHc------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11100 011223456788899999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=433.80 Aligned_cols=246 Identities=22% Similarity=0.281 Sum_probs=205.8
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
..|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++++.++|||||++++++.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46889999999999999999976 79999999998776666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
+||+|.+++.. ..+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+.+..... ..
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 227 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 227 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cc
Confidence 99999999864 45999999999999999999999 77799999999999999999999999999998754432 23
Q ss_pred ccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
...+||+.|||||++ ++.++||||+||++|||++|++||.+....+ .... +.+.. ...
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~--------i~~~~--------~~~ 289 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKM--------IRDNL--------PPR 289 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH--------HHHSS--------CCC
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHH--------HHcCC--------CCC
Confidence 446899999999984 7889999999999999999999997531111 0000 00000 001
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+..++.++.+++.+||..||++|||++|++++
T Consensus 290 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 290 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11123456788999999999999999999999885
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=434.78 Aligned_cols=247 Identities=22% Similarity=0.338 Sum_probs=198.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++++++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999975 79999999997653 334578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 814 EYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+||+|.+++...+ ..+++..+..|+.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999997554 45799999999999999999999 7789999999999999999999999999998764321
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
......+||+.|||||++ ++.++||||+||++|||++|+.||.+....+ ... .......
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-----~~~--------~i~~~~~--- 242 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-----LVL--------KIISGSF--- 242 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHH--------HHHHTCC---
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----HHH--------HHHcCCC---
Confidence 122345799999999984 6779999999999999999999997532111 011 1111000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+..++.++.+++.+||+.||++|||++|++++
T Consensus 243 ----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 243 ----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01123456789999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=428.69 Aligned_cols=252 Identities=22% Similarity=0.266 Sum_probs=204.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.+.|+..++||+|+||+||+|++. +|+.||||+++.... ..+|+++++.++|||||++++++.+++..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 345778889999999999999975 799999999975422 24799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC-cEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM-VACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+||+|.+++.+. +.+++..+..++.||+.||+||| +++||||||||+|||++.++ .+||+|||+|+.+......
T Consensus 132 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999999654 56999999999999999999999 78899999999999999987 6999999999877543211
Q ss_pred ----eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 895 ----TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 895 ----~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.....+||+.|||||++ ++.++||||+||++|||++|++||.+....+. ...+ ..
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i-----------~~---- 270 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLKI-----------AS---- 270 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HHHH-----------HH----
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHH-----------Hc----
Confidence 12235799999999984 67899999999999999999999976422211 1000 00
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
........+..++..+.+++.+||+.||++|||+.|+++++..+....
T Consensus 271 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 271 -EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp -SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 000111223456788999999999999999999999999998877654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=426.69 Aligned_cols=272 Identities=22% Similarity=0.317 Sum_probs=201.9
Q ss_pred CCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCC----eEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDH----FKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 813 (1029)
++|.+.+.||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||++++++.+++ ..++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3567788999999999999988 6899999998754321 223345666667889999999999997653 579999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD-----HPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
||+++|+|.+++.. ..+++..+.+++.|+++||+|||+. ++++||||||||+|||++.++++||+|||+|+..
T Consensus 81 Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999965 4589999999999999999999954 3448999999999999999999999999999876
Q ss_pred CCCCCc---eeccccCCccccCccCC----------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc-c
Q 036879 889 GDETSM---TQTQTLATIGYMAPEWK----------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL-H 954 (1029)
Q Consensus 889 ~~~~~~---~~~~~~gt~~y~aPE~~----------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~ 954 (1029)
...... .....+||+.|||||++ ++.++|||||||++|||+||++||......+..+........ .
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 543322 12235799999999985 345799999999999999999988664443333333221111 0
Q ss_pred hhhhhhh-hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 955 GKIINVV-DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 955 ~~~~~~~-d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
..+...+ +...... -+.......++..+.+++.+||+.||++||||+||++.|+++.+.
T Consensus 239 ~~~~~~~~~~~~rp~-~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPN-IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCCCCC-CCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhcccCCCC-CCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1111111 1111000 000111234567899999999999999999999999999998764
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=459.73 Aligned_cols=440 Identities=18% Similarity=0.181 Sum_probs=277.2
Q ss_pred CccceeccccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCccccccc
Q 036879 121 PKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQ 200 (1029)
Q Consensus 121 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~ 200 (1029)
++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++++++. .+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l--------- 89 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PT--------- 89 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CC---------
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--cc---------
Confidence 4455555555555544444555555555555555555544455555555555555555555433222 11
Q ss_pred ccccchhccccccccC-CCCcccccccccceEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcc
Q 036879 201 YNSLAELHLAYNQLSG-QIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRL 279 (1029)
Q Consensus 201 ~~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l 279 (1029)
.+|++|+|++|++++ .+|..|+.+++|++|++++|++++ ..+..+++| +|+.|+|++|++
T Consensus 90 -~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L---------------~L~~L~l~~n~l 150 (520)
T 2z7x_B 90 -VNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHL---------------NISKVLLVLGET 150 (520)
T ss_dssp -CCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTS---------------CEEEEEEEECTT
T ss_pred -CCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccc---------------eeeEEEeecccc
Confidence 134444555555554 357788888999999999988875 345555444 136788888888
Q ss_pred --cCCCCCCcccCC-CCcEEEccCcccCCCCCchhhhcccccceEeecCcc-------cCCCCCcccccccccceecCCC
Q 036879 280 --TGVIPPEIINIS-SLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNR-------LTGPIPSSISNASMLTLIDMPY 349 (1029)
Q Consensus 280 --~~~~p~~~~~l~-~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~-------l~~~~p~~l~~l~~L~~L~ls~ 349 (1029)
++..|..+..+. +...+++++|.+.+.++...+..+++|+.|++++|. +.+.+| .+..+++|+.|++++
T Consensus 151 ~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~ 229 (520)
T 2z7x_B 151 YGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNN 229 (520)
T ss_dssp TTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEE
T ss_pred cccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccc
Confidence 777788877766 355678888888877777776778888888888886 443333 444444444444444
Q ss_pred ccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCc--hhhhcceecccccccccccccc---
Q 036879 350 NLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNL--SNAMDVLYLSACNIKGSIPSEI--- 424 (1029)
Q Consensus 350 N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~~L~~L~L~~n~l~~~~p~~~--- 424 (1029)
|.+ ++..+..+... ...|++|++++|++++.+|..+
T Consensus 230 ~~l---------------------------------------~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~ 270 (520)
T 2z7x_B 230 IET---------------------------------------TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY 270 (520)
T ss_dssp EEE---------------------------------------EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCC
T ss_pred ccc---------------------------------------CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhc
Confidence 444 32211111100 0125566666666665666655
Q ss_pred --CCcCcCcEEEecCcccccccc-ccccCC---CCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCcccccccc
Q 036879 425 --GNLNNLTTLHLETNELTGSIP-KAIGRL---QKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDS 498 (1029)
Q Consensus 425 --~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 498 (1029)
.++++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..+++|++|++++|++++..|..++.
T Consensus 271 ~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 346 (520)
T 2z7x_B 271 SGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGH 346 (520)
T ss_dssp CSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCC
T ss_pred ccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhcc
Confidence 6677777777777777 233 444443 56777777777765332 1256667777777777777667777777
Q ss_pred ccccceeeccCccccC--CCCCCccCCCCCcEEEccCCcccCcCCc-cccccccccEEEccCCcCCCCCCccccCccccc
Q 036879 499 LISLRTLSLGFNRLTS--VIPSSLWSLRDILNVNLSSNSLNGTLPV-EIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQ 575 (1029)
Q Consensus 499 l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 575 (1029)
+++|++|+|++|++++ ..|..+..+++|+.|++++|.+++.+|. .+..+++|+.|++++|++++..|..+. ++|+
T Consensus 347 l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~ 424 (520)
T 2z7x_B 347 LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIK 424 (520)
T ss_dssp CSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCC
T ss_pred CCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCC
Confidence 7777777777777775 3445677777777777777777763443 466777777777777777766665554 6777
Q ss_pred ccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCC
Q 036879 576 HLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 576 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 637 (1029)
.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..+..+++|+.|++++|+++|.++
T Consensus 425 ~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 425 VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp EEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred EEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 7788888777 667666677788888888888774433447777778888888877776554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=423.42 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=203.7
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|++++++++|||||++++++++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999875 79999999997642 334567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||++||+|.+++.+ .+.+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999964 456999999999999999999999 77899999999999999999999999999998754322
Q ss_pred -ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 894 -MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 894 -~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
......+||+.|||||++ ++.++||||+||++|||++|+.||.+....+. ... ... ..
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-----~~~--------i~~----~~ 250 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI-----FAK--------IIK----LE 250 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHH--------HHH----TC
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHH--------HHc----CC
Confidence 233456899999999984 78899999999999999999999975311110 000 000 00
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+..+++++.+++.+|+..||++|||++|+..+
T Consensus 251 ----~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 251 ----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ----CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ----CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 11123356778999999999999999999997543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=413.95 Aligned_cols=243 Identities=24% Similarity=0.388 Sum_probs=188.2
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999875 79999999997643 23356799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+ +|+|.+++.+ .+.+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EeCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 9999 6899999865 456999999999999999999999 7789999999999999999999999999998764432
Q ss_pred CceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.....+||+.|||||++ .+.++||||+||++|||++|+.||.+.... ..... ...
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-----~~~~~--------i~~----- 226 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-----VLFKN--------ISN----- 226 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH--------HHH-----
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHH--------HHc-----
Confidence 22346799999999983 356899999999999999999999752111 10000 000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....+..+++++.+++.+|++.||++|||++|++++
T Consensus 227 ---~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 227 ---GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0011123356778999999999999999999999985
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=467.32 Aligned_cols=468 Identities=18% Similarity=0.219 Sum_probs=297.5
Q ss_pred CccceeccccccccCCCcccccCccccCeEec-cCCcCcccCCccccCC----CcCc--ccc----------cCCCcCcc
Q 036879 121 PKLEHLYLDGNSFIGTIPPSICNISSLLTLDL-SFNQLQGHVPSSILNI----PSLL--AID----------LSNNQFSG 183 (1029)
Q Consensus 121 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L-s~N~l~~~~p~~~~~l----~~L~--~L~----------ls~N~l~~ 183 (1029)
..++.|+|++|.+.|.+|+.|++|++|++|+| ++|.+.|..|-..... +..+ .+. .....+++
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 45777777777777777777777777777777 7777766544321111 0000 000 00000000
Q ss_pred cC-------CCCCCCCCcccccccccccchhcccc--ccccCCCCcccccccccceEEcccccccCC-------------
Q 036879 184 PM-------PSIYNTSPLQNIDMQYNSLAELHLAY--NQLSGQIPSTLFECKQLKILSLSVNNFIGS------------- 241 (1029)
Q Consensus 184 ~~-------~~~~~~~~l~~l~l~~~~L~~L~Ls~--N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~------------- 241 (1029)
.. +....... ...-.++.+.++. |++++ +|..|+++++|++|+|++|++++.
T Consensus 403 l~~~~l~~~~~~~~i~~-----~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~ 476 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKK-----DSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY 476 (876)
T ss_dssp HHHHHHHTCTTSCCCCC-----CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHH
T ss_pred HHHHHhhhCcccccccc-----ccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccccccccc
Confidence 00 00000000 0011233444443 77776 777777777888888888777762
Q ss_pred ----CCcccc--ccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcc-cCC-CCCchhhh
Q 036879 242 ----IPREIG--NITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANN-LLG-NLPSNIGH 313 (1029)
Q Consensus 242 ----~p~~~~--~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~lp~~~~~ 313 (1029)
+|..++ ++++|+ +|+|++|++.+.+|..|.++++|++|+|++|+ +++ .+|..++.
T Consensus 477 ~~g~iP~~l~f~~L~~L~-----------------~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~ 539 (876)
T 4ecn_A 477 AKQYENEELSWSNLKDLT-----------------DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539 (876)
T ss_dssp HHHHTTSCCCGGGCTTCC-----------------EEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHH
T ss_pred ccccCChhhhhccCCCCC-----------------EEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHh
Confidence 444443 443333 45555555555555555555555555555555 544 45554432
Q ss_pred ccc-------ccceEeecCcccCCCCCc--ccccccccceecCCCccccCCCCCCCCCCCCCccccccccccccccccee
Q 036879 314 SLP-------NLQQLILGGNRLTGPIPS--SISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKL 384 (1029)
Q Consensus 314 ~l~-------~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L 384 (1029)
++ +|++|+|++|+++ .+|. .|.++ ++|+.|
T Consensus 540 -L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L---------------------------------------~~L~~L 578 (876)
T 4ecn_A 540 -LADDEDTGPKIQIFYMGYNNLE-EFPASASLQKM---------------------------------------VKLGLL 578 (876)
T ss_dssp -HHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTC---------------------------------------TTCCEE
T ss_pred -hhhcccccCCccEEEeeCCcCC-ccCChhhhhcC---------------------------------------CCCCEE
Confidence 33 5555555555555 4444 44444 455555
Q ss_pred eccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCc-CcEEEecCccccccccccccCCCC--CCEEEecc
Q 036879 385 ILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNN-LTTLHLETNELTGSIPKAIGRLQK--LQGLYLQH 461 (1029)
Q Consensus 385 ~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~L~~ 461 (1029)
+|++|+++ .+| .+..+.+ |+.|+|++|+++ .+|..|.++++ |++|+|++|+|+ .+|..+..++. |+.|+|++
T Consensus 579 ~Ls~N~l~-~lp-~~~~L~~-L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~ 653 (876)
T 4ecn_A 579 DCVHNKVR-HLE-AFGTNVK-LTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSY 653 (876)
T ss_dssp ECTTSCCC-BCC-CCCTTSE-ESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCS
T ss_pred ECCCCCcc-cch-hhcCCCc-ceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcC
Confidence 55555555 444 4455444 566666666666 56666666666 777777777776 55666655543 77777777
Q ss_pred ccccCcccccc---c--CCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCC-------CCCcEE
Q 036879 462 NKLQGSITTDL---C--GLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSL-------RDILNV 529 (1029)
Q Consensus 462 N~l~~~~~~~~---~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-------~~L~~L 529 (1029)
|++.+.++... . .+++|+.|++++|+++...+..+..+++|+.|+|++|+|+.+.+..+... ++|+.|
T Consensus 654 N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L 733 (876)
T 4ecn_A 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTI 733 (876)
T ss_dssp SCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEE
T ss_pred CcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEE
Confidence 77766544322 1 23477788888888875555555688899999999999985544444433 399999
Q ss_pred EccCCcccCcCCcccc--ccccccEEEccCCcCCCCCCccccCccccccccccc------ccccccCCccccCCCCCCEE
Q 036879 530 NLSSNSLNGTLPVEIG--NLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLAD------NKFQGSIPDSLGGLTSLNFL 601 (1029)
Q Consensus 530 ~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~------N~l~~~~~~~~~~l~~L~~L 601 (1029)
+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |++.+.+|..|..+++|++|
T Consensus 734 ~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L 811 (876)
T 4ecn_A 734 DLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811 (876)
T ss_dssp ECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEE
T ss_pred ECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEE
Confidence 99999999 6788887 99999999999999997 799999999999999976 88888999999999999999
Q ss_pred eCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCC-CCCCccCcccccCCCCC--CCCCCC
Q 036879 602 DMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHG-GPFTNLSSQSFVGNKGL--CGAPEL 662 (1029)
Q Consensus 602 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~--c~~~~~ 662 (1029)
+|++|+| +.+|..+. ++|+.|+|++|++....+.. .+........+.+|++. ||||..
T Consensus 812 ~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC~~L 872 (876)
T 4ecn_A 812 QIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDAL 872 (876)
T ss_dssp ECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESCGGG
T ss_pred ECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccccCCCCCc
Confidence 9999999 57887765 69999999999998644321 11223344556666655 477643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=435.03 Aligned_cols=246 Identities=22% Similarity=0.282 Sum_probs=205.7
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|+.++|||||+++++|.+++..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999976 79999999998776666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
+||+|.+++.. ..+++..+..++.||+.||+||| ++|||||||||+|||++.+|.+||+|||+|+.+..... ..
T Consensus 231 ~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 304 (423)
T 4fie_A 231 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 304 (423)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CB
T ss_pred CCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cc
Confidence 99999999854 45899999999999999999999 77899999999999999999999999999998754432 23
Q ss_pred ccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
...+||+.|||||++ ++.++||||+||++|||++|+.||.+....+. ... +..... ..
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~--------i~~~~~--------~~ 366 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKM--------IRDNLP--------PR 366 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHH--------HHHSCC--------CC
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHH--------HHcCCC--------CC
Confidence 446799999999984 78899999999999999999999975311110 000 000000 00
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+..++.++.+++.+||..||++|||++|++++
T Consensus 367 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 367 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11122356788999999999999999999999885
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=413.19 Aligned_cols=242 Identities=25% Similarity=0.404 Sum_probs=194.5
Q ss_pred CCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEec----CCeEEEEE
Q 036879 741 SENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSS----DHFKALVL 813 (1029)
Q Consensus 741 ~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 813 (1029)
++.++||+|+||+||+|++. +++.||+|++.... ....+.|.+|++++++++|||||+++++|.+ ++..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999875 78999999997543 3345679999999999999999999999865 35679999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCEEEC-CCCcEEEEccCCceecCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP--IIHCDLNPSNILLN-ESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~g--ivH~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~ 890 (1029)
|||++|+|.+++.+ ...+++..+..++.||+.||+||| +++ ||||||||+|||++ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999964 456899999999999999999999 666 99999999999998 489999999999986433
Q ss_pred CCCceeccccCCccccCccCC---CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK---LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
. .....+||+.|||||++ ++.++|||||||++|||+||+.||.+...... +...+. . ..
T Consensus 185 ~---~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~~~~i~-----------~-~~-- 246 (290)
T 3fpq_A 185 S---FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVT-----------S-GV-- 246 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHHT-----------T-TC--
T ss_pred C---ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-HHHHHH-----------c-CC--
Confidence 2 22346799999999984 78899999999999999999999965321111 000000 0 00
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....+..+++++.+++.+||+.||++|||++|++++
T Consensus 247 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 247 ---KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011122345678999999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=428.09 Aligned_cols=262 Identities=22% Similarity=0.375 Sum_probs=212.3
Q ss_pred HHHHHHhCCCCCCceeccCcceEEEEEEecC------CcEEEEEEeecccc-hhhHHHHHHHHHHhcCCC-CceEEEEEE
Q 036879 731 QELFRATDGFSENNLLGKGSFGSVYKGTLSD------GMQIAVKVFNLELE-GTLRSFDAECEILGSIRH-RNLVKIIST 802 (1029)
Q Consensus 731 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~~~ 802 (1029)
.+++...++|++.+.||+|+||+||+|++.. ++.||||.++.... ...+.|.+|++++++++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 4555677889999999999999999998642 46799999976543 345679999999999965 899999999
Q ss_pred Eec-CCeEEEEEeccCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCC
Q 036879 803 CSS-DHFKALVLEYMPNGSLENWMYNK---------------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNP 866 (1029)
Q Consensus 803 ~~~-~~~~~lV~E~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~ 866 (1029)
|.+ ++..++|||||++|+|.++++.. ...+++..+..++.|||+||+||| +++||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCc
Confidence 976 45689999999999999999753 234889999999999999999999 67799999999
Q ss_pred CCEEECCCCcEEEEccCCceecCCCCC-ceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccc
Q 036879 867 SNILLNESMVACLSDFGISKLLGDETS-MTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFV 940 (1029)
Q Consensus 867 ~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~ 940 (1029)
+|||+++++.+||+|||+|+....... .......||+.|||||+ .++.++|||||||++|||+| |+.||.+...
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654433 23345678999999998 47889999999999999998 8999976321
Q ss_pred cccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 941 GEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.+. +. ..+. . ......|..+++++.+++.+||+.||++|||++|++++|+.+.+.
T Consensus 294 ~~~-~~------------~~i~----~--g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 294 DEE-FC------------RRLK----E--GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp SHH-HH------------HHHH----H--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH-HH------------HHHH----c--CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 111 10 0110 0 011223345678899999999999999999999999999988654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=451.64 Aligned_cols=456 Identities=20% Similarity=0.211 Sum_probs=369.8
Q ss_pred ceeccccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccc
Q 036879 124 EHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNS 203 (1029)
Q Consensus 124 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~ 203 (1029)
++|++++|+++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~-------------------- 59 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-------------------- 59 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCE--------------------
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCC--------------------
Confidence 46788888888 5777666 788888888888886666788888888888777777653
Q ss_pred cchhccccccccCCCCcccccccccceEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccC-C
Q 036879 204 LAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTG-V 282 (1029)
Q Consensus 204 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~-~ 282 (1029)
..|..|.++++|++|+|++|+++ .+|.. .+ ++|++|+|++|++++ .
T Consensus 60 -------------~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l-----------------~~L~~L~L~~N~l~~~~ 106 (520)
T 2z7x_B 60 -------------LDISVFKFNQELEYLDLSHNKLV-KISCH--PT-----------------VNLKHLDLSFNAFDALP 106 (520)
T ss_dssp -------------EEGGGGTTCTTCCEEECCSSCCC-EEECC--CC-----------------CCCSEEECCSSCCSSCC
T ss_pred -------------cChHHhhcccCCCEEecCCCcee-ecCcc--cc-----------------CCccEEeccCCcccccc
Confidence 34567777888888888888877 45543 33 345578888888886 3
Q ss_pred CCCCcccCCCCcEEEccCcccCCCCCchhhhccccc--ceEeecCccc--CCCCCccccccc-ccceecCCCccccCCCC
Q 036879 283 IPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNL--QQLILGGNRL--TGPIPSSISNAS-MLTLIDMPYNLFSGFIP 357 (1029)
Q Consensus 283 ~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L--~~L~L~~N~l--~~~~p~~l~~l~-~L~~L~ls~N~l~~~~p 357 (1029)
+|..|.++++|++|+|++|.+.+ .. +..+++| ++|+|++|++ .+..|..+..+. ....+++++|.+.+.++
T Consensus 107 ~p~~~~~l~~L~~L~L~~n~l~~---~~-~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~ 182 (520)
T 2z7x_B 107 ICKEFGNMSQLKFLGLSTTHLEK---SS-VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL 182 (520)
T ss_dssp CCGGGGGCTTCCEEEEEESSCCG---GG-GGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCC
T ss_pred chhhhccCCcceEEEecCcccch---hh-ccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhh
Confidence 67888999999999999998864 22 3357777 9999999999 788888888876 45567888888876655
Q ss_pred CCCCCCCCCcccccccccccccccceeeccCCc-------CCCCCCccccCchhhhcceeccccccccccccccC---Cc
Q 036879 358 NSLGFCHPYDELGFLTSLTNCKDLRKLILSENP-------LSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIG---NL 427 (1029)
Q Consensus 358 ~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~-------l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~---~l 427 (1029)
.. .+..+++|+.|++++|. +.+.+| .+..+.. ++.|++++|.+++..+..+. ..
T Consensus 183 ~~--------------~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~-L~~L~l~~~~l~~~~~~~~~~~~~~ 246 (520)
T 2z7x_B 183 DV--------------SVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPK-LSNLTLNNIETTWNSFIRILQLVWH 246 (520)
T ss_dssp CC--------------CCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTT-CCEEEEEEEEEEHHHHHHHHHHHHT
T ss_pred hh--------------hhhcccceeeccccccccccccceeecchh-hhccccc-hhhccccccccCHHHHHHHHHHhhh
Confidence 43 24578899999999997 666555 6777776 99999999998864333222 24
Q ss_pred CcCcEEEecCccccccccccc-----cCCCCCCEEEeccccccCcccccccCC---CCCcEEecCCCcccCccccccccc
Q 036879 428 NNLTTLHLETNELTGSIPKAI-----GRLQKLQGLYLQHNKLQGSITTDLCGL---RSLSEFYSDGNELNGSLPQCLDSL 499 (1029)
Q Consensus 428 ~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~l 499 (1029)
++|++|++++|++++.+|..+ ..+++|+.+++++|.+ ..+...+..+ .+|+.|++++|.+.... .+..+
T Consensus 247 ~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l 323 (520)
T 2z7x_B 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKI 323 (520)
T ss_dssp SSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSC
T ss_pred CcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCcccccc--chhhC
Confidence 689999999999998899888 8999999999999999 3433445444 67999999999987543 23788
Q ss_pred cccceeeccCccccCCCCCCccCCCCCcEEEccCCcccC--cCCccccccccccEEEccCCcCCCCCCc-cccCcccccc
Q 036879 500 ISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNG--TLPVEIGNLKVVTKIDLSRNDLSGEIPS-SIGDLKNMQH 576 (1029)
Q Consensus 500 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~ 576 (1029)
++|++|++++|++++..|..+..+++|+.|+|++|++++ ..|..++.+++|++|++++|++++.+|. .+..+++|+.
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~ 403 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence 999999999999999899999999999999999999997 5567899999999999999999985665 5889999999
Q ss_pred cccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCC-CCCCCccCcccccCCCC
Q 036879 577 LSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH-GGPFTNLSSQSFVGNKG 655 (1029)
Q Consensus 577 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~~~~~~n~~ 655 (1029)
|+|++|++++..|..+. ++|++|+|++|+++ .+|..+..+++|+.|++++|++++.++. ...+.++..+.+.+||+
T Consensus 404 L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~ 480 (520)
T 2z7x_B 404 LNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480 (520)
T ss_dssp EECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCB
T ss_pred EECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCC
Confidence 99999999988887775 79999999999999 7788777999999999999999965444 45677888999999999
Q ss_pred CCCCCC
Q 036879 656 LCGAPE 661 (1029)
Q Consensus 656 ~c~~~~ 661 (1029)
.|+|+.
T Consensus 481 ~c~c~~ 486 (520)
T 2z7x_B 481 DCSCPR 486 (520)
T ss_dssp CCCHHH
T ss_pred cccCCc
Confidence 998863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=416.34 Aligned_cols=244 Identities=25% Similarity=0.307 Sum_probs=192.6
Q ss_pred CCCCCCceeccCcceEEEEEEec----CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
++|++.+.||+|+||+||+|+.. +++.||||++++.. ......+.+|++++++++|||||++++++++++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56999999999999999999862 47889999997643 2234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||++||+|.+++.+ .+.+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999999965 456999999999999999999999 778999999999999999999999999999865443
Q ss_pred CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.. .....+||+.|||||++ ++.++||||+||++|||+||+.||.+....+. .. .... .
T Consensus 180 ~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-----~~--------~i~~----~ 241 (304)
T 3ubd_A 180 EK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-----MT--------MILK----A 241 (304)
T ss_dssp -C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HH--------HHHH----C
T ss_pred Cc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-----HH--------HHHc----C
Confidence 22 22346799999999983 78899999999999999999999975321110 00 0000 0
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCH-----HHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINI-----KEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~evl~~ 1007 (1029)
....|..+++++.+++.+||+.||++|||+ +|++++
T Consensus 242 ----~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 242 ----KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ----CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 011223457789999999999999999984 677653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=448.01 Aligned_cols=555 Identities=19% Similarity=0.193 Sum_probs=381.9
Q ss_pred hhHHHHHHHHHHhccCCCCCcccCCCCCCCCCCcee----eEEEcCC---------CCceEEEecccccccccCCccCCC
Q 036879 4 GRDQSALLALKAHVTNDPLNVLASNWSTNTSVCNWF----GVTCSPR---------HRRVTALNLAYMGLLGTIPPELGN 70 (1029)
Q Consensus 4 ~~~~~al~~~~~~~~~~~~~~~~~~w~~~~~~c~w~----gv~c~~~---------~~~v~~l~l~~~~l~~~~p~~~~~ 70 (1029)
..|-++|.+.-.++ |. + |. +|.|. -|.|... ...++.|||++|+|.+-.|..|.+
T Consensus 7 ~~~~~~~~~~~~~~---p~----~-~~----~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~ 74 (635)
T 4g8a_A 7 KDDDDKLAAANSSI---PE----S-WE----PCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFS 74 (635)
T ss_dssp --------------------------C----CSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTT
T ss_pred CCCcchhhcccCCC---CC----C-CC----CccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhC
Confidence 44556665555544 32 3 64 45553 4668632 136899999999999655668999
Q ss_pred CcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeE
Q 036879 71 LSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTL 150 (1029)
Q Consensus 71 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 150 (1029)
+++|++|||++|+|++..|.+|+++++|++|+|++|+|+.++ +..|..+++|++|+|++|++++..+..|+++++|++|
T Consensus 75 l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~-~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L 153 (635)
T 4g8a_A 75 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA-LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 153 (635)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEEC-GGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCC-HHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCee
Confidence 999999999999999777888999999999999999999642 4578999999999999999997666789999999999
Q ss_pred eccCCcCcc-cCCccccCCCcCcccccCCCcCcccCCCCCC-CCCcccccccccccchhccccccccCCCCccccccccc
Q 036879 151 DLSFNQLQG-HVPSSILNIPSLLAIDLSNNQFSGPMPSIYN-TSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQL 228 (1029)
Q Consensus 151 ~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~-~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L 228 (1029)
+|++|++++ .+|..+.++++|++|++++|+|++..+..+. +..++ .....++++.|.++...+..+ ....+
T Consensus 154 ~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~------~~~~~~~ls~n~l~~i~~~~~-~~~~~ 226 (635)
T 4g8a_A 154 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP------LLNLSLDLSLNPMNFIQPGAF-KEIRL 226 (635)
T ss_dssp ECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT------TCCCEEECTTCCCCEECTTTT-TTCEE
T ss_pred ccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhh------hhhhhhhcccCcccccCcccc-cchhh
Confidence 999999975 4688899999999999999999887664331 11111 122345667777765444433 34456
Q ss_pred ceEEcccccccCCC-CccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCC
Q 036879 229 KILSLSVNNFIGSI-PREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNL 307 (1029)
Q Consensus 229 ~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~l 307 (1029)
+.|++++|.....+ +..+..+..++...+..+... ....+....+..+..+..+..+++..+......
T Consensus 227 ~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~-----------~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~ 295 (635)
T 4g8a_A 227 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR-----------NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 295 (635)
T ss_dssp EEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCT-----------TSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCE
T ss_pred hhhhhhcccccccccchhhcCCcccccccccccccc-----------cccccccccccccccccchhhhhhhhhhhcccc
Confidence 67777776544222 233444544443332211111 112233334445555555655555544332111
Q ss_pred Cc--hhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceee
Q 036879 308 PS--NIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLI 385 (1029)
Q Consensus 308 p~--~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~ 385 (1029)
.. ..+..+.+++.+.+.+|.+.... .+.. ...|+.|+
T Consensus 296 ~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~---------------------------------------~~~L~~L~ 334 (635)
T 4g8a_A 296 DGIIDLFNCLTNVSSFSLVSVTIERVK--DFSY---------------------------------------NFGWQHLE 334 (635)
T ss_dssp EECTTTTGGGTTCSEEEEESCEEEECG--GGGS---------------------------------------CCCCSEEE
T ss_pred cchhhhhhhhccccccccccccccccc--cccc---------------------------------------chhhhhhh
Confidence 10 11223445555555555554221 1222 34455555
Q ss_pred ccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccc--cccccccCCCCCCEEEecccc
Q 036879 386 LSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTG--SIPKAIGRLQKLQGLYLQHNK 463 (1029)
Q Consensus 386 Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~ 463 (1029)
+++|.+.+..+..+. .++.+++..|.+... ..+..+++|+.|++++|.+.. ..+..+..+.+|++|++..|.
T Consensus 335 l~~~~~~~~~~~~l~----~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~ 408 (635)
T 4g8a_A 335 LVNCKFGQFPTLKLK----SLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNG 408 (635)
T ss_dssp EESCEESSCCCCBCT----TCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCS
T ss_pred cccccccCcCcccch----hhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccc
Confidence 555555533332222 145566666655432 234467778888888887753 345556677788888888887
Q ss_pred ccCcccccccCCCCCcEEecCCCcccCcc-ccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCccc-CcCC
Q 036879 464 LQGSITTDLCGLRSLSEFYSDGNELNGSL-PQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLN-GTLP 541 (1029)
Q Consensus 464 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p 541 (1029)
+.. .+..+..+++|+.+++..|+..... +..|..+++++.++++.|.+++..+..+..++.|+.|+|++|.+. +..|
T Consensus 409 ~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~ 487 (635)
T 4g8a_A 409 VIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 487 (635)
T ss_dssp EEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEEC
T ss_pred ccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCc
Confidence 753 4456777788888888777665443 456788899999999999999888899999999999999999754 4678
Q ss_pred ccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcc-c
Q 036879 542 VEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKAL-S 620 (1029)
Q Consensus 542 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~ 620 (1029)
..|..+++|+.|||++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|++|||++|+|++.+|..+..+ +
T Consensus 488 ~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 567 (635)
T 4g8a_A 488 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS 567 (635)
T ss_dssp SCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCT
T ss_pred hhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhC
Confidence 889999999999999999998889999999999999999999998888889999999999999999999999999888 6
Q ss_pred ccceeeccCCCCcCCCC
Q 036879 621 LLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 621 ~L~~L~l~~N~l~~~~~ 637 (1029)
+|+.|+|++|+|+|.+.
T Consensus 568 ~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 568 SLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TCCEEECTTCCBCCSGG
T ss_pred cCCEEEeeCCCCcccCC
Confidence 89999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=400.24 Aligned_cols=245 Identities=22% Similarity=0.373 Sum_probs=184.4
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCC--------
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDH-------- 807 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 807 (1029)
.+|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35889999999999999999975 799999999976543 34567899999999999999999999986543
Q ss_pred ----eEEEEEeccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEc
Q 036879 808 ----FKALVLEYMPNGSLENWMYNKNR--SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSD 881 (1029)
Q Consensus 808 ----~~~lV~E~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~D 881 (1029)
..|+||||+++|+|.+++..... ..++..+..++.||++||+||| ++|||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999965432 3456678899999999999999 77899999999999999999999999
Q ss_pred cCCceecCCCCCc-----------eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccc
Q 036879 882 FGISKLLGDETSM-----------TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLK 946 (1029)
Q Consensus 882 fg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~ 946 (1029)
||+|+........ ..+..+||+.|||||++ ++.++||||+||++|||++ ||...... .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~----~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER----V 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH----H
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH----H
Confidence 9999876533211 12335799999999983 6889999999999999996 77531100 0
Q ss_pred hhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 947 SRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 947 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. .+....... ..+.....++.+.+++.+||+.||++|||+.|++++
T Consensus 235 ~--------~~~~~~~~~-------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 235 R--------TLTDVRNLK-------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp H--------HHHHHHTTC-------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H--------HHHHHhcCC-------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 000111100 111223345567889999999999999999999874
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=435.68 Aligned_cols=459 Identities=20% Similarity=0.191 Sum_probs=300.1
Q ss_pred CeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccC
Q 036879 75 SLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSF 154 (1029)
Q Consensus 75 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 154 (1029)
+++|+++|+++ .+|..+. ++|++|+|++|+++.+. |..|..+++|++|+|++|++++..|..|.++++|++|||++
T Consensus 34 ~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELR-MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCC-GGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred cEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccC-hhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 56666666666 4555442 55566666666555321 34555555555555555555544455555555555555555
Q ss_pred CcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccC-CCCcccccccccceEEc
Q 036879 155 NQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSG-QIPSTLFECKQLKILSL 233 (1029)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L 233 (1029)
|+++ .+|.. .+++|++|++++|+ +++ .+|..|+++++|++|+|
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~---------------------------------l~~l~~p~~~~~l~~L~~L~L 153 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFND---------------------------------FDVLPVCKEFGNLTKLTFLGL 153 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSC---------------------------------CSBCCCCGGGGGCTTCCEEEE
T ss_pred CcCC-ccCcc--ccccCCEEECCCCC---------------------------------ccccCchHhhcccCcccEEec
Confidence 5555 34443 44444444444444 443 24678888999999999
Q ss_pred ccccccCCCCccccccccccceeecccccccccCcccEEEccCCcc--cCCCCCCcccCC-CCcEEEccCcccCCCCCch
Q 036879 234 SVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRL--TGVIPPEIINIS-SLTVLSLTANNLLGNLPSN 310 (1029)
Q Consensus 234 s~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l--~~~~p~~~~~l~-~L~~L~Ls~N~l~~~lp~~ 310 (1029)
++|++++ ..+..+++| +|+.|+|++|++ ++..|..+..+. ..-.++++.|.+.+.++..
T Consensus 154 ~~n~l~~---~~~~~l~~L---------------~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~ 215 (562)
T 3a79_B 154 SAAKFRQ---LDLLPVAHL---------------HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNM 215 (562)
T ss_dssp ECSBCCT---TTTGGGTTS---------------CEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEE
T ss_pred CCCcccc---Cchhhhhhc---------------eeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhh
Confidence 9998875 234444433 236788888888 777888887765 2225688888888777777
Q ss_pred hhhcccccceEeecCcccCC----CCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeec
Q 036879 311 IGHSLPNLQQLILGGNRLTG----PIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLIL 386 (1029)
Q Consensus 311 ~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~L 386 (1029)
.+..+++|+.|++++|+... ..+..+.. +++|+.|++
T Consensus 216 ~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~---------------------------------------l~~L~~L~L 256 (562)
T 3a79_B 216 SVNALGHLQLSNIKLNDENCQRLMTFLSELTR---------------------------------------GPTLLNVTL 256 (562)
T ss_dssp EESSEEEEEEEEEECCSTTHHHHHHHHHHHHS---------------------------------------CSSCEEEEE
T ss_pred cccccceEEEecccccccccchHHHHHHHHhc---------------------------------------cCcceEEEe
Confidence 77778888888888875210 01122333 344444444
Q ss_pred cCCcCCCCC----CccccCchhhhcceecccccccccccccc-----CCcCcCcEEEecCccccccccccccC---CCCC
Q 036879 387 SENPLSGVL----PISIGNLSNAMDVLYLSACNIKGSIPSEI-----GNLNNLTTLHLETNELTGSIPKAIGR---LQKL 454 (1029)
Q Consensus 387 s~N~l~~~~----p~~~~~l~~~L~~L~L~~n~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~---l~~L 454 (1029)
+++.+.+.. +..+. .. .|++|++++|++++.+|..+ .+++.|+.++++.|.+. ..+..+.. ..+|
T Consensus 257 ~~~~l~~~~~~~~~~~~~-~~-~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~-~p~~~~~~~~~~~~L 333 (562)
T 3a79_B 257 QHIETTWKCSVKLFQFFW-PR-PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNI 333 (562)
T ss_dssp EEEEECHHHHHHHHHHHT-TS-SEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCS-SCHHHHHHHHHTCCC
T ss_pred cCCcCcHHHHHHHHHhhh-cc-cccEEEEeccEeeccccchhhhcccccchheehhhcccceee-cChhhhhhhhccCcc
Confidence 444433211 11111 11 36677777777776666666 66777777777777762 22233322 2578
Q ss_pred CEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCC--CCCccCCCCCcEEEcc
Q 036879 455 QGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVI--PSSLWSLRDILNVNLS 532 (1029)
Q Consensus 455 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls 532 (1029)
++|++++|.+.... ....+++|++|++++|++++..|..+.++++|++|+|++|+++++. |..+..+++|+.|+++
T Consensus 334 ~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~ 411 (562)
T 3a79_B 334 KMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVS 411 (562)
T ss_dssp SEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECT
T ss_pred eEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECC
Confidence 88888888875322 1256778888888888888777888888888888888888887643 4567888888888888
Q ss_pred CCcccCcCC-ccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCc
Q 036879 533 SNSLNGTLP-VEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGE 611 (1029)
Q Consensus 533 ~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 611 (1029)
+|++++.+| ..+..+++|+.|++++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++.
T Consensus 412 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l 488 (562)
T 3a79_B 412 LNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSV 488 (562)
T ss_dssp TSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCC
T ss_pred CCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCC
Confidence 888887344 4577788888888888888776666554 67888888888888 6776666888888888888888844
Q ss_pred CchhhhcccccceeeccCCCCcCCCCC
Q 036879 612 IPNSLKALSLLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 612 ~~~~~~~l~~L~~L~l~~N~l~~~~~~ 638 (1029)
.+..+..+++|+.|++++|+++|.++.
T Consensus 489 ~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 489 PDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp CTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred CHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 444488888888888888888876653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=429.95 Aligned_cols=463 Identities=21% Similarity=0.214 Sum_probs=304.0
Q ss_pred EEEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceecccc
Q 036879 51 TALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDG 130 (1029)
Q Consensus 51 ~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~ 130 (1029)
+.++++++++. .+|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|+++.+ .|..|..+++|++|+|++
T Consensus 34 ~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSL-DFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEE-CTTTTTTCTTCCEEECTT
T ss_pred cEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcC-CHHHhCCCCCCCEEECCC
Confidence 67999999999 5998775 8999999999999988888999999999999999999964 378899999999999999
Q ss_pred ccccCCCcccccCccccCeEeccCCcCcc-cCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhcc
Q 036879 131 NSFIGTIPPSICNISSLLTLDLSFNQLQG-HVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHL 209 (1029)
Q Consensus 131 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~L 209 (1029)
|+++ .+|.. .+++|++|+|++|++++ .+|..|.++++|++|++++|++++.. +..... -+|++|++
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~--~~~l~~--------L~L~~L~L 176 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD--LLPVAH--------LHLSCILL 176 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTT--TGGGTT--------SCEEEEEE
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCc--hhhhhh--------ceeeEEEe
Confidence 9999 68877 89999999999999996 34689999999999999999887421 111100 02344555
Q ss_pred ccccc--cCCCCccccccc--ccceEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCC
Q 036879 210 AYNQL--SGQIPSTLFECK--QLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPP 285 (1029)
Q Consensus 210 s~N~l--~~~~p~~l~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~ 285 (1029)
++|++ ++..|..+..+. .| .+++++|.+.+.+++.
T Consensus 177 ~~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~---------------------------------------- 215 (562)
T 3a79_B 177 DLVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNM---------------------------------------- 215 (562)
T ss_dssp EESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEE----------------------------------------
T ss_pred ecccccccccCcccccccCcceE-EEEecCccchhhhhhh----------------------------------------
Confidence 55555 444444444433 22 3344444444333321
Q ss_pred CcccCCCCcEEEccCcc-----cCCCCCchhhhcccccceEeecCcccCCCCCcc---cccccccceecCCCccccCCCC
Q 036879 286 EIINISSLTVLSLTANN-----LLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSS---ISNASMLTLIDMPYNLFSGFIP 357 (1029)
Q Consensus 286 ~~~~l~~L~~L~Ls~N~-----l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~---l~~l~~L~~L~ls~N~l~~~~p 357 (1029)
.+.++++|+.|++++|. +.+. +..+ ..+++|+.|+|+++.+.+..... ....++|++|++++|.+.+.+|
T Consensus 216 ~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l-~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip 293 (562)
T 3a79_B 216 SVNALGHLQLSNIKLNDENCQRLMTF-LSEL-TRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERID 293 (562)
T ss_dssp EESSEEEEEEEEEECCSTTHHHHHHH-HHHH-HSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCC
T ss_pred cccccceEEEecccccccccchHHHH-HHHH-hccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeecccc
Confidence 22334444444444442 1101 1111 12444444444444433210000 0001133333333333333333
Q ss_pred CCCCCCCCCcccccccccccccccceeeccCCcCCCCCC-ccccCchhhhcceeccccccccccccccCCcCcCcEEEec
Q 036879 358 NSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLP-ISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLE 436 (1029)
Q Consensus 358 ~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 436 (1029)
..+.. .....++.|+.++++.|.+ .+| ..+..+. ...+|++|+++
T Consensus 294 ~~~~~----------~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~----------------------~~~~L~~L~l~ 339 (562)
T 3a79_B 294 REEFT----------YSETALKSLMIEHVKNQVF--LFSKEALYSVF----------------------AEMNIKMLSIS 339 (562)
T ss_dssp CCCCC----------CCSCSCCEEEEEEEEECCC--SSCHHHHHHHH----------------------HTCCCSEEEEE
T ss_pred chhhh----------cccccchheehhhccccee--ecChhhhhhhh----------------------ccCcceEEEcc
Confidence 22100 0012344455555555544 222 1111110 11346666666
Q ss_pred CccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccC--ccccccccccccceeeccCccccC
Q 036879 437 TNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNG--SLPQCLDSLISLRTLSLGFNRLTS 514 (1029)
Q Consensus 437 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~ 514 (1029)
+|.+.... .+..+++|++|++++|++++..+..+..+++|++|++++|++++ ..|..|..+++|++|++++|++++
T Consensus 340 ~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~ 417 (562)
T 3a79_B 340 DTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS 417 (562)
T ss_dssp SSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBS
T ss_pred CCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCC
Confidence 66654211 12456666666666666666666666666666666666666665 335678888999999999999987
Q ss_pred -CCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCcc-c
Q 036879 515 -VIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDS-L 592 (1029)
Q Consensus 515 -~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~-~ 592 (1029)
+.+..+..+++|+.|++++|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++ +|.. +
T Consensus 418 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~ 493 (562)
T 3a79_B 418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVF 493 (562)
T ss_dssp CCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTST
T ss_pred ccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHH
Confidence 5555688899999999999999877776654 78999999999998 677777799999999999999994 5555 8
Q ss_pred cCCCCCCEEeCcCCcccCcCc
Q 036879 593 GGLTSLNFLDMSSNNLSGEIP 613 (1029)
Q Consensus 593 ~~l~~L~~L~Ls~N~l~~~~~ 613 (1029)
..+++|++|+|++|++++..+
T Consensus 494 ~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 494 DRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp TTCTTCCCEECCSCCBCCCHH
T ss_pred hcCCCCCEEEecCCCcCCCcc
Confidence 999999999999999997655
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=404.51 Aligned_cols=265 Identities=22% Similarity=0.271 Sum_probs=198.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEec------CC
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSS------DH 807 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 807 (1029)
.++|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999975 79999999997543 3345678899999999999999999998754 36
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
..|+|||||+ |+|.+++.. .+.+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 7899999995 689999854 567999999999999999999999 77899999999999999999999999999987
Q ss_pred cCCCC---CceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc---cc--
Q 036879 888 LGDET---SMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS---LH-- 954 (1029)
Q Consensus 888 ~~~~~---~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~-- 954 (1029)
+.... .......+||+.|||||++ ++.++||||+||++|||++|++||.+....+. +....... ..
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMMVLGTPSPAV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCGGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCChHH
Confidence 64321 2223346899999999983 47789999999999999999999975321110 00000000 00
Q ss_pred ------hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 955 ------GKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 955 ------~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
......+..................+.++.+++.+|+..||++|||++|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000000000001112245678999999999999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=393.81 Aligned_cols=194 Identities=23% Similarity=0.336 Sum_probs=166.3
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec----CCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeE
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 809 (1029)
...++|++.+.||+|+||+||+|+.+ +++.||||.+.... ....+.+|+++++.+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34678999999999999999999753 46889999986543 345678999999998 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC-CcEEEEccCCceec
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES-MVACLSDFGISKLL 888 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~-~~~kl~Dfg~a~~~ 888 (1029)
|+||||+++|+|.+++. .+++.++..++.|++.||+||| ++|||||||||+|||++.+ +.+||+|||+|+..
T Consensus 96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999883 4899999999999999999999 7789999999999999876 89999999999865
Q ss_pred CCCCCc---------------------------eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCC
Q 036879 889 GDETSM---------------------------TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTD 936 (1029)
Q Consensus 889 ~~~~~~---------------------------~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~ 936 (1029)
...... .....+||+.|||||++ ++.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 432110 11234799999999973 5778999999999999999999996
Q ss_pred c
Q 036879 937 E 937 (1029)
Q Consensus 937 ~ 937 (1029)
.
T Consensus 249 ~ 249 (361)
T 4f9c_A 249 K 249 (361)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=384.47 Aligned_cols=225 Identities=30% Similarity=0.549 Sum_probs=182.8
Q ss_pred CCchhHHHHHHHHHHhccCCCCCcccCCCCCCCCCCc--eeeEEEcCCC--CceEEEecccccccc--cCCccCCCCcCC
Q 036879 1 TNVGRDQSALLALKAHVTNDPLNVLASNWSTNTSVCN--WFGVTCSPRH--RRVTALNLAYMGLLG--TIPPELGNLSFL 74 (1029)
Q Consensus 1 ~~~~~~~~al~~~~~~~~~~~~~~~~~~w~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~~--~~p~~~~~l~~L 74 (1029)
+|.+.|++||++||+++. ||. .+++ |..++|||+ |.||+|+..+ ++|+.|+|+++++.| .+|+.++++++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~-~~~-~l~~-W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLG-NPT-TLSS-WLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CCG-GGTT-CCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhcC-Ccc-cccC-CCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 478999999999999995 665 7777 988889999 9999998765 899999999999999 999999999999
Q ss_pred CeEeccC-cccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEecc
Q 036879 75 SLLNVTN-NSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLS 153 (1029)
Q Consensus 75 ~~L~l~~-n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 153 (1029)
++|+|++ |.+++.+|..|+++++|++|+|++|+++. .+|..+..+++|++|+|++|++++.+|..+..+++|++|+|+
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 157 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG-AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEE-ECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCC-cCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECc
Confidence 9999995 99999999999999999999999999985 468889999999999999999999999999999999999999
Q ss_pred CCcCcccCCccccCCC-cCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEE
Q 036879 154 FNQLQGHVPSSILNIP-SLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILS 232 (1029)
Q Consensus 154 ~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 232 (1029)
+|++++.+|..+.+++ +|++|++++|++++..|..+.. ..|++|+|++|++++.+|..|..+++|++|+
T Consensus 158 ~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~----------l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 227 (313)
T 1ogq_A 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN----------LNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG----------CCCSEEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred CCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhC----------CcccEEECcCCcccCcCCHHHhcCCCCCEEE
Confidence 9999988999998887 7888888888777554432211 0144444444444444444444444444444
Q ss_pred ccccccc
Q 036879 233 LSVNNFI 239 (1029)
Q Consensus 233 Ls~N~l~ 239 (1029)
|++|+++
T Consensus 228 L~~N~l~ 234 (313)
T 1ogq_A 228 LAKNSLA 234 (313)
T ss_dssp CCSSEEC
T ss_pred CCCCcee
Confidence 4444444
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=412.63 Aligned_cols=249 Identities=22% Similarity=0.284 Sum_probs=207.0
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||+|++........+.+.+|+++|+.++|||||+++++|.+.+..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999875 7999999999877666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC--CcEEEEccCCceecCCCCC
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES--MVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~--~~~kl~Dfg~a~~~~~~~~ 893 (1029)
|+||+|.+++......+++..+..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.+.....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999999999777778999999999999999999999 7779999999999999854 8999999999998755432
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
....+||+.|||||++ ++.++||||+||++|||++|+.||.+....+. + . .+.. ...
T Consensus 313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~----~--------~i~~----~~~ 373 (573)
T 3uto_A 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-L----R--------NVKS----CDW 373 (573)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-H----H--------HHHT----TCC
T ss_pred --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-H----H--------HHHh----CCC
Confidence 2345799999999984 56789999999999999999999976321111 0 0 0000 000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.........++.++.++|.+||..||++|||+.|+++|
T Consensus 374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011122346778999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=407.47 Aligned_cols=246 Identities=19% Similarity=0.273 Sum_probs=198.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHH---HHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSF---DAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ......+ ..++.+++.++|||||+++++|++.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999976 79999999997542 1112223 3446778888999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
|+||||++||+|.+++.+ .+.+++..+..++.||+.||+||| ++|||||||||+|||++.+|++||+|||+|+.+.
T Consensus 268 ylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999965 456999999999999999999999 8889999999999999999999999999998775
Q ss_pred CCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
.... ...+||+.|||||++ ++.++||||+||++|||++|++||.+...... ..... ...
T Consensus 344 ~~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~--------~i~--- 407 (689)
T 3v5w_A 344 KKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDR--------MTL--- 407 (689)
T ss_dssp SCCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHH--------HHH---
T ss_pred CCCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHH--------hhc---
Confidence 4322 335799999999984 57789999999999999999999975322111 00000 000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERIN-----IKEALTK 1007 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~~ 1007 (1029)
......+..++.++.+++.+|+..||++|++ ++||.+|
T Consensus 408 -----~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 408 -----TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -----HCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -----CCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 0001122345778999999999999999998 7888764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=394.99 Aligned_cols=420 Identities=24% Similarity=0.296 Sum_probs=254.0
Q ss_pred ccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCccc
Q 036879 95 LRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAI 174 (1029)
Q Consensus 95 l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 174 (1029)
.++|++|++++|++. ++|+.++.+++|++|++++|+++|.+|..++++++|+.++++.|.. .++++|
T Consensus 10 ~~~L~~L~l~~n~l~--~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L 76 (454)
T 1jl5_A 10 NTFLQEPLRHSSNLT--EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL 76 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred cccchhhhcccCchh--hCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence 467777888888774 5677777778888888888877777777777777776666655542 245666
Q ss_pred ccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcccccccCCCCccccccccccc
Q 036879 175 DLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKG 254 (1029)
Q Consensus 175 ~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 254 (1029)
++++|++++.+.. . .+|++|++++|++++ +|.. +++|++|++++|++++ +|.
T Consensus 77 ~l~~~~l~~lp~~-~------------~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~---------- 128 (454)
T 1jl5_A 77 ELNNLGLSSLPEL-P------------PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSD---------- 128 (454)
T ss_dssp ECTTSCCSCCCSC-C------------TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCS----------
T ss_pred EecCCccccCCCC-c------------CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccC----------
Confidence 6666666654321 0 135555666666665 4432 3667777777776653 221
Q ss_pred eeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCc
Q 036879 255 LYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPS 334 (1029)
Q Consensus 255 L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~ 334 (1029)
..++|++|+|++|++++ +| ++.++++|++|++++|++. .+|.. ..+|++|++++|++++ +|
T Consensus 129 ----------~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~-~lp~~----~~~L~~L~L~~n~l~~-l~- 189 (454)
T 1jl5_A 129 ----------LPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK-KLPDL----PPSLEFIAAGNNQLEE-LP- 189 (454)
T ss_dssp ----------CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSS-CC-
T ss_pred ----------CCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCc-ccCCC----cccccEEECcCCcCCc-Cc-
Confidence 11467799999999996 66 6999999999999999997 57754 3589999999999997 55
Q ss_pred ccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceecccc
Q 036879 335 SISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSAC 414 (1029)
Q Consensus 335 ~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n 414 (1029)
.+.++++|+.|++++|.+++ +|.. .++|++|++++|++. .+| .++.+.+ |++|++++|
T Consensus 190 ~~~~l~~L~~L~l~~N~l~~-l~~~------------------~~~L~~L~l~~n~l~-~lp-~~~~l~~-L~~L~l~~N 247 (454)
T 1jl5_A 190 ELQNLPFLTAIYADNNSLKK-LPDL------------------PLSLESIVAGNNILE-ELP-ELQNLPF-LTTIYADNN 247 (454)
T ss_dssp CCTTCTTCCEEECCSSCCSS-CCCC------------------CTTCCEEECCSSCCS-SCC-CCTTCTT-CCEEECCSS
T ss_pred cccCCCCCCEEECCCCcCCc-CCCC------------------cCcccEEECcCCcCC-ccc-ccCCCCC-CCEEECCCC
Confidence 68999999999999999875 3321 247899999999988 666 4777776 899999999
Q ss_pred ccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCcccc
Q 036879 415 NIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQ 494 (1029)
Q Consensus 415 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 494 (1029)
++++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++.... .++|+.|++++|++++.
T Consensus 248 ~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~----~~~L~~L~l~~N~l~~i--- 312 (454)
T 1jl5_A 248 LLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSEL----PPNLYYLNASSNEIRSL--- 312 (454)
T ss_dssp CCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCC----CTTCCEEECCSSCCSEE---
T ss_pred cCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCc----CCcCCEEECcCCcCCcc---
Confidence 9985 4543 3789999999999985 5543 37899999999998763321 26888899999988752
Q ss_pred ccccc-cccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCC--CCCccccCc
Q 036879 495 CLDSL-ISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSG--EIPSSIGDL 571 (1029)
Q Consensus 495 ~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l 571 (1029)
..+ ++|++|++++|++++ +|.. +++|+.|++++|++++ +|. .+++|++|++++|++++ .+|.++..
T Consensus 313 --~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~- 381 (454)
T 1jl5_A 313 --CDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED- 381 (454)
T ss_dssp --CCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE-
T ss_pred --cCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh-
Confidence 223 488899999999886 4443 5788899999998884 555 46788999999999887 56665543
Q ss_pred ccccccccccccccccCCccccCCCCCCEEeCcCCcccC--cCchhhhcccccceeeccCCCCcCCCCC
Q 036879 572 KNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSG--EIPNSLKALSLLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 572 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 638 (1029)
|+.|.+.+.+|.. +++|++||+++|++++ .+|. .++.|.+.+|.+.+.++.
T Consensus 382 -------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~------sl~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 382 -------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE------SVEDLRMNSERVVDPYEF 434 (454)
T ss_dssp -------EECCC---------------------------------------------------------
T ss_pred -------hhhcccccccccc---cCcCCEEECCCCcCCccccchh------hHhheeCcCcccCCcccc
Confidence 3346666666653 4789999999999997 5554 356678899998886654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=389.58 Aligned_cols=231 Identities=22% Similarity=0.304 Sum_probs=156.5
Q ss_pred CCCCceee--EEEcCCCCceEEEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccC
Q 036879 33 TSVCNWFG--VTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSS 110 (1029)
Q Consensus 33 ~~~c~w~g--v~c~~~~~~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 110 (1029)
.+.|.|.+ |.|+. .++. .+|. + .++|++|+|++|.+++..|..|+++++|++|+|++|.+..
T Consensus 5 ~~~c~~~~~~~~c~~------------~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~ 68 (455)
T 3v47_A 5 TSECSVIGYNAICIN------------RGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGL 68 (455)
T ss_dssp --CCEEETTEEECCS------------SCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTC
T ss_pred cceeEEEccccCcCC------------CCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccc
Confidence 34577766 55542 2333 6666 2 3789999999999998888899999999999999998864
Q ss_pred CCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCCcCcccCCcc--ccCCCcCcccccCCCcCcccCCCC
Q 036879 111 IEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSS--ILNIPSLLAIDLSNNQFSGPMPSI 188 (1029)
Q Consensus 111 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~ls~N~l~~~~~~~ 188 (1029)
.-.|..|..+++|++|+|++|++++..|..|+++++|++|+|++|++++.+|.. +.++++|++|+|++|++++.
T Consensus 69 ~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~---- 144 (455)
T 3v47_A 69 VIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI---- 144 (455)
T ss_dssp EECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSC----
T ss_pred eECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCcc----
Confidence 222567888888999999998888777888888888888888888888655444 77777777777776666533
Q ss_pred CCCCCcccccccccccchhccccccccCCCCcc-cccccccceEEcccccccCCCCccccccccccceeecccccccccC
Q 036879 189 YNTSPLQNIDMQYNSLAELHLAYNQLSGQIPST-LFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQ 267 (1029)
Q Consensus 189 ~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~ 267 (1029)
.|.. +..+++|++|++++|++++..|..+.++.. .
T Consensus 145 -----------------------------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~---------------~ 180 (455)
T 3v47_A 145 -----------------------------QPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQG---------------K 180 (455)
T ss_dssp -----------------------------CCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTT---------------C
T ss_pred -----------------------------CcccccCCCCcccEEeCCCCcccccChhhhhcccc---------------c
Confidence 3433 667788888888888888777777665532 2
Q ss_pred cccEEEccCCcccCCCCCCc--------ccCCCCcEEEccCcccCCCCCchhhhc--ccccceEeecCcc
Q 036879 268 GLQVLALSSNRLTGVIPPEI--------INISSLTVLSLTANNLLGNLPSNIGHS--LPNLQQLILGGNR 327 (1029)
Q Consensus 268 ~L~~L~Ls~N~l~~~~p~~~--------~~l~~L~~L~Ls~N~l~~~lp~~~~~~--l~~L~~L~L~~N~ 327 (1029)
+|+.|++++|.+++..+..+ ..+++|++|+|++|.+.+.+|..++.. .++|+.|++++|.
T Consensus 181 ~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~ 250 (455)
T 3v47_A 181 HFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250 (455)
T ss_dssp EEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCT
T ss_pred cccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccc
Confidence 35567777777765444332 244556666666666555455444321 1344444444443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=391.62 Aligned_cols=376 Identities=18% Similarity=0.182 Sum_probs=313.6
Q ss_pred ceEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCC
Q 036879 229 KILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLP 308 (1029)
Q Consensus 229 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp 308 (1029)
+.++.+++.++ .+|. + .++|++|+|++|+|++..|..|.++++|++|+|++|.+.+.++
T Consensus 13 ~~~~c~~~~l~-~lp~-l-------------------~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~ 71 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-L-------------------PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR 71 (455)
T ss_dssp TEEECCSSCCS-SCCC-C-------------------CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEEC
T ss_pred cccCcCCCCcc-cCCC-C-------------------CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceEC
Confidence 45777777766 4444 2 1356789999999998889999999999999999999877787
Q ss_pred chhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccC
Q 036879 309 SNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE 388 (1029)
Q Consensus 309 ~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 388 (1029)
...+..+++|++|+|++|++++..|..|.++++|++|++++|.+.+..|.. ..+..+++|++|++++
T Consensus 72 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------------~~~~~l~~L~~L~L~~ 138 (455)
T 3v47_A 72 NNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSG-------------NFFKPLTSLEMLVLRD 138 (455)
T ss_dssp TTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHS-------------STTTTCTTCCEEECCS
T ss_pred cccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCc-------------ccccCcccCCEEECCC
Confidence 766667999999999999999888999999999999999999987644332 1145788999999999
Q ss_pred CcCCCCCCcc-ccCchhhhcceeccccccccccccccCCc--CcCcEEEecCcccccccccc--------ccCCCCCCEE
Q 036879 389 NPLSGVLPIS-IGNLSNAMDVLYLSACNIKGSIPSEIGNL--NNLTTLHLETNELTGSIPKA--------IGRLQKLQGL 457 (1029)
Q Consensus 389 N~l~~~~p~~-~~~l~~~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~--------~~~l~~L~~L 457 (1029)
|++++..|.. +..+.+ |++|++++|++++..+..+..+ .+|+.|++++|.+.+..+.. +..+++|++|
T Consensus 139 n~l~~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L 217 (455)
T 3v47_A 139 NNIKKIQPASFFLNMRR-FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTL 217 (455)
T ss_dssp SBCCSCCCCGGGGGCTT-CCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEE
T ss_pred CccCccCcccccCCCCc-ccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeE
Confidence 9999887876 667765 9999999999998888888877 78999999999998654433 3366789999
Q ss_pred EeccccccCcccccccCC---CCCcEEecCCCcccCc----------cccccccc--cccceeeccCccccCCCCCCccC
Q 036879 458 YLQHNKLQGSITTDLCGL---RSLSEFYSDGNELNGS----------LPQCLDSL--ISLRTLSLGFNRLTSVIPSSLWS 522 (1029)
Q Consensus 458 ~L~~N~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~----------~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~ 522 (1029)
++++|++++..+..+... .+|+.|++++|.+.+. .+..+..+ ++|++|++++|++++..|..|..
T Consensus 218 ~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 297 (455)
T 3v47_A 218 DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSH 297 (455)
T ss_dssp ECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTT
T ss_pred ecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhccc
Confidence 999999988777766554 7889999988865432 22333333 68999999999999989999999
Q ss_pred CCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEe
Q 036879 523 LRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLD 602 (1029)
Q Consensus 523 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 602 (1029)
+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|..+++|++|+
T Consensus 298 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 377 (455)
T 3v47_A 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELA 377 (455)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEE
Confidence 99999999999999988888999999999999999999888888899999999999999999988889999999999999
Q ss_pred CcCCcccCcCchhhhcccccceeeccCCCCcCCCCCC
Q 036879 603 MSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHG 639 (1029)
Q Consensus 603 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 639 (1029)
|++|++++..+..+..+++|+.|++++|+++|.+|..
T Consensus 378 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 378 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CCCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence 9999999877778889999999999999999988854
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=388.02 Aligned_cols=423 Identities=23% Similarity=0.269 Sum_probs=247.8
Q ss_pred ceEEEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceecc
Q 036879 49 RVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYL 128 (1029)
Q Consensus 49 ~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~L 128 (1029)
+++.++++++++ |+||+++++|++|++|++++|+++|.+|.+++++++|+.++++.|.. .++++|++
T Consensus 12 ~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~------------~~l~~L~l 78 (454)
T 1jl5_A 12 FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD------------RQAHELEL 78 (454)
T ss_dssp -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH------------HTCSEEEC
T ss_pred cchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc------------cCCCEEEe
Confidence 455666666666 56666666666666666666666666666666666666666655542 34677888
Q ss_pred ccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhc
Q 036879 129 DGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELH 208 (1029)
Q Consensus 129 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~ 208 (1029)
++|++++ +|.. .++|++|++++|++++ +|.. +++|++|++++|++++.+... .+|++|+
T Consensus 79 ~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~~-------------~~L~~L~ 137 (454)
T 1jl5_A 79 NNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDLP-------------PLLEYLG 137 (454)
T ss_dssp TTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSCC-------------TTCCEEE
T ss_pred cCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccCCC-------------CCCCEEE
Confidence 8888774 4442 3677888888888875 6643 367777888888777533210 2466677
Q ss_pred cccccccCCCCcccccccccceEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcc
Q 036879 209 LAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEII 288 (1029)
Q Consensus 209 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~ 288 (1029)
+++|++++ +| .|+++++|++|++++|++++ +|..+ .+|++|+|++|++++ +| .+.
T Consensus 138 L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~--------------------~~L~~L~L~~n~l~~-l~-~~~ 192 (454)
T 1jl5_A 138 VSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP--------------------PSLEFIAAGNNQLEE-LP-ELQ 192 (454)
T ss_dssp CCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC--------------------TTCCEEECCSSCCSS-CC-CCT
T ss_pred CcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc--------------------ccccEEECcCCcCCc-Cc-ccc
Confidence 77777775 55 47777777777777777664 44322 357789999999986 55 689
Q ss_pred cCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcc
Q 036879 289 NISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDE 368 (1029)
Q Consensus 289 ~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~ 368 (1029)
++++|++|++++|.+. .+|.. .++|++|++++|+++ .+| .+..+++|+.|++++|++++ +|.
T Consensus 193 ~l~~L~~L~l~~N~l~-~l~~~----~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~---------- 254 (454)
T 1jl5_A 193 NLPFLTAIYADNNSLK-KLPDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---------- 254 (454)
T ss_dssp TCTTCCEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS----------
T ss_pred CCCCCCEEECCCCcCC-cCCCC----cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-ccc----------
Confidence 9999999999999997 46653 358999999999998 566 48899999999999999875 332
Q ss_pred cccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccc
Q 036879 369 LGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAI 448 (1029)
Q Consensus 369 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 448 (1029)
.+++|+.|++++|++++ +|..+ ..|+.|++++|++++. |.. .++|++|++++|++++ ++
T Consensus 255 --------~~~~L~~L~l~~N~l~~-l~~~~----~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~--- 313 (454)
T 1jl5_A 255 --------LPPSLEALNVRDNYLTD-LPELP----QSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC--- 313 (454)
T ss_dssp --------CCTTCCEEECCSSCCSC-CCCCC----TTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC---
T ss_pred --------cccccCEEECCCCcccc-cCccc----CcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc---
Confidence 13688999999999885 45433 3488899999988862 221 2678899999998884 22
Q ss_pred cCC-CCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccC--CCCCCccCCCC
Q 036879 449 GRL-QKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTS--VIPSSLWSLRD 525 (1029)
Q Consensus 449 ~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~ 525 (1029)
.+ ++|++|++++|++++.. .. +++|+.|++++|++++ +|. .+++|++|++++|++++ .+|..+..
T Consensus 314 -~~~~~L~~L~Ls~N~l~~lp-~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--- 381 (454)
T 1jl5_A 314 -DLPPSLEELNVSNNKLIELP-AL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--- 381 (454)
T ss_dssp -CCCTTCCEEECCSSCCSCCC-CC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE---
T ss_pred -CCcCcCCEEECCCCcccccc-cc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh---
Confidence 23 47889999999887633 22 5788888888888874 444 46788888888888887 45555433
Q ss_pred CcEEEccCCcccCcCCccccccccccEEEccCCcCCC--CCCccccCcccccccccccccccccCCccccCC
Q 036879 526 ILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSG--EIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGL 595 (1029)
Q Consensus 526 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 595 (1029)
|+.|.+.+.+|.. +++|+.|++++|.+++ .+|. +|+.|.+.+|.+.+..+.+....
T Consensus 382 -----L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~------sl~~L~~~~~~~~~~~~~~~~~~ 439 (454)
T 1jl5_A 382 -----LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE------SVEDLRMNSERVVDPYEFAHETT 439 (454)
T ss_dssp -----EECCC--------------------------------------------------------------
T ss_pred -----hhhcccccccccc---cCcCCEEECCCCcCCccccchh------hHhheeCcCcccCCccccCHHHh
Confidence 2346666666653 4789999999999986 4553 46777889999988776555443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=375.09 Aligned_cols=280 Identities=35% Similarity=0.556 Sum_probs=225.8
Q ss_pred ccccCHHHHHHHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEE
Q 036879 725 WRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTC 803 (1029)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~ 803 (1029)
...+++.++....++|++.+.||+|+||.||+|+..+|+.||||++..... .....+.+|+++++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 457888999999999999999999999999999988899999999876532 2334789999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEE
Q 036879 804 SSDHFKALVLEYMPNGSLENWMYNKN---RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLS 880 (1029)
Q Consensus 804 ~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~ 880 (1029)
...+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||..+..||+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997643 348999999999999999999995544489999999999999999999999
Q ss_pred ccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCccc---ccccccchhchhcc
Q 036879 881 DFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELF---VGEISLKSRVNDSL 953 (1029)
Q Consensus 881 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~---~~~~~~~~~~~~~~ 953 (1029)
|||++...............||+.|+|||++ ++.++||||+||++|||++|+.||+... ........++....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 9999988765544445556699999999984 6779999999999999999999996422 11222222222222
Q ss_pred chh-hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHH
Q 036879 954 HGK-IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLK 1010 (1029)
Q Consensus 954 ~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1010 (1029)
... .....+..... ..+..++..+.+++.+||+.||++|||++|++++|+.
T Consensus 257 ~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKKLEALVDVDLQG------NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCCSTTSSCTTCTT------SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchhhhhhcChhhcc------ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 111 22222222211 1234567889999999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=370.09 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=215.0
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||+||+|++. +++.||+|.+........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 457888999999999999999975 6899999998776666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999999887788999999999999999999999 7779999999999999999999999999998764432211
Q ss_pred -------------eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhh
Q 036879 896 -------------QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKII 958 (1029)
Q Consensus 896 -------------~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1029)
.....||+.|+|||++ ++.++|||||||++|||++|..||.............. .
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~--------~ 237 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV--------R 237 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH--------H
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh--------h
Confidence 1135699999999984 57799999999999999999999875433222111110 0
Q ss_pred hhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcc
Q 036879 959 NVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLT 1017 (1029)
Q Consensus 959 ~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~ 1017 (1029)
...+ ...+..++..+.+++.+||+.||++|||++|+++.|+.+.+.+..
T Consensus 238 ~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 238 GFLD----------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp HHHH----------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred cccc----------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 1111 011234566789999999999999999999999999999887654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=371.73 Aligned_cols=274 Identities=34% Similarity=0.548 Sum_probs=220.1
Q ss_pred HHHHHHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 731 QELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 731 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
.++...+++|+..+.||+|+||.||+|++.+++.||||++........+.+.+|+++++.++||||+++++++...+..+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34445778999999999999999999998889999999988776666788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 811 LVLEYMPNGSLENWMYNKN---RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
+||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999886543 35899999999999999999999 67899999999999999999999999999986
Q ss_pred cCCCC-CceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhcCCCCCCccccccc-ccchhchhcc-chhhhhh
Q 036879 888 LGDET-SMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEI-SLKSRVNDSL-HGKIINV 960 (1029)
Q Consensus 888 ~~~~~-~~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~ 960 (1029)
..... ........||+.|+|||+ .++.++|||||||++|||++|+.||......+. ....+..... .+.+...
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 54322 122233458999999998 368899999999999999999999976433221 1111111111 1111222
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 961 ~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
++.... ...+..++..+.+++.+||+.||++|||++|++++|+.+.+
T Consensus 269 ~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 269 VDPNLA------DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSCT------TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChhhc------cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 222111 12234568889999999999999999999999999998865
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=363.15 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=205.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||+||+|+.. +++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 467999999999999999999864 7999999999876666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++|+|.+++... .+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence 9999999998653 5899999999999999999999 67899999999999999999999999999987654433 2
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
.....||+.|+|||++ ++.++||||+||++|||++|+.||.......... ... .....
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------------~~~-----~~~~~ 234 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-------------LIA-----TNGTP 234 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------------HHH-----HHCSC
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHH-----hCCCC
Confidence 3346799999999983 6789999999999999999999996532111000 000 00000
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+..++..+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111123456778999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=364.96 Aligned_cols=273 Identities=20% Similarity=0.289 Sum_probs=206.4
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCC----eEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDH----FKAL 811 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 811 (1029)
..++|++.+.||+|+||+||+|+.. ++.||||++.... .......+|+.++++++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3567899999999999999999875 7999999997553 23345667899999999999999999997743 4699
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CcEEcCCCCCCEEECCCCcEEEEc
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT----------PIIHCDLNPSNILLNESMVACLSD 881 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~----------givH~Dlk~~Nill~~~~~~kl~D 881 (1029)
||||+++|+|.+++.. ..+++..+..++.|++.||+||| +. ||+||||||+||+++.++.+||+|
T Consensus 100 v~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999965 34899999999999999999999 66 899999999999999999999999
Q ss_pred cCCceecCCCCCc-eeccccCCccccCccCCCC---------CCcchhHHHHHHHHHhcCCCCCCcccccccc-cchhch
Q 036879 882 FGISKLLGDETSM-TQTQTLATIGYMAPEWKLS---------RKGDVYSYGIILMETFTKKKPTDELFVGEIS-LKSRVN 950 (1029)
Q Consensus 882 fg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~---------~~~DvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~ 950 (1029)
||+|+........ ......||+.|+|||++.+ .++|||||||++|||++|+.||......... +.....
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999876543322 2233578999999998533 3679999999999999999999764322111 111000
Q ss_pred hcc-chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 951 DSL-HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 951 ~~~-~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
... ...+.+.+.................++.++.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 000 01111111110000000001112245677999999999999999999999999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=359.19 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=210.5
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.++|++.+.||+|+||.||+|+..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 457888999999999999999998899999999976533 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
++++|.+++......+++..+..++.|+++|++||| +.||+||||||+||+++.++.+||+|||++...........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999999877778999999999999999999999 77799999999999999999999999999987654333333
Q ss_pred ccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
....+++.|+|||.+ ++.++||||+|+++|||++ |+.||......+. . ...... .
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~--~-----------~~~~~~-~------ 224 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--V-----------EDISTG-F------ 224 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--H-----------HHHHTT-C------
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH--H-----------HHHhcC-c------
Confidence 345577889999983 6779999999999999999 9999875321110 0 000000 0
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
....+..++..+.+++.+||+.||++|||++|++++|+++.++
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0011123466789999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=358.01 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=210.9
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..++|++.+.||+|+||.||+|+..++..||+|+++.... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3567889999999999999999998888999999976532 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++......+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||.+..........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999999877677999999999999999999999 7789999999999999999999999999998776554444
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
.....+|+.|+|||.+ ++.++||||+|+++|||++ |+.||......+.. . ......
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~-----------~~~~~~------ 222 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV--L-----------KVSQGH------ 222 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--H-----------HHHTTC------
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH--H-----------HHHcCC------
Confidence 4445567889999983 6789999999999999999 99998753211110 0 000000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
....+..++..+.+++.+||+.+|++|||++|++++|+.+.+.
T Consensus 223 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 223 -RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0011122456789999999999999999999999999988754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=364.60 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=200.4
Q ss_pred HHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
...++|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 4456789999999999999999987 68899999987653 33456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 813 LEYMPNGSLENWMYNKNR--SFDILQRLNMVIDVASALEYLHYDHPTP--IIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~~~~g--ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
|||+++|+|.+++..... .+++..+..++.|++.||+||| +.| |+||||||+||+++.++.+||+|||+++..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999965432 3899999999999999999999 788 999999999999999999999999999765
Q ss_pred CCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
.... .......||+.|+|||++ ++.++|||||||++|||++|+.||......+. .. .+..
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~------------~~~~- 253 (309)
T 3p86_A 190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VA------------AVGF- 253 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HH------------HHHH-
T ss_pred cccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH------------HHHh-
Confidence 4322 222345689999999984 67799999999999999999999975321111 00 0000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccccc
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIE 1020 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~ 1020 (1029)
.......+..++..+.+++.+||+.||++|||++|+++.|+.+.+......+
T Consensus 254 ----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 254 ----KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp ----SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred ----cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 0000111234567789999999999999999999999999999877654443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=365.71 Aligned_cols=257 Identities=25% Similarity=0.464 Sum_probs=208.0
Q ss_pred hCCCCCCceeccCcceEEEEEEec----CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
.++|++.+.||+|+||.||+|++. .+..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 456888899999999999999874 34569999998653 3445679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999877778999999999999999999999 678999999999999999999999999999877543
Q ss_pred CCc--eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 892 TSM--TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 892 ~~~--~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
... ......+|+.|+|||++ ++.++|||||||++|||++ |+.||......+. . ..+...
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~------------~~~~~~ 270 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV--I------------SSVEEG 270 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--H------------HHHHTT
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH--H------------HHHHcC
Confidence 221 22234467889999984 6778999999999999999 9999865321111 0 000000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
.....+..++..+.+++..||..||++|||+.|+++.|+.+.+...
T Consensus 271 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 271 ------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred ------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 0011123456789999999999999999999999999999987543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=355.04 Aligned_cols=278 Identities=30% Similarity=0.480 Sum_probs=223.0
Q ss_pred cccccCHHHHHHHhCCCCCC------ceeccCcceEEEEEEecCCcEEEEEEeeccc----chhhHHHHHHHHHHhcCCC
Q 036879 724 TWRRISYQELFRATDGFSEN------NLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL----EGTLRSFDAECEILGSIRH 793 (1029)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h 793 (1029)
....+++.++..+++.|... +.||+|+||.||+|+. +++.||||++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678899999999999887 8999999999999987 68899999987532 2345679999999999999
Q ss_pred CceEEEEEEEecCCeEEEEEeccCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE
Q 036879 794 RNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNK--NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL 871 (1029)
Q Consensus 794 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill 871 (1029)
|||+++++++...+..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.||+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence 99999999999999999999999999999998643 356899999999999999999999 6789999999999999
Q ss_pred CCCCcEEEEccCCceecCCCCCc-eeccccCCccccCccCC---CCCCcchhHHHHHHHHHhcCCCCCCcccccccccch
Q 036879 872 NESMVACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEWK---LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKS 947 (1029)
Q Consensus 872 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~ 947 (1029)
+.++.+||+|||++......... ......||+.|+|||.. ++.++||||||+++|||++|+.||........ ...
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHH
Confidence 99999999999999876543222 22335689999999984 57799999999999999999999976432221 111
Q ss_pred hchhcc--chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 948 RVNDSL--HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 948 ~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
+..... ...+.+.++..+. ..+..++..+.+++.+||+.||++|||+++++++|+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMN-------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCS-------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHhhhhhhhhhhhcccccc-------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111110 0112222222221 1234567889999999999999999999999999998864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=370.83 Aligned_cols=256 Identities=23% Similarity=0.446 Sum_probs=207.9
Q ss_pred hCCCCCCceeccCcceEEEEEEec--------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecC
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS--------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSD 806 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 806 (1029)
.++|++.+.||+|+||.||+|++. ++..||||+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999852 35679999997653 33456799999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE
Q 036879 807 HFKALVLEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL 871 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill 871 (1029)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||+||| ++||+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 99999999999999999997653 34789999999999999999999 6789999999999999
Q ss_pred CCCCcEEEEccCCceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCccccccccc
Q 036879 872 NESMVACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISL 945 (1029)
Q Consensus 872 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~ 945 (1029)
+.++.+||+|||+++........ ......+|+.|+|||++ ++.++|||||||++|||++ |+.||.+....+.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-- 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 99999999999999876543222 22334578899999974 6778999999999999999 9999875321110
Q ss_pred chhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 946 KSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 946 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
. ..+... .....+..++.++.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 315 ~------------~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 315 F------------KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp H------------HHHHTT------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H------------HHHhcC------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0 000000 001122345678999999999999999999999999999987543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=365.83 Aligned_cols=245 Identities=21% Similarity=0.293 Sum_probs=202.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
..++|++.+.||+|+||.||+|++ .+|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356799999999999999999997 489999999997653 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++|+|.+++... +.+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999998654 56899999999999999999999 6789999999999999999999999999998664432
Q ss_pred CceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
......||+.|+|||++ .+.++||||+||++|||++|+.||.+....+ .. ......
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~------------~~i~~~ 229 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-----LR------------ERVLRG 229 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH------------HHHHHC
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-----HH------------HHHHhC
Confidence 23346799999999984 2468999999999999999999997531110 00 000000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. ...+..++..+.+++.+|+..||++|||++|++++
T Consensus 230 ~----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 230 K----YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp C----CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred C----CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 01122346678999999999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=381.41 Aligned_cols=259 Identities=17% Similarity=0.230 Sum_probs=209.2
Q ss_pred HHHHHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEec
Q 036879 730 YQELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSS 805 (1029)
Q Consensus 730 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 805 (1029)
+.++....++|++.+.||+|+||+||+|+.. +++.||+|++++.. ....+.+.+|+.+++.++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3444556789999999999999999999986 58899999997642 2233458899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 806 DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 806 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
.+..++||||+++|+|.+++......+++..+..++.|++.||+||| +.|||||||||+|||++.++.+||+|||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999999999999876778999999999999999999999 677999999999999999999999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGK 956 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 956 (1029)
+.............+||+.|+|||++ ++.++||||+||++|||++|+.||......+.
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~------------- 289 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------------- 289 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-------------
Confidence 87765544444456799999999984 57789999999999999999999975311110
Q ss_pred hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccC--CCCHHHHHHH
Q 036879 957 IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEE--RINIKEALTK 1007 (1029)
Q Consensus 957 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~ 1007 (1029)
.......... .........++..+.+++.+|+..+|++ ||+++|++++
T Consensus 290 ~~~i~~~~~~---~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 290 YGKIMNHKER---FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHHHTHHHH---CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred HHhhhhcccc---ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0011100000 0000001124677899999999988888 9999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=363.25 Aligned_cols=270 Identities=27% Similarity=0.467 Sum_probs=208.3
Q ss_pred hCCCCCCceeccCcceEEEEEEe-----cCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEec--CCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTL-----SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS--DHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 809 (1029)
.++|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46788999999999999999984 2689999999987766667889999999999999999999999855 3557
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999999877777999999999999999999999 6789999999999999999999999999998764
Q ss_pred CCCC--ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchh-h-hhhh
Q 036879 890 DETS--MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGK-I-INVV 961 (1029)
Q Consensus 890 ~~~~--~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~-~~~~ 961 (1029)
.... .......++..|+|||.+ ++.++|||||||++|||++|..||........ .......... . ....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM---RMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHH---HHHCTTCCTHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHH---hhhcCccccchhHHHHH
Confidence 4322 122334577889999983 67899999999999999999999865321111 0000000000 0 0000
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
+ ... .......+..++.++.+++.+||+.||++|||++|+++.|+++.+++
T Consensus 243 ~-~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 243 E-LLK--NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp H-HHH--TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred H-HHh--ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0 000 00111223456788999999999999999999999999999998765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=360.32 Aligned_cols=249 Identities=19% Similarity=0.260 Sum_probs=205.0
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999876 68999999987543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC--CCcEEEEccCCceecCCCCC
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE--SMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
+++|+|.+++......+++..+..++.|++.|++||| +.||+||||||+||+++. ++.+||+|||++........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999999776678999999999999999999999 778999999999999987 89999999999987754332
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
.....||+.|+|||++ ++.++||||+||++|||++|+.||......+. . ...... ..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~--------~~i~~~----~~ 220 (321)
T 1tki_A 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-----I--------ENIMNA----EY 220 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----H--------HHHHHT----CC
T ss_pred --cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-----H--------HHHHcC----CC
Confidence 2345689999999984 56789999999999999999999975321110 0 000000 00
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.........++.++.+++.+|+..||++|||+.|++++-
T Consensus 221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 001111234567899999999999999999999999854
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=359.39 Aligned_cols=259 Identities=21% Similarity=0.269 Sum_probs=209.1
Q ss_pred cccCHHHHHHHhCC----------CCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCC
Q 036879 726 RRISYQELFRATDG----------FSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHR 794 (1029)
Q Consensus 726 ~~~~~~~~~~~~~~----------~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ 794 (1029)
..++++++..+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45666766666543 666789999999999999976 7999999999876666667899999999999999
Q ss_pred ceEEEEEEEecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC
Q 036879 795 NLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES 874 (1029)
Q Consensus 795 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~ 874 (1029)
||+++++++...+..++||||+++++|.+++. ...+++..+..++.|++.||+||| +.||+||||||+||+++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence 99999999999999999999999999999884 356899999999999999999999 6789999999999999999
Q ss_pred CcEEEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch
Q 036879 875 MVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN 950 (1029)
Q Consensus 875 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 950 (1029)
+.+||+|||++........ ......||+.|+|||++ ++.++|||||||++|||++|+.||......+ ...
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~--- 251 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMK--- 251 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH---
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH---
Confidence 9999999999987654322 22345799999999984 6778999999999999999999996531110 000
Q ss_pred hccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 951 DSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 951 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.+....... ......++..+.+++.+||+.||++|||++|++++-
T Consensus 252 -----~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 252 -----RLRDSPPPK--------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp -----HHHHSSCCC--------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred -----HHhcCCCCC--------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000 011123466789999999999999999999999853
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=375.66 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=209.9
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
..++|++.+.||+|+||.||+|++. +++.||||.++... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3567888999999999999999986 78999999987553 233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999999876667999999999999999999999 77799999999999999999999999999986543221
Q ss_pred cee-ccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 894 MTQ-TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 894 ~~~-~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
... ....+++.|+|||++ ++.++|||||||++|||++ |+.||......+. .+.+...
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--------------~~~~~~~--- 331 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--------------REFVEKG--- 331 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--------------HHHHHTT---
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcC---
Confidence 111 112357789999984 5778999999999999998 9999875321110 0111100
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
...+.+..++..+.+++.+||+.||++|||++++++.|+++.+..
T Consensus 332 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 332 ---GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 011123346778999999999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.60 Aligned_cols=255 Identities=26% Similarity=0.444 Sum_probs=207.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..++|++.+.||+|+||.||+|++.++..||+|+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 4567889999999999999999998888999999976532 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++++|.+++......+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||.+..........
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999999999776778999999999999999999999 6789999999999999999999999999998765433223
Q ss_pred eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
.....+|+.|+|||+. ++.++||||+|+++|||++ |+.||......+. .. .+....
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--~~--------~~~~~~--------- 238 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AE--------HIAQGL--------- 238 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HH--------HHHTTC---------
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--HH--------HHhccc---------
Confidence 3334577889999983 6778999999999999998 9999975321110 00 000000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
....+..++..+.+++.+||+.+|++|||++|++++|+++.+.
T Consensus 239 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 0011123356789999999999999999999999999988764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=356.26 Aligned_cols=259 Identities=22% Similarity=0.390 Sum_probs=203.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999875 78999999986542 33456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++++|.+++... ..+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999998654 46899999999999999999999 7789999999999999999999999999998765443
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
........||+.|+|||.+ ++.++||||+||++|||++|+.||........... ..... .
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-------------~~~~~---~ 229 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK-------------HIQDS---V 229 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH-------------HHSSC---C
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------------Hhhcc---C
Confidence 3333445699999999983 67789999999999999999999976321111000 00000 0
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCC-CHHHHHHHHHHhHHhh
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERI-NIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~evl~~L~~i~~~~ 1015 (1029)
.......+..++..+.+++.+|++.||++|| +++++.+.|+.+....
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0001111233567899999999999999999 9999999998776443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=362.30 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=202.2
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccch------hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG------TLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||+|+++..... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 567999999999999999999976 7999999999865322 246789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC----cEEEEccCCc
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM----VACLSDFGIS 885 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~----~~kl~Dfg~a 885 (1029)
++||||+++|+|.+++.. ...+++..+..++.||+.|++||| +.||+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999999854 457999999999999999999999 67899999999999998777 7999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
........ .....||+.|+|||++ ++.++||||+||++|+|++|+.||.+....+. . ....
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-----~--------~~i~ 231 (361)
T 2yab_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----L--------ANIT 231 (361)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-----H--------HHHH
T ss_pred eEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-----H--------HHHH
Confidence 87754322 2345699999999983 67789999999999999999999965311110 0 0000
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. .........+...+..+.+++.+|+..||++|||+.|++++
T Consensus 232 ~----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 232 A----VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp T----TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred h----cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00000111223456778999999999999999999999863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=369.21 Aligned_cols=256 Identities=28% Similarity=0.519 Sum_probs=198.0
Q ss_pred hCCCCCCceeccCcceEEEEEEec----CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457999999999999999999864 57789999997653 3345679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999877778999999999999999999999 678999999999999999999999999999876543
Q ss_pred CCc--eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 892 TSM--TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 892 ~~~--~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
... ......+++.|+|||++ ++.++|||||||++|||++ |+.||......+ ....+...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--------------~~~~i~~~ 266 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------------VIKAVDEG 266 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--------------HHHHHHTT
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHHcC
Confidence 221 11223457789999983 6778999999999999998 999986532111 00111110
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
. ....+..++..+.+++.+||+.||++||++.|+++.|+.+.+..
T Consensus 267 ~------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 267 Y------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp E------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred C------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0 01112245678999999999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=360.61 Aligned_cols=245 Identities=22% Similarity=0.298 Sum_probs=201.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||+|++++.. ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 457899999999999999999976 79999999997652 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++|+|.+++.. .+.+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999999998854 456899999999999999999999 6789999999999999999999999999998643322
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
. ......||+.|+|||++ ++.++||||+||++|||++|+.||....... ... .....
T Consensus 160 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~--------~i~~~----- 220 (337)
T 1o6l_A 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFE--------LILME----- 220 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHH--------HHHHC-----
T ss_pred C-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-----HHH--------HHHcC-----
Confidence 2 22345799999999984 6789999999999999999999996531110 000 00000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
....+..++.++.+++.+||+.||++|| +++|++++
T Consensus 221 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 221 ---EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0011223567789999999999999999 89999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=356.50 Aligned_cols=266 Identities=22% Similarity=0.328 Sum_probs=203.0
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
..++|++.+.||+|+||+||+|+..+|+.||+|++..... .....+.+|++++++++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3577999999999999999999998899999999875432 23467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||++ +++.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.......
T Consensus 99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 9997 5898888777778999999999999999999999 67899999999999999999999999999987653322
Q ss_pred ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhhhhhhhhh-
Q 036879 894 MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKIINVVDIN- 964 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~d~~- 964 (1029)
......+|+.|+|||++ ++.++||||+||++|||++|+.||......+. +..... ......+....+..
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHCCCChHHhhhhhccch
Confidence 23345689999999973 56789999999999999999999976432211 111100 00000000000000
Q ss_pred -----hhh-hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 965 -----LLQ-KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 965 -----~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
... ...........++.++.+++.+|++.||++|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 0000111122346678999999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=371.93 Aligned_cols=255 Identities=21% Similarity=0.288 Sum_probs=206.2
Q ss_pred HHHHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecC
Q 036879 731 QELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSD 806 (1029)
Q Consensus 731 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 806 (1029)
.++....++|++.+.||+|+||+||+|+.. +++.||+|++++.. ....+.+.+|+++++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344456788999999999999999999976 68999999997642 22345688999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 807 HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
+..|+||||+++|+|.+++.. ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999999864 35899999999999999999999 6789999999999999999999999999998
Q ss_pred ecCCCCCceeccccCCccccCccCC--------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhh
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK--------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKII 958 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~--------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1029)
..............||+.|+|||++ ++.++|||||||++|||++|+.||......+. ..
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------------~~ 283 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------------YS 283 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HH
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-------------HH
Confidence 7765443344456799999999984 56789999999999999999999975311100 00
Q ss_pred hhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccC--CCCHHHHHHH
Q 036879 959 NVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEE--RINIKEALTK 1007 (1029)
Q Consensus 959 ~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~ 1007 (1029)
...... .....+....++.++.+++.+|+..+|++ ||+++|++++
T Consensus 284 ~i~~~~----~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 284 KIMNHK----NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHTHH----HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHHhcc----ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111000 00000111134677899999999999999 9999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=350.00 Aligned_cols=266 Identities=16% Similarity=0.204 Sum_probs=213.7
Q ss_pred hCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+++++.+ +|++++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 56799999999999999999996 479999999986442 345688999999999 89999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc-----EEEEccCCceecC
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV-----ACLSDFGISKLLG 889 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~-----~kl~Dfg~a~~~~ 889 (1029)
|+ +++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+|||+++...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 99999999877778999999999999999999999 788999999999999987776 9999999998765
Q ss_pred CCCCc------eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhh
Q 036879 890 DETSM------TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959 (1029)
Q Consensus 890 ~~~~~------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1029)
..... ......||+.|+|||++ ++.++|||||||++|||++|+.||........ .. .+..
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~--------~~~~ 232 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQ--------KYER 232 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HH--------HHHH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--HH--------HHHH
Confidence 43221 22345699999999984 56789999999999999999999976321111 00 0000
Q ss_pred hhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcccccC
Q 036879 960 VVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIEN 1021 (1029)
Q Consensus 960 ~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~~ 1021 (1029)
...... ..........++..+.+++..||+.||++|||++++++.|+++.+....+.+.
T Consensus 233 ~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~ 291 (298)
T 1csn_A 233 IGEKKQ---STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 291 (298)
T ss_dssp HHHHHH---HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCS
T ss_pred HHhhcc---CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCC
Confidence 000000 00011112245778999999999999999999999999999999887655543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=352.34 Aligned_cols=256 Identities=21% Similarity=0.374 Sum_probs=196.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEec----CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
..++|++.+.||+|+||.||+|+.. .+..||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 3467888999999999999999874 24579999987543 334567899999999999999999999985 45678
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+++++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999999877778999999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
..........+++.|+|||++ ++.++|||||||++|||++ |+.||......+. ... .....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~~-----------i~~~~- 234 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGR-----------IENGE- 234 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHH-----------HHTTC-
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HHH-----------HHcCC-
Confidence 433333445578899999983 6778999999999999996 9999975322111 000 00000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
....+..++..+.+++.+||+.||++|||+.|+++.|+++.+.-
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 01112345678899999999999999999999999999987654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=366.46 Aligned_cols=364 Identities=20% Similarity=0.216 Sum_probs=212.5
Q ss_pred cccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCc
Q 036879 59 GLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIP 138 (1029)
Q Consensus 59 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 138 (1029)
+..+..+..++++++|++|++++|.+++ +| .++.+++|++|+|++|+++.+ | ++.+++|++|+|++|++++ +|
T Consensus 29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~--~--~~~l~~L~~L~Ls~N~l~~-~~ 101 (457)
T 3bz5_A 29 EMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL--D--LSQNTNLTYLACDSNKLTN-LD 101 (457)
T ss_dssp TCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC--C--CTTCTTCSEEECCSSCCSC-CC
T ss_pred CcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE--c--cccCCCCCEEECcCCCCce-ee
Confidence 3444555667778888888888888885 45 678888888888888888853 3 7778888888888888875 33
Q ss_pred ccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCC
Q 036879 139 PSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQI 218 (1029)
Q Consensus 139 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~ 218 (1029)
++++++|++|+|++|++++ +| +.++++|++|++++|++++..
T Consensus 102 --~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l~--------------------------------- 143 (457)
T 3bz5_A 102 --VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEID--------------------------------- 143 (457)
T ss_dssp --CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCCC---------------------------------
T ss_pred --cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccceec---------------------------------
Confidence 7788888888888888874 44 777777777777777766431
Q ss_pred CcccccccccceEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEc
Q 036879 219 PSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSL 298 (1029)
Q Consensus 219 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 298 (1029)
++.+++|++|++++|+..+.+ .++.++ +|+.|+|++|++++ +| +..+++|++|++
T Consensus 144 ---l~~l~~L~~L~l~~n~~~~~~--~~~~l~-----------------~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l 198 (457)
T 3bz5_A 144 ---VSHNTQLTELDCHLNKKITKL--DVTPQT-----------------QLTTLDCSFNKITE-LD--VSQNKLLNRLNC 198 (457)
T ss_dssp ---CTTCTTCCEEECTTCSCCCCC--CCTTCT-----------------TCCEEECCSSCCCC-CC--CTTCTTCCEEEC
T ss_pred ---cccCCcCCEEECCCCCccccc--ccccCC-----------------cCCEEECCCCccce-ec--cccCCCCCEEEC
Confidence 334455555555555443333 133322 23345555555554 22 455555666666
Q ss_pred cCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccc
Q 036879 299 TANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNC 378 (1029)
Q Consensus 299 s~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l 378 (1029)
++|++.+ ++ + ..+++|++|+|++|++++ +| +..+++|+.|++++|.+++..+ ..+
T Consensus 199 ~~N~l~~-~~--l-~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~------------------~~l 253 (457)
T 3bz5_A 199 DTNNITK-LD--L-NQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV------------------STL 253 (457)
T ss_dssp CSSCCSC-CC--C-TTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC------------------TTC
T ss_pred cCCcCCe-ec--c-ccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH------------------HHC
Confidence 6666542 22 2 235566666666666665 33 5555666666666666654321 234
Q ss_pred cccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEE
Q 036879 379 KDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLY 458 (1029)
Q Consensus 379 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 458 (1029)
++|+.|++++|+ ++.|++++|.+.+.+| ++.+++|+.|+|++|...+.+|. ..++|+.|+
T Consensus 254 ~~L~~L~l~~n~---------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~ 313 (457)
T 3bz5_A 254 SKLTTLHCIQTD---------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELD 313 (457)
T ss_dssp TTCCEEECTTCC---------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCC
T ss_pred CCCCEEeccCCC---------------CCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEec
Confidence 566677766654 4456677776665555 45667777777777766655553 234455554
Q ss_pred eccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccC
Q 036879 459 LQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNG 538 (1029)
Q Consensus 459 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 538 (1029)
+++| ++|++|++++|++++. + ++.+++|+.|++++|+|++ ++.|..|++++|.+.|
T Consensus 314 l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g 369 (457)
T 3bz5_A 314 LSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEA 369 (457)
T ss_dssp CTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEE
T ss_pred hhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEe
Confidence 4444 3455555555555542 1 4455555555555555543 1233334444444443
Q ss_pred cCCccccccccccEEEccCCcCCCCCCc
Q 036879 539 TLPVEIGNLKVVTKIDLSRNDLSGEIPS 566 (1029)
Q Consensus 539 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 566 (1029)
. +.+..|+.+++++|+++|.+|.
T Consensus 370 ~-----~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 370 E-----GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp E-----EEEEECCCBCCBTTBEEEECCT
T ss_pred c-----ceeeecCccccccCcEEEEcCh
Confidence 2 2333344444444444444443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=349.72 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=209.4
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.++|++.+.||+|+||.||+|+..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 457888999999999999999998889999999986543 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
++++|.+++......+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||++...........
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999999877778999999999999999999999 77799999999999999999999999999986644322222
Q ss_pred ccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
....+++.|+|||+. ++.++||||+|+++|||++ |+.||......+. .. ..... .
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~--------~i~~~-~------ 222 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VE--------DISTG-F------ 222 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HH--------HHHTT-C------
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH-----HH--------HHhcC-C------
Confidence 334577889999983 6778999999999999999 8999875321110 00 00000 0
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
....+..++..+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0011123466789999999999999999999999999998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=369.81 Aligned_cols=258 Identities=20% Similarity=0.261 Sum_probs=207.7
Q ss_pred HHHHHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEec
Q 036879 730 YQELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSS 805 (1029)
Q Consensus 730 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 805 (1029)
+.+.....++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|.+++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444456788999999999999999999975 79999999997542 2334568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 806 DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 806 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
.+..|+||||+++|+|.+++.+.+..+++..+..++.||+.||+||| +.||+||||||+||+++.++++||+|||+|
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999999776668999999999999999999999 677999999999999999999999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC-----------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccc
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK-----------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLH 954 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 954 (1029)
+..............||+.|+|||++ ++.++|||||||++|||++|+.||......+.
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----------- 278 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET----------- 278 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-----------
Confidence 88765444334446799999999974 47789999999999999999999975321110
Q ss_pred hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCC---CCHHHHHHH
Q 036879 955 GKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEER---INIKEALTK 1007 (1029)
Q Consensus 955 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---pt~~evl~~ 1007 (1029)
+........ .......+..++.++.+++.+|+. +|++| |+++|++++
T Consensus 279 --~~~i~~~~~---~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 279 --YGKIVHYKE---HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --HHHHHTHHH---HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --HHHHHhccc---CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 001110000 000011123457789999999999 99998 589999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=356.52 Aligned_cols=261 Identities=19% Similarity=0.235 Sum_probs=208.8
Q ss_pred hCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999996 479999999987543 235688999999999 99999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc-----EEEEccCCceecC
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV-----ACLSDFGISKLLG 889 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~-----~kl~Dfg~a~~~~ 889 (1029)
|+ +++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++. +||+|||+|+.+.
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 99999999877778999999999999999999999 678999999999999998887 9999999998764
Q ss_pred CCCCc------eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhh
Q 036879 890 DETSM------TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959 (1029)
Q Consensus 890 ~~~~~------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1029)
..... ......||+.|+|||++ ++.++|||||||++|||++|+.||........ ... +..
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~--------~~~ 231 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KER--------YQK 231 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHH--------HHH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHH--------HHH
Confidence 43221 12345799999999984 56789999999999999999999976321111 100 000
Q ss_pred hhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcc
Q 036879 960 VVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLT 1017 (1029)
Q Consensus 960 ~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~ 1017 (1029)
...... ..........++ ++.+++..||+.||++||+++++.+.|+++.++...
T Consensus 232 i~~~~~---~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 232 IGDTKR---ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HHHHHH---HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHhhhc---cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 100000 000000111234 899999999999999999999999999999887644
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=354.68 Aligned_cols=248 Identities=21% Similarity=0.309 Sum_probs=201.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccch------hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG------TLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|+++++.++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356889999999999999999976 6899999999765321 356789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC----cEEEEccCCc
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM----VACLSDFGIS 885 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~----~~kl~Dfg~a 885 (1029)
++||||+++++|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++.++ .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999854 457999999999999999999999 67899999999999999887 8999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
+....... .....||+.|+|||++ ++.++||||+||++|||++|+.||......+. +....
T Consensus 166 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------------~~~~~ 230 (326)
T 2y0a_A 166 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------------LANVS 230 (326)
T ss_dssp EECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------------HHHHH
T ss_pred eECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-------------HHHHH
Confidence 87654322 2335699999999983 67789999999999999999999965311100 00000
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.. ...........++..+.+++.+||..||++|||+.|++++
T Consensus 231 ~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 231 AV----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HT----CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hc----CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0000011123356778999999999999999999999974
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=349.03 Aligned_cols=261 Identities=25% Similarity=0.421 Sum_probs=198.7
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhc--CCCCceEEEEEEEec----CCeE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGS--IRHRNLVKIISTCSS----DHFK 809 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~ 809 (1029)
..++|++.+.||+|+||+||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 356799999999999999999987 6899999998654 23455667777666 799999999998644 3567
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEEcCCCCCCEEECCCCcEEEEccCC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD-----HPTPIIHCDLNPSNILLNESMVACLSDFGI 884 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~givH~Dlk~~Nill~~~~~~kl~Dfg~ 884 (1029)
++||||+++|+|.+++. ...+++..+..++.|++.||+|||.. ++++|+||||||+||+++.++.+||+|||+
T Consensus 82 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 89999999999999994 45799999999999999999999932 256799999999999999999999999999
Q ss_pred ceecCCCCCce---eccccCCccccCccCCCC----------CCcchhHHHHHHHHHhcC----------CCCCCccccc
Q 036879 885 SKLLGDETSMT---QTQTLATIGYMAPEWKLS----------RKGDVYSYGIILMETFTK----------KKPTDELFVG 941 (1029)
Q Consensus 885 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~----------~~~DvwSlGvil~elltg----------~~p~~~~~~~ 941 (1029)
|+......... .....||+.|+|||++.+ .++|||||||++|||++| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 98764433221 223479999999998533 479999999999999999 6776543322
Q ss_pred ccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 942 EISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
....... .............+.......++..+.+++.+||+.||++|||++|+++.|+++
T Consensus 240 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFEDM---------RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHHHH---------HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccchhhh---------hHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2211111 010000000000011112234678899999999999999999999999999876
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=363.22 Aligned_cols=249 Identities=19% Similarity=0.266 Sum_probs=204.0
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||+|++..........+.+|+++++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999876 7899999999876555566889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC--CCCcEEEEccCCceecCCCCC
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN--ESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
+++|+|.+++......+++..+..++.||+.||+||| +.||+||||||+||+++ ..+.+||+|||+++.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999999776668999999999999999999999 67899999999999997 457899999999987754332
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
.....||+.|+|||++ ++.++||||+||++|||++|+.||......+ ... .+......
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~-----------~i~~~~~~--- 268 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQ-----------NVKRCDWE--- 268 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHH-----------HHHHCCCC---
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--HHH-----------HHHhCCCC---
Confidence 2234699999999984 5678999999999999999999997532110 000 00000000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
........++.++.+++.+||..||++|||+.|++++
T Consensus 269 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 -FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000112346678999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.12 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=202.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccch-------hhHHHHHHHHHHhcCCCCceEEEEEEEecCCe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG-------TLRSFDAECEILGSIRHRNLVKIISTCSSDHF 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 808 (1029)
.++|++.+.||+|+||+||+|++. +++.||+|++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467889999999999999999975 7899999998654321 1267899999999999999999999997665
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCEEECCCCc-----EEEEc
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP--IIHCDLNPSNILLNESMV-----ACLSD 881 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~g--ivH~Dlk~~Nill~~~~~-----~kl~D 881 (1029)
++||||+++++|.+++......+++..+..++.|++.|++||| +.| |+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6999999999999999888888999999999999999999999 778 999999999999988776 99999
Q ss_pred cCCceecCCCCCceeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccch
Q 036879 882 FGISKLLGDETSMTQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG 955 (1029)
Q Consensus 882 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 955 (1029)
||+++.... ......||+.|+|||++ ++.++||||+||++|||++|+.||...............
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----- 243 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR----- 243 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH-----
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh-----
Confidence 999975433 23345689999999985 356899999999999999999999764322211111000
Q ss_pred hhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 956 KIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 956 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
. .......+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus 244 ------~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 ------E------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ------H------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ------c------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0 0000111234567899999999999999999999999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=361.36 Aligned_cols=249 Identities=24% Similarity=0.307 Sum_probs=200.2
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-----chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-----EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356899999999999999999875 79999999987532 113567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc---EEEEccCC
Q 036879 811 LVLEYMPNGSLENWMYNK---NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV---ACLSDFGI 884 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~---~kl~Dfg~ 884 (1029)
+||||+++++|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999887543 345899999999999999999999 678999999999999986554 99999999
Q ss_pred ceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhh
Q 036879 885 SKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960 (1029)
Q Consensus 885 a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1029)
+........ ......||+.|+|||++ ++.++||||+||++|||++|+.||..... . . ....
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~----~--------~~~i 244 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--R----L--------FEGI 244 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--H----H--------HHHH
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--H----H--------HHHH
Confidence 987754322 23345799999999984 67899999999999999999999975210 0 0 0000
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 961 ~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
... ...........++..+.+++.+||..||++|||+.|++++
T Consensus 245 ~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 245 IKG----KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHT----CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HcC----CCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 0000011122356789999999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=362.51 Aligned_cols=245 Identities=23% Similarity=0.304 Sum_probs=196.4
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 810 (1029)
..++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|.++++.+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999876 68999999998652 33456788999999988 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+++|+|.+++... +.+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+....
T Consensus 101 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999998643 56999999999999999999999 67899999999999999999999999999986433
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.. .......||+.|+|||++ ++.++||||+||++|||++|+.||......+. . .......
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-----~--------~~i~~~~-- 240 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL-----F--------EAILNDE-- 240 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----H--------HHHHHCC--
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH-----H--------HHHHcCC--
Confidence 22 223345799999999984 78899999999999999999999975321110 0 0000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCH------HHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINI------KEALT 1006 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~evl~ 1006 (1029)
...+...+..+.+++.+|++.||++||++ +|+++
T Consensus 241 ------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 ------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01122346678999999999999999998 77776
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=361.51 Aligned_cols=246 Identities=25% Similarity=0.333 Sum_probs=200.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++|||||++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357889999999999999999876 68999999997543 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+.+|+|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+|+......
T Consensus 94 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp ECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 999999999999854 556999999999999999999999 7789999999999999999999999999998765432
Q ss_pred CceeccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
......||+.|+|||++ ++.++||||+||++|||++|+.||........ ... ...+...
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~---------~~~~~~~- 235 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEI---------VHTFETT- 235 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHH---------HHHHHHC-
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHH---------HHHHhhc-
Confidence 22346799999999985 56789999999999999999999964321110 000 0000000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCC-HHHHHH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERIN-IKEALT 1006 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~evl~ 1006 (1029)
....+..++..+.+++.+||+.||++||+ ++++.+
T Consensus 236 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01112335678999999999999999998 777665
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=352.09 Aligned_cols=274 Identities=24% Similarity=0.350 Sum_probs=202.1
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcC--CCCceEEEEEEEecC----C
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSI--RHRNLVKIISTCSSD----H 807 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~ 807 (1029)
....++|++.+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++... +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 345678999999999999999999875 8999999986442 24455666666655 899999999999876 7
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--------CcEEcCCCCCCEEECCCCcEEE
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT--------PIIHCDLNPSNILLNESMVACL 879 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~--------givH~Dlk~~Nill~~~~~~kl 879 (1029)
..++||||+++|+|.+++.. ..+++..+..++.|++.||+||| +. ||+||||||+||+++.++.+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 88999999999999999954 36899999999999999999999 55 8999999999999999999999
Q ss_pred EccCCceecCCCCCce---eccccCCccccCccCCC----CCC------cchhHHHHHHHHHhcCCCCCCcccccccccc
Q 036879 880 SDFGISKLLGDETSMT---QTQTLATIGYMAPEWKL----SRK------GDVYSYGIILMETFTKKKPTDELFVGEISLK 946 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~----~~~------~DvwSlGvil~elltg~~p~~~~~~~~~~~~ 946 (1029)
+|||+|+.+....... .....||+.|+|||++. +.+ +|||||||++|||++|+.|+.........+.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999998764432221 12356999999999842 233 8999999999999999555433222222221
Q ss_pred hhchhcc-chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 947 SRVNDSL-HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 947 ~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
....... ...+.....................++..+.+++.+||+.||++|||+.|++++|+.+.++..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 1111110 011111111111111111111223678889999999999999999999999999999987653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=365.47 Aligned_cols=264 Identities=22% Similarity=0.371 Sum_probs=210.0
Q ss_pred CHHHHHHHhCCCCCCceeccCcceEEEEEEe------cCCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEE
Q 036879 729 SYQELFRATDGFSENNLLGKGSFGSVYKGTL------SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKII 800 (1029)
Q Consensus 729 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~ 800 (1029)
....+....++|++.+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|+++++++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3445556778999999999999999999974 256889999997653 33456799999999999 899999999
Q ss_pred EEEecCC-eEEEEEeccCCCCHHHHHhcCCC-------------------------------------------------
Q 036879 801 STCSSDH-FKALVLEYMPNGSLENWMYNKNR------------------------------------------------- 830 (1029)
Q Consensus 801 ~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------- 830 (1029)
+++.+.+ ..++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998754 48999999999999999976432
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC-
Q 036879 831 ----------------SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS- 893 (1029)
Q Consensus 831 ----------------~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 893 (1029)
.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 1889999999999999999999 77899999999999999999999999999986643322
Q ss_pred ceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
.......||+.|+|||+ .++.++|||||||++|||++ |+.||......+. +. ..+...
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~------------~~~~~~---- 312 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FC------------RRLKEG---- 312 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HH------------HHHHHT----
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HH------------HHHHcC----
Confidence 23334568899999997 36789999999999999998 9999975321111 00 000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.....+..++..+.+++.+||+.||++|||++|++++|+.+.+.
T Consensus 313 --~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 313 --TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 00111223466789999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=377.16 Aligned_cols=254 Identities=24% Similarity=0.441 Sum_probs=206.7
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..++|++.+.||+|+||+||+|++.++..||||+++... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 456788889999999999999999888999999997653 34678999999999999999999999986 5678999999
Q ss_pred cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++|+|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++........
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 99999999996543 36889999999999999999999 677999999999999999999999999999876443222
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......+++.|+|||++ ++.++|||||||++|||++ |+.||.+....+. ...+...
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~--------------~~~i~~~----- 401 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--------------IRALERG----- 401 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--------------HHHHHHT-----
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcC-----
Confidence 22334567899999983 6789999999999999999 9999975321110 0000000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
...+.+..++..+.+++.+||+.||++|||++++++.|+.+...
T Consensus 402 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 402 -YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 01112335678899999999999999999999999999877543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=367.77 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=200.3
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
..++|++.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3567999999999999999999875 79999999997653 23456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC---CCCcEEEEccCCceecC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN---ESMVACLSDFGISKLLG 889 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~---~~~~~kl~Dfg~a~~~~ 889 (1029)
|||+++|+|.+++... ..+++..+..++.||+.|++||| ++||+||||||+||+++ .++.+||+|||+|....
T Consensus 89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999998654 56999999999999999999999 77899999999999998 56889999999998765
Q ss_pred CCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
.... ......||+.|+|||++ ++.++||||+||++|+|++|++||......+ ... ....
T Consensus 165 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--~~~-----------~i~~--- 227 (444)
T 3soa_A 165 GEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--LYQ-----------QIKA--- 227 (444)
T ss_dssp TTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH-----------HHHH---
T ss_pred CCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--HHH-----------HHHh---
Confidence 4322 22345799999999983 6789999999999999999999996531110 000 0000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.......+....++..+.+++.+|++.||++|||+.|++++
T Consensus 228 -~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 228 -GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000001112346778999999999999999999999974
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=361.41 Aligned_cols=261 Identities=23% Similarity=0.410 Sum_probs=208.2
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH 807 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 807 (1029)
...++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34678999999999999999999874 34889999998654 334567999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC
Q 036879 808 FKALVLEYMPNGSLENWMYNKN-----------------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dl 864 (1029)
..++||||+++|+|.+++.... ..+++..++.++.||++||+||| ++||+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 9999999999999999997642 56899999999999999999999 778999999
Q ss_pred CCCCEEECCCCcEEEEccCCceecCCCCC-ceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcc
Q 036879 865 NPSNILLNESMVACLSDFGISKLLGDETS-MTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDEL 938 (1029)
Q Consensus 865 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~ 938 (1029)
||+||+++.++.+||+|||+++....... .......+|+.|+|||+ .++.++|||||||++|||++ |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999986543221 12233567899999997 46789999999999999999 99998753
Q ss_pred cccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccc
Q 036879 939 FVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTN 1018 (1029)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~ 1018 (1029)
...+. . ....+... ...+..++..+.+++.+||+.||++|||+.|+++.|+++.+....+
T Consensus 281 ~~~~~--~-----------~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~ 340 (343)
T 1luf_A 281 AHEEV--I-----------YYVRDGNI-------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGT 340 (343)
T ss_dssp CHHHH--H-----------HHHHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-----
T ss_pred ChHHH--H-----------HHHhCCCc-------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhh
Confidence 21110 0 00000000 0112345678999999999999999999999999999988776543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=349.65 Aligned_cols=265 Identities=21% Similarity=0.305 Sum_probs=201.0
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999976 68999999997653 2335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+++ ++.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 9964 777777676778999999999999999999999 67899999999999999999999999999987654322
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh---ccchhhhhhh---hh
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND---SLHGKIINVV---DI 963 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~---d~ 963 (1029)
......||+.|+|||++ ++.++||||+||++|||++|+.||.........+...... .....+.... +.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 23345789999999973 5778999999999999999988864322111111111000 0000000000 00
Q ss_pred h---hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 N---LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. ..............++..+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 0000000011112346778999999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=361.15 Aligned_cols=271 Identities=16% Similarity=0.204 Sum_probs=206.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEecC------CcEEEEEEeecccchh-----------hHHHHHHHHHHhcCCCCceEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSD------GMQIAVKVFNLELEGT-----------LRSFDAECEILGSIRHRNLVK 798 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 798 (1029)
..++|++.+.||+|+||.||+|++.. ++.||||++....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 4789999987653211 123445666778889999999
Q ss_pred EEEEEecC----CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC--
Q 036879 799 IISTCSSD----HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN-- 872 (1029)
Q Consensus 799 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~-- 872 (1029)
+++++... ...++||||+ +++|.+++......+++..+..++.||+.||+||| ++||+||||||+||+++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence 99998764 4579999999 99999999887788999999999999999999999 67899999999999999
Q ss_pred CCCcEEEEccCCceecCCCCCc------eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccc
Q 036879 873 ESMVACLSDFGISKLLGDETSM------TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGE 942 (1029)
Q Consensus 873 ~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~ 942 (1029)
.++.+||+|||+|+.+...... ......||+.|+|||++ ++.++|||||||++|||++|+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8999999999999876432111 11234599999999984 5678999999999999999999997532211
Q ss_pred cccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccccc
Q 036879 943 ISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIE 1020 (1029)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~ 1020 (1029)
. +...........+.+..+..+. ...++.++.+++..||+.+|++||+++++++.|+++.+......+
T Consensus 269 ~-~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 269 K-YVRDSKIRYRENIASLMDKCFP---------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp H-HHHHHHHHHHHCHHHHHHHHSC---------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred H-HHHHHHHHhhhhHHHHHHHhcc---------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 1 1111111111111111111110 023477899999999999999999999999999999887655443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=363.34 Aligned_cols=258 Identities=24% Similarity=0.421 Sum_probs=209.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEec--------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS--------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSS 805 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 805 (1029)
..++|.+.+.||+|+||.||+|+.. .+..||||+++... ....+.+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467888999999999999999852 34679999997654 33457789999999999 99999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEE
Q 036879 806 DHFKALVLEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNIL 870 (1029)
Q Consensus 806 ~~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nil 870 (1029)
++..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEE
Confidence 999999999999999999997654 35899999999999999999999 678999999999999
Q ss_pred ECCCCcEEEEccCCceecCCCCC-ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccc
Q 036879 871 LNESMVACLSDFGISKLLGDETS-MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEIS 944 (1029)
Q Consensus 871 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 944 (1029)
++.++.+||+|||+|+....... .......+|+.|+|||++ ++.++|||||||++|||++ |+.||......+
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~-- 301 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 301 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999987654322 223334578899999984 6778999999999999999 999987532111
Q ss_pred cchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 945 LKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 945 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
+. ..+.... ....+..++.++.+++.+||+.||++|||++|++++|+++.....
T Consensus 302 ~~------------~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 302 LF------------KLLKEGH------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HH------------HHHHTTC------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HH------------HHHHcCC------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 00 0000000 011122356779999999999999999999999999999987654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=358.95 Aligned_cols=248 Identities=22% Similarity=0.342 Sum_probs=200.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999876 78999999997653 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC---CcEEEEccCCceecCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES---MVACLSDFGISKLLGD 890 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~---~~~kl~Dfg~a~~~~~ 890 (1029)
||+++|+|.+++.. ...+++..+..++.||+.||+||| +.||+||||||+||+++.+ +.+||+|||++.....
T Consensus 108 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999999998854 456899999999999999999999 6789999999999999864 4599999999987654
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
... .....||+.|+|||++ ++.++||||+||++|||++|+.||......+ ... .. ..
T Consensus 184 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~---~i--------~~---- 244 (362)
T 2bdw_A 184 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYA---QI--------KA---- 244 (362)
T ss_dssp CCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---HH--------HH----
T ss_pred Ccc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHH---HH--------Hh----
Confidence 322 2345799999999983 6779999999999999999999996531110 000 00 00
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
............++..+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 245 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000001112346778999999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=360.78 Aligned_cols=243 Identities=21% Similarity=0.308 Sum_probs=195.0
Q ss_pred CceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 743 NNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
.+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 578999999999999875 7999999999876656677899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE--CCCCcEEEEccCCceecCCCCCceeccc
Q 036879 822 ENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL--NESMVACLSDFGISKLLGDETSMTQTQT 899 (1029)
Q Consensus 822 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 899 (1029)
.+++......+++..+..++.||+.||+||| +.||+||||||+||++ +.++.+||+|||+++....... ....
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~ 248 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVN 248 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccc
Confidence 9999777777999999999999999999999 7789999999999999 6778999999999987754332 2235
Q ss_pred cCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHH
Q 036879 900 LATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTA 975 (1029)
Q Consensus 900 ~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 975 (1029)
.||+.|+|||++ ++.++|||||||++|||++|+.||......+. +......... .....
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------------~~~i~~~~~~----~~~~~ 311 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-------------LNNILACRWD----LEDEE 311 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHHTCCC----SCSGG
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHhccCC----CChhh
Confidence 699999999974 56689999999999999999999975321110 0011100000 00011
Q ss_pred HHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 976 KEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 976 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...++.++.+++.+|++.||++|||+.|++++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 12346778999999999999999999999983
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.72 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=199.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 78999999987543 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC-C
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET-S 893 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~ 893 (1029)
|+++|+|.+++. ....+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++..+.... .
T Consensus 86 ~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999884 4456999999999999999999999 7789999999999999999999999999998654221 1
Q ss_pred ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
.......||+.|+|||++ .+.++||||+||++|||++|+.||.........+..+.... .
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------------~--- 226 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK------------T--- 226 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC------------T---
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc------------c---
Confidence 122345799999999984 35579999999999999999999976432222111111100 0
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.......++..+.+++.+||+.||++|||++|++++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 227 ---YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 001112346678899999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=350.69 Aligned_cols=264 Identities=23% Similarity=0.330 Sum_probs=199.4
Q ss_pred CCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
++|++.+.||+|+||+||+|+..+|+.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57889999999999999999988899999999875532 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+++ +|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 975 999999777778999999999999999999999 67899999999999999999999999999987643221 2
Q ss_pred eccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhhhhhh-----h
Q 036879 896 QTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKIINVV-----D 962 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~-----d 962 (1029)
.....+|+.|+|||++ ++.++||||+||++|||++|+.||......+. +..... ......+.... +
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHHCCCChhhchhhhcccccc
Confidence 2335689999999973 57789999999999999999999976322111 000000 00000000000 0
Q ss_pred hhhhh-hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 963 INLLQ-KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 963 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..... ...........++..+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 0000001112346678999999999999999999999874
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=370.36 Aligned_cols=329 Identities=21% Similarity=0.222 Sum_probs=225.5
Q ss_pred ccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCC
Q 036879 317 NLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLP 396 (1029)
Q Consensus 317 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 396 (1029)
+|+.|+|++|++++..+..|.++++|++|++++|.+.+..|..+ .++++|++|+|++|++++..+
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~---------------~~l~~L~~L~L~~n~l~~~~~ 97 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAF---------------NNLFNLRTLGLRSNRLKLIPL 97 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTT---------------TTCTTCCEEECCSSCCCSCCT
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhh---------------hCCccCCEEECCCCcCCccCc
Confidence 44444444444444444444444444444444444444333322 244555555555555554444
Q ss_pred ccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCC
Q 036879 397 ISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLR 476 (1029)
Q Consensus 397 ~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 476 (1029)
..|.++.+ |++|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..++
T Consensus 98 ~~~~~l~~-L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~ 176 (477)
T 2id5_A 98 GVFTGLSN-LTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLH 176 (477)
T ss_dssp TSSTTCTT-CCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCT
T ss_pred ccccCCCC-CCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccC
Confidence 44445444 56666666666655666666666777777777777666666666677777777777777666666666777
Q ss_pred CCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEcc
Q 036879 477 SLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLS 556 (1029)
Q Consensus 477 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 556 (1029)
+|+.|++++|.+.+..+..|..+++|++|++++|.+.+.+|.......+|+.|+|++|++++..+..+..+++|+.|+|+
T Consensus 177 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls 256 (477)
T 2id5_A 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLS 256 (477)
T ss_dssp TCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECC
T ss_pred CCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECC
Confidence 77777777777776667777778888888888877766666666666688888888888886555678888888888888
Q ss_pred CCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCC
Q 036879 557 RNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQV 636 (1029)
Q Consensus 557 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 636 (1029)
+|.+++..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|++++|++.+.+
T Consensus 257 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 257 YNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp SSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred CCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCcc
Confidence 88888777778888888888888888888888888888888999999999988777778888888999999999888765
Q ss_pred CCCCCCCccCcccccCCCCCCCCCC
Q 036879 637 PHGGPFTNLSSQSFVGNKGLCGAPE 661 (1029)
Q Consensus 637 ~~~~~~~~l~~~~~~~n~~~c~~~~ 661 (1029)
+....+.......+.++...|++|.
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 337 RLLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp GGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred chHhHHhhhhccccCccCceeCCch
Confidence 4321122333455677788887764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=357.98 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=199.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 467999999999999999999974 78999999997542 22345789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+ +|+|.+++... ..+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9999 78999988653 56899999999999999999999 6679999999999999999999999999998765432
Q ss_pred CceeccccCCccccCccCCC-----CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~~-----~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
. .....||+.|+|||++. +.++||||+||++|||++|+.||.+...... ...+...
T Consensus 163 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~~i~~~--------------- 223 (336)
T 3h4j_B 163 F--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--FKKVNSC--------------- 223 (336)
T ss_dssp T--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--BCCCCSS---------------
T ss_pred c--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--HHHHHcC---------------
Confidence 2 23356999999999852 5689999999999999999999976322111 1000000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
....+..++..+.+++.+|++.||++|||++|++++-
T Consensus 224 ----~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 224 ----VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp ----CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred ----CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 0011123456789999999999999999999998853
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=350.43 Aligned_cols=270 Identities=20% Similarity=0.269 Sum_probs=206.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC--eEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH--FKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 812 (1029)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 356889999999999999999976 68999999997543 334567889999999999999999999997754 77999
Q ss_pred EeccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE----CCCCcEEEEccCCce
Q 036879 813 LEYMPNGSLENWMYNKNR--SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL----NESMVACLSDFGISK 886 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill----~~~~~~kl~Dfg~a~ 886 (1029)
|||+++++|.+++..... .+++..+..++.|++.||+||| +.||+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976433 3899999999999999999999 7789999999999999 788899999999998
Q ss_pred ecCCCCCceeccccCCccccCccCC------------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccc
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK------------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLH 954 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~------------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 954 (1029)
....... .....||+.|+|||++ ++.++|||||||++|||++|+.||........ ..........
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR-NKEVMYKIIT 241 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG-CHHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch-hHHHHHHHhc
Confidence 7754432 2235699999999963 56789999999999999999999964322111 1111111100
Q ss_pred hhh----hhh---hhhh--hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 955 GKI----INV---VDIN--LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 955 ~~~----~~~---~d~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
+.. ... .... ...............+..+.+++.+||+.||++|||++|++++..+..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 000 000 0000 000000111223566788999999999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=365.04 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=205.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
.++|++.+.||+|+||+||+|++. +++.||||+++... ......+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356888999999999999999843 46789999997543 34456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC---cEEEE
Q 036879 810 ALVLEYMPNGSLENWMYNKN------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM---VACLS 880 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~---~~kl~ 880 (1029)
++||||+++|+|.+++.... ..+++..++.++.||+.||+||| ++||+||||||+||+++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997543 45899999999999999999999 77899999999999999554 59999
Q ss_pred ccCCceecCCC-CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccc
Q 036879 881 DFGISKLLGDE-TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLH 954 (1029)
Q Consensus 881 Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 954 (1029)
|||+|+..... .........+|+.|+|||++ ++.++|||||||++|||++ |+.||......+ ..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~~-------- 296 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VL-------- 296 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HH--------
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH--------
Confidence 99999754221 11222335678999999984 6789999999999999998 999987532111 00
Q ss_pred hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 955 GKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 955 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
+.+... .....+..++..+.+++.+||+.||++|||+.|++++|+.+.+...
T Consensus 297 ----~~i~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 297 ----EFVTSG------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp ----HHHHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ----HHHHcC------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 000000 0011123456778999999999999999999999999999887543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.78 Aligned_cols=267 Identities=22% Similarity=0.398 Sum_probs=205.2
Q ss_pred hCCCCCCceeccCcceEEEEEEe-----cCCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecC--Ce
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTL-----SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSD--HF 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 808 (1029)
.+.|++.+.||+|+||.||+|++ .+++.||+|+++... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34588889999999999999984 368999999997553 33457789999999999999999999999876 66
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.++||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 89999999999999999777778999999999999999999999 778999999999999999999999999999877
Q ss_pred CCCCC--ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch-hccchhhhhhh
Q 036879 889 GDETS--MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN-DSLHGKIINVV 961 (1029)
Q Consensus 889 ~~~~~--~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 961 (1029)
..... .......+|..|+|||.+ ++.++||||+||++|||++|+.|+............... ......+...+
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 54432 122335678889999984 567899999999999999999987543211000000000 00000000000
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
. .......+..++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 257 ~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 K------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp H------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred h------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0 00011122345678999999999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=376.71 Aligned_cols=253 Identities=24% Similarity=0.434 Sum_probs=208.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||.||+|++. ++..||||+++... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 456788899999999999999987 48899999997653 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++|+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999999764 356899999999999999999999 677999999999999999999999999999876544333
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......+++.|+|||++ ++.++|||||||++|||++ |+.||......+. . +.+...
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~--~------------~~~~~~----- 435 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--Y------------ELLEKD----- 435 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--H------------HHHHTT-----
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH--H------------HHHHcC-----
Confidence 33344567899999984 6789999999999999999 9999875321110 0 111100
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
.....+..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 436 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 436 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 0111233467789999999999999999999999999987653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=368.88 Aligned_cols=249 Identities=29% Similarity=0.472 Sum_probs=203.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCC-eEEEEEe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDH-FKALVLE 814 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E 814 (1029)
..++|++.+.||+|+||.||+|++. |+.||||+++... ..+.+.+|++++++++||||+++++++.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 4567888999999999999999885 7899999997553 4578999999999999999999999987654 7899999
Q ss_pred ccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 815 YMPNGSLENWMYNKNR-SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
|+++|+|.+++..... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999976554 3799999999999999999999 677999999999999999999999999999864322
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
.....+++.|+|||++ ++.++|||||||++|||++ |+.||......+. ... +..
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~------------i~~----- 401 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPR------------VEK----- 401 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HHH------------HHT-----
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH------------HHc-----
Confidence 1223578899999984 6778999999999999998 9999975321111 000 000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
......+..++..+.++|.+||+.||++|||+.++++.|+.+...
T Consensus 402 -~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 402 -GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 001122345678899999999999999999999999999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=362.24 Aligned_cols=255 Identities=21% Similarity=0.261 Sum_probs=198.7
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 810 (1029)
..++|++.+.||+|+||+||+|+.. +++.||+|++++.. ....+.+.+|..+++++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3467999999999999999999976 68899999998653 23345688999999887 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+++|+|.+++.. .+.+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+....
T Consensus 130 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999864 356999999999999999999999 77899999999999999999999999999986332
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.. .......||+.|+|||++ ++.++||||+||++|||++|+.||......+..... ....+...+..
T Consensus 206 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~-----~~~~~~~~i~~--- 276 (396)
T 4dc2_A 206 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-----TEDYLFQVILE--- 276 (396)
T ss_dssp TT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C-----CHHHHHHHHHH---
T ss_pred CC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh-----hHHHHHHHHhc---
Confidence 22 223346799999999984 677899999999999999999999653211110000 00000000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCH------HHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINI------KEALTK 1007 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~evl~~ 1007 (1029)
.....+..++..+.+++.+||+.||++||++ +|++++
T Consensus 277 ----~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 277 ----KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ----cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 0011223456778999999999999999985 566653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=345.31 Aligned_cols=261 Identities=24% Similarity=0.425 Sum_probs=210.8
Q ss_pred CCCCCCc-eeccCcceEEEEEEec---CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 738 DGFSENN-LLGKGSFGSVYKGTLS---DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 738 ~~~~~~~-~lg~G~fg~V~~~~~~---~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
++|.+.+ .||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++. .+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence 4566665 8999999999999853 67889999998653 345677999999999999999999999994 5568999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999999777778999999999999999999999 6789999999999999999999999999998775433
Q ss_pred Cce--eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 893 SMT--QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 893 ~~~--~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
... .....+|+.|+|||+. ++.++|||||||++|||++ |+.||......+. .. .+...
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~------------~i~~~- 229 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MA------------FIEQG- 229 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HH------------HHHTT-
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--HH------------HHhcC-
Confidence 221 2233468899999984 5778999999999999998 9999975321110 00 00000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcccccCC
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIENS 1022 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~~~ 1022 (1029)
.....+..++..+.+++.+||+.||++||++.|++++|+.+..+...+.+..
T Consensus 230 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~ 281 (287)
T 1u59_A 230 -----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281 (287)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred -----CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence 0011123456789999999999999999999999999999998877665543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=356.52 Aligned_cols=254 Identities=25% Similarity=0.457 Sum_probs=199.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcE----EEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQ----IAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
.++|++.+.||+|+||+||+|++. +++. ||+|.+.... ....+.+.+|++++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 456888999999999999999864 4444 5888775443 334577999999999999999999999998765 67
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+.+|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|+....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999999888888999999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCc-eeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 891 ETSM-TQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 891 ~~~~-~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
.... ......+|+.|+|||+ .++.++|||||||++|||++ |+.||......+. . ..+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~------------~~~~~~ 235 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S------------SILEKG 235 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--H------------HHHHTT
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--H------------HHHHcC
Confidence 3222 2233456889999998 36789999999999999999 9999976322111 0 111100
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
. ....+..++..+.+++.+||+.||++|||++|++++|+.+.+.
T Consensus 236 ~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 236 E------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp C------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred C------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0 0111233566789999999999999999999999999988764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=350.47 Aligned_cols=242 Identities=24% Similarity=0.330 Sum_probs=200.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 457889999999999999999976 79999999997653 23356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++|+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999999999965 456899999999999999999999 788999999999999999999999999999876432
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
.....||+.|+|||++ ++.++||||+||++|||++|+.||........ ........
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------------~~~i~~~~---- 219 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------------YEKILNAE---- 219 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHHCC----
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHhCC----
Confidence 1235699999999984 67899999999999999999999965311100 00111100
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
...+..++.++.+++.+|+..||++|| +++|++++
T Consensus 220 ----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 011223466789999999999999999 89999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=351.37 Aligned_cols=246 Identities=24% Similarity=0.322 Sum_probs=193.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--------------------------hhhHHHHHHHHHHh
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--------------------------GTLRSFDAECEILG 789 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--------------------------~~~~~~~~E~~~l~ 789 (1029)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999875 789999999875421 12356889999999
Q ss_pred cCCCCceEEEEEEEec--CCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCC
Q 036879 790 SIRHRNLVKIISTCSS--DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPS 867 (1029)
Q Consensus 790 ~l~h~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~ 867 (1029)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.|++.||+||| +.||+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence 9999999999999986 56889999999999998754 3457999999999999999999999 677999999999
Q ss_pred CEEECCCCcEEEEccCCceecCCCCCceeccccCCccccCccCCC-------CCCcchhHHHHHHHHHhcCCCCCCcccc
Q 036879 868 NILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL-------SRKGDVYSYGIILMETFTKKKPTDELFV 940 (1029)
Q Consensus 868 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~DvwSlGvil~elltg~~p~~~~~~ 940 (1029)
||+++.++.+||+|||+++....... ......||+.|+|||.+. +.++|||||||++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999987654322 233457999999999853 4568999999999999999999965311
Q ss_pred cccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 941 GEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.. ... . ...... . .+....++..+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~-----~~~-----~---~~~~~~-~-----~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 MC-----LHS-----K---IKSQAL-E-----FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HH-----HHH-----H---HHHCCC-C-----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HH-----HHH-----H---HhcccC-C-----CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 10 000 0 000000 0 00012345678999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=346.34 Aligned_cols=255 Identities=24% Similarity=0.428 Sum_probs=202.7
Q ss_pred HhCCCCCCceeccCcceEEEEEEecC----CcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSD----GMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
..++|++.+.||+|+||+||+|++.. +..||+|.+.... ....+.+.+|+++++.++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 35678889999999999999998642 3469999988653 34467899999999999999999999998754 468
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+++++|.+++......+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999999877778999999999999999999999 77899999999999999999999999999987654
Q ss_pred CCCceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
..........+++.|+|||+ .++.++||||||+++|||++ |+.||........ .. .+...
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--~~------------~~~~~- 230 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--IG------------VLEKG- 230 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--HH------------HHHHT-
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--HH------------HHhcC-
Confidence 43333344567889999997 36778999999999999998 9999864321111 00 00000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.....+..++..+.+++.+||+.||++|||+.|++++|+++.+.
T Consensus 231 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 231 -----DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 00011223467789999999999999999999999999988764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=351.30 Aligned_cols=256 Identities=24% Similarity=0.425 Sum_probs=208.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEe------cCCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL------SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHF 808 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 808 (1029)
..++|.+.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356788899999999999999986 245889999997653 3445778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCC
Q 036879 809 KALVLEYMPNGSLENWMYNKN-----------------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLN 865 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk 865 (1029)
.++||||+++++|.+++.... ..+++..+..++.|+++||+||| +.||+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence 999999999999999997643 23889999999999999999999 6779999999
Q ss_pred CCCEEECCCCcEEEEccCCceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCccc
Q 036879 866 PSNILLNESMVACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELF 939 (1029)
Q Consensus 866 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~ 939 (1029)
|+||+++.++.+||+|||++......... ......+++.|+|||.. ++.++||||+||++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876543322 22334578899999984 6789999999999999999 999997532
Q ss_pred ccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 940 VGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.... .. .+.... ....+..++..+.+++.+||+.||++|||+.|++++|+++...
T Consensus 258 ~~~~--~~------------~~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PERL--FN------------LLKTGH------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGGH--HH------------HHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHH--HH------------HhhcCC------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 2111 00 000000 0111223567899999999999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=357.05 Aligned_cols=272 Identities=25% Similarity=0.343 Sum_probs=209.9
Q ss_pred hCCCCCCceeccCcceEEEEEEe-----cCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEe--cCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTL-----SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS--SDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 809 (1029)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46788899999999999999984 368899999998776666778999999999999999999999886 45678
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999999776667999999999999999999999 6789999999999999999999999999998775
Q ss_pred CCCCc--eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 890 DETSM--TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 890 ~~~~~--~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
..... ......+|+.|+|||++ ++.++||||+||++|||++|+.||............. ...........+.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC--ERDVPALSRLLEL 256 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc--ccccccHHHHHHH
Confidence 43322 22334578889999984 5778999999999999999999986532211100000 0000000111110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
.. .......+..++..+.+++.+||+.||++|||++|++++|+.+.....
T Consensus 257 ~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 LE---EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hh---cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 00 000111233467789999999999999999999999999999876554
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=372.35 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=201.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..++|++.+.||+|+||.||+|++.++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 345688889999999999999999888889999997653 234679999999999999999999999976 668999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999999653 356899999999999999999999 677999999999999999999999999999876543333
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......+++.|+|||.+ ++.++|||||||++|||++ |+.||.+....+. . +.+...
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~------------~~i~~~----- 397 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--L------------DQVERG----- 397 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--H------------HHHHTT-----
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH--H------------HHHHcC-----
Confidence 33344578899999973 6789999999999999999 9999875321110 0 000000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
...+.+..++..+.+++.+||+.||++|||++++++.|+.+....
T Consensus 398 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 398 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 011123356778999999999999999999999999998876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=358.12 Aligned_cols=247 Identities=21% Similarity=0.312 Sum_probs=199.1
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCe
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHF 808 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 808 (1029)
....++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|.++++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345688999999999999999999976 68999999998653 33456678899999876 99999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.|+||||+++|+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999999864 346899999999999999999999 678999999999999999999999999999864
Q ss_pred CCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
..... ......||+.|+|||++ ++.++||||+||++|||++|+.||......+. .. ....
T Consensus 169 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~--------~i~~-- 232 (345)
T 1xjd_A 169 MLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----FH--------SIRM-- 232 (345)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HH--------HHHH--
T ss_pred ccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH-----HH--------HHHh--
Confidence 33222 23346799999999984 67789999999999999999999975321100 00 0000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHH-HHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIK-EALT 1006 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-evl~ 1006 (1029)
.. ...+..++..+.+++.+|+..||++||++. |+++
T Consensus 233 --~~----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 233 --DN----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp --CC----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CC----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 00 011123467789999999999999999997 6654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=350.63 Aligned_cols=256 Identities=24% Similarity=0.434 Sum_probs=211.6
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
..++|++.+.||+|+||.||+|.+. ++..||+|.+... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4667889999999999999999976 5889999998754 3345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 815 YMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
|+++++|.+++... ...+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||.+........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999999764 356899999999999999999999 66799999999999999999999999999987765544
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
.......+++.|+|||.. ++.++||||+|+++|+|++ |+.||........ . +.+....
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--~------------~~~~~~~--- 229 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--Y------------ELLEKDY--- 229 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--H------------HHHHTTC---
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--H------------HHHhccC---
Confidence 444445678899999983 6778999999999999999 9999875321111 0 0010000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
....+..++..+.+++.+|++.||++|||++|+++.|+.+....
T Consensus 230 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 230 ---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 01112345677999999999999999999999999999887654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.58 Aligned_cols=250 Identities=25% Similarity=0.430 Sum_probs=190.3
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccc----hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE----GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||.||+|++. ++.||||+++.... ...+.+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467888999999999999999974 88999999875432 2346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC--------CCcEEEEccCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE--------SMVACLSDFGI 884 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~--------~~~~kl~Dfg~ 884 (1029)
|||+++++|.+++. ...+++..+..++.|++.|++|||..+..+|+||||||+||+++. ++.+||+|||.
T Consensus 85 ~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 85 MEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999999884 457899999999999999999999433223999999999999986 78899999999
Q ss_pred ceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhh
Q 036879 885 SKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960 (1029)
Q Consensus 885 a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1029)
+........ ....|++.|+|||.. ++.++||||+|+++|||++|+.||.......... ..
T Consensus 163 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------------~~ 226 (271)
T 3dtc_A 163 AREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-------------GV 226 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-------------HH
T ss_pred ccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------hh
Confidence 986644322 234689999999983 6778999999999999999999997532111100 00
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 961 ~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
.... .....+..++..+.+++.+||+.||++|||+.|++++|+++
T Consensus 227 ~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 AMNK------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HTSC------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hcCC------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0000 00111233567799999999999999999999999999764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=350.99 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=194.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC-------
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH------- 807 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 807 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457889999999999999999986 89999999997543 335578999999999999999999999985543
Q ss_pred --------------------------------------------------eEEEEEeccCCCCHHHHHhcCCC--CCCHH
Q 036879 808 --------------------------------------------------FKALVLEYMPNGSLENWMYNKNR--SFDIL 835 (1029)
Q Consensus 808 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~--~~~~~ 835 (1029)
..++||||+++++|.+++..... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999976432 35666
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC-----------ceeccccCCcc
Q 036879 836 QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS-----------MTQTQTLATIG 904 (1029)
Q Consensus 836 ~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~gt~~ 904 (1029)
.+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999 77899999999999999999999999999987754321 12233569999
Q ss_pred ccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHH
Q 036879 905 YMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCV 980 (1029)
Q Consensus 905 y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 980 (1029)
|+|||++ ++.++||||+||++|||++|..|+..... ....... ..........+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~---------------~~~~~~~-------~~~~~~~~~~~ 299 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR---------------IITDVRN-------LKFPLLFTQKY 299 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH---------------HHHHHHT-------TCCCHHHHHHC
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH---------------HHHHhhc-------cCCCcccccCC
Confidence 9999983 67899999999999999998776432100 0000000 01112223455
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 981 SSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 981 ~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
+.+.+++.+||+.||++|||++|++++
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 677999999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=352.35 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=200.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CC-------cEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DG-------MQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHF 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~-------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 808 (1029)
.++|++.+.||+|+||.||+|+.. ++ ..||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 457888999999999999999865 33 5799999987766667889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc--------EEEE
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV--------ACLS 880 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~--------~kl~ 880 (1029)
.++||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999999877667999999999999999999999 777999999999999998887 9999
Q ss_pred ccCCceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccch
Q 036879 881 DFGISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG 955 (1029)
Q Consensus 881 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 955 (1029)
|||.+...... ....+++.|+|||++ ++.++||||+||++|||++|+.|+..........
T Consensus 164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~---------- 228 (289)
T 4fvq_A 164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL---------- 228 (289)
T ss_dssp CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----------
T ss_pred cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH----------
Confidence 99998754321 224578899999973 5778999999999999999655543211110000
Q ss_pred hhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 956 KIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 956 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
..... ....+...+..+.+++.+||+.||++|||++|++++|+++....
T Consensus 229 ---~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 229 ---QFYED--------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp ---HHHHT--------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ---HHhhc--------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 00000 00001122456889999999999999999999999998886543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=348.51 Aligned_cols=265 Identities=25% Similarity=0.372 Sum_probs=187.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999875 68999999997653 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 815 YMPNGSLENWMYNKN-----RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
|++ ++|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999886432 45899999999999999999999 6789999999999999999999999999998765
Q ss_pred CCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh---ccchhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND---SLHGKIINVV 961 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 961 (1029)
.... ......+|+.|+|||++ ++.++||||+||++|||++|+.||......+. +...... .....+....
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-LKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCTTTCGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhHhhhhh
Confidence 3322 22345689999999973 57789999999999999999999975322111 0000000 0000000000
Q ss_pred h-----hhhhhh------hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 D-----INLLQK------EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 d-----~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. ...... .......+..++..+.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 000000 000000111345679999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=351.59 Aligned_cols=268 Identities=22% Similarity=0.381 Sum_probs=208.0
Q ss_pred CCCCceeccCcceEEEEEEec-----CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEec--CCeEEE
Q 036879 740 FSENNLLGKGSFGSVYKGTLS-----DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSS--DHFKAL 811 (1029)
Q Consensus 740 ~~~~~~lg~G~fg~V~~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 811 (1029)
|++.+.||+|+||+||+|.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999988642 68899999998654 2345679999999999999999999999987 467899
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++++|.+++... .+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999998543 4899999999999999999999 778999999999999999999999999999877544
Q ss_pred CCc--eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc-chhhhhhhhhh
Q 036879 892 TSM--TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL-HGKIINVVDIN 964 (1029)
Q Consensus 892 ~~~--~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~ 964 (1029)
... ......+|+.|+|||++ ++.++||||+||++|||++|+.||............+..... ...+.+.++..
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 321 22334578889999984 567899999999999999999998753222111111111000 00011111111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccc
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTN 1018 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~ 1018 (1029)
.....+..++..+.+++.+||+.||++|||++|+++.|+.+.+.+...
T Consensus 268 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 268 ------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 011123346778999999999999999999999999999999887544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=348.70 Aligned_cols=243 Identities=22% Similarity=0.208 Sum_probs=193.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.++||+|+||+||+|+.. +|+.||||++..... ........|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357999999999999999999986 799999999865432 2233445555555544 999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999 77999999877778999999999999999999999 6779999999999999999999999999998765432
Q ss_pred CceeccccCCccccCccCC---CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK---LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......||++|+|||++ ++.++|||||||++|||++|..|+..... ... .....
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~------------~~~~~----- 268 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG----WQQ------------LRQGY----- 268 (311)
T ss_dssp -----CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHH------------HTTTC-----
T ss_pred --CCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHH------------HhccC-----
Confidence 22345689999999984 57789999999999999999776543110 000 00000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....+..++.++.+++.+||+.||++|||++|++++
T Consensus 269 -~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 269 -LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0111223456789999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=351.07 Aligned_cols=260 Identities=23% Similarity=0.400 Sum_probs=210.4
Q ss_pred HhCCCCCCceeccCcceEEEEEEe------cCCcEEEEEEeecccc-hhhHHHHHHHHHHhcC-CCCceEEEEEEEecCC
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL------SDGMQIAVKVFNLELE-GTLRSFDAECEILGSI-RHRNLVKIISTCSSDH 807 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 807 (1029)
..++|++.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++..++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346788999999999999999985 2578899999986543 3457799999999999 9999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEE
Q 036879 808 FKALVLEYMPNGSLENWMYNKNR-----------------SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNIL 870 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nil 870 (1029)
..++||||+++|+|.+++..... .+++..+..++.|++.||+||| +.||+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence 99999999999999999976543 4899999999999999999999 678999999999999
Q ss_pred ECCCCcEEEEccCCceecCCCCCc-eeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccc
Q 036879 871 LNESMVACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEIS 944 (1029)
Q Consensus 871 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 944 (1029)
++.++.+||+|||++......... ......+|+.|+|||. .++.++|||||||++|||++ |+.||........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence 999999999999999876544322 2233457889999997 36778999999999999999 9999875321111
Q ss_pred cchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcc
Q 036879 945 LKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLT 1017 (1029)
Q Consensus 945 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~ 1017 (1029)
. ...+..... ...+..++..+.+++.+||+.||++|||+.|++++|+++..+...
T Consensus 257 ~------------~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 257 F------------YKMIKEGFR------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp H------------HHHHHHTCC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred H------------HHHhccCCC------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 0 001100000 001123467789999999999999999999999999998876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=352.60 Aligned_cols=258 Identities=24% Similarity=0.436 Sum_probs=191.6
Q ss_pred HhCCCCCCceeccCcceEEEEEEecC-C---cEEEEEEeecc--cchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSD-G---MQIAVKVFNLE--LEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~-~---~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
..++|++.+.||+|+||.||+|++.. + ..||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45689999999999999999998753 3 27999999765 344567899999999999999999999999876655
Q ss_pred ------EEEEeccCCCCHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEE
Q 036879 810 ------ALVLEYMPNGSLENWMYNKN-----RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC 878 (1029)
Q Consensus 810 ------~lV~E~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~k 878 (1029)
++||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence 89999999999999985432 25899999999999999999999 77899999999999999999999
Q ss_pred EEccCCceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhc
Q 036879 879 LSDFGISKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDS 952 (1029)
Q Consensus 879 l~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 952 (1029)
|+|||+++........ ......+++.|+|||.+ ++.++|||||||++|||++ |+.||......+. ..
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~----- 250 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--YN----- 250 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH-----
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--HH-----
Confidence 9999999876443221 22234567899999983 6789999999999999999 8999876322111 00
Q ss_pred cchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 953 LHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 953 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
...... ....+..++..+.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus 251 ------~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 251 ------YLIGGN-------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp ------HHHTTC-------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ------HHhcCC-------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 000000 011122356779999999999999999999999999999987554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=343.53 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=201.9
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC--CeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD--HFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 812 (1029)
.++|++.+.||+|+||.||+|++. ++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 457889999999999999999984 8899999997653 33456799999999999999999999999876 778999
Q ss_pred EeccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 813 LEYMPNGSLENWMYNKNR-SFDILQRLNMVIDVASALEYLHYDHPTP--IIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~~~g--ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
|||+++|+|.+++..... .+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.++++|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999976544 5899999999999999999999 777 9999999999999999999999999875432
Q ss_pred CCCCceeccccCCccccCccCCC----CC---CcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWKL----SR---KGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~~----~~---~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 962 (1029)
. ....+|+.|+|||.+. +. ++|||||||++|||++|+.||......+.. .....
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------------~~~~~ 225 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-------------MKVAL 225 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-------------HHHHH
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-------------HHHHh
Confidence 2 2346899999999842 22 699999999999999999999753211110 00000
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
.. .....+..++..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 226 ~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 226 EG------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp SC------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred cC------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 00 0011123356779999999999999999999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=341.45 Aligned_cols=248 Identities=22% Similarity=0.288 Sum_probs=203.8
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 456899999999999999999876 6789999999876666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE---CCCCcEEEEccCCceecCCCC
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
+++++|.+++.. ...+++..+..++.|++.|++||| ++||+||||||+||++ +.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 999999998854 455899999999999999999999 7789999999999999 788999999999998765433
Q ss_pred CceeccccCCccccCccCC---CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK---LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
. .....||+.|+|||.+ ++.++||||+|+++|||++|+.||......+. ....... ..
T Consensus 164 ~--~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------------~~~~~~~----~~ 224 (277)
T 3f3z_A 164 M--MRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-------------MLKIREG----TF 224 (277)
T ss_dssp C--BCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------HHHHHHC----CC
T ss_pred c--hhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHHhC----CC
Confidence 2 2335699999999984 68899999999999999999999975321111 0000000 00
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.........++..+.+++.+|++.||++|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011112356789999999999999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=347.80 Aligned_cols=264 Identities=22% Similarity=0.255 Sum_probs=197.6
Q ss_pred hCCCCCC-ceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEE
Q 036879 737 TDGFSEN-NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 737 ~~~~~~~-~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.+.|++. +.||+|+||.||+|+.. +++.||||++........+.+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 78999999999999865 7999999999876655667899999999885 7999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc---EEEEccCCceecCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV---ACLSDFGISKLLGD 890 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~---~kl~Dfg~a~~~~~ 890 (1029)
||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++. +||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999998653 56899999999999999999999 678999999999999998776 99999999976532
Q ss_pred CCC------ceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccch
Q 036879 891 ETS------MTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG 955 (1029)
Q Consensus 891 ~~~------~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 955 (1029)
... .......||+.|+|||++ ++.++||||+||++|||++|+.||......+..+.. .....
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~ 243 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---GEACP 243 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc---cccch
Confidence 211 111234589999999974 578999999999999999999999764332221111 00000
Q ss_pred h-hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 K-IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 ~-~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. ......................++..+.+++.+|++.||++|||++|++++
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0 000000000000000011112356789999999999999999999999985
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=353.96 Aligned_cols=254 Identities=21% Similarity=0.268 Sum_probs=199.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 811 (1029)
.++|++.+.||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|.++++++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 356888999999999999999976 68999999998653 33456788999999988 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus 88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999998643 56899999999999999999999 678999999999999999999999999999864322
Q ss_pred CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.. ......||+.|+|||++ ++.++||||+||++|||++|+.||........... .....+...+..
T Consensus 164 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----~~~~~~~~~i~~---- 233 (345)
T 3a8x_A 164 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-----NTEDYLFQVILE---- 233 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------------CHHHHHHHHHH----
T ss_pred CC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-----ccHHHHHHHHHc----
Confidence 22 23345799999999984 67789999999999999999999965321111000 000000000000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCH------HHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINI------KEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~evl~~ 1007 (1029)
.....+..++..+.+++.+||+.||++||++ .|++++
T Consensus 234 ---~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 234 ---KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0011123456778999999999999999995 677653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.41 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=197.7
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.++|++.+.||+|+||+||+|+.. ++.||||.+... ...+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 356888899999999999999874 789999998643 345778999999999999999999999874 378999999
Q ss_pred CCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc-EEEEccCCceecCCCCC
Q 036879 817 PNGSLENWMYNKNR--SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV-ACLSDFGISKLLGDETS 893 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~-~kl~Dfg~a~~~~~~~~ 893 (1029)
++|+|.+++..... .+++..+..++.|+++|++|||+.+.+||+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999975543 4788999999999999999999654489999999999999998886 799999999765432
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
.....||+.|+|||++ ++.++|||||||++|||++|+.||............. ...
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----------~~~------- 219 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA-----------VHN------- 219 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH-----------HHT-------
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH-----------Hhc-------
Confidence 1234589999999984 5778999999999999999999997532111100000 000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcc
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLT 1017 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~ 1017 (1029)
......+..++..+.+++.+||+.||++|||++|+++.|+.+.+.+..
T Consensus 220 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 000111123466789999999999999999999999999999877653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=359.15 Aligned_cols=257 Identities=27% Similarity=0.454 Sum_probs=196.0
Q ss_pred CCCCCceeccCcceEEEEEEec--CC--cEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEec-CCeEEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS--DG--MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSS-DHFKALV 812 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~--~~--~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV 812 (1029)
.|+..+.||+|+||+||+|++. ++ ..||||.++... ....+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3666789999999999999864 22 468999987543 3456789999999999999999999998754 5678999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++|+|.+++......+++..+..++.|+++||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999877778999999999999999999999 6789999999999999999999999999998654322
Q ss_pred Cc---eeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 893 SM---TQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 893 ~~---~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
.. ......+|+.|+|||. .++.++|||||||++|||++ |.+||......+. ...+. ..
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~~~-----------~~- 312 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL-----------QG- 312 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHHHH-----------TT-
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHHHH-----------cC-
Confidence 11 1233457889999998 36789999999999999999 6777765321111 10000 00
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccc
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTN 1018 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~ 1018 (1029)
.....+..++..+.+++.+||+.||++|||++|+++.|+++...+...
T Consensus 313 ------~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 313 ------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 001112345677999999999999999999999999999999877543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=346.29 Aligned_cols=257 Identities=26% Similarity=0.438 Sum_probs=193.6
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
..++|++.+.||+|+||+||+|+.. ..||+|+++... ....+.+.+|++++++++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 4678999999999999999999864 359999987553 33457799999999999999999999965 455678999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC-
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET- 892 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 892 (1029)
||+++++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999999777788999999999999999999999 6789999999999999999999999999997654321
Q ss_pred CceeccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
........||+.|+|||++ ++.++||||+||++|||++|+.||......+. .. ..+....
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~------------~~~~~~~ 242 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-II------------EMVGRGS 242 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HH------------HHHHHTS
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HH------------HHhcccc
Confidence 2222335689999999974 35589999999999999999999975321111 00 0000000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
... ........++..+.+++.+||+.+|++|||+.|+++.|+++.+
T Consensus 243 ~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 LSP--DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCC--CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCc--chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 000 0001112456789999999999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=355.39 Aligned_cols=260 Identities=22% Similarity=0.356 Sum_probs=205.1
Q ss_pred HHhCCCCCCceeccCcceEEEEEEe------cCCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecC
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTL------SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSD 806 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 806 (1029)
...++|++.+.||+|+||.||+|+. .++..||||++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457899999999999999999986 246689999997543 33457899999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC
Q 036879 807 HFKALVLEYMPNGSLENWMYNKNR----------------------SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dl 864 (1029)
+..++||||+++|+|.+++..... .+++..+..++.|++.||+||| +.||+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence 999999999999999999976543 3789999999999999999999 678999999
Q ss_pred CCCCEEECCCCcEEEEccCCceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcc
Q 036879 865 NPSNILLNESMVACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDEL 938 (1029)
Q Consensus 865 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~ 938 (1029)
||+||+++.++.+||+|||++......... ......+|+.|+|||.+ ++.++|||||||++|||++ |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999866433222 23345578899999973 6788999999999999998 99999763
Q ss_pred cccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 939 FVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
..... +. ..+.... ....+..++..+.+++.+||+.||++|||+.|++++|+.+.+...
T Consensus 279 ~~~~~-~~------------~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 279 PVDAN-FY------------KLIQNGF------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCSHH-HH------------HHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcHHH-HH------------HHHhcCC------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 21111 00 0010000 011122346778999999999999999999999999998876654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=342.47 Aligned_cols=267 Identities=19% Similarity=0.290 Sum_probs=206.0
Q ss_pred HHhCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEE-ecCCeEEEE
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC-SSDHFKALV 812 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV 812 (1029)
...++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+|+++++.++|++++..++++ ...+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3467899999999999999999997 478999999876443 234688999999999988777666655 667888999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE---CCCCcEEEEccCCceecC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLG 889 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill---~~~~~~kl~Dfg~a~~~~ 889 (1029)
|||+ +++|.+++......+++..+..++.|++.||+||| +.||+||||||+||++ +.++.+||+|||+++...
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 99999999877778999999999999999999999 7779999999999999 789999999999998765
Q ss_pred CCCC------ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhh
Q 036879 890 DETS------MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959 (1029)
Q Consensus 890 ~~~~------~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1029)
.... .......||+.|+|||.. ++.++|||||||++|||++|+.||......... .. +..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~--------~~~ 229 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QK--------YER 229 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SH--------HHH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh--hh--------hhh
Confidence 4322 122345689999999984 566899999999999999999999763222110 00 000
Q ss_pred hhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccccc
Q 036879 960 VVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIE 1020 (1029)
Q Consensus 960 ~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~ 1020 (1029)
....... .........++..+.+++..||+.||++|||++++++.|+++..+...+.+
T Consensus 230 ~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 4hgt_A 230 ISEKKMS---TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp HHHHHHH---SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTT
T ss_pred hhccccc---chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCcc
Confidence 0000000 000111123467899999999999999999999999999999988765554
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=343.12 Aligned_cols=246 Identities=24% Similarity=0.425 Sum_probs=186.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 457889999999999999999874 799999999975432 2346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++++|.+++......+++..+..++.|+++|++||| +.||+||||||+||+++.++.+||+|||.+.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999877778999999999999999999999 6789999999999999999999999999998765332
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
. ......|++.|+|||.. ++.++||||+|+++|||++|+.||......+. ....... +.
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~------~~----- 229 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNKVVLA------DY----- 229 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCSS------CC-----
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHHHhhc------cc-----
Confidence 2 12235689999999984 56799999999999999999999975321111 0000000 00
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..+..++..+.+++.+||+.||++|||+++++++
T Consensus 230 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 -----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0112245678999999999999999999999874
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=355.69 Aligned_cols=151 Identities=27% Similarity=0.445 Sum_probs=73.9
Q ss_pred cCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccc
Q 036879 424 IGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLR 503 (1029)
Q Consensus 424 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 503 (1029)
+..+++|++|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|+
T Consensus 239 l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--------------------------~~~l~~L~ 290 (466)
T 1o6v_A 239 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--------------------------LAGLTALT 290 (466)
T ss_dssp GGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--------------------------GTTCTTCS
T ss_pred hhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--------------------------ccCCCccC
Confidence 4444555555555555553322 4445555555555555543322 34444444
Q ss_pred eeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccccccc
Q 036879 504 TLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNK 583 (1029)
Q Consensus 504 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 583 (1029)
.|++++|++++..+ +..+++|+.|++++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|+
T Consensus 291 ~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~ 364 (466)
T 1o6v_A 291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQ 364 (466)
T ss_dssp EEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSC
T ss_pred eEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCc
Confidence 44444444444322 4444455555555555544333 44555555555555555432 244555555555555555
Q ss_pred ccccCCccccCCCCCCEEeCcCCcccC
Q 036879 584 FQGSIPDSLGGLTSLNFLDMSSNNLSG 610 (1029)
Q Consensus 584 l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 610 (1029)
+++..| +..+++|+.|++++|++++
T Consensus 365 l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 365 ISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred cCccch--hhcCCCCCEEeccCCcccC
Confidence 554444 4555555555555555553
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=343.70 Aligned_cols=256 Identities=24% Similarity=0.412 Sum_probs=207.0
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..++|++.+.||+|+||.||+|+..++..||+|.+.... ...+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 356788999999999999999998888899999987553 235678999999999999999999999874 457899999
Q ss_pred cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++++|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999999985432 26899999999999999999999 778999999999999999999999999999877554333
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......+++.|+|||.. ++.++||||||+++|||++ |+.||......+. .. .+....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~------------~~~~~~---- 227 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--IQ------------NLERGY---- 227 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HH------------HHHTTC----
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH--HH------------HHhccc----
Confidence 33345578899999984 5778999999999999999 8999875321110 00 000000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
....+..++..+.+++.+|++.||++|||++++++.|+++.....
T Consensus 228 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 228 --RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 001122346789999999999999999999999999999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=351.57 Aligned_cols=280 Identities=26% Similarity=0.365 Sum_probs=197.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHH--HhcCCCCceEEEEEEEec-----CCe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEI--LGSIRHRNLVKIISTCSS-----DHF 808 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~ 808 (1029)
..++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 356899999999999999999977 68999999987543 2334445555 445899999999986532 336
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CcEEcCCCCCCEEECCCCcEEE
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT---------PIIHCDLNPSNILLNESMVACL 879 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~---------givH~Dlk~~Nill~~~~~~kl 879 (1029)
.++||||+++|+|.+++... ..++..+..++.|+++||+||| +. ||+||||||+||+++.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEE
Confidence 68999999999999999654 3588999999999999999999 66 8999999999999999999999
Q ss_pred EccCCceecCCCC-------CceeccccCCccccCccCCCC-----------CCcchhHHHHHHHHHhcCCCCCCccccc
Q 036879 880 SDFGISKLLGDET-------SMTQTQTLATIGYMAPEWKLS-----------RKGDVYSYGIILMETFTKKKPTDELFVG 941 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-----------~~~DvwSlGvil~elltg~~p~~~~~~~ 941 (1029)
+|||+++.+.... ........||+.|+|||++.+ .++|||||||++|||++|+.||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998764321 112223569999999998543 4789999999999999998876432211
Q ss_pred ccccchhchhcc-----chhhhhhhhhhh-hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 942 EISLKSRVNDSL-----HGKIINVVDINL-LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 942 ~~~~~~~~~~~~-----~~~~~~~~d~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
.. +........ ...+...+.... .............++..+.+++.+||+.||++|||++|+++.|+++....
T Consensus 242 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 242 PE-YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CC-CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hH-HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 11 110000000 000000000000 00000000111235678999999999999999999999999999999888
Q ss_pred cccccCCCCc
Q 036879 1016 LTNIENSSDK 1025 (1029)
Q Consensus 1016 ~~~~~~~~~~ 1025 (1029)
..+.+.+.+.
T Consensus 321 ~~~~~~~~~~ 330 (336)
T 3g2f_A 321 ERNKSVSPTA 330 (336)
T ss_dssp CC--------
T ss_pred HhcccCCCcc
Confidence 7766655443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=357.63 Aligned_cols=264 Identities=19% Similarity=0.268 Sum_probs=201.4
Q ss_pred HhCCCCCCceeccC--cceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 736 ATDGFSENNLLGKG--SFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G--~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
..++|++.+.||+| +||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++|||||++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35679999999999 99999999986 79999999998654 334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 811 LVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
+||||+++|+|.+++... ...+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999765 356999999999999999999999 6779999999999999999999999999886542
Q ss_pred CCC------CceeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhh
Q 036879 890 DET------SMTQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKI 957 (1029)
Q Consensus 890 ~~~------~~~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 957 (1029)
... ........||+.|+|||++ ++.++||||+||++|||++|+.||.+....+... .... +..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~----~~~ 254 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLN----GTV 254 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH-HC---------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHhc----CCC
Confidence 211 1111224689999999973 5678999999999999999999997632221111 1000 000
Q ss_pred hhhhhhh------------------------------hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 958 INVVDIN------------------------------LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 958 ~~~~d~~------------------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+.. ...........+..++..+.+++.+||+.||++|||++|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000000 0000000112234467789999999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=354.54 Aligned_cols=246 Identities=20% Similarity=0.266 Sum_probs=199.7
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 810 (1029)
..++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+..|.++++.+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4578999999999999999999986 58899999998653 23456788999999988 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+++|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+....
T Consensus 98 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999998643 46899999999999999999999 77899999999999999999999999999986432
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
... ......||+.|+|||++ ++.++||||+||++|||++|+.||......+ .. .......
T Consensus 174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~~--------~~i~~~~-- 237 (353)
T 2i0e_A 174 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----LF--------QSIMEHN-- 237 (353)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH--------HHHHHCC--
T ss_pred CCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-----HH--------HHHHhCC--
Confidence 222 23345799999999984 6778999999999999999999997531110 00 0011000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERIN-----IKEALTK 1007 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~~ 1007 (1029)
...+..++.++.+++.+|+..||++||+ ++|++++
T Consensus 238 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0112235677899999999999999995 5777764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=353.53 Aligned_cols=242 Identities=21% Similarity=0.258 Sum_probs=200.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 357899999999999999999976 79999999997653 23356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++|+|.+++... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 9999999999999654 46899999999999999999999 7789999999999999999999999999998764432
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
....||+.|+|||++ ++.++||||+||++|||++|+.||......+ .. .......
T Consensus 196 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~--------~~i~~~~---- 254 (350)
T 1rdq_E 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-----IY--------EKIVSGK---- 254 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH--------HHHHHCC----
T ss_pred ----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-----HH--------HHHHcCC----
Confidence 235689999999984 6778999999999999999999997531110 00 0000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERIN-----IKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~~ 1007 (1029)
...+..++..+.+++.+||+.||++||+ ++|++++
T Consensus 255 ----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1112235677899999999999999998 8888864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=351.38 Aligned_cols=245 Identities=25% Similarity=0.325 Sum_probs=190.1
Q ss_pred hCCCCCCceeccCcceEEEEEEe----cCCcEEEEEEeeccc----chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTL----SDGMQIAVKVFNLEL----EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHF 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 808 (1029)
.++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+++++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46789999999999999999987 478999999997642 2234567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.++||||+++++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999999864 346889999999999999999999 678999999999999999999999999999764
Q ss_pred CCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
..... ......||+.|+|||++ ++.++||||+||++|||++|+.||......+. +.......
T Consensus 172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------~~~i~~~~ 237 (327)
T 3a62_A 172 IHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-------------IDKILKCK 237 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------------HHHHHHTC
T ss_pred ccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHHhCC
Confidence 33222 22335689999999984 67789999999999999999999975321100 00011000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
...+..++..+.+++.+||+.||++|| ++.|++++
T Consensus 238 --------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 --------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 011223467789999999999999999 78888874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.89 Aligned_cols=259 Identities=20% Similarity=0.252 Sum_probs=198.9
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999976 789999999976532 234678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++++|.+++... ..+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999998643 56899999999999999999999 677999999999999999999999999999876543
Q ss_pred CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.........|++.|+|||.+ ++.++||||||+++|||++|+.||...... ... ..+....
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~------------~~~~~~~-- 251 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMG------------AHINQAI-- 251 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHH------------HHHHSCC--
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHH------------HHhccCC--
Confidence 33333345689999999985 577999999999999999999999753211 000 0000000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCC-CHHHHHHHHHHhHHhhc
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-NIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~evl~~L~~i~~~~~ 1016 (1029)
......+..++..+.+++.+||+.||++|| +++++++.|+++.+...
T Consensus 252 --~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 252 --PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp --CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred --CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 000111234567789999999999999999 99999999988765553
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=350.60 Aligned_cols=258 Identities=23% Similarity=0.439 Sum_probs=207.9
Q ss_pred HhCCCCCCceeccCcceEEEEEEec--------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS--------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSS 805 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 805 (1029)
..++|++.+.||+|+||.||+|++. ++..||||+++... ....+.+.+|+++++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3567899999999999999999863 46789999997653 33456789999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEE
Q 036879 806 DHFKALVLEYMPNGSLENWMYNKNR---------------SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNIL 870 (1029)
Q Consensus 806 ~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nil 870 (1029)
.+..++||||+++|+|.+++..... .+++..+..++.|++.||+||| +.||+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence 9999999999999999999976432 4889999999999999999999 678999999999999
Q ss_pred ECCCCcEEEEccCCceecCCCCCce-eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccc
Q 036879 871 LNESMVACLSDFGISKLLGDETSMT-QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEIS 944 (1029)
Q Consensus 871 l~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 944 (1029)
++.++.+||+|||+++......... .....+++.|+|||++ ++.++|||||||++|||++ |+.||......+.
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 268 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-
Confidence 9999999999999998765433222 2234578899999974 6778999999999999999 9999865321110
Q ss_pred cchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 945 LKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 945 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
. ..+.... ....+..++..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 269 -~------------~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 269 -F------------KLLKEGH------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp -H------------HHHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -H------------HHHhcCC------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 0 0000000 011122356778999999999999999999999999999986543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=354.84 Aligned_cols=255 Identities=24% Similarity=0.429 Sum_probs=201.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcE----EEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQ----IAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
.++|++.+.||+|+||+||+|++. +++. ||+|.+.... ......+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 457888999999999999999865 4554 7778775432 333456788999999999999999999986 45678
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+++|+|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999999877678999999999999999999999 67799999999999999999999999999987654
Q ss_pred CCC-ceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 891 ETS-MTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 891 ~~~-~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
... .......+++.|+|||+ .++.++|||||||++|||++ |+.||......+. .. .+...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~------------~~~~~ 233 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--PD------------LLEKG 233 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--HH------------HHHTT
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--HH------------HHHcC
Confidence 322 22334567889999998 36789999999999999999 9999976321111 00 00000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
.....+..++..+.+++.+||+.||++|||++|++++|+.+.+..
T Consensus 234 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 234 ------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 001111224556889999999999999999999999999887543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=349.96 Aligned_cols=259 Identities=23% Similarity=0.282 Sum_probs=205.3
Q ss_pred HhCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEe----cCCeEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS----SDHFKA 810 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~ 810 (1029)
..++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|+++++.++||||+++++++. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 356799999999999999999997 479999999997766666788999999999999999999999986 345778
Q ss_pred EEEeccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 811 LVLEYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
+||||+++|+|.+++.. ....+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||.+..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999999865 4567999999999999999999999 67899999999999999999999999999876
Q ss_pred cCCCCCc--------eeccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc
Q 036879 888 LGDETSM--------TQTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS 952 (1029)
Q Consensus 888 ~~~~~~~--------~~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 952 (1029)
....... ......||+.|+|||++ ++.++|||||||++|||++|+.||................
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~- 262 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN- 262 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-
Confidence 5321110 01123579999999985 4678999999999999999999996532211111110000
Q ss_pred cchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 953 LHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 953 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
.. ....+..++..+.+++.+||+.||++|||++|++++|+.+....
T Consensus 263 -----------~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 263 -----------QL------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp -----------C--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred -----------cC------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 00 00111234667999999999999999999999999998876543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=352.75 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=185.2
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
..++|++.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3567899999999999999999986 68899999997543 34568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC---CCcEEEEccCCceecCCC
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE---SMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~ 891 (1029)
|+++++|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++. ++.+||+|||+++.....
T Consensus 129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999999854 456899999999999999999999 678999999999999975 899999999999865432
Q ss_pred CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
. ......||+.|+|||++ ++.++|||||||++|||++|+.||.........+.. .......
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------------i~~~~~~- 269 (349)
T 2w4o_A 205 V--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR------------ILNCEYY- 269 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH------------HHTTCCC-
T ss_pred c--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH------------HHhCCCc-
Confidence 2 22335689999999984 677999999999999999999999653221111110 0000000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
........++..+.+++.+|++.||++|||+.|++++
T Consensus 270 ---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 ---FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000112346678999999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=364.50 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=201.8
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467889999999999999999976 79999999997653 22356789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++|+|.+++.. ...+++..+..++.||+.|++||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999999854 456999999999999999999999 7889999999999999999999999999998765432
Q ss_pred CceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
. .....||+.|+|||++ .+.++||||+||++|||++|+.||.+.... ... ....+..
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----~~~--------~~i~~~~--- 232 (476)
T 2y94_A 171 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-----TLF--------KKICDGI--- 232 (476)
T ss_dssp C--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-----HHH--------HHHHTTC---
T ss_pred c--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-----HHH--------HHHhcCC---
Confidence 2 2335699999999984 256899999999999999999999753211 000 0011000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+..++..+.+++.+||..||++|||++|++++
T Consensus 233 -----~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 -----FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 01112345678999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=377.37 Aligned_cols=260 Identities=23% Similarity=0.421 Sum_probs=205.9
Q ss_pred CCCCc-eeccCcceEEEEEEec---CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 740 FSENN-LLGKGSFGSVYKGTLS---DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 740 ~~~~~-~lg~G~fg~V~~~~~~---~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
+.+.+ .||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++|||||++++++.. +..++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 33334 7999999999999764 46779999998653 3356789999999999999999999999976 56899999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+++|+|.+++......+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|+........
T Consensus 416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence 99999999999877778999999999999999999999 678999999999999999999999999999876433221
Q ss_pred --eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 895 --TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 895 --~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
......+++.|+|||++ ++.++|||||||++|||++ |+.||......+ .. ..+..
T Consensus 493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~------------~~i~~---- 554 (613)
T 2ozo_A 493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM------------AFIEQ---- 554 (613)
T ss_dssp ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HH------------HHHHT----
T ss_pred eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HH------------HHHHc----
Confidence 11223456899999983 6789999999999999998 999997632111 00 00100
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcccccCCC
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIENSS 1023 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~~~~ 1023 (1029)
......+..++..+.++|..||+.||++||++.++++.|+.+........+..+
T Consensus 555 --~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s 608 (613)
T 2ozo_A 555 --GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGS 608 (613)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSS
T ss_pred --CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCcc
Confidence 001122335678899999999999999999999999999999988766655443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=340.42 Aligned_cols=267 Identities=19% Similarity=0.283 Sum_probs=209.9
Q ss_pred HhCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEE-ecCCeEEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC-SSDHFKALVL 813 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~ 813 (1029)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+++++.++|++++..+.++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999997 489999999987543 235688999999999988866666555 6677889999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE---CCCCcEEEEccCCceecCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill---~~~~~~kl~Dfg~a~~~~~ 890 (1029)
||+ +++|.+++......+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999 99999999877778999999999999999999999 6789999999999999 4889999999999987654
Q ss_pred CCCc------eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhh
Q 036879 891 ETSM------TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960 (1029)
Q Consensus 891 ~~~~------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1029)
.... ......||+.|+|||.+ ++.++|||||||++|||++|+.||......... .. +...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~--------~~~~ 230 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QK--------YERI 230 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SH--------HHHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh--hh--------hhhh
Confidence 3221 12345689999999984 566899999999999999999999763221110 00 0000
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcccccC
Q 036879 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIEN 1021 (1029)
Q Consensus 961 ~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~~ 1021 (1029)
...... .........++..+.+++.+||+.||++|||++++++.|+++........+.
T Consensus 231 ~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~ 288 (296)
T 3uzp_A 231 SEKKMS---TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 288 (296)
T ss_dssp HHHHHH---SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSC
T ss_pred cccccC---CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccc
Confidence 100000 0001112345678999999999999999999999999999999887665443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=341.36 Aligned_cols=245 Identities=25% Similarity=0.379 Sum_probs=197.8
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
+.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3567899999999999999999876 67899999987543 2234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++++|.+++... ..+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999998643 56899999999999999999999 788999999999999999999999999998654332
Q ss_pred CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
. .....|++.|+|||.+ ++.++||||+|+++|||++|+.||......+. . .....
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~--------~~~~~----- 221 (279)
T 3fdn_A 163 R---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----Y--------KRISR----- 221 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----H--------HHHHH-----
T ss_pred c---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-----H--------HHHHh-----
Confidence 2 2335689999999983 57789999999999999999999975311100 0 00000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.....+..++..+.+++.+||+.||++|||++|++++-
T Consensus 222 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 222 ---VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp ---TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred ---CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00111223466789999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=353.40 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=197.7
Q ss_pred HHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-----chhhHHHHHHHHHHhcCCCCceEEEEEEEecC
Q 036879 733 LFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-----EGTLRSFDAECEILGSIRHRNLVKIISTCSSD 806 (1029)
Q Consensus 733 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 806 (1029)
+....++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3455778999999999999999999875 78899999987542 34457899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 036879 807 HFKALVLEYMPNGSLENWMYNK---------------------------------------NRSFDILQRLNMVIDVASA 847 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~ 847 (1029)
+..++||||+++|+|.+++... ...+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988421 1123567788899999999
Q ss_pred HHHHHhcCCCCcEEcCCCCCCEEECCCC--cEEEEccCCceecCCC---CCceeccccCCccccCccCC------CCCCc
Q 036879 848 LEYLHYDHPTPIIHCDLNPSNILLNESM--VACLSDFGISKLLGDE---TSMTQTQTLATIGYMAPEWK------LSRKG 916 (1029)
Q Consensus 848 l~~Lh~~~~~givH~Dlk~~Nill~~~~--~~kl~Dfg~a~~~~~~---~~~~~~~~~gt~~y~aPE~~------~~~~~ 916 (1029)
|+||| ++||+||||||+||+++.++ .+||+|||+++.+... .........||+.|+|||++ ++.++
T Consensus 181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999 67899999999999998776 8999999999865331 12223445799999999973 46789
Q ss_pred chhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHccccccc
Q 036879 917 DVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAE 996 (1029)
Q Consensus 917 DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 996 (1029)
|||||||++|||++|+.||......+. .......... ...+....++..+.+++.+||+.||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~-------------~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADT-------------ISQVLNKKLC----FENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHH-------------HHHHHHCCCC----TTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHH-------------HHHHHhcccc----cCCcccccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999975321111 0011111000 00111123467789999999999999
Q ss_pred CCCCHHHHHHH
Q 036879 997 ERINIKEALTK 1007 (1029)
Q Consensus 997 ~Rpt~~evl~~ 1007 (1029)
+|||+.|++++
T Consensus 321 ~Rps~~~~l~h 331 (345)
T 3hko_A 321 ERFDAMRALQH 331 (345)
T ss_dssp TSCCHHHHHHS
T ss_pred HCCCHHHHhcC
Confidence 99999999984
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=348.75 Aligned_cols=257 Identities=29% Similarity=0.496 Sum_probs=201.0
Q ss_pred hCCCCCCceeccCcceEEEEEEecC-----CcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSD-----GMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
..+|+..+.||+|+||.||+|+... +..||||+++... ......+.+|+++++.++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567778999999999999998642 2469999997653 334567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+++++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999999877788999999999999999999999 67899999999999999999999999999987644
Q ss_pred CCC--ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 891 ETS--MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 891 ~~~--~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
... .......+|+.|+|||++ ++.++|||||||++|||++ |+.||......+. . ....+.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~-----------~~~~~~ 266 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--M-----------KAINDG 266 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--H-----------HHHHTT
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH--H-----------HHHHCC
Confidence 321 112223467889999984 5678999999999999999 9999965321110 0 000000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
. ....+..++..+.+++.+||+.+|++||++.|+++.|+++.+...
T Consensus 267 ~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 267 F-------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp C-------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred C-------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 0 011122356778999999999999999999999999999886544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=349.92 Aligned_cols=268 Identities=26% Similarity=0.446 Sum_probs=211.5
Q ss_pred hCCCCCCceeccCcceEEEEEEe-----cCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCC--eE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTL-----SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDH--FK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 809 (1029)
.++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688899999999999999984 368999999998776666788999999999999999999999987644 67
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 8999999999999999887778999999999999999999999 6789999999999999999999999999998775
Q ss_pred CCCCce--eccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccc-----hhhh
Q 036879 890 DETSMT--QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLH-----GKII 958 (1029)
Q Consensus 890 ~~~~~~--~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~ 958 (1029)
...... .....++..|+|||.. ++.++|||||||++|||++|+.||...... +......... ..+.
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHH
Confidence 443221 2234567789999984 567899999999999999999997642111 0000000000 0011
Q ss_pred hhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 959 NVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 959 ~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
+.+.. ......+..++.++.+++.+||+.||++|||+.|+++.|+++.+.+.
T Consensus 274 ~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 274 ELLKN------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHT------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHhhc------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11110 00111233467789999999999999999999999999999988763
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=354.19 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=198.1
Q ss_pred CCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
+.|+..+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4488889999999999999986 479999999997543 233467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+. |++.+++......+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9996 6888888766778999999999999999999999 677999999999999999999999999999865432
Q ss_pred ceeccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
....||+.|+|||++ ++.++|||||||++|||++|+.||........ +.........
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------------~~~~~~~~~~ 271 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------LYHIAQNESP 271 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------------HHHHHHSCCC
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-------------HHHHHhcCCC
Confidence 234689999999973 56789999999999999999999865321110 0000000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
...+..++..+.+++.+||+.||++|||+++++++-
T Consensus 272 ------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 272 ------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred ------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 000123456789999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=345.62 Aligned_cols=248 Identities=22% Similarity=0.323 Sum_probs=201.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccch------hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG------TLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456899999999999999999976 7899999999765321 356799999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC----cEEEEccCCc
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM----VACLSDFGIS 885 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~----~~kl~Dfg~a 885 (1029)
++||||+++++|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999854 456899999999999999999999 67899999999999999888 8999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
........ .....||+.|+|||+. ++.++||||+||++|||++|+.||......+. . ....
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~--------~~i~ 231 (321)
T 2a2a_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----L--------ANIT 231 (321)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-----H--------HHHH
T ss_pred eecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-----H--------HHHH
Confidence 87654322 2335689999999983 57789999999999999999999965311100 0 0000
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.. ...........++..+.+++.+|++.||++|||+.|++++
T Consensus 232 ~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 232 SV----SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TT----CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hc----ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000011123346778999999999999999999999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=349.48 Aligned_cols=254 Identities=25% Similarity=0.455 Sum_probs=198.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcE----EEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQ----IAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
.++|++.+.||+|+||.||+|++. +++. ||+|.+.... ....+.+.+|++++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467899999999999999999864 5554 4677665432 334678999999999999999999999998765 78
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+.+|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999888888999999999999999999999 67799999999999999999999999999987643
Q ss_pred CCC-ceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 891 ETS-MTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 891 ~~~-~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
... .......+|+.|+|||. .++.++|||||||++|||++ |+.||......+. . ..+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~------------~~~~~~ 235 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S------------SILEKG 235 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--H------------HHHHTT
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--H------------HHHHcC
Confidence 322 22233456889999998 36789999999999999999 9999976322111 1 111000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
. ....+..++..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 236 ~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 236 E------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp C------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred C------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0 0111233566789999999999999999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=350.95 Aligned_cols=257 Identities=21% Similarity=0.374 Sum_probs=193.3
Q ss_pred hCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC----e
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH----F 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 808 (1029)
.++|++.+.||+|+||.||+|++ .+++.||||+++... ......+.+|++++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999997 478999999997653 233457899999999999999999999987643 3
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.++||||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 49999999999999998643 46899999999999999999999 677999999999999999999999999999866
Q ss_pred CCCCC--ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhh
Q 036879 889 GDETS--MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962 (1029)
Q Consensus 889 ~~~~~--~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 962 (1029)
..... .......||+.|+|||++ ++.++|||||||++|||++|+.||.......... ..
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-------------~~-- 231 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-------------QH-- 231 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------------HH--
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-------------HH--
Confidence 43321 122235689999999984 5678999999999999999999997532111100 00
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHH-HHHHHhHHh
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL-TKLLKIRNT 1014 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl-~~L~~i~~~ 1014 (1029)
..............++.++.+++.+||+.||++||++.+++ +.+.++...
T Consensus 232 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 232 --VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp --HHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred --hcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 00000011111223567899999999999999999655544 555555443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=344.41 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=201.9
Q ss_pred hCCCCCCceeccCcceEEEEEEecC----CcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEe-cCCeEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSD----GMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCS-SDHFKA 810 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 810 (1029)
..+|++.+.||+|+||.||+|+..+ ...||+|.+.... ....+.+.+|++++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3458888999999999999998642 2358999987543 344577999999999999999999999864 566789
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999999877778999999999999999999999 77899999999999999999999999999986643
Q ss_pred CCC---ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhh
Q 036879 891 ETS---MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962 (1029)
Q Consensus 891 ~~~---~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 962 (1029)
... .......+|+.|+|||.. ++.++||||+|+++|||++ |.+||......+. ..... .
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--~~~~~-----------~ 247 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL-----------Q 247 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--HHHHH-----------T
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--HHHHh-----------c
Confidence 321 122334578899999983 6778999999999999999 4555544211111 00000 0
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
. .....+..++..+.+++.+||+.||++|||++|+++.|+++.+.+.
T Consensus 248 ~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 248 G-------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp T-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred C-------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 0001122346678999999999999999999999999999988764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=352.95 Aligned_cols=207 Identities=28% Similarity=0.342 Sum_probs=178.1
Q ss_pred ccccccCHHHHHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCC-----CCce
Q 036879 723 VTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIR-----HRNL 796 (1029)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni 796 (1029)
.+...+++.+.....++|++.+.||+|+||+||+|+.. +++.||||+++.. ....+.+..|+++++.++ ||||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 34445556666667889999999999999999999975 7899999998743 334466788999999996 9999
Q ss_pred EEEEEEEecCCeEEEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC--
Q 036879 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-- 873 (1029)
Q Consensus 797 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-- 873 (1029)
+++++++...+..++||||+ +++|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPY 174 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTT
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccc
Confidence 99999999999999999999 999999997654 45899999999999999999999 778999999999999975
Q ss_pred -----------------------CCcEEEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHH
Q 036879 874 -----------------------SMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILM 926 (1029)
Q Consensus 874 -----------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ 926 (1029)
++.+||+|||+|....... ....||+.|+|||++ ++.++||||+||++|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 8899999999998654322 235689999999984 678999999999999
Q ss_pred HHhcCCCCCCcc
Q 036879 927 ETFTKKKPTDEL 938 (1029)
Q Consensus 927 elltg~~p~~~~ 938 (1029)
||++|+.||...
T Consensus 251 ell~g~~pf~~~ 262 (360)
T 3llt_A 251 ELYTGSLLFRTH 262 (360)
T ss_dssp HHHHSSCSCCCS
T ss_pred HHHHCCCCCCCC
Confidence 999999999753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=346.93 Aligned_cols=257 Identities=28% Similarity=0.472 Sum_probs=203.5
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEE--EEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQI--AVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~v--AvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 812 (1029)
++|++.+.||+|+||.||+|+.. ++..+ |+|.++... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888999999999999999865 56654 999887543 33456789999999999 999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcE
Q 036879 813 LEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVA 877 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~ 877 (1029)
|||+++++|.+++.... ..+++..+..++.|+++||+||| ++||+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 99999999999997543 46899999999999999999999 7789999999999999999999
Q ss_pred EEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhc
Q 036879 878 CLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDS 952 (1029)
Q Consensus 878 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 952 (1029)
||+|||+++..... .......+++.|+|||++ ++.++|||||||++|||++ |+.||......+. ..
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~----- 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YE----- 252 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH-----
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH--HH-----
Confidence 99999999743221 122234578899999984 5789999999999999998 9999975321110 00
Q ss_pred cchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcccc
Q 036879 953 LHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNI 1019 (1029)
Q Consensus 953 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~ 1019 (1029)
.+.... ....+..++..+.+++.+||+.||++|||++|++++|+.+.+......
T Consensus 253 -------~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 253 -------KLPQGY------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp -------HGGGTC------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred -------HhhcCC------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence 000000 001122346778999999999999999999999999999988765443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=347.07 Aligned_cols=247 Identities=19% Similarity=0.255 Sum_probs=179.3
Q ss_pred CceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEEEEEeccCCCC
Q 036879 743 NNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKIISTCSSDHFKALVLEYMPNGS 820 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gs 820 (1029)
.+.||+|+||.||+|+.. +++.||||++... ....+.+|+++++.++ ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999976 7899999998754 3456788999999997 9999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC---cEEEEccCCceecCCCCCceec
Q 036879 821 LENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM---VACLSDFGISKLLGDETSMTQT 897 (1029)
Q Consensus 821 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~ 897 (1029)
|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+|||+++....... ...
T Consensus 93 L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 167 (325)
T 3kn6_A 93 LFERIKK-KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK 167 (325)
T ss_dssp HHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence 9999965 457999999999999999999999 77899999999999997665 899999999987654322 223
Q ss_pred cccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhh
Q 036879 898 QTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYL 973 (1029)
Q Consensus 898 ~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 973 (1029)
...||+.|+|||++ ++.++||||+||++|||++|+.||......... . ...+..............
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~---------~~~~~~~~i~~~~~~~~~ 237 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-T---------SAVEIMKKIKKGDFSFEG 237 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-C---------CHHHHHHHHTTTCCCCCS
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-c---------cHHHHHHHHHcCCCCCCc
Confidence 45689999999984 567899999999999999999999763221100 0 000111111111111111
Q ss_pred HHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 974 TAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 974 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....++.++.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 2223467789999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=350.88 Aligned_cols=239 Identities=24% Similarity=0.328 Sum_probs=198.7
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--------hhhHHHHHHHHHHhcCCCCceEEEEEEEecC
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--------GTLRSFDAECEILGSIRHRNLVKIISTCSSD 806 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 806 (1029)
..++|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3567999999999999999999865 789999999986531 1344678899999999999999999999999
Q ss_pred CeEEEEEeccCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 807 HFKALVLEYMPNG-SLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 807 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
+..++||||+.+| +|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999998776 99998854 456999999999999999999999 778999999999999999999999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1029)
........ .....||+.|+|||++ .+.++|||||||++|||++|+.||...... ..
T Consensus 178 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~---------- 238 (335)
T 3dls_A 178 AYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------VE---------- 238 (335)
T ss_dssp EECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------TT----------
T ss_pred eECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------Hh----------
Confidence 87754332 2235699999999984 266789999999999999999999652110 00
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 961 ~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
... ..+..++.++.+++.+||+.||++|||++|++++
T Consensus 239 --~~~--------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 --AAI--------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --TCC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --hcc--------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0011235678999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=344.12 Aligned_cols=263 Identities=21% Similarity=0.349 Sum_probs=197.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecc---cchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLE---LEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 457899999999999999999874 7999999999753 233456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 813 LEYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
|||+++++|.+++.. ....+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999864 3566899999999999999999999 6789999999999999999999999999998664
Q ss_pred CCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
.... ......+++.|+|||+. ++.++||||||+++|||++|+.||.........+...+. ....
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----------~~~~ 255 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-----------QCDY 255 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH-----------TTCS
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh-----------cccC
Confidence 4322 22235689999999984 567899999999999999999998653211111100000 0000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccccc
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIE 1020 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~ 1020 (1029)
. ......++.++.+++.+||+.||++|||++++++.++++......+..
T Consensus 256 ~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 256 P------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp C------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred C------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 0 000123466789999999999999999999999999999988766543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=338.20 Aligned_cols=249 Identities=21% Similarity=0.343 Sum_probs=200.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999876 68999999997653 334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc---EEEEccCCceecCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV---ACLSDFGISKLLGD 890 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~---~kl~Dfg~a~~~~~ 890 (1029)
||+++++|.+++... ..+++..+..++.|++.|++||| +.||+||||||+||+++.++. +||+|||.+.....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999888543 56899999999999999999999 677999999999999986655 99999999987654
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
... .....||+.|+|||++ ++.++||||+|+++|+|++|+.||........ .. .+....
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~------------~~~~~~- 223 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YA------------QIKAGA- 223 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH------------HHHHTC-
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH--HH------------HHHhcc-
Confidence 322 2335689999999984 57789999999999999999999965311100 00 000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
..........++..+.+++.+|++.||++|||++|++++-
T Consensus 224 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 224 --YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp --CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred --ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 0000011123466789999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=359.57 Aligned_cols=197 Identities=23% Similarity=0.340 Sum_probs=165.8
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC-----C
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD-----H 807 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 807 (1029)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999875 68999999997543 33456789999999999999999999999765 5
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
..|+||||++ ++|.+++.. ...+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+|+.
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 7899999995 699999854 456999999999999999999999 77899999999999999999999999999987
Q ss_pred cCCCCCc---------------------eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCc
Q 036879 888 LGDETSM---------------------TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDE 937 (1029)
Q Consensus 888 ~~~~~~~---------------------~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~ 937 (1029)
....... .....+||+.|+|||++ ++.++||||+||++|||++|..||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 6433211 12456799999999973 67789999999999999997777654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=350.05 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=195.2
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
++|++.+.||+|+||+||+|+.. +++.||+|++...... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999976 7899999998754322 223456799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
++ |+|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence 96 6999999887788999999999999999999999 77899999999999999999999999999986543322 2
Q ss_pred eccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhc---hhccchhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV---NDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~d~~~~~ 967 (1029)
.....||+.|+|||++ ++.++||||+||++|||++|+.||......+. ..... .......+..........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHhchhhhcchhhc
Confidence 2335689999999973 46789999999999999999999976422111 00000 000000011111000000
Q ss_pred -------hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 -------KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 -------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...........++..+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000011122356778999999999999999999999984
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=352.93 Aligned_cols=251 Identities=22% Similarity=0.262 Sum_probs=190.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
..++|++.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999976 799999999975432 33668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc--EEEEccCCceecCCCC
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV--ACLSDFGISKLLGDET 892 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~--~kl~Dfg~a~~~~~~~ 892 (1029)
|+++|+|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+|||+|+......
T Consensus 97 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 97 YASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 9999999999854 346899999999999999999999 778999999999999987765 9999999997543222
Q ss_pred CceeccccCCccccCccCC----C-CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----L-SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
......||+.|+|||++ + +.++||||+||++|||++|+.||........ +..... ........
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~--------~~~~~~~~- 240 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQ--------RILSVKYS- 240 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHH--------HHHTTCCC-
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHH--------HHhcCCCC-
Confidence 22335699999999984 2 2348999999999999999999976322111 111110 01000000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.+....++..+.+++.+||+.||++|||+.|++++-
T Consensus 241 -----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 241 -----IPDDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp -----CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred -----CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 000112356789999999999999999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=341.76 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=195.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|.+.+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 356889999999999999999875 78999999997654 3345789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE---CCCCcEEEEccCCceec
Q 036879 815 YMPNGSLENWMYNK---NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLL 888 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill---~~~~~~kl~Dfg~a~~~ 888 (1029)
|+++|+|.+++... ...+++..+..++.|++.||+||| +.||+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988543 467999999999999999999999 7789999999999999 45688999999999866
Q ss_pred CCCCCceeccccCCccccCccCC---CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK---LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
.... ......||+.|+|||++ ++.++||||+||++|||++|+.||......+. ..... ......
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~---------~~~~~~ 244 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKAT---------YKEPNY 244 (285)
T ss_dssp -----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH---------HCCCCC
T ss_pred CCcc--cCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--Hhhhc---------cCCccc
Confidence 4432 22345689999999984 56789999999999999999999975321111 00000 000000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. ......+..+.+++.+||+.||++|||++|++++
T Consensus 245 ~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 245 A-------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp C-------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred c-------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0001135678899999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=344.05 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=196.2
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
++|++.+.||+|+||+||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67899999999999999999976 699999999865532 235678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+++++|.+++. ....+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||.+........
T Consensus 83 ~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 83 YCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp CCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 999999988774 4566999999999999999999999 77899999999999999999999999999987653322
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccc---hhhhhhhhh-h-
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLH---GKIINVVDI-N- 964 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~-~- 964 (1029)
......||+.|+|||++ ++.++||||+||++|||++|+.||......+.. ..+..... ......... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL--YLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhcccccccccccccccc
Confidence 22345689999999973 577899999999999999999999764222110 00000000 000000000 0
Q ss_pred -----h--hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 965 -----L--LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 965 -----~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. .............++..+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 000000000112356678999999999999999999999974
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=353.22 Aligned_cols=348 Identities=27% Similarity=0.421 Sum_probs=263.4
Q ss_pred ccccccceEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcc
Q 036879 223 FECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANN 302 (1029)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 302 (1029)
..+++|+.|++++|.+.. +|. +..+++ |++|+|++|++++..| +.++++|++|++++|.
T Consensus 43 ~~l~~l~~L~l~~~~i~~-l~~-~~~l~~-----------------L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~ 101 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIKS-IDG-VEYLNN-----------------LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 101 (466)
T ss_dssp HHHHTCCEEECCSSCCCC-CTT-GGGCTT-----------------CCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred hHhccccEEecCCCCCcc-Ccc-hhhhcC-----------------CCEEECCCCccCCchh--hhccccCCEEECCCCc
Confidence 346677777777777653 342 444433 3466666666664433 6666777777777776
Q ss_pred cCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccc
Q 036879 303 LLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLR 382 (1029)
Q Consensus 303 l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~ 382 (1029)
+.+ ++. + ..+++|++|+|++|++++..+ +.++++|++|++++|.+.+. + .+..+++|+
T Consensus 102 l~~-~~~-~-~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~----------------~~~~l~~L~ 159 (466)
T 1o6v_A 102 IAD-ITP-L-ANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S----------------ALSGLTSLQ 159 (466)
T ss_dssp CCC-CGG-G-TTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G----------------GGTTCTTCS
T ss_pred ccc-Chh-h-cCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h----------------hhccCCccc
Confidence 653 333 3 346677777777777665432 66677777777777766532 1 134567777
Q ss_pred eeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccc
Q 036879 383 KLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHN 462 (1029)
Q Consensus 383 ~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 462 (1029)
.|+++ |.+.+.. .+..+.. |+.|++++|.+++. ..+..+++|++|++++|.+++..| +..+++|++|++++|
T Consensus 160 ~L~l~-~~~~~~~--~~~~l~~-L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n 231 (466)
T 1o6v_A 160 QLSFG-NQVTDLK--PLANLTT-LERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGN 231 (466)
T ss_dssp EEEEE-ESCCCCG--GGTTCTT-CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred EeecC-CcccCch--hhccCCC-CCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCC
Confidence 77775 4444332 2666655 77888888877743 347788899999999999886555 777889999999999
Q ss_pred cccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCc
Q 036879 463 KLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPV 542 (1029)
Q Consensus 463 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 542 (1029)
++++. ..+..+++|+.|++++|.+.+..+ +..+++|++|++++|++++..+ +..+++|+.|++++|++++..+
T Consensus 232 ~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~- 304 (466)
T 1o6v_A 232 QLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP- 304 (466)
T ss_dssp CCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-
T ss_pred Ccccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-
Confidence 88764 467888999999999999987665 8899999999999999997655 8899999999999999997544
Q ss_pred cccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhccccc
Q 036879 543 EIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLL 622 (1029)
Q Consensus 543 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 622 (1029)
++.+++|+.|++++|++++..| +..+++|+.|++++|++++. ..+..+++|++|++++|++++..| +..+++|
T Consensus 305 -~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L 377 (466)
T 1o6v_A 305 -ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRI 377 (466)
T ss_dssp -GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTC
T ss_pred -hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCC
Confidence 8899999999999999997665 78899999999999999965 468899999999999999998877 8899999
Q ss_pred ceeeccCCCCcCC
Q 036879 623 KFLNLSFNGLQGQ 635 (1029)
Q Consensus 623 ~~L~l~~N~l~~~ 635 (1029)
+.|++++|++++.
T Consensus 378 ~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 378 TQLGLNDQAWTNA 390 (466)
T ss_dssp CEEECCCEEEECC
T ss_pred CEEeccCCcccCC
Confidence 9999999999974
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=348.49 Aligned_cols=265 Identities=22% Similarity=0.366 Sum_probs=210.3
Q ss_pred CHHHHHHHhCCCCCCceeccCcceEEEEEEe------cCCcEEEEEEeecccc-hhhHHHHHHHHHHhcC-CCCceEEEE
Q 036879 729 SYQELFRATDGFSENNLLGKGSFGSVYKGTL------SDGMQIAVKVFNLELE-GTLRSFDAECEILGSI-RHRNLVKII 800 (1029)
Q Consensus 729 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~ 800 (1029)
....+....++|++.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444555678899999999999999999974 2568899999976543 3456789999999999 799999999
Q ss_pred EEEecCC-eEEEEEeccCCCCHHHHHhcCCCC---------------CCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC
Q 036879 801 STCSSDH-FKALVLEYMPNGSLENWMYNKNRS---------------FDILQRLNMVIDVASALEYLHYDHPTPIIHCDL 864 (1029)
Q Consensus 801 ~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~---------------~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dl 864 (1029)
+++...+ ..++||||+++++|.+++...... +++..+..++.|++.|++||| +.||+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence 9987654 589999999999999999765432 789999999999999999999 678999999
Q ss_pred CCCCEEECCCCcEEEEccCCceecCCCCC-ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcc
Q 036879 865 NPSNILLNESMVACLSDFGISKLLGDETS-MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDEL 938 (1029)
Q Consensus 865 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~ 938 (1029)
||+||+++.++.+||+|||+++....... .......+|+.|+|||++ ++.++||||+||++|||++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987644322 223345678899999973 6779999999999999998 99998653
Q ss_pred cccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 939 FVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
..... +.. .+.... ....+..++..+.+++.+||+.||++|||+.|++++|+.+.+..
T Consensus 255 ~~~~~-~~~------------~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 255 KIDEE-FCR------------RLKEGT------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCSHH-HHH------------HHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhHH-HHH------------HhccCc------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 21111 000 000000 00111234667899999999999999999999999999987654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=351.74 Aligned_cols=250 Identities=21% Similarity=0.297 Sum_probs=196.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+|++++.++ +||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467999999999999999999976 789999999976532 345688888887 79999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC----CcEEEEccCCceecCC
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES----MVACLSDFGISKLLGD 890 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~----~~~kl~Dfg~a~~~~~ 890 (1029)
|+++|+|.+++.. .+.+++..+..++.||+.||+||| +.||+||||||+||++... +.+||+|||+++....
T Consensus 97 ~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 97 LMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999999999854 456999999999999999999999 7789999999999998533 3599999999987654
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
... ......||+.|+|||++ ++.++||||+||++|||++|+.||...... ......... .....
T Consensus 173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i--------~~~~~- 240 (342)
T 2qr7_A 173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARI--------GSGKF- 240 (342)
T ss_dssp TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHH--------HHCCC-
T ss_pred CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHH--------ccCCc-
Confidence 322 22335689999999984 677999999999999999999999752111 000000000 00000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
......+..++.++.+++.+|+..||++|||+.|++++-.
T Consensus 241 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 241 ---SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp ---CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred ---ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 0000011234677899999999999999999999998543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=351.40 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=194.7
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCC--CceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRH--RNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++| |||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 46789999999999999999998889999999987553 3345778999999999976 9999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
||+ .+++|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++ ++.+||+|||+++......
T Consensus 88 ~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp ECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 995 58899999965 456899999999999999999999 67799999999999997 6789999999998765432
Q ss_pred Cc-eeccccCCccccCccCC---------------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchh
Q 036879 893 SM-TQTQTLATIGYMAPEWK---------------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGK 956 (1029)
Q Consensus 893 ~~-~~~~~~gt~~y~aPE~~---------------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 956 (1029)
.. ......||+.|+|||++ ++.++|||||||++|||++|+.||.........
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------------ 229 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------------ 229 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH------------
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH------------
Confidence 21 22345799999999974 355799999999999999999999753211110
Q ss_pred hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 957 IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 957 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
+...++.... ...+...+..+.+++..||+.||++|||+.|++++-
T Consensus 230 ~~~~~~~~~~------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 230 LHAIIDPNHE------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HHHHHCTTSC------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHhcCCcc------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1111111100 011112345688999999999999999999999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=351.84 Aligned_cols=266 Identities=21% Similarity=0.377 Sum_probs=210.5
Q ss_pred HHHHHhCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEe
Q 036879 732 ELFRATDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCS 804 (1029)
Q Consensus 732 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 804 (1029)
++....++|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+++++.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445678999999999999999999764 367899999975532 34457899999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC
Q 036879 805 SDHFKALVLEYMPNGSLENWMYNKN---------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM 875 (1029)
Q Consensus 805 ~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~ 875 (1029)
+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCC
Confidence 9999999999999999999986532 45789999999999999999999 67899999999999999999
Q ss_pred cEEEEccCCceecCCCCCc-eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhc
Q 036879 876 VACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRV 949 (1029)
Q Consensus 876 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 949 (1029)
.+||+|||+++........ ......+|+.|+|||++ ++.++||||+||++|||++ |+.||......+. ..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~-- 251 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--LR-- 251 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--HH--
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH--HH--
Confidence 9999999999865432221 12234568899999983 6778999999999999999 8899865321110 00
Q ss_pred hhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccccc
Q 036879 950 NDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIE 1020 (1029)
Q Consensus 950 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~ 1020 (1029)
....... ...+..++..+.+++.+||+.||++|||+.|++++|+++......+.+
T Consensus 252 ---------~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~ 306 (322)
T 1p4o_A 252 ---------FVMEGGL-------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306 (322)
T ss_dssp ---------HHHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred ---------HHHcCCc-------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence 0000000 011224567789999999999999999999999999987665544433
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=363.17 Aligned_cols=190 Identities=23% Similarity=0.344 Sum_probs=151.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEec-----CCe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSS-----DHF 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 808 (1029)
.++|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|+++++.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999876 78999999987543 3345678999999999999999999999843 357
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.|+||||+ +++|.+++. ....+++..+..++.||+.||+||| +.|||||||||+|||++.++.+||+|||+|+..
T Consensus 132 ~~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 89999998 579999885 4466999999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCC--------------------------ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcC
Q 036879 889 GDETS--------------------------MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTK 931 (1029)
Q Consensus 889 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg 931 (1029)
..... ......+||+.|+|||++ ++.++||||+||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 42211 112345789999999963 67789999999999999994
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=351.55 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=207.4
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEec-CC-----cEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEec
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLS-DG-----MQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSS 805 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 805 (1029)
....++|++.+.||+|+||.||+|... ++ ..||+|.+.... ....+.+.+|+++++++ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 345678999999999999999999864 23 479999997654 23456789999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC
Q 036879 806 DHFKALVLEYMPNGSLENWMYNK-------------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN 872 (1029)
Q Consensus 806 ~~~~~lV~E~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~ 872 (1029)
.+..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.||+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEEC
Confidence 99999999999999999998653 345799999999999999999999 67899999999999999
Q ss_pred CCCcEEEEccCCceecCCCCCc-eeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccc
Q 036879 873 ESMVACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLK 946 (1029)
Q Consensus 873 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 946 (1029)
.++.+||+|||++......... ......+|+.|+|||. .++.++|||||||++|||++ |..||........ +
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~- 276 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-F- 276 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-H-
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-H-
Confidence 9999999999999865433222 2233457889999997 36789999999999999998 9999875321111 0
Q ss_pred hhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 947 SRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 947 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
...+.... ....+..++..+.+++..||+.||++|||+.|+++.|+++....
T Consensus 277 -----------~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 277 -----------YKLVKDGY------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp -----------HHHHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------HHHHhcCC------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 00110000 00111234567899999999999999999999999999887653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=355.29 Aligned_cols=246 Identities=25% Similarity=0.391 Sum_probs=194.6
Q ss_pred CCCCCCceeccCcceEEEEEEecCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCC--CCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIR--HRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4599999999999999999998889999999997553 334577999999999996 599999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
| +.+++|.+++... ..+++..+..++.||+.||+||| +.||+||||||+||+++ ++.+||+|||+++.+.....
T Consensus 136 E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 5688999999654 47889999999999999999999 78899999999999995 58999999999987654322
Q ss_pred -ceeccccCCccccCccCC---------------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhh
Q 036879 894 -MTQTQTLATIGYMAPEWK---------------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKI 957 (1029)
Q Consensus 894 -~~~~~~~gt~~y~aPE~~---------------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 957 (1029)
.......||+.|+|||++ ++.++|||||||++|||++|+.||........ .+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------------~~ 277 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------------KL 277 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------------HH
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH------------HH
Confidence 123345799999999974 45689999999999999999999965321100 01
Q ss_pred hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 958 INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 958 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...++.... ...+...+..+.+++.+||+.||++|||+.|++++
T Consensus 278 ~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 278 HAIIDPNHE------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHCTTSC------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhCcccc------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111110 00111224568999999999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=343.73 Aligned_cols=259 Identities=23% Similarity=0.425 Sum_probs=196.3
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec----CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC-
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH- 807 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 807 (1029)
...++|.+.+.||+|+||.||+|+.. ++..||+|+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 35677899999999999999999764 34589999987553 334567899999999999999999999997754
Q ss_pred ----eEEEEEeccCCCCHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEE
Q 036879 808 ----FKALVLEYMPNGSLENWMYN-----KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC 878 (1029)
Q Consensus 808 ----~~~lV~E~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~k 878 (1029)
..++||||+++++|.+++.. ....+++..++.++.|+++||+||| +.||+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEE
Confidence 34899999999999999853 3456999999999999999999999 78899999999999999999999
Q ss_pred EEccCCceecCCCCC-ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhc
Q 036879 879 LSDFGISKLLGDETS-MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDS 952 (1029)
Q Consensus 879 l~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 952 (1029)
|+|||++........ .......+++.|+|||.. ++.++|||||||++|||++ |+.||........ ..
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~----- 260 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--YD----- 260 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HH-----
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HH-----
Confidence 999999986644322 122334578899999984 5778999999999999999 8889865321111 00
Q ss_pred cchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 953 LHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 953 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
...... ....+..++..+.+++.+||+.||++|||+.+++++|+++.+.+.
T Consensus 261 ------~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 261 ------YLLHGH-------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp ------HHHTTC-------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ------HHHcCC-------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 000000 011123456779999999999999999999999999999987653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=366.79 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=191.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+++++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 79999999997642 33446678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP-TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
|||+++|+|.+++.. ...+++..+..++.|++.||+||| + +||+||||||+||+++.++.+||+|||+|+.....
T Consensus 227 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999999999854 456899999999999999999999 5 67999999999999999999999999999864332
Q ss_pred CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.. ......||+.|+|||++ ++.++|||||||++|||++|+.||........ .. .... .
T Consensus 303 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~--------~i~~----~ 364 (446)
T 4ejn_A 303 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----FE--------LILM----E 364 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HH--------HHHH----C
T ss_pred Cc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-----HH--------HHHh----C
Confidence 22 23346799999999984 68899999999999999999999965311100 00 0000 0
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
. ...+..++..+.+++.+||+.||++|| +++|++++
T Consensus 365 ~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 365 E----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp C----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 0 011223467789999999999999999 99999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=342.76 Aligned_cols=265 Identities=22% Similarity=0.303 Sum_probs=196.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-----hhhHHHHHHHHHHhcCC---CCceEEEEEEEecC
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-----GTLRSFDAECEILGSIR---HRNLVKIISTCSSD 806 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 806 (1029)
..++|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999974 789999999875431 12346777888877764 99999999999775
Q ss_pred C-----eEEEEEeccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEE
Q 036879 807 H-----FKALVLEYMPNGSLENWMYNKNR-SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLS 880 (1029)
Q Consensus 807 ~-----~~~lV~E~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~ 880 (1029)
. ..++||||++ ++|.+++..... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5789999996 699999876543 4999999999999999999999 6779999999999999999999999
Q ss_pred ccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh---cc
Q 036879 881 DFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND---SL 953 (1029)
Q Consensus 881 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~ 953 (1029)
|||+++...... ......||+.|+|||++ ++.++||||+||++|||++|+.||......+. +...... ..
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~ 239 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPP 239 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-HHHHHHHHCCCC
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCC
Confidence 999998664332 22345789999999983 68899999999999999999999975322111 0000000 00
Q ss_pred chhhhhhh---hhhhh-hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 954 HGKIINVV---DINLL-QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 954 ~~~~~~~~---d~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+.... ..... ............++..+.+++.+|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000000 00000 00001111122356788999999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=348.61 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=202.6
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--------hhhHHHHHHHHHHhcC-CCCceEEEEEEE
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--------GTLRSFDAECEILGSI-RHRNLVKIISTC 803 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 803 (1029)
....++|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+++++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 445577999999999999999999986 799999999875431 1245688999999999 899999999999
Q ss_pred ecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccC
Q 036879 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFG 883 (1029)
Q Consensus 804 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg 883 (1029)
......++||||+++++|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecC
Confidence 999999999999999999999864 356899999999999999999999 6789999999999999999999999999
Q ss_pred CceecCCCCCceeccccCCccccCccCC----------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc
Q 036879 884 ISKLLGDETSMTQTQTLATIGYMAPEWK----------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL 953 (1029)
Q Consensus 884 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 953 (1029)
++........ .....||+.|+|||++ ++.++|||||||++|||++|+.||...... ....
T Consensus 246 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~------ 315 (365)
T 2y7j_A 246 FSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LMLR------ 315 (365)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH------
T ss_pred cccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--HHHH------
Confidence 9987754332 2345799999999973 567899999999999999999999652110 0000
Q ss_pred chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 954 HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 954 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.... .......+....++..+.+++.+|++.||++|||+.|++++
T Consensus 316 -----~i~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 316 -----MIME----GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -----HHHH----TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----HHHh----CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000 00000011112346678999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=374.35 Aligned_cols=254 Identities=27% Similarity=0.456 Sum_probs=205.8
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..++|++.+.||+|+||.||+|++.++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 456688889999999999999999888889999997653 234679999999999999999999999976 668999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++|+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 9999999999653 356899999999999999999999 677999999999999999999999999999866432222
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......++..|+|||++ ++.++|||||||++|||++ |+.||.+....+. .+.+...
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~--------------~~~i~~~----- 480 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERG----- 480 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH--------------HHHHHTT-----
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcC-----
Confidence 22234567899999973 6789999999999999999 9999875321110 0000000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.....+..++..+.++|.+||+.||++|||++++++.|+.+...
T Consensus 481 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 481 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 00112234677899999999999999999999999999877543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=341.08 Aligned_cols=257 Identities=24% Similarity=0.383 Sum_probs=202.6
Q ss_pred CCCCCceeccCcceEEEEEEec-C---CcEEEEEEeecccc-hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE-EEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-D---GMQIAVKVFNLELE-GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFK-ALV 812 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~---~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV 812 (1029)
.|...+.||+|+||+||+|++. + +..||+|.+..... ...+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3556689999999999999853 2 33799999875433 3457889999999999999999999999876554 899
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+.+++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999877788999999999999999999999 6789999999999999999999999999998654322
Q ss_pred ---CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 893 ---SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 893 ---~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
........+++.|+|||.. ++.++||||+||++|||++|+.|+...... ...... +....
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~------------~~~~~ 245 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHF------------LAQGR 245 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHH------------HHTTC
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHH------------hhcCC
Confidence 1122334678899999984 567899999999999999966664321111 101100 00000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcc
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLT 1017 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~ 1017 (1029)
....+..++..+.+++.+||+.||++|||++|+++.|+++.+.+..
T Consensus 246 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 ------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 0111223466789999999999999999999999999999887753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=353.63 Aligned_cols=266 Identities=24% Similarity=0.308 Sum_probs=189.3
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCC-CCceEEEEEEEecCC--e
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIR-HRNLVKIISTCSSDH--F 808 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 808 (1029)
...++|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 35678999999999999999999875 79999999986542 344567889999999997 999999999997543 6
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.|+||||++ ++|.+++.. ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+|+.+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 899999996 689998865 46889999999999999999999 778999999999999999999999999999865
Q ss_pred CCCC--------------------CceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCccccccc
Q 036879 889 GDET--------------------SMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEI 943 (1029)
Q Consensus 889 ~~~~--------------------~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~ 943 (1029)
.... ....+..+||+.|+|||++ ++.++||||+||++|||++|++||.+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3211 1122335799999999973 56789999999999999999999976321111
Q ss_pred ccchhchhc---cchhh--------hhhhhhh----------hhhhhh------hhhHHHHHHHHHHHHHHHHccccccc
Q 036879 944 SLKSRVNDS---LHGKI--------INVVDIN----------LLQKED------AYLTAKEQCVSSVLSLAMQCTRESAE 996 (1029)
Q Consensus 944 ~~~~~~~~~---~~~~~--------~~~~d~~----------~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~ 996 (1029)
+....... ....+ ...+... ...... .....+..++..+.+++.+||..||+
T Consensus 240 -~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 240 -LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp -HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred -HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 10000000 00000 0000000 000000 00000113467899999999999999
Q ss_pred CCCCHHHHHHH
Q 036879 997 ERINIKEALTK 1007 (1029)
Q Consensus 997 ~Rpt~~evl~~ 1007 (1029)
+|||++|++++
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=364.71 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=203.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
..++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3466889999999999999999876 79999999997642 2334668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 812 VLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
||||+++|+|.+++.... ..+++..+..++.||+.||+||| ++|||||||||+||+++.++.+||+|||+|+....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999987654 35999999999999999999999 67899999999999999999999999999987754
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
... .....||+.|+|||++ ++.++||||+||++|||++|+.||........ . ..+...+...
T Consensus 339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~---------~~i~~~i~~~-- 404 (576)
T 2acx_A 339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-R---------EEVERLVKEV-- 404 (576)
T ss_dssp TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-H---------HHHHHHHHHC--
T ss_pred Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-H---------HHHHHHhhcc--
Confidence 332 2335799999999984 57789999999999999999999976321110 0 0000000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
....+..++..+.+++.+|+..||++|| +++|++++
T Consensus 405 -----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 -----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0011223467889999999999999999 78999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=341.41 Aligned_cols=272 Identities=22% Similarity=0.367 Sum_probs=208.7
Q ss_pred CHHHHHHHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhc--CCCCceEEEEEEEecC
Q 036879 729 SYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGS--IRHRNLVKIISTCSSD 806 (1029)
Q Consensus 729 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~ 806 (1029)
+........++|++.+.||+|+||.||+|+. +++.||||++... ..+.+.+|+++++. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3333445677899999999999999999988 5899999998644 33567788988887 7999999999999877
Q ss_pred C----eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEEcCCCCCCEEECCCCcE
Q 036879 807 H----FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD-----HPTPIIHCDLNPSNILLNESMVA 877 (1029)
Q Consensus 807 ~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~givH~Dlk~~Nill~~~~~~ 877 (1029)
. ..++||||+++|+|.+++.. ..+++..+..++.|++.|++|||.. ++.+|+||||||+||+++.++.+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred CCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence 5 78999999999999999965 4689999999999999999999932 14579999999999999999999
Q ss_pred EEEccCCceecCCCCCc---eeccccCCccccCccCCCC----------CCcchhHHHHHHHHHhcC----------CCC
Q 036879 878 CLSDFGISKLLGDETSM---TQTQTLATIGYMAPEWKLS----------RKGDVYSYGIILMETFTK----------KKP 934 (1029)
Q Consensus 878 kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~----------~~~DvwSlGvil~elltg----------~~p 934 (1029)
||+|||++......... ......||+.|+|||++.+ .++|||||||++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999999876543322 1234568999999998533 479999999999999999 566
Q ss_pred CCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 935 TDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
|............+...... ......... ......++..+.+++.+||+.||++|||+.|++++|+++.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCE----QKLRPNIPN-----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTT----SCCCCCCCG-----GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccccCcCcccHHHHHHHHHH----HHhCCCCcc-----cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 65432222111111110000 000000100 001235677899999999999999999999999999999876
Q ss_pred h
Q 036879 1015 L 1015 (1029)
Q Consensus 1015 ~ 1015 (1029)
.
T Consensus 338 ~ 338 (342)
T 1b6c_B 338 E 338 (342)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=353.64 Aligned_cols=249 Identities=21% Similarity=0.277 Sum_probs=187.9
Q ss_pred hCCCCCC-ceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHH-hcCCCCceEEEEEEEec----CCeE
Q 036879 737 TDGFSEN-NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEIL-GSIRHRNLVKIISTCSS----DHFK 809 (1029)
Q Consensus 737 ~~~~~~~-~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 809 (1029)
.++|.+. +.||+|+||+||+|+.. +++.||||++... ..+.+|++++ +..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3456665 68999999999999876 7899999998643 4567888887 45589999999999865 5678
Q ss_pred EEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC---CCcEEEEccCCc
Q 036879 810 ALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE---SMVACLSDFGIS 885 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~---~~~~kl~Dfg~a 885 (1029)
++||||+++|+|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 99999999999999997653 46999999999999999999999 678999999999999997 789999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
+....... .....||+.|+|||++ ++.++|||||||++|||++|+.||......... .........+
T Consensus 212 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~i~~~------ 282 (400)
T 1nxk_A 212 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTRIRMG------ 282 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CSHHHHHHHT------
T ss_pred cccCCCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HHHHHHHHcC------
Confidence 87643322 2345689999999985 677899999999999999999999764222110 0000000000
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
...........++.++.+++.+||+.||++|||+.|++++-
T Consensus 283 ------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 283 ------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp ------CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ------cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00000001123567789999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=353.91 Aligned_cols=241 Identities=27% Similarity=0.340 Sum_probs=187.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHH-HhcCCCCceEEEEEEEecCCeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEI-LGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
.++|++.+.||+|+||+||+|+.. +++.||||++++... .....+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 457899999999999999999976 688999999986532 234456667776 577899999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++|+|.+++.. .+.+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999864 456889999999999999999999 778999999999999999999999999999864332
Q ss_pred CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.. ......||+.|+|||++ ++.++||||+||++|||++|+.||......+. .........
T Consensus 193 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-------------~~~i~~~~~-- 256 (373)
T 2r5t_A 193 NS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-------------YDNILNKPL-- 256 (373)
T ss_dssp CC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH-------------HHHHHHSCC--
T ss_pred CC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-------------HHHHHhccc--
Confidence 22 23345799999999984 67789999999999999999999975311100 001111000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKE 1003 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e 1003 (1029)
..+..++..+.+++.+|++.||++||++.+
T Consensus 257 ------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 111234667899999999999999999853
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=356.69 Aligned_cols=249 Identities=25% Similarity=0.344 Sum_probs=190.2
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--------chhhHHHHHHHHHHhcCCCCceEEEEEEEecC
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--------EGTLRSFDAECEILGSIRHRNLVKIISTCSSD 806 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 806 (1029)
..++|.+.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4678999999999999999999875 68999999997542 1123358899999999999999999999864
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC---CcEEEEccC
Q 036879 807 HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES---MVACLSDFG 883 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~---~~~kl~Dfg 883 (1029)
+..++||||+++|+|.+++. ....+++..+..++.|++.||+||| ++||+||||||+||+++.+ +.+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 45789999999999999874 4457999999999999999999999 6779999999999999754 459999999
Q ss_pred CceecCCCCCceeccccCCccccCccCCC-------CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchh
Q 036879 884 ISKLLGDETSMTQTQTLATIGYMAPEWKL-------SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGK 956 (1029)
Q Consensus 884 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 956 (1029)
+|+...... ......||+.|+|||++. +.++||||+||++|||++|+.||........ +...+..
T Consensus 288 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~i~~----- 359 (419)
T 3i6u_A 288 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITS----- 359 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHHHHHT-----
T ss_pred cceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHHHHhc-----
Confidence 998765432 223456999999999853 4479999999999999999999975321111 1110000
Q ss_pred hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 957 IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 957 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
............++..+.+++.+||+.||++|||++|++++
T Consensus 360 ----------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 ----------GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ----------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----------CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000111123356789999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=346.45 Aligned_cols=250 Identities=17% Similarity=0.149 Sum_probs=201.8
Q ss_pred HhCCCCCCceeccCcceEEEEEE------ecCCcEEEEEEeecccchhhHHHHHHHHHHhcCC---CCceEEEEEEEecC
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGT------LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIR---HRNLVKIISTCSSD 806 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~------~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 806 (1029)
..++|++.+.||+|+||+||+|+ ..+++.||||+++... ...+..|+++++.++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45779999999999999999994 3468999999987543 356778888888886 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC---------
Q 036879 807 HFKALVLEYMPNGSLENWMYN----KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE--------- 873 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~--------- 873 (1029)
+..++||||+++|+|.+++.. ....+++..+..++.||+.||+||| ++|||||||||+||+++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999965 3567999999999999999999999 788999999999999998
Q ss_pred --CCcEEEEccCCceecCC-CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccc
Q 036879 874 --SMVACLSDFGISKLLGD-ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLK 946 (1029)
Q Consensus 874 --~~~~kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~ 946 (1029)
++.+||+|||+|+.+.. ..........||++|+|||++ ++.++|||||||++|||++|+.||.....+.....
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 296 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEEC
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeec
Confidence 89999999999976532 222334456799999999984 67899999999999999999999865332211111
Q ss_pred hhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCC-CCHHHHHHHHHHhHHhhc
Q 036879 947 SRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEER-INIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 947 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-pt~~evl~~L~~i~~~~~ 1016 (1029)
... ... .....+.+++..|+..+|.+| |+++++.+.|+++.....
T Consensus 297 ~~~-----------------~~~--------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 297 GLF-----------------RRL--------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp SCC-----------------TTC--------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hhc-----------------ccc--------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 000 000 013456789999999999998 588888888888776543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=351.79 Aligned_cols=359 Identities=21% Similarity=0.179 Sum_probs=245.1
Q ss_pred hhccccccccCCCCcccccccccceEEcccccccCCCCccccccccccceeeccccccc----ccCcccEEEccCCcccC
Q 036879 206 ELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTG----EIQGLQVLALSSNRLTG 281 (1029)
Q Consensus 206 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~----~l~~L~~L~Ls~N~l~~ 281 (1029)
..........+..+..++.+++|++|++++|++++. | .|+.+++|+.|++++|++++ .+++|++|+|++|+|++
T Consensus 22 ~~~~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~~~~~l~~L~~L~Ls~N~l~~ 99 (457)
T 3bz5_A 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTLDLSQNTNLTYLACDSNKLTN 99 (457)
T ss_dssp HHHHHHTTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCCCCTTCTTCSEEECCSSCCSC
T ss_pred HHHHHhcCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeEccccCCCCCEEECcCCCCce
Confidence 333334444555566777788888888888887753 4 57777777777777776663 45667788888888876
Q ss_pred CCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCC
Q 036879 282 VIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLG 361 (1029)
Q Consensus 282 ~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~ 361 (1029)
. | +.++++|++|++++|++.+ +| + ..+++|++|++++|++++. .++.+++|+.|++++|...+.++
T Consensus 100 ~-~--~~~l~~L~~L~L~~N~l~~-l~--~-~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~~---- 165 (457)
T 3bz5_A 100 L-D--VTPLTKLTYLNCDTNKLTK-LD--V-SQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD---- 165 (457)
T ss_dssp C-C--CTTCTTCCEEECCSSCCSC-CC--C-TTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCCC----
T ss_pred e-e--cCCCCcCCEEECCCCcCCe-ec--C-CCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCcccccc----
Confidence 4 3 7778888888888888864 55 3 3578888888888888764 27777888888888885443331
Q ss_pred CCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCcccc
Q 036879 362 FCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELT 441 (1029)
Q Consensus 362 ~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 441 (1029)
+..+++|+.|++++|++++ +| +..+.. |+.|++++|++++. .++.+++|++|+|++|+++
T Consensus 166 -------------~~~l~~L~~L~ls~n~l~~-l~--l~~l~~-L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~ 225 (457)
T 3bz5_A 166 -------------VTPQTQLTTLDCSFNKITE-LD--VSQNKL-LNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT 225 (457)
T ss_dssp -------------CTTCTTCCEEECCSSCCCC-CC--CTTCTT-CCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCS
T ss_pred -------------cccCCcCCEEECCCCccce-ec--cccCCC-CCEEECcCCcCCee---ccccCCCCCEEECcCCccc
Confidence 3456778888888888875 34 556554 77888888888754 3777788888888888887
Q ss_pred ccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCcc
Q 036879 442 GSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLW 521 (1029)
Q Consensus 442 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 521 (1029)
+ +| +..+++|++|++++|++++..+. .+++|+.|++++| +|+.|++++|.+.+.+| +.
T Consensus 226 ~-ip--~~~l~~L~~L~l~~N~l~~~~~~---~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~ 283 (457)
T 3bz5_A 226 E-ID--VTPLTQLTYFDCSVNPLTELDVS---TLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AE 283 (457)
T ss_dssp C-CC--CTTCTTCSEEECCSSCCSCCCCT---TCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CT
T ss_pred c-cC--ccccCCCCEEEeeCCcCCCcCHH---HCCCCCEEeccCC--------------CCCEEECCCCccCCccc--cc
Confidence 5 45 67778888888888888766533 3444444444433 23444455554444333 33
Q ss_pred CCCCCcEEEccCCcccCcCCc--------cccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCcccc
Q 036879 522 SLRDILNVNLSSNSLNGTLPV--------EIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLG 593 (1029)
Q Consensus 522 ~l~~L~~L~Ls~N~l~~~~p~--------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 593 (1029)
.+++|+.|++++|...+.+|. .++++++|+.|++++|++++. + ++.+++|+.|++++|+|++
T Consensus 284 ~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~------- 353 (457)
T 3bz5_A 284 GCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD------- 353 (457)
T ss_dssp TCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB-------
T ss_pred ccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC-------
Confidence 445555555555544333332 244557888888888888864 3 7888888888888888885
Q ss_pred CCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCC
Q 036879 594 GLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 594 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 638 (1029)
++.|..|++++|.++|. ..+..|..+++++|+++|.+|.
T Consensus 354 -l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 354 -FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp -CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred -ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence 24566778888888865 3567788899999999998875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=350.20 Aligned_cols=262 Identities=16% Similarity=0.212 Sum_probs=195.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec----CCcEEEEEEeecccch-----------hhHHHHHHHHHHhcCCCCceEEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLELEG-----------TLRSFDAECEILGSIRHRNLVKIIS 801 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 801 (1029)
.++|++.+.||+|+||.||+|+.. ++..||||++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 5788999998765321 1234678889999999999999999
Q ss_pred EEec----CCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC--
Q 036879 802 TCSS----DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM-- 875 (1029)
Q Consensus 802 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~-- 875 (1029)
++.. ....++||||+ +++|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence 9987 77889999999 999999986544 7999999999999999999999 67899999999999999877
Q ss_pred cEEEEccCCceecCCCCC------ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCccccccccc
Q 036879 876 VACLSDFGISKLLGDETS------MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISL 945 (1029)
Q Consensus 876 ~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 945 (1029)
.+||+|||+|+.+..... .......||+.|+|||++ ++.++|||||||++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999987643211 111345799999999984 6778999999999999999999996422111111
Q ss_pred chhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 946 KSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 946 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
.. ........+..... . ......++..+.+++..||+.||++|||++++++.|+.+.-
T Consensus 271 ~~-~~~~~~~~~~~~~~----~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 271 QT-AKTNLLDELPQSVL----K-----WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HH-HHHHHHHTTTHHHH----H-----HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HH-HHHhhcccccHHHH----h-----hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 00 00000000000000 0 00001356789999999999999999999999999987653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=335.16 Aligned_cols=254 Identities=22% Similarity=0.312 Sum_probs=201.4
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccch------hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG------TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
++|++.+.||+|+||.||+|+.. +++.||+|+++..... ..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999986 7999999998765321 3567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC----cEEEEccCCce
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM----VACLSDFGISK 886 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~----~~kl~Dfg~a~ 886 (1029)
+||||+++++|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++.++ .+||+|||.+.
T Consensus 85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999999854 456899999999999999999999 67899999999999998877 89999999998
Q ss_pred ecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhh
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 962 (1029)
....... .....+++.|+|||++ ++.++||||||+++|||++|+.||......+. ......
T Consensus 161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------------~~~~~~ 225 (283)
T 3bhy_A 161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-------------LTNISA 225 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHT
T ss_pred eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-------------HHHhHh
Confidence 7654322 2335689999999973 57789999999999999999999975321100 000000
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHH--HHHHhHHh
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT--KLLKIRNT 1014 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~--~L~~i~~~ 1014 (1029)
............++..+.+++.+||..||++|||+.|+++ .++.+.+.
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 226 ----VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp ----TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred ----cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 0000001112334677899999999999999999999998 45555543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=341.57 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=203.3
Q ss_pred HhCCCCCCc-eeccCcceEEEEEEec---CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 736 ATDGFSENN-LLGKGSFGSVYKGTLS---DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 736 ~~~~~~~~~-~lg~G~fg~V~~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
..++|++.+ .||+|+||.||+|.+. +++.||||+++... ....+.+.+|+++++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345677777 9999999999999642 47889999997653 23356799999999999999999999999 55678
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++++|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 899999999999999965 456899999999999999999999 6789999999999999999999999999998775
Q ss_pred CCCCce--eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhh
Q 036879 890 DETSMT--QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962 (1029)
Q Consensus 890 ~~~~~~--~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 962 (1029)
...... .....+++.|+|||.. ++.++||||||+++|||++ |+.||......+ .. ..+.
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~------------~~~~ 234 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT------------AMLE 234 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH------------HHHH
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HH------------HHHH
Confidence 443322 1223467889999984 5678999999999999999 999997632111 00 0000
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcc
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLT 1017 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~ 1017 (1029)
... ....+..++..+.+++.+||+.||++||++.|+++.|+.+......
T Consensus 235 ~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 235 KGE------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp TTC------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred cCC------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 000 0111234567899999999999999999999999999999876643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=355.90 Aligned_cols=274 Identities=20% Similarity=0.278 Sum_probs=208.8
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC--eEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH--FKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 812 (1029)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 456889999999999999999976 69999999997543 234567889999999999999999999998754 77999
Q ss_pred EeccCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE----CCCCcEEEEccCCce
Q 036879 813 LEYMPNGSLENWMYNKN--RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL----NESMVACLSDFGISK 886 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill----~~~~~~kl~Dfg~a~ 886 (1029)
|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||++ +.++.+||+|||+|+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999996543 23899999999999999999999 6779999999999999 788889999999998
Q ss_pred ecCCCCCceeccccCCccccCccCC------------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccc
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK------------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLH 954 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~------------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 954 (1029)
....... .....||+.|+|||++ ++.++|||||||++|||++|+.||......... .........
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~-~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYKIIT 241 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC-HHHHHHHHH
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch-HHHHHHHhc
Confidence 7654322 2335699999999974 345899999999999999999999653221111 111111110
Q ss_pred hhhhh----h---hhh--hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 955 GKIIN----V---VDI--NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 955 ~~~~~----~---~d~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
+.... . ... ................+..+.+++.+||+.||++||+++|+++.++++.+...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~~ 312 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMV 312 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCEE
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhceE
Confidence 00000 0 000 00000000112235567889999999999999999999999999998876543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=336.16 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=196.8
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
+.|.....||+|+||.||+|+.. +++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555679999999999999975 78999999998776666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC-CCcEEEEccCCceecCCCCC
Q 036879 817 PNGSLENWMYNKNR--SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-SMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
++++|.+++..... .+++..+..++.|++.||+||| +.||+||||||+||+++. ++.+||+|||.+........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999976533 4678889999999999999999 678999999999999987 89999999999987654322
Q ss_pred ceeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
......|++.|+|||+. ++.++||||||+++|||++|+.||........... .. ...
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------------~~---~~~- 241 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF------------KV---GMF- 241 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH------------HH---HHH-
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH------------hh---ccc-
Confidence 22335689999999983 56789999999999999999999965311111000 00 000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
......+..++..+.+++.+||+.||++|||+.|++++
T Consensus 242 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 242 --KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp --CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred --cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00011123456778999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=358.11 Aligned_cols=262 Identities=20% Similarity=0.238 Sum_probs=192.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecc--cchhhHHHHHHHHHHhcCCCCceEEEEEEEecC------
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLE--LEGTLRSFDAECEILGSIRHRNLVKIISTCSSD------ 806 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 806 (1029)
..++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+++++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999875 7899999999765 234456788999999999999999999999654
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 807 HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
...|+||||+++ ++.+++. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred CeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 467999999965 5666663 34889999999999999999999 6789999999999999999999999999998
Q ss_pred ecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh----------c
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND----------S 952 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----------~ 952 (1029)
...... .....+||+.|+|||++ ++.++||||+||++|||++|+.||.+....+. +...+.. .
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 213 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp ----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHTT
T ss_pred ecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHH
Confidence 764432 23346799999999984 67899999999999999999999976321110 0000000 0
Q ss_pred cchhhhhhhhhhh----------hhh--hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 953 LHGKIINVVDINL----------LQK--EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 953 ~~~~~~~~~d~~~----------~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
........++... ... ...........+..+.+++.+|+..||++|||++|++++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 000 000011122346789999999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=345.51 Aligned_cols=256 Identities=23% Similarity=0.287 Sum_probs=190.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCC-CCceEEEEEEEe--------cC
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKIISTCS--------SD 806 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~ 806 (1029)
..+|++.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457889999999999999999975 78999999997776666778999999999996 999999999983 34
Q ss_pred CeEEEEEeccCCCCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCEEECCCCcEEEEcc
Q 036879 807 HFKALVLEYMPNGSLENWMYN--KNRSFDILQRLNMVIDVASALEYLHYDHPTP--IIHCDLNPSNILLNESMVACLSDF 882 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~g--ivH~Dlk~~Nill~~~~~~kl~Df 882 (1029)
...++||||++ |+|.+++.. ....+++..+..++.|++.||+||| +.| |+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 56789999995 799998864 4556999999999999999999999 777 999999999999999999999999
Q ss_pred CCceecCCCCCce-----------eccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccc
Q 036879 883 GISKLLGDETSMT-----------QTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEIS 944 (1029)
Q Consensus 883 g~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~ 944 (1029)
|++.......... .....||+.|+|||++ ++.++|||||||++|||++|+.||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 9998765432211 1134589999999985 45689999999999999999999965321110
Q ss_pred cchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcccc
Q 036879 945 LKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNI 1019 (1029)
Q Consensus 945 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~ 1019 (1029)
..... . ...+..++..+.+++.+||+.||++|||+.|++++|+.+........
T Consensus 262 ----~~~~~------------~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 262 ----VNGKY------------S------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp --------C------------C------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred ----hcCcc------------c------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence 00000 0 00001123447889999999999999999999999999987655433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=344.43 Aligned_cols=266 Identities=23% Similarity=0.300 Sum_probs=199.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEec--------
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSS-------- 805 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 805 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 467999999999999999999974 799999999865532 234578899999999999999999999976
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 806 DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 806 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
.+..++||||++ +++.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+|
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 346899999996 5888888777778999999999999999999999 778999999999999999999999999999
Q ss_pred eecCCCC---CceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhc---hhccc
Q 036879 886 KLLGDET---SMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV---NDSLH 954 (1029)
Q Consensus 886 ~~~~~~~---~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~ 954 (1029)
+.+.... ........||+.|+|||++ ++.++||||+||++|||++|+.||........ ..... .....
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITP 250 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCh
Confidence 8765321 1222345689999999973 57789999999999999999999976322111 00000 00000
Q ss_pred hhhhhhhhhhh------h--hhhhhh-hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 955 GKIINVVDINL------L--QKEDAY-LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 955 ~~~~~~~d~~~------~--~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..+........ . ...... .-.....++.+.+++.+|++.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000000 0 000000 00011125668999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=351.63 Aligned_cols=266 Identities=13% Similarity=0.137 Sum_probs=205.0
Q ss_pred hCCCCCCceeccCcceEEEEEEecC---------CcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEE---------
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSD---------GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVK--------- 798 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 798 (1029)
.++|++.+.||+|+||.||+|+... ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999998763 789999998754 46889999999999999987
Q ss_pred ------EEEEEec-CCeEEEEEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEE
Q 036879 799 ------IISTCSS-DHFKALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNIL 870 (1029)
Q Consensus 799 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nil 870 (1029)
+++++.. ....++||||+ +++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence 5677765 78889999999 99999999765 467999999999999999999999 678999999999999
Q ss_pred ECCCC--cEEEEccCCceecCCCCCc------eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcc
Q 036879 871 LNESM--VACLSDFGISKLLGDETSM------TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDEL 938 (1029)
Q Consensus 871 l~~~~--~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~ 938 (1029)
++.++ .+||+|||+++.+...... ......||+.|+|||++ ++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999866432111 11334799999999984 567899999999999999999999764
Q ss_pred cccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccc
Q 036879 939 FVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTN 1018 (1029)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~ 1018 (1029)
......+...... .........+. . .....++..+.+++.+||+.||++|||++++++.|+++.+.....
T Consensus 272 ~~~~~~~~~~~~~-~~~~~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 272 LPNTEDIMKQKQK-FVDKPGPFVGP-----C----GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp TTCHHHHHHHHHH-HHHSCCCEECT-----T----SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CcCHHHHHHHHHh-ccCChhhhhhh-----c----cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 2111111110000 00000000000 0 000123577999999999999999999999999999999887655
Q ss_pred ccC
Q 036879 1019 IEN 1021 (1029)
Q Consensus 1019 ~~~ 1021 (1029)
.+.
T Consensus 342 ~~~ 344 (352)
T 2jii_A 342 PYD 344 (352)
T ss_dssp TTS
T ss_pred cCc
Confidence 443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.62 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=195.9
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEec----CCeEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSS----DHFKA 810 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 810 (1029)
..|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 44777889999999999999875 78899999987543 3345678999999999999999999999865 45689
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCEEEC-CCCcEEEEccCCcee
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP--IIHCDLNPSNILLN-ESMVACLSDFGISKL 887 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~g--ivH~Dlk~~Nill~-~~~~~kl~Dfg~a~~ 887 (1029)
+||||+++++|.+++.. ...+++..+..++.|++.||+||| +.+ |+||||||+||+++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999964 356899999999999999999999 777 99999999999998 889999999999975
Q ss_pred cCCCCCceeccccCCccccCccCC---CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 888 LGDETSMTQTQTLATIGYMAPEWK---LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
..... .....||+.|+|||++ ++.++||||+||++|+|++|+.||............. .. .
T Consensus 182 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------------~~-~ 245 (290)
T 1t4h_A 182 KRASF---AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------------TS-G 245 (290)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH------------TT-T
T ss_pred ccccc---cccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH------------hc-c
Confidence 54332 2235689999999984 6779999999999999999999996532111111000 00 0
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. .....+...+..+.+++.+||+.||++|||++|++++
T Consensus 246 ~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 246 V-----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp C-----CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C-----CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 0011112234678999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=351.84 Aligned_cols=251 Identities=24% Similarity=0.292 Sum_probs=201.2
Q ss_pred hCCCCCCceeccCcceEEEEEEe----cCCcEEEEEEeeccc----chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCC
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTL----SDGMQIAVKVFNLEL----EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDH 807 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 807 (1029)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 45789999999999999999987 378999999987542 23345677899999999 6999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
..++||||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999998653 46899999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCceeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhh
Q 036879 888 LGDETSMTQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
+............||+.|+|||++ ++.++|||||||++|||++|+.||........ ... +...+
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~---------~~~~~ 278 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAE---------ISRRI 278 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHH---------HHHHH
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHH---------HHHHH
Confidence 654333333345799999999984 45689999999999999999999975321111 000 00000
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTKL 1008 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~L 1008 (1029)
... ....+..++..+.+++.+||..||++|| +++|++++.
T Consensus 279 ---~~~----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 279 ---LKS----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ---HHC----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ---hcc----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 000 0111233466789999999999999999 999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=363.34 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=196.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.++|++.+.||+|+||+||+|+.. ++..||+|++.... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346899999999999999999976 78999999997653 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC---CCcEEEEccCCceecCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE---SMVACLSDFGISKLLGD 890 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~---~~~~kl~Dfg~a~~~~~ 890 (1029)
||+++|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++. ++.+||+|||+|..+..
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999988543 56899999999999999999999 678999999999999975 45699999999987654
Q ss_pred CCCceeccccCCccccCccCC---CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK---LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
... .....||+.|+|||++ ++.++||||+||++|+|++|+.||......+. ... ... .
T Consensus 192 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~-----------i~~----~ 252 (494)
T 3lij_A 192 QKK--MKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI--LRK-----------VEK----G 252 (494)
T ss_dssp TBC--BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-----------HHH----T
T ss_pred Ccc--ccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-----------HHh----C
Confidence 322 2345699999999984 67899999999999999999999976321110 000 000 0
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
......+....++..+.+++.+||+.||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 253 KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0000011112346778999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=361.75 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=200.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-------------hhhHHHHHHHHHHhcCCCCceEEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-------------GTLRSFDAECEILGSIRHRNLVKIIS 801 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 801 (1029)
..++|++.+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999976 689999999875431 23467889999999999999999999
Q ss_pred EEecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC---cEE
Q 036879 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM---VAC 878 (1029)
Q Consensus 802 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~---~~k 878 (1029)
++.+....++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999988553 56999999999999999999999 67899999999999998775 699
Q ss_pred EEccCCceecCCCCCceeccccCCccccCccCC---CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccch
Q 036879 879 LSDFGISKLLGDETSMTQTQTLATIGYMAPEWK---LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG 955 (1029)
Q Consensus 879 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 955 (1029)
|+|||+|........ .....||+.|+|||++ ++.++||||+||++|+|++|+.||......+. . .
T Consensus 190 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~---~----- 257 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI--I---K----- 257 (504)
T ss_dssp ECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H---H-----
T ss_pred EEECCCCEEcCCCCc--cccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H---H-----
Confidence 999999987754322 2345699999999984 67899999999999999999999976321110 0 0
Q ss_pred hhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 956 KIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 956 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.+. .............++..+.+++.+|+..||++|||++|++++-
T Consensus 258 ---~i~----~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 258 ---KVE----KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp ---HHH----HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---HHH----cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 000 0000001111234567899999999999999999999999753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=336.52 Aligned_cols=248 Identities=24% Similarity=0.397 Sum_probs=201.3
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEec---------
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS--------- 805 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 805 (1029)
...+|++.+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467899999999999999999986 79999999987553 456789999999999999999998854
Q ss_pred -------CCeEEEEEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcE
Q 036879 806 -------DHFKALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVA 877 (1029)
Q Consensus 806 -------~~~~~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~ 877 (1029)
....++||||+++++|.+++... ...+++..+..++.|++.|++||| +.||+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence 44578999999999999999654 357899999999999999999999 6789999999999999999999
Q ss_pred EEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc
Q 036879 878 CLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL 953 (1029)
Q Consensus 878 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 953 (1029)
||+|||++........ .....+++.|+|||+. ++.++||||||+++|||++|+.|+.... ..
T Consensus 162 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~~----- 227 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------KF----- 227 (284)
T ss_dssp EECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------HH-----
T ss_pred EECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------HH-----
Confidence 9999999987654322 2335689999999983 6788999999999999999998864310 00
Q ss_pred chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcc
Q 036879 954 HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLT 1017 (1029)
Q Consensus 954 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~ 1017 (1029)
......... +..++..+.+++.+||+.||++|||+.|++++++.+.++...
T Consensus 228 ---~~~~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 228 ---FTDLRDGII----------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp ---HHHHHTTCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred ---HHHhhcccc----------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 000000000 112356688999999999999999999999999998876543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.17 Aligned_cols=248 Identities=29% Similarity=0.463 Sum_probs=194.7
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecC-CeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSD-HFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||.||+|+. .|+.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46788999999999999999987 48899999987543 456789999999999999999999997554 578999999
Q ss_pred cCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNKNR-SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++++|.+++..... .+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 999999999965433 3788999999999999999999 6789999999999999999999999999997654321
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
....+++.|+|||.. ++.++||||||+++|||++ |+.||......+. ... +...
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~------------~~~~----- 230 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPR------------VEKG----- 230 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHH------------HTTT-----
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH------------HhcC-----
Confidence 223578899999984 6778999999999999998 9999875321110 000 0000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
.....+..++..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 231 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 231 -YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 00111234567899999999999999999999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=334.37 Aligned_cols=249 Identities=23% Similarity=0.319 Sum_probs=201.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 457899999999999999999976 78999999997553 3345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC-C
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET-S 893 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~ 893 (1029)
|+++++|.+++. ....+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+....... .
T Consensus 86 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999874 3456899999999999999999999 6789999999999999999999999999998654321 1
Q ss_pred ceeccccCCccccCccCCC-----CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~~-----~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
.......|++.|+|||... +.++||||+|+++|||++|+.||.........+..+.... .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------~--- 226 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK------------T--- 226 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC------------T---
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc------------c---
Confidence 1223456899999999852 4579999999999999999999976432222111111100 0
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.......++..+.+++.+||+.||++|||++|++++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 227 ---YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ---TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 000112346678999999999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=362.68 Aligned_cols=248 Identities=26% Similarity=0.320 Sum_probs=200.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457999999999999999999976 79999999997542 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC---CCCcEEEEccCCceecCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN---ESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~---~~~~~kl~Dfg~a~~~~~ 890 (1029)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||+++ .++.+||+|||+|+.+..
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999988554 56899999999999999999999 77899999999999995 567899999999986644
Q ss_pred CCCceeccccCCccccCccCC---CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK---LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
... .....||+.|+|||++ ++.++||||+||++|+|++|+.||......+. .. .+. ..
T Consensus 177 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~-----------~i~----~~ 237 (486)
T 3mwu_A 177 NTK--MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI--LK-----------RVE----TG 237 (486)
T ss_dssp C------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH-----------HHH----HT
T ss_pred CCc--cCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-----------HHH----hC
Confidence 322 2345799999999985 56789999999999999999999975321110 00 000 00
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
......+....++..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000011123356778999999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=335.60 Aligned_cols=243 Identities=25% Similarity=0.373 Sum_probs=200.0
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 457889999999999999999876 68899999987542 22346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++++|.+++... ..+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999998654 46899999999999999999999 7889999999999999999999999999997654322
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
.....|++.|+|||++ ++.++||||+|+++|||++|+.||......+. ........
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------------~~~~~~~~---- 228 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-------------HRRIVNVD---- 228 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHTTC----
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-------------HHHHhccc----
Confidence 2335689999999983 57799999999999999999999975321110 00000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+..++..+.+++.+|++.||++|||++|++++
T Consensus 229 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 ----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 01112346678999999999999999999999984
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=338.54 Aligned_cols=246 Identities=22% Similarity=0.291 Sum_probs=201.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467889999999999999999976 68899999987653 23456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++++|.+++.. ...+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||.+.......
T Consensus 94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999998854 356899999999999999999999 6789999999999999999999999999998764332
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
. ......|++.|+|||.. ++.++||||+|+++|||++|+.||......+. ........
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------------~~~~~~~~---- 231 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------------YLRIKKNE---- 231 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHTTC----
T ss_pred c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHhhcc----
Confidence 2 22345689999999984 57789999999999999999999975321110 00000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
...+..++..+.+++.+||+.||++|||++|++++-
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 232 ----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 011123456789999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=347.83 Aligned_cols=260 Identities=23% Similarity=0.296 Sum_probs=192.0
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC------
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH------ 807 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 807 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 567999999999999999999975 79999999986542 334567889999999999999999999997653
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 459999999 8899999865 46899999999999999999999 77899999999999999999999999999987
Q ss_pred cCCCCCceeccccCCccccCccC-----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh--ccchh----
Q 036879 888 LGDETSMTQTQTLATIGYMAPEW-----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND--SLHGK---- 956 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~---- 956 (1029)
.... .....+|+.|+|||+ .++.++||||+||++|||++|+.||.+....+. +...... .....
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHT
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHH
Confidence 6432 233568999999997 367899999999999999999999975321110 0000000 00000
Q ss_pred -----hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 957 -----IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 957 -----~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+..................+..+.+++.+|+..||++|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000000000000011112346778999999999999999999999984
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.00 Aligned_cols=250 Identities=25% Similarity=0.353 Sum_probs=197.8
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
..++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3567899999999999999999986 689999999987666667789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+++++|.+++......+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||++...... ..
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 172 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ 172 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 99999999999776778999999999999999999999 678999999999999999999999999987543211 11
Q ss_pred eeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
......|++.|+|||++ ++.++|||||||++|||++|+.||........ . .......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~--------~~~~~~~- 238 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----L--------LKIAKSD- 238 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----H--------HHHHHSC-
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----H--------HHHhccC-
Confidence 11234689999999974 46789999999999999999999875321110 0 0000000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
......+..++..+.+++.+||+.||++|||+.+++++
T Consensus 239 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 239 ----PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ----CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ----CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00001122346678999999999999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=363.90 Aligned_cols=249 Identities=26% Similarity=0.360 Sum_probs=203.0
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 456899999999999999999976 79999999997543 33457799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE---CCCCcEEEEccCCceecC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLG 889 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill---~~~~~~kl~Dfg~a~~~~ 889 (1029)
|||+.+|+|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||+|..+.
T Consensus 105 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999998854 456999999999999999999999 6789999999999999 578899999999998765
Q ss_pred CCCCceeccccCCccccCccC---CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEW---KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~---~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.... .....||+.|+|||+ .++.++||||+||++|+|++|++||......+. ...+ ..
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i-----------~~---- 241 (484)
T 3nyv_A 181 ASKK--MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDI--LKKV-----------EK---- 241 (484)
T ss_dssp CCCS--HHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH-----------HH----
T ss_pred cccc--cccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH--HHHH-----------Hc----
Confidence 4332 233569999999998 468899999999999999999999976321110 0000 00
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.......+....++..+.+++.+||+.||++|||+.|++++-
T Consensus 242 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 242 GKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp CCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 000000111223567789999999999999999999999853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=340.51 Aligned_cols=247 Identities=24% Similarity=0.322 Sum_probs=197.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456889999999999999999976 7999999999866554556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE---CCCCcEEEEccCCceecCCCC
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
+++++|.+++... ..+++..+..++.|++.|++||| +.||+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 88 VSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred CCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 9999999988543 46899999999999999999999 6789999999999999 78899999999999754332
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
......|++.|+|||++ ++.++||||+||++|||++|+.||....... ... ......
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~-----------~i~~~~---- 223 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--LFE-----------KIKEGY---- 223 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH-----------HHHHCC----
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHH-----------HHHcCC----
Confidence 12234689999999985 4668999999999999999999996532110 000 000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..........++..+.+++.+|++.||++|||++|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 224 YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000001112346778999999999999999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=352.16 Aligned_cols=261 Identities=18% Similarity=0.269 Sum_probs=206.9
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCC-CceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRH-RNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 468999999999999999999974 799999998775432 3468899999999976 556666667777889999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE---CCCCcEEEEccCCceecCCC
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL---NESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
|+ +++|.+++......+++..++.++.||+.||+||| ++|||||||||+|||+ +.++.+||+|||+++.+...
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 99999999877788999999999999999999999 6789999999999999 68899999999999876543
Q ss_pred CCc------eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhh
Q 036879 892 TSM------TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 892 ~~~------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
... ......||+.|+|||++ ++.++|||||||++|||++|+.||........ ... +....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~--------~~~i~ 229 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQK--------YEKIS 229 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HHH--------HHHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HHH--------HHHHh
Confidence 221 12245799999999984 56789999999999999999999976422111 000 11111
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
..... .........++.++.+++..||+.+|++||++.++++.|+++.....
T Consensus 230 ~~~~~---~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 230 EKKVA---TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HHHHH---SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred hcccc---ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 11110 00112223457789999999999999999999999999999876553
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=344.79 Aligned_cols=245 Identities=22% Similarity=0.296 Sum_probs=201.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467888999999999999999976 68899999987653 23456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++++|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999999998854 456899999999999999999999 6789999999999999999999999999998764332
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
. ......|++.|+|||++ ++.++|||||||++|||++|+.||......+. ........
T Consensus 196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------------~~~~~~~~---- 257 (335)
T 2owb_A 196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------------YLRIKKNE---- 257 (335)
T ss_dssp C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHHTC----
T ss_pred c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-------------HHHHhcCC----
Confidence 2 22345689999999984 67789999999999999999999975321110 00000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+..++..+.+++.+||+.||++|||++|++++
T Consensus 258 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 ----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112345678999999999999999999999985
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=353.92 Aligned_cols=347 Identities=21% Similarity=0.191 Sum_probs=264.4
Q ss_pred EEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCc
Q 036879 271 VLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYN 350 (1029)
Q Consensus 271 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N 350 (1029)
.++.++++++ .+|..+. ++++.|+|++|++.+ ++...+..+++|++|+|++|.+++..|..|.++++|++|++++|
T Consensus 15 ~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKT-LNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccce-ECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 4566666666 3444432 466777777777753 33333335777777777777777666777777777777777777
Q ss_pred cccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcC
Q 036879 351 LFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNL 430 (1029)
Q Consensus 351 ~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L 430 (1029)
.+.+..+.. +..+++|++|+|++|++.+..|..+..+.+ |++|++++|.+++..+..|.++++|
T Consensus 91 ~l~~~~~~~---------------~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L 154 (477)
T 2id5_A 91 RLKLIPLGV---------------FTGLSNLTKLDISENKIVILLDYMFQDLYN-LKSLEVGDNDLVYISHRAFSGLNSL 154 (477)
T ss_dssp CCCSCCTTS---------------STTCTTCCEEECTTSCCCEECTTTTTTCTT-CCEEEECCTTCCEECTTSSTTCTTC
T ss_pred cCCccCccc---------------ccCCCCCCEEECCCCccccCChhHcccccc-CCEEECCCCccceeChhhccCCCCC
Confidence 776443332 235677777778777777777777777766 8888888888887777888888888
Q ss_pred cEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCc
Q 036879 431 TTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFN 510 (1029)
Q Consensus 431 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 510 (1029)
++|+|++|++++..+..|..+++|+.|+|++|.+.+..+..|..+++|+.|++++|...+.+|.......+|++|+|++|
T Consensus 155 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n 234 (477)
T 2id5_A 155 EQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234 (477)
T ss_dssp CEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESS
T ss_pred CEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCC
Confidence 88888888888766677888888888888888888888888888888888888888877777777666778999999999
Q ss_pred cccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCc
Q 036879 511 RLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPD 590 (1029)
Q Consensus 511 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 590 (1029)
+++++.+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+.
T Consensus 235 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 314 (477)
T 2id5_A 235 NLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEES 314 (477)
T ss_dssp CCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGG
T ss_pred cccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHh
Confidence 99877667888899999999999999988888889999999999999999988888999999999999999999977777
Q ss_pred cccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCC
Q 036879 591 SLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 591 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 638 (1029)
.|..+++|++|+|++|+++...+ ..+-+..+..+++.++...+..|.
T Consensus 315 ~~~~l~~L~~L~l~~N~l~c~c~-~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 315 VFHSVGNLETLILDSNPLACDCR-LLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp GBSCGGGCCEEECCSSCEECSGG-GHHHHTTTTSSCCTTCCCBEEESG
T ss_pred HcCCCcccCEEEccCCCccCccc-hHhHHhhhhccccCccCceeCCch
Confidence 78889999999999999885433 222233344566777777665553
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=359.76 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=201.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|+..+.||+|+||+||+|+.. +|+.||+|++.+.. ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999986 79999999997653 23346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 813 LEYMPNGSLENWMYNK---NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
|||++||+|.+++... ...+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999998654 346999999999999999999999 6789999999999999999999999999998765
Q ss_pred CCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
..... .....||+.|+|||++ ++.++||||+||++|||++|+.||....... ...... ......
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~--------~~i~~~-- 408 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELK--------QRVLEQ-- 408 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHH--------HHHHHC--
T ss_pred CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHH--------HHHhhc--
Confidence 43322 2335799999999984 6788999999999999999999997532110 000000 000000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCH-----HHHHH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINI-----KEALT 1006 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~evl~ 1006 (1029)
....+..++..+.+++.+||..||++||++ +++++
T Consensus 409 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 409 ------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 011123456788999999999999999965 66765
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=343.92 Aligned_cols=267 Identities=23% Similarity=0.307 Sum_probs=191.8
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
....++|++.+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 445678999999999999999999865 789999999975532 23456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE-----CCCCcEEEEccCCc
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL-----NESMVACLSDFGIS 885 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill-----~~~~~~kl~Dfg~a 885 (1029)
+||||++ |+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||++ +..+.+||+|||++
T Consensus 110 lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9999997 5999998654 46899999999999999999999 6789999999999999 45566999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc---cchhh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS---LHGKI 957 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~ 957 (1029)
+....... ......+|+.|+|||++ ++.++||||+||++|||++|+.||......+. +....... ....+
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTS
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HHHHHHHhCCCchhhh
Confidence 87653322 22345689999999973 57789999999999999999999975322111 00000000 00000
Q ss_pred hhhh---hh--hh--hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 958 INVV---DI--NL--LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 958 ~~~~---d~--~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.... +. .. ..........+..++.++.+++.+|++.||++|||++|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 00 00 000000111122356778999999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=341.71 Aligned_cols=259 Identities=17% Similarity=0.259 Sum_probs=197.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCC-CCceEEEEEEEec--CCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKIISTCSS--DHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV 812 (1029)
.++|++.+.||+|+||+||+|+.. +++.||||+++... .+.+.+|++++++++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 467899999999999999999864 78999999987432 467889999999997 9999999999987 6678999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC-cEEEEccCCceecCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM-VACLSDFGISKLLGDE 891 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~ 891 (1029)
|||+++++|.+++. .+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+|||+|+.....
T Consensus 112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999874 3889999999999999999999 77899999999999999776 8999999999876543
Q ss_pred CCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.. .....+++.|+|||++ ++.++||||+||++|||++|+.||.........+.............+.++....
T Consensus 185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 32 2335689999999973 5678999999999999999999995432221111111110000011111110000
Q ss_pred h---------------hh--hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 967 Q---------------KE--DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 967 ~---------------~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. .. ......+..++..+.+++.+|++.||++|||++|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 00 00001112256789999999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=347.26 Aligned_cols=272 Identities=21% Similarity=0.262 Sum_probs=199.3
Q ss_pred CHHHHHHHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccc-----------hhhHHHHHHHHHHhcCCCCceE
Q 036879 729 SYQELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE-----------GTLRSFDAECEILGSIRHRNLV 797 (1029)
Q Consensus 729 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv 797 (1029)
...++....++|++.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 34567788899999999999999999999988899999999865322 1236789999999999999999
Q ss_pred EEEEEEec-----CCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC
Q 036879 798 KIISTCSS-----DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN 872 (1029)
Q Consensus 798 ~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~ 872 (1029)
++++++.. ....++||||++ |+|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLA 168 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEc
Confidence 99999843 346899999997 6999988877778999999999999999999999 67799999999999999
Q ss_pred CCCcEEEEccCCceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccch
Q 036879 873 ESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKS 947 (1029)
Q Consensus 873 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~ 947 (1029)
.++.+||+|||++....... ......+|+.|+|||++ ++.++||||+||++|||++|+.||......+. +..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~ 245 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ-LNK 245 (362)
T ss_dssp TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH
T ss_pred CCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 99999999999997543322 22345689999999973 56789999999999999999999976321110 000
Q ss_pred hchhccchh-----------hhhhhhhhhhh-hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 948 RVNDSLHGK-----------IINVVDINLLQ-KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 948 ~~~~~~~~~-----------~~~~~d~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+....... ..+........ ...........++..+.+++.+|++.||++|||++|++++
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000000000 00000000000 0001111223346778999999999999999999999984
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=344.22 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=202.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEe------cCCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL------SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHF 808 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 808 (1029)
..++|++.+.||+|+||.||+|++ .+++.||||.+.... ......+.+|+.++++++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 356799999999999999999984 257789999997543 3445678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC---CCcEEE
Q 036879 809 KALVLEYMPNGSLENWMYNKN------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE---SMVACL 879 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~---~~~~kl 879 (1029)
.++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999997654 34889999999999999999999 678999999999999984 456999
Q ss_pred EccCCceecCCCCC-ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhcc
Q 036879 880 SDFGISKLLGDETS-MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSL 953 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 953 (1029)
+|||++........ .......+++.|+|||++ ++.++|||||||++|||++ |+.||......+ ..
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~------- 255 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VL------- 255 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HH-------
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HH-------
Confidence 99999975433221 122335678999999973 6789999999999999998 999986531110 00
Q ss_pred chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 954 HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 954 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
+.+.... ....+..++..+.+++.+||+.||++||++.|++++++.+.....
T Consensus 256 -----~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 256 -----EFVTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp -----HHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred -----HHHhcCC------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 0000000 001122356778999999999999999999999999999886543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=336.38 Aligned_cols=247 Identities=26% Similarity=0.362 Sum_probs=202.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 456888999999999999999875 78999999997654 3446789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+++++|.+++. ...+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||.+........
T Consensus 101 ~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 101 YLGGGSALDLLE--PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp CCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred eCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 999999999984 356899999999999999999999 67899999999999999999999999999987654322
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
......|++.|+|||+. ++.++||||||+++|||++|+.||........ ... +....
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~--------~~~~~--------- 235 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--LFL--------IPKNN--------- 235 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHH--------HHHSC---------
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH--HHH--------hhcCC---------
Confidence 22345689999999984 57789999999999999999999875321110 000 00000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
....+..++..+.+++.+||+.||++|||+.|++++..
T Consensus 236 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 236 -PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp -CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred -CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 00111234567899999999999999999999998653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=370.51 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=196.5
Q ss_pred ceeccCcceEEEEEEec---CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS---DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~---~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
+.||+|+||+||+|.+. .++.||||+++.... ...+.+.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 468899999976532 335789999999999999999999999975 457899999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC--cee
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS--MTQ 896 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~ 896 (1029)
|+|.+++.. ...+++..+..++.||+.||+||| ++|||||||||+||+++.++.+||+|||+|+.+..... ...
T Consensus 454 g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 999999954 456899999999999999999999 67799999999999999999999999999987654322 122
Q ss_pred ccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
....+|+.|+|||+ .++.++|||||||++|||++ |+.||......+. ...+... .
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--------------~~~i~~~------~ 589 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--------------TAMLEKG------E 589 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------------HHHHHTT------C
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcC------C
Confidence 33456789999998 36789999999999999998 9999976321110 0111100 0
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
....+..++.++.++|..||+.||++||+++++++.|+++..++
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11122346788999999999999999999999999999988765
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.58 Aligned_cols=248 Identities=26% Similarity=0.354 Sum_probs=198.1
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
..++|++.+.||+|+||.||+|+.. +|+.||+|.+.... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4678999999999999999999876 68999999987543 34678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+++++|.+++......+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||.+........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 99999999999766778999999999999999999999 67899999999999999999999999999987644322
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
......|++.|+|||.+ ++.++||||||+++|||++|+.||......... .. .. ....
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------~~-~~----~~~~ 242 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI-------------FM-IP----TNPP 242 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------------HH-HH----HSCC
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-------------HH-Hh----cCCC
Confidence 22345689999999983 578999999999999999999999753211100 00 00 0000
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....+..++..+.+++.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 243 PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0001122346778999999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=344.58 Aligned_cols=264 Identities=23% Similarity=0.307 Sum_probs=196.9
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467889999999999999999976 689999999865532 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++++|.++.. ....+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 104 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp ECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999988888764 4556999999999999999999999 77899999999999999999999999999986644322
Q ss_pred ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh--ccchhhhhh------
Q 036879 894 MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND--SLHGKIINV------ 960 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~------ 960 (1029)
......|++.|+|||++ ++.++||||+||++|||++|+.||......+. +...... .........
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhccc
Confidence 22345689999999973 56789999999999999999999976422111 0000000 000000000
Q ss_pred ----hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 961 ----VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 961 ----~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...... ...........++..+.+++.+||+.||++|||++|++++
T Consensus 258 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIK-EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCS-SCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCcccc-ccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 0000111122457789999999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=346.68 Aligned_cols=268 Identities=23% Similarity=0.285 Sum_probs=196.8
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-----hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCe
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-----GTLRSFDAECEILGSIRHRNLVKIISTCSSDHF 808 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 808 (1029)
...++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++++.++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34678999999999999999999975 689999999875422 123568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.++||||+++ +|.+++......+++..+..++.|+++||+||| +.||+||||||+||+++.++.+||+|||+++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999975 899998777777899999999999999999999 677999999999999999999999999999876
Q ss_pred CCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc---cchhhhhh
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS---LHGKIINV 960 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 960 (1029)
..... ......+|+.|+|||++ ++.++||||+||++|||++|.+||......+. +....... ....+.+.
T Consensus 163 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 163 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSST
T ss_pred cCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHcCCCChhhhhhh
Confidence 43322 23345689999999974 45689999999999999999999875321111 11000000 00000000
Q ss_pred ---hhhhhhhh--hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 961 ---VDINLLQK--EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 961 ---~d~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.+...... ..+.......++..+.+++.+|++.||++|||++|++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00000000 0000111123467899999999999999999999999853
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=340.31 Aligned_cols=247 Identities=26% Similarity=0.349 Sum_probs=193.9
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--------chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--------EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH 807 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 807 (1029)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467999999999999999999875 68999999987542 122345889999999999999999999997665
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc---EEEEccCC
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV---ACLSDFGI 884 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~---~kl~Dfg~ 884 (1029)
.++||||+++++|.+++. ....+++..+..++.|++.||+||| +.||+||||||+||+++.++. +||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 799999999999999885 4557899999999999999999999 678999999999999987654 99999999
Q ss_pred ceecCCCCCceeccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhh
Q 036879 885 SKLLGDETSMTQTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKI 957 (1029)
Q Consensus 885 a~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 957 (1029)
+....... ......||+.|+|||++ ++.++|||||||++|||++|+.||........ +...+..
T Consensus 164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~------ 234 (322)
T 2ycf_A 164 SKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITS------ 234 (322)
T ss_dssp CEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHHHH------
T ss_pred ceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHHHh------
Confidence 98765432 12235689999999973 56789999999999999999999975322111 1110000
Q ss_pred hhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 036879 958 INVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 958 ~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1006 (1029)
............++..+.+++.+||+.||++|||+.|+++
T Consensus 235 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 ---------GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---------CccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0000001112335678899999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=333.37 Aligned_cols=245 Identities=25% Similarity=0.389 Sum_probs=192.8
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3467999999999999999999986 79999999997543 2235678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++++|.+++... ..+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||.+......
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999998654 45899999999999999999999 667999999999999999999999999999876443
Q ss_pred CCceeccccCCccccCccCCC-----CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~~-----~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.. .....+++.|+|||... +.++||||+|+++|||++|+.||....... .. ..+....
T Consensus 165 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~---------~~~~~~~- 227 (276)
T 2h6d_A 165 EF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-----LF---------KKIRGGV- 227 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH---------HHHHHCC-
T ss_pred cc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-----HH---------HHhhcCc-
Confidence 22 22346899999999853 457999999999999999999996531110 00 0000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+..++..+.+++.+|++.||++|||++|++++
T Consensus 228 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 ------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00112345678999999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=353.90 Aligned_cols=245 Identities=17% Similarity=0.219 Sum_probs=189.1
Q ss_pred hCCCCCCceeccCcceEEEEEEe-cCCcEEEEEEeecc---cchhhHHHHHHHH---HHhcCCCCceEEEE-------EE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLE---LEGTLRSFDAECE---ILGSIRHRNLVKII-------ST 802 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~ 802 (1029)
.++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|++ ++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999996 47999999999743 2345678899994 55556899999998 66
Q ss_pred EecCC-----------------eEEEEEeccCCCCHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 036879 803 CSSDH-----------------FKALVLEYMPNGSLENWMYNKNR------SFDILQRLNMVIDVASALEYLHYDHPTPI 859 (1029)
Q Consensus 803 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~Lh~~~~~gi 859 (1029)
+...+ ..++||||+ +|+|.+++..... .+++..+..++.||+.||+||| +.||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 65553 278999999 6899999965322 2335788889999999999999 6789
Q ss_pred EEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccCCccccCccCC---------------CCCCcchhHHHHH
Q 036879 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK---------------LSRKGDVYSYGII 924 (1029)
Q Consensus 860 vH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~---------------~~~~~DvwSlGvi 924 (1029)
+||||||+||+++.++.+||+|||+|+.... ......| +.|+|||++ ++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2233457 999999983 5678999999999
Q ss_pred HHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHH
Q 036879 925 LMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEA 1004 (1029)
Q Consensus 925 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev 1004 (1029)
+|||++|+.||........ ...+ . .. ...++..+.+++.+||+.||++|||+.|+
T Consensus 303 l~elltg~~Pf~~~~~~~~--~~~~-----------~-----~~-------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG--SEWI-----------F-----RS-------CKNIPQPVRALLEGFLRYPKEDRLLPLQA 357 (377)
T ss_dssp HHHHHHSSCCC------CC--SGGG-----------G-----SS-------CCCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred HHHHHHCCCCCcccccccc--hhhh-----------h-----hh-------ccCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 9999999999965321111 0000 0 00 01235678999999999999999999999
Q ss_pred HH--HHHHhHHhh
Q 036879 1005 LT--KLLKIRNTL 1015 (1029)
Q Consensus 1005 l~--~L~~i~~~~ 1015 (1029)
++ .++.+.+..
T Consensus 358 l~hp~f~~~~~~~ 370 (377)
T 3byv_A 358 METPEYEQLRTEL 370 (377)
T ss_dssp HTSHHHHHHHHHH
T ss_pred hhChHHHHHHHHH
Confidence 97 555555443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.28 Aligned_cols=240 Identities=19% Similarity=0.263 Sum_probs=195.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467899999999999999999986 79999999998643 33456788999999999 999999999999999999999
Q ss_pred EeccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC----------------
Q 036879 813 LEYMPNGSLENWMYNK---NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE---------------- 873 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~---------------- 873 (1029)
|||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999654 256899999999999999999999 678999999999999984
Q ss_pred ---CCcEEEEccCCceecCCCCCceeccccCCccccCccCCC-----CCCcchhHHHHHHHHHhcCCCCCCccccccccc
Q 036879 874 ---SMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL-----SRKGDVYSYGIILMETFTKKKPTDELFVGEISL 945 (1029)
Q Consensus 874 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 945 (1029)
...+||+|||.+....... ...||+.|+|||++. +.++|||||||++|||++|++|+..... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~ 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----W 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----H
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----H
Confidence 4489999999998765432 234899999999843 3489999999999999999987643210 0
Q ss_pred chhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 946 KSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 946 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. ....... ...+..++..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~------------~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 238 H------------EIRQGRL-------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp H------------HHHTTCC-------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred H------------HHHcCCC-------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0 0000000 01112346778999999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=336.55 Aligned_cols=248 Identities=25% Similarity=0.311 Sum_probs=186.0
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc--hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE--GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
..++|++.+.||+|+||+||+|+.. +|+.||+|+++.... ...+.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3567899999999999999999974 799999999976532 2233455566668889999999999999999999999
Q ss_pred EeccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 813 LEYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDHPT-PIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
|||++ |+|.+++.. ....+++..+..++.|++.|++||| ++ ||+||||||+||+++.++.+||+|||++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 588777654 4667999999999999999999999 55 7999999999999999999999999999876
Q ss_pred CCCCCceeccccCCccccCccCC--------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhh
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK--------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~--------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1029)
..... .....||+.|+|||++ ++.++||||+||++|||++|+.||.........+.. .
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------~ 226 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ------------V 226 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH------------H
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH------------H
Confidence 44322 2234689999999984 456899999999999999999999753211111111 1
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 961 ~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
........ ....++..+.+++.+||+.||++|||+.|++++
T Consensus 227 ~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 227 VEEPSPQL------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHSCCCCC------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hccCCCCc------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 11000000 012346678999999999999999999999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=338.87 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=194.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec--CCc--EEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS--DGM--QIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~--~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
.++|++.+.||+|+||+||+|++. +++ .||||+++... ....+.+.+|++++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457889999999999999999853 333 68999987542 344678899999999999999999999998765 7
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++++|.+++......+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 8999999999999999876677999999999999999999999 6789999999999999999999999999998775
Q ss_pred CCCCc--eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhh
Q 036879 890 DETSM--TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962 (1029)
Q Consensus 890 ~~~~~--~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 962 (1029)
..... ......+++.|+|||.. ++.++||||||+++|||++ |+.||......+. .. ....
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~--------~~~~ 239 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LH--------KIDK 239 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HH--------HHHT
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH-----HH--------HHHc
Confidence 43322 12234578889999984 5678999999999999999 9999975321110 00 0000
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
. ......+..++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 240 ~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 240 E------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp S------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred c------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0 00011122456789999999999999999999999999988764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.54 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=200.8
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---------chhhHHHHHHHHHHhcCC-CCceEEEEEEEe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---------EGTLRSFDAECEILGSIR-HRNLVKIISTCS 804 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 804 (1029)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999976 78999999997543 122456889999999995 999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCC
Q 036879 805 SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGI 884 (1029)
Q Consensus 805 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~ 884 (1029)
..+..++||||+++++|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999999865 356899999999999999999999 77899999999999999999999999999
Q ss_pred ceecCCCCCceeccccCCccccCccCC----------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccc
Q 036879 885 SKLLGDETSMTQTQTLATIGYMAPEWK----------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLH 954 (1029)
Q Consensus 885 a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 954 (1029)
+........ .....+++.|+|||++ ++.++||||||+++|||++|+.||....... ...
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~------- 239 (298)
T 1phk_A 171 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--MLR------- 239 (298)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH-------
T ss_pred hhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--HHH-------
Confidence 987654322 2335689999999973 5678999999999999999999986531110 000
Q ss_pred hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 955 GKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 955 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....... ....+....++..+.+++.+||+.||++|||+.|++++
T Consensus 240 ----~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 240 ----MIMSGNY----QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp ----HHHHTCC----CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ----HHhcCCc----ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 0000000 00001112356779999999999999999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=369.56 Aligned_cols=256 Identities=21% Similarity=0.364 Sum_probs=203.6
Q ss_pred HhCCCCCCceeccCcceEEEEEEec----CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
..++|++.+.||+|+||.||+|++. .+..||||.++... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 3467889999999999999999874 25679999987543 3345679999999999999999999999854 5679
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 999999999999999877778999999999999999999999 67899999999999999999999999999987655
Q ss_pred CCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
..........+|+.|+|||++ ++.++|||||||++|||++ |+.||.+....+. .. .....
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~~-----------~i~~~-- 608 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IG-----------RIENG-- 608 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH-----------HHHHT--
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH--HH-----------HHHcC--
Confidence 443333445678899999983 6778999999999999997 9999875321110 00 00000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
.....+..++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 609 -----~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 609 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 001112345678999999999999999999999999999987643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=341.81 Aligned_cols=257 Identities=20% Similarity=0.266 Sum_probs=200.5
Q ss_pred CHHHHHHHhCCCCCC-ceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcC-CCCceEEEEEEE
Q 036879 729 SYQELFRATDGFSEN-NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSI-RHRNLVKIISTC 803 (1029)
Q Consensus 729 ~~~~~~~~~~~~~~~-~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 803 (1029)
.+.......++|.+. +.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 334444556677777 88999999999999876 69999999997653 23356789999999999 569999999999
Q ss_pred ecCCeEEEEEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC---CCcEEE
Q 036879 804 SSDHFKALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE---SMVACL 879 (1029)
Q Consensus 804 ~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~---~~~~kl 879 (1029)
...+..++||||+++|+|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEE
Confidence 9999999999999999999988543 457999999999999999999999 778999999999999997 789999
Q ss_pred EccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccch
Q 036879 880 SDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG 955 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 955 (1029)
+|||+++....... .....||+.|+|||++ ++.++||||+||++|||++|+.||......+.. .
T Consensus 176 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~--------- 243 (327)
T 3lm5_A 176 VDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY-L--------- 243 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-H---------
T ss_pred eeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-H---------
Confidence 99999987654322 2335699999999984 577899999999999999999999653211110 0
Q ss_pred hhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 KIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...... ..........++..+.+++.+||+.||++|||++|++++
T Consensus 244 ---~i~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 244 ---NISQVN----VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ---HHHHTC----CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ---HHHhcc----cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000000 000011112346678999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=338.13 Aligned_cols=264 Identities=20% Similarity=0.274 Sum_probs=193.0
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEe-----------
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS----------- 804 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 804 (1029)
.++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467899999999999999999986 58999999998776666788999999999999999999999873
Q ss_pred ---cCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC-CCCcEEEE
Q 036879 805 ---SDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN-ESMVACLS 880 (1029)
Q Consensus 805 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~-~~~~~kl~ 880 (1029)
+....++||||++ |+|.+++. ...+++..+..++.|++.||+||| +.||+||||||+||+++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 69999884 356899999999999999999999 67899999999999997 67799999
Q ss_pred ccCCceecCCCCC--ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc-
Q 036879 881 DFGISKLLGDETS--MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS- 952 (1029)
Q Consensus 881 Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~- 952 (1029)
|||+++....... .......++..|+|||.. ++.++|||||||++|||++|+.||......+. ........
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~ 242 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLILESIP 242 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHSC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence 9999986643211 112334578999999963 56689999999999999999999976322111 00000000
Q ss_pred --cchhhhhh-------hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 953 --LHGKIINV-------VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 953 --~~~~~~~~-------~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..+...+. ..................++.++.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00000000 00000000001111123457789999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=345.99 Aligned_cols=261 Identities=22% Similarity=0.278 Sum_probs=181.2
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC------
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD------ 806 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 806 (1029)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3578999999999999999999865 78999999987542 33456788999999999999999999998654
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 807 HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
...++||||+ +++|.+++.. ..+++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||+++
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred CeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 5679999999 7899998854 56999999999999999999999 7789999999999999999999999999998
Q ss_pred ecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch-----------
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN----------- 950 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~----------- 950 (1029)
..... .....||+.|+|||++ ++.++||||+||++|||++|+.||.+....+. +.....
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLK 255 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHT
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence 65432 2335789999999973 57789999999999999999999976321110 000000
Q ss_pred hccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 951 DSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 951 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..........+..................+..+.+++.+|+..||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000000000000000011112345678999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=337.33 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=198.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEe--cCCeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCS--SDHFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 811 (1029)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467889999999999999999876 78999999997643 334567899999999999999999999874 4678899
Q ss_pred EEeccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----cEEcCCCCCCEEECCCCcEEEEccC
Q 036879 812 VLEYMPNGSLENWMYNK---NRSFDILQRLNMVIDVASALEYLHYDHPTP-----IIHCDLNPSNILLNESMVACLSDFG 883 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~g-----ivH~Dlk~~Nill~~~~~~kl~Dfg 883 (1029)
||||+++++|.+++... ...+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998653 345899999999999999999999 555 9999999999999999999999999
Q ss_pred CceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhh
Q 036879 884 ISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959 (1029)
Q Consensus 884 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1029)
.+........ ......|++.|+|||.. ++.++||||||+++|||++|+.||......+ ... .
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~--------~--- 227 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAG--------K--- 227 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH--------H---
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HHH--------H---
Confidence 9986644322 12234689999999984 5678999999999999999999997532110 000 0
Q ss_pred hhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 960 VVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 960 ~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
...... ...+..++..+.+++.+||+.||++|||+.|+++++.
T Consensus 228 i~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 228 IREGKF-------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHTCC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred Hhhccc-------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 000000 0112235677999999999999999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=338.25 Aligned_cols=260 Identities=23% Similarity=0.309 Sum_probs=183.8
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
....++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999865 78999999987543 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCC
Q 036879 812 VLEYMPNGSLENWMYN-------KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGI 884 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~ 884 (1029)
||||+++++|.+++.. ....+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999864 3456899999999999999999999 67899999999999999999999999999
Q ss_pred ceecCCCCC----ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccch
Q 036879 885 SKLLGDETS----MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG 955 (1029)
Q Consensus 885 a~~~~~~~~----~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 955 (1029)
+........ .......||+.|+|||+. ++.++|||||||++|||++|+.||........... ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~ 242 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----TLQN 242 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-----HHTS
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-----Hhcc
Confidence 876543211 112234689999999973 68899999999999999999999976322111000 0000
Q ss_pred hhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 KIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.... . ............++..+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~-----~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPS-----L-ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCC-----T-TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCc-----c-ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000 0 00000000112245678999999999999999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=341.85 Aligned_cols=265 Identities=20% Similarity=0.278 Sum_probs=199.6
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecC-----Ce
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSD-----HF 808 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 808 (1029)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999876 78899999997543 33456789999999999999999999999654 46
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.++||||++ ++|.+++.. ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++...
T Consensus 105 ~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 899999996 599998854 45899999999999999999999 778999999999999999999999999999876
Q ss_pred CCCCCce--eccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhhh
Q 036879 889 GDETSMT--QTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKII 958 (1029)
Q Consensus 889 ~~~~~~~--~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~ 958 (1029)
....... .....||+.|+|||++ ++.++||||+||++|||++|+.||......+. +..... ....+.+.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLN 257 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHHHCSCCHHHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHHhCCCCHHHHH
Confidence 5332211 2335799999999973 67889999999999999999999976322111 111000 00000000
Q ss_pred hhhh--------hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 959 NVVD--------INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 959 ~~~d--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+ ................++..+.+++.+|++.||++|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000000111112346778999999999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=343.75 Aligned_cols=262 Identities=21% Similarity=0.260 Sum_probs=200.8
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchh-----------------hHHHHHHHHHHhcCCCCceEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGT-----------------LRSFDAECEILGSIRHRNLVKI 799 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 799 (1029)
.++|++.+.||+|+||.||+|+. +|+.||||.+....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 99999999997543221 1789999999999999999999
Q ss_pred EEEEecCCeEEEEEeccCCCCHHHH------HhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCEEE
Q 036879 800 ISTCSSDHFKALVLEYMPNGSLENW------MYNK-NRSFDILQRLNMVIDVASALEYLHYDHP-TPIIHCDLNPSNILL 871 (1029)
Q Consensus 800 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~givH~Dlk~~Nill 871 (1029)
++++.+.+..++||||+++++|.++ +... ...+++..+..++.|++.|++||| + .||+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence 9999999999999999999999998 5432 567999999999999999999999 5 789999999999999
Q ss_pred CCCCcEEEEccCCceecCCCCCceeccccCCccccCccCCCCC------CcchhHHHHHHHHHhcCCCCCCccccccccc
Q 036879 872 NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLSR------KGDVYSYGIILMETFTKKKPTDELFVGEISL 945 (1029)
Q Consensus 872 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 945 (1029)
+.++.+||+|||.+...... ......|++.|+|||+..+. ++||||+||++|||++|+.||........ .
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~ 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE-L 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-H
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-H
Confidence 99999999999999876443 33445789999999985432 79999999999999999999975422111 1
Q ss_pred chhchhccchhhhhhhhhhhhh-hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 946 KSRVNDSLHGKIINVVDINLLQ-KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 946 ~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+..... .+.......... ...........++..+.+++.+||+.||++|||++|++++
T Consensus 262 ~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110000000 000000000000 0000011113456789999999999999999999999973
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=342.57 Aligned_cols=269 Identities=23% Similarity=0.309 Sum_probs=196.8
Q ss_pred HHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEec-------
Q 036879 734 FRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS------- 805 (1029)
Q Consensus 734 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 805 (1029)
....++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999874 79999999987543 223479999999999999999999843
Q ss_pred -------------------------------CCeEEEEEeccCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHH
Q 036879 806 -------------------------------DHFKALVLEYMPNGSLENWMY---NKNRSFDILQRLNMVIDVASALEYL 851 (1029)
Q Consensus 806 -------------------------------~~~~~lV~E~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~L 851 (1029)
....++||||++ |+|.+++. .....+++..+..++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334789999997 58777765 3456799999999999999999999
Q ss_pred HhcCCCCcEEcCCCCCCEEEC-CCCcEEEEccCCceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHH
Q 036879 852 HYDHPTPIIHCDLNPSNILLN-ESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIIL 925 (1029)
Q Consensus 852 h~~~~~givH~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil 925 (1029)
| +.||+||||||+||+++ .++.+||+|||+|+....... .....+|+.|+|||++ ++.++||||+||++
T Consensus 158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9 88899999999999998 689999999999987654332 2345689999999973 57789999999999
Q ss_pred HHHhcCCCCCCcccccccccchhchh---ccchhhhhhh----hhhh--hhhhhhhhHHHHHHHHHHHHHHHHccccccc
Q 036879 926 METFTKKKPTDELFVGEISLKSRVND---SLHGKIINVV----DINL--LQKEDAYLTAKEQCVSSVLSLAMQCTRESAE 996 (1029)
Q Consensus 926 ~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~----d~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 996 (1029)
|||++|+.||.+....+. +...+.. ...+.+..+. +... ..........+..++..+.+++.+||+.||+
T Consensus 233 ~ell~g~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999976322111 1111100 0000000000 0000 0000001112233567799999999999999
Q ss_pred CCCCHHHHHHH--HHHhHH
Q 036879 997 ERINIKEALTK--LLKIRN 1013 (1029)
Q Consensus 997 ~Rpt~~evl~~--L~~i~~ 1013 (1029)
+|||+.|++++ ++.+++
T Consensus 312 ~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GSCCHHHHHTSGGGHHHHH
T ss_pred hCCCHHHHhcCHHHHHHHh
Confidence 99999999963 455544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=333.93 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=195.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc----chhhHHHHHHHHHHhcCCCCceEEEEEEE--ecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL----EGTLRSFDAECEILGSIRHRNLVKIISTC--SSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~ 809 (1029)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 578999999999999999999975 78999999997643 23456799999999999999999999998 445678
Q ss_pred EEEEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 810 ALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
++||||++++ +.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 77776543 457999999999999999999999 678999999999999999999999999999876
Q ss_pred CCC-CCceeccccCCccccCccCCC------CCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhh
Q 036879 889 GDE-TSMTQTQTLATIGYMAPEWKL------SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 889 ~~~-~~~~~~~~~gt~~y~aPE~~~------~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
... .........|++.|+|||+.. +.++||||+||++|||++|+.||...... ... ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~---------~~i 225 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-----KLF---------ENI 225 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHH---------HHH
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-----HHH---------HHH
Confidence 432 222233456899999999842 45799999999999999999999753110 000 000
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
... ....+..++..+.+++.+||+.||++|||++|++++-
T Consensus 226 ~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 226 GKG-------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp HHC-------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred hcC-------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 000 0011223566789999999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=350.15 Aligned_cols=258 Identities=12% Similarity=0.101 Sum_probs=182.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHHHhcC--CCCceEEEE-------EEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEILGSI--RHRNLVKII-------STC 803 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 803 (1029)
...|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|+++++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999975 789999999987542 3355677885544444 699988855 444
Q ss_pred ecC-----------------CeEEEEEeccCCCCHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCcE
Q 036879 804 SSD-----------------HFKALVLEYMPNGSLENWMYNKNRSFDILQR------LNMVIDVASALEYLHYDHPTPII 860 (1029)
Q Consensus 804 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~Lh~~~~~giv 860 (1029)
... ...++||||++ |+|.+++......+++..+ ..++.||+.||+||| ++||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence 332 33799999998 8999999765555555666 778899999999999 77899
Q ss_pred EcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCC
Q 036879 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKP 934 (1029)
Q Consensus 861 H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p 934 (1029)
||||||+||+++.++.+||+|||+|+..... .....+|+.|+|||++ ++.++|||||||++|||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876432 1134577999999984 46689999999999999999999
Q ss_pred CCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHH--HHHHhH
Q 036879 935 TDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT--KLLKIR 1012 (1029)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~--~L~~i~ 1012 (1029)
|.................. ... ..........++..+.+++.+||+.||++|||+.|+++ .++++.
T Consensus 293 f~~~~~~~~~~~~~~~~~~------~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRV------PGT------DSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTS------CCC------CSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCCcCcccccchhhhhhhh------ccc------cccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 9875332211111000000 000 00000011234677899999999999999999999986 344444
Q ss_pred Hh
Q 036879 1013 NT 1014 (1029)
Q Consensus 1013 ~~ 1014 (1029)
..
T Consensus 361 ~~ 362 (371)
T 3q60_A 361 NE 362 (371)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=342.82 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=196.3
Q ss_pred HHHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEec----
Q 036879 732 ELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSS---- 805 (1029)
Q Consensus 732 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 805 (1029)
++....++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 33446788999999999999999999975 78999999987543 3446788999999999 89999999999976
Q ss_pred --CCeEEEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEcc
Q 036879 806 --DHFKALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDF 882 (1029)
Q Consensus 806 --~~~~~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Df 882 (1029)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 467899999999999999997643 56899999999999999999999 678999999999999999999999999
Q ss_pred CCceecCCCCCceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc
Q 036879 883 GISKLLGDETSMTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL 953 (1029)
Q Consensus 883 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 953 (1029)
|++........ ......|++.|+|||++ ++.++|||||||++|||++|+.||........ ...
T Consensus 174 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~-- 245 (326)
T 2x7f_A 174 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFL-- 245 (326)
T ss_dssp TTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHH--
T ss_pred cCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-----HHH--
Confidence 99986643221 22335689999999974 46789999999999999999999965321100 000
Q ss_pred chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 954 HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 954 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
+........ ....++..+.+++.+||..||++|||++|++++
T Consensus 246 ---~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 246 ---IPRNPAPRL---------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ---HHHSCCCCC---------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---hhcCccccC---------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 012245678999999999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=339.80 Aligned_cols=262 Identities=19% Similarity=0.225 Sum_probs=189.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC------
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH------ 807 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 807 (1029)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467999999999999999999875 78999999997642 334567889999999999999999999997654
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
..++||||++ ++|.+++. ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+|+.
T Consensus 104 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999996 57888874 34889999999999999999999 67899999999999999999999999999986
Q ss_pred cCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh----------cc
Q 036879 888 LGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND----------SL 953 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----------~~ 953 (1029)
..... ......||+.|+|||++ ++.++||||+||++|||++|+.||.+....+. +...+.. ..
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHHTTS
T ss_pred ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHh
Confidence 64322 22345789999999984 67899999999999999999999976322110 0000000 00
Q ss_pred chhhhhhhhhhh-----------hhh-hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 954 HGKIINVVDINL-----------LQK-EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 954 ~~~~~~~~d~~~-----------~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
...+........ ... ...........+..+.+++.+|+..||++|||++|++++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000000000000 000 0000112234577899999999999999999999999853
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=369.03 Aligned_cols=246 Identities=20% Similarity=0.272 Sum_probs=200.7
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeE
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 809 (1029)
...++|++.+.||+|+||+||+|+.. +++.||||++++.. ....+.+..|.+++..+ +||+|+++++++++.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 35678999999999999999999976 68899999998642 33456788899999988 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
|+||||+++|+|.+++... ..+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+...
T Consensus 418 ~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999999654 46999999999999999999999 7789999999999999999999999999998643
Q ss_pred CCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
.... ......||+.|+|||++ ++.++|||||||++|||++|+.||......+. . ..+....
T Consensus 494 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~-----~--------~~i~~~~- 558 (674)
T 3pfq_A 494 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----F--------QSIMEHN- 558 (674)
T ss_dssp CTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----H--------HHHHSSC-
T ss_pred cCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH-----H--------HHHHhCC-
Confidence 3322 23346799999999984 67899999999999999999999976321110 0 0011000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCH-----HHHHH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINI-----KEALT 1006 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~evl~ 1006 (1029)
...+...+.++.+++.+||+.||++||++ +|+++
T Consensus 559 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11123456789999999999999999987 77765
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=348.42 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=200.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999976 78999999998653 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+++++|.+++... ..+++..+..++.|++.|++|||+. .||+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 99999999998653 4689999999999999999999942 27999999999999999999999999999755321
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccc----------------
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLH---------------- 954 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---------------- 954 (1029)
......||+.|+|||++ ++.++||||+||++|||++|+.||......+... .......
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL--MFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHH--HHC--------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HhcccccccCCCCCCCcccCCCc
Confidence 12235689999999984 5668999999999999999999997532221100 0000000
Q ss_pred -----------hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 955 -----------GKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 955 -----------~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
....+..+....... .......++.++.+++.+||+.||++|||++|++++-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred ccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 000011111000000 0000112466799999999999999999999999853
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=346.33 Aligned_cols=262 Identities=19% Similarity=0.232 Sum_probs=196.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCC--------CCceEEEEEEEe---
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIR--------HRNLVKIISTCS--- 804 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 804 (1029)
.++|++.+.||+|+||+||+|+.. +++.||||+++.. ....+.+.+|++++++++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999865 7899999999754 334567889999999985 788999999987
Q ss_pred -cCCeEEEEEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCEEECCCC------
Q 036879 805 -SDHFKALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPT-PIIHCDLNPSNILLNESM------ 875 (1029)
Q Consensus 805 -~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-givH~Dlk~~Nill~~~~------ 875 (1029)
.....++||||+ ++++.+++... ...+++..+..++.||+.||+||| ++ ||+||||||+||+++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence 566789999999 56666666544 467999999999999999999999 66 899999999999999775
Q ss_pred -------------------------------------------cEEEEccCCceecCCCCCceeccccCCccccCccCC-
Q 036879 876 -------------------------------------------VACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK- 911 (1029)
Q Consensus 876 -------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~- 911 (1029)
.+||+|||.|...... .....||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 8999999999876432 2335689999999984
Q ss_pred ---CCCCcchhHHHHHHHHHhcCCCCCCcccccccccc----hhchhccchhhhhhh----------h------------
Q 036879 912 ---LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLK----SRVNDSLHGKIINVV----------D------------ 962 (1029)
Q Consensus 912 ---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~----------d------------ 962 (1029)
++.++|||||||++|||++|+.||........... ..............+ .
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 67899999999999999999999975332211000 000000000000000 0
Q ss_pred -hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 963 -INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 963 -~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.............+...+..+.+++.+||+.||++|||++|++++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000000000111234567889999999999999999999999874
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=334.98 Aligned_cols=270 Identities=21% Similarity=0.307 Sum_probs=192.1
Q ss_pred CchhHHHHHHHHHHhccCCCCCcccCCC----CCCCCCCceeeEEEcC--------CCCceEEEecccccccccCCccCC
Q 036879 2 NVGRDQSALLALKAHVTNDPLNVLASNW----STNTSVCNWFGVTCSP--------RHRRVTALNLAYMGLLGTIPPELG 69 (1029)
Q Consensus 2 ~~~~~~~al~~~~~~~~~~~~~~~~~~w----~~~~~~c~w~gv~c~~--------~~~~v~~l~l~~~~l~~~~p~~~~ 69 (1029)
.+..|++||++||+++..||.+++++ | ....++|.|.||+|.. ...+|+.|+|+++++. .+|+.++
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~-w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~ 101 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSA-WRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHH-HHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhh-hcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence 56789999999999998889999988 8 5678899999999952 3467888899888887 8888888
Q ss_pred CCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccC------
Q 036879 70 NLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICN------ 143 (1029)
Q Consensus 70 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------ 143 (1029)
++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++.+++|++|+|++|++.+.+|..++.
T Consensus 102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~--~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR--ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC--CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc--cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 8888888888888888 88888888888888888888888 56888888888888888888888788877654
Q ss_pred ---ccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCc
Q 036879 144 ---ISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPS 220 (1029)
Q Consensus 144 ---l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~ 220 (1029)
+++|++|+|++|+++ .+|..+.++++|++|++++|++++ +|.
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~----------------------------------l~~ 223 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA----------------------------------LGP 223 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC----------------------------------CCG
T ss_pred hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc----------------------------------Cch
Confidence 667777777777776 666666666666666666665542 233
Q ss_pred ccccccccceEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccC
Q 036879 221 TLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTA 300 (1029)
Q Consensus 221 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 300 (1029)
.+..+++|++|+|++|++.+.+|..|+++++|+ +|+|++|.+.+.+|..+.++++|++|+|++
T Consensus 224 ~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~-----------------~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~ 286 (328)
T 4fcg_A 224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK-----------------RLILKDCSNLLTLPLDIHRLTQLEKLDLRG 286 (328)
T ss_dssp GGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC-----------------EEECTTCTTCCBCCTTGGGCTTCCEEECTT
T ss_pred hhccCCCCCEEECcCCcchhhhHHHhcCCCCCC-----------------EEECCCCCchhhcchhhhcCCCCCEEeCCC
Confidence 455555566666666665555555555444333 444555555555555555555555555555
Q ss_pred cccCCCCCchhhhcccccceEeecCcccC
Q 036879 301 NNLLGNLPSNIGHSLPNLQQLILGGNRLT 329 (1029)
Q Consensus 301 N~l~~~lp~~~~~~l~~L~~L~L~~N~l~ 329 (1029)
|++.+.+|..+.. +++|+.+++..|.+.
T Consensus 287 n~~~~~iP~~l~~-L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 287 CVNLSRLPSLIAQ-LPANCIILVPPHLQA 314 (328)
T ss_dssp CTTCCCCCGGGGG-SCTTCEEECCGGGSC
T ss_pred CCchhhccHHHhh-ccCceEEeCCHHHHH
Confidence 5555555555542 555555555554443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=331.83 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=189.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEec----------
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS---------- 805 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 805 (1029)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457899999999999999999975 7999999999654 3445778999999999999999999998854
Q ss_pred ---CCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEcc
Q 036879 806 ---DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDF 882 (1029)
Q Consensus 806 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Df 882 (1029)
....++||||+++++|.+++......+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 45678999999999999999877777889999999999999999999 677999999999999999999999999
Q ss_pred CCceecCCCC-------------CceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccc
Q 036879 883 GISKLLGDET-------------SMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEIS 944 (1029)
Q Consensus 883 g~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~ 944 (1029)
|.+....... ........|++.|+|||++ ++.++||||+||++|||++ ||........
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~- 236 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN- 236 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH-
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH-
Confidence 9998654321 1112335689999999973 5678999999999999998 5532111000
Q ss_pred cchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 945 LKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 945 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
... .+.. ..... ....+..++..+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~--------~~~~-~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 ILK--------KLRS-VSIEF------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHH--------HHHS-TTCCC------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHH--------hccc-ccccc------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 000 0000 00000 001112345668999999999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=338.67 Aligned_cols=265 Identities=23% Similarity=0.249 Sum_probs=197.2
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecC-----Ce
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSD-----HF 808 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 808 (1029)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3568999999999999999999976 78999999997543 33456788999999999999999999988654 67
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.++||||++ ++|.+++.. ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++...
T Consensus 89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 899999996 699998865 46899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCc---------eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch----
Q 036879 889 GDETSM---------TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---- 950 (1029)
Q Consensus 889 ~~~~~~---------~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---- 950 (1029)
...... ......||+.|+|||++ ++.++||||+||++|||++|+.||........ +.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~ 241 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFGIIGT 241 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCC
Confidence 532211 11224689999999963 56689999999999999999999976321110 000000
Q ss_pred --------hccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 951 --------DSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 951 --------~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
........+...................++.++.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000000000000011122457788999999999999999999999984
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=346.93 Aligned_cols=193 Identities=25% Similarity=0.322 Sum_probs=167.0
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcC------CCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSI------RHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 809 (1029)
..+|++.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|+++++.+ .|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 567999999999999999999876 6899999999754 23346677888888777 577999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc--EEEEccCCce
Q 036879 810 ALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV--ACLSDFGISK 886 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~--~kl~Dfg~a~ 886 (1029)
++||||+. ++|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++. +||+|||+|.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999995 69999887654 45999999999999999999999 667999999999999999887 9999999997
Q ss_pred ecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcc
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDEL 938 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~ 938 (1029)
..... .....||+.|+|||++ ++.++|||||||++|||++|++||...
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 65432 2235689999999983 688999999999999999999999764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=340.59 Aligned_cols=259 Identities=20% Similarity=0.283 Sum_probs=193.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE----
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFK---- 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 809 (1029)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467889999999999999999875 79999999997643 33356788999999999999999999999876654
Q ss_pred --EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 810 --ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 810 --~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
++||||++ ++|.+++ ...+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999996 6888876 344899999999999999999999 67899999999999999999999999999986
Q ss_pred cCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch-----------h
Q 036879 888 LGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN-----------D 951 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-----------~ 951 (1029)
.... .....||+.|+|||++ ++.++||||+||++|||++|+.||......+. +..... .
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHTT
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCcHHHHHH
Confidence 5432 2335689999999973 57789999999999999999999976321111 000000 0
Q ss_pred ccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 952 SLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 952 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...........................++..+.+++.+|++.||++|||++|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000000000000000111122346789999999999999999999999975
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=336.43 Aligned_cols=335 Identities=19% Similarity=0.216 Sum_probs=230.3
Q ss_pred CCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCccc
Q 036879 290 ISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDEL 369 (1029)
Q Consensus 290 l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~ 369 (1029)
+++++.|++++|.+. .+|..++..+++|++|+|++|++++..+..|..+++|++|++++|.+.+..|..+
T Consensus 44 l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~--------- 113 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF--------- 113 (390)
T ss_dssp GCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTT---------
T ss_pred cCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHh---------
Confidence 455666666666653 5555555556666666666666665555566666666666666666655444332
Q ss_pred ccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCcccccccccccc
Q 036879 370 GFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIG 449 (1029)
Q Consensus 370 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 449 (1029)
..+++|++|++++|+++...+..+..+.+ |++|++++|++++..|..|.++++|++|+|++|++++. .+.
T Consensus 114 ------~~l~~L~~L~L~~n~l~~l~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~ 183 (390)
T 3o6n_A 114 ------QNVPLLTVLVLERNDLSSLPRGIFHNTPK-LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLS 183 (390)
T ss_dssp ------TTCTTCCEEECCSSCCCCCCTTTTTTCTT-CCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGG
T ss_pred ------cCCCCCCEEECCCCccCcCCHHHhcCCCC-CcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccc
Confidence 35566666666666666433333455554 67777777777766666777777777777777777743 245
Q ss_pred CCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEE
Q 036879 450 RLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNV 529 (1029)
Q Consensus 450 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 529 (1029)
.+++|+.|++++|.+++. ...++|++|++++|.+...... ..++|+.|++++|++++. ..+..+++|+.|
T Consensus 184 ~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 253 (390)
T 3o6n_A 184 LIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT--AWLLNYPGLVEV 253 (390)
T ss_dssp GCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cccccceeeccccccccc-----CCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCccc--HHHcCCCCccEE
Confidence 567777777777777532 3345677777777777644322 236788888888888754 567788888888
Q ss_pred EccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCccc
Q 036879 530 NLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS 609 (1029)
Q Consensus 530 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 609 (1029)
+|++|.+++..|..+..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+++
T Consensus 254 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~ 331 (390)
T 3o6n_A 254 DLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331 (390)
T ss_dssp ECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC
T ss_pred ECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccc
Confidence 888888887778888888888888888888874 5666677888888888888888 56667778888888888888888
Q ss_pred CcCchhhhcccccceeeccCCCCcCCCCCCCCCCccCcccccCCCCCCCCC
Q 036879 610 GEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAP 660 (1029)
Q Consensus 610 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~ 660 (1029)
.. + +..+++|+.|++++|++++.... ..+..+....+.+++..|+++
T Consensus 332 ~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 332 TL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 378 (390)
T ss_dssp CC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred ee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence 54 3 66778888888888888874321 234455566677888888765
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=344.39 Aligned_cols=195 Identities=23% Similarity=0.321 Sum_probs=150.2
Q ss_pred CCCCC-CceeccCcceEEEEEEec---CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEe--cCCeEEE
Q 036879 738 DGFSE-NNLLGKGSFGSVYKGTLS---DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCS--SDHFKAL 811 (1029)
Q Consensus 738 ~~~~~-~~~lg~G~fg~V~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 811 (1029)
+.|++ .++||+|+||+||+|+.. +++.||||++.... ....+.+|++++++++||||+++++++. .....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 458999999999999965 57899999987542 2356889999999999999999999994 4778999
Q ss_pred EEeccCCCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE----CCCCcEEE
Q 036879 812 VLEYMPNGSLENWMYNK--------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL----NESMVACL 879 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill----~~~~~~kl 879 (1029)
||||++ ++|.+++... ...+++..+..++.||+.||+||| +.||+||||||+||++ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 5888877422 224899999999999999999999 6779999999999999 77899999
Q ss_pred EccCCceecCCCCC--ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcc
Q 036879 880 SDFGISKLLGDETS--MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDEL 938 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~ 938 (1029)
+|||+|+.+..... .......||+.|+|||++ ++.++||||+||++|||++|++||...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999987643211 222345789999999974 566899999999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=327.41 Aligned_cols=249 Identities=26% Similarity=0.316 Sum_probs=199.9
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4568999999999999999999976 78999999987653 23456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC---CCcEEEEccCCceecC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE---SMVACLSDFGISKLLG 889 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~---~~~~kl~Dfg~a~~~~ 889 (1029)
|||+++++|.+++... ..+++..+..++.|++.|++||| +.||+||||||+||+++. ++.+||+|||++....
T Consensus 100 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999988543 46899999999999999999999 678999999999999975 4479999999998664
Q ss_pred CCCCceeccccCCccccCccCC---CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK---LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.... .....+++.|+|||.+ ++.++||||+|+++|+|++|+.||......+ ....+ ...
T Consensus 176 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~-----------~~~--- 237 (287)
T 2wei_A 176 QNTK--MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRV-----------ETG--- 237 (287)
T ss_dssp CCSS--CSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH-----------HHC---
T ss_pred CCCc--cccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHH-----------HcC---
Confidence 4322 1234588999999984 5778999999999999999999997532111 00000 000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
......+....++..+.+++.+|++.||++|||+.|++++
T Consensus 238 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 238 -KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0000011112346778999999999999999999999984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=342.28 Aligned_cols=257 Identities=21% Similarity=0.345 Sum_probs=197.9
Q ss_pred HHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
...++|++.+.||+|+||.||+|+... .||+|+++... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 346789999999999999999998754 59999987543 23345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++++|.+++......+++..+..++.|++.|++||| +.||+||||||+||+++ ++.+||+|||++.......
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999999999776668999999999999999999999 67899999999999998 6899999999987553211
Q ss_pred ----CceeccccCCccccCccCC-------------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccch
Q 036879 893 ----SMTQTQTLATIGYMAPEWK-------------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG 955 (1029)
Q Consensus 893 ----~~~~~~~~gt~~y~aPE~~-------------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 955 (1029)
........|++.|+|||++ ++.++|||||||++|||++|+.||........ ..
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~----- 253 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-----IW----- 253 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-----HH-----
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HH-----
Confidence 1122234588999999984 35679999999999999999999975321111 00
Q ss_pred hhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 956 KIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 956 ~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
........... +..++.++.+++.+||..||++|||+.++++.|+.+.+...
T Consensus 254 ~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 254 QMGTGMKPNLS---------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHHTTCCCCCC---------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred HhccCCCCCCC---------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00000000000 01235568999999999999999999999999999887643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=340.82 Aligned_cols=261 Identities=22% Similarity=0.307 Sum_probs=190.7
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCC------eEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDH------FKA 810 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 810 (1029)
..+|++.+.||+|+||+||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346888999999999999999988777799998865432 2347999999999999999999985433 378
Q ss_pred EEEeccCCCCHHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC-CCCcEEEEccCCcee
Q 036879 811 LVLEYMPNGSLENWM--YNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN-ESMVACLSDFGISKL 887 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l--~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~-~~~~~kl~Dfg~a~~ 887 (1029)
+||||++++.+.... ......+++..+..++.|+++||+||| ++||+||||||+||+++ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999999765433322 234567999999999999999999999 77899999999999999 899999999999987
Q ss_pred cCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhhhh
Q 036879 888 LGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKIIN 959 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~ 959 (1029)
...... .....||+.|+|||++ ++.++||||+||++|||++|+.||.+....+. +...+. ....+.+..
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHh
Confidence 644332 2345689999999973 57789999999999999999999976321111 111100 000000000
Q ss_pred h----hhhhhhh--hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 960 V----VDINLLQ--KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 960 ~----~d~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
+ ....... ........+..++.++.+++.+||+.||++|||+.|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 0000000 0000001112256789999999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=334.15 Aligned_cols=250 Identities=25% Similarity=0.315 Sum_probs=178.8
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc-hhhHHHHHHHH-HHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-GTLRSFDAECE-ILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.++|+..+.||+|+||.||+|+.. +|+.||||+++.... .....+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467889999999999999999975 799999999976532 33445556665 778889999999999999999999999
Q ss_pred eccCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 814 EYMPNGSLENWMYN----KNRSFDILQRLNMVIDVASALEYLHYDHPT-PIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 814 E~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
||+++ +|.+++.. ....+++..+..++.|++.|++||| +. ||+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 88877642 3567899999999999999999999 55 7999999999999999999999999999866
Q ss_pred CCCCCceeccccCCccccCccCC--------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhh
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK--------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~--------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1029)
..... .....||+.|+|||++ ++.++|||||||++|||++|+.||.........+..... +...
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~-- 248 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK----GDPP-- 248 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC----SCCC--
T ss_pred ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc----CCCC--
Confidence 43322 2234689999999985 567899999999999999999999753221111111100 0000
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 961 ~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.... .....++..+.+++.+||+.||++|||+.|++++
T Consensus 249 ---~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 249 ---QLSN------SEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ---CCCC------CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---CCCC------cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000 0011245678999999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=339.78 Aligned_cols=259 Identities=22% Similarity=0.311 Sum_probs=189.6
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEec----C--CeEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS----D--HFKA 810 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~--~~~~ 810 (1029)
.+|+..+.||+|+||+||+|++. +|+.||||++.... +...+|+++++.++||||+++++++.. . ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35788899999999999999986 69999999986542 233479999999999999999998843 1 2357
Q ss_pred EEEeccCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC-CcEEEEccCCce
Q 036879 811 LVLEYMPNGSLENWMY---NKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES-MVACLSDFGISK 886 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~-~~~kl~Dfg~a~ 886 (1029)
+||||+++ ++.+.+. .....+++..+..++.||++||+||| +.||+||||||+||+++.+ +.+||+|||+|+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 6666553 34567999999999999999999999 7889999999999999955 678999999998
Q ss_pred ecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh---ccchhhh
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND---SLHGKII 958 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~ 958 (1029)
....... .....||+.|+|||++ ++.++||||+||++|||++|+.||.+....+ .+...+.. ...+.+.
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence 7644322 2335789999999973 5678999999999999999999997632111 11111110 0001111
Q ss_pred hhh----hhhhhhh--hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 959 NVV----DINLLQK--EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 959 ~~~----d~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+. +..+... .......+...+.++.+++.+||..||++|||+.|++++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 100 0000000 000000112345779999999999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=331.95 Aligned_cols=270 Identities=21% Similarity=0.255 Sum_probs=187.7
Q ss_pred HHHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCC---
Q 036879 732 ELFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDH--- 807 (1029)
Q Consensus 732 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 807 (1029)
......++|++.+.||+|+||.||+|+.. +|+.||||++.... .......+|++.++.++||||+++++++...+
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 44567889999999999999999999975 78999999986542 23345677888889999999999999986533
Q ss_pred ----eEEEEEeccCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC-CCcEEE
Q 036879 808 ----FKALVLEYMPNGSLENWMY---NKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-SMVACL 879 (1029)
Q Consensus 808 ----~~~lV~E~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-~~~~kl 879 (1029)
..++||||+++ ++.+.+. .....+++..+..++.|++.|++||| .|+.||+||||||+||+++. ++.+||
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 27899999975 5554443 35567899999999999999999999 33567999999999999996 899999
Q ss_pred EccCCceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc-
Q 036879 880 SDFGISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL- 953 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~- 953 (1029)
+|||+++....... .....||+.|+|||++ ++.++|||||||++|||++|+.||........ +...+....
T Consensus 174 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~ 250 (360)
T 3e3p_A 174 CDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LHEIVRVLGC 250 (360)
T ss_dssp CCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCC
T ss_pred eeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HHHHHHHcCC
Confidence 99999987654332 2345689999999973 57789999999999999999999976321111 111110000
Q ss_pred -chhhhhhhhh-----hhh-----hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 954 -HGKIINVVDI-----NLL-----QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 954 -~~~~~~~~d~-----~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
........+. ... ............++..+.+++.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000000 000 00000000111246789999999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.94 Aligned_cols=265 Identities=22% Similarity=0.310 Sum_probs=197.0
Q ss_pred HhCCCCCCceeccCcceEEEEEEe--cCCcEEEEEEeecccc--hhhHHHHHHHHHHhcC---CCCceEEEEEEEe----
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL--SDGMQIAVKVFNLELE--GTLRSFDAECEILGSI---RHRNLVKIISTCS---- 804 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~--~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 804 (1029)
..++|++.+.||+|+||.||+|+. .+|+.||+|+++.... .....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 467899999999999999999997 3688999999875432 2234677788877766 8999999999987
Q ss_pred -cCCeEEEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEcc
Q 036879 805 -SDHFKALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDF 882 (1029)
Q Consensus 805 -~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Df 882 (1029)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence 5567899999997 69999987654 45899999999999999999999 778999999999999999999999999
Q ss_pred CCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh---ccch
Q 036879 883 GISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND---SLHG 955 (1029)
Q Consensus 883 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~ 955 (1029)
|++....... ......|++.|+|||+. ++.++|||||||++|||++|+.||........ +...... ....
T Consensus 165 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 165 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEE 241 (326)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGG
T ss_pred cccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCcc
Confidence 9998654322 22345689999999983 67789999999999999999999976322110 0000000 0000
Q ss_pred hhhhhhh---hhhh-hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 KIINVVD---INLL-QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 ~~~~~~d---~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.+..... .... ............++..+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 0000 00000011122356778999999999999999999999964
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=330.46 Aligned_cols=259 Identities=20% Similarity=0.290 Sum_probs=197.4
Q ss_pred hCCCCCCceeccCcceEEEEEEe-c-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCC------ceEEEEEEEecCCe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTL-S-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHR------NLVKIISTCSSDHF 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~-~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~ 808 (1029)
.++|++.+.||+|+||.||+|.. . +++.||||+++.. ....+.+.+|+++++.++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999987 3 6899999998754 33456788999999988665 49999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC--------------
Q 036879 809 KALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-------------- 873 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-------------- 873 (1029)
.++||||+ +++|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 899999987654 36899999999999999999999 678999999999999987
Q ss_pred -----CCcEEEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccc
Q 036879 874 -----SMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEIS 944 (1029)
Q Consensus 874 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~ 944 (1029)
++.+||+|||++...... .....||+.|+|||++ ++.++||||+||++|||++|+.||......+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH- 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH-
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-
Confidence 678999999999875432 2235689999999983 57789999999999999999999975322111
Q ss_pred cchhchhccc---hhh-h----------------------hhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCC
Q 036879 945 LKSRVNDSLH---GKI-I----------------------NVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEER 998 (1029)
Q Consensus 945 ~~~~~~~~~~---~~~-~----------------------~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 998 (1029)
...+..... ..+ . ..+..... ...........++..+.+++.+||+.||++|
T Consensus 243 -~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 243 -LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp -HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred -HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc-chhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 000000000 000 0 00000000 0000001122457789999999999999999
Q ss_pred CCHHHHHHH
Q 036879 999 INIKEALTK 1007 (1029)
Q Consensus 999 pt~~evl~~ 1007 (1029)
||++|++++
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.63 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=194.6
Q ss_pred HHHHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCC--CCceEEEEEEEecCCe
Q 036879 733 LFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIR--HRNLVKIISTCSSDHF 808 (1029)
Q Consensus 733 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 808 (1029)
+....++|++.+.||+|+||.||+|+..+++.||||++.... ....+.+.+|++++++++ ||||+++++++...+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 334567799999999999999999998889999999997543 334577899999999997 5999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.++||| +.+++|.+++... ..+++..+..++.|+++||+||| +.||+||||||+||++++ +.+||+|||++...
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 999999 5588999999654 56899999999999999999999 678999999999999964 89999999999876
Q ss_pred CCCCCc-eeccccCCccccCccCC---------------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc
Q 036879 889 GDETSM-TQTQTLATIGYMAPEWK---------------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS 952 (1029)
Q Consensus 889 ~~~~~~-~~~~~~gt~~y~aPE~~---------------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 952 (1029)
...... ......|++.|+|||.+ ++.++|||||||++|||++|+.||.........
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-------- 248 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-------- 248 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--------
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH--------
Confidence 443221 22335689999999984 344799999999999999999999653211110
Q ss_pred cchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 953 LHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 953 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
+....+.... ...+..++..+.+++.+||+.||++||+++|++++-
T Consensus 249 ----~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 249 ----LHAIIDPNHE------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp ----HHHHHCTTSC------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ----HHHHHhcccc------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1111111100 011112356789999999999999999999999854
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=331.60 Aligned_cols=250 Identities=20% Similarity=0.268 Sum_probs=172.1
Q ss_pred HhCCCCCCc-eeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEec----CCeE
Q 036879 736 ATDGFSENN-LLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS----DHFK 809 (1029)
Q Consensus 736 ~~~~~~~~~-~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 809 (1029)
..++|.+.+ .||+|+||+||+|+.. +|+.||||++.... ....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 356788854 6999999999999976 79999999986542 222233344677799999999999876 4557
Q ss_pred EEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC---CCcEEEEccCCc
Q 036879 810 ALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE---SMVACLSDFGIS 885 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~---~~~~kl~Dfg~a 885 (1029)
++||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999997654 46999999999999999999999 678999999999999976 556999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
....... .....+|+.|+|||++ ++.++||||+||++|||++|+.||........... ... .+
T Consensus 179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~-----~~---- 245 (336)
T 3fhr_A 179 KETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-MKR-----RI---- 245 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-HHH-----hh----
Confidence 8664322 2235689999999985 45689999999999999999999975422211000 000 00
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
. .............++..+.+++.+||+.||++|||++|++++-
T Consensus 246 ~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 246 R---LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred h---ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 0000000011123467789999999999999999999999854
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=342.00 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=185.9
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..+|+..+.||+|+||+||.....+++.||||++..... ..+.+|+++++.+ +|||||++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 346888899999999997665566899999999865432 3456899999999 899999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC-----CCcEEEEccCCceecCC
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-----SMVACLSDFGISKLLGD 890 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-----~~~~kl~Dfg~a~~~~~ 890 (1029)
++ |+|.+++........+..+..++.||+.||+||| +.||+||||||+||+++. ...+||+|||+|+....
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 95 6999999877666666677899999999999999 677999999999999953 34688999999987653
Q ss_pred CCC--ceeccccCCccccCccCCC-------CCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhh
Q 036879 891 ETS--MTQTQTLATIGYMAPEWKL-------SRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINV 960 (1029)
Q Consensus 891 ~~~--~~~~~~~gt~~y~aPE~~~-------~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1029)
... .......||+.|+|||++. +.++||||+||++|||++ |+.||.......... .
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--------------~ 241 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--------------L 241 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--------------H
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--------------H
Confidence 321 2233457999999999853 447999999999999999 899986432111100 0
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 036879 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 961 ~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1006 (1029)
...... .....+...+..+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 LGACSL----DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCCCC----TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCc----cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000000 000011223556889999999999999999999995
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=332.60 Aligned_cols=239 Identities=22% Similarity=0.299 Sum_probs=196.3
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccch------hhHHHHHHHHHHhcCC--CCceEEEEEEEec
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG------TLRSFDAECEILGSIR--HRNLVKIISTCSS 805 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 805 (1029)
...++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34678999999999999999999865 7899999999765321 2355778999999996 5999999999999
Q ss_pred CCeEEEEEeccCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC-CCCcEEEEccC
Q 036879 806 DHFKALVLEYMPN-GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN-ESMVACLSDFG 883 (1029)
Q Consensus 806 ~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~-~~~~~kl~Dfg 883 (1029)
.+..++||||+.+ ++|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++ .++.+||+|||
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 9999999999976 899999865 456899999999999999999999 77899999999999999 78999999999
Q ss_pred CceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhh
Q 036879 884 ISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKII 958 (1029)
Q Consensus 884 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1029)
++....... .....||+.|+|||++ .+.++|||||||++|||++|+.||..... .
T Consensus 196 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~---------- 255 (320)
T 3a99_A 196 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------I---------- 255 (320)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------H----------
T ss_pred ccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------h----------
Confidence 998765432 2235689999999973 35678999999999999999999965210 0
Q ss_pred hhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 959 NVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 959 ~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..... ..+..++.++.+++.+||+.||++|||++|++++
T Consensus 256 --~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 256 --IRGQV--------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --HHCCC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --hcccc--------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0011235678999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=334.73 Aligned_cols=259 Identities=20% Similarity=0.275 Sum_probs=191.9
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCe-----
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHF----- 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 808 (1029)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467889999999999999999875 79999999997643 2335678899999999999999999999987654
Q ss_pred -EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 809 -KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 809 -~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
.++||||++ ++|.+++. ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 489999996 68887663 35899999999999999999999 67799999999999999999999999999976
Q ss_pred cCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch-----------h
Q 036879 888 LGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN-----------D 951 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-----------~ 951 (1029)
.... .....+|+.|+|||++ ++.++||||+||++|||++|+.||......+. +..... .
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHHHCBCCHHHHTT
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHH
Confidence 5332 2235689999999973 56789999999999999999999976321110 000000 0
Q ss_pred ccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 952 SLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 952 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...........................++..+.+++.+|++.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000000000000000011112356789999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=332.09 Aligned_cols=241 Identities=24% Similarity=0.347 Sum_probs=188.0
Q ss_pred HHHHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc------hhhHHHHHHHHHHhcC----CCCceEEEEE
Q 036879 733 LFRATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE------GTLRSFDAECEILGSI----RHRNLVKIIS 801 (1029)
Q Consensus 733 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~ 801 (1029)
.....++|++.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+++++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999874 789999999975432 1234466789999888 8999999999
Q ss_pred EEecCCeEEEEEec-cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC-CCCcEEE
Q 036879 802 TCSSDHFKALVLEY-MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN-ESMVACL 879 (1029)
Q Consensus 802 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~-~~~~~kl 879 (1029)
++...+..++|||| +.+++|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++ .++.+||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence 99999999999999 789999999965 346899999999999999999999 66799999999999999 8999999
Q ss_pred EccCCceecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccc
Q 036879 880 SDFGISKLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLH 954 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 954 (1029)
+|||++....... .....|++.|+|||++ .+.++||||+||++|||++|+.||.....
T Consensus 182 ~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------------- 244 (312)
T 2iwi_A 182 IDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------------- 244 (312)
T ss_dssp CCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------
T ss_pred EEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------------
Confidence 9999998765432 2335689999999973 23479999999999999999999965210
Q ss_pred hhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 955 GKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 955 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..... ...+..++..+.+++.+||+.||++|||++|++++
T Consensus 245 -----~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 -----ILEAE--------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -----HHHTC--------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----Hhhhc--------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00112345678999999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=340.40 Aligned_cols=245 Identities=24% Similarity=0.336 Sum_probs=181.5
Q ss_pred CCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEEeccC
Q 036879 739 GFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVLEYMP 817 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~ 817 (1029)
.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++.+++..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 345568899999999987766789999999987542 35678899999876 89999999999999999999999995
Q ss_pred CCCHHHHHhcCCCCC------CHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCC-------------CcEE
Q 036879 818 NGSLENWMYNKNRSF------DILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNES-------------MVAC 878 (1029)
Q Consensus 818 ~gsL~~~l~~~~~~~------~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~-------------~~~k 878 (1029)
|+|.+++....... .+..+..++.||+.||+||| +.||+||||||+||+++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999996543221 22345789999999999999 6789999999999999754 4899
Q ss_pred EEccCCceecCCCCCc---eeccccCCccccCccCC-----------CCCCcchhHHHHHHHHHhc-CCCCCCccccccc
Q 036879 879 LSDFGISKLLGDETSM---TQTQTLATIGYMAPEWK-----------LSRKGDVYSYGIILMETFT-KKKPTDELFVGEI 943 (1029)
Q Consensus 879 l~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~-----------~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~ 943 (1029)
|+|||+|+........ ......||+.|+|||++ ++.++|||||||++|||++ |+.||......+.
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 9999999877543221 12235699999999974 4668999999999999999 9999975322111
Q ss_pred ccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 036879 944 SLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1006 (1029)
.+. .. ...... ........++.++.+++.+||+.||++|||+.|+++
T Consensus 249 ~i~---~~--------~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NII---RG--------IFSLDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH---HT--------CCCCCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHh---cC--------CCCccc-----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 000 00 000000 000012345678999999999999999999999986
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=349.95 Aligned_cols=334 Identities=19% Similarity=0.219 Sum_probs=222.3
Q ss_pred CCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccc
Q 036879 291 SSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELG 370 (1029)
Q Consensus 291 ~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~ 370 (1029)
.+++.|++++|.+. .+|..++..+++|++|+|++|.+++..|..|..+++|+.|++++|.+.+..|..+
T Consensus 51 ~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---------- 119 (597)
T 3oja_B 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF---------- 119 (597)
T ss_dssp CCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTT----------
T ss_pred CCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHH----------
Confidence 44455555555543 4444444445555555555555555555555555555555555555554443322
Q ss_pred cccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccC
Q 036879 371 FLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGR 450 (1029)
Q Consensus 371 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 450 (1029)
..+++|++|+|++|.+++..+..|..+.+ |++|+|++|.+++..|..|.++++|++|+|++|.+++. + +..
T Consensus 120 -----~~l~~L~~L~L~~n~l~~l~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~--~~~ 190 (597)
T 3oja_B 120 -----QNVPLLTVLVLERNDLSSLPRGIFHNTPK-LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--LSL 190 (597)
T ss_dssp -----TTCTTCCEEECCSSCCCCCCTTTTTTCTT-CCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-C--GGG
T ss_pred -----cCCCCCCEEEeeCCCCCCCCHHHhccCCC-CCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-C--hhh
Confidence 24555666666666665444444455554 66666666666666666677777777777777777643 2 445
Q ss_pred CCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEE
Q 036879 451 LQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVN 530 (1029)
Q Consensus 451 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 530 (1029)
+++|+.|++++|.+++ +....+|+.|++++|.+....+.. .++|+.|+|++|.+++ +..+..+++|+.|+
T Consensus 191 l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~ 260 (597)
T 3oja_B 191 IPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVD 260 (597)
T ss_dssp CTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEE
T ss_pred hhhhhhhhcccCcccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEE
Confidence 6667777777776653 233456777777777776443332 2578888888888875 36778888888888
Q ss_pred ccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccC
Q 036879 531 LSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSG 610 (1029)
Q Consensus 531 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 610 (1029)
|++|.+++..|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|++++
T Consensus 261 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~ 338 (597)
T 3oja_B 261 LSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT 338 (597)
T ss_dssp CCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC
T ss_pred CCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCC
Confidence 88888888888888888888888888888884 5667777888888888888888 577778888889999999998885
Q ss_pred cCchhhhcccccceeeccCCCCcCCCCCCCCCCccCcccccCCCCCCCCC
Q 036879 611 EIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAP 660 (1029)
Q Consensus 611 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~ 660 (1029)
.. +..+++|+.|++++|+++|.... ..+..+....+.+++..|+.+
T Consensus 339 ~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 339 LK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp CC---CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred cC---hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence 53 56678888899999998875422 234555566678888888874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=335.51 Aligned_cols=262 Identities=15% Similarity=0.234 Sum_probs=194.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCC-----------CCceEEEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIR-----------HRNLVKIISTCS 804 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 804 (1029)
.++|++.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 467999999999999999999974 7899999998754 234467888999998886 899999999987
Q ss_pred cCC----eEEEEEeccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCEEEC------
Q 036879 805 SDH----FKALVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPT-PIIHCDLNPSNILLN------ 872 (1029)
Q Consensus 805 ~~~----~~~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-givH~Dlk~~Nill~------ 872 (1029)
..+ ..++||||+ +++|.+++... ...+++..+..++.||+.||+||| ++ ||+||||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence 644 789999999 89999999764 345999999999999999999999 65 899999999999994
Q ss_pred CCCcEEEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccc-h
Q 036879 873 ESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLK-S 947 (1029)
Q Consensus 873 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~-~ 947 (1029)
..+.+||+|||++...... .....||+.|+|||++ ++.++|||||||++|||++|+.||........... .
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4458999999999876432 2234689999999983 67889999999999999999999975322111000 0
Q ss_pred hchhcc--chhhhh-h----------hh-------------hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCH
Q 036879 948 RVNDSL--HGKIIN-V----------VD-------------INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINI 1001 (1029)
Q Consensus 948 ~~~~~~--~~~~~~-~----------~d-------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 1001 (1029)
...... .+.+.. . .. .............+..++..+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 000000 000000 0 00 000000011112235678889999999999999999999
Q ss_pred HHHHHH
Q 036879 1002 KEALTK 1007 (1029)
Q Consensus 1002 ~evl~~ 1007 (1029)
+|++++
T Consensus 329 ~ell~h 334 (373)
T 1q8y_A 329 GGLVNH 334 (373)
T ss_dssp HHHHTC
T ss_pred HHHhhC
Confidence 999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=332.10 Aligned_cols=196 Identities=28% Similarity=0.377 Sum_probs=167.5
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCC-CC-----ceEEEEEEEecCCe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIR-HR-----NLVKIISTCSSDHF 808 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~ 808 (1029)
..++|++.+.||+|+||+||+|+.. +++.||||+++.. ......+..|+++++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4678999999999999999999876 7889999999754 234566788899888884 54 49999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC--CCCcEEEEccCCc
Q 036879 809 KALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN--ESMVACLSDFGIS 885 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~--~~~~~kl~Dfg~a 885 (1029)
.++||||++ ++|.+++.... ..+++..+..++.|++.||+|||. ++.|||||||||+||+++ .++.+||+|||+|
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999995 59999987654 568999999999999999999994 246899999999999995 5788999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcc
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDEL 938 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~ 938 (1029)
+..... .....||+.|+|||++ ++.++|||||||++|||++|+.||...
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 876442 2235689999999984 678999999999999999999999753
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=322.02 Aligned_cols=255 Identities=35% Similarity=0.562 Sum_probs=229.6
Q ss_pred hcceecccccccc--ccccccCCcCcCcEEEecC-ccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEe
Q 036879 406 MDVLYLSACNIKG--SIPSEIGNLNNLTTLHLET-NELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFY 482 (1029)
Q Consensus 406 L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 482 (1029)
++.|++++|++++ .+|..|.++++|++|+|++ |.+.+.+|..|..+++|++|+|++|.+++..+..|..+++|++|+
T Consensus 52 l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 131 (313)
T 1ogq_A 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEe
Confidence 6777777777777 7788888888888888884 888878888888888888888888888878888888888888888
Q ss_pred cCCCcccCccccccccccccceeeccCccccCCCCCCccCCC-CCcEEEccCCcccCcCCccccccccccEEEccCCcCC
Q 036879 483 SDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLR-DILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLS 561 (1029)
Q Consensus 483 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 561 (1029)
+++|.+++..|..|..+++|++|+|++|++++.+|..+..++ +|+.|++++|++++..|..+..++ |+.|++++|.++
T Consensus 132 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~ 210 (313)
T 1ogq_A 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEE
T ss_pred CCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCccc
Confidence 888888888899999999999999999999988899999988 899999999999988999999987 999999999999
Q ss_pred CCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCCCC
Q 036879 562 GEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGP 641 (1029)
Q Consensus 562 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 641 (1029)
+..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|++++|+++|.+|....
T Consensus 211 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~ 289 (313)
T 1ogq_A 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred CcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCcc
Confidence 88999999999999999999999976665 88899999999999999999999999999999999999999999999888
Q ss_pred CCccCcccccCCCCCCCCCCC
Q 036879 642 FTNLSSQSFVGNKGLCGAPEL 662 (1029)
Q Consensus 642 ~~~l~~~~~~~n~~~c~~~~~ 662 (1029)
++++..+.+.+||++||.|..
T Consensus 290 l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 290 LQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp GGGSCGGGTCSSSEEESTTSS
T ss_pred ccccChHHhcCCCCccCCCCC
Confidence 999999999999999998853
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=327.93 Aligned_cols=248 Identities=25% Similarity=0.295 Sum_probs=180.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccch--hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG--TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.++|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 456888899999999999999986 7999999999765322 2334555666788889999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT-PIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
||+ ++.+..+.......+++..+..++.|+++||+||| ++ ||+||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 56666666555677999999999999999999999 53 79999999999999999999999999997664432
Q ss_pred CceeccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
. .....+++.|+|||++ ++.++|||||||++|||++|+.||.........+. .....
T Consensus 180 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------------~~~~~ 245 (318)
T 2dyl_A 180 A--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT------------KVLQE 245 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH------------HHHHS
T ss_pred c--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH------------HHhcc
Confidence 2 2334689999999984 45689999999999999999999975211111000 00000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.. ........++..+.+++.+||+.||++|||++|++++
T Consensus 246 ~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 246 EP-----PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CC-----CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CC-----CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 0000011245678999999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=328.35 Aligned_cols=260 Identities=20% Similarity=0.273 Sum_probs=195.0
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CC-cEEEEEEeecccchhhHHHHHHHHHHhcCCCCc------eEEEEEEEecCCe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DG-MQIAVKVFNLELEGTLRSFDAECEILGSIRHRN------LVKIISTCSSDHF 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 808 (1029)
.++|++.+.||+|+||+||+|+.. ++ +.||+|+++.. ....+.+.+|+++++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 568999999999999999999875 44 78999999754 334567888999999997665 9999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE----------------
Q 036879 809 KALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL---------------- 871 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill---------------- 871 (1029)
.++||||+ ++++.+++.... ..+++..+..++.||+.||+||| ++||+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 667777776544 57999999999999999999999 7889999999999999
Q ss_pred ---CCCCcEEEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccc
Q 036879 872 ---NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEIS 944 (1029)
Q Consensus 872 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~ 944 (1029)
+.++.+||+|||+++...... ....||+.|+|||++ ++.++||||+||++|||++|+.||......+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH- 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred ccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 568899999999998754322 235689999999984 57789999999999999999999975322110
Q ss_pred cchhchhccchhhhhhhhhh------------hh-------------hhhhhhhHHHHHHHHHHHHHHHHcccccccCCC
Q 036879 945 LKSRVNDSLHGKIINVVDIN------------LL-------------QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI 999 (1029)
Q Consensus 945 ~~~~~~~~~~~~~~~~~d~~------------~~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 999 (1029)
...+..........+.... .. .............+..+.+++.+||+.||++||
T Consensus 248 -~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 248 -LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp -HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred -HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 0000000000000000000 00 000000001123456899999999999999999
Q ss_pred CHHHHHHH
Q 036879 1000 NIKEALTK 1007 (1029)
Q Consensus 1000 t~~evl~~ 1007 (1029)
|++|++++
T Consensus 327 t~~e~l~h 334 (355)
T 2eu9_A 327 TLAEALLH 334 (355)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.04 Aligned_cols=234 Identities=12% Similarity=0.077 Sum_probs=185.9
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999986 58999999998653 23347789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++++|.+++.. . ....++..++.|++.||+||| ++||+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999843 2 356678899999999999999 7789999999999999999999998544
Q ss_pred CceeccccCCccccCccCCCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
|++| ++.++|||||||++|||++|+.||.+......... ......+. ....
T Consensus 175 ------------~~~~---~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--~~~~~~~~------------~~~~ 225 (286)
T 3uqc_A 175 ------------TMPD---ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--AERDTAGQ------------PIEP 225 (286)
T ss_dssp ------------CCTT---CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--CCBCTTSC------------BCCH
T ss_pred ------------ccCC---CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--HHHHhccC------------CCCh
Confidence 3333 46789999999999999999999976432211000 00000000 0000
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
......++..+.+++.+||+.||++| |+.|+++.|+++....
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 11122356779999999999999999 9999999999987543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=324.42 Aligned_cols=313 Identities=19% Similarity=0.208 Sum_probs=278.4
Q ss_pred ccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCC
Q 036879 315 LPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGV 394 (1029)
Q Consensus 315 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 394 (1029)
+.+|+.|++++|.++...+..|..+++|++|++++|.+.+..+..+ ..+++|++|++++|++++.
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~---------------~~l~~L~~L~L~~n~l~~~ 108 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAF---------------AYAHTIQKLYMGFNAIRYL 108 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTT---------------TTCTTCCEEECCSSCCCCC
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhc---------------cCCCCcCEEECCCCCCCcC
Confidence 7899999999999998777778999999999999999987665444 4789999999999999988
Q ss_pred CCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccC
Q 036879 395 LPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCG 474 (1029)
Q Consensus 395 ~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 474 (1029)
.|..+..+.. |++|++++|+++...+..|.++++|++|+|++|++++..+..|..+++|++|++++|++++. .+..
T Consensus 109 ~~~~~~~l~~-L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~ 184 (390)
T 3o6n_A 109 PPHVFQNVPL-LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSL 184 (390)
T ss_dssp CTTTTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGG
T ss_pred CHHHhcCCCC-CCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---cccc
Confidence 8888999887 99999999999976666789999999999999999988888899999999999999999865 4667
Q ss_pred CCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEE
Q 036879 475 LRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKID 554 (1029)
Q Consensus 475 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 554 (1029)
+++|+.|++++|.+.+ +...++|+.|++++|.++.+... ..++|+.|++++|.+++. ..+..+++|++|+
T Consensus 185 l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 254 (390)
T 3o6n_A 185 IPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT--AWLLNYPGLVEVD 254 (390)
T ss_dssp CTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred ccccceeecccccccc-----cCCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCccc--HHHcCCCCccEEE
Confidence 8999999999999874 34457899999999999876432 257899999999999963 5789999999999
Q ss_pred ccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcC
Q 036879 555 LSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 555 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 634 (1029)
+++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|++++|+++.
T Consensus 255 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~ 332 (390)
T 3o6n_A 255 LSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT 332 (390)
T ss_dssp CCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC
T ss_pred CCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce
Confidence 99999998889999999999999999999995 6777788999999999999999 667778999999999999999987
Q ss_pred CCCCCCCCCccCcccccCCCCCCCCC
Q 036879 635 QVPHGGPFTNLSSQSFVGNKGLCGAP 660 (1029)
Q Consensus 635 ~~~~~~~~~~l~~~~~~~n~~~c~~~ 660 (1029)
.. ...+.+++.+.+.+|||.|++.
T Consensus 333 ~~--~~~~~~L~~L~l~~N~~~~~~~ 356 (390)
T 3o6n_A 333 LK--LSTHHTLKNLTLSHNDWDCNSL 356 (390)
T ss_dssp CC--CCTTCCCSEEECCSSCEEHHHH
T ss_pred eC--chhhccCCEEEcCCCCccchhH
Confidence 53 4567899999999999999874
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=312.77 Aligned_cols=305 Identities=23% Similarity=0.379 Sum_probs=211.2
Q ss_pred ccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccce
Q 036879 265 EIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTL 344 (1029)
Q Consensus 265 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 344 (1029)
.+++|+.|++++|.++.. | .+..+++|++|++++|.+. .+|. +..+++|++|+|++|.+++. ..+..+++|++
T Consensus 42 ~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~-~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~ 114 (347)
T 4fmz_A 42 ELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQIT-DISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRE 114 (347)
T ss_dssp HHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSE
T ss_pred hcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccc-cchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCCE
Confidence 456777777777777643 3 3677777777777777775 4444 33577777777777777642 24555555555
Q ss_pred ecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceecccccccccccccc
Q 036879 345 IDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI 424 (1029)
Q Consensus 345 L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~ 424 (1029)
|++++|.+.+..+ +..+++|+.|+++ +|.....++ .+
T Consensus 115 L~l~~n~i~~~~~-----------------~~~l~~L~~L~l~-------------------------~n~~~~~~~-~~ 151 (347)
T 4fmz_A 115 LYLNEDNISDISP-----------------LANLTKMYSLNLG-------------------------ANHNLSDLS-PL 151 (347)
T ss_dssp EECTTSCCCCCGG-----------------GTTCTTCCEEECT-------------------------TCTTCCCCG-GG
T ss_pred EECcCCcccCchh-----------------hccCCceeEEECC-------------------------CCCCccccc-ch
Confidence 5555555543211 2234444444444 443332222 25
Q ss_pred CCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccce
Q 036879 425 GNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRT 504 (1029)
Q Consensus 425 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 504 (1029)
..+++|++|++++|.+.+..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|.+.+..+ +..+++|++
T Consensus 152 ~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~ 225 (347)
T 4fmz_A 152 SNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNS 225 (347)
T ss_dssp TTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCE
T ss_pred hhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCE
Confidence 666777777777777764333 6677777777777777765443 6667777777777777765544 777888888
Q ss_pred eeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccc
Q 036879 505 LSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKF 584 (1029)
Q Consensus 505 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 584 (1029)
|++++|++++..+ +..+++|+.|++++|.+++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++
T Consensus 226 L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l 299 (347)
T 4fmz_A 226 LKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQL 299 (347)
T ss_dssp EECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred EEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcC
Confidence 8888888876554 77888888888888888753 4578888888888888888754 4578888899999999988
Q ss_pred cccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCc
Q 036879 585 QGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQ 633 (1029)
Q Consensus 585 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 633 (1029)
++..|..+..+++|++|+|++|++++..| +..+++|+.|++++|+++
T Consensus 300 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 88888888888899999999999887666 788888999999998875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=344.28 Aligned_cols=271 Identities=21% Similarity=0.268 Sum_probs=196.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEec------CCe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSS------DHF 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 808 (1029)
.++|++.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999875 78999999987653 3345678999999999999999999999765 677
Q ss_pred EEEEEeccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCc---EEEEccC
Q 036879 809 KALVLEYMPNGSLENWMYNKNR--SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMV---ACLSDFG 883 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~---~kl~Dfg 883 (1029)
.++||||+++|+|.+++..... .+++..+..++.|++.|++||| +.||+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976432 5888999999999999999999 678999999999999997664 9999999
Q ss_pred CceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchh--h
Q 036879 884 ISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGK--I 957 (1029)
Q Consensus 884 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~ 957 (1029)
.+........ .....||+.|+|||++ ++.++||||+||++|||++|+.||........ +...+....... .
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-WHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-SSTTCC------CCS
T ss_pred cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-hhhhhhcccchhhhh
Confidence 9987654322 2345799999999984 57799999999999999999999965311100 000000000000 0
Q ss_pred hhhhhhh--hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHH-----HHHHHHhHH
Q 036879 958 INVVDIN--LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEA-----LTKLLKIRN 1013 (1029)
Q Consensus 958 ~~~~d~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev-----l~~L~~i~~ 1013 (1029)
.+..... ..............++..+.+++..|+..||++|||++|+ .+.++.+.+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000000 0000000011123357789999999999999999999884 455555544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=313.18 Aligned_cols=232 Identities=20% Similarity=0.281 Sum_probs=180.3
Q ss_pred hCCCCCC-ceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHH-hcCCCCceEEEEEEEec----CCeE
Q 036879 737 TDGFSEN-NLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEIL-GSIRHRNLVKIISTCSS----DHFK 809 (1029)
Q Consensus 737 ~~~~~~~-~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 809 (1029)
.++|.+. +.||+|+||.||+|... +++.||+|+++.. ..+.+|++++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3556666 77999999999999875 7899999998643 4577888887 66699999999999876 6778
Q ss_pred EEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC---CCcEEEEccCCc
Q 036879 810 ALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE---SMVACLSDFGIS 885 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~---~~~~kl~Dfg~a 885 (1029)
++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999997654 46999999999999999999999 778999999999999998 889999999999
Q ss_pred eecCCCCCceeccccCCccccCccCCCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
...... .++.++||||+||++|||++|+.||......... ........
T Consensus 168 ~~~~~~-------------------~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~------------ 215 (299)
T 3m2w_A 168 KETTGE-------------------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTRIR------------ 215 (299)
T ss_dssp EECTTC-------------------GGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSC------------
T ss_pred cccccc-------------------cCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-HHHHHHHh------------
Confidence 764321 1356899999999999999999999753221110 00000000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
.............++..+.+++.+||+.||++|||++|++++-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 0000000111133567899999999999999999999999853
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=338.54 Aligned_cols=313 Identities=19% Similarity=0.197 Sum_probs=281.5
Q ss_pred ccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCC
Q 036879 315 LPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGV 394 (1029)
Q Consensus 315 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 394 (1029)
+.+++.|++++|.+...++..|..+++|+.|++++|.+.+..|..+ ..+++|+.|+|++|.+++.
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~---------------~~l~~L~~L~L~~n~l~~~ 114 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAF---------------AYAHTIQKLYMGFNAIRYL 114 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTT---------------TTCTTCCEEECCSSCCCCC
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHh---------------cCCCCCCEEECCCCcCCCC
Confidence 6899999999999998888889999999999999999998766554 4789999999999999998
Q ss_pred CCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccC
Q 036879 395 LPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCG 474 (1029)
Q Consensus 395 ~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 474 (1029)
.|..|+.+.. |++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|.+++.. +..
T Consensus 115 ~~~~~~~l~~-L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~ 190 (597)
T 3oja_B 115 PPHVFQNVPL-LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSL 190 (597)
T ss_dssp CTTTTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGG
T ss_pred CHHHHcCCCC-CCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhh
Confidence 8888999987 999999999999777777899999999999999999888889999999999999999998753 566
Q ss_pred CCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEE
Q 036879 475 LRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKID 554 (1029)
Q Consensus 475 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 554 (1029)
+++|+.|++++|.+++ +...++|+.|++++|.++.+.+.. .++|+.|+|++|.+++ +..+..+++|+.|+
T Consensus 191 l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~ 260 (597)
T 3oja_B 191 IPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVD 260 (597)
T ss_dssp CTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEE
T ss_pred hhhhhhhhcccCcccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEE
Confidence 7899999999999874 345678999999999998665433 3689999999999996 57899999999999
Q ss_pred ccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcC
Q 036879 555 LSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 555 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 634 (1029)
|++|.+++..|..|+.+++|+.|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|++++
T Consensus 261 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~ 338 (597)
T 3oja_B 261 LSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT 338 (597)
T ss_dssp CCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC
T ss_pred CCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCC
Confidence 99999999999999999999999999999995 6777888999999999999999 678888999999999999999987
Q ss_pred CCCCCCCCCccCcccccCCCCCCCCC
Q 036879 635 QVPHGGPFTNLSSQSFVGNKGLCGAP 660 (1029)
Q Consensus 635 ~~~~~~~~~~l~~~~~~~n~~~c~~~ 660 (1029)
.. ...+..+..+.+.+|||.|++.
T Consensus 339 ~~--~~~~~~L~~L~l~~N~~~~~~~ 362 (597)
T 3oja_B 339 LK--LSTHHTLKNLTLSHNDWDCNSL 362 (597)
T ss_dssp CC--CCTTCCCSEEECCSSCEEHHHH
T ss_pred cC--hhhcCCCCEEEeeCCCCCChhH
Confidence 64 4567889999999999999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=348.11 Aligned_cols=239 Identities=19% Similarity=0.268 Sum_probs=193.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec--CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCe-----
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS--DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHF----- 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 808 (1029)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999975 68999999986543 3445678999999999999999999999987554
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.|+||||+++++|.+++.. .+++..+..++.||+.||+||| ++|||||||||+||+++.+ .+||+|||+++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 6999999999999987643 6899999999999999999999 6789999999999999985 8999999999876
Q ss_pred CCCCCceeccccCCccccCccCC---CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK---LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
... ....||++|+|||++ .+.++|||||||++|||++|.+||.........
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~--------------------- 285 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP--------------------- 285 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---------------------
T ss_pred ccC-----CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccccc---------------------
Confidence 543 235699999999984 467899999999999999999887652111110
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCC-CHHHHHHHHHHhHHh
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-NIKEALTKLLKIRNT 1014 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~evl~~L~~i~~~ 1014 (1029)
. .......+..+.+++.+||+.||++|| +++++.+.+..+.+.
T Consensus 286 -~-----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 286 -E-----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp -T-----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred -c-----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 0 000112346789999999999999999 567777777766543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=308.46 Aligned_cols=303 Identities=22% Similarity=0.373 Sum_probs=223.7
Q ss_pred cccccccccceeecccccc-----cccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccc
Q 036879 245 EIGNITMLKGLYLVYTNLT-----GEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQ 319 (1029)
Q Consensus 245 ~~~~l~~L~~L~l~~n~l~-----~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~ 319 (1029)
.+..+++|+.|++.++.+. ..+++|++|+|++|++++..+ +.++++|++|++++|.+. .+| .+ ..+++|+
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~~~~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~-~~~-~~-~~l~~L~ 113 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DIS-AL-QNLTNLR 113 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GG-TTCTTCS
T ss_pred cchhcccccEEEEeCCccccchhhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCccc-Cch-HH-cCCCcCC
Confidence 4567899999999999987 357889999999999996544 999999999999999997 555 33 4699999
Q ss_pred eEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccc
Q 036879 320 QLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISI 399 (1029)
Q Consensus 320 ~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 399 (1029)
+|+|++|++++..+ +..+++|+.|++++|.....++ .+..+++|++|++++|.+.+..+
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~----------------~~~~l~~L~~L~l~~~~~~~~~~--- 172 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS----------------PLSNMTGLNYLTVTESKVKDVTP--- 172 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG----------------GGTTCTTCCEEECCSSCCCCCGG---
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCccccc----------------chhhCCCCcEEEecCCCcCCchh---
Confidence 99999999996544 9999999999999997654332 24467777888887777663322
Q ss_pred cCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCc
Q 036879 400 GNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLS 479 (1029)
Q Consensus 400 ~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 479 (1029)
+..+++|++|++++|.+++..+ +..+++|+.|++++|.+.+..+ +..+++|+
T Consensus 173 ------------------------~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~ 224 (347)
T 4fmz_A 173 ------------------------IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLN 224 (347)
T ss_dssp ------------------------GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCC
T ss_pred ------------------------hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCC
Confidence 3344555555555555553222 5555556666666665554433 55555666
Q ss_pred EEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCc
Q 036879 480 EFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRND 559 (1029)
Q Consensus 480 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 559 (1029)
+|++++|++++..+ +..+++|++|++++|+++++ ..+..+++|+.|++++|++++. ..+..+++|+.|++++|+
T Consensus 225 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~ 298 (347)
T 4fmz_A 225 SLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQ 298 (347)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSC
T ss_pred EEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCc
Confidence 66666666654433 67777788888888877754 4577788888888888888753 357788888888888888
Q ss_pred CCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCccc
Q 036879 560 LSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS 609 (1029)
Q Consensus 560 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 609 (1029)
+++..|..|..+++|+.|+|++|++++..| +..+++|++|++++|+|+
T Consensus 299 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 299 LGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 887778888888888999999998886655 778888999999998876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=329.67 Aligned_cols=236 Identities=18% Similarity=0.204 Sum_probs=176.0
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc---hhhHHHHHHHHHHhcCCC-Cce---------------E
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---GTLRSFDAECEILGSIRH-RNL---------------V 797 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni---------------v 797 (1029)
..|...+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|+.+++.++| ++. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 34667789999999999999965 799999999874432 235779999999999977 211 1
Q ss_pred E------EEEEEec-----CCeEEEEEeccCCCCHHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 036879 798 K------IISTCSS-----DHFKALVLEYMPNGSLENWMY------NKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860 (1029)
Q Consensus 798 ~------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~giv 860 (1029)
. ++.++.. ....+++|+++ +++|.+++. .....+++..+..++.|+++||+||| ++||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 1 1111111 12346777766 789999884 22445778899999999999999999 77899
Q ss_pred EcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccCCccccCccCC--------------CCCCcchhHHHHHHH
Q 036879 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK--------------LSRKGDVYSYGIILM 926 (1029)
Q Consensus 861 H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~--------------~~~~~DvwSlGvil~ 926 (1029)
||||||+||+++.++.+||+|||+++..... .....| +.|+|||++ ++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999865432 233457 999999986 455899999999999
Q ss_pred HHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 036879 927 ETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 927 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1006 (1029)
||++|+.||......+. .. ..+... ..++..+.+++.+||+.||++||++.|+++
T Consensus 309 elltg~~Pf~~~~~~~~--~~---------------~~~~~~--------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG--SE---------------WIFRSC--------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSC--SG---------------GGGSSC--------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhh--HH---------------HHHhhc--------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999976321111 00 000000 123467899999999999999999988876
Q ss_pred H
Q 036879 1007 K 1007 (1029)
Q Consensus 1007 ~ 1007 (1029)
+
T Consensus 364 ~ 364 (413)
T 3dzo_A 364 T 364 (413)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-31 Score=300.40 Aligned_cols=288 Identities=20% Similarity=0.267 Sum_probs=178.4
Q ss_pred CCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCccccc
Q 036879 292 SLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGF 371 (1029)
Q Consensus 292 ~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~ 371 (1029)
+|+.+++++|.+. .+|..++ ++|+.|+|++|.+++..|..|.++++|++|++++|.+++..|..
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~------------ 97 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKA------------ 97 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGG------------
T ss_pred cCCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhH------------
Confidence 5677777777775 6666553 46777777777777666666777777777777777666544433
Q ss_pred ccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccc--ccccccc
Q 036879 372 LTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTG--SIPKAIG 449 (1029)
Q Consensus 372 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~ 449 (1029)
+..+++|++|++++|+++ .+|..+. ..|++|++++|++++..+..|.++++|++|++++|.++. ..+..+.
T Consensus 98 ---~~~l~~L~~L~L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 170 (332)
T 2ft3_A 98 ---FSPLRKLQKLYISKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170 (332)
T ss_dssp ---STTCTTCCEEECCSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSC
T ss_pred ---hhCcCCCCEEECCCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCccccc
Confidence 235666777777777666 3444333 236666666666665555556666666666666666642 4455555
Q ss_pred CCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEE
Q 036879 450 RLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNV 529 (1029)
Q Consensus 450 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 529 (1029)
.+ +|++|++++|++++. |..+. ++|++|++++|++++..+..|..+++|+.|
T Consensus 171 ~l-~L~~L~l~~n~l~~l-------------------------~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L 222 (332)
T 2ft3_A 171 GL-KLNYLRISEAKLTGI-------------------------PKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRL 222 (332)
T ss_dssp SC-CCSCCBCCSSBCSSC-------------------------CSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCC
T ss_pred CC-ccCEEECcCCCCCcc-------------------------Ccccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 55 666666666666532 22221 456666666666665555566666666666
Q ss_pred EccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccC------CCCCCEEeC
Q 036879 530 NLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGG------LTSLNFLDM 603 (1029)
Q Consensus 530 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------l~~L~~L~L 603 (1029)
+|++|++++..+..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+|++..+..|.. ..+|+.|++
T Consensus 223 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l 301 (332)
T 2ft3_A 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISL 301 (332)
T ss_dssp BCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEEC
T ss_pred ECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEe
Confidence 66666666555556666666666666666666 55556666666666666666666555555543 356778888
Q ss_pred cCCccc--CcCchhhhcccccceeeccCCC
Q 036879 604 SSNNLS--GEIPNSLKALSLLKFLNLSFNG 631 (1029)
Q Consensus 604 s~N~l~--~~~~~~~~~l~~L~~L~l~~N~ 631 (1029)
++|.++ +..|..|..+++|+.+++++|+
T Consensus 302 ~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 302 FNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ecCcccccccCcccccccchhhhhhccccc
Confidence 888776 5667777788888888887774
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=296.68 Aligned_cols=267 Identities=22% Similarity=0.264 Sum_probs=218.8
Q ss_pred cccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEE
Q 036879 379 KDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLY 458 (1029)
Q Consensus 379 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 458 (1029)
++|+.|++++|.+++..|..+.++.. |++|++++|++++..|..|.++++|++|+|++|+++ .+|..+. ++|++|+
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~ 129 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQH-LYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELR 129 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTT-CCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEE
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCC-CcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEE
Confidence 45677777777777666667777765 778888888888777888888888888888888888 4555444 7888888
Q ss_pred eccccccCcccccccCCCCCcEEecCCCccc--CccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcc
Q 036879 459 LQHNKLQGSITTDLCGLRSLSEFYSDGNELN--GSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSL 536 (1029)
Q Consensus 459 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 536 (1029)
+++|++++..+..|..+++|+.|++++|.++ +..+..+..+ +|++|++++|+++++ |..+. ++|+.|++++|.+
T Consensus 130 l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l-~~~~~--~~L~~L~l~~n~i 205 (332)
T 2ft3_A 130 IHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGI-PKDLP--ETLNELHLDHNKI 205 (332)
T ss_dssp CCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSC-CSSSC--SSCSCCBCCSSCC
T ss_pred CCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCcc-Ccccc--CCCCEEECCCCcC
Confidence 9888888877778888888999999988885 3778888888 999999999999974 44443 7899999999999
Q ss_pred cCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhh
Q 036879 537 NGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSL 616 (1029)
Q Consensus 537 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 616 (1029)
++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|+++ .+|..+..+++|++|++++|++++..+..|
T Consensus 206 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~ 284 (332)
T 2ft3_A 206 QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDF 284 (332)
T ss_dssp CCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSS
T ss_pred CccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHc
Confidence 9888899999999999999999999888889999999999999999999 788889999999999999999998887777
Q ss_pred hc------ccccceeeccCCCCcC--CCCC-CCCCCccCcccccCCC
Q 036879 617 KA------LSLLKFLNLSFNGLQG--QVPH-GGPFTNLSSQSFVGNK 654 (1029)
Q Consensus 617 ~~------l~~L~~L~l~~N~l~~--~~~~-~~~~~~l~~~~~~~n~ 654 (1029)
.. .+.|+.|++++|++.. ..|. ...++.+..+.+.+|.
T Consensus 285 ~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 65 3679999999999983 3332 2345666677777663
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=296.99 Aligned_cols=289 Identities=22% Similarity=0.263 Sum_probs=157.2
Q ss_pred CCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCccccc
Q 036879 292 SLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGF 371 (1029)
Q Consensus 292 ~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~ 371 (1029)
+|+.++++++.+. .+|..++ ++|+.|+|++|++++..+..|.++++|++|++++|.+.+..|..+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~----------- 96 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF----------- 96 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT-----------
T ss_pred CCeEEEecCCCcc-ccCccCC---CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHh-----------
Confidence 3455555555553 4444332 345555555555555544455555555555555555544433332
Q ss_pred ccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccc--ccccccc
Q 036879 372 LTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTG--SIPKAIG 449 (1029)
Q Consensus 372 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~ 449 (1029)
..+++|++|++++|+++ .+|..+. ..|++|++++|++++..+..|.++++|++|+|++|.++. ..+..|.
T Consensus 97 ----~~l~~L~~L~Ls~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 168 (330)
T 1xku_A 97 ----APLVKLERLYLSKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168 (330)
T ss_dssp ----TTCTTCCEEECCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGG
T ss_pred ----cCCCCCCEEECCCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhcc
Confidence 24455566666666555 3333332 235666666666665555566666667777777766642 4455666
Q ss_pred CCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEE
Q 036879 450 RLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNV 529 (1029)
Q Consensus 450 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 529 (1029)
.+++|++|++++|.++..... +. ++|++|++++|+++++.|..|..+++|+.|
T Consensus 169 ~l~~L~~L~l~~n~l~~l~~~-------------------------~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 221 (330)
T 1xku_A 169 GMKKLSYIRIADTNITTIPQG-------------------------LP--PSLTELHLDGNKITKVDAASLKGLNNLAKL 221 (330)
T ss_dssp GCTTCCEEECCSSCCCSCCSS-------------------------CC--TTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred CCCCcCEEECCCCccccCCcc-------------------------cc--ccCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 666666666666666532221 11 344555555555554444455555555555
Q ss_pred EccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccC------CCCCCEEeC
Q 036879 530 NLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGG------LTSLNFLDM 603 (1029)
Q Consensus 530 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------l~~L~~L~L 603 (1029)
+|++|.+++..+..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..|.. ...|+.|++
T Consensus 222 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l 300 (330)
T 1xku_A 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 300 (330)
T ss_dssp ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEEC
T ss_pred ECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEe
Confidence 55555555444445555555555555555555 44555555555555555555555444444432 356777777
Q ss_pred cCCcccC--cCchhhhcccccceeeccCCC
Q 036879 604 SSNNLSG--EIPNSLKALSLLKFLNLSFNG 631 (1029)
Q Consensus 604 s~N~l~~--~~~~~~~~l~~L~~L~l~~N~ 631 (1029)
++|.+.. ..|..|..+..++.++|++|+
T Consensus 301 ~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 301 FSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ecCcccccccCccccccccceeEEEecccC
Confidence 7777653 556677777777777777774
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-33 Score=315.87 Aligned_cols=241 Identities=17% Similarity=0.177 Sum_probs=182.0
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccc--------hhhHHHHHHHHHHhcCC---------CCceEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE--------GTLRSFDAECEILGSIR---------HRNLVKI 799 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~l 799 (1029)
.++|++.+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45688899999999999999998 789999999986531 23367889999998886 7777777
Q ss_pred EEEE-----------------ec-------------CCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q 036879 800 ISTC-----------------SS-------------DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALE 849 (1029)
Q Consensus 800 ~~~~-----------------~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 849 (1029)
.+.+ .+ .+..++||||+++|++.+.+. +..+++..+..++.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHHH
Confidence 6654 22 678999999999997766663 356899999999999999999
Q ss_pred HHH-hcCCCCcEEcCCCCCCEEECCCC--------------------cEEEEccCCceecCCCCCceeccccCCccccCc
Q 036879 850 YLH-YDHPTPIIHCDLNPSNILLNESM--------------------VACLSDFGISKLLGDETSMTQTQTLATIGYMAP 908 (1029)
Q Consensus 850 ~Lh-~~~~~givH~Dlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aP 908 (1029)
||| +. ||+||||||+|||++.++ .+||+|||+|+..... ...||+.|+||
T Consensus 176 ~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred HHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence 999 55 499999999999999887 9999999999876432 24699999999
Q ss_pred cCCC---CCCcchhHHHHH-HHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHH
Q 036879 909 EWKL---SRKGDVYSYGII-LMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVL 984 (1029)
Q Consensus 909 E~~~---~~~~DvwSlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~ 984 (1029)
|++. +.++||||+|++ .+++++|..||.... |.... ........ ..........+..++.++.
T Consensus 247 E~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~--------~~~~~----~~~~~~~~-~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 247 DLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVL--------WLHYL----TDKMLKQM-TFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp GGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHH--------HHHHH----HHHHHHTC-CCSSCCCSHHHHHHHHHHH
T ss_pred hhhcCCCccceehhhhhCCCCcccccccCCCcchh--------hhhHH----HHhhhhhh-ccCcccchhhhhhcCHHHH
Confidence 9954 557999998777 778899999975410 00000 00000000 0001111223456788999
Q ss_pred HHHHHcccccccCCCCHHHHH-HH
Q 036879 985 SLAMQCTRESAEERINIKEAL-TK 1007 (1029)
Q Consensus 985 ~li~~cl~~dP~~Rpt~~evl-~~ 1007 (1029)
+++.+|++.| |++|++ ++
T Consensus 314 dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHhccC-----CHHHHHhcC
Confidence 9999999966 999988 53
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=291.80 Aligned_cols=267 Identities=20% Similarity=0.238 Sum_probs=214.9
Q ss_pred cccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEE
Q 036879 379 KDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLY 458 (1029)
Q Consensus 379 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 458 (1029)
++|+.|++++|++++..+..+.++.+ |++|++++|++++..|..|.++++|++|+|++|+++ .+|..+. ++|++|+
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~ 127 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELR 127 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTT-CCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEE
T ss_pred CCCeEEECCCCcCCEeChhhhccCCC-CCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEE
Confidence 35666777777776665656666665 777777777777777778888888888888888887 4554443 6788888
Q ss_pred eccccccCcccccccCCCCCcEEecCCCcccC--ccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcc
Q 036879 459 LQHNKLQGSITTDLCGLRSLSEFYSDGNELNG--SLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSL 536 (1029)
Q Consensus 459 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 536 (1029)
+++|++++..+..|.++++|+.|++++|.+.. ..+..|.++++|++|++++|+++.+ |..+. ++|+.|++++|++
T Consensus 128 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l-~~~~~--~~L~~L~l~~n~l 204 (330)
T 1xku_A 128 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI-PQGLP--PSLTELHLDGNKI 204 (330)
T ss_dssp CCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC-CSSCC--TTCSEEECTTSCC
T ss_pred CCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccC-Ccccc--ccCCEEECCCCcC
Confidence 88888887777778888888888888888853 6788899999999999999999864 44443 8999999999999
Q ss_pred cCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhh
Q 036879 537 NGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSL 616 (1029)
Q Consensus 537 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 616 (1029)
++..|..+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|
T Consensus 205 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f 283 (330)
T 1xku_A 205 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283 (330)
T ss_dssp CEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred CccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhc
Confidence 9888999999999999999999999888889999999999999999999 788899999999999999999998877777
Q ss_pred hc------ccccceeeccCCCCcCC--CCC-CCCCCccCcccccCC
Q 036879 617 KA------LSLLKFLNLSFNGLQGQ--VPH-GGPFTNLSSQSFVGN 653 (1029)
Q Consensus 617 ~~------l~~L~~L~l~~N~l~~~--~~~-~~~~~~l~~~~~~~n 653 (1029)
.. .+.|+.|++++|++... .|. ......+..+.+.+|
T Consensus 284 ~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp SCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred CCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence 54 37899999999999752 222 233455666666666
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-34 Score=338.77 Aligned_cols=315 Identities=22% Similarity=0.170 Sum_probs=163.7
Q ss_pred CCcccCCCCcEEEccCcccCCCCCchhhhccc----ccceEeecCcccCC----CCCcccccccccceecCCCccccCCC
Q 036879 285 PEIINISSLTVLSLTANNLLGNLPSNIGHSLP----NLQQLILGGNRLTG----PIPSSISNASMLTLIDMPYNLFSGFI 356 (1029)
Q Consensus 285 ~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~----~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~ls~N~l~~~~ 356 (1029)
..+..+++|++|+|++|.+.+..+..++..++ +|++|+|++|+++. .++..+..+++|+.|++++|.+.+..
T Consensus 50 ~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 129 (461)
T 1z7x_W 50 SALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAG 129 (461)
T ss_dssp HHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHH
T ss_pred HHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHH
Confidence 33444455555555555544323333333333 45555555555552 23445555555555555555543221
Q ss_pred CCCCCCCCCCcccccccc-cccccccceeeccCCcCCCCC----CccccCchhhhcceeccccccccccccccC-----C
Q 036879 357 PNSLGFCHPYDELGFLTS-LTNCKDLRKLILSENPLSGVL----PISIGNLSNAMDVLYLSACNIKGSIPSEIG-----N 426 (1029)
Q Consensus 357 p~~~~~~~~~~~~~~~~~-l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~-----~ 426 (1029)
+..+. .. ....++|++|++++|++++.. +..+..+++ |++|++++|.+++..+..+. .
T Consensus 130 ~~~l~-----------~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~-L~~L~L~~n~i~~~~~~~l~~~l~~~ 197 (461)
T 1z7x_W 130 LQLLC-----------EGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD-FKELTVSNNDINEAGVRVLCQGLKDS 197 (461)
T ss_dssp HHHHH-----------HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTT-CCEEECCSSBCHHHHHHHHHHHHHHS
T ss_pred HHHHH-----------HHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCC-CCEEECcCCCcchHHHHHHHHHHhcC
Confidence 11110 00 112345666666666655432 222222232 55555555555443333332 2
Q ss_pred cCcCcEEEecCcccccc----ccccccCCCCCCEEEeccccccCccc-----ccccCCCCCcEEecCCCcccCc----cc
Q 036879 427 LNNLTTLHLETNELTGS----IPKAIGRLQKLQGLYLQHNKLQGSIT-----TDLCGLRSLSEFYSDGNELNGS----LP 493 (1029)
Q Consensus 427 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~-----~~~~~l~~L~~L~l~~N~l~~~----~~ 493 (1029)
.++|++|+|++|.+++. ++..+..+++|++|++++|.++.... ..+..+++|++|++++|.++.. ++
T Consensus 198 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 277 (461)
T 1z7x_W 198 PCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277 (461)
T ss_dssp CCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred CCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHH
Confidence 44667777777766642 35556666677777777776654322 1222456666666666666543 45
Q ss_pred cccccccccceeeccCccccCCCCCCccC-----CCCCcEEEccCCcccCc----CCccccccccccEEEccCCcCCCCC
Q 036879 494 QCLDSLISLRTLSLGFNRLTSVIPSSLWS-----LRDILNVNLSSNSLNGT----LPVEIGNLKVVTKIDLSRNDLSGEI 564 (1029)
Q Consensus 494 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~ 564 (1029)
..+..+++|++|+|++|.+++..+..+.. .++|+.|++++|.+++. ++..+..+++|+.|++++|.+++..
T Consensus 278 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 357 (461)
T 1z7x_W 278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG 357 (461)
T ss_dssp HHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred HHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence 55556666777777766665433332222 24666666666666643 3344455566666666666665443
Q ss_pred CccccC-----cccccccccccccccc----cCCccccCCCCCCEEeCcCCcccCc
Q 036879 565 PSSIGD-----LKNMQHLSLADNKFQG----SIPDSLGGLTSLNFLDMSSNNLSGE 611 (1029)
Q Consensus 565 p~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~ 611 (1029)
+..+.. .++|+.|+|++|++++ .+|..+..+++|++|+|++|++++.
T Consensus 358 ~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 358 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred HHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 433332 4566666666666664 4555555666666666666666543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-34 Score=333.87 Aligned_cols=381 Identities=20% Similarity=0.163 Sum_probs=224.5
Q ss_pred cchhccccccccCCCCc-ccccccccceEEcccccccC----CCCccccccccccceeeccccccc--------ccC---
Q 036879 204 LAELHLAYNQLSGQIPS-TLFECKQLKILSLSVNNFIG----SIPREIGNITMLKGLYLVYTNLTG--------EIQ--- 267 (1029)
Q Consensus 204 L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~n~l~~--------~l~--- 267 (1029)
+++|+|++|+++..... .+..+++|++|+|++|++++ .++..+..+++|+.|++++|.+.+ .+.
T Consensus 5 l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~ 84 (461)
T 1z7x_W 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS 84 (461)
T ss_dssp EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred ceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCC
Confidence 44455555554432222 25566777777777777653 234555566666666666665542 122
Q ss_pred -cccEEEccCCcccC----CCCCCcccCCCCcEEEccCcccCCCCCchhhh----cccccceEeecCcccCCCC----Cc
Q 036879 268 -GLQVLALSSNRLTG----VIPPEIINISSLTVLSLTANNLLGNLPSNIGH----SLPNLQQLILGGNRLTGPI----PS 334 (1029)
Q Consensus 268 -~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~----~l~~L~~L~L~~N~l~~~~----p~ 334 (1029)
+|++|+|++|+|+. .++..+..+++|++|+|++|.+.+..+..+.. ..++|++|+|++|++++.. +.
T Consensus 85 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 164 (461)
T 1z7x_W 85 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS 164 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHH
Confidence 57788888888774 45777778888888888888775433433332 2346777888777777532 34
Q ss_pred ccccccccceecCCCccccCCCCCCCCCCCCCcccccccccc-cccccceeeccCCcCCCCCCccccCchhhhcceeccc
Q 036879 335 SISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLT-NCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSA 413 (1029)
Q Consensus 335 ~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~ 413 (1029)
.+..+++|+.|++++|.+....+..+. ..+. ..++|++|++++|.+++....
T Consensus 165 ~l~~~~~L~~L~L~~n~i~~~~~~~l~-----------~~l~~~~~~L~~L~L~~n~l~~~~~~---------------- 217 (461)
T 1z7x_W 165 VLRAKPDFKELTVSNNDINEAGVRVLC-----------QGLKDSPCQLEALKLESCGVTSDNCR---------------- 217 (461)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHH-----------HHHHHSCCCCCEEECTTSCCBTTHHH----------------
T ss_pred HHhhCCCCCEEECcCCCcchHHHHHHH-----------HHHhcCCCCceEEEccCCCCcHHHHH----------------
Confidence 444455666666666555422111100 0000 123455555555544421000
Q ss_pred cccccccccccCCcCcCcEEEecCccccccc-----cccccCCCCCCEEEeccccccCc----ccccccCCCCCcEEecC
Q 036879 414 CNIKGSIPSEIGNLNNLTTLHLETNELTGSI-----PKAIGRLQKLQGLYLQHNKLQGS----ITTDLCGLRSLSEFYSD 484 (1029)
Q Consensus 414 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~ 484 (1029)
.++..+..+++|++|+|++|.+++.. +..+..+++|++|++++|.++.. .+..+..+++|++|+++
T Consensus 218 -----~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls 292 (461)
T 1z7x_W 218 -----DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLA 292 (461)
T ss_dssp -----HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECT
T ss_pred -----HHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECC
Confidence 13444555666666666666665322 22223456666666666666543 33444556666666666
Q ss_pred CCcccCccccccccc-----cccceeeccCccccCC----CCCCccCCCCCcEEEccCCcccCcCCccccc-----cccc
Q 036879 485 GNELNGSLPQCLDSL-----ISLRTLSLGFNRLTSV----IPSSLWSLRDILNVNLSSNSLNGTLPVEIGN-----LKVV 550 (1029)
Q Consensus 485 ~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L 550 (1029)
+|.+++..+..+... ++|++|+|++|.+++. ++..+..+++|+.|++++|.+++..+..+.. .++|
T Consensus 293 ~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L 372 (461)
T 1z7x_W 293 GNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL 372 (461)
T ss_dssp TCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCC
T ss_pred CCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCce
Confidence 666655444444332 5777777777777654 3455666678888888888777654544443 5688
Q ss_pred cEEEccCCcCCC----CCCccccCcccccccccccccccccCCcccc-----CCCCCCEEeCcCCcccCcCchhh
Q 036879 551 TKIDLSRNDLSG----EIPSSIGDLKNMQHLSLADNKFQGSIPDSLG-----GLTSLNFLDMSSNNLSGEIPNSL 616 (1029)
Q Consensus 551 ~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~~~~~ 616 (1029)
+.|+|++|.+++ .+|..+..+++|+.|+|++|++++.....+. ...+|+.|++.++.+....++.+
T Consensus 373 ~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~l 447 (461)
T 1z7x_W 373 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 447 (461)
T ss_dssp CEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred EEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHHH
Confidence 888888888875 5677777788888888888888764222221 23468888888887775554443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-31 Score=293.83 Aligned_cols=283 Identities=21% Similarity=0.277 Sum_probs=210.4
Q ss_pred CCCCCcccCCCCC--CCCCCceeeEEEcCCC--CceEEEecccccccccCCccC--CCCcCCCeEeccCcccccCCcccc
Q 036879 19 NDPLNVLASNWST--NTSVCNWFGVTCSPRH--RRVTALNLAYMGLLGTIPPEL--GNLSFLSLLNVTNNSFSGTLPIQL 92 (1029)
Q Consensus 19 ~~~~~~~~~~w~~--~~~~c~w~gv~c~~~~--~~v~~l~l~~~~l~~~~p~~~--~~l~~L~~L~l~~n~l~~~~p~~~ 92 (1029)
.|+...|.+ |.. ..|+|+|.++-|.... ..+. ...+.... .+|..+ ...+.++.|+|++|+++ .+|..+
T Consensus 26 ~~~~~aLl~-~k~~~~~~~~~~~~~w~~~~~~~~~~~--~~~g~~~~-~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 26 RPYHDVLSQ-WQRHYNADRNRWHSAWRQANSNNPQIE--TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp CCHHHHHHH-HHHHHHHCCTTHHHHHHHHTTTCTTSC--CSHHHHHH-HHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred chHHHHHHH-HHHhccCCchhhhhhhccccccccccc--ccCCcchh-hhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 355566766 754 3578999998884221 1111 11111111 122222 23577899999999998 888889
Q ss_pred ccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCc
Q 036879 93 SNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLL 172 (1029)
Q Consensus 93 ~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 172 (1029)
+++++|++|+|++|+++ .+|..++.+++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..+....
T Consensus 101 ~~l~~L~~L~L~~n~l~--~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~--- 174 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM--ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD--- 174 (328)
T ss_dssp GGGTTCSEEEEESSCCC--CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC---
T ss_pred hhCCCCCEEECCCCCcc--chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhcc---
Confidence 99999999999999998 57888999999999999999988 7898999999999999999888878887665410
Q ss_pred ccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcccccccCCCCccccccccc
Q 036879 173 AIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITML 252 (1029)
Q Consensus 173 ~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 252 (1029)
+.+. +. ...+|++|+|++|+++ .+|..++.+++|++|+|++|++++ +|..++++++|
T Consensus 175 --------~~~~---~~----------~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L 231 (328)
T 4fcg_A 175 --------ASGE---HQ----------GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231 (328)
T ss_dssp ---------CCC---EE----------ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTC
T ss_pred --------chhh---hc----------cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCC
Confidence 0000 00 0124555566666666 567778888888888888888874 56667666554
Q ss_pred cceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCC
Q 036879 253 KGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPI 332 (1029)
Q Consensus 253 ~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~ 332 (1029)
+ +|+|++|.+.+.+|..+.++++|++|+|++|++.+.+|..+. .+++|++|+|++|.+.+.+
T Consensus 232 ~-----------------~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~l~~L~~L~L~~n~~~~~i 293 (328)
T 4fcg_A 232 E-----------------ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH-RLTQLEKLDLRGCVNLSRL 293 (328)
T ss_dssp C-----------------EEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGG-GCTTCCEEECTTCTTCCCC
T ss_pred C-----------------EEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhh-cCCCCCEEeCCCCCchhhc
Confidence 4 778888888888888899999999999999888888888876 5899999999999999899
Q ss_pred CcccccccccceecCCCcccc
Q 036879 333 PSSISNASMLTLIDMPYNLFS 353 (1029)
Q Consensus 333 p~~l~~l~~L~~L~ls~N~l~ 353 (1029)
|..+.++++|+.++++.+.+.
T Consensus 294 P~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 294 PSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CGGGGGSCTTCEEECCGGGSC
T ss_pred cHHHhhccCceEEeCCHHHHH
Confidence 999999998888888877664
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=278.29 Aligned_cols=275 Identities=21% Similarity=0.247 Sum_probs=218.4
Q ss_pred ceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCcccccc--ccccccCCCCCCEEEe
Q 036879 382 RKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGS--IPKAIGRLQKLQGLYL 459 (1029)
Q Consensus 382 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L 459 (1029)
+.++++++.++ .+|..+. ..+++|++++|+++...+..|.++++|++|+|++|+++.. .+..+..+++|++|+|
T Consensus 10 ~~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 56788888877 5555443 2478888888888866556688888999999999988733 2566778888999999
Q ss_pred ccccccCcccccccCCCCCcEEecCCCcccCccc-cccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccC
Q 036879 460 QHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLP-QCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNG 538 (1029)
Q Consensus 460 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 538 (1029)
++|.++. .+..+..+++|++|++++|++++..+ ..+..+++|++|++++|++++..+..+..+++|+.|++++|.+++
T Consensus 86 s~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 86 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp CSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 9998874 45568888899999999998887665 678888999999999999988888888889999999999999886
Q ss_pred -cCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhh
Q 036879 539 -TLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLK 617 (1029)
Q Consensus 539 -~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 617 (1029)
..|..+..+++|+.|++++|++++..|..|..+++|+.|+|++|++++..+..+..+++|++|+|++|++++..|..+.
T Consensus 165 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 244 (306)
T 2z66_A 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 244 (306)
T ss_dssp GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCC
T ss_pred ccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHH
Confidence 5788888999999999999999887788888899999999999999877777888889999999999999988888888
Q ss_pred ccc-ccceeeccCCCCcCCCCCCC---CCCccCcccccCCCCCCCCCC
Q 036879 618 ALS-LLKFLNLSFNGLQGQVPHGG---PFTNLSSQSFVGNKGLCGAPE 661 (1029)
Q Consensus 618 ~l~-~L~~L~l~~N~l~~~~~~~~---~~~~l~~~~~~~n~~~c~~~~ 661 (1029)
.++ +|+.|++++|++++..+... .+.....+....+...|..|.
T Consensus 245 ~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 245 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 292 (306)
T ss_dssp CCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred hhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence 884 89999999999987654311 112223333455666676653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=285.43 Aligned_cols=257 Identities=19% Similarity=0.171 Sum_probs=166.7
Q ss_pred ccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEe
Q 036879 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYL 459 (1029)
Q Consensus 380 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 459 (1029)
+|++|++++|++++..+..+..+.+ |++|++++|++++..|..|.++++|++|+|++|+|++..+..|..+++|++|++
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVN-LQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTT-CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred cCcEEECCCCcCcccCHHHhccCCC-CCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 4556666666665544445555554 666666666666655666666677777777777776544445666677777777
Q ss_pred ccccccCccc-ccccCCCCCcEEecCCC-cccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCccc
Q 036879 460 QHNKLQGSIT-TDLCGLRSLSEFYSDGN-ELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLN 537 (1029)
Q Consensus 460 ~~N~l~~~~~-~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 537 (1029)
++|++++... ..|..+++|++|++++| .+....+..|.++++|++|++++|++++..|..+..+++|++|++++|+++
T Consensus 132 ~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred CCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 7777665544 45666677777777666 355555666777777777777777777766777777777777777777776
Q ss_pred CcCCccccccccccEEEccCCcCCCCCCcccc---Ccccccccccccccccc----cCCccccCCCCCCEEeCcCCcccC
Q 036879 538 GTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIG---DLKNMQHLSLADNKFQG----SIPDSLGGLTSLNFLDMSSNNLSG 610 (1029)
Q Consensus 538 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~ 610 (1029)
...+..+..+++|+.|++++|.+++..+..+. ....++.++|++|.+++ .+|..+..+++|++|+|++|+++.
T Consensus 212 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~ 291 (353)
T 2z80_A 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS 291 (353)
T ss_dssp THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC
T ss_pred cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc
Confidence 44333444567777777777777755444332 24445555665555554 356667777778888888887774
Q ss_pred cCchhhhcccccceeeccCCCCcCCCC
Q 036879 611 EIPNSLKALSLLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 611 ~~~~~~~~l~~L~~L~l~~N~l~~~~~ 637 (1029)
..+..|..+++|+.|++++|+++|.+|
T Consensus 292 i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 292 VPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 444445777778888888877777665
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=283.97 Aligned_cols=280 Identities=19% Similarity=0.163 Sum_probs=243.7
Q ss_pred cccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCE
Q 036879 377 NCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQG 456 (1029)
Q Consensus 377 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 456 (1029)
.++.....++++|.++ .+|..+.. .+++|++++|++++..+..|.++++|++|+|++|++++..|..|..+++|++
T Consensus 29 ~C~~~~~c~~~~~~l~-~iP~~~~~---~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (353)
T 2z80_A 29 SCDRNGICKGSSGSLN-SIPSGLTE---AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH 104 (353)
T ss_dssp EECTTSEEECCSTTCS-SCCTTCCT---TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCCCeEeeCCCCCcc-cccccccc---cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCE
Confidence 4556667899999998 66766553 4999999999999877779999999999999999999888889999999999
Q ss_pred EEeccccccCcccccccCCCCCcEEecCCCcccCccc-cccccccccceeeccCc-cccCCCCCCccCCCCCcEEEccCC
Q 036879 457 LYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLP-QCLDSLISLRTLSLGFN-RLTSVIPSSLWSLRDILNVNLSSN 534 (1029)
Q Consensus 457 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N 534 (1029)
|+|++|++++..+..|..+++|++|++++|+++...+ ..|..+++|++|++++| .++++.+..|.++++|+.|++++|
T Consensus 105 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 184 (353)
T 2z80_A 105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184 (353)
T ss_dssp EECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred EECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCC
Confidence 9999999998888889999999999999999996655 58999999999999999 588888889999999999999999
Q ss_pred cccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCcccc---CCCCCCEEeCcCCcccC-
Q 036879 535 SLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLG---GLTSLNFLDMSSNNLSG- 610 (1029)
Q Consensus 535 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~- 610 (1029)
++++..|..+..+++|++|++++|+++...+..+..+++|+.|+|++|++++..+..+. ....++.++|++|.+++
T Consensus 185 ~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~ 264 (353)
T 2z80_A 185 DLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264 (353)
T ss_dssp TCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHH
T ss_pred CcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCc
Confidence 99998899999999999999999999754444456689999999999999976655443 35778899999998886
Q ss_pred ---cCchhhhcccccceeeccCCCCcCCCCCC-CCCCccCcccccCCCCCCCCC
Q 036879 611 ---EIPNSLKALSLLKFLNLSFNGLQGQVPHG-GPFTNLSSQSFVGNKGLCGAP 660 (1029)
Q Consensus 611 ---~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~~ 660 (1029)
.+|..+..+++|+.|++++|+++..++.. ..+.++..+.+.+||+.|+||
T Consensus 265 ~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 265 SLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred chhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 46788999999999999999999544443 578899999999999999886
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-28 Score=284.67 Aligned_cols=252 Identities=24% Similarity=0.290 Sum_probs=225.4
Q ss_pred ccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEe
Q 036879 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYL 459 (1029)
Q Consensus 380 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 459 (1029)
..+.++.+++.++ .+|..+. ..++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 3567888888888 6676655 34889999999999888899999999999999999999888889999999999999
Q ss_pred ccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccC-ccccCCCCCCccCCCCCcEEEccCCcccC
Q 036879 460 QHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGF-NRLTSVIPSSLWSLRDILNVNLSSNSLNG 538 (1029)
Q Consensus 460 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 538 (1029)
++|+++...+..|..+++|++|++++|++....+..|..+++|++|+|++ |.++.+.+..|.++++|+.|+|++|+++.
T Consensus 120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 199 (440)
T 3zyj_A 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE 199 (440)
T ss_dssp CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred CCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence 99999988888899999999999999999988888999999999999998 56666666789999999999999999984
Q ss_pred cCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhc
Q 036879 539 TLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKA 618 (1029)
Q Consensus 539 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 618 (1029)
+| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..
T Consensus 200 -~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 277 (440)
T 3zyj_A 200 -IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP 277 (440)
T ss_dssp -CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSS
T ss_pred -cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcc
Confidence 45 4888999999999999999888999999999999999999999888899999999999999999999888888999
Q ss_pred ccccceeeccCCCCcCCCC
Q 036879 619 LSLLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 619 l~~L~~L~l~~N~l~~~~~ 637 (1029)
+++|+.|+|++|++.|...
T Consensus 278 l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 278 LHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp CTTCCEEECCSSCEECSST
T ss_pred ccCCCEEEcCCCCccCCCC
Confidence 9999999999999987653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=285.62 Aligned_cols=252 Identities=22% Similarity=0.259 Sum_probs=221.3
Q ss_pred ccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEe
Q 036879 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYL 459 (1029)
Q Consensus 380 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 459 (1029)
....++.+++.++ .+|..+. ..+++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 3467888888887 5665554 34889999999999888889999999999999999999888888999999999999
Q ss_pred ccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccC-ccccCCCCCCccCCCCCcEEEccCCcccC
Q 036879 460 QHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGF-NRLTSVIPSSLWSLRDILNVNLSSNSLNG 538 (1029)
Q Consensus 460 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 538 (1029)
++|+++...+..|..+++|++|++++|++....+..|..+++|++|++++ |.+..+.+..|.++++|+.|+|++|++++
T Consensus 131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp CSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred CCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence 99999988888899999999999999999988888899999999999998 66666666789999999999999999985
Q ss_pred cCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhc
Q 036879 539 TLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKA 618 (1029)
Q Consensus 539 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 618 (1029)
. | .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..|..
T Consensus 211 ~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 288 (452)
T 3zyi_A 211 M-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288 (452)
T ss_dssp C-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred c-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence 3 4 5888999999999999999888999999999999999999999888899999999999999999999888888899
Q ss_pred ccccceeeccCCCCcCCCC
Q 036879 619 LSLLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 619 l~~L~~L~l~~N~l~~~~~ 637 (1029)
+++|+.|+|++|++.+...
T Consensus 289 l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 289 LRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CTTCCEEECCSSCEECSTT
T ss_pred ccCCCEEEccCCCcCCCCC
Confidence 9999999999999987654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=298.73 Aligned_cols=294 Identities=28% Similarity=0.343 Sum_probs=222.1
Q ss_pred CCcccCCCCCCCCCCceeeEEE------cCCCCceEEEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccc
Q 036879 22 LNVLASNWSTNTSVCNWFGVTC------SPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNL 95 (1029)
Q Consensus 22 ~~~~~~~w~~~~~~c~w~gv~c------~~~~~~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 95 (1029)
..+.++ |..+.+||.|+|..| .+....++.|+++++++. .+|..+. ++|+.|+|++|+|+ .+|. .+
T Consensus 9 ~~~w~~-W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l 80 (622)
T 3g06_A 9 DAVWSA-WRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LP 80 (622)
T ss_dssp -CHHHH-HHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CC
T ss_pred HHHHHH-HHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cC
Confidence 345555 887889999977542 222345889999999998 9999886 89999999999998 6776 57
Q ss_pred cCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccc
Q 036879 96 RRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAID 175 (1029)
Q Consensus 96 ~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 175 (1029)
++|++|+|++|+|+. +|. .+++|++|+|++|++++ +|. .+++|+.|++++|+++ .+|.. +++|++|+
T Consensus 81 ~~L~~L~Ls~N~l~~--lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~-~lp~~---l~~L~~L~ 147 (622)
T 3g06_A 81 PELRTLEVSGNQLTS--LPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLT-SLPVL---PPGLQELS 147 (622)
T ss_dssp TTCCEEEECSCCCSC--CCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEE
T ss_pred CCCCEEEcCCCcCCc--CCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCC-cCCCC---CCCCCEEE
Confidence 899999999999995 565 67999999999999994 665 6789999999999999 57764 48899999
Q ss_pred cCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcccccccCCCCccccccccccce
Q 036879 176 LSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGL 255 (1029)
Q Consensus 176 ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 255 (1029)
+++|++++++... .+|+.|++++|+|++ +| ..+++|+.|+|++|++++ +|..+
T Consensus 148 Ls~N~l~~l~~~~-------------~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~~--------- 200 (622)
T 3g06_A 148 VSDNQLASLPALP-------------SELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTLP--------- 200 (622)
T ss_dssp CCSSCCSCCCCCC-------------TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCCC---------
T ss_pred CcCCcCCCcCCcc-------------CCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCcc---------
Confidence 9999998754321 256778888888885 45 456889999999998874 44322
Q ss_pred eecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcc
Q 036879 256 YLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSS 335 (1029)
Q Consensus 256 ~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~ 335 (1029)
++|+.|++++|.|+. +|.. +++|++|+|++|+++ .+| ..+++|+.|+|++|+|++ +|.
T Consensus 201 -----------~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~-~lp----~~l~~L~~L~Ls~N~L~~-lp~- 258 (622)
T 3g06_A 201 -----------SELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT-SLP----VLPSELKELMVSGNRLTS-LPM- 258 (622)
T ss_dssp -----------TTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCC-
T ss_pred -----------chhhEEECcCCcccc-cCCC---CCCCCEEEccCCccC-cCC----CCCCcCcEEECCCCCCCc-CCc-
Confidence 345567777777773 3432 367888888888776 466 235778888888888874 443
Q ss_pred cccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCch
Q 036879 336 ISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLS 403 (1029)
Q Consensus 336 l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 403 (1029)
.+++|+.|++++|.++ .+|.. +..+++|+.|+|++|++++..|..+..+.
T Consensus 259 --~~~~L~~L~Ls~N~L~-~lp~~---------------l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 259 --LPSGLLSLSVYRNQLT-RLPES---------------LIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp --CCTTCCEEECCSSCCC-SCCGG---------------GGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred --ccccCcEEeCCCCCCC-cCCHH---------------HhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 5577888888888877 44433 44778888889999988888888766544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=272.04 Aligned_cols=258 Identities=19% Similarity=0.229 Sum_probs=214.2
Q ss_pred cccceeeccCCcCCCCCCccccCchhhhcceeccccccccc--cccccCCcCcCcEEEecCccccccccccccCCCCCCE
Q 036879 379 KDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGS--IPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQG 456 (1029)
Q Consensus 379 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 456 (1029)
++|++|++++|+++...+..+..+.+ |++|++++|+++.. .+..+..+++|++|+|++|.++ .+|..+..+++|++
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~ 105 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQ-LTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH 105 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTT-CSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCE
T ss_pred CCCCEEECCCCccCccCHhHhhcccc-CCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCE
Confidence 45666777777766444444556554 77777777777632 3566677889999999999998 56777889999999
Q ss_pred EEeccccccCccc-ccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccC-CCCCCccCCCCCcEEEccCC
Q 036879 457 LYLQHNKLQGSIT-TDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTS-VIPSSLWSLRDILNVNLSSN 534 (1029)
Q Consensus 457 L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N 534 (1029)
|++++|++++..+ ..+..+++|++|++++|.+.+..+..|..+++|++|++++|++++ ..|..+..+++|+.|++++|
T Consensus 106 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n 185 (306)
T 2z66_A 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185 (306)
T ss_dssp EECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred EECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCC
Confidence 9999999987766 678889999999999999998889999999999999999999987 68889999999999999999
Q ss_pred cccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCC-CCCEEeCcCCcccCcCc
Q 036879 535 SLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLT-SLNFLDMSSNNLSGEIP 613 (1029)
Q Consensus 535 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~ 613 (1029)
++++..|..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+..++ +|++|+|++|++++..+
T Consensus 186 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 186 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred CcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 99988899999999999999999999987777899999999999999999999999999884 99999999999986533
Q ss_pred --hhhhcccccceeeccCCCCcCCCCC
Q 036879 614 --NSLKALSLLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 614 --~~~~~l~~L~~L~l~~N~l~~~~~~ 638 (1029)
.....+...+.+.+..+.+.|..|.
T Consensus 266 ~~~~~~~l~~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 266 HQSFLQWIKDQRQLLVEVERMECATPS 292 (306)
T ss_dssp GHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred hHHHHHHHHhhhhhhccccccccCCch
Confidence 2234456666777788888887665
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-29 Score=271.19 Aligned_cols=251 Identities=23% Similarity=0.243 Sum_probs=136.7
Q ss_pred ceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEecc
Q 036879 382 RKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQH 461 (1029)
Q Consensus 382 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 461 (1029)
+.++++++.++ .+|..+. ..+++|++++|++++..+..|.++++|++|+|++|.+++..|..|..+++|++|++++
T Consensus 14 ~~~~c~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCCC---CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 56777777766 3444332 2366666666666655555666666666666666666655566666666666666666
Q ss_pred cc-ccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcC
Q 036879 462 NK-LQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTL 540 (1029)
Q Consensus 462 N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 540 (1029)
|. ++...+..|..+++ |++|++++|++++..|..|..+++|++|++++|++++..
T Consensus 90 n~~l~~~~~~~~~~l~~------------------------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 145 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGR------------------------LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145 (285)
T ss_dssp CTTCCCCCTTTTTTCTT------------------------CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCCccccCHHHhcCCcC------------------------CCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccC
Confidence 65 55444444444444 455555555544444444555555555555555555444
Q ss_pred CccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhccc
Q 036879 541 PVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALS 620 (1029)
Q Consensus 541 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 620 (1029)
+..++.+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..+..+..++
T Consensus 146 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 225 (285)
T 1ozn_A 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred HhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCc
Confidence 44455555555555555555544444455555555555555555555555555555555555555555554445555555
Q ss_pred ccceeeccCCCCcCCCCCCCCCCccCcccccCCCCCCCCC
Q 036879 621 LLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAP 660 (1029)
Q Consensus 621 ~L~~L~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~ 660 (1029)
+|+.|++++|++.+..+....+.++.......+...|..|
T Consensus 226 ~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p 265 (285)
T 1ozn_A 226 ALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265 (285)
T ss_dssp TCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred ccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCc
Confidence 5555555555555544332222333333444444455444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-28 Score=283.09 Aligned_cols=251 Identities=21% Similarity=0.236 Sum_probs=229.1
Q ss_pred hcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCC
Q 036879 406 MDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485 (1029)
Q Consensus 406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 485 (1029)
...++.++++++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 457888888998 6676664 6899999999999988889999999999999999999999999999999999999999
Q ss_pred CcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccC-CcccCcCCccccccccccEEEccCCcCCCCC
Q 036879 486 NELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSS-NSLNGTLPVEIGNLKVVTKIDLSRNDLSGEI 564 (1029)
Q Consensus 486 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 564 (1029)
|+++...+..|..+++|++|+|++|+++++.+..|..+++|+.|+|++ |.++...+..|.++++|+.|+|++|.++ .+
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~ 200 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EI 200 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SC
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cc
Confidence 999988888999999999999999999998888999999999999999 5566556668999999999999999998 45
Q ss_pred CccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCC-CCCC
Q 036879 565 PSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHG-GPFT 643 (1029)
Q Consensus 565 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~ 643 (1029)
| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|++++..+.. ..+.
T Consensus 201 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 5 4889999999999999999988999999999999999999999999999999999999999999999876653 5678
Q ss_pred ccCcccccCCCCCCCCCC
Q 036879 644 NLSSQSFVGNKGLCGAPE 661 (1029)
Q Consensus 644 ~l~~~~~~~n~~~c~~~~ 661 (1029)
++..+.+.+|||.|+|..
T Consensus 280 ~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 280 HLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp TCCEEECCSSCEECSSTT
T ss_pred CCCEEEcCCCCccCCCCc
Confidence 888999999999999953
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=283.19 Aligned_cols=251 Identities=21% Similarity=0.232 Sum_probs=228.9
Q ss_pred hcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCC
Q 036879 406 MDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485 (1029)
Q Consensus 406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 485 (1029)
...++.+++.++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 456888888888 5676554 6899999999999988899999999999999999999999999999999999999999
Q ss_pred CcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccC-CcccCcCCccccccccccEEEccCCcCCCCC
Q 036879 486 NELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSS-NSLNGTLPVEIGNLKVVTKIDLSRNDLSGEI 564 (1029)
Q Consensus 486 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 564 (1029)
|+++...+..|..+++|++|+|++|+++++.+..|..+++|+.|++++ |.++...+..|.++++|+.|+|++|++++.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~- 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM- 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-
Confidence 999988889999999999999999999988888999999999999999 566655566799999999999999999854
Q ss_pred CccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCC-CCCC
Q 036879 565 PSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHG-GPFT 643 (1029)
Q Consensus 565 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~ 643 (1029)
| .+..+++|+.|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|+.|+|++|++++.++.. ..+.
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 4 5889999999999999999988999999999999999999999999999999999999999999999766653 5678
Q ss_pred ccCcccccCCCCCCCCCC
Q 036879 644 NLSSQSFVGNKGLCGAPE 661 (1029)
Q Consensus 644 ~l~~~~~~~n~~~c~~~~ 661 (1029)
++..+.+.+|||.|+|..
T Consensus 291 ~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 291 YLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TCCEEECCSSCEECSTTT
T ss_pred CCCEEEccCCCcCCCCCc
Confidence 888999999999999963
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-28 Score=263.77 Aligned_cols=253 Identities=21% Similarity=0.242 Sum_probs=171.4
Q ss_pred cceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccc
Q 036879 342 LTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIP 421 (1029)
Q Consensus 342 L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p 421 (1029)
-+.++.+++.+.. +|.. -.++|++|++++|.+++..+..+..+.+ |++|++++|++++..|
T Consensus 13 ~~~~~c~~~~l~~-ip~~-----------------~~~~l~~L~l~~n~i~~~~~~~~~~~~~-L~~L~l~~n~l~~~~~ 73 (285)
T 1ozn_A 13 KVTTSCPQQGLQA-VPVG-----------------IPAASQRIFLHGNRISHVPAASFRACRN-LTILWLHSNVLARIDA 73 (285)
T ss_dssp SCEEECCSSCCSS-CCTT-----------------CCTTCSEEECTTSCCCEECTTTTTTCTT-CCEEECCSSCCCEECT
T ss_pred CeEEEcCcCCccc-CCcC-----------------CCCCceEEEeeCCcCCccCHHHcccCCC-CCEEECCCCccceeCH
Confidence 3678888888873 3422 2468999999999999888888988887 9999999999998889
Q ss_pred cccCCcCcCcEEEecCcc-ccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCcccccccccc
Q 036879 422 SEIGNLNNLTTLHLETNE-LTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLI 500 (1029)
Q Consensus 422 ~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 500 (1029)
..|.++++|++|+|++|. +++..|..|..+++|++|++++|.+++..+..|..+++|++|++++|++++..+..|..++
T Consensus 74 ~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 153 (285)
T 1ozn_A 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153 (285)
T ss_dssp TTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCC
Confidence 999999999999999997 8877788999999999999999999866665565555555555555555544444455555
Q ss_pred ccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccc
Q 036879 501 SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLA 580 (1029)
Q Consensus 501 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 580 (1029)
+|++|+|++|+++++.+ ..+..+++|+.|++++|.+++..|..|..+++|+.|+|+
T Consensus 154 ~L~~L~l~~n~l~~~~~------------------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 209 (285)
T 1ozn_A 154 NLTHLFLHGNRISSVPE------------------------RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209 (285)
T ss_dssp TCCEEECCSSCCCEECT------------------------TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CccEEECCCCcccccCH------------------------HHhcCccccCEEECCCCcccccCHhHccCcccccEeeCC
Confidence 55555555555544433 345555555555555555555555555555556666666
Q ss_pred cccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCC
Q 036879 581 DNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 581 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 638 (1029)
+|++++..+..+..+++|++|+|++|+++...+. ..-...++.+..+.|.+.|..|.
T Consensus 210 ~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp SSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESG
T ss_pred CCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCch
Confidence 6665544444555666666666666666543321 11223344455566666665554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-29 Score=280.42 Aligned_cols=266 Identities=21% Similarity=0.225 Sum_probs=146.0
Q ss_pred CCCCCCCCceeeEEEcCCCCceEEEecccccccccCCccCCCCcCCCeEeccCccc-ccCCccccc-------cccCCce
Q 036879 29 WSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSF-SGTLPIQLS-------NLRRLKY 100 (1029)
Q Consensus 29 w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l-~~~~p~~~~-------~l~~L~~ 100 (1029)
|.....|+.|..+........++.++++++.+ .+|..+... |+.|+|++|++ .+.+|..+. ++++|++
T Consensus 24 ~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~ 99 (312)
T 1wwl_A 24 WSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99 (312)
T ss_dssp GGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCE
T ss_pred hHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccE
Confidence 43333444444443332333444555555555 445444332 55555555555 233444443 4555555
Q ss_pred eecccccccCCCCCCcC--CCCCccceeccccccccCCCcccccCc-----cccCeEeccCCcCcccCCccccCCCcCcc
Q 036879 101 LSFRSNNFSSIEIPPWL--DSFPKLEHLYLDGNSFIGTIPPSICNI-----SSLLTLDLSFNQLQGHVPSSILNIPSLLA 173 (1029)
Q Consensus 101 L~l~~N~l~~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 173 (1029)
|+|++|+++. .+|..+ ..+++|++|+|++|++++. |+.++.+ ++|++|+|++|++++..|..|.++++|++
T Consensus 100 L~L~~n~l~~-~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 177 (312)
T 1wwl_A 100 LTLENLEVTG-TAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALST 177 (312)
T ss_dssp EEEEEEBCBS-CCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCE
T ss_pred EEccCCcccc-hhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCE
Confidence 5555555543 234333 4555555555555555533 4444444 45555555555555444455555555555
Q ss_pred cccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCccc--ccccccceEEcccccccCC--CCc-cccc
Q 036879 174 IDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTL--FECKQLKILSLSVNNFIGS--IPR-EIGN 248 (1029)
Q Consensus 174 L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~--~p~-~~~~ 248 (1029)
|++++|++.+..+ .|..+ ..+++|++|+|++|++++. ++. .+.+
T Consensus 178 L~Ls~N~l~~~~~-------------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 226 (312)
T 1wwl_A 178 LDLSDNPELGERG-------------------------------LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226 (312)
T ss_dssp EECCSCTTCHHHH-------------------------------HHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHT
T ss_pred EECCCCCcCcchH-------------------------------HHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhc
Confidence 5555554432100 12222 5566777777777766521 111 1122
Q ss_pred cccccceeecccccccccCcccEEEccCCcccCCCC-CCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcc
Q 036879 249 ITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIP-PEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNR 327 (1029)
Q Consensus 249 l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~ 327 (1029)
+++|++|+|++|+|++..| ..+..+++|++|+|++|.++ .+|..++ ++|++|+|++|+
T Consensus 227 -----------------l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~---~~L~~L~Ls~N~ 285 (312)
T 1wwl_A 227 -----------------RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP---AKLSVLDLSYNR 285 (312)
T ss_dssp -----------------TCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC---SEEEEEECCSSC
T ss_pred -----------------CCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc---CCceEEECCCCC
Confidence 2455677888888877665 45666788888888888886 7777665 678888888888
Q ss_pred cCCCCCcccccccccceecCCCccccC
Q 036879 328 LTGPIPSSISNASMLTLIDMPYNLFSG 354 (1029)
Q Consensus 328 l~~~~p~~l~~l~~L~~L~ls~N~l~~ 354 (1029)
|++. |. +..+++|++|++++|.+++
T Consensus 286 l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 286 LDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 8865 44 7777777777777777653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-29 Score=298.23 Aligned_cols=237 Identities=19% Similarity=0.214 Sum_probs=167.3
Q ss_pred cccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCE
Q 036879 377 NCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQG 456 (1029)
Q Consensus 377 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 456 (1029)
.+++|+.|+|++|.+++..|..|..++. |++|+|++|.+++..| |..+++|++|+|++|.|++..+ .++|++
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~ 103 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTK-LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIET 103 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTT-CCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCC-CCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCE
Confidence 4457888888888887777777777765 7788888888776555 7777788888888887774322 267788
Q ss_pred EEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCcc-CCCCCcEEEccCCc
Q 036879 457 LYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLW-SLRDILNVNLSSNS 535 (1029)
Q Consensus 457 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~ 535 (1029)
|++++|.+++..+.. +++|+.|++++|.+++..|..|+.+++|++|+|++|.+++..|..+. .+++|+.|+|++|.
T Consensus 104 L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 104 LHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp EECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 888888777665543 46677777777777777777777777777777777777776666665 57777777777777
Q ss_pred ccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCccc-CcCch
Q 036879 536 LNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS-GEIPN 614 (1029)
Q Consensus 536 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~ 614 (1029)
|++.. .+..+++|+.|+|++|.+++. |..|..+++|+.|+|++|+|++ +|..+..+++|+.|++++|.++ +.+|.
T Consensus 181 l~~~~--~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~ 256 (487)
T 3oja_A 181 IYDVK--GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (487)
T ss_dssp CCEEE--CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHH
T ss_pred ccccc--ccccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHH
Confidence 77542 233477777777777777743 3346777777777777777774 5666777777777777777776 55666
Q ss_pred hhhcccccceeecc
Q 036879 615 SLKALSLLKFLNLS 628 (1029)
Q Consensus 615 ~~~~l~~L~~L~l~ 628 (1029)
.+..++.|+.++++
T Consensus 257 ~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 257 FFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHTTCHHHHHHHHH
T ss_pred HHHhCCCCcEEecc
Confidence 66666666666664
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-29 Score=275.30 Aligned_cols=249 Identities=20% Similarity=0.200 Sum_probs=208.8
Q ss_pred cccccccceeeccCCcCCCCCCccccCchhhhcceeccccccc-cccccccC-------CcCcCcEEEecCccccccccc
Q 036879 375 LTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIK-GSIPSEIG-------NLNNLTTLHLETNELTGSIPK 446 (1029)
Q Consensus 375 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~-~~~p~~~~-------~l~~L~~L~L~~N~l~~~~~~ 446 (1029)
+...++|+.|++++|.+ .+|..+... ++.|++++|+++ ..+|..+. ++++|++|+|++|++++..|.
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI---IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH---HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH---HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 34667899999999998 667665543 888999999994 45666555 689999999999999988888
Q ss_pred cc--cCCCCCCEEEeccccccCcccccccCC-----CCCcEEecCCCcccCccccccccccccceeeccCccccCC--CC
Q 036879 447 AI--GRLQKLQGLYLQHNKLQGSITTDLCGL-----RSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSV--IP 517 (1029)
Q Consensus 447 ~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~ 517 (1029)
.+ ..+++|++|+|++|++++. +..+..+ ++|++|++++|++.+..|..|+.+++|++|+|++|++.+. .+
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 76 8899999999999999887 6777766 8999999999999988889999999999999999998764 23
Q ss_pred CC--ccCCCCCcEEEccCCcccC---cCCccccccccccEEEccCCcCCCCCC-ccccCcccccccccccccccccCCcc
Q 036879 518 SS--LWSLRDILNVNLSSNSLNG---TLPVEIGNLKVVTKIDLSRNDLSGEIP-SSIGDLKNMQHLSLADNKFQGSIPDS 591 (1029)
Q Consensus 518 ~~--~~~l~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~ 591 (1029)
.. +..+++|++|+|++|++++ .....+..+++|+.|+|++|++++..| ..+..+++|+.|+|++|+|+ .+|..
T Consensus 193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~ 271 (312)
T 1wwl_A 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271 (312)
T ss_dssp HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS
T ss_pred HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh
Confidence 33 3889999999999999983 222344678999999999999998775 56677899999999999999 77877
Q ss_pred ccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcC
Q 036879 592 LGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 592 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 634 (1029)
+. ++|++|||++|+|++. |. +..+++|+.|++++|++++
T Consensus 272 ~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 272 LP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred cc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 76 8999999999999966 65 8899999999999999985
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=307.69 Aligned_cols=433 Identities=15% Similarity=0.083 Sum_probs=284.2
Q ss_pred cCCccccCCCcCcccccCCCcCc---ccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcccc
Q 036879 160 HVPSSILNIPSLLAIDLSNNQFS---GPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVN 236 (1029)
Q Consensus 160 ~~p~~~~~l~~L~~L~ls~N~l~---~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 236 (1029)
.++..+..+++|+.|+++++... +..|..++... ...++..+..+++|++|+|++|
T Consensus 64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~---------------------~~~l~~l~~~~~~L~~L~L~~~ 122 (592)
T 3ogk_B 64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYV---------------------TPWVTEISNNLRQLKSVHFRRM 122 (592)
T ss_dssp CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBC---------------------HHHHHHHHHHCTTCCEEEEESC
T ss_pred ChHHHHHhCCCCeEEEecCCcchhhcccccccccccc---------------------hHHHHHHHhhCCCCCeEEeecc
Confidence 34455667888999999886532 12221111000 0001112235677777777777
Q ss_pred cccCCCCcccccc--ccccceeecccc-cc--------cccCcccEEEccCCcccCC----CCCCcccCCCCcEEEccCc
Q 036879 237 NFIGSIPREIGNI--TMLKGLYLVYTN-LT--------GEIQGLQVLALSSNRLTGV----IPPEIINISSLTVLSLTAN 301 (1029)
Q Consensus 237 ~l~~~~p~~~~~l--~~L~~L~l~~n~-l~--------~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N 301 (1029)
.+++..+..++.. .+|+.|++.+|. ++ ..+++|++|+|++|.+++. ++..+.++++|++|+|++|
T Consensus 123 ~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n 202 (592)
T 3ogk_B 123 IVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMT 202 (592)
T ss_dssp BCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTC
T ss_pred EecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeecc
Confidence 7666555556553 347777777665 22 2457888999999988765 3334567889999999999
Q ss_pred ccCC----CCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCccccccccccc
Q 036879 302 NLLG----NLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTN 377 (1029)
Q Consensus 302 ~l~~----~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~ 377 (1029)
.+.+ .++. ++..+++|++|+|++|.+.+ +|..+..+++|+.|+++..... .+. ......+..
T Consensus 203 ~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~--~~~----------~~~~~~l~~ 268 (592)
T 3ogk_B 203 EFAKISPKDLET-IARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNED--IGM----------PEKYMNLVF 268 (592)
T ss_dssp CCSSCCHHHHHH-HHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCC--TTC----------TTSSSCCCC
T ss_pred CCCccCHHHHHH-HHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccc--cch----------HHHHHHhhc
Confidence 8862 2222 23357899999999998886 6688888999999998863222 110 011233556
Q ss_pred ccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccc-cccCCcCcCcEEEecCccccc-cccccccCCCCCC
Q 036879 378 CKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIP-SEIGNLNNLTTLHLETNELTG-SIPKAIGRLQKLQ 455 (1029)
Q Consensus 378 l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~ 455 (1029)
+++|+.|+++++.. ..+|..+..+++ |++|++++|.+++... ..+..+++|++|+|+ +.+.. .++..+..+++|+
T Consensus 269 ~~~L~~L~l~~~~~-~~l~~~~~~~~~-L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~ 345 (592)
T 3ogk_B 269 PRKLCRLGLSYMGP-NEMPILFPFAAQ-IRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLK 345 (592)
T ss_dssp CTTCCEEEETTCCT-TTGGGGGGGGGG-CCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCC
T ss_pred cccccccCccccch-hHHHHHHhhcCC-CcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCC
Confidence 78889999888643 356666666665 8899999988765444 346788899999998 44442 3444456788899
Q ss_pred EEEec-----------cccccCccccc-ccCCCCCcEEecCCCcccCcccccccc-ccccceeecc----CccccCC---
Q 036879 456 GLYLQ-----------HNKLQGSITTD-LCGLRSLSEFYSDGNELNGSLPQCLDS-LISLRTLSLG----FNRLTSV--- 515 (1029)
Q Consensus 456 ~L~L~-----------~N~l~~~~~~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~L~Ls----~N~l~~~--- 515 (1029)
+|+++ .|.++...... +..+++|++|+++.|.+++..+..+.. +++|+.|+++ .|.+++.
T Consensus 346 ~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~ 425 (592)
T 3ogk_B 346 RLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLD 425 (592)
T ss_dssp EEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCH
T ss_pred EEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHH
Confidence 99998 35665443322 345788888888888888777777765 8888888885 6777753
Q ss_pred --CCCCccCCCCCcEEEccCC--cccCcCCcccc-ccccccEEEccCCcCCCC-CCccccCcccccccccccccccccC-
Q 036879 516 --IPSSLWSLRDILNVNLSSN--SLNGTLPVEIG-NLKVVTKIDLSRNDLSGE-IPSSIGDLKNMQHLSLADNKFQGSI- 588 (1029)
Q Consensus 516 --~~~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~- 588 (1029)
++..+.++++|+.|++++| .+++..+..+. .+++|+.|++++|++++. ++..+..+++|+.|+|++|++++..
T Consensus 426 ~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 505 (592)
T 3ogk_B 426 NGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAI 505 (592)
T ss_dssp HHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHH
T ss_pred HHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHH
Confidence 2333666888888888743 36554444443 377888888888888753 3445567788888888888876543
Q ss_pred CccccCCCCCCEEeCcCCcccCcCchhh-hcccccceeeccCC
Q 036879 589 PDSLGGLTSLNFLDMSSNNLSGEIPNSL-KALSLLKFLNLSFN 630 (1029)
Q Consensus 589 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~l~~N 630 (1029)
+..+..+++|++|+|++|+++......+ ..++.+....+..+
T Consensus 506 ~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 506 AAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp HHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred HHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 3334567888888888888876543333 35566655555444
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-30 Score=309.68 Aligned_cols=456 Identities=15% Similarity=0.113 Sum_probs=252.1
Q ss_pred CCceeeEEEcCCCCceEEEecccccccccCCccCCCCcCCCeEeccCccc---ccCCccccc------------cccCCc
Q 036879 35 VCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSF---SGTLPIQLS------------NLRRLK 99 (1029)
Q Consensus 35 ~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l---~~~~p~~~~------------~l~~L~ 99 (1029)
|++|.++.+.. ++ .+.+.. .....++..+..+++|+.|+|+++.. .+.+|..++ .+++|+
T Consensus 41 ck~W~~~~~~~--~~--~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~ 115 (592)
T 3ogk_B 41 CRRWFKIDSET--RE--HVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115 (592)
T ss_dssp CHHHHHHHHHH--CC--EEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred hHHHHHhhhcc--cc--EEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence 45799995432 11 122221 12223344566788899999987532 134444433 789999
Q ss_pred eeecccccccCCCCCCcCCC-CCc-cceecccccc-ccC-CCcccccCccccCeEeccCCcCccc----CCccccCCCcC
Q 036879 100 YLSFRSNNFSSIEIPPWLDS-FPK-LEHLYLDGNS-FIG-TIPPSICNISSLLTLDLSFNQLQGH----VPSSILNIPSL 171 (1029)
Q Consensus 100 ~L~l~~N~l~~~~~p~~~~~-l~~-L~~L~Ls~N~-l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L 171 (1029)
+|+|++|.++.. .+.++.. +++ |++|+|++|. ++. .++..+..+++|++|+|++|.+++. ++..+.++++|
T Consensus 116 ~L~L~~~~i~~~-~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L 194 (592)
T 3ogk_B 116 SVHFRRMIVSDL-DLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194 (592)
T ss_dssp EEEEESCBCCHH-HHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCC
T ss_pred eEEeeccEecHH-HHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCc
Confidence 999999988752 2444544 344 9999999987 221 2334445789999999999998755 34456678999
Q ss_pred cccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcccccccCCCCcccccccc
Q 036879 172 LAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITM 251 (1029)
Q Consensus 172 ~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 251 (1029)
+.|++++|.+++.... .++..+.++++|+.|++++|.+.+ +|..+.++++
T Consensus 195 ~~L~L~~n~~~~~~~~-----------------------------~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~ 244 (592)
T 3ogk_B 195 EVLNFYMTEFAKISPK-----------------------------DLETIARNCRSLVSVKVGDFEILE-LVGFFKAAAN 244 (592)
T ss_dssp CEEECTTCCCSSCCHH-----------------------------HHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTT
T ss_pred cEEEeeccCCCccCHH-----------------------------HHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhH
Confidence 9999999988632110 112334455666666666666553 4555555555
Q ss_pred ccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCC
Q 036879 252 LKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGP 331 (1029)
Q Consensus 252 L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~ 331 (1029)
|+.|+++....... ....+..+..+++|+.|+++++.. +.+|..+. .+++|++|+|++|.+++.
T Consensus 245 L~~L~l~~~~~~~~--------------~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~-~~~~L~~L~Ls~~~l~~~ 308 (592)
T 3ogk_B 245 LEEFCGGSLNEDIG--------------MPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFP-FAAQIRKLDLLYALLETE 308 (592)
T ss_dssp CCEEEECBCCCCTT--------------CTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGG-GGGGCCEEEETTCCCCHH
T ss_pred HHhhcccccccccc--------------hHHHHHHhhccccccccCccccch-hHHHHHHh-hcCCCcEEecCCCcCCHH
Confidence 55544432111000 011222333344444444444322 13333222 244444444444443322
Q ss_pred CC-cccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccC-----------CcCCCCCCccc
Q 036879 332 IP-SSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE-----------NPLSGVLPISI 399 (1029)
Q Consensus 332 ~p-~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~-----------N~l~~~~p~~~ 399 (1029)
.. ..+..+++|+.|+++ +.+... ........+++|++|++++ |.+++.....+
T Consensus 309 ~~~~~~~~~~~L~~L~L~-~~~~~~--------------~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l 373 (592)
T 3ogk_B 309 DHCTLIQKCPNLEVLETR-NVIGDR--------------GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373 (592)
T ss_dssp HHHHHHTTCTTCCEEEEE-GGGHHH--------------HHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHH
T ss_pred HHHHHHHhCcCCCEEecc-CccCHH--------------HHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHH
Confidence 11 223444444444444 222110 0001122445555555552 33332211111
Q ss_pred -cCchhhhcceeccccccccccccccCC-cCcCcEEEec----Ccccccc-----ccccccCCCCCCEEEeccc--cccC
Q 036879 400 -GNLSNAMDVLYLSACNIKGSIPSEIGN-LNNLTTLHLE----TNELTGS-----IPKAIGRLQKLQGLYLQHN--KLQG 466 (1029)
Q Consensus 400 -~~l~~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~-----~~~~~~~l~~L~~L~L~~N--~l~~ 466 (1029)
..+++ |++|+++.|++++..+..+.. +++|+.|+|+ .|.+++. ++..+..+++|++|++++| .+++
T Consensus 374 ~~~~~~-L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~ 452 (592)
T 3ogk_B 374 AQGCQE-LEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTD 452 (592)
T ss_dssp HHHCTT-CSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCH
T ss_pred HhhCcc-CeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccH
Confidence 11222 666666666666555555544 6677777775 5666642 3334566777777777643 2544
Q ss_pred ccccccc-CCCCCcEEecCCCcccC-ccccccccccccceeeccCccccCC-CCCCccCCCCCcEEEccCCcccCcCCcc
Q 036879 467 SITTDLC-GLRSLSEFYSDGNELNG-SLPQCLDSLISLRTLSLGFNRLTSV-IPSSLWSLRDILNVNLSSNSLNGTLPVE 543 (1029)
Q Consensus 467 ~~~~~~~-~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 543 (1029)
.....+. .+++|++|++++|++++ ..+..+.++++|++|+|++|.+++. ++..+..+++|+.|+|++|++++.....
T Consensus 453 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~ 532 (592)
T 3ogk_B 453 LGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDL 532 (592)
T ss_dssp HHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTG
T ss_pred HHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHH
Confidence 4433333 36777778887777765 3344557778888888888887643 3334456788888888888887653333
Q ss_pred c-cccccccEEEccCC
Q 036879 544 I-GNLKVVTKIDLSRN 558 (1029)
Q Consensus 544 ~-~~l~~L~~L~Ls~N 558 (1029)
+ ..++.+....+..+
T Consensus 533 l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 533 MQMARPYWNIELIPSR 548 (592)
T ss_dssp GGGCCTTEEEEEECCC
T ss_pred HHHhCCCcEEEEecCc
Confidence 3 34566666555544
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-28 Score=271.33 Aligned_cols=247 Identities=19% Similarity=0.223 Sum_probs=208.4
Q ss_pred ccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCC
Q 036879 376 TNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQ 455 (1029)
Q Consensus 376 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 455 (1029)
..+++|++|+|++|++++..|..+..+.+ |++|++++|++++..+ |..+++|++|+|++|+|++. + ..++|+
T Consensus 31 ~~~~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l-~----~~~~L~ 102 (317)
T 3o53_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTK-LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-L----VGPSIE 102 (317)
T ss_dssp TTGGGCSEEECTTSCCCCCCHHHHTTCTT-CCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEE-E----ECTTCC
T ss_pred ccCCCCCEEECcCCccCcCCHHHhhCCCc-CCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccc-c----CCCCcC
Confidence 35668888888888888777778888876 8999999999886655 88899999999999999853 2 348999
Q ss_pred EEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCcc-CCCCCcEEEccCC
Q 036879 456 GLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLW-SLRDILNVNLSSN 534 (1029)
Q Consensus 456 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N 534 (1029)
+|++++|++++..+.. +++|++|++++|++++..+..+..+++|++|+|++|++++..+..+. .+++|+.|+|++|
T Consensus 103 ~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N 179 (317)
T 3o53_A 103 TLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179 (317)
T ss_dssp EEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTS
T ss_pred EEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCC
Confidence 9999999998766554 57899999999999988888999999999999999999988777764 7899999999999
Q ss_pred cccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCccc-CcCc
Q 036879 535 SLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS-GEIP 613 (1029)
Q Consensus 535 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~ 613 (1029)
.+++. + ....+++|++|+|++|++++ +|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|
T Consensus 180 ~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~ 255 (317)
T 3o53_A 180 FIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLR 255 (317)
T ss_dssp CCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHH
T ss_pred cCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHH
Confidence 99865 3 23458999999999999985 4556899999999999999999 57888999999999999999998 7888
Q ss_pred hhhhcccccceeecc-CCCCcCCCC
Q 036879 614 NSLKALSLLKFLNLS-FNGLQGQVP 637 (1029)
Q Consensus 614 ~~~~~l~~L~~L~l~-~N~l~~~~~ 637 (1029)
..+..+++|+.|+++ .+.++|..|
T Consensus 256 ~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 256 DFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp HHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred HHHhccccceEEECCCchhccCCch
Confidence 899999999999998 445665444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-28 Score=266.97 Aligned_cols=255 Identities=20% Similarity=0.202 Sum_probs=118.6
Q ss_pred EEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccc
Q 036879 295 VLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTS 374 (1029)
Q Consensus 295 ~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~ 374 (1029)
.++++.+.+. ..+..++..+++|++|+|++|++++..|..|..+++|+.|++++|.+.+..+
T Consensus 14 i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~----------------- 75 (317)
T 3o53_A 14 IEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD----------------- 75 (317)
T ss_dssp EESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-----------------
T ss_pred Eeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-----------------
Confidence 3444444443 3334444445555555555555555555555555555555555555543211
Q ss_pred cccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCC
Q 036879 375 LTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKL 454 (1029)
Q Consensus 375 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 454 (1029)
+..+++|++|++++|++++..+ .+ .|++|++++|++++..+.. +++|++|+|++|++++..+..+..+++|
T Consensus 76 ~~~l~~L~~L~Ls~n~l~~l~~-----~~-~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L 146 (317)
T 3o53_A 76 LESLSTLRTLDLNNNYVQELLV-----GP-SIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRV 146 (317)
T ss_dssp ETTCTTCCEEECCSSEEEEEEE-----CT-TCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSE
T ss_pred hhhcCCCCEEECcCCccccccC-----CC-CcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCC
Confidence 2344555555555555542211 11 2444444444444333322 3445555555555554444455555555
Q ss_pred CEEEeccccccCccccccc-CCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccC
Q 036879 455 QGLYLQHNKLQGSITTDLC-GLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSS 533 (1029)
Q Consensus 455 ~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 533 (1029)
++|+|++|++++..+..+. .+++|++|++++|.+++..+ ...+++|++|+|++|+++++.+ .+..+++|+.|+|++
T Consensus 147 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~ 223 (317)
T 3o53_A 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRN 223 (317)
T ss_dssp EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTT
T ss_pred CEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCcchh-hhcccCcccEEECcC
Confidence 5555555555444333332 33444444444444432211 1124445555555555543322 244445555555555
Q ss_pred CcccCcCCccccccccccEEEccCCcCC-CCCCccccCcccccccccc
Q 036879 534 NSLNGTLPVEIGNLKVVTKIDLSRNDLS-GEIPSSIGDLKNMQHLSLA 580 (1029)
Q Consensus 534 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~ 580 (1029)
|+++ .+|..+..+++|+.|++++|.++ +.+|..+..+++|+.|+++
T Consensus 224 N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp SCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred Cccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 5554 23444444455555555555554 3344444445555555554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.3e-28 Score=287.33 Aligned_cols=182 Identities=16% Similarity=0.096 Sum_probs=130.8
Q ss_pred eccCcceEEEEEEe-cCCcEEEEEEeeccc----------chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEEE
Q 036879 746 LGKGSFGSVYKGTL-SDGMQIAVKVFNLEL----------EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 746 lg~G~fg~V~~~~~-~~~~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.+.|++|.+..++. .-|+.||+|.+.+.. +...+.|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 56677776666543 368899999997542 22345799999999999 7999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||++|++|.+++.+ ...++.. +|+.||+.||+|+| ++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 322 Eyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp ECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred ecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 99999999999965 4456654 58899999999999 78899999999999999999999999999987654332
Q ss_pred ceeccccCCccccCccCC---CCCCcchhHHHHHHHHHhcCCCCC
Q 036879 894 MTQTQTLATIGYMAPEWK---LSRKGDVYSYGIILMETFTKKKPT 935 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~---~~~~~DvwSlGvil~elltg~~p~ 935 (1029)
.....+||++|||||++ ...++|+||+|++++++.++..|+
T Consensus 395 -~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 395 -WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -CSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred -cccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence 23346799999999996 455799999999988887765553
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=267.47 Aligned_cols=268 Identities=28% Similarity=0.364 Sum_probs=162.6
Q ss_pred cccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecC
Q 036879 268 GLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDM 347 (1029)
Q Consensus 268 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l 347 (1029)
+++.|++++|.|+ .+|..+. ++|++|+|++|++. .+|. .+++|++|+|++|+|++ +|. .+++|++|++
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 108 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI 108 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence 5778999999888 5666655 78888888888886 6776 36788888888888874 333 4556666666
Q ss_pred CCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCc
Q 036879 348 PYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNL 427 (1029)
Q Consensus 348 s~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l 427 (1029)
++|.+++. |. .+++|+.|++++|++++ +|.. +
T Consensus 109 s~N~l~~l-~~------------------~l~~L~~L~L~~N~l~~-lp~~----------------------------l 140 (622)
T 3g06_A 109 FSNPLTHL-PA------------------LPSGLCKLWIFGNQLTS-LPVL----------------------------P 140 (622)
T ss_dssp CSCCCCCC-CC------------------CCTTCCEEECCSSCCSC-CCCC----------------------------C
T ss_pred cCCcCCCC-CC------------------CCCCcCEEECCCCCCCc-CCCC----------------------------C
Confidence 66665532 11 12445555555555542 2221 2
Q ss_pred CcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeec
Q 036879 428 NNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSL 507 (1029)
Q Consensus 428 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 507 (1029)
++|++|+|++|+|++ +|. .+++|+.|++++|.+++.. ..+++|+.|++++|.+++ +|. .+++|+.|++
T Consensus 141 ~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~l~----~~~~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L 208 (622)
T 3g06_A 141 PGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTSLP----MLPSGLQELSVSDNQLAS-LPT---LPSELYKLWA 208 (622)
T ss_dssp TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCCCc----ccCCCCcEEECCCCCCCC-CCC---ccchhhEEEC
Confidence 445555555555542 222 1234555555555554322 223444444444444443 222 1356666677
Q ss_pred cCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccccccccccc
Q 036879 508 GFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGS 587 (1029)
Q Consensus 508 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 587 (1029)
++|.++.+ |. .+++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .
T Consensus 209 ~~N~l~~l-~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~ 275 (622)
T 3g06_A 209 YNNRLTSL-PA---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-R 275 (622)
T ss_dssp CSSCCSSC-CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-S
T ss_pred cCCccccc-CC---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-c
Confidence 77776643 22 23667777777777774 44 34567777777777776 3444 4567777777777777 5
Q ss_pred CCccccCCCCCCEEeCcCCcccCcCchhhhccc
Q 036879 588 IPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALS 620 (1029)
Q Consensus 588 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 620 (1029)
+|..+..+++|+.|+|++|++++.+|..+..++
T Consensus 276 lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 276 LPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 677777777777777777777777776666554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=273.12 Aligned_cols=243 Identities=16% Similarity=0.186 Sum_probs=209.2
Q ss_pred hhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecC
Q 036879 405 AMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSD 484 (1029)
Q Consensus 405 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 484 (1029)
.|++|+|++|.+++..|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.|++..+ .++|+.|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 49999999999999889999999999999999999997665 9999999999999999986553 3899999999
Q ss_pred CCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCcccc-ccccccEEEccCCcCCCC
Q 036879 485 GNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIG-NLKVVTKIDLSRNDLSGE 563 (1029)
Q Consensus 485 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~ 563 (1029)
+|.+++..+.. +++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++..|..+. .+++|+.|+|++|.|++.
T Consensus 108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 99999877654 57899999999999999999999999999999999999998888886 799999999999999966
Q ss_pred CCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcC-CCCC-CCC
Q 036879 564 IPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQG-QVPH-GGP 641 (1029)
Q Consensus 564 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~-~~~ 641 (1029)
|. +..+++|+.|+|++|+|++. |..+..+++|+.|+|++|+|++ +|..+..+++|+.|++++|++.+ .+|. ...
T Consensus 185 -~~-~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 185 -KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp -EC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred -cc-cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 32 44689999999999999964 4559999999999999999995 67789999999999999999984 3322 233
Q ss_pred CCccCccccc-------CCCCCCCCCC
Q 036879 642 FTNLSSQSFV-------GNKGLCGAPE 661 (1029)
Q Consensus 642 ~~~l~~~~~~-------~n~~~c~~~~ 661 (1029)
+..+..+... +|++.|.++.
T Consensus 261 l~~L~~l~~~~~~~~~~~~~~~c~~~~ 287 (487)
T 3oja_A 261 NQRVQTVAKQTVKKLTGQNEEECTVPT 287 (487)
T ss_dssp CHHHHHHHHHHHHHHTSSSSCCCSSTT
T ss_pred CCCCcEEeccccccccCCCcccccCCc
Confidence 4455555554 7888888763
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.9e-26 Score=244.54 Aligned_cols=212 Identities=22% Similarity=0.289 Sum_probs=178.8
Q ss_pred CCCCCceeeEEEcCCCCceEEEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCC
Q 036879 32 NTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSI 111 (1029)
Q Consensus 32 ~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 111 (1029)
+.++|.|.|+.|.+. ..++.++++++++. .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+++.+
T Consensus 1 ~~~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i 76 (270)
T 2o6q_A 1 NEALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL 76 (270)
T ss_dssp CCCCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCC
T ss_pred CCccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCee
Confidence 358999999888754 34678999999998 7888765 6899999999999977777899999999999999999953
Q ss_pred CCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCC
Q 036879 112 EIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNT 191 (1029)
Q Consensus 112 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~ 191 (1029)
. +..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++.++..+..
T Consensus 77 ~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 155 (270)
T 2o6q_A 77 P-AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDK 155 (270)
T ss_dssp C-TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred C-hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccC
Confidence 2 345688999999999999999766677899999999999999999877888999999999999999999887765432
Q ss_pred CCcccccccccccchhccccccccCCCCcccccccccceEEcccccccCCCCccccccccccceee
Q 036879 192 SPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYL 257 (1029)
Q Consensus 192 ~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 257 (1029)
..+|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++
T Consensus 156 ---------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 212 (270)
T 2o6q_A 156 ---------LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212 (270)
T ss_dssp ---------CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred ---------CcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEe
Confidence 236788889999999887888999999999999999999766666777766664333
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=244.02 Aligned_cols=210 Identities=22% Similarity=0.207 Sum_probs=152.3
Q ss_pred cCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeecc
Q 036879 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLG 508 (1029)
Q Consensus 429 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 508 (1029)
+|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45556666666554444455556666666666666655555556666666666666666666666677777777777777
Q ss_pred CccccCCCCCCccCCCCCcEEEccCCcccCc-CCccccccccccEEEccCCcCCCCCCccccCccccc----cccccccc
Q 036879 509 FNRLTSVIPSSLWSLRDILNVNLSSNSLNGT-LPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQ----HLSLADNK 583 (1029)
Q Consensus 509 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~L~~N~ 583 (1029)
+|++++..+..+..+++|+.|++++|++++. +|..++.+++|+.|++++|++++..+..|..+.+|+ .|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 7777776666777788888888888888753 477888888888888888888877777777777777 78888998
Q ss_pred ccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCC
Q 036879 584 FQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHG 639 (1029)
Q Consensus 584 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 639 (1029)
+++..+..+. ..+|++|+|++|++++..+..+..+++|+.|++++|+++|.+|..
T Consensus 189 l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 189 MNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred ccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 8865555554 447999999999998777777888899999999999888876643
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=234.55 Aligned_cols=205 Identities=23% Similarity=0.290 Sum_probs=126.4
Q ss_pred CcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccC
Q 036879 430 LTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGF 509 (1029)
Q Consensus 430 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 509 (1029)
.+.+++++|+++ .+|..+. ++|++|+|++|++++..+..|..+++|++|++++|.++...+..|..+++|++|+|++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 344444444444 2333222 3444555555555444444444445555555555555544455556666666666666
Q ss_pred ccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCC
Q 036879 510 NRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIP 589 (1029)
Q Consensus 510 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 589 (1029)
|+++++.+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 174 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE 174 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence 66666666666666667777777777766666666677777777777777765555556777777777777777776555
Q ss_pred ccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCC
Q 036879 590 DSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 590 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 637 (1029)
..|..+++|++|+|++|++++..+..+..+++|+.|++++|++.+..+
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 667777777777777777776666667777777777777776665443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-28 Score=294.78 Aligned_cols=391 Identities=16% Similarity=0.132 Sum_probs=221.9
Q ss_pred cccccceEEcccccccCCCCcccc-ccccccceeeccc-ccc--------cccCcccEEEccCCcccCCCCCCcc----c
Q 036879 224 ECKQLKILSLSVNNFIGSIPREIG-NITMLKGLYLVYT-NLT--------GEIQGLQVLALSSNRLTGVIPPEII----N 289 (1029)
Q Consensus 224 ~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~n-~l~--------~~l~~L~~L~Ls~N~l~~~~p~~~~----~ 289 (1029)
.+++|++|+|++|.+++..+..+. .+++|+.|++.+| .++ ..+++|++|+|++|.+++..+..+. .
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 182 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence 345555555555555544444443 4555555555555 222 1456777888888887765544443 5
Q ss_pred CCCCcEEEccCcccCCCCCc----hhhhcccccceEeecCc-ccCCCCCcccccccccceecCCCccccCCCCCCCCCCC
Q 036879 290 ISSLTVLSLTANNLLGNLPS----NIGHSLPNLQQLILGGN-RLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCH 364 (1029)
Q Consensus 290 l~~L~~L~Ls~N~l~~~lp~----~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~ 364 (1029)
+++|++|+|++|. +.++. .+...+++|++|+|++| .+.+ ++..+..+++|+.|+++.+... ..+..+
T Consensus 183 ~~~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~-~~~~~~---- 254 (594)
T 2p1m_B 183 YTSLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAE-VRPDVY---- 254 (594)
T ss_dssp CCCCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCC-CCHHHH----
T ss_pred CCcCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCc-cchhhH----
Confidence 6689999999886 23332 22234689999999988 4443 7777888888888886654310 000000
Q ss_pred CCccccccccccccccccee-eccCCcCCCCCCccccCchhhhcceecccccccccccc-ccCCcCcCcEEEecCccccc
Q 036879 365 PYDELGFLTSLTNCKDLRKL-ILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPS-EIGNLNNLTTLHLETNELTG 442 (1029)
Q Consensus 365 ~~~~~~~~~~l~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~ 442 (1029)
......+.++++|+.| .+.+... +.++..+..+++ |+.|++++|.+++.... .+..+++|++|++++| ++.
T Consensus 255 ----~~l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~-L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~ 327 (594)
T 2p1m_B 255 ----SGLSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSR-LTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IED 327 (594)
T ss_dssp ----HHHHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTT-CCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHH
T ss_pred ----HHHHHHHhcCCCcccccCCcccch-hhHHHHHHhhCC-CCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCH
Confidence 0111235567777777 3433222 123333333333 77777777776643222 2456777888888877 432
Q ss_pred c-ccccccCCCCCCEEEecc---------ccccCccccccc-CCCCCcEEecCCCcccCccccccc-cccccceeecc--
Q 036879 443 S-IPKAIGRLQKLQGLYLQH---------NKLQGSITTDLC-GLRSLSEFYSDGNELNGSLPQCLD-SLISLRTLSLG-- 508 (1029)
Q Consensus 443 ~-~~~~~~~l~~L~~L~L~~---------N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~Ls-- 508 (1029)
. ++.....+++|++|++++ +.++......+. ++++|+.|.+..|.+++.....+. .+++|+.|+++
T Consensus 328 ~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~ 407 (594)
T 2p1m_B 328 AGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCII 407 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEES
T ss_pred HHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecc
Confidence 2 222333577788887733 444433333333 366777777777777655555554 46777777777
Q ss_pred C----ccccCCC-----CCCccCCCCCcEEEccCCcccCcCCccccc-cccccEEEccCCcCCCCCCccc-cCccccccc
Q 036879 509 F----NRLTSVI-----PSSLWSLRDILNVNLSSNSLNGTLPVEIGN-LKVVTKIDLSRNDLSGEIPSSI-GDLKNMQHL 577 (1029)
Q Consensus 509 ~----N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L 577 (1029)
+ |.+++.. +..+..+++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|
T Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L 486 (594)
T 2p1m_B 408 EPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKL 486 (594)
T ss_dssp STTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEE
T ss_pred cCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEE
Confidence 3 4454221 11245566777777766 555444444444 6667777777777665444444 456777777
Q ss_pred ccccccccccCCc-cccCCCCCCEEeCcCCcccCcCchhh-hcccccceeeccCC
Q 036879 578 SLADNKFQGSIPD-SLGGLTSLNFLDMSSNNLSGEIPNSL-KALSLLKFLNLSFN 630 (1029)
Q Consensus 578 ~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~l~~N 630 (1029)
+|++|++++.... ....+++|++|++++|+++......+ ..+++|+...+..+
T Consensus 487 ~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~ 541 (594)
T 2p1m_B 487 EIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDER 541 (594)
T ss_dssp EEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSS
T ss_pred ECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCC
Confidence 7777776544333 23346677777777776653333333 34555555444444
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=236.75 Aligned_cols=226 Identities=21% Similarity=0.224 Sum_probs=195.2
Q ss_pred eeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccc
Q 036879 383 KLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHN 462 (1029)
Q Consensus 383 ~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 462 (1029)
.++.++..+. .+|..+. ..+++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 11 ~~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 86 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (276)
T ss_dssp EEECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred eEEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence 4556666665 4555443 34889999999999877778999999999999999999777778999999999999999
Q ss_pred cccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCC-CCCCccCCCCCcEEEccCCcccCcCC
Q 036879 463 KLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSV-IPSSLWSLRDILNVNLSSNSLNGTLP 541 (1029)
Q Consensus 463 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p 541 (1029)
++++..+..|.++++|++|++++|.+.+..+..+..+++|++|++++|+++++ +|..|..+++|+.|+|++|++++..+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~ 166 (276)
T 2z62_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (276)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred ccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence 99988888999999999999999999988888899999999999999999875 58899999999999999999998888
Q ss_pred cccccccccc----EEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCc
Q 036879 542 VEIGNLKVVT----KIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIP 613 (1029)
Q Consensus 542 ~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 613 (1029)
..+..+++|+ .|++++|.+++..+..+. ..+|+.|+|++|++++..+..|..+++|+.|+|++|++++..|
T Consensus 167 ~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp GGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred HHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 8888888888 899999999966555554 4589999999999997777778999999999999999997554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-24 Score=235.49 Aligned_cols=204 Identities=24% Similarity=0.257 Sum_probs=136.4
Q ss_pred cCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccc
Q 036879 424 IGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLR 503 (1029)
Q Consensus 424 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 503 (1029)
+.++++++++++++|.++ .+|..+. ++++.|+|++|.+++..+..|..+++|+.|++++|.+++..+. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 567788888888888888 4555543 5788888888888877777777777777777777777654332 5667777
Q ss_pred eeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccccccc
Q 036879 504 TLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNK 583 (1029)
Q Consensus 504 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 583 (1029)
+|+|++|+++ .+|..+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 7777777776 345566666666667776666666555666666666666666666665555556666666666666666
Q ss_pred ccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcC
Q 036879 584 FQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 584 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 634 (1029)
|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.+
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 66544445566666666666666666 445555555556666665555554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-28 Score=298.76 Aligned_cols=461 Identities=14% Similarity=0.096 Sum_probs=218.5
Q ss_pred CCceeeEEEcCCCCceEEEecccccccccCCc-cCCCCcCCCeEeccCccccc---CCcc------------ccccccCC
Q 036879 35 VCNWFGVTCSPRHRRVTALNLAYMGLLGTIPP-ELGNLSFLSLLNVTNNSFSG---TLPI------------QLSNLRRL 98 (1029)
Q Consensus 35 ~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~p~-~~~~l~~L~~L~l~~n~l~~---~~p~------------~~~~l~~L 98 (1029)
|++|.++.. .....++++... +..|. .+..+++|+.|+|+++.... ..|. .+..+++|
T Consensus 34 ck~W~~~~~----~~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 34 CKSWYEIER----WCRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp CHHHHHHHH----HHCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHhhh----hhceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 557999821 223345554432 22332 34567888999998875321 2221 23457788
Q ss_pred ceeecccccccCCCCCCcCC-CCCccceeccccc-cccCC-CcccccCccccCeEeccCCcCcccCCcccc----CCCcC
Q 036879 99 KYLSFRSNNFSSIEIPPWLD-SFPKLEHLYLDGN-SFIGT-IPPSICNISSLLTLDLSFNQLQGHVPSSIL----NIPSL 171 (1029)
Q Consensus 99 ~~L~l~~N~l~~~~~p~~~~-~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~~L 171 (1029)
++|+|++|.++... +..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++|
T Consensus 108 ~~L~L~~~~~~~~~-~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L 186 (594)
T 2p1m_B 108 EEIRLKRMVVTDDC-LELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSL 186 (594)
T ss_dssp CEEEEESCBCCHHH-HHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCC
T ss_pred CeEEeeCcEEcHHH-HHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcC
Confidence 88888888776432 23333 5778888888888 44422 445555788888888888887654433333 55677
Q ss_pred cccccCCCcCcccCCCCCCCCCcccccccccccchhccccc-cccCCCCcccccccccceEEcccc-------cccCCCC
Q 036879 172 LAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYN-QLSGQIPSTLFECKQLKILSLSVN-------NFIGSIP 243 (1029)
Q Consensus 172 ~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~Ls~N-------~l~~~~p 243 (1029)
+.|++++|. .. .. ...+..+.-...+|++|++++| .+.+ +|..+..+++|+.|+++.+ .+.+ ++
T Consensus 187 ~~L~l~~~~-~~-~~----~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~ 258 (594)
T 2p1m_B 187 VSLNISCLA-SE-VS----FSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LS 258 (594)
T ss_dssp CEEECTTCC-SC-CC----HHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HH
T ss_pred cEEEecccC-Cc-CC----HHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HH
Confidence 777777775 10 00 0000111011123344444443 2221 3334444444444442222 1111 12
Q ss_pred ccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEee
Q 036879 244 REIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLIL 323 (1029)
Q Consensus 244 ~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L 323 (1029)
..+.++++|+.|. .+.+... +.++..+..+++|++|+|++|.+.+.....+...+++|++|++
T Consensus 259 ~~l~~~~~L~~Ls----------------~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l 321 (594)
T 2p1m_B 259 VALSGCKELRCLS----------------GFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWV 321 (594)
T ss_dssp HHHHTCTTCCEEE----------------CCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEE
T ss_pred HHHhcCCCccccc----------------CCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeC
Confidence 2233333333221 1111111 1122222234444444444444332212222223444444444
Q ss_pred cCcccCCC-CCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccC-
Q 036879 324 GGNRLTGP-IPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGN- 401 (1029)
Q Consensus 324 ~~N~l~~~-~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~- 401 (1029)
++| ++.. ++.....+++|+.|+++.+.-.| ..+.+.+++.....+..
T Consensus 322 ~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g------------------------------~~~~~~l~~~~l~~l~~~ 370 (594)
T 2p1m_B 322 LDY-IEDAGLEVLASTCKDLRELRVFPSEPFV------------------------------MEPNVALTEQGLVSVSMG 370 (594)
T ss_dssp EGG-GHHHHHHHHHHHCTTCCEEEEECSCTTC------------------------------SSCSSCCCHHHHHHHHHH
T ss_pred cCc-cCHHHHHHHHHhCCCCCEEEEecCcccc------------------------------cccCCCCCHHHHHHHHHh
Confidence 444 2210 11111123333333332110000 00112222111111111
Q ss_pred chhhhcceeccccccccccccccC-CcCcCcEEEec--C----cccccc-----ccccccCCCCCCEEEeccccccCccc
Q 036879 402 LSNAMDVLYLSACNIKGSIPSEIG-NLNNLTTLHLE--T----NELTGS-----IPKAIGRLQKLQGLYLQHNKLQGSIT 469 (1029)
Q Consensus 402 l~~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~--~----N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~~~ 469 (1029)
++ .|+.|.++.|++++..+..+. .+++|+.|+|+ + |.+++. ++..+..+++|++|+|++ .++....
T Consensus 371 ~~-~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~ 448 (594)
T 2p1m_B 371 CP-KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVF 448 (594)
T ss_dssp CT-TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHH
T ss_pred ch-hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHH
Confidence 11 244454444555443333333 35666666666 3 444421 122245566677777755 4444444
Q ss_pred ccccC-CCCCcEEecCCCcccCcccccc-ccccccceeeccCccccCCCCC-CccCCCCCcEEEccCCcccCcCCccc-c
Q 036879 470 TDLCG-LRSLSEFYSDGNELNGSLPQCL-DSLISLRTLSLGFNRLTSVIPS-SLWSLRDILNVNLSSNSLNGTLPVEI-G 545 (1029)
Q Consensus 470 ~~~~~-l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~ 545 (1029)
..+.. +++|+.|++++|.+++..+..+ ..+++|++|+|++|.+++.... ....+++|+.|++++|.++......+ .
T Consensus 449 ~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~ 528 (594)
T 2p1m_B 449 EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQ 528 (594)
T ss_dssp HHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHH
T ss_pred HHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHH
Confidence 44443 6667777777776655544444 5677788888888877543332 34457788888888887754333333 4
Q ss_pred ccccccEEEccCCcC
Q 036879 546 NLKVVTKIDLSRNDL 560 (1029)
Q Consensus 546 ~l~~L~~L~Ls~N~l 560 (1029)
.++.|+...+..+.-
T Consensus 529 ~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 529 KMPKLNVEVIDERGA 543 (594)
T ss_dssp HCTTEEEEEECSSSC
T ss_pred hCCCCEEEEecCCCc
Confidence 556776666665543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.5e-24 Score=231.36 Aligned_cols=197 Identities=25% Similarity=0.299 Sum_probs=114.4
Q ss_pred hcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCC
Q 036879 406 MDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485 (1029)
Q Consensus 406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 485 (1029)
++.+++++|+++ .+|..+. ++++.|+|++|+|++..+..|..+++|++|+|++|.+++..+. ..+++|+.|++++
T Consensus 12 l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~ 86 (290)
T 1p9a_G 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSH 86 (290)
T ss_dssp CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCS
T ss_pred ccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECCC
Confidence 555666666665 3333332 4556666666666655555566666666666666666544332 4555666666666
Q ss_pred CcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCC
Q 036879 486 NELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIP 565 (1029)
Q Consensus 486 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 565 (1029)
|+++ .+|..+..+++|++|+|++|+|+++.+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+
T Consensus 87 N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~ 165 (290)
T 1p9a_G 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA 165 (290)
T ss_dssp SCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCT
T ss_pred CcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCH
Confidence 6665 445555566666666666666665555556666666666666666665555555566666666666666664444
Q ss_pred ccccCcccccccccccccccccCCccccCCCCCCEEeCcCCccc
Q 036879 566 SSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS 609 (1029)
Q Consensus 566 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 609 (1029)
..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|.+.
T Consensus 166 ~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 166 GLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred HHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 44555666666666666665 45555555556666666666654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=231.61 Aligned_cols=220 Identities=22% Similarity=0.271 Sum_probs=177.2
Q ss_pred hcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCC
Q 036879 406 MDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485 (1029)
Q Consensus 406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 485 (1029)
+..+++..+.+.+. ..+..+++|+.|++++|.++. ++ .+..+++|++|++++|.+++. ..+..+++|++|++++
T Consensus 21 l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~ 94 (272)
T 3rfs_A 21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTG 94 (272)
T ss_dssp HHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTT
T ss_pred HHHHHhcCcccccc--cccccccceeeeeeCCCCccc-cc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCC
Confidence 34455555555533 234567788888888888773 33 477788888888888888753 3677788888888888
Q ss_pred CcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCC
Q 036879 486 NELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIP 565 (1029)
Q Consensus 486 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 565 (1029)
|.+++..+..|..+++|++|+|++|+++++.+..|..+++|+.|++++|++++..+..++.+++|+.|++++|++++..+
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 174 (272)
T 3rfs_A 95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE 174 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence 88887778888888899999999999888888888888999999999999987777778889999999999999987777
Q ss_pred ccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCC
Q 036879 566 SSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 566 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 638 (1029)
..|..+++|+.|+|++|++++..+..+..+++|++|+|++|.+++. ++.|+.|+++.|.++|.+|.
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccC
Confidence 7788899999999999999987777788899999999999988754 44688888999999988876
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-24 Score=232.58 Aligned_cols=231 Identities=24% Similarity=0.286 Sum_probs=192.4
Q ss_pred cccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCE
Q 036879 377 NCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQG 456 (1029)
Q Consensus 377 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 456 (1029)
.+..+..+++.++.+.+.. ....+.. ++.|++++|.++. + ..+..+++|++|+|++|.+++ + ..+..+++|++
T Consensus 17 ~~~~l~~l~l~~~~~~~~~--~~~~l~~-L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~ 89 (272)
T 3rfs_A 17 AFAETIKANLKKKSVTDAV--TQNELNS-IDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTY 89 (272)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTT-CCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCE
T ss_pred hHHHHHHHHhcCccccccc--ccccccc-eeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCE
Confidence 3455666777777665432 2333443 7788888888873 2 357888999999999999985 3 36888999999
Q ss_pred EEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcc
Q 036879 457 LYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSL 536 (1029)
Q Consensus 457 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 536 (1029)
|+|++|.+++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|+++++.+..|..+++|+.|++++|++
T Consensus 90 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 169 (272)
T 3rfs_A 90 LILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL 169 (272)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCc
Confidence 99999999988888889999999999999999988888899999999999999999988888889999999999999999
Q ss_pred cCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhh
Q 036879 537 NGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSL 616 (1029)
Q Consensus 537 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 616 (1029)
++..+..++.+++|+.|++++|++++..|..|..+++|+.|+|++|++.+. +++|++|+++.|+++|.+|..+
T Consensus 170 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~ 242 (272)
T 3rfs_A 170 QSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSA 242 (272)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTT
T ss_pred CccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcc
Confidence 987777889999999999999999988888889999999999999988754 4578899999999999999888
Q ss_pred hcccc
Q 036879 617 KALSL 621 (1029)
Q Consensus 617 ~~l~~ 621 (1029)
+.++.
T Consensus 243 ~~~~~ 247 (272)
T 3rfs_A 243 GSVAP 247 (272)
T ss_dssp SCBCG
T ss_pred cccCC
Confidence 76643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-24 Score=258.18 Aligned_cols=181 Identities=15% Similarity=0.180 Sum_probs=140.8
Q ss_pred CCCceeccCcceEEEEEEecCCcEEEEEEeecccc--------hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 741 SENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE--------GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 741 ~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
...+.||+|+||+||+|.. .++.+|+|....... ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 578899998654321 1234589999999999999999666565566777999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++++|.+++.. +..++.|+++||+||| +++|+||||||+||+++. .+||+|||+|+......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999854 5689999999999999 777999999999999999 99999999999875432
Q ss_pred Cce------eccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCC
Q 036879 893 SMT------QTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTD 936 (1029)
Q Consensus 893 ~~~------~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~ 936 (1029)
... .....||+.|||||++ ++..+|+||..+-..+-+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 211 1245799999999984 5667899999999888888877764
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-23 Score=218.95 Aligned_cols=196 Identities=19% Similarity=0.207 Sum_probs=112.9
Q ss_pred cCcEEEecCccccccccccccCCCCCCEEEecccc-ccCcccccccCCCCCcEEecCC-CcccCccccccccccccceee
Q 036879 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNK-LQGSITTDLCGLRSLSEFYSDG-NELNGSLPQCLDSLISLRTLS 506 (1029)
Q Consensus 429 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~ 506 (1029)
+|++|+|++|+|++..+..|..+++|++|++++|+ ++.+.+..|.++++|++|++++ |+++...+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 44444444444444333344444445555555443 4444444444444444444444 444444455566666666666
Q ss_pred ccCccccCCCCCCccCCCCCc---EEEccCC-cccCcCCcccccccccc-EEEccCCcCCCCCCccccCccccccccccc
Q 036879 507 LGFNRLTSVIPSSLWSLRDIL---NVNLSSN-SLNGTLPVEIGNLKVVT-KIDLSRNDLSGEIPSSIGDLKNMQHLSLAD 581 (1029)
Q Consensus 507 Ls~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 581 (1029)
+++|++++ +|. |..+++|+ .|++++| ++++..+..|.++++|+ .|++++|+++...+..|.. ++|+.|+|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 66666665 333 56666666 6677776 66655555666677777 7777777776333333333 6777777777
Q ss_pred cc-ccccCCccccCC-CCCCEEeCcCCcccCcCchhhhcccccceeeccCC
Q 036879 582 NK-FQGSIPDSLGGL-TSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFN 630 (1029)
Q Consensus 582 N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 630 (1029)
|+ +++..+..|.++ ++|++|+|++|++++..+. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 74 765555666777 7777777777777744333 4556666666654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=215.54 Aligned_cols=206 Identities=17% Similarity=0.191 Sum_probs=178.5
Q ss_pred CCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCcc-ccccccccccCCCCCCEEEecc-ccccCcc
Q 036879 391 LSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNE-LTGSIPKAIGRLQKLQGLYLQH-NKLQGSI 468 (1029)
Q Consensus 391 l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~ 468 (1029)
++ .+|. +.. .+++|++++|++++..+..|.++++|++|+|++|+ +++..+..|..+++|++|++++ |++++..
T Consensus 23 l~-~ip~-~~~---~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~ 97 (239)
T 2xwt_C 23 IQ-RIPS-LPP---STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID 97 (239)
T ss_dssp CS-SCCC-CCT---TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC
T ss_pred cc-ccCC-CCC---cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC
Confidence 54 5565 332 58999999999998888899999999999999997 8877777899999999999999 9999888
Q ss_pred cccccCCCCCcEEecCCCcccCccccccccccccc---eeeccCc-cccCCCCCCccCCCCCc-EEEccCCcccCcCCcc
Q 036879 469 TTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLR---TLSLGFN-RLTSVIPSSLWSLRDIL-NVNLSSNSLNGTLPVE 543 (1029)
Q Consensus 469 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~ 543 (1029)
+..|.++++|++|++++|++++ +|. |..+++|+ +|++++| +++++.+..|.++++|+ .|++++|+++...+..
T Consensus 98 ~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~ 175 (239)
T 2xwt_C 98 PDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYA 175 (239)
T ss_dssp TTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTT
T ss_pred HHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhh
Confidence 8899999999999999999986 555 88889998 9999999 99988888999999999 9999999999544445
Q ss_pred ccccccccEEEccCCc-CCCCCCccccCc-ccccccccccccccccCCccccCCCCCCEEeCcCCc
Q 036879 544 IGNLKVVTKIDLSRND-LSGEIPSSIGDL-KNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNN 607 (1029)
Q Consensus 544 ~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 607 (1029)
+.. ++|+.|++++|+ +++..+..|..+ ++|+.|+|++|+|++ +|.. .+++|+.|+++++.
T Consensus 176 ~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 176 FNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNTW 237 (239)
T ss_dssp TTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC-
T ss_pred cCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCcc
Confidence 555 899999999995 997777889999 999999999999995 5543 57899999999873
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-24 Score=243.52 Aligned_cols=236 Identities=18% Similarity=0.191 Sum_probs=105.4
Q ss_pred cccceeeccCCcCCCCCC----ccccCchhhhcceeccccccccccccccCCc-----CcCcEEEecCcccccccccccc
Q 036879 379 KDLRKLILSENPLSGVLP----ISIGNLSNAMDVLYLSACNIKGSIPSEIGNL-----NNLTTLHLETNELTGSIPKAIG 449 (1029)
Q Consensus 379 ~~L~~L~Ls~N~l~~~~p----~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~ 449 (1029)
++|++|+|++|.+++..+ ..+..++..|++|+|++|+|++..+..|..+ ++|++|+|++|++++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 346666666666654444 3333443225555555555554444444443 5555555555555543333222
Q ss_pred ----CC-CCCCEEEeccccccCccccccc----C-CCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCC
Q 036879 450 ----RL-QKLQGLYLQHNKLQGSITTDLC----G-LRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSS 519 (1029)
Q Consensus 450 ----~l-~~L~~L~L~~N~l~~~~~~~~~----~-l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 519 (1029)
.+ ++|++|+|++|++++..+..+. . .++|++|++++|+++...+..+ +..
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l--------------------~~~ 161 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL--------------------IQI 161 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH--------------------HHH
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH--------------------HHH
Confidence 22 4555555555555444333322 1 1344444444444443222211 112
Q ss_pred ccCCC-CCcEEEccCCcccCcCCccccc----c-ccccEEEccCCcCCCC----CCccccC-cccccccccccccccccC
Q 036879 520 LWSLR-DILNVNLSSNSLNGTLPVEIGN----L-KVVTKIDLSRNDLSGE----IPSSIGD-LKNMQHLSLADNKFQGSI 588 (1029)
Q Consensus 520 ~~~l~-~L~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~L~~N~l~~~~ 588 (1029)
+..++ +|+.|+|++|++++..+..+.. + ++|+.|||++|.+++. ++..+.. .++|+.|+|++|+|++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 22222 4555555555554433332222 2 3555555555555432 2222222 235555555555554432
Q ss_pred C----ccccCCCCCCEEeCcCCcccCcCch-------hhhcccccceeeccCCCCcC
Q 036879 589 P----DSLGGLTSLNFLDMSSNNLSGEIPN-------SLKALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 589 ~----~~~~~l~~L~~L~Ls~N~l~~~~~~-------~~~~l~~L~~L~l~~N~l~~ 634 (1029)
+ ..+..+++|++|+|++|.+++..+. .+..+++|+.||+++|++..
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 2 2233445555555555554332222 33344555555555555543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=224.14 Aligned_cols=202 Identities=20% Similarity=0.185 Sum_probs=143.3
Q ss_pred cCcCcEEEecCccccccccccc--cCCCCCCEEEeccccccCccc----ccccCCCCCcEEecCCCcccCcccccccccc
Q 036879 427 LNNLTTLHLETNELTGSIPKAI--GRLQKLQGLYLQHNKLQGSIT----TDLCGLRSLSEFYSDGNELNGSLPQCLDSLI 500 (1029)
Q Consensus 427 l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 500 (1029)
+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|++++|++.+..+..|+.++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 3456666666666666666655 666666666666666665332 3344566777777777777667777777777
Q ss_pred ccceeeccCccccC---CC-CCCccCCCCCcEEEccCCcccCcCCc----cccccccccEEEccCCcCCCCCCccccCc-
Q 036879 501 SLRTLSLGFNRLTS---VI-PSSLWSLRDILNVNLSSNSLNGTLPV----EIGNLKVVTKIDLSRNDLSGEIPSSIGDL- 571 (1029)
Q Consensus 501 ~L~~L~Ls~N~l~~---~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l- 571 (1029)
+|++|+|++|++.+ .. +..+..+++|++|+|++|+++. ++. .++.+++|++|||++|++++..|..+..+
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence 77777777777654 22 2334677788888888888863 232 24677888888888888887777777666
Q ss_pred --ccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcC
Q 036879 572 --KNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 572 --~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 634 (1029)
++|+.|+|++|+|+ .+|..+. ++|++|||++|+|++. |. +..+++|+.|++++|+++.
T Consensus 249 ~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 249 WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 68888888888888 5677664 7888999999998854 33 6778888999999998874
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=5e-22 Score=212.46 Aligned_cols=179 Identities=23% Similarity=0.274 Sum_probs=106.7
Q ss_pred CcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccC
Q 036879 430 LTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGF 509 (1029)
Q Consensus 430 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 509 (1029)
.++++++++.++ .+|..+. ++++.|+|++|.+++..+..|..+++|++|++++|.+++..+..|..+++|++|+|++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 445555555555 3443332 3555555555555555444455555555555555555555555566666666666666
Q ss_pred ccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCC
Q 036879 510 NRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIP 589 (1029)
Q Consensus 510 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 589 (1029)
|+++++.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 66666555666666666666666666665555555666666666666666665555556666666666666666665555
Q ss_pred ccccCCCCCCEEeCcCCcccCc
Q 036879 590 DSLGGLTSLNFLDMSSNNLSGE 611 (1029)
Q Consensus 590 ~~~~~l~~L~~L~Ls~N~l~~~ 611 (1029)
..|..+++|++|+|++|++++.
T Consensus 173 ~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 173 GAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHhCCCCCCEEEeeCCceeCC
Confidence 5666666666666666666644
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=6.7e-23 Score=226.72 Aligned_cols=200 Identities=17% Similarity=0.202 Sum_probs=156.2
Q ss_pred hcceecccccccccccccc--CCcCcCcEEEecCcccccccc----ccccCCCCCCEEEeccccccCcccccccCCCCCc
Q 036879 406 MDVLYLSACNIKGSIPSEI--GNLNNLTTLHLETNELTGSIP----KAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLS 479 (1029)
Q Consensus 406 L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 479 (1029)
|++|++++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++.+..+..|..+++|+
T Consensus 93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 172 (310)
T 4glp_A 93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALT 172 (310)
T ss_dssp CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCC
T ss_pred eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCC
Confidence 7888888888888888887 888888888888888886444 3445788888888888888888888888888888
Q ss_pred EEecCCCcccCc--c--ccccccccccceeeccCccccCCCCC---CccCCCCCcEEEccCCcccCcCCcccccc---cc
Q 036879 480 EFYSDGNELNGS--L--PQCLDSLISLRTLSLGFNRLTSVIPS---SLWSLRDILNVNLSSNSLNGTLPVEIGNL---KV 549 (1029)
Q Consensus 480 ~L~l~~N~l~~~--~--~~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~ 549 (1029)
+|++++|++.+. . +..+..+++|++|+|++|+++...+. .+..+++|++|+|++|++++..|..+..+ ++
T Consensus 173 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~ 252 (310)
T 4glp_A 173 SLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSA 252 (310)
T ss_dssp EEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTT
T ss_pred EEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCc
Confidence 888888887642 1 23346788888888888888743221 35677888888888888887777777766 58
Q ss_pred ccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccC
Q 036879 550 VTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSG 610 (1029)
Q Consensus 550 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 610 (1029)
|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|++|+|++|+|+.
T Consensus 253 L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 253 LNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 888888888888 5666664 7888888888888853 43 6777888888888888873
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-22 Score=221.50 Aligned_cols=193 Identities=26% Similarity=0.388 Sum_probs=110.5
Q ss_pred CcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCcccccccccccccee
Q 036879 426 NLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTL 505 (1029)
Q Consensus 426 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 505 (1029)
.+++|++|++++|.++. ++ .+..+++|++|+|++|.+++..+ +..+++|++|++++|++++. ..+..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L 112 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTL 112 (308)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEE
T ss_pred HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEE
Confidence 34455555555555542 22 34455555555555555544333 45555555555555555432 245566666666
Q ss_pred eccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccccccccc
Q 036879 506 SLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQ 585 (1029)
Q Consensus 506 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 585 (1029)
+|++|+++++.+ +..+++|+.|++++|++++..+ ++.+++|+.|++++|++++..+ +..+++|+.|+|++|+++
T Consensus 113 ~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp ECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCchh--hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence 666666655322 5666666666666666664332 5666666666666666664322 666666666666666666
Q ss_pred ccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcC
Q 036879 586 GSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 586 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 634 (1029)
+..+ +..+++|++|+|++|++++..+ +..+++|+.|++++|++++
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred cChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 4332 5666666666776666664442 5666666667776666664
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-24 Score=245.88 Aligned_cols=213 Identities=20% Similarity=0.271 Sum_probs=138.1
Q ss_pred cCCcCcCcEEEecCcc---ccccccccc-------cCCCCCCEEEeccccccC----cccccccCCCCCcEEecCCCccc
Q 036879 424 IGNLNNLTTLHLETNE---LTGSIPKAI-------GRLQKLQGLYLQHNKLQG----SITTDLCGLRSLSEFYSDGNELN 489 (1029)
Q Consensus 424 ~~~l~~L~~L~L~~N~---l~~~~~~~~-------~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~ 489 (1029)
|..+++|++|+|++|. +++.+|..+ ..+++|++|+|++|.++. ..+..+..+++|+.|++++|.++
T Consensus 56 l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 135 (386)
T 2ca6_A 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 135 (386)
T ss_dssp TTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred HHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCC
Confidence 4455666666666642 333333333 456666666666666655 24445556666666666666665
Q ss_pred Cccccccc----cc---------cccceeeccCcccc-CCCC---CCccCCCCCcEEEccCCcccC-----cCCcccccc
Q 036879 490 GSLPQCLD----SL---------ISLRTLSLGFNRLT-SVIP---SSLWSLRDILNVNLSSNSLNG-----TLPVEIGNL 547 (1029)
Q Consensus 490 ~~~~~~~~----~l---------~~L~~L~Ls~N~l~-~~~~---~~~~~l~~L~~L~Ls~N~l~~-----~~p~~~~~l 547 (1029)
...+..+. .+ ++|++|+|++|+++ ...+ ..+..+++|+.|+|++|+++. ..|..+..+
T Consensus 136 ~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~ 215 (386)
T 2ca6_A 136 PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGC
T ss_pred HHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcC
Confidence 43333333 33 67777777777776 2233 355567777777777777762 334467777
Q ss_pred ccccEEEccCCcCC----CCCCccccCccccccccccccccccc----CCcccc--CCCCCCEEeCcCCcccC----cCc
Q 036879 548 KVVTKIDLSRNDLS----GEIPSSIGDLKNMQHLSLADNKFQGS----IPDSLG--GLTSLNFLDMSSNNLSG----EIP 613 (1029)
Q Consensus 548 ~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~--~l~~L~~L~Ls~N~l~~----~~~ 613 (1029)
++|+.|+|++|.++ ..+|..+..+++|+.|+|++|+|++. ++..+. .+++|++|+|++|++++ .+|
T Consensus 216 ~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~ 295 (386)
T 2ca6_A 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 295 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred CCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHH
Confidence 78888888888875 45667777788888888888888765 455553 37888888888888886 366
Q ss_pred hhh-hcccccceeeccCCCCcCCC
Q 036879 614 NSL-KALSLLKFLNLSFNGLQGQV 636 (1029)
Q Consensus 614 ~~~-~~l~~L~~L~l~~N~l~~~~ 636 (1029)
..+ .++++|+.|++++|++++..
T Consensus 296 ~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 296 TVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHhcCCCceEEEccCCcCCcch
Confidence 666 56788888888888887543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=9.7e-22 Score=210.23 Aligned_cols=183 Identities=19% Similarity=0.203 Sum_probs=166.3
Q ss_pred CCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEc
Q 036879 452 QKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNL 531 (1029)
Q Consensus 452 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 531 (1029)
...++++++++.++..+. .+. ++++.|++++|.+.+..+..|.++++|++|+|++|+++++.+..|..+++|+.|+|
T Consensus 14 ~~~~~l~~~~~~l~~~p~-~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLDSVPS-GIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCSSCCS-CCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCccccCC-CCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 457889999999985544 333 68999999999999999999999999999999999999999999999999999999
Q ss_pred cCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCc
Q 036879 532 SSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGE 611 (1029)
Q Consensus 532 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 611 (1029)
++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 99999988888899999999999999999977777889999999999999999977777899999999999999999988
Q ss_pred CchhhhcccccceeeccCCCCcCCCC
Q 036879 612 IPNSLKALSLLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 612 ~~~~~~~l~~L~~L~l~~N~l~~~~~ 637 (1029)
.+..+..+++|+.|++++|++++...
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred CHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 88899999999999999999998643
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.8e-24 Score=244.80 Aligned_cols=269 Identities=17% Similarity=0.224 Sum_probs=197.5
Q ss_pred CCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCC---CCCCccccCchhhhc
Q 036879 331 PIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLS---GVLPISIGNLSNAMD 407 (1029)
Q Consensus 331 ~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~---~~~p~~~~~l~~~L~ 407 (1029)
.++..+..+++|+.|++++|.+....+..+ ...+..+++|+.|+|++|.+. +.+|..+..
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l-----------~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~------ 85 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWL-----------SENIASKKDLEIAEFSDIFTGRVKDEIPEALRL------ 85 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHH-----------HHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHH------
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHH-----------HHHHHhCCCccEEeCcccccCccccchhHHHHH------
Confidence 566777777777777777777764433222 123456677777777775432 222322211
Q ss_pred ceeccccccccccccccCCcCcCcEEEecCccccc----cccccccCCCCCCEEEeccccccCcccccccC----C----
Q 036879 408 VLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTG----SIPKAIGRLQKLQGLYLQHNKLQGSITTDLCG----L---- 475 (1029)
Q Consensus 408 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----l---- 475 (1029)
+...|..+++|++|+|++|.+++ .+|..+..+++|++|+|++|.++...+..+.. +
T Consensus 86 ------------l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~ 153 (386)
T 2ca6_A 86 ------------LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNK 153 (386)
T ss_dssp ------------HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred ------------HHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhh
Confidence 11334677888888888888886 36777888888888888888886554444433 3
Q ss_pred -----CCCcEEecCCCccc-Cccc---cccccccccceeeccCccccC-----CCCCCccCCCCCcEEEccCCccc----
Q 036879 476 -----RSLSEFYSDGNELN-GSLP---QCLDSLISLRTLSLGFNRLTS-----VIPSSLWSLRDILNVNLSSNSLN---- 537 (1029)
Q Consensus 476 -----~~L~~L~l~~N~l~-~~~~---~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~---- 537 (1029)
++|+.|++++|+++ ...+ ..+..+++|++|+|++|+++. ..+..+..+++|+.|+|++|.++
T Consensus 154 ~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~ 233 (386)
T 2ca6_A 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 233 (386)
T ss_dssp HHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHH
T ss_pred hcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHH
Confidence 78899999999887 3444 467788999999999999973 45558889999999999999996
Q ss_pred CcCCccccccccccEEEccCCcCCCC----CCccc--cCcccccccccccccccc----cCCccc-cCCCCCCEEeCcCC
Q 036879 538 GTLPVEIGNLKVVTKIDLSRNDLSGE----IPSSI--GDLKNMQHLSLADNKFQG----SIPDSL-GGLTSLNFLDMSSN 606 (1029)
Q Consensus 538 ~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~Ls~N 606 (1029)
..+|..+..+++|+.|+|++|.+++. +|..+ +.+++|+.|+|++|+|++ .+|..+ .++++|++|+|++|
T Consensus 234 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N 313 (386)
T 2ca6_A 234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN 313 (386)
T ss_dssp HHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTS
T ss_pred HHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCC
Confidence 56788899999999999999999865 45666 348999999999999997 477777 66899999999999
Q ss_pred cccCcCc--hhh-hcccccceeecc
Q 036879 607 NLSGEIP--NSL-KALSLLKFLNLS 628 (1029)
Q Consensus 607 ~l~~~~~--~~~-~~l~~L~~L~l~ 628 (1029)
++++..+ ..+ ..++.++.+++.
T Consensus 314 ~l~~~~~~~~~l~~~l~~~~~~~l~ 338 (386)
T 2ca6_A 314 RFSEEDDVVDEIREVFSTRGRGELD 338 (386)
T ss_dssp BSCTTSHHHHHHHHHHHHHTCCEEC
T ss_pred cCCcchhHHHHHHHHhhhcCcchhh
Confidence 9998774 333 345666655553
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=7.1e-24 Score=240.04 Aligned_cols=267 Identities=18% Similarity=0.186 Sum_probs=183.7
Q ss_pred eEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCccccccccccccc-ccceeeccCCcCCCCCCcc
Q 036879 320 QLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCK-DLRKLILSENPLSGVLPIS 398 (1029)
Q Consensus 320 ~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~p~~ 398 (1029)
.+.|+.|.+++.+|..+...++|+.|++++|.+.+..+..+ ...+..++ +|++|+|++|++++..+..
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l-----------~~~l~~~~~~L~~L~Ls~N~l~~~~~~~ 70 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVEL-----------IQAFANTPASVTSLNLSGNSLGFKNSDE 70 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHH-----------HHHHHTCCTTCCEEECCSSCGGGSCHHH
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHH-----------HHHHHhCCCceeEEECcCCCCCHHHHHH
Confidence 46899999999999988888889999999999986544211 13456777 8999999999999887877
Q ss_pred ccCc----hhhhcceeccccccccccccccCCc-----CcCcEEEecCcccccccccccc----C-CCCCCEEEeccccc
Q 036879 399 IGNL----SNAMDVLYLSACNIKGSIPSEIGNL-----NNLTTLHLETNELTGSIPKAIG----R-LQKLQGLYLQHNKL 464 (1029)
Q Consensus 399 ~~~l----~~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~----~-l~~L~~L~L~~N~l 464 (1029)
+..+ ...|++|+|++|++++..+..+... ++|++|+|++|+|++..+..+. . .++|++|+|++|.+
T Consensus 71 l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l 150 (362)
T 3goz_A 71 LVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDL 150 (362)
T ss_dssp HHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCG
T ss_pred HHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcC
Confidence 7775 1349999999999998777755544 8999999999999976665544 3 36999999999999
Q ss_pred cCcccccc----cCCC-CCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCC-CCCcEEEccCCcccC
Q 036879 465 QGSITTDL----CGLR-SLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSL-RDILNVNLSSNSLNG 538 (1029)
Q Consensus 465 ~~~~~~~~----~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~ 538 (1029)
+......+ ...+ +|++|++++|++++..+..+... +... ++|+.|+|++|.|++
T Consensus 151 ~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~--------------------l~~~~~~L~~L~Ls~N~i~~ 210 (362)
T 3goz_A 151 GIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKF--------------------LASIPASVTSLDLSANLLGL 210 (362)
T ss_dssp GGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHH--------------------HHTSCTTCCEEECTTSCGGG
T ss_pred CHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHH--------------------HHhCCCCCCEEECCCCCCCh
Confidence 86544333 3333 56666666666655444433322 1112 244444444444443
Q ss_pred c----CCccccc-cccccEEEccCCcCCCCCC----ccccCccccccccccccccccc-------CCccccCCCCCCEEe
Q 036879 539 T----LPVEIGN-LKVVTKIDLSRNDLSGEIP----SSIGDLKNMQHLSLADNKFQGS-------IPDSLGGLTSLNFLD 602 (1029)
Q Consensus 539 ~----~p~~~~~-l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~ 602 (1029)
. ++..+.. .++|+.|+|++|.+++..+ ..+..+++|+.|+|++|.+.+. ++..+..+++|++||
T Consensus 211 ~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~Ld 290 (362)
T 3goz_A 211 KSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVD 290 (362)
T ss_dssp SCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEEC
T ss_pred hHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEe
Confidence 1 2333333 3466777777777665433 2345567778888888874432 334677888899999
Q ss_pred CcCCcccCcCchhhh
Q 036879 603 MSSNNLSGEIPNSLK 617 (1029)
Q Consensus 603 Ls~N~l~~~~~~~~~ 617 (1029)
+++|++....+..+.
T Consensus 291 L~~N~l~~~~~~~~~ 305 (362)
T 3goz_A 291 KNGKEIHPSHSIPIS 305 (362)
T ss_dssp TTSCBCCGGGCHHHH
T ss_pred cCCCcCCCcchHHHH
Confidence 999998876554443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.8e-23 Score=231.81 Aligned_cols=251 Identities=20% Similarity=0.224 Sum_probs=201.9
Q ss_pred ccceeeccCCcCCCCCCccccCc-hhhhcceeccccccccccccccCCcCcCcEEEecCcccccc-ccccccCCCCCCEE
Q 036879 380 DLRKLILSENPLSGVLPISIGNL-SNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGS-IPKAIGRLQKLQGL 457 (1029)
Q Consensus 380 ~L~~L~Ls~N~l~~~~p~~~~~l-~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L 457 (1029)
.++.+++++|.+. +..+..+ ...++.|++++|.+.+..+. +..+++|++|+|++|.+++. ++..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3677888888765 4444444 12388889999988876665 55789999999999998865 77888899999999
Q ss_pred EeccccccCcccccccCCCCCcEEecCCC-cccC-ccccccccccccceeeccCc-cccCC-CCCCccCCC-CCcEEEcc
Q 036879 458 YLQHNKLQGSITTDLCGLRSLSEFYSDGN-ELNG-SLPQCLDSLISLRTLSLGFN-RLTSV-IPSSLWSLR-DILNVNLS 532 (1029)
Q Consensus 458 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~-~~~~~~~~l~~L~~L~Ls~N-~l~~~-~~~~~~~l~-~L~~L~Ls 532 (1029)
+|++|.+++..+..+..+++|++|++++| .+++ ..+..+..+++|++|++++| .+++. ++..+..++ +|+.|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999988888888888999999999999 6775 36777889999999999999 88864 566788899 99999999
Q ss_pred CC--ccc-CcCCccccccccccEEEccCCc-CCCCCCccccCccccccccccccc-ccccCCccccCCCCCCEEeCcCCc
Q 036879 533 SN--SLN-GTLPVEIGNLKVVTKIDLSRND-LSGEIPSSIGDLKNMQHLSLADNK-FQGSIPDSLGGLTSLNFLDMSSNN 607 (1029)
Q Consensus 533 ~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~ 607 (1029)
+| .++ +.+|..+..+++|+.|++++|. +++..+..+..+++|+.|+|++|. +.......+..+++|+.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 99 455 4567778889999999999999 777778889999999999999995 33222236888999999999999
Q ss_pred ccCcCchhhhccc-ccceeeccCCCCcCCCCC
Q 036879 608 LSGEIPNSLKALS-LLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 608 l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~ 638 (1029)
++. ..+..+. .+..|++++|++++..|.
T Consensus 283 i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 283 VPD---GTLQLLKEALPHLQINCSHFTTIARP 311 (336)
T ss_dssp SCT---TCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred cCH---HHHHHHHhhCcceEEecccCccccCC
Confidence 442 3445553 488888999999998775
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.6e-22 Score=223.92 Aligned_cols=245 Identities=16% Similarity=0.173 Sum_probs=123.1
Q ss_pred ceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCcccccccc-ccccCCCCCCE-EEe
Q 036879 382 RKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIP-KAIGRLQKLQG-LYL 459 (1029)
Q Consensus 382 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~-L~L 459 (1029)
++++.++++++ .+|..+. ..+++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| .+|.+++++++ +.+
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~---~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC---TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC---CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 45666666665 4444332 224555555555554334445555555555555555433222 33444444433 333
Q ss_pred ccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccC-CcccC
Q 036879 460 QHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSS-NSLNG 538 (1029)
Q Consensus 460 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~ 538 (1029)
+.|++ +...|..|..+++|++|++++|+++.+.+..+....++..|++++ |+++.
T Consensus 88 ~~N~l------------------------~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~ 143 (350)
T 4ay9_X 88 KANNL------------------------LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143 (350)
T ss_dssp EETTC------------------------CEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCE
T ss_pred cCCcc------------------------cccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccc
Confidence 34444 445555555556666666666666555555555555555555543 44554
Q ss_pred cCCccccccc-cccEEEccCCcCCCCCCccccCccccccccccc-ccccccCCccccCCCCCCEEeCcCCcccCcCchhh
Q 036879 539 TLPVEIGNLK-VVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLAD-NKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSL 616 (1029)
Q Consensus 539 ~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 616 (1029)
..+..|..+. .++.|+|++|+|+. +|.......+|+.|++++ |.++...++.|.++++|++|||++|+|+...+..+
T Consensus 144 l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~ 222 (350)
T 4ay9_X 144 IERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL 222 (350)
T ss_dssp ECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC
T ss_pred ccccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhh
Confidence 4444444443 45666666666653 333333345566666653 45553333455666666666666666664444444
Q ss_pred hcccccceeeccCCCCcCCCCCCCCCCccCcccccCCCCCCCC
Q 036879 617 KALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGA 659 (1029)
Q Consensus 617 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~ 659 (1029)
.++++|+.+++ .--..+|....++++..+.+ .+++.|.+
T Consensus 223 ~~L~~L~~l~~---~~l~~lP~l~~l~~L~~l~l-~~~~~c~~ 261 (350)
T 4ay9_X 223 ENLKKLRARST---YNLKKLPTLEKLVALMEASL-TYPSHCCA 261 (350)
T ss_dssp TTCCEEECTTC---TTCCCCCCTTTCCSCCEEEC-SCHHHHHH
T ss_pred ccchHhhhccC---CCcCcCCCchhCcChhhCcC-CCCccccc
Confidence 44333333322 22224444444555555444 35555544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=5.6e-22 Score=218.78 Aligned_cols=215 Identities=21% Similarity=0.381 Sum_probs=166.1
Q ss_pred cccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEE
Q 036879 379 KDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLY 458 (1029)
Q Consensus 379 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 458 (1029)
..+..+.+..+.+.+.+. ...+.+ ++.|++++|.++. ++ .+..+++|++|+|++|++++..+ +..+++|++|+
T Consensus 19 ~~~~~~~l~~~~~~~~~~--~~~l~~-L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~ 91 (308)
T 1h6u_A 19 ANAIKIAAGKSNVTDTVT--QADLDG-ITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (308)
T ss_dssp HHHHHHHTTCSSTTSEEC--HHHHHT-CCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHhCCCCcCceec--HHHcCC-cCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEE
Confidence 334444555555553322 233443 7777777777774 34 57778888888888888885433 88888888888
Q ss_pred eccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccC
Q 036879 459 LQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNG 538 (1029)
Q Consensus 459 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 538 (1029)
|++|++++. ..+..+++|+.|++++|++++.. .+..+++|++|++++|+++++.+ +..+++|+.|++++|++++
T Consensus 92 L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 92 LSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp CCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred ccCCcCCCc--hhhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence 888888764 36788888888888888887643 38889999999999999987654 8889999999999999986
Q ss_pred cCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcC
Q 036879 539 TLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEI 612 (1029)
Q Consensus 539 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 612 (1029)
..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..+ +..+++|++|+|++|++++..
T Consensus 166 ~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 166 LTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCC
T ss_pred Chh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCC
Confidence 443 8899999999999999985543 8889999999999999996553 888999999999999998543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.4e-22 Score=227.11 Aligned_cols=253 Identities=15% Similarity=0.228 Sum_probs=124.4
Q ss_pred CcEEEccCcccCCCCCchhhhcc--cccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccc
Q 036879 293 LTVLSLTANNLLGNLPSNIGHSL--PNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELG 370 (1029)
Q Consensus 293 L~~L~Ls~N~l~~~lp~~~~~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~ 370 (1029)
++.+++++|.+. |..+. .+ ++++.|++++|.+.+..+. +..+++|+.|++++|.+.+.
T Consensus 49 ~~~l~l~~~~~~---~~~~~-~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~--------------- 108 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTG-RLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS--------------- 108 (336)
T ss_dssp SSEEECTTCBCC---HHHHH-HHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH---------------
T ss_pred heeeccccccCC---HHHHH-hhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH---------------
Confidence 678888888764 33333 35 6778888888877765544 33445555555555544321
Q ss_pred cccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCc-ccccc-ccccc
Q 036879 371 FLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETN-ELTGS-IPKAI 448 (1029)
Q Consensus 371 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~ 448 (1029)
.+|..+..+++ |++|++++|++++..+..|+.+++|++|+|++| .+++. ++..+
T Consensus 109 -----------------------~~~~~~~~~~~-L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~ 164 (336)
T 2ast_B 109 -----------------------TLHGILSQCSK-LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 164 (336)
T ss_dssp -----------------------HHHHHHTTBCC-CSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH
T ss_pred -----------------------HHHHHHhhCCC-CCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHH
Confidence 02222222222 334444444443344444445555555555555 44431 34445
Q ss_pred cCCCCCCEEEeccc-cccCc-ccccccCCC-CCcEEecCCC--ccc-CccccccccccccceeeccCcc-ccCCCCCCcc
Q 036879 449 GRLQKLQGLYLQHN-KLQGS-ITTDLCGLR-SLSEFYSDGN--ELN-GSLPQCLDSLISLRTLSLGFNR-LTSVIPSSLW 521 (1029)
Q Consensus 449 ~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~l~~N--~l~-~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~ 521 (1029)
..+++|++|++++| .+++. .+..+..++ +|++|++++| .++ +.++..+..+++|++|++++|. +++..+..+.
T Consensus 165 ~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~ 244 (336)
T 2ast_B 165 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF 244 (336)
T ss_dssp HHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGG
T ss_pred hcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHh
Confidence 55555555555555 55432 233344444 4555555544 222 2344445555556666666555 4444444555
Q ss_pred CCCCCcEEEccCCc-ccCcCCccccccccccEEEccCCcCCCCCCccccCc-ccccccccccccccccCCcccc
Q 036879 522 SLRDILNVNLSSNS-LNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDL-KNMQHLSLADNKFQGSIPDSLG 593 (1029)
Q Consensus 522 ~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~ 593 (1029)
.+++|+.|++++|. ++......++.+++|+.|++++| ++ ...+..+ ..|+.|++++|++++..|..++
T Consensus 245 ~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 245 QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp GCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred CCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence 55555555555553 22111123455555555555555 22 1223333 2245555555555555554443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.4e-21 Score=218.03 Aligned_cols=247 Identities=16% Similarity=0.137 Sum_probs=181.9
Q ss_pred cccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccc
Q 036879 336 ISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACN 415 (1029)
Q Consensus 336 l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~ 415 (1029)
++.+.. +.++-+++.++ .+|..+ .+++++|+|++|+|+...+.+|.++.+ |++|+|++|+
T Consensus 6 ~C~C~~-~~v~C~~~~Lt-~iP~~l-----------------~~~l~~L~Ls~N~i~~i~~~~f~~l~~-L~~L~Ls~N~ 65 (350)
T 4ay9_X 6 ICHCSN-RVFLCQESKVT-EIPSDL-----------------PRNAIELRFVLTKLRVIQKGAFSGFGD-LEKIEISQND 65 (350)
T ss_dssp SSEEET-TEEEEESTTCC-SCCTTC-----------------CTTCSEEEEESCCCSEECTTSSTTCTT-CCEEEEECCT
T ss_pred ccEeeC-CEEEecCCCCC-ccCcCc-----------------CCCCCEEEccCCcCCCcCHHHHcCCCC-CCEEECcCCC
Confidence 344433 67788888887 445322 257999999999999766678899987 9999999999
Q ss_pred cccccc-cccCCcCcCcE-EEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCC-CcccCcc
Q 036879 416 IKGSIP-SEIGNLNNLTT-LHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG-NELNGSL 492 (1029)
Q Consensus 416 l~~~~p-~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~ 492 (1029)
+.+.+| .+|.++++|.+ +.++.|+|++..|..|..+++|++|++++|+++...+..+....++..+++.+ |++....
T Consensus 66 i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 66 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145 (350)
T ss_dssp TCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEEC
T ss_pred CCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccc
Confidence 976555 57899998875 67778999988889999999999999999999988887777777888888754 6677666
Q ss_pred cccccccc-ccceeeccCccccCCCCCCccCCCCCcEEEccC-CcccCcCCccccccccccEEEccCCcCCCCCCccccC
Q 036879 493 PQCLDSLI-SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSS-NSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGD 570 (1029)
Q Consensus 493 ~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 570 (1029)
+..|..+. .++.|+|++|+|+.+.+..| ...+|+.|++++ |.++.+.+..|.++++|+.|||++|+|+...+..|.+
T Consensus 146 ~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~ 224 (350)
T 4ay9_X 146 RNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 224 (350)
T ss_dssp TTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT
T ss_pred ccchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc
Confidence 66777664 57778888888876555554 345677777764 6666554556777788888888888887554555655
Q ss_pred cccccccccccccccccCCccccCCCCCCEEeCcCCc
Q 036879 571 LKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNN 607 (1029)
Q Consensus 571 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 607 (1029)
+++|+.+++ +.++ .+| .+..+++|+.++++++.
T Consensus 225 L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 225 LKKLRARST--YNLK-KLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp CCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred chHhhhccC--CCcC-cCC-CchhCcChhhCcCCCCc
Confidence 555555544 3344 455 36677777777776654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-21 Score=231.31 Aligned_cols=212 Identities=25% Similarity=0.358 Sum_probs=129.9
Q ss_pred ccCCCCCCCCCC-----ceeeE-EEcCCCCceEEEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCC
Q 036879 25 LASNWSTNTSVC-----NWFGV-TCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRL 98 (1029)
Q Consensus 25 ~~~~w~~~~~~c-----~w~gv-~c~~~~~~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 98 (1029)
+.+ |..+.++| .|.|+ +|.. ++++.|+|+++++.+ ||+.+. ++|+.|+|++|+|+ .+| ..+++|
T Consensus 33 l~~-W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L 102 (571)
T 3cvr_A 33 WDK-WEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASL 102 (571)
T ss_dssp HHH-HHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred HHH-HhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCC
Confidence 445 87677788 79999 7863 478888888888875 887764 77888888888887 666 446777
Q ss_pred ceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCC
Q 036879 99 KYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSN 178 (1029)
Q Consensus 99 ~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 178 (1029)
++|+|++|+|+. +|. +.. +|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|+.|+|++
T Consensus 103 ~~L~Ls~N~l~~--ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~ 169 (571)
T 3cvr_A 103 EYLDACDNRLST--LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRN 169 (571)
T ss_dssp CEEECCSSCCSC--CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred CEEEccCCCCCC--cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCC
Confidence 777777777774 455 443 77777777777774 555 46677777777777763 554 345555555555
Q ss_pred CcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcccccccCCCCccccccccccceeec
Q 036879 179 NQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLV 258 (1029)
Q Consensus 179 N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 258 (1029)
|+|++ +|. |. ++|++|+|++|+|+ .+|. |.. +|
T Consensus 170 N~L~~----------------------------------lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L------ 202 (571)
T 3cvr_A 170 NQLTF----------------------------------LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RN------ 202 (571)
T ss_dssp SCCSC----------------------------------CCC-CC--TTCCEEECCSSCCS-SCCC-CC-----------
T ss_pred CCCCC----------------------------------cch-hh--CCCCEEECcCCCCC-chhh-HHH--hh------
Confidence 55443 333 33 56677777777666 4444 332 11
Q ss_pred ccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchh
Q 036879 259 YTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNI 311 (1029)
Q Consensus 259 ~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~ 311 (1029)
....+.|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+++.+|..+
T Consensus 203 ----~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l 250 (571)
T 3cvr_A 203 ----HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250 (571)
T ss_dssp ---------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHH
T ss_pred ----hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHH
Confidence 111122345555555555 345555555555555555555554444443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=6.1e-21 Score=197.75 Aligned_cols=186 Identities=20% Similarity=0.282 Sum_probs=125.3
Q ss_pred CCCceeeEEEcCCCCceEEEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCC
Q 036879 34 SVCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEI 113 (1029)
Q Consensus 34 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 113 (1029)
..|.|.+|.|+.. ++. .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|+++.+.
T Consensus 5 C~C~~~~v~c~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~- 68 (208)
T 2o6s_A 5 CSCSGTTVECYSQ------------GRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLP- 68 (208)
T ss_dssp CEEETTEEECCSS------------CCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC-
T ss_pred CEECCCEEEecCC------------Ccc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccC-
Confidence 4589999999743 222 455443 346777777777777555556677777777777777777431
Q ss_pred CCcCCCCCccceeccccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCC
Q 036879 114 PPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSP 193 (1029)
Q Consensus 114 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~ 193 (1029)
+..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+.++++|++|++++|++++.++..+..
T Consensus 69 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-- 146 (208)
T 2o6s_A 69 NGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDR-- 146 (208)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTT--
T ss_pred hhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhcc--
Confidence 334577777777777777777555555677777777777777777555556777777777777777777666654321
Q ss_pred cccccccccccchhccccccccCCCCcccccccccceEEcccccccCCCCcccccccc
Q 036879 194 LQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITM 251 (1029)
Q Consensus 194 l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 251 (1029)
..+|++|++++|.+.+ .+++|++|+++.|+++|.+|..++++..
T Consensus 147 -------l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 147 -------LTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp -------CTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred -------CCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 1245666666666543 3456777777777777777777776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.5e-21 Score=209.84 Aligned_cols=141 Identities=17% Similarity=0.154 Sum_probs=114.0
Q ss_pred HHHHHHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccc------------------hhhHHHHHHHHHHhcCC
Q 036879 731 QELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE------------------GTLRSFDAECEILGSIR 792 (1029)
Q Consensus 731 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 792 (1029)
..+......|++.+.||+|+||.||+|+..+|+.||+|.++.... .....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344455667778899999999999999997799999999864321 13456889999999999
Q ss_pred CCceEEEEEEEecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC
Q 036879 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN 872 (1029)
Q Consensus 793 h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~ 872 (1029)
| +++++++.. +..++||||+++++|.+ +.. .....++.|++.|++||| +.||+||||||+||+++
T Consensus 163 ~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS 227 (282)
T ss_dssp T---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred C---CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE
Confidence 4 555555543 45589999999999987 421 234579999999999999 77899999999999999
Q ss_pred CCCcEEEEccCCcee
Q 036879 873 ESMVACLSDFGISKL 887 (1029)
Q Consensus 873 ~~~~~kl~Dfg~a~~ 887 (1029)
++.+||+|||+|+.
T Consensus 228 -~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE 241 (282)
T ss_dssp -TTEEEECCCTTCEE
T ss_pred -CCcEEEEECCCCeE
Confidence 99999999999963
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.9e-20 Score=191.67 Aligned_cols=162 Identities=27% Similarity=0.268 Sum_probs=98.0
Q ss_pred cCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeecc
Q 036879 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLG 508 (1029)
Q Consensus 429 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 508 (1029)
+|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 45555555555554444445555555555555555554444444555555555555555555555556666666666666
Q ss_pred CccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccC
Q 036879 509 FNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI 588 (1029)
Q Consensus 509 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 588 (1029)
+|+++++.+..|..+++|+.|++++|++++..+..+..+++|+.|++++|.+.+ .+++|+.|+++.|+++|.+
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~i 181 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVV 181 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTB
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCcee
Confidence 666666666566666666666666666665555556666677777777776543 3446667777777777777
Q ss_pred CccccCCCC
Q 036879 589 PDSLGGLTS 597 (1029)
Q Consensus 589 ~~~~~~l~~ 597 (1029)
|.+++.++.
T Consensus 182 p~~~~~l~~ 190 (208)
T 2o6s_A 182 RNSAGSVAP 190 (208)
T ss_dssp BCTTSSBCT
T ss_pred eccCccccC
Confidence 766665543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.5e-20 Score=216.82 Aligned_cols=168 Identities=25% Similarity=0.323 Sum_probs=106.3
Q ss_pred cCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeecc
Q 036879 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLG 508 (1029)
Q Consensus 429 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 508 (1029)
+|++|+|++|+|+ .+| ..+++|++|+|++|+|+++ +. +.. +|+.|++++|++++ +|. .+++|+.|+|+
T Consensus 81 ~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~i-p~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 148 (571)
T 3cvr_A 81 QITVLEITQNALI-SLP---ELPASLEYLDACDNRLSTL-PE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINAD 148 (571)
T ss_dssp TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCC-CC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCCc-ch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCC
Confidence 3444444444444 233 2234444444444444432 22 222 44444555554444 333 45677777777
Q ss_pred CccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccc-------ccccccc
Q 036879 509 FNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNM-------QHLSLAD 581 (1029)
Q Consensus 509 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~L~~ 581 (1029)
+|+|++ +|. .+++|+.|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++
T Consensus 149 ~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~ 216 (571)
T 3cvr_A 149 NNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRE 216 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCS
T ss_pred CCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCC
Confidence 777776 333 46777888888888775 555 55 78888888888887 5555 554 66 8899999
Q ss_pred ccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccc
Q 036879 582 NKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSL 621 (1029)
Q Consensus 582 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 621 (1029)
|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..++.
T Consensus 217 N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp SCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred Ccce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 9998 57887878899999999999998888888877654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.2e-21 Score=236.85 Aligned_cols=204 Identities=19% Similarity=0.155 Sum_probs=110.3
Q ss_pred chhHHHHHHHHHHhccCCCCCcccCCC-CCCCCCCceeeEEEcCCCCceEEEecccccccccCCccCCCCcCCC-----e
Q 036879 3 VGRDQSALLALKAHVTNDPLNVLASNW-STNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLS-----L 76 (1029)
Q Consensus 3 ~~~~~~al~~~~~~~~~~~~~~~~~~w-~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~p~~~~~l~~L~-----~ 76 (1029)
+..|++||+++..++....+..-+. | ...+.++.|.+++++. .+++.|+|..+++.+ +|..+.....|. .
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~ 205 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQ-PTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDE 205 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCC-CcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhhHhhcCccCcccccC
Confidence 4678899999998875443333334 6 4455678899999974 579999999998875 455443332222 2
Q ss_pred EeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCCc
Q 036879 77 LNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQ 156 (1029)
Q Consensus 77 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 156 (1029)
++++.|.+. ..|..+..+++|++|+|++|++. .+|..+..+++|++|+|++|+|+ .+|..|+++++|++|+|++|+
T Consensus 206 ~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~--~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~ 281 (727)
T 4b8c_D 206 DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF--NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNR 281 (727)
T ss_dssp -----------------CCCCCCEEECTTSCCS--CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSC
T ss_pred cccccccee-cChhhhccCCCCcEEECCCCCCC--CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCc
Confidence 334445554 56778888999999999999988 56777888899999999999988 788889999999999999999
Q ss_pred CcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcccc
Q 036879 157 LQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVN 236 (1029)
Q Consensus 157 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 236 (1029)
|+ .+|..|.++++|++|+|++|.|+. +|..|+.|++|++|+|++|
T Consensus 282 l~-~lp~~~~~l~~L~~L~L~~N~l~~----------------------------------lp~~~~~l~~L~~L~L~~N 326 (727)
T 4b8c_D 282 LT-SLPAELGSCFQLKYFYFFDNMVTT----------------------------------LPWEFGNLCNLQFLGVEGN 326 (727)
T ss_dssp CS-SCCSSGGGGTTCSEEECCSSCCCC----------------------------------CCSSTTSCTTCCCEECTTS
T ss_pred CC-ccChhhcCCCCCCEEECCCCCCCc----------------------------------cChhhhcCCCccEEeCCCC
Confidence 98 788888888888888888887753 3455666777777777777
Q ss_pred cccCCCCcccccc
Q 036879 237 NFIGSIPREIGNI 249 (1029)
Q Consensus 237 ~l~~~~p~~~~~l 249 (1029)
++++.+|..+..+
T Consensus 327 ~l~~~~p~~~~~~ 339 (727)
T 4b8c_D 327 PLEKQFLKILTEK 339 (727)
T ss_dssp CCCSHHHHHHHHH
T ss_pred ccCCCChHHHhhc
Confidence 7777666666543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.1e-20 Score=192.99 Aligned_cols=137 Identities=23% Similarity=0.256 Sum_probs=94.3
Q ss_pred ccceeeccCccccCCCC-CCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccc
Q 036879 501 SLRTLSLGFNRLTSVIP-SSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSL 579 (1029)
Q Consensus 501 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 579 (1029)
.+++|+|++|+|+++.+ ..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 112 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence 34566666666665533 34666666667777777666666666677777777777777777666666777777777777
Q ss_pred ccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCC
Q 036879 580 ADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 580 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 637 (1029)
++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|++++|+|+|.++
T Consensus 113 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 113 RSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 7777776666777777777777777777776667777777777777777777776544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=2e-19 Score=189.08 Aligned_cols=163 Identities=20% Similarity=0.226 Sum_probs=133.3
Q ss_pred CCCCCCCCceeeEEEcCCCCceEEEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccc
Q 036879 29 WSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNF 108 (1029)
Q Consensus 29 w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l 108 (1029)
|..+.+.|+|.+|.|+.. ++ +.+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 12 ~~~~~~~Cs~~~v~c~~~------------~l-~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l 76 (229)
T 3e6j_A 12 ACPSQCSCSGTTVDCRSK------------RH-ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL 76 (229)
T ss_dssp CCCTTCEEETTEEECTTS------------CC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred cCCCCCEEeCCEeEccCC------------Cc-CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCC
Confidence 556788999999999743 22 37777654 8899999999999988899999999999999999999
Q ss_pred cCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcccCCCC
Q 036879 109 SSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSI 188 (1029)
Q Consensus 109 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~ 188 (1029)
+.++ +..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+.++++|+.|+|++|+|++.+
T Consensus 77 ~~i~-~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~--- 151 (229)
T 3e6j_A 77 GALP-VGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIP--- 151 (229)
T ss_dssp CCCC-TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCC---
T ss_pred CCcC-hhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccC---
Confidence 8532 355789999999999999999766667889999999999999998 78888888888888888888776433
Q ss_pred CCCCCcccccccccccchhccccccccCCCCcccccccccceEEcccccccCC
Q 036879 189 YNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGS 241 (1029)
Q Consensus 189 ~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (1029)
+..|..+++|+.|+|++|.+...
T Consensus 152 ------------------------------~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 152 ------------------------------HGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp ------------------------------TTTTTTCTTCCEEECTTSCBCTT
T ss_pred ------------------------------HHHHhCCCCCCEEEeeCCCccCC
Confidence 33455677788888888887643
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=6.1e-20 Score=191.65 Aligned_cols=136 Identities=20% Similarity=0.282 Sum_probs=87.9
Q ss_pred cccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccc
Q 036879 500 ISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSL 579 (1029)
Q Consensus 500 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 579 (1029)
++|+.|+|++|+|+++.+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|+.|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 45666666666666555556666666666666666666555666666666666666666666544455666666666666
Q ss_pred ccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCC
Q 036879 580 ADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQ 635 (1029)
Q Consensus 580 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 635 (1029)
++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|++++|++.+.
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 66666666666666666677777777766666666666666666666666666653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.5e-19 Score=197.43 Aligned_cols=187 Identities=22% Similarity=0.402 Sum_probs=110.6
Q ss_pred ceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCc
Q 036879 408 VLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNE 487 (1029)
Q Consensus 408 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 487 (1029)
.+.+..+.+++..+ +..+++|+.|++++|.++. ++ .+..+++|++|+|++|++++..+ +..+++|+.|++++|.
T Consensus 28 ~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~ 101 (291)
T 1h6t_A 28 KDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENK 101 (291)
T ss_dssp HHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhcCCCcccccc--hhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCc
Confidence 33444444443222 3456667777777777663 33 36666777777777777765443 5556666666666666
Q ss_pred ccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCcc
Q 036879 488 LNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSS 567 (1029)
Q Consensus 488 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 567 (1029)
+++. ..+..+++|++|+|++|+++++ ..+..+++|+.|++++|++++. ..++.+++|+.|++++|++++..|
T Consensus 102 l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-- 173 (291)
T 1h6t_A 102 VKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-- 173 (291)
T ss_dssp CCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred CCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--
Confidence 5532 2366666666666666666653 3455666666666666666643 455666666666666666664433
Q ss_pred ccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccC
Q 036879 568 IGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSG 610 (1029)
Q Consensus 568 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 610 (1029)
+..+++|+.|+|++|+|++ ++ .+..+++|+.|++++|+++.
T Consensus 174 l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 174 LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 5666666666666666663 33 25666666666666666654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.7e-19 Score=202.15 Aligned_cols=177 Identities=23% Similarity=0.203 Sum_probs=100.7
Q ss_pred cEEEecCccccccccccccCCCCCCEEEeccccccCccccccc-CCCCCcEEecCCCcccCccccccccccccceeeccC
Q 036879 431 TTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLC-GLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGF 509 (1029)
Q Consensus 431 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 509 (1029)
+.+++++|+++ .+|..+. +.++.|+|++|+|++..+..|. .+++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 57888888888 4565543 3578888888888766665555 566666666666666555555555555555555555
Q ss_pred ccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCC
Q 036879 510 NRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIP 589 (1029)
Q Consensus 510 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 589 (1029)
|+|+++.+..|.++++|+.|+|++|+|++..|. .|..+++|+.|+|++|+|++..+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~------------------------~~~~l~~L~~L~L~~N~l~~l~~ 153 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRN------------------------AFEDMAQLQKLYLSQNQISRFPV 153 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTT------------------------TTTTCTTCCEEECCSSCCCSCCG
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHH------------------------HhCCcccCCEEECCCCcCCeeCH
Confidence 555554444455555555555555555544444 44444445555555555443222
Q ss_pred ccc---cCCCCCCEEeCcCCcccCcCchhhhcccc--cceeeccCCCCcC
Q 036879 590 DSL---GGLTSLNFLDMSSNNLSGEIPNSLKALSL--LKFLNLSFNGLQG 634 (1029)
Q Consensus 590 ~~~---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~l~~N~l~~ 634 (1029)
..| ..+++|+.|||++|+|++..+..+..++. ++.|+|++|+|.+
T Consensus 154 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp GGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred HHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 223 34566666666666666554455555554 2556666666554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-19 Score=197.28 Aligned_cols=193 Identities=23% Similarity=0.358 Sum_probs=166.3
Q ss_pred cCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceee
Q 036879 427 LNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLS 506 (1029)
Q Consensus 427 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 506 (1029)
+.++..+.+..+.+++.. .+..+++|++|++++|.++.. ..+..+++|+.|++++|++++..+ +..+++|++|+
T Consensus 23 l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~ 96 (291)
T 1h6t_A 23 FAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF 96 (291)
T ss_dssp HHHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEE
Confidence 344556677788877533 356789999999999999865 348889999999999999997665 99999999999
Q ss_pred ccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccc
Q 036879 507 LGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQG 586 (1029)
Q Consensus 507 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 586 (1029)
|++|+++++ ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++
T Consensus 97 l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~ 170 (291)
T 1h6t_A 97 LDENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 170 (291)
T ss_dssp CCSSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred CCCCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc
Confidence 999999874 3489999999999999999964 5688999999999999999865 678999999999999999997
Q ss_pred cCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCC
Q 036879 587 SIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQ 635 (1029)
Q Consensus 587 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 635 (1029)
..| +..+++|++|+|++|++++. + .+..+++|+.|++++|+++..
T Consensus 171 ~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 171 IVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred chh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCC
Confidence 655 89999999999999999954 4 489999999999999999863
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.2e-19 Score=211.60 Aligned_cols=184 Identities=23% Similarity=0.401 Sum_probs=108.3
Q ss_pred CcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCcccccccccccccee
Q 036879 426 NLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTL 505 (1029)
Q Consensus 426 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 505 (1029)
.+++|+.|+|++|.|.. ++ .+..+++|+.|+|++|++++..+ +..+++|+.|+|++|.+.+. ..+..+++|+.|
T Consensus 41 ~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L 114 (605)
T 1m9s_A 41 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSL 114 (605)
T ss_dssp HHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCEE
T ss_pred cCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--hhhccCCCCCEE
Confidence 34444444444444442 22 24444455555555554443333 44444444444444444431 245666666666
Q ss_pred eccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccccccccc
Q 036879 506 SLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQ 585 (1029)
Q Consensus 506 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 585 (1029)
+|++|+|+++ ..+..+++|+.|+|++|+|++. ..++.+++|+.|+|++|+|++..| +..+++|+.|+|++|+|+
T Consensus 115 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 115 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp ECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred EecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCC
Confidence 6666666653 3466667777777777777643 456777777777777777775544 777777777777777777
Q ss_pred ccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccc
Q 036879 586 GSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLK 623 (1029)
Q Consensus 586 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 623 (1029)
+. ..+..+++|+.|+|++|++++.....+..+..+.
T Consensus 189 ~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~~ 224 (605)
T 1m9s_A 189 DL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 224 (605)
T ss_dssp BC--GGGTTCTTCSEEECCSEEEECCCCCCCSSCEEEC
T ss_pred CC--hHHccCCCCCEEEccCCcCcCCcccccccEEecc
Confidence 53 3477777788888888877755444444443333
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.9e-18 Score=181.50 Aligned_cols=137 Identities=24% Similarity=0.258 Sum_probs=90.3
Q ss_pred cccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccc
Q 036879 500 ISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSL 579 (1029)
Q Consensus 500 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 579 (1029)
++|++|+|++|+|+++.|..|..+++|+.|+|++|+|+...+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 55666666666666666666666666666666666666555555666666666666666666555555666677777777
Q ss_pred ccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCC
Q 036879 580 ADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 580 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 637 (1029)
++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|++++|++.|.++
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 777776 566666667777777777777776555666667777777777776665543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=5.2e-19 Score=199.76 Aligned_cols=176 Identities=22% Similarity=0.225 Sum_probs=149.9
Q ss_pred cceeccccccccccccccCCcCcCcEEEecCcccccccccccc-CCCCCCEEEeccccccCcccccccCCCCCcEEecCC
Q 036879 407 DVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIG-RLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485 (1029)
Q Consensus 407 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 485 (1029)
+.+++++++++ .+|..+. ..++.|+|++|+|++..+..|. .+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 57999999999 5676554 4689999999999987788887 999999999999999999999999999999999999
Q ss_pred CcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccc---cccccccEEEccCCcCCC
Q 036879 486 NELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEI---GNLKVVTKIDLSRNDLSG 562 (1029)
Q Consensus 486 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~ 562 (1029)
|+|+...+..|..+++|++|+|++|+|+++.|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99998888999999999999999999999999999999999999999999996555555 567888888888888886
Q ss_pred CCCccccCccc--cccccccccccc
Q 036879 563 EIPSSIGDLKN--MQHLSLADNKFQ 585 (1029)
Q Consensus 563 ~~p~~~~~l~~--L~~L~L~~N~l~ 585 (1029)
..+..|..++. |+.|+|++|++.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 55566666665 356666666665
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.9e-18 Score=180.22 Aligned_cols=116 Identities=21% Similarity=0.289 Sum_probs=63.7
Q ss_pred ccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccc
Q 036879 495 CLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNM 574 (1029)
Q Consensus 495 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 574 (1029)
.|..+++|++|+|++|+|+++.|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|
T Consensus 51 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 130 (220)
T 2v9t_B 51 AFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNL 130 (220)
T ss_dssp SSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred HhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCC
Confidence 33344444444444444444444444444555555555555544434444555555555555555555555556666666
Q ss_pred cccccccccccccCCccccCCCCCCEEeCcCCcccC
Q 036879 575 QHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSG 610 (1029)
Q Consensus 575 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 610 (1029)
+.|+|++|+|++..+..|..+++|++|+|++|++..
T Consensus 131 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 131 NLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 666666666665555556666666777777776653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-18 Score=209.00 Aligned_cols=194 Identities=25% Similarity=0.375 Sum_probs=140.5
Q ss_pred ccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEE
Q 036879 378 CKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGL 457 (1029)
Q Consensus 378 l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 457 (1029)
+..+..+.++.+.+.+..+ +..+.. |+.|++++|.|... + .|..+++|+.|+|++|+|++..+ +..+++|+.|
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~-L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L 92 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNS-IDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL 92 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTT-CCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCC-CCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEE
Confidence 3445556666666554333 233333 67777777777643 3 47777888888888888875444 7778888888
Q ss_pred EeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCccc
Q 036879 458 YLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLN 537 (1029)
Q Consensus 458 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 537 (1029)
+|++|.+++. ..+..+++|+.|+|++|++.+. ..+..+++|+.|+|++|+|+++ ..+..+++|+.|+|++|+|+
T Consensus 93 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~ 166 (605)
T 1m9s_A 93 FLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 166 (605)
T ss_dssp ECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCC
T ss_pred ECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCC
Confidence 8888887653 2677778888888888888753 4577888888888888888865 56778888888888888888
Q ss_pred CcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccC
Q 036879 538 GTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI 588 (1029)
Q Consensus 538 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 588 (1029)
+..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++.+..
T Consensus 167 ~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 167 DIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCC
T ss_pred Cchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCc
Confidence 6555 78888888888888888753 35788888888888888887543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-20 Score=224.08 Aligned_cols=190 Identities=20% Similarity=0.252 Sum_probs=135.0
Q ss_pred CCCCccceeccccccccCCCcccccCccccCeEeccCCc-------------CcccCCccccCCCcCcccc-cCCCcCcc
Q 036879 118 DSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQ-------------LQGHVPSSILNIPSLLAID-LSNNQFSG 183 (1029)
Q Consensus 118 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-ls~N~l~~ 183 (1029)
...++|+.|+|++|+++ .+|+.++++++|+.|++++|. +.+.+|..+.++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 44566777777777776 667777777777777776654 4456667777777777777 6666543
Q ss_pred cCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcccccccCCCCccccccccccceeecccccc
Q 036879 184 PMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT 263 (1029)
Q Consensus 184 ~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~ 263 (1029)
.|..+.+++|.++...+ ..|+.|+|++|++++ +|. |+++++|+
T Consensus 424 -------------------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~---------- 466 (567)
T 1dce_A 424 -------------------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVT---------- 466 (567)
T ss_dssp -------------------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCC----------
T ss_pred -------------------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCc----------
Confidence 45666677777664222 247888888888875 565 66665544
Q ss_pred cccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCC-Cccccccccc
Q 036879 264 GEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPI-PSSISNASML 342 (1029)
Q Consensus 264 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L 342 (1029)
.|+|++|+|+ .+|..+.++++|++|+|++|.++ .+| .+. .+++|++|+|++|+|++.. |..|..+++|
T Consensus 467 -------~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp-~l~-~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L 535 (567)
T 1dce_A 467 -------HLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVA-NLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535 (567)
T ss_dssp -------EEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGT-TCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred -------EeecCccccc-ccchhhhcCCCCCEEECCCCCCC-CCc-ccC-CCCCCcEEECCCCCCCCCCCcHHHhcCCCC
Confidence 6777777777 66778888888888888888886 467 444 5888888888888888776 8888888888
Q ss_pred ceecCCCccccCCCC
Q 036879 343 TLIDMPYNLFSGFIP 357 (1029)
Q Consensus 343 ~~L~ls~N~l~~~~p 357 (1029)
+.|++++|.+++.+|
T Consensus 536 ~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 536 VLLNLQGNSLCQEEG 550 (567)
T ss_dssp CEEECTTSGGGGSSS
T ss_pred CEEEecCCcCCCCcc
Confidence 888888888876554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-18 Score=179.03 Aligned_cols=157 Identities=22% Similarity=0.269 Sum_probs=118.8
Q ss_pred cEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCc
Q 036879 431 TTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFN 510 (1029)
Q Consensus 431 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 510 (1029)
+.+++++|.++ .+|..+. ..+++|+|++|+|++..+ +..|..+++|++|+|++|
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~-----------------------~~~~~~l~~L~~L~L~~N 67 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEA-----------------------TGIFKKLPQLRKINFSNN 67 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECC-----------------------CCCGGGCTTCCEEECCSS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCc-----------------------hhhhccCCCCCEEECCCC
Confidence 46777777777 3454443 245666666666653321 234667777777777777
Q ss_pred cccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCc
Q 036879 511 RLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPD 590 (1029)
Q Consensus 511 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 590 (1029)
+|+++.+..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|.
T Consensus 68 ~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 68 KITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred cCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence 77777777788888888888888888877777788888888888888888877788888888888889989988887788
Q ss_pred cccCCCCCCEEeCcCCcccCcCc
Q 036879 591 SLGGLTSLNFLDMSSNNLSGEIP 613 (1029)
Q Consensus 591 ~~~~l~~L~~L~Ls~N~l~~~~~ 613 (1029)
.|..+++|++|+|++|.+++..+
T Consensus 148 ~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 148 AFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTTTCTTCCEEECCSCCEECSGG
T ss_pred HhcCCCCCCEEEecCcCCcCCCc
Confidence 88889999999999999886544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-20 Score=224.41 Aligned_cols=217 Identities=19% Similarity=0.183 Sum_probs=130.4
Q ss_pred ccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCC
Q 036879 376 TNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQ 455 (1029)
Q Consensus 376 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 455 (1029)
..+++|+.|+|++|+++ .+|..++++.+ |+.|++++|......|.. +..+.+.+..|..+..+++|+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~-L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L~ 412 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKE-LQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTLK 412 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHH-HHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHH-HHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhcc
Confidence 45666777777777765 56666666665 666666554421111100 011123345566666666666
Q ss_pred EEE-eccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCC
Q 036879 456 GLY-LQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSN 534 (1029)
Q Consensus 456 ~L~-L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 534 (1029)
.|+ ++.|.+. +|..+.+.+|.++...+ ..|+.|+|++|+|++ +|. |..+++|+.|+|++|
T Consensus 413 ~L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N 473 (567)
T 1dce_A 413 AVDPMRAAYLD-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHN 473 (567)
T ss_dssp HHCGGGHHHHH-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSS
T ss_pred cCcchhhcccc-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCcc
Confidence 666 5555442 33344444554443222 136667777777765 344 677777777777777
Q ss_pred cccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccC-CccccCCCCCCEEeCcCCcccCcCc
Q 036879 535 SLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI-PDSLGGLTSLNFLDMSSNNLSGEIP 613 (1029)
Q Consensus 535 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~ 613 (1029)
+|+ .+|..++.+++|+.|+|++|+|++ +| .|+.+++|+.|+|++|+|++.. |..+..+++|+.|+|++|+|++.+|
T Consensus 474 ~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 474 RLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred ccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 776 566677777777777777777764 45 6777777777777777777655 6777777777777777777775544
Q ss_pred h---hhhcccccceeec
Q 036879 614 N---SLKALSLLKFLNL 627 (1029)
Q Consensus 614 ~---~~~~l~~L~~L~l 627 (1029)
. .+..+++|+.|++
T Consensus 551 ~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 551 IQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTHHHHHCTTCSEEEC
T ss_pred HHHHHHHHCcccCccCC
Confidence 2 2334666766653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-18 Score=187.30 Aligned_cols=167 Identities=21% Similarity=0.311 Sum_probs=96.7
Q ss_pred hcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCC
Q 036879 406 MDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485 (1029)
Q Consensus 406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 485 (1029)
+..+++++|.+++.. .+..+++|++|++++|.|+. ++ .+..+++|++|+|++|++++
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~------------------- 77 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISD------------------- 77 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-------------------
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCC-------------------
Confidence 455566666665332 35555666666666666552 33 45555555555555555543
Q ss_pred CcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCC
Q 036879 486 NELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIP 565 (1029)
Q Consensus 486 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 565 (1029)
..+ +..+++|++|+|++|+++++.+ +.. ++|+.|+|++|++++. ..+..+++|+.|++++|++++. +
T Consensus 78 -----~~~--l~~l~~L~~L~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~ 144 (263)
T 1xeu_A 78 -----LSP--LKDLTKLEELSVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V 144 (263)
T ss_dssp -----CGG--GTTCSSCCEEECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G
T ss_pred -----Chh--hccCCCCCEEECCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h
Confidence 222 5555666666666666654322 112 6666666666666642 2466666666777777666643 2
Q ss_pred ccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCc
Q 036879 566 SSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGE 611 (1029)
Q Consensus 566 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 611 (1029)
.+..+++|+.|+|++|+|++. ..+..+++|+.|++++|++++.
T Consensus 145 -~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 145 -MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred -HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 466666666666666666644 4566666777777777766644
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.6e-18 Score=181.35 Aligned_cols=171 Identities=23% Similarity=0.341 Sum_probs=119.0
Q ss_pred cccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCE
Q 036879 377 NCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQG 456 (1029)
Q Consensus 377 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 456 (1029)
.+.+++.+++++|.+++.. .+..+.. |+.|++++|+++. ++ .+..+++|++|+|++|+|++..+ +..+++|++
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~-L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~ 89 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSG-VQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEE 89 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTT-CSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCc-CcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCE
Confidence 5778899999999998543 4666665 9999999999994 45 78999999999999999996544 999999999
Q ss_pred EEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcc
Q 036879 457 LYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSL 536 (1029)
Q Consensus 457 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 536 (1029)
|+|++|++++..... . ++|+.| +|++|+++++ ..+..+++|+.|+|++|++
T Consensus 90 L~L~~N~l~~l~~~~--~-~~L~~L------------------------~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i 140 (263)
T 1xeu_A 90 LSVNRNRLKNLNGIP--S-ACLSRL------------------------FLDNNELRDT--DSLIHLKNLEILSIRNNKL 140 (263)
T ss_dssp EECCSSCCSCCTTCC--C-SSCCEE------------------------ECCSSCCSBS--GGGTTCTTCCEEECTTSCC
T ss_pred EECCCCccCCcCccc--c-CcccEE------------------------EccCCccCCC--hhhcCcccccEEECCCCcC
Confidence 999999997543211 1 444444 4555544432 2355555555555555555
Q ss_pred cCcCCccccccccccEEEccCCcCCCCCCccccCccccccccccccccccc
Q 036879 537 NGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGS 587 (1029)
Q Consensus 537 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 587 (1029)
++. + .++.+++|+.|++++|++++. ..+..+++|+.|++++|++++.
T Consensus 141 ~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 141 KSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 532 2 455666666666666666644 4566666667777777766643
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=4.4e-18 Score=173.45 Aligned_cols=130 Identities=22% Similarity=0.321 Sum_probs=69.6
Q ss_pred cEEecCCCcccCccccccccccccceeeccCccccCCCCC-CccCCCCCcEEEccCCcccCcCCccccccccccEEEccC
Q 036879 479 SEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPS-SLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSR 557 (1029)
Q Consensus 479 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 557 (1029)
+.+++++|+++ .+|..+.. +|++|+|++|+|+++.+. .|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45555555554 33333322 555555555555554443 355555555555555555555555555555555555555
Q ss_pred CcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCc
Q 036879 558 NDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGE 611 (1029)
Q Consensus 558 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 611 (1029)
|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|.+++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 555555555555555555555555555555555555555555555555555543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-17 Score=171.18 Aligned_cols=153 Identities=20% Similarity=0.272 Sum_probs=86.8
Q ss_pred CCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccce
Q 036879 425 GNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRT 504 (1029)
Q Consensus 425 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 504 (1029)
..+++|++|++++|.|+ .+| .+..+++|++|++++|.++. +..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--------------------------~~~l~~l~~L~~ 92 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--------------------------YNPISGLSNLER 92 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--------------------------CGGGTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--------------------------chhhhcCCCCCE
Confidence 55677788888888777 445 57777777777777776531 123455556666
Q ss_pred eeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCc-CCCCCCccccCccccccccccccc
Q 036879 505 LSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRND-LSGEIPSSIGDLKNMQHLSLADNK 583 (1029)
Q Consensus 505 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~ 583 (1029)
|++++|++++..+..+..+++|+.|++++|++++..|..++.+++|++|++++|. ++ .+| .+..+++|+.|++++|+
T Consensus 93 L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp EEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBC
T ss_pred EEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCC
Confidence 6666666655555555555555555555555555455555555555555555555 33 233 34555555555555555
Q ss_pred ccccCCccccCCCCCCEEeCcCCccc
Q 036879 584 FQGSIPDSLGGLTSLNFLDMSSNNLS 609 (1029)
Q Consensus 584 l~~~~~~~~~~l~~L~~L~Ls~N~l~ 609 (1029)
+++ ++ .+..+++|++|++++|++.
T Consensus 171 i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 171 VHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CcC-hH-HhccCCCCCEEEeeCcccC
Confidence 553 22 3445555555555555543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.7e-18 Score=208.74 Aligned_cols=223 Identities=23% Similarity=0.261 Sum_probs=109.5
Q ss_pred cccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEE
Q 036879 379 KDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLY 458 (1029)
Q Consensus 379 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 458 (1029)
+.++.|+|.+|.+.. .+.. .++.++|+.|.|. .+++..|.+. ..+..|..+++|+.|+
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~------~l~~l~Ls~~~i~--------------~~~~~~n~~~-~~~~~~~~l~~L~~L~ 230 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQA------LLQHKKLSQYSID--------------EDDDIENRMV-MPKDSKYDDQLWHALD 230 (727)
T ss_dssp -----------------------------------------------------------------------CCCCCCEEE
T ss_pred CccceEEeeCCCCCc-chhh------HhhcCccCccccc--------------Ccccccccee-cChhhhccCCCCcEEE
Confidence 445666666666553 1211 1344445544443 2234445554 4566666667777777
Q ss_pred eccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccC
Q 036879 459 LQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNG 538 (1029)
Q Consensus 459 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 538 (1029)
|++|.+. .++..+..+++|++|+|++|.|+ .+|..|..+++|++|+|++|+|+ .+|..|..+++|+.|+|++|.|+
T Consensus 231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~- 306 (727)
T 4b8c_D 231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT- 306 (727)
T ss_dssp CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-
T ss_pred CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-
Confidence 7777766 33333446677777777777777 67788888899999999999988 56888889999999999999997
Q ss_pred cCCccccccccccEEEccCCcCCCCCCccccCccc-ccccccccccccccCCccccCCCCCCEEeCcCC--------ccc
Q 036879 539 TLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKN-MQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSN--------NLS 609 (1029)
Q Consensus 539 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N--------~l~ 609 (1029)
.+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.. |+.|++++| .|+
T Consensus 307 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~ 380 (727)
T 4b8c_D 307 TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQ 380 (727)
T ss_dssp CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--------------------------
T ss_pred ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCcc
Confidence 67878999999999999999999888888766432 345889999999887754 456777777 333
Q ss_pred CcCchhhhcccccceeeccCCCCc
Q 036879 610 GEIPNSLKALSLLKFLNLSFNGLQ 633 (1029)
Q Consensus 610 ~~~~~~~~~l~~L~~L~l~~N~l~ 633 (1029)
+..+..+..+..+....+++|-+.
T Consensus 381 ~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 381 QSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp ---------------------CCC
T ss_pred ccccchhhcccccceeeeeccccc
Confidence 333344445555555566666554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.4e-17 Score=170.53 Aligned_cols=154 Identities=15% Similarity=0.230 Sum_probs=129.7
Q ss_pred cCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcE
Q 036879 449 GRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILN 528 (1029)
Q Consensus 449 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 528 (1029)
..+++|++|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-------------------------~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~ 92 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-------------------------DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLER 92 (197)
T ss_dssp HHHHTCCEEEEESSCCS-------------------------CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-------------------------ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCE
Confidence 45566677777766664 334 57788899999999998764 347889999999
Q ss_pred EEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccccccc-ccccCCccccCCCCCCEEeCcCCc
Q 036879 529 VNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNK-FQGSIPDSLGGLTSLNFLDMSSNN 607 (1029)
Q Consensus 529 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~ 607 (1029)
|++++|++++..+..++.+++|++|++++|++++..|..+..+++|+.|+|++|+ ++ .+| .+..+++|++|++++|+
T Consensus 93 L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp EEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBC
T ss_pred EEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCC
Confidence 9999999998889999999999999999999998888999999999999999998 66 555 68999999999999999
Q ss_pred ccCcCchhhhcccccceeeccCCCCcC
Q 036879 608 LSGEIPNSLKALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 608 l~~~~~~~~~~l~~L~~L~l~~N~l~~ 634 (1029)
+++. + .+..+++|+.|++++|++.+
T Consensus 171 i~~~-~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 171 VHDY-R-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCCC-T-TGGGCSSCCEEEECBC----
T ss_pred CcCh-H-HhccCCCCCEEEeeCcccCC
Confidence 9964 4 78899999999999999864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=4.9e-17 Score=165.70 Aligned_cols=155 Identities=27% Similarity=0.350 Sum_probs=110.8
Q ss_pred ceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCc-cccccccccEEEccCCcCCCCCCccccCccccccccccc
Q 036879 503 RTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPV-EIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLAD 581 (1029)
Q Consensus 503 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 581 (1029)
+++++++|.++. +|..+. .+|+.|++++|+|++..+. .|+.+++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~~-ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCc-CccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 677888888864 444443 2778888888888765554 477788888888888888877777788888888888888
Q ss_pred ccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCCCCCCccCcccccCCCCCCCCC
Q 036879 582 NKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLCGAP 660 (1029)
Q Consensus 582 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~ 660 (1029)
|+|++..+..|.++++|++|+|++|+|++.+|..+..+++|+.|+|++|+|+|..+......++....+.++...|+.|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 8888777777778888888888888888777777888888888888888887765532111223333455566667665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.3e-17 Score=178.42 Aligned_cols=139 Identities=18% Similarity=0.236 Sum_probs=106.8
Q ss_pred CCCCCCceeccCcceEEEEEEe-cCCcE--EEEEEeecccch------------------------hhHHHHHHHHHHhc
Q 036879 738 DGFSENNLLGKGSFGSVYKGTL-SDGMQ--IAVKVFNLELEG------------------------TLRSFDAECEILGS 790 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~--vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~ 790 (1029)
.-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++++++
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3367789999999999999998 68989 999987543111 11367899999999
Q ss_pred CCCCce--EEEEEEEecCCeEEEEEeccCC-C----CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcC
Q 036879 791 IRHRNL--VKIISTCSSDHFKALVLEYMPN-G----SLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863 (1029)
Q Consensus 791 l~h~ni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~D 863 (1029)
+.|+++ +..+++ ...++||||+.+ | +|.++... .++..+..++.|++.|++|||. +.||+|||
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrD 196 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHAD 196 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSS
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCC
Confidence 988754 344432 245899999942 3 77776532 2244677899999999999993 33699999
Q ss_pred CCCCCEEECCCCcEEEEccCCceec
Q 036879 864 LNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 864 lk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
|||.|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999765
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.6e-17 Score=185.09 Aligned_cols=215 Identities=11% Similarity=0.064 Sum_probs=102.9
Q ss_pred hcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEecccc----ccCcccccccCCCCCc-E
Q 036879 406 MDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNK----LQGSITTDLCGLRSLS-E 480 (1029)
Q Consensus 406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~----l~~~~~~~~~~l~~L~-~ 480 (1029)
|+.|+|.+ +++.+.+.+|.++++|+.|++++|.+..+.+.+|..+.++..+.+..+. ........|.++..|+ .
T Consensus 103 L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~ 181 (329)
T 3sb4_A 103 LEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETT 181 (329)
T ss_dssp CCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEE
T ss_pred CcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccccee
Confidence 44444444 4444444455555555555555555554445555555444444444321 1222333444444444 2
Q ss_pred EecCCCcccCcccccc----ccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEcc
Q 036879 481 FYSDGNELNGSLPQCL----DSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLS 556 (1029)
Q Consensus 481 L~l~~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 556 (1029)
+.+.... .++..+ -...++..+.+.++-...........+++|+.|+|++|+++.+.+..|.++++|+.|+|.
T Consensus 182 i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~ 258 (329)
T 3sb4_A 182 IQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP 258 (329)
T ss_dssp EEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred EEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence 2222211 011111 122334444443331110000001124555555555555555555555666666666665
Q ss_pred CCcCCCCCCccccCccccc-ccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceee
Q 036879 557 RNDLSGEIPSSIGDLKNMQ-HLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLN 626 (1029)
Q Consensus 557 ~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 626 (1029)
+| ++.+.+..|.++.+|+ .+++.+ .++.+.+.+|.++++|+.|++++|+++.+.+.+|.++++|+.++
T Consensus 259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 55 5444455566666666 666655 55544556666666666666666666655555666666666654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=5.4e-17 Score=180.80 Aligned_cols=100 Identities=8% Similarity=-0.017 Sum_probs=45.4
Q ss_pred CCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCc-EEEccCCcccCcCCccccccccccEEEc
Q 036879 477 SLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDIL-NVNLSSNSLNGTLPVEIGNLKVVTKIDL 555 (1029)
Q Consensus 477 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 555 (1029)
+|+.+++.+|+++.+.+.+|.++++|+.|+|.+| ++.+.+.+|.++++|+ .+++++ .++.+.+.+|.++++|+.|++
T Consensus 227 ~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l 304 (329)
T 3sb4_A 227 NLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLA 304 (329)
T ss_dssp TCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEE
T ss_pred CCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEe
Confidence 3333333333333333344444444444444444 4444444444444444 444444 344344444555555555555
Q ss_pred cCCcCCCCCCccccCcccccccc
Q 036879 556 SRNDLSGEIPSSIGDLKNMQHLS 578 (1029)
Q Consensus 556 s~N~l~~~~p~~~~~l~~L~~L~ 578 (1029)
++|.++.+.+..|.++++|+.++
T Consensus 305 ~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 305 TGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCCccCccchhhhcCCcchhhhc
Confidence 55555444444555555555443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1e-16 Score=163.28 Aligned_cols=131 Identities=27% Similarity=0.388 Sum_probs=107.9
Q ss_pred ceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccc
Q 036879 503 RTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADN 582 (1029)
Q Consensus 503 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 582 (1029)
+.+++++|.++. +|..+ .++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~~-ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKV-LPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSS-CCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCc-CCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 567888888875 44433 257888888888888 56788888889999999999998877788888999999999999
Q ss_pred cccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCC
Q 036879 583 KFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 583 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 637 (1029)
+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|++++|+|.+...
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 9988777888889999999999999987777778888899999998888887543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=5.8e-16 Score=154.14 Aligned_cols=133 Identities=22% Similarity=0.239 Sum_probs=85.9
Q ss_pred cccceeeccCcccc-CCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccc
Q 036879 500 ISLRTLSLGFNRLT-SVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLS 578 (1029)
Q Consensus 500 ~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 578 (1029)
++|+.|++++|+++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 45666666666665 44555566666666666666666643 5566666666677777766655666666667777777
Q ss_pred cccccccccC-CccccCCCCCCEEeCcCCcccCcCc---hhhhcccccceeeccCCCCcC
Q 036879 579 LADNKFQGSI-PDSLGGLTSLNFLDMSSNNLSGEIP---NSLKALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 579 L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~~ 634 (1029)
|++|+|++.. +..+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+..
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 7777776432 1566677777777777777775544 466777777777777777653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=7.2e-16 Score=153.47 Aligned_cols=136 Identities=25% Similarity=0.280 Sum_probs=104.7
Q ss_pred CCCcEEecCCCccc-CccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEE
Q 036879 476 RSLSEFYSDGNELN-GSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKID 554 (1029)
Q Consensus 476 ~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 554 (1029)
++|+.|++++|+++ +.+|..+..+++|++|+|++|.++++ ..+..+++|+.|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44555555555554 45666677888888888888888865 7788888888888888888876777777788899999
Q ss_pred ccCCcCCCCC-CccccCcccccccccccccccccCC---ccccCCCCCCEEeCcCCcccCcCch
Q 036879 555 LSRNDLSGEI-PSSIGDLKNMQHLSLADNKFQGSIP---DSLGGLTSLNFLDMSSNNLSGEIPN 614 (1029)
Q Consensus 555 Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~ 614 (1029)
|++|++++.. +..+..+++|+.|++++|++++..+ ..+..+++|++|++++|.++ .+|.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 9999888543 2678888999999999999985544 47888899999999999887 4443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=7.2e-16 Score=150.09 Aligned_cols=129 Identities=21% Similarity=0.254 Sum_probs=102.5
Q ss_pred ccccceeeccCcccc-CCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccc
Q 036879 499 LISLRTLSLGFNRLT-SVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHL 577 (1029)
Q Consensus 499 l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 577 (1029)
.++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..++.+++|++|++++|.+++.+|..+..+++|+.|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 367777888888877 56677777888888888888888754 677888888888888888887677777778888888
Q ss_pred cccccccccc-CCccccCCCCCCEEeCcCCcccCcCc---hhhhcccccceeeccC
Q 036879 578 SLADNKFQGS-IPDSLGGLTSLNFLDMSSNNLSGEIP---NSLKALSLLKFLNLSF 629 (1029)
Q Consensus 578 ~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~l~~ 629 (1029)
++++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 8888888863 34778888899999999999887666 5788888899888864
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-15 Score=151.35 Aligned_cols=132 Identities=24% Similarity=0.275 Sum_probs=82.0
Q ss_pred ceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccc
Q 036879 503 RTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADN 582 (1029)
Q Consensus 503 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 582 (1029)
+.+++++|+++.+ |..+ .++|+.|++++|++++..+..|+.+++|++|++++|++++..+..|..+++|+.|+|++|
T Consensus 10 ~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCccC-CCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 4555566665543 2222 245666666666666555555666666666666666666555555666666666777666
Q ss_pred cccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCC
Q 036879 583 KFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 583 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 637 (1029)
+|++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|++++.+|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 6665555556666677777777777765555556666677777777776666544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.9e-15 Score=153.78 Aligned_cols=127 Identities=20% Similarity=0.285 Sum_probs=111.7
Q ss_pred EEecccccccccCCccCCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccc
Q 036879 52 ALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGN 131 (1029)
Q Consensus 52 ~l~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N 131 (1029)
.++++++++. ++|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|+.+. +..|..+++|++|+|++|
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~-~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLS-NQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCC-TTTTTTCTTCCEEECCSS
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeC-HhHccCCCCCCEEECCCC
Confidence 3566677776 7887764 68999999999998 88899999999999999999999743 567999999999999999
Q ss_pred cccCCCcccccCccccCeEeccCCcCcccCCccccCCCcCcccccCCCcCcc
Q 036879 132 SFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSG 183 (1029)
Q Consensus 132 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 183 (1029)
+|++..|..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 9998777889999999999999999996666679999999999999999863
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.59 E-value=8.7e-15 Score=166.40 Aligned_cols=241 Identities=10% Similarity=0.132 Sum_probs=151.5
Q ss_pred ccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEe
Q 036879 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYL 459 (1029)
Q Consensus 380 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 459 (1029)
+|+.+.+..+ ++.....+|.+. .|+.+.+.. .++.+.+.+|.++++|+.++|.+|+++.+...+|. ..+|+.+.|
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~~--~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~l 210 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFNS--TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLL 210 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTC--CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEEC
T ss_pred CccEEEeCCC-ccEECHHhcCCC--CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEe
Confidence 3555555444 333333344442 255566654 45545566777777777777777777755455555 467777777
Q ss_pred ccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCccc--
Q 036879 460 QHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLN-- 537 (1029)
Q Consensus 460 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-- 537 (1029)
.++ ++.+...+|.++++|+.+.+.+| ++.+...+|.+ .+|+.+.+ .|.++.+...+|.++++|+.+.+.+|.+.
T Consensus 211 p~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~ 286 (401)
T 4fdw_A 211 PVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDD 286 (401)
T ss_dssp CTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCC
T ss_pred CCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCC
Confidence 644 66666677777777777777654 55566666666 66777777 34456566677777777777777766654
Q ss_pred ---CcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCch
Q 036879 538 ---GTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPN 614 (1029)
Q Consensus 538 ---~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 614 (1029)
.+.+..|.++++|+.++|. +.++.+....|.++.+|+.++|..| ++...+.+|.++ +|+.|++++|.+....+.
T Consensus 287 ~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~ 363 (401)
T 4fdw_A 287 PEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEK 363 (401)
T ss_dssp TTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCS
T ss_pred cccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccc
Confidence 3455667777777777776 3465555666777777777777444 554556667777 777777777776655556
Q ss_pred hhhccc-ccceeeccCCCC
Q 036879 615 SLKALS-LLKFLNLSFNGL 632 (1029)
Q Consensus 615 ~~~~l~-~L~~L~l~~N~l 632 (1029)
.|.+++ .++.|++..+.+
T Consensus 364 ~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 364 VWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp SCCCSCTTCCEEEECGGGH
T ss_pred cccCCCCCccEEEeCHHHH
Confidence 666663 456666655443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.9e-14 Score=163.54 Aligned_cols=205 Identities=13% Similarity=0.173 Sum_probs=97.9
Q ss_pred cccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCE
Q 036879 377 NCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQG 456 (1029)
Q Consensus 377 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 456 (1029)
+|++|+.+++++|+++......|. .. .|+.+.+.. .++.+...+|.++++|+.++|..| ++.+...+|.+ .+|+.
T Consensus 178 ~c~~L~~l~l~~n~l~~I~~~aF~-~~-~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~ 252 (401)
T 4fdw_A 178 YCYNLKKADLSKTKITKLPASTFV-YA-GIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITT 252 (401)
T ss_dssp TCTTCCEEECTTSCCSEECTTTTT-TC-CCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSE
T ss_pred CcccCCeeecCCCcceEechhhEe-ec-ccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccE
Confidence 444555555555544422222222 12 244444442 244444555666666666666553 34344445554 45666
Q ss_pred EEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcc
Q 036879 457 LYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSL 536 (1029)
Q Consensus 457 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 536 (1029)
+.+ .|.++.+...+|.++++|+.+.+.+|.+. .+.+..+.+.+|.++++|+.+.|. +.+
T Consensus 253 i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~-------------------~~~~~~I~~~aF~~c~~L~~l~l~-~~i 311 (401)
T 4fdw_A 253 VKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN-------------------DDPEAMIHPYCLEGCPKLARFEIP-ESI 311 (401)
T ss_dssp EEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC-------------------CCTTCEECTTTTTTCTTCCEECCC-TTC
T ss_pred EEe-CCCccEEChhHhhCCCCCCEEEeCCcccc-------------------CCcccEECHHHhhCCccCCeEEeC-Cce
Confidence 665 33344444455555555555554444332 000012344445555555555554 234
Q ss_pred cCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCC-CCCEEeCcCCccc
Q 036879 537 NGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLT-SLNFLDMSSNNLS 609 (1029)
Q Consensus 537 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~ 609 (1029)
+.+...+|.++++|+.++|..| ++.+.+..|.++ +|+.+++++|.+....+..|.+++ +++.|++..+.+.
T Consensus 312 ~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 312 RILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred EEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 4444445555555555555333 443444555555 555555555555544445555552 4566666655543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.5e-15 Score=147.73 Aligned_cols=128 Identities=25% Similarity=0.287 Sum_probs=97.5
Q ss_pred CCCcEEecCCCccc-CccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEE
Q 036879 476 RSLSEFYSDGNELN-GSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKID 554 (1029)
Q Consensus 476 ~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 554 (1029)
++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|+.|++++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45555555555555 45666677777888888888887765 6777888888888888888876777777788888888
Q ss_pred ccCCcCCCC-CCccccCcccccccccccccccccCC---ccccCCCCCCEEeCcC
Q 036879 555 LSRNDLSGE-IPSSIGDLKNMQHLSLADNKFQGSIP---DSLGGLTSLNFLDMSS 605 (1029)
Q Consensus 555 Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~ 605 (1029)
+++|++++. .+..+..+++|+.|++++|++++..+ ..+..+++|++||+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 888888753 34778888888899999998886555 4678888899888864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.7e-16 Score=174.03 Aligned_cols=143 Identities=16% Similarity=0.157 Sum_probs=103.0
Q ss_pred HHHHHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccc--------------hh--------hHHHHHHHHHHh
Q 036879 732 ELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE--------------GT--------LRSFDAECEILG 789 (1029)
Q Consensus 732 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~--------------~~--------~~~~~~E~~~l~ 789 (1029)
.+.....-|++.+.||+|+||.||+|...+|+.||||+++.... .. .....+|...+.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 34344445899999999999999999998999999998753210 00 011245677777
Q ss_pred cCCCCceE--EEEEEEecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCC
Q 036879 790 SIRHRNLV--KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPS 867 (1029)
Q Consensus 790 ~l~h~niv--~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~ 867 (1029)
++.+.++. ..+++ . ..++||||++|++|.++.. . .....++.|++.++.||| +.|||||||||.
T Consensus 169 rL~~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~ 234 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLA---KHGLIHGDFNEF 234 (397)
T ss_dssp HHHHTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHH---HTTEECSCCSTT
T ss_pred HHHhcCCCCCeeeec--c--CceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHH
Confidence 77544432 22222 1 2369999999988865321 1 234567899999999999 678999999999
Q ss_pred CEEECCCC----------cEEEEccCCceec
Q 036879 868 NILLNESM----------VACLSDFGISKLL 888 (1029)
Q Consensus 868 Nill~~~~----------~~kl~Dfg~a~~~ 888 (1029)
|||+++++ .+.|+||+-+...
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99998776 3899999977643
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.1e-14 Score=146.08 Aligned_cols=132 Identities=21% Similarity=0.257 Sum_probs=104.8
Q ss_pred cEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCC
Q 036879 479 SEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRN 558 (1029)
Q Consensus 479 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 558 (1029)
+.+++++|+++. +|..+ .++|++|++++|+++++.+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|
T Consensus 10 ~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 344555555543 33322 257888888888888777777888888888888888888777777888999999999999
Q ss_pred cCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCc
Q 036879 559 DLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIP 613 (1029)
Q Consensus 559 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 613 (1029)
++++..+..|..+++|+.|+|++|+|++..+..+..+++|++|+|++|++++..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9987777778889999999999999997666667889999999999999987655
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=7.1e-15 Score=147.41 Aligned_cols=132 Identities=16% Similarity=0.209 Sum_probs=80.5
Q ss_pred cccccccceeeccCccccCCCCCCccCCC-CCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccc
Q 036879 496 LDSLISLRTLSLGFNRLTSVIPSSLWSLR-DILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNM 574 (1029)
Q Consensus 496 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 574 (1029)
+..+++|+.|++++|+++.+ |. +..+. +|+.|+|++|.|++. ..+..+++|++|+|++|+|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 34455566666666666543 33 33333 666666666666643 456666666666666666664444444666677
Q ss_pred cccccccccccccCCc--cccCCCCCCEEeCcCCcccCcCch----hhhcccccceeeccCCCCc
Q 036879 575 QHLSLADNKFQGSIPD--SLGGLTSLNFLDMSSNNLSGEIPN----SLKALSLLKFLNLSFNGLQ 633 (1029)
Q Consensus 575 ~~L~L~~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~l~~N~l~ 633 (1029)
+.|+|++|+|+ .+|. .+..+++|+.|++++|+++ .+|. .+..+++|+.||+++|...
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 77777777765 3444 5666777777777777776 3344 3667777777777777654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.5e-13 Score=155.08 Aligned_cols=319 Identities=9% Similarity=0.076 Sum_probs=196.1
Q ss_pred EEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCc
Q 036879 271 VLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYN 350 (1029)
Q Consensus 271 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N 350 (1029)
.+.|.+ .++.+...+|.++++|+.++|..+ +. .++...|.+..+|+.+.+..+ +.......|.++..+........
T Consensus 75 ~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~~~~ 150 (394)
T 4fs7_A 75 EIKIPS-TVREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIPEGV 150 (394)
T ss_dssp EEECCT-TCCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECCTTC
T ss_pred EEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeecceeeecccccccccCccc
Confidence 444542 355455667777777777777644 43 566666666777777666544 33344455555543333222222
Q ss_pred cccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcC
Q 036879 351 LFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNL 430 (1029)
Q Consensus 351 ~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L 430 (1029)
..-+ -.+|.++++|+.+.+.++. .......|.+... |+.+.+..+ ++.....+|.+...|
T Consensus 151 ~~i~-----------------~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~-L~~i~l~~~-~~~I~~~~F~~~~~L 210 (394)
T 4fs7_A 151 TVIG-----------------DEAFATCESLEYVSLPDSM-ETLHNGLFSGCGK-LKSIKLPRN-LKIIRDYCFAECILL 210 (394)
T ss_dssp CEEC-----------------TTTTTTCTTCCEEECCTTC-CEECTTTTTTCTT-CCBCCCCTT-CCEECTTTTTTCTTC
T ss_pred cccc-----------------hhhhcccCCCcEEecCCcc-ceeccccccCCCC-ceEEEcCCC-ceEeCchhhcccccc
Confidence 1110 1235677788888886553 2234444555544 777777665 454556677777778
Q ss_pred cEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCc
Q 036879 431 TTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFN 510 (1029)
Q Consensus 431 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 510 (1029)
+.+.+..+... +...+....+|+.+.+..+ ++.+....|.+...|+.+.+..+... ....+|..+..++.+....+
T Consensus 211 ~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~ 286 (394)
T 4fs7_A 211 ENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSV 286 (394)
T ss_dssp CBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSS
T ss_pred ceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCce
Confidence 77777766543 2333444567777777543 34455667777777777777766443 56667777777777777665
Q ss_pred cccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCc
Q 036879 511 RLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPD 590 (1029)
Q Consensus 511 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 590 (1029)
.+ ....|..+.+|+.+.+..+ ++.+...+|.++.+|+.++|.++ ++.+....|.++.+|+.+++..| ++.....
T Consensus 287 ~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~ 360 (394)
T 4fs7_A 287 IV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGAN 360 (394)
T ss_dssp EE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTT
T ss_pred ee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHH
Confidence 43 3356777777777777654 55556667777777777777644 55455667777777777777666 6655566
Q ss_pred cccCCCCCCEEeCcCCcccCcCchhhhccccccee
Q 036879 591 SLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFL 625 (1029)
Q Consensus 591 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 625 (1029)
+|.++.+|+.+++..+ ++ .+...|.+.++|+.+
T Consensus 361 aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 361 AFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp TBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred HhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 7777777777777654 33 234556666666543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2.4e-16 Score=161.60 Aligned_cols=134 Identities=22% Similarity=0.272 Sum_probs=105.2
Q ss_pred ccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcc
Q 036879 493 PQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLK 572 (1029)
Q Consensus 493 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 572 (1029)
|..+..+++|++|+|++|++++ +| .+..+++|+.|++++|.++ .+|..+..+++|+.|++++|++++ +| .+..++
T Consensus 41 ~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~ 115 (198)
T 1ds9_A 41 DATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLV 115 (198)
T ss_dssp HHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHH
T ss_pred hHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCC
Confidence 3477888888888888888876 45 7788888888888888888 567777778888888888888885 44 578888
Q ss_pred cccccccccccccccCC-ccccCCCCCCEEeCcCCcccCcCch----------hhhcccccceeeccCCCCc
Q 036879 573 NMQHLSLADNKFQGSIP-DSLGGLTSLNFLDMSSNNLSGEIPN----------SLKALSLLKFLNLSFNGLQ 633 (1029)
Q Consensus 573 ~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~----------~~~~l~~L~~L~l~~N~l~ 633 (1029)
+|+.|+|++|++++..+ ..+..+++|++|++++|++++.+|. .+..+++|+.|| +|+++
T Consensus 116 ~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 89999999998885332 4678888899999999988876554 377888888886 66665
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=1.8e-14 Score=144.51 Aligned_cols=129 Identities=16% Similarity=0.170 Sum_probs=93.1
Q ss_pred CCCCcEEecCCCcccCccccccccc-cccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEE
Q 036879 475 LRSLSEFYSDGNELNGSLPQCLDSL-ISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKI 553 (1029)
Q Consensus 475 l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 553 (1029)
..+|++|++++|+++. ++. +..+ ++|++|+|++|+|+++ ..|..+++|+.|+|++|+|++..+..+..+++|+.|
T Consensus 18 ~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 3344444444444442 233 3333 3788888888888765 577788888888888888886555555888888888
Q ss_pred EccCCcCCCCCCc--cccCcccccccccccccccccCCcc----ccCCCCCCEEeCcCCccc
Q 036879 554 DLSRNDLSGEIPS--SIGDLKNMQHLSLADNKFQGSIPDS----LGGLTSLNFLDMSSNNLS 609 (1029)
Q Consensus 554 ~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~ 609 (1029)
++++|+++ .+|. .+..+++|+.|++++|+++ .+|.. +..+++|++||+++|.+.
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 88888886 4554 7888888999999999988 45654 788899999999999876
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-13 Score=137.47 Aligned_cols=105 Identities=22% Similarity=0.278 Sum_probs=49.8
Q ss_pred cceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccccc
Q 036879 502 LRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLAD 581 (1029)
Q Consensus 502 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 581 (1029)
.+.+++++|+++. +|..+ .++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 3455566655554 23222 24455555555555544444444555555555555555444344444444444444444
Q ss_pred ccccccCCccccCCCCCCEEeCcCCccc
Q 036879 582 NKFQGSIPDSLGGLTSLNFLDMSSNNLS 609 (1029)
Q Consensus 582 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 609 (1029)
|+|++..+..|..+++|++|+|++|+++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 4444333334444444444444444444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.45 E-value=9.5e-16 Score=157.07 Aligned_cols=156 Identities=22% Similarity=0.293 Sum_probs=108.5
Q ss_pred cCCcCcCcEEEecCccccccccc------cccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccc
Q 036879 424 IGNLNNLTTLHLETNELTGSIPK------AIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLD 497 (1029)
Q Consensus 424 ~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 497 (1029)
+.....++.++++.+.+++..|. .|..+++|++|++++|.+++ +| .+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-------------------------l~-~~~ 67 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-------------------------IS-SLS 67 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-------------------------CC-CHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-------------------------cc-ccc
Confidence 33445666666666666655554 66666666666666666653 33 566
Q ss_pred cccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCC-ccccCcccccc
Q 036879 498 SLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIP-SSIGDLKNMQH 576 (1029)
Q Consensus 498 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~ 576 (1029)
.+++|++|++++|+++. +|..+..+++|+.|+|++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|+.
T Consensus 68 ~l~~L~~L~l~~n~l~~-l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~ 144 (198)
T 1ds9_A 68 GMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLED 144 (198)
T ss_dssp HHTTCCEEEEEEEEECS-CSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSE
T ss_pred cCCCCCEEECCCCCccc-ccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCE
Confidence 66777777777777763 45566666777777777777775 34 57778888888888888874332 46788888888
Q ss_pred cccccccccccCCcc----------ccCCCCCCEEeCcCCcccC
Q 036879 577 LSLADNKFQGSIPDS----------LGGLTSLNFLDMSSNNLSG 610 (1029)
Q Consensus 577 L~L~~N~l~~~~~~~----------~~~l~~L~~L~Ls~N~l~~ 610 (1029)
|++++|++++.+|.. +..+++|+.|| +|.++.
T Consensus 145 L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 145 LLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp EEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred EEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 888888888766553 77888999887 777763
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.5e-12 Score=148.66 Aligned_cols=318 Identities=11% Similarity=0.062 Sum_probs=222.7
Q ss_pred ccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCC
Q 036879 279 LTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPN 358 (1029)
Q Consensus 279 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~ 358 (1029)
++.+-..+|.++.+|+.+.|.. .++ .++...|.++.+|+.++|.++ ++.+....|.+++.|+.+.+..+- ......
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l-~~i~~~ 134 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLML-KSIGVE 134 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTC-CEECTT
T ss_pred EeEhHHHHhhCCCCceEEEeCC-Ccc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCce-eeecce
Confidence 4556677899999999999974 465 788888888999999999765 666777888888888888776552 222222
Q ss_pred CCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCc
Q 036879 359 SLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETN 438 (1029)
Q Consensus 359 ~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 438 (1029)
+| ..+..+....... +.......|.+... |+.+.+.++. ......+|.++.+|+.+++..|
T Consensus 135 aF---------------~~~~~~~~~~~~~--~~~i~~~aF~~c~~-L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~ 195 (394)
T 4fs7_A 135 AF---------------KGCDFKEITIPEG--VTVIGDEAFATCES-LEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN 195 (394)
T ss_dssp TT---------------TTCCCSEEECCTT--CCEECTTTTTTCTT-CCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT
T ss_pred ee---------------ecccccccccCcc--ccccchhhhcccCC-CcEEecCCcc-ceeccccccCCCCceEEEcCCC
Confidence 22 2332222222222 12123344555554 7777776543 3355667888888888888766
Q ss_pred cccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCC
Q 036879 439 ELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPS 518 (1029)
Q Consensus 439 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 518 (1029)
++.+...+|.++..|+.+.+..+... ....+....+|+.+.+..+ +......+|..+..|+.+.+..+..+ +...
T Consensus 196 -~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~ 270 (394)
T 4fs7_A 196 -LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGS 270 (394)
T ss_dssp -CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSC
T ss_pred -ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eecc
Confidence 44455677778888888877766542 2233334467777777543 34456677888888888888877554 6777
Q ss_pred CccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCC
Q 036879 519 SLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSL 598 (1029)
Q Consensus 519 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 598 (1029)
.|.....++.+....+.+. ...|..+.+|+.+.+.++ ++.+....|.++.+|+.++|..+ ++.....+|.++.+|
T Consensus 271 ~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L 345 (394)
T 4fs7_A 271 LFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSL 345 (394)
T ss_dssp TTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTC
T ss_pred ccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCC
Confidence 8888888888888776543 456788889999988765 65566778888999999999754 765667888889999
Q ss_pred CEEeCcCCcccCcCchhhhcccccceeeccCC
Q 036879 599 NFLDMSSNNLSGEIPNSLKALSLLKFLNLSFN 630 (1029)
Q Consensus 599 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 630 (1029)
+.+++..| ++.+...+|.++++|+.+++..+
T Consensus 346 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 346 SNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred CEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 99999877 77677788999999999888654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.7e-13 Score=135.24 Aligned_cols=87 Identities=23% Similarity=0.268 Sum_probs=42.2
Q ss_pred ccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeec
Q 036879 548 KVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNL 627 (1029)
Q Consensus 548 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 627 (1029)
++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 34444444444444444444444555555555555554433333444555555555555555444444555555555555
Q ss_pred cCCCCcC
Q 036879 628 SFNGLQG 634 (1029)
Q Consensus 628 ~~N~l~~ 634 (1029)
++|+|.+
T Consensus 113 ~~N~~~c 119 (174)
T 2r9u_A 113 YNNPWDC 119 (174)
T ss_dssp CSSCBCT
T ss_pred CCCCccc
Confidence 5555444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.40 E-value=8.5e-13 Score=131.16 Aligned_cols=111 Identities=21% Similarity=0.235 Sum_probs=97.0
Q ss_pred CCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCc
Q 036879 525 DILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMS 604 (1029)
Q Consensus 525 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 604 (1029)
..+.|++++|+++. +|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 35789999999984 666553 789999999999998888899999999999999999997777778999999999999
Q ss_pred CCcccCcCchhhhcccccceeeccCCCCcCCCCC
Q 036879 605 SNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 605 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 638 (1029)
+|+|++..+..|..+++|+.|+|++|++++.++.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 9999988778899999999999999999987653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-12 Score=130.40 Aligned_cols=106 Identities=20% Similarity=0.265 Sum_probs=89.5
Q ss_pred ceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccc
Q 036879 503 RTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADN 582 (1029)
Q Consensus 503 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 582 (1029)
+.+++++|+++. +|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 678888888874 455443 78889999999999888888999999999999999999766677889999999999999
Q ss_pred cccccCCccccCCCCCCEEeCcCCcccCc
Q 036879 583 KFQGSIPDSLGGLTSLNFLDMSSNNLSGE 611 (1029)
Q Consensus 583 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 611 (1029)
+|++..+..|..+++|++|+|++|++...
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 99976666799999999999999999844
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=5.6e-14 Score=158.16 Aligned_cols=168 Identities=23% Similarity=0.249 Sum_probs=87.2
Q ss_pred cCcCcEEEecCccccccccccccCC-----CCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccc
Q 036879 427 LNNLTTLHLETNELTGSIPKAIGRL-----QKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLIS 501 (1029)
Q Consensus 427 l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 501 (1029)
+++|+.|+|++|.|+......+... ++|++|+|++|.++......+. ..+++
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~-----------------------~~L~~ 127 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLL-----------------------PVFLR 127 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTH-----------------------HHHHT
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHH-----------------------HHHHh
Confidence 3567788888887774333333322 5677777777776533222221 12334
Q ss_pred cceeeccCccccCCCCCCc-----cCCCCCcEEEccCCcccCc----CCccccccccccEEEccCCcCCCCC----Cccc
Q 036879 502 LRTLSLGFNRLTSVIPSSL-----WSLRDILNVNLSSNSLNGT----LPVEIGNLKVVTKIDLSRNDLSGEI----PSSI 568 (1029)
Q Consensus 502 L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~ 568 (1029)
|+.|+|++|.|+......+ ...++|+.|+|++|.|+.. ++..+..+++|++|+|++|.|++.. +..+
T Consensus 128 L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L 207 (372)
T 3un9_A 128 ARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQL 207 (372)
T ss_dssp EEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHG
T ss_pred ccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHH
Confidence 5555555555543222222 1234555566666555431 2223345556666666666665322 3334
Q ss_pred cCcccccccccccccccccC----CccccCCCCCCEEeCcCCcccCcCchhhh
Q 036879 569 GDLKNMQHLSLADNKFQGSI----PDSLGGLTSLNFLDMSSNNLSGEIPNSLK 617 (1029)
Q Consensus 569 ~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 617 (1029)
...++|+.|+|++|.|++.. +..+...++|++|||++|.|+......+.
T Consensus 208 ~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 208 DRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp GGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred hcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 44556666666666665432 23333456677777777776654444443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.4e-10 Score=132.25 Aligned_cols=133 Identities=11% Similarity=0.160 Sum_probs=69.6
Q ss_pred ccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccC
Q 036879 491 SLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGD 570 (1029)
Q Consensus 491 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 570 (1029)
....+|.++..|+.+.+..+.. .+...+|.++.+|+.+.+. +.++.+....|.++.+|+.++|..+ ++.+....|.+
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred cccceeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence 4445566666666666654433 2455566666666666664 3344445555666666666666543 44344555666
Q ss_pred cccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCC
Q 036879 571 LKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFN 630 (1029)
Q Consensus 571 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 630 (1029)
+.+|+.+.|..+ ++.....+|.++.+|+.+++.+|.... ..+.....|+.+.+..|
T Consensus 333 C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~ 388 (394)
T 4gt6_A 333 CEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPG 388 (394)
T ss_dssp CTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC--------
T ss_pred CCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCC
Confidence 666666666443 443444566666666666666654331 23444455555555444
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=7.6e-14 Score=157.06 Aligned_cols=185 Identities=14% Similarity=0.165 Sum_probs=106.6
Q ss_pred hhcceeccccccccccccccCCc-----CcCcEEEecCccccccccccc-cCCCCCCEEEeccccccCccccccc-----
Q 036879 405 AMDVLYLSACNIKGSIPSEIGNL-----NNLTTLHLETNELTGSIPKAI-GRLQKLQGLYLQHNKLQGSITTDLC----- 473 (1029)
Q Consensus 405 ~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~----- 473 (1029)
.++.|+|++|.|+......+... ++|++|+|++|.|+......+ ..+++|++|+|++|.++......++
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 48899999999986555554433 799999999999985433333 3467899999999998755444432
Q ss_pred CCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCc----CCcccccccc
Q 036879 474 GLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGT----LPVEIGNLKV 549 (1029)
Q Consensus 474 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~ 549 (1029)
..++|++|+|++|.|+...... ++..+...++|++|+|++|.|++. ++..+...++
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~~--------------------l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~ 212 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVAV--------------------LMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQ 212 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHHH--------------------HHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSC
T ss_pred cCCccceeeCCCCCCChHHHHH--------------------HHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCC
Confidence 2345555555555554321111 122223444455555555555432 2334455566
Q ss_pred ccEEEccCCcCCCCC----CccccCcccccccccccccccccCCccccCC---C--CCCEEe--CcCCccc
Q 036879 550 VTKIDLSRNDLSGEI----PSSIGDLKNMQHLSLADNKFQGSIPDSLGGL---T--SLNFLD--MSSNNLS 609 (1029)
Q Consensus 550 L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l---~--~L~~L~--Ls~N~l~ 609 (1029)
|+.|+|++|.|++.. +..+...++|+.|+|++|.|++.....+..+ . .|+.+. +..|.++
T Consensus 213 L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 213 LQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp CCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred cCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 777777777666432 2333445677777777777775544444332 1 155665 5555554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-11 Score=138.58 Aligned_cols=132 Identities=16% Similarity=0.128 Sum_probs=85.1
Q ss_pred eeeccCc-cccCCCCCCccCCCCCcEEEccC-CcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccccc
Q 036879 504 TLSLGFN-RLTSVIPSSLWSLRDILNVNLSS-NSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLAD 581 (1029)
Q Consensus 504 ~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 581 (1029)
.++++++ +|++ +|. +..+++|+.|+|++ |+|++..+..|+++++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4566666 6764 444 77777777777775 777766666777777777777777777777777777777777777777
Q ss_pred ccccccCCccccCCCCCCEEeCcCCcccCcCc-hhhhcccccceeeccCCCCcCCCCC
Q 036879 582 NKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIP-NSLKALSLLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 582 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~ 638 (1029)
|+|++..+..|..++ |+.|+|++|++...-. .+|..........+..+.+++..|.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 777755555555554 7778888877764322 2333333333344445556555444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=5.3e-12 Score=141.51 Aligned_cols=132 Identities=17% Similarity=0.179 Sum_probs=108.4
Q ss_pred cEEEccCC-cccCcCCccccccccccEEEccC-CcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCc
Q 036879 527 LNVNLSSN-SLNGTLPVEIGNLKVVTKIDLSR-NDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMS 604 (1029)
Q Consensus 527 ~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 604 (1029)
..++++++ +|++ +|. +..+++|+.|+|++ |+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|+
T Consensus 11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 45789998 8985 777 99999999999996 99998888999999999999999999999999999999999999999
Q ss_pred CCcccCcCchhhhcccccceeeccCCCCcCCCCCC--CCCCccCcccccCCCCCCCCCC
Q 036879 605 SNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHG--GPFTNLSSQSFVGNKGLCGAPE 661 (1029)
Q Consensus 605 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~~l~~~~~~~n~~~c~~~~ 661 (1029)
+|+|++.++..|..++ |+.|+|.+|+|.+...-. ..+.......+..+...|.+|.
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 9999988877887776 999999999999865421 0111112233445677787764
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.22 E-value=3.7e-10 Score=128.70 Aligned_cols=309 Identities=10% Similarity=0.151 Sum_probs=204.8
Q ss_pred ccEEEccCCcccCCCCCCcccCCCCcEEEccCcc---cCCCCCchhhhcccccceEeecCcccCCCCCccccccccccee
Q 036879 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANN---LLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLI 345 (1029)
Q Consensus 269 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 345 (1029)
|+.+.+-+ .++.+-..+|.++++|+.+.++.|. ++ .+....|....+|+.+.+..+ ++.+....|..+.+|+.+
T Consensus 66 L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~-~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i 142 (394)
T 4gt6_A 66 LTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVK-KIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTV 142 (394)
T ss_dssp CCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCC-EECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEE
T ss_pred CEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeee-EechhhchhcccceeeccCCc-cceehhhhhhhhcccccc
Confidence 33455543 3555667788888888888887664 43 566777766777887777654 554666777888888888
Q ss_pred cCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccC
Q 036879 346 DMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIG 425 (1029)
Q Consensus 346 ~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~ 425 (1029)
.+..+... ... ..+..+..|+.+.+..+ +.......|.. . .|+.+.+..+-.. ....+|.
T Consensus 143 ~lp~~~~~-I~~---------------~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~-~l~~i~ip~~~~~-i~~~af~ 202 (394)
T 4gt6_A 143 TIPEGVTS-VAD---------------GMFSYCYSLHTVTLPDS-VTAIEERAFTG-T-ALTQIHIPAKVTR-IGTNAFS 202 (394)
T ss_dssp ECCTTCCE-ECT---------------TTTTTCTTCCEEECCTT-CCEECTTTTTT-C-CCSEEEECTTCCE-ECTTTTT
T ss_pred cccceeee-ecc---------------cceecccccccccccce-eeEeccccccc-c-ceeEEEECCcccc-cccchhh
Confidence 87654321 111 12446677777777654 33233334433 2 2666666654333 5566788
Q ss_pred CcCcCcEEEecCcccccccccc--------------ccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCc
Q 036879 426 NLNNLTTLHLETNELTGSIPKA--------------IGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGS 491 (1029)
Q Consensus 426 ~l~~L~~L~L~~N~l~~~~~~~--------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 491 (1029)
+..+++......+.... .... +.....+..+.+. +.++.+...+|.++.+|+.+.+.++.. .+
T Consensus 203 ~c~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~-~I 279 (394)
T 4gt6_A 203 ECFALSTITSDSESYPA-IDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVV-SI 279 (394)
T ss_dssp TCTTCCEEEECCSSSCB-SSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCC-EE
T ss_pred hccccceeccccccccc-ccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccc-ee
Confidence 88888888777665542 2211 1122334444443 334456677889999999999876654 37
Q ss_pred cccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCc
Q 036879 492 LPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDL 571 (1029)
Q Consensus 492 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 571 (1029)
...+|.++++|+.+.+. +.++.+...+|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+..+ ++.+....|.++
T Consensus 280 ~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C 356 (394)
T 4gt6_A 280 GTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNC 356 (394)
T ss_dssp CTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTC
T ss_pred cCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCC
Confidence 77889999999999996 5677788889999999999999865 66677789999999999999765 665667889999
Q ss_pred ccccccccccccccccCCccccCCCCCCEEeCcCCccc
Q 036879 572 KNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS 609 (1029)
Q Consensus 572 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 609 (1029)
.+|+.+++.+|.... ..+....+|+.+.+..|.+.
T Consensus 357 ~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 357 TALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp TTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred CCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 999999999987652 46777889999998887664
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=2.7e-11 Score=129.89 Aligned_cols=145 Identities=17% Similarity=0.138 Sum_probs=115.6
Q ss_pred HHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEEEEE
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 813 (1029)
...+.|+.....+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..|+||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 44567888888899999999999754 6899999987543233456889999999884 677889999999889999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH-------------------------------------- 855 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-------------------------------------- 855 (1029)
||++|.++.+... +......++.+++++++.||...
T Consensus 90 e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 90 SEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp ECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 9999999987531 11234478899999999999711
Q ss_pred ------------------CCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 856 ------------------PTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 856 ------------------~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
..+++|+|++|.||+++++..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876667799999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.01 E-value=3.5e-10 Score=121.05 Aligned_cols=137 Identities=17% Similarity=0.136 Sum_probs=101.5
Q ss_pred CCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCc--eEEEEEEEecCCeEEEEEecc
Q 036879 739 GFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRN--LVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.|.+....+.|..+.||++...+|..+++|+.... ....+.+|+++++.+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34443333456669999998777888999997643 2356789999999985444 566888888888889999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH----------------------------------------- 855 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~----------------------------------------- 855 (1029)
+|.++. . .. . ....++.++++.++.||...
T Consensus 98 ~G~~l~--~-~~---~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDLL--S-SH---L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEETT--T-SC---C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCcccC--c-Cc---C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 998874 2 11 1 12356788888888888532
Q ss_pred --------------CCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 856 --------------PTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 856 --------------~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
..+++|||++|.||+++.++.+.|+|||.+..
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998877778999998753
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.7e-08 Score=114.35 Aligned_cols=54 Identities=9% Similarity=0.089 Sum_probs=28.8
Q ss_pred CcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeec
Q 036879 267 QGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILG 324 (1029)
Q Consensus 267 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~ 324 (1029)
.+|+.+.+.. .++.+...+|.++.+|+.++|..+ ++ .++...|.+. +|+.+.+-
T Consensus 46 ~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~-~Ig~~aF~~c-~l~~i~~~ 99 (379)
T 4h09_A 46 DRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VT-SIGDGAFADT-KLQSYTGM 99 (379)
T ss_dssp GGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CC-EECTTTTTTC-CCCEEEEC
T ss_pred cCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ce-EechhhhcCC-CCceEECC
Confidence 3455555543 355455566666666666666533 43 5555555433 45555443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.97 E-value=3.7e-08 Score=111.52 Aligned_cols=165 Identities=12% Similarity=0.095 Sum_probs=77.3
Q ss_pred cCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccc
Q 036879 424 IGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLR 503 (1029)
Q Consensus 424 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 503 (1029)
+.....+..+.+..+.-. .....+....+|+.+.+..+ +..+....|.+...|+.+.+..+ ++.+...+|.++.+|+
T Consensus 190 ~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~ 266 (379)
T 4h09_A 190 YPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALK 266 (379)
T ss_dssp CCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred ccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhc
Confidence 333344444444433222 33444555555666655443 33344445555555555555433 3334444555555555
Q ss_pred eeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccccccccccc
Q 036879 504 TLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNK 583 (1029)
Q Consensus 504 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 583 (1029)
.+.+..+ ++.+...+|.++.+|+.+.+.++.++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+
T Consensus 267 ~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~- 343 (379)
T 4h09_A 267 TLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS- 343 (379)
T ss_dssp EEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-
T ss_pred ccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-
Confidence 5555432 33344445555555555555555554444445555555555555433 33333444555555555555433
Q ss_pred ccccCCccccC
Q 036879 584 FQGSIPDSLGG 594 (1029)
Q Consensus 584 l~~~~~~~~~~ 594 (1029)
++.+...+|.+
T Consensus 344 v~~I~~~aF~~ 354 (379)
T 4h09_A 344 ITLIESGAFEG 354 (379)
T ss_dssp CCEECTTTTTT
T ss_pred cCEEchhHhhC
Confidence 33233344443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.93 E-value=4.9e-11 Score=125.75 Aligned_cols=139 Identities=23% Similarity=0.247 Sum_probs=76.7
Q ss_pred CCceeeEEEcCCCCceEEEeccc---ccccccCCcc-C-----------------------CCCcCCCe--EeccCcccc
Q 036879 35 VCNWFGVTCSPRHRRVTALNLAY---MGLLGTIPPE-L-----------------------GNLSFLSL--LNVTNNSFS 85 (1029)
Q Consensus 35 ~c~w~gv~c~~~~~~v~~l~l~~---~~l~~~~p~~-~-----------------------~~l~~L~~--L~l~~n~l~ 85 (1029)
-|+|.|+.|++...+|+.+...+ ..+.+.++++ + ...+.|.. ++++.|...
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 38999999998877887665544 3444555432 1 11222222 444555322
Q ss_pred ---cCCccccccccCCceeecccccccCCC-CCCcCCCCCccceeccccccccCCCcccccCcc--ccCeEeccCCcCcc
Q 036879 86 ---GTLPIQLSNLRRLKYLSFRSNNFSSIE-IPPWLDSFPKLEHLYLDGNSFIGTIPPSICNIS--SLLTLDLSFNQLQG 159 (1029)
Q Consensus 86 ---~~~p~~~~~l~~L~~L~l~~N~l~~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~ 159 (1029)
+.++....++++|++|+|++|+|+.+. +|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++
T Consensus 157 ~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~ 234 (267)
T 3rw6_A 157 CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD 234 (267)
T ss_dssp HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG
T ss_pred HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc
Confidence 111222245666667777777666532 344555666666666666666643 2334443 66666666666665
Q ss_pred cCCc-------cccCCCcCcccc
Q 036879 160 HVPS-------SILNIPSLLAID 175 (1029)
Q Consensus 160 ~~p~-------~~~~l~~L~~L~ 175 (1029)
.+|. .+..+|+|+.||
T Consensus 235 ~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 235 TFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GCSSHHHHHHHHHHHCTTCCEES
T ss_pred ccCcchhHHHHHHHHCcccCeEC
Confidence 5542 244556665554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.85 E-value=9.7e-10 Score=122.36 Aligned_cols=184 Identities=13% Similarity=0.137 Sum_probs=97.0
Q ss_pred ccCCcCcCcEEEecCcccc---------ccccccccCCCCCCEEEecccc-ccCcccccccCCCCCcEEecCCCcccCcc
Q 036879 423 EIGNLNNLTTLHLETNELT---------GSIPKAIGRLQKLQGLYLQHNK-LQGSITTDLCGLRSLSEFYSDGNELNGSL 492 (1029)
Q Consensus 423 ~~~~l~~L~~L~L~~N~l~---------~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 492 (1029)
+...+++|+.|.+..+... +.+...+..+|+|+.|+|++|. +. . +. + .+++|+.|.+..+.+....
T Consensus 134 s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~-l-~~-~-~~~~L~~L~L~~~~l~~~~ 209 (362)
T 2ra8_A 134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS-I-GK-K-PRPNLKSLEIISGGLPDSV 209 (362)
T ss_dssp THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB-C-CS-C-BCTTCSEEEEECSBCCHHH
T ss_pred hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce-e-cc-c-cCCCCcEEEEecCCCChHH
Confidence 3445667777777654321 1233455667778888877763 21 1 11 2 2556666666655554333
Q ss_pred ccccc--cccccceeeccC--ccccCCCCCCccCCCCCcEEEccCCcccCcCCccc--cccccccEEEccCCcCCCCCCc
Q 036879 493 PQCLD--SLISLRTLSLGF--NRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEI--GNLKVVTKIDLSRNDLSGEIPS 566 (1029)
Q Consensus 493 ~~~~~--~l~~L~~L~Ls~--N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~ 566 (1029)
...+. .+++|+.|+|+. |...+.. .+.+ +...+ ..+++|+.|+|++|.+++..+.
T Consensus 210 l~~l~~~~lp~L~~L~L~~~~~~~~~~~------------------~~~~-l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~ 270 (362)
T 2ra8_A 210 VEDILGSDLPNLEKLVLYVGVEDYGFDG------------------DMNV-FRPLFSKDRFPNLKWLGIVDAEEQNVVVE 270 (362)
T ss_dssp HHHHHHSBCTTCCEEEEECBCGGGTCCS------------------CGGG-TGGGSCTTTCTTCCEEEEESCTTHHHHHH
T ss_pred HHHHHHccCCCCcEEEEeccccccccch------------------hHHH-HHHHHhcCCCCCcCEEeCCCCCCchHHHH
Confidence 33333 455565555542 1111000 0000 00111 2356677777777666533322
Q ss_pred cc---cCcccccccccccccccccC----CccccCCCCCCEEeCcCCcccCcCchhhhc-ccccceeeccCCC
Q 036879 567 SI---GDLKNMQHLSLADNKFQGSI----PDSLGGLTSLNFLDMSSNNLSGEIPNSLKA-LSLLKFLNLSFNG 631 (1029)
Q Consensus 567 ~~---~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~l~~N~ 631 (1029)
.+ ..+++|+.|+|+.|.|++.. +..+..+++|+.|+|++|.|+...-..+.. + ...+++++|+
T Consensus 271 ~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 271 MFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred HHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 22 24677788888877777642 333345678888888888877544444433 2 3557888776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.84 E-value=4.7e-09 Score=117.95 Aligned_cols=142 Identities=12% Similarity=0.203 Sum_probs=107.2
Q ss_pred CCceeccCcceEEEEEEecCCcEEEEEEee--ccc-chhhHHHHHHHHHHhcCC--CCceEEEEEEEecC---CeEEEEE
Q 036879 742 ENNLLGKGSFGSVYKGTLSDGMQIAVKVFN--LEL-EGTLRSFDAECEILGSIR--HRNLVKIISTCSSD---HFKALVL 813 (1029)
Q Consensus 742 ~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~ 813 (1029)
..+.++.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45779999999999998754 678888775 322 123457889999999996 45688899988776 4578999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH-------------------------------------- 855 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-------------------------------------- 855 (1029)
||++|..+.+. ....++..++..++.+++++|+.||...
T Consensus 121 e~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99998877431 2234678888899999999999999631
Q ss_pred -----------------CCCcEEcCCCCCCEEECCCCc--EEEEccCCcee
Q 036879 856 -----------------PTPIIHCDLNPSNILLNESMV--ACLSDFGISKL 887 (1029)
Q Consensus 856 -----------------~~givH~Dlk~~Nill~~~~~--~kl~Dfg~a~~ 887 (1029)
..+++|||+++.||+++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997653 68999998864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.83 E-value=9e-10 Score=122.63 Aligned_cols=169 Identities=20% Similarity=0.275 Sum_probs=108.1
Q ss_pred cccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCcc-ccCCCCCCccCCCC
Q 036879 447 AIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNR-LTSVIPSSLWSLRD 525 (1029)
Q Consensus 447 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~ 525 (1029)
+...+++|+.|.+..+...... + +... .+.+...+..+++|+.|+|++|. +. .+. + .+++
T Consensus 134 s~~~l~~L~~L~l~~~~~e~~~---i-----------s~~~-~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~-~~~~ 194 (362)
T 2ra8_A 134 NKEKFAHFEGLFWGDIDFEEQE---I-----------SWIE-QVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-K-PRPN 194 (362)
T ss_dssp THHHHTTCSEEEECCCCTTTCC---G-----------GGCB-CCBCHHHHHTCTTCCEEEEECCBTCB--CCS-C-BCTT
T ss_pred hhhhcchhhheeecCcchhhcc---c-----------cccc-ccCHHHHHhcCCCCcEEEEeCCCCce--ecc-c-cCCC
Confidence 3556778888888765332100 0 0000 01233455667778888887763 22 222 3 3778
Q ss_pred CcEEEccCCcccCcCCcccc--ccccccEEEccC--CcCCCC-----CCccc--cCcccccccccccccccccCCcccc-
Q 036879 526 ILNVNLSSNSLNGTLPVEIG--NLKVVTKIDLSR--NDLSGE-----IPSSI--GDLKNMQHLSLADNKFQGSIPDSLG- 593 (1029)
Q Consensus 526 L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~--~~l~~L~~L~L~~N~l~~~~~~~~~- 593 (1029)
|+.|+|..+.++......+. .+++|+.|+|+. |...+. +...+ ..+++|+.|+|++|.+++..+..+.
T Consensus 195 L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~ 274 (362)
T 2ra8_A 195 LKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLE 274 (362)
T ss_dssp CSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHH
T ss_pred CcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHh
Confidence 88888888887644333443 678888888863 221111 11122 2478999999999999864443332
Q ss_pred --CCCCCCEEeCcCCcccCcC----chhhhcccccceeeccCCCCcC
Q 036879 594 --GLTSLNFLDMSSNNLSGEI----PNSLKALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 594 --~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~ 634 (1029)
.+++|++|+|+.|.|++.. +..+..+++|+.|+|++|.++.
T Consensus 275 a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 275 SDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp CSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 5789999999999998643 3444678999999999998874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.76 E-value=9.3e-09 Score=112.55 Aligned_cols=185 Identities=15% Similarity=0.144 Sum_probs=123.6
Q ss_pred CceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcC-CCCc--eEEEEEEEecCC---eEEEEEecc
Q 036879 743 NNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRN--LVKIISTCSSDH---FKALVLEYM 816 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lV~E~~ 816 (1029)
.+.++.|....||+.. ..+++|+.... .....+.+|+++++.+ .+.. +.+.+......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 56889986433 3456789999999887 3332 445555543333 458999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH----------------------------------------- 855 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~----------------------------------------- 855 (1029)
+|.++.+... ..++..++..++.++++.++.||...
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988865332 23567778888889999998888511
Q ss_pred --------------CCCcEEcCCCCCCEEECC--CCcEEEEccCCceecCCCCCceeccc----cCC-------ccc--c
Q 036879 856 --------------PTPIIHCDLNPSNILLNE--SMVACLSDFGISKLLGDETSMTQTQT----LAT-------IGY--M 906 (1029)
Q Consensus 856 --------------~~givH~Dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~----~gt-------~~y--~ 906 (1029)
...++|+|++|.||+++. ...+.++||+.+.............. .+. .+| .
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 145899999999999998 56688999999875432111100000 000 011 1
Q ss_pred C-ccCC--CCCCcchhHHHHHHHHHhcCCCCCC
Q 036879 907 A-PEWK--LSRKGDVYSYGIILMETFTKKKPTD 936 (1029)
Q Consensus 907 a-PE~~--~~~~~DvwSlGvil~elltg~~p~~ 936 (1029)
. |+.. .....+.|++|.++|++.+|+.+|.
T Consensus 256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 2221 1112589999999999999988763
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.43 E-value=1.1e-08 Score=107.82 Aligned_cols=105 Identities=22% Similarity=0.289 Sum_probs=67.2
Q ss_pred ccCCCCCcE--EEccCCccc---CcCCccccccccccEEEccCCcCCC--CCCccccCcccccccccccccccccCCccc
Q 036879 520 LWSLRDILN--VNLSSNSLN---GTLPVEIGNLKVVTKIDLSRNDLSG--EIPSSIGDLKNMQHLSLADNKFQGSIPDSL 592 (1029)
Q Consensus 520 ~~~l~~L~~--L~Ls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 592 (1029)
|...+.|.. ++++.|+.. +..+....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 444444444 555666433 1112222456778888888888876 3345666788888888888888754 223
Q ss_pred cCCC--CCCEEeCcCCcccCcCc-------hhhhcccccceee
Q 036879 593 GGLT--SLNFLDMSSNNLSGEIP-------NSLKALSLLKFLN 626 (1029)
Q Consensus 593 ~~l~--~L~~L~Ls~N~l~~~~~-------~~~~~l~~L~~L~ 626 (1029)
..+. +|++|+|++|.+++.+| ..+..+|+|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 3333 88899999998887665 2467788888775
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=6.3e-08 Score=97.17 Aligned_cols=117 Identities=10% Similarity=0.119 Sum_probs=57.4
Q ss_pred cccccccccccceeeccCc-cccCC----CCCCccCCCCCcEEEccCCcccCcC----CccccccccccEEEccCCcCCC
Q 036879 492 LPQCLDSLISLRTLSLGFN-RLTSV----IPSSLWSLRDILNVNLSSNSLNGTL----PVEIGNLKVVTKIDLSRNDLSG 562 (1029)
Q Consensus 492 ~~~~~~~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~ 562 (1029)
+...+...+.|++|+|++| .|... +...+...++|++|+|++|.|+... ...+...++|++|+|++|.|+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3445566677777777777 66532 2233444556666666666665321 2223334555666666665553
Q ss_pred C----CCccccCccccccccc--ccccccccC----CccccCCCCCCEEeCcCCcc
Q 036879 563 E----IPSSIGDLKNMQHLSL--ADNKFQGSI----PDSLGGLTSLNFLDMSSNNL 608 (1029)
Q Consensus 563 ~----~p~~~~~l~~L~~L~L--~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l 608 (1029)
. +...+...+.|++|+| ++|.|+... ...+...+.|++|+|++|.+
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 2 1223333444555555 444444321 12222234444444444444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=2.5e-08 Score=100.07 Aligned_cols=116 Identities=18% Similarity=0.180 Sum_probs=70.8
Q ss_pred CCccCCCCCcEEEccCC-cccCc----CCccccccccccEEEccCCcCCCCC----CccccCccccccccccccccccc-
Q 036879 518 SSLWSLRDILNVNLSSN-SLNGT----LPVEIGNLKVVTKIDLSRNDLSGEI----PSSIGDLKNMQHLSLADNKFQGS- 587 (1029)
Q Consensus 518 ~~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~- 587 (1029)
..+...+.|++|+|++| .|... +...+...++|++|+|++|.|.... ...+...++|++|+|++|.|++.
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34555677777777777 66632 2333455567777777777776432 22334446677777777777653
Q ss_pred ---CCccccCCCCCCEEeC--cCCcccCcC----chhhhcccccceeeccCCCCc
Q 036879 588 ---IPDSLGGLTSLNFLDM--SSNNLSGEI----PNSLKALSLLKFLNLSFNGLQ 633 (1029)
Q Consensus 588 ---~~~~~~~l~~L~~L~L--s~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~ 633 (1029)
+...+...+.|++|+| ++|.|+... ...+...+.|+.|+|++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2445555667777777 667776432 233444567777777777664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=5.8e-06 Score=88.48 Aligned_cols=135 Identities=16% Similarity=0.092 Sum_probs=99.2
Q ss_pred eeccCcce-EEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 745 LLGKGSFG-SVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 745 ~lg~G~fg-~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
.+..|..| .||+.... ++..+++|+-... ....+.+|+++++.+. +-.|.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45566666 68988765 5678999986533 4567888999998884 33477888999989999999999999888
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 036879 822 ENWMYNKNRSFDILQRLNMVIDVASALEYLHYD----------------------------------------------- 854 (1029)
Q Consensus 822 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----------------------------------------------- 854 (1029)
.+..... ......+..+++..++.||..
T Consensus 108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 7754321 123345666777777777742
Q ss_pred --------CCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 855 --------HPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 855 --------~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
....++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112379999999999999887778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=5.7e-06 Score=90.18 Aligned_cols=136 Identities=15% Similarity=0.103 Sum_probs=96.9
Q ss_pred CceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCC---ceEEEEEEEe-cCCeEEEEEeccCC
Q 036879 743 NNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHR---NLVKIISTCS-SDHFKALVLEYMPN 818 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~E~~~~ 818 (1029)
.+.++.|....||+. |..+++|+... ......+.+|+++++.+.+. .|.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888999999987 57788898532 23456789999999999642 3566676664 45667899999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD-------------------------------------------- 854 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-------------------------------------------- 854 (1029)
.++.+... ..++..+...++.++++.++.||..
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88876321 1234455555666666666666642
Q ss_pred -------------CCCCcEEcCCCCCCEEECC---CCc-EEEEccCCcee
Q 036879 855 -------------HPTPIIHCDLNPSNILLNE---SMV-ACLSDFGISKL 887 (1029)
Q Consensus 855 -------------~~~givH~Dlk~~Nill~~---~~~-~kl~Dfg~a~~ 887 (1029)
....++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999987 455 58999997754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=3.7e-06 Score=94.09 Aligned_cols=79 Identities=8% Similarity=-0.006 Sum_probs=56.3
Q ss_pred cee-ccCcceEEEEEEec-------CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCC-C--CceEEEEEEEecC---
Q 036879 744 NLL-GKGSFGSVYKGTLS-------DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIR-H--RNLVKIISTCSSD--- 806 (1029)
Q Consensus 744 ~~l-g~G~fg~V~~~~~~-------~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--- 806 (1029)
+.| +.|....+|+.... ++..+++|+..... ......+.+|+++++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88989999998764 26788999865432 112356788999988884 2 3577788887655
Q ss_pred CeEEEEEeccCCCCHH
Q 036879 807 HFKALVLEYMPNGSLE 822 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~ 822 (1029)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 4568999999886653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.78 E-value=5.7e-05 Score=83.71 Aligned_cols=138 Identities=13% Similarity=0.119 Sum_probs=79.9
Q ss_pred ceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCC--CceEEEEE------EEecCCeEEEEEec
Q 036879 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRH--RNLVKIIS------TCSSDHFKALVLEY 815 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lV~E~ 815 (1029)
+.++.|..+.||+....+| .+++|+.... ...+..|+++++.+.. -.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987655 5899988752 1334455665555521 12333332 12346678899999
Q ss_pred cCCCCHH-----H---------HHhc--CCC--C---------CCHHHH-------------------------------
Q 036879 816 MPNGSLE-----N---------WMYN--KNR--S---------FDILQR------------------------------- 837 (1029)
Q Consensus 816 ~~~gsL~-----~---------~l~~--~~~--~---------~~~~~~------------------------------- 837 (1029)
++|..+. + .++. ... + ..|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986432 1 1111 100 0 122211
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 838 LNMVIDVASALEYLHY----------DHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 838 ~~i~~~i~~~l~~Lh~----------~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
..+..++.+++++|+. ....+++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111224445666653 135789999999999999888899999999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=5.4e-05 Score=85.84 Aligned_cols=75 Identities=12% Similarity=0.057 Sum_probs=49.7
Q ss_pred CceeccCcceEEEEEEec-CCcEEEEEEeecccc-------hhhHHHHHHHHHHhcCCC--C-ceEEEEEEEecCCeEEE
Q 036879 743 NNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE-------GTLRSFDAECEILGSIRH--R-NLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l 811 (1029)
.+.+|.|.++.||++... +++.|+||....... .....+..|+++++.+.. | .+.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 467999999999999764 568899998653221 123456789999887732 3 344566543 344579
Q ss_pred EEeccCCC
Q 036879 812 VLEYMPNG 819 (1029)
Q Consensus 812 V~E~~~~g 819 (1029)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.76 E-value=5.2e-06 Score=80.88 Aligned_cols=87 Identities=15% Similarity=0.162 Sum_probs=54.6
Q ss_pred CCCCcEEEccCCcccCcCCccccccccccEEEccCCc-CCCCCCccccCc----cccccccccccc-ccccCCccccCCC
Q 036879 523 LRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRND-LSGEIPSSIGDL----KNMQHLSLADNK-FQGSIPDSLGGLT 596 (1029)
Q Consensus 523 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~ 596 (1029)
-..|+.||++++.|+...-..+..+++|+.|+|++|. |++..-..+..+ ++|++|+|++|. |++..-..+..++
T Consensus 60 ~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 60 KYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred CceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 3467777777777776555566677777777777774 554333444443 357777777763 6655445566667
Q ss_pred CCCEEeCcCCc-cc
Q 036879 597 SLNFLDMSSNN-LS 609 (1029)
Q Consensus 597 ~L~~L~Ls~N~-l~ 609 (1029)
+|++|+|+++. ++
T Consensus 140 ~L~~L~L~~c~~It 153 (176)
T 3e4g_A 140 NLKYLFLSDLPGVK 153 (176)
T ss_dssp TCCEEEEESCTTCC
T ss_pred CCCEEECCCCCCCC
Confidence 77777777763 44
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.68 E-value=8.4e-06 Score=79.42 Aligned_cols=84 Identities=18% Similarity=0.159 Sum_probs=49.1
Q ss_pred ccccEEEccCCcCCCCCCccccCccccccccccccc-ccccCCccccCC----CCCCEEeCcCC-cccCcCchhhhcccc
Q 036879 548 KVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNK-FQGSIPDSLGGL----TSLNFLDMSSN-NLSGEIPNSLKALSL 621 (1029)
Q Consensus 548 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~Ls~N-~l~~~~~~~~~~l~~ 621 (1029)
..|+.||++++.++...-..+..+++|+.|+|++|. |++..-..++.+ ++|++|+|++| ++|..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356666666666665544555666666666666663 554443444443 25666666665 365544445556666
Q ss_pred cceeeccCCC
Q 036879 622 LKFLNLSFNG 631 (1029)
Q Consensus 622 L~~L~l~~N~ 631 (1029)
|+.|++++++
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666666654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00036 Score=75.55 Aligned_cols=137 Identities=13% Similarity=0.111 Sum_probs=92.1
Q ss_pred CCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCC---CCceEEEEEEEecCCeEEEEEeccCC
Q 036879 742 ENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIR---HRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 742 ~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
..+.|+.|....+|+... ++..+++|+.... ....+..|++.++.+. ...+.+++++....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356799999999999876 4678889987643 3567889999998883 36788889888888889999999998
Q ss_pred CCHH--------H---HHhcCCC--C-------------------CCHHHHH---HHHHH----------------HH-H
Q 036879 819 GSLE--------N---WMYNKNR--S-------------------FDILQRL---NMVID----------------VA-S 846 (1029)
Q Consensus 819 gsL~--------~---~l~~~~~--~-------------------~~~~~~~---~i~~~----------------i~-~ 846 (1029)
..+. + .++.... . -+|.... ++..+ +. .
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7542 1 1122111 1 1343321 11111 11 1
Q ss_pred HHHHHHh-cCCCCcEEcCCCCCCEEECCCCcEEEEccC
Q 036879 847 ALEYLHY-DHPTPIIHCDLNPSNILLNESMVACLSDFG 883 (1029)
Q Consensus 847 ~l~~Lh~-~~~~givH~Dlk~~Nill~~~~~~kl~Dfg 883 (1029)
..+.|.. ....++||+|+.+.|++++.++ +.|+||+
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1223321 2246799999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00048 Score=74.11 Aligned_cols=79 Identities=16% Similarity=0.136 Sum_probs=57.9
Q ss_pred CCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCC-C--CceEEEEEEEecCCeEEEEEec
Q 036879 739 GFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIR-H--RNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.....+.+|.|..+.||+.+..+|+.|.+|+...........+..|++.|+.+. . -.+.+.+++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 444567899999999999999999999999876544444456889999998884 2 2344555542 23689999
Q ss_pred cCCCCH
Q 036879 816 MPNGSL 821 (1029)
Q Consensus 816 ~~~gsL 821 (1029)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 877643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00077 Score=76.85 Aligned_cols=76 Identities=13% Similarity=0.089 Sum_probs=46.1
Q ss_pred CCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceeccccCCccccCccCCCC-------CCcchhHHHHHHHHH
Q 036879 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKLS-------RKGDVYSYGIILMET 928 (1029)
Q Consensus 856 ~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~DvwSlGvil~el 928 (1029)
...++|||++|.||+++.++ ++++||+.+..-............-...|.+|+.... ...++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 67899999999999999876 9999999987543221111000001123555544221 123445677777777
Q ss_pred hcCC
Q 036879 929 FTKK 932 (1029)
Q Consensus 929 ltg~ 932 (1029)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00012 Score=72.65 Aligned_cols=41 Identities=10% Similarity=0.229 Sum_probs=19.7
Q ss_pred ccccccceeeccCc-cccCC----CCCCccCCCCCcEEEccCCccc
Q 036879 497 DSLISLRTLSLGFN-RLTSV----IPSSLWSLRDILNVNLSSNSLN 537 (1029)
Q Consensus 497 ~~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~ 537 (1029)
.+-+.|+.|+|++| +|... +.+++..-+.|+.|+|++|+|.
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~ig 83 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 83 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCC
Confidence 34455666666653 55321 2233344445555555555554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00058 Score=63.36 Aligned_cols=56 Identities=23% Similarity=0.301 Sum_probs=30.1
Q ss_pred cccccccccc-ccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCc
Q 036879 576 HLSLADNKFQ-GSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQ 633 (1029)
Q Consensus 576 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 633 (1029)
.++.+++.|+ ..+|..+. ++|++|+|++|+|+...+..|..+++|+.|+|++|+|.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 3444455543 12343333 35666666666666555556666666666655544443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0024 Score=69.82 Aligned_cols=155 Identities=12% Similarity=0.132 Sum_probs=86.5
Q ss_pred CHHHHHHHhCCCCC-----CceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCc--eEEEEE
Q 036879 729 SYQELFRATDGFSE-----NNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRN--LVKIIS 801 (1029)
Q Consensus 729 ~~~~~~~~~~~~~~-----~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~ 801 (1029)
+.+++......|.. .+.|+.|....+|+....+| .+++|+.... .....+..|+++++.+.... +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 34444444445554 24566788889999987665 6889987652 12345667888877763212 233332
Q ss_pred E------EecCCeEEEEEeccCCCCHH-----HH---------HhcC----CCC----C---CHHHHHH-----------
Q 036879 802 T------CSSDHFKALVLEYMPNGSLE-----NW---------MYNK----NRS----F---DILQRLN----------- 839 (1029)
Q Consensus 802 ~------~~~~~~~~lV~E~~~~gsL~-----~~---------l~~~----~~~----~---~~~~~~~----------- 839 (1029)
. ....+..++||+|++|..+. .+ ++.. ... . .|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 12245678999999876431 10 1111 000 0 1221100
Q ss_pred -HHHHHHHHHHHHHhc----CCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 840 -MVIDVASALEYLHYD----HPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 840 -i~~~i~~~l~~Lh~~----~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
+...+.+.+++++.. ...+++|+|+.+.||+++.+..+.++||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455555532 24579999999999999987666899999775
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00014 Score=72.13 Aligned_cols=42 Identities=10% Similarity=0.223 Sum_probs=25.0
Q ss_pred CcCcCcEEEecCc-ccccc----ccccccCCCCCCEEEeccccccCc
Q 036879 426 NLNNLTTLHLETN-ELTGS----IPKAIGRLQKLQGLYLQHNKLQGS 467 (1029)
Q Consensus 426 ~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~ 467 (1029)
+-+.|++|+|++| +|... +..++...+.|+.|+|++|.|...
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ 85 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDS 85 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChH
Confidence 3456777777764 66521 234455566677777777776533
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0031 Score=69.02 Aligned_cols=140 Identities=14% Similarity=0.115 Sum_probs=82.2
Q ss_pred ceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCC--ceEEEEEE-----EecCCeEEEEEecc
Q 036879 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHR--NLVKIIST-----CSSDHFKALVLEYM 816 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lV~E~~ 816 (1029)
..++ |....||+....+|+.+++|...... .....+..|.++++.+... .+++++.. ....+..++|||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999887778789999986331 2345667788888777321 24444443 12245668899999
Q ss_pred CCCCHH-----HH---------Hhc--C------CCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 036879 817 PNGSLE-----NW---------MYN--K------NRSFDILQR----LNM---------------VIDVASALEYLHYD- 854 (1029)
Q Consensus 817 ~~gsL~-----~~---------l~~--~------~~~~~~~~~----~~i---------------~~~i~~~l~~Lh~~- 854 (1029)
+|..+. .+ ++. . ....++... ..+ ...+...++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875421 11 110 0 011222111 000 11112223333221
Q ss_pred ---CCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 855 ---HPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 855 ---~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
...+++|||+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 245689999999999999 4 899999997754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0041 Score=68.32 Aligned_cols=140 Identities=12% Similarity=0.077 Sum_probs=75.0
Q ss_pred ceeccCcceE-EEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCC--CceEEEEEEEecCCeEEEEEeccCCCC
Q 036879 744 NLLGKGSFGS-VYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRH--RNLVKIISTCSSDHFKALVLEYMPNGS 820 (1029)
Q Consensus 744 ~~lg~G~fg~-V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gs 820 (1029)
+.++.|+... +|+....+|..+++|...... ...+..|+++++.+.. -.+.+++.+....+ ++|||++++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3455554444 667765446778777654321 1344567777766632 23556666644444 68999997777
Q ss_pred HHHHHhcCC-------------------------CCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 036879 821 LENWMYNKN-------------------------RSFDILQRL-------N-------------MVIDVASALEYLH--- 852 (1029)
Q Consensus 821 L~~~l~~~~-------------------------~~~~~~~~~-------~-------------i~~~i~~~l~~Lh--- 852 (1029)
+.+++.... ..++..... . ....+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 655442110 112211100 0 0011112222221
Q ss_pred hcCCCCcEEcCCCCCCEEECCC----CcEEEEccCCceec
Q 036879 853 YDHPTPIIHCDLNPSNILLNES----MVACLSDFGISKLL 888 (1029)
Q Consensus 853 ~~~~~givH~Dlk~~Nill~~~----~~~kl~Dfg~a~~~ 888 (1029)
.....+++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1135679999999999999874 78999999988653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0024 Score=71.03 Aligned_cols=139 Identities=14% Similarity=0.199 Sum_probs=82.3
Q ss_pred ceeccCcceEEEEEEec--------CCcEEEEEEeecccchhhHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEEEEEe
Q 036879 744 NLLGKGSFGSVYKGTLS--------DGMQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 814 (1029)
+.+..|-...+|+.... +++.+++|+.... ........+|.++++.+. +.-..++++++.. .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 56777888899998864 2478999986322 223455678999988883 3223566776653 28999
Q ss_pred ccCCCCHHH-----------H---H---hcC----CCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 036879 815 YMPNGSLEN-----------W---M---YNK----NRSFD--ILQRLNMVIDVAS-------------------ALEYLH 852 (1029)
Q Consensus 815 ~~~~gsL~~-----------~---l---~~~----~~~~~--~~~~~~i~~~i~~-------------------~l~~Lh 852 (1029)
|++|.++.. . + +.. .+... +.++.++..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998765421 0 0 111 11122 3444445544322 223332
Q ss_pred ----h-cCCCCcEEcCCCCCCEEECCC----CcEEEEccCCcee
Q 036879 853 ----Y-DHPTPIIHCDLNPSNILLNES----MVACLSDFGISKL 887 (1029)
Q Consensus 853 ----~-~~~~givH~Dlk~~Nill~~~----~~~kl~Dfg~a~~ 887 (1029)
. .....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 123568999999999999876 7899999998753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0018 Score=70.14 Aligned_cols=128 Identities=14% Similarity=0.141 Sum_probs=75.3
Q ss_pred CceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCce-EEEEEEEecCCeEEEEEecc-CCCC
Q 036879 743 NNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNL-VKIISTCSSDHFKALVLEYM-PNGS 820 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~-~~gs 820 (1029)
.+.|+.|....+|+. ..+++|+....... .....+|+++++.+...++ .+++++.. +.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence 678999999999998 56888887643211 1233568877777632222 45555443 3346899999 6554
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 036879 821 LENWMYNKNRSFDILQRLNMVIDVASALEYLHY----------------------------------------------- 853 (1029)
Q Consensus 821 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~----------------------------------------------- 853 (1029)
+....... +..++.++++.|+-+|.
T Consensus 95 l~~~~~~~--------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l 166 (301)
T 3dxq_A 95 MSPEKFKT--------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSAL 166 (301)
T ss_dssp CCHHHHHH--------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHH
T ss_pred CCHhhHhh--------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHH
Confidence 42100000 00112222222222221
Q ss_pred ---cCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 854 ---DHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 854 ---~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
.....++|+|+.+.||+ ..++.+.++||..+..
T Consensus 167 ~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 167 AAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 12345899999999999 5667789999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0037 Score=71.10 Aligned_cols=72 Identities=19% Similarity=0.227 Sum_probs=48.9
Q ss_pred CceeccCcceEEEEEEecC--------CcEEEEEEeecccchhhHHHHHHHHHHhcCCCCc-eEEEEEEEecCCeEEEEE
Q 036879 743 NNLLGKGSFGSVYKGTLSD--------GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRN-LVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 813 (1029)
.+.|+.|....||++...+ +..+++|+.... .....+..|..+++.+...+ ..++++.+.. .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3568888889999998753 578999987432 11245557898888874223 3566776542 3899
Q ss_pred eccCCCC
Q 036879 814 EYMPNGS 820 (1029)
Q Consensus 814 E~~~~gs 820 (1029)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9997643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.27 E-value=0.012 Score=58.65 Aligned_cols=100 Identities=14% Similarity=0.054 Sum_probs=67.6
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCceecc
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQ 898 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 898 (1029)
-+|.+.+...+.++++.+++.++.|.+.+|.-.-..... ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------------
Confidence 389999999999999999999999999998776321111 1223457889999999988763 1110
Q ss_pred ccCCccccCccCCC---CCCcchhHHHHHHHHHhcCCCC
Q 036879 899 TLATIGYMAPEWKL---SRKGDVYSYGIILMETFTKKKP 934 (1029)
Q Consensus 899 ~~gt~~y~aPE~~~---~~~~DvwSlGvil~elltg~~p 934 (1029)
.....+.|||... +.+.=|||+|+++|..+--..|
T Consensus 98 -~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122456888754 5677899999999999885555
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0048 Score=57.10 Aligned_cols=56 Identities=21% Similarity=0.369 Sum_probs=37.5
Q ss_pred EEEccCCcCC-CCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCccc
Q 036879 552 KIDLSRNDLS-GEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS 609 (1029)
Q Consensus 552 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 609 (1029)
.++.+++.++ ..+|..+. .+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666666665 23444332 35777777777777655666777788888888888775
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.21 E-value=0.017 Score=63.39 Aligned_cols=66 Identities=12% Similarity=0.150 Sum_probs=42.9
Q ss_pred CcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCC---CCceEEEEEE------EecCCeEEEEEeccCCC
Q 036879 749 GSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIR---HRNLVKIIST------CSSDHFKALVLEYMPNG 819 (1029)
Q Consensus 749 G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lV~E~~~~g 819 (1029)
|....||+....+| .+++|+...... ..|+++++.+. -|.+++.+.. ....+..++||||++|.
T Consensus 34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 33679999987777 899998765431 35666665552 2224455432 23356788999999887
Q ss_pred CH
Q 036879 820 SL 821 (1029)
Q Consensus 820 sL 821 (1029)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 55
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.14 E-value=0.013 Score=66.91 Aligned_cols=74 Identities=14% Similarity=0.174 Sum_probs=47.8
Q ss_pred CceeccCcceEEEEEEecC-CcEEEEEEeecccchhhHHHHHHHHHHhcCCCCce-EEEEEEEecCCeEEEEEeccCCCC
Q 036879 743 NNLLGKGSFGSVYKGTLSD-GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNL-VKIISTCSSDHFKALVLEYMPNGS 820 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gs 820 (1029)
.+.|+.|-...+|+....+ +..+++|+....... .-.-.+|..+++.+...++ .++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3568888889999998764 578889987433211 1122588999888854444 56777763 2 25999998754
Q ss_pred H
Q 036879 821 L 821 (1029)
Q Consensus 821 L 821 (1029)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.10 E-value=0.0061 Score=67.97 Aligned_cols=72 Identities=10% Similarity=0.241 Sum_probs=43.5
Q ss_pred ceeccCcceEEEEEEecC---------CcEEEEEEeecccchhhHHHHHHHHHHhcCCCCc-eEEEEEEEecCCeEEEEE
Q 036879 744 NLLGKGSFGSVYKGTLSD---------GMQIAVKVFNLELEGTLRSFDAECEILGSIRHRN-LVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 813 (1029)
+.++.|....+|+....+ +..+++|+...... .......|.++++.+...+ +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457788888999998653 26888888754322 1123467888888774323 44666554 2 26899
Q ss_pred eccCCCC
Q 036879 814 EYMPNGS 820 (1029)
Q Consensus 814 E~~~~gs 820 (1029)
||++|.+
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.07 E-value=0.11 Score=58.42 Aligned_cols=73 Identities=11% Similarity=0.230 Sum_probs=47.4
Q ss_pred ceeccCcceEEEEEEecC--------CcEEEEEEeecccchhhHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEEEEEe
Q 036879 744 NLLGKGSFGSVYKGTLSD--------GMQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 814 (1029)
+.+..|-...+|+....+ +..+++|+..... ...-...+|.++++.+. +.-..++++.+. -+.|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 457778888999998753 5789999864332 22223467888888874 322445555442 268999
Q ss_pred ccCCCCH
Q 036879 815 YMPNGSL 821 (1029)
Q Consensus 815 ~~~~gsL 821 (1029)
|++|.++
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9988653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.24 E-value=0.39 Score=53.76 Aligned_cols=30 Identities=37% Similarity=0.406 Sum_probs=25.4
Q ss_pred CcEEcCCCCCCEEE------CCCCcEEEEccCCcee
Q 036879 858 PIIHCDLNPSNILL------NESMVACLSDFGISKL 887 (1029)
Q Consensus 858 givH~Dlk~~Nill------~~~~~~kl~Dfg~a~~ 887 (1029)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567899999998753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1029 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-28 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-07 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 5e-61
Identities = 69/282 (24%), Positives = 130/282 (46%), Gaps = 31/282 (10%)
Query: 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIIS 801
+G GSFG+VYKG +AVK+ N+ L++F E +L RH N++ +
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIH 861
++ A+V ++ SL + ++ F++++ +++ A ++YLH IIH
Sbjct: 72 YSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIH 127
Query: 862 CDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA-TIGYMAPEW-------KLS 913
DL +NI L+E + + DFG++ + + Q + L+ +I +MAPE S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 914 RKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYL 973
+ DVY++GI+L E T + P + + +II +V L +
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNI-------------NNRDQIIFMVGRGYLSPD--LS 232
Query: 974 TAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015
+ C ++ L +C ++ +ER + L + + +L
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (492), Expect = 6e-56
Identities = 72/305 (23%), Positives = 135/305 (44%), Gaps = 44/305 (14%)
Query: 729 SYQELFRATDGFSEN---------NLLGKGSFGSVYKGTL----SDGMQIAVKVFNLEL- 774
++++ A F++ ++G G FG V G L + +A+K
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 775 EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDI 834
E R F +E I+G H N++ + + ++ E+M NGSL++++ + F +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127
Query: 835 LQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894
+Q + M+ +A+ ++YL + +H DL NIL+N ++V +SDFG+S+ L D+TS
Sbjct: 128 IQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 895 TQTQT----LATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLK 946
+ I + APE K + DV+SYGI++ E + +
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW--------- 235
Query: 947 SRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT 1006
D + +IN ++ +D L C S++ L + C ++ R + +
Sbjct: 236 ----DMTNQDVINAIE------QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 1007 KLLKI 1011
L K+
Sbjct: 286 TLDKM 290
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-55
Identities = 67/276 (24%), Positives = 112/276 (40%), Gaps = 27/276 (9%)
Query: 740 FSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKI 799
+ LG G FG V G +A+K+ F E +++ ++ H LV++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQL 64
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
C+ ++ EYM NG L N++ F Q L M DV A+EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 121
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRK 915
+H DL N L+N+ V +SDFG+S+ + D+ + + + + PE K S K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 916 GDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTA 975
D++++G+++ E ++ K E N I + L
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYE---------RFTNSETAEHI----------AQGLRLYR 222
Query: 976 KEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011
V ++ C E A+ER K L+ +L +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-54
Identities = 59/276 (21%), Positives = 117/276 (42%), Gaps = 29/276 (10%)
Query: 738 DGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLV 797
+ LG G FG V+ G + ++AVK + +F AE ++ ++H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNR-SFDILQRLNMVIDVASALEYLHYDHP 856
++ + + + ++ EYM NGSL +++ + I + L+M +A + ++ +
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KL 912
IH DL +NIL+++++ ++DFG+++L+ D + I + APE
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 913 SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972
+ K DV+S+GI+L E T + ++ +
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGM-------------------TNPEVIQNLERGYR 228
Query: 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008
+ + C + L C +E E+R + L
Sbjct: 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-54
Identities = 66/279 (23%), Positives = 116/279 (41%), Gaps = 27/279 (9%)
Query: 740 FSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKI 799
+ +G G FG V+ G + ++A+K F E E++ + H LV++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQL 65
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
C LV E+M +G L +++ + F L M +DV + Y +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEEACV 122
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRK 915
IH DL N L+ E+ V +SDFG+++ + D+ + T T + + +PE + S K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 916 GDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTA 975
DV+S+G+++ E F++ K E +R N + I L
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYE---------NRSNSEVVEDI----------STGFRLYK 223
Query: 976 KEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014
+ V + C +E E+R L +L +I +
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 4e-54
Identities = 62/302 (20%), Positives = 119/302 (39%), Gaps = 34/302 (11%)
Query: 731 QELFRATDGFS-ENNLLGKGSFGSVYKGTL---SDGMQIAVKVFNLEL-EGTLRSFDAEC 785
++LF D + LG G+FGSV +G + +A+KV + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 786 EILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVA 845
+I+ + + +V++I C ++ LV+E G L ++ K + ++ V+
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 846 SALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG--DETSMTQTQTLATI 903
++YL +H DL N+LL A +SDFG+SK LG D ++ +
Sbjct: 120 MGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 904 GYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959
+ APE K S + DV+SYG+ + E + + +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK---PYKKM----------------K 217
Query: 960 VVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNI 1019
++ ++ + +C + +L C E+R + ++ +L + +
Sbjct: 218 GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
Query: 1020 EN 1021
E
Sbjct: 278 EG 279
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-52
Identities = 68/276 (24%), Positives = 127/276 (46%), Gaps = 29/276 (10%)
Query: 738 DGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLV 797
+ LG+G FG V+ GT + ++A+K +F E +++ +RH LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDIL-QRLNMVIDVASALEYLHYDHP 856
++ + S + +V EYM GSL +++ + + L Q ++M +AS + Y+ +
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KL 912
+H DL +NIL+ E++V ++DFG+++L+ D + I + APE +
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 913 SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972
+ K DV+S+GI+L E TK + ++ ++++ V +
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYP-------------GMVNREVLDQV------ERGYR 232
Query: 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008
+ +C S+ L QC R+ EER + L
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-52
Identities = 65/299 (21%), Positives = 109/299 (36%), Gaps = 35/299 (11%)
Query: 736 ATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRH 793
D F + + LG G+ G V+K + G+ +A K+ +LE+ E ++L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 794 RNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHY 853
+V SD ++ +E+M GSL+ + R + I V L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE 122
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW--- 910
H I+H D+ PSNIL+N L DFG+S L D + + T YM+PE
Sbjct: 123 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQG 177
Query: 911 -KLSRKGDVYSYGIILMETFTKKKP-----------------------TDELFVGEISLK 946
S + D++S G+ L+E + P T
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 947 SRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
S + ++ + E +C ++ ER ++K+ +
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-51
Identities = 75/276 (27%), Positives = 126/276 (45%), Gaps = 35/276 (12%)
Query: 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
+GKG FG V G G ++AVK ++ + T ++F AE ++ +RH NLV+++
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 804 SSDHFK-ALVLEYMPNGSLENWMYNKNRS-FDILQRLNMVIDVASALEYLHYDHPTPIIH 861
+ +V EYM GSL +++ ++ RS L +DV A+EYL + +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 126
Query: 862 CDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGD 917
DL N+L++E VA +SDFG++K S TQ + + APE K S K D
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 918 VYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKE 977
V+S+GI+L E ++ + I + D+ ++ + A +
Sbjct: 183 VWSFGILLWEIYSFGRVPYP-------------------RIPLKDVVPRVEKGYKMDAPD 223
Query: 978 QCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013
C +V + C A R + + +L I+
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-51
Identities = 75/329 (22%), Positives = 134/329 (40%), Gaps = 40/329 (12%)
Query: 714 QIDEEMSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSD----GMQIAVKV 769
++ E+ V I L N ++G+G FG VY GTL D + AVK
Sbjct: 8 ALNPELVQAVQHVVIGPSSLI-----VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62
Query: 770 FNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA-LVLEYMPNGSLENWMYN 827
N G + F E I+ H N++ ++ C +VL YM +G L N++ N
Sbjct: 63 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 122
Query: 828 KNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887
+ + + + + VA + + +H DL N +L+E ++DFG+++
Sbjct: 123 ETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 179
Query: 888 LGDE---TSMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFV 940
+ D+ + +T + +MA E K + K DV+S+G++L E T+ P
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-- 237
Query: 941 GEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERIN 1000
+N DI + + L E C + + ++C AE R +
Sbjct: 238 -----------------VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPS 280
Query: 1001 IKEALTKLLKIRNTLLTNIENSSDKRYCN 1029
E ++++ I +T + + Y N
Sbjct: 281 FSELVSRISAIFSTFIGEHYVHVNATYVN 309
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 5e-51
Identities = 60/291 (20%), Positives = 116/291 (39%), Gaps = 27/291 (9%)
Query: 746 LGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS 805
+GKG FG V++G G ++AVK+F+ E + +AE +RH N++ I+ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 806 DHFKA----LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLH-----YDHP 856
D+ LV +Y +GSL +++ + + + + + AS L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQT---LATIGYMAPEW--- 910
I H DL NIL+ ++ C++D G++ T + T YMAPE
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 911 -------KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN-DSLHGKIINVVD 962
+ ++ D+Y+ G++ E + ++ V D ++ VV
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013
L+ + + + + +C + R+ L ++
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (454), Expect = 6e-51
Identities = 70/313 (22%), Positives = 130/313 (41%), Gaps = 35/313 (11%)
Query: 719 MSPEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGTLSD-GMQIAVKVFNLELEGT 777
M P +Y + + + LG G +G VY+G + +AVK +
Sbjct: 2 MDP----SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TME 56
Query: 778 LRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNR-SFDILQ 836
+ F E ++ I+H NLV+++ C+ + ++ E+M G+L +++ NR +
Sbjct: 57 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 116
Query: 837 RLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896
L M ++SA+EYL IH DL N L+ E+ + ++DFG+S+L+ +T
Sbjct: 117 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173
Query: 897 TQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS 952
I + APE K S K DV+++G++L E T
Sbjct: 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------------GI 220
Query: 953 LHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012
++ +++ +D + E C V L C + + +R + E +
Sbjct: 221 DLSQVYELLE------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
Query: 1013 NTLLTNIENSSDK 1025
++I + +K
Sbjct: 275 QE--SSISDEVEK 285
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-50
Identities = 64/278 (23%), Positives = 114/278 (41%), Gaps = 35/278 (12%)
Query: 742 ENNLLGKGSFGSVYKGTLSD---GMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNL 796
E+ LG G+FG+V KG +AVK+ E AE ++ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHP 856
V++I C ++ + LV+E G L ++ +NR + +V V+ ++YL +
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESN- 127
Query: 857 TPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA--TIGYMAPEW---- 910
+H DL N+LL A +SDFG+SK L + + + QT + + APE
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 911 KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970
K S K DV+S+G+++ E F+ + + G ++ + ++
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQK---PYRGM----------------KGSEVTAMLEKG 226
Query: 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008
+ C + L C E R +L
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-50
Identities = 59/285 (20%), Positives = 110/285 (38%), Gaps = 36/285 (12%)
Query: 735 RATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSI 791
RA D + +G GS+G K SDG + K + E + +E +L +
Sbjct: 2 RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 792 RHRNLVKIISTC--SSDHFKALVLEYMPNGSLENWMYNKNRS---FDILQRLNMVIDVAS 846
+H N+V+ ++ +V+EY G L + + + D L ++ +
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 847 ALEYLHY--DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIG 904
AL+ H D ++H DL P+N+ L+ L DFG++++L +TS + T
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPY 179
Query: 905 YMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960
YM+PE + K D++S G +L E P F +
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF----------------SQ 219
Query: 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
++ +E + + + + + R +++E L
Sbjct: 220 KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-50
Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 34/284 (11%)
Query: 740 FSENNLLGKGSFGSVYKGTLSDG-----MQIAVKVFNLEL-EGTLRSFDAECEILGSIRH 793
+ ++G G FG VYKG L + +A+K E F E I+G H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 794 RNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHY 853
N++++ S ++ EYM NG+L+ ++ K+ F +LQ + M+ +A+ + Y
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG---MKY 125
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA--TIGYMAPEW- 910
+H DL NIL+N ++V +SDFG+S++L D+ T T + I + APE
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 911 ---KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967
K + DV+S+GI++ E T + + + +++ ++
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYW-------------ELSNHEVMKAIN----- 227
Query: 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011
+ L C S++ L MQC ++ R + ++ L K+
Sbjct: 228 -DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 8e-50
Identities = 68/272 (25%), Positives = 105/272 (38%), Gaps = 32/272 (11%)
Query: 744 NLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIIST 802
LG G+FG VYK + A KV + + E L + E +IL S H N+VK++
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
++ +++E+ G+++ M R Q + AL YLH + IIH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHR 134
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW---------KLS 913
DL NIL L+DFG+S + T +MAPE
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYD 193
Query: 914 RKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYL 973
K DV+S GI L+E + P EL + LK + + E L
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRVLLK------------------IAKSEPPTL 235
Query: 974 TAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
+ S+ +C ++ + R + L
Sbjct: 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 5e-49
Identities = 64/274 (23%), Positives = 118/274 (43%), Gaps = 34/274 (12%)
Query: 743 NNLLGKGSFGSVYKGTLSD-GMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKI 799
+ +G+GSF +VYKG ++ +++A + + F E E+L ++H N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 800 I----STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH 855
ST LV E M +G+L+ ++ + + I + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 856 PTPIIHCDLNPSNILLN-ESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW---K 911
P PIIH DL NI + + + D G++ L + + T +MAPE K
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEEK 188
Query: 912 LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971
DVY++G+ ++E T + P E + ++ ++ + V K
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSE---------CQNAAQIYRRVTSGVKPASFDKV-- 237
Query: 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
+ V + C R++ +ER +IK+ L
Sbjct: 238 -------AIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (433), Expect = 8e-48
Identities = 56/280 (20%), Positives = 101/280 (36%), Gaps = 39/280 (13%)
Query: 737 TDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIR 792
FS+ +G GSFG+VY + + +A+K + + E L +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLH 852
H N ++ +H LV+EY + + +K ++ + L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132
Query: 853 YDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW-- 910
+ +IH D+ NILL+E + L DFG + ++ S T +MAPE
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 184
Query: 911 -----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965
+ K DV+S GI +E +K P + +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------------LYH 225
Query: 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
+ + ++ + C ++ ++R + L
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 9e-47
Identities = 56/276 (20%), Positives = 109/276 (39%), Gaps = 32/276 (11%)
Query: 745 LLGKGSFGSVYKGTLSD----GMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKI 799
+G+G FG V++G + +A+K + F E + H ++VK+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
I + ++ +++E G L +++ + S D+ + +++AL YL
Sbjct: 74 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---F 129
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRK 915
+H D+ N+L++ + L DFG+S+ + D T ++ I +MAPE + +
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 916 GDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTA 975
DV+ +G+ + E + N+ + G+I N L
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQ---------GVKNNDVIGRIEN----------GERLPM 230
Query: 976 KEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011
C ++ SL +C R E +L I
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-46
Identities = 67/281 (23%), Positives = 108/281 (38%), Gaps = 37/281 (13%)
Query: 746 LGKGSFGSVYKGTL----SDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVK 798
LG GSFG V +G + +AVK ++ + F E + S+ HRNL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 799 IISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP 858
+ + K +V E P GSL + + F + + VA + YL
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--- 131
Query: 859 IIHCDLNPSNILLNESMVACLSDFGISKLL--GDETSMTQTQTLATIGYMAPEW----KL 912
IH DL N+LL + + DFG+ + L D+ + Q + APE
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 913 SRKGDVYSYGIILMETFTKKK-PTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971
S D + +G+ L E FT + P L +I ++ + KE
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-------------------LHKIDKEGE 232
Query: 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012
L E C + ++ +QC E+R LL+ +
Sbjct: 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-46
Identities = 61/306 (19%), Positives = 124/306 (40%), Gaps = 35/306 (11%)
Query: 732 ELFRATDGFSENNLLGKGSFGSVYKGTLSD-----GMQIAVKVFNLEL-EGTLRSFDAEC 785
+ + T+ F + +LG G+FG+VYKG + +A+K + E
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 786 EILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVA 845
++ S+ + ++ +++ C + + L+ + MP G L +++ + LN + +A
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 846 SALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG-DETSMTQTQTLATIG 904
+ YL ++H DL N+L+ ++DFG++KLLG +E I
Sbjct: 122 KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 905 YMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960
+MA E + + DV+SYG+ + E T + +I ++
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-------------GIPASEISSI 225
Query: 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIE 1020
+ ++ L C V + ++C A+ R +E + + K+ +
Sbjct: 226 L------EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 279
Query: 1021 NSSDKR 1026
D+R
Sbjct: 280 IQGDER 285
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-46
Identities = 57/276 (20%), Positives = 105/276 (38%), Gaps = 30/276 (10%)
Query: 738 DGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLE-LEGTLRSFDAECEILGSIRHRN 795
+ + LG+G++G V +AVK+ +++ + E I + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH 855
+VK + + L LEY G L + + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA-TIGYMAPEWKL-- 912
I H D+ P N+LL+E +SDFG++ + + T+ Y+APE
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 913 ---SRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969
+ DV+S GI+L + P D + + + +++
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWD------------------QPSDSCQEYSDWKEK 222
Query: 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
YL ++ S+ L+L + E+ RI I +
Sbjct: 223 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 258
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-46
Identities = 59/267 (22%), Positives = 108/267 (40%), Gaps = 29/267 (10%)
Query: 744 NLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIIST 802
+G+G+ G+VY ++ G ++A++ NL+ + E ++ ++ N+V + +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862
+V+EY+ GSL + + Q + + ALE+LH + +IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHSNQ---VIHR 140
Query: 863 DLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGDV 918
D+ NILL L+DFG + E S + + T +MAPE K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 919 YSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQ 978
+S GI+ +E + P ++ E L+ + L E+
Sbjct: 200 WSLGIMAIEMIEGEPP----YLNENPLR--------------ALYLIATNGTPELQNPEK 241
Query: 979 CVSSVLSLAMQCTRESAEERINIKEAL 1005
+ +C E+R + KE L
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELL 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 5e-46
Identities = 59/318 (18%), Positives = 113/318 (35%), Gaps = 57/318 (17%)
Query: 729 SYQELFRATDGFSENNLLGKGSFGSVYKGTL------SDGMQIAVKVFNLEL-EGTLRSF 781
L + +G+G+FG V++ +AVK+ E F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 782 DAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRS---------- 831
E ++ + N+VK++ C+ L+ EYM G L ++ + +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 832 -------------FDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVAC 878
++L + VA+ + YL +H DL N L+ E+MV
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 879 LSDFGISKLLGDETSMTQTQTLA-TIGYMAPE----WKLSRKGDVYSYGIILMETFTKKK 933
++DFG+S+ + A I +M PE + + + DV++YG++L E F+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 934 PTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRE 993
+ G ++ ++ L E C + +L C +
Sbjct: 241 QP---YYGM----------------AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSK 281
Query: 994 SAEERINIKEALTKLLKI 1011
+R + L ++
Sbjct: 282 LPADRPSFCSIHRILQRM 299
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-45
Identities = 65/276 (23%), Positives = 106/276 (38%), Gaps = 36/276 (13%)
Query: 738 DGFSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFN---LELEGTLRSFDAECEILGSIRH 793
+ F LGKG FG+VY +A+KV LE G E EI +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 794 RNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHY 853
N++++ L+LEY P G++ + K FD + + ++A+AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHS 124
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE---- 909
+IH D+ P N+LL + ++DFG S T T+ Y+ PE
Sbjct: 125 KR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG---TLDYLPPEMIEG 178
Query: 910 WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969
K D++S G++ E K P ++ + +I V
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPP----------FEANTYQETYKRISRVE-------- 220
Query: 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
T + L + + + +R ++E L
Sbjct: 221 ---FTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-45
Identities = 69/316 (21%), Positives = 122/316 (38%), Gaps = 48/316 (15%)
Query: 738 DGFSENNLLGKGSFGSVYKGTLSDG---MQIAVKVFNLEL-EGTLRSFDAECEILGSI-R 792
+ +++G+G+FG V K + M A+K + R F E E+L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKN---------------RSFDILQR 837
H N++ ++ C + L +EY P+G+L +++ + Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 838 LNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897
L+ DVA ++YL IH DL NIL+ E+ VA ++DFG+S+ T
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 898 QTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL 953
+ + +MA E + DV+SYG++L E + + G
Sbjct: 187 RL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---YCGM----------- 230
Query: 954 HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013
++ + L C V L QC RE ER + + L L ++
Sbjct: 231 -----TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
Query: 1014 TLLTNIENSSDKRYCN 1029
T + + +++
Sbjct: 286 ERKTYVNTTLYEKFTY 301
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-45
Identities = 69/280 (24%), Positives = 109/280 (38%), Gaps = 34/280 (12%)
Query: 735 RATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL---EGTLRSFDAECEILGS 790
+ + F +LG+GSF +V L+ + A+K+ E + E +++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 791 IRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEY 850
+ H VK+ T D L Y NG L ++ K SFD ++ SALEY
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEY 123
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLA-TIGYMAPE 909
LH IIH DL P NILLNE M ++DFG +K+L E+ + + T Y++PE
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 910 W----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965
+ D+++ G I+ + P F + KII
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGN------EYLIFQKIIK------ 224
Query: 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
E+ L + A +R+ +E
Sbjct: 225 -----LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 163 bits (413), Expect = 9e-45
Identities = 56/268 (20%), Positives = 103/268 (38%), Gaps = 29/268 (10%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
LG G+FG V++ T + G A K E + E + + +RH LV +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
D+ ++ E+M G L + +++ + + + V L ++H ++ +H D
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 149
Query: 864 LNPSNILLN--ESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGD 917
L P NI+ S L DFG++ L + S+ T T + APE + D
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTD 207
Query: 918 VYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKE 977
++S G++ + P F GE +D + + D N+ + ++
Sbjct: 208 MWSVGVLSYILLSGLSP----FGGEN------DDETLRNVKS-CDWNMDDSAFSGIS--- 253
Query: 978 QCVSSVLSLAMQCTRESAEERINIKEAL 1005
+ R+ I +AL
Sbjct: 254 ---EDGKDFIRKLLLADPNTRMTIHQAL 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 6e-44
Identities = 63/306 (20%), Positives = 113/306 (36%), Gaps = 51/306 (16%)
Query: 738 DGFSENNLLGKGSFGSVYKGTL------SDGMQIAVKVFNLE-LEGTLRSFDAECEILGS 790
+ S LG G+FG V + T M +AVK+ + +E ++L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 791 I-RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRS-----------------F 832
+ H N+V ++ C+ ++ EY G L N++ K S
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 833 DILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL-GDE 891
D+ L+ VA + +L + IH DL NILL + + DFG+++ + D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 892 TSMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKS 947
+ + + +MAPE + + DV+SYGI L E F+
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP---------- 249
Query: 948 RVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007
+ K ++ KE + + E + + + C +R K+ +
Sbjct: 250 --GMPVDSKFYKMI------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 1008 LLKIRN 1013
+ K +
Sbjct: 302 IEKQIS 307
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-43
Identities = 56/299 (18%), Positives = 106/299 (35%), Gaps = 56/299 (18%)
Query: 745 LLGKGSFGSVYKGTLSD------GMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNL 796
+LG G+FG V T +Q+AVK+ + + +E +++ + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 797 VKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSF----------------------DI 834
V ++ C+ L+ EY G L N++ +K F
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 835 LQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL-GDETS 893
L VA +E+L + +H DL N+L+ V + DFG+++ + D
Sbjct: 164 EDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 894 MTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV 949
+ + + +MAPE + K DV+SYGI+L E F+
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP------------ 268
Query: 950 NDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008
+ ++ + + + + C + +R + + L
Sbjct: 269 GIPVDANFYKLI------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 159 bits (403), Expect = 2e-43
Identities = 51/268 (19%), Positives = 105/268 (39%), Gaps = 29/268 (10%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
LG G+FG V++ + G K N + E I+ + H L+ +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
+ L+LE++ G L + + ++ + +N + L+++H I+H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLD 152
Query: 864 LNPSNILL--NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRKGD 917
+ P NI+ ++ + DFG++ L + + T T + APE + D
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA--TAEFAAPEIVDREPVGFYTD 210
Query: 918 VYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKE 977
+++ G++ + P F GE L++ + NV + EDA+ +
Sbjct: 211 MWAIGVLGYVLLSGLSP----FAGEDDLET---------LQNVKRCDWEFDEDAFSSVSP 257
Query: 978 QCVSSVLSLAMQCTRESAEERINIKEAL 1005
+ ++ +R+ + +AL
Sbjct: 258 EAK----DFIKNLLQKEPRKRLTVHDAL 281
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 64/304 (21%), Positives = 119/304 (39%), Gaps = 52/304 (17%)
Query: 738 DGFSENNLLGKGSFGSVYKGTL--------SDGMQIAVKVFNLEL-EGTLRSFDAECEIL 788
D LG+G+FG V + ++AVK+ + E L +E E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 789 GSI-RHRNLVKIISTCSSDHFKALVLEYMPNGSLENWM---------------YNKNRSF 832
I +H+N++ ++ C+ D +++EY G+L ++ +N
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 833 DILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892
++ VA +EYL IH DL N+L+ E V ++DFG+++ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 893 SMTQTQTLA-TIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKS 947
+T + +MAPE + + DV+S+G++L E FT + G
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGV----- 241
Query: 948 RVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007
V ++ L KE + C + + + C +R K+ +
Sbjct: 242 -----------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 1008 LLKI 1011
L +I
Sbjct: 291 LDRI 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 1e-40
Identities = 58/282 (20%), Positives = 105/282 (37%), Gaps = 26/282 (9%)
Query: 730 YQELFRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLE-LEGTLRSFDAECEI 787
+++ D + ++LG G+F V +A+K + LEG S + E +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 788 LGSIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASA 847
L I+H N+V + S L+++ + G L + + K + ++ V A
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDA 119
Query: 848 LEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMA 907
++YLH N L+E +SDFG+SK+ + + + T GY+A
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGTPGYVA 177
Query: 908 PEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963
PE S+ D +S G+I P F E + L +I+
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPP----FYDE------NDAKLFEQILK---- 223
Query: 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
+ + + S + E+R ++AL
Sbjct: 224 ---AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 6e-40
Identities = 54/293 (18%), Positives = 118/293 (40%), Gaps = 43/293 (14%)
Query: 740 FSENNLLGKGSFGSVYKGTL------SDGMQIAVKVFNLE-LEGTLRSFDAECEILGSIR 792
+ + LG+GSFG VY+G ++A+K N F E ++
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRS---------FDILQRLNMVID 843
++V+++ S +++E M G L++++ + + + + + M +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 844 VASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD-ETSMTQTQTLAT 902
+A + YL+ + +H DL N ++ E + DFG+++ + + + + L
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 903 IGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKII 958
+ +M+PE + DV+S+G++L E T + + S +
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ------------GLSNEQVLR 246
Query: 959 NVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011
V++ LL K D C + L C + + + R + E ++ + +
Sbjct: 247 FVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 146 bits (369), Expect = 1e-39
Identities = 58/289 (20%), Positives = 112/289 (38%), Gaps = 44/289 (15%)
Query: 738 DGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNL---------ELEGTLRSFDAECEI 787
+ + +LG+G V + + AVK+ ++ E++ + E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 788 LGSIR-HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVAS 846
L + H N++++ T ++ F LV + M G L +++ + + + ++ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121
Query: 847 ALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYM 906
+ LH + I+H DL P NILL++ M L+DFG S L + + T Y+
Sbjct: 122 VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG--TPSYL 176
Query: 907 APEW----------KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGK 956
APE ++ D++S G+I+ P F L +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHR-------KQMLMLR 225
Query: 957 IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
+I + E + +V L + ++R +EAL
Sbjct: 226 MIMSGNYQFGSPEWDDYS------DTVKDLVSRFLVVQPQKRYTAEEAL 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-39
Identities = 55/309 (17%), Positives = 116/309 (37%), Gaps = 39/309 (12%)
Query: 731 QELFRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILG 789
+EL+ + + LG+G FG V++ S K ++ + E IL
Sbjct: 1 KELY---EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILN 56
Query: 790 SIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALE 849
RHRN++ + + S ++ E++ + + + + ++ V V AL+
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 850 YLHYDHPTPIIHCDLNPSNILL--NESMVACLSDFGISKLLGDETSMTQTQTLATIGYMA 907
+LH + I H D+ P NI+ S + +FG ++ L + T Y A
Sbjct: 117 FLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYA 171
Query: 908 PEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963
PE +S D++S G ++ + P F+ E N + I+N +
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINP----FLAET------NQQIIENIMN-AEY 220
Query: 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT------KLLKIRNTLLT 1017
++ ++ + + + + R+ EAL K+ ++ ++
Sbjct: 221 TFDEEAFKEIS------IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIR 274
Query: 1018 NIENSSDKR 1026
+++
Sbjct: 275 TLKHRRYYH 283
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-39
Identities = 56/295 (18%), Positives = 119/295 (40%), Gaps = 24/295 (8%)
Query: 732 ELFRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFN-LELEGTLRSFDAECEILG 789
++F ++ + +G+G++G V + +++A+K + E + + E +IL
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 790 SIRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYN--KNRSFDILQRLNMVIDVASA 847
RH N++ I + + + Y+ + +Y K + + +
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 848 LEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE--TSMTQTQTLATIGY 905
L+Y+H + ++H DL PSN+LLN + + DFG++++ + + T+ +AT Y
Sbjct: 122 LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 906 MAPE-----WKLSRKGDVYSYGIILMETFTKKKP-----TDELFVGEISLKSRVNDSLHG 955
APE ++ D++S G IL E + + + + + +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 956 KIINVVDINLLQKEDAYLTAKEQCVSSVLS-----LAMQCTRESAEERINIKEAL 1005
IIN+ N L + L + + +RI +++AL
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 144 bits (364), Expect = 4e-39
Identities = 62/292 (21%), Positives = 124/292 (42%), Gaps = 36/292 (12%)
Query: 737 TDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIR 792
+D + +LG G V+ L +AVKV +L F E + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 793 HRNLVKIISTCSSDHFKA----LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASAL 848
H +V + T ++ +V+EY+ +L + ++ + + + ++ D AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE-TSMTQTQTLA-TIGYM 906
+ H + IIH D+ P+NI+++ + + DFGI++ + D S+TQT + T Y+
Sbjct: 125 NFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 907 APEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962
+PE + + DVYS G +L E T + P F G+ ++V
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD-------------SPVSVAY 224
Query: 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-NIKEALTKLLKIRN 1013
++ + E + + ++ ++ ++ E R E L+++ N
Sbjct: 225 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (362), Expect = 1e-38
Identities = 61/277 (22%), Positives = 113/277 (40%), Gaps = 20/277 (7%)
Query: 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIIS 801
+G+G++G VYK + G A+K LE EG + E IL ++H N+VK+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 802 TCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIH 861
+ LV E++ + L+ + + + + ++ + + + Y H ++H
Sbjct: 68 VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLH 123
Query: 862 CDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW-----KLSRKG 916
DL P N+L+N ++DFG+++ G + T+ Y AP+ K S
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKKYSTTI 182
Query: 917 DVYSYGIILMETFTKKKP------TDELF-VGEISLKSRVNDSLHGKIINVVDINLLQKE 969
D++S G I E D+L + I + + + D N E
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 970 DAYLTAKEQCVS-SVLSLAMQCTRESAEERINIKEAL 1005
+ + + S + L + + +RI K+AL
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-38
Identities = 61/280 (21%), Positives = 105/280 (37%), Gaps = 23/280 (8%)
Query: 744 NLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL-----EGTLRSFDAECEILGSIRHRNLV 797
+ LG+G F +VYK + +A+K L +G R+ E ++L + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 798 KIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPT 857
++ +LV ++M + + + ++ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 858 PIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPE-----WKL 912
I+H DL P+N+LL+E+ V L+DFG++K G T + T Y APE
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMY 178
Query: 913 SRKGDVYSYGIILMETFTKKKP------TDELFVGEISLKSRVNDSLHGKIINVVDINLL 966
D+++ G IL E + D+L +L + + +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 967 QKEDAYLTAKEQCVSS-VLSLAMQCTRESAEERINIKEAL 1005
L +L L + RI +AL
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (354), Expect = 2e-37
Identities = 50/286 (17%), Positives = 109/286 (38%), Gaps = 35/286 (12%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
+G GSFG +Y GT ++ G ++A+K+ ++ + E +I ++ + I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
++ +++ + SLE+ +R F + L + + S +EY+H + IH D
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 128
Query: 864 LNPSNILLNES---MVACLSDFGISKLLGDETSMTQ------TQTLATIGYMAPE----W 910
+ P N L+ + + DFG++K D + T Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 911 KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970
+ SR+ D+ S G +LM +G + + + K + + + +
Sbjct: 189 EQSRRDDLESLGYVLM----------YFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 971 AYLTAKEQCVSSVLSLAMQCTRESAEERIN---IKEALTKLLKIRN 1013
+ S + C +++ + +++ L +
Sbjct: 239 VL---CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 140 bits (355), Expect = 2e-37
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 744 NLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKI 799
LG GSFG V+ +G A+KV E+ + + E +L + H ++++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 800 ISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPI 859
T ++++Y+ G L + + R + + + A L Y H I
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA----AEVCLALEYLHSKDI 125
Query: 860 IHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW----KLSRK 915
I+ DL P NILL+++ ++DFG +K + D T Y+APE ++
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 916 GDVYSYGIILMETFTKKKP 934
D +S+GI++ E P
Sbjct: 182 IDWWSFGILIYEMLAGYTP 200
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-36
Identities = 57/303 (18%), Positives = 107/303 (35%), Gaps = 50/303 (16%)
Query: 738 DGFSENNLLGKGSFGSVYKGT------LSDGMQIAVKVFNLE-LEGTLRSFDAECEILGS 790
D LG+G+FG V + + +AVK+ R+ +E +IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 791 IRHRNLVKII--STCSSDHFKALVLEYMPNGSLENWMYNKNRSF---------------D 833
I H V + + +++E+ G+L ++ +K F
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 834 ILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893
+ + VA +E+L IH DL NILL+E V + DFG+++ + +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 894 MTQTQTLA-TIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSR 948
+ + +MAPE + + DV+S+G++L E F+
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----------- 238
Query: 949 VNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008
+ + + KE + A + + + C +R E + L
Sbjct: 239 -GVKIDEEFCRRL------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 1009 LKI 1011
+
Sbjct: 292 GNL 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 139 bits (352), Expect = 2e-36
Identities = 51/252 (20%), Positives = 105/252 (41%), Gaps = 28/252 (11%)
Query: 738 DGFSENNLLGKGSFGSVYKGTLSD-GMQIAVKVFNL------ELEGTLRSFDAECEILGS 790
+ FS + ++G+G FG VY +D G A+K + + E + ++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 791 IRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEY 850
+V + + + +L+ M G L + +++ F ++ LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 122
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW 910
+H +++ DL P+NILL+E +SD G++ + ++ T GYMAPE
Sbjct: 123 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEV 176
Query: 911 -----KLSRKGDVYSYGIILMETFTKKKPTD--------ELFVGEISLKSRVNDSLHGKI 957
D +S G +L + P E+ +++ + DS ++
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236
Query: 958 INVVDINLLQKE 969
++++ LLQ++
Sbjct: 237 RSLLE-GLLQRD 247
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-36
Identities = 55/277 (19%), Positives = 107/277 (38%), Gaps = 35/277 (12%)
Query: 738 DGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL---EGTLRSFDAECEILG-SIR 792
+ F + +LGKGSFG V+ A+K ++ + + E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 793 HRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLH 852
H L + T + V+EY+ G L + + ++ FD+ + ++ L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120
Query: 853 YDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW-- 910
I++ DL NILL++ ++DFG+ K + T Y+APE
Sbjct: 121 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILL 176
Query: 911 --KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968
K + D +S+G++L E + P F G+ + ++ +
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQ----------------DEEELFHSIR 216
Query: 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
D L ++ E+R+ ++ +
Sbjct: 217 MDNP-FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 54/279 (19%), Positives = 89/279 (31%), Gaps = 54/279 (19%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL------EGTLRSFDAECEILGSIR--HRN 795
LLG G FGSVY G +SD + +A+K + E +L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 796 LVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH 855
+++++ L+LE + + + V A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 128
Query: 856 PTPIIHCDLNPSNILLNES-MVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW---- 910
++H D+ NIL++ + L DFG LL D T Y PEW
Sbjct: 129 -CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWIRYH 184
Query: 911 -KLSRKGDVYSYGIILMETFTKKKP---TDELFVGEISLKSRVNDSLHGKIINVVDINLL 966
R V+S GI+L + P +E+ G++ + RV+
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ------------ 232
Query: 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
L C +R +E
Sbjct: 233 ------------------HLIRWCLALRPSDRPTFEEIQ 253
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 7e-36
Identities = 54/279 (19%), Positives = 110/279 (39%), Gaps = 22/279 (7%)
Query: 744 NLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKII 800
+G+G++G+V+K +A+K L+ EG S E +L ++H+N+V++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 801 STCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPII 860
SD LV E+ + + + + + L+ L + H ++
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL----FQLLKGLGFCHSRNVL 123
Query: 861 HCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL-----SRK 915
H DL P N+L+N + L++FG+++ G + + T+ Y P+ S
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 916 GDVYSYGIILMETFTKKKP------TDELFVGEISLKSRVNDSLHGKIINVVDIN---LL 966
D++S G I E +P D+ L + + + D +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
+ + + ++ L + + +RI+ +EAL
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 8e-36
Identities = 61/284 (21%), Positives = 109/284 (38%), Gaps = 20/284 (7%)
Query: 738 DGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHR 794
+ F + +G+G++G VYK G +A+K L+ EG + E +L + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 795 NLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD 854
N+VK++ +++ LV E++ + + + + + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 855 HPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW---- 910
++H DL P N+L+N L+DFG+++ G T + T+ Y APE
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGC 177
Query: 911 -KLSRKGDVYSYGIILMETFTKKKP------TDELF--VGEISLKSRVNDSLHGKIINVV 961
S D++S G I E T++ D+LF + V + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
+ SL Q +RI+ K AL
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 8e-36
Identities = 56/283 (19%), Positives = 106/283 (37%), Gaps = 38/283 (13%)
Query: 738 DGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL------EGTLRSFDAECEILGS 790
D + LG G F V K S G+Q A K + + E IL
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 791 IRHRNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEY 850
I+H N++ + + L+LE + G L +++ K + + L
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL----KQILNG 125
Query: 851 LHYDHPTPIIHCDLNPSNILLNESMVA----CLSDFGISKLLGDETSMTQTQTLATIGYM 906
++Y H I H DL P NI+L + V + DFG++ + T ++
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFV 183
Query: 907 APEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962
APE L + D++S G+I + P F+G+ ++ N ++ V+
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLAN-------VSAVN 232
Query: 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
+ + + + + + ++R+ I+++L
Sbjct: 233 YEFEDEYFSNTS------ALAKDFIRRLLVKDPKKRMTIQDSL 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 9e-36
Identities = 58/293 (19%), Positives = 112/293 (38%), Gaps = 27/293 (9%)
Query: 735 RATDGFSENNLLGKGSFGSVYKGT--LSDGMQIAVKVFNLEL--EGTLRSFDAECEI--- 787
RA + +G+G++G V+K + G +A+K ++ EG S E +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 788 LGSIRHRNLVKIISTCSSDHFKA-----LVLEYMPNGSLENWMYNKNRSFDILQRLNMVI 842
L + H N+V++ C+ LV E++ +M+
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 843 DVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLAT 902
+ L++LH ++H DL P NIL+ S L+DFG++++ + ++T T
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--T 178
Query: 903 IGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTD-----ELFVGEISLKSRVNDSL 953
+ Y APE + D++S G I E F +K + + + +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 954 HGKIINVVDINLLQKEDAYLTAKEQCVSS-VLSLAMQCTRESAEERINIKEAL 1005
+ + + K + + L ++C + +RI+ AL
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-35
Identities = 59/289 (20%), Positives = 112/289 (38%), Gaps = 32/289 (11%)
Query: 740 FSENNLLGKGSFGSVYKGTL-SDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVK 798
+++ ++G GSFG VY+ L G +A+K + R + E +I+ + H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77
Query: 799 IISTCSS------DHFKALVLEYMPNGSLENWMY--NKNRSFDILQRLNMVIDVASALEY 850
+ S + + LVL+Y+P + ++ ++ + + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 851 LHYDHPTPIIHCDLNPSNILLN-ESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAP- 908
+H I H D+ P N+LL+ ++ V L DFG +K L + Y AP
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPE 192
Query: 909 ----EWKLSRKGDVYSYGIILMETFTKKKP------TDELFVGEISLKSRVNDSLHGKII 958
+ DV+S G +L E + D+L L + + +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 959 NVVDINLLQKEDAYLTAKEQCVSS--VLSLAMQCTRESAEERINIKEAL 1005
N + Q + T + + ++L + + R+ EA
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 1e-34
Identities = 60/292 (20%), Positives = 123/292 (42%), Gaps = 34/292 (11%)
Query: 744 NLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKII 800
+G+G+FG V+K G ++A+K +E EG + E +IL ++H N+V +I
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 801 STCSSDHFKA--------LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLH 852
C + LV ++ + + F + + ++ + + L Y+H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIH 134
Query: 853 YDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS---MTQTQTLATIGYMAPE 909
+ I+H D+ +N+L+ V L+DFG+++ + T + T+ Y PE
Sbjct: 135 RNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 910 WKLSRKG-----DVYSYGIILMETFTKKKP-TDELFVGEISLKSRVNDSLHGKIINVVDI 963
L + D++ G I+ E +T+ +++L S++ S+ ++ VD
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 964 NLLQKEDAYLTAKEQCVSSVLS----------LAMQCTRESAEERINIKEAL 1005
L ++ + +++ V L L + +RI+ +AL
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-34
Identities = 53/275 (19%), Positives = 105/275 (38%), Gaps = 37/275 (13%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSI-RHRNLVKIIST 802
+LG G G V + + A+K+ E E+ + ++V+I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 803 CSSDHFKA----LVLEYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPT 857
+ + +V+E + G L + + ++ +++F + ++ + A++YLH +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 858 PIIHCDLNPSNILLN---ESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW---- 910
I H D+ P N+L + + L+DFG +K S+T T Y+APE
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPE 188
Query: 911 KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970
K + D++S G+I+ P IS + I + E
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------TRIRMGQYEFPNPEW 241
Query: 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
+ ++ V L + +R+ I E +
Sbjct: 242 SEVS------EEVKMLIRNLLKTEPTQRMTITEFM 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (325), Expect = 9e-34
Identities = 41/289 (14%), Positives = 95/289 (32%), Gaps = 37/289 (12%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
+G+GSFG +++GT L + Q+A+K + E + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 804 SSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCD 863
+ +++ + SLE+ + R F + + + ++ +H +++ D
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 126
Query: 864 LNPSNILLNESM-----VACLSDFGISKLLGDETS------MTQTQTLATIGYMAPE--- 909
+ P N L+ + + DFG+ K D + + T YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 910 -WKLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968
+ SR+ D+ + G + M G + + + K + +
Sbjct: 187 GREQSRRDDLEALGHVFM----------YFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236
Query: 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERIN---IKEALTKLLKIRNT 1014
+ + + ++ +K+L+ NT
Sbjct: 237 LRELC---AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 4e-32
Identities = 59/305 (19%), Positives = 107/305 (35%), Gaps = 38/305 (12%)
Query: 729 SYQELFRATDGFSEN----NLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL--EGTLRSF 781
QE+ + +G G++G+V G ++A+K E +
Sbjct: 5 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA 64
Query: 782 DAECEILGSIRHRNLVKIISTCSSDHFKA------LVLEYMPNGSLENWMYNKNRSFDIL 835
E +L +RH N++ ++ + D LV+ +M + K+
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGED 121
Query: 836 QRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895
+ +V + L Y+H IH DL P N+ +NE + DFG+++ E +
Sbjct: 122 RIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 178
Query: 896 QTQTLATIGYMAPEW-----KLSRKGDVYSYGIILMETFTKKKP---------TDELFVG 941
Y APE + ++ D++S G I+ E T K E+
Sbjct: 179 VVTR----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234
Query: 942 EISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSS-VLSLAMQCTRESAEERIN 1000
+ + L L + E + S ++L + AE+R+
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294
Query: 1001 IKEAL 1005
EAL
Sbjct: 295 AGEAL 299
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 19/212 (8%)
Query: 738 DGFSENNLLGKGSFGSVYKGTL----SDGMQIAVKVFN----LELEGTLRSFDAECEILG 789
+ F +LG G++G V+ G A+KV ++ T E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 790 SIRHR-NLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASAL 848
IR LV + ++ L+L+Y+ G L + + R + I V +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139
Query: 849 EYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAP 908
L + H II+ D+ NILL+ + L+DFG+SK + + TI YMAP
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 909 EW------KLSRKGDVYSYGIILMETFTKKKP 934
+ + D +S G+++ E T P
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 5e-31
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 13/205 (6%)
Query: 738 DGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRH 793
+ F LLGKG+FG V + G A+K+ E+ + + E +L + RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 794 RNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHY 853
L + + V+EY G L + ++ R F + ++ SAL Y
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSAL---EY 120
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW--- 910
H +++ D+ N++L++ ++DFG+ K + + +T T Y+APE
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLED 179
Query: 911 -KLSRKGDVYSYGIILMETFTKKKP 934
R D + G+++ E + P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 117 bits (293), Expect = 4e-29
Identities = 53/312 (16%), Positives = 120/312 (38%), Gaps = 39/312 (12%)
Query: 721 PEVTWRRISYQELFRATDGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLR 779
P W S+ + D + LG+G + V++ +++ ++ VK+ + +
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---K 74
Query: 780 SFDAECEILGSIR-HRNLVKIISTCSS--DHFKALVLEYMPNGSLENWMYNKNRSFDILQ 836
E +IL ++R N++ + ALV E++ N + ++
Sbjct: 75 KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYD 130
Query: 837 RLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL-NESMVACLSDFGISKLLGDETSMT 895
+ ++ AL+Y H I+H D+ P N+++ +E L D+G+++
Sbjct: 131 IRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186
Query: 896 QTQTLATIGYMAPE-----WKLSRKGDVYSYGIILMETFTKKKP----TDELFVGEISLK 946
+A+ + PE D++S G +L +K+P D K
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245
Query: 947 -----------SRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSS--VLSLAMQCTRE 993
+ N L + +++ + ++ + ++ ++ Q + S L + R
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305
Query: 994 SAEERINIKEAL 1005
+ R+ +EA+
Sbjct: 306 DHQSRLTAREAM 317
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (293), Expect = 5e-29
Identities = 46/205 (22%), Positives = 80/205 (39%), Gaps = 16/205 (7%)
Query: 738 DGFSENNLLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRH 793
D F LG GSFG V G A+K+ + + + E IL ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 794 RNLVKIISTCSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHY 853
LVK+ + + +V+EY+ G + + + R F + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHS 159
Query: 854 DHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEW--- 910
+I+ DL P N+L+++ ++DFG +K T +APE
Sbjct: 160 LD---LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILS 212
Query: 911 -KLSRKGDVYSYGIILMETFTKKKP 934
++ D ++ G+++ E P
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-28
Identities = 57/303 (18%), Positives = 114/303 (37%), Gaps = 36/303 (11%)
Query: 730 YQELFRATDGFSEN----NLLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGT--LRSFD 782
QEL + E + +G G++GSV G+++AVK + + +
Sbjct: 6 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 65
Query: 783 AECEILGSIRHRNLVKIISTCSS-----DHFKALVLEYMPNGSLENWMYNKNRSFDILQR 837
E +L ++H N++ ++ + + ++ ++ L N + K +
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHV 123
Query: 838 LNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQT 897
++ + L+Y+H IIH DL PSN+ +NE + DFG++ T T
Sbjct: 124 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMT 176
Query: 898 QTLATIGYMAPEW-----KLSRKGDVYSYGIILMETFTKKKP---------TDELFVGEI 943
+AT Y APE ++ D++S G I+ E T + +
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 944 SLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSS-VLSLAMQCTRESAEERINIK 1002
+ + + + + +L Q + + L + +++RI
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 1003 EAL 1005
+AL
Sbjct: 297 QAL 299
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 109 bits (273), Expect = 1e-26
Identities = 85/337 (25%), Positives = 134/337 (39%), Gaps = 38/337 (11%)
Query: 5 RDQSALLALKAHVTNDPLNVLASNWSTNTSVCN--WFGVTCSP--RHRRVTALNLAYMGL 60
+D+ ALL +K + N L+S W T CN W GV C + RV L+L+ + L
Sbjct: 6 QDKQALLQIKKDLGNP--TTLSS-WLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSF 120
P +P L+NL L +L N IPP +
Sbjct: 63 PKPYP----------------------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL 100
Query: 121 PKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQ 180
+L +LY+ + G IP + I +L+TLD S+N L G +P SI ++P+L+ I N+
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 181 FSGP-MPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFI 239
SG S + S L + L L + + + +
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRN----RLTGKIPPTFANLNLAFVDLSRNMLEGDASVL 216
Query: 240 GSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLT 299
+ I + K G + L L L +NR+ G +P + + L L+++
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 300 ANNLLGNLPSNIGHSLPNLQQLILGGNR-LTG-PIPS 334
NNL G +P G +L N+ L G P+P+
Sbjct: 277 FNNLCGEIPQ--GGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 91.4 bits (225), Expect = 2e-20
Identities = 72/262 (27%), Positives = 114/262 (43%), Gaps = 7/262 (2%)
Query: 409 LYLSACNIKG--SIPSEIGNLNNLTTLHLETNE-LTGSIPKAIGRLQKLQGLYLQHNKLQ 465
L LS N+ IPS + NL L L++ L G IP AI +L +L LY+ H +
Sbjct: 55 LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114
Query: 466 GSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRD 525
G+I L +++L N L+G+LP + SL +L ++ NR++ IP S +
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS-YGSFS 173
Query: 526 ILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQ 585
L +++ + T + + ++ S +
Sbjct: 174 KLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233
Query: 586 GSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNL 645
+G +LN LD+ +N + G +P L L L LN+SFN L G++P GG
Sbjct: 234 AFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRF 293
Query: 646 SSQSFVGNKGLCGAPELKFPAC 667
++ NK LCG+P PAC
Sbjct: 294 DVSAYANNKCLCGSP---LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 56/283 (19%), Positives = 98/283 (34%), Gaps = 21/283 (7%)
Query: 310 NIGHSLPNLQQLILGGNRLTG--PIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYD 367
+ + L L G L PIPSS++N L + +
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 368 ELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNL 427
++T + + L L S + G++P I +L
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTL---------------VTLDFSYNALSGTLPPSISSL 148
Query: 428 NNLTTLHLETNELTGSIPKAIGRLQKLQG-LYLQHNKLQGSITTDLCGLRSLSEFYSDGN 486
NL + + N ++G+IP + G KL + + N+L G I L S
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM 208
Query: 487 ELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGN 546
L + + +++ ++L +N + GTLP +
Sbjct: 209 LEGD--ASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266
Query: 547 LKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIP 589
LK + +++S N+L GEIP G+L+ + A+NK P
Sbjct: 267 LKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.4 bits (124), Expect = 1e-07
Identities = 16/62 (25%), Positives = 23/62 (37%), Gaps = 2/62 (3%)
Query: 81 NNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPS 140
NN GTLP L+ L+ L L+ NN P + + + N + P
Sbjct: 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE--IPQGGNLQRFDVSAYANNKCLCGSPLP 310
Query: 141 IC 142
C
Sbjct: 311 AC 312
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-25
Identities = 49/295 (16%), Positives = 101/295 (34%), Gaps = 43/295 (14%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIIS 801
+G G+ G V +A+K + + + E ++ + H+N++ +++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 802 TCSSDHFK------ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDH 855
+ LV+E M + + + ++ + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE----RMSYLLYQMLCGIKHLHSAG 139
Query: 856 PTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWKL--- 912
IH DL PSNI++ + DFG+++ G MT T Y APE L
Sbjct: 140 I---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMG 194
Query: 913 -SRKGDVYSYGIILMETFTKKKP---------------------TDELFVGEISLKSRVN 950
D++S G I+ E K + + + ++++ V
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 951 DSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEAL 1005
+ + + A + S L + +RI++ +AL
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (255), Expect = 6e-24
Identities = 40/238 (16%), Positives = 80/238 (33%), Gaps = 29/238 (12%)
Query: 745 LLGKGSFGSVYKGT-LSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTC 803
LG G F +V+ + + +A+K+ + + + + E ++L + + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 804 SSDHFK---------------ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASAL 848
++ K +V E + L ++R ++ + + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 849 EYLHYDHPTPIIHCDLNPSNILLN-ESMVACLSDFGISKLLGDETSMTQTQTLATI-GYM 906
+Y+H IIH D+ P N+L+ L I+ L Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 907 APEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960
+PE D++S ++ E T F + +D +II +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPDEGHSYTKDDDHIAQIIEL 250
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.5 bits (244), Expect = 2e-22
Identities = 86/380 (22%), Positives = 144/380 (37%), Gaps = 44/380 (11%)
Query: 272 LALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGP 331
L +T + ++ +T L + + + L NL Q+ N+LT
Sbjct: 27 TVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEY-LNNLTQINFSNNQLTDI 81
Query: 332 IPSSISNASMLTLIDM---------------------PYNLFSGFIPNSLGFCHPYDELG 370
P + N + L I M +N I +
Sbjct: 82 TP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 139
Query: 371 FLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNL 430
++++ L L + G + L+N + L + K S S + L NL
Sbjct: 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL 199
Query: 431 TTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNG 490
+L N+++ P I L L L N+L+ T L L +L++ N+++
Sbjct: 200 ESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISN 255
Query: 491 SLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVV 550
P L L L L LG N+++++ P L L + N+ L+ N I NLK +
Sbjct: 256 LAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN--QLEDISPISNLKNL 309
Query: 551 TKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSG 610
T + L N++S P + L +Q L A+NK SL LT++N+L N +S
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365
Query: 611 EIPNSLKALSLLKFLNLSFN 630
P L L+ + L L+
Sbjct: 366 LTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.2 bits (243), Expect = 2e-22
Identities = 71/398 (17%), Positives = 154/398 (38%), Gaps = 39/398 (9%)
Query: 70 NLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLD 129
L+ + + + T + ++L ++ L SI+ ++ L +
Sbjct: 20 ALAEKMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGIKSID---GVEYLNNLTQINFS 74
Query: 130 GNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIY 189
N P + N++ L+ + ++ NQ+ P + L N + +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPL---ANLTNLTGLTLFNNQITDIDPLK 129
Query: 190 NTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNI 249
N + L +++ N+++++ S Q S + LK L+
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER---------- 179
Query: 250 TMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPS 309
+ + ++ ++ L+ L ++N+++ + P I+ ++L LSL N L
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IG 235
Query: 310 NIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIP-----NSLGFCH 364
+ SL NL L L N+++ P +S + LT + + N S P
Sbjct: 236 TLA-SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292
Query: 365 PYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEI 424
++L ++ ++N K+L L L N +S + P+ +L+ + L+ + + S +
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISPV--SSLTK-LQRLFFANNKVSD--VSSL 347
Query: 425 GNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHN 462
NL N+ L N+++ P + L ++ L L
Sbjct: 348 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.1 bits (191), Expect = 9e-16
Identities = 76/391 (19%), Positives = 138/391 (35%), Gaps = 53/391 (13%)
Query: 49 RVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPI-QLSNLRRLKYLSFRSNN 107
+VT L +G+ + L+ L+ +N +NN + P+ L+ L + + + +
Sbjct: 45 QVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIAD 102
Query: 108 FSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILN 167
+ + L + D + + +SS D+S +
Sbjct: 103 ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG 162
Query: 168 IPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQ 227
L+N + N ++ + +L L NQ+S P +
Sbjct: 163 NQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI--LTN 220
Query: 228 LKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEI 287
L LSL+ N ++IG + L L L L++N+++ + P +
Sbjct: 221 LDELSLNGNQL-----KDIGTLASLTNLT--------------DLDLANNQISNLAP--L 259
Query: 288 INISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDM 347
++ LT L L AN + P L L L L N+L P S LT + +
Sbjct: 260 SGLTKLTELKLGANQISNISPL---AGLTALTNLELNENQLEDISPISNLK--NLTYLTL 314
Query: 348 PYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMD 407
+N S P +++ L++L + N +S S+ NL+N ++
Sbjct: 315 YFNNISDISP-----------------VSSLTKLQRLFFANNKVSD--VSSLANLTN-IN 354
Query: 408 VLYLSACNIKGSIPSEIGNLNNLTTLHLETN 438
L I P + NL +T L L
Sbjct: 355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 61.6 bits (148), Expect = 2e-10
Identities = 35/160 (21%), Positives = 63/160 (39%), Gaps = 11/160 (6%)
Query: 20 DPLNVLASNWSTNTSVCNWFGVTCSPRHRRVTALNLAYMGLLGTIPPELGNLSFLSLLNV 79
L L + + + + ++T L L + P L L+ L+ L +
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLEL 292
Query: 80 TNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPP 139
N PI NL+ L YL+ NN S I + S KL+ L+ N +
Sbjct: 293 NENQLEDISPIS--NLKNLTYLTLYFNNISDI---SPVSSLTKLQRLFFANNKV--SDVS 345
Query: 140 SICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNN 179
S+ N++++ L NQ+ P + N+ + + L++
Sbjct: 346 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (225), Expect = 9e-21
Identities = 56/256 (21%), Positives = 90/256 (35%), Gaps = 4/256 (1%)
Query: 379 KDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETN 438
+++ L N +S V S N + S + + G +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 439 ELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDS 498
+L P L +L L+L LQ GL +L Y N L
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 499 LISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRN 558
L +L L L NR++SV + L + + L N + P +L + + L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 559 DLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKA 618
+LS ++ L+ +Q+L L DN + + L SS+ + +P L
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLAG 270
Query: 619 LSLLKFLNLSFNGLQG 634
L L+ N LQG
Sbjct: 271 RDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (207), Expect = 3e-18
Identities = 59/286 (20%), Positives = 96/286 (33%), Gaps = 22/286 (7%)
Query: 301 NNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSL 360
L +P I Q++ L GNR++ +S LT++ + N+ + +
Sbjct: 20 QQGLQAVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 361 GFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSI 420
++L L V P + L + L+L C ++
Sbjct: 77 TGLALLEQLDLSD--------------NAQLRSVDPATFHGLGR-LHTLHLDRCGLQELG 121
Query: 421 PSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSE 480
P L L L+L+ N L L L L+L N++ GL SL
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 481 FYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTL 540
N + P L L TL L N L+++ +L LR + + L+ N
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241
Query: 541 PVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQG 586
+ K S +++ +P L LA N QG
Sbjct: 242 RA-RPLWAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (181), Expect = 5e-15
Identities = 54/251 (21%), Positives = 88/251 (35%), Gaps = 5/251 (1%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
C +G ++P I + L N ++ + + L L+L N L
Sbjct: 18 CPQQGLQAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 472 LCGLRSLSEFYSDGNELNGSL-PQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVN 530
GL L + N S+ P L L TL L L + P L + +
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135
Query: 531 LSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPD 590
L N+L +L +T + L N +S + L ++ L L N+ P
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 591 SLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSF 650
+ L L L + +NNLS +L L L++L L+ N + L
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRG 255
Query: 651 VGNKGLCGAPE 661
++ C P+
Sbjct: 256 SSSEVPCSLPQ 266
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.9 bits (177), Expect = 2e-14
Identities = 56/296 (18%), Positives = 98/296 (33%), Gaps = 23/296 (7%)
Query: 267 QGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGN 326
+ + L +P I ++ + L N + ++P+ + NL L L N
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLH-GNRISHVPAASFRACRNLTILWLHSN 66
Query: 327 RLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLIL 386
L ++ + ++L +D+ N + + L L L
Sbjct: 67 VLARIDAAAFTGLALLEQLDLSDNAQLRSVDP--------------ATFHGLGRLHTLHL 112
Query: 387 SENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPK 446
L + A+ LYL ++ +L NLT L L N ++ +
Sbjct: 113 D-RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171
Query: 447 AIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLS 506
A L L L L N++ L L Y N L+ + L L +L+ L
Sbjct: 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231
Query: 507 LGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSG 562
L N + + SS+ + +LP + + L+ NDL G
Sbjct: 232 LNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (171), Expect = 9e-14
Identities = 53/287 (18%), Positives = 93/287 (32%), Gaps = 20/287 (6%)
Query: 27 SNWSTNTSVCNWFGVTCSPRH--RRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSF 84
N T+ C G+ P + L + L++L + +N
Sbjct: 9 YNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL 68
Query: 85 SGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNI 144
+ + L L+ L N P +L L+LD P +
Sbjct: 69 ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128
Query: 145 SSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSL 204
++L L L N LQ + ++ +L + L N+ S + SL
Sbjct: 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH---------SL 179
Query: 205 AELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTG 264
L L N+++ P + +L L L NN + + L+ L L
Sbjct: 180 DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
Query: 265 EIQG------LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLG 305
+ + LQ SS+ + +P ++ + L AN+L G
Sbjct: 240 DCRARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.7 bits (219), Expect = 1e-20
Identities = 25/164 (15%), Positives = 52/164 (31%), Gaps = 26/164 (15%)
Query: 744 NLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL----------EGTLRSFDAECEILGSIRH 793
L+G+G +V+ + VK + + F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 794 RNLVKIISTCSSDHF----KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALE 849
R L K+ + A+++E + L + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEV--------LDMILEEVA 117
Query: 850 YLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893
++ I+H DL+ N+L++E + + DF S +G+E
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGW 157
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.9 bits (224), Expect = 2e-20
Identities = 53/277 (19%), Positives = 104/277 (37%), Gaps = 12/277 (4%)
Query: 379 KDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETN 438
D L L N ++ + NL N + L L I P L L L+L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 439 ELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDS 498
+L K LQ+L+ + K++ S+ L + + E ++ + +G
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQG 148
Query: 499 LISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRN 558
+ L + + +T++ SL ++ +L N + + L + K+ LS N
Sbjct: 149 MKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 559 DLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSG------EI 612
+S S+ + +++ L L +NK +P L + + + +NN+S
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 613 PNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQS 649
P + ++L N +Q F + ++
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.2 bits (212), Expect = 8e-19
Identities = 52/310 (16%), Positives = 106/310 (34%), Gaps = 36/310 (11%)
Query: 36 CNWFGVTCSPRH---------RRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSG 86
C+ V CS L+L + + NL L L + NN S
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 87 TLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISS 146
P + L +L+ L N +P + + ++ + + + + N
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKE--LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 147 LLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAE 206
++ L + + G + + L I +++ + + SL E
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL------------PPSLTE 175
Query: 207 LHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLT--- 263
LHL N+++ ++L L L LS N+ + N L+ L+L L
Sbjct: 176 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 235
Query: 264 ---GEIQGLQVLALSSNRLTGV------IPPEIINISSLTVLSLTANNL-LGNLPSNIGH 313
+ + +QV+ L +N ++ + P +S + +SL +N + + +
Sbjct: 236 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
Query: 314 SLPNLQQLIL 323
+ + L
Sbjct: 296 CVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.7 bits (208), Expect = 2e-18
Identities = 50/263 (19%), Positives = 100/263 (38%), Gaps = 15/263 (5%)
Query: 401 NLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQ 460
+L +L L I + NL NL TL L N+++ P A L KL+ LYL
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 461 HNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSL 520
N+L+ L+ L ++ ++ S+ L+ +I + L + + + +
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAF 146
Query: 521 WSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLA 580
++ + + ++ ++ + G +T++ L N ++ +S+ L N+ L L+
Sbjct: 147 QGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203
Query: 581 DNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGG 640
N SL L L +++N L ++P L ++ + L N
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN---------- 252
Query: 641 PFTNLSSQSFVGNKGLCGAPELK 663
+ + S F
Sbjct: 253 NISAIGSNDFCPPGYNTKKASYS 275
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.1 bits (178), Expect = 2e-14
Identities = 54/285 (18%), Positives = 102/285 (35%), Gaps = 27/285 (9%)
Query: 112 EIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSL 171
++P L P L L N N+ +L TL L N++ P + + L
Sbjct: 24 KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 172 LAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKIL 231
+ LS NQ + L ++ + + L + + L
Sbjct: 82 ERLYLSKNQLKELPEKMP---------KTLQELRVHENEITKVRKSVFNGLNQMIVV-EL 131
Query: 232 SLSVNNFIGSIPREIGNITMLKGLYLVYTNLT----GEIQGLQVLALSSNRLTGVIPPEI 287
+ G + L + + TN+T G L L L N++T V +
Sbjct: 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASL 191
Query: 288 INISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDM 347
+++L L L+ N++ ++ ++ P+L++L L N+L +P +++ + ++ +
Sbjct: 192 KGLNNLAKLGLSFNSISAVDNGSLANT-PHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249
Query: 348 PYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLS 392
N S N FC P T + L NP+
Sbjct: 250 HNNNISAIGSND--FCPP-------GYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.1 bits (126), Expect = 7e-08
Identities = 27/133 (20%), Positives = 43/133 (32%), Gaps = 3/133 (2%)
Query: 529 VNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI 588
V S L +P ++ +DL N ++ +LKN+ L L +NK
Sbjct: 15 VQCSDLGLE-KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 589 PDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQ 648
P + L L L +S N L K L L+ ++ V +G +
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL 131
Query: 649 SFVGNKGLCGAPE 661
K
Sbjct: 132 GTNPLKSSGIENG 144
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (152), Expect = 2e-11
Identities = 45/197 (22%), Positives = 77/197 (39%), Gaps = 8/197 (4%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
C+ + ++P ++ + T LHL N L + +L L L + +
Sbjct: 17 CDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA--ELTKLQV 72
Query: 472 LCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNL 531
L L N+L +L +L L + FNRLTS+ +L L ++ + L
Sbjct: 73 DGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131
Query: 532 SSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDS 591
N L P + + K+ L+ N+L+ + L+N+ L L +N +IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 592 LGGLTSLNFLDMSSNNL 608
G L F + N
Sbjct: 191 FFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.8 bits (125), Expect = 6e-08
Identities = 35/211 (16%), Positives = 67/211 (31%), Gaps = 10/211 (4%)
Query: 118 DSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLS 177
+ D + +PP + L LS N L ++++ L ++L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 178 NNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNN 237
+ + + L + S +L T+ + ++ SL +
Sbjct: 64 RAE----LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 238 FIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLS 297
G + + + L L L+ L+L++N LT + + + +L L
Sbjct: 120 LRGLGELQELYLKGNELKTL-PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 298 LTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
L N L +P L L GN
Sbjct: 179 L-QENSLYTIPKGFF-GSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 8e-08
Identities = 45/229 (19%), Positives = 72/229 (31%), Gaps = 26/229 (11%)
Query: 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRL 328
+L LS N L ++ + LT L+L + +LP L L L N+L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE---LTKLQVDGTLPVLGTLDLSHNQL 89
Query: 329 TGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSE 388
+ ++ L L S + G + L
Sbjct: 90 QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT----------- 138
Query: 389 NPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAI 448
LP + + ++ L L+ N+ + L NL TL L+ N L +IPK
Sbjct: 139 ------LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191
Query: 449 GRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLD 497
L +L N + C + + D E Q +D
Sbjct: 192 FGSHLLPFAFLHGNPWLCN-----CEILYFRRWLQDNAENVYVWKQGVD 235
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 34/197 (17%), Positives = 64/197 (32%), Gaps = 16/197 (8%)
Query: 61 LGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSF 120
L +PP+L ++L+++ N L RL L+ + +++ L
Sbjct: 22 LTALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVL 79
Query: 121 PKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQ 180
L+ + S D+SFN+L ++ + L + L N+
Sbjct: 80 GTLDLSHNQLQSLPLLGQTLPALTVL----DVSFNRLTSLPLGALRGLGELQELYLKGNE 135
Query: 181 FSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIG 240
P + +P N L+ L + L L L N+
Sbjct: 136 LKTLPPGLLTPTPKLEKLSLA---------NNNLTELPAGLLNGLENLDTLLLQENSLY- 185
Query: 241 SIPREIGNITMLKGLYL 257
+IP+ +L +L
Sbjct: 186 TIPKGFFGSHLLPFAFL 202
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 47/226 (20%), Positives = 71/226 (31%), Gaps = 38/226 (16%)
Query: 93 SNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDL 152
S + ++ N +++ PP L L+L N ++ + L L+L
Sbjct: 7 SKVASHLEVNCDKRNLTAL--PPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 153 SFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAEL----- 207
+L L P L +DLS+NQ L +D+ +N L L
Sbjct: 63 DRAELTKLQVDGTL--PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 208 ---------HLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLV 258
+L N+L P L +L+ LSL+ NN + + L L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL- 179
Query: 259 YTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLL 304
N L IP L L N L
Sbjct: 180 ----------------QENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 11/65 (16%), Positives = 27/65 (41%), Gaps = 3/65 (4%)
Query: 543 EIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLD 602
E+ + +++ + +L+ +P + K+ L L++N +L T L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 603 MSSNN 607
+
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 2e-04
Identities = 40/236 (16%), Positives = 69/236 (29%), Gaps = 32/236 (13%)
Query: 423 EIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFY 482
E+ + + ++ + LT ++P + + L+L N L L L++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 483 -SDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLP 541
+ L L +L L + + ++
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS------------- 108
Query: 542 VEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFL 601
N L+ ++ L +Q L L N+ + P L L L
Sbjct: 109 ---------------FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153
Query: 602 DMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLC 657
+++NNL+ L L L L L N L L GN LC
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 9e-04
Identities = 17/71 (23%), Positives = 21/71 (29%), Gaps = 1/71 (1%)
Query: 88 LPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSL 147
LP L +NN + L+ L+ L L NS TIP L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
Query: 148 LTLDLSFNQLQ 158
L N
Sbjct: 198 PFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 0.001
Identities = 15/67 (22%), Positives = 24/67 (35%), Gaps = 7/67 (10%)
Query: 81 NNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPS 140
NN+ + L+ L L L + N+ +I P L +L GN ++
Sbjct: 157 NNNLTELPAGLLNGLENLDTLLLQENSLYTI--PKGFFGSHLLPFAFLHGNPWLCN---- 210
Query: 141 ICNISSL 147
C I
Sbjct: 211 -CEILYF 216
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 37/235 (15%), Positives = 59/235 (25%), Gaps = 31/235 (13%)
Query: 160 HVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIP 219
H + + S L ++ T+ ++ LHL+ N L
Sbjct: 1 HPICEVSKVASHLEVNCDKRNL---------TALPPDLP---KDTTILHLSENLLYTFSL 48
Query: 220 STLFECKQLKILSLSVNNFIGSIPREI---GNITMLKGLYLVYTNLTGEIQGLQVLALSS 276
+TL +L L+L L L L G+ + S
Sbjct: 49 ATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS 108
Query: 277 NRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSI 336
+P + N L LP + P L++L L N LT +
Sbjct: 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLL 168
Query: 337 SNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPL 391
+ L + + N L L NP
Sbjct: 169 NGLENLDTLLLQENSLYTIPK----------------GFFGSHLLPFAFLHGNPW 207
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.2 bits (131), Expect = 2e-08
Identities = 51/340 (15%), Positives = 107/340 (31%), Gaps = 28/340 (8%)
Query: 291 SSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYN 350
L L L S++ P+L+ L+ N LT +P + L + + N
Sbjct: 38 RQAHELELNNLGL-----SSLPELPPHLESLVASCNSLT-ELPELPQS---LKSLLVDNN 88
Query: 351 LFSGF--IPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDV 408
+P L + + K+I +N +
Sbjct: 89 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDN------NSLKKLPDLPPSL 142
Query: 409 LYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSI 468
+++A N + E+ NL LT ++ + N L + + G + +
Sbjct: 143 EFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQN 202
Query: 469 TTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISL--RTLSLGFNRLTSVIPSSLWSLRDI 526
L + + + +L SL L V + L ++
Sbjct: 203 LPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSEL 262
Query: 527 LNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQG 586
N+ + + + ++++S N L E+P+ ++ L + N
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA- 317
Query: 587 SIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLN 626
+P+ L L + N L E P+ +++ L+ +
Sbjct: 318 EVPELPQNLKQ---LHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 60/326 (18%), Positives = 103/326 (31%), Gaps = 16/326 (4%)
Query: 202 NSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTN 261
EL L LS +P L+ L S N + +P ++ L
Sbjct: 38 RQAHELELNNLGLS-SLPELP---PHLESLVAS-CNSLTELPELPQSLKSLLVDNNNLKA 92
Query: 262 LTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQL 321
L+ L+ L +S+N+L + + + + + + L +LP ++ QL
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 322 ILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDL 381
P ++I + L I EL L LT
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 382 RKLILSENPLSGVLPISIGNLSNAMDVLYL-SACNIKGSIPSEIGNLNNLTTLHLETNEL 440
L+ + L L + D+ L + + L+ L N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 441 TGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLI 500
+ I L+ L + +NKL + L L + N L +P+
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQ--- 324
Query: 501 SLRTLSLGFNRLTSV--IPSSLWSLR 524
+L+ L + +N L IP S+ LR
Sbjct: 325 NLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 2e-06
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 10/91 (10%)
Query: 81 NNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPS 140
N+ S + L+ L+ +N + P+LE L N + +P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIELP-----ALPPRLERLIASFNH-LAEVPEL 322
Query: 141 ICNISSLLTLDLSFNQLQGHVPSSILNIPSL 171
+L L + +N L+ P ++ L
Sbjct: 323 ---PQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 31/155 (20%), Positives = 52/155 (33%), Gaps = 8/155 (5%)
Query: 142 CNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQY 201
LT + N L +P ++ +L D S+ +NI
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259
Query: 202 NSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTN 261
+ L N S +I S L+ L++S NN + +P L+ L + +
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVS-NNKLIELPALPPR---LERLIASFNH 315
Query: 262 LT---GEIQGLQVLALSSNRLTGVIPPEIINISSL 293
L Q L+ L + N L P ++ L
Sbjct: 316 LAEVPELPQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 3e-05
Identities = 53/324 (16%), Positives = 94/324 (29%), Gaps = 24/324 (7%)
Query: 48 RRVTALNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNN 107
R+ L L +GL ++P +L L + NS + LP +L+ L +
Sbjct: 38 RQAHELELNNLGL-SSLPELPPHLESLVA---SCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 108 FSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILN 167
S + + L + + +SL L L+ +
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 168 IPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPS------- 220
+L + P + ++ L +P
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 221 -TLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRL 279
L + SL N + ++ + V N+ + L N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 280 TGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNA 339
+ I SL L+++ N L + P L++LI N L +P N
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKL-----IELPALPPRLERLIASFNHLAE-VPELPQN- 325
Query: 340 SMLTLIDMPYNLFSGF--IPNSLG 361
L + + YN F IP S+
Sbjct: 326 --LKQLHVEYNPLREFPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 4e-05
Identities = 21/80 (26%), Positives = 37/80 (46%), Gaps = 8/80 (10%)
Query: 555 LSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPN 614
N S EI S +++ L++++NK +P L L S N+L+ E+P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPE 321
Query: 615 SLKALSLLKFLNLSFNGLQG 634
+ LK L++ +N L+
Sbjct: 322 LPQN---LKQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 22/106 (20%), Positives = 37/106 (34%), Gaps = 18/106 (16%)
Query: 125 HLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGP 184
N+ I SL L++S N+L +P+ P L + S N
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNH---- 315
Query: 185 MPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKI 230
L + +L +LH+ YN L + P + L++
Sbjct: 316 ---------LAEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 2e-04
Identities = 50/343 (14%), Positives = 92/343 (26%), Gaps = 39/343 (11%)
Query: 96 RRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFN 155
R+ L + SS+ + P LE L NS + +P ++ SLL + +
Sbjct: 38 RQAHELELNNLGLSSLP-----ELPPHLESLVASCNS-LTELPELPQSLKSLLVDNNNLK 91
Query: 156 QLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTS--------PLQNIDMQYNSLAEL 207
L P S ++ + I + L +
Sbjct: 92 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151
Query: 208 HLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQ 267
+L T + L NI LT
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211
Query: 268 GLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNR 327
+L + + + + + L + ++ NI L L + N
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271
Query: 328 LTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILS 387
+ I S L +++ N +P L +LI S
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP------------------RLERLIAS 312
Query: 388 ENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNL 430
N L+ +P NL L++ ++ P ++ +L
Sbjct: 313 FNHLAE-VPELPQNLK----QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 16/92 (17%), Positives = 32/92 (34%), Gaps = 10/92 (10%)
Query: 550 VTKIDLSRNDLSGE-IPSSIGDLKNMQHLSLADNKFQG----SIPDSLGGLTSLNFLDMS 604
+ +D+ +LS + L+ Q + L D I +L +L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 605 SNNLSGEIPNSL-----KALSLLKFLNLSFNG 631
SN L + + ++ L+L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 16/114 (14%), Positives = 36/114 (31%), Gaps = 9/114 (7%)
Query: 98 LKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSF----IGTIPPSICNISSLLTLDLS 153
++ L + S L + + + LD I ++ +L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 154 FNQLQGHVPSSIL-----NIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYN 202
N+L +L + + L N +G + +++ +Q
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 117
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 16/87 (18%), Positives = 34/87 (39%), Gaps = 9/87 (10%)
Query: 546 NLKVVTKIDLSRNDLSGE----IPSSIGDLKNMQHLSLADNKFQGSIPDSLGG-----LT 596
V+ + L+ D+S + +++ +++ L L++N + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 597 SLNFLDMSSNNLSGEIPNSLKALSLLK 623
L L + S E+ + L+AL K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 19/91 (20%), Positives = 32/91 (35%), Gaps = 4/91 (4%)
Query: 380 DLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKG----SIPSEIGNLNNLTTLHL 435
D++ L + LS + L V+ L C + I S + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 436 ETNELTGSIPKAIGRLQKLQGLYLQHNKLQG 466
+NEL + + + +Q LQ
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 17/111 (15%), Positives = 34/111 (30%), Gaps = 21/111 (18%)
Query: 429 NLTTLHLETNELTGS-IPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNE 487
++ +L ++ EL+ + + + LQ+ Q + L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL--------------------TEA 42
Query: 488 LNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNG 538
+ L +L L+L N L V + + + SL
Sbjct: 43 RCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 15/75 (20%), Positives = 26/75 (34%), Gaps = 4/75 (5%)
Query: 269 LQVLALSSNRLTGVIPPEII-NISSLTVLSLTANNLLGNLPSNIGHSL---PNLQQLILG 324
+Q L + L+ E++ + V+ L L +I +L P L +L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 325 GNRLTGPIPSSISNA 339
N L +
Sbjct: 64 SNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 6e-05
Identities = 13/68 (19%), Positives = 25/68 (36%), Gaps = 5/68 (7%)
Query: 573 NMQHLSLADNKFQGS-IPDSLGGLTSLNFLDMSSNNLSGE----IPNSLKALSLLKFLNL 627
++Q L + + + + L L + + L+ I ++L+ L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 628 SFNGLQGQ 635
N L
Sbjct: 63 RSNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 18/75 (24%), Positives = 28/75 (37%), Gaps = 9/75 (12%)
Query: 572 KNMQHLSLADNKFQG----SIPDSLGGLTSLNFLDMSSNNLSGEIPNSL-----KALSLL 622
++ L LAD S+ +L SL LD+S+N L L + LL
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 623 KFLNLSFNGLQGQVP 637
+ L L ++
Sbjct: 429 EQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 10/85 (11%), Positives = 27/85 (31%), Gaps = 5/85 (5%)
Query: 500 ISLRTLSLGFNRLTSVIPSSLWS-LRDILNVNLSSNSLNG----TLPVEIGNLKVVTKID 554
+ +++L + L+ + L L+ V L L + + + +++
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 555 LSRNDLSGEIPSSIGDLKNMQHLSL 579
L N+L + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 19/101 (18%), Positives = 32/101 (31%), Gaps = 14/101 (13%)
Query: 116 WLDSFPKLEHLYLDGNSF----IGTIPPSICNISSLLTLDLSFNQLQGHVPSSIL----- 166
L L+L ++ ++ SL LDLS N L ++
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 167 NIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAEL 207
L + L + +S M LQ ++ SL +
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDR-----LQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 18/94 (19%), Positives = 33/94 (35%), Gaps = 13/94 (13%)
Query: 426 NLNNLTTLHLETNELTG----SIPKAIGRLQKLQGLYLQHNKLQGSITTDLC-GLRS--- 477
+ L L L +++ S+ + L+ L L +N L + L +R
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 478 -LSEFYSDGNELNGSLPQCLDSLI----SLRTLS 506
L + + + L +L SLR +S
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 16/94 (17%), Positives = 36/94 (38%), Gaps = 10/94 (10%)
Query: 495 CLDSLISLRTLSLGFNRLT----SVIPSSLWSLRDILNVNLSSNSLNGTLPVEIG----- 545
LR L L ++ S + ++L + + ++LS+N L +++
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 546 NLKVVTKIDLSRNDLSGEIPSSIGDL-KNMQHLS 578
++ ++ L S E+ + L K+ L
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 5e-04
Identities = 20/90 (22%), Positives = 32/90 (35%), Gaps = 10/90 (11%)
Query: 201 YNSLAELHLAYNQLSGQ----IPSTLFECKQLKILSLSVNNFIGSIPREIG-----NITM 251
+ L L LA +S + +TL L+ L LS N + ++ +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 252 LKGLYLVYTNLTGEI-QGLQVLALSSNRLT 280
L+ L L + E+ LQ L L
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 15/99 (15%), Positives = 35/99 (35%), Gaps = 11/99 (11%)
Query: 146 SLLTLDLSFNQLQGHVPSSIL-NIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSL 204
+ +LD+ +L + +L + + L + + + + +L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA-----RCKDISSALRVNPAL 57
Query: 205 AELHLAYNQLSGQIPSTLFE-----CKQLKILSLSVNNF 238
AEL+L N+L + + +++ LSL
Sbjct: 58 AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 11/86 (12%), Positives = 19/86 (22%), Gaps = 8/86 (9%)
Query: 91 QLSNLRRLKYLSFRSNNFSSI---EIPPWLDSFPKLEHLYLDGNSFIGTIPPSIC----- 142
L+ L + S + L + L L L N +
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 143 NISSLLTLDLSFNQLQGHVPSSILNI 168
L L L + + +
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 11/74 (14%), Positives = 23/74 (31%), Gaps = 4/74 (5%)
Query: 292 SLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTG----PIPSSISNASMLTLIDM 347
+ L + L + + L Q + L LT I S++ L +++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 348 PYNLFSGFIPNSLG 361
N + +
Sbjct: 63 RSNELGDVGVHCVL 76
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 15/80 (18%), Positives = 32/80 (40%), Gaps = 8/80 (10%)
Query: 289 NISSLTVLSLTANNLLGNLPSNIGHSL---PNLQQLILGGNRLTGPIPSSISNA-----S 340
S L VL L ++ + S++ +L +L++L L N L + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 341 MLTLIDMPYNLFSGFIPNSL 360
+L + + +S + + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 16/103 (15%), Positives = 27/103 (26%), Gaps = 15/103 (14%)
Query: 166 LNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQ----IPST 221
L+I SL D+ + S + + + L L+ I S
Sbjct: 2 LDIQSL---DIQCEELSD--------ARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA 50
Query: 222 LFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTG 264
L L L+L N + + +L
Sbjct: 51 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 29/125 (23%), Positives = 50/125 (40%), Gaps = 6/125 (4%)
Query: 503 RTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSG 562
R L L LT L L + +++LS N L P + L+ + + S N
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--L 55
Query: 563 EIPSSIGDLKNMQHLSLADNKFQG-SIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSL 621
E + +L +Q L L +N+ Q + L L L++ N+L E + +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 622 LKFLN 626
L ++
Sbjct: 116 LPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 7e-05
Identities = 31/121 (25%), Positives = 48/121 (39%), Gaps = 7/121 (5%)
Query: 408 VLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGS 467
VL+L+ ++ ++ + L +T L L N L P A+ L+ L+ L N L+
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE-- 56
Query: 468 ITTDLCGLRSLSEFYSDGNELNG-SLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDI 526
+ L L E N L + Q L S L L+L N L L ++
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
Query: 527 L 527
L
Sbjct: 116 L 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 1e-04
Identities = 24/124 (19%), Positives = 50/124 (40%), Gaps = 8/124 (6%)
Query: 99 KYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQ 158
+ L + + + L+ + HL L N + +PP++ + L L +
Sbjct: 1 RVLHLAHKDLTVL---CHLEQLLLVTHLDLSHNR-LRALPPALAALRCLEVLQ--ASDNA 54
Query: 159 GHVPSSILNIPSLLAIDLSNNQFSG--PMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSG 216
+ N+P L + L NN+ + + + L +++Q NSL + +L+
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 217 QIPS 220
+PS
Sbjct: 115 MLPS 118
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 1e-04
Identities = 28/125 (22%), Positives = 46/125 (36%), Gaps = 31/125 (24%)
Query: 53 LNLAYMGLLGTIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRL-------------- 98
L+LA+ L T+ L L ++ L++++N P L+ LR L
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 99 --------KYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGN------SFIGTIPPSICNI 144
+ L +N L S P+L L L GN + + ++
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
Query: 145 SSLLT 149
SS+LT
Sbjct: 120 SSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.1 bits (93), Expect = 2e-04
Identities = 27/107 (25%), Positives = 41/107 (38%), Gaps = 8/107 (7%)
Query: 530 NLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI- 588
+L+ L T+ + L +VT +DLS N L P+ L ++ L +
Sbjct: 4 HLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNALEN 57
Query: 589 PDSLGGLTSLNFLDMSSNNL-SGEIPNSLKALSLLKFLNLSFNGLQG 634
D + L L L + +N L L + L LNL N L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 3e-04
Identities = 22/106 (20%), Positives = 38/106 (35%), Gaps = 6/106 (5%)
Query: 229 KILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLA----LSSNRLTGVIP 284
++L L+ + ++ + + ++ L L + L L L L ++
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 285 PEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTG 330
+ N+ L L L N L + S P L L L GN L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 4e-04
Identities = 23/127 (18%), Positives = 46/127 (36%), Gaps = 14/127 (11%)
Query: 126 LYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPM 185
L+L T+ + + + LDLS N+L+ P+ L L + +++ +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA--LAALRCLEVLQASDNALENV 58
Query: 186 PSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPRE 245
+ N LQ + + N L + L C +L +L+L N +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQS---------AAIQPLVSCPRLVLLNLQ-GNSLCQEEGI 108
Query: 246 IGNITML 252
+ +
Sbjct: 109 QERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.003
Identities = 20/108 (18%), Positives = 34/108 (31%), Gaps = 12/108 (11%)
Query: 295 VLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSG 354
VL L +L + ++ L + L L NRL P +++ L ++ N
Sbjct: 2 VLHLAHKDL--TVLCHLEQ-LLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 355 FIPNSLGFCHPY--------DELGFLTSLTNCKDLRKLILSENPLSGV 394
+ + + L +C L L L N L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 37/219 (16%), Positives = 74/219 (33%), Gaps = 20/219 (9%)
Query: 241 SIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTA 300
++P I I L +T + ++S+ +
Sbjct: 9 TVPTPIKQIFSDDAF-----------AETIKDNLKKKSVTDAVTQN--ELNSIDQIIANN 55
Query: 301 NNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSL 360
+++ I + LPN+ +L L GN+LT P + +D + +
Sbjct: 56 SDIKS--VQGIQY-LPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLK 112
Query: 361 GFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSI 420
E ++ + L +L + + I++ + +D L L I +
Sbjct: 113 KLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV 172
Query: 421 PSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYL 459
P + L L L+L N ++ +A+ L+ L L L
Sbjct: 173 P--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 2e-05
Identities = 29/205 (14%), Positives = 64/205 (31%), Gaps = 17/205 (8%)
Query: 401 NLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQ 460
+ + L ++ ++ LN++ + +++ + I L + L+L
Sbjct: 22 AFAETIK-DNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLN 76
Query: 461 HNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSL 520
NKL + L + D L L S +
Sbjct: 77 GNKLTDIKP---------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI 127
Query: 521 WSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLA 580
L + + N + + + ++ +I + L +Q+L L+
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLS 186
Query: 581 DNKFQGSIPDSLGGLTSLNFLDMSS 605
N +L GL +L+ L++ S
Sbjct: 187 KNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 39/225 (17%), Positives = 78/225 (34%), Gaps = 24/225 (10%)
Query: 410 YLSACNIKGSIPSEIG------NLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNK 463
L + I ++P+ I +L+ +T ++ + L + + ++
Sbjct: 2 PLGSETI--TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSD 57
Query: 464 LQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSL 523
++ + L ++++ + +GN+L L L S
Sbjct: 58 IKS--VQGIQYLPNVTKLFLNGNKLTDI--------KPLANLKNLGWLFLDENKVKDLSS 107
Query: 524 RDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNK 583
L S + + + G + + L + + + L + LSL DN+
Sbjct: 108 LKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQ 167
Query: 584 FQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLS 628
+P L GLT L L +S N++S +L L L L L
Sbjct: 168 ISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 34/195 (17%), Positives = 65/195 (33%), Gaps = 16/195 (8%)
Query: 70 NLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLD 129
+ N+ S + + + L + + +++ S+ + P + L+L+
Sbjct: 22 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSV---QGIQYLPNVTKLFLN 76
Query: 130 GNSFIGTIPPSICNISSLLTLDLSFN-------QLQGHVPSSILNIPSLLAIDLSNNQFS 182
GN P + L LD + L+ S+ + L +
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 183 GPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSI 242
+ N + + L L L NQ+S +P L +L+ L LS N I +
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS-KNHISDL 193
Query: 243 PREIGNITMLKGLYL 257
+ + L L L
Sbjct: 194 R-ALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 35/213 (16%), Positives = 69/213 (32%), Gaps = 17/213 (7%)
Query: 367 DELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGN 426
+ + S + K L + ++ ++ L++ +D + + +IK I
Sbjct: 12 TPIKQIFSDDAFAETIKDNLKKKSVTDA--VTQNELNS-IDQIIANNSDIKSVQG--IQY 66
Query: 427 LNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGN 486
L N+T L L N+LT P L L+ L + S +
Sbjct: 67 LPNVTKLFLNGNKLTDIKP-----LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEH 121
Query: 487 ELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGN 546
+ + + S L L + + + + V +
Sbjct: 122 NGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLAG 176
Query: 547 LKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSL 579
L + + LS+N +S ++ LKN+ L L
Sbjct: 177 LTKLQNLYLSKNHISD--LRALAGLKNLDVLEL 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 2e-06
Identities = 34/260 (13%), Positives = 81/260 (31%), Gaps = 12/260 (4%)
Query: 267 QGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGN 326
QG+ + + E + + + L+ + + + I LQ L L G
Sbjct: 23 QGVIAFRCPRSFMDQ-PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81
Query: 327 RLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLIL 386
RL+ PI ++++ S L +++ + L
Sbjct: 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS-------CSRLDELNLSWCFDF 134
Query: 387 SENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPK 446
+E + + ++ Y N + ++ L +
Sbjct: 135 TEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 194
Query: 447 AIGRLQKLQGLYLQH-NKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTL 505
+L LQ L L + +L + +L G +G+L ++L L+
Sbjct: 195 EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ-- 252
Query: 506 SLGFNRLTSVIPSSLWSLRD 525
+ + T++ ++ + ++
Sbjct: 253 -INCSHFTTIARPTIGNKKN 271
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 3e-05
Identities = 40/262 (15%), Positives = 79/262 (30%), Gaps = 14/262 (5%)
Query: 382 RKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELT 441
+ L L+ L + + LS + + + + + L + +
Sbjct: 3 QTLDLTGKNLHPDVTGRL--LSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIE 59
Query: 442 G-SIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSE--------FYSDGNELNGSL 492
++ + + KLQ L L+ +L I L +L F + S
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 493 PQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTK 552
LD L + + ++ + N L + +
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179
Query: 553 IDLSRNDL-SGEIPSSIGDLKNMQHLSLAD-NKFQGSIPDSLGGLTSLNFLDMSSNNLSG 610
+DLS + + + L +QHLSL+ LG + +L L + G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 611 EIPNSLKALSLLKFLNLSFNGL 632
+ +AL L+ F +
Sbjct: 240 TLQLLKEALPHLQINCSHFTTI 261
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 41/228 (17%), Positives = 81/228 (35%), Gaps = 19/228 (8%)
Query: 401 NLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQ 460
L+NA+ + N+ ++ +L+ +TTL +T +I + L L GL L+
Sbjct: 17 ALANAIK-IAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELK 71
Query: 461 HNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSL 520
N++ + E + + ++ T + + S+L
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 521 WSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLA 580
L LN + + L G ++ + + + + +L + L
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLS----------IGNAQVSDLTPLANLSKLTTLKAD 181
Query: 581 DNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLS 628
DNK P L L +L + + +N +S P L S L + L+
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 9e-06
Identities = 38/211 (18%), Positives = 79/211 (37%), Gaps = 11/211 (5%)
Query: 272 LALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGP 331
+A + +T + ++ +T LS + + + L NL L L N++
Sbjct: 24 IAAGKSNVTDTVTQA--DLDGITTLSAFGTGV--TTIEGVQY-LNNLIGLELKDNQI--T 76
Query: 332 IPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPL 391
+ + N + +T +++ N + +L L L
Sbjct: 77 DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYL 136
Query: 392 SGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRL 451
+I L+ ++ YLS N + S + + NL+ LTTL + N+++ P + L
Sbjct: 137 DLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASL 194
Query: 452 QKLQGLYLQHNKLQGSITTDLCGLRSLSEFY 482
L ++L++N++ L +L
Sbjct: 195 PNLIEVHLKNNQISDVS--PLANTSNLFIVT 223
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 34/235 (14%), Positives = 68/235 (28%), Gaps = 31/235 (13%)
Query: 70 NLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLD 129
L+ + ++ + T+ ++L + LS ++IE + L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIE---GVQYLNNLIGLELK 71
Query: 130 GNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSN-----NQFSGP 184
N P + L L + + + L S
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 185 MPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPR 244
+ + + NI +L+ + L +L L N P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 245 EIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLT 299
+ L + L +N+++ V P + N S+L +++LT
Sbjct: 191 ------------------LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 21/68 (30%), Positives = 29/68 (42%), Gaps = 6/68 (8%)
Query: 89 PIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLL 148
L+NL +L L N S I L S P L ++L N P + N S+L
Sbjct: 166 LTPLANLSKLTTLKADDNKISDI---SPLASLPNLIEVHLKNNQISDVSP--LANTSNLF 220
Query: 149 TLDLSFNQ 156
+ L+ NQ
Sbjct: 221 IVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 17/76 (22%), Positives = 32/76 (42%), Gaps = 4/76 (5%)
Query: 103 FRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVP 162
+ S + + L + KL L D N P + ++ +L+ + L NQ+ P
Sbjct: 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
Query: 163 SSILNIPSLLAIDLSN 178
+ N +L + L+N
Sbjct: 213 --LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 37/222 (16%), Positives = 67/222 (30%), Gaps = 20/222 (9%)
Query: 426 NLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485
L N + + +T ++ +A L + L + + L +L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 486 NELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIG 545
N++ P + I+ LS + S I L ++ +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 546 NLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSS 605
L + + + L+G + N Q S L L+ L L
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQV----------SDLTPLANLSKLTTLKADD 182
Query: 606 NNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSS 647
N +S P L +L L ++L N + P N S+
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVS----PLANTSN 218
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.4 bits (108), Expect = 6e-06
Identities = 37/250 (14%), Positives = 70/250 (28%), Gaps = 19/250 (7%)
Query: 292 SLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNL 351
S V + + +PS++ N +L +L + S L I++ N
Sbjct: 9 SNRVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 64
Query: 352 FSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYL 411
I + P + N + P L IS + + DV +
Sbjct: 65 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 124
Query: 412 SACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
+ + N++ + + L+L N +Q
Sbjct: 125 HSLQKVLLDIQDNINIHTIERNSFVGLS------------FESVILWLNKNGIQEIHNCA 172
Query: 472 LCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNL 531
G + SD N L L + R+ S+ L +L+ + +
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
Query: 532 SSNSLNGTLP 541
+ LP
Sbjct: 233 YNLK---KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (103), Expect = 3e-05
Identities = 32/221 (14%), Positives = 62/221 (28%), Gaps = 8/221 (3%)
Query: 414 CNIKG--SIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTD 471
C IPS++ N L +L A L+ + + N + I D
Sbjct: 15 CQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72
Query: 472 LCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNR--LTSVIPSSLWSLRDILNV 529
+ N L + + + + +
Sbjct: 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132
Query: 530 NLSSNSLNGTLPVEIGNLKVVTKIDLS-RNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI 588
++ N T+ + L + EI + + + L+L+DN +
Sbjct: 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEEL 192
Query: 589 P-DSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLS 628
P D G + LD+S + L+ L L+ +
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 6e-04
Identities = 24/217 (11%), Positives = 62/217 (28%), Gaps = 4/217 (1%)
Query: 136 TIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQ 195
IP + + + L +L+ + L I++S N + + ++ +
Sbjct: 22 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 196 NIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGL 255
+++ L + +P+ + + + +++
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 256 YLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTAN-NLLGNLPSNIGHS 314
+ + + L N+ + ++ N L LP+++ H
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 315 LPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNL 351
L + R+ + N L YNL
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARST-YNL 235
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 42/328 (12%), Positives = 93/328 (28%), Gaps = 23/328 (7%)
Query: 146 SLLTLDLSFNQLQG----HVPSSILNIPSLLAIDLSNNQFSGPM-----PSIYNTSPLQN 196
S+ L + + V + +L S+ I LS N +I + L+
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 197 IDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLY 256
+ + + + L +C +L + LS N F + + +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 257 LVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLP 316
+ ++ + + N L + N L +
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 317 NLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLT 376
+ + L G P I + + L N +L
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDN---TFTHLGSSALAIALK 240
Query: 377 NCKDLRKLILSENPLSGVLPISIGNLSNAMD-----VLYLSACNIKGSIPSEI-----GN 426
+ +LR+L L++ LS ++ + + ++ L L I+ +
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 427 LNNLTTLHLETNELTGSIPKAIGRLQKL 454
+ +L L L N + ++++
Sbjct: 301 MPDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.3 bits (100), Expect = 4e-05
Identities = 34/186 (18%), Positives = 65/186 (34%), Gaps = 8/186 (4%)
Query: 431 TTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRS-LSEFYSDGNELN 489
TT+ L IP+ I L L N+L + L G L + N+L
Sbjct: 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 490 GSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKV 549
G P + ++ L LG N++ + L + +NL N ++ +P +L
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 550 VTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLS 609
+T ++ ++ + ++ SL + P + + D+ +
Sbjct: 128 LTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQ---IKDLPHSEFK 183
Query: 610 GEIPNS 615
NS
Sbjct: 184 CSSENS 189
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 5e-05
Identities = 32/186 (17%), Positives = 65/186 (34%), Gaps = 9/186 (4%)
Query: 272 LALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGP 331
L +T + ++ +T L + + + L NL Q+ N+LT
Sbjct: 23 TVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEY-LNNLTQINFSNNQLTDI 77
Query: 332 IPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPL 391
P + L++ + N +T + K+L L E
Sbjct: 78 TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS 137
Query: 392 SGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRL 451
+ + IS + ++ L S+ + P + NL L L + +N+++ + +L
Sbjct: 138 NTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKL 193
Query: 452 QKLQGL 457
L+ L
Sbjct: 194 TNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 30/217 (13%), Positives = 68/217 (31%), Gaps = 19/217 (8%)
Query: 385 ILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSI 444
I + P++ + + L+ M L N+ ++ +L+ +TTL + + SI
Sbjct: 2 ITQDTPINQIFTDT--ALAEKM-KTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI 55
Query: 445 PKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRT 504
+ L L + +N+L ++ L +
Sbjct: 56 D-GVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF 114
Query: 505 LSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEI 564
+ + ++L L + T+ + + L+ +
Sbjct: 115 NNQITDIDPLKNLTNLNRLELS----------SNTISDISALSGLTSLQQLNFSSNQVTD 164
Query: 565 PSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFL 601
+ +L ++ L ++ NK L LT+L L
Sbjct: 165 LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 6e-05
Identities = 20/141 (14%), Positives = 46/141 (32%), Gaps = 9/141 (6%)
Query: 91 QLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTL 150
Q +N R + L R IE + + + + N + L TL
Sbjct: 13 QYTNAVRDRELDLRGYKIPVIE--NLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTL 68
Query: 151 DLSFNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLA 210
++ N++ +P L + L+NN + + + L+++
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCIL----RNP 123
Query: 211 YNQLSGQIPSTLFECKQLKIL 231
+++ Q+++L
Sbjct: 124 VTNKKHYRLYVIYKVPQVRVL 144
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 1e-04
Identities = 26/145 (17%), Positives = 51/145 (35%), Gaps = 12/145 (8%)
Query: 491 SLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVV 550
L + +L L S L + + +N S+ TL + N+ +
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 551 TKIDLSRNDLSG--EIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNL 608
++LS N L ++ S + N++ L+L+ N+ + L L + N+L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 609 SGEIPNS-------LKALSLLKFLN 626
S + + L L+
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 2e-04
Identities = 23/113 (20%), Positives = 39/113 (34%), Gaps = 2/113 (1%)
Query: 63 TIPPELGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIE-IPPWLDSFP 121
P+L + +LN ++ + TL I N+ L L+ +N ++ + + P
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91
Query: 122 KLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLAI 174
L+ L L GN L L L N L I ++
Sbjct: 92 NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 22/108 (20%), Positives = 40/108 (37%), Gaps = 2/108 (1%)
Query: 551 TKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIP-DSLGGLTSLNFLDMSSNNLS 609
+ + +R+ + + +N+ L + + + + L GL L L + + L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 610 GEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFVGNKGLC 657
P++ L LNLSFN L+ +L GN C
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 17/100 (17%), Positives = 33/100 (33%), Gaps = 1/100 (1%)
Query: 106 NNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSIC-NISSLLTLDLSFNQLQGHVPSS 164
+++ L L LY++ + + + L L + + L+ P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 165 ILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSL 204
P L ++LS N LQ + + N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 5e-04
Identities = 21/130 (16%), Positives = 41/130 (31%), Gaps = 1/130 (0%)
Query: 267 QGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGN 326
G L + + + +LT L + L +L L L+ L + +
Sbjct: 8 HGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 327 RLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLIL 386
L P + L+ +++ +N ++ + + L LR L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 387 SENPLSGVLP 396
E G +P
Sbjct: 127 WEEEGLGGVP 136
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.7 bits (86), Expect = 0.003
Identities = 33/178 (18%), Positives = 56/178 (31%), Gaps = 13/178 (7%)
Query: 63 TIPPELGNLS---FLSLLNVTNNSFSG------TLPIQLSNLRRLKYLSFRSNNFSSIEI 113
TI + + G + LS L+ K+L+ +NN I
Sbjct: 6 TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-- 63
Query: 114 PPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQLQGHVPSSILNIPSLLA 173
L L L G + I I +L L +S+NQ+ L +L
Sbjct: 64 -SSLSGMENLRILS-LGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLY 121
Query: 174 IDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKIL 231
+ + G + + L+++ + N L + N S + LK L
Sbjct: 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1029 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.81 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.49 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.48 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.45 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.32 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.26 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.5 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.47 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.38 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.52 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.35 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.06 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.73 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.72 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.48 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.82 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.42 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=423.38 Aligned_cols=260 Identities=25% Similarity=0.440 Sum_probs=206.0
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
..++|++.+.||+|+||+||+|+.+ ..||||+++... ....+.|.+|++++++++|||||++++++.+ +..++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 4578999999999999999999864 369999987542 4456789999999999999999999998765 4579999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++......+++..+..++.|||+||+||| +++||||||||+|||++.++.+||+|||+|+.......
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999877788999999999999999999999 67899999999999999999999999999987643322
Q ss_pred -ceeccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 894 -MTQTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 894 -~~~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
.......||+.|||||++ ++.++|||||||++|||+||+.||.+...... +.. .+....
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~------------~~~~~~ 226 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIF------------MVGRGY 226 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHH------------HHHHTS
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHH------------HHhcCC
Confidence 223345799999999984 46689999999999999999999976321111 000 000000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
. .......+..++.++.+++.+||+.||++||||+|++++|+.+.+++.
T Consensus 227 ~--~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 227 L--SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp C--CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred C--CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 0 000011223467789999999999999999999999999999988653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=418.11 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=199.4
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.++|++.+.||+|+||+||+|++.+++.||||+++... ...+.+.+|++++++++|||||+++|+|.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 35788899999999999999999888999999997643 33467999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
++|+|.+++......+++..+..++.|||+||+||| +++|+||||||+||++++++.+||+|||+|+..........
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999999887788999999999999999999999 67799999999999999999999999999987755444444
Q ss_pred ccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCC-CCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKP-TDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
....||+.|+|||++ ++.++|||||||++|||+|++.| |.... . ..+.. .+.. ..
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~-~~~~~------------~i~~------~~ 219 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-N-SEVVE------------DIST------GF 219 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-H-HHHHH------------HHHH------TC
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-H-HHHHH------------HHHh------cC
Confidence 446789999999983 67789999999999999996444 43311 1 00000 0000 00
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
....+..++.++.+++.+||+.||++||||+|++++|+++.++
T Consensus 220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 1112234567899999999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=407.87 Aligned_cols=251 Identities=26% Similarity=0.458 Sum_probs=212.6
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.++|++.+.||+|+||+||+|++++++.||||+++.... ..+.+.+|++++++++||||++++|+|.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 468999999999999999999998889999999986533 3468999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
++|++.+++......+++..+.+++.|+|+||+||| ++||+||||||+||++++++.+||+|||+|+..........
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999999998888888999999999999999999999 67899999999999999999999999999987765544444
Q ss_pred ccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
....||+.|+|||. .++.++|||||||++|||+| |+.||......+. ...+. . ..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--~~~i~--------~----------~~ 218 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AEHIA--------Q----------GL 218 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HHHHH--------T----------TC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH--HHHHH--------h----------CC
Confidence 45678999999998 36889999999999999998 8999976422211 11000 0 00
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
+...+..++.++.+++.+||+.||++|||++|++++|.+|
T Consensus 219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1122334567899999999999999999999999998654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=412.53 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=205.3
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999875 79999999998766556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
++|+|.+++.+ ..+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+.+..... ..
T Consensus 100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (293)
T ss_dssp TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cc
Confidence 99999998754 45899999999999999999999 77899999999999999999999999999998754332 23
Q ss_pred ccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAY 972 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 972 (1029)
....||+.|+|||++ ++.++||||+||++|||++|+.||.+....+. +..... .....
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------------~~~~~~-----~~~~~ 235 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------------LYLIAT-----NGTPE 235 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------------HHHHHH-----HCSCC
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-------------HHHHHh-----CCCCC
Confidence 446799999999983 68899999999999999999999965321110 000000 00011
Q ss_pred hHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 973 LTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 973 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+..++..+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11233457789999999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=419.01 Aligned_cols=248 Identities=27% Similarity=0.379 Sum_probs=206.6
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
+.|++.+.||+|+||+||+|++. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999975 78999999998776677788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCcee
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMTQ 896 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 896 (1029)
++|+|.+++.+..+.+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+...... ...
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccc
Confidence 999999998777778999999999999999999999 6779999999999999999999999999997653221 122
Q ss_pred ccccCCccccCccCC---------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK---------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~---------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
....||+.|+|||++ ++.++||||+||++|||++|+.||.+....+. + . ....
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~----~--------~i~~----- 229 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-L----L--------KIAK----- 229 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-H----H--------HHHH-----
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-H----H--------HHHc-----
Confidence 346799999999974 46789999999999999999999976321111 0 0 0000
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
........+..++.++.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 230 SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000111223457789999999999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=413.90 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=200.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999975 79999999997653 2345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC-C
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET-S 893 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~ 893 (1029)
|+++|+|.+++. ....+++..+..++.||++||+||| ++||+||||||+|||+++++.+||+|||+|+...... .
T Consensus 84 y~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999884 4567999999999999999999999 7789999999999999999999999999998764332 2
Q ss_pred ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
......+||+.|||||++ ++.++||||+||++|||++|++||.........+..... ..
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~------------~~---- 223 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------KK---- 223 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT------------TC----
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc------------CC----
Confidence 223446799999999983 356799999999999999999999764322221111100 00
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.........+.++.+++.+||+.||++|||++|++++
T Consensus 224 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 224 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011112346678899999999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=408.12 Aligned_cols=242 Identities=25% Similarity=0.391 Sum_probs=201.8
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||+||+|+.. +++.||+|++.+.. ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56899999999999999999985 78999999987542 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++.. ...+++..+..++.||++||+||| ++|||||||||+||+++.++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred eecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 99999999999864 456899999999999999999999 7789999999999999999999999999998664432
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
.....||+.|||||++ ++.++||||+||++|||++|+.||.+....+. .. .....
T Consensus 161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~--------~i~~~------ 219 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----YK--------RISRV------ 219 (263)
T ss_dssp --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HH--------HHHTT------
T ss_pred --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-----HH--------HHHcC------
Confidence 2345799999999983 68899999999999999999999975311100 00 00000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
....+..+++++.+++.+||+.||++|||++|++++
T Consensus 220 --~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 220 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 011123356788999999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-47 Score=415.50 Aligned_cols=254 Identities=28% Similarity=0.507 Sum_probs=197.3
Q ss_pred CCCCCCceeccCcceEEEEEEec-CC---cEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DG---MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
++|++.+.||+|+||+||+|++. ++ ..||||.+.... ....+.|.+|++++++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45777889999999999999875 33 358999887543 34456799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++|+|.+++....+.+++.++..++.|||+||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999999877778999999999999999999999 6789999999999999999999999999998765432
Q ss_pred Cc----eeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 893 SM----TQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 893 ~~----~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
.. ......||+.|||||. .++.++|||||||++|||+| |+.||.+....+ +. ..+..
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~------------~~i~~ 248 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VI------------NAIEQ 248 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH------------HHHHT
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--HH------------HHHHc
Confidence 21 1122457899999998 36778999999999999998 899987632111 11 01100
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
....+.+..++..+.+++.+||+.||++||||+|+++.|+++.++
T Consensus 249 ------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 249 ------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 001122345678899999999999999999999999999988654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-48 Score=417.22 Aligned_cols=256 Identities=24% Similarity=0.412 Sum_probs=211.1
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
...++|++.+.||+|+||+||+|++. +|+.||||+++... ...+.+.+|++++++++|||||+++++|.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34567888999999999999999976 68999999987553 34567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 814 EYMPNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
||+++|+|.+++... ...+++..+..++.||++||+||| ++||+||||||+|||+++++.+||+|||+|+......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999998754 457899999999999999999999 6679999999999999999999999999998776554
Q ss_pred CceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
........|++.|+|||+ .++.++|||||||++|||++|+.||....... .+.+.+...
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-------------~~~~~i~~~---- 232 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------------QVYELLEKD---- 232 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------------HHHHHHHTT----
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-------------HHHHHHhcC----
Confidence 445555668999999998 46789999999999999999877764321110 011111111
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
...+.+..++.++.+++.+||+.||++||||+|+++.|+.+.+
T Consensus 233 --~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 233 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred --CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0112233467789999999999999999999999999987653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=408.51 Aligned_cols=259 Identities=24% Similarity=0.426 Sum_probs=210.7
Q ss_pred CCCCCCc-eeccCcceEEEEEEec---CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 738 DGFSENN-LLGKGSFGSVYKGTLS---DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 738 ~~~~~~~-~lg~G~fg~V~~~~~~---~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
++|.+.+ +||+|+||+||+|.+. ++..||||+++... ....+.|.+|++++++++|||||+++|++.++ ..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence 4455566 4999999999999764 45679999997654 34467899999999999999999999999754 57899
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++|+|.+++...+..+++..+..++.|||+||+||| +++|+||||||+||+++.++.+||+|||+|+......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999998777788999999999999999999999 6779999999999999999999999999999875443
Q ss_pred Cce--eccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 893 SMT--QTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 893 ~~~--~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
... .....||+.|+|||++ ++.++|||||||++|||+| |+.||.+....+ +... +..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~------------i~~-- 227 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAF------------IEQ-- 227 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHH------------HHT--
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HHHH------------HHc--
Confidence 222 2335688999999984 6889999999999999998 899997632111 1111 000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccccc
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIE 1020 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~ 1020 (1029)
....+.+..++.++.+++.+||+.||++|||+.+|.+.|+.+..++....+
T Consensus 228 ----~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~ 278 (285)
T d1u59a_ 228 ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278 (285)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred ----CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccc
Confidence 011122345678899999999999999999999999999998877765554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=412.28 Aligned_cols=253 Identities=23% Similarity=0.400 Sum_probs=205.0
Q ss_pred HhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
..++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 346788899999999999999999888999999997543 345679999999999999999999998865 456899999
Q ss_pred cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++|+|.+++.... ..+++..+..++.||++||+||| +++|+||||||+||++++++.+||+|||+|+........
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 99999999875433 35899999999999999999999 677999999999999999999999999999987655444
Q ss_pred eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKED 970 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 970 (1029)
......||+.|+|||++ ++.++|||||||++|||+||+.|+........ .... + .. .
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-~~~~--------i---~~-------~ 226 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQN--------L---ER-------G 226 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHH--------H---HT-------T
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-HHHH--------H---Hh-------c
Confidence 44556789999999983 67899999999999999997666543211100 0000 0 00 0
Q ss_pred hhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 971 AYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 971 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
.....+..++.++.+++.+||+.||++||||+|+++.|+.+.
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 011122345778999999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=406.11 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=190.0
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEec--CCeEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSS--DHFKALV 812 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 812 (1029)
++|++.+.||+|+||+||+|+.. +|+.||||.+.... +...+.+.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999875 79999999987653 3345678999999999999999999999864 4568999
Q ss_pred EeccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 813 LEYMPNGSLENWMYN---KNRSFDILQRLNMVIDVASALEYLHYDH--PTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
|||+++|+|.+++.+ ....+++..++.++.|++.||+|||+.+ ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999864 3567999999999999999999999543 23499999999999999999999999999987
Q ss_pred cCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhh
Q 036879 888 LGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDI 963 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 963 (1029)
+...... .....||+.|||||++ ++.++|||||||++|||+||+.||.+....+ +.. .....
T Consensus 164 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~~-----------~i~~~ 229 (269)
T d2java1 164 LNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAG-----------KIREG 229 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH-----------HHHHT
T ss_pred cccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HHH-----------HHHcC
Confidence 6543322 2346799999999984 6789999999999999999999997532111 000 00000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.. ...+..+++++.+++.+||+.||++|||++|++++
T Consensus 230 ~~-------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 230 KF-------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC-------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00 11123456789999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=394.97 Aligned_cols=242 Identities=25% Similarity=0.406 Sum_probs=193.9
Q ss_pred CCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEec----CCeEEEEE
Q 036879 741 SENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSS----DHFKALVL 813 (1029)
Q Consensus 741 ~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 813 (1029)
+..++||+|+||+||+|++. +++.||+|.+.... ....+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999976 78899999987653 3445679999999999999999999999864 45679999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCEEEC-CCCcEEEEccCCceecCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTP--IIHCDLNPSNILLN-ESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~g--ivH~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~ 890 (1029)
||+++|+|.+++.+ ...+++..+..++.||++||+||| +++ |+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999964 356899999999999999999999 666 99999999999996 589999999999986433
Q ss_pred CCCceeccccCCccccCccCC---CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 891 ETSMTQTQTLATIGYMAPEWK---LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 891 ~~~~~~~~~~gt~~y~aPE~~---~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.. ....+||+.|||||++ ++.++||||+||++|||++|+.||.+...... +...+... .
T Consensus 168 ~~---~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-~~~~i~~~--------~------ 229 (270)
T d1t4ha_ 168 SF---AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVTSG--------V------ 229 (270)
T ss_dssp TS---BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHHTTT--------C------
T ss_pred Cc---cCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-HHHHHHcC--------C------
Confidence 22 2346799999999984 78899999999999999999999965321111 00000000 0
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.....+..+++++.+++.+||+.||++|||++|++++
T Consensus 230 ---~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 230 ---KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ---CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 0011122345678999999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.2e-46 Score=410.89 Aligned_cols=249 Identities=22% Similarity=0.282 Sum_probs=206.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 458999999999999999999975 7999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC--CCCcEEEEccCCceecCCCCC
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN--ESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
+++|+|.+++......+++..+..++.||+.||+||| ++|||||||||+||+++ .++.+||+|||+|+.+.....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999999777778999999999999999999999 77799999999999996 468999999999998754432
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
.....||+.|||||++ ++.++||||+||++|||++|+.||.+....+. ... ... ...
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~--------i~~----~~~ 242 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-----LRN--------VKS----CDW 242 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHH--------HHH----TCC
T ss_pred --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-----HHH--------HHh----CCC
Confidence 2345799999999984 67789999999999999999999975311110 000 000 000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.........++.++.+++.+||..||++|||++|++++
T Consensus 243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011112346678999999999999999999999885
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=405.13 Aligned_cols=246 Identities=26% Similarity=0.340 Sum_probs=199.9
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999975 79999999997542 334567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC-
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET- 892 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 892 (1029)
||+++|+|.+++.. .+.+++..+..++.|++.||+||| ++|||||||||+||++++++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999998854 456999999999999999999999 7779999999999999999999999999999875432
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
........||+.|+|||++ ++.++||||+||++|||++|+.||......+. .......
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----~~~i~~~------------- 225 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKL------------- 225 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHTT-------------
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-----HHHHHcC-------------
Confidence 2223345799999999984 67799999999999999999999975311110 0000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKL 1008 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1008 (1029)
....+..+++.+.+++.+||+.||++|||++|+.++-
T Consensus 226 ---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 226 ---EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp ---CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred ---CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 0111233567789999999999999999999986643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-46 Score=401.15 Aligned_cols=256 Identities=28% Similarity=0.491 Sum_probs=200.1
Q ss_pred hCCCCCCceeccCcceEEEEEEecCC-----cEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDG-----MQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 810 (1029)
...|+..+.||+|+||+||+|++.++ ..||||+++... ......|.+|++++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 34577889999999999999987532 479999997653 334557899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+||||+.++++.+++......+++.++..++.||+.|++||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999999888888999999999999999999999 67799999999999999999999999999987644
Q ss_pred CCC--ceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 891 ETS--MTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 891 ~~~--~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
... .......||+.|||||+ .++.++|||||||++|||++|+.|+........ +. ..+...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~------------~~i~~~ 229 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VM------------KAINDG 229 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HH------------HHHHTT
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HH------------HHHhcc
Confidence 322 22233568999999998 467789999999999999997666543211110 00 111100
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
...+.+..++..+.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 230 ------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 ------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 01122334677899999999999999999999999999988764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=397.95 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=196.9
Q ss_pred ceeccCcceEEEEEEec---CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEeccCC
Q 036879 744 NLLGKGSFGSVYKGTLS---DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYMPN 818 (1029)
Q Consensus 744 ~~lg~G~fg~V~~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 818 (1029)
++||+|+||+||+|.+. .++.||||+++... ....+.+.+|++++++++|||||+++++|..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 46999999999999864 35689999997543 23456799999999999999999999999754 56899999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce--e
Q 036879 819 GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT--Q 896 (1029)
Q Consensus 819 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~ 896 (1029)
|+|.+++.. ...+++..+..++.||++||+||| +++||||||||+||+++.++.+||+|||+|+......... .
T Consensus 92 g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 999999864 456999999999999999999999 6779999999999999999999999999998765443222 2
Q ss_pred ccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 897 TQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 897 ~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
....||+.|||||++ ++.++|||||||++|||+| |+.||.+....+ +. ..+.. ..
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~------------~~i~~------~~ 227 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT------------AMLEK------GE 227 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH------------HHHHT------TC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HH------------HHHHc------CC
Confidence 335689999999984 6789999999999999998 899997632111 11 11110 01
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhh
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTL 1015 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~ 1015 (1029)
+.+.+..++.++.+++.+||+.||++|||++||.+.|+.+..+.
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 11223456788999999999999999999999999998876543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-46 Score=404.62 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=186.9
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
.+.|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 466999999999999999999975 78999999997653 3334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC---CCCcEEEEccCCceecCCC
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN---ESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~---~~~~~kl~Dfg~a~~~~~~ 891 (1029)
|++||+|.+++.. ...+++..+..++.||+.||+||| ++|||||||||+||++. +++.+||+|||+|+.....
T Consensus 88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999999954 557999999999999999999999 77899999999999995 5789999999999866443
Q ss_pred CCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQ 967 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 967 (1029)
.. ....+||+.|||||++ ++.++||||+||++|||++|+.||.+....+. .. .... .
T Consensus 164 ~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~-----------~i~~----~ 224 (307)
T d1a06a_ 164 SV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL--FE-----------QILK----A 224 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH-----------HHHT----T
T ss_pred Ce--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH--HH-----------HHhc----c
Confidence 22 2345799999999983 68899999999999999999999975321111 00 0000 0
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 968 KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 968 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
......+.+..+++++.+++.+||+.||++|||++|++++
T Consensus 225 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 225 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0000011123456778999999999999999999999984
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-45 Score=409.68 Aligned_cols=249 Identities=19% Similarity=0.266 Sum_probs=206.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999975 7999999999877655667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC--CCCcEEEEccCCceecCCCCC
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN--ESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
+++|+|.+++......+++.++..++.||+.||+||| ++|||||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999999988777778999999999999999999999 77899999999999998 678999999999998765432
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
.....||+.|+|||++ ++.++||||+||++|||++|+.||.+....+. . . .+.. ...
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~---~--------~i~~----~~~ 245 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--L---Q--------NVKR----CDW 245 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--H---H--------HHHH----CCC
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--H---H--------HHHh----CCC
Confidence 2345699999999984 67789999999999999999999975321110 0 0 0000 000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.........++.++.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011112346778999999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-46 Score=407.93 Aligned_cols=241 Identities=22% Similarity=0.312 Sum_probs=197.7
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
+.|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34888999999999999999875 78999999997653 233467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|++..++. ....+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp ECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 9999999977654 4567999999999999999999999 777999999999999999999999999999865432
Q ss_pred ceeccccCCccccCccCC-------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK-------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~-------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
....||+.|||||++ ++.++|||||||++|||++|+.||.+....+. +.........
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-------------~~~i~~~~~~ 232 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------LYHIAQNESP 232 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------------HHHHHHSCCC
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHHhCCCC
Confidence 235699999999974 57789999999999999999999975321111 0000000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALT 1006 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1006 (1029)
...+..+++.+.+++.+||+.||++|||++|+++
T Consensus 233 ------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 ------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0011234677999999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=411.22 Aligned_cols=262 Identities=25% Similarity=0.332 Sum_probs=201.6
Q ss_pred HhCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
..++|++.+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|++++++++|||||+++++|.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999975 78999999998653 334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+++|+|.+++.+. +.+++..+..++.|++.||+|||+. .||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 84 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp ECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred EcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 999999999999654 4689999999999999999999942 279999999999999999999999999998653321
Q ss_pred ceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchh-------------
Q 036879 894 MTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGK------------- 956 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------- 956 (1029)
....+||+.|||||+ .++.++||||+||++|||++|+.||......+..... .....+.
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF--GCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HHHhcCCcccCCcccccccc
Confidence 234579999999998 4788999999999999999999999753221110000 0000000
Q ss_pred --------------hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 957 --------------IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 957 --------------~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..+..+....... ........+.++.+++.+|+..||++||||+|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCC--CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhHHHHHhhhhccCC--ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000000000 000001235678999999999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=405.71 Aligned_cols=252 Identities=22% Similarity=0.381 Sum_probs=201.8
Q ss_pred HhCCCCCCceeccCcceEEEEEEecC------CcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCC
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLSD------GMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDH 807 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 807 (1029)
..++|++.+.||+|+||+||+|++.. ...||||.+.... ......+.+|+.+++++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34678899999999999999998642 2369999986543 33456789999999998 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCC
Q 036879 808 FKALVLEYMPNGSLENWMYNKNR----------------------SFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLN 865 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk 865 (1029)
..++||||+++|+|.+++..... .+++..+..++.||++||+||| +++|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence 99999999999999999976532 4788999999999999999999 6779999999
Q ss_pred CCCEEECCCCcEEEEccCCceecCCCCCc-eeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCccc
Q 036879 866 PSNILLNESMVACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELF 939 (1029)
Q Consensus 866 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~ 939 (1029)
|+||+++.++.+||+|||+|+........ ......||+.|||||+ .++.++|||||||++|||+| |+.||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876443322 3334568999999997 47889999999999999998 899997532
Q ss_pred ccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHH
Q 036879 940 VGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLL 1009 (1029)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1009 (1029)
..+. +.. .+... ...+.+..++.++.++|.+||+.||++|||++||+++|.
T Consensus 272 ~~~~-~~~------------~~~~~------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDAN-FYK------------LIQNG------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSHH-HHH------------HHHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH-HHH------------HHhcC------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2111 111 11100 011223456778999999999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=395.88 Aligned_cols=254 Identities=22% Similarity=0.390 Sum_probs=196.7
Q ss_pred hCCCCCCceeccCcceEEEEEEecC----CcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSD----GMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
.++|++.+.||+|+||+||+|++.. +..||||.++... ....+.+.+|++++++++|||||++++++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 4678899999999999999998642 4568999886543 3345679999999999999999999999964 56799
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+++|++.+++......+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999998888888999999999999999999999 777999999999999999999999999999877554
Q ss_pred CCceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhh
Q 036879 892 TSMTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLL 966 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 966 (1029)
.........||+.|+|||+ .++.++|||||||++|||++ |++||......+. ...+ ..
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--~~~i-----------~~---- 224 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRI-----------EN---- 224 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHH-----------HT----
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH--HHHH-----------Hc----
Confidence 4444455678999999998 46789999999999999998 8999876422111 1100 00
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 967 QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 967 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
....+.+..++..+.+++.+||+.||++|||++|++++|+.+.+.
T Consensus 225 ---~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 225 ---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 001122345677899999999999999999999999999988654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-45 Score=395.65 Aligned_cols=248 Identities=22% Similarity=0.303 Sum_probs=202.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc------hhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE------GTLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||||++++... ...+.+.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999975 799999999975421 2356799999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC----cEEEEccCCc
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM----VACLSDFGIS 885 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~----~~kl~Dfg~a 885 (1029)
|+||||+++|+|.+++... +.+++..+..++.|++.||+||| +++||||||||+||+++.++ .+|++|||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999998654 46999999999999999999999 77799999999999998776 5999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
........ .....||+.|+|||++ ++.++||||+||++|||++|+.||.+....+. + ....
T Consensus 165 ~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~------------~~i~ 229 (293)
T d1jksa_ 165 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-L------------ANVS 229 (293)
T ss_dssp EECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H------------HHHH
T ss_pred hhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-H------------HHHH
Confidence 87754322 2345689999999983 68899999999999999999999975321110 0 0000
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..........+..++..+.+++.+||+.||++|||++|++++
T Consensus 230 ----~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 230 ----AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ----TTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----hcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111112223456788999999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=397.62 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=198.8
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEecc
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEYM 816 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 816 (1029)
.++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 45789999999999999999999888899999997553 345779999999999999999999999965 4578999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 817 PNGSLENWMYNK-NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 817 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
++|+|..++... ...+++.++..++.||++||+||| +.+|+||||||+||+++.++++||+|||+|+.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999999888654 356899999999999999999999 6679999999999999999999999999998765544444
Q ss_pred eccccCCccccCccC----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhhhh
Q 036879 896 QTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDA 971 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 971 (1029)
.....||+.|+|||+ .++.++|||||||++|||++|+.||........ . ...+... .
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~------------~~~i~~~------~ 231 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-V------------LDQVERG------Y 231 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-H------------HHHHHTT------C
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-H------------HHHHHhc------C
Confidence 445678999999998 467899999999999999997766543211111 0 0111100 0
Q ss_pred hhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 972 YLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 972 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
..+.+..++.++.+++.+||+.||++||||++|++.|+.+..+
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1122345677899999999999999999999999988775543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=399.56 Aligned_cols=245 Identities=23% Similarity=0.309 Sum_probs=203.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357999999999999999999975 79999999998652 33457789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++|+|.+++.. .+.+++..+..++.|++.||+||| ++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999999854 456899999999999999999999 7789999999999999999999999999998764432
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
. .....+||+.|+|||++ ++.++||||+||++|||++|++||.+....+. .... ..
T Consensus 160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-----~~~i------------~~-- 219 (337)
T d1o6la_ 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELI------------LM-- 219 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHH------------HH--
T ss_pred c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-----HHHH------------hc--
Confidence 2 23346799999999994 68899999999999999999999976321110 0000 00
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERIN-----IKEALTK 1007 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~~ 1007 (1029)
.....|..+++++.+++.+||++||++|++ ++|++++
T Consensus 220 --~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 220 --EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 011123345778899999999999999994 8888874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=393.43 Aligned_cols=272 Identities=21% Similarity=0.316 Sum_probs=201.0
Q ss_pred CCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCC----eEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDH----FKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 813 (1029)
++|...+.||+|+||+||+|++ +|+.||||+++.... .....+.|+..++.++|||||++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4567778999999999999987 689999999865432 1122334555566789999999999997643 578999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD-----HPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
||+++|+|.+++.+. .+++..+..++.|+|.|++|+|.. +++|||||||||+|||++.++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 999999999999653 589999999999999999999953 3579999999999999999999999999999877
Q ss_pred CCCCCc---eeccccCCccccCccCC----------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccc-
Q 036879 889 GDETSM---TQTQTLATIGYMAPEWK----------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLH- 954 (1029)
Q Consensus 889 ~~~~~~---~~~~~~gt~~y~aPE~~----------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~- 954 (1029)
...... ......||++|+|||++ ++.++|||||||++|||+||..||.........+.........
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 543222 22346799999999984 3457999999999999999999886543333322222111111
Q ss_pred hhhhhh-hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 955 GKIINV-VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 955 ~~~~~~-~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
..+.+. .+...... -+.......+...+.+++.+||+.||++|||+.||+++|+++.+.
T Consensus 239 ~~~~~~~~~~~~~p~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPN-IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCCCCC-CCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhccccCCC-CCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 111111 11111000 001111234567799999999999999999999999999998864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-44 Score=387.05 Aligned_cols=247 Identities=21% Similarity=0.303 Sum_probs=202.6
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc---------hhhHHHHHHHHHHhcCC-CCceEEEEEEEecC
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE---------GTLRSFDAECEILGSIR-HRNLVKIISTCSSD 806 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 806 (1029)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999875 799999999976431 12346889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 807 HFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
+..|+||||+++|+|.+++.. ...+++..+..++.||++||+||| ++||+||||||+||+++.++.+||+|||+|+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999999965 457999999999999999999999 6779999999999999999999999999999
Q ss_pred ecCCCCCceeccccCCccccCccCC----------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchh
Q 036879 887 LLGDETSMTQTQTLATIGYMAPEWK----------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGK 956 (1029)
Q Consensus 887 ~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 956 (1029)
....... .....||+.|+|||.. ++.++||||+||++|||++|+.||.+....+. ..
T Consensus 159 ~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~--~~--------- 225 (277)
T d1phka_ 159 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--LR--------- 225 (277)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---------
T ss_pred EccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH--HH---------
Confidence 8755332 3346799999999973 47789999999999999999999976321110 00
Q ss_pred hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 957 IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 957 ~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
... .............+++++.+++.+||++||++|||++|++++
T Consensus 226 --~i~----~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 226 --MIM----SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp --HHH----HTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --HHH----hCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000 000001111123457789999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=393.96 Aligned_cols=248 Identities=20% Similarity=0.260 Sum_probs=203.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.... ....+.+|+++++.++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999976 789999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC--CCcEEEEccCCceecCCCCC
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE--SMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
++||+|.+++......+++.++..++.||++|++||| ++||+||||||+||+++. ...+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 9999999999777668999999999999999999999 778999999999999984 4589999999998764432
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......+|+.|+|||.. ++.++||||+||++|||++|+.||......+. +.... ....
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-------------~~~i~----~~~~ 220 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-------------IENIM----NAEY 220 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHH----HTCC
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHH----hCCC
Confidence 23345689999999984 67789999999999999999999975321100 00000 0001
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.........++.++.+++.+|+..||++|||++|++++
T Consensus 221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111222456778999999999999999999999984
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=397.11 Aligned_cols=253 Identities=25% Similarity=0.458 Sum_probs=201.5
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCc----EEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGM----QIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 811 (1029)
++|++.+.||+|+||+||+|++. +|+ .||+|.++... ....+.+.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999875 444 58888886543 34467899999999999999999999999875 4578
Q ss_pred EEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCC
Q 036879 812 VLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 812 V~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 891 (1029)
||||+.+|+|.+++......+++..+..++.|||.||+||| +++||||||||+||+++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999999999888889999999999999999999999 677999999999999999999999999999876543
Q ss_pred CCc-eeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhh
Q 036879 892 TSM-TQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINL 965 (1029)
Q Consensus 892 ~~~-~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 965 (1029)
... ......||+.|+|||+ .++.++|||||||++|||+| |++||++....+. . ..+..
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~--~------------~~i~~-- 228 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S------------SILEK-- 228 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH--H------------HHHHH--
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH--H------------HHHHc--
Confidence 322 2233568999999998 47889999999999999998 7888875321111 1 11100
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 966 LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 966 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
+.+.+.+..++..+.+++.+||+.||++|||++|++++++.+.++
T Consensus 229 ----~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 229 ----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 011122345678899999999999999999999999999988653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-45 Score=386.64 Aligned_cols=247 Identities=29% Similarity=0.467 Sum_probs=194.4
Q ss_pred hCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEec-CCeEEEEEec
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS-DHFKALVLEY 815 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~ 815 (1029)
.++|++.+.||+|+||.||+|++ .|+.||||+++.. ...+.+.+|++++++++||||++++|++.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 45678889999999999999998 5789999999654 345779999999999999999999999855 4567999999
Q ss_pred cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 816 MPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
+++|+|.+++.... ..+++..++.++.||+.|++||| +.+|+||||||+||+++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC---
Confidence 99999999996543 35899999999999999999999 677999999999999999999999999999865432
Q ss_pred eeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 895 TQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
.....+++.|+|||+ .++.++|||||||++|||+| |++||......+ +...+..
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i~~------------------ 215 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEK------------------ 215 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTT------------------
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHc------------------
Confidence 223458899999998 47889999999999999998 677776532111 1111100
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
....+.+..+++++.+++.+||+.||++||||+|++++|++++.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 01112233456789999999999999999999999999998864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-44 Score=395.99 Aligned_cols=257 Identities=24% Similarity=0.416 Sum_probs=206.3
Q ss_pred HHHHhCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeecccch-hhHHHHHHHHHHhcCCCCceEEEEEEEec
Q 036879 733 LFRATDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLELEG-TLRSFDAECEILGSIRHRNLVKIISTCSS 805 (1029)
Q Consensus 733 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 805 (1029)
++...++|++.+.||+|+||+||+|+.. +++.||||+++..... ..+.+.+|++++++++||||+++++++..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3335678999999999999999999863 4578999999765433 45679999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEc
Q 036879 806 DHFKALVLEYMPNGSLENWMYNKN-----------------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHC 862 (1029)
Q Consensus 806 ~~~~~lV~E~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~ 862 (1029)
.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEee
Confidence 999999999999999999996432 24789999999999999999999 7779999
Q ss_pred CCCCCCEEECCCCcEEEEccCCceecCCCCC-ceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhcCC-CCCC
Q 036879 863 DLNPSNILLNESMVACLSDFGISKLLGDETS-MTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKK-KPTD 936 (1029)
Q Consensus 863 Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~elltg~-~p~~ 936 (1029)
||||+|||++.++.+||+|||+|+....... ...+...+++.|+|||. .++.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999999986643322 22334568899999998 4788999999999999999996 5665
Q ss_pred cccccccccchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhH
Q 036879 937 ELFVGEISLKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIR 1012 (1029)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~ 1012 (1029)
.....+. .. .+.+.. ..+.+..++.++.+++..||+.+|++||||.||++.|++|.
T Consensus 245 ~~~~~e~--~~-----------~v~~~~-------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHEEV--IY-----------YVRDGN-------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHHHH--HH-----------HHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHHHH--HH-----------HHHcCC-------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 4321111 00 011100 11123456778999999999999999999999999999874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-44 Score=392.13 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=200.6
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56899999999999999999975 79999999997542 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||++||++..++. ....+++..+..++.||+.|++||| ++|||||||||+|||++.++.+||+|||+|+......
T Consensus 84 E~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 84 DYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp CCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred eecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 9999999999875 4556788889999999999999999 8889999999999999999999999999998765432
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
....||+.|||||++ ++.++||||+||++|||++|+.||.+....+. ...... .
T Consensus 159 ---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------------~~~i~~----~-- 216 (316)
T d1fota_ 159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------------YEKILN----A-- 216 (316)
T ss_dssp ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHH----C--
T ss_pred ---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-------------HHHHHc----C--
Confidence 235799999999983 68899999999999999999999975311110 000000 0
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
....+...+.++.+++.+|+..||++|+ |++|++++
T Consensus 217 --~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 217 --ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0111233567789999999999999996 89999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-45 Score=389.43 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=194.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec--CC--cEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS--DG--MQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~--~~--~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
.++|++.+.||+|+||+||+|++. ++ ..||||+++... ....+.|.+|++++++++|||||+++|++.++ ..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence 356889999999999999999864 22 478999987542 34457899999999999999999999999764 56
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
++||||+++|++.+++......+++..+..++.|||+||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 8999999999999998877778999999999999999999999 6779999999999999999999999999999775
Q ss_pred CCCCc--eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhc-CCCCCCcccccccccchhchhccchhhhhhhh
Q 036879 890 DETSM--TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFT-KKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962 (1029)
Q Consensus 890 ~~~~~--~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 962 (1029)
..... ......|+..|+|||.+ ++.++|||||||++|||+| |+.||.+....+. ...+ ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~--~~~i-----------~~ 229 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHKI-----------DK 229 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHH-----------HT
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH--HHHH-----------Hh
Confidence 43222 22334578899999983 6778999999999999998 8999975321111 0000 00
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHh
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKI 1011 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i 1011 (1029)
.....+.+..++.++.+++.+||+.||++||||+||.+.|++.
T Consensus 230 ------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 ------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0011122234567899999999999999999999999998765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.1e-44 Score=387.09 Aligned_cols=256 Identities=21% Similarity=0.355 Sum_probs=198.6
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC----e
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH----F 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 808 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999874 79999999997653 234567899999999999999999999987643 4
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.|+||||++|++|.+++.. .+.+++.++..++.||+.||+||| ++|||||||||+||+++.++..+++|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence 7899999999999998854 456899999999999999999999 678999999999999999999999999998765
Q ss_pred CCCC--CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhh
Q 036879 889 GDET--SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962 (1029)
Q Consensus 889 ~~~~--~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 962 (1029)
.... ........||+.|+|||++ ++.++||||+||++|||+||++||.+....+. ...
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~--------------- 225 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQ--------------- 225 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH---------------
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHH---------------
Confidence 4322 2223345799999999984 67789999999999999999999975321111 000
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCC-CHHHHHHHHHHhHH
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-NIKEALTKLLKIRN 1013 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~evl~~L~~i~~ 1013 (1029)
...............++.++.+++.+|++.||++|| |++|+.+.|.++.+
T Consensus 226 -~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 226 -HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp -HHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred -HHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 000000011111223567899999999999999999 89999999988764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=388.34 Aligned_cols=252 Identities=27% Similarity=0.463 Sum_probs=202.8
Q ss_pred CceeccCcceEEEEEEecC----CcEEEEEEeecc-cchhhHHHHHHHHHHhcCCCCceEEEEEEEec-CCeEEEEEecc
Q 036879 743 NNLLGKGSFGSVYKGTLSD----GMQIAVKVFNLE-LEGTLRSFDAECEILGSIRHRNLVKIISTCSS-DHFKALVLEYM 816 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~~----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~~ 816 (1029)
.++||+|+||+||+|++.+ ...||||+++.. .....+.|.+|++++++++|||||+++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999998753 236899998754 34456789999999999999999999999865 56889999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc--
Q 036879 817 PNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM-- 894 (1029)
Q Consensus 817 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 894 (1029)
++|+|.+++.......++..+..++.|+|+||+|+| +++|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999888888899999999999999999999 777999999999999999999999999999876443221
Q ss_pred -eeccccCCccccCccC----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 895 -TQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 895 -~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
......||+.|+|||. .++.++||||||+++|||+||+.||...... .++...+...
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~g----------------- 250 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQG----------------- 250 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTT-----------------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcC-----------------
Confidence 2233568999999998 4788999999999999999988887542211 1111111000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhc
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLL 1016 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~ 1016 (1029)
.+...+..++..+.+++.+||+.||++||+|.||+++|+.+.+++.
T Consensus 251 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 251 -RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 0111223456789999999999999999999999999999987643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-43 Score=396.70 Aligned_cols=246 Identities=20% Similarity=0.288 Sum_probs=196.9
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHH---HHHHHHHhcCCCCceEEEEEEEecCCeE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSF---DAECEILGSIRHRNLVKIISTCSSDHFK 809 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~ 809 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ......+ .+|+++++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999975 79999999987542 1112223 3457778888999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecC
Q 036879 810 ALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLG 889 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 889 (1029)
|+||||+++|+|.+++.. ...+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999865 456889999999999999999999 7789999999999999999999999999998775
Q ss_pred CCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhh
Q 036879 890 DETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDIN 964 (1029)
Q Consensus 890 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 964 (1029)
... .....||+.|+|||++ ++.++||||+||++|||+||+.||......... . .....
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~------------~~~~~ 221 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--E------------IDRMT 221 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--H------------HHHHS
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--H------------HHHhc
Confidence 432 2335799999999973 577899999999999999999999763221110 0 00000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 036879 965 LLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERIN-----IKEALTK 1007 (1029)
Q Consensus 965 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~~ 1007 (1029)
. ......+..+++++.++|.+||+.||++||| |+|++++
T Consensus 222 ~----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 222 L----TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp S----SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred c----cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0 0001112235677899999999999999999 7888864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=386.89 Aligned_cols=258 Identities=23% Similarity=0.396 Sum_probs=195.1
Q ss_pred HHhCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecC
Q 036879 735 RATDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSD 806 (1029)
Q Consensus 735 ~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 806 (1029)
...++|++.+.||+|+||+||+|++. +++.||||+++... ....+.+.+|.+++.++ +|+|||.+++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 34578999999999999999999863 35689999987543 33456788888888776 789999999998664
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEE
Q 036879 807 -HFKALVLEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNIL 870 (1029)
Q Consensus 807 -~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nil 870 (1029)
...++||||+++|+|.+++.... ..+++..+..++.||++||+||| +++||||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCcccee
Confidence 56799999999999999996542 34889999999999999999999 677999999999999
Q ss_pred ECCCCcEEEEccCCceecCCCCC-ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCC-CCCCcccccccc
Q 036879 871 LNESMVACLSDFGISKLLGDETS-MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKK-KPTDELFVGEIS 944 (1029)
Q Consensus 871 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~-~p~~~~~~~~~~ 944 (1029)
+++++.+||+|||+|+....... .......||+.|+|||++ ++.++|||||||++|||++|. +||......+ .
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~ 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-H
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-H
Confidence 99999999999999987644332 233345799999999983 788999999999999999975 5665421111 1
Q ss_pred cchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 945 LKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 945 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
+...+.. ......+..+++++.+++.+||+.||++|||++|++++|+.+.+.
T Consensus 246 ~~~~~~~------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 246 FCRRLKE------------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHH------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhc------------------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111000 001122234567899999999999999999999999999988653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=388.82 Aligned_cols=248 Identities=20% Similarity=0.260 Sum_probs=195.3
Q ss_pred hCCCCCCc-eeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhc-CCCCceEEEEEEEec----CCeE
Q 036879 737 TDGFSENN-LLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGS-IRHRNLVKIISTCSS----DHFK 809 (1029)
Q Consensus 737 ~~~~~~~~-~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 809 (1029)
.++|++.. .||+|+||+||+|++. +++.||||+++.. ..+.+|++++.+ .+|||||+++++|++ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 45788765 5999999999999874 7999999998643 557789998755 589999999999865 4668
Q ss_pred EEEEeccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC---CCcEEEEccCCc
Q 036879 810 ALVLEYMPNGSLENWMYNKN-RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE---SMVACLSDFGIS 885 (1029)
Q Consensus 810 ~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~---~~~~kl~Dfg~a 885 (1029)
|+|||||+||+|.+++.+.. ..+++.++..++.||+.|++||| ++||+||||||+||+++. .+.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence 99999999999999997653 56999999999999999999999 778999999999999985 567999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
+....... .....||+.|||||++ ++.++||||+||++|||+||+.||.+...... ..........
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~~~~i~~------- 231 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKTRIRM------- 231 (335)
T ss_dssp EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCS-------
T ss_pred eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHHHHHHhc-------
Confidence 87755432 2345799999999994 67899999999999999999999975322111 1100000000
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
............+++++.+++.+|++.||++|||+.|++++
T Consensus 232 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 232 -----GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000111223567789999999999999999999999885
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-43 Score=393.35 Aligned_cols=241 Identities=21% Similarity=0.276 Sum_probs=200.6
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 813 (1029)
++|++.+.||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+++++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 79999999997542 233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCC
Q 036879 814 EYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETS 893 (1029)
Q Consensus 814 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 893 (1029)
||+.+|+|.+++... +.+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+......
T Consensus 121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~- 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence 999999999998654 46999999999999999999999 6779999999999999999999999999998765332
Q ss_pred ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhhh
Q 036879 894 MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQKE 969 (1029)
Q Consensus 894 ~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 969 (1029)
....||+.|||||++ ++.++||||+||++|||+||+.||.+..... . .. ....
T Consensus 196 ---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~---~~--------~i~~------- 252 (350)
T d1rdqe_ 196 ---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--I---YE--------KIVS------- 252 (350)
T ss_dssp ---CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HH--------HHHH-------
T ss_pred ---ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH--H---HH--------HHhc-------
Confidence 235699999999984 6788999999999999999999997531110 0 00 0000
Q ss_pred hhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 970 DAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 970 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
.....+..+++++.+++.+||..||++|+ |++|++++
T Consensus 253 -~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 253 -GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 00111234567899999999999999994 89999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=386.85 Aligned_cols=256 Identities=28% Similarity=0.464 Sum_probs=202.0
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCc--EEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCCeEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGM--QIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 812 (1029)
++|++.+.||+|+||+||+|++. +|. .||||.++... ....+.+.+|+++++++ +|||||+++++|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56888899999999999999875 454 47888876442 33556799999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcE
Q 036879 813 LEYMPNGSLENWMYNK---------------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVA 877 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~ 877 (1029)
|||+++|+|.++++.. ...+++..+..++.|||+|++|+| +++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999999643 356899999999999999999999 6789999999999999999999
Q ss_pred EEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCC-CCCcccccccccchhchhc
Q 036879 878 CLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKK-PTDELFVGEISLKSRVNDS 952 (1029)
Q Consensus 878 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~ 952 (1029)
||+|||+|+...... ......||..|+|||.+ ++.++|||||||++|||++|.. ||.+....+ +...+
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--~~~~i--- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKL--- 239 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHG---
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--HHHHH---
Confidence 999999998654322 22234689999999984 6889999999999999999765 565421111 11100
Q ss_pred cchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhccc
Q 036879 953 LHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTN 1018 (1029)
Q Consensus 953 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~ 1018 (1029)
.. . .+.+.+..+++++.+++.+||+.||++||||+||+++|+++.+.....
T Consensus 240 --------~~-----~--~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~ 290 (309)
T d1fvra_ 240 --------PQ-----G--YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 290 (309)
T ss_dssp --------GG-----T--CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred --------Hh-----c--CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCC
Confidence 00 0 011223346778999999999999999999999999999998765543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=385.87 Aligned_cols=265 Identities=23% Similarity=0.301 Sum_probs=198.7
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
++|++.+.||+|+||+||+|++. +|+.||||+++... +...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999974 79999999997553 2335788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
|+.++.+..........+++..+..++.|++.||+||| ++|||||||||+||+++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 99655444443445667999999999999999999999 77799999999999999999999999999987654332
Q ss_pred eeccccCCccccCccC-----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc---cchhhhhhh---hh
Q 036879 895 TQTQTLATIGYMAPEW-----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS---LHGKIINVV---DI 963 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~-----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~---d~ 963 (1029)
......||+.|+|||. ..+.++||||+||++|||++|+.||.+....+. +....... ....+.... +.
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH-HHHHHHhcCCCchhhcccccccccc
Confidence 3334579999999997 257789999999999999999999975321111 00000000 000000000 00
Q ss_pred h--h-hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 964 N--L-LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 964 ~--~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
. . ..............+..+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 0 000000011112345678999999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=389.42 Aligned_cols=243 Identities=21% Similarity=0.327 Sum_probs=197.8
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc---chhhHHHHHHHHHHh-cCCCCceEEEEEEEecCCeEEEE
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL---EGTLRSFDAECEILG-SIRHRNLVKIISTCSSDHFKALV 812 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV 812 (1029)
++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999976 79999999997542 233455667777664 68999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDET 892 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 892 (1029)
|||+++|+|.+++.. ...+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999999999864 456899999999999999999999 6779999999999999999999999999998664432
Q ss_pred CceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhhhhhhhh
Q 036879 893 SMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVDINLLQK 968 (1029)
Q Consensus 893 ~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 968 (1029)
. ......||+.|+|||++ ++.++||||+||++|||++|+.||.+....+. .. .. ...
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~-----------~i----~~~- 218 (320)
T d1xjda_ 158 A-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FH-----------SI----RMD- 218 (320)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH-----------HH----HHC-
T ss_pred c-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH--HH-----------HH----HcC-
Confidence 2 33446799999999983 67899999999999999999999975321110 00 00 000
Q ss_pred hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHH-HHHH
Q 036879 969 EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIK-EALT 1006 (1029)
Q Consensus 969 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-evl~ 1006 (1029)
....+..++.++.+++.+||+.||++|||+. |+++
T Consensus 219 ---~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 ---NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0112234567899999999999999999995 6764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=382.76 Aligned_cols=254 Identities=24% Similarity=0.432 Sum_probs=200.9
Q ss_pred hCCCCCCceeccCcceEEEEEEecC--------CcEEEEEEeecccc-hhhHHHHHHHHHHhcC-CCCceEEEEEEEecC
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLSD--------GMQIAVKVFNLELE-GTLRSFDAECEILGSI-RHRNLVKIISTCSSD 806 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~~--------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 806 (1029)
.++|++.+.||+|+||.||+|+... +..||||+++.... .....+.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4678889999999999999998532 35799999987653 3457788899998888 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEE
Q 036879 807 HFKALVLEYMPNGSLENWMYNKN---------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILL 871 (1029)
Q Consensus 807 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill 871 (1029)
+..++||||+++|+|.+++.... ..+++.++..++.||+.||+||| +.+||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence 99999999999999999996543 34899999999999999999999 7779999999999999
Q ss_pred CCCCcEEEEccCCceecCCCCCc-eeccccCCccccCccC----CCCCCcchhHHHHHHHHHhc-CCCCCCccccccccc
Q 036879 872 NESMVACLSDFGISKLLGDETSM-TQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFT-KKKPTDELFVGEISL 945 (1029)
Q Consensus 872 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~ 945 (1029)
+.++.+||+|||+++........ ......+++.|+|||. .+++++|||||||++|||++ |.+||.+....+ .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--~ 246 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L 246 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--H
Confidence 99999999999999876443222 2334568999999998 47889999999999999998 688876532111 0
Q ss_pred chhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHH
Q 036879 946 KSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRN 1013 (1029)
Q Consensus 946 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~ 1013 (1029)
. ..+.. ....+.+..++.++.+++.+||+.||++||||.||++.|+++.+
T Consensus 247 ~------------~~i~~------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 F------------KLLKE------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp H------------HHHHT------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H------------HHHHc------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 0 01100 00112223456789999999999999999999999999988854
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=381.85 Aligned_cols=257 Identities=23% Similarity=0.389 Sum_probs=206.3
Q ss_pred HhCCCCCCceeccCcceEEEEEEe------cCCcEEEEEEeeccc-chhhHHHHHHHHHHhcC-CCCceEEEEEEEecCC
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTL------SDGMQIAVKVFNLEL-EGTLRSFDAECEILGSI-RHRNLVKIISTCSSDH 807 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 807 (1029)
..++|++.+.||+|+||.||+|++ .+++.||||+++... ......+.+|+.+++++ +|||||++++++.+++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 346788899999999999999975 246789999997654 33456789999999999 6999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEE
Q 036879 808 FKALVLEYMPNGSLENWMYNKN-----------------RSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNIL 870 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nil 870 (1029)
..++||||+++|+|.++++... ..+++..+..++.||++|++||| +++||||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccc
Confidence 9999999999999999997543 25889999999999999999999 777999999999999
Q ss_pred ECCCCcEEEEccCCceecCCCCC-ceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhcCCCC-CCcccccccc
Q 036879 871 LNESMVACLSDFGISKLLGDETS-MTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKKKP-TDELFVGEIS 944 (1029)
Q Consensus 871 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~elltg~~p-~~~~~~~~~~ 944 (1029)
++.++.+|++|||.++....... .......||+.|+|||. .++.++|||||||++|||+|++.| |... .....
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-~~~~~ 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDSK 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CSSHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-CHHHH
Confidence 99999999999999987754332 33344678999999998 468899999999999999995554 4332 11111
Q ss_pred cchhchhccchhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 945 LKSRVNDSLHGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 945 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
+. ..+.... ....+..++..+.++|.+||+.||++||||+|+++.|+++..+
T Consensus 257 ~~------------~~i~~~~------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 FY------------KMIKEGF------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HH------------HHHHHTC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH------------HHHhcCC------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 11 1111111 1111234567899999999999999999999999999876543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=384.78 Aligned_cols=260 Identities=22% Similarity=0.254 Sum_probs=192.3
Q ss_pred CCceeccCcceEEEEEEec-CCcEEEEEEeecccch-----hhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 742 ENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEG-----TLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 742 ~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
.++.||+|+||+||+|++. +|+.||||+++..... ..+.+.+|++++++++|||||++++++..++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4578999999999999975 7999999998754321 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+.++++..+ ......+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+....... .
T Consensus 82 ~~~~~~~~~-~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~ 156 (299)
T d1ua2a_ 82 METDLEVII-KDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-A 156 (299)
T ss_dssp CSEEHHHHH-TTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-C
T ss_pred hcchHHhhh-hhcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc-c
Confidence 987766654 455677899999999999999999999 77899999999999999999999999999987654332 2
Q ss_pred eccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh---ccchhhhhhhh---hh
Q 036879 896 QTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND---SLHGKIINVVD---IN 964 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~d---~~ 964 (1029)
....+||+.|+|||++ ++.++||||+||++|||++|++||......+. +...... .....+.+... ..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHhcCCCChhhccchhccchhh
Confidence 2345799999999983 46789999999999999999999975321111 0000000 00000000000 00
Q ss_pred hh-hh-hhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 965 LL-QK-EDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 965 ~~-~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.. .. ...........++.+.+++.+|++.||++||||+|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 00 000011112345678999999999999999999999875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.2e-42 Score=380.36 Aligned_cols=292 Identities=29% Similarity=0.531 Sum_probs=225.5
Q ss_pred CchhHHHHHHHHHHhccCCCCCcccCCCCCCCCCCc--eeeEEEcCCC--CceEEEecccccccc--cCCccCCCCcCCC
Q 036879 2 NVGRDQSALLALKAHVTNDPLNVLASNWSTNTSVCN--WFGVTCSPRH--RRVTALNLAYMGLLG--TIPPELGNLSFLS 75 (1029)
Q Consensus 2 ~~~~~~~al~~~~~~~~~~~~~~~~~~w~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~~--~~p~~~~~l~~L~ 75 (1029)
|.++|++||++||+++. || +.++| |..++|||. |+||+|+..+ +||+.|+|+++++.| .||+++++|++|+
T Consensus 3 c~~~e~~aLl~~k~~~~-~~-~~l~s-W~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLG-NP-TTLSS-WLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp SCHHHHHHHHHHHHHTT-CC-GGGTT-CCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCHHHHHHHHHHHHHCC-CC-CcCCC-CCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 78999999999999996 45 46888 888899995 9999998754 489999999999998 6899999999999
Q ss_pred eEeccC-cccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccC
Q 036879 76 LLNVTN-NSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSF 154 (1029)
Q Consensus 76 ~L~l~~-n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 154 (1029)
+|+|++ |+++|.+|.+|+++++|++|+|++|++..+ .|..+..+++|+++++++|++.+.+|..+++++.|+++++++
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~-~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~ 158 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA-IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE-CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred ccccccccccccccccccccccccchhhhcccccccc-ccccccchhhhcccccccccccccCchhhccCcccceeeccc
Confidence 999997 899999999999999999999999999974 466788999999999999999999999999999999999999
Q ss_pred CcCcccCCccccCCCcC-cccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEc
Q 036879 155 NQLQGHVPSSILNIPSL-LAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSL 233 (1029)
Q Consensus 155 N~l~~~~p~~~~~l~~L-~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 233 (1029)
|++++.+|..+..+.++ +.+++++|++++..+..+.. .....++++++...+.+|..+..+++|+.|++
T Consensus 159 n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~----------l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~ 228 (313)
T d1ogqa_ 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN----------LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHL 228 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG----------CCCSEEECCSSEEEECCGGGCCTTSCCSEEEC
T ss_pred cccccccccccccccccccccccccccccccccccccc----------cccccccccccccccccccccccccccccccc
Confidence 99999999999988876 77888888887766543321 12334555666666666666666666666666
Q ss_pred ccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhh
Q 036879 234 SVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGH 313 (1029)
Q Consensus 234 s~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~ 313 (1029)
++|.+.+.+| .++.++ +|+.|+|++|+++|.+|+.|.++++|++|+|++|+++|.+|.. .
T Consensus 229 ~~~~l~~~~~-~~~~~~-----------------~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~--~ 288 (313)
T d1ogqa_ 229 AKNSLAFDLG-KVGLSK-----------------NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG--G 288 (313)
T ss_dssp CSSEECCBGG-GCCCCT-----------------TCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS--T
T ss_pred cccccccccc-cccccc-----------------ccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCc--c
Confidence 6666654433 233333 2335666666666666666666666666666666666666542 2
Q ss_pred cccccceEeecCcc
Q 036879 314 SLPNLQQLILGGNR 327 (1029)
Q Consensus 314 ~l~~L~~L~L~~N~ 327 (1029)
.+++|+.+++++|+
T Consensus 289 ~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 289 NLQRFDVSAYANNK 302 (313)
T ss_dssp TGGGSCGGGTCSSS
T ss_pred cCCCCCHHHhCCCc
Confidence 35556666666554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-42 Score=376.71 Aligned_cols=264 Identities=22% Similarity=0.283 Sum_probs=199.1
Q ss_pred CCCCCCceeccCcceEEEEEEecCCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEec
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLEY 815 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 815 (1029)
++|++.+.||+|+||+||+|++.+|+.||||+++... ....+.+.+|+.++++++|||||++++++..++..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999999999999997653 23357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCce
Q 036879 816 MPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSMT 895 (1029)
Q Consensus 816 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 895 (1029)
+.++.+..+ ....+.+++..+..++.||+.||+||| +.+||||||||+||+++.++.+|++|||.|........ .
T Consensus 82 ~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 156 (286)
T d1ob3a_ 82 LDQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (286)
T ss_dssp CSEEHHHHH-HTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHH-HhhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-c
Confidence 976655554 466678999999999999999999999 67799999999999999999999999999987654322 2
Q ss_pred eccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc---cchhhhhh------h
Q 036879 896 QTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS---LHGKIINV------V 961 (1029)
Q Consensus 896 ~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~------~ 961 (1029)
.....+++.|+|||.+ ++.++||||+||++|||++|+.||.+....+. +.+..... ....+... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhhcc
Confidence 3345689999999983 57899999999999999999999975321111 11000000 00000000 0
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
..................++.+.+++++|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000111111123346778999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=377.30 Aligned_cols=237 Identities=22% Similarity=0.315 Sum_probs=193.5
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccc------hhhHHHHHHHHHHhcCC--CCceEEEEEEEecCC
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELE------GTLRSFDAECEILGSIR--HRNLVKIISTCSSDH 807 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 807 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999975 799999999975421 12244678999999986 899999999999999
Q ss_pred eEEEEEeccCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC-CCcEEEEccCCc
Q 036879 808 FKALVLEYMPN-GSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-SMVACLSDFGIS 885 (1029)
Q Consensus 808 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-~~~~kl~Dfg~a 885 (1029)
..++||||+.+ +++.+++.. ...+++..+..++.|+++||+||| ++||+||||||+||+++. ++.+||+|||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence 99999999976 577777754 456999999999999999999999 778999999999999985 579999999999
Q ss_pred eecCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhh
Q 036879 886 KLLGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINV 960 (1029)
Q Consensus 886 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 960 (1029)
+..... ......||+.|+|||++ ++.++||||+||++|||++|+.||..... .....
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------i~~~~---- 220 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIRGQ---- 220 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HHHCC----
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----------Hhhcc----
Confidence 875433 22346799999999983 35678999999999999999999965210 00000
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 961 ~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...+..++.++.+++.+||+.||++|||++|++++
T Consensus 221 ------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 ------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00111245678999999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=380.84 Aligned_cols=256 Identities=21% Similarity=0.373 Sum_probs=205.0
Q ss_pred HhCCCCCCceeccCcceEEEEEEec------CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCe
Q 036879 736 ATDGFSENNLLGKGSFGSVYKGTLS------DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHF 808 (1029)
Q Consensus 736 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 808 (1029)
..++|+..+.||+|+||+||+|.+. +++.||||+++... ......+.+|++++++++|||||++++++..++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3467888999999999999999763 35789999997543 3344578999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEE
Q 036879 809 KALVLEYMPNGSLENWMYNK---------NRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACL 879 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl 879 (1029)
.++||||+++|+|.+++... ....++..+..++.|+|+||+||| +++|+||||||+|||++.++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEE
Confidence 99999999999999998642 234688999999999999999999 667999999999999999999999
Q ss_pred EccCCceecCCCCC-ceeccccCCccccCccC----CCCCCcchhHHHHHHHHHhcCC-CCCCcccccccccchhchhcc
Q 036879 880 SDFGISKLLGDETS-MTQTQTLATIGYMAPEW----KLSRKGDVYSYGIILMETFTKK-KPTDELFVGEISLKSRVNDSL 953 (1029)
Q Consensus 880 ~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~----~~~~~~DvwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~ 953 (1029)
+|||+|+....... .......+|+.|+|||. .++.++|||||||++|||+||+ +||.+....+ .
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-----~----- 244 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-----V----- 244 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----H-----
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-----H-----
Confidence 99999986643322 22333468999999998 3677899999999999999985 6665421111 0
Q ss_pred chhhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHh
Q 036879 954 HGKIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNT 1014 (1029)
Q Consensus 954 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~ 1014 (1029)
+..+.+.. ..+.+..++..+.+++.+||+.+|++|||++||+++|++....
T Consensus 245 ---~~~i~~~~-------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 245 ---LRFVMEGG-------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ---HHHHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ---HHHHHhCC-------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11111111 1112334567899999999999999999999999999876543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-42 Score=375.80 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=196.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-C-CcEEEEEEeecccc--hhhHHHHHHHHHHhcC---CCCceEEEEEEEec----
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-D-GMQIAVKVFNLELE--GTLRSFDAECEILGSI---RHRNLVKIISTCSS---- 805 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~-~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 805 (1029)
.++|++.+.||+|+||+||+|++. + ++.||||+++.... .....+.+|+++++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 578999999999999999999874 4 67799999876432 2334567788877665 79999999999853
Q ss_pred -CCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCC
Q 036879 806 -DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGI 884 (1029)
Q Consensus 806 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~ 884 (1029)
....++||||++++.+..........+++..+..++.|++.||+||| +++||||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 34678999999888777666667778999999999999999999999 77799999999999999999999999999
Q ss_pred ceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh---ccchhh
Q 036879 885 SKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND---SLHGKI 957 (1029)
Q Consensus 885 a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~ 957 (1029)
++..... .......||+.|+|||++ ++.++||||+||++|||++|++||.+....+. +...... .....+
T Consensus 163 ~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 163 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGGGS
T ss_pred hhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCchhcc
Confidence 9765332 223446799999999984 78899999999999999999999975321111 0000000 000000
Q ss_pred hhhh---hhhh-hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 958 INVV---DINL-LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 958 ~~~~---d~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.... .... ..............++.+.+++.+|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0000 000000111122345678999999999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.2e-40 Score=360.15 Aligned_cols=267 Identities=15% Similarity=0.204 Sum_probs=212.3
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCC-CceEEEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRH-RNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ..+.+.+|++.++.++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999975 78999999886543 33567889999999965 899999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECC-----CCcEEEEccCCceecC
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNE-----SMVACLSDFGISKLLG 889 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~-----~~~~kl~Dfg~a~~~~ 889 (1029)
|+ +++|.+++......+++.++..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||+|+.+.
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 78999999887888999999999999999999999 888999999999999974 6789999999998764
Q ss_pred CCCC------ceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhh
Q 036879 890 DETS------MTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIIN 959 (1029)
Q Consensus 890 ~~~~------~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1029)
.... .......||+.|||||++ ++.++|||||||++|||++|+.||......... .. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~--~~--------~~~ 227 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--QK--------YER 227 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--HH--------HHH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH--HH--------HHH
Confidence 3221 112335799999999984 677899999999999999999999753221110 00 000
Q ss_pred hhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcccccCC
Q 036879 960 VVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNIENS 1022 (1029)
Q Consensus 960 ~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~~~~ 1022 (1029)
...... .....+....+++++.+++..|+..+|++||+++.+.+.++++.++...+.+..
T Consensus 228 i~~~~~---~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~ 287 (293)
T d1csna_ 228 IGEKKQ---STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN 287 (293)
T ss_dssp HHHHHH---HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSC
T ss_pred HHhccC---CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCC
Confidence 110000 001111223456789999999999999999999999999999988776665543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-40 Score=363.19 Aligned_cols=264 Identities=19% Similarity=0.267 Sum_probs=202.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceE-EEEEEEecCCeEEEEEe
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLV-KIISTCSSDHFKALVLE 814 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E 814 (1029)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+..|+++++.++|++++ .+.+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 467999999999999999999874 78999999987543 235688999999999877655 55566677888999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEEC---CCCcEEEEccCCceecCCC
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLN---ESMVACLSDFGISKLLGDE 891 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~---~~~~~kl~Dfg~a~~~~~~ 891 (1029)
|+ ++++.+.+....+.+++..+..++.|++.||+||| ++|||||||||+||+++ .+..+|++|||+|+.+...
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99 66787777777888999999999999999999999 67799999999999986 4567999999999977543
Q ss_pred CCc------eeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhh
Q 036879 892 TSM------TQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVV 961 (1029)
Q Consensus 892 ~~~------~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 961 (1029)
... ......||+.|||||.+ ++.++|||||||++|||++|+.||........... +. ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~--~~--------~~~ 229 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--YE--------RIS 229 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------HH--------HHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH--HH--------Hhh
Confidence 211 22345799999999983 67899999999999999999999976422211110 00 000
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHHHHHhHHhhcccc
Q 036879 962 DINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTKLLKIRNTLLTNI 1019 (1029)
Q Consensus 962 d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~i~~~~~~~~ 1019 (1029)
.... ..........+++++.+++..||+.+|++||+++++.+.|+.+..+...+.
T Consensus 230 ~~~~---~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 284 (299)
T d1ckia_ 230 EKKM---STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284 (299)
T ss_dssp HHHH---HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred cccC---CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCC
Confidence 0000 001111223467889999999999999999999999999998876544333
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=371.47 Aligned_cols=265 Identities=19% Similarity=0.236 Sum_probs=193.7
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc-chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC----eEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH----FKA 810 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 810 (1029)
..+|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999864 89999999997543 344567899999999999999999999996543 234
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCC
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGD 890 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 890 (1029)
+++||+.+|+|.+++.. +.+++..+..++.|+++||+||| ++|||||||||+|||++.++.+||+|||+|+....
T Consensus 87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 55566679999999854 36899999999999999999999 67799999999999999999999999999987643
Q ss_pred CCC--ceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccch--------
Q 036879 891 ETS--MTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHG-------- 955 (1029)
Q Consensus 891 ~~~--~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 955 (1029)
... ......+||+.|+|||++ ++.++||||+||++|||++|+.||......... ..........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHHTC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH-HHHhhhccCCChhhhhhh
Confidence 221 122345689999999984 567899999999999999999999753221110 0000000000
Q ss_pred ---hhhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 ---KIINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 ---~~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
........................+.++.+++.+|++.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000000011112234678999999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=362.62 Aligned_cols=265 Identities=20% Similarity=0.281 Sum_probs=202.0
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCCeEEEEEe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDHFKALVLE 814 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 814 (1029)
++|++.+.||+|+||+||+|++. +++.||||+++... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 78999999997553 3446789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceecCCCCCc
Q 036879 815 YMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLLGDETSM 894 (1029)
Q Consensus 815 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 894 (1029)
++.++++..++ ...+.+++..+..++.|++.||+||| ++|||||||||+||+++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred ecccccccccc-ccccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 99988887766 45667899999999999999999999 67799999999999999999999999999987754332
Q ss_pred eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhc---hhccchhh------hhh
Q 036879 895 TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRV---NDSLHGKI------INV 960 (1029)
Q Consensus 895 ~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~------~~~ 960 (1029)
......+++.|+|||.+ ++.++||||+||++|||++|+.||.........+.... .......+ .+.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 22334578899999973 57789999999999999999999743221111111000 00000000 000
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 961 VDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 961 ~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
...................++.+.+++++|++.||++||||+|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000111111123345678999999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-40 Score=362.38 Aligned_cols=267 Identities=20% Similarity=0.278 Sum_probs=193.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEec--------
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSS-------- 805 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 805 (1029)
.++|++.+.||+|+||+||+|++. +|+.||||++.... +...+.+.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999975 89999999986553 3345678899999999999999999999855
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCc
Q 036879 806 DHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGIS 885 (1029)
Q Consensus 806 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a 885 (1029)
.+..++||||++++.+.. .......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+|++|||+|
T Consensus 89 ~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence 345789999997766554 4456677999999999999999999999 778999999999999999999999999999
Q ss_pred eecCCCCCc---eeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccc--cchhchhccch
Q 036879 886 KLLGDETSM---TQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEIS--LKSRVNDSLHG 955 (1029)
Q Consensus 886 ~~~~~~~~~---~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~ 955 (1029)
+.+...... ......||+.|+|||++ ++.++||||+||++|||++|+.||.+....+.. +..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 876543221 22235699999999973 578999999999999999999999753211110 00000000000
Q ss_pred --------hhhhhhhhhhh-hhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 956 --------KIINVVDINLL-QKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 956 --------~~~~~~d~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
........... .......-......+.+.+++.+|++.||++||||+|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000000000 00000001112235677899999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=370.28 Aligned_cols=249 Identities=23% Similarity=0.274 Sum_probs=200.6
Q ss_pred CCCCCCceeccCcceEEEEEEec----CCcEEEEEEeeccc----chhhHHHHHHHHHHhcCCC-CceEEEEEEEecCCe
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS----DGMQIAVKVFNLEL----EGTLRSFDAECEILGSIRH-RNLVKIISTCSSDHF 808 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~----~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 808 (1029)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999752 58899999986542 2345678899999999966 899999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.++||||+.+|+|.+++... +.+++..+..++.|++.|++|+| +++||||||||+||+++.++.+||+|||+|+.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999998544 45678889999999999999999 677999999999999999999999999999877
Q ss_pred CCCCCceeccccCCccccCccCC------CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhccchhhhhhhh
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK------LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSLHGKIINVVD 962 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 962 (1029)
............|++.|+|||.+ ++.++||||+||++|||++|+.||......+. ......
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~------------ 246 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISR------------ 246 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHH------------
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH------------
Confidence 55444444456799999999974 56789999999999999999999976422211 000000
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 036879 963 INLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERI-----NIKEALTK 1007 (1029)
Q Consensus 963 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1007 (1029)
. ........+..++.++.+++.+||++||++|| |++|++++
T Consensus 247 ~----~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 247 R----ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp H----HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred h----cccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0 00001112234678899999999999999999 58999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=369.51 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=193.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecCC------
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSDH------ 807 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 807 (1029)
.++|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|++++++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 79999999997543 334567899999999999999999999997654
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
..++||||+ +.+|..+.. ...+++..+..++.||+.||+||| ++|||||||||+|||++.++.+|++|||.|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence 468999999 667877764 346999999999999999999999 77899999999999999999999999999987
Q ss_pred cCCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchh--ccchhhhh-
Q 036879 888 LGDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVND--SLHGKIIN- 959 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~- 959 (1029)
.... .+...||+.|+|||++ ++.++||||+||++|||++|+.||........ +...... .....+..
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHT
T ss_pred cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHhccCCCcHHHHhh
Confidence 6443 2345799999999973 57799999999999999999999976321111 0000000 00000000
Q ss_pred -------hhhhhhhh-hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH--HHHh
Q 036879 960 -------VVDINLLQ-KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK--LLKI 1011 (1029)
Q Consensus 960 -------~~d~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~i 1011 (1029)
........ ............++.+.+++.+|+..||++|||++|++++ ++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00000000 0000001112345678999999999999999999999986 5444
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=363.97 Aligned_cols=264 Identities=22% Similarity=0.314 Sum_probs=192.1
Q ss_pred CCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCceEEEEEEEec------CCeEEE
Q 036879 739 GFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRNLVKIISTCSS------DHFKAL 811 (1029)
Q Consensus 739 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~l 811 (1029)
+|+..++||+|+||+||+|++. +|+.||||++..... ...+|++++++++||||++++++|.. ....++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778899999999999999975 799999999976532 23479999999999999999999854 235789
Q ss_pred EEeccCCCCHHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC-cEEEEccCCceec
Q 036879 812 VLEYMPNGSLENWM--YNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM-VACLSDFGISKLL 888 (1029)
Q Consensus 812 V~E~~~~gsL~~~l--~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~ 888 (1029)
||||++++.+.... ......+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999766433322 235667999999999999999999999 78899999999999999775 8999999999877
Q ss_pred CCCCCceeccccCCccccCccC-----CCCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch---hccchhhhhh
Q 036879 889 GDETSMTQTQTLATIGYMAPEW-----KLSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN---DSLHGKIINV 960 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~ 960 (1029)
..... .....||+.|+|||. .++.++||||+||++|||++|+.||......+. +..... ......+...
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhhhh
Confidence 54332 233579999999997 367899999999999999999999975322111 111000 0000000000
Q ss_pred ----hhhhhhhhh--hhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH--HHHhH
Q 036879 961 ----VDINLLQKE--DAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK--LLKIR 1012 (1029)
Q Consensus 961 ----~d~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~i~ 1012 (1029)
.+....... ..........++++.+++.+|+..||++|||++|++++ ++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000000000 00000011245678999999999999999999999975 55554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.9e-40 Score=362.14 Aligned_cols=259 Identities=17% Similarity=0.272 Sum_probs=194.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCC-CCceEEEEEEEec--CCeEEEE
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKIISTCSS--DHFKALV 812 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV 812 (1029)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.. ..+.+.+|++++++++ ||||+++++++.. ....++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 367999999999999999999975 7999999998754 2467889999999995 9999999999974 4568999
Q ss_pred EeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC-cEEEEccCCceecCCC
Q 036879 813 LEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM-VACLSDFGISKLLGDE 891 (1029)
Q Consensus 813 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~ 891 (1029)
|||+++++|.++ .+.+++..+..++.||+.||+||| ++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 111 ~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 111 FEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999998764 356899999999999999999999 77899999999999998654 6999999999876543
Q ss_pred CCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhc--------------
Q 036879 892 TSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDS-------------- 952 (1029)
Q Consensus 892 ~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------------- 952 (1029)
.. .....+|+.|+|||.. ++.++||||+||++|||++|+.||.................
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 22 2345789999999983 57789999999999999999999865322111000000000
Q ss_pred -cchhhhhhhhhhhhh--hhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 953 -LHGKIINVVDINLLQ--KEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 953 -~~~~~~~~~d~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
............... ............++++.+++++|+..||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000000 0000011122346678999999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-39 Score=359.77 Aligned_cols=261 Identities=20% Similarity=0.224 Sum_probs=187.1
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEec------CC
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSS------DH 807 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 807 (1029)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+.++++++|||||++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999976 79999999997653 3345678999999999999999999999954 36
Q ss_pred eEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 808 FKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 808 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
..|+||||+.++.+ +.+ ...+++..+..++.|++.|++||| +.||+||||||+||+++.++.+|++|||.++.
T Consensus 96 ~~~iv~Ey~~~~l~-~~~---~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVI---QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEEECCSEEHH-HHH---TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eeEEEEeccchHHH-Hhh---hcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhc
Confidence 78999999966544 444 245899999999999999999999 77899999999999999999999999999886
Q ss_pred cCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhch----------hcc
Q 036879 888 LGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVN----------DSL 953 (1029)
Q Consensus 888 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~----------~~~ 953 (1029)
..... ......+|+.|+|||++ ++.++||||+||+++||++|+.||.+...... ...... ...
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHTTS
T ss_pred ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH-HHHHHHhccCCCHHHHHHh
Confidence 54432 23445789999999984 67899999999999999999999965321110 000000 000
Q ss_pred chhhhhhhhhhh------------hhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 954 HGKIINVVDINL------------LQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 954 ~~~~~~~~d~~~------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
........+... ..............+..+.+++.+|+..||++||||+|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000 000001112234467789999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=362.23 Aligned_cols=261 Identities=20% Similarity=0.260 Sum_probs=192.4
Q ss_pred hCCCCCCceeccCcceEEEEEEec-CCcEEEEEEeeccc--chhhHHHHHHHHHHhcCCCCceEEEEEEEecC-----Ce
Q 036879 737 TDGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL--EGTLRSFDAECEILGSIRHRNLVKIISTCSSD-----HF 808 (1029)
Q Consensus 737 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 808 (1029)
.++|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999875 79999999997653 23456788999999999999999999998643 34
Q ss_pred EEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEccCCceec
Q 036879 809 KALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDFGISKLL 888 (1029)
Q Consensus 809 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 888 (1029)
.++||||+.+|+|.+++. .+.+++..+..++.||+.||+||| ++||+||||||+||+++.++.+|++|||.|...
T Consensus 97 ~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence 467778888999999984 356999999999999999999999 778999999999999999999999999999754
Q ss_pred CCCCCceeccccCCccccCccCC-----CCCCcchhHHHHHHHHHhcCCCCCCcccccccccchhchhcc--chh-----
Q 036879 889 GDETSMTQTQTLATIGYMAPEWK-----LSRKGDVYSYGIILMETFTKKKPTDELFVGEISLKSRVNDSL--HGK----- 956 (1029)
Q Consensus 889 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~----- 956 (1029)
.. ......|++.|+|||.. ++.++||||+||++|+|++|+.||.+...... ......... ...
T Consensus 172 ~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 172 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp TG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHTTC
T ss_pred Cc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHhhhc
Confidence 32 22345689999999972 57799999999999999999999975321100 000000000 000
Q ss_pred ----hhhhhhhhhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 036879 957 ----IINVVDINLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEALTK 1007 (1029)
Q Consensus 957 ----~~~~~d~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1007 (1029)
.......................+..+.+++.+|++.||++||||+|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000000000000001112346678999999999999999999999984
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-34 Score=324.58 Aligned_cols=263 Identities=14% Similarity=0.184 Sum_probs=185.2
Q ss_pred CCCCCCceeccCcceEEEEEEec-CCcEEEEEEeecccchhhHHHHHHHHHHhcCC-----------CCceEEEEEEEec
Q 036879 738 DGFSENNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLELEGTLRSFDAECEILGSIR-----------HRNLVKIISTCSS 805 (1029)
Q Consensus 738 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 805 (1029)
.+|++.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999975 79999999997553 23467788999888875 5789999988854
Q ss_pred --CCeEEEEEeccCCCCHH-H-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCC------
Q 036879 806 --DHFKALVLEYMPNGSLE-N-WMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESM------ 875 (1029)
Q Consensus 806 --~~~~~lV~E~~~~gsL~-~-~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~------ 875 (1029)
....++||+++..+... . ........+++..+..++.||+.|++|||+ ..||+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 45666777765544332 2 223345678999999999999999999994 26899999999999998655
Q ss_pred cEEEEccCCceecCCCCCceeccccCCccccCccCC----CCCCcchhHHHHHHHHHhcCCCCCCcccccccc-cchhch
Q 036879 876 VACLSDFGISKLLGDETSMTQTQTLATIGYMAPEWK----LSRKGDVYSYGIILMETFTKKKPTDELFVGEIS-LKSRVN 950 (1029)
Q Consensus 876 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~ 950 (1029)
.++++|||.|...... .....||+.|+|||++ ++.++||||+||+++||++|+.||......... ......
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 4999999999865432 2345699999999983 678999999999999999999999653211000 000000
Q ss_pred hcc--ch----h-h------hhhhhh-------------hhhhhhhhhhHHHHHHHHHHHHHHHHcccccccCCCCHHHH
Q 036879 951 DSL--HG----K-I------INVVDI-------------NLLQKEDAYLTAKEQCVSSVLSLAMQCTRESAEERINIKEA 1004 (1029)
Q Consensus 951 ~~~--~~----~-~------~~~~d~-------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev 1004 (1029)
... .+ . . ....+. ................+..+.+++.+|+..||++||||+|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 000 00 0 0 000000 00000001111234567889999999999999999999999
Q ss_pred HHH
Q 036879 1005 LTK 1007 (1029)
Q Consensus 1005 l~~ 1007 (1029)
+++
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 885
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.1e-31 Score=295.27 Aligned_cols=258 Identities=36% Similarity=0.593 Sum_probs=231.5
Q ss_pred hcceecccccccc--ccccccCCcCcCcEEEecC-ccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEe
Q 036879 406 MDVLYLSACNIKG--SIPSEIGNLNNLTTLHLET-NELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFY 482 (1029)
Q Consensus 406 L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 482 (1029)
++.|+|++|++++ .+|..++++++|++|+|++ |+++|.+|..|.++++|++|+|++|++.+..+..+..+.+|+.++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence 6667777777766 4678888899999999986 788888888899999999999999999888888888899999999
Q ss_pred cCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCC-cEEEccCCcccCcCCccccccccccEEEccCCcCC
Q 036879 483 SDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDI-LNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLS 561 (1029)
Q Consensus 483 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 561 (1029)
+++|.+.+.+|..+.++++|+.+++++|++++.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+.
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 99999988999999999999999999999999999999888876 889999999999889888887554 7999999999
Q ss_pred CCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCCCC
Q 036879 562 GEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGP 641 (1029)
Q Consensus 562 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 641 (1029)
+.+|..+..+++|+.|++++|.+.+.+| .+..+++|+.|+|++|+++|.+|..+.++++|++|+|++|+|+|.+|..+.
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~ 289 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred cccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence 9999999999999999999999997655 688899999999999999999999999999999999999999999999888
Q ss_pred CCccCcccccCCCCCCCCCCCCCCCCC
Q 036879 642 FTNLSSQSFVGNKGLCGAPELKFPACK 668 (1029)
Q Consensus 642 ~~~l~~~~~~~n~~~c~~~~~~~~~~~ 668 (1029)
++.+..+++.||+.+||.|. |+|.
T Consensus 290 L~~L~~l~l~~N~~l~g~pl---p~c~ 313 (313)
T d1ogqa_ 290 LQRFDVSAYANNKCLCGSPL---PACT 313 (313)
T ss_dssp GGGSCGGGTCSSSEEESTTS---SCCC
T ss_pred CCCCCHHHhCCCccccCCCC---CCCC
Confidence 99999999999999999984 6773
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=3.1e-27 Score=267.67 Aligned_cols=357 Identities=24% Similarity=0.354 Sum_probs=202.6
Q ss_pred EeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccCCc
Q 036879 77 LNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSFNQ 156 (1029)
Q Consensus 77 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 156 (1029)
.+++.+.+++.++ ...+.+|++|++++|.|+.+ +.++.+++|++|+|++|+|++ +|+ ++++++|++|++++|+
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l---~gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~ 99 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI---DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQ 99 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC---TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSC
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc---cccccCCCCCEEeCcCCcCCC-Ccc-ccCCcccccccccccc
Confidence 4566666665544 35677788888888888753 357778888888888888884 443 8888888888888888
Q ss_pred CcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEcccc
Q 036879 157 LQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVN 236 (1029)
Q Consensus 157 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 236 (1029)
+.+ ++ .+.++++|+.|++++|.+++..+.... . .+..+....|.+....+.................
T Consensus 100 i~~-i~-~l~~l~~L~~L~~~~~~~~~~~~~~~~-~----------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 166 (384)
T d2omza2 100 IAD-IT-PLANLTNLTGLTLFNNQITDIDPLKNL-T----------NLNRLELSSNTISDISALSGLTSLQQLSFGNQVT 166 (384)
T ss_dssp CCC-CG-GGTTCTTCCEEECCSSCCCCCGGGTTC-T----------TCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC
T ss_pred ccc-cc-ccccccccccccccccccccccccccc-c----------cccccccccccccccccccccccccccccccccc
Confidence 874 33 377888888888888887755432211 1 1222333333333222211111111111111111
Q ss_pred cccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhccc
Q 036879 237 NFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLP 316 (1029)
Q Consensus 237 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~ 316 (1029)
. ...+... ..........|... ....+..+++++.+++++|.+.+..|. ...+
T Consensus 167 ~-----~~~~~~~-----------------~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~~---~~~~ 219 (384)
T d2omza2 167 D-----LKPLANL-----------------TTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITPL---GILT 219 (384)
T ss_dssp C-----CGGGTTC-----------------TTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGGG---GGCT
T ss_pred h-----hhhhccc-----------------cccccccccccccc--cccccccccccceeeccCCccCCCCcc---cccC
Confidence 1 1111111 12223344444433 344566677777777777777643332 2356
Q ss_pred ccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCC
Q 036879 317 NLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLP 396 (1029)
Q Consensus 317 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 396 (1029)
+|++|++++|+++.. ..+..+++|+.+++++|.+++..+ +..+++|++|++++|++.+.
T Consensus 220 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-----------------~~~~~~L~~L~l~~~~l~~~-- 278 (384)
T d2omza2 220 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP-----------------LSGLTKLTELKLGANQISNI-- 278 (384)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-----------------GTTCTTCSEEECCSSCCCCC--
T ss_pred CCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc-----------------ccccccCCEeeccCcccCCC--
Confidence 777777777777642 345555666666666665543221 22344555555555554422
Q ss_pred ccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCC
Q 036879 397 ISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLR 476 (1029)
Q Consensus 397 ~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 476 (1029)
. .+..++.++.++++.|++++. ..+..+++++.|++++|++++.. .+..++
T Consensus 279 -----------------------~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~ 329 (384)
T d2omza2 279 -----------------------S--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLT 329 (384)
T ss_dssp -----------------------G--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCT
T ss_pred -----------------------C--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCC
Confidence 1 134455555555555555531 23455555666666666655432 255556
Q ss_pred CCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCC
Q 036879 477 SLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSN 534 (1029)
Q Consensus 477 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 534 (1029)
+|++|++++|++++ ++ .++++++|++|++++|+|+++.| +.++++|+.|+|++|
T Consensus 330 ~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 330 KLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp TCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 66666666666553 22 47777777777777777776654 777778888888776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=4.9e-27 Score=266.07 Aligned_cols=194 Identities=30% Similarity=0.450 Sum_probs=154.3
Q ss_pred ccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCcccccccccc
Q 036879 421 PSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLI 500 (1029)
Q Consensus 421 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 500 (1029)
...+..+++++.+++++|.+++..| +...++|++|++++|+++.. ..+..+++|+.|++++|.+++..+ +..++
T Consensus 190 ~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~ 263 (384)
T d2omza2 190 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLT 263 (384)
T ss_dssp CGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCT
T ss_pred ccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccc
Confidence 4456677788888888888886544 45567888888888888653 356777888888888888876543 77888
Q ss_pred ccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccc
Q 036879 501 SLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLA 580 (1029)
Q Consensus 501 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 580 (1029)
+|++|++++|++++.. .+..++.++.+.+++|++++ ...+..+++++.|++++|++++.. .+..+++|+.|+++
T Consensus 264 ~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~ 337 (384)
T d2omza2 264 KLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFA 337 (384)
T ss_dssp TCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECC
T ss_pred cCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECC
Confidence 9999999999988654 37788889999999999885 345788889999999999998653 37888999999999
Q ss_pred cccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCC
Q 036879 581 DNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFN 630 (1029)
Q Consensus 581 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 630 (1029)
+|+|++ ++ .+.++++|++|+|++|+|++.+| +.++++|+.|++++|
T Consensus 338 ~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 338 NNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 999984 44 58889999999999999997655 788999999999987
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=8.5e-26 Score=244.07 Aligned_cols=208 Identities=23% Similarity=0.248 Sum_probs=118.3
Q ss_pred CcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEec-CCCcccCccccccccccccceeecc
Q 036879 430 LTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYS-DGNELNGSLPQCLDSLISLRTLSLG 508 (1029)
Q Consensus 430 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l-~~N~l~~~~~~~~~~l~~L~~L~Ls 508 (1029)
+++|+|++|+|++..+.+|.++++|++|++++|++..+.+..+..+..+..+.. ..|.+....+..|+++++|++|+++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~ 113 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred CCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecC
Confidence 444444444444333334444444444444444444444444444444444432 2344444445555566666666666
Q ss_pred CccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccC
Q 036879 509 FNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSI 588 (1029)
Q Consensus 509 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 588 (1029)
+|.+..+.+..+...++|+.+++++|+|+++.+..|..+++|+.|++++|++++..+..|.++++|+.+++++|++++..
T Consensus 114 ~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~ 193 (284)
T d1ozna_ 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193 (284)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccC
Confidence 66665555555555666666666666666555555666666666666666666555566666666666666666666666
Q ss_pred CccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCC
Q 036879 589 PDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVP 637 (1029)
Q Consensus 589 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 637 (1029)
|..|..+++|++||+++|++++..+..|.++++|++|++++|++.|..+
T Consensus 194 ~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 6666666666666666666666666666666666666666666665443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=2.2e-24 Score=235.64 Aligned_cols=279 Identities=23% Similarity=0.299 Sum_probs=159.9
Q ss_pred ccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCC
Q 036879 269 LQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMP 348 (1029)
Q Consensus 269 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls 348 (1029)
++.+|-++++++ .+|..+. +++++|+|++|+|+ .+|...+..+++|++|++++|.+....|..|.+++.|+.|+++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 345677777777 4455543 56777777777775 6666555567777777777777777667777777777777777
Q ss_pred CccccCCCCCCCCCCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcC
Q 036879 349 YNLFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLN 428 (1029)
Q Consensus 349 ~N~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~ 428 (1029)
+|+++. +|..+ ...++.|++++|.+.+..+ ..+....
T Consensus 88 ~n~l~~-l~~~~-----------------~~~l~~L~~~~n~l~~l~~-------------------------~~~~~~~ 124 (305)
T d1xkua_ 88 KNQLKE-LPEKM-----------------PKTLQELRVHENEITKVRK-------------------------SVFNGLN 124 (305)
T ss_dssp SSCCSB-CCSSC-----------------CTTCCEEECCSSCCCBBCH-------------------------HHHTTCT
T ss_pred CCccCc-Cccch-----------------hhhhhhhhccccchhhhhh-------------------------hhhhccc
Confidence 776653 22211 2345556666665553333 2333333
Q ss_pred cCcEEEecCcccc--ccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceee
Q 036879 429 NLTTLHLETNELT--GSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLS 506 (1029)
Q Consensus 429 ~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 506 (1029)
.+..++...|... ...+..|..+++|+.+++++|.+...... ..++|+.|++++|.+....+..|.+++.+++|+
T Consensus 125 ~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~---~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~ 201 (305)
T d1xkua_ 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG---LPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201 (305)
T ss_dssp TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSS---CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEE
T ss_pred cccccccccccccccCCCccccccccccCccccccCCccccCcc---cCCccCEEECCCCcCCCCChhHhhccccccccc
Confidence 4444444444322 12233344455555555555554432211 134555555555555555556666666666666
Q ss_pred ccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccc------cCcccccccccc
Q 036879 507 LGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSI------GDLKNMQHLSLA 580 (1029)
Q Consensus 507 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~------~~l~~L~~L~L~ 580 (1029)
+++|.++++.+..+.++++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+......| ..+.+|+.|+|+
T Consensus 202 ~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~ 280 (305)
T d1xkua_ 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF 280 (305)
T ss_dssp CCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECC
T ss_pred cccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECC
Confidence 6666666666666666666666666666666 345566666666666666666664333332 345667777777
Q ss_pred ccccc--ccCCccccCCCCC
Q 036879 581 DNKFQ--GSIPDSLGGLTSL 598 (1029)
Q Consensus 581 ~N~l~--~~~~~~~~~l~~L 598 (1029)
+|+++ ...|.+|.-+...
T Consensus 281 ~N~~~~~~~~~~~f~~~~~~ 300 (305)
T d1xkua_ 281 SNPVQYWEIQPSTFRCVYVR 300 (305)
T ss_dssp SSSSCGGGSCGGGGTTCCCG
T ss_pred CCcCccCcCCHhHhcccccC
Confidence 77765 2344555444333
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=2.9e-24 Score=234.63 Aligned_cols=282 Identities=23% Similarity=0.302 Sum_probs=212.5
Q ss_pred CCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCCCCCCCccccc
Q 036879 292 SLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLGFCHPYDELGF 371 (1029)
Q Consensus 292 ~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~ 371 (1029)
.++.+|-+++.++ .+|..++ +++++|+|++|+|+...+.+|.++++|++|++++|.+...
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i---------------- 70 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI---------------- 70 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCB----------------
T ss_pred cCCEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhcccccccccccccccccc----------------
Confidence 4667777777775 7787764 5688888888888766555666666666666655555543
Q ss_pred ccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCC
Q 036879 372 LTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRL 451 (1029)
Q Consensus 372 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 451 (1029)
.|..|.++.. |++|++++|+++ .+|..+ ...++.|++.+|.+.+..+..+...
T Consensus 71 -----------------------~~~~f~~l~~-L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~ 123 (305)
T d1xkua_ 71 -----------------------SPGAFAPLVK-LERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGL 123 (305)
T ss_dssp -----------------------CTTTTTTCTT-CCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTC
T ss_pred -----------------------chhhhhCCCc-cCEecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhcc
Confidence 3444444443 555555555555 233322 3578899999999997777778888
Q ss_pred CCCCEEEecccccc--CcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEE
Q 036879 452 QKLQGLYLQHNKLQ--GSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNV 529 (1029)
Q Consensus 452 ~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 529 (1029)
..++.++...|... ......|..+++|+.+.+.+|.+... |..+ .++|+.|++++|.+++..+..|.+++.++.|
T Consensus 124 ~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l-~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L 200 (305)
T d1xkua_ 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI-PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKL 200 (305)
T ss_dssp TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC-CSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred ccccccccccccccccCCCccccccccccCccccccCCcccc-Cccc--CCccCEEECCCCcCCCCChhHhhcccccccc
Confidence 99999999998654 34456788999999999999999854 4433 5789999999999999999999999999999
Q ss_pred EccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccc------cCCCCCCEEeC
Q 036879 530 NLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSL------GGLTSLNFLDM 603 (1029)
Q Consensus 530 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~------~~l~~L~~L~L 603 (1029)
++++|.+++..+..+.++++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|+......| ..+.+|+.|+|
T Consensus 201 ~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L 279 (305)
T d1xkua_ 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 279 (305)
T ss_dssp ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEEC
T ss_pred ccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEEC
Confidence 99999999988999999999999999999998 568899999999999999999996544443 34577888888
Q ss_pred cCCccc--CcCchhhhcccccce
Q 036879 604 SSNNLS--GEIPNSLKALSLLKF 624 (1029)
Q Consensus 604 s~N~l~--~~~~~~~~~l~~L~~ 624 (1029)
++|+++ ...|..|..+.....
T Consensus 280 ~~N~~~~~~~~~~~f~~~~~~~~ 302 (305)
T d1xkua_ 280 FSNPVQYWEIQPSTFRCVYVRAA 302 (305)
T ss_dssp CSSSSCGGGSCGGGGTTCCCGGG
T ss_pred CCCcCccCcCCHhHhcccccCcc
Confidence 888765 345555555444333
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1e-24 Score=235.44 Aligned_cols=252 Identities=20% Similarity=0.243 Sum_probs=218.2
Q ss_pred ceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEec-
Q 036879 382 RKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQ- 460 (1029)
Q Consensus 382 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~- 460 (1029)
..++.+++.++ .+|..+. ..+++|+|++|+|+...+.+|.++++|++|++++|+|.+..+..+..+..++.+...
T Consensus 14 ~~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~ 89 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccc
Confidence 34677777777 5666554 347899999999997777889999999999999999998888888889999998765
Q ss_pred cccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcC
Q 036879 461 HNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTL 540 (1029)
Q Consensus 461 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 540 (1029)
.|.++...+..|.++++|++|++++|.+....+..+...++|+.+++++|+|+++.+..|..+++|+.|++++|++++..
T Consensus 90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~ 169 (284)
T d1ozna_ 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (284)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence 66788888899999999999999999998888889999999999999999999988899999999999999999999888
Q ss_pred CccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhccc
Q 036879 541 PVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALS 620 (1029)
Q Consensus 541 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 620 (1029)
+..|.++++|+.+++++|++++..|..|..+++|++|++++|++++..+..|..+++|++|+|++|++...-+ ..+-..
T Consensus 170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~ 248 (284)
T d1ozna_ 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWA 248 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHH
T ss_pred hhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHH
Confidence 8999999999999999999998889999999999999999999998888899999999999999999986543 222233
Q ss_pred ccceeeccCCCCcCCCCC
Q 036879 621 LLKFLNLSFNGLQGQVPH 638 (1029)
Q Consensus 621 ~L~~L~l~~N~l~~~~~~ 638 (1029)
.++.+....+.+.|..|.
T Consensus 249 ~l~~~~~~~~~~~C~~p~ 266 (284)
T d1ozna_ 249 WLQKFRGSSSEVPCSLPQ 266 (284)
T ss_dssp HHHHCCSEECCCBEEESG
T ss_pred HHHhCcCCCCceEeCCch
Confidence 466677777888876554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.9e-23 Score=221.41 Aligned_cols=203 Identities=24% Similarity=0.256 Sum_probs=147.8
Q ss_pred CCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccce
Q 036879 425 GNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRT 504 (1029)
Q Consensus 425 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 504 (1029)
.+...+.+++.+++.|+ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|+|+.. + .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccc
Confidence 45567778899999998 5676554 4789999999999877777888888888888888888743 2 3567778888
Q ss_pred eeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccc
Q 036879 505 LSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKF 584 (1029)
Q Consensus 505 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 584 (1029)
|+|++|+++. .+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|
T Consensus 82 L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred cccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 8888888774 455677777777777777777766666677777777777777777766666666777777777777777
Q ss_pred cccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcC
Q 036879 585 QGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 585 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 634 (1029)
++..+..|..+++|++|||++|+|+ .+|..+..+++|+.|+|++|+|.|
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 7666666777777777777777777 556555566666666666555543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3.1e-23 Score=221.13 Aligned_cols=198 Identities=24% Similarity=0.279 Sum_probs=151.0
Q ss_pred hcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCC
Q 036879 406 MDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDG 485 (1029)
Q Consensus 406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 485 (1029)
+.+++.++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+... .+..+++|+.|++++
T Consensus 12 ~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~Ls~ 86 (266)
T d1p9ag_ 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLDLSH 86 (266)
T ss_dssp CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEECCS
T ss_pred CeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccccccccc
Confidence 344677777887 4565553 46788888888888666677888888888888888886443 346678888888888
Q ss_pred CcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCC
Q 036879 486 NELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIP 565 (1029)
Q Consensus 486 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 565 (1029)
|++.. .+..+..+++|++|++++|++.++.+..+..+.+++.|++++|.++...+..+..+++|+.|++++|++++..+
T Consensus 87 N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~ 165 (266)
T d1p9ag_ 87 NQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA 165 (266)
T ss_dssp SCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCT
T ss_pred ccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCc
Confidence 88773 46677788888888888888887777777888888888888888887777777778888888888888887777
Q ss_pred ccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccC
Q 036879 566 SSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSG 610 (1029)
Q Consensus 566 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 610 (1029)
..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus 166 ~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 166 GLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 77788888888888888887 677777778888888888887763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=6e-22 Score=199.48 Aligned_cols=160 Identities=18% Similarity=0.171 Sum_probs=118.7
Q ss_pred CCCceeccCcceEEEEEEecCCcEEEEEEeecccc------------------hhhHHHHHHHHHHhcCCCCceEEEEEE
Q 036879 741 SENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELE------------------GTLRSFDAECEILGSIRHRNLVKIIST 802 (1029)
Q Consensus 741 ~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 802 (1029)
.+.++||+|+||+||+|+..+|+.||||+++.... .......+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999988999999998753210 012345678899999999999998866
Q ss_pred EecCCeEEEEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCEEECCCCcEEEEcc
Q 036879 803 CSSDHFKALVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYDHPTPIIHCDLNPSNILLNESMVACLSDF 882 (1029)
Q Consensus 803 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~givH~Dlk~~Nill~~~~~~kl~Df 882 (1029)
.. .++||||+++..+.+ ++......++.|++++++||| +.||+||||||+||+++++ .++++||
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence 42 269999998765533 333456678999999999999 7789999999999999965 5899999
Q ss_pred CCceecCCCCCceeccccCCccccCc------c---CCCCCCcchhHHHHHH
Q 036879 883 GISKLLGDETSMTQTQTLATIGYMAP------E---WKLSRKGDVYSYGIIL 925 (1029)
Q Consensus 883 g~a~~~~~~~~~~~~~~~gt~~y~aP------E---~~~~~~~DvwSlGvil 925 (1029)
|.|......... .|... | ..++.++|+||+.--+
T Consensus 147 G~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999865432211 11111 1 1257789999976444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=2.1e-19 Score=199.87 Aligned_cols=198 Identities=27% Similarity=0.288 Sum_probs=91.8
Q ss_pred CCeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEecc
Q 036879 74 LSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLS 153 (1029)
Q Consensus 74 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 153 (1029)
+++|||++|+++ .+|+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++.- .+.|++|+++
T Consensus 40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~--~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT--ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS--SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc--ccccc---hhhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 344444444444 33421 234444444444444 23332 223444444444444 22210 1235555555
Q ss_pred CCcCcccCCccccCCCcCcccccCCCcCcccCCCCCCCCCcccccccccccchhccccccccCCCCcccccccccceEEc
Q 036879 154 FNQLQGHVPSSILNIPSLLAIDLSNNQFSGPMPSIYNTSPLQNIDMQYNSLAELHLAYNQLSGQIPSTLFECKQLKILSL 233 (1029)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~l~~l~l~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 233 (1029)
+|+++ .+|. ++++++|+.|++++|.++..+.... .+..+.+..+... .+..+..++.++.|++
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~-------------~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l 169 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLPP-------------SLEFIAAGNNQLE--ELPELQNLPFLTAIYA 169 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCCT-------------TCCEEECCSSCCS--SCCCCTTCTTCCEEEC
T ss_pred ccccc-cccc-hhhhccceeeccccccccccccccc-------------cccchhhcccccc--ccccccccccceeccc
Confidence 55554 3442 3455555555555555543332211 1122222222222 2344566777777888
Q ss_pred ccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhh
Q 036879 234 SVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGH 313 (1029)
Q Consensus 234 s~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~ 313 (1029)
++|.+.. ++.... ..+.+..+++.++ .++ .+..++.|+.+++++|... .+|..
T Consensus 170 ~~n~~~~-~~~~~~--------------------~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~~--- 222 (353)
T d1jl5a_ 170 DNNSLKK-LPDLPL--------------------SLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDL--- 222 (353)
T ss_dssp CSSCCSS-CCCCCT--------------------TCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCCSC---
T ss_pred ccccccc-cccccc--------------------ccccccccccccc-ccc-ccccccccccccccccccc-ccccc---
Confidence 8777652 222111 1224445555444 222 3456777777777777664 44432
Q ss_pred cccccceEeecCcccC
Q 036879 314 SLPNLQQLILGGNRLT 329 (1029)
Q Consensus 314 ~l~~L~~L~L~~N~l~ 329 (1029)
..++..+.+.+|++.
T Consensus 223 -~~~l~~~~~~~~~~~ 237 (353)
T d1jl5a_ 223 -PPSLEALNVRDNYLT 237 (353)
T ss_dssp -CTTCCEEECCSSCCS
T ss_pred -ccccccccccccccc
Confidence 345666666666655
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.81 E-value=1e-18 Score=194.14 Aligned_cols=200 Identities=25% Similarity=0.295 Sum_probs=103.4
Q ss_pred cccchhccccccccCCCCcccccccccceEEcccccccCCCCccccccccccceeecccccccccCcccEEEccCCcccC
Q 036879 202 NSLAELHLAYNQLSGQIPSTLFECKQLKILSLSVNNFIGSIPREIGNITMLKGLYLVYTNLTGEIQGLQVLALSSNRLTG 281 (1029)
Q Consensus 202 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~l~~L~~L~Ls~N~l~~ 281 (1029)
+++++|+|++|.++ .+|+. .++|++|+|++|+|+ .+|+.++ +|+ .|++++|+++.
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~---~L~-----------------~L~l~~n~l~~ 92 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQ---SLK-----------------SLLVDNNNLKA 92 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCCT---TCC-----------------EEECCSSCCSC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccchh---hhh-----------------hhhhhhcccch
Confidence 35666777777776 35543 456777888888777 5565433 333 44555555542
Q ss_pred CCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCccccCCCCCCCC
Q 036879 282 VIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYNLFSGFIPNSLG 361 (1029)
Q Consensus 282 ~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~ 361 (1029)
++.. .+.|++|++++|.+. .+|.. . .+++|++|++++|.+... +.. ...+..+.+..+.....
T Consensus 93 -l~~l---p~~L~~L~L~~n~l~-~lp~~-~-~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~~~------ 155 (353)
T d1jl5a_ 93 -LSDL---PPLLEYLGVSNNQLE-KLPEL-Q-NSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEEL------ 155 (353)
T ss_dssp -CCSC---CTTCCEEECCSSCCS-SCCCC-T-TCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSSC------
T ss_pred -hhhh---ccccccccccccccc-cccch-h-hhccceeecccccccccc-ccc---cccccchhhcccccccc------
Confidence 2211 124666666666654 45532 2 356666666666665532 222 22333444443333211
Q ss_pred CCCCCcccccccccccccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCcccc
Q 036879 362 FCHPYDELGFLTSLTNCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELT 441 (1029)
Q Consensus 362 ~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 441 (1029)
..+..++.++.+++++|.+.. .+.... ..+.+...++.+. .++ .+..++.|+.+++++|...
T Consensus 156 -----------~~l~~l~~l~~L~l~~n~~~~-~~~~~~----~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~ 217 (353)
T d1jl5a_ 156 -----------PELQNLPFLTAIYADNNSLKK-LPDLPL----SLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK 217 (353)
T ss_dssp -----------CCCTTCTTCCEEECCSSCCSS-CCCCCT----TCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS
T ss_pred -----------ccccccccceecccccccccc-cccccc----ccccccccccccc-ccc-ccccccccccccccccccc
Confidence 112345667777777776652 222111 1234444444444 222 3456677777777777665
Q ss_pred ccccccccCCCCCCEEEecccccc
Q 036879 442 GSIPKAIGRLQKLQGLYLQHNKLQ 465 (1029)
Q Consensus 442 ~~~~~~~~~l~~L~~L~L~~N~l~ 465 (1029)
. .+. ...++..+.+.+|.+.
T Consensus 218 ~-~~~---~~~~l~~~~~~~~~~~ 237 (353)
T d1jl5a_ 218 T-LPD---LPPSLEALNVRDNYLT 237 (353)
T ss_dssp S-CCS---CCTTCCEEECCSSCCS
T ss_pred c-ccc---cccccccccccccccc
Confidence 2 332 2345666666666664
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.2e-18 Score=182.52 Aligned_cols=200 Identities=15% Similarity=0.122 Sum_probs=131.5
Q ss_pred cCcEEEecCccccccccccccCCCCCCEEEeccccccCc-ccccccCCCCCcEEecC-CCcccCccccccccccccceee
Q 036879 429 NLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGS-ITTDLCGLRSLSEFYSD-GNELNGSLPQCLDSLISLRTLS 506 (1029)
Q Consensus 429 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~-~N~l~~~~~~~~~~l~~L~~L~ 506 (1029)
++++|+|++|+|+...+..|.++++|++|++++|.+... .+..|.++++++++.+. .|++....+..|.++++|++|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 455666666666544444555666666666666655432 33455566666666543 3455556667777777777777
Q ss_pred ccCccccCCCCC-CccCCCCCcEEEccCCcccCcCCccccccc-cccEEEccCCcCCCCCCccccCcccc-ccccccccc
Q 036879 507 LGFNRLTSVIPS-SLWSLRDILNVNLSSNSLNGTLPVEIGNLK-VVTKIDLSRNDLSGEIPSSIGDLKNM-QHLSLADNK 583 (1029)
Q Consensus 507 Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~L~~N~ 583 (1029)
+++|+++...+. .+..+..+..+..+++.+....+..|.+++ .++.|++++|+++...+..|. ..++ +.+++++|+
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~ 188 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNN 188 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTT
T ss_pred cchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccccccccc-chhhhccccccccc
Confidence 777777654332 234456666666777777766666666654 678888888888854444444 4444 444678888
Q ss_pred ccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccC
Q 036879 584 FQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSF 629 (1029)
Q Consensus 584 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 629 (1029)
|+...+..|.++++|++|+|++|+|+...+..|.++++|+.+++.+
T Consensus 189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 8855556688889999999999999866667788888888877754
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=2.1e-18 Score=178.61 Aligned_cols=203 Identities=24% Similarity=0.353 Sum_probs=139.9
Q ss_pred eeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcc
Q 036879 409 LYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNEL 488 (1029)
Q Consensus 409 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 488 (1029)
++++.+.+++.. .+..+.+|++|++.+|.|+. ++ .+..+++|++|++++|++++..+ +..+++|+.+.+++|.+
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence 444455554332 33455666666777666663 32 36666677777777776654432 66666677777776666
Q ss_pred cCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccc
Q 036879 489 NGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSI 568 (1029)
Q Consensus 489 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 568 (1029)
+.. ..+.++++|+.++++++...+. ..+...+.+..+.++++.+... ..+..+++|+.|++++|.+++. ..+
T Consensus 98 ~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l 169 (227)
T d1h6ua2 98 KNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPL 169 (227)
T ss_dssp SCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGG
T ss_pred ccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhh
Confidence 532 2466778888888888777643 3356677788888888887643 3467778888888888888643 337
Q ss_pred cCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccC
Q 036879 569 GDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSF 629 (1029)
Q Consensus 569 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 629 (1029)
+++++|+.|+|++|++++ ++ .+.++++|++|+|++|++++..| +.++++|+.|++++
T Consensus 170 ~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp TTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred cccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence 788888888888888885 33 37888889999999998885443 77888888888864
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.8e-18 Score=177.71 Aligned_cols=209 Identities=21% Similarity=0.354 Sum_probs=155.9
Q ss_pred ccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEE
Q 036879 378 CKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGL 457 (1029)
Q Consensus 378 l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 457 (1029)
+.++..++++.+++++.. .+..+.+ |+.|++.+|+|+.. +.+..+++|++|++++|+|++..| +..+++|+++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~-L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l 90 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDG-ITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHT-CCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCC-cCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccc
Confidence 334455566666666433 2334444 77778888877743 347788888888888888875433 7788888888
Q ss_pred EeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCccc
Q 036879 458 YLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLN 537 (1029)
Q Consensus 458 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 537 (1029)
++++|.++.. ..+.++++|+.+.++++...+. ..+...+.++.+.++++.+... ..+..+++|+.|++++|.++
T Consensus 91 ~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~ 164 (227)
T d1h6ua2 91 ELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS 164 (227)
T ss_dssp ECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCC
T ss_pred cccccccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccc
Confidence 8888887643 3577788888888888877643 3466778888899988888754 34778888999999999887
Q ss_pred CcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcC
Q 036879 538 GTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSS 605 (1029)
Q Consensus 538 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 605 (1029)
+. ..++++++|+.|+|++|++++. + .+.++++|++|+|++|+|++..| +.++++|++|++++
T Consensus 165 ~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 165 DL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp CC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred cc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence 43 3478899999999999999853 3 37889999999999999985433 88899999999874
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=4.1e-18 Score=171.17 Aligned_cols=175 Identities=18% Similarity=0.246 Sum_probs=124.4
Q ss_pred EecCCCcccCccccccccccccceeeccCccccC-CCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCc
Q 036879 481 FYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTS-VIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRND 559 (1029)
Q Consensus 481 L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 559 (1029)
++.++++++ .+|..+. +++++|+|++|+|++ +.+..|.++++|+.|+|++|.+++..+..|..+++|++|+|++|+
T Consensus 13 v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 344444444 3333332 467777777777765 445667778888888888888887777788888888888888888
Q ss_pred CCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCC
Q 036879 560 LSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHG 639 (1029)
Q Consensus 560 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 639 (1029)
|+...|..|.++++|+.|+|++|+|++..+.+|..+++|++|+|++|.+....+ ...-...++.+.+..|.+++..|.
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~- 167 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPS- 167 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSST-
T ss_pred ccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCCh-
Confidence 887777788888888888888888887777888888888888888888874432 222233466677788888876664
Q ss_pred CCCCccCcccccCCCCCCCCCC
Q 036879 640 GPFTNLSSQSFVGNKGLCGAPE 661 (1029)
Q Consensus 640 ~~~~~l~~~~~~~n~~~c~~~~ 661 (1029)
.+..+.-.++..|...|.++.
T Consensus 168 -~l~~~~l~~L~~n~l~C~~~~ 188 (192)
T d1w8aa_ 168 -KVRDVQIKDLPHSEFKCSSEN 188 (192)
T ss_dssp -TTTTSBGGGSCTTTCCCCCC-
T ss_pred -hhcCCEeeecCHhhCcCCCCC
Confidence 355566666777877787764
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=3.8e-18 Score=178.69 Aligned_cols=220 Identities=12% Similarity=0.097 Sum_probs=170.0
Q ss_pred cceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccc-cccccCCCCCCEEEe
Q 036879 381 LRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSI-PKAIGRLQKLQGLYL 459 (1029)
Q Consensus 381 L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L 459 (1029)
.+.++.+++.++ .+|..+. ..+++|++++|+|+...+.+|.++++|++|+|++|.+...+ +.+|..+++++++.+
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CCEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence 367888888877 5665554 23788999999998666678899999999999999887543 557888999999987
Q ss_pred cc-ccccCcccccccCCCCCcEEecCCCcccCcccc-ccccccccceeeccCccccCCCCCCccCCC-CCcEEEccCCcc
Q 036879 460 QH-NKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQ-CLDSLISLRTLSLGFNRLTSVIPSSLWSLR-DILNVNLSSNSL 536 (1029)
Q Consensus 460 ~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l 536 (1029)
.. |.+....+..|.++++|+.+++.+|++....+. .+..+..+..+..+++.+..+.+..|.+++ .++.|++++|++
T Consensus 86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l 165 (242)
T d1xwdc1 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 165 (242)
T ss_dssp ECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred cccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccc
Confidence 64 678878888899999999999999988754332 345667777778888888888888888765 788899999999
Q ss_pred cCcCCcccccccccc-EEEccCCcCCCCCCccccCcccccccccccccccccCCccccCCCCCCEEeCcC
Q 036879 537 NGTLPVEIGNLKVVT-KIDLSRNDLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSS 605 (1029)
Q Consensus 537 ~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 605 (1029)
+...+..+. ..+++ .+++++|+++...+..|.++++|+.|+|++|+|+...+..|.++++|+.|++.+
T Consensus 166 ~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 166 QEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred ccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 865555444 44544 446788889865566789999999999999999965566777777777766643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=6.3e-21 Score=220.47 Aligned_cols=64 Identities=25% Similarity=0.285 Sum_probs=32.5
Q ss_pred CcCcCcEEEecCccccc-----cccccccCCCCCCEEEeccccccCccc----ccccCCCCCcEEecCCCccc
Q 036879 426 NLNNLTTLHLETNELTG-----SIPKAIGRLQKLQGLYLQHNKLQGSIT----TDLCGLRSLSEFYSDGNELN 489 (1029)
Q Consensus 426 ~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~l~~N~l~ 489 (1029)
..+.++.+++++|++.. ..+..+.....++.+++++|.+..... ..+...+.++.+++++|.++
T Consensus 224 ~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~ 296 (460)
T d1z7xw1 224 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 296 (460)
T ss_dssp HCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred ccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 44566666666666532 112233345566666666666543322 12233455555555555554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=4e-18 Score=171.29 Aligned_cols=128 Identities=23% Similarity=0.359 Sum_probs=71.1
Q ss_pred cEEEecCccccccccccccCCCCCCEEEeccccccC-cccccccCCCCCcEEecCCCcccCccccccccccccceeeccC
Q 036879 431 TTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQG-SITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGF 509 (1029)
Q Consensus 431 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 509 (1029)
++++.++++++ .+|..+. +++++|+|++|+|++ .....|.++++|+.|++++|.+....+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 34555555555 3444332 355666666666643 2334444455555555555555555555555556666666666
Q ss_pred ccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCC
Q 036879 510 NRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLS 561 (1029)
Q Consensus 510 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 561 (1029)
|+|+++.+.+|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 6666555555666666666666666666555555555666666666666554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=4.2e-20 Score=213.42 Aligned_cols=206 Identities=22% Similarity=0.133 Sum_probs=140.6
Q ss_pred cCcEEEecCcccccc----ccccccCCCCCCEEEeccccccCc-----ccccccCCCCCcEEecCCCcccCcc----ccc
Q 036879 429 NLTTLHLETNELTGS----IPKAIGRLQKLQGLYLQHNKLQGS-----ITTDLCGLRSLSEFYSDGNELNGSL----PQC 495 (1029)
Q Consensus 429 ~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~~----~~~ 495 (1029)
....+++..+.+... ....+...+.++.+++++|++... ....+.....++.+++++|.+.... ...
T Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~ 278 (460)
T d1z7xw1 199 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 278 (460)
T ss_dssp CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred cccccccccccccchhhhcccccccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccc
Confidence 456777777776532 123355678899999999986432 2334455678999999999886432 334
Q ss_pred cccccccceeeccCccccCCCCCC-----ccCCCCCcEEEccCCcccCcCCccc----cccccccEEEccCCcCCCCC--
Q 036879 496 LDSLISLRTLSLGFNRLTSVIPSS-----LWSLRDILNVNLSSNSLNGTLPVEI----GNLKVVTKIDLSRNDLSGEI-- 564 (1029)
Q Consensus 496 ~~~l~~L~~L~Ls~N~l~~~~~~~-----~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~-- 564 (1029)
+...+.++.+++++|.++...... ......|+.+++++|.++......+ ...++|++|+|++|++++..
T Consensus 279 l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~ 358 (460)
T d1z7xw1 279 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 358 (460)
T ss_dssp HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred ccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccc
Confidence 567788999999999986432221 1234578999999998875433333 44568999999999987432
Q ss_pred --Ccccc-Cccccccccccccccccc----CCccccCCCCCCEEeCcCCcccCcCchhhh-----cccccceeeccCCCC
Q 036879 565 --PSSIG-DLKNMQHLSLADNKFQGS----IPDSLGGLTSLNFLDMSSNNLSGEIPNSLK-----ALSLLKFLNLSFNGL 632 (1029)
Q Consensus 565 --p~~~~-~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l 632 (1029)
+..+. ..+.|+.|+|++|+|++. ++..+..+++|++|||++|+|+......+. +-..|+.|++++|.+
T Consensus 359 ~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~ 438 (460)
T d1z7xw1 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 438 (460)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCC
T ss_pred hhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCC
Confidence 22332 356799999999998753 344566678899999999998864443332 234688899988887
Q ss_pred cC
Q 036879 633 QG 634 (1029)
Q Consensus 633 ~~ 634 (1029)
..
T Consensus 439 ~~ 440 (460)
T d1z7xw1 439 SE 440 (460)
T ss_dssp CH
T ss_pred CH
Confidence 64
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=1.2e-17 Score=168.91 Aligned_cols=178 Identities=26% Similarity=0.405 Sum_probs=102.3
Q ss_pred ceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCc
Q 036879 408 VLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNE 487 (1029)
Q Consensus 408 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 487 (1029)
.+.++.+.+++.++ ...+.++++|++++|.|+. ++ .+..+++|++|++++|++++..+
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~------------------ 79 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP------------------ 79 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG------------------
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc------------------
Confidence 34566666665433 2356677777777777763 32 35666777777777777654322
Q ss_pred ccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCcc
Q 036879 488 LNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSS 567 (1029)
Q Consensus 488 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 567 (1029)
++++++|++|++++|.+..+. .+.+++.|+.|++++|.+... ..+..+++|+.|++++|++.. + ..
T Consensus 80 --------l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~ 145 (199)
T d2omxa2 80 --------LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SA 145 (199)
T ss_dssp --------GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GG
T ss_pred --------ccCCccccccccccccccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-cc
Confidence 444455555555555544322 245555555555555555432 235556666666666666652 2 24
Q ss_pred ccCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhccccccee
Q 036879 568 IGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFL 625 (1029)
Q Consensus 568 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 625 (1029)
+..+++|+.|++++|++++.. .+.++++|++|++++|++++ ++ .+.++++|+.|
T Consensus 146 l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 146 LSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp GTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 566666666666666666432 36666777777777777764 22 35666666654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=3.4e-17 Score=166.88 Aligned_cols=180 Identities=24% Similarity=0.374 Sum_probs=87.9
Q ss_pred eeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcc
Q 036879 409 LYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNEL 488 (1029)
Q Consensus 409 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 488 (1029)
..++.+.+++.++. ..+.+|++|++++|.++.. + .+..+++|++|+|++|+|++.. .+..+++|+.|++++|++
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 34445555443332 2355667777777776632 2 2566667777777777665432 133344444444444444
Q ss_pred cCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccc
Q 036879 489 NGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSI 568 (1029)
Q Consensus 489 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 568 (1029)
+++ + .+..+++|+.|++++|.+.. ...+..++.++.+++++|.+++ +..+
T Consensus 103 ------------------------~~l-~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~ 152 (210)
T d1h6ta2 103 ------------------------KDL-S-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVL 152 (210)
T ss_dssp ------------------------CCG-G-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGG
T ss_pred ------------------------ccc-c-cccccccccccccccccccc--cccccccccccccccccccccc--cccc
Confidence 321 1 23344444444444444431 1234444455555555555542 2234
Q ss_pred cCcccccccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeecc
Q 036879 569 GDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLS 628 (1029)
Q Consensus 569 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 628 (1029)
..+++|+.+++++|++++. + .+.++++|++|+|++|+|+. +| .+.++++|+.|+|+
T Consensus 153 ~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 153 SRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp GGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred ccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 4455555555555555532 2 24555555555555555552 22 35555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=2.4e-17 Score=166.54 Aligned_cols=170 Identities=25% Similarity=0.387 Sum_probs=105.7
Q ss_pred cccccceeeccCCcCCCCCCccccCchhhhcceeccccccccccccccCCcCcCcEEEecCccccccccccccCCCCCCE
Q 036879 377 NCKDLRKLILSENPLSGVLPISIGNLSNAMDVLYLSACNIKGSIPSEIGNLNNLTTLHLETNELTGSIPKAIGRLQKLQG 456 (1029)
Q Consensus 377 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 456 (1029)
++++...+.++.+.+++.++. ..+.. +++|++++|+|+.. +.+..+++|++|+|++|+|++..| +.++++|++
T Consensus 16 ~l~~~i~~~l~~~~~~~~~~~--~~l~~-l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~ 88 (199)
T d2omxa2 16 ALAEKMKTVLGKTNVTDTVSQ--TDLDQ-VTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 88 (199)
T ss_dssp HHHHHHHHHTTCSSTTSEECH--HHHTT-CCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred HHHHHHHHHhCCCCCCCccCH--HHhcC-CCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccc
Confidence 445556678888888765432 23444 88999999999853 358889999999999999996443 899999999
Q ss_pred EEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcc
Q 036879 457 LYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSL 536 (1029)
Q Consensus 457 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 536 (1029)
|++++|.+.... .+.++++|+.|++++|.+... ..+..+++|+.|++++|++..+ ..+..+++|+.|++++|++
T Consensus 89 L~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l 162 (199)
T d2omxa2 89 ILMNNNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQV 162 (199)
T ss_dssp EECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCC
T ss_pred cccccccccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccc
Confidence 999999986432 355666666666666555432 2244455555555555555422 1244444444444444444
Q ss_pred cCcCCccccccccccEEEccCCcCC
Q 036879 537 NGTLPVEIGNLKVVTKIDLSRNDLS 561 (1029)
Q Consensus 537 ~~~~p~~~~~l~~L~~L~Ls~N~l~ 561 (1029)
++.. .++++++|++|++++|+++
T Consensus 163 ~~l~--~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 163 TDLK--PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp CCCG--GGTTCTTCCEEECCSSCCC
T ss_pred cCCc--cccCCCCCCEEECCCCCCC
Confidence 4211 2334444444444444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=3.9e-17 Score=166.39 Aligned_cols=145 Identities=26% Similarity=0.356 Sum_probs=121.1
Q ss_pred cccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccc
Q 036879 496 LDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQ 575 (1029)
Q Consensus 496 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 575 (1029)
+..+++|++|+|++|+|+++. .+..+++|+.|++++|+|++ +| .+..+++|+.|++++|.+.. + ..+..+++|+
T Consensus 64 l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~ 137 (210)
T d1h6ta2 64 IQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLE 137 (210)
T ss_dssp GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCC
T ss_pred HhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccccccccccc-c-cccccccccc
Confidence 677889999999999998754 36789999999999999995 44 58899999999999999873 3 4688899999
Q ss_pred ccccccccccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCCCCCCCCCccCccccc
Q 036879 576 HLSLADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQVPHGGPFTNLSSQSFV 651 (1029)
Q Consensus 576 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~~~ 651 (1029)
.+++++|.+++ +..+..+++|+++++++|++++.. .+.++++|+.|+|++|+++. +|....+++++.+.++
T Consensus 138 ~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 138 SLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELF 208 (210)
T ss_dssp EEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEE
T ss_pred ccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEcc
Confidence 99999999984 345778999999999999999643 38899999999999999985 4555556677666654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=9.8e-15 Score=141.03 Aligned_cols=129 Identities=16% Similarity=0.176 Sum_probs=90.6
Q ss_pred cccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCccccc
Q 036879 496 LDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQ 575 (1029)
Q Consensus 496 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 575 (1029)
|.+..+|++|+|++|+|+.+ +..+..+++|+.|+|++|+|+.. ..+..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 44566677777777777754 55566677777777777777743 3467777888888888888755555566778888
Q ss_pred ccccccccccccCC-ccccCCCCCCEEeCcCCcccCcC---chhhhcccccceeec
Q 036879 576 HLSLADNKFQGSIP-DSLGGLTSLNFLDMSSNNLSGEI---PNSLKALSLLKFLNL 627 (1029)
Q Consensus 576 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~l 627 (1029)
.|++++|+|+.... ..+..+++|++|++++|+++... +..+..+|+|++||-
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 88888888874321 45777888888888888887433 135677888888763
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=4.3e-15 Score=158.64 Aligned_cols=208 Identities=20% Similarity=0.219 Sum_probs=140.7
Q ss_pred CcCcCcEEEecCcccccc-ccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCC-cccCcc-cccccccccc
Q 036879 426 NLNNLTTLHLETNELTGS-IPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGN-ELNGSL-PQCLDSLISL 502 (1029)
Q Consensus 426 ~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~-~~~~~~l~~L 502 (1029)
...+|++|||+++.++.. ++..+..+++|++|+|++|.+.......+..+++|+.|+++++ .++... ...+.++++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 445788888888877643 3455677888888888888877666777777788888888874 454322 2334567888
Q ss_pred ceeeccCc-cccCC-CCCCccC-CCCCcEEEccCC--cccCc-CCccccccccccEEEccCC-cCCCCCCccccCccccc
Q 036879 503 RTLSLGFN-RLTSV-IPSSLWS-LRDILNVNLSSN--SLNGT-LPVEIGNLKVVTKIDLSRN-DLSGEIPSSIGDLKNMQ 575 (1029)
Q Consensus 503 ~~L~Ls~N-~l~~~-~~~~~~~-l~~L~~L~Ls~N--~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~ 575 (1029)
++|+++++ .+++. ....+.. .++|+.|+++++ .++.. +...+.++++|++|++++| .+++.....+..+++|+
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~ 203 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred cccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCC
Confidence 88888885 44321 1122222 467889998875 34432 2233456889999999986 47767777888889999
Q ss_pred ccccccc-cccccCCccccCCCCCCEEeCcCCcccCcCchhhhcccccceeeccCCCCcCCC
Q 036879 576 HLSLADN-KFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQGQV 636 (1029)
Q Consensus 576 ~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 636 (1029)
+|+|+++ .+++.....++++++|++|+++++--.+.++.....+|+ |.+..++++...
T Consensus 204 ~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~---L~i~~~~ls~~~ 262 (284)
T d2astb2 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIA 262 (284)
T ss_dssp EEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTT---SEESCCCSCCTT
T ss_pred EEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCcc---ccccCccCCCCC
Confidence 9999984 687777777888899999999988222222222334555 445677777543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=4.4e-14 Score=129.50 Aligned_cols=118 Identities=26% Similarity=0.372 Sum_probs=70.5
Q ss_pred ceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccCcccccccccccc
Q 036879 503 RTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGDLKNMQHLSLADN 582 (1029)
Q Consensus 503 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 582 (1029)
|+|+|++|+|+.+ + .+..+++|++|++++|+|+ .+|..++.+++|+.|++++|+|++ +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 4566666666633 2 3566666666666666666 345556666667777777776663 33 3666677777777777
Q ss_pred cccccCC-ccccCCCCCCEEeCcCCcccCcC---chhhhccccccee
Q 036879 583 KFQGSIP-DSLGGLTSLNFLDMSSNNLSGEI---PNSLKALSLLKFL 625 (1029)
Q Consensus 583 ~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L 625 (1029)
+|+.... ..+..+++|++|++++|+++... ......+|+|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 7664321 34666677777777777765322 2233445655554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.49 E-value=6.7e-16 Score=170.52 Aligned_cols=139 Identities=17% Similarity=0.231 Sum_probs=72.1
Q ss_pred ccCCcCcCcEEEecCcccccc----ccccccCCCCCCEEEeccccccCcccccc-------------cCCCCCcEEecCC
Q 036879 423 EIGNLNNLTTLHLETNELTGS----IPKAIGRLQKLQGLYLQHNKLQGSITTDL-------------CGLRSLSEFYSDG 485 (1029)
Q Consensus 423 ~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------~~l~~L~~L~l~~ 485 (1029)
.+...++|++|+|++|.++.. +...+...++|++|++++|.+.......+ ...+.|+.+.+++
T Consensus 88 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~ 167 (344)
T d2ca6a1 88 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 167 (344)
T ss_dssp HHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCS
T ss_pred HHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccc
Confidence 344456677777777776643 23334456677777777776642211111 2334555666665
Q ss_pred CcccCc----cccccccccccceeeccCccccCC-----CCCCccCCCCCcEEEccCCcccCc----CCccccccccccE
Q 036879 486 NELNGS----LPQCLDSLISLRTLSLGFNRLTSV-----IPSSLWSLRDILNVNLSSNSLNGT----LPVEIGNLKVVTK 552 (1029)
Q Consensus 486 N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~ 552 (1029)
|.+... +...+...+.|+.|+|++|+++.. +...+...++|+.|+|++|.++.. +...+..+++|++
T Consensus 168 n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~ 247 (344)
T d2ca6a1 168 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247 (344)
T ss_dssp SCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCE
T ss_pred ccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchh
Confidence 555422 222334455666666666665431 223444555555666665555421 2233444555555
Q ss_pred EEccCCcCC
Q 036879 553 IDLSRNDLS 561 (1029)
Q Consensus 553 L~Ls~N~l~ 561 (1029)
|+|++|.|+
T Consensus 248 L~Ls~n~i~ 256 (344)
T d2ca6a1 248 LGLNDCLLS 256 (344)
T ss_dssp EECTTCCCC
T ss_pred hhhhcCccC
Confidence 555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=7.2e-15 Score=156.87 Aligned_cols=201 Identities=21% Similarity=0.243 Sum_probs=108.5
Q ss_pred EEEccCCcccCCCCCCcccCCCCcEEEccCcccCCCCCchhhhcccccceEeecCcccCCCCCcccccccccceecCCCc
Q 036879 271 VLALSSNRLTGVIPPEIINISSLTVLSLTANNLLGNLPSNIGHSLPNLQQLILGGNRLTGPIPSSISNASMLTLIDMPYN 350 (1029)
Q Consensus 271 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N 350 (1029)
.+.++...+... ........+|++|||+++.+.......++..+++|++|+|++|.+++..+..+..+++|+.|+++++
T Consensus 27 ~lrl~~~~~~~~-~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c 105 (284)
T d2astb2 27 AFRCPRSFMDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105 (284)
T ss_dssp EEECTTCEECSC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred Eeeccccccccc-hhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccc
Confidence 455555554422 2333445678888888887764444555667888888888888888777777888888888888875
Q ss_pred -cccCCCCCCCCCCCCCcccccccccccccccceeeccCCc-CCCC-CCccccCchhhhcceecccc--ccccc-ccccc
Q 036879 351 -LFSGFIPNSLGFCHPYDELGFLTSLTNCKDLRKLILSENP-LSGV-LPISIGNLSNAMDVLYLSAC--NIKGS-IPSEI 424 (1029)
Q Consensus 351 -~l~~~~p~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~-l~~~-~p~~~~~l~~~L~~L~L~~n--~l~~~-~p~~~ 424 (1029)
.++.. ++......+++|++|+++++. ++.. +...+......|+.|+++++ .++.. +...+
T Consensus 106 ~~itd~--------------~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~ 171 (284)
T d2astb2 106 SGFSEF--------------ALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLV 171 (284)
T ss_dssp BSCCHH--------------HHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHH
T ss_pred cccccc--------------ccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccc
Confidence 33310 111113457788888888763 3311 11122222223555555543 22211 11122
Q ss_pred CCcCcCcEEEecCc-cccccccccccCCCCCCEEEeccc-cccCcccccccCCCCCcEEecCCC
Q 036879 425 GNLNNLTTLHLETN-ELTGSIPKAIGRLQKLQGLYLQHN-KLQGSITTDLCGLRSLSEFYSDGN 486 (1029)
Q Consensus 425 ~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N 486 (1029)
.++++|++|+|++| .+++.....+.++++|++|+|+++ .++......+..+++|+.|++.++
T Consensus 172 ~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 33455555555553 344444444555555555555553 344333333444444444444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=4e-14 Score=136.63 Aligned_cols=110 Identities=18% Similarity=0.167 Sum_probs=61.2
Q ss_pred cCCcCcCcEEEecCccccccccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccc
Q 036879 424 IGNLNNLTTLHLETNELTGSIPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLR 503 (1029)
Q Consensus 424 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 503 (1029)
|.+..+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+.. ..|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 456667777888888777 3466666777777777777777633 2345555555555555555544444444555555
Q ss_pred eeeccCccccCCCC-CCccCCCCCcEEEccCCcc
Q 036879 504 TLSLGFNRLTSVIP-SSLWSLRDILNVNLSSNSL 536 (1029)
Q Consensus 504 ~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l 536 (1029)
.|++++|+|+.... ..+..+++|+.|++++|.+
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred cceeccccccccccccccccccccchhhcCCCcc
Confidence 55555555543211 2333344444444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=7.7e-14 Score=127.87 Aligned_cols=103 Identities=23% Similarity=0.388 Sum_probs=66.6
Q ss_pred CeEeccCcccccCCccccccccCCceeecccccccCCCCCCcCCCCCccceeccccccccCCCcccccCccccCeEeccC
Q 036879 75 SLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIEIPPWLDSFPKLEHLYLDGNSFIGTIPPSICNISSLLTLDLSF 154 (1029)
Q Consensus 75 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 154 (1029)
++|||++|+++ .+| .++.+++|++|++++|+|+ .+|+.++.+++|++|++++|+|+ .+| .+..+++|++|++++
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~--~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR--ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC--CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC--cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCC
Confidence 35677777776 444 3666777777777777776 34666666777777777777766 344 366777777777777
Q ss_pred CcCcccC-CccccCCCcCcccccCCCcCcc
Q 036879 155 NQLQGHV-PSSILNIPSLLAIDLSNNQFSG 183 (1029)
Q Consensus 155 N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~ 183 (1029)
|+++... ...+..+++|+.|++++|+++.
T Consensus 75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 7776322 2356666777777777776653
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.45 E-value=4.6e-15 Score=163.65 Aligned_cols=213 Identities=18% Similarity=0.204 Sum_probs=154.9
Q ss_pred cccCCcCcCcEEEecCcccccc----------ccccccCCCCCCEEEeccccccCccc----ccccCCCCCcEEecCCCc
Q 036879 422 SEIGNLNNLTTLHLETNELTGS----------IPKAIGRLQKLQGLYLQHNKLQGSIT----TDLCGLRSLSEFYSDGNE 487 (1029)
Q Consensus 422 ~~~~~l~~L~~L~L~~N~l~~~----------~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~l~~N~ 487 (1029)
..+...++|+.|+++++..... +...+...++|++|+|++|.++.... ..+...++|+.|++++|.
T Consensus 53 ~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~ 132 (344)
T d2ca6a1 53 ENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNG 132 (344)
T ss_dssp HTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSC
T ss_pred HHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccc
Confidence 3455677888888887755421 22345678899999999999976533 334567899999999998
Q ss_pred ccCcccccc-------------ccccccceeeccCccccCC----CCCCccCCCCCcEEEccCCcccCc-----CCcccc
Q 036879 488 LNGSLPQCL-------------DSLISLRTLSLGFNRLTSV----IPSSLWSLRDILNVNLSSNSLNGT-----LPVEIG 545 (1029)
Q Consensus 488 l~~~~~~~~-------------~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~ 545 (1029)
+.......+ ...+.|+.+++++|+++.. +...+...+.|+.|+|++|+++.. +...+.
T Consensus 133 l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~ 212 (344)
T d2ca6a1 133 LGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 212 (344)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGG
T ss_pred ccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhc
Confidence 753222211 3457899999999998743 233456678999999999998742 344577
Q ss_pred ccccccEEEccCCcCCCC----CCccccCcccccccccccccccccCCccc----cC--CCCCCEEeCcCCcccCcCc--
Q 036879 546 NLKVVTKIDLSRNDLSGE----IPSSIGDLKNMQHLSLADNKFQGSIPDSL----GG--LTSLNFLDMSSNNLSGEIP-- 613 (1029)
Q Consensus 546 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~--l~~L~~L~Ls~N~l~~~~~-- 613 (1029)
.+++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.....+ .. .+.|++||+++|+|+....
T Consensus 213 ~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~ 292 (344)
T d2ca6a1 213 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 292 (344)
T ss_dssp GCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHH
T ss_pred chhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHH
Confidence 889999999999998643 34556778999999999999986533333 22 3679999999999975332
Q ss_pred --hhhh-cccccceeeccCCCCcC
Q 036879 614 --NSLK-ALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 614 --~~~~-~l~~L~~L~l~~N~l~~ 634 (1029)
..+. +.+.|+.|++++|++..
T Consensus 293 l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 293 LKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHHHccCCCCCEEECCCCcCCC
Confidence 2332 57889999999999864
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=2.9e-14 Score=142.80 Aligned_cols=136 Identities=23% Similarity=0.272 Sum_probs=100.9
Q ss_pred ccccccccccccceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCCccccC
Q 036879 491 SLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIPSSIGD 570 (1029)
Q Consensus 491 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 570 (1029)
..+..+..+++|++|+|++|+|+.+ +.+.++++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++.. ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCCc--ccccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence 3456677888888888888888754 24778888888888888887 4555556667888899998888743 34777
Q ss_pred cccccccccccccccccCC-ccccCCCCCCEEeCcCCcccCcCchh----------hhcccccceeeccCCCCc
Q 036879 571 LKNMQHLSLADNKFQGSIP-DSLGGLTSLNFLDMSSNNLSGEIPNS----------LKALSLLKFLNLSFNGLQ 633 (1029)
Q Consensus 571 l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~----------~~~l~~L~~L~l~~N~l~ 633 (1029)
+++|+.|+|++|+|+.... ..+..+++|++|+|++|+++...+.. +..+|+|+.|| +.+++
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence 8889999999998874322 46788889999999999887544432 56788888876 44443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=1.8e-12 Score=123.94 Aligned_cols=110 Identities=16% Similarity=0.135 Sum_probs=79.7
Q ss_pred CCCCcEEEccCCcccCcCCccccccccccEEEccCC-cCCCCCCccccCcccccccccccccccccCCccccCCCCCCEE
Q 036879 523 LRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRN-DLSGEIPSSIGDLKNMQHLSLADNKFQGSIPDSLGGLTSLNFL 601 (1029)
Q Consensus 523 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 601 (1029)
......++.+++.+. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 344556777777777 45677777788888888655 4776666777888888888888888887667778888888888
Q ss_pred eCcCCcccCcCchhhhcccccceeeccCCCCcC
Q 036879 602 DMSSNNLSGEIPNSLKALSLLKFLNLSFNGLQG 634 (1029)
Q Consensus 602 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 634 (1029)
+|++|+|+...+..|..+ .|+.|+|++|+|.+
T Consensus 86 ~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C 117 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGL-SLQELVLSGNPLHC 117 (156)
T ss_dssp ECCSSCCSCCCSTTTCSC-CCCEEECCSSCCCC
T ss_pred eccCCCCcccChhhhccc-cccccccCCCcccC
Confidence 888888875555555544 57777777777764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.26 E-value=1e-13 Score=138.63 Aligned_cols=135 Identities=21% Similarity=0.258 Sum_probs=72.5
Q ss_pred ccccccCCCCCCEEEeccccccCcccccccCCCCCcEEecCCCcccCccccccccccccceeeccCccccCCCCCCccCC
Q 036879 444 IPKAIGRLQKLQGLYLQHNKLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLGFNRLTSVIPSSLWSL 523 (1029)
Q Consensus 444 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 523 (1029)
++..+..+++|++|+|++|+|+.+ + .+..+++|++|+|++|+|+. +|..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~i-------------------------~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~ 92 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEKI-------------------------S-SLSGMENLRILSLGRNLIKK-IENLDAVA 92 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESCC-------------------------C-CHHHHTTCCEEECCEEEECS-CSSHHHHH
T ss_pred hhhHHhcccccceeECcccCCCCc-------------------------c-cccCCccccChhhccccccc-cccccccc
Confidence 445566666666666666666522 1 23344444444444444442 22223333
Q ss_pred CCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCCC-ccccCcccccccccccccccccCCcc----------c
Q 036879 524 RDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEIP-SSIGDLKNMQHLSLADNKFQGSIPDS----------L 592 (1029)
Q Consensus 524 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~----------~ 592 (1029)
++|+.|++++|+|+.. ..+..+++|+.|++++|+|+.... ..+..+++|+.|+|++|++....+.. +
T Consensus 93 ~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi 170 (198)
T d1m9la_ 93 DTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV 170 (198)
T ss_dssp HHCCEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHH
T ss_pred cccccccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHH
Confidence 4455555555555432 235556666666666666653221 34566677777777777665443322 4
Q ss_pred cCCCCCCEEeCcCCccc
Q 036879 593 GGLTSLNFLDMSSNNLS 609 (1029)
Q Consensus 593 ~~l~~L~~L~Ls~N~l~ 609 (1029)
..+++|+.|| +..++
T Consensus 171 ~~lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 171 KRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHCSSCCEES--SGGGT
T ss_pred HHCCCcCEeC--CccCC
Confidence 5678888877 44554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=8.8e-12 Score=119.05 Aligned_cols=105 Identities=24% Similarity=0.261 Sum_probs=54.3
Q ss_pred CcEEEecCccccccccccccCCCCCCEEEeccc-cccCcccccccCCCCCcEEecCCCcccCccccccccccccceeecc
Q 036879 430 LTTLHLETNELTGSIPKAIGRLQKLQGLYLQHN-KLQGSITTDLCGLRSLSEFYSDGNELNGSLPQCLDSLISLRTLSLG 508 (1029)
Q Consensus 430 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 508 (1029)
.+.++.+++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|++++|+|+.+.+.+|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 344556666555 34555555666666666544 3554444445555555555555555554445555555555555555
Q ss_pred CccccCCCCCCccCCCCCcEEEccCCcc
Q 036879 509 FNRLTSVIPSSLWSLRDILNVNLSSNSL 536 (1029)
Q Consensus 509 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 536 (1029)
+|+|+.+.+..|..+ +|+.|+|++|.+
T Consensus 89 ~N~l~~l~~~~~~~~-~l~~L~L~~Np~ 115 (156)
T d2ifga3 89 FNALESLSWKTVQGL-SLQELVLSGNPL 115 (156)
T ss_dssp SSCCSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred CCCCcccChhhhccc-cccccccCCCcc
Confidence 555554443333332 344444444444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=5.5e-09 Score=99.95 Aligned_cols=106 Identities=24% Similarity=0.232 Sum_probs=66.0
Q ss_pred CCCCcCCCeEeccCcccccCCccccccccCCceeecccccccCCC-CCCcCCCCCccceeccccccccCCCcc-cccCcc
Q 036879 68 LGNLSFLSLLNVTNNSFSGTLPIQLSNLRRLKYLSFRSNNFSSIE-IPPWLDSFPKLEHLYLDGNSFIGTIPP-SICNIS 145 (1029)
Q Consensus 68 ~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~ 145 (1029)
+..+..+..++..++... .++..+..+++|++|+|++|+|+.+. ++..+..+++|+.|+|++|+++. +++ .+....
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~ 115 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGL 115 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhcc
Confidence 444555555555555443 44555567778888888888887543 23445667788888888888773 333 333445
Q ss_pred ccCeEeccCCcCcccCCc-------cccCCCcCcccc
Q 036879 146 SLLTLDLSFNQLQGHVPS-------SILNIPSLLAID 175 (1029)
Q Consensus 146 ~L~~L~Ls~N~l~~~~p~-------~~~~l~~L~~L~ 175 (1029)
.|+.|++++|+++..... .+..+|+|+.||
T Consensus 116 ~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 116 KLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred ccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 677788888877644332 245567777665
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.47 E-value=4.8e-09 Score=100.36 Aligned_cols=120 Identities=21% Similarity=0.119 Sum_probs=71.2
Q ss_pred cceeeccCccccCCCCCCccCCCCCcEEEccCCcccCcCCccccccccccEEEccCCcCCCCC--CccccCccccccccc
Q 036879 502 LRTLSLGFNRLTSVIPSSLWSLRDILNVNLSSNSLNGTLPVEIGNLKVVTKIDLSRNDLSGEI--PSSIGDLKNMQHLSL 579 (1029)
Q Consensus 502 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L 579 (1029)
.+.|++++++.. ..+..+..+..++...|... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 445555554422 12333333333444444333 33444456777888888888887542 344667788888888
Q ss_pred ccccccccCCccccCCCCCCEEeCcCCcccCcCch-------hhhcccccceee
Q 036879 580 ADNKFQGSIPDSLGGLTSLNFLDMSSNNLSGEIPN-------SLKALSLLKFLN 626 (1029)
Q Consensus 580 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-------~~~~l~~L~~L~ 626 (1029)
++|+|+...+-.+....+|+.|++++|+++..... .+..+|+|+.||
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred ccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 88888754333344456788888888888755442 255678888764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.38 E-value=5.4e-07 Score=93.48 Aligned_cols=148 Identities=17% Similarity=0.153 Sum_probs=103.6
Q ss_pred HHHHHhCCCCCCceeccCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEE
Q 036879 732 ELFRATDGFSENNLLGKGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKIISTCSSDHFKA 810 (1029)
Q Consensus 732 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 810 (1029)
++......|+..+..+-++.+.||+... +++.+++|+...........+.+|..+++.+. +--+.+++++...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3445556676655444444568998864 56677889887665555667888999988773 444677888888889999
Q ss_pred EEEeccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------
Q 036879 811 LVLEYMPNGSLENWMYNKNRSFDILQRLNMVIDVASALEYLHYD------------------------------------ 854 (1029)
Q Consensus 811 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~------------------------------------ 854 (1029)
+|||+++|.++.+..... .....++.++++.++.||..
T Consensus 87 lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999998886543211 12233455666666666632
Q ss_pred --------------------CCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 855 --------------------HPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 855 --------------------~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
....++|+|+.|.||++++++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 12237999999999999987777899999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=8.5e-06 Score=83.65 Aligned_cols=131 Identities=17% Similarity=0.139 Sum_probs=87.3
Q ss_pred eeccCcc-eEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCC--CCceEEEEEEEecCCeEEEEEeccCCCCH
Q 036879 745 LLGKGSF-GSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIR--HRNLVKIISTCSSDHFKALVLEYMPNGSL 821 (1029)
Q Consensus 745 ~lg~G~f-g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~E~~~~gsL 821 (1029)
.+..|.. +.||+...+++..+++|..... ....+..|++.++.+. .-.+.+++++..+++..++|||+++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455553 5799998888888999986543 2345778888887773 33467788888888889999999987655
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 036879 822 ENWMYNKNRSFDILQRLNMVIDVASALEYLHY------------------------------------------------ 853 (1029)
Q Consensus 822 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~------------------------------------------------ 853 (1029)
.+. ... ....+.++++.++-||.
T Consensus 94 ~~~------~~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSS------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTS------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred ccc------ccc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 321 011 01112233333333331
Q ss_pred ---c----CCCCcEEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 854 ---D----HPTPIIHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 854 ---~----~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
. ....++|+|+.|.||+++.+..+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 123479999999999999887788999997753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.52 E-value=1.4e-05 Score=75.88 Aligned_cols=60 Identities=13% Similarity=0.053 Sum_probs=28.9
Q ss_pred cccccccccccccccccC----CccccCCCCCCEEeCcCCcccCc-------CchhhhcccccceeeccCC
Q 036879 571 LKNMQHLSLADNKFQGSI----PDSLGGLTSLNFLDMSSNNLSGE-------IPNSLKALSLLKFLNLSFN 630 (1029)
Q Consensus 571 l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~-------~~~~~~~l~~L~~L~l~~N 630 (1029)
.+.|+.|+|++|.|+... -..+...+.|++|+|++|++... +...+..-+.|+.|+++++
T Consensus 71 n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 71 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred cccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 344555555555554321 12344445566666666654422 1223334455666665544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.35 E-value=3.5e-05 Score=73.07 Aligned_cols=39 Identities=8% Similarity=0.202 Sum_probs=22.1
Q ss_pred cCcCcEEEecCc-ccccc----ccccccCCCCCCEEEecccccc
Q 036879 427 LNNLTTLHLETN-ELTGS----IPKAIGRLQKLQGLYLQHNKLQ 465 (1029)
Q Consensus 427 l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 465 (1029)
.++|++|+|+++ .++.. +-..+...++|++|+|++|.+.
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence 456777777653 35421 2233455566666666666664
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.06 E-value=0.00056 Score=74.34 Aligned_cols=76 Identities=13% Similarity=0.093 Sum_probs=49.0
Q ss_pred CceeccCcceEEEEEEec-CCcEEEEEEeeccc-------chhhHHHHHHHHHHhcC-CC--CceEEEEEEEecCCeEEE
Q 036879 743 NNLLGKGSFGSVYKGTLS-DGMQIAVKVFNLEL-------EGTLRSFDAECEILGSI-RH--RNLVKIISTCSSDHFKAL 811 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~-~~~~vAvK~~~~~~-------~~~~~~~~~E~~~l~~l-~h--~niv~l~~~~~~~~~~~l 811 (1029)
.+.||.|....||++... +++.|+||.-.... .........|++.++.+ .+ ..+.+++.+.. +..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEE
Confidence 356899999999999875 46789999754321 11233456788888766 22 34666665543 34568
Q ss_pred EEeccCCCC
Q 036879 812 VLEYMPNGS 820 (1029)
Q Consensus 812 V~E~~~~gs 820 (1029)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.73 E-value=4.6e-05 Score=72.23 Aligned_cols=40 Identities=10% Similarity=0.115 Sum_probs=18.2
Q ss_pred CCCCCcEEEccCCcccCc----CCccccccccccEEEccCCcCC
Q 036879 522 SLRDILNVNLSSNSLNGT----LPVEIGNLKVVTKIDLSRNDLS 561 (1029)
Q Consensus 522 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 561 (1029)
..+.|++|+|++|.++.. +...+...+.++.+++++|.++
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 344455555555544421 1112333445555555555554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.72 E-value=0.00011 Score=69.38 Aligned_cols=112 Identities=21% Similarity=0.192 Sum_probs=77.0
Q ss_pred cCCCCCcEEEccC-CcccC----cCCccccccccccEEEccCCcCCCCCC----ccccCcccccccccccccccccC---
Q 036879 521 WSLRDILNVNLSS-NSLNG----TLPVEIGNLKVVTKIDLSRNDLSGEIP----SSIGDLKNMQHLSLADNKFQGSI--- 588 (1029)
Q Consensus 521 ~~l~~L~~L~Ls~-N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~--- 588 (1029)
.+.++|++|+|++ +.++. .+...+...+.|++|+|++|.++.... ..+...+.++.|++++|.++...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3446667777765 44542 233345678899999999999875433 33455789999999999987542
Q ss_pred -CccccCCCCCCEEeC--cCCcccC----cCchhhhcccccceeeccCCCC
Q 036879 589 -PDSLGGLTSLNFLDM--SSNNLSG----EIPNSLKALSLLKFLNLSFNGL 632 (1029)
Q Consensus 589 -~~~~~~l~~L~~L~L--s~N~l~~----~~~~~~~~l~~L~~L~l~~N~l 632 (1029)
...+...++|+.++| ++|.+.. .+...+...+.|+.|+++.+..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 356677788987555 5677764 2334556788899999887654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.48 E-value=0.0031 Score=66.35 Aligned_cols=133 Identities=13% Similarity=0.147 Sum_probs=78.2
Q ss_pred eEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCc--eEEEE-----EEEecCCeEEEEEeccCCCCH---
Q 036879 752 GSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRN--LVKII-----STCSSDHFKALVLEYMPNGSL--- 821 (1029)
Q Consensus 752 g~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~-----~~~~~~~~~~lV~E~~~~gsL--- 821 (1029)
-.||++..++|+.|++|+.+.. ..+.+++..|.+.+..+.... ++..+ ..+...+..+.|+++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 3899999999999999997643 334577888999888874222 22221 122346677889999875422
Q ss_pred --HHHH---------h----cC----CCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCCc
Q 036879 822 --ENWM---------Y----NK----NRSFDIL-------------------QRLNMVIDVASALEYLHY----DHPTPI 859 (1029)
Q Consensus 822 --~~~l---------~----~~----~~~~~~~-------------------~~~~i~~~i~~~l~~Lh~----~~~~gi 859 (1029)
..+- + .. +...+.. .+..+...+.+.++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1110 0 00 0111111 111122223333333322 224678
Q ss_pred EEcCCCCCCEEECCCCcEEEEccCCcee
Q 036879 860 IHCDLNPSNILLNESMVACLSDFGISKL 887 (1029)
Q Consensus 860 vH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 887 (1029)
||+|+.+.||+++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 45899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.82 E-value=0.01 Score=61.82 Aligned_cols=156 Identities=13% Similarity=0.118 Sum_probs=82.2
Q ss_pred cCHHHHHHHhCCCCCCceec-----cCcceEEEEEEecCCcEEEEEEeecccchhhHHHHHHHHHHhcCCCCc--eEEEE
Q 036879 728 ISYQELFRATDGFSENNLLG-----KGSFGSVYKGTLSDGMQIAVKVFNLELEGTLRSFDAECEILGSIRHRN--LVKII 800 (1029)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~lg-----~G~fg~V~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 800 (1029)
++.+++.....+|.+.+... .|.--+.|+.+.++| .+++|+..... ..+.+..|++++..+...+ +...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 45567777777887754443 455567899887665 48899876432 2345666777777763222 21111
Q ss_pred E------EEecCCeEEEEEeccCCCCHH-----HH---------Hhc--C--C----CCCC------------------H
Q 036879 801 S------TCSSDHFKALVLEYMPNGSLE-----NW---------MYN--K--N----RSFD------------------I 834 (1029)
Q Consensus 801 ~------~~~~~~~~~lV~E~~~~gsL~-----~~---------l~~--~--~----~~~~------------------~ 834 (1029)
. +.........++.++.+.... .. ++. . . .... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 112234455666665543221 10 000 0 0 0000 0
Q ss_pred HHHHHHHHHHHHHHHHHH-hcCCCCcEEcCCCCCCEEECCCCcEEEEccCCce
Q 036879 835 LQRLNMVIDVASALEYLH-YDHPTPIIHCDLNPSNILLNESMVACLSDFGISK 886 (1029)
Q Consensus 835 ~~~~~i~~~i~~~l~~Lh-~~~~~givH~Dlk~~Nill~~~~~~kl~Dfg~a~ 886 (1029)
......+......+.-.+ ..-..|+||+|+.++||+++.+...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011111222222222222 1235789999999999999998888899999775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.42 E-value=0.014 Score=63.07 Aligned_cols=73 Identities=21% Similarity=0.227 Sum_probs=48.2
Q ss_pred CceeccCcceEEEEEEecCC--------cEEEEEEeecccchhhHHHHHHHHHHhcCC-CCceEEEEEEEecCCeEEEEE
Q 036879 743 NNLLGKGSFGSVYKGTLSDG--------MQIAVKVFNLELEGTLRSFDAECEILGSIR-HRNLVKIISTCSSDHFKALVL 813 (1029)
Q Consensus 743 ~~~lg~G~fg~V~~~~~~~~--------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 813 (1029)
.+.|+-|--=.+|++...++ +.|.+++.- ... ......+|.++++.+. +.-..++++++.. .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35688788889999987542 456666654 222 2234567888888884 4334577777753 5899
Q ss_pred eccCCCCH
Q 036879 814 EYMPNGSL 821 (1029)
Q Consensus 814 E~~~~gsL 821 (1029)
||++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|